PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Pickens, LB; Tang, Y				Pickens, Lauren B.; Tang, Yi			Oxytetracycline Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							TETRACYCLINE RESISTANCE DETERMINANTS; R1128 POLYKETIDE SYNTHASE; STREPTOMYCES-RIMOSUS; GENE-CLUSTER; HETEROLOGOUS EXPRESSION; ENGINEERED BIOSYNTHESIS; RIBOSOMAL PROTECTION; NUCLEOTIDE-SEQUENCE; INITIATION MODULE; MOLECULAR-CLONING	Oxytetracycline (OTC) is a broad-spectrum antibiotic that acts by inhibiting protein synthesis in bacteria. It is an important member of the bacterial aromatic polyketide family, which is a structurally diverse class of natural products. OTC is synthesized by a type II polyketide synthase that generates the poly-beta-ketone backbone through successive decarboxylative condensation of malonyl-CoA extender units, followed by modifications by cyclases, oxygenases, transferases, and additional tailoring enzymes. Genetic and biochemical studies have illuminated most of the steps involved in the biosynthesis of OTC, which is detailed here as a representative case study in type II polyketide biosynthesis.	[Pickens, Lauren B.; Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Tang, Y (corresponding author), Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA.	yitang@ucla.edu			National Science Foundation [CBET 0545860]; National Institutes of Health [1T32GM067555]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067555] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Science Foundation Grant CBET 0545860.; Supported by National Institutes of Health Training Grant 1T32GM067555.	Abdelfattah MS, 2006, ANGEW CHEM INT EDIT, V45, P5685, DOI 10.1002/anie.200600511; Agwuh KN, 2006, J ANTIMICROB CHEMOTH, V58, P256, DOI 10.1093/jac/dkl224; Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; Bao WL, 1999, BIOCHEMISTRY-US, V38, P9752, DOI 10.1021/bi990751h; BEHAL V, 1979, BIOTECHNOL LETT, V1, P177, DOI 10.1007/BF01388144; Bergeron J, 1996, ANTIMICROB AGENTS CH, V40, P2226, DOI 10.1128/AAC.40.9.2226; Bililign T, 2004, CHEM BIOL, V11, P959, DOI 10.1016/j.chembiol.2004.04.016; BINNIE C, 1989, J BACTERIOL, V171, P887, DOI 10.1128/jb.171.2.887-895.1989; BOEHLEIN SK, 1994, J BIOL CHEM, V269, P7450; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; Burdett V, 1996, J BACTERIOL, V178, P3246, DOI 10.1128/jb.178.11.3246-3251.1996; BUTLER MJ, 1989, MOL GEN GENET, V215, P231, DOI 10.1007/BF00339722; BUTLER MJ, 1989, BIOTECHNOL TECH, V4, P235; CABALLERO JL, 1991, MOL GEN GENET, V230, P401, DOI 10.1007/BF00280297; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Chopra Ian, 2001, Current Opinion in Pharmacology, V1, P464, DOI 10.1016/S1471-4892(01)00081-9; Chung JY, 2002, J BACTERIOL, V184, P6115, DOI 10.1128/JB.184.22.6115-6122.2002; Connell SR, 2003, ANTIMICROB AGENTS CH, V47, P3675, DOI 10.1128/AAC.47.12.3675-3681.2003; DAIRI T, 1995, BIOSCI BIOTECH BIOCH, V59, P1099, DOI 10.1271/bbb.59.1099; Das A, 2009, CHEM BIOL, V16, P1197, DOI 10.1016/j.chembiol.2009.11.005; Das A, 2009, ACCOUNTS CHEM RES, V42, P631, DOI 10.1021/ar8002249; Daum M, 2009, CHEMBIOCHEM, V10, P1073, DOI 10.1002/cbic.200800823; DOYLE D, 1991, MOL MICROBIOL, V5, P2923, DOI 10.1111/j.1365-2958.1991.tb01852.x; DUGGAR BM, 1948, ANN NY ACAD SCI, V51, P177, DOI 10.1111/j.1749-6632.1948.tb27262.x; Duggar BM, 1949, [No title captured], Patent No. [2482055, 2,482,055]; FINLAY AC, 1950, SCIENCE, V111, P85, DOI 10.1126/science.111.2874.85; Fritzsche K, 2008, J AM CHEM SOC, V130, P8307, DOI 10.1021/ja800251m; FU H, 1994, J AM CHEM SOC, V116, P4166, DOI 10.1021/ja00089a003; FU H, 1994, J AM CHEM SOC, V116, P6443, DOI 10.1021/ja00093a058; Hertweck C, 2007, NAT PROD REP, V24, P162, DOI 10.1039/b507395m; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; HOCHSTEIN FA, 1953, J AM CHEM SOC, V75, P5455, DOI 10.1021/ja01118a001; Hunter I. S., 1997, BIOTECHNOLOGY ANTIBI, P659; Hutchinson CR, 1997, CHEM REV, V97, P2525, DOI 10.1021/cr960022x; Ichinose K, 1998, CHEM BIOL, V5, P647, DOI 10.1016/S1074-5521(98)90292-7; Keatinge-Clay A, 2004, NAT STRUCT MOL BIOL, V11, P888, DOI 10.1038/nsmb808; KIM ES, 1994, GENE, V141, P141, DOI 10.1016/0378-1119(94)90144-9; Korman TP, 2008, BIOCHEMISTRY-US, V47, P1837, DOI 10.1021/bi7016427; Kunzel E, 1997, CHEM-EUR J, V3, P1675, DOI 10.1002/chem.19970031017; Lesnik U, 2009, FOOD TECHNOL BIOTECH, V47, P323; Levy SB, 1999, ANTIMICROB AGENTS CH, V43, P1523, DOI 10.1128/AAC.43.6.1523; LEVY SB, 1989, ANTIMICROB AGENTS CH, V33, P1373, DOI 10.1128/AAC.33.8.1373; Lombo F, 1996, GENE, V172, P87, DOI 10.1016/0378-1119(96)00029-7; Lombo F, 2006, APPL MICROBIOL BIOT, V73, P1, DOI 10.1007/s00253-006-0511-6; Lomovskaya N, 1998, J BACTERIOL, V180, P2379, DOI 10.1128/JB.180.9.2379-2386.1998; Lykkeberg AK, 2004, J PHARMACEUT BIOMED, V34, P559, DOI 10.1016/S0731-7085(03)00629-0; MCCORMICK JR, 1965, J AM CHEM SOC, V87, P1794, DOI 10.1021/ja01086a034; MCCORMICK JR, 1968, J AM CHEM SOC, V90, P2201, DOI 10.1021/ja01010a063; MCCORMICK JRD, 1963, J AM CHEM SOC, V85, P1692, DOI 10.1021/ja00894a037; MCCORMICK JRD, 1962, J AM CHEM SOC, V84, P3023, DOI 10.1021/ja00874a040; MCCORMICK JRD, 1963, J AM CHEM SOC, V85, P1694, DOI 10.1021/ja00894a038; Meadows ES, 2001, BIOCHEMISTRY-US, V40, P14855, DOI 10.1021/bi0113723; Moore BS, 2002, NAT PROD REP, V19, P70, DOI 10.1039/b003939j; Nakai T, 1999, BIOCHEMISTRY-US, V38, P2413, DOI 10.1021/bi9819881; Nakano T, 2004, BIOSCI BIOTECH BIOCH, V68, P1345, DOI 10.1271/bbb.68.1345; Nelson ML, 2002, ANNU REP MED CHEM, V37, P105, DOI 10.1016/S0065-7743(02)37012-X; NELSON ML, 1994, J MED CHEM, V37, P1355, DOI 10.1021/jm00035a016; OHNUKI T, 1985, J BACTERIOL, V161, P1010, DOI 10.1128/JB.161.3.1010-1016.1985; Peric-Concha N, 2005, J BIOL CHEM, V280, P37455, DOI 10.1074/jbc.M503191200; Petkovic H, 1999, J BIOL CHEM, V274, P32829; Petkovic H, 2006, MICROBIOL MOL BIOL R, V70, P704, DOI 10.1128/MMBR.00004-06; Pickens LB, 2009, J AM CHEM SOC, V131, P17677, DOI 10.1021/ja907852c; Pickens LB, 2009, METAB ENG, V11, P69, DOI 10.1016/j.ymben.2008.10.001; Prado L, 1999, MOL GEN GENET, V261, P216, DOI 10.1007/s004380050960; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; REVILL WP, 1995, J BACTERIOL, V177, P3946, DOI 10.1128/jb.177.14.3946-3952.1995; REYNES JP, 1988, J GEN MICROBIOL, V134, P585; RHODES PM, 1984, BIOCHEM SOC T, V12, P586, DOI 10.1042/bst0120586; RHODES PM, 1981, J GEN MICROBIOL, V124, P329; Ryan MJ, 1996, United States patent, Patent No. 5589385; SCOTT AI, 1975, TETRAHEDRON LETT, V16, P1369; STEPHENS CR, 1963, J AM CHEM SOC, V85, P2643, DOI 10.1021/ja00900a027; STEPHENS CR, 1954, J AM CHEM SOC, V76, P3568, DOI 10.1021/ja01642a064; Stevens DC, 2010, APPL ENVIRON MICROB, V76, P2681, DOI 10.1128/AEM.02841-09; Sum PE, 1999, BIOORG MED CHEM LETT, V9, P1459, DOI 10.1016/S0960-894X(99)00216-4; Tang Y, 2004, BIOCHEMISTRY-US, V43, P9546, DOI 10.1021/bi049157k; Tang Y, 2003, J AM CHEM SOC, V125, P12708, DOI 10.1021/ja0378759; Tang Y, 2003, BIOCHEMISTRY-US, V42, P6588, DOI 10.1021/bi0341962; THOMAS R, 1983, J CHEM SOC CHEM COMM, P128, DOI 10.1039/c39830000128; THOMAS R, 1983, J CHEM SOC CHEM COMM, P677, DOI 10.1039/c39830000677; TSUNAKAWA M, 1989, J ORG CHEM, V54, P2532, DOI 10.1021/jo00272a013; VILLAX I, 1985, Patent No. 4500458; Wang P, 2009, CHEMBIOCHEM, V10, P1544, DOI 10.1002/cbic.200900122; Wietzorrek A, 1997, MOL MICROBIOL, V25, P1181, DOI 10.1046/j.1365-2958.1997.5421903.x; Zhang W, 2008, J AM CHEM SOC, V130, P6068, DOI 10.1021/ja800951e; Zhang W, 2007, J BIOL CHEM, V282, P25717, DOI 10.1074/jbc.M703437200; Zhang WJ, 2006, APPL ENVIRON MICROB, V72, P2573, DOI 10.1128/AEM.72.4.2573-2580.2006	87	58	61	3	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27509	27515		10.1074/jbc.R110.130419	http://dx.doi.org/10.1074/jbc.R110.130419			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20522541	Green Published, hybrid			2022-12-27	WOS:000281404100004
J	Ye, SY; Cihil, K; Stolz, DB; Pilewski, JM; Stanton, BA; Swiatecka-Urban, A				Ye, Siying; Cihil, Kristine; Stolz, Donna Beer; Pilewski, Joseph M.; Stanton, Bruce A.; Swiatecka-Urban, Agnieszka			c-Cbl Facilitates Endocytosis and Lysosomal Degradation of Cystic Fibrosis Transmembrane Conductance Regulator in Human Airway Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; CLATHRIN-COATED PITS; EGF RECEPTOR; MEDIATED ENDOCYTOSIS; NEGATIVE REGULATION; DOWN-REGULATION; RING FINGER; CFTR; MEMBRANE; UBIQUITIN	Cystic fibrosis transmembrane conductance regulator (CFTR) is a cAMP-activated Cl- channel expressed in the apical membrane of fluid-transporting epithelia. The apical membrane density of CFTR channels is determined, in part, by endocytosis and the postendocytic sorting of CFTR for lysosomal degradation or recycling to the plasma membrane. Although previous studies suggested that ubiquitination plays a role in the postendocytic sorting of CFTR, the specific ubiquitin ligases are unknown. c-Cbl is a multifunctional molecule with ubiquitin ligase activity and a protein adaptor function. c-Cbl co-immunoprecipitated with CFTR in primary differentiated human bronchial epithelial cells and in cultured human airway cells. Small interfering RNA-mediated silencing of c-Cbl increased CFTR expression in the plasma membrane by inhibiting CFTR endocytosis and increased CFTR-mediated Cl- currents. Silencing c-Cbl did not change the expression of the ubiquitinated fraction of plasma membrane CFTR. Moreover, the c-Cbl mutant with impaired ubiquitin ligase activity (FLAG-70Z-Cbl) did not affect the plasma membrane expression or the endocytosis of CFTR. In contrast, the c-Cbl mutant with the truncated C-terminal region (FLAG-Cbl-480), responsible for protein adaptor function, had a dominant interfering effect on the endocytosis and plasma membrane expression of CFTR. Moreover, CFTR and c-Cbl co-localized and co-immunoprecipitated in early endosomes, and silencing c-Cbl reduced the amount of ubiquitinated CFTR in early endosomes. In summary, our data demonstrate that in human airway epithelial cells, c-Cbl regulates CFTR by two mechanisms: first by acting as an adaptor protein and facilitating CFTR endocytosis by a ubiquitin-independent mechanism, and second by ubiquitinating CFTR in early endosomes and thereby facilitating the lysosomal degradation of CFTR.	[Cihil, Kristine; Swiatecka-Urban, Agnieszka] Childrens Hosp Pittsburgh, Dept Nephrol, Pittsburgh, PA 15224 USA; [Ye, Siying; Stanton, Bruce A.] Dartmouth Med Sch, Dept Physiol, Hanover, NH 03755 USA; [Stolz, Donna Beer; Pilewski, Joseph M.; Swiatecka-Urban, Agnieszka] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15201 USA; [Pilewski, Joseph M.] Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Dartmouth College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Swiatecka-Urban, A (corresponding author), Childrens Hosp Pittsburgh, Dept Nephrol, Pittsburgh, PA 15224 USA.	asurban@pitt.edu	Ye, Siying/H-3156-2013; Swiatecka-Urban, Agnieszka/AAP-6041-2020; SWIATECKA-URBAN, AGNIESZKA/H-6494-2015; Pilewski, Joseph/AAF-5149-2021	Ye, Siying/0000-0002-0882-1642; SWIATECKA-URBAN, AGNIESZKA/0000-0002-6575-0334; 	National Institutes of Health [R01HL090767, R01-DK/HL-45881, R01-DK34533]; National Center for Research Resources [P20-RR018787]; Cystic Fibrosis Foundation;  [P30-DK072506]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018787] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090767, R01HL074175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034533, R01DK045881, P30DK072506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL090767 (to A. S.-U.), R01-DK/HL-45881 (to B. A. S.), R01-DK34533 (to B. A. S.), P20-RR018787 from the National Center for Research Resources (to B. A. S.), and P30-DK072506 (to J. M. P.). This work was also supported by Research Development Program grants from the Cystic Fibrosis Foundation (to J. M. P. and B. A. S.).	Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Bertrand CA, 2003, AM J PHYSIOL-CELL PH, V285, pC1, DOI 10.1152/ajpcell.00554.2002; BLAKE TJ, 1991, ONCOGENE, V6, P653; Bomberger JM, 2009, J BIOL CHEM, V284, P18778, DOI 10.1074/jbc.M109.001685; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Caohuy H, 2009, J BIOL CHEM, V284, P25241, DOI 10.1074/jbc.M109.035345; Chang CW, 1997, J NEUROCHEM, V69, P859; de Melker AA, 2004, J BIOL CHEM, V279, P55465, DOI 10.1074/jbc.M409765200; de Melker AA, 2001, J CELL SCI, V114, P2167; Devor DC, 2000, AM J PHYSIOL-CELL PH, V279, pC461, DOI 10.1152/ajpcell.2000.279.2.C461; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Dikic I, 2003, CELL MOL LIFE SCI, V60, P1805, DOI 10.1007/s00018-003-3029-4; GALISTEO ML, 1995, J BIOL CHEM, V270, P20242, DOI 10.1074/jbc.270.35.20242; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Howard M, 2000, AM J PHYSIOL-CELL PH, V279, pC375, DOI 10.1152/ajpcell.2000.279.2.C375; Jiang XJ, 2003, TRAFFIC, V4, P529, DOI 10.1034/j.1600-0854.2003.t01-1-00109.x; Kues WA, 2000, BIOL REPROD, V62, P412, DOI 10.1095/biolreprod62.2.412; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Lin DH, 2005, P NATL ACAD SCI USA, V102, P4306, DOI 10.1073/pnas.0409767102; Magnifico A, 2003, J BIOL CHEM, V278, P43169, DOI 10.1074/jbc.M308009200; Morris SM, 2002, TRAFFIC, V3, P331, DOI 10.1034/j.1600-0854.2002.30503.x; Moyer BD, 1998, J BIOL CHEM, V273, P21759, DOI 10.1074/jbc.273.34.21759; Myerburg MM, 2007, AM J PHYSIOL-LUNG C, V292, pL1352, DOI 10.1152/ajplung.00328.2006; Peschard P, 2004, J BIOL CHEM, V279, P29565, DOI 10.1074/jbc.M403954200; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Ryan PE, 2006, TRENDS BIOCHEM SCI, V31, P79, DOI 10.1016/j.tibs.2005.12.004; Scaife RM, 2000, J CELL SCI, V113, P215; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Sheff DR, 1999, J CELL BIOL, V145, P123, DOI 10.1083/jcb.145.1.123; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Swiatecka-Urban A, 2006, AM J PHYSIOL-CELL PH, V290, pC862, DOI 10.1152/ajpcell.00108.2005; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Swiatecka-Urban A, 2004, J BIOL CHEM, V279, P38025, DOI 10.1074/jbc.M403141200; Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200; Swiatecka-Urban A, 2007, J BIOL CHEM, V282, P23725, DOI 10.1074/jbc.M608531200; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; Thien CBF, 2005, BIOCHEM J, V391, P153, DOI 10.1042/BJ20050892; Wang H, 2006, J BIOL CHEM, V281, P14129, DOI 10.1074/jbc.M512511200; WATTS C, 1988, EMBO J, V7, P1937, DOI 10.1002/j.1460-2075.1988.tb03031.x	45	38	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27008	27018		10.1074/jbc.M110.139881	http://dx.doi.org/10.1074/jbc.M110.139881			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20525683	hybrid, Green Published			2022-12-27	WOS:000281172700032
J	Costa, TRD; Edqvist, PJ; Broms, JE; Ahlund, MK; Forsberg, A; Francis, MS				Costa, Tiago R. D.; Edqvist, Petra J.; Broems, Jeanette E.; Ahlund, Monika K.; Forsberg, Ake; Francis, Matthew S.			YopD Self-assembly and Binding to LcrV Facilitate Type III Secretion Activity by Yersinia pseudotuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-CALCIUM-RESPONSE; TARGET-CELL CONTACT; V-ANTIGEN; TRANSLOCATORS YOPB; TIP COMPLEX; POSTTRANSCRIPTIONAL MECHANISM; PSEUDOMONAS-AERUGINOSA; AMPHIPATHIC DOMAIN; SHIGELLA-FLEXNERI; GENETIC-ANALYSIS	YopD-like translocator proteins encoded by several Gram-negative bacteria are important for type III secretion-dependent delivery of anti-host effectors into eukaryotic cells. This probably depends on their ability to form pores in the infected cell plasma membrane, through which effectors may gain access to the cell interior. In addition, Yersinia YopD is a negative regulator essential for the control of effector synthesis and secretion. As a prerequisite for this functional duality, YopD may need to establish molecular interactions with other key T3S components. A putative coiled-coil domain and an alpha-helical amphipathic domain, both situated in the YopD C terminus, may represent key protein-protein interaction domains. Therefore, residues within the YopD C terminus were systematically mutagenized. All 68 mutant bacteria were first screened in a variety of assays designed to identify individual residues essential for YopD function, possibly by providing the interaction interface for the docking of other T3S proteins. Mirroring the effect of a full-length yopD gene deletion, five mutant bacteria were defective for both yop regulatory control and effector delivery. Interestingly, all mutations clustered to hydrophobic amino acids of the amphipathic domain. Also situated within this domain, two additional mutants rendered YopD primarily defective in the control of Yop synthesis and secretion. Significantly, protein-protein interaction studies revealed that functionally compromised YopD variants were also defective in self-oligomerization and in the ability to engage another translocator protein, LcrV. Thus, the YopD amphipathic domain facilitates the formation of YopD/YopD and YopD/LcrV interactions, two critical events in the type III secretion process.	[Francis, Matthew S.] Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden; [Francis, Matthew S.] Umea Univ, Umea Ctr Microbial Res, SE-90187 Umea, Sweden; [Broems, Jeanette E.; Forsberg, Ake] Swedish Def Res Agcy, Div NBC Def, Dept Med Countermeasures, SE-90182 Umea, Sweden	Umea University; Umea University; Saab Group	Francis, MS (corresponding author), Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden.	matthew.francis@molbiol.umu.se	Costa, Tiago/K-8999-2019; Costa, Tiago/V-8203-2017	Costa, Tiago/0000-0003-2716-9669; Costa, Tiago/0000-0003-2716-9669; Francis, Matthew/0000-0001-6817-9535	Carl Tryggers Foundation for Scientific Research; Swedish Research Council; Foundation for Medical Research at Umea University; Swedish Medical Association; J.C. Kempe Memorial Fund	Carl Tryggers Foundation for Scientific Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Foundation for Medical Research at Umea University; Swedish Medical Association; J.C. Kempe Memorial Fund	This work was performed within the framework of the Umea Centre for Microbial Research (UCMR) Linnaeus Program and supported by grants from the Carl Tryggers Foundation for Scientific Research, the Swedish Research Council, the Foundation for Medical Research at Umea University, the Swedish Medical Association, and the J.C. Kempe Memorial Fund.	Alli M, 2008, INT J MED MICROBIOL, V298, P183, DOI 10.1016/j.ijmm.2007.04.007; Anderson DM, 2002, J BACTERIOL, V184, P1287, DOI 10.1128/JB.184.5.1287-1295.2002; Aurora R, 1998, PROTEIN SCI, V7, P21, DOI 10.1002/pro.5560070103; BERGMAN T, 1991, J BACTERIOL, V173, P1607, DOI 10.1128/jb.173.5.1607-1616.1991; Blocker A, 2000, CELL MICROBIOL, V2, P387, DOI 10.1046/j.1462-5822.2000.00068.x; BOLIN I, 1982, INFECT IMMUN, V37, P506; BOLIN I, 1984, INFECT IMMUN, V43, P72; Brodsky IE, 2010, CELL HOST MICROBE, V7, P376, DOI 10.1016/j.chom.2010.04.009; Broms JE, 2005, J BACTERIOL, V187, P7738, DOI 10.1128/JB.187.22.7738-7752.2005; Broms JE, 2003, MICROBIOL-SGM, V149, P2615, DOI 10.1099/mic.0.26322-0; Broms JE, 2003, J INFECT DIS, V188, P239, DOI 10.1086/376452; Broz P, 2007, MOL MICROBIOL, V65, P1311, DOI 10.1111/j.1365-2958.2007.05871.x; Brubaker RR, 2007, ADV EXP MED BIOL, V603, P116; Brubaker RR, 2005, INFECT IMMUN, V73, P4743, DOI 10.1128/IAI.73.8.4743-4752.2005; Buttner D, 2002, TRENDS MICROBIOL, V10, P186, DOI 10.1016/S0966-842X(02)02331-4; Cambronne ED, 2002, J BACTERIOL, V184, P5880, DOI 10.1128/JB.184.21.5880-5893.2002; Coburn B, 2007, CLIN MICROBIOL REV, V20, P535, DOI 10.1128/CMR.00013-07; Coombes BK, 2005, TRENDS MICROBIOL, V13, P92, DOI 10.1016/j.tim.2005.01.008; Deleage G, 2001, COMPUT BIOL MED, V31, P259, DOI 10.1016/S0010-4825(01)00008-7; Faudry E, 2007, FEBS J, V274, P3601, DOI 10.1111/j.1742-4658.2007.05893.x; Feldman MF, 2002, MOL MICROBIOL, V46, P1183, DOI 10.1046/j.1365-2958.2002.03241.x; Fields KA, 1999, INFECT IMMUN, V67, P5395, DOI 10.1128/IAI.67.10.5395-5408.1999; Fowler JM, 2009, MICROBIOL-SGM, V155, P2509, DOI 10.1099/mic.0.028852-0; Francis MS, 2000, MOL MICROBIOL, V38, P85, DOI 10.1046/j.1365-2958.2000.02112.x; Francis MS, 1998, MOL MICROBIOL, V29, P799, DOI 10.1046/j.1365-2958.1998.00973.x; Francis MS, 2001, MOL MICROBIOL, V42, P1075, DOI 10.1046/j.1365-2958.2001.02702.x; Frithz-Lindsten E, 1998, MOL MICROBIOL, V29, P1155, DOI 10.1046/j.1365-2958.1998.00994.x; GEMSKI P, 1980, INFECT IMMUN, V27, P682, DOI 10.1128/IAI.27.2.682-685.1980; GEMSKI P, 1980, INFECT IMMUN, V28, P1044; GOGUEN JD, 1984, J BACTERIOL, V160, P842, DOI 10.1128/JB.160.3.842-848.1984; Goure J, 2005, J INFECT DIS, V192, P218, DOI 10.1086/430932; Grabenstein JP, 2004, INFECT IMMUN, V72, P4973, DOI 10.1128/IAI.72.9.4973-4984.2004; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HAKANSSON S, 1993, INFECT IMMUN, V61, P71; Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x; Hamada D, 2005, FEBS J, V272, P756, DOI 10.1111/j.1742-4658.2004.04513.x; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; Hartland EL, 1998, FEMS MICROBIOL LETT, V162, P207, DOI 10.1016/S0378-1097(98)00123-2; Higuchi R., 1989, PCR TECHNOLOGY, P61; Holmstrom A, 1997, MOL MICROBIOL, V24, P73, DOI 10.1046/j.1365-2958.1997.3211681.x; Holmstrom A, 2001, MOL MICROBIOL, V39, P620, DOI 10.1046/j.1365-2958.2001.02259.x; Ivanov MI, 2008, INFECT IMMUN, V76, P5181, DOI 10.1128/IAI.00189-08; Kueltzo LA, 2003, J BIOL CHEM, V278, P2792, DOI 10.1074/jbc.M208383200; Lloyd SA, 2001, MOL MICROBIOL, V39, P520, DOI 10.1046/j.1365-2958.2001.02271.x; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; MANT CT, 1993, AMPHIPATHIC HELIX, P39; Marenne MN, 2003, MICROB PATHOGENESIS, V35, P243, DOI 10.1016/S0882-4010(03)00154-2; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Motin VL, 2004, J BACTERIOL, V186, P6298, DOI 10.1128/JB.186.18.6298-6305.2004; Mueller CA, 2008, MOL MICROBIOL, V68, P1085, DOI 10.1111/j.1365-2958.2008.06237.x; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; Neyt C, 1999, MOL MICROBIOL, V31, P143, DOI 10.1046/j.1365-2958.1999.01154.x; Neyt C, 1999, MOL MICROBIOL, V33, P971, DOI 10.1046/j.1365-2958.1999.01537.x; Olive AJ, 2007, INFECT IMMUN, V75, P2626, DOI 10.1128/IAI.01599-06; Olsson J, 2004, J BACTERIOL, V186, P4110, DOI 10.1128/JB.186.13.4110-4123.2004; Ottmann C, 2007, EMBO J, V26, P902, DOI 10.1038/sj.emboj.7601530; Pallen MJ, 1997, MOL MICROBIOL, V25, P423, DOI 10.1046/j.1365-2958.1997.4901850.x; Pettersson J, 1999, MOL MICROBIOL, V32, P961, DOI 10.1046/j.1365-2958.1999.01408.x; Raab R, 2008, PROTEIN EXPRES PURIF, V58, P53, DOI 10.1016/j.pep.2007.11.001; Roehrich AD, 2010, INFECT IMMUN, V78, P1682, DOI 10.1128/IAI.00645-09; ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x; Ryndak MB, 2005, INFECT IMMUN, V73, P2433, DOI 10.1128/IAI.73.4.2433-2443.2005; Sarker MR, 1998, J BACTERIOL, V180, P1207, DOI 10.1128/JB.180.5.1207-1214.1998; Schmid A, 2006, PROTEIN EXPRES PURIF, V49, P176, DOI 10.1016/j.pep.2006.04.012; Schoehn G, 2003, EMBO J, V22, P4957, DOI 10.1093/emboj/cdg499; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; Shao F, 2008, CURR OPIN MICROBIOL, V11, P21, DOI 10.1016/j.mib.2008.01.005; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Swietnicki W, 2004, J BIOL CHEM, V279, P38693, DOI 10.1074/jbc.M405217200; Tardy F, 1999, EMBO J, V18, P6793, DOI 10.1093/emboj/18.23.6793; Tengel T, 2002, EUR J BIOCHEM, V269, P3659, DOI 10.1046/j.1432-1033.2002.03051.x; Torruellas J, 2005, MOL MICROBIOL, V57, P1719, DOI 10.1111/j.1365-2958.2005.04790.x; Veenendaal AKJ, 2007, MOL MICROBIOL, V63, P1719, DOI 10.1111/j.1365-2958.2007.05620.x; Williams AW, 1998, J BACTERIOL, V180, P350, DOI 10.1128/JB.180.2.350-358.1998; Wulff-Strobel CR, 2002, MOL MICROBIOL, V43, P411, DOI 10.1046/j.1365-2958.2002.02752.x; ZAHORCHAK RJ, 1979, J BACTERIOL, V139, P792, DOI 10.1128/JB.139.3.792-799.1979	78	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25269	25284		10.1074/jbc.M110.144311	http://dx.doi.org/10.1074/jbc.M110.144311			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20525687	hybrid, Green Published			2022-12-27	WOS:000280682400020
J	Craft, CS; Zou, W; Watkins, M; Grimston, S; Brodt, MD; Broekelmann, TJ; Weinbaum, JS; Teitelbaum, SL; Pierce, RA; Civitelli, R; Silva, MJ; Mecham, RP				Craft, Clarissa S.; Zou, Wei; Watkins, Marcus; Grimston, Susan; Brodt, Michael D.; Broekelmann, Thomas J.; Weinbaum, Justin S.; Teitelbaum, Steven L.; Pierce, Richard A.; Civitelli, Roberto; Silva, Matthew J.; Mecham, Robert P.			Microfibril-associated Glycoprotein-1, an Extracellular Matrix Regulator of Bone Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRILLIN-CONTAINING MICROFIBRILS; QUANTITATIVE TRAIT LOCI; TGF-BETA ACTIVATION; MARFAN-SYNDROME; AORTIC DEVELOPMENT; RICH MICROFIBRILS; IN-VIVO; EXPRESSION; RECEPTOR; PROTEIN	MAGP1 is an extracellular matrix protein that, in vertebrates, is a ubiquitous component of fibrillin-rich microfibrils. We previously reported that aged MAGP1-deficient mice (MAGP1 Delta) develop lesions that are the consequence of spontaneous bone fracture. We now present a more defined bone phenotype found in MAGP1 Delta mice. A longitudinal DEXA study demonstrated age-associated osteopenia in MAGP1 Delta animals and mu CT confirmed reduced bone mineral density in the trabecular and cortical bone. Further, MAGP1 Delta mice have significantly less trabecular bone, the trabecular microarchitecture is more fragmented, and the diaphyseal cross-sectional area is significantly reduced. There modeling defect seen in MAGP1 Delta mice is likely not due to an osteoblast defect, because MAGP1 Delta bone marrow stromal cells undergo osteoblastogenesis and form mineralized nodules. In vivo, MAGP1 Delta mice exhibit normal osteoblast number, mineralized bone surface, and bone formation rate. Instead, our findings suggest increased bone resorption is responsible for the osteopenia. The number of osteoclasts derived from MAGP1 Delta bone marrow macrophage cells is increased relative to the wild type, and osteoclast differentiation markers are expressed at earlier time points in MAGP1 Delta cells. In vivo, MAGP1 Delta mice have more osteoclasts lining the bone surface. RANKL(receptor activator of NF-kappa B ligand) expression is significantly higher in MAGP1 Delta bone, and likely contributes to enhanced osteoclastogenesis. However, bone marrow macrophage cells from MAGP1 Delta mice show a higher propensity than do wildtype cells to differentiate to osteoclasts in response to RANKL, suggesting that they are also primed to respond to osteoclast-promoting signals. Together, our findings suggest that MAGP1 is a regulator of bone remodeling, and its absence results in osteopenia associated with an increase in osteoclast number.	Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Zou, Wei; Teitelbaum, Steven L.] Washington Univ, Sch Med, Dept Anat & Mol Pathol, St Louis, MO 63110 USA; [Watkins, Marcus; Grimston, Susan; Pierce, Richard A.; Civitelli, Roberto] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Brodt, Michael D.; Silva, Matthew J.] Washington Univ, Sch Med, Dept Orthoped Surg, St Louis, MO 63110 USA; [Weinbaum, Justin S.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Minnesota System; University of Minnesota Twin Cities	Mecham, RP (corresponding author), Campus Box 8228,660 S Euclid Ave, St Louis, MO 63110 USA.	bmecham@wustl.edu	Watkins, Marcus/V-8817-2019; Civitelli, Roberto/AAA-8260-2019; Weinbaum, Justin S/C-3192-2009	Watkins, Marcus/0000-0002-1224-3478; Civitelli, Roberto/0000-0003-4076-4315; Weinbaum, Justin S/0000-0002-0626-6083; Silva, Matthew/0000-0001-7375-4522; Teitelbaum, Steven/0000-0002-4054-6679; Zou, Wei/0000-0001-8081-268X	National Institutes of Health [HL71960, HL084922, T32-HL007275-30, AR0327888, AR046523, AR057037, AR054618, P30AR057235]; National Marfan Foundation; Washington University Core Center for Musculoskeletal Biology and Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105314, T32HL007275, R01HL071960, P50HL084922, R01HL053325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR046523, R01AR054618, R01AR057037, R01AR046523, R01AR032788, R01AR047867, P30AR057235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Marfan Foundation; Washington University Core Center for Musculoskeletal Biology and Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL71960 and HL084922 (to R.P.M.), T32-HL007275-30 (to C.S.C.), AR0327888, AR046523, AR057037, and AR054618 (to S.L.T.), and P30AR057235. This work was also supported by a National Marfan Foundation Research Grant (to R.P.M.) and by the Washington University Core Center for Musculoskeletal Biology and Medicine.	Arteaga-Solis E, 2001, J CELL BIOL, V154, P275, DOI 10.1083/jcb.200105046; Arteage-Solis E, 2008, PRIMER METABOLIC BON, P450; Balooch G, 2005, P NATL ACAD SCI USA, V102, P18813, DOI 10.1073/pnas.0507417102; Barisic-Dujmovic T, 2007, CALCIFIED TISSUE INT, V81, P305, DOI 10.1007/s00223-007-9059-4; Beamer WG, 2001, J BONE MINER RES, V16, P1195, DOI 10.1359/jbmr.2001.16.7.1195; Bona C A, 1997, DNA Res, V4, P267, DOI 10.1093/dnares/4.4.267; Bouxsein ML, 2004, J BONE MINER RES, V19, P587, DOI 10.1359/JBMR.0301255; Cain SA, 2006, PROTEOMICS, V6, P111, DOI 10.1002/pmic.200401340; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; Chaudhry SS, 2007, J CELL BIOL, V176, P355, DOI 10.1083/jcb.200608167; CHEN YP, 1993, J BIOL CHEM, V268, P27381; Corson GM, 2004, GENOMICS, V83, P461, DOI 10.1016/j.ygeno.2003.08.023; Dallas SL, 2000, J BONE MINER RES, V15, P68, DOI 10.1359/jbmr.2000.15.1.68; El-Hallous E, 2007, J BIOL CHEM, V282, P8935, DOI 10.1074/jbc.M608204200; Faivre L, 2003, J MED GENET, V40, P34, DOI 10.1136/jmg.40.1.34; Filvaroff E, 1999, DEVELOPMENT, V126, P4267; GOLTZMAN D, 2008, PRIMER METABOLIC BON, V7th, ppp104; Gregory KE, 2005, J BIOL CHEM, V280, P27970, DOI 10.1074/jbc.M504270200; Hanssen E, 2004, J BIOL CHEM, V279, P29185, DOI 10.1074/jbc.M313672200; Hofbauer LC, 2004, JAMA-J AM MED ASSOC, V292, P490, DOI 10.1001/jama.292.4.490; Ishida A, 2002, J BIOL CHEM, V277, P26217, DOI 10.1074/jbc.M111093200; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Jensen SA, 2001, J BIOL CHEM, V276, P39661, DOI 10.1074/jbc.M104533200; Jurado S, 2010, J CELL BIOCHEM, V110, P304, DOI 10.1002/jcb.22538; Kaartinen V, 2003, NAT GENET, V33, P331, DOI 10.1038/ng0303-331; Karst M, 2004, J CELL PHYSIOL, V200, P99, DOI 10.1002/jcp.20036; KEENE DR, 1991, J HISTOCHEM CYTOCHEM, V39, P59, DOI 10.1177/39.1.1983874; Kelleher CM, 2004, CURR TOP DEV BIOL, V62, P153; Kitahama S, 2000, BONE, V27, P61, DOI 10.1016/S8756-3282(00)00292-1; LEE B, 1991, NATURE, V352, P330, DOI 10.1038/352330a0; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Mariani TJ, 2002, AM J RESP CELL MOL, V26, P541, DOI 10.1165/ajrcmb.26.5.2001-00080c; MASLEN CL, 1991, NATURE, V352, P334, DOI 10.1038/352334a0; Mc Donnell P, 2007, ANN BIOMED ENG, V35, P170, DOI 10.1007/s10439-006-9239-9; MCLEAN SE, 2005, EXTRACELLULAR MATRIC, P82; Miyamoto A, 2006, J BIOL CHEM, V281, P10089, DOI 10.1074/jbc.M600298200; Mohammad KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005275; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; PUTNAM EA, 1995, NAT GENET, V11, P456, DOI 10.1038/ng1295-456; Ramirez F, 2008, CONNECT TISSUE RES, V49, P1, DOI 10.1080/03008200701820708; Reeve JL, 2009, J IMMUNOL, V183, P1804, DOI 10.4049/jimmunol.0804206; Rock MJ, 2004, J BIOL CHEM, V279, P23748, DOI 10.1074/jbc.M400212200; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; Sakamoto H, 1996, J BIOL CHEM, V271, P4916; Segade F, 2009, GENE, V439, P43, DOI 10.1016/j.gene.2009.03.013; Silva MJ, 2002, J BONE MINER RES, V17, P1597, DOI 10.1359/jbmr.2002.17.9.1597; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; TSIPOURAS P, 1992, NEW ENGL J MED, V326, P905, DOI 10.1056/NEJM199204023261401; Weinbaum JS, 2008, J BIOL CHEM, V283, P25533, DOI 10.1074/jbc.M709962200; Werneck CC, 2008, BLOOD, V111, P4137, DOI 10.1182/blood-2007-07-101733; Wu XW, 2007, ANN NY ACAD SCI, V1116, P29, DOI 10.1196/annals.1402.053; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; ZHANG H, 1995, J CELL BIOL, V129, P1165, DOI 10.1083/jcb.129.4.1165; Zhang J, 2004, PROSTATE, V59, P360, DOI 10.1002/pros.20019	56	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23858	23867		10.1074/jbc.M110.113019	http://dx.doi.org/10.1074/jbc.M110.113019			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20501659	hybrid, Green Published			2022-12-27	WOS:000280291400036
J	Dulic, M; Cvetesic, N; Perona, JJ; Gruic-Sovulj, I				Dulic, Morana; Cvetesic, Nevena; Perona, John J.; Gruic-Sovulj, Ita			Partitioning of tRNA-dependent Editing between Pre- and Post-transfer Pathways in Class I Aminoacyl-tRNA Synthetases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOLEUCYL-TRANSFER-RNA; PROTEIN-SYNTHESIS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; DNA-POLYMERASES; QUALITY-CONTROL; MECHANISM; HYDROLYSIS; ADENYLATE	Hydrolytic editing activities are present in aminoacyl-tRNA synthetases possessing reduced amino acid discrimination in the synthetic reactions. Post-transfer hydrolysis of misacylated tRNA in class I editing enzymes occurs in a spatially separate domain inserted into the catalytic Rossmann fold, but the location and mechanisms of pre-transfer hydrolysis of misactivated amino acids have been uncertain. Here, we use novel kinetic approaches to distinguish among three models for pre-transfer editing by Escherichia coli isoleucyl-tRNA synthetase (IleRS). We demonstrate that tRNA-dependent hydrolysis of noncognate valyl-adenylate by IleRS is largely insensitive to mutations in the editing domain of the enzyme and that noncatalytic hydrolysis after release is too slow to account for the observed rate of clearing. Measurements of the microscopic rate constants for amino acid transfer to tRNA in IleRS and the related valyl-tRNA synthetase (ValRS) further suggest that pre-transfer editing in IleRS is an enzyme-catalyzed activity residing in the synthetic active site. In this model, the balance between pre-transfer and post-transfer editing pathways is controlled by kinetic partitioning of the noncognate aminoacyl-adenylate. Rate constants for hydrolysis and transfer of a noncognate intermediate are roughly equal in IleRS, whereas in ValRS transfer to tRNA is 200-fold faster than hydrolysis. In consequence, editing by ValRS occurs nearly exclusively by post-transfer hydrolysis in the editing domain, whereas in IleRS both pre- and post-transfer editing are important. In both enzymes, the rates of amino acid transfer to tRNA are similar for cognate and noncognate aminoacyl-adenylates, providing a significant contrast with editing DNA polymerases.	[Dulic, Morana; Cvetesic, Nevena; Gruic-Sovulj, Ita] Univ Zagreb, Dept Chem, Fac Sci, Zagreb 10000, Croatia; [Perona, John J.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA	University of Zagreb; University of California System; University of California Santa Barbara	Gruic-Sovulj, I (corresponding author), Univ Zagreb, Dept Chem, Fac Sci, Horvatovac 102A, Zagreb 10000, Croatia.	gruic@chem.pmf.hr		Cvetesic, Nevena/0000-0002-1575-5612	National Institutes of Health [1R03TW008024, GM63713]; Ministry of Science, Education, and Sports of the Republic of Croatia [119-0982913-1358]; FOGARTY INTERNATIONAL CENTER [R03TW008024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063713] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science, Education, and Sports of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R03TW008024 (to J.J.P. and I.G.-S.) and GM63713 (to J.J.P.). This work was also supported by the Ministry of Science, Education, and Sports of the Republic of Croatia Grant 119-0982913-1358 (to Ivana Weygand-Durasevic).	BALDWIN AN, 1966, J BIOL CHEM, V241, P839; Betha AK, 2007, BIOCHEMISTRY-US, V46, P6258, DOI 10.1021/bi061965j; Boniecki MT, 2008, P NATL ACAD SCI USA, V105, P19223, DOI 10.1073/pnas.0809336105; Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351; Dock-Bregeon AC, 2004, MOL CELL, V16, P375, DOI 10.1016/S1097-2765(04)00591-X; ENGLISCH S, 1986, NUCLEIC ACIDS RES, V14, P7529, DOI 10.1093/nar/14.19.7529; Fersht A.R., 1999, STRUCTURE MECH PROTE, P384; FERSHT AR, 1977, BIOCHEMISTRY-US, V16, P1025, DOI 10.1021/bi00624a034; FERSHT AR, 1976, BIOCHEMISTRY-US, V15, P3342, DOI 10.1021/bi00660a026; FERSHT AR, 1976, BIOCHEMISTRY-US, V15, P818, DOI 10.1021/bi00649a014; Francklyn CS, 2008, BIOCHEMISTRY-US, V47, P11695, DOI 10.1021/bi801500z; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Fukunaga R, 2005, NAT STRUCT MOL BIOL, V12, P915, DOI 10.1038/nsmb985; Fukunaga R, 2005, J BIOL CHEM, V280, P29937, DOI 10.1074/jbc.M502668200; Gruic-Sovulj I, 2005, J BIOL CHEM, V280, P23978, DOI 10.1074/jbc.M414260200; Gruic-Sovulj I, 2007, FEBS LETT, V581, P5110, DOI 10.1016/j.febslet.2007.09.058; GRUICSOVULJ I, 2010, CROAT CHEM IN PRESS; Hale SP, 1996, P NATL ACAD SCI USA, V93, P2755, DOI 10.1073/pnas.93.7.2755; Hati S, 2006, J BIOL CHEM, V281, P27862, DOI 10.1074/jbc.M605856200; Hendrickson TL, 2002, MOL CELL, V9, P353, DOI 10.1016/S1097-2765(02)00449-5; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JAKUBOWSKI H, 1980, BIOCHEMISTRY-US, V19, P5071, DOI 10.1021/bi00563a021; Johnson KA, 2010, BBA-PROTEINS PROTEOM, V1804, P1041, DOI 10.1016/j.bbapap.2010.01.006; JOHNSSON MSA, 1992, CRIT REV ORAL BIOL M, V3, P61, DOI 10.1177/10454411920030010601; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; Lue SW, 2005, BIOCHEMISTRY-US, V44, P3010, DOI 10.1021/bi047901v; Minajigi A, 2010, J BIOL CHEM, V285, P23810, DOI 10.1074/jbc.M110.105320; Minajigi A, 2008, P NATL ACAD SCI USA, V105, P17748, DOI 10.1073/pnas.0804247105; Nomanbhoy TK, 1999, MOL CELL, V4, P519, DOI 10.1016/S1097-2765(00)80203-8; NUREKI O, 1994, J MOL BIOL, V236, P710, DOI 10.1006/jmbi.1994.1184; Nureki O, 1998, SCIENCE, V280, P578, DOI 10.1126/science.280.5363.578; O'Donoghue P, 2003, MICROBIOL MOL BIOL R, V67, P550, DOI 10.1128/MMBR.67.4.550-573.2003; Reynolds NM, 2010, P NATL ACAD SCI USA, V107, P4063, DOI 10.1073/pnas.0909640107; Rock FL, 2007, SCIENCE, V316, P1759, DOI 10.1126/science.1142189; Salazar JC, 2004, P NATL ACAD SCI USA, V101, P7536, DOI 10.1073/pnas.0401982101; SCHIMMEL P, 1995, TRENDS BIOCHEM SCI, V20, P1, DOI 10.1016/S0968-0004(00)88937-9; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Splan KE, 2008, J BIOL CHEM, V283, P7128, DOI 10.1074/jbc.M709902200; Tan M, 2010, J BIOL CHEM, V285, P3235, DOI 10.1074/jbc.M109.060616; Tukalo M, 2005, NAT STRUCT MOL BIOL, V12, P923, DOI 10.1038/nsmb986; Uter NT, 2004, P NATL ACAD SCI USA, V101, P14396, DOI 10.1073/pnas.0404017101; Wolfson AD, 2002, P NATL ACAD SCI USA, V99, P5965, DOI 10.1073/pnas.092152799; Zhang CM, 2006, J MOL BIOL, V361, P300, DOI 10.1016/j.jmb.2006.06.015; Zhu B, 2009, J BIOL CHEM, V284, P3418, DOI 10.1074/jbc.M806717200	45	58	60	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23799	23809		10.1074/jbc.M110.133553	http://dx.doi.org/10.1074/jbc.M110.133553			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20498377	Green Published, hybrid			2022-12-27	WOS:000280291400030
J	Maeda, K; Singh, SK; Eda, K; Kitabatake, M; Pham, P; Goodman, MF; Sakaguchi, N				Maeda, Kazuhiko; Singh, Shailendra Kumar; Eda, Kazufumi; Kitabatake, Masahiro; Pham, Phuong; Goodman, Myron F.; Sakaguchi, Nobuo			GANP-mediated Recruitment of Activation-induced Cytidine Deaminase to Cell Nuclei and to Immunoglobulin Variable Region DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS SWITCH RECOMBINATION; SINGLE-STRANDED-DNA; SOMATIC HYPERMUTATION; GERMINAL CENTER; DIVERSIFICATION ENZYME; AFFINITY-MATURATION; PROTEIN; AID; RNA; ANTIBODY	AID (activation-induced cytidine deaminase) catalyzes transcription-dependent deamination of C 3 U in immunoglobulin variable (IgV) regions to initiate somatic hypermutation (SHM) in germinal center B-cells. SHM is essential in generating high affinity antibodies. Here we show that when coexpressed with GANP ( germinal center-associated nuclear protein) in COS-7 cells, AID is transported from the cytoplasm and concentrated in the nucleus. GANP forms a complex with AID in cotransfected cells in vivo and in vitro. We have isolated AID mutants that bind with reduced affinity to GANP compared with wild type AID. One of these mutants, AID (D143A) binds GANP with a 10-fold lower affinity compared with wild type AID yet retains substantial C-deamination activity in vitro. Mutant AID (D143A) remains localized predominantly in the cytoplasm when coexpressed with GANP. Exogenous expression of GANP in Ramos B-cells promotes binding of AID to IgV DNA and mRNA and increases SHM frequency. These data suggest that GANP may serve as an essential link required to transport AID to B-cell nuclei and to target AID to actively transcribed IgV regions.	[Maeda, Kazuhiko; Singh, Shailendra Kumar; Eda, Kazufumi; Kitabatake, Masahiro; Sakaguchi, Nobuo] Kumamoto Univ, Dept Immunol, Grad Sch Life Sci, Kumamoto 8608556, Japan; [Pham, Phuong; Goodman, Myron F.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Pham, Phuong; Goodman, Myron F.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA	Kumamoto University; University of Southern California; University of Southern California	Sakaguchi, N (corresponding author), Kumamoto Univ, Dept Immunol, Grad Sch Life Sci, 1-1-1 Honjo, Kumamoto 8608556, Japan.	nobusaka@kumamoto-u.ac.jp			National Institutes of Health [ES013192, GM21422]; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Founding Research Centers for Emerging and Reemerging Infectious Diseases; Global Centers of Excellence (COE); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R56ES013192, R01ES013192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021422, R37GM021422] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22590436] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Founding Research Centers for Emerging and Reemerging Infectious Diseases(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global Centers of Excellence (COE); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants ES013192 (to M.F.G.) and GM21422 (to P.P.). This work was also supported by a grant-in-aid for scientific research in priority areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases, and by the Global Centers of Excellence (COE) program Global Education Research Center Aiming at the Control of AIDS (to N.S.).	Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Conticello SG, 2008, MOL CELL, V31, P474, DOI 10.1016/j.molcel.2008.07.009; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Fischer T, 2002, EMBO J, V21, P5843, DOI 10.1093/emboj/cdf590; Fujimura S, 2005, CANCER RES, V65, P5925, DOI 10.1158/0008-5472.CAN-04-3259; Gallardo M, 2003, J BIOL CHEM, V278, P24225, DOI 10.1074/jbc.M302900200; Kawatani Y, 2005, J IMMUNOL, V175, P5615, DOI 10.4049/jimmunol.175.9.5615; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Kuwahara K, 2000, BLOOD, V95, P2321, DOI 10.1182/blood.V95.7.2321.007k33_2321_2328; Kuwahara K, 2004, P NATL ACAD SCI USA, V101, P1010, DOI 10.1073/pnas.0307609100; Kuwahara K, 2001, P NATL ACAD SCI USA, V98, P10279, DOI 10.1073/pnas.181335698; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Osman W, 2006, BIOCHEM BIOPH RES CO, V348, P1239, DOI 10.1016/j.bbrc.2006.07.182; Pasqualucci L, 2004, BLOOD, V104, P3318, DOI 10.1182/blood-2004-04-1558; Patenaude AM, 2009, NAT STRUCT MOL BIOL, V16, P517, DOI 10.1038/nsmb.1598; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Rada C, 2002, P NATL ACAD SCI USA, V99, P7003, DOI 10.1073/pnas.092160999; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Sakaguchi N, 2005, J IMMUNOL, V174, P4485, DOI 10.4049/jimmunol.174.8.4485; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Takei Y, 1998, J BIOL CHEM, V273, P22177, DOI 10.1074/jbc.273.35.22177; Takei Y, 2001, EMBO REP, V2, P119, DOI 10.1093/embo-reports/kve026	28	46	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23945	23953		10.1074/jbc.M110.131441	http://dx.doi.org/10.1074/jbc.M110.131441			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20507984	Green Published, hybrid			2022-12-27	WOS:000280291400045
J	Bakrac, B; Kladnik, A; Macek, P; McHaffie, G; Werner, A; Lakey, JH; Anderluh, G				Bakrac, Biserka; Kladnik, Ales; Macek, Peter; McHaffie, Gavin; Werner, Andreas; Lakey, Jeremy H.; Anderluh, Gregor			A Toxin-based Probe Reveals Cytoplasmic Exposure of Golgi Sphingomyelin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE-FORMING TOXIN; SEA-ANEMONE; NEUTRAL SPHINGOMYELINASE; STICHOLYSIN-II; MEMBRANE-BINDING; LIPID-MEMBRANES; EQUINATOXIN-II; DISTINCT POOL; BREFELDIN-A; CIS-GOLGI	Although sphingomyelin is an important cellular lipid, its subcellular distribution is not precisely known. Here we use a sea anemone cytolysin, equinatoxin II (EqtII), which specifically binds sphingomyelin, as a new marker to detect cellular sphingomyelin. A purified fusion protein composed of EqtII and green fluorescent protein (EqtII-GFP) binds to the SM rich apical membrane of Madin-Darby canine kidney (MDCK) II cells when added exogenously, but not to the SM-free basolateral membrane. When expressed intracellularly within MDCK II cells, EqtII-GFP colocalizes with markers for Golgi apparatus and not with those for nucleus, mitochondria, endoplasmic reticulum or plasma membrane. Colocalization with the Golgi apparatus was confirmed by also using NIH 3T3 fibroblasts. Moreover, EqtII-GFP was enriched in cis-Golgi compartments isolated by gradient ultracentrifugation. The data reveal that EqtII-GFP is a sensitive probe for membrane sphingomyelin, which provides new information on cytosolic exposure, essential to understand its diverse physiological roles.	[Bakrac, Biserka; Kladnik, Ales; Macek, Peter; Anderluh, Gregor] Univ Ljubljana, Dept Biol, Biotech Fac, Ljubljana 1000, Slovenia; [McHaffie, Gavin; Werner, Andreas; Lakey, Jeremy H.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [McHaffie, Gavin] Nottingham Univ Hosp NHS Trust, Nottingham Renal Unit, Nottingham NG5 1PB, England	University of Ljubljana; Newcastle University - UK; Nottingham University Hospital NHS Trust	Anderluh, G (corresponding author), Univ Ljubljana, Dept Biol, Biotech Fac, Vecna Pot 111, Ljubljana 1000, Slovenia.	gregor.anderluh@bf.uni-lj.si	Maček, Peter/Y-9877-2019; Maček, Peter/U-4662-2017; Kladnik, Aleš/B-6045-2008; Anderluh, Gregor/C-6905-2014	Maček, Peter/0000-0001-6470-7759; Maček, Peter/0000-0001-6470-7759; Kladnik, Aleš/0000-0002-3466-0088; Anderluh, Gregor/0000-0002-9916-8465	Slovenian Research Agency [P1-0207]; Slovene Human Resources Development and Scholarship Fund	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Slovene Human Resources Development and Scholarship Fund	This work was supported in part by the Slovenian Research Agency (P1-0207) and a fellowship from the Slovene Human Resources Development and Scholarship Fund (to B. B.).	Alegre-Cebollada J, 2004, FEBS LETT, V575, P14, DOI 10.1016/j.febslet.2004.08.031; Anderluh G, 2005, ANAL BIOCHEM, V344, P43, DOI 10.1016/j.ab.2005.06.013; Anderluh G, 2003, J BIOL CHEM, V278, P45216, DOI 10.1074/jbc.M305916200; Anderluh G, 1999, EUR J BIOCHEM, V263, P128, DOI 10.1046/j.1432-1327.1999.00477.x; Anderluh G, 1996, BIOCHEM BIOPH RES CO, V220, P437, DOI 10.1006/bbrc.1996.0391; Anderluh G, 2002, TOXICON, V40, P111, DOI 10.1016/S0041-0101(01)00191-X; Andrieu N, 1996, EUR J BIOCHEM, V236, P738, DOI 10.1111/j.1432-1033.1996.00738.x; Aye ILMH, 2009, CHEM-BIOL INTERACT, V180, P327, DOI 10.1016/j.cbi.2009.04.012; Bakrac B, 2008, J BIOL CHEM, V283, P18665, DOI 10.1074/jbc.M708747200; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Clarke CJ, 2006, BIOCHEMISTRY-US, V45, P11247, DOI 10.1021/bi061307z; Collins MD, 2008, P NATL ACAD SCI USA, V105, P124, DOI 10.1073/pnas.0702970105; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; FUTERMAN AH, 1990, J BIOL CHEM, V265, P8650; Gutierrez-Aguirre I, 2006, BIOCHEM J, V398, P381, DOI 10.1042/BJ20060206; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hansen RE, 2009, P NATL ACAD SCI USA, V106, P422, DOI 10.1073/pnas.0812149106; Hofmann K, 2000, P NATL ACAD SCI USA, V97, P5895, DOI 10.1073/pnas.97.11.5895; Hong Q, 2002, J BIOL CHEM, V277, P41916, DOI 10.1074/jbc.M204625200; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; JECKEL D, 1992, J CELL BIOL, V117, P259, DOI 10.1083/jcb.117.2.259; JECKEL D, 1990, FEBS LETT, V261, P155, DOI 10.1016/0014-5793(90)80659-7; Karakashian AA, 2004, FASEB J, V18, P968, DOI 10.1096/fj.03-0875fje; Kiessling V, 2009, BBA-BIOMEMBRANES, V1788, P64, DOI 10.1016/j.bbamem.2008.09.003; KOVAL M, 1991, BIOCHIM BIOPHYS ACTA, V1082, P113, DOI 10.1016/0005-2760(91)90184-J; Kristan K, 2004, J BIOL CHEM, V279, P46509, DOI 10.1074/jbc.M406193200; Kristan K, 2007, FEBS J, V274, P539, DOI 10.1111/j.1742-4658.2006.05608.x; Li ZQ, 2007, BBA-MOL CELL BIOL L, V1771, P1186, DOI 10.1016/j.bbalip.2007.05.007; LINARDIC CM, 1994, J BIOL CHEM, V269, P23530; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Lorizate M, 2009, J BIOL CHEM, V284, P22238, DOI 10.1074/jbc.M109.029256; Luberto C, 1998, J BIOL CHEM, V273, P14550, DOI 10.1074/jbc.273.23.14550; LUZIO JP, 1990, BIOCHEM J, V270, P97, DOI 10.1042/bj2700097; Malovrh P, 2003, J BIOL CHEM, V278, P22678, DOI 10.1074/jbc.M300622200; Mancheno JM, 2003, STRUCTURE, V11, P1319, DOI 10.1016/j.str.2003.09.019; Manes S, 2003, NAT REV IMMUNOL, V3, P557, DOI 10.1038/nri1129; MARCHESELLI VL, 1990, J BIOL CHEM, V265, P9140; Marchetti B, 2002, ONCOGENE, V21, P7808, DOI 10.1038/sj.onc.1205885; MEINARDI E, 1995, BIOCHEM BIOPH RES CO, V216, P348, DOI 10.1006/bbrc.1995.2630; Meng AM, 2004, EXP CELL RES, V292, P385, DOI 10.1016/j.yexcr.2003.10.001; Murakami MT, 2005, J BIOL CHEM, V280, P13658, DOI 10.1074/jbc.M412437200; Nagata Y, 2006, J CELL BIOL, V174, P245, DOI 10.1083/jcb.200605028; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Openshaw AEA, 2005, J BIOL CHEM, V280, P35011, DOI 10.1074/jbc.M506800200; Shogomori H, 2008, BBA-GEN SUBJECTS, V1780, P612, DOI 10.1016/j.bbagen.2007.09.001; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Tafesse FG, 2007, J BIOL CHEM, V282, P17537, DOI 10.1074/jbc.M702423200; Tafesse FG, 2006, J BIOL CHEM, V281, P29421, DOI 10.1074/jbc.R600021200; Tani M, 2007, FEBS LETT, V581, P1323, DOI 10.1016/j.febslet.2007.02.046; ULLMAN MD, 1974, J BIOL CHEM, V249, P1506; Valcarcel CA, 2001, BIOPHYS J, V80, P2761, DOI 10.1016/S0006-3495(01)76244-3; VAN MEER G, 1988, J CELL BIOCHEM, V36, P51, DOI 10.1002/jcb.240360106; van Meer G, 2005, EMBO J, V24, P3159, DOI 10.1038/sj.emboj.7600798; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; Zhang P, 1997, J BIOL CHEM, V272, P9609	62	52	52	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22186	22195		10.1074/jbc.M110.105122	http://dx.doi.org/10.1074/jbc.M110.105122			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20463009	hybrid, Green Published			2022-12-27	WOS:000279702200031
J	Grishin, AA; Wang, CIA; Muttenthaler, M; Alewood, PF; Lewis, RJ; Adams, DJ				Grishin, Anton A.; Wang, Ching-I A.; Muttenthaler, Markus; Alewood, Paul F.; Lewis, Richard J.; Adams, David J.			alpha-Conotoxin AuIB Isomers Exhibit Distinct Inhibitory Mechanisms and Differential Sensitivity to Stoichiometry of alpha 3 beta 4 Nicotinic Acetylcholine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACH-BINDING PROTEIN; SUBUNIT INTERFACES; CRYSTAL-STRUCTURE; ALTERNATE STOICHIOMETRIES; ANTAGONISTS; IMII; (ALPHA-4)(2)(BETA-2)(3); PHARMACOLOGY; EXPRESSION; DIVERSITY	Non-native disulfide isomers of alpha-conotoxins are generally inactive although some unexpectedly demonstrate comparable or enhanced bioactivity. The actions of "globular" and "ribbon" isomers of alpha-conotoxin AuIB have been characterized on alpha 3 beta 4 nicotinic acetylcholine receptors (nAChRs) heterologously expressed in Xenopus oocytes. Using two-electrode voltage clamp recording, we showed that the inhibitory efficacy of the ribbon isomer of AuIB is limited to similar to 50%. The maximal inhibition was stoichiometry-dependent because altering alpha 3:beta 4 RNA injection ratios either increased AuIB(ribbon) efficacy (10 alpha:1 beta) or completely abolished blockade (1 alpha:10 beta). In contrast, inhibition by AuIB(globular) was independent of injection ratios. ACh-evoked current amplitude was largest for 1:10 injected oocytes and smallest for the 10:1 ratio. ACh concentration-response curves revealed high (HS, 1:10) and low (LS, 10:1) sensitivity alpha 3 beta 4 nAChRs with corresponding EC50 values of 22.6 and 176.9 mu M, respectively. Increasing the agonist concentration antagonized the inhibition of LS alpha 3 beta 4 nAChRs by AuIB(ribbon), whereas inhibition of HS and LS alpha 3 beta 4 nAChRs by AuIB-(globular) was unaffected. Inhibition of LS and HS alpha 3 beta 4 nAChRs by AuIB(globular) was insurmountable and independent of membrane potential. Molecular docking simulation suggested that AuIB(globular) is likely to bind to both alpha 3 beta 4 nAChR stoichiometries outside of the ACh-binding pocket, whereas AuIB(ribbon) binds to the classical agonist-binding site of the LS alpha 3 beta 4 nAChR only. In conclusion, the two isomers of AuIB differ in their inhibitory mechanisms such that AuIB(ribbon) inhibits only LS alpha 3 beta 4 nAChRs competitively, whereas AuIB( globular) inhibits alpha 3 beta 4 nAChRs irrespective of receptor stoichiometry, primarily by a non-competitive mechanism.	[Grishin, Anton A.; Adams, David J.] RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic 3083, Australia; [Grishin, Anton A.; Adams, David J.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld 4072, Australia; [Wang, Ching-I A.; Muttenthaler, Markus; Alewood, Paul F.; Lewis, Richard J.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia	Royal Melbourne Institute of Technology (RMIT); University of Queensland; University of Queensland	Adams, DJ (corresponding author), RMIT Univ, Hlth Innovat Res Inst, POB 71, Bundoora, Vic 3083, Australia.	david.adams@rmit.edu.au	Muttenthaler, Markus/B-4944-2017; Lewis, Richard/T-8763-2019; Alewood, Paul F/J-2412-2014; Adams, David/J-9125-2014; Muttenthaler, Markus/AAF-5944-2021; Lewis, Richard J/E-8674-2013; Adams, David John/K-3578-2019	Muttenthaler, Markus/0000-0003-1996-4646; Lewis, Richard/0000-0003-3470-923X; Adams, David/0000-0002-7030-2288; Muttenthaler, Markus/0000-0003-1996-4646; Lewis, Richard J/0000-0003-3470-923X; Adams, David John/0000-0002-7030-2288; Alewood, Paul/0000-0001-7454-6522	National Health & Medical Research Council	National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a National Health & Medical Research Council Program Grant ( to R.J.L., P.F.A., and D.J.A.).	Arias HR, 2006, INT J BIOCHEM CELL B, V38, P1254, DOI 10.1016/j.biocel.2006.01.006; Azam L, 2009, ACTA PHARMACOL SIN, V30, P771, DOI 10.1038/aps.2009.47; Boorman JPB, 2000, J PHYSIOL-LONDON, V529, P565, DOI 10.1111/j.1469-7793.2000.00565.x; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Callaghan B, 2008, J NEUROSCI, V28, P10943, DOI 10.1523/JNEUROSCI.3594-08.2008; Carbone AL, 2009, BRIT J PHARMACOL, V156, P970, DOI 10.1111/j.1476-5381.2008.00104.x; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Dutertre S, 2005, J BIOL CHEM, V280, P30460, DOI 10.1074/jbc.M504229200; Dutertre S, 2007, EMBO J, V26, P3858, DOI 10.1038/sj.emboj.7601785; Dutton JL, 2002, J BIOL CHEM, V277, P48849, DOI 10.1074/jbc.M208842200; Ellison M, 2004, BIOCHEMISTRY-US, V43, P16019, DOI 10.1021/bi048918g; Ellison M, 2003, J BIOL CHEM, V278, P757, DOI 10.1074/jbc.M204565200; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Gotti C, 2008, MOL PHARMACOL, V73, P1796, DOI 10.1124/mol.108.045203; Groot-Kormelink PJ, 2006, MOL PHARMACOL, V69, P558, DOI 10.1124/mol.105.019356; Groot-Kormelink PJ, 2004, J GEN PHYSIOL, V123, P697, DOI 10.1085/jgp.200409042; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2007, J MOL BIOL, V369, P895, DOI 10.1016/j.jmb.2007.03.067; Jacobsen R, 1997, J BIOL CHEM, V272, P22531, DOI 10.1074/jbc.272.36.22531; Kasheverov IE, 2009, J NEUROCHEM, V111, P934, DOI 10.1111/j.1471-4159.2009.06359.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Loughnan M, 2006, J BIOL CHEM, V281, P24745, DOI 10.1074/jbc.M603703200; Luo SQ, 1998, J NEUROSCI, V18, P8571; Millar NS, 2009, NEUROPHARMACOLOGY, V56, P237, DOI 10.1016/j.neuropharm.2008.07.041; Moroni M, 2008, J NEUROSCI, V28, P6884, DOI 10.1523/JNEUROSCI.1228-08.2008; Moroni M, 2006, J MOL NEUROSCI, V30, P95, DOI 10.1385/JMN:30:1:95; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Nicke A, 2003, FEBS LETT, V554, P219, DOI 10.1016/S0014-5793(03)01161-X; PAPKE RL, 1991, J PHYSIOL-LONDON, V440, P95, DOI 10.1113/jphysiol.1991.sp018698; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Seo S, 2009, J NEUROSCI, V29, P8734, DOI 10.1523/JNEUROSCI.1859-09.2009; Shon KJ, 1997, BIOCHEMISTRY-US, V36, P9581, DOI 10.1021/bi970235w; Tapia L, 2007, MOL PHARMACOL, V71, P769, DOI 10.1124/mol.106.030445; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Zhou Y, 2003, J NEUROSCI, V23, P9004; Zwart R, 1998, MOL PHARMACOL, V54, P1124, DOI 10.1124/mol.54.6.1124	43	59	63	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22254	22263		10.1074/jbc.M110.111880	http://dx.doi.org/10.1074/jbc.M110.111880			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20466726	Green Published, hybrid			2022-12-27	WOS:000279702200038
J	Martin, F; Baskaran, P; Ma, XL; Dunten, PW; Schaefer, M; Stasch, JP; Beuve, A; van den Akker, F				Martin, Faye; Baskaran, Padmamalini; Ma, Xiaolei; Dunten, Pete W.; Schaefer, Martina; Stasch, Johannes-Peter; Beuve, Annie; van den Akker, Focco			Structure of Cinaciguat (BAY 58-2667) Bound to Nostoc H-NOX Domain Reveals Insights into Heme-mimetic Activation of the Soluble Guanylyl Cyclase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; DRUG DEVELOPMENT; BINDING; IDENTIFICATION; DISCOVERY; MOIETY; SENSOR	Heme is a vital molecule for all life forms with heme being capable of assisting in catalysis, binding ligands, and undergoing redox changes. Heme-related dysfunction can lead to cardiovascular diseases with the oxidation of the heme of soluble guanylyl cyclase (sGC) critically implicated in some of these cardiovascular diseases. sGC, the main nitric oxide (NO) receptor, stimulates second messenger cGMP production, whereas reactive oxygen species are known to scavenge NO and oxidize/inactivate the heme leading to sGC degradation. This vulnerability of NO-heme signaling to oxidative stress led to the discovery of an NO-independent activator of sGC, cinaciguat (BAY 58-2667), which is a candidate drug in clinical trials to treat acute decompensated heart failure. Here, we present crystallographic and mutagenesis data that reveal the mode of action of BAY 58-2667. The 2.3-angstrom resolution structure of BAY 58-2667 bound to a heme NO and oxygen binding domain (H-NOX) from Nostoc homologous to that of sGC reveals that the trifurcated BAY 58-2667 molecule has displaced the heme and acts as a heme mimetic. Carboxylate groups of BAY 58-2667 make interactions similar to the heme-propionate groups, whereas its hydrophobic phenyl ring linker folds up within the heme cavity in a planar-like fashion. BAY 58-2667 binding causes a rotation of the alpha F helix away from the heme pocket, as this helix is normally held in place via the inhibitory His(105)-heme covalent bond. The structure provides insights into how BAY 58-2667 binds and activates sGC to rescue heme-NO dysfunction in cardiovascular diseases.	[Martin, Faye; van den Akker, Focco] Case Western Reserve Univ, Dept Biochem RT500, Cleveland, OH 44120 USA; [Baskaran, Padmamalini; Beuve, Annie] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA; [Ma, Xiaolei] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; [Dunten, Pete W.] Stanford Univ, Stanford Synchrotron Radiat Lab, Menlo Pk, CA 94025 USA; [Stasch, Johannes-Peter] Bayer Schering Pharma AG, Cardiovasc Res, D-42096 Wuppertal, Germany	Case Western Reserve University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Roche Holding; Genentech; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Bayer AG; Bayer Healthcare Pharmaceuticals	van den Akker, F (corresponding author), Case Western Reserve Univ, Dept Biochem RT500, 10900 Euclid Ave, Cleveland, OH 44106 USA.	focco.vandenakker@case.edu	Martin, Faye/I-1759-2012; Ma, Xiaolei/G-2058-2010	Ma, Xiaolei/0000-0002-5307-827X	National Institutes of Health [R01 HL075329, R01 GM067640]; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources, Biomedical Technology; NIGMS, National Institutes of Health; National Center for Research Resources (NCRR), National Institutes of Health [5 P41 RR001209]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067640] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources, Biomedical Technology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources (NCRR), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was financially supported, in whole or in part, by National Institutes of Health Grants R01 HL075329 (to F. v. d. A.) and R01 GM067640 (to A. B.). The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program and the NIGMS, National Institutes of Health. The projects described were partially supported by Grant 5 P41 RR001209 from the National Center for Research Resources (NCRR), National Institutes of Health.	Behrends S, 2003, CURR MED CHEM, V10, P291, DOI 10.2174/0929867033368286; BITTNER AR, 2009, Patent No. 20090209556; Boerrigter Guido, 2009, V191, P485, DOI 10.1007/978-3-540-68964-5_21; Bryan NS, 2009, FRONT BIOSCI-LANDMRK, V14, P1, DOI 10.2741/3228; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erbil WK, 2009, P NATL ACAD SCI USA, V106, P19753, DOI 10.1073/pnas.0911645106; Evgenov OV, 2006, NAT REV DRUG DISCOV, V5, P755, DOI 10.1038/nrd2038; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; Krishnamurthy P, 2007, PHARMACOL THERAPEUT, V114, P345, DOI 10.1016/j.pharmthera.2007.02.001; Lamothe M, 2004, BIOCHEMISTRY-US, V43, P3039, DOI 10.1021/bi0360051; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Ma XL, 2007, EMBO J, V26, P578, DOI 10.1038/sj.emboj.7601521; Meurer S, 2009, CIRC RES, V105, P33, DOI 10.1161/CIRCRESAHA.109.198234; Murad F, 2006, NEW ENGL J MED, V355, P2003, DOI 10.1056/NEJMsa063904; Nioche P, 2004, SCIENCE, V306, P1550, DOI 10.1126/science.1103596; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pellicena P, 2004, P NATL ACAD SCI USA, V101, P12854, DOI 10.1073/pnas.0405188101; Rothkegel C, 2006, FEBS LETT, V580, P4205, DOI 10.1016/j.febslet.2006.06.079; Schmidt Harald H. H. W., 2009, V191, P309, DOI 10.1007/978-3-540-68964-5_14; Schmidt PM, 2005, EUR J PHARMACOL, V513, P67, DOI 10.1016/j.ejphar.2005.02.046; Schmidt PM, 2004, J BIOL CHEM, V279, P3025, DOI 10.1074/jbc.M310141200; Schneider TR, 2000, ACTA CRYSTALLOGR D, V56, P714, DOI 10.1107/S0907444900003723; Stasch JP, 2002, BRIT J PHARMACOL, V136, P773, DOI 10.1038/sj.bjp.0704778; Stone JR, 1996, BIOCHEMISTRY-US, V35, P1093, DOI 10.1021/bi9519718; vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047; Winger JA, 2005, BIOCHEMISTRY-US, V44, P4083, DOI 10.1021/bi047601d; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Yeates TO, 1997, METHOD ENZYMOL, V276, P344, DOI 10.1016/S0076-6879(97)76068-3	29	87	91	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22651	22657		10.1074/jbc.M110.111559	http://dx.doi.org/10.1074/jbc.M110.111559			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20463019	Green Published, hybrid			2022-12-27	WOS:000279702200075
J	Lee, DE; Lee, KW; Song, NR; Seo, SK; Heo, YS; Kang, NJ; Bode, AM; Lee, HJ; Dong, ZG				Lee, Dong Eun; Lee, Ki Won; Song, Nu Ry; Seo, Sang Kwon; Heo, Yong-Seok; Kang, Nam Joo; Bode, Ann M.; Lee, Hyong Joo; Dong, Zigang			7,3 ',4 '-Trihydroxyisoflavone Inhibits Epidermal Growth Factor-induced Proliferation and Transformation of JB6 P+ Mouse Epidermal Cells by Suppressing Cyclin-dependent Kinases and Phosphatidylinositol 3-Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; IN-VITRO; OXIDATIVE-METABOLISM; THERAPEUTIC TARGETS; PROSTATE-CANCER; SOY ISOFLAVONES; D1 EXPRESSION; CL41 CELLS; GENISTEIN; PATHWAY	Numerous in vitro and in vivo studies have shown that isoflavones exhibit anti-proliferative activity against epidermal growth factor (EGF) receptor-positive malignancies of the breast, colon, skin, and prostate. 7,3',4'-Trihydroxyisoflavone (7,3',4'-THIF) is one of the metabolites of daidzein, a well known soy isoflavone, but its chemopreventive activity and the underlying molecular mechanisms are poorly understood. In this study, 7,3',4'-THIF prevented EGF-induced neoplastic transformation and proliferation of JB6 P+ mouse epidermal cells. It significantly blocked cell cycle progression of EGF-stimulated cells at the G(1) phase. As shown by Western blot, 7,3',4'-THIF suppressed the phosphorylation of retinoblastoma protein at Ser-795 and Ser-807/Ser-811, which are the specific sites of phosphorylation by cyclin-dependent kinase (CDK) 4. It also inhibited the expression of G(1) phase-regulatory proteins, including cyclin D1, CDK4, cyclin E, and CDK2. In addition to regulating the expression of cell cycle-regulatory proteins, 7,3',4'-THIF bound to CDK4 and CDK2 and strongly inhibited their kinase activities. It also bound to phosphatidylinositol 3-kinase (PI3K), strongly inhibiting its kinase activity and thereby suppressing the Akt/GSK-3 beta/AP-1 pathway and subsequently attenuating the expression of cyclin D1. Collectively, these results suggest that CDKs and PI3K are the primary molecular targets of 7,3',4'-THIF in the suppression of EGF-induced cell proliferation. These insights into the biological actions of 7,3',4'-THIF provide a molecular basis for the possible development of new chemoprotective agents.	[Lee, Dong Eun; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Lee, Dong Eun; Song, Nu Ry; Seo, Sang Kwon; Lee, Hyong Joo] Seoul Natl Univ, Dept Agr Biotechnol, WCU, Seoul 151921, South Korea; [Lee, Dong Eun; Lee, Ki Won] Konkuk Univ, Dept Biosci & Biotechnol, Bio Mol Informat Ctr, Seoul 143701, South Korea; [Heo, Yong-Seok] Konkuk Univ, Dept Chem, Seoul 143701, South Korea; [Kang, Nam Joo] Kyungpook Natl Univ, Sch Appl Biosci, Taegu 702701, South Korea	University of Minnesota System; Seoul National University (SNU); Konkuk University; Konkuk University; Kyungpook National University	Lee, HJ (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151742, South Korea.	leehyjo@snu.ac.kr; zgdong@hi.umn.edu	Heo, Yong-Seok/D-8244-2011; Lee, Ki Won/M-4114-2018		National Institutes of Health [CA027502, CA120388, CA111536, CA077646, CA081064]; Hormel Foundation; World Class University [R31-2008-00-10056-0]; Priority Research Centers Program [2009-0093824]; Ministry of Education, Science and Technology, Republic of Korea [314-2007-1-F00054, 2009-0090797]; NATIONAL CANCER INSTITUTE [R01CA081064, R37CA081064, R01CA111536, R01CA120388, R01CA077646, P01CA027502] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hormel Foundation; World Class University; Priority Research Centers Program; Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA027502, CA120388, CA111536, CA077646, and CA081064. This work was also supported by The Hormel Foundation, by grants from the World Class University Program (R31-2008-00-10056-0), Priority Research Centers Program (2009-0093824), and Basic Science Research Program (314-2007-1-F00054, and 2009-0090797) through the National Research Foundation (NRF) of Korea, Funded by the Ministry of Education, Science and Technology, Republic of Korea.	Ahmad N, 1997, JNCI-J NATL CANCER I, V89, P1881, DOI 10.1093/jnci/89.24.1881; Bennink MR, 2001, ADV EXP MED BIOL, V492, P11; Bode AM, 2006, MOL CARCINOGEN, V45, P422, DOI 10.1002/mc.20222; BROWN PH, 1993, ONCOGENE, V8, P877; COLBURN NH, 1979, NATURE, V281, P589, DOI 10.1038/281589a0; Day PJ, 2009, P NATL ACAD SCI USA, V106, P4166, DOI 10.1073/pnas.0809645106; Diehl JA, 2002, CANCER BIOL THER, V1, P226, DOI 10.4161/cbt.72; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; DONG ZG, 1994, P NATL ACAD SCI USA, V91, P609, DOI 10.1073/pnas.91.2.609; Elangovan S, 2008, ANTICANCER RES, V28, P2641; Farina HG, 2006, ONCOL REP, V16, P885; Furuse J, 2008, CRIT REV ONCOL HEMAT, V67, P8, DOI 10.1016/j.critrevonc.2008.02.009; Hewitt AL, 2003, CANCER LETT, V192, P133, DOI 10.1016/S0304-3835(02)00712-7; Jian L, 2009, MOL NUTR FOOD RES, V53, P217, DOI 10.1002/mnfr.200800167; Kang NJ, 2007, J BIOL CHEM, V282, P32856, DOI 10.1074/jbc.M701459200; Khalil Mazen Y, 2003, Expert Rev Anticancer Ther, V3, P367, DOI 10.1586/14737140.3.3.367; Kulling SE, 2000, J AGR FOOD CHEM, V48, P4963, DOI 10.1021/jf000524i; Kulling SE, 2002, J CHROMATOGR B, V777, P211, DOI 10.1016/S1570-0232(02)00215-5; Kulling SE, 2001, J AGR FOOD CHEM, V49, P3024, DOI 10.1021/jf0012695; Lee MH, 2003, CANCER METAST REV, V22, P435, DOI 10.1023/A:1023785332315; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Ma C, 2007, CANCER RES, V67, P7756, DOI 10.1158/0008-5472.CAN-06-4665; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; MESSINA MJ, 1994, NUTR CANCER, V21, P113, DOI 10.1080/01635589409514310; Mimeault M, 2003, GROWTH FACTORS, V21, P1, DOI 10.1080/0897719031000094921; Ouyang W, 2006, CARCINOGENESIS, V27, P864, DOI 10.1093/carcin/bgi321; Petty WJ, 2003, LUNG CANCER, V41, pS155, DOI 10.1016/S0169-5002(03)00159-4; Rogozin EA, 2008, CARCINOGENESIS, V29, P1228, DOI 10.1093/carcin/bgn016; Rufer CE, 2006, DRUG METAB DISPOS, V34, P51, DOI 10.1124/dmd.105.004929; Sarkar FH, 2006, MINI-REV MED CHEM, V6, P401, DOI 10.2174/138955706776361439; Sebolt-Leopold JS, 2006, NATURE, V441, P457, DOI 10.1038/nature04874; Shapiro GI, 2006, J CLIN ONCOL, V24, P1770, DOI 10.1200/JCO.2005.03.7689; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shukla S, 2007, CELL CYCLE, V6, P1102, DOI 10.4161/cc.6.9.4146; Song WO, 2007, J MED FOOD, V10, P571, DOI 10.1089/jmf.2006.0620; Steelman LS, 2008, EXPERT OPIN THER TAR, V12, P1139, DOI [10.1517/14728222.12.9.1139, 10.1517/14728222.12.9.1139 ]; Takahashi-Yanaga F, 2008, CELL SIGNAL, V20, P581, DOI 10.1016/j.cellsig.2007.10.018; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Wang J, 2004, MOL CELL ENDOCRINOL, V219, P171, DOI 10.1016/j.mce.2003.12.018; Wu AH, 1998, AM J CLIN NUTR, V68, p1437S, DOI 10.1093/ajcn/68.6.1437S; Yokota T, 2007, CANCER SCI, V98, P1447, DOI 10.1111/j.1349-7006.2007.00560.x; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhang DY, 2009, TOXICOL APPL PHARM, V235, P18, DOI 10.1016/j.taap.2008.11.002	45	34	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21458	21466		10.1074/jbc.M109.094797	http://dx.doi.org/10.1074/jbc.M109.094797			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20444693	hybrid, Green Published			2022-12-27	WOS:000279516100032
J	Lee, TY; Lai, TY; Lin, SC; Wu, CW; Ni, IF; Yang, YS; Hung, LY; Law, BK; Chiang, CW				Lee, Ting-Yuan; Lai, Tai-Yu; Lin, Shin-Chih; Wu, Cheng-Wei; Ni, In-Fan; Yang, Yu-San; Hung, Liang-Yi; Law, Brian K.; Chiang, Chi-Wu			The B56 gamma 3 Regulatory Subunit of Protein Phosphatase 2A (PP2A) Regulates S Phase-specific Nuclear Accumulation of PP2A and the G(1) to S Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT KINASE INHIBITOR; CDK INHIBITOR; B-SUBUNIT; PHOSPHORYLATION; P27(KIP1); IDENTIFICATION; FAMILY; LOCALIZATION; CLONING; BETA	Protein phosphatase 2A (PP2A) is a heterotrimeric enzyme consisting of a scaffold subunit (A), a catalytic subunit (C), and a variable regulatory subunit (B). The regulatory B subunits determine the substrate specificity and subcellular localization of the PP2A holoenzyme. Here, we demonstrate that the subcellular localization of the B56 gamma 3 regulatory subunit is regulated in a cell cycle-specific manner. Notably, B56 gamma 3 becomes enriched in the nucleus at the G(1)/S border and in S phase. The S phase-specific nuclear enrichment of B56 gamma 3 is accompanied by increases of nuclear A and C subunits and nuclear PP2A activity. Overexpression of B56 gamma 3 promotes nuclear localization of the A and C subunits, whereas silencing both B56 gamma 2 and B56 gamma 3 blocks the S phase-specific increase in the nuclear localization and activity of PP2A. In NIH3T3 cells, B56 gamma 3 overexpression reduces p27 phosphorylation at Thr-187, concomitantly elevates p27 protein levels, delays the G(1) to S transition, and retards cell proliferation. Consistently, knockdown of endogenous B56 gamma 3 expression reduces p27 protein levels and increases cell proliferation in HeLa cells. These findings demonstrate that the dynamic nuclear distribution of the B56 gamma 3 regulatory subunit controls nuclear PP2A activity, which regulates cell cycle controllers, such as p27, to restrain cell cycle progression, and may be responsible for the tumor suppressor function of PP2A.	[Lin, Shin-Chih; Wu, Cheng-Wei; Ni, In-Fan; Yang, Yu-San; Chiang, Chi-Wu] Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan 701, Taiwan; [Lee, Ting-Yuan; Lai, Tai-Yu; Chiang, Chi-Wu] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 701, Taiwan; [Hung, Liang-Yi] Natl Cheng Kung Univ, Coll Med, Inst Biosignal Transduct, Tainan 701, Taiwan; [Hung, Liang-Yi; Chiang, Chi-Wu] Natl Cheng Kung Univ, Coll Med, Ctr Gene Regulat & Signal Transduct Res, Tainan 701, Taiwan; [Law, Brian K.] Univ Florida, Dept Pharmacol & Therapeut, Shands Canc Ctr, Gainesville, FL 32610 USA	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; State University System of Florida; University of Florida	Chiang, CW (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Mol Med, 1 Univ Rd, Tainan 701, Taiwan.	chiangcw@mail.ncku.edu.tw	Law, Brian/L-6043-2019; Hung, Liang-Yi/AAG-4174-2019	, Liang-Yi/0000-0002-7284-2608	National Science Council [96-2320-B006-045-MY3, DOH99-TD-C-111-003]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council Grants 96-2320-B006-045-MY3 and DOH99-TD-C-111-003 (to the Comprehensive Cancer Center in southern Taiwan).	Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chiang CW, 2001, BLOOD, V97, P1289, DOI 10.1182/blood.V97.5.1289; Coats S, 1996, SCIENCE, V272, P877, DOI 10.1126/science.272.5263.877; Csortos C, 1996, J BIOL CHEM, V271, P2578, DOI 10.1074/jbc.271.5.2578; Dagda RK, 2003, J BIOL CHEM, V278, P24976, DOI 10.1074/jbc.M302832200; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Gentry MS, 2002, MOL BIOL CELL, V13, P3477, DOI 10.1091/mbc.02-05-0065; Gigena MS, 2005, AM J PHYSIOL-HEART C, V289, pH285, DOI 10.1152/ajpheart.01291.2004; Harper Jane V., 2004, V296, P157; HEALY AM, 1991, MOL CELL BIOL, V11, P5767, DOI 10.1128/MCB.11.11.5767; Ito A, 2000, EMBO J, V19, P562, DOI 10.1093/emboj/19.4.562; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jiang W, 2000, GENETICS, V154, P1025; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Li HH, 2007, EMBO J, V26, P402, DOI 10.1038/sj.emboj.7601519; Lubert EJ, 2003, BIOCHEM BIOPH RES CO, V303, P908, DOI 10.1016/S0006-291X(03)00434-0; MAYER RE, 1991, BIOCHEMISTRY-US, V30, P3589, DOI 10.1021/bi00229a001; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; MCCRIGHT B, 1995, J BIOL CHEM, V270, P26123, DOI 10.1074/jbc.270.44.26123; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Moreno CS, 2000, J BIOL CHEM, V275, P5257, DOI 10.1074/jbc.275.8.5257; Morisaki H, 1997, BIOCHEM BIOPH RES CO, V240, P386, DOI 10.1006/bbrc.1997.7590; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Shouse GP, 2008, MOL CELL BIOL, V28, P448, DOI 10.1128/MCB.00983-07; Strack S, 1999, FEBS LETT, V460, P462, DOI 10.1016/S0014-5793(99)01377-0; Strack S, 1998, J COMP NEUROL, V392, P515; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Tanabe O, 1996, FEBS LETT, V379, P107, DOI 10.1016/0014-5793(95)01500-0; Tang ZY, 2006, DEV CELL, V10, P575, DOI 10.1016/j.devcel.2006.03.010; Tehrani MA, 1996, J BIOL CHEM, V271, P5164; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Waltregny D, 2004, AM J PATHOL, V165, P553, DOI 10.1016/S0002-9440(10)63320-2; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033	40	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21567	21580		10.1074/jbc.M109.094953	http://dx.doi.org/10.1074/jbc.M109.094953			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20448040	Green Published, hybrid			2022-12-27	WOS:000279516100043
J	Chen, Z; Medina, F; Liu, MY; Thomas, C; Sprang, SR; Sternweis, PC				Chen, Zhe; Medina, Frank; Liu, Mu-Ya; Thomas, Celestine; Sprang, Stephen R.; Sternweis, Paul C.			Activated RhoA Binds to the Pleckstrin Homology (PH) Domain of PDZ-RhoGEF, a Potential Site for Autoregulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; PLASMA-MEMBRANE RECRUITMENT; CRYSTAL-STRUCTURE; P115 RHOGEF; RECOGNITION; COMPLEX; GTPASES; DETERMINANTS; G-ALPHA(12); P115RHOGEF	Guanine nucleotide exchange factors (GEFs) catalyze exchange of GDP for GTP by stabilizing the nucleotide-free state of the small GTPases through their Dbl homology/pleckstrin homology (DH.PH) domains. Unconventionally, PDZ-RhoGEF (PRG), a member of the RGS-RhoGEFs, binds tightly to both nucleotide-free and activated RhoA (RhoA.GTP). We have characterized the interaction between PRG and activated RhoA and determined the structure of the PRG-DH.PH-RhoA.GTP gamma S (guanosine 5'-O-[gamma-thio]triphosphate) complex. The interface bears striking similarity to a GTPase-effector interface and involves the switch regions in RhoA and a hydrophobic patch in PRG-PH that is conserved among all Lbc RhoGEFs. The two surfaces that bind activated and nucleotide-free RhoA on PRG-DH.PH do not overlap, and a ternary complex of PRG-DH.PH bound to both forms of RhoA can be isolated by size-exclusion chromatography. This novel interaction between activated RhoA and PH could play a key role in regulation of RhoGEF activity in vivo.	[Chen, Zhe; Medina, Frank; Liu, Mu-Ya; Sternweis, Paul C.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Thomas, Celestine; Sprang, Stephen R.] Univ Montana, Div Biol Sci, Ctr Biomol Struct & Dynam, Missoula, MT 59812 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Montana System; University of Montana	Chen, Z (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.	Zhe.Chen@utsouthwestern.edu; Paul.Sternweis@utsouthwestern.edu		Chen, Zhe/0000-0002-1668-4051	National Institutes of Health [GM31954, DK46371]; Robert A. Welch Foundation [I-1262]; Alfred and Mabel Gilman Chair in Molecular Pharmacology; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK046371, R01DK046371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Alfred and Mabel Gilman Chair in Molecular Pharmacology; United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM31954 (to P. C. S.) and DK46371 (to S. R. S.). This work was also supported by the Robert A. Welch Foundation Grant I-1262 (to P. C. S.) and a grant from the Alfred and Mabel Gilman Chair in Molecular Pharmacology (to P. C. S.).; We thank Jana Hadas and Stephen Gutowski for superb technical assistance and Diana Tomchick for assistance with data collection. Results shown in this report are derived from work performed at the Argonne National Laboratory, Structural Biology Center, at the Advanced Photon Source. Argonne is operated by UChicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357.	Aittaleb M, 2009, CELL SIGNAL, V21, P1569, DOI 10.1016/j.cellsig.2009.06.003; Aurandt J, 2002, P NATL ACAD SCI USA, V99, P12085, DOI 10.1073/pnas.142433199; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baumeister MA, 2003, J BIOL CHEM, V278, P11457, DOI 10.1074/jbc.M211901200; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhattacharyya R, 2003, BIOCHEM J, V371, P709, DOI 10.1042/BJ20021897; Bhattacharyya R, 2000, J BIOL CHEM, V275, P14992, DOI 10.1074/jbc.M000415200; Bhattacharyya R, 2009, CELL SIGNAL, V21, P996, DOI 10.1016/j.cellsig.2009.02.010; Chen Z, 2005, NAT STRUCT MOL BIOL, V12, P191, DOI 10.1038/nsmb888; Chen Z, 2008, STRUCTURE, V16, P1532, DOI 10.1016/j.str.2008.07.009; Chikumi H, 2004, ONCOGENE, V23, P233, DOI 10.1038/sj.onc.1207012; Cierpicki T, 2009, PROTEIN SCI, V18, P2067, DOI 10.1002/pro.219; DeLano W.L, PYMOL MOL GRAPHICS S; Derewenda U, 2004, STRUCTURE, V12, P1955, DOI 10.1016/j.str.2004.09.003; Dvorsky R, 2004, J BIOL CHEM, V279, P7098, DOI 10.1074/jbc.M311911200; Eisenhaure TM, 2003, J BIOL CHEM, V278, P30975, DOI 10.1074/jbc.M303277200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Hemsath L, 2005, MOL CELL, V20, P313, DOI 10.1016/j.molcel.2005.08.036; Ihara K, 1998, J BIOL CHEM, V273, P9656, DOI 10.1074/jbc.273.16.9656; Jackson M, 2001, NATURE, V410, P89, DOI 10.1038/35065091; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kristelly R, 2004, J BIOL CHEM, V279, P47352, DOI 10.1074/jbc.M406056200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lemmon MA, 2001, BIOCHEM SOC T, V29, P377, DOI 10.1042/BST0290377; Maesaki R, 1999, MOL CELL, V4, P793, DOI 10.1016/S1097-2765(00)80389-5; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Rossman KL, 2003, J BIOL CHEM, V278, P18393, DOI 10.1074/jbc.M300127200; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Sternweis PC, 2007, ADV PROTEIN CHEM, V74, P189, DOI 10.1016/S0065-3233(07)74006-8; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Taya S, 2001, J CELL BIOL, V155, P809, DOI 10.1083/jcb.200106139; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wei YY, 1997, NAT STRUCT BIOL, V4, P699, DOI 10.1038/nsb0997-699; Wells CD, 2001, J BIOL CHEM, V276, P28897, DOI 10.1074/jbc.M102913200; Yamada T, 2005, J BIOL CHEM, V280, P19358, DOI 10.1074/jbc.M414561200; Zheng MY, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-36	46	36	37	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21070	21081		10.1074/jbc.M110.122549	http://dx.doi.org/10.1074/jbc.M110.122549			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20430886	Green Published, hybrid			2022-12-27	WOS:000279228600070
J	Claessen, JHL; Mueller, B; Spooner, E; Pivorunas, VL; Ploegh, HL				Claessen, Jasper H. L.; Mueller, Britta; Spooner, Eric; Pivorunas, Valerie L.; Ploegh, Hidde L.			The Transmembrane Segment of a Tail-anchored Protein Determines Its Degradative Fate through Dislocation from the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; MEMBRANE-PROTEIN; QUALITY-CONTROL; MISFOLDED PROTEINS; UBIQUITIN-LIGASE; COMPLEX; CYTOSOL; RECOGNITION; INSERTION; ENZYME	Terminally misfolded proteins that accumulate in the endoplasmic reticulum (ER) are dislocated and targeted for ubiquitin-dependent destruction by the proteasome. UBC6e is a tail-anchored E2 ubiquitin-conjugating enzyme that is part of a dislocation complex nucleated by the ER-resident protein SEL1L. Little is known about the turnover of tail-anchored ER proteins. We constructed a set of UBC6e transmembrane domain replacement mutants and found that the tail anchor of UBC6e is vital for its function, its stability, and its mode of membrane integration, the last step dependent on the ASNA1/TRC40 chaperone. We constructed a tail-anchored UBC6e variant that requires for its removal from the ER membrane not only YOD1 and p97, two cytosolic proteins involved in the extraction of ER transmembrane or luminal proteins, but also UBXD8, AUP1 and members of the Derlin family. Degradation of tail-anchored proteins thus relies on components that are also used in other aspects of protein quality control in the ER.	[Ploegh, Hidde L.] MIT, Dept Biol, Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Ploegh, HL (corresponding author), MIT, Dept Biol, Whitehead Inst Biomed Res, Cambridge Ctr 9, 77 Massachusetts Ave, Cambridge, MA 02142 USA.	ploegh@wi.mit.edu			National Institutes of Health; Boehringer Ingelheim Fonds	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Fonds(Boehringer Ingelheim)	This work was supported, in whole or in part, by grants from the National Institutes of Health (to H. L. P.). This work was also supported by a fellowship from the Boehringer Ingelheim Fonds (to J. H. L. C.).	Ahn KS, 1996, P NATL ACAD SCI USA, V93, P10990, DOI 10.1073/pnas.93.20.10990; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; HEBERT DN, 2010, SEMIN CELL IN PRESS; Horn SC, 2009, MOL CELL, V36, P782, DOI 10.1016/j.molcel.2009.10.015; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Mateja A, 2009, NATURE, V461, P361, DOI 10.1038/nature08319; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Oh RS, 2006, J BIOL CHEM, V281, P21480, DOI 10.1074/jbc.M601843200; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Ronchi P, 2008, J CELL BIOL, V181, P105, DOI 10.1083/jcb.200710093; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Suloway CJM, 2009, P NATL ACAD SCI USA, V106, P14849, DOI 10.1073/pnas.0907522106; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041	26	28	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20732	20739		10.1074/jbc.M110.120766	http://dx.doi.org/10.1074/jbc.M110.120766			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20435896	Green Published, hybrid			2022-12-27	WOS:000279228600037
J	Singh, G; Singh, SK; Konig, A; Reutlinger, K; Nye, MD; Adhikary, T; Eilers, M; Gress, TM; Fernandez-Zapico, ME; Ellenrieder, V				Singh, Garima; Singh, Shiv K.; Koenig, Alexander; Reutlinger, Kristina; Nye, Monica D.; Adhikary, Tillman; Eilers, Martin; Gress, Thomas M.; Fernandez-Zapico, Martin E.; Ellenrieder, Volker			Sequential Activation of NFAT and c-Myc Transcription Factors Mediates the TGF-beta Switch from a Suppressor to a Promoter of Cancer Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; SIGNALING PATHWAY; GENE-EXPRESSION; SMAD PROTEINS; REPRESSION; P15(INK4B); CARCINOGENESIS; MECHANISMS; RESPONSES; ARREST	Transforming growth factor beta (TGF-beta) has a dual role in carcinogenesis, acting as a growth inhibitor in early tumor stages and a promoter of cell proliferation in advanced diseases. Although this cellular phenomenon is well established, the underlying molecular mechanisms remain elusive. Here, we report that sequential induction of NFAT and c-Myc transcription factors is sufficient and required for the TGF-beta switch from a cell cycle inhibitor to a growth promoter pathway in cancer cells. Mechanistically, TGF-beta induces in a calcineurin-dependent manner the expression and activation of NFAT factors, which then translocate into the nucleus to promote c-Myc expression. In response to TGF-beta, activated NFAT factors bind to and displace Smad3 repressor complexes from the previously identified TGF-beta inhibitory element (TIE) to transactivate the c-Myc promoter. c-Myc in turn stimulates cell cycle progression and growth through up-regulation of D-type cyclins. Most importantly, NFAT knockdown not only prevents c-Myc activation and cell proliferation, but also partially restores TGF-beta-induced cell cycle arrest and growth suppression. Taken together, this study provides the first evidence for a Smad-independent master regulatory pathway in TGF-beta-promoted cell growth that is defined by sequential transcriptional activation of NFAT and c-Myc factors.	[Nye, Monica D.; Fernandez-Zapico, Martin E.] Mayo Clin, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA; [Singh, Garima; Singh, Shiv K.; Koenig, Alexander; Reutlinger, Kristina; Gress, Thomas M.; Ellenrieder, Volker] Univ Marburg, Signal Transduct & Transcript Lab, Dept Gastroenterol & Endocrinol, D-35043 Marburg, Germany; [Adhikary, Tillman] Univ Marburg, Inst Mol Biol & Tumor Res, D-35032 Marburg, Germany; [Eilers, Martin] Univ Wurzburg, Dept Physiol Chem 2, Theodor Boveri Inst, D-97074 Wurzburg, Germany	Mayo Clinic; Philipps University Marburg; Philipps University Marburg; University of Wurzburg	Fernandez-Zapico, ME (corresponding author), Mayo Clin, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA.	fernandezzapico.martin@mayo.edu; ellenrie@med.uni-marburg.de		Gress, Thomas/0000-0002-9333-5461; Eilers, Martin/0000-0002-0376-6533	Deutsche Forschungsgemeinschaft (DFG) [SFB-TR17, KFO 210]; German Cancer Research Foundation (Deutsche Krebshilfe) [70-3022-El I]; Division of Oncology Research, Mayo Clinic Cancer Center, Miles and Shirley Fiterman Center for Digestive Disease [CA136526]; Carole and Bob Daly AACR-PANCAN Career Development Award for Pancreatic Cancer Research, Mayo Clinic Pancreatic SPORE [P50 CA102701]; NIDDK [P30DK084567]; Leukemia and Lymphoma Society Translational Research Program; NATIONAL CANCER INSTITUTE [R01CA136526, P50CA102701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Cancer Research Foundation (Deutsche Krebshilfe)(Deutsche Krebshilfe); Division of Oncology Research, Mayo Clinic Cancer Center, Miles and Shirley Fiterman Center for Digestive Disease; Carole and Bob Daly AACR-PANCAN Career Development Award for Pancreatic Cancer Research, Mayo Clinic Pancreatic SPORE; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Leukemia and Lymphoma Society Translational Research Program(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, SFB-TR17, and KFO 210) and the Max Eder programme of the German Cancer Research Foundation (Deutsche Krebshilfe, 70-3022-El I) (to V. E.). This work was also supported by the Division of Oncology Research, Mayo Clinic Cancer Center, Miles and Shirley Fiterman Center for Digestive Disease, CA136526, Carole and Bob Daly AACR-PANCAN Career Development Award for Pancreatic Cancer Research, Mayo Clinic Pancreatic SPORE P50 CA102701, Mayo Clinic Center for Cell Signaling in Gastroenterology (NIDDK P30DK084567), and Leukemia and Lymphoma Society Translational Research Program (to M. E. F.-Z.).	Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Buchholz M, 2007, CELL CYCLE, V6, P16, DOI 10.4161/cc.6.1.3650; Buchholz M, 2006, EMBO J, V25, P3714, DOI 10.1038/sj.emboj.7601246; Calonge MJ, 1999, J BIOL CHEM, V274, P33637, DOI 10.1074/jbc.274.47.33637; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chen CR, 2001, P NATL ACAD SCI USA, V98, P992, DOI 10.1073/pnas.98.3.992; de Caestecker MP, 2000, JNCI-J NATL CANCER I, V92, P1388, DOI 10.1093/jnci/92.17.1388; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ellenrieder V, 2008, ANTICANCER RES, V28, P1531; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Im SH, 2004, MOL CELLS, V18, P1; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Jonson T, 2001, INT J ONCOL, V19, P71; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Medyouf H, 2008, CELL CYCLE, V7, P297, DOI 10.4161/cc.7.3.5357; Moore PS, 2001, VIRCHOWS ARCH, V439, P798, DOI 10.1007/s004280100474; ORIAN A, 2001, SCI STKE, V26, P88; Pardali K, 2000, J BIOL CHEM, V275, P29244, DOI 10.1074/jbc.M909467199; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Robbs BK, 2008, MOL CELL BIOL, V28, P7168, DOI 10.1128/MCB.00256-08; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Seoane J, 2006, CARCINOGENESIS, V27, P2148, DOI 10.1093/carcin/bgl068; SERFLING E, 2007, SCI STKE, V398, P42; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Ten Dijke PT, 2002, J CELL PHYSIOL, V191, P1, DOI 10.1002/jcp.10066; Woodford-Richens KL, 2001, P NATL ACAD SCI USA, V98, P9719, DOI 10.1073/pnas.171321498; Yan ZF, 2002, J BIOL CHEM, V277, P9870, DOI 10.1074/jbc.M107646200; Yoeli-Lerner M, 2009, MOL CANCER RES, V7, P425, DOI 10.1158/1541-7786.MCR-08-0342	41	71	72	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27241	27250		10.1074/jbc.M110.100438	http://dx.doi.org/10.1074/jbc.M110.100438			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20516082	Green Published, hybrid			2022-12-27	WOS:000281172700055
J	Wakabayashi, H; Griffiths, AE; Fay, PJ				Wakabayashi, Hironao; Griffiths, Amy E.; Fay, Philip J.			Factor VIII Lacking the C2 Domain Retains Cofactor Activity in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; ACTIVATED PROTEIN-C; PORCINE FACTOR-VIII; CRYSTAL-STRUCTURE; MEMBRANE-BINDING; THROMBIN GENERATION; CHARGED RESIDUES; SITE; COMPLEX; INTERFACE	Factor (F) VIII consists of a heavy chain (A1A2B domains) and light chain (A3C1C2 domains). The activated form of FVIII, FVIIIa, functions as a cofactor for FIXa in catalyzing the membrane-dependent activation of FX. Whereas the FVIII C2 domain is believed to anchor FVIIIa to the phospholipid surface, recent x-ray crystal structures of FVIII suggest that the C1 domain may also contribute to this function. We constructed a FVIII variant lacking the C2 domain (designated Delta C2) to characterize the contributions of the C1 domain to function. Binding affinity of the Delta C2 variant to phospholipid vesicles as measured by energy transfer was reduced similar to 14-fold. However, the activity of Delta C2 as measured by FXa generation and one-stage clotting assays retained 76 and 36%, respectively, of the WT FVIII value. Modest reductions (similar to 4-fold) were observed in the functional affinity of Delta C2 FVIII for FIXa and rates of thrombin activation. On the other hand, deletion of C2 resulted in significant reductions in FVIIIa stability (similar to 3.6-fold). Thrombin generation assays showed peak thrombin and endogenous thrombin potential were reduced as much as similar to 60-fold. These effects likely result from a combination of the intermolecular functional defects plus reduced protein stability. Together, these results indicate that FVIII domains other than C2, likely C1, make significant contributions to membrane-binding and membrane-dependent function.	[Wakabayashi, Hironao; Griffiths, Amy E.; Fay, Philip J.] Univ Rochester, Sch Med, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Fay, PJ (corresponding author), Univ Rochester, Sch Med, Dept Biochem & Biophys, POB 712,601 Elmwood Ave, Rochester, NY 14642 USA.	philip_fay@urmc.rochester.edu			National Institutes of Health [HL76213, HL38199]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038199, R01HL076213] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL76213 and HL38199. Portions of this work were presented at the annual meeting of the National Hemophilia Foundation, October 30, 2009, in San Francisco, CA.	Adams TE, 2004, P NATL ACAD SCI USA, V101, P8918, DOI 10.1073/pnas.0403072101; Blostein MD, 2003, J BIOL CHEM, V278, P31297, DOI 10.1074/jbc.M302840200; Doering CB, 2002, THROMB HAEMOSTASIS, V88, P450; FAY PJ, 1991, J BIOL CHEM, V266, P8957; Fay PJ, 2004, BLOOD REV, V18, P1, DOI 10.1016/S0268-960X(03)00025-0; GILBERT GE, 1992, J BIOL CHEM, V267, P15861; Gilbert GE, 2002, J BIOL CHEM, V277, P6374, DOI 10.1074/jbc.M104732200; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; HEMKER HC, 1995, THROMB HAEMOSTASIS, V74, P134; Hsu TC, 2008, BLOOD, V111, P200, DOI 10.1182/blood-2007-01-068957; LOLLAR P, 1990, J BIOL CHEM, V265, P1688; LOLLAR P, 1993, METHOD ENZYMOL, V222, P128; LOLLAR P, 1992, J BIOL CHEM, V267, P23652; Majumder R, 2008, BLOOD, V112, P2795, DOI 10.1182/blood-2008-02-138941; Meems H, 2009, BLOOD, V114, P3938, DOI 10.1182/blood-2009-01-197707; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; Newell JL, 2009, J BIOL CHEM, V284, P11080, DOI 10.1074/jbc.M900234200; Ngo JCK, 2008, STRUCTURE, V16, P597, DOI 10.1016/j.str.2008.03.001; Nogami K, 2000, J BIOL CHEM, V275, P25774, DOI 10.1074/jbc.M002007200; OVER J, 1984, SCAND J HAEMATOL, V33, P13; Pemberton S, 1997, BLOOD, V89, P2413, DOI 10.1182/blood.V89.7.2413; Pratt KP, 1999, NATURE, V402, P439, DOI 10.1038/46601; SAENKO EL, 1994, J BIOL CHEM, V269, P11601; Saleh M, 2004, THROMB HAEMOSTASIS, V91, P16, DOI 10.1160/TH03-04-0222; Shen BW, 2008, BLOOD, V111, P1240, DOI 10.1182/blood-2007-08-109918; Wakabayashi H, 2005, BIOCHEMISTRY-US, V44, P10298, DOI 10.1021/bi050638t; Wakabayashi H, 2001, BIOCHEMISTRY-US, V40, P10293, DOI 10.1021/bi010353q; Wakabayashi H, 2004, J BIOL CHEM, V279, P12677, DOI 10.1074/jbc.M311042200; Wakabayashi H, 2009, J THROMB HAEMOST, V7, P438, DOI 10.1111/j.1538-7836.2008.03256.x; Wakabayashi H, 2008, BLOOD, V112, P2761, DOI 10.1182/blood-2008-02-142158; Yegneswaran S, 1997, J BIOL CHEM, V272, P25013, DOI 10.1074/jbc.272.40.25013	31	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25176	25184		10.1074/jbc.M110.106906	http://dx.doi.org/10.1074/jbc.M110.106906			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20529839	hybrid, Green Published			2022-12-27	WOS:000280682400010
J	Sancho, P; Fabregat, I				Sancho, Patricia; Fabregat, Isabel			NADPH Oxidase NOX1 Controls Autocrine Growth of Liver Tumor Cells through Up-regulation of the Epidermal Growth Factor Receptor Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; FACTOR-KAPPA-B; HEPATOCELLULAR-CARCINOMA; EPITHELIAL-CELLS; HEPATOMA-CELLS; TGF-BETA; SUPEROXIDE GENERATION; SIGNALING PATHWAYS; CATALYTIC SUBUNIT; FACTOR-ALPHA	FaO rat hepatoma cells proliferate in the absence of serum through a mechanism that requires activation of the epidermal growth factor receptor (EGFR) pathway. The aim of this work was to analyze the molecular mechanisms that control EGFR activation in these and other liver tumor cells. Reactive oxygen species production is observed a short time after serum withdrawal in FaO cells, coincident with up-regulation of the NADPH oxidase NOX1. NOX1-targeted knockdown, the use of antioxidants, or pharmacological inhibition of NADPH oxidase attenuates autocrine growth, coincident with lower mRNA levels of EGFR and its ligand transforming growth factor-alpha (TGF-alpha) and a decrease in phosphorylation of EGFR. EGFR-targeted knockdown induces similar effects on cell growth and downstream signals to those observed in NOX1-depleted cells. Early NOX1 activation induces both a feedback-positive loop via an Src-ERK pathway that up-regulates its own levels, and a parallel signaling pathway through p38 MAPK and AKT resulting in EGFR and TGF-alpha up-regulation. Human hepatocellular carcinoma cell lines, but not non-tumoral hepatocytes, show autocrine growth upon serum withdrawal, which is also coincident with NOX1 up-regulation that mediates EGFR and TGF-alpha expression. The use of antioxidants, or pharmacological inhibition of NADPH oxidase, effectively attenuates autocrine growth in hepatocellular carcinoma cell lines. In summary, results presented in this study indicate that NOX1 might control autocrine cell growth of liver tumor cells through regulation of the EGFR pathway.	[Sancho, Patricia; Fabregat, Isabel] Univ Barcelona, Oncol Mol Lab, Inst Invest Biomed Bellvitge, Barcelona 08907, Spain; [Fabregat, Isabel] Univ Barcelona, Dept Ciencies Fisiol 2, Inst Invest Biomed Bellvitge, Barcelona 08907, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Sancho, P (corresponding author), Univ Barcelona, Oncol Mol Lab, Inst Invest Biomed Bellvitge, Barcelona 08907, Spain.	psancho@idibell.cat	Sancho, Patricia/ABH-5258-2020; Fabregat, Isabel/H-7038-2015	Sancho, Patricia/0000-0002-1092-5395; Fabregat, Isabel/0000-0003-0136-8440	Ministerio de Ciencia e Innovacion, Spain [BFU2006-01036, BFU2009-07219]; ISCIII-RTICC [RD06/0020]; AGAUR-Generalitat de Catalunya [2005SGR-00549, 2009SGR-312]	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ISCIII-RTICC(Instituto de Salud Carlos III); AGAUR-Generalitat de Catalunya(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya)	This work was supported in part by Ministerio de Ciencia e Innovacion, Spain, Grants BFU2006-01036, BFU2009-07219, and ISCIII-RTICC RD06/0020 and AGAUR-Generalitat de Catalunya Grants 2005SGR-00549 and 2009SGR-312.	Adachi Y, 2008, ONCOGENE, V27, P4921, DOI 10.1038/onc.2008.133; Aslan M, 2003, ANTIOXID REDOX SIGN, V5, P781, DOI 10.1089/152308603770380089; Banfi B, 2003, J BIOL CHEM, V278, P3510, DOI 10.1074/jbc.C200613200; Baselga J, 2005, J CLIN ONCOL, V23, P2445, DOI 10.1200/JCO.2005.11.890; Brewer AC, 2006, FREE RADICAL BIO MED, V40, P260, DOI 10.1016/j.freeradbiomed.2005.08.022; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Caja L, 2007, CELL SIGNAL, V19, P683, DOI 10.1016/j.cellsig.2006.09.002; Caja L, 2009, CANCER RES, V69, P7595, DOI 10.1158/0008-5472.CAN-09-1482; Calvisi DF, 2004, J HEPATOL, V41, P815, DOI 10.1016/j.jhep.2004.07.030; Carmona-Cuenca I, 2008, J HEPATOL, V49, P965, DOI 10.1016/j.jhep.2008.07.021; Carnesecchi S, 2006, EXP CELL RES, V312, P3413, DOI 10.1016/j.yexcr.2006.07.003; Cheng G, 2006, J BIOL CHEM, V281, P17718, DOI 10.1074/jbc.M512751200; Cosgrove BD, 2008, HEPATOLOGY, V48, P276, DOI 10.1002/hep.22335; de Carvalho DD, 2008, INT J CANCER, V122, P1757, DOI 10.1002/ijc.23300; De Minicis S, 2007, ARCH BIOCHEM BIOPHYS, V462, P266, DOI 10.1016/j.abb.2007.04.016; Fabregat I, 2009, WORLD J GASTROENTERO, V15, P513, DOI 10.3748/wjg.15.513; Fan CY, 2005, FEBS LETT, V579, P1301, DOI 10.1016/j.febslet.2005.01.021; Fukuyama M, 2005, CANCER LETT, V221, P97, DOI 10.1016/j.canlet.2004.08.031; Hisaka T, 1999, INT J ONCOL, V14, P453; Hsieh HL, 2008, J CELL BIOCHEM, V103, P1732, DOI 10.1002/jcb.21563; Hsieh HL, 2009, ARTERIOSCL THROM VAS, V29, P1594, DOI 10.1161/ATVBAHA.109.185801; Jaquet V, 2009, ANTIOXID REDOX SIGN, V11, P2535, DOI [10.1089/ars.2009.2585, 10.1089/ARS.2009.2585]; Katsuyama M, 2005, BIOCHEM J, V386, P255, DOI 10.1042/BJ20041180; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; Lassegue B, 2001, CIRC RES, V88, P888, DOI 10.1161/hh0901.090299; Laurent A, 2005, CANCER RES, V65, P948; Lee SB, 2006, J BIOL CHEM, V281, P36228, DOI 10.1074/jbc.M606702200; Lim SD, 2005, PROSTATE, V62, P200, DOI 10.1002/pros.20137; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Miyano K, 2006, J BIOL CHEM, V281, P21857, DOI 10.1074/jbc.M513665200; Mukohara T, 2004, ANTICANCER RES, V24, P11; Murillo MM, 2007, BIOCHEM J, V405, P251, DOI 10.1042/BJ20061846; Nakai K, 2008, J DERMATOL SCI, V51, P181, DOI 10.1016/j.jdermsci.2008.03.004; Nauseef WM, 2008, J BIOL CHEM, V283, P16961, DOI 10.1074/jbc.R700045200; Ortiz C, 2008, BIOCHEM PHARMACOL, V75, P1935, DOI 10.1016/j.bcp.2008.02.015; Ranjan P, 2006, ANTIOXID REDOX SIGN, V8, P1447, DOI 10.1089/ars.2006.8.1447; Sanchez A, 1996, J BIOL CHEM, V271, P7416, DOI 10.1074/jbc.271.13.7416; Sancho P, 2009, BBA-MOL CELL RES, V1793, P253, DOI 10.1016/j.bbamcr.2008.09.003; Sato Y, 2006, GUT, V55, P1801, DOI 10.1136/gut.2005.070417; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-05-1554; Sherman M, 2005, SEMIN LIVER DIS, V25, P143, DOI 10.1055/s-2005-871194; Shi DY, 2003, FEBS LETT, V542, P60, DOI 10.1016/S0014-5793(03)00338-7; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; Teshima S, 2000, AM J PHYSIOL-GASTR L, V279, pG1169, DOI 10.1152/ajpgi.2000.279.6.G1169; Teufelhofer O, 2005, CARCINOGENESIS, V26, P319, DOI 10.1093/carcin/bgh320; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Yan FG, 2008, BIOCHEM BIOPH RES CO, V366, P513, DOI 10.1016/j.bbrc.2007.11.172	49	57	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24815	24824		10.1074/jbc.M110.114280	http://dx.doi.org/10.1074/jbc.M110.114280			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20525691	Green Published, hybrid			2022-12-27	WOS:000280542100054
J	Stalnaker, SH; Hashmi, S; Lim, JM; Aoki, K; Porterfield, M; Gutierrez-Sanchez, G; Wheeler, J; Ervasti, JM; Bergmann, C; Tiemeyer, M; Wells, L				Stalnaker, Stephanie H.; Hashmi, Sana; Lim, Jae-Min; Aoki, Kazuhiro; Porterfield, Mindy; Gutierrez-Sanchez, Gerardo; Wheeler, James; Ervasti, James M.; Bergmann, Carl; Tiemeyer, Michael; Wells, Lance			Site Mapping and Characterization of O-Glycan Structures on alpha-Dystroglycan Isolated from Rabbit Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LAMININ-BINDING; MANNOSYLATION; BRAIN; SEQUENCES	The main extracellular matrix binding component of the dystrophin- glycoprotein complex, alpha-dystroglycan (alpha-DG), which was originally isolated from rabbit skeletal muscle, is an extensively O-glycosylated protein. Previous studies have shown alpha-DG to be modified by both O-GalNAc- and O-mannose-initiated glycan structures. O-Mannosylation, which accounts for up to 30% of the reportedO-linked structures in certain tissues, has been rarely observed on mammalian proteins. Mutations in multiple genes encoding defined or putative glycosyltransferases involved in O-mannosylation are causal for various forms of congenital muscular dystrophy. Here, we explore the glycosylation of purified rabbit skeletal muscle alpha-DG in detail. Using tandem mass spectrometry approaches, we identify 4 O-mannose-initiated and 17 O-GalNAc-initiated structures on alpha-DG isolated from rabbit skeletal muscle. Additionally, we demonstrate the use of tandem mass spectrometry-based workflows to directly analyze glycopeptides generated from the purified protein. By combining glycomics and tandem mass spectrometry analysis of 91 glycopeptides from alpha-DG, we were able to assign 21 different residues as being modified by O-glycosylation with differing degrees of microheterogeneity; 9 sites of O-mannosylation and 14 sites of O-GalNAcylation were observed with only two sites definitively exhibiting occupancy by either type of glycan. The distribution of identified sites of O-mannosylation suggests a limited role for local primary sequence in dictating sites of attachment.	[Gutierrez-Sanchez, Gerardo; Wheeler, James; Bergmann, Carl; Tiemeyer, Michael; Wells, Lance] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Bergmann, Carl; Tiemeyer, Michael; Wells, Lance] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Ervasti, James M.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Stalnaker, Stephanie H.; Porterfield, Mindy; Wells, Lance] Univ Georgia, Dept Chem, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Minnesota System; University of Minnesota Twin Cities; University System of Georgia; University of Georgia	Wells, L (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	lwells@ccrc.uga.edu	Aoki, Kazuhiro/H-8283-2014; Wells, Lance/H-3118-2013; Ervasti, James/AAZ-4786-2020	Wells, Lance/0000-0003-4956-5363; Aoki, Kazuhiro/0000-0003-0029-4291	National Institutes of Health [P41 RR018502]; NCRR; Muscular Dystrophy Association; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant P41 RR018502 from NCRR (to L.W. and M.T.). This work was also supported by the Muscular Dystrophy Association (to J.M.E. and L.W.).	Aebi M, 1999, Glycoconj J, V16, P669; Alvarez-Manilla G, 2010, GLYCOBIOLOGY, V20, P166, DOI 10.1093/glycob/cwp158; Aoki K, 2008, J BIOL CHEM, V283, P30385, DOI 10.1074/jbc.M804925200; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Breloy I, 2008, J BIOL CHEM, V283, P18832, DOI 10.1074/jbc.M802834200; Chai WG, 1999, EUR J BIOCHEM, V263, P879, DOI 10.1046/j.1432-1327.1999.00572.x; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Cohn RD, 2005, NEUROMUSCULAR DISORD, V15, P207, DOI 10.1016/j.nmd.2004.11.005; Colognato H, 1999, J CELL BIOL, V145, P619, DOI 10.1083/jcb.145.3.619; Combs AC, 2005, BIOCHEM J, V390, P303, DOI 10.1042/BJ20050375; Endo Tamao, 2006, V347, P43; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; FINNE J, 1979, J BIOL CHEM, V254, P295; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Jaeken J, 2008, J INHERIT METAB DIS, V31, P669, DOI 10.1007/s10545-008-0983-x; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Manya H, 2007, J BIOL CHEM, V282, P20200, DOI 10.1074/jbc.M702369200; Martin PT, 2007, CURR MOL MED, V7, P417, DOI 10.2174/156652407780831601; NILSSON J, 2010, GLYCOBIOLOGY, DOI DOI 10.1093/GLYCOB/CWG082; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smalheiser NR, 1998, J BIOL CHEM, V273, P23698, DOI 10.1074/jbc.273.37.23698; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512	25	78	81	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24882	24891		10.1074/jbc.M110.126474	http://dx.doi.org/10.1074/jbc.M110.126474			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20507986	Green Published, hybrid			2022-12-27	WOS:000280542100061
J	Chen, H; Xiong, LM				Chen, Hao; Xiong, Liming			myo-Inositol-1-phosphate Synthase Is Required for Polar Auxin Transport and Organ Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROOT CAP CELLS; ARABIDOPSIS-THALIANA; EFFLUX CARRIER; ARF-GAP; INOSITOL HEXAKISPHOSPHATE; MYOINOSITOL METABOLISM; ABSCISIC-ACID; LOCALIZATION; PLANTS; PIN2	myo-Inositol-1-phosphate synthase is a conserved enzyme that catalyzes the first committed and rate-limiting step in inositol biosynthesis. Despite its wide occurrence in all eukaryotes, the role of myo-inositol-1-phosphate synthase and de novo inositol biosynthesis in cell signaling and organism development has been unclear. In this study, we isolated loss-of-function mutants in the Arabidopsis MIPS1 gene from different ecotypes. It was found that all null mips1 mutants are defective in embryogenesis, cotyledon venation patterning, root growth, and root cap development. The mutant roots are also agravitropic and have reduced basipetal auxin transport. mips1 mutants have significantly reduced levels of major phosphatidylinositols and exhibit much slower rates of endocytosis. Treatment with brefeldin A induces slower PIN2 protein aggregation in mips1, indicating altered PIN2 trafficking. Our results demonstrate that MIPS1 is critical for maintaining phosphatidylinositol levels and affects pattern formation in plants likely through regulation of auxin distribution.	[Xiong, Liming] King Abdullah Univ Sci & Technol, Plant Stress Genom Res Ctr, Thuwal 239556900, Saudi Arabia; [Xiong, Liming] King Abdullah Univ Sci & Technol, Div Chem & Life Sci & Engn, Thuwal 239556900, Saudi Arabia; Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; Donald Danforth Plant Science Center	Xiong, LM (corresponding author), King Abdullah Univ Sci & Technol, Plant Stress Genom Res Ctr, Thuwal 239556900, Saudi Arabia.	liming.xiong@kaust.edu.sa	Chen, Hao/AAF-3704-2020	Xiong, Liming/0000-0001-8099-0806	National Science Foundation [0446359]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant 0446359 (to L. X.).	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Blancaflor EB, 1999, ADV SPACE RES-SERIES, V24, P731, DOI 10.1016/S0273-1177(99)00406-8; Carland FM, 2004, PLANT CELL, V16, P1263, DOI 10.1105/tpc.021030; Carland F, 2009, PLANT J, V59, P895, DOI 10.1111/j.1365-313X.2009.03920.x; Chen M, 2006, PLANT CELL, V18, P3576, DOI 10.1105/tpc.105.040774; Chen R, 2002, PLANT MOL BIOL, V49, P305, DOI 10.1023/A:1015294711391; CULBERTSON MR, 1976, J BACTERIOL, V126, P232, DOI 10.1128/JB.126.1.232-242.1976; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Donahue JL, 2010, PLANT CELL, V22, P888, DOI 10.1105/tpc.109.071779; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Ishitani M, 1997, PLANT CELL, V9, P1935, DOI 10.1105/tpc.9.11.1935; JOHNSON MD, 1995, PLANT PHYSIOL, V107, P613, DOI 10.1104/pp.107.2.613; Keller R, 1998, PLANT J, V16, P403, DOI 10.1046/j.1365-313x.1998.00309.x; Kleine-Vehn J, 2008, P NATL ACAD SCI USA, V105, P17812, DOI 10.1073/pnas.0808073105; Koizumi K, 2005, DEVELOPMENT, V132, P1699, DOI 10.1242/dev.01716; Kutter C, 2007, PLANT CELL, V19, P2417, DOI 10.1105/tpc.107.050377; Lackey KH, 2003, PLANT PHYSIOL, V132, P2240, DOI 10.1104/pp.103.020610; Laxmi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001510; Lemtiri-Chlieh F, 2003, P NATL ACAD SCI USA, V100, P10091, DOI 10.1073/pnas.1133289100; Li G, 2007, PLANT CELL, V19, P281, DOI 10.1105/tpc.106.041426; Loewus FA, 2000, PLANT SCI, V150, P1, DOI 10.1016/S0168-9452(99)00150-8; Martin KL, 2006, MOL MICROBIOL, V61, P89, DOI 10.1111/j.1365-2958.2006.05216.x; Men SZ, 2008, NAT CELL BIOL, V10, P237, DOI 10.1038/ncb1686; Meng PH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007364; Michell RH, 2008, NAT REV MOL CELL BIO, V9, P151, DOI 10.1038/nrm2334; Mitsuhashi N, 2008, J EXP BOT, V59, P3069, DOI 10.1093/jxb/ern161; Muday GK, 2001, TRENDS PLANT SCI, V6, P535, DOI 10.1016/S1360-1385(01)02101-X; Murphy AM, 2008, PLANT J, V56, P638, DOI 10.1111/j.1365-313X.2008.03629.x; Nagy R, 2009, J BIOL CHEM, V284, P33614, DOI 10.1074/jbc.M109.030247; Naramoto S, 2009, DEVELOPMENT, V136, P1529, DOI 10.1242/dev.030098; Nelson DE, 1998, PLANT CELL, V10, P753; Nunes ACS, 2006, PLANTA, V224, P125, DOI 10.1007/s00425-005-0201-0; Ottenschlager I, 2003, P NATL ACAD SCI USA, V100, P2987, DOI 10.1073/pnas.0437936100; Pilu R, 2005, CROP SCI, V45, P2096, DOI 10.2135/cropsci2004.0651; Raboy V, 2003, PHYTOCHEMISTRY, V64, P1033, DOI 10.1016/S0031-9422(03)00446-1; Rashotte AM, 2000, PLANT PHYSIOL, V122, P481, DOI 10.1104/pp.122.2.481; Shi JR, 2007, NAT BIOTECHNOL, V25, P930, DOI 10.1038/nbt1322; Sieburth LE, 2006, PLANT CELL, V18, P1396, DOI 10.1105/tpc.105.039008; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; Stevenson JM, 2000, TRENDS PLANT SCI, V5, P252, DOI 10.1016/S1360-1385(00)01652-6; Swarup R, 2001, GENE DEV, V15, P2648, DOI 10.1101/gad.210501; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Tanizawa Y, 2006, GENE DEV, V20, P3296, DOI 10.1101/gad.1497806; Vanoosthuyse V, 2003, PLANT PHYSIOL, V133, P919, DOI 10.1104/pp.103.023846; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Xiong LM, 2001, GENE DEV, V15, P1971, DOI 10.1101/gad.891901; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Zeng Q, 2007, PLANT PHYSIOL, V143, P1119, DOI 10.1104/pp.106.093583; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	53	44	46	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24238	24247		10.1074/jbc.M110.123661	http://dx.doi.org/10.1074/jbc.M110.123661			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20516080	Green Published, hybrid			2022-12-27	WOS:000280291400073
J	Tsay, JM; Sippy, J; delToro, D; Andrews, BT; Draper, B; Rao, V; Catalano, CE; Feiss, M; Smith, DE				Tsay, James M.; Sippy, Jean; delToro, Damian; Andrews, Benjamin T.; Draper, Bonnie; Rao, Venigalla; Catalano, Carlos E.; Feiss, Michael; Smith, Douglas E.			Mutations Altering a Structurally Conserved Loop-Helix-Loop Region of a Viral Packaging Motor Change DNA Translocation Velocity and Processivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIOPHAGE-LAMBDA TERMINASE; FORCE GENERATION; PORTAL MOTOR; LARGE SUBUNIT; ATPASE CENTER; MATURATION; MECHANISM; SUGGESTS; ENZYME	Many double-stranded DNA viruses employ ATP-driven motors to translocate their genomes into small, preformed viral capsids against large forces resisting confinement. Here, we show via direct single-molecule measurements that a mutation T194M downstream of the Walker B motif in the phage lambda gpA packaging motor causes an 8-fold reduction in translocation velocity without substantially changing processivity or force dependence, whereas the mutation G212S in the putative C (coupling) motif causes a 3-fold reduction in velocity and a 6-fold reduction in processivity. Meanwhile a T194M pseudorevertant (T194V) showed a near restoration of the wild-type dynamics. Structural comparisons and modeling show that these mutations are in a loop-helix-loop region that positions the key residues of the catalytic motifs, Walker B and C, in the ATPase center and is structurally homologous with analogous regions in chromosome transporters and SF2 RNA helicases. Together with recently published studies of SpoIIIE chromosome transporter and Ded1 RNA helicase mutants, these findings suggest the presence of a structurally conserved region that may be a part of the mechanism that determines motor velocity and processivity in several different types of nucleic acid translocases.	[Tsay, James M.; delToro, Damian; Smith, Douglas E.] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Sippy, Jean; Feiss, Michael] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Andrews, Benjamin T.; Catalano, Carlos E.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA; [Draper, Bonnie; Rao, Venigalla] Catholic Univ Amer, Dept Biol, Washington, DC 20064 USA	University of California System; University of California San Diego; University of Iowa; University of Washington; University of Washington Seattle; Catholic University of America	Smith, DE (corresponding author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.	des@physics.ucsd.edu	Smith, Douglas E/A-3131-2017	Smith, Douglas E/0000-0002-8206-3632; Rao, Venigalla/0000-0002-0777-6587; Catalano, Carlos E./0000-0003-2349-5758	National Institutes of Health [F32GM083440, GM-51611, F32GM-905652, GM-063943]; National Science Foundation [MCB-0717620, PHY-0848905]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051611, R01GM063943, F32GM090565, F32GM083440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by a National Institutes of Health Postdoctoral Fellowship Award F32GM083440.; Supported by National Institutes of Health Grant GM-51611 and National Science Foundation Grant MCB-0717620.; Supported by National Institutes of Health Postdoctoral Fellowship Award F32GM-905652.; Supported by National Institutes of Health Grant GM-063943.; Supported by National Science Foundation Grant PHY-0848905. To whom correspondence should be addressed. E-mail: des@physics.ucsd.edu.	Arber W., 1983, LAMBDA, P433; Banroques J, 2010, J MOL BIOL, V396, P949, DOI 10.1016/j.jmb.2009.12.025; Burton BM, 2007, CELL, V131, P1301, DOI 10.1016/j.cell.2007.11.009; Campbell A. M., 2007, FIELDS VIROLOGY, P769; Catalano C.E., 2005, VIRAL GENOME PACKAGI; Chemla YR, 2005, CELL, V122, P683, DOI 10.1016/j.cell.2005.06.024; Dhar A, 2005, J MOL BIOL, V354, P738, DOI 10.1016/j.jmb.2005.10.004; Draper B, 2007, J MOL BIOL, V369, P79, DOI 10.1016/j.jmb.2007.03.019; Duffy C, 2002, J MOL BIOL, V316, P547, DOI 10.1006/jmbi.2001.5368; Feiss Michael, 2005, P5; Fuller DN, 2007, J MOL BIOL, V373, P1113, DOI 10.1016/j.jmb.2007.09.011; Fuller DN, 2007, P NATL ACAD SCI USA, V104, P16868, DOI 10.1073/pnas.0704008104; Fuller DN, 2007, P NATL ACAD SCI USA, V104, P11245, DOI 10.1073/pnas.0701323104; Hang JQ, 2000, J MOL BIOL, V302, P777, DOI 10.1006/jmbi.2000.4086; Hang Q, 1999, J BIOL CHEM, V274, P15305, DOI 10.1074/jbc.274.22.15305; Hwang Y, 1996, BIOCHEMISTRY-US, V35, P2796, DOI 10.1021/bi952322z; Maluf NK, 2006, BIOCHEMISTRY-US, V45, P15259, DOI 10.1021/bi0615036; Maluf NK, 2005, J MOL BIOL, V347, P523, DOI 10.1016/j.jmb.2005.01.016; Mitchell MS, 2002, NUCLEIC ACIDS RES, V30, P4009, DOI 10.1093/nar/gkf524; Ortega ME, 2007, J MOL BIOL, V373, P851, DOI 10.1016/j.jmb.2007.07.067; PAL SK, 1988, J BACTERIOL, V172, P2819; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Rickgauer JR, 2007, BIOPHYS J, p48A; Roizman B, 2007, FIELDS VIROLOGY, V2, P2501, DOI DOI 10.1148/RADIOL.14144045; Sisakova E, 2008, J MOL BIOL, V384, P1273, DOI 10.1016/j.jmb.2008.10.017; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Story RM, 2001, P NATL ACAD SCI USA, V98, P3624; Sun S, 2008, CELL, V135, P1251, DOI 10.1016/j.cell.2008.11.015; TOMKA MA, 1993, J BIOL CHEM, V268, P3056; Tsay JM, 2009, P NATL ACAD SCI USA, V106, P14355, DOI 10.1073/pnas.0904364106; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; [No title captured]	32	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24282	24289		10.1074/jbc.M110.129395	http://dx.doi.org/10.1074/jbc.M110.129395			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20525695	hybrid, Green Published			2022-12-27	WOS:000280291400077
J	Yang, KS; Macdonald-Obermann, JL; Piwnica-Worms, D; Pike, LJ				Yang, Katherine S.; Macdonald-Obermann, Jennifer L.; Piwnica-Worms, David; Pike, Linda J.			Asp-960/Glu-961 Controls the Movement of the C-terminal Tail of the Epidermal Growth Factor Receptor to Regulate Asymmetric Dimer Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGF RECEPTOR; KINASE DOMAIN; CRYSTAL-STRUCTURE; ACTIVATION; PHOSPHORYLATION; CELLS; INHIBITOR; MECHANISM; COMPLEX	The epidermal growth factor (EGF) receptor is a tyrosine kinase that dimerizes in response to ligand binding. Ligand-induced dimerization of the extracellular domain of the receptor promotes formation of an asymmetric dimer of the intracellular kinase domains, leading to stimulation of the tyrosine kinase activity of the receptor. We recently monitored ligand-promoted conformational changes within the EGF receptor in real time using luciferase fragment complementation imaging and showed that there was significant movement of the C-terminal tail of the EGF receptor following EGF binding (Yang, K. S., Ilagan, M. X. G., Piwnica-Worms, D., and Pike, L. J. (2009) J. Biol. Chem. 284, 7474-7482). To investigate the structural basis for this conformational change, we analyzed the effect of several mutations on the kinase activity and luciferase fragment complementation activity of the EGF receptor. Mutation of Asp-960 and Glu-961, two residues at the beginning of the C-terminal tail, to alanine resulted in a marked enhancement of EGF-stimulated kinase activity as well as enhanced downstream signaling. The side chain of Asp-960 interacts with that of Ser-787. Mutation of Ser-787 to Phe, which precludes this interaction, also leads to enhanced receptor kinase activity. Our data are consistent with the hypothesis that Asp-960/Glu-961 represents a hinge or fulcrum for the movement of the C-terminal tail of the EGF receptor. Mutation of these residues destabilizes this hinge, facilitating the formation of the activating asymmetric dimer and leading to enhanced receptor signaling.	[Yang, Katherine S.; Macdonald-Obermann, Jennifer L.; Pike, Linda J.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Pike, LJ (corresponding author), 660 S Euclid Ave,Box 8231, St Louis, MO 63110 USA.	pike@biochem.wustl.edu			National Institutes of Health [R01 GM064491, P50 CA94056]; NATIONAL CANCER INSTITUTE [P50CA094056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM064491 (to L.J.P.) and P50 CA94056 (to D. P. W.).	Blair JA, 2007, NAT CHEM BIOL, V3, P229, DOI 10.1038/nchembio866; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; HEISERMANN GJ, 1990, J BIOL CHEM, V265, P12820; Il Na I, 2007, LUNG CANCER, V57, P96, DOI 10.1016/j.lungcan.2007.01.027; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Li X, 2008, CELL SIGNAL, V20, P2145, DOI 10.1016/j.cellsig.2008.08.006; Marcoux N, 2003, ONCOGENE, V22, P6100, DOI 10.1038/sj.onc.1206712; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; Moro L, 2002, J BIOL CHEM, V277, P9405, DOI 10.1074/jbc.M109101200; NORTHWOOD IC, 1991, J BIOL CHEM, V266, P15266; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; Thiel KW, 2007, P NATL ACAD SCI USA, V104, P19238, DOI 10.1073/pnas.0703854104; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Wood ER, 2008, P NATL ACAD SCI USA, V105, P2773, DOI 10.1073/pnas.0708281105; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Yang KS, 2009, J BIOL CHEM, V284, P7474, DOI 10.1074/jbc.M808041200; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998	29	6	6	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24014	24022		10.1074/jbc.M110.103317	http://dx.doi.org/10.1074/jbc.M110.103317			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20507979	Green Published, hybrid			2022-12-27	WOS:000280291400052
J	Xu, YL; Toure, F; Qu, W; Lin, LL; Song, F; Shen, XP; Rosario, R; Garcia, J; Schmidt, AM; Yan, SF				Xu, Yunlu; Toure, Fatouma; Qu, Wu; Lin, Lili; Song, Fei; Shen, Xiaoping; Rosario, Rosa; Garcia, Joel; Schmidt, Ann Marie; Yan, Shi-Fang			Advanced Glycation End Product (AGE)-Receptor for AGE (RAGE) Signaling and Up-regulation of Egr-1 in Hypoxic Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY GROWTH RESPONSE-1; GENE-EXPRESSION; ISCHEMIC-INJURY; RECEPTOR; ACTIVATION; DISEASE; OXYGEN; CELLS; ATHEROSCLEROSIS; PATHOGENESIS	Receptor for advanced glycation end product (RAGE)-dependent signaling has been implicated in ischemia/reperfusion injury in the heart, lung, liver, and brain. Because macrophages contribute to vascular perturbation and tissue injury in hypoxic settings, we tested the hypothesis that RAGE regulates early growth response-1 (Egr-1) expression in hypoxia-exposed macrophages. Molecular analysis, including silencing of RAGE, or blockade of RAGE with sRAGE (the extracellular ligand-binding domain of RAGE), anti-RAGE IgG, or anti-AGE IgG in THP-1 cells, and genetic deletion of RAGE in peritoneal macrophages, revealed that hypoxia-induced up-regulation of Egr-1 is mediated by RAGE signaling. In addition, the observation of increased cellular release of RAGE ligand AGEs in hypoxic THP-1 cells suggests that recruitment of RAGE in hypoxia is stimulated by rapid production of RAGE ligands in this setting. Finally, we show that mDia-1, previously shown to interact with the RAGE cytoplasmic domain, is essential for hypoxia-stimulated regulation of Egr-1, at least in part through protein kinase C beta II, ERK1/2, and c-Jun NH2-terminal kinase signaling triggered by RAGE ligands. Our findings highlight a novel mechanism by which an extracellular signal initiated by RAGE ligand AGEs regulates Egr-1 in a manner requiring mDia-1.	[Xu, Yunlu; Toure, Fatouma; Qu, Wu; Lin, Lili; Song, Fei; Shen, Xiaoping; Rosario, Rosa; Garcia, Joel; Schmidt, Ann Marie; Yan, Shi-Fang] Columbia Univ, Med Ctr, Dept Surg, Div Surg Sci, New York, NY 10032 USA	Columbia University	Yan, SF (corresponding author), Columbia Univ Coll Phys & Surg, Dept Surg, Div Surg Sci, 630 W 168th St, New York, NY 10032 USA.	sy18@columbia.edu			National Institutes of Health, NHLBI [HL60901]; U.S. Public Health Service; Juvenile Diabetes Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060901] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL60901 through the NHLBI. This work was also supported by the U.S. Public Health Service and the Juvenile Diabetes Research Foundation.	Albina JE, 2003, WOUND REPAIR REGEN, V11, P445, DOI 10.1046/j.1524-475X.2003.11619.x; Aleshin A, 2008, AM J PHYSIOL-HEART C, V294, pH1823, DOI 10.1152/ajpheart.01210.2007; BANKA CL, 1991, J LIPID RES, V32, P35; BIANCO C, 1975, J EXP MED, V141, P1278, DOI 10.1084/jem.141.6.1278; Bjornheden T, 1999, ARTERIOSCL THROM VAS, V19, P870, DOI 10.1161/01.ATV.19.4.870; Blouw B, 2003, CANCER CELL, V4, P133, DOI 10.1016/S1535-6108(03)00194-6; BROWNLEE M, 1992, DIABETES CARE, V15, P1835, DOI 10.2337/diacare.15.12.1835; Bucciarelli LG, 2006, CIRCULATION, V113, P1226, DOI 10.1161/CIRCULATIONAHA.105.575993; Bucciarelli LG, 2008, DIABETES, V57, P1941, DOI 10.2337/db07-0326; Chang JS, 2008, CIRC RES, V102, P905, DOI 10.1161/CIRCRESAHA.107.165308; Davies MG, 1996, J SURG RES, V63, P474, DOI 10.1006/jsre.1996.0295; Guo JC, 2008, J AM SOC NEPHROL, V19, P961, DOI 10.1681/ASN.2007101109; Harja E, 2004, CIRC RES, V94, P333, DOI 10.1161/01.RES.0000112405.61577.95; Harja E, 2008, J CLIN INVEST, V118, P183, DOI 10.1172/JCI32703; Hudson BI, 2008, J BIOL CHEM, V283, P34457, DOI 10.1074/jbc.M801465200; Ikeda E, 2005, PATHOL INT, V55, P603, DOI 10.1111/j.1440-1827.2005.01877.x; Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740; Lambert JM, 2008, INT J CARDIOL, V130, P147, DOI 10.1016/j.ijcard.2008.04.059; Lewis JS, 1999, J LEUKOCYTE BIOL, V66, P889, DOI 10.1002/jlb.66.6.889; Liao H, 2007, FASEB J, V21, P935, DOI 10.1096/fj.06-6285com; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCarthy AD, 1997, MOL CELL BIOCHEM, V170, P43, DOI 10.1023/A:1006816223292; Miyata T, 1996, NEPHROL DIAL TRANSPL, V11, P54; Peng J, 2007, CANCER RES, V67, P7565, DOI 10.1158/0008-5472.CAN-07-1467; STEVENS CR, 1991, ANN RHEUM DIS, V50, P124, DOI 10.1136/ard.50.2.124; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Takagi M, 1997, J BONE MINER RES, V12, P439, DOI 10.1359/jbmr.1997.12.3.439; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Yan SF, 1998, P NATL ACAD SCI USA, V95, P8298, DOI 10.1073/pnas.95.14.8298; Yan SF, 1999, ARTERIOSCL THROM VAS, V19, P2029, DOI 10.1161/01.ATV.19.9.2029; Yan SF, 2000, NAT MED, V6, P1355, DOI 10.1038/82168; Yan SF, 1999, J BIOL CHEM, V274, P15030, DOI 10.1074/jbc.274.21.15030; Yan SF, 2010, BIOCHEM PHARMACOL, V79, P1379, DOI 10.1016/j.bcp.2010.01.013; Yan SF, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S146239940900101X; Yeh CH, 2001, DIABETES, V50, P1495, DOI 10.2337/diabetes.50.6.1495	36	86	93	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23231	23238		10.1074/jbc.M110.117457	http://dx.doi.org/10.1074/jbc.M110.117457			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20507991	Green Published, hybrid			2022-12-27	WOS:000279999900057
J	Cussiol, JRR; Alegria, TGP; Szweda, LI; Netto, LES				Cussiol, Jose R. R.; Alegria, Thiago G. P.; Szweda, Luke I.; Netto, Luis E. S.			Ohr (Organic Hydroperoxide Resistance Protein) Possesses a Previously Undescribed Activity, Lipoyl-dependent Peroxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID DEHYDROGENASE COMPLEXES; ESCHERICHIA-COLI; DIHYDROLIPOAMIDE DEHYDROGENASE; FUNCTIONAL-CHARACTERIZATION; STREPTOCOCCUS-PNEUMONIAE; HYPERSENSITIVE REACTION; XYLELLA-FASTIDIOSA; LIPID-PEROXIDATION; PEROXIREDOXINS; THIOREDOXIN	The Ohr (organic hydroperoxide resistance) family of 15-kDa Cys-based, thiol-dependent peroxidases is central to the bacterial response to stress induced by organic hydroperoxides but not by hydrogen peroxide. Ohr has a unique three-dimensional structure and requires dithiols, but not monothiols, to support its activity. However, the physiological reducing system of Ohr has not yet been identified. Here we show that lipoylated enzymes present in the bacterial extracts of Xylella fastidiosa interacted physically and functionally with this Cys-based peroxidase, whereas thioredoxin and glutathione systems failed to support Ohr peroxidase activity. Furthermore, we could reconstitute in vitro three lipoyl-dependent systems as the Ohr physiological reducing systems. We also showed that OsmC from Escherichia coli, an orthologue of Ohr from Xylella fastidiosa, is specifically reduced by lipoyl-dependent systems. These results represent the first description of a Cys-based peroxidase that is directly reduced by lipoylated enzymes.	[Cussiol, Jose R. R.; Alegria, Thiago G. P.; Netto, Luis E. S.] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, BR-05508900 Sao Paulo, Brazil; [Szweda, Luke I.] Oklahoma Med Res Fdn, Free Rad Biol & Aging Res Program, Oklahoma City, OK 73104 USA	Universidade de Sao Paulo; Oklahoma Medical Research Foundation	Netto, LES (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Rua Matao 277, BR-05508900 Sao Paulo, Brazil.	nettoles@ib.usp.br	Cussiol, José Renato/E-5142-2015; Netto, Luis/A-3783-2008	Cussiol, José Renato/0000-0001-5909-8215; Netto, Luis/0000-0002-4250-9177; Alegria, Thiago Geronimo Pires/0000-0002-3086-4059	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [07/58147-6]; National Institute of Science and Technology	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Institute of Science and Technology	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grant 07/58147-6 and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico under the National Institute of Science and Technology for Redox Processes in Biomedicine (Redoxome).	Allary M, 2007, MOL MICROBIOL, V63, P1331, DOI 10.1111/j.1365-2958.2007.05592.x; Atichartpongkul S, 2001, MICROBIOL-SGM, V147, P1775, DOI 10.1099/00221287-147-7-1775; Beckwith J, 2009, J BIOL CHEM, V284, P12585, DOI 10.1074/jbc.X800017200; Brehelin C, 2003, PLANT PHYSIOL, V132, P2045, DOI 10.1104/pp.103.022533; Bryk R, 2002, SCIENCE, V295, P1073, DOI 10.1126/science.1067798; Bunik VI, 2003, EUR J BIOCHEM, V270, P1036, DOI 10.1046/j.1432-1033.2003.03470.x; ELLMAN G, 1979, ANAL BIOCHEM, V93, P98, DOI 10.1016/S0003-2697(79)80122-0; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Fourquet S, 2008, ANTIOXID REDOX SIGN, V10, P1565, DOI 10.1089/ars.2008.2049; Gobel C, 2003, J BIOL CHEM, V278, P52834, DOI 10.1074/jbc.M310833200; GUTIERREZ C, 1991, J MOL BIOL, V220, P959, DOI 10.1016/0022-2836(91)90366-E; Hakansson AP, 2007, J BIOL CHEM, V282, P29521, DOI 10.1074/jbc.M703144200; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Jalloul A, 2002, PLANT J, V32, P1, DOI 10.1046/j.1365-313X.2002.01393.x; Janssen R, 2003, MICROBES INFECT, V5, P527, DOI 10.1016/S1286-4579(03)00069-8; Jordan SW, 1997, J BIOL CHEM, V272, P17903, DOI 10.1074/jbc.272.29.17903; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kruger N J, 1994, Methods Mol Biol, V32, P9; Lesniak J, 2002, EMBO J, V21, P6649, DOI 10.1093/emboj/cdf670; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; Ma QJ, 2006, P NATL ACAD SCI USA, V103, P8662, DOI 10.1073/pnas.0510436103; Maeng JH, 1996, J BACTERIOL, V178, P3695, DOI 10.1128/jb.178.13.3695-3700.1996; Meunier-Jamin C, 2004, J BIOL CHEM, V279, P25830, DOI 10.1074/jbc.M312983200; Moini H, 2002, TOXICOL APPL PHARM, V182, P84, DOI 10.1006/taap.2002.9437; Montillet JL, 2002, PLANT PHYSIOL BIOCH, V40, P633, DOI 10.1016/S0981-9428(02)01402-X; MORRIS TW, 1995, J BACTERIOL, V177, P1; Munhoz DC, 2004, J BIOL CHEM, V279, P35219, DOI 10.1074/jbc.M313773200; NOLL KM, 1988, J BACTERIOL, V170, P4315, DOI 10.1128/jb.170.9.4315-4321.1988; O'Riordan M, 2003, SCIENCE, V302, P462, DOI 10.1126/science.1088170; Oliveira MA, 2006, J MOL BIOL, V359, P433, DOI 10.1016/j.jmb.2006.03.054; PEDERSEN S, 1978, CELL, V14, P179, DOI 10.1016/0092-8674(78)90312-4; Poole LB, 2005, ARCH BIOCHEM BIOPHYS, V433, P240, DOI 10.1016/j.abb.2004.09.006; Purcell AH, 1996, ANNU REV PHYTOPATHOL, V34, P131, DOI 10.1146/annurev.phyto.34.1.131; REED KE, 1993, J BACTERIOL, V175, P1325, DOI 10.1128/JB.175.5.1325-1336.1993; REED LJ, 1958, J BIOL CHEM, V232, P143; Reed LJ, 2001, J BIOL CHEM, V276, P38329, DOI 10.1074/jbc.R100026200; Renato J, 2003, J BIOL CHEM, V278, P11570, DOI 10.1074/jbc.M300252200; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rouhier N, 2002, J BIOL CHEM, V277, P13609, DOI 10.1074/jbc.M111489200; Schupke H, 2001, DRUG METAB DISPOS, V29, P855; SEGEL H, 1993, ENZYME KINETICS BEHA, P606; Shin DH, 2004, ACTA CRYSTALLOGR D, V60, P903, DOI 10.1107/S0907444904005013; Smith AW, 2002, MOL MICROBIOL, V44, P431, DOI 10.1046/j.1365-2958.2002.02883.x; SMITH MW, 1983, J BACTERIOL, V154, P344, DOI 10.1128/JB.154.1.344-350.1983; Smolka MB, 2003, PROTEOMICS, V3, P224, DOI 10.1002/pmic.200390031; SUZUKI YJ, 1994, METHODS ENZYMOL, V234, P454; TENHAKEN R, 1995, P NATL ACAD SCI USA, V92, P4158, DOI 10.1073/pnas.92.10.4158; Tosatto SCE, 2008, ANTIOXID REDOX SIGN, V10, P1515, DOI 10.1089/ars.2008.2055; Trujillo Madia, 2007, V44, P83; Wang G, 2006, MOL MICROBIOL, V61, P847, DOI 10.1111/j.1365-2958.2006.05302.x; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004	51	46	47	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					21943	21950		10.1074/jbc.M110.117283	http://dx.doi.org/10.1074/jbc.M110.117283			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20463026	Green Published, hybrid			2022-12-27	WOS:000279702200006
J	Hall, J; Song, YJ; Karplus, PA; Barbar, E				Hall, Justin; Song, Yujuan; Karplus, P. Andrew; Barbar, Elisar			The Crystal Structure of Dynein Intermediate Chain-Light Chain Roadblock Complex Gives New Insights into Dynein Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-INTERACTING PROTEIN; CYTOPLASMIC DYNEIN; AXONAL-TRANSPORT; DIFFRACTION DATA; GENETIC-ANALYSIS; DATA QUALITY; MOTOR; LC8; IDENTIFICATION; DYNACTIN	The roadblock/LC7 dynein light chain is a ubiquitous component of all dyneins and is essential for many diverse processes including proper axonal transport and dendrite growth. In addition, LC7 functions in non-dynein transcriptional activation of the transforming growth factor-beta complex. Crystal structures of Drosophila melanogaster LC7 in the apo form and in complex with a segment of the disordered N-terminal domain of dynein intermediate chain (IC) provide the first definitive identification of the IC sequence recognized by LC7. The site, confirmed by isothermal titration calorimetry studies, overlaps the IC sequence considered in the literature to be an IC self-association domain. The IC peptide binds as two amphipathic helices that lie along an extensive hydrophobic cleft on LC7 and ends with a polar side-chain interaction network that includes conserved residues from both proteins. The LC7 recognition sequence on IC and its interface with LC7 are well conserved and are, thus, likely representative of all IC.LC7 structures. Interestingly, the position of bound IC in the IC.LC7 complex mimics a helix that is integrated into the primary structure in distantly related LC7 homologs. The IC.LC7 structure further shows that the naturally occurring robl(Z) deletion mutation contains the majority of the IC binding site and suggests that promotion of IC binding by phosphorylation of LC7 is an indirect effect.	[Hall, Justin; Song, Yujuan; Karplus, P. Andrew; Barbar, Elisar] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	Oregon State University	Barbar, E (corresponding author), Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA.	barbare@science.oregonstate.edu		Karplus, Paul/0000-0001-8725-6292; Barbar, Elisar/0000-0003-4892-5259	National Science Foundation [0818896]; American Heart Association [09PRE2250819]	National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association)	This work was supported by National Science Foundation Grant MCB 0818896 (to E. B.) and American Heart Association Predoctoral Fellowship 09PRE2250819 (to J. H.).	Ashokkumar B, 2009, AM J PHYSIOL-GASTR L, V297, pG480, DOI 10.1152/ajpgi.00154.2009; Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; Benison G, 2006, J MOL BIOL, V362, P1082, DOI 10.1016/j.jmb.2006.08.006; Benison G, 2008, J MOL BIOL, V384, P954, DOI 10.1016/j.jmb.2008.09.083; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bowman AB, 1999, J CELL BIOL, V146, P165; Compton DA, 2000, ANNU REV BIOCHEM, V69, P95, DOI 10.1146/annurev.biochem.69.1.95; DeLano W.L, PYMOL MOL GRAPHICS S; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Ding W, 2005, CANCER RES, V65, P6526, DOI 10.1158/0008-5472.CAN-04-4385; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; El-Kadi AM, 2007, J NEUROSCI RES, V85, P2557, DOI 10.1002/jnr.21188; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Hall J, 2009, J BIOL CHEM, V284, P33115, DOI 10.1074/jbc.M109.048587; Hollingsworth SA, 2009, PROTEIN SCI, V18, P1321, DOI 10.1002/pro.133; Ilangovan U, 2005, J MOL BIOL, V352, P338, DOI 10.1016/j.jmb.2005.07.002; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; Jiang JM, 2001, GENE, V281, P103, DOI 10.1016/S0378-1119(01)00787-9; Jin QY, 2009, J CELL PHYSIOL, V221, P707, DOI 10.1002/jcp.21910; Kardon JR, 2009, P NATL ACAD SCI USA, V106, P5669, DOI 10.1073/pnas.0900976106; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Koonin EV, 2000, CURR BIOL, V10, pR774, DOI 10.1016/S0960-9822(00)00774-0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913; Liu JF, 2006, BIOCHEM BIOPH RES CO, V349, P1125, DOI 10.1016/j.bbrc.2006.08.161; Lo KWH, 2006, J BIOL CHEM, V281, P9552, DOI 10.1074/jbc.M511721200; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Makokha M, 2002, BIOCHEMISTRY-US, V41, P4302, DOI 10.1021/bi011970h; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mische S, 2007, MOL BIOL CELL, V18, P2254, DOI 10.1091/mbc.E06-10-0959; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nikulina K, 2004, CELL MOTIL CYTOSKEL, V57, P233, DOI 10.1002/cm.10172; Nurminsky DI, 1998, MOL CELL BIOL, V18, P6816, DOI 10.1128/MCB.18.11.6816; Nyarko A, 2004, BIOCHEMISTRY-US, V43, P15595, DOI 10.1021/bi048451+; Pazour GJ, 2000, METHODS, V22, P285, DOI 10.1006/meth.2000.1081; Persson BD, 2009, J VIROL, V83, P673, DOI 10.1128/JVI.01967-08; Reuter JE, 2003, DEVELOPMENT, V130, P1203, DOI 10.1242/dev.00319; Sarma GN, 2003, J MOL BIOL, V328, P893, DOI 10.1016/S0022-2836(03)00347-4; Soetens JC, 1997, J PHYS CHEM B, V101, P10910, DOI 10.1021/jp972113j; Song J, 2005, J MOL BIOL, V354, P1043, DOI 10.1016/j.jmb.2005.10.017; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Susalka SJ, 2002, J BIOL CHEM, V277, P32939, DOI 10.1074/jbc.M205510200; Susalka SJ, 2000, J NEUROCYTOL, V29, P819, DOI 10.1023/A:1010995408343; Tang Q, 2002, MOL BIOL CELL, V13, P4484, DOI 10.1091/mbc.e02-05-0245; Tsodikov OV, 2002, J COMPUT CHEM, V23, P600, DOI 10.1002/jcc.10061; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Wanschers B, 2008, CELL MOTIL CYTOSKEL, V65, P183, DOI 10.1002/cm.20254; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Wickstead B, 2007, TRAFFIC, V8, P1708, DOI 10.1111/j.1600-0854.2007.00646.x; Wilkins MR, 1999, METH MOL B, V112, P531; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; Ye GJ, 2000, J VIROL, V74, P1355, DOI 10.1128/JVI.74.3.1355-1363.2000; Zhang J, 2009, J BIOL CHEM, V284, P34760, DOI 10.1074/jbc.M109.026872; Zuccarello D, 2008, HUM REPROD, V23, P1957, DOI 10.1093/humrep/den193	59	33	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22566	22575		10.1074/jbc.M110.103861	http://dx.doi.org/10.1074/jbc.M110.103861			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20472935	Green Published, hybrid			2022-12-27	WOS:000279702200068
J	Kokhan, O; Shinkarev, VP; Wraight, CA				Kokhan, Oleksandr; Shinkarev, Vladimir P.; Wraight, Colin A.			Binding of Imidazole to the Heme of Cytochrome c(1) and Inhibition of the bc(1) Complex from Rhodobacter sphaeroides I. EQUILIBRIUM AND MODELING STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR PROTEIN; C-TYPE CYTOCHROMES; LIGAND-BINDING; ELECTRON-TRANSFER; Q-CYCLE; PHYSICOCHEMICAL PROPERTIES; MOLECULAR-DYNAMICS; CYANIDE INHIBITION; AXIAL LIGAND; BC COMPLEXES	We have used imidazole (Im) and N-methylimidazole (MeIm) as probes of the heme-binding cavity of membrane-bound cytochrome (cyt) c(1) in detergent-solubilized bc(1) complex from Rhodobacter sphaeroides. Imidazole binding to cyt c1 substantially lowers the midpoint potential of the heme and fully inhibits bc1 complex activity. Temperature dependences showed that binding of Im (K-d approximate to 330 mu M, 25 degrees C, pH 8) is enthalpically driven (Delta H-0 = -56 kJ/mol, Delta S-0 = -121 J/mol/K), whereas binding of MeIm is 30 times weaker (K-d approximate to 9.3 mM) and is entropically driven (Delta H-0 = 47 kJ/mol, Delta S-0 degrees = 197 J/mol/K). The large enthalpic and entropic contributions suggest significant structural and solvation changes in cyt c1 triggered by ligand binding. Comparison of these results with those obtained previously for soluble cyts c and c(2) suggested that Im binding to cyt c(1) is assisted by formation of hydrogen bonds within the heme cleft. This was strongly supported by molecular dynamics simulations of Im adducts of cyts c, c2, and c1, which showed hydrogen bonds formed between the N delta H of Im and the cyt c(1) protein, or with a water molecule sequestered with the ligand in the heme cleft.	[Kokhan, Oleksandr; Wraight, Colin A.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Shinkarev, Vladimir P.; Wraight, Colin A.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Wraight, CA (corresponding author), Univ Illinois, Ctr Biophys & Computat Biol, 156 Davenport Hall,607 S Mathews Ave, Urbana, IL 61801 USA.	cwraight@illinois.edu		Kokhan, Oleksandr/0000-0001-9867-8044	National Institutes of Health [R01GM053508]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM053508.	Autenrieth F, 2004, J COMPUT CHEM, V25, P1613, DOI 10.1002/jcc.20079; AXELROD HL, 1994, ACTA CRYSTALLOGR D, V50, P596, DOI 10.1107/S0907444994001319; Banci L, 2001, J BIOL INORG CHEM, V6, P628, DOI 10.1007/s007750100240; Battistuzzi G, 2001, ANTIOXID REDOX SIGN, V3, P279, DOI 10.1089/152308601300185232; Battistuzzi G, 2002, J AM CHEM SOC, V124, P5315, DOI 10.1021/ja017479v; Baymann F, 2004, P NATL ACAD SCI USA, V101, P17737, DOI 10.1073/pnas.0407442101; Berry EA, 2000, ANNU REV BIOCHEM, V69, P1005, DOI 10.1146/annurev.biochem.69.1.1005; Bertini I, 2006, CHEM REV, V106, P90, DOI 10.1021/cr050241v; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Cape JL, 2006, TRENDS PLANT SCI, V11, P46, DOI 10.1016/j.tplants.2005.11.007; Caroppi P, 2009, CURR MED CHEM, V16, P4058, DOI 10.2174/092986709789378206; CLARK WM, 1972, OXIDATION REDUCTION, P469; Cooper A, 2005, BIOPHYS CHEM, V115, P89, DOI 10.1016/j.bpc.2004.12.011; Covian R, 2008, BBA-BIOENERGETICS, V1777, P1079, DOI 10.1016/j.bbabio.2008.04.022; Crofts AR, 2008, BBA-BIOENERGETICS, V1777, P1001, DOI 10.1016/j.bbabio.2008.04.037; Crofts AR, 2004, ANNU REV PHYSIOL, V66, P689, DOI 10.1146/annurev.physiol.66.032102.150251; Darrouzet E, 1999, BIOCHEMISTRY-US, V38, P7908, DOI 10.1021/bi990211k; Driscoll WJ, 2007, J BIOL CHEM, V282, P22353, DOI 10.1074/jbc.M610070200; Dumortier C, 1998, J BIOL CHEM, V273, P25647, DOI 10.1074/jbc.273.40.25647; Dumortier C, 2004, BIOCHEMISTRY-US, V43, P7717, DOI 10.1021/bi0362370; Dumortier C, 1999, ARCH BIOCHEM BIOPHYS, V371, P142, DOI 10.1006/abbi.1999.1440; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; Elberry M, 2006, BIOCHEMISTRY-US, V45, P4991, DOI 10.1021/bi0522246; Elberry M, 2006, BBA-BIOENERGETICS, V1757, P835, DOI 10.1016/j.bbabio.2006.05.031; Englander SW, 2007, Q REV BIOPHYS, V40, P287, DOI 10.1017/S0033583508004654; Engstrom G, 2003, BIOCHEMISTRY-US, V42, P2816, DOI 10.1021/bi027213g; Engstrom G, 2002, J BIOL CHEM, V277, P31072, DOI 10.1074/jbc.M202594200; Esser L, 2006, P NATL ACAD SCI USA, V103, P13045, DOI 10.1073/pnas.0601149103; GRAY KA, 1994, BIOCHEMISTRY-US, V33, P723, DOI 10.1021/bi00169a014; GRAY KA, 1992, BIOCHEMISTRY-US, V31, P11864, DOI 10.1021/bi00162a027; GREENWOOD C, 1965, J BIOL CHEM, V240, P3660; Guergova-Kuras M, 1999, PROTEIN EXPRES PURIF, V15, P370, DOI 10.1006/prep.1998.1018; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IKEDASAITO M, 1975, BIOCHIM BIOPHYS ACTA, V393, P335, DOI 10.1016/0005-2795(75)90059-8; Kagan VE, 2009, FREE RADICAL BIO MED, V46, P1439, DOI 10.1016/j.freeradbiomed.2009.03.004; Kalanxhi E, 2007, BIOCHEM J, V407, P179, DOI 10.1042/BJ20070459; Kokhan O, 2010, J BIOL CHEM, V285, P22522, DOI 10.1074/jbc.M110.128082; Li J, 2002, BBA-BIOENERGETICS, V1556, P175, DOI 10.1016/S0005-2728(02)00360-2; LIU GH, 1995, J INORG BIOCHEM, V60, P123, DOI 10.1016/0162-0134(95)00007-B; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maity H, 2004, J MOL BIOL, V343, P223, DOI 10.1016/j.jmb.2004.08.005; MARGALIT R, 1973, EUR J BIOCHEM, V32, P492, DOI 10.1111/j.1432-1033.1973.tb02633.x; MARGOLIASH E, 1959, BIOCHEM J, V71, P570, DOI 10.1042/bj0710570; Millett F, 2004, PHOTOSYNTH RES, V82, P1, DOI 10.1023/B:PRES.0000040434.77061.ca; MOORE GR, 1990, CYTOCHROMES EVOLUTIO; Osyczka A, 2005, TRENDS BIOCHEM SCI, V30, P176, DOI 10.1016/j.tibs.2005.02.001; Osyczka A, 2004, BBA-BIOENERGETICS, V1655, P71, DOI 10.1016/j.bbabio.2003.07.005; PERRIN DD, 1965, DISSOCIATION CONSTAN, P190; PETTIGREW GW, 1975, BIOCHEM J, V149, P155, DOI 10.1042/bj1490155; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Potter VR, 1941, J BIOL CHEM, V137, P13; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P112, DOI 10.1016/0003-9861(91)90171-E; SALEEM MMM, 1988, INORG CHIM A-BIOINOR, V153, P93, DOI 10.1016/S0020-1693(00)83865-7; SCHEJTER A, 1964, BIOCHEMISTRY-US, V3, P1045, DOI 10.1021/bi00896a006; SCHEJTER A, 1969, BIOCHEMISTRY-US, V8, P149, DOI 10.1021/bi00829a021; SCHEJTER A, 1968, BIOCHIM BIOPHYS ACTA, V162, P459, DOI 10.1016/0005-2728(68)90133-3; SCOTT RA, 1996, CYTOCHROME MULTIDISC; SHAO WP, 1992, ACTA CHIM SINICA, V50, P1129; SHAO WP, 1995, J INORG BIOCHEM, V57, P103; Stephanos JJ, 1996, BBA-PROTEIN STRUCT M, V1295, P209, DOI 10.1016/0167-4838(96)00041-6; Stewart JM, 2000, BIOCHEM CELL BIOL, V78, P675, DOI 10.1139/bcb-78-6-675; SUTIN N, 1972, J BIOL CHEM, V247, P6932; TALER G, 1995, BIOCHEMISTRY-US, V34, P14209, DOI 10.1021/bi00043a027; TANOKURA M, 1983, BIOCHIM BIOPHYS ACTA, V742, P576, DOI 10.1016/0167-4838(83)90276-5; TRUMPOWER BL, 1979, J BIOL CHEM, V254, P8697; Viola F, 1996, J INORG BIOCHEM, V62, P213, DOI 10.1016/0162-0134(95)00155-7; WOOD PM, 1980, BIOCHEM J, V192, P761, DOI 10.1042/bj1920761; Yao Y, 2002, J BIOL INORG CHEM, V7, P539, DOI 10.1007/s00775-001-0334-y; Zakariassen H, 2007, THERMOCHIM ACTA, V464, P24, DOI 10.1016/j.tca.2007.07.021; Zhang HB, 2006, BIOCHEMISTRY-US, V45, P14247, DOI 10.1021/bi061345i	70	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22513	22521		10.1074/jbc.M110.128058	http://dx.doi.org/10.1074/jbc.M110.128058			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20448035	Green Published, hybrid			2022-12-27	WOS:000279702200063
J	Manna, SK; Bose, JS; Gangan, V; Raviprakash, N; Navaneetha, T; Raghavendra, PB; Babajan, B; Kumar, CS; Jain, SK				Manna, Sunil K.; Bose, Julie S.; Gangan, Vijay; Raviprakash, Nune; Navaneetha, Thota; Raghavendra, Pongali B.; Babajan, Banaganapalli; Kumar, Chitta S.; Jain, Swatantra K.			Novel Derivative of Benzofuran Induces Cell Death Mostly by G2/M Cell Cycle Arrest through p53-dependent Pathway but Partially by Inhibition of NF-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR KAPPAB; RELA PHOSPHORYLATION; APOPTOSIS; P53; ACTIVATION; MDM2; DOXORUBICIN; INDUCTION; KINASE; REQUIREMENT	The Dracaena resin is widely used in traditional medicine as an anticancer agent, and benzofuran lignan is the active component. In this report, we provide evidence that the synthetic derivative of benzofuran lignan (Benfur) showed antitumor activities. It induced apoptosis in p53-positive cells. Though it inhibited endotoxin-induced nuclear factor kappa B (NF-kappa B) activation in both p53-positive and -negative cells, the activation of caspase 3 was observed in p53-positive cells. It showed partial cell death effect in both p53-positive and -negative cells through inhibition of NF-kappa B. Cell cycle analysis using flow cytometry showed that treatment with this novel benozofuran lignan derivative to Jurkat T-cells, but not U-937 cells, resulted in a G2/M arrest in a dose- and time-dependent manner. It increased amounts of p21, p27, and cyclin B, but not phospho-Rb through p53 nuclear translocation in Jurkat T-cells, but not in U-937 cells. It inhibited amounts of MDM2(murine double minute 2) by repressing the transcription factor Sp1, which was also proved in silico. It induced cell death in tumor cells, but not in primary T-cells. Overall, our data suggest that Benfur-mediated cell death is partially dependent upon NF-kappa B, but predominantly dependent on p53. Thus, this novel benzofuran lignan derivative can be effective chemopreventive or chemo-therapeutic agent against malignant T-cells.	[Manna, Sunil K.; Raviprakash, Nune; Navaneetha, Thota] Ctr DNA Fingerprinting & Diagnost, Immunol Lab, Hyderabad 500001, Andhra Pradesh, India; [Bose, Julie S.; Gangan, Vijay] Reliance Life Sci Pvt Ltd, Bombay 400701, Maharashtra, India; [Raghavendra, Pongali B.; Babajan, Banaganapalli; Kumar, Chitta S.] Sri Krishnadevaraya Univ, Dept Biochem, Anantapur 515003, Andhra Pradesh, India; [Jain, Swatantra K.] Jamia Hamdard, Dept Biotechnol, New Delhi 110062, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Reliance Life Sciences Private Limited; Sri Krishnadevaraya University; Jamia Hamdard University	Manna, SK (corresponding author), Ctr DNA Fingerprinting & Diagnost, Hyderabad 500076, Andhra Pradesh, India.	manna@cdfd.org.in	Kumar, Dr Suresh/HHZ-2615-2022; KUMAR, P. SURESH/AAT-8951-2020; chitta, suresh kumar/N-1569-2016; Banaganapalli, Babajan/A-6282-2013	Kumar, Dr Suresh/0000-0002-2539-6553; KUMAR, P. SURESH/0000-0003-3222-2604; Banaganapalli, Babajan/0000-0001-8089-2210; Navaneetha, Thota/0000-0002-0669-7107	Department of Biotechnology (DBT), Government of India	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology (DBT), Government of India.	Aggarwal BB, 2004, EXPERT OPIN INV DRUG, V13, P1327, DOI 10.1517/13543784.13.10.1327; Apers S, 2002, J NAT PROD, V65, P718, DOI 10.1021/np0103968; Basu A, 1998, MOL HUM REPROD, V4, P1099, DOI 10.1093/molehr/4.12.1099; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chen HW, 1998, BRIT J PHARMACOL, V124, P1029, DOI 10.1038/sj.bjp.0701914; Chene P, 2004, MOL CANCER RES, V2, P20; Concin N, 2003, INT J ONCOL, V22, P51; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; Dash BC, 2005, MOL CELL BIOL, V25, P3364, DOI 10.1128/MCB.25.8.3364-3387.2005; Gangadharan C, 2010, BREAST CANCER RES TR, V120, P671, DOI 10.1007/s10549-009-0493-z; Gangadharan C, 2009, J CELL BIOCHEM, V107, P203, DOI 10.1002/jcb.22115; Gu LB, 2002, BLOOD, V99, P3367, DOI 10.1182/blood.V99.9.3367; Hale AJ, 1996, EUR J BIOCHEM, V236, P1, DOI 10.1111/j.1432-1033.1996.00001.x; Hausott B, 2003, J CANCER RES CLIN, V129, P569, DOI 10.1007/s00432-003-0461-7; Jordan A, 1998, MED RES REV, V18, P259, DOI 10.1002/(SICI)1098-1128(199807)18:4<259::AID-MED3>3.3.CO;2-T; Kaku S, 2001, NUCLEIC ACIDS RES, V29, P1989, DOI 10.1093/nar/29.9.1989; Levi MS, 2001, CURR MED CHEM, V8, P1349, DOI 10.2174/0929867013372229; Li Q, 1999, ANNU REP MED CHEM, V34, P139; Manna SK, 2007, CELL DEATH DIFFER, V14, P158, DOI 10.1038/sj.cdd.4401929; Manna SK, 2010, J BIOL CHEM, V285, P11617, DOI 10.1074/jbc.M109.094961; Manna SK, 2009, MOL IMMUNOL, V46, P1340, DOI 10.1016/j.molimm.2008.11.014; Mansilla S, 2003, BIOCHEM J, V372, P703, DOI 10.1042/BJ20021950; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Narayan VA, 1997, J BIOL CHEM, V272, P7801, DOI 10.1074/jbc.272.12.7801; Perez-Stable C, 2006, CANCER LETT, V231, P49, DOI 10.1016/j.canlet.2005.01.018; PIETERS L, 1993, J NAT PROD, V56, P899, DOI 10.1021/np50096a013; Pieters L, 1999, J MED CHEM, V42, P5475, DOI 10.1021/jm990251m; Piette J, 1997, ONCOGENE, V15, P1001, DOI 10.1038/sj.onc.1201432; Poppelmann B, 2005, J BIOL CHEM, V280, P15635, DOI 10.1074/jbc.M413006200; Potter AJ, 2002, CARCINOGENESIS, V23, P389, DOI 10.1093/carcin/23.3.389; Raghavendra PB, 2007, APOPTOSIS, V12, P307, DOI 10.1007/s10495-006-0626-3; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sreenivasan Y, 2003, ONCOGENE, V22, P4356, DOI 10.1038/sj.onc.1206486; STEWART N, 1995, ONCOGENE, V10, P109; SUGIMOTO K, 1992, BLOOD, V79, P2378, DOI 10.1182/blood.V79.9.2378.2378; Takizawa CG, 2000, CURR OPIN CELL BIOL, V12, P658, DOI 10.1016/S0955-0674(00)00149-6; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; TRIZIO D, 1974, J IMMUNOL, V113, P1093	39	38	40	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22318	22327		10.1074/jbc.M110.131797	http://dx.doi.org/10.1074/jbc.M110.131797			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20472557	Green Published, hybrid			2022-12-27	WOS:000279702200045
J	Low, KL; Shui, GH; Natter, K; Yeo, WK; Kohlwein, SD; Dick, T; Rao, SPS; Wenk, MR				Low, Kai Leng; Shui, Guanghou; Natter, Klaus; Yeo, Wee Kiang; Kohlwein, Sepp D.; Dick, Thomas; Rao, Srinivasa P. S.; Wenk, Markus R.			Lipid Droplet-associated Proteins Are Involved in the Biosynthesis and Hydrolysis of Triacylglycerol in Mycobacterium bovis Bacillus Calmette-Guerin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; DIACYLGLYCEROL ACYLTRANSFERASE; PHOSPHATIDATE PHOSPHATASE; SACCHAROMYCES-CEREVISIAE; TUBERCULOSIS; IDENTIFICATION; FAMILY; LOCALIZATION; ACCUMULATION; METABOLISM	Mycobacteria store triacylglycerols (TGs) in the form of intracellular lipid droplets (LDs) during hypoxia-induced nonreplicating persistence. These bacteria are phenotypically drug-resistant and therefore are believed to be the cause for prolonged tuberculosis treatment. LDs are also associated with bacilli in tuberculosis patient sputum and hypervirulent strains. Although proteins bound to LDs are well characterized in eukaryotes, the identities and functions of such proteins have not been described in mycobacteria. Here, we have identified five proteins: Tgs1 (BCG3153c), Tgs2 (BCG3794c), BCG1169c, BCG1489c, and BCG1721, which are exclusively associated with LDs purified from hypoxic nonreplicating Mycobacterium bovis bacillus Calmette-Guerin (BCG). Disruption of genes tgs1, tgs2, BCG1169c, and BCG1489c in M. bovis BCG revealed that they are indeed involved in TG metabolism. We also characterized BCG1721, an essential bi-functional enzyme capable of promoting buildup and hydrolysis of TGs, depending on the metabolic state. Nonreplicating mycobacteria overexpressing a BCG1721 construct with an inactive lipase domain displayed a phenotype of attenuated TG breakdown and regrowth upon resuscitation. In addition, by heterologous expression in baker's yeast, these mycobacterial proteins also co-localized with LDs and complemented a lipase-deficient yeast strain, indicating that neutral lipid deposition and homeostasis in eukaryotic and prokaryotic microorganisms are functionally related. The demonstrated functional role of BCG1721 to support growth upon resuscitation makes this novel LD-associated factor a potential new target for therapeutic intervention.	[Low, Kai Leng; Wenk, Markus R.] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore; [Shui, Guanghou; Wenk, Markus R.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117456, Singapore; [Wenk, Markus R.] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117456, Singapore; [Yeo, Wee Kiang; Dick, Thomas; Rao, Srinivasa P. S.] Novartis Inst Trop Dis, Singapore 138670, Singapore; [Natter, Klaus; Kohlwein, Sepp D.] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria	National University of Singapore; National University of Singapore; National University of Singapore; Novartis; University of Graz	Rao, SPS (corresponding author), 10 Biopolis Rd,Chromos Bldg,Level 05-01, Singapore 138670, Singapore.	srinivasa.rao@novartis.com; bchmrw@nus.edu.sg	Wenk, Markus Rene/D-1441-2014; Dick, Thomas/AAB-4109-2019; Yeo, Wee Kiang/A-4566-2009; Dick, Thomas/AAC-4824-2019	Dick, Thomas/0000-0002-9604-9452; Kohlwein, Sepp Dieter/0000-0002-1030-0598; Yeo, Wee Kiang/0000-0002-5329-1062; Shui, Guanghou/0000-0002-1621-9643	Singapore National Research Foundation [2007-04]; Academic Research Fund [R-183-000-160-112]; Novartis Institute for Tropical Diseases [R-183-000-166-592]; FWF; NUS Graduate School for Integrative Sciences and Engineering; Austrian Science Fund (FWF) [F 3005] Funding Source: researchfish	Singapore National Research Foundation(National Research Foundation, Singapore); Academic Research Fund(Ministry of Education, Singapore); Novartis Institute for Tropical Diseases; FWF(Austrian Science Fund (FWF)); NUS Graduate School for Integrative Sciences and Engineering(National University of Singapore); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported in part by Singapore National Research Foundation Competitive Research Programme Award 2007-04, Academic Research Fund Grant R-183-000-160-112, Novartis Institute for Tropical Diseases Grant R-183-000-166-592, and Austrian Science Fund FWF Project SFB LIPOTOX (to K.N. and S.D.K.).; Recipient of a scholarship from the NUS Graduate School for Integrative Sciences and Engineering.	Athenstaedt K, 1999, J BACTERIOL, V181, P6441, DOI 10.1128/JB.181.20.6441-6448.1999; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; Beller M, 2006, MOL CELL PROTEOMICS, V5, P1082, DOI 10.1074/mcp.M600011-MCP200; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Cunningham AF, 1998, J BACTERIOL, V180, P801, DOI 10.1128/JB.180.4.801-808.1998; Daniel J, 2004, J BACTERIOL, V186, P5017, DOI 10.1128/jb.186.15.5017-5030.2004; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Deb C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006077; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; Garcia-Martinez C, 2005, AM J PHYSIOL-CELL PH, V288, pC1264, DOI 10.1152/ajpcell.00271.2004; Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075; Garton NJ, 2002, MICROBIOL-SGM, V148, P2951, DOI 10.1099/00221287-148-10-2951; Hanisch J, 2006, APPL ENVIRON MICROB, V72, P6743, DOI 10.1128/AEM.00584-06; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Hatch GM, 2002, J LIPID RES, V43, P1380, DOI 10.1194/jlr.M200130-JLR200; Kalscheuer R, 2004, APPL ENVIRON MICROB, V70, P7119, DOI 10.1128/AEM.70.12.7119-7125.2004; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; KLEIN HP, 1953, J BIOL CHEM, V203, P95; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIN YP, 1989, J BIOL CHEM, V264, P8641; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Low KL, 2009, J BACTERIOL, V191, P5037, DOI 10.1128/JB.00530-09; MAHLER HR, 1953, J BIOL CHEM, V204, P453; Marmiesse M, 2004, MICROBIOL-SGM, V150, P483, DOI 10.1099/mic.0.26662-0; Miura S, 2002, J BIOL CHEM, V277, P32253, DOI 10.1074/jbc.M204410200; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Rajakumari S, 2010, MOL BIOL CELL, V21, P501, DOI 10.1091/mbc.E09-09-0775; Reed MB, 2007, J BACTERIOL, V189, P2583, DOI 10.1128/JB.01670-06; Russell DG, 2003, NAT CELL BIOL, V5, P776, DOI 10.1038/ncb0903-776; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sato S, 2006, J BIOCHEM, V139, P921, DOI 10.1093/jb/mvj104; Secundo F, 2006, J MOL CATAL B-ENZYM, V39, P166, DOI 10.1016/j.molcatb.2006.01.018; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sirakova TD, 2006, MICROBIOL-SGM, V152, P2717, DOI 10.1099/mic.0.28993-0; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Waltermann M, 2005, MOL MICROBIOL, V55, P750, DOI 10.1111/j.1365-2958.2004.04441.x; Wan HC, 2007, FASEB J, V21, P167, DOI 10.1096/fj.06-6711com; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Yuan Y, 1998, P NATL ACAD SCI USA, V95, P9578, DOI 10.1073/pnas.95.16.9578; Yuan Y., 1996, J BACTERIOL, V178, P4484, DOI DOI 10.1128/JB.178.15.4484-4492.1996; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	51	55	57	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21662	21670		10.1074/jbc.M110.135731	http://dx.doi.org/10.1074/jbc.M110.135731			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20452973	Green Published, hybrid			2022-12-27	WOS:000279516100053
J	Blais, JD; Chin, KT; Zito, E; Zhang, YH; Heldman, N; Harding, HP; Fass, D; Thorpe, C; Ron, D				Blais, Jaime D.; Chin, King-Tung; Zito, Ester; Zhang, Yuhong; Heldman, Nimrod; Harding, Heather P.; Fass, Deborah; Thorpe, Colin; Ron, David			A Small Molecule Inhibitor of Endoplasmic Reticulum Oxidation 1 (ERO1) with Selectively Reversible Thiol Reactivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; DISULFIDE-BOND FORMATION; CELL-SURVIVAL; REVEAL; DEGRADATION; HOMEOSTASIS; EXPRESSION; ERO1-BETA; OXIDASE; STRESS	Endoplasmic reticulum oxidation 1 (ERO1) is a conserved eukaryotic flavin adenine nucleotide-containing enzyme that promotes disulfide bond formation by accepting electrons from reduced protein disulfide isomerase (PDI) and passing them on to molecular oxygen. Although disulfide bond formation is an essential process, recent experiments suggest a surprisingly broad tolerance to genetic manipulations that attenuate the rate of disulfide bond formation and that a hyperoxidizing ER may place stressed cells at a disadvantage. In this study, we report on the development of a high throughput in vitro assay for mammalian ERO1 alpha activity and its application to identify small molecule inhibitors. The inhibitor EN460 (IC50, 1.9 mu M) interacts selectively with the reduced, active form of ERO1 alpha and prevents its reoxidation. Despite rapid and promiscuous reactivity with thiolates, EN460 exhibits selectivity for ERO1. This selectivity is explained by the rapid reversibility of the reaction of EN460 with unstructured thiols, in contrast to the formation of a stable bond with ERO1 alpha followed by displacement of bound flavin adenine dinucleotide from the active site of the enzyme. Modest concentrations of EN460 and a functionally related inhibitor, QM295, promote signaling in the unfolded protein response and precondition cells against severe ER stress. Together, these observations point to the feasibility of targeting the enzymatic activity of ERO1 alpha with small molecule inhibitors.	[Blais, Jaime D.; Chin, King-Tung; Zito, Ester; Zhang, Yuhong; Harding, Heather P.; Ron, David] NYU, Sch Med, Kimmel Ctr Biol, New York, NY 10016 USA; [Blais, Jaime D.; Chin, King-Tung; Zito, Ester; Zhang, Yuhong; Harding, Heather P.; Ron, David] NYU, Sch Med, Med Skirball Inst, New York, NY 10016 USA; [Blais, Jaime D.; Chin, King-Tung; Zito, Ester; Zhang, Yuhong; Harding, Heather P.; Ron, David] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Blais, Jaime D.; Chin, King-Tung; Zito, Ester; Zhang, Yuhong; Harding, Heather P.; Ron, David] NYU, Sch Med, Dept Med, New York, NY 10016 USA; [Harding, Heather P.; Ron, David] Univ Cambridge, Inst Metab Sci, Cambridge CB2 0QQ, England; [Heldman, Nimrod; Fass, Deborah] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Thorpe, Colin] Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA	New York University; New York University; New York University; New York University; University of Cambridge; Weizmann Institute of Science; University of Delaware	Blais, JD (corresponding author), NYU, Sch Med, Kimmel Ctr Biol, Sl 3-10,540 1st Ave, New York, NY 10016 USA.	jaime.blais@med.nyu.edu; david.ron@med.nyu.edu	Zito, Ester/ABB-9687-2020; Zito, Ester/AAA-7246-2020	Ron, David/0000-0002-3014-5636; Harding, Heather P/0000-0002-7359-7974	National Institutes of Health [DK075311, DK47119, ES08681, GM26643]; National Cancer Institute of Canada; Canadian Institute of Health Research; Medical Research Council [G0600717B] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK047119, R01DK047119, R37DK047119, R01DK075311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026643] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK075311, DK47119, and ES08681(to D. R.) and GM26643(to C. T.). This work was also supported by fellowships from the National Cancer Institute of Canada and the Canadian Institute of Health Research (to J.D.B.).	ANFINSEN CB, 1956, ADV PROTEIN CHEM, V11, P1, DOI 10.1016/S0065-3233(08)60420-9; Appenzeller-Herzog C, 2008, EMBO J, V27, P2977, DOI 10.1038/emboj.2008.202; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; Dias-Gunasekara S, 2005, J BIOL CHEM, V280, P33066, DOI 10.1074/jbc.M505023200; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V70, P82; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Fry DW, 1998, P NATL ACAD SCI USA, V95, P12022, DOI 10.1073/pnas.95.20.12022; Gross E, 2004, CELL, V117, P601, DOI 10.1016/S0092-8674(04)00418-0; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2005, CELL METAB, V2, P361, DOI 10.1016/j.cmet.2005.11.005; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Pagani M, 2000, J BIOL CHEM, V275, P23685, DOI 10.1074/jbc.M003061200; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Rokita S. E., 2009, QUINONE METHIDES REA, V1, P297; Sevier CS, 2008, BBA-MOL CELL RES, V1783, P549, DOI 10.1016/j.bbamcr.2007.12.011; Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086	25	74	74	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20993	21003		10.1074/jbc.M110.126599	http://dx.doi.org/10.1074/jbc.M110.126599			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20442408	Green Published, hybrid			2022-12-27	WOS:000279228600063
J	Bruzzone, S; Basile, G; Chothi, MP; Nobbio, L; Usai, C; Jacchetti, E; Schenone, A; Guse, AH; Di Virgilio, F; De Flora, A; Zocchi, E				Bruzzone, Santina; Basile, Giovanna; Chothi, Madhu Parakkottil; Nobbio, Lucilla; Usai, Cesare; Jacchetti, Emanuela; Schenone, Angelo; Guse, Andreas H.; Di Virgilio, Francesco; De Flora, Antonio; Zocchi, Elena			Diadenosine Homodinucleotide Products of ADP-ribosyl Cyclases Behave as Modulators of the Purinergic Receptor P2X7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P2X(7) RECEPTOR; ADENINE-DINUCLEOTIDE; NEUROPATHIC PAIN; CALCIUM; CELLS; ACTIVATION; ATP; ANTAGONISTS; CHANNEL; NAADP	ADP-ribosyl cyclases from both vertebrates and invertebrates were previously shown to produce two isomers of P1,P2 diadenosine 5',5'''-P1, P2-diphosphate, P18 and P24, from cyclic ADP-ribose (cADPR) and adenine. P18 and P24 are characterized by an unusual N-glycosidic linkage in one of the adenylic mononucleotides (Basile, G., Taglialatela-Scafati, O., Damonte, G., Armirotti, A., Bruzzone, S., Guida, L., Franco, L., Usai, C., Fattorusso, E., De Flora, A., and Zocchi, E. (2005) Proc. Natl. Acad. Sci. U.S.A. 102, 14509-14514). P24, but not P18, proved to increase the intracellular Ca2+ concentration ([Ca2+](i)) in HeLa cells and to negatively affect mitochondrial function. Here we show that micromolar P24, but not P18, triggers a slow and sustained influx of extracellular Ca2+ through the opening of the purinergic receptor/channel P2X7. On the other hand, P18 inhibits the Ca2+ influx induced by 0.6 mM ATP in HEK293 cells stably transfected with P2X7, with an IC50 of similar to 1 mu M. Thus, P18 is devoid of intrinsic P2X7 stimulatory activity and behaves as an ATP antagonist. A P2X7-mediated increase of the basal [Ca2+](i) has been demonstrated to negatively affect Schwann cell (SC) function in rats with the inherited, peripheral neuropathy Charcot-Marie-Tooth 1A (CMT1A) (Nobbio, L., Sturla, L., Fiorese, F., Usai, C., Basile, G., Moreschi, I., Benvenuto, F., Zocchi, E., De Flora, A., Schenone, A., and Bruzzone S. (2009) J. Biol. Chem. 284, 23146-23158). Preincubation of CMT1A SC with 200 nM P18 restored the basal [Ca2+](i) to values similar to those recorded in wild-type SC. These results identify P18 as a new P2X7 antagonist, potentially useful in the treatment of CMT1A.	[Bruzzone, Santina] Univ Genoa, Dept Expt Med, Biochem Sect, DIMES Sect Biochem, I-16132 Genoa, Italy; [Bruzzone, Santina; Basile, Giovanna; Chothi, Madhu Parakkottil; Nobbio, Lucilla; Schenone, Angelo; De Flora, Antonio; Zocchi, Elena] Univ Genoa, CEBR, I-16132 Genoa, Italy; [Chothi, Madhu Parakkottil; Nobbio, Lucilla; Schenone, Angelo] Univ Genoa, Dept Neurosci Ophthalmol & Genet, I-16132 Genoa, Italy; [Usai, Cesare; Jacchetti, Emanuela] CNR, Inst Biophys, I-16149 Genoa, Italy; [Nobbio, Lucilla; Schenone, Angelo] CNR, Inst Physiol & Bioimages, I-16149 Genoa, Italy; [Guse, Andreas H.] Univ Med Ctr Hamburg Eppendorf, Inst Biochem & Mol Biol 1, Ctr Med Expt, D-20246 Hamburg, Germany; [Di Virgilio, Francesco] Univ Ferrara, Dept Expt & Diagnost Med, Sect Gen Pathol, I-44100 Ferrara, Italy; [Di Virgilio, Francesco] Univ Ferrara, Interdisciplinary Ctr Study Inflammat, I-44100 Ferrara, Italy	University of Genoa; University of Genoa; University of Genoa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); Consiglio Nazionale delle Ricerche (CNR); University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Ferrara; University of Ferrara	Bruzzone, S (corresponding author), Univ Genoa, Dept Expt Med, Biochem Sect, DIMES Sect Biochem, Viale Benedetto XV-1, I-16132 Genoa, Italy.	santina.bruzzone@unige.it	JACCHETTI, Emanuela/AAP-2453-2021; schenone, angelo/I-3194-2012; Madhu, Parakkottil Chothi/AAF-8251-2021; Nobbio, Lucilla/J-1213-2018; Bruzzone, Santina/A-4264-2015; Di Virgilio, Francesco/J-3754-2018; DI VIRGILIO, Francesco/O-4634-2019	JACCHETTI, Emanuela/0000-0001-5990-001X; schenone, angelo/0000-0002-2604-7830; Madhu, Parakkottil Chothi/0000-0002-3138-1075; Nobbio, Lucilla/0000-0003-2150-3953; Bruzzone, Santina/0000-0003-2034-3716; Di Virgilio, Francesco/0000-0003-3566-1362; DI VIRGILIO, Francesco/0000-0003-3566-1362; Usai, Cesare/0000-0001-8863-7759	Telethon [GGP06178, GUP05007]; Regione Liguria; Italian Ministry of Education, University and Scientific Research [MIUR-PRIN 2005, MIUR FIRB RBAUO19A3C, MIUR FIRB RBNE01ERXR, MIUR FIRB RBLA039LSF, MIUR FIRB RBIP06LSS2]; University of Genova; Fondazione Cassa di Risparmio di Genova e Imperia; Fondazione Compagnia di S. Paolo; Associazione Italiana per la Ricerca sul Cancro (AIRC)	Telethon(Fondazione Telethon); Regione Liguria(Regione Liguria); Italian Ministry of Education, University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); University of Genova; Fondazione Cassa di Risparmio di Genova e Imperia; Fondazione Compagnia di S. Paolo(Compagnia di San Paolo); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported in part by grants from Telethon (GGP06178 and GUP05007), from Regione Liguria, from the Italian Ministry of Education, University and Scientific Research (MIUR-PRIN 2005, MIUR FIRB RBAUO19A3C, MIUR FIRB RBNE01ERXR, MIUR FIRB RBLA039LSF, MIUR FIRB RBIP06LSS2) from the University of Genova, from Fondazione Cassa di Risparmio di Genova e Imperia, from Fondazione Compagnia di S. Paolo, and from Associazione Italiana per la Ricerca sul Cancro (AIRC).	Adinolfi E, 2005, MOL BIOL CELL, V16, P3260, DOI 10.1091/mbc.E04-11-1025; Adriouch S, 2008, FASEB J, V22, P861, DOI 10.1096/fj.07-9294com; Baraldi PG, 2004, CURR TOP MED CHEM, V4, P1707, DOI 10.2174/1568026043387223; Basile G, 2005, P NATL ACAD SCI USA, V102, P14509, DOI 10.1073/pnas.0503691102; Bruzzone S, 2007, J BIOL CHEM, V282, P5045, DOI 10.1074/jbc.M609802200; Chen LF, 2006, J IMMUNOL, V176, P3115, DOI 10.4049/jimmunol.176.5.3115; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; DeFlora A, 1997, J BIOL CHEM, V272, P12945, DOI 10.1074/jbc.272.20.12945; Dell'Antonio G, 2002, ARTHRITIS RHEUM-US, V46, P3378, DOI 10.1002/art.10678; Dell'Antonio G, 2002, NEUROSCI LETT, V327, P87, DOI 10.1016/S0304-3940(02)00385-3; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; DIVIRGILIO F, 1995, IMMUNOL TODAY, V16, P524, DOI 10.1016/0167-5699(95)80045-X; Donnelly-Roberts DL, 2007, BRIT J PHARMACOL, V151, P571, DOI 10.1038/sj.bjp.0707265; Elssner A, 2004, J IMMUNOL, V172, P4987, DOI 10.4049/jimmunol.172.8.4987; Feng YH, 2006, J BIOL CHEM, V281, P17228, DOI 10.1074/jbc.M602999200; Ferrari D, 2007, BRIT J PHARMACOL, V150, P445, DOI 10.1038/sj.bjp.0706994; Gargett CE, 1997, BRIT J PHARMACOL, V120, P1483, DOI 10.1038/sj.bjp.0701081; Guse AH, 2005, FEBS J, V272, P4590, DOI 10.1111/j.1742-4658.2005.04863.x; Guse AH, 2009, CURR BIOL, V19, pR521, DOI 10.1016/j.cub.2009.05.045; Hong SY, 2009, J IMMUNOL, V183, P578, DOI 10.4049/jimmunol.0900120; Honore P, 2006, BEHAV BRAIN RES, V167, P355, DOI 10.1016/j.bbr.2005.09.024; Honore P, 2006, J PHARMACOL EXP THER, V319, P1376, DOI 10.1124/jpet.106.111559; Jankowski J, 2001, J BIOL CHEM, V276, P8904, DOI 10.1074/jbc.M009527200; Kawamura H, 2006, J IMMUNOL, V176, P2152, DOI 10.4049/jimmunol.176.4.2152; Klapperstuck M, 2001, J PHYSIOL-LONDON, V534, P25, DOI 10.1111/j.1469-7793.2001.00025.x; Koch-Nolte F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.257mr1; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; Lee HC, 2005, J BIOL CHEM, V280, P33693, DOI 10.1074/jbc.R500012200; Lister Martin F, 2007, J Inflamm (Lond), V4, P5, DOI 10.1186/1476-9255-4-5; Mackenzie AB, 2005, J BIOL CHEM, V280, P33968, DOI 10.1074/jbc.M502705200; Magnone M, 2008, J BIOL CHEM, V283, P24460, DOI 10.1074/jbc.M710568200; Michel AD, 2007, BRIT J PHARMACOL, V152, P523, DOI 10.1038/sj.bjp.0707417; Michel AD, 1999, N-S ARCH PHARMACOL, V359, P102, DOI 10.1007/PL00005328; Nagaoka I, 2006, J IMMUNOL, V176, P3044, DOI 10.4049/jimmunol.176.5.3044; Nelson DW, 2006, J MED CHEM, V49, P3659, DOI 10.1021/jm051202e; Nobbio L, 2009, J BIOL CHEM, V284, P23146, DOI 10.1074/jbc.M109.027128; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Riedel T, 2007, BIOPHYS J, V93, P846, DOI 10.1529/biophysj.106.103614; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Schluter H, 1996, J AUTON PHARMACOL, V16, P357, DOI 10.1111/j.1474-8673.1996.tb00053.x; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Tomasinsig L, 2008, J BIOL CHEM, V283, P30471, DOI 10.1074/jbc.M802185200; Verhoef PA, 2005, J IMMUNOL, V175, P7623, DOI 10.4049/jimmunol.175.11.7623; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; Walseth TF, 2005, P NATL ACAD SCI USA, V102, P14941, DOI 10.1073/pnas.0507258102; Zocchi E, 1998, J BIOL CHEM, V273, P8017, DOI 10.1074/jbc.273.14.8017	49	11	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21165	21174		10.1074/jbc.M109.097964	http://dx.doi.org/10.1074/jbc.M109.097964			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20439466	Green Published, hybrid			2022-12-27	WOS:000279228600079
J	Guengerich, FP				Guengerich, F. Peter			Thematic Minireview Series: Metals in Biology 2010	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Metals are present in nearly one-half of protein structures analyzed to date and play important roles in many of these enzymes. This prologue introduces the third of the Thematic Minireview Series on Metals in Biology, which is focused on iron homeostasis. The four minireviews in the current series deal with redox cycling in iron metabolism, the biogenesis and assembly of iron-sulfur centers (two articles), and the assembly of iron into heme.	[Guengerich, F. Peter] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Guengerich, F. Peter] Vanderbilt Univ, Ctr Mol Toxicol, Sch Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA.	fguengerich@asbmb.org						Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; Guengerich FP, 2009, J BIOL CHEM, V284, P18557, DOI 10.1074/jbc.M109.003863; Guengerich FP, 2009, J BIOL CHEM, V284, P709, DOI 10.1074/jbc.R800060200; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300	4	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26727	26727		10.1074/jbc.R110.150870	http://dx.doi.org/10.1074/jbc.R110.150870			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20522544	Green Published, hybrid			2022-12-27	WOS:000281172700001
J	Cavanaugh, NA; Beard, WA; Wilson, SH				Cavanaugh, Nisha A.; Beard, William A.; Wilson, Samuel H.			DNA Polymerase beta Ribonucleotide Discrimination INSERTION, MISINSERTION, EXTENSION, AND CODING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; I KLENOW FRAGMENT; ESCHERICHIA-COLI; NUCLEOTIDE INCORPORATION; TERNARY COMPLEXES; SINGLE RESIDUE; MINOR-GROOVE; ABASIC SITE; FIDELITY; REPLICATION	DNA polymerases must select nucleotides that preserve Watson-Crick base pairing rules and choose substrates with the correct (deoxyribose) sugar. Sugar discrimination represents a great challenge because ribonucleotide triphosphates are present at much higher cellular concentrations than their deoxy-counterparts. Although DNA polymerases discriminate against ribonucleotides, many therapeutic nucleotide analogs that target polymerases have sugar modifications, and their efficacy depends on their ability to be incorporated into DNA. Here, we investigate the ability of DNA polymerase beta to utilize nucleotides with modified sugars. DNA polymerase beta readily inserts dideoxynucleoside triphosphates but inserts ribonucleotides nearly 4 orders of magnitude less efficiently than natural deoxynucleotides. The efficiency of ribonucleotide insertion is similar to that reported for other DNA polymerases. The poor polymerase-dependent insertion represents a key step in discriminating against ribonucleotides because, once inserted, a ribonucleotide is easily extended. Likewise, a templating ribonucleotide has little effect on insertion efficiency or fidelity. In contrast to insertion and extension of a ribonucleotide, the chemotherapeutic drug arabinofuranosylcytosine triphosphate is efficiently inserted but poorly extended. These results suggest that the sugar pucker at the primer terminus plays a crucial role in DNA synthesis; a 3'-endo sugar pucker facilitates nucleotide insertion, whereas a 2'-endo conformation inhibits insertion.	[Cavanaugh, Nisha A.; Beard, William A.; Wilson, Samuel H.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Beard, WA (corresponding author), NIEHS, Struct Biol Lab, NIH, 111 TW Alexander Dr,POB 12233,MD F1-12, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293	National Institutes of Health [Z01-ES050158, P41 RR-01081]; NIEHS [Z01-ES050161, 1U19CA105010]; NATIONAL CANCER INSTITUTE [U19CA105010] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050158, Z01ES050161, Z01ES050158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants Z01-ES050158 and Z01-ES050161 Intramural Research Program, NIEHS (to S. H. W.), and was in association with Grant 1U19CA105010.; Molecular graphics images were produced using the Chimera package (58) from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by National Institutes of Health Grant P41 RR-01081).	Astatke M, 1998, J MOL BIOL, V278, P147, DOI 10.1006/jmbi.1998.1672; Astatke M, 1998, P NATL ACAD SCI USA, V95, P3402, DOI 10.1073/pnas.95.7.3402; Batra VK, 2008, MOL CELL, V30, P315, DOI 10.1016/j.molcel.2008.02.025; Batra VK, 2005, STRUCTURE, V13, P1225, DOI 10.1016/j.str.2005.05.010; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Beard WA, 1996, J BIOL CHEM, V271, P12141, DOI 10.1074/jbc.271.21.12141; Beard WA, 2004, J BIOL CHEM, V279, P31921, DOI 10.1074/jbc.M404016200; Beard WA, 2006, CHEM REV, V106, P361, DOI 10.1021/cr0404904; Beard WA, 2002, J BIOL CHEM, V277, P47393, DOI 10.1074/jbc.M210036200; Beard WA, 2002, J BIOL CHEM, V277, P8235, DOI 10.1074/jbc.M107286200; Beard WA, 1995, METHOD ENZYMOL, V262, P98; Beard WA, 1998, CHEM BIOL, V5, pR7, DOI 10.1016/S1074-5521(98)90081-3; Beard WA, 2009, J BIOL CHEM, V284, P31680, DOI 10.1074/jbc.M109.029843; Berg BJV, 2001, J BIOL CHEM, V276, P3408, DOI 10.1074/jbc.M002884200; Bergoglio V, 2003, J MOL BIOL, V331, P1017, DOI 10.1016/S0022-2836(03)00837-4; BISWAS G, 1988, ACTA CRYSTALLOGR C, V44, P1269, DOI 10.1107/S0108270188002264; Bonnin A, 1999, J MOL BIOL, V290, P241, DOI 10.1006/jmbi.1999.2900; Boyer PL, 2000, P NATL ACAD SCI USA, V97, P3056, DOI 10.1073/pnas.97.7.3056; Brown JA, 2010, J MOL BIOL, V395, P282, DOI 10.1016/j.jmb.2009.11.003; Cases-Gonzalez CE, 2000, J BIOL CHEM, V275, P19759, DOI 10.1074/jbc.M910361199; DeLucia AM, 2003, NUCLEIC ACIDS RES, V31, P4129, DOI 10.1093/nar/gkg417; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; FERSHT AR, 1982, J MOL BIOL, V156, P37, DOI 10.1016/0022-2836(82)90457-0; Gao GX, 1997, P NATL ACAD SCI USA, V94, P407, DOI 10.1073/pnas.94.2.407; Gardner AF, 2004, J BIOL CHEM, V279, P11834, DOI 10.1074/jbc.M308286200; GOODMAN MF, 1983, J BIOL CHEM, V258, P3469; GOODMAN MF, 1993, CRIT REV BIOCHEM MOL, V28, P83, DOI 10.3109/10409239309086792; HARRINGTON C, 1995, J BIOL CHEM, V270, P26664, DOI 10.1074/jbc.270.44.26664; Horton NC, 1996, J MOL BIOL, V264, P521, DOI 10.1006/jmbi.1996.0658; Joyce CM, 1997, P NATL ACAD SCI USA, V94, P1619, DOI 10.1073/pnas.94.5.1619; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; Kirk BW, 1999, BIOCHEMISTRY-US, V38, P7727, DOI 10.1021/bi990247c; Kool ET, 2002, ANNU REV BIOCHEM, V71, P191, DOI 10.1146/annurev.biochem.71.110601.135453; KUCHTA RD, 1992, BIOCHEMISTRY-US, V31, P4720, DOI 10.1021/bi00134a027; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Liang FT, 2008, J MED CHEM, V51, P6460, DOI 10.1021/jm800692a; Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4; Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200; Liu Y, 2005, J BIOL CHEM, V280, P3665, DOI 10.1074/jbc.M412922200; McElhinny SAN, 2003, MOL CELL BIOL, V23, P2309, DOI 10.1128/MCB.23.7.2309-2315.2003; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; McKenna CE, 2007, J AM CHEM SOC, V129, P15412, DOI 10.1021/ja072127v; Moon AF, 2007, DNA REPAIR, V6, P1709, DOI 10.1016/j.dnarep.2007.05.009; Nakamura J, 1999, CANCER RES, V59, P2522; Osheroff WP, 1999, J BIOL CHEM, V274, P20749, DOI 10.1074/jbc.274.30.20749; Osheroff WP, 2000, J BIOL CHEM, V275, P28033; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; REID R, 1988, J BIOL CHEM, V263, P3898; Roettger MP, 2004, BIOCHEMISTRY-US, V43, P13827, DOI 10.1021/bi048782m; Ruiz JF, 2003, NUCLEIC ACIDS RES, V31, P4441, DOI 10.1093/nar/gkg637; Rydberg B, 2002, P NATL ACAD SCI USA, V99, P16654, DOI 10.1073/pnas.262591699; Sekiguchi J, 1997, MOL CELL, V1, P89, DOI 10.1016/S1097-2765(00)80010-6; Sharma B, 2008, PROTEINS, V71, P715, DOI 10.1002/prot.21829; Sucato CA, 2008, BIOCHEMISTRY-US, V47, P870, DOI 10.1021/bi7014162; Sucato CA, 2007, BIOCHEMISTRY-US, V46, P461, DOI 10.1021/bi061517b; TABOR S, 1995, P NATL ACAD SCI USA, V92, P6339, DOI 10.1073/pnas.92.14.6339; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Upton TG, 2009, ORG LETT, V11, P1883, DOI 10.1021/ol701755k; Urban M, 2010, BIOCHEMISTRY-US, V49, P727, DOI 10.1021/bi9019516; Williams AA, 2009, BIOCHEMISTRY-US, V48, P11994, DOI 10.1021/bi9014133; Yang GW, 2002, BIOCHEMISTRY-US, V41, P10256, DOI 10.1021/bi0202171	63	51	51	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24457	24465		10.1074/jbc.M110.132407	http://dx.doi.org/10.1074/jbc.M110.132407			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20519499	Green Published, hybrid			2022-12-27	WOS:000280542100018
J	Boudko, SP; Zientek, KD; Vance, J; Hacker, JL; Engel, J; Bachinger, HP				Boudko, Sergei P.; Zientek, Keith D.; Vance, Jesse; Hacker, Jessica L.; Engel, Juergen; Baechinger, Hans Peter			The NC2 Domain of Collagen IX Provides Chain Selection and Heterotrimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOMERIC MATRIX PROTEIN; CARTILAGE FIBRILS; CRYSTAL-STRUCTURE; TRIPLE-HELIX; ALPHA-CHAINS; ARTHRITIS; SEQUENCE; GLYCOSAMINOGLYCANS; TRIMERIZATION; PROTEOGLYCAN	The mechanism of chain selection and trimerization of fibril-associated collagens with interrupted triple helices (FACITs) differs from that of fibrillar collagens that have special C-propeptides. We recently showed that the second carboxyl-terminal non-collagenous domain (NC2) of homotrimeric collagen XIX forms a stable trimer and substantially stabilizes a collagen triple helix attached to either end. We then hypothesized a general trimerizing role for the NC2 domain in other FACITs. Here we analyzed the NC2 domain of human heterotrimeric collagen IX, the only member of FACITs with all three chains encoded by distinct genes. Upon oxidative folding of equimolar amounts of the alpha 1, alpha 2, and alpha 3 chains of NC2, a stable heterotrimer with a disulfide bridge between alpha 1 and alpha 3 chains is formed. Our experiments show that this heterotrimerization domain can stabilize a short triple helix attached at the carboxyl-terminal end and allows for the proper oxidation of the cystine knot of type III collagen after the short triple helix.	Shriners Hosp Children, Res Dept, Portland, OR 97239 USA; [Boudko, Sergei P.; Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Engel, Juergen] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	Oregon Health & Science University; University of Basel	Bachinger, HP (corresponding author), 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	hpb@shcc.org		Boudko, Sergei/0000-0003-3856-4859	Shriners Hospital for Children	Shriners Hospital for Children	This work was supported by a grant from the Shriners Hospital for Children.	Asamura K, 2005, NEUROSCIENCE, V132, P493, DOI 10.1016/j.neuroscience.2005.01.013; Boudko SP, 2008, J BIOL CHEM, V283, P32580, DOI 10.1074/jbc.M805394200; Boudko SP, 2008, J BIOL CHEM, V283, P34345, DOI 10.1074/jbc.M806352200; Boudko SP, 2004, J MOL BIOL, V335, P1289, DOI 10.1016/j.jmb.2003.11.054; Boyd LM, 2008, ARTHRITIS RHEUM, V58, P164, DOI 10.1002/art.23231; BRUCKNER P, 1988, J BIOL CHEM, V263, P16911; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Carter EM, 2009, CURR OPIN PEDIATR, V21, P46, DOI 10.1097/MOP.0b013e32832185c5; Diab M, 1993, Orthop Rev, V22, P165; DICESARE P, 1994, FEBS LETT, V354, P237, DOI 10.1016/0014-5793(94)01134-6; EYRE DR, 1995, J RHEUMATOL, V22, P82; FASSLER R, 1994, P NATL ACAD SCI USA, V91, P5070, DOI 10.1073/pnas.91.11.5070; Fresquet M, 2007, J BIOL CHEM, V282, P34634, DOI 10.1074/jbc.M705301200; HEDBOM E, 1992, J BIOL CHEM, V267, P6132; Holden P, 2001, J BIOL CHEM, V276, P6046, DOI 10.1074/jbc.M009507200; Jaalinoja J, 2008, J RHEUMATOL, V35, P745; Jaalinoja J, 2008, BIOCHEM J, V409, P545, DOI 10.1042/BJ20070984; Kammerer RA, 1998, J BIOL CHEM, V273, P10602, DOI 10.1074/jbc.273.17.10602; LABOURDETTE L, 1993, FEBS LETT, V320, P211, DOI 10.1016/0014-5793(93)80588-L; Leppanen VM, 2007, J BIOL CHEM, V282, P23219, DOI 10.1074/jbc.M702514200; Lesage A, 1996, BIOCHEMISTRY-US, V35, P9647, DOI 10.1021/bi952666p; MAZZORANA M, 1993, J BIOL CHEM, V268, P3029; Mazzorana M, 2001, J BIOL CHEM, V276, P27989, DOI 10.1074/jbc.M101633200; McAlinden A, 2003, J BIOL CHEM, V278, P42200, DOI 10.1074/jbc.M302429200; Mechling DE, 1996, J BIOL CHEM, V271, P13781, DOI 10.1074/jbc.271.23.13781; MORGELIN M, 1994, BIOPHYS CHEM, V50, P113, DOI 10.1016/0301-4622(94)85024-0; Munakata H, 1999, GLYCOBIOLOGY, V9, P1023, DOI 10.1093/glycob/9.10.1023; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; OKADA Y, 1989, FEBS LETT, V244, P473, DOI 10.1016/0014-5793(89)80586-1; Paassilta P, 1999, J BIOL CHEM, V274, P22469, DOI 10.1074/jbc.274.32.22469; Pihlajamaa T, 2004, J BIOL CHEM, V279, P24265, DOI 10.1074/jbc.M402865200; Pihlajamaa T, 1999, J BIOL CHEM, V274, P22464, DOI 10.1074/jbc.274.32.22464; Ricard-Blum S, 2005, PATHOL BIOL, V53, P430, DOI 10.1016/j.patbio.2004.12.024; Rosenberg K, 1998, J BIOL CHEM, V273, P20397, DOI 10.1074/jbc.273.32.20397; Rowley MJ, 2008, MOD RHEUMATOL, V18, P429, DOI 10.1007/s10165-008-0080-x; Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200; VANDERREST M, 1988, J BIOL CHEM, V263, P1615; VAUGHAN L, 1988, J CELL BIOL, V106, P991, DOI 10.1083/jcb.106.3.991; WU JJ, 1991, J BIOL CHEM, V266, P5625	39	13	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23721	23731		10.1074/jbc.M110.128405	http://dx.doi.org/10.1074/jbc.M110.128405			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20507993	Green Published, hybrid			2022-12-27	WOS:000280291400022
J	D'Alessio, A; Kluger, MS; Li, JH; Al-Lamki, R; Bradley, JR; Pober, JS				D'Alessio, Alessio; Kluger, Martin S.; Li, Jie H.; Al-Lamki, Rafia; Bradley, John R.; Pober, Jordan S.			Targeting of Tumor Necrosis Factor Receptor 1 to Low Density Plasma Membrane Domains in Human Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA B ACTIVATION; DEATH DOMAIN; TNF; ENDOCYTOSIS; CAVEOLIN-1; LOCALIZATION; PROTEINS; SIGNAL; INTERNALIZATION; APOPTOSIS	TNFR1 ( tumor necrosis factor receptor 1) localizes to caveolae of human endothelial-derived EA.hy926 cells. Transduced TNFR1 molecules lacking amino acid residues 229-244 ( spanning the transmembrane/intercellular boundary) are expressed on the cell surface equivalently to full-length TNFR1 molecules but incompletely localize to caveolae. A peptide containing this sequence pulls down CAV-1 (caveolin-1) and TNFR1 from cell lysates but fails to do so following disruption of caveolae with methyl-beta-cyclodextrin. We previously reported that methyl-beta-cyclodextrin eliminates caveolae and blocks tumor necrosis factor (TNF)-induced internalization of TNFR1 but not TNF-induced activation of NF-kappa B in EA.hy926 cells. Both CAV-1 and FLOT-2 (flotillin-2), organizing proteins of caveolae and lipid rafts, respectively, associate with caveolae in EA.hy926 cells. Small interfering RNA-mediated knockdown of CAV-1 but not FLOT-2 strikingly reduces caveolae number. Both knockdowns reduce total TNFR1 protein expression, but neither prevents TNFR1 localization to low density membrane domains, TNF-induced internalization of TNFR1, or NF-kappa B activation by TNF. Both CAV-1 and FLOT-2 knockdowns reduce TNF-mediated activation of stress-activated protein kinase ( SAPK). However, both knockdowns reduce expression of TRAF2 (TNF receptor-associated factor-2) protein, and small interfering RNA targeting of TRAF2 also selectively inhibits SAPK activation. We conclude that TNFR1 contains a membrane-proximal sequence that targets the receptor to caveolae/lipid rafts. Neither TNFR1 targeting to nor internalization from these low density membrane domains depends upon CAV-1 or FLOT-2. Furthermore, both NF-kappa B and SAPK activation appear independent of both TNFR1 localization to low density membrane domains and to TNF-induced receptor internalization.	[D'Alessio, Alessio; Kluger, Martin S.; Li, Jie H.; Pober, Jordan S.] Yale Univ, Sch Med, Interdept Program Vasc Biol & Therapeut, New Haven, CT 06520 USA; [D'Alessio, Alessio; Li, Jie H.; Pober, Jordan S.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Kluger, Martin S.; Pober, Jordan S.] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06520 USA; [Pober, Jordan S.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Al-Lamki, Rafia; Bradley, John R.] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Al-Lamki, Rafia; Bradley, John R.] Addenbrookes Hosp, Cambridge CB2 2QQ, England; [D'Alessio, Alessio] Univ Roma La Sapienza, Dept Histol & Med Embryol, I-00161 Rome, Italy	Yale University; Yale University; Yale University; Yale University; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Sapienza University Rome	Pober, JS (corresponding author), Yale Univ, Sch Med, Interdept Program Vasc Biol & Therapeut, 10 Amistad St,Rm 401D, New Haven, CT 06520 USA.	jordan.pober@yale.edu	D'Alessio, Alessio/F-3778-2010	D'Alessio, Alessio/0000-0002-3340-2634; Bradley, John/0000-0002-7774-8805	National Institutes of Health [RO1-HL36003, NO1-HV28186]; Ministero dell'Istruzione dell'Universita e della Ricerca (MIUR); British Heart Foundation; National Institute for Health Research Cambridge Biomedical Research Centre; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028186] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036003] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministero dell'Istruzione dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); British Heart Foundation(British Heart Foundation); National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-HL36003 and NO1-HV28186. This work was also supported by the Ministero dell'Istruzione dell'Universita e della Ricerca (MIUR), the British Heart Foundation, and the National Institute for Health Research Cambridge Biomedical Research Centre.	Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Bilderback TR, 2001, J NEUROCHEM, V76, P1540, DOI 10.1046/j.1471-4159.2001.00171.x; BRADLEY JR, 1995, AM J PATHOL, V146, P27; BRADLEY JR, 1993, J IMMUNOL, V150, P5544; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Cao HM, 2002, J BIOL CHEM, V277, P8771, DOI 10.1074/jbc.C100661200; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Feng X, 2001, J BIOL CHEM, V276, P8341, DOI 10.1074/jbc.M007116200; Gaeta ML, 2000, LAB INVEST, V80, P1185, DOI 10.1038/labinvest.3780126; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gimbrone M A Jr, 1976, Prog Hemost Thromb, V3, P1; Gonzalez E, 2004, J BIOL CHEM, V279, P40659, DOI 10.1074/jbc.M407051200; HIGUCHI M, 1994, J IMMUNOL, V152, P3550; Jadot M, 2001, EUR J BIOCHEM, V268, P1392, DOI 10.1046/j.1432-1327.2001.02006.x; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Langhorst MF, 2005, CELL MOL LIFE SCI, V62, P2228, DOI 10.1007/s00018-005-5166-4; Ledgerwood EC, 1999, LAB INVEST, V79, P1041; Ledgerwood EC, 1998, LAB INVEST, V78, P1583; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; LOETSCHER H, 1993, J BIOL CHEM, V268, P26350; Means CK, 2008, J BIOL CHEM, V283, P11954, DOI 10.1074/jbc.M707422200; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Miyawaki-Shimizu K, 2006, AM J PHYSIOL-LUNG C, V290, pL405, DOI 10.1152/ajplung.00292.2005; Morales-Ruiz M, 2001, J BIOL CHEM, V276, P19672, DOI 10.1074/jbc.M009993200; Natoli G, 1997, SCIENCE, V275, P200, DOI 10.1126/science.275.5297.200; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Schutze S, 1999, J BIOL CHEM, V274, P10203, DOI 10.1074/jbc.274.15.10203; SLOWIK MR, 1993, AM J PATHOL, V143, P1724; Storey H, 2002, BIOCHEM J, V366, P15, DOI 10.1042/BJ20020048; Tkachenko E, 2004, J CELL SCI, V117, P3189, DOI 10.1242/jcs.01190; Vasile E, 1999, J HISTOCHEM CYTOCHEM, V47, P159, DOI 10.1177/002215549904700205; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Zeng YC, 2003, J BIOL CHEM, V278, P45931, DOI 10.1074/jbc.M307722200; Zhang HF, 2004, J BIOL CHEM, V279, P44955, DOI 10.1074/jbc.M407617200	41	28	28	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23868	23879		10.1074/jbc.M110.122853	http://dx.doi.org/10.1074/jbc.M110.122853			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20511226	Green Published, hybrid			2022-12-27	WOS:000280291400037
J	de Jesus, TCL; Tonelli, RR; Nardelli, SC; Augusto, LD; Motta, MCM; Girard-Dias, W; Miranda, K; Ulrich, P; Jimenez, V; Barquilla, A; Navarro, M; Docampo, R; Schenkman, S				Leandro de Jesus, Teresa Cristina; Tonelli, Renata Rosito; Nardelli, Sheila C.; Augusto, Leonardo da Silva; Motta, Maria Cristina M.; Girard-Dias, Wendell; Miranda, Kildare; Ulrich, Paul; Jimenez, Veronica; Barquilla, Antonio; Navarro, Miguel; Docampo, Roberto; Schenkman, Sergio			Target of Rapamycin (TOR)-like 1 Kinase Is Involved in the Control of Polyphosphate Levels and Acidocalcisome Maintenance in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE EXPRESSION SYSTEM; INORGANIC POLYPHOSPHATE; CELL-GROWTH; FKBP12-RAPAMYCIN-ASSOCIATED PROTEIN; RNA INTERFERENCE; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; ACIDIC VACUOLES; GENE-EXPRESSION; OSMOTIC-STRESS	Target of rapamycin (TOR) kinases are highly conserved protein kinases that integrate signals from nutrients and growth factors to coordinate cell growth and cell cycle progression. It has been previously described that two TOR kinases control cell growth in the protozoan parasite Trypanosoma brucei, the causative agent of African trypanosomiasis. Here we studied an unusual TOR-like protein named TbTOR-like 1 containing a PDZ domain and found exclusively in kinetoplastids. TbTOR-like 1 localizes to unique cytosolic granules. After hyperosmotic stress, the localization of the protein shifts to the cell periphery, different from other organelle markers. Ablation of TbTOR-like 1 causes a progressive inhibition of cell proliferation, producing parasites accumulating in the S/G(2) phase of the cell cycle. TbTOR-like 1 knocked down cells have an increased area occupied by acidic vacuoles, known as acidocalcisomes, and are enriched in polyphosphate and pyrophosphate. These results suggest that TbTOR-like 1 might be involved in the control of acidocalcisome and polyphosphate metabolism in T. brucei.	[Leandro de Jesus, Teresa Cristina; Ulrich, Paul; Jimenez, Veronica; Docampo, Roberto] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Leandro de Jesus, Teresa Cristina; Ulrich, Paul; Jimenez, Veronica; Docampo, Roberto] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Leandro de Jesus, Teresa Cristina; Tonelli, Renata Rosito; Nardelli, Sheila C.; Augusto, Leonardo da Silva; Schenkman, Sergio] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, BR-04023062 Sao Paulo, Brazil; [Motta, Maria Cristina M.; Girard-Dias, Wendell; Miranda, Kildare] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21949900 Rio De Janeiro, Brazil; [Miranda, Kildare] Inst Nacl Metrol Normalizacao & Qualidade Ind, Diretoria Programas, BR-25250020 Rio De Janeiro, Brazil; [Barquilla, Antonio; Navarro, Miguel] Consejo Super Invest Cient, Inst Parasitol & Biomed Lopez Neyra, Granada 18100, Spain	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Rio de Janeiro; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN)	Docampo, R (corresponding author), Univ Georgia, Ctr Trop & Emerging Global Dis, 500 DW Brooks Dr, Athens, GA 30602 USA.	rdocampo@cb.uga.edu; sschenkman@unifesp.br	Motta, Maria Cristina M/I-3140-2014; Nardelli, Sheila/E-7787-2013; Schenkman, Sergio/A-9227-2013; Navarro, Miguel/C-3685-2009; Tonelli, Renata R/H-1334-2012; Nardelli, Sheila/D-4809-2018	Schenkman, Sergio/0000-0001-9353-8480; Navarro, Miguel/0000-0003-2301-2699; Tonelli, Renata R/0000-0002-1685-9042; Motta, Maria Cristina/0000-0002-0947-4830; da Silva Augusto, Leonardo/0000-0003-0430-8216	National Institutes of Health [AI-077538]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico e Instituto Nacional de Ciencia e Tecnologia de Vacinas do Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil; Ellison Medical Foundation to the Center for Tropical and Emerging Global Diseases; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico e Instituto Nacional de Ciencia e Tecnologia de Vacinas do Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ellison Medical Foundation to the Center for Tropical and Emerging Global Diseases(Lawrence Ellison Foundation); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI-077538 (to R. D.). This work was also supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico e Instituto Nacional de Ciencia e Tecnologia de Vacinas do Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil. Supported in part by a training grant from the Ellison Medical Foundation to the Center for Tropical and Emerging Global Diseases.; Supported by a postdoctoral fellowship from the American Heart Association.	Abuin G, 1999, J BIOL CHEM, V274, P13041, DOI 10.1074/jbc.274.19.13041; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Ault-Riche D, 1998, J BACTERIOL, V180, P1841; BANGS JD, 1993, J CELL SCI, V105, P1101; Barquilla A, 2008, P NATL ACAD SCI USA, V105, P14579, DOI 10.1073/pnas.0802668105; Barquilla A, 2009, AUTOPHAGY, V5, P256, DOI 10.4161/auto.5.2.7591; Barquilla A, 2009, CELL CYCLE, V8, P697, DOI 10.4161/cc.8.5.7808; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Brown MRW, 2004, P NATL ACAD SCI USA, V101, P16085, DOI 10.1073/pnas.0406909101; CASTRO CD, 1995, APPL ENVIRON MICROB, V61, P4448, DOI 10.1128/AEM.61.12.4448-4453.1995; Charest A, 2001, J BIOL CHEM, V276, P29456, DOI 10.1074/jbc.M104137200; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Clayton CE, 2005, METH MOL B, V309, P39; Desai BN, 2002, P NATL ACAD SCI USA, V99, P4319, DOI 10.1073/pnas.261702698; Diaz-Troya S, 2008, AUTOPHAGY, V4, P851, DOI 10.4161/auto.6555; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; DOCAMPO R, 1995, BIOCHEM J, V310, P1005, DOI 10.1042/bj3101005; Drenan RM, 2004, J BIOL CHEM, V279, P772, DOI 10.1074/jbc.M305912200; Fang JM, 2007, BIOCHEM J, V407, P161, DOI 10.1042/BJ20070612; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Gull K, 2001, INT J PARASITOL, V31, P443, DOI 10.1016/S0020-7519(01)00154-0; Hammarton TC, 2003, J BIOL CHEM, V278, P22877, DOI 10.1074/jbc.M300813200; HAROLD FM, 1965, J BACTERIOL, V89, P1262, DOI 10.1128/JB.89.5.1262-1270.1965; Holetz FB, 2007, BIOCHEM BIOPH RES CO, V356, P1062, DOI 10.1016/j.bbrc.2007.03.104; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Kim JE, 2000, P NATL ACAD SCI USA, V97, P14340, DOI 10.1073/pnas.011511898; Kocic I, 2001, CARDIOVASC RES, V51, P59, DOI 10.1016/S0008-6363(01)00279-6; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Lopez-Aviles S, 2005, MOL CELL, V17, P49, DOI 10.1016/j.molcel.2004.11.043; McDowell MA, 1998, BIOCHEM J, V335, P681, DOI 10.1042/bj3350681; Monnerat Severine, 2009, BMC Res Notes, V2, P46, DOI 10.1186/1756-0500-2-46; Petersen J, 2009, BIOCHEM SOC T, V37, P273, DOI 10.1042/BST0370273; PICK U, 1991, PLANT PHYSIOL, V97, P1234, DOI 10.1104/pp.97.3.1234; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; Rao NN, 1998, J BACTERIOL, V180, P2186, DOI 10.1128/JB.180.8.2186-2193.1998; Rohloff P, 2003, MOL BIOCHEM PARASIT, V126, P219, DOI 10.1016/S0166-6851(02)00277-3; Rohloff P, 2004, J BIOL CHEM, V279, P52270, DOI 10.1074/jbc.M410372200; Ruiz FA, 2004, MICROSC MICROANAL, V10, P563, DOI 10.1017/S1431927604040875; Ruiz FA, 2001, J BIOL CHEM, V276, P26114, DOI 10.1074/jbc.M102402200; Schoneck R, 1997, EUR J BIOCHEM, V243, P739, DOI 10.1111/j.1432-1033.1997.00739.x; Scott DA, 1998, J BIOL CHEM, V273, P22151, DOI 10.1074/jbc.273.34.22151; Scott DA, 1997, J BIOL CHEM, V272, P28020, DOI 10.1074/jbc.272.44.28020; Scott DA, 2000, J BIOL CHEM, V275, P24215, DOI 10.1074/jbc.M002454200; Takahashi K, 2004, P NATL ACAD SCI USA, V101, P4320, DOI 10.1073/pnas.0308555101; Tu XM, 2004, J BIOL CHEM, V279, P20519, DOI 10.1074/jbc.M312862200; VERCESI AE, 1994, BIOCHEM J, V304, P227, DOI 10.1042/bj3040227; Vieira LL, 1998, BBA-REV BIOMEMBRANES, V1376, P221, DOI 10.1016/S0304-4157(98)00007-0; Wang LH, 2003, P NATL ACAD SCI USA, V100, P11249, DOI 10.1073/pnas.1534805100; Wang X, 2009, TRENDS CELL BIOL, V19, P260, DOI 10.1016/j.tcb.2009.03.005; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; YANG YC, 1993, BIOCHIM BIOPHYS ACTA, V1179, P141, DOI 10.1016/0167-4889(93)90135-C	58	40	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24131	24140		10.1074/jbc.M110.120212	http://dx.doi.org/10.1074/jbc.M110.120212			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20495004	Green Published, hybrid			2022-12-27	WOS:000280291400063
J	Matilainen, JM; Malinen, M; Turunen, MM; Carlberg, C; Vaisanen, S				Matilainen, Juha M.; Malinen, Marjo; Turunen, Mikko M.; Carlberg, Carsten; Vaisanen, Sami			The Number of Vitamin D Receptor Binding Sites Defines the Different Vitamin D Responsiveness of the CYP24 Gene in Malignant and Normal Mammary Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; DEVELOPMENTAL REGULATORS; RESPONSE ELEMENTS; CO-REPRESSOR; HUMAN GENOME; TRANSCRIPTION; CHROMATIN; ACTIVATION; ENHANCERS	Primary 1 alpha,25-dihydroxyvitamin D-3 (1 alpha,25(OH)(2)D-3)-responding genes are controlled by the vitamin D receptor (VDR) binding to specific sites (VDREs) that are located within the regulatory regions of these genes. According to previous studies, the gene encoding 25-dihydroxyvitamin D-3 24-hydroxylase, CYP24, which is the strongest known 1 alpha,25(OH)(2)D-3-responsive gene, has multiple VDREs that locate within the proximal and the distal promoter. However, it has remained unclear, what is the biological role of these regions and how they participate in the regulation of transcription. In this study, we found a different CYP24 expression profile in normal (MCF-10A) and malignant (MCF-7) human mammary cells. Moreover, CYP24 mRNA showed to be three times more stable in MCF-7 cells than in MCF-10A cells. We studied the mechanism of this difference using expression profiling, quantitative chromatin immunoprecipitation and chromosome conformation capture assays. Interestingly, the number of functional VDREs was higher in MCF-7 cells than in MCF-10A cells. Three functional VDREs in MCF-7 cells are connected to linear mRNA accumulation, whereas only one VDRE seems to lead to stepwise CYP24 mRNA accumulation in MCF-10A cells. The distal VDREs were involved in transcriptional regulation via ligand-dependent, dynamic chromatin looping, which brings cyclically the distal elements together either individually or simultaneously next to the transcription start site. In conclusion, our data suggest that in comparison to normal cells, clearing of 1 alpha,25(OH)(2)D-3 is enhanced in malignant cells due to differences in transcriptional regulation of CYP24 and metabolism of CYP24 mRNA.	[Matilainen, Juha M.; Malinen, Marjo; Turunen, Mikko M.; Carlberg, Carsten; Vaisanen, Sami] Univ Eastern Finland, Dept Biosci, FIN-70211 Kuopio, Finland; [Carlberg, Carsten] Univ Luxembourg, Life Sci Res Unit, L-1511 Luxembourg, Luxembourg	University of Eastern Finland; University of Luxembourg	Vaisanen, S (corresponding author), Univ Eastern Finland, Dept Biosci, POB 1627, FIN-70211 Kuopio, Finland.	Sami.Vaisanen@uef.fi	Carlberg, Carsten/C-9075-2011	Carlberg, Carsten/0000-0003-2633-0684; Turunen, Mikko/0000-0001-5134-1559	Academy of Finland [129139]	Academy of Finland(Academy of Finland)	This work was supported by The Academy of Finland Grant Number 129139.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Carlberg C, 1998, CRIT REV EUKAR GENE, V8, P19, DOI 10.1615/CritRevEukarGeneExpr.v8.i1.20; Chan HM, 2001, J CELL SCI, V114, P2363; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; de Lyra EC, 2006, J STEROID BIOCHEM, V100, P184, DOI 10.1016/j.jsbmb.2006.04.009; Degenhardt T, 2009, CELL, V138, P489, DOI 10.1016/j.cell.2009.05.029; Garland CF, 2009, ANN EPIDEMIOL, V19, P468, DOI 10.1016/j.annepidem.2009.03.021; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Makkonen H, 2009, NUCLEIC ACIDS RES, V37, P4135, DOI 10.1093/nar/gkp352; Matilainen M, 2005, NUCLEIC ACIDS RES, V33, P5521, DOI 10.1093/nar/gki872; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Miele A, 2006, CURR PROTOC MOL BIOL; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; Pan YF, 2008, J BIOL CHEM, V283, P32977, DOI 10.1074/jbc.M802024200; PETERSON CL, 1995, TRENDS BIOCHEM SCI, V20, P143, DOI 10.1016/S0968-0004(00)88990-2; Saramaki A, 2009, J BIOL CHEM, V284, P8073, DOI 10.1074/jbc.M808090200; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; STAUDT LM, 1991, ANNU REV IMMUNOL, V9, P373; Sutton ALM, 2003, MOL ENDOCRINOL, V17, P777, DOI 10.1210/me.2002-0363; Turunen MM, 2007, NUCLEIC ACIDS RES, V35, P2734, DOI 10.1093/nar/gkm179; Vaisanen S, 1997, EUR J BIOCHEM, V248, P156, DOI 10.1111/j.1432-1033.1997.t01-1-00156.x; Vaisanen S, 2005, J MOL BIOL, V350, P65, DOI 10.1016/j.jmb.2005.04.057; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Xu W, 2005, BIOCHEM CELL BIOL, V83, P418, DOI 10.1139/O05-057; Zella LA, 2006, MOL ENDOCRINOL, V20, P1231, DOI 10.1210/me.2006-0015; Zhang B, 2007, ONCOGENE, V26, P7153, DOI 10.1038/sj.onc.1210509	32	28	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24174	24183		10.1074/jbc.M110.124073	http://dx.doi.org/10.1074/jbc.M110.124073			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20460683	hybrid, Green Published			2022-12-27	WOS:000280291400067
J	Rajapaksa, TE; Bennett, KM; Hamer, M; Lytle, C; Rodgers, VGJ; Lo, DD				Rajapaksa, Thejani E.; Bennett, Kaila M.; Hamer, Mary; Lytle, Christian; Rodgers, Victor G. J.; Lo, David D.			Intranasal M Cell Uptake of Nanoparticles Is Independently Influenced by Targeting Ligands and Buffer Ionic Strength	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEYERS PATCH; HUMAN MUCUS; POLOXAMER; DELIVERY; PLGA; DRUG; IMMUNIZATION; MUCOSAL; PROTEIN; SURFACE	In mucosal tissues, epithelial M cells capture and transport microbes across the barrier to underlying immune cells. Previous studies suggested that high affinity ligands targeting M cells may be used to deliver mucosal vaccines; here, we show that particle composition and dispersion buffer ionic strength can independently influence their uptake in vivo. First, addition of a poloxamer 188 to nanoparticle formulations increased uptake of intranasally administered nanoparticles in vivo, but the effect was dependent on the presence of the M cell-targeting ligand. Second, solvent ionic strength is known to effect electrostatic interactions; accordingly, reduced ionic strength increased the electrostatic potential between the epithelium and the particles. Interestingly, below a critical ionic strength, intranasal particle uptake in vivo significantly was increased even when controlled for osmolarity. Similar results were obtained for uptake of bacterial particles. Surprisingly, at low ionic strength, the specific enhancement effect by the targeting peptide was negligible. Modeling of the electrostatic forces predicted that the enhancing effects of the M cell-targeting ligand only are enabled at high ionic strength, as particle electrostatic forces are reduced through Debye screening. Thus, electrostatic forces can have a dramatic effect on the in vivo M cell particle uptake independent of the action of targeting ligands. Examination of these forces will be helpful to optimizing mucosal vaccine and drug delivery.	[Lo, David D.] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA; [Bennett, Kaila M.; Rodgers, Victor G. J.] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Lo, DD (corresponding author), Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA.	david.lo@ucr.edu	Lytle, Christian/X-2836-2019; Rodgers, Victor G. J./AAF-3838-2021; Rodgers, Victor G/G-3652-2016	Lytle, Christian/0000-0001-5442-1546; Rodgers, Victor G. J./0000-0002-1857-8025; Rodgers, Victor G/0000-0002-1857-8025	National Institutes of Health [AI63426, AI73689]; Foundation for the National Institutes of Health; Grand Challenges in Global Health; Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073689, R01AI063426] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grand Challenges in Global Health; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI63426 and AI73689 and the Foundation for the National Institutes of Health. This work was also supported by an award from the Grand Challenges in Global Health and the Bill and Melinda Gates Foundation.	Al Haushey L, 2007, INT J PHARMACEUT, V344, P16, DOI 10.1016/j.ijpharm.2007.05.067; Allen MJ, 2004, INT J FOOD MICROBIOL, V92, P265, DOI 10.1016/j.ijfoodmicro.2003.08.017; BESHEER A, 2009, MOL PHARM IN PRESS; Bielinska AU, 2008, AIDS RES HUM RETROV, V24, P271, DOI 10.1089/aid.2007.0148; Bonferoni M C, 2000, AAPS PharmSciTech, V1, pE15, DOI 10.1208/pt010215; Busscher HJ, 2008, LANGMUIR, V24, P10968, DOI 10.1021/la8016968; Busscher HJ, 2006, ENVIRON SCI TECHNOL, V40, P6799, DOI 10.1021/es061282r; Clark MA, 2001, ADV DRUG DELIVER REV, V50, P81, DOI 10.1016/S0169-409X(01)00149-1; Csaba N, 2006, J CONTROL RELEASE, V113, P164, DOI 10.1016/j.jconrel.2006.03.017; Cu Y, 2009, MOL PHARMACEUT, V6, P173, DOI 10.1021/mp8001254; Doble MA, 2002, J GASTROINTEST SURG, V6, P387, DOI 10.1016/S1091-255X(01)00049-X; ELDRIDGE JH, 1989, CURR TOP MICROBIOL, V146, P59; Florence Alexander T, 2005, Drug Discov Today Technol, V2, P75, DOI 10.1016/j.ddtec.2005.05.019; Florence AT, 2004, J DRUG TARGET, V12, P65, DOI 10.1080/10611860410001693706; Foster N, 1998, VACCINE, V16, P536, DOI 10.1016/S0264-410X(97)00222-3; Gregory J., 2005, PARTICLES WATER PROP, DOI DOI 10.1201/9780203508459; Gupta PN, 2007, J DRUG TARGET, V15, P701, DOI 10.1080/10611860701637982; Gurtovenko AA, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2166396; Helander A, 2003, J VIROL, V77, P7964, DOI 10.1128/JVI.77.14.7964-7977.2003; Hillery AM, 1996, INT J PHARM, V132, P123, DOI 10.1016/0378-5173(95)04353-5; Jepson MA, 1996, J ANAT, V189, P507; Kharenko EA, 2009, PHARM CHEM J, V43, P200, DOI 10.1007/s11094-009-0271-6; Kimura J, 2010, J BIOL CHEM, V285, P401, DOI 10.1074/jbc.M109.051417; Kondoh M, 2006, BIOL PHARM BULL, V29, P1783, DOI 10.1248/bpb.29.1783; Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P158, DOI 10.1016/j.addr.2008.11.002; Lavelle EC, 1999, VACCINE, V17, P512, DOI 10.1016/S0264-410X(98)00229-1; Li Q, 1999, WATER RES, V33, P1090, DOI 10.1016/S0043-1354(98)00291-7; Ling J, 2008, J BIOL CHEM, V283, P30585, DOI 10.1074/jbc.M803548200; Lo D, 2004, INT IMMUNOL, V16, P91, DOI 10.1093/intimm/dxh011; Manocha M, 2005, VACCINE, V23, P5599, DOI 10.1016/j.vaccine.2005.06.031; Moghimi SM, 2000, TRENDS BIOTECHNOL, V18, P412, DOI 10.1016/S0167-7799(00)01485-2; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Neutra MR, 1999, SEMIN IMMUNOL, V11, P171, DOI 10.1006/smim.1999.0173; Rajapaksa TE, 2010, J CONTROL RELEASE, V142, P196, DOI 10.1016/j.jconrel.2009.10.033; Rajapaksa Thejani E., 2010, Current Immunology Reviews, V6, P29; RYAN JN, 1994, J COLLOID INTERF SCI, V165, P536; Santander-Ortega MJ, 2007, COLLOID SURFACE A, V296, P132, DOI 10.1016/j.colsurfa.2006.09.036; Shahiwala Aliasgar, 2007, Recent Pat Drug Deliv Formul, V1, P1, DOI 10.2174/187221107779814140; Shakweh Monjed, 2004, Expert Opin Drug Deliv, V1, P141, DOI 10.1517/17425247.1.1.141; Sleator RD, 2002, FEMS MICROBIOL REV, V26, P49, DOI 10.1111/j.1574-6976.2002.tb00598.x; Suzuki H, 2008, GASTROENTEROLOGY, V135, P917, DOI 10.1053/j.gastro.2008.05.037; Tang BC, 2009, P NATL ACAD SCI USA, V106, P19268, DOI 10.1073/pnas.0905998106; Tobio M, 1999, PHARMACEUT RES, V16, P682, DOI 10.1023/A:1018820507379; Tsao HK, 2001, J COLLOID INTERF SCI, V233, P124, DOI 10.1006/jcis.2000.7261; van Merode AEJ, 2008, COLLOID SURFACE B, V64, P302, DOI 10.1016/j.colsurfb.2008.02.004; Wu YP, 2001, P NATL ACAD SCI USA, V98, P9318, DOI 10.1073/pnas.161204098; Zhang Y, 2008, BIOMED MICRODEVICES, V10, P321, DOI 10.1007/s10544-007-9139-2	48	43	48	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23739	23746		10.1074/jbc.M110.126359	http://dx.doi.org/10.1074/jbc.M110.126359			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20511224	Green Published, hybrid			2022-12-27	WOS:000280291400024
J	Saga, G; Giorgetti, A; Fufezan, C; Giacometti, GM; Bassi, R; Morosinotto, T				Saga, Giorgia; Giorgetti, Alejandro; Fufezan, Christian; Giacometti, Giorgio M.; Bassi, Roberto; Morosinotto, Tomas			Mutation Analysis of Violaxanthin De-epoxidase Identifies Substrate-binding Sites and Residues Involved in Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XANTHOPHYLL-CYCLE ENZYME; CRYSTAL-STRUCTURE; ZEAXANTHIN FORMATION; ESCHERICHIA-COLI; EXCESS LIGHT; PROTEIN; LIPOCALIN; ENERGY; PH; MEMBRANE	Plants are able to deal with variable environmental conditions; when exposed to strong illumination, they safely dissipate excess energy as heat and increase their capacity for scavenging reacting oxygen species. Both these protection mechanisms involve activation of the xanthophyll cycle, in which the carotenoid violaxanthin is converted to zeaxanthin by violaxanthin de-epoxidase, using ascorbate as the source of reducing power. In this work, following determination of the three-dimensional structure of the violaxanthin de-epoxidase catalytic domain, we identified the putative binding sites for violaxanthin and ascorbate by in silico docking. Amino acid residues lying in close contact with the two substrates were analyzed for their involvement in the catalytic mechanism. Experimental results supported the proposed substrate-binding sites and point to two residues, Asp-177 and Tyr-198, which are suggested to participate in the catalytic mechanism, based on complete loss of activity in mutant proteins. The role of other residues and the mechanistic similarity to aspartic proteases and epoxide hydrolases are discussed.	[Morosinotto, Tomas] Univ Padua, Dipartimento Biol, I-35121 Padua, Italy; [Saga, Giorgia; Giorgetti, Alejandro; Bassi, Roberto] Univ Verona, Dipartimento Biotecnol, I-37134 Verona, Italy; [Fufezan, Christian] Univ Munster, Inst Biochem & Biotechnol Pflanzen, D-48143 Munster, Germany	University of Padua; University of Verona; University of Munster	Morosinotto, T (corresponding author), Univ Padua, Dipartimento Biol, Via Ugo Bassi 58 B, I-35121 Padua, Italy.	tomas.morosinotto@unipd.it	Morosinotto, Tomas/AAC-3188-2019	Morosinotto, Tomas/0000-0002-0803-7591; Giorgetti, Alejandro/0000-0001-8738-6150; bassi, roberto/0000-0002-4140-8446; Fufezan, Christian/0000-0002-7048-6822	MIUR [PRIN 20073YHRLE]; University of Padova [CPDA089403]	MIUR(Ministry of Education, Universities and Research (MIUR)); University of Padova	This work was supported in part by MIUR Grant PRIN 20073YHRLE and the University of Padova Grant CPDA089403 (to T.M.).	Arand M, 2003, DRUG METAB REV, V35, P365, DOI 10.1081/DMR-120026498; Arnoux P, 2009, PLANT CELL, V21, P2036, DOI 10.1105/tpc.109.068007; Ballottari M, 2007, J BIOL CHEM, V282, P8947, DOI 10.1074/jbc.M606417200; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; BRATT CE, 1995, PHOTOSYNTH RES, V45, P169, DOI 10.1007/BF00032588; Bugos RC, 1996, P NATL ACAD SCI USA, V93, P6320, DOI 10.1073/pnas.93.13.6320; Bugos RC, 1998, J BIOL CHEM, V273, P15321, DOI 10.1074/jbc.273.25.15321; Campanacci V, 2006, FEBS LETT, V580, P4877, DOI 10.1016/j.febslet.2006.07.086; Coesel S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002896; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; Dall'Osto L, 2010, MOL PLANT, V3, P576, DOI 10.1093/mp/ssp117; DeLano WL., 2020, PYMOL MOL GRAPHICS S; DEMMIG B, 1987, PLANT PHYSIOL, V84, P218, DOI 10.1104/pp.84.2.218; Fufezan C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-258; Ganfornina MD, 2000, MOL BIOL EVOL, V17, P114, DOI 10.1093/oxfordjournals.molbev.a026224; Garcia-Martin A, 2008, J MOL BIOL, V382, P154, DOI 10.1016/j.jmb.2008.07.002; GILMORE AM, 1995, P NATL ACAD SCI USA, V92, P2273, DOI 10.1073/pnas.92.6.2273; GILMORE AM, 1991, PLANT PHYSIOL, V96, P635, DOI 10.1104/pp.96.2.635; Gisselsson A, 2004, PHYSIOL PLANTARUM, V122, P337, DOI 10.1111/j.1399-3054.2004.00415.x; HAGER A, 1994, PLANTA, V192, P581, DOI 10.1007/BF00203597; Havaux M, 2007, PLANT PHYSIOL, V145, P1506, DOI 10.1104/pp.107.108480; Havir EA, 1997, PLANT SCI, V123, P57, DOI 10.1016/S0168-9452(97)04579-2; Hieber AD, 2000, BBA-PROTEIN STRUCT M, V1482, P84, DOI 10.1016/S0167-4838(00)00141-2; Hieber AD, 2002, PLANTA, V214, P476, DOI 10.1007/s00425-001-0704-2; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Jahns P, 2009, BBA-BIOENERGETICS, V1787, P3, DOI 10.1016/j.bbabio.2008.09.013; Kawano M, 2000, FEBS LETT, V481, P101, DOI 10.1016/S0014-5793(00)01991-8; Kerfeld CA, 2003, STRUCTURE, V11, P55, DOI 10.1016/S0969-2126(02)00936-X; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; Kuwabara T, 1999, PLANT CELL PHYSIOL, V40, P1119, DOI 10.1093/oxfordjournals.pcp.a029496; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lascombe MB, 2000, J BIOL CHEM, V275, P21572, DOI 10.1074/jbc.M002854200; Latowski D, 2004, BIOCHEMISTRY-US, V43, P4417, DOI 10.1021/bi049652g; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Lohr M, 1999, P NATL ACAD SCI USA, V96, P8784, DOI 10.1073/pnas.96.15.8784; Morosinotto T, 2002, J BIOL CHEM, V277, P36913, DOI 10.1074/jbc.M205339200; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; NEUBAUER C, 1994, PHOTOSYNTH RES, V39, P137, DOI 10.1007/BF00029381; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Rockholm DC, 1996, PLANT PHYSIOL, V110, P697, DOI 10.1104/pp.110.2.697; Song YF, 2009, J COMPUT CHEM, V30, P2231, DOI 10.1002/jcc.21222; Urade Y, 2000, BBA-PROTEIN STRUCT M, V1482, P259, DOI 10.1016/S0167-4838(00)00161-8; YAMAMOTO HY, 1978, ARCH BIOCHEM BIOPHYS, V190, P514, DOI 10.1016/0003-9861(78)90305-3; YAMAMOTO HY, 1971, BIOCHEM BIOPH RES CO, V42, P37, DOI 10.1016/0006-291X(71)90358-5	48	42	44	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23763	23778		10.1074/jbc.M110.115097	http://dx.doi.org/10.1074/jbc.M110.115097			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20507981	hybrid, Green Published			2022-12-27	WOS:000280291400027
J	Stuible, M; Abella, JV; Feldhammer, M; Nossov, M; Sangwan, V; Blagoev, B; Park, M; Tremblay, ML				Stuible, Matthew; Abella, Jasmine V.; Feldhammer, Matthew; Nossov, Misha; Sangwan, Veena; Blagoev, Blagoy; Park, Morag; Tremblay, Michel L.			PTP1B Targets the Endosomal Sorting Machinery DEPHOSPHORYLATION OF REGULATORY SITES ON THE ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT COMPONENT STAM2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; GROWTH-FACTOR RECEPTOR; INSULIN SENSITIVITY; SIGNALING NETWORKS; CELL DEVELOPMENT; MOLECULAR-BASIS; DOWN-REGULATION; MICE LACKING; 1B; HRS	Dephosphorylation and endocytic down-regulation are distinct processes that together control the signaling output of a variety of receptor tyrosine kinases (RTKs). PTP1B can directly dephosphorylate several RTKs, but it can also promote activation of downstream pathways through largely unknown mechanisms. These positive signaling functions likely contribute to the tumor-promoting effect of PTP1B in mouse cancer models. Here, we have identified STAM2, an endosomal protein involved in sorting activated RTKs for lysosomal degradation, as a substrate of PTP1B. PTP1B interacts with STAM2 at defined phosphotyrosine sites, and knockdown of PTP1B expression augments STAM2 phosphorylation. Intriguingly, manipulating the expression and phosphorylation state of STAM2 did not have a general effect on epidermal growth factor (EGF)-induced EGF receptor trafficking, degradation, or signaling. Instead, phosphorylated STAM2 specifically suppressed Akt activation, and a phosphorylation-deficient STAM2 mutant displayed prolonged localization on endosomes following EGF stimulation. These results reveal a novel link between the dephosphorylation and endocytic machinery and suggest that PTP1B can affect RTK signaling in a previously unrecognized manner.	[Park, Morag; Tremblay, Michel L.] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Park, Morag; Tremblay, Michel L.] McGill Univ, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ H3A 1A3, Canada; [Park, Morag; Tremblay, Michel L.] McGill Univ, Dept Oncol, Montreal, PQ H3A 1A3, Canada; [Blagoev, Blagoy] Univ So Denmark, Dept Biochem & Mol Biol, Ctr Expt BioInformat, DK-5230 Odense, Denmark	McGill University; McGill University; McGill University; University of Southern Denmark	Tremblay, ML (corresponding author), McGill Univ, Dept Biochem, 1160 Pine Ave W, Montreal, PQ H3A 1A3, Canada.	michel.tremblay@mcgill.ca		Blagoev, Blagoy/0000-0002-3596-0066	Canadian Institutes of Health Research [MOP-62887, MOP-1154]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Operating Grants MOP-62887 (to M.L.T.) and MOP-1154 (to M.P.).	Abella JV, 2009, AM J PHYSIOL-ENDOC M, V296, pE973, DOI 10.1152/ajpendo.90857.2008; Anderie I, 2007, CELL SIGNAL, V19, P582, DOI 10.1016/j.cellsig.2006.08.007; Barriere H, 2006, TRAFFIC, V7, P282, DOI 10.1111/j.1600-0854.2006.00384.x; Barriere H, 2007, MOL BIOL CELL, V18, P3952, DOI 10.1091/mbc.E07-07-0678; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Burz DS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002571; Confalonieri S, 2000, J CELL BIOL, V150, P905, DOI 10.1083/jcb.150.4.905; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; Dube N, 2005, CANCER RES, V65, P10088, DOI 10.1158/0008-5472.CAN-05-1353; Dube N, 2004, P NATL ACAD SCI USA, V101, P1834, DOI 10.1073/pnas.0304242101; Eden ER, 2010, NAT CELL BIOL, V12, P267, DOI 10.1038/ncb2026; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Haj FG, 2003, J BIOL CHEM, V278, P739, DOI 10.1074/jbc.M210194200; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Hammond DE, 2003, MOL BIOL CELL, V14, P1346, DOI 10.1091/mbc.E02-09-0578; Julien SG, 2007, NAT GENET, V39, P338, DOI 10.1038/ng1963; Kanazawa C, 2003, BIOCHEM BIOPH RES CO, V309, P848, DOI 10.1016/j.bbrc.2003.08.078; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Komada M, 2005, J BIOCHEM, V137, P1, DOI 10.1093/jb/mvi001; Komada M, 1999, GENE DEV, V13, P1475, DOI 10.1101/gad.13.11.1475; Lohi O, 1998, FEBS LETT, V432, P225, DOI 10.1016/S0014-5793(98)00874-6; Mizuno E, 2004, J BIOCHEM, V135, P385, DOI 10.1093/jb/mvh046; Mizuno E, 2003, MOL BIOL CELL, V14, P3675, DOI 10.1091/mbc.E02-12-0823; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Pandey A, 2000, J BIOL CHEM, V275, P38633, DOI 10.1074/jbc.M007849200; Parachoniak CA, 2009, J BIOL CHEM, V284, P8382, DOI 10.1074/jbc.M807607200; Peschard P, 2007, ONCOGENE, V26, P1276, DOI 10.1038/sj.onc.1210201; Raiborg C, 2008, EXP CELL RES, V314, P801, DOI 10.1016/j.yexcr.2007.10.014; Romsicki Y, 2004, J BIOL CHEM, V279, P12868, DOI 10.1074/jbc.M309600200; Row PE, 2005, BIOCHEM J, V389, P629, DOI 10.1042/BJ20050067; Salmeen A, 2000, MOL CELL, V6, P1401, DOI 10.1016/S1097-2765(00)00137-4; Sangwan V, 2008, J BIOL CHEM, V283, P34374, DOI 10.1074/jbc.M805916200; Simoncic PD, 2002, CURR BIOL, V12, P446, DOI 10.1016/S0960-9822(02)00697-8; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Sorkina T, 2002, J BIOL CHEM, V277, P27433, DOI 10.1074/jbc.M201595200; Stuible M, 2008, CANCER METAST REV, V27, P215, DOI 10.1007/s10555-008-9115-1; Stuible M, 2008, J BIOL CHEM, V283, P15740, DOI 10.1074/jbc.M710534200; Stuible M, 2007, CHEMBIOCHEM, V8, P179, DOI 10.1002/cbic.200600287; Uetani N, 2009, J CLIN INVEST, V119, P924, DOI 10.1172/JCI37196; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; Yamada M, 2002, MOL CELL BIOL, V22, P8648, DOI 10.1128/MCB.22.24.8648-8658.2002; Yamada M, 2001, MOL CELL BIOL, V21, P3807, DOI 10.1128/MCB.21.11.3807-3819.2001	44	39	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23899	23907		10.1074/jbc.M110.115295	http://dx.doi.org/10.1074/jbc.M110.115295			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20504764	Green Published, hybrid			2022-12-27	WOS:000280291400040
J	Chen, L; Jeffries, O; Rowe, ICM; Liang, Z; Knaus, HG; Ruth, P; Shipston, MJ				Chen, Lie; Jeffries, Owen; Rowe, Iain C. M.; Liang, Zhi; Knaus, Hans-Guenther; Ruth, Peter; Shipston, Michael J.			Membrane Trafficking of Large Conductance Calcium-activated Potassium Channels Is Regulated by Alternative Splicing of a Transplantable, Acidic Trafficking Motif in the RCK1-RCK2 Linker	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNEL; SURFACE EXPRESSION; BK CHANNEL; G-PROTEIN; PHOSPHORYLATION; DYSFUNCTION; MOVEMENT; SIGNALS; VARIANT; SUBUNIT	Trafficking of the pore-forming alpha-subunits of large conductance calcium-and voltage-activated potassium (BK) channels to the cell surface represents an important regulatory step in controlling BK channel function. Here, we identify multiple trafficking signals within the intracellular RCK1-RCK2 linker of the cytosolic C terminus of the channel that are required for efficient cell surface expression of the channel. In particular, an acidic cluster-like motif was essential for channel exit from the endoplasmic reticulum and subsequent cell surface expression. This motif could be transplanted onto a heterologous nonchannel protein to enhance cell surface expression by accelerating endoplasmic reticulum export. Importantly, we identified a human alternatively spliced BK channel variant, hSlo Delta(579-664), in which these trafficking signals are excluded because of in-frame exon skipping. The hSlo Delta(579-664) variant is expressed in multiple human tissues and cannot form functional channels at the cell surface even though it retains the putative RCK domains and down stream trafficking signals. Functionally, the hSlo Delta(579-664) variant acts as a dominant negative subunit to suppress cell surface expression of BK channels. Thus alternative splicing of the intracellular RCK1-RCK2 linker plays a critical role in determining cell surface expression of BK channels by controlling the inclusion/exclusion of multiple trafficking motifs.	[Chen, Lie; Jeffries, Owen; Rowe, Iain C. M.; Liang, Zhi; Shipston, Michael J.] Univ Edinburgh, Ctr Integrat Physiol, Coll Med & Vet Med, Edinburgh EH8 9XD, Midlothian, Scotland; [Knaus, Hans-Guenther] Med Univ Innsbruck, Dept Med Genet Mol & Clin Pharmacol, Div Mol & Cellular Pharmacol, A-6020 Innsbruck, Austria; [Ruth, Peter] Univ Tubingen, Inst Pharm, D-72076 Tubingen, Germany	University of Edinburgh; Medical University of Innsbruck; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Shipston, MJ (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Coll Med & Vet Med, Hugh Robson Bldg, Edinburgh EH8 9XD, Midlothian, Scotland.	mike.shipston@ed.ac.uk	Shipston, Mike/C-7309-2013	Shipston, Mike/0000-0001-7544-582X; jeffries, owen/0000-0002-8169-1100; Chen, Lie/0000-0001-9764-4299; Rowe, Iain C M/0000-0002-0148-5332	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust.	Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Chen L, 2005, J BIOL CHEM, V280, P33599, DOI 10.1074/jbc.M505383200; Davies KP, 2007, EUR UROL, V52, P1229, DOI 10.1016/j.eururo.2006.11.028; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Korovkina VP, 2006, J PHYSIOL-LONDON, V573, P329, DOI 10.1113/jphysiol.2006.106922; Kwon SH, 2004, P NATL ACAD SCI USA, V101, P15237, DOI 10.1073/pnas.0404877101; Lee JH, 2009, BIOPHYS J, V97, P730, DOI 10.1016/j.bpj.2009.04.058; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Ma DH, 2007, FEBS LETT, V581, P1000, DOI 10.1016/j.febslet.2007.01.077; Madrid R, 2001, EMBO J, V20, P7008, DOI 10.1093/emboj/20.24.7008; Marijic J, 2001, CIRC RES, V88, P210; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; Mikosch M, 2009, TRAFFIC, V10, P1481, DOI 10.1111/j.1600-0854.2009.00962.x; Raffaelli G, 2004, J PHYSIOL-LONDON, V557, P147, DOI 10.1113/jphysiol.2004.062661; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Saleem F, 2009, BRIT J PHARMACOL, V156, P143, DOI 10.1111/j.1476-5381.2008.00011.x; Sandoval IV, 2000, J BIOL CHEM, V275, P39874, DOI 10.1074/jbc.M006261200; Sausbier M, 2005, CIRCULATION, V112, P60, DOI 10.1161/01.CIR.0000156448.74296.FE; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Sevier CS, 2000, MOL BIOL CELL, V11, P13, DOI 10.1091/mbc.11.1.13; Song M, 1999, FEBS LETT, V460, P427, DOI 10.1016/S0014-5793(99)01394-0; Sorensen MV, 2008, J PHYSIOL-LONDON, V586, P4251, DOI 10.1113/jphysiol.2008.156968; Taneja TK, 2009, HUM MOL GENET, V18, P2400, DOI 10.1093/hmg/ddp179; Tian L, 2004, P NATL ACAD SCI USA, V101, P11897, DOI 10.1073/pnas.0402590101; Tian LJ, 2008, P NATL ACAD SCI USA, V105, P21006, DOI 10.1073/pnas.0806700106; Tian LJ, 2001, J BIOL CHEM, V276, P7717, DOI 10.1074/jbc.C000741200; Werner ME, 2005, J PHYSIOL-LONDON, V567, P545, DOI 10.1113/jphysiol.2005.093823; Xu WH, 2002, SCIENCE, V298, P1029, DOI 10.1126/science.1074360; Yusifov T, 2008, P NATL ACAD SCI USA, V105, P376, DOI 10.1073/pnas.0705261105; Zarei MM, 2004, P NATL ACAD SCI USA, V101, P10072, DOI 10.1073/pnas.0302919101; Zarei MM, 2001, J BIOL CHEM, V276, P16232, DOI 10.1074/jbc.M008852200; Zuzarte M, 2007, TRAFFIC, V8, P1093, DOI 10.1111/j.1600-0854.2007.00593.x	35	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23263	23273		10.1074/jbc.M110.139758	http://dx.doi.org/10.1074/jbc.M110.139758			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20479001	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000279999900060
J	Kim, J; Lilliehook, C; Dudak, A; Prox, J; Saftig, P; Federoff, HJ; Lim, ST				Kim, Jinsook; Lilliehook, Christina; Dudak, Amanda; Prox, Johannes; Saftig, Paul; Federoff, Howard J.; Lim, Seung T.			Activity-dependent alpha-Cleavage of Nectin-1 Is Mediated by A Disintegrin and Metalloprotease 10 (ADAM10)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL ADHESION; MOSSY FIBER TERMINALS; AMYLOID PRECURSOR PROTEIN; ADULT-MOUSE HIPPOCAMPUS; N-CADHERIN; PRESENILIN/GAMMA-SECRETASE; PYRAMIDAL CELLS; BETA-CATENIN; SYNAPTIC PLASTICITY; ADHERENS JUNCTIONS	Nectin-1 is known to undergo ectodomain shedding by alpha-secretase and subsequent proteolytic processing by gamma-secretase. How secretase-mediated cleavage of nectin-1 is regulated in neuronal cells and how nectin-1 cleavage affects synaptic adhesion is poorly understood. We have investigated alpha-and gamma-secretase-mediated processing of nectin-1 in primary cortical neurons and identified which protease acts as a alpha-secretase. We report here that NMDA receptor activation, but not stimulation of AMPA or metabotropic glutamate receptors, resulted in robust alpha- and gamma-secretase cleavage of nectin-1 in mature cortical neurons. Cleavage of nectin-1 required influx of Ca2+ through the NMDA receptor, and activation of calmodulin, but was not dependent on calcium/calmodulin-dependent protein kinase II (CaMKII) activation. We found that ADAM10 is the major secretase responsible for nectin-1 ectodomain cleavage in neurons and the brain. These observations suggest that alpha- and gamma-secretase processing of nectin-1 is a Ca2+/calmodulin-regulated event that occurs under conditions of activity-dependent synaptic plasticity and ADAM10 and gamma-secretase are responsible for these cleavage events.	[Lim, Seung T.] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20057 USA; [Lilliehook, Christina] Univ Rochester, Sch Med & Dent, Ctr Aging & Dev Biol, Rochester, NY 14642 USA; [Prox, Johannes; Saftig, Paul] Univ Kiel, Inst Biochem, D-24098 Kiel, Germany	Georgetown University; University of Rochester; University of Kiel	Lim, ST (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, 3970 Reservoir Rd NW, Washington, DC 20057 USA.	ls379@georgetown.edu	Saftig, Paul/A-7966-2010		National Institutes of Health [R01 AG027233]; NATIONAL INSTITUTE ON AGING [R01AG027233] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AG027233.	Benson DL, 1998, J NEUROSCI, V18, P6892; Buchert M, 2007, J CELL PHYSIOL, V210, P212, DOI 10.1002/jcp.20853; Dell'Acqua ML, 2006, EUR J CELL BIOL, V85, P627, DOI 10.1016/j.ejcb.2006.01.010; Dihne M, 2003, J NEUROSCI, V23, P6638; Fabre-Lafay S, 2005, J BIOL CHEM, V280, P19543, DOI 10.1074/jbc.M410943200; Haarr L, 2001, VIROLOGY, V287, P301, DOI 10.1006/viro.2001.1041; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Honda T, 2003, GENES CELLS, V8, P51, DOI 10.1046/j.1365-2443.2003.00616.x; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Inagaki M, 2003, J COMP NEUROL, V460, P514, DOI 10.1002/cne.10653; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Kalus I, 2003, J BIOL CHEM, V278, P10381, DOI 10.1074/jbc.M208351200; Kawakatsu T, 2005, J BIOL CHEM, V280, P4940, DOI 10.1074/jbc.M408710200; Kawakatsu T, 2002, J BIOL CHEM, V277, P50749, DOI 10.1074/jbc.M209846200; Kim DY, 2002, J BIOL CHEM, V277, P49976, DOI 10.1074/jbc.M210179200; Lee TW, 2008, NEURON GLIA BIOL, V4, P223, DOI 10.1017/S1740925X09990172; Li T, 2003, J NEUROSCI, V23, P3272; Li Y, 2009, J CELL BIOL, V185, P1065, DOI 10.1083/jcb.200811033; Lim ST, 2008, J COMP NEUROL, V507, P1228, DOI 10.1002/cne.21608; Ma GJ, 2005, J NEUROSCI, V25, P192, DOI 10.1523/JNEUROSCI.3814-04.2005; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Miyamoto E, 2006, J PHARMACOL SCI, V100, P433, DOI 10.1254/jphs.CPJ06007X; Mizoguchi A, 2002, J CELL BIOL, V156, P555, DOI 10.1083/jcb.200103113; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Nishioka H, 2000, J COMP NEUROL, V424, P297, DOI 10.1002/1096-9861(20000821)424:2<297::AID-CNE8>3.0.CO;2-J; Pillai-Nair N, 2005, J NEUROSCI, V25, P4659, DOI 10.1523/JNEUROSCI.0565-05.2005; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Reymond N, 2001, J BIOL CHEM, V276, P43205, DOI 10.1074/jbc.M103810200; Saito S, 1998, DNA Res, V5, P115, DOI 10.1093/dnares/5.2.115; Sakisaka T, 2007, CURR OPIN CELL BIOL, V19, P593, DOI 10.1016/j.ceb.2007.09.007; Sozen MA, 2001, NAT GENET, V29, P141, DOI 10.1038/ng740; Sugawa M, 1997, NEUROREPORT, V8, P3157, DOI 10.1097/00001756-199709290-00030; Suzuki K, 2000, NAT GENET, V25, P427, DOI 10.1038/78119; Takahashi K, 1999, J CELL BIOL, V145, P539, DOI 10.1083/jcb.145.3.539; Takai Y, 2003, CURR OPIN NEUROBIOL, V13, P520, DOI 10.1016/j.conb.2003.09.003; Tanaka Y, 2002, BIOCHEM BIOPH RES CO, V299, P472, DOI 10.1016/S0006-291X(02)02681-5; Togashi H, 2006, J CELL BIOL, V174, P141, DOI 10.1083/jcb.200601089; Uemura K, 2006, BIOCHEM BIOPH RES CO, V345, P951, DOI 10.1016/j.bbrc.2006.04.157; Xia ZG, 2005, NAT REV NEUROSCI, V6, P267, DOI 10.1038/nrn1647; Yamada A, 2003, GENES CELLS, V8, P985, DOI 10.1046/j.1356-9597.2003.00690.x; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	46	39	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22917	22924		10.1074/jbc.M110.126649	http://dx.doi.org/10.1074/jbc.M110.126649			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20501653	hybrid, Green Published			2022-12-27	WOS:000279999900025
J	Salameh, A; Galvagni, F; Anselmi, F; De Clemente, C; Orlandini, M; Oliviero, S				Salameh, Ahmad; Galvagni, Federico; Anselmi, Francesca; De Clemente, Caterina; Orlandini, Maurizio; Oliviero, Salvatore			Growth Factor Stimulation Induces Cell Survival by c-Jun center dot ATF2-dependent Activation of Bcl-X-L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-JUN; GENE; APOPTOSIS; PHOSPHORYLATION; PROMOTER; JNK; PROLIFERATION; LYMPHOCYTES; EXPRESSION; AP-1	Growth factor stimulation induces c-Jun-dependent survival of primary endothelial cells. However, the mechanism of c-Jun anti-apoptotic activity has not been identified. We here demonstrate that in response to growth factor treatment, primary human endothelial cells as well as mouse fibroblasts respond with an increased expression of c-Jun that forms a complex with ATF2. This complex activates the expression of the anti-apoptotic protein Bcl-XL. By site-directed mutagenesis experiments, we identified two AP-1-binding sites located within the proximal promoter of the Bcl-X gene. Site-directed mutagenesis demonstrated that these AP-1 sites are required for the transcriptional activation of the promoter. Chromatin immunoprecipitation experiments show that in response to growth factor treatment, the heterodimer c-Jun center dot ATF2 binds to these functional AP-1 sites. Silencing of either c-Jun or ATF2 demonstrated that both nuclear factors are required for the activation of the proximal Bcl-X promoter. Taken together, our experiments provide evidence that growth factor-independent signaling pathways converge in the formation of an active c-Jun center dot AFT2 dimer, which induces the expression of the anti-apoptotic factor Bcl-XL that mediates a pro-survival response.	[Salameh, Ahmad; Galvagni, Federico; Anselmi, Francesca; De Clemente, Caterina; Orlandini, Maurizio; Oliviero, Salvatore] Univ Siena, Dipartimento Biol Mol, I-53100 Siena, Italy	University of Siena	Oliviero, S (corresponding author), Via Fiorentina 1, I-53100 Siena, Italy.	Oliviero@unisi.it	oliviero, salvatore/R-6657-2019; Orlandini, Maurizio/AAF-8247-2020; Galvagni, Federico/F-9186-2013	oliviero, salvatore/0000-0002-3405-765X; Orlandini, Maurizio/0000-0002-6112-4889; 	Associazione Italiana Ricerca sul Cancro, Istituto Tosscano Tumori; Ministero Italiano dell'Istruzione, dell'Universita e della Ricerca	Associazione Italiana Ricerca sul Cancro, Istituto Tosscano Tumori(Fondazione AIRC per la ricerca sul cancro); Ministero Italiano dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from Associazione Italiana Ricerca sul Cancro, Istituto Tosscano Tumori, and Ministero Italiano dell'Istruzione, dell'Universita e della Ricerca.	Ameyar M, 2003, BIOCHIMIE, V85, P747, DOI 10.1016/j.biochi.2003.09.006; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Ezzat S, 2006, MOL ENDOCRINOL, V20, P2976, DOI 10.1210/me.2006-0265; FANG W, 1994, J IMMUNOL, V153, P4388; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Grad JM, 2000, CURR OPIN ONCOL, V12, P543, DOI 10.1097/00001622-200011000-00006; Grillot DAM, 1997, J IMMUNOL, V158, P4750; Habens F, 2007, ONCOGENE, V26, P1910, DOI 10.1038/sj.onc.1209979; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kawasaki H, 2000, NATURE, V405, P195, DOI 10.1038/35012097; Khoshnan A, 2000, J IMMUNOL, V165, P1743, DOI 10.4049/jimmunol.165.4.1743; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Ma C, 2007, J BIOL CHEM, V282, P30901, DOI 10.1074/jbc.M608694200; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mechta-Grigoriou F, 2001, ONCOGENE, V20, P2378, DOI 10.1038/sj.onc.1204381; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Ouwens DM, 2002, EMBO J, V21, P3782, DOI 10.1093/emboj/cdf361; Pecci A, 2001, J BIOL CHEM, V276, P21062, DOI 10.1074/jbc.M008665200; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Salameh A, 2005, BLOOD, V106, P3423, DOI 10.1182/blood-2005-04-1388; Shiraiwa N, 1996, J BIOL CHEM, V271, P13258, DOI 10.1074/jbc.271.22.13258; Viegas LR, 2004, J BIOL CHEM, V279, P9831, DOI 10.1074/jbc.M312402200; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Weiss C, 2003, EMBO J, V22, P3686, DOI 10.1093/emboj/cdg364; Yang XF, 1997, IMMUNITY, V7, P629, DOI 10.1016/S1074-7613(00)80384-2; Yuan ZM, 2009, MOL CELL BIOL, V29, P2431, DOI 10.1128/MCB.01344-08; Zippo A, 2004, BLOOD, V103, P4536, DOI 10.1182/blood-2003-11-3827; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	30	36	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23094	23102		10.1074/jbc.M109.087221	http://dx.doi.org/10.1074/jbc.M109.087221			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20507983	Green Published, hybrid			2022-12-27	WOS:000279999900044
J	Zong, HL; Madden, A; Ward, M; Mooney, MH; Elliott, CT; Stitt, AW				Zong, Hongliang; Madden, Angelina; Ward, Micheal; Mooney, Mark H.; Elliott, Christopher T.; Stitt, Alan W.			Homodimerization Is Essential for the Receptor for Advanced Glycation End Products (RAGE)-mediated Signal Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; CELL-SURFACE RECEPTOR; ENDPRODUCTS RAGE; PATTERN-RECOGNITION; CYTOPLASMIC DOMAIN; NEURITE OUTGROWTH; ACTIVATION; EXPRESSION; GLYCOSYLATION; NEUROTOXICITY	The receptor for advanced glycation end products (RAGE) is a pattern-recognition receptor that binds to diverse ligands and initiates a downstream proinflammatory signaling cascade. RAGE activation has been linked to diabetic complications, Alzheimer disease, infections, and cancers. RAGE is known to mediate cell signaling and downstream proinflammatory gene transcription activation, although the precise mechanism surrounding receptor-ligand interactions is still being elucidated. Recent fluorescence resonance energy transfer evidence indicates that RAGE may form oligomers on the cell surface and that this could be related to signal transduction. To investigate whether RAGE forms oligomers, protein-protein interaction assays were carried out. Here, we demonstrate the interaction between RAGE molecules via their N-terminal V domain, which is an important region involved in ligand recognition. By protein cross-linking using water-soluble and membrane-impermeable cross-linker bis(sulfosuccinimidyl) suberate and nondenaturing gels, we show that RAGE forms homodimers at the plasma membrane, a process potentiated by S100B and advanced glycation end products. Soluble RAGE, the RAGE inhibitor, is also capable of binding to RAGE, similar to V peptide, as shown by surface plasmon resonance. Incubation of cells with soluble RAGE or RAGE V domain peptide inhibits RAGE dimerization, subsequent phosphorylation of intracellular MAPK proteins, and activation of NF-kappa B pathways. Thus, the data indicate that dimerization of RAGE represents an important component of RAGE-mediated cell signaling.	[Zong, Hongliang; Madden, Angelina; Ward, Micheal; Stitt, Alan W.] Queens Univ Belfast, Ctr Vis & Vasc Sci, Belfast BT12 6BA, Antrim, North Ireland; [Mooney, Mark H.; Elliott, Christopher T.] Queens Univ Belfast, Sch Biol Sci, Belfast BT12 6BA, Antrim, North Ireland	Queens University Belfast; Queens University Belfast	Stitt, AW (corresponding author), Queens Univ Belfast, Royal Victoria Hosp, Ctr Vis & Vasc Sci, Belfast BT12 6BA, Antrim, North Ireland.	a.stitt@qub.ac.uk	Ward, Micheal/G-1379-2012; Stitt, Alan/A-9842-2009; Zong, Hongliang/F-9366-2013	Ward, Micheal/0000-0001-8988-5797; Stitt, Alan/0000-0002-8647-9918; Zong, Hongliang/0000-0002-5855-5733	Juvenile Diabetes Research Foundation; Fight for Sight (United Kingdom)	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Fight for Sight (United Kingdom)	This work was supported by the Juvenile Diabetes Research Foundation and Fight for Sight (United Kingdom).	Bhatwadekar A, 2007, EXPERT REV OPHTHALMO, V2, P105, DOI 10.1586/17469899.2.1.105; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; BRETT J, 1993, AM J PATHOL, V143, P1699; Chaney MO, 2005, BBA-MOL BASIS DIS, V1741, P199, DOI 10.1016/j.bbadis.2005.03.014; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; CHUONG C, 2009, J CELL PHYSL; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; George SR, 2002, NAT REV DRUG DISCOV, V1, P808, DOI 10.1038/nrd913; Ghavami S, 2008, J LEUKOCYTE BIOL, V83, P1484, DOI 10.1189/jlb.0607397; Hermani A, 2005, EXP CELL RES, V312, P184, DOI 10.1016/j.yexcr.2005.10.013; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hudson BI, 2008, J BIOL CHEM, V283, P34457, DOI 10.1074/jbc.M801465200; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Leclerc E, 2007, J BIOL CHEM, V282, P31317, DOI 10.1074/jbc.M703951200; Lemmon MA, 2009, EXP CELL RES, V315, P638, DOI 10.1016/j.yexcr.2008.10.024; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Loeser RF, 2005, ARTHRITIS RHEUM, V52, P2376, DOI 10.1002/art.21199; MARTINEZ A, 1995, BIOCHEM J, V306, P589, DOI 10.1042/bj3060589; Milligan G, 2008, BRIT J PHARMACOL, V153, pS216, DOI 10.1038/sj.bjp.0707490; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Nlatsumoto S, 2008, BIOCHEMISTRY-US, V47, P12299, DOI 10.1021/bi800910v; Osawa M, 2007, BBA-GEN SUBJECTS, V1770, P1468, DOI 10.1016/j.bbagen.2007.07.003; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Ramsay AJ, 2008, J BIOL CHEM, V283, P12293, DOI 10.1074/jbc.M709493200; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; Sasahira T, 2005, VIRCHOWS ARCH, V446, P411, DOI 10.1007/s00428-005-1210-x; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI200114002; Stern DM, 2002, AGEING RES REV, V1, P1, DOI 10.1016/S0047-6374(01)00366-9; Stitt AW, 1999, BIOCHEM BIOPH RES CO, V256, P549, DOI 10.1006/bbrc.1999.0291; Sturchler E, 2008, J NEUROSCI, V28, P5149, DOI 10.1523/JNEUROSCI.4878-07.2008; Taniguchi N, 2003, ARTHRITIS RHEUM, V48, P971, DOI 10.1002/art.10859; Uchida T, 2006, AM J RESP CRIT CARE, V173, P1008, DOI 10.1164/rccm.200509-1477OC; van Zoelen MAD, 2009, VIROLOGY, V391, P265, DOI 10.1016/j.virol.2009.05.032; Wang LY, 2008, J NEUROSCI RES, V86, P1254, DOI 10.1002/jnr.21578; Wendt TM, 2003, AM J PATHOL, V162, P1123, DOI 10.1016/S0002-9440(10)63909-0; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yan SF, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S146239940900101X; Yeh CH, 2001, DIABETES, V50, P1495, DOI 10.2337/diabetes.50.6.1495	40	97	98	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23135	23144		10.1074/jbc.M110.133827	http://dx.doi.org/10.1074/jbc.M110.133827			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20504772	Green Published, hybrid			2022-12-27	WOS:000279999900048
J	Garg, P; Verma, R; Cook, L; Soofi, A; Venkatareddy, M; George, B; Mizuno, K; Gurniak, C; Witke, W; Holzman, LB				Garg, Puneet; Verma, Rakesh; Cook, Leslie; Soofi, Abdul; Venkatareddy, Madhusudan; George, Britta; Mizuno, Kensaku; Gurniak, Christine; Witke, Walter; Holzman, Lawrence B.			Actin-depolymerizing Factor Cofilin-1 Is Necessary in Maintaining Mature Podocyte Architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; SLIT DIAPHRAGM; PROTEIN-KINASE; CELL MOTILITY; PHOSPHATASE SLINGSHOT; LAMELLIPOD EXTENSION; NEPHROTIC-SYNDROME; REGULATES COFILIN; TRANSGENIC MICE; ARP2/3 COMPLEX	Actin dynamics determines podocyte morphology during development and in response to podocyte injury and might be necessary for maintaining normal podocyte morphology. Because podocyte intercellular junction receptor Nephrin plays a role in regulating actin dynamics, and given the described role of cofilin in actin filament polymerization and severing, we hypothesized that cofilin-1 activity is regulated by Nephrin and is necessary in normal podocyte actin dynamics. Nephrin activation induced cofilin dephosphorylation via intermediaries that include phosphatidylinositol 3-kinase, SSH1, 14-3-3, and LIMK in a cell culture model. This Nephrin-induced cofilin activation required a direct interaction between Nephrin and the p85 subunit of phosphatidylinositol 3-kinase. In a similar fashion, cofilin-1 dephosphorylation was observed in a rat model of podocyte injury at a time when foot process spreading is initially observed. To investigate the necessity of cofilin-1 in the glomerulus, podocyte-specific Cfl1 null mice were generated. Cfl1 null podocytes developed normally. However, these mice developed persistent proteinuria by 3 months of age, although they did not exhibit foot process spreading until 8 months, when the rate of urinary protein excretion became more exaggerated. In a mouse model of podocyte injury, protamine sulfate perfusion of the Cfl1 mutant mouse induced a broadened and flattened foot process morphology that was distinct from that observed following perfusion of control kidneys, and mutant podocytes did not recover normal structure following additional perfusion with heparin sulfate. We conclude that cofilin-1 is necessary for maintenance of normal podocyte architecture and for actin structural changes that occur during induction and recovery from podocyte injury.	[Garg, Puneet; Verma, Rakesh; Cook, Leslie; Soofi, Abdul; Venkatareddy, Madhusudan] Univ Michigan, Sch Med, Div Nephrol, Ann Arbor, MI 48109 USA; [George, Britta; Holzman, Lawrence B.] Dept Vet Affairs, Philadelphia, PA 19104 USA; [Mizuno, Kensaku] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan; [Gurniak, Christine; Witke, Walter] Univ Bonn, Inst Genet, D-53117 Bonn, Germany; [Holzman, Lawrence B.] Univ Penn, Sch Med, Div Nephrol, Philadelphia, PA 19104 USA	University of Michigan System; University of Michigan; Tohoku University; University of Bonn; University of Pennsylvania	Holzman, LB (corresponding author), 410E Hill Pavil,380 S Univ Ave, Philadelphia, PA 19104 USA.	lholzman@upenn.edu	George, Britta/AAL-2031-2021; Mizuno, Kensaku/G-8631-2015	Holzman, Lawrence/0000-0002-8961-234X; George, Britta/0000-0001-5430-5086; Garg, Puneet/0000-0001-7439-459X	National Institutes of Health [DK081403]; American Recovery and Reinvestment Act [DK081403-02W1]; Veterans Affairs Merit Review; National Kidney Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK081403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act; Veterans Affairs Merit Review(US Department of Veterans Affairs); National Kidney Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK081403 (to P.G.). This work was also supported by American Recovery and Reinvestment Act supplement DK081403-02W1 (to L.B.H.), a Veterans Affairs Merit Review (to L.B.H.), and a National Kidney Foundation Young Investigator Award (to P.G.).	Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Bellenchi GC, 2007, GENE DEV, V21, P2347, DOI 10.1101/gad.434307; Blasutig IM, 2008, MOL CELL BIOL, V28, P2035, DOI 10.1128/MCB.01770-07; BOLENDER RP, 1979, ANAT REC, V195, P257, DOI 10.1002/ar.1091950202; Brown EJ, 2010, NAT GENET, V42, P72, DOI 10.1038/ng.505; Condeelis J, 2001, TRENDS CELL BIOL, V11, P288, DOI 10.1016/S0962-8924(01)02008-6; DesMarais V, 2004, J CELL SCI, V117, P3499, DOI 10.1242/jcs.01211; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; Garg P, 2007, NEPHRON EXP NEPHROL, V106, pE67, DOI 10.1159/000101795; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gurniak CB, 2005, DEV BIOL, V278, P231, DOI 10.1016/j.ydbio.2004.11.010; Harita Y, 2009, J BIOL CHEM, V284, P8951, DOI 10.1074/jbc.M806851200; Hatanaka H, 1996, CELL, V85, P1047, DOI 10.1016/S0092-8674(00)81305-7; Holzman LB, 1999, KIDNEY INT, V56, P1481, DOI 10.1046/j.1523-1755.1999.00719.x; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Ichetovkin I, 2002, CURR BIOL, V12, P79, DOI 10.1016/S0960-9822(01)00629-7; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kim JM, 2003, SCIENCE, V300, P1298, DOI 10.1126/science.1081068; Lahdenpera J, 2003, KIDNEY INT, V64, P404, DOI 10.1046/j.1523-1755.2003.00097.x; Lehtonen S, 2008, KIDNEY INT, V73, P903, DOI 10.1038/ki.2008.69; Lehtonen S, 2005, P NATL ACAD SCI USA, V102, P9814, DOI 10.1073/pnas.0504166102; MIZUNO K, 1994, ONCOGENE, V9, P1605; Moeller MJ, 2003, GENESIS, V35, P39, DOI 10.1002/gene.10164; Moeller MJ, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015614.68893.0B; Moriyama K, 1999, EMBO J, V18, P6752, DOI 10.1093/emboj/18.23.6752; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Nishita M, 2004, J BIOL CHEM, V279, P7193, DOI 10.1074/jbc.M312591200; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Pollak MR, 2003, SEMIN NEPHROL, V23, P141, DOI 10.1053/snep.2003.50014; Reiser J, 2004, J AM SOC NEPHROL, V15, P2246, DOI 10.1097/01.ASN.0000136312.46464.33; Reiser J, 2004, J CLIN INVEST, V113, P1390, DOI 10.1172/JCI200420402; Rivera GM, 2004, CURR BIOL, V14, P11, DOI 10.1016/j.cub.2003.12.033; Rosenblatt J, 1997, J CELL BIOL, V136, P1323, DOI 10.1083/jcb.136.6.1323; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Schiwek D, 2004, KIDNEY INT, V66, P91, DOI 10.1111/j.1523-1755.2004.00711.x; Soosairajah J, 2005, EMBO J, V24, P473, DOI 10.1038/sj.emboj.7600543; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; WEIBEL ER, 1962, J APPL PHYSIOL, V17, P343, DOI 10.1152/jappl.1962.17.2.343; Wharram BL, 2000, J CLIN INVEST, V106, P1281, DOI 10.1172/JCI7236; Wharram BL, 2005, J AM SOC NEPHROL, V16, P2941, DOI 10.1681/ASN.2005010055; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Zebda N, 2000, J CELL BIOL, V151, P1119, DOI 10.1083/jcb.151.5.1119; Zhu J, 2008, KIDNEY INT, V73, P556, DOI 10.1038/sj.ki.5002691	53	84	91	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22676	22688		10.1074/jbc.M110.122929	http://dx.doi.org/10.1074/jbc.M110.122929			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20472933	Green Published, hybrid			2022-12-27	WOS:000279702200078
J	Jain, A; Lamark, T; Sjottem, E; Larsen, KB; Awuh, JA; Overvatn, A; McMahon, M; Hayes, JD; Johansen, T				Jain, Ashish; Lamark, Trond; Sjottem, Eva; Larsen, Kenneth Bowitz; Awuh, Jane Atesoh; Overvatn, Aud; McMahon, Michael; Hayes, John D.; Johansen, Terje			p62/SQSTM1 Is a Target Gene for Transcription Factor NRF2 and Creates a Positive Feedback Loop by Inducing Antioxidant Response Element-driven Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; PHOSPHOTYROSINE-INDEPENDENT LIGAND; CUL3-BASED E3 LIGASE; KAPPA-B ACTIVATION; OXIDATIVE STRESS; SELECTIVE AUTOPHAGY; PROTEASOMAL DEGRADATION; NEURITE OUTGROWTH; SIGNALING PATHWAY; BINDING PROTEIN	The p62/SQSTM1 (sequestosome 1) protein, which acts as a cargo receptor for autophagic degradation of ubiquitinated targets, is up-regulated by various stressors. Induction of the p62 gene by oxidative stress is mediated by NF-E2-related factor 2 (NRF2) and, at the same time, p62 protein contributes to the activation of NRF2, but hitherto the mechanisms involved were not known. Herein, we have mapped an antioxidant response element (ARE) in the p62 promoter that is responsible for its induction by oxidative stress via NRF2. Chromatin immunoprecipitation and gel mobility-shift assays verified that NRF2 binds to this cis-element in vivo and in vitro. Also, p62 docks directly onto the Kelch-repeat domain of Kelch-like ECH-associated protein 1 (KEAP1), via a motif designated the KEAP1 interacting region (KIR), thereby blocking binding between KEAP1 and NRF2 that leads to ubiquitylation and degradation of the transcription factor. The KIR motif in p62 is located immediately C-terminal to the LC3-interacting region (LIR) and resembles the ETGE motif utilized by NRF2 for its interaction with KEAP1. KIR is required for p62 to stabilize NRF2, and inhibition of KEAP1 by p62 occurs from a cytoplasmic location within the cell. The LIR and KIR motifs cannot be engaged simultaneously by LC3 and KEAP1, but because p62 is polymeric the interaction between KEAP1 and p62 leads to accumulation of KEAP1 in p62 bodies, which is followed by autophagic degradation of KEAP1. Our data explain how p62 contributes to activation of NRF2 target genes in response to oxidative stress through creating a positive feedback loop.	[Jain, Ashish; Lamark, Trond; Sjottem, Eva; Larsen, Kenneth Bowitz; Awuh, Jane Atesoh; Overvatn, Aud; Johansen, Terje] Univ Tromso, Inst Med Biol, Mol Canc Res Grp, N-9037 Tromso, Norway; [McMahon, Michael; Hayes, John D.] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Inst, Dundee DD1 9SY, Scotland	UiT The Arctic University of Tromso; University of Dundee	Johansen, T (corresponding author), Univ Tromso, Inst Med Biol, Mol Canc Res Grp, N-9037 Tromso, Norway.	terje.johansen@uit.no	Johansen, Terje/N-2971-2015; Larsen, Kenneth/HDO-5510-2022; Jain, Ashish/H-7356-2017; Johansen, Terje/AAY-1753-2021; McMahon, Michael J/A-1702-2008; McMahon, Michael J/F-7070-2010	Johansen, Terje/0000-0003-1451-9578; Jain, Ashish/0000-0001-6549-2788; Johansen, Terje/0000-0003-1451-9578; McMahon, Michael J/0000-0001-8615-9351; Awuh, Jane Atesoh/0000-0001-9737-927X; Hayes, John/0000-0002-2927-5548; Lamark, Trond/0000-0001-6338-3342; Sjottem, Eva/0000-0003-2668-1708	Norwegian Research Council; Norwegian Cancer Society; Blix Foundation; Cancer Research-UK [C4909/A9990]	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); Blix Foundation; Cancer Research-UK(Cancer Research UK)	This work was supported by grants from the FUGE programme of the Norwegian Research Council, the Norwegian Cancer Society, and the Blix Foundation (to T. J.) and by Cancer Research-UK (project grant C4909/A9990 to J. D. H.).	Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; Clausen TH, 2010, AUTOPHAGY, V6, P330, DOI 10.4161/auto.6.3.11226; Copple IM, 2010, J BIOL CHEM, V285, P16782, DOI 10.1074/jbc.M109.096545; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Du YF, 2009, NEUROBIOL DIS, V35, P302, DOI 10.1016/j.nbd.2009.05.015; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; Gal J, 2009, J NEUROCHEM, V111, P1062, DOI 10.1111/j.1471-4159.2009.06388.x; Halliwell B., 2007, FREE RADICALS BIOL M, V4, P187, DOI DOI 10.1093/ACPROF:OSO/9780198717478.001.0001; Hammarstrom M, 2002, PROTEIN SCI, V11, P313, DOI 10.1110/ps.22102; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Ishii T, 1997, BIOCHEM BIOPH RES CO, V232, P33, DOI 10.1006/bbrc.1997.6221; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Joung I, 1996, P NATL ACAD SCI USA, V93, P5991, DOI 10.1073/pnas.93.12.5991; Karapetian RN, 2005, MOL CELL BIOL, V25, P1089, DOI 10.1128/MCB.25.3.1089-1099.2005; Katsuoka F, 2005, MOL CELL BIOL, V25, P8044, DOI 10.1128/MCB.25.18.8044-8051.2005; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kimura M, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706863200; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kitamura H, 2006, HISTOPATHOLOGY, V48, P157, DOI 10.1111/j.1365-2559.2005.02313.x; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kosaka K, 2010, J BIOCHEM, V147, P73, DOI 10.1093/jb/mvp149; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Lamark T, 2009, CELL CYCLE, V8, P1986, DOI 10.4161/cc.8.13.8892; Liu YX, 2007, P NATL ACAD SCI USA, V104, P5205, DOI 10.1073/pnas.0700898104; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; Nagaoka U, 2004, J NEUROCHEM, V91, P57, DOI 10.1111/j.1471-4159.2004.02692.x; Nakaso K, 2006, BIOCHEM BIOPH RES CO, V339, P915, DOI 10.1016/j.bbrc.2005.11.095; Nguyen T, 2005, J BIOL CHEM, V280, P32485, DOI 10.1074/jbc.M503074200; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Nioi P, 2003, BIOCHEM J, V374, P337, DOI 10.1042/BJ20030754; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pankiv S, 2010, J BIOL CHEM, V285, P5941, DOI 10.1074/jbc.M109.039925; PRESTERA T, 1993, P NATL ACAD SCI USA, V90, P2965, DOI 10.1073/pnas.90.7.2965; Puls A, 1997, P NATL ACAD SCI USA, V94, P6191, DOI 10.1073/pnas.94.12.6191; Rekdal C, 2000, J BIOL CHEM, V275, P40288, DOI 10.1074/jbc.M006978200; Rolland P, 2007, ENDOCR-RELAT CANCER, V14, P73, DOI 10.1677/erc.1.01312; Sanchez P, 1998, MOL CELL BIOL, V18, P3069, DOI 10.1128/MCB.18.5.3069; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; Sanz L, 1999, EMBO J, V18, P3044, DOI 10.1093/emboj/18.11.3044; Sjottem E, 2007, NUCLEIC ACIDS RES, V35, P6648, DOI 10.1093/nar/gkm739; Sun Z, 2007, MOL CELL BIOL, V27, P6334, DOI 10.1128/MCB.00630-07; Thompson HGR, 2003, ONCOGENE, V22, P2322, DOI 10.1038/sj.onc.1206325; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Torocsik B, 2002, J NEUROSCI, V22, P8971; Vadlamudi RK, 1996, J BIOL CHEM, V271, P20235, DOI 10.1074/jbc.271.34.20235; Velichkova M, 2005, MOL CELL BIOL, V25, P4501, DOI 10.1128/MCB.25.11.4501-4513.2005; Watai Y, 2007, GENES CELLS, V12, P1163, DOI 10.1111/j.1365-2443.2007.01118.x; Wooten MW, 2000, MOL CELL BIOL, V20, P4494, DOI 10.1128/MCB.20.13.4494-4504.2000; Yamamoto T, 2006, GENES CELLS, V11, P575, DOI 10.1111/j.1365-2443.2006.00965.x; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003	64	949	974	4	78	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22576	22591		10.1074/jbc.M110.118976	http://dx.doi.org/10.1074/jbc.M110.118976			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20452972	hybrid, Green Published			2022-12-27	WOS:000279702200069
J	Liu, HB; Qiu, JM; Li, N; Chen, TY; Cao, XT				Liu, Haibo; Qiu, Jianming; Li, Nan; Chen, Taoyong; Cao, Xuetao			Human Phosphatidylethanolamine-binding Protein 4 Promotes Transactivation of Estrogen Receptor alpha (ER alpha) in Human Cancer Cells by Inhibiting Proteasome-dependent ER alpha Degradation via Association with Src (Publication with Expression of Concern. See vol. 295, pg. 8883, 2020) (Withdrawn Publication. See vol. 296, 2021) (Withdrawn Publication. See vol. 296, 2021)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Withdrawn Publication							TRAIL-INDUCED APOPTOSIS; BREAST-CANCER; TRANSCRIPTIONAL ACTIVITY; PATHWAY ACTIVATION; DOWN-REGULATION; PHOSPHORYLATION; PROTEOLYSIS; GROWTH; SIGNAL; COACTIVATOR	We identified human phosphatidylethanolamine-binding protein 4 (hPEBP4) as a human-derived novel member of the phosphatidylethanolamine-binding protein family, which is involved in apoptosis resistance of tumor cells. Because of its preferential expression in estrogen-related cancers, we wondered whether hPEBP4 plays a role in estrogen-induced cancer cell growth. Here, we demonstrated that hPEBP4 inhibited the 17 beta-estradiol (E-2)- induced, proteasome-dependent estrogen receptor alpha (ER alpha) degradation to increase the protein level of ER alpha. Silencing of hPEBP4 inhibited the recruitment of ER alpha to the promoter of the ER alpha target gene pS2 in MCF-7 breast cancer cells after E-2 treatment. E-2-induced, ER alpha-mediated transcription via the estrogen-response element, as well as the cellular proliferation, was significantly suppressed in hPEBP4-silenced MCF-7 cells. We found that Src, whose association with ER alpha facilitates the ER alpha binding to components of proteolytic machinery, could associate with hPEBP4 and that overexpression of hPEBP4 prevented the E2-induced interaction between ER alpha and Src. ER alpha overexpression, proteasome inhibitor, or Src inhibitor could reverse the suppression of ER alpha-mediated transactivation by hPEBP4 silencing. The inhibition of the proteasome degradation and the promotion of transactivation of ER alpha by hPEBP4 via the Src pathway were further confirmed in HeLa cells. Finally, we found that the promoting effects of hPEBP4 on ER alpha-mediated transactivation and estrogen-induced proliferation of cancer cells did not depend on its regulation of Akt and ERK activity. Our data suggest that hPEBP4 inhibits proteasome-dependent ER alpha degradation through the Src pathway, thus enhancing ER alpha-mediated transactivation and promoting the proliferation of cancer cells in response to estrogen.	[Liu, Haibo; Li, Nan; Chen, Taoyong; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China; [Liu, Haibo; Li, Nan; Chen, Taoyong; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China; [Qiu, Jianming; Cao, Xuetao] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China	Naval Medical University; Naval Medical University; Zhejiang University	Cao, XT (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China.	caoxt@immunol.org			National High Biotechnology Development Program of China [006AA02A305, 2009ZX09503-003, 2009AA02Z101]; National Natural Science Foundation of China [30721091, 30772504]; Shanghai Committee of Science and Technology [09QH1402800, 09SG35]	National High Biotechnology Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by National High Biotechnology Development Program of China Grants 2006AA02A305, 2009ZX09503-003, and 2009AA02Z101, National Key Basic Research Program of China Grant 2010CB911903, National Natural Science Foundation of China Grants 30721091 and 30772504, and Shanghai Committee of Science and Technology Grants 09QH1402800 and 09SG35.	Acconcia F, 2006, CANCER LETT, V238, P1, DOI 10.1016/j.canlet.2005.06.018; Alarid ET, 1999, MOL ENDOCRINOL, V13, P1522, DOI 10.1210/me.13.9.1522; Alarid ET, 2003, ENDOCRINOLOGY, V144, P3469, DOI 10.1210/en.2002-0092; Arnold SF, 1997, MOL ENDOCRINOL, V11, P48, DOI 10.1210/me.11.1.48; ARNOLD SF, 1995, MOL ENDOCRINOL, V9, P24, DOI 10.1210/me.9.1.24; Brunnberg S, 2003, P NATL ACAD SCI USA, V100, P6517, DOI 10.1073/pnas.1136688100; Callige M, 2005, MOL CELL BIOL, V25, P4349, DOI 10.1128/MCB.25.11.4349-4358.2005; Chu I, 2007, J CLIN INVEST, V117, P2205, DOI 10.1172/JCI21739; Delaunay F, 2000, MOL PHARMACOL, V58, P584, DOI 10.1124/mol.58.3.584; Edwards DP, 2005, ANNU REV PHYSIOL, V67, P335, DOI 10.1146/annurev.physiol.67.040403.120151; Fan MY, 2004, MOL ENDOCRINOL, V18, P2603, DOI 10.1210/me.2004-0164; Fan S, 1999, SCIENCE, V284, P1354, DOI 10.1126/science.284.5418.1354; Fiskus W, 2007, CLIN CANCER RES, V13, P4882, DOI 10.1158/1078-0432.CCR-06-3093; Fowler AM, 2004, FASEB J, V18, P81, DOI 10.1096/fj.03-0038com; Frasor J, 2004, CANCER RES, V64, P1522, DOI 10.1158/0008-5472.CAN-03-3326; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; Li HZ, 2007, J BIOL CHEM, V282, P4943, DOI 10.1074/jbc.M609494200; Li N, 2009, J BIOL CHEM, V284, P3021, DOI 10.1074/jbc.M805483200; Li P, 2006, INT J MOL MED, V18, P505; Liu J, 2010, MOL CELL BIOCHEM, V335, P29, DOI 10.1007/s11010-009-0237-8; Liu XG, 2008, BLOOD, V112, P4961, DOI 10.1182/blood-2008-03-144022; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Marsaud V, 2003, MOL ENDOCRINOL, V17, P2013, DOI 10.1210/me.2002-0269; Matthews J, 2006, MOL ENDOCRINOL, V20, P534, DOI 10.1210/me.2005-0140; Migliaccio A, 1996, EMBO J, V15, P1292, DOI 10.1002/j.1460-2075.1996.tb00471.x; Persson I, 2000, J STEROID BIOCHEM, V74, P357, DOI 10.1016/S0960-0760(00)00113-8; Petrel TA, 2003, J CELL BIOCHEM, V88, P181, DOI 10.1002/jcb.10353; Razandi M, 2000, MOL ENDOCRINOL, V14, P1434, DOI 10.1210/me.14.9.1434; Saji S, 2001, BIOCHEM BIOPH RES CO, V281, P259, DOI 10.1006/bbrc.2001.4339; Schiff R, 2005, BREAST CANCER RES, V7, P205, DOI 10.1186/bcr1287; Schreihofer DA, 2001, ENDOCRINOLOGY, V142, P3361, DOI 10.1210/en.142.8.3361; Shah YM, 2005, MOL ENDOCRINOL, V19, P732, DOI 10.1210/me.2004-0298; Shen TJ, 2001, MOL CELL BIOL, V21, P6122, DOI 10.1128/MCB.21.18.6122-6131.2001; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wang CM, 2008, J BIOL CHEM, V283, P11565, DOI 10.1074/jbc.M800436200; Wang LH, 2006, CANCER CELL, V10, P487, DOI 10.1016/j.ccr.2006.09.015; Wang XJ, 2005, CLIN CANCER RES, V11, P7545, DOI 10.1158/1078-0432.CCR-05-0879; Wang XJ, 2002, MOL ENDOCRINOL, V16, P1987, DOI 10.1210/me.2001-0287; Wang XJ, 2004, J BIOL CHEM, V279, P45855, DOI 10.1074/jbc.M405147200; WEBB P, 1992, MOL ENDOCRINOL, V6, P157, DOI 10.1210/me.6.2.157; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Yue W, 2005, CLIN CANCER RES, V11, p925S; Zhao CY, 2007, CANCER RES, V67, P3955, DOI 10.1158/0008-5472.CAN-06-3505	46	24	30	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					21934	21942		10.1074/jbc.M110.109876	http://dx.doi.org/10.1074/jbc.M110.109876			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20460377	Green Published, hybrid			2022-12-27	WOS:000279702200005
J	Chang, L; Thompson, AD; Ung, P; Carlson, HA; Gestwicki, JE				Chang, Lyra; Thompson, Andrea D.; Ung, Peter; Carlson, Heather A.; Gestwicki, Jason E.			Mutagenesis Reveals the Complex Relationships between ATPase Rate and the Chaperone Activities of Escherichia coli Heat Shock Protein 70 (Hsp70/DnaK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; SUBSTRATE-BINDING DOMAIN; EXCHANGE FACTOR GRPE; MOLECULAR CHAPERONE; DNAK CHAPERONE; NUCLEOTIDE EXCHANGE; PEPTIDE-BINDING; INTERDOMAIN COMMUNICATION; CONFORMATIONAL-CHANGES; HIGH-THROUGHPUT	The Escherichia coli 70-kDa heat shock protein, DnaK, is a molecular chaperone that engages in a variety of cellular activities, including the folding of proteins. During this process, DnaK binds its substrates in coordination with a catalytic ATPase cycle. Both the ATPase and protein folding activities of DnaK are stimulated by its co-chaperones, DnaJ and GrpE. However, it is not yet clear how changes in the stimulated ATPase rate of DnaK impact the folding process. In this study, we performed mutagenesis throughout the nucleotide-binding domain of DnaK to generate a collection of mutants in which the stimulated ATPase rates varied from 0.7 to 13.6 pmol/mu g/min(-1). We found that this range was largely established by differences in the ability of the mutants to be stimulated by one or both of the co-chaperones. Next, we explored how changes in ATPase rate might impact refolding of denatured luciferase in vitro and found that the two activities were poorly correlated. Unexpectedly, we found several mutants that refold luciferase normally in the absence of significant ATP turnover, presumably by increasing the flexibility of DnaK. Finally, we tested whether DnaK mutants could complement growth of Delta dnaK E. coli cells under heat shock and found that the ability to refold luciferase was more predictive of in vivo activity than ATPase rate. This study provides insights into how flexibility and co-chaperone interactions affect DnaK-mediated ATP turnover and protein folding.	[Gestwicki, Jason E.] Univ Michigan, Inst Life Sci, Chem Biol Grad Program, Ann Arbor, MI 48109 USA; [Ung, Peter; Carlson, Heather A.; Gestwicki, Jason E.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Gestwicki, Jason E.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Gestwicki, JE (corresponding author), Univ Michigan, Inst Life Sci, Chem Biol Grad Program, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	gestwick@umich.edu	Thompson, Andrea/AAQ-5735-2020; Ung, Peter Man-Un/J-1654-2019; Chang, Lyra/A-9516-2012	Ung, Peter Man-Un/0000-0002-6849-5252; Thompson, Andrea/0000-0001-8798-2024; Carlson, Heather/0000-0002-7495-1699; Chang, Chia Yin/0000-0002-9608-4952	National Institutes of Health [NS059690, MCB-0844512, F30AG035464]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG035464] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS059690 and MCB-0844512 (to J.E.G.).; Supported by National Institutes of Health Predoctoral Fellowship F30AG035464.	ANG D, 1989, J BACTERIOL, V171, P2748, DOI 10.1128/jb.171.5.2748-2755.1989; BARDWELL JCA, 1984, P NATL ACAD SCI-BIOL, V81, P848, DOI 10.1073/pnas.81.3.848; Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Barthel TK, 2001, J BACTERIOL, V183, P5482, DOI 10.1128/JB.183.19.5482-5490.2001; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Bhattacharya A, 2009, J MOL BIOL, V388, P475, DOI 10.1016/j.jmb.2009.01.062; Brehmer D, 2004, J BIOL CHEM, V279, P27957, DOI 10.1074/jbc.M403558200; Brehmer D, 2001, NAT STRUCT BIOL, V8, P427, DOI 10.1038/87588; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; Buchberger A, 1999, J BIOL CHEM, V274, P38017, DOI 10.1074/jbc.274.53.38017; BUCHBERGER A, 1994, EMBO J, V13, P1687, DOI 10.1002/j.1460-2075.1994.tb06433.x; Buczynski G, 2001, J BIOL CHEM, V276, P27231, DOI 10.1074/jbc.M100237200; Cajo GC, 2006, J BIOL CHEM, V281, P12436, DOI 10.1074/jbc.M511192200; Chang L, 2008, ANAL BIOCHEM, V372, P167, DOI 10.1016/j.ab.2007.08.020; Chang TC, 2001, ARCH BIOCHEM BIOPHYS, V386, P30, DOI 10.1006/abbi.2000.2176; Davis JE, 1999, P NATL ACAD SCI USA, V96, P9269, DOI 10.1073/pnas.96.16.9269; De los Rios P, 2006, P NATL ACAD SCI USA, V103, P6166, DOI 10.1073/pnas.0510496103; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; Gamer J, 1996, EMBO J, V15, P607, DOI 10.1002/j.1460-2075.1996.tb00393.x; Goffin L, 1998, MOL MICROBIOL, V30, P329, DOI 10.1046/j.1365-2958.1998.01067.x; GRAGEROV A, 1992, P NATL ACAD SCI USA, V89, P10341, DOI 10.1073/pnas.89.21.10341; Grimshaw JPA, 2005, J MOL BIOL, V353, P888, DOI 10.1016/j.jmb.2005.08.069; Grimshaw JPA, 2003, J BIOL CHEM, V278, P19048, DOI 10.1074/jbc.M300924200; Groemping Y, 2001, J MOL BIOL, V314, P167, DOI 10.1006/jmbi.2001.5116; Han WJ, 2003, J BIOL CHEM, V278, P19038, DOI 10.1074/jbc.M300756200; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Hesterkamp T, 1998, EMBO J, V17, P4818, DOI 10.1093/emboj/17.16.4818; Hu SM, 2002, ARCH BIOCHEM BIOPHYS, V407, P135, DOI 10.1016/S0003-9861(02)00515-5; Jiang JW, 2007, MOL CELL, V28, P422, DOI 10.1016/j.molcel.2007.08.022; Jinwal UK, 2009, J NEUROSCI, V29, P12079, DOI 10.1523/JNEUROSCI.3345-09.2009; KAMATHLOEB AS, 1995, J BIOL CHEM, V270, P30051; Karzai AW, 1996, J BIOL CHEM, V271, P11236, DOI 10.1074/jbc.271.19.11236; Klucken J, 2004, BIOCHEM BIOPH RES CO, V325, P367, DOI 10.1016/j.bbrc.2004.10.037; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; LIBEREK K, 1995, P NATL ACAD SCI USA, V92, P6224, DOI 10.1073/pnas.92.14.6224; LIBEREK K, 1991, J BIOL CHEM, V266, P14491; Linke K, 2003, J BIOL CHEM, V278, P44457, DOI 10.1074/jbc.M307491200; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; McClellan AJ, 2000, GENETICS, V156, P501; Montgomery DL, 1999, J MOL BIOL, V286, P915, DOI 10.1006/jmbi.1998.2514; OBrien MC, 1996, J BIOL CHEM, V271, P15874, DOI 10.1074/jbc.271.27.15874; PAEK KH, 1987, J BACTERIOL, V169, P283, DOI 10.1128/jb.169.1.283-290.1987; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Patury S, 2009, CURR TOP MED CHEM, V9, P1337, DOI 10.2174/156802609789895674; Pierpaoli EV, 1997, J MOL BIOL, V269, P757, DOI 10.1006/jmbi.1997.1072; RENSING SA, 1994, J MOL EVOL, V39, P80, DOI 10.1007/BF00178252; Schuermann JP, 2008, MOL CELL, V31, P232, DOI 10.1016/j.molcel.2008.05.006; SELL SM, 1990, J BACTERIOL, V172, P4827, DOI 10.1128/jb.172.9.4827-4835.1990; Shaner L, 2006, BIOCHEMISTRY-US, V45, P15075, DOI 10.1021/bi061279k; Slepenkov SV, 2003, FEBS LETT, V539, P100, DOI 10.1016/S0014-5793(03)00207-2; Stevens SY, 2003, PROTEIN SCI, V12, P2588, DOI 10.1110/ps.03269103; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Sugimoto S, 2008, BIOSCI BIOTECH BIOCH, V72, P811, DOI 10.1271/bbb.70691; Sugimoto S, 2008, PROTEIN EXPRES PURIF, V60, P31, DOI 10.1016/j.pep.2008.03.007; Sugimoto S, 2007, FEBS LETT, V581, P2993, DOI 10.1016/j.febslet.2007.05.055; Szabo A, 1996, EMBO J, V15, P408, DOI 10.1002/j.1460-2075.1996.tb00371.x; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Tanaka N, 2002, P NATL ACAD SCI USA, V99, P15398, DOI 10.1073/pnas.242317099; Theyssen H, 1996, J MOL BIOL, V263, P657, DOI 10.1006/jmbi.1996.0606; WALL D, 1995, J BIOL CHEM, V270, P2139, DOI 10.1074/jbc.270.5.2139; Wisen S, 2008, ANAL BIOCHEM, V374, P371, DOI 10.1016/j.ab.2007.12.009; Woo HJ, 2009, BIOCHEMISTRY-US, V48, P11470, DOI 10.1021/bi901256y; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	65	53	55	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21282	21291		10.1074/jbc.M110.124149	http://dx.doi.org/10.1074/jbc.M110.124149			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20439464	Green Published, hybrid			2022-12-27	WOS:000279516100013
J	Hale, SJ; Lovell, SC; de Keyzer, J; Stirling, CJ				Hale, Sarah J.; Lovell, Simon C.; de Keyzer, Jeanine; Stirling, Colin J.			Interactions between Kar2p and Its Nucleotide Exchange Factors Sil1p and Lhs1p Are Mechanistically Distinct	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARINESCO-SJOGREN-SYNDROME; REGULATED PROTEIN ORP150; MOLECULAR CHAPERONE; HSP70 CHAPERONES; ENDOPLASMIC-RETICULUM; INTERDOMAIN LINKER; HSP110 CHAPERONES; STRUCTURAL BASIS; YEAST ER; TRANSLOCATION	Kar2p, an essential Hsp70 chaperone in the endoplasmic reticulum of Saccharomyces cerevisiae, facilitates the transport and folding of nascent polypeptides within the endoplasmic reticulum lumen. The chaperone activity of Kar2p is regulated by its intrinsic ATPase activity that can be stimulated by two different nucleotide exchange factors, namely Sil1p and Lhs1p. Here, we demonstrate that the binding requirements for Lhs1p are complex, requiring both the nucleotide binding domain plus the linker domain of Kar2p. In contrast, the IIB domain of Kar2p is sufficient for binding of Sil1p, and point mutations within IIB specifically blocked Sil1p-dependent activation while remaining competent for activation by Lhs1p. Taken together, these results demonstrate that the interactions between Kar2p and its two nucleotide exchange factors can be functionally resolved and are thus mechanistically distinct.	[Stirling, Colin J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [de Keyzer, Jeanine] Univ Groningen, Dept Microbiol, Groningen Biomol Sci & Biotechnol Inst, NL-9751 NN Haren, Netherlands	University of Manchester; University of Groningen	Stirling, CJ (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	colin.stirling@manchester.ac.uk		Lovell, Simon/0000-0002-4092-8458	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust.	Andreasson C, 2008, P NATL ACAD SCI USA, V105, P16519, DOI 10.1073/pnas.0804187105; Andreasson C, 2008, J BIOL CHEM, V283, P8877, DOI 10.1074/jbc.M710063200; Anttonen AK, 2005, NAT GENET, V37, P1309, DOI 10.1038/ng1677; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; Corsi AK, 1997, J CELL BIOL, V137, P1483, DOI 10.1083/jcb.137.7.1483; Craven RA, 1996, EMBO J, V15, P2640, DOI 10.1002/j.1460-2075.1996.tb00624.x; de Keyzer J, 2009, J BIOL CHEM, V284, P31564, DOI 10.1074/jbc.M109.055160; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Easton DP, 2000, CELL STRESS CHAPERON, V5, P276, DOI 10.1379/1466-1268(2000)005<0276:THAGSP>2.0.CO;2; Huang P, 2005, NAT STRUCT MOL BIOL, V12, P497, DOI 10.1038/nsmb942; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; Kabani M, 2002, FEBS LETT, V531, P339, DOI 10.1016/S0014-5793(02)03570-6; KAMATHLOEB AS, 1995, J BIOL CHEM, V270, P30051; KASSENBROCK CK, 1989, EMBO J, V8, P1461, DOI 10.1002/j.1460-2075.1989.tb03529.x; Kuwabara K, 1996, J BIOL CHEM, V271, P5025; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McClellan AJ, 1998, MOL BIOL CELL, V9, P3533, DOI 10.1091/mbc.9.12.3533; McLellan CA, 2003, J BIOL CHEM, V278, P19017, DOI 10.1074/jbc.M301109200; Morano KA, 2007, ANN NY ACAD SCI, V1113, P1, DOI 10.1196/annals.1391.018; Ozawa K, 1999, J BIOL CHEM, V274, P6397, DOI 10.1074/jbc.274.10.6397; Park J, 2003, BIOCHEMISTRY-US, V42, P14893, DOI 10.1021/bi030122e; Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022; Raviol H, 2006, FEBS LETT, V580, P168, DOI 10.1016/j.febslet.2005.11.069; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schuermann JP, 2008, MOL CELL, V31, P232, DOI 10.1016/j.molcel.2008.05.006; Senderek J, 2005, NAT GENET, V37, P1312, DOI 10.1038/ng1678; Shaner L, 2004, J BIOL CHEM, V279, P21992, DOI 10.1074/jbc.M313739200; Shomura Y, 2005, MOL CELL, V17, P367, DOI 10.1016/j.molcel.2004.12.023; SIMONS JF, 1995, J CELL BIOL, V130, P41, DOI 10.1083/jcb.130.1.41; Steel GJ, 2004, SCIENCE, V303, P98, DOI 10.1126/science.1092287; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Tamatani M, 2001, NAT MED, V7, P317, DOI 10.1038/85463; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tyson JR, 2000, EMBO J, V19, P6440, DOI 10.1093/emboj/19.23.6440; Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200	38	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21600	21606		10.1074/jbc.M110.111211	http://dx.doi.org/10.1074/jbc.M110.111211			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20430899	Green Published, hybrid			2022-12-27	WOS:000279516100046
J	Munter, LM; Botev, A; Richter, L; Hildebrand, PW; Althoff, V; Weise, C; Kaden, D; Multhaup, G				Munter, Lisa-Marie; Botev, Anne; Richter, Luise; Hildebrand, Peter W.; Althoff, Veit; Weise, Christoph; Kaden, Daniela; Multhaup, Gerd			Aberrant Amyloid Precursor Protein (APP) Processing in Hereditary Forms of Alzheimer Disease Caused by APP Familial Alzheimer Disease Mutations Can Be Rescued by Mutations in the APP GxxxG Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE; BETA-PROTEIN; TRANSMEMBRANE DOMAIN; PRESENILIN MUTATIONS; TERMINAL FRAGMENT; A-BETA-42; CLEAVAGE; DIMERIZATION; DEPOSITION; INCREASES	The identification of hereditary familial Alzheimer disease (FAD) mutations in the amyloid precursor protein (APP) and presenilin-1 (PS1) corroborated the causative role of amyloid-beta peptides with 42 amino acid residues (A beta 42) in the pathogenesis of AD. Although most FAD mutations are known to increase A beta 42 levels, mutations within the APP GxxxG motif are known to lower A beta 42 levels by attenuating transmembrane sequence dimerization. Here, we show that aberrant A beta 42 levels of FAD mutations can be rescued by GxxxG mutations. The combination of the APP-GxxxG mutation G33A with APP-FAD mutations yielded a constant 60% decrease of A beta 42 levels and a concomitant 3-fold increase of A beta 38 levels compared with the Gly(33) wild-type as determined by ELISA. In the presence of PS1-FAD mutations, the effects of G33A were attenuated, apparently attributable to a different mechanism of PS1-FAD mutants compared with APP-FAD mutants. Our results contribute to a general understanding of the mechanism how APP is processed by the gamma-secretase module and strongly emphasize the potential of the GxxxG motif in the prevention of sporadic AD as well as FAD.	[Munter, Lisa-Marie; Botev, Anne; Richter, Luise; Althoff, Veit; Weise, Christoph; Kaden, Daniela; Multhaup, Gerd] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [Hildebrand, Peter W.] Charite, Inst Med Phys & Biophys, D-10117 Berlin, Germany	Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Multhaup, G (corresponding author), Free Univ Berlin, Inst Chem & Biochem, Thielallee 63, D-14195 Berlin, Germany.	multhaup@biochemie.fu-berlin.de		Munter, Lisa/0000-0001-5736-1462	Alzheimer Forschung Initiative e.V.; Deutsche Forschungsgemeinschaft [MU901, HI 1502/1-1]; Kompetenznetz Degenerative Demenzen [Forderkennzeichen 01 GI 0723]; Hans und Ilse Breuer Stiftung;  [SFB740]	Alzheimer Forschung Initiative e.V.; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Kompetenznetz Degenerative Demenzen; Hans und Ilse Breuer Stiftung; 	This work was supported by the Alzheimer Forschung Initiative e.V. (to L.-M. M.), the Deutsche Forschungsgemeinschaft (MU901 (to G. M.), HI 1502/1-1 (to P. W. H.)), the SFB740, Kompetenznetz Degenerative Demenzen (Forderkennzeichen 01 GI 0723), and the Hans und Ilse Breuer Stiftung.	Ancolio K, 1999, P NATL ACAD SCI USA, V96, P4119, DOI 10.1073/pnas.96.7.4119; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; Chen CD, 2006, J NEUROCHEM, V97, P30, DOI 10.1111/j.1471-4159.2006.03705.x; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; CRUTS M, 1995, HUM MOL GENET, V4, P2363, DOI 10.1093/hmg/4.12.2363; Czirr E, 2008, J BIOL CHEM, V283, P17049, DOI 10.1074/jbc.M802912200; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; DYRKS T, 1992, FEBS LETT, V309, P20, DOI 10.1016/0014-5793(92)80730-5; Eckman CB, 1997, HUM MOL GENET, V6, P2087, DOI 10.1093/hmg/6.12.2087; Funamoto S, 2004, BIOCHEMISTRY-US, V43, P13532, DOI 10.1021/bi049399k; Gorman PM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-17; Gralle M, 2009, J BIOL CHEM, V284, P15016, DOI 10.1074/jbc.M808755200; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Ikeuchi T, 2008, DEMENT GERIATR COGN, V26, P43, DOI 10.1159/000141483; Isoo N, 2007, J BIOL CHEM, V282, P12388, DOI 10.1074/jbc.M611549200; Janssen JC, 2003, NEUROLOGY, V60, P235, DOI 10.1212/01.WNL.0000042088.22694.E3; Kaden D, 2008, J BIOL CHEM, V283, P7271, DOI 10.1074/jbc.M708046200; Kaden D, 2009, J CELL SCI, V122, P368, DOI 10.1242/jcs.034058; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; KAMINO K, 1992, AM J HUM GENET, V51, P998; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Kumar-Singh S, 2000, HUM MOL GENET, V9, P2589, DOI 10.1093/hmg/9.18.2589; Kwok JBJ, 2000, ANN NEUROL, V47, P249, DOI 10.1002/1531-8249(200002)47:2<249::AID-ANA18>3.3.CO;2-#; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Rossjohn J, 1999, NAT STRUCT BIOL, V6, P327; Sato T, 2003, J BIOL CHEM, V278, P24294, DOI 10.1074/jbc.M211161200; Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Soba P, 2006, EMBO J, V25, P653, DOI 10.1038/sj.emboj.7600956; St George-Hyslop PH, 2000, BIOL PSYCHIAT, V47, P183, DOI 10.1016/S0006-3223(99)00301-7; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Zhao GJ, 2005, J BIOL CHEM, V280, P37689, DOI 10.1074/jbc.M507993200; Zhao GJ, 2007, J NEUROCHEM, V100, P1234, DOI 10.1111/j.1471-4159.2006.04302.x	44	51	52	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21636	21643		10.1074/jbc.M109.088005	http://dx.doi.org/10.1074/jbc.M109.088005			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20452985	Green Published, hybrid			2022-12-27	WOS:000279516100050
J	Peng, L; Liang, DY; Tong, WY; Li, JH; Yuan, ZH				Peng, Lu; Liang, Dongyu; Tong, Wenyan; Li, Jianhua; Yuan, Zhenghong			Hepatitis C Virus NS5A Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Contributing to Cell Survival by Disrupting the Interaction between FK506-binding Protein 38 (FKBP38) and mTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA REPLICATION; CORE PROTEIN; DOMAIN-III; APOPTOSIS; INTERFERON; INHIBITOR; MUTATIONS; KINASE; P53; 5A	Hepatitis C virus (HCV) often establishes a persistent infection that most likely involves a complex host-virus interplay. We previously reported that the HCV nonstructural protein 5A (NS5A) bound to cellular protein FKBP38 and resulted in apoptosis suppression in human hepatoma cell line Huh7. In the present research we further found that NS5A increased phosphorylation levels of two mTOR-targeted substrates, S6K1 and 4EBP1, in Huh7 in the absence of serum. mTOR inhibitor rapamycin or NS5A knockdown blocked S6K1 and 4EBP1 phosphorylation increase in NS5A-Huh7 and HCV replicon cells, suggesting that NS5A specifically regulated mTOR activation. Overexpression of NS5A and FKBP38 mutants or FKBP38 knockdown revealed this mTOR activation was dependent on NS5A-FKBP38 interaction. Phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 treatment in NS5A-Huh7 showed that the mTOR activation was independent of PI3K. Moreover, NS5A suppressed caspase 3 and poly(ADP-ribose) polymerase activation, which was abolished by NS5A knockdown or rapamycin, indicating NS5A inhibited apoptosis specifically through the mTOR pathway. Further analyses suggested that apoptotic inhibition exerted by NS5A via mTOR also required NS5A-FKBP38 interaction. Glutathione S-transferase pulldown and co-immunoprecipitation showed that NS5A disrupted the mTOR-FKBP38 association. Additionally, NS5A or FKBP38 mutants recovered the mTOR-FKBP38 interaction; this indicated that the impairment of mTOR-FKBP38 association was dependent on NS5A-FKBP38 binding. Collectively, our data demonstrate that HCV NS5A activates the mTOR pathway to inhibit apoptosis through impairing the interaction between mTOR and FKBP38, which may represent a pivotal mechanism for HCV persistence and pathogenesis.	[Peng, Lu; Liang, Dongyu; Tong, Wenyan; Li, Jianhua; Yuan, Zhenghong] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, Shanghai 200032, Peoples R China; [Yuan, Zhenghong] Fudan Univ, Inst Med Microbiol & Biomed Sci, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Yuan, ZH (corresponding author), POB 228,138 Yi Xue Yuan Rd, Shanghai 200032, Peoples R China.	zhyuan@shmu.edu.cn	liang, dy/GZA-4770-2022		Chinese State Basic Research Foundation [2005CB522902]; National Natural Science Fund for Distinguished Scholars of China [30425041]; Chinese National Mega Projects for Infectious Diseases [2008ZX10203]; National Natural Science Fund of China [30970158]; Program for Outstanding Medical Academic Leader of Shanghai	Chinese State Basic Research Foundation; National Natural Science Fund for Distinguished Scholars of China; Chinese National Mega Projects for Infectious Diseases; National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Program for Outstanding Medical Academic Leader of Shanghai	This work was supported by Chinese State Basic Research Foundation Grant 2005CB522902, National Natural Science Fund for Distinguished Scholars of China Grant 30425041, Chinese National Mega Projects for Infectious Diseases Grant 2008ZX10203, National Natural Science Fund of China Grant 30970158, and the Program for Outstanding Medical Academic Leader of Shanghai.	Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Arima N, 2001, J BIOL CHEM, V276, P12675, DOI 10.1074/jbc.M008329200; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Benali-Furet NL, 2005, ONCOGENE, V24, P4921, DOI 10.1038/sj.onc.1208673; Buchkovich NJ, 2008, NAT REV MICROBIOL, V6, P265, DOI 10.1038/nrmicro1855; Castedo M, 2002, EMBO J, V21, P4070, DOI 10.1093/emboj/cdf391; Chiou HL, 2006, BIOCHEM BIOPH RES CO, V345, P453, DOI 10.1016/j.bbrc.2006.04.118; Chisari FV, 2005, NATURE, V436, P930, DOI 10.1038/nature04076; Ciccaglione AR, 2004, VIRUS RES, V104, P1, DOI 10.1016/j.virusres.2004.02.002; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Deng L, 2008, J VIROL, V82, P10375, DOI 10.1128/JVI.00395-08; Pastor MD, 2009, J BIOL CHEM, V284, P22067, DOI 10.1074/jbc.M109.033100; Dunlop EA, 2009, CELL SIGNAL, V21, P1073, DOI 10.1016/j.cellsig.2009.02.024; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; ENOMOTO N, 1995, J CLIN INVEST, V96, P224, DOI 10.1172/JCI118025; Erdtmann L, 2003, J BIOL CHEM, V278, P18256, DOI 10.1074/jbc.M209732200; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; He YP, 2002, J VIROL, V76, P9207, DOI 10.1128/JVI.76.18.9207-9217.2002; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Hughes M, 2009, J VIROL, V83, P10788, DOI 10.1128/JVI.02406-08; Hughes M, 2009, J GEN VIROL, V90, P1329, DOI 10.1099/vir.0.009332-0; Kang CB, 2008, NEUROSIGNALS, V16, P318, DOI 10.1159/000123041; KNIPE D, 2007, FIELDS VIROLOGY, P1253; Kriegs M, 2009, J BIOL CHEM, V284, P28343, DOI 10.1074/jbc.M109.038877; Kudchodkar SB, 2007, J VIROL, V81, P3649, DOI 10.1128/JVI.02079-06; Lan KH, 2002, ONCOGENE, V21, P4801, DOI 10.1038/sj.onc.1205589; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lemm JA, 2010, J VIROL, V84, P482, DOI 10.1128/JVI.01360-09; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Macdonald A, 2003, J BIOL CHEM, V278, P17775, DOI 10.1074/jbc.M210900200; Mankouri J, 2009, P NATL ACAD SCI USA, V106, P15903, DOI 10.1073/pnas.0906798106; Mannova P, 2005, J VIROL, V79, P8742, DOI 10.1128/JVI.79.14.8742-8749.2005; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; Mateu G, 2008, VIROLOGY, V376, P397, DOI 10.1016/j.virol.2008.03.027; Nakagawa T, 2007, GENES CELLS, V12, P709, DOI 10.1111/j.1365-2443.2007.01086.x; Nanda SK, 2006, GASTROENTEROLOGY, V130, P794, DOI 10.1053/j.gastro.2005.12.030; Nomura-Takigawa Y, 2006, J GEN VIROL, V87, P1935, DOI 10.1099/vir.0.81701-0; O'Shea C, 2005, EMBO J, V24, P1211, DOI 10.1038/sj.emboj.7600597; Oh KJ, 2006, J VIROL, V80, P7079, DOI 10.1128/JVI.02380-05; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; Pazienza V, 2007, HEPATOLOGY, V45, P1164, DOI 10.1002/hep.21634; Rosner M, 2003, ONCOGENE, V22, P4786, DOI 10.1038/sj.onc.1206776; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Street A, 2004, J BIOL CHEM, V279, P12232, DOI 10.1074/jbc.M312245200; Tanaka M, 2006, BIOCHEM BIOPH RES CO, V340, P792, DOI 10.1016/j.bbrc.2005.12.076; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Tellinghuisen TL, 2008, J VIROL, V82, P1073, DOI 10.1128/JVI.00328-07; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Thedieck K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001217; Tran G, 2008, BIOSCIENCE HORIZONS, V1, P167, DOI DOI 10.1093/BIOHORIZONS/HZN020; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang JD, 2006, FEBS LETT, V580, P4392, DOI 10.1016/j.febslet.2006.07.002; Wang XM, 2008, J BIOL CHEM, V283, P30482, DOI 10.1074/jbc.M803348200; Yi MK, 2004, J VIROL, V78, P7904, DOI 10.1128/JVI.78.15.7904-7915.2004	60	50	51	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20870	20881		10.1074/jbc.M110.112045	http://dx.doi.org/10.1074/jbc.M110.112045			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20439463	hybrid, Green Published			2022-12-27	WOS:000279228600051
J	Bijland, S; Pieterman, EJ; Maas, ACE; van der Hoorn, JWA; van Erk, MJ; van Klinken, JB; Havekes, LM; van Dijk, KW; Princen, HMG; Rensen, PCN				Bijland, Silvia; Pieterman, Elsbet J.; Maas, Annemarie C. E.; van der Hoorn, Jose W. A.; van Erk, Marjan J.; van Klinken, Jan B.; Havekes, Louis M.; van Dijk, Ko Willems; Princen, Hans M. G.; Rensen, Patrick C. N.			Fenofibrate Increases Very Low Density Lipoprotein Triglyceride Production Despite Reducing Plasma Triglyceride Levels in APOE*3-Leiden.CETP Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTERYL ESTER TRANSFER; TRANSFER PROTEIN; TRANSGENIC MICE; PPAR-ALPHA; LDL RECEPTOR; SECRETION; EXPRESSION; KINETICS; B-100; VLDL	The peroxisome proliferator-activated receptor alpha (PPAR alpha) activator fenofibrate efficiently decreases plasma triglycerides (TG), which is generally attributed to enhanced very low density lipoprotein (VLDL)-TG clearance and decreased VLDL-TG production. However, because data on the effect of fenofibrate on VLDL production are controversial, we aimed to investigate in (more) detail the mechanism underlying the TG-lowering effect by studying VLDL-TG production and clearance using APOE*3-Leiden.CETP mice, a unique mouse model for human-like lipoprotein metabolism. Male mice were fed a Western-type diet for 4 weeks, followed by the same diet without or with fenofibrate (30 mg/kg bodyweight/day) for 4 weeks. Fenofibrate strongly lowered plasma cholesterol (-38%) and TG (-60%) caused by reduction of VLDL. Fenofibrate markedly accelerated VLDL-TG clearance, as judged from a reduced plasma half-life of glycerol tri[H-3]oleate-labeled VLDL-like emulsion particles (-68%). This was associated with an increased post-heparin lipoprotein lipase (LPL) activity (+110%) and an increased uptake of VLDL-derived fatty acids by skeletal muscle, white adipose tissue, and liver. Concomitantly, fenofibrate markedly increased the VLDL-TG production rate (+73%) but not the VLDL-apolipoprotein B (apoB) production rate. Kinetic studies using [H-3] palmitic acid showed that fenofibrate increased VLDL-TG production by equally increasing incorporation of re-esterified plasma fatty acids and liver TG into VLDL, which was supported by hepatic gene expression profiling data. We conclude that fenofibrate decreases plasma TG by enhancing LPL-mediated VLDL-TG clearance, which results in a compensatory increase in VLDL-TG production by the liver.	[Havekes, Louis M.; van Dijk, Ko Willems; Rensen, Patrick C. N.] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, Dept Gen Internal Med, NL-2300 RC Leiden, Netherlands; [Bijland, Silvia; van Klinken, Jan B.; van Dijk, Ko Willems] Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RC Leiden, Netherlands; [Havekes, Louis M.] Leiden Univ, Med Ctr, Dept Cardiol, NL-2300 RC Leiden, Netherlands; [Pieterman, Elsbet J.; Maas, Annemarie C. E.; van der Hoorn, Jose W. A.; Havekes, Louis M.; Princen, Hans M. G.] Netherlands Org Appl Sci Res Qual Life, Gaubius Lab, NL-2301 CE Leiden, Netherlands; [van Erk, Marjan J.] Netherlands Org Appl Sci Res Qual Life, NL-3700 AJ Zeist, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Organization Applied Science Research; Netherlands Organization Applied Science Research	Rensen, PCN (corresponding author), Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, Dept Gen Internal Med, Room C4-R81,Albinusdreef 2,POB 9600, NL-2300 RC Leiden, Netherlands.	P.C.N.Rensen@lumc.nl	van Dijk, Ko Willems/A-1798-2008; van Dijk, Ko Willems/AAT-4681-2021; Princen, Hans MG/AID-9392-2022; Rensen, Patrick C.N./D-7176-2018	van Dijk, Ko Willems/0000-0002-2172-7394; van Dijk, Ko Willems/0000-0002-2172-7394; Princen, Hans MG/0000-0002-7206-1596; Rensen, Patrick C.N./0000-0002-8455-4988	Leiden Center for Cardiovascular Research LUMC-TNO; Nutrigenomics Consortium/Top Institute Food and Nutrition (TiFN); Center for Medical Systems Biology (CMSB); Netherlands Consortium for Systems Biology (NCSB); Netherlands Genomics Initiative (NGI/NWO); Netherlands Organization for Health Care Research Medical Sciences (ZON-MW) [948 000 04]; Netherlands Organization for Scientific Research (NWO VIDI) [917.36.351]	Leiden Center for Cardiovascular Research LUMC-TNO; Nutrigenomics Consortium/Top Institute Food and Nutrition (TiFN); Center for Medical Systems Biology (CMSB); Netherlands Consortium for Systems Biology (NCSB); Netherlands Genomics Initiative (NGI/NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Health Care Research Medical Sciences (ZON-MW)(Netherlands Organization for Health Research and Development); Netherlands Organization for Scientific Research (NWO VIDI)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Leiden Center for Cardiovascular Research LUMC-TNO and supported by grants from the Nutrigenomics Consortium/Top Institute Food and Nutrition (TiFN), the Center for Medical Systems Biology (CMSB), and the Netherlands Consortium for Systems Biology (NCSB), within the framework of the Netherlands Genomics Initiative (NGI/NWO), the Netherlands Organization for Health Care Research Medical Sciences (ZON-MW Project nr. 948 000 04), and the Netherlands Organization for Scientific Research (NWO VIDI Grant 917.36.351, to P. C. N. R.).	AALTOSETALA K, 1992, J CLIN INVEST, V90, P1889, DOI 10.1172/JCI116066; Adiels M, 2006, DIABETOLOGIA, V49, P755, DOI 10.1007/s00125-005-0125-z; Ameen C, 2005, J BIOL CHEM, V280, P1224, DOI 10.1074/jbc.M412107200; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Berbee JFP, 2005, J LIPID RES, V46, P297, DOI 10.1194/jlr.M400301-JLR200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BODEN WE, 2000, AM J CARDIOL, V86, P19, DOI DOI 10.1016/S0002-9149(00)01464-8; Boorsma A, 2005, NUCLEIC ACIDS RES, V33, pW592, DOI 10.1093/nar/gki484; Chapman MJ, 2003, ATHEROSCLEROSIS, V171, P1, DOI 10.1016/S0021-9150(03)00156-4; Duivenvoorden I, 2005, J LIPID RES, V46, P988, DOI 10.1194/jlr.M400505-JLR200; Duval C, 2007, BBA-MOL CELL BIOL L, V1771, P961, DOI 10.1016/j.bbalip.2007.05.003; EGUSA G, 1983, J LIPID RES, V24, P1261; Fabbrini E, 2010, J CLIN ENDOCR METAB, V95, P2727, DOI 10.1210/jc.2009-2622; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; Guerin M, 1996, ARTERIOSCL THROM VAS, V16, P763, DOI 10.1161/01.ATV.16.6.763; GULICK T, 1994, P NATL ACAD SCI USA, V91, P11012, DOI 10.1073/pnas.91.23.11012; HAHN SE, 1992, BIOCHEM PHARMACOL, V43, P625, DOI 10.1016/0006-2952(92)90586-8; HELLER F, 1983, EUR J CLIN PHARMACOL, V25, P57, DOI 10.1007/BF00544015; Hogue JC, 2008, METABOLISM, V57, P246, DOI 10.1016/j.metabol.2007.09.008; JIANG XC, 1992, J CLIN INVEST, V90, P1290, DOI 10.1172/JCI115993; Kersten S, 2008, PPAR RES, V2008, DOI 10.1155/2008/132960; LAMB RG, 1993, BIOCHIM BIOPHYS ACTA, V1165, P299, DOI 10.1016/0005-2760(93)90140-5; Li XH, 1996, J LIPID RES, V37, P210; Linden D, 2002, J BIOL CHEM, V277, P23044, DOI 10.1074/jbc.M110416200; Linden D, 2001, J LIPID RES, V42, P1831; MALMENDIER CL, 1989, ATHEROSCLEROSIS, V77, P139, DOI 10.1016/0021-9150(89)90075-0; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; PIETZSCH J, 1995, BBA-LIPID LIPID MET, V1254, P77, DOI 10.1016/0005-2760(94)00171-T; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rensen PCN, 1997, J LIPID RES, V38, P1070; Schoderbock P, 1996, APPL SURF SCI, V93, P109, DOI 10.1016/0169-4332(95)00327-4; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Shiri-Sverdlov R, 2006, J HEPATOL, V44, P732, DOI 10.1016/j.jhep.2005.10.033; Srivastava RAK, 2006, MOL CELL BIOCHEM, V285, P35, DOI 10.1007/s11010-005-9053-y; Staels B, 1998, CIRCULATION, V98, P2088, DOI 10.1161/01.CIR.98.19.2088; STAELS B, 1995, J CLIN INVEST, V95, P705, DOI 10.1172/JCI117717; Teusink B, 2003, DIABETES, V52, P614, DOI 10.2337/diabetes.52.3.614; Tordjman K, 2001, J CLIN INVEST, V107, P1025, DOI 10.1172/JCI11497; van der Hoogt CC, 2007, J LIPID RES, V48, P1763, DOI 10.1194/jlr.M700108-JLR200; van der Hoorn JWA, 2008, ARTERIOSCL THROM VAS, V28, P2016, DOI 10.1161/ATVBAHA.108.171363; VANDENMAAGDENBERG AMJM, 1993, J BIOL CHEM, V268, P10540; Watts GF, 2006, CLIN SCI, V111, P193, DOI 10.1042/CS20060072; Watts GF, 2003, DIABETES, V52, P803, DOI 10.2337/diabetes.52.3.803; Westerterp M, 2006, ARTERIOSCL THROM VAS, V26, P2552, DOI 10.1161/01.ATV.0000243925.65265.3c; ZECHNER R, 1990, BIOCHIM BIOPHYS ACTA, V1044, P20, DOI 10.1016/0005-2760(90)90213-H	45	25	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25168	25175		10.1074/jbc.M110.123992	http://dx.doi.org/10.1074/jbc.M110.123992			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20501652	Green Published, hybrid			2022-12-27	WOS:000280682400009
J	Newcomer, ME; Gilbert, NC				Newcomer, Marcia E.; Gilbert, Nathaniel C.			Location, Location, Location: Compartmentalization of Early Events in Leukotriene Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							5-LIPOXYGENASE ACTIVATING PROTEIN; CYTOSOLIC PHOSPHOLIPASE A(2); MEMBRANE-ASSOCIATED PROTEINS; N-TERMINAL DOMAIN; CRYSTAL-STRUCTURE; C-4 SYNTHASE; SOYBEAN LIPOXYGENASE-1; NUCLEAR-LOCALIZATION; STRUCTURAL BASIS; A(4) HYDROLASE	Leukotrienes (LTs), derived from arachidonic acid (AA) released from the membrane by the action of phospholipase A(2), are potent lipid mediators of the inflammatory response. In 1983, Dahlen et al. demonstrated that LTC4, LTD4, and LTE4 mediate antigen-induced constriction of bronchi in tissue obtained from subjects with asthma (Dahlen, S. E., Hansson, G., Hedqvist, P., Bjorck, T., Granstrom, E., and Dahlen, B. (1983) Proc. Natl. Acad. Sci. U.S.A. 80, 1712-1716). Over the last 25+ years, substantial progress has been made in understanding how LTs exert their effects, and a broader appreciation for the numerous biological processes they mediate has emerged. LT biosynthesis is initiated by the action of 5-lipoxygenase (5-LOX), which catalyzes the transformation of AA to LTA(4) in a two-step reaction. Ca2+ targets 5-LOX to the nuclear membrane, where it co-localizes with the 5-LOX-activating protein FLAP and, when present, the downstream enzyme LTC4 synthase, both transmembrane proteins. Crystal structures of the AA-metabolizing LOXs, LTC4 synthase, and FLAP combined with biochemical data provide a framework for understanding how subcellular organizations optimize the biosynthesis of these labile hydrophobic signaling compounds, which must navigate pathways that include both membrane and soluble enzymes. The insights these structures afford and the questions they engender are discussed in this minireview.	[Newcomer, Marcia E.; Gilbert, Nathaniel C.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Newcomer, ME (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	newcomer@lsu.edu	Gilbert, Nathaniel/I-8223-2018	Gilbert, Nathaniel/0000-0002-6706-811X	American Heart Association [0855392E]; National Science Foundation [MCB 0818387]	American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF))	Supported by American Heart Association Grant 0855392E and National Science Foundation Grant MCB 0818387. To whom correspondence should be addressed. E-mail: newcomer@lsu.edu.	Ago H, 2007, NATURE, V448, P609, DOI 10.1038/nature05936; An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; Bauvois Cedric, 2008, J Biol Chem, V283, P23315, DOI 10.1074/jbc.M802158200; BENNETT AF, 1982, BIOCHEMISTRY-US, V21, P4407, DOI 10.1021/bi00261a033; BENNETT CF, 1993, BIOCHEM J, V289, P33, DOI 10.1042/bj2890033; BOYINGTON JC, 1993, SCIENCE, V260, P1482, DOI 10.1126/science.8502991; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Brock TG, 2005, AM J PHYSIOL-LUNG C, V289, pL224, DOI 10.1152/ajplung.00423.2004; Chapman ER, 1998, J BIOL CHEM, V273, P13995, DOI 10.1074/jbc.273.22.13995; Chen XS, 2001, J BIOL CHEM, V276, P811, DOI 10.1074/jbc.M008203200; Chen XS, 1998, J BIOL CHEM, V273, P31237, DOI 10.1074/jbc.273.47.31237; Choi J, 2008, PROTEINS, V70, P1023, DOI 10.1002/prot.21590; Christmas P, 2002, J BIOL CHEM, V277, P28902, DOI 10.1074/jbc.M203074200; COFFEY MJ, 1994, AM J RESP CELL MOL, V11, P153, DOI 10.1165/ajrcmb.11.2.8049076; Davletov B, 1998, J BIOL CHEM, V273, P19093, DOI 10.1074/jbc.273.30.19093; Dessen A, 1999, CELL, V97, P349, DOI 10.1016/S0092-8674(00)80744-8; Evans JF, 2008, TRENDS PHARMACOL SCI, V29, P72, DOI 10.1016/j.tips.2007.11.006; Ferguson AD, 2007, SCIENCE, V317, P510, DOI 10.1126/science.1144346; FIORE S, 1989, BIOCHEM BIOPH RES CO, V159, P477, DOI 10.1016/0006-291X(89)90017-X; Flamand N, 2009, J BIOL CHEM, V284, P306, DOI 10.1074/jbc.M805593200; Forneris F, 2008, SCIENCE, V321, P213, DOI 10.1126/science.1151118; Gillmor SA, 1997, NAT STRUCT BIOL, V4, P1003, DOI 10.1038/nsb1297-1003; Gupta N, 1998, BBA-LIPID LIPID MET, V1391, P157, DOI 10.1016/S0005-2760(98)00002-2; Hammarberg T, 2000, J BIOL CHEM, V275, P38787, DOI 10.1074/jbc.M006136200; HILL E, 1992, J BIOL CHEM, V267, P22048; Jakobsson PJ, 2000, AM J RESP CRIT CARE, V161, pS20, DOI 10.1164/ajrccm.161.supplement_1.ltta-5; Jakobsson PJ, 1999, PROTEIN SCI, V8, P689, DOI 10.1110/ps.8.3.689; Jones SM, 2003, J BIOL CHEM, V278, P10257, DOI 10.1074/jbc.M211021200; Jones SM, 2002, J BIOL CHEM, V277, P38550, DOI 10.1074/jbc.M206070200; Knapp MJ, 2003, BIOCHEMISTRY-US, V42, P11466, DOI 10.1021/bi0300884; Knapp MJ, 2001, J AM CHEM SOC, V123, P2931, DOI 10.1021/ja003855k; Kuhn H, 1999, FEBS LETT, V449, P7, DOI 10.1016/S0014-5793(99)00396-8; Kulkarni S, 2002, J BIOL CHEM, V277, P13167, DOI 10.1074/jbc.M112393200; Luo M, 2003, P NATL ACAD SCI USA, V100, P12165, DOI 10.1073/pnas.2133253100; Maccarrone M, 2001, BIOCHEMISTRY-US, V40, P6819, DOI 10.1021/bi010187m; Mandal AK, 2004, P NATL ACAD SCI USA, V101, P6587, DOI 10.1073/pnas.0308523101; Mandal AK, 2008, P NATL ACAD SCI USA, V105, P20434, DOI 10.1073/pnas.0808211106; Minor W, 1996, BIOCHEMISTRY-US, V35, P10687, DOI 10.1021/bi960576u; Molina DM, 2008, CURR OPIN STRUC BIOL, V18, P442, DOI 10.1016/j.sbi.2008.04.005; Molina DM, 2007, NATURE, V448, P613, DOI 10.1038/nature06009; Naylor CE, 1999, J MOL BIOL, V294, P757, DOI 10.1006/jmbi.1999.3279; Neau DB, 2009, BIOCHEMISTRY-US, V48, P7906, DOI 10.1021/bi900084m; NOGUCHI M, 1994, BBA-LIPID LIPID MET, V1215, P300, DOI 10.1016/0005-2760(94)90057-4; Oldham ML, 2005, J BIOL CHEM, V280, P39545, DOI 10.1074/jbc.M506675200; Pande AH, 2005, BIOPHYS J, V88, P4084, DOI 10.1529/biophysj.104.056788; Perisic O, 1999, J BIOL CHEM, V274, P14979, DOI 10.1074/jbc.274.21.14979; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Schultz MJ, 2001, J IMMUNOL, V166, P4059, DOI 10.4049/jimmunol.166.6.4059; Schwarz K, 2001, J BIOL CHEM, V276, P773, DOI 10.1074/jbc.M005114200; Skrzypczak-Jankun E, 2001, J AM CHEM SOC, V123, P10814, DOI 10.1021/ja011759t; Strid T, 2009, BIOCHEM BIOPH RES CO, V381, P518, DOI 10.1016/j.bbrc.2009.02.074; Thunnissen MMGM, 2002, FASEB J, V16, P1648, DOI 10.1096/fj.01-1017fje; Thunnissen MMGM, 2001, NAT STRUCT BIOL, V8, P131, DOI 10.1038/84117; Walther M, 2002, J BIOL CHEM, V277, P27360, DOI 10.1074/jbc.M203234200; Youn B, 2006, PROTEINS, V65, P1008, DOI 10.1002/prot.21182; Zarini S, 2009, P NATL ACAD SCI USA, V106, P8296, DOI 10.1073/pnas.0903851106; Zimmer JSD, 2004, J BIOL CHEM, V279, P7420, DOI 10.1074/jbc.M311404200	57	41	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25109	25114		10.1074/jbc.R110.125880	http://dx.doi.org/10.1074/jbc.R110.125880			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20507998	Green Published, hybrid			2022-12-27	WOS:000280682400002
J	Daiho, T; Danko, S; Yamasaki, K; Suzuki, H				Daiho, Takashi; Danko, Stefania; Yamasaki, Kazuo; Suzuki, Hiroshi			Stable Structural Analog of Ca2+-ATPase ADP-insensitive Phosphoenzyme with Occluded Ca2+ Formed by Elongation of A-domain/M1 '-linker and Beryllium Fluoride Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; 1ST TRANSMEMBRANE HELIX; CALCIUM-PUMP; A-DOMAIN; REACTION-MECHANISM; CRYSTAL-STRUCTURE; TIGHT-BINDING; ION-TRANSPORT; PROTEINASE-K; COS-1 CELLS	We have developed a stable analog for the ADP-insensitive phosphoenzyme intermediate with two occluded Ca2+ at the transport sites (E2PCa(2)) of sarcoplasmic reticulum Ca2+-ATPase. This is normally a transient intermediate state during phosphoenzyme isomerization from the ADP-sensitive to ADP-insensitive form and Ca2+ deocclusion/ release to the lumen; E1PCa(2) -> E2PCa(2) -> E2P + 2Ca(2+). Stabilization was achieved by elongation of the Glu(40)-Ser(48) loop linking the Actuator domain and M1 (1st transmembrane helix) with four glycine insertions at Gly(46)/Lys(47) and by binding of beryllium fluoride (BeFx) to the phosphorylation site of the Ca2+-bound ATPase (E1Ca(2)). The complex E2Ca(2)center dot BeF3- was also produced by lumenal Ca2+ binding to E2 center dot BeF3- (E2P ground state analog) of the elongated linker mutant. The complex was stable for at least 1 week at 25 degrees C. Only BeFx, but not AlFx or MgFx, produced the E2PCa(2) structural analog. Complex formation required binding of Mg2+, Mn2+, or Ca2+ at the catalytic Mg2+ site. Results reveal that the phosphorylation product E1PCa(2) and the E2P ground state (but not the transition states) become competent to produce the E2PCa(2) transient state during forward and reverse phosphoenzyme isomerization. Thus, isomerization and lumenal Ca2+ release processes are strictly coupled with the formation of the acylphosphate covalent bond at the catalytic site. Results also demonstrate the critical structural roles of the Glu(40)-Ser(48) linker and of Mg2+ at the catalytic site in these processes.	[Daiho, Takashi; Danko, Stefania; Yamasaki, Kazuo; Suzuki, Hiroshi] Asahikawa Med Univ, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan	Asahikawa Medical College	Daiho, T (corresponding author), Asahikawa Med Univ, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan.	daiho@asahikawa-med.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [21570127] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for Scientific Research (C) (to T.D.) and (B) (to H.S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Daiho T, 1999, J BIOL CHEM, V274, P23910, DOI 10.1074/jbc.274.34.23910; Daiho T, 2003, J BIOL CHEM, V278, P39197, DOI 10.1074/jbc.M305200200; Daiho T, 1999, FEBS LETT, V444, P54, DOI 10.1016/S0014-5793(99)00027-7; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; Danko S, 2001, FEBS LETT, V489, P277, DOI 10.1016/S0014-5793(01)02111-1; Danko S, 2009, J BIOL CHEM, V284, P22722, DOI 10.1074/jbc.M109.029702; de Meis L, 1974, Biochemistry, V13, P2057, DOI 10.1021/bi00707a009; DEMEIS L, 1982, J BIOL CHEM, V257, P1289; Gonzalez DA, 2006, BIOPHYS CHEM, V124, P27, DOI 10.1016/j.bpc.2006.05.025; HASSELBACH W, 1981, FED PROC, V40, P2657; HASSELBACH W, 1961, BIOCHEM Z, V333, P518; Holdensen AN, 2009, J BIOL CHEM, V284, P12258, DOI 10.1074/jbc.M900977200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JUUL B, 1995, J BIOL CHEM, V270, P20123, DOI 10.1074/jbc.270.34.20123; KANAZAWA T, 1975, J BIOL CHEM, V250, P113; Kato S, 2003, J BIOL CHEM, V278, P9624, DOI 10.1074/jbc.M208861200; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; KUBOTA T, 1993, BIOCHIM BIOPHYS ACTA, V1163, P131, DOI 10.1016/0167-4838(93)90174-P; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lenoir G, 2004, J BIOL CHEM, V279, P9156, DOI 10.1074/jbc.M311411200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; MASUDA H, 1973, BIOCHEMISTRY-US, V12, P4581, DOI 10.1021/bi00747a006; McIntosh D.B., 1998, ADV MOL CEL A&B, V23A, P33; Moller JV, 2002, J BIOL CHEM, V277, P38647, DOI 10.1074/jbc.M204603200; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; MURPHY AJ, 1992, J BIOL CHEM, V267, P5229; MURPHY AJ, 1993, J BIOL CHEM, V268, P23307; OGURUSU T, 1991, J BIOCHEM-TOKYO, V109, P472, DOI 10.1093/oxfordjournals.jbchem.a123406; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Peeraer Y, 2004, EUR J BIOCHEM, V271, P3421, DOI 10.1111/j.0014-2956.2004.04277.x; Picard M, 2007, J MOL BIOL, V368, P1, DOI 10.1016/j.jmb.2007.01.082; Seekoe T, 2001, J BIOL CHEM, V276, P46737, DOI 10.1074/jbc.M106320200; SHIGEKAWA M, 1983, J BIOL CHEM, V258, P8698; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; TROULLIER A, 1992, J BIOL CHEM, V267, P22821; WAKABAYASHI S, 1987, J BIOL CHEM, V262, P11524; Wang GL, 2005, J BIOL CHEM, V280, P26508, DOI 10.1074/jbc.M503789200; WEBER K, 1969, J BIOL CHEM, V244, P4406; YAMADA S, 1980, J BIOL CHEM, V255, P3108; Yamasaki K, 2004, J BIOL CHEM, V279, P2202, DOI 10.1074/jbc.M309398200; Yamasaki K, 2008, J BIOL CHEM, V283, P29144, DOI 10.1074/jbc.M804596200	54	15	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24538	24547		10.1074/jbc.M110.144535	http://dx.doi.org/10.1074/jbc.M110.144535			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529842	hybrid, Green Submitted, Green Published			2022-12-27	WOS:000280542100026
J	Peng, P; Zhao, J; Zhu, YY; Asami, T; Li, JM				Peng, Peng; Zhao, Jun; Zhu, Yongyou; Asami, Tadao; Li, Jianming			A Direct Docking Mechanism for a Plant GSK3-like Kinase to Phosphorylate Its Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE; REGULATED GENE-EXPRESSION; RECEPTOR KINASES; BIN2; GSK3; BZR1; PROTEINS; GROWTH; BES1; BRASSINOSTEROIDS	Glycogen synthase kinase 3 (GSK3) is a highly conserved serine/threonine protein kinase that plays important roles in a variety of physiological and developmental processes in animals. It is well known that the GSK3 kinase-catalyzed protein phosphorylation often requires a stable kinase-substrate docking interaction, which is achieved mainly by two mechanisms as follows: priming phosphorylation of a substrate by a distinct kinase to create a docking phosphate group and scaffold protein-mediated protein complex formation. Brassinosteroid-INsensitive 2 (BIN2) is an Arabidopsis GSK3-like kinase that negatively regulates brassinosteroid (BR) signaling by phosphorylating BES1 (bri1 EMS suppressor 1) and BZR1 (brassinazole-resistant 1), two highly similar transcription factors critical for bringing about characteristic BR responses. However, little is known about the biochemical mechanism by which BIN2 phosphorylates its substrates. Here, we show that BIN2 interacts directly with BZR1 through a 12-amino acid BIN2-docking motif adjacent to the C terminus of BZR1. Interestingly, this 12-amino acid motif is sufficient to allow a Drosophila GSK3 substrate Armadillo to be phosphorylated by BIN2 in vitro. Deletion of this motif inhibits the phosphorylation and subsequent degradation of BZR1 in vivo, resulting in phenotypic suppression of a hypermorphic bin2 mutation and enhanced resistance to a BR biosynthesis inhibitor. We thus concluded that BIN2 utilizes a direct kinase-substrate docking mechanism to phosphorylate BZR1 and regulate its protein stability.	Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Asami, Tadao] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	University of Michigan System; University of Michigan; University of Tokyo	Li, JM (corresponding author), 4071B Nat Sci Bldg,830 N Univ, Ann Arbor, MI 48109 USA.	jian@umich.edu	Zhu, Yongyou/H-3791-2013; Li, Jianming/O-1772-2014	Li, Jianming/0000-0003-3231-0778	National Institutes of Health [GM060519]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060519] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM060519 (to J. L.).	Bai MY, 2007, P NATL ACAD SCI USA, V104, P13839, DOI 10.1073/pnas.0706386104; Choe S, 2002, PLANT PHYSIOL, V130, P1506, DOI 10.1104/pp.010496; Claisse G, 2007, PLANT MOL BIOL, V64, P113, DOI 10.1007/s11103-007-9138-y; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dornelas MC, 2000, PLANT J, V21, P419, DOI 10.1046/j.1365-313x.2000.00691.x; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Harwood AJ, 2001, CELL, V105, P821, DOI 10.1016/S0092-8674(01)00412-3; He JX, 2005, SCIENCE, V307, P1634, DOI 10.1126/science.1107580; He JX, 2002, P NATL ACAD SCI USA, V99, P10185, DOI 10.1073/pnas.152342599; Jonak C, 2000, PLANT CELL, V12, P1467, DOI 10.1105/tpc.12.8.1467; Jonak C, 2002, TRENDS PLANT SCI, V7, P457, DOI 10.1016/S1360-1385(02)02331-2; Kim TW, 2009, NAT CELL BIOL, V11, P1254, DOI 10.1038/ncb1970; Lefevre F, 1997, NUCLEIC ACIDS RES, V25, P447, DOI 10.1093/nar/25.2.447; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li JM, 2005, CURR OPIN PLANT BIOL, V8, P526, DOI 10.1016/j.pbi.2005.07.009; Li JM, 2002, SCIENCE, V295, P1299; Li JM, 2001, PLANT PHYSIOL, V127, P14, DOI 10.1104/pp.127.1.14; Li L, 2010, P NATL ACAD SCI USA, V107, P3918, DOI 10.1073/pnas.0909198107; Li L, 2009, PLANT J, V58, P275, DOI 10.1111/j.1365-313X.2008.03778.x; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Mora-Garcia S, 2004, GENE DEV, V18, P448, DOI 10.1101/gad.1174204; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Pai LM, 1997, DEVELOPMENT, V124, P2255; Peng P, 2008, MOL PLANT, V1, P338, DOI 10.1093/mp/ssn001; Perez-Perez JM, 2002, DEV BIOL, V242, P161, DOI 10.1006/dbio.2001.0543; Piao HL, 2001, PLANT J, V27, P305, DOI 10.1046/j.1365-313x.2001.01099.x; Rozhon W, 2010, PLANT J, V62, P215, DOI 10.1111/j.1365-313X.2010.04145.x; Ryu H, 2007, PLANT CELL, V19, P2749, DOI 10.1105/tpc.107.053728; ter Haar E, 2001, NAT STRUCT BIOL, V8, P593, DOI 10.1038/89624; Vert G, 2006, NATURE, V441, P96, DOI 10.1038/nature04681; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; WOODGETT JR, 2001, SCI STKE, pRE12; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Yan ZY, 2009, PLANT PHYSIOL, V150, P710, DOI 10.1104/pp.109.138099; Yin YH, 2005, CELL, V120, P249, DOI 10.1016/j.cell.2004.11.044; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3; Yu XF, 2008, P NATL ACAD SCI USA, V105, P7618, DOI 10.1073/pnas.0802254105; Zhang LY, 2009, PLANT CELL, V21, P3767, DOI 10.1105/tpc.109.070441; Zhao J, 2002, PLANT PHYSIOL, V130, P1221, DOI 10.1104/pp.102.010918	48	38	44	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24646	24653		10.1074/jbc.M110.142547	http://dx.doi.org/10.1074/jbc.M110.142547			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20522560	hybrid, Green Published			2022-12-27	WOS:000280542100037
J	Harada, K; Fukuda, E; Hirohashi, N; Chiba, K				Harada, Kaori; Fukuda, Eriko; Hirohashi, Noritaka; Chiba, Kazuyoshi			Regulation of Intracellular pH by p90Rsk-dependent Activation of an Na+/H+ Exchanger in Starfish Oocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEA-URCHIN EGGS; GERMINAL VESICLE BREAKDOWN; XENOPUS-LAEVIS OOCYTES; RAT NA/H EXCHANGER; METAPHASE-I ARREST; PROTEIN-KINASE; MEIOSIS REINITIATION; NHE3 ACTIVITY; BRUSH-BORDER; CELL-CYCLE	Starfish oocytes arrest at metaphase of the first meiotic division (MI arrest) in the ovary and resume meiosis after spawning into seawater. MI arrest is maintained by lower intracellular pH (pH(i)) and release from arrest by cellular alkalization. To elucidate pH(i) regulation in oocytes, we cloned the starfish (Asterina pectinifera) Na+/H+ exchanger 3 (ApNHE3) expressed in the plasma membrane of oocytes. The cytoplasmic domain of ApNHE3 contains p90 ribosomal S6 kinase (p90Rsk) phosphorylation sites, and injection of a constitutively active p90Rsk and the upstream regulator Mos to immature oocytes, stimulated an increase in pH(i). This increase was blocked by 5-(N-ethyl-N-isopropyl)-amiloride, a NHE inhibitor, and SL0101, a specific Rsk inhibitor. The MAPK kinase (MEK) inhibitor U0126 blocked the Mos-induced, but not the p90Rsk-induced, pH(i) increase, suggesting that the Mos-MEK-MAPK-p90Rsk pathway promotes ApNHE3 activation. In a cell-free extract, the Mos-MEK-MAPK-p90Rsk pathway phosphorylates ApNHE3 at Ser-590, -606, and -673. When p90Rsk-dependent ApNHE3 phosphorylation was blocked by a dominant-negative C-terminal fragment, or neutralizing antibody, the p90Rsk-induced pH(i) increase was suppressed in immature oocytes. However, ApNHE3 is up-regulated via the upstream phosphatidylinositol 3-kinase pathway before MAPK activation and the active state is maintained until spawning, suggesting that the p90Rsk-dependent ApNHE3 phosphorylation is unlikely to be the primary regulatory mechanism involved in MI arrest exit. After meiosis is completed, unfertilized eggs maintain their elevated pH(i) (similar to 7.4) until the onset of apoptosis. We suggest that the p90Rsk/ApNHE3-dependent elevation of pH(i) increases fertilization success by delaying apoptosis initiation.	Ochanomizu Univ, Dept Biol, Tokyo 1128610, Japan; [Fukuda, Eriko] Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki 3058566, Japan; [Hirohashi, Noritaka] Ochanomizu Univ, Grad Sch Humanities & Sci, Genet Counseling Program, Bunkyo Ku, Tokyo 1128610, Japan	Ochanomizu University; National Institute of Advanced Industrial Science & Technology (AIST); Ochanomizu University	Hirohashi, N (corresponding author), 2-1-1 Otsuka,Bunkyo Ku, Tokyo 1128610, Japan.	hirohashi.noritaka@ocha.ac.jp	Fukuda, Eriko/M-2854-2018	Fukuda, Eriko/0000-0003-3086-3707	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ocean Research Institute, University of Tokyo; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ocean Research Institute, University of Tokyo; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Human Frontier Science Program, the Ministry of Education, Culture, Sports, Science and Technology of Japan (to K. C.), the Cooperative Program provided by the Ocean Research Institute, University of Tokyo (to K. C. and N.H.), and Research Fellowships for Young Scientists from Japan Society for the Promotion of Science (to K. H.).	Ben Ammar Y, 2006, EMBO J, V25, P2315, DOI 10.1038/sj.emboj.7601145; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Cha B, 2006, MOL BIOL CELL, V17, P2661, DOI 10.1091/mbc.E05-09-0843; Chalumeau C, 2001, AM J PHYSIOL-RENAL, V280, pF283, DOI 10.1152/ajprenal.2001.280.2.F283; Chiba K, 1999, DEV BIOL, V205, P217, DOI 10.1006/dbio.1998.9118; CHIBA K, 1993, MOL BIOL CELL, V4, P1027, DOI 10.1091/mbc.4.10.1027; DEGUCHI R, 1995, DEV BIOL, V171, P483, DOI 10.1006/dbio.1995.1298; DEGUCHI R, 1994, DEV BIOL, V163, P162, DOI 10.1006/dbio.1994.1132; EPEL D, 1974, DEV BIOL, V40, P245, DOI 10.1016/0012-1606(74)90127-4; FitzHarris G, 2007, DEVELOPMENT, V134, P4283, DOI 10.1242/dev.005272; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; HANOCQQUERTIER J, 1981, EUR J BIOCHEM, V120, P351, DOI 10.1111/j.1432-1033.1981.tb05711.x; Harada K, 2003, DEVELOPMENT, V130, P4581, DOI 10.1242/dev.00649; KANATANI H, 1969, NATURE, V221, P273, DOI 10.1038/221273a0; Kang MG, 1998, BIOL CELL, V90, P477, DOI 10.1016/S0248-4900(99)80006-9; Khaled AR, 2001, MOL CELL BIOL, V21, P7545, DOI 10.1128/MCB.21.22.7545-7557.2001; Kishimoto T, 1998, SEMIN CELL DEV BIOL, V9, P549, DOI 10.1006/scdb.1998.0249; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Kozikowski AP, 2003, J AM CHEM SOC, V125, P1144, DOI 10.1021/ja0285159; KRUPPA J, 1983, EUR J BIOCHEM, V129, P537; Kurashima K, 1999, J BIOL CHEM, V274, P29843, DOI 10.1074/jbc.274.42.29843; Liu D, 2000, J BIOL CHEM, V275, P9244, DOI 10.1074/jbc.275.13.9244; Luo J, 2007, CURR NEUROVASC RES, V4, P205; Marino M, 2000, MOL REPROD DEV, V56, P155, DOI 10.1002/(SICI)1098-2795(200006)56:2<155::AID-MRD6>3.0.CO;2-1; MAZIA D, 1974, EXP CELL RES, V85, P167, DOI 10.1016/0014-4827(74)90227-4; Moor AN, 2001, J BIOL CHEM, V276, P16113, DOI 10.1074/jbc.M100519200; Mori M, 2006, DEVELOPMENT, V133, P1823, DOI 10.1242/dev.02348; MORRILL GA, 1984, BIOCHIM BIOPHYS ACTA, V804, P107, DOI 10.1016/0167-4889(84)90104-6; Murtazina R, 2006, J BIOL CHEM, V281, P17845, DOI 10.1074/jbc.M601740200; NEANT I, 1988, DEVELOPMENT, V102, P505; Nofer JR, 2006, BIOCHEM BIOPH RES CO, V340, P751, DOI 10.1016/j.bbrc.2005.12.070; Oita E, 2004, J BIOL CHEM, V279, P18633, DOI 10.1074/jbc.M311122200; Okumura E, 2002, NAT CELL BIOL, V4, P111, DOI 10.1038/ncb741; Orlowski J, 1996, J BIOL CHEM, V271, P19922, DOI 10.1074/jbc.271.33.19922; ORLOWSKI J, 1993, J BIOL CHEM, V268, P16369; Perdiguero E, 2003, EMBO J, V22, P5746, DOI 10.1093/emboj/cdg559; Rangel-Mata F, 2007, BIOCHEM BIOPH RES CO, V352, P264, DOI 10.1016/j.bbrc.2006.11.015; Sakaue M, 2006, BIOCHEM BIOPH RES CO, V350, P878, DOI 10.1016/j.bbrc.2006.09.119; Sasaki K, 2004, MOL BIOL CELL, V15, P1387, DOI 10.1091/mbc.E03-06-0367; Sasaki K, 2001, DEV BIOL, V237, P18, DOI 10.1006/dbio.2001.0337; Smith JA, 2005, CANCER RES, V65, P1027; STITH BJ, 1985, DEV BIOL, V107, P460, DOI 10.1016/0012-1606(85)90327-6; Tachibana K, 2000, P NATL ACAD SCI USA, V97, P14301, DOI 10.1073/pnas.97.26.14301; Takahashi E, 1999, J BIOL CHEM, V274, P20206, DOI 10.1074/jbc.274.29.20206; Thangaraju M, 1999, CANCER RES, V59, P1649; Thangaraju M, 1999, J BIOL CHEM, V274, P29549, DOI 10.1074/jbc.274.41.29549; Usui K, 2008, DEV GROWTH DIFFER, V50, P357, DOI [10.1111/j.1440-169x.2008.01036.x, 10.1111/j.1440-169X.2008.01036.x]; Wang DS, 2005, AM J PHYSIOL-CELL PH, V289, pC802, DOI 10.1152/ajpcell.00597.2004; Wiederkehr MR, 1999, AM J PHYSIOL-CELL PH, V276, pC1205, DOI 10.1152/ajpcell.1999.276.5.C1205; Yamamoto DS, 2008, MECH DEVELOP, V125, P996, DOI 10.1016/j.mod.2008.08.004; Yamamoto K, 1997, DEV GROWTH DIFFER, V39, P763; YU FH, 1993, J BIOL CHEM, V268, P25536; Yun CC, 2002, J BIOL CHEM, V277, P7676, DOI 10.1074/jbc.M107768200; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856; Zhou CX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007417	56	10	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24044	24054		10.1074/jbc.M109.072553	http://dx.doi.org/10.1074/jbc.M109.072553			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20507995	Green Published, hybrid			2022-12-27	WOS:000280291400055
J	Kang, EL; Cameron, AN; Piazza, F; Walker, KR; Tesco, G				Kang, Eugene L.; Cameron, Andrew N.; Piazza, Fabrizio; Walker, Kendall R.; Tesco, Giuseppina			Ubiquitin Regulates GGA3-mediated Degradation of BACE1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; TRANS-GOLGI NETWORK; SECRETASE CYTOSOLIC DOMAIN; DISEASE BETA-SECRETASE; GGA PROTEINS; SORTING-SIGNAL; BODY FORMATION; EGF RECEPTOR; VHS DOMAINS; ENDOSOMES	BACE1 (beta-site amyloid precursor protein-cleaving enzyme 1) is a membrane-tethered member of the aspartyl proteases, essential for the production of beta-amyloid, a toxic peptide that accumulates in the brain of subjects affected by Alzheimer disease. The BACE1 C-terminal fragment contains a DXXLL motif that has been shown to bind the VHS (VPS27, Hrs, and STAM) domain of GGA1-3 (Golgi-localized gamma-ear-containing ARF-binding proteins). GGAs are trafficking molecules involved in the transport of proteins containing the DXXLL signal from the Golgi complex to endosomes. Moreover, GGAs bind ubiquitin and traffic synthetic and endosomal ubiquitinated cargoes to lysosomes. We have previously shown that depletion of GGA3 results in increased BACE1 levels and activity because of impaired lysosomal degradation. Here, we report that the accumulation of BACE1 is rescued by the ectopic expression of GGA3 in H4 neuroglioma cells depleted of GGA3. Accordingly, the overexpression of GGA3 reduces the levels of BACE1 and alpha-amyloid. We then established that mutations in the GGA3 VPS27, Hrs, and STAM domain (N91A) or in BACE1 di-leucine motif (L499A/L500A), able to abrogate their binding, did not affect the ability of ectopically expressed GGA3 to rescue BACE1 accumulation in cells depleted of GGA3. Instead, we found that BACE1 is ubiquitinated at lysine 501 and is mainly monoubiquitinated and Lys-63-linked polyubiquitinated. Finally, a GGA3 mutant with reduced ability to bind ubiquitin (GGA3L276A) was unable to regulate BACE1 levels both in rescue and overexpression experiments. These findings indicate that levels of GGA3 tightly and inversely regulate BACE1 levels via interaction with ubiquitin sorting machinery.	[Kang, Eugene L.; Cameron, Andrew N.; Piazza, Fabrizio; Walker, Kendall R.; Tesco, Giuseppina] Tufts Univ, Sch Med, Alzheimers Dis Res Lab, Dept Neurosci, Boston, MA 02111 USA	Tufts University	Tesco, G (corresponding author), Tufts Univ, Sch Med, Alzheimers Dis Res Lab, Dept Neurosci, 136 Harrison Ave,Ste 328A, Boston, MA 02111 USA.	Giuseppina.Tesco@Tufts.edu	Piazza, Fabrizio/L-2094-2016	Piazza, Fabrizio/0000-0002-3385-3224	National Institutes of Health [1R01AG025952-04, 1R01AG033016-01A1]; NATIONAL INSTITUTE ON AGING [R01AG033016, R01AG025952] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01AG025952-04 and 1R01AG033016-01A1 (to G. T.).	Bache KG, 2003, J CELL BIOL, V162, P435, DOI 10.1083/jcb.200302131; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Bilodeau PS, 2004, J BIOL CHEM, V279, P54808, DOI 10.1074/jbc.M406654200; Bishop N, 2002, J CELL BIOL, V157, P91, DOI 10.1083/jcb.200112080; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Davies BA, 2009, CHEM REV, V109, P1575, DOI 10.1021/cr800473s; De Strooper B, 2000, J CELL SCI, V113, P1857; Deng Y, 2009, J BIOL CHEM, V284, P23830, DOI 10.1074/jbc.M109.030015; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; He XY, 2005, J BIOL CHEM, V280, P11696, DOI 10.1074/jbc.M411296200; He XY, 2003, BIOCHEMISTRY-US, V42, P12174, DOI 10.1021/bi035199h; He XY, 2002, FEBS LETT, V524, P183, DOI 10.1016/S0014-5793(02)03052-1; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Kawasaki M, 2005, GENES CELLS, V10, P639, DOI 10.1111/j.1365-2443.2005.00865.x; Koh YH, 2005, J BIOL CHEM, V280, P32499, DOI 10.1074/jbc.M506199200; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; Mattera R, 2003, EMBO J, V22, P78, DOI 10.1093/emboj/cdg015; Misra S, 2002, NATURE, V415, P933, DOI 10.1038/415933a; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Pastorino L, 2002, MOL CELL NEUROSCI, V19, P175, DOI 10.1006/mcne.2001.1065; Prag G, 2005, P NATL ACAD SCI USA, V102, P2334, DOI 10.1073/pnas.0500118102; Puertollano R, 2004, NAT CELL BIOL, V6, P244, DOI 10.1038/ncb1106; Qing H, 2004, FASEB J, V18, P1571, DOI 10.1096/fj.04-1994fje; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Scott PM, 2004, NAT CELL BIOL, V6, P252, DOI 10.1038/ncb1107; Sena-Esteves M, 2004, J VIROL METHODS, V122, P131, DOI 10.1016/j.jviromet.2004.08.017; Shi Q, 2009, J NEUROSCI, V29, P9163, DOI 10.1523/JNEUROSCI.5741-08.2009; Shiba T, 2004, TRAFFIC, V5, P437, DOI 10.1111/j.1600-0854.2004.00188.x; Shiba Y, 2004, J BIOL CHEM, V279, P7105, DOI 10.1074/jbc.M311702200; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; van Tijn P, 2007, J CELL SCI, V120, P1615, DOI 10.1242/jcs.03438; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; von Arnim CAF, 2004, J CELL SCI, V117, P5437, DOI 10.1242/jcs.01422; Wahle T, 2005, MOL CELL NEUROSCI, V29, P453, DOI 10.1016/j.mcn.2005.03.014; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Zhang Y, 2010, J CEREBR BLOOD F MET, V30, P566, DOI 10.1038/jcbfm.2009.228	45	84	85	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24108	24119		10.1074/jbc.M109.092742	http://dx.doi.org/10.1074/jbc.M109.092742			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20484053	Green Published, hybrid			2022-12-27	WOS:000280291400061
J	Tian, LJ; McClafferty, H; Jeffries, O; Shipston, MJ				Tian, Lijun; McClafferty, Heather; Jeffries, Owen; Shipston, Michael J.			Multiple Palmitoyltransferases Are Required for Palmitoylation-dependent Regulation of Large Conductance Calcium- and Voltage-activated Potassium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-RICH DOMAIN; PROTEIN PALMITOYLATION; GABA(A) RECEPTORS; MEDIATED PALMITOYLATION; DYNAMIC PALMITOYLATION; MEMBRANE INTERACTIONS; NEURONAL DEVELOPMENT; TRAFFICKING; SUBUNIT; PHOSPHORYLATION	Palmitoylation is emerging as an important and dynamic regulator of ion channel function; however, the specificity with which the large family of acyl palmitoyltransferases ( zinc finger Asp-His-His-Cystype-containing acyl palmitoyltransferase (DHHCs)) control channel palmitoylation is poorly understood. We have previously demonstrated that the alternatively spliced stress-regulated exon (STREX) variant of the intracellular C-terminal domain of the large conductance calcium- and voltage- activated potassium (BK) channels is palmitoylated and targets the STREX domain to the plasma membrane. Using a combined imaging, biochemical, and functional approach coupled with loss-of-function ( small interfering RNA knockdown of endogenous DHHCs) and gain-of-function ( overexpression of recombinant DHHCs) assays, we demonstrate that multiple DHHCs control palmitoylation of the C terminus of STREX channels, the association of the STREX domain with the plasma membrane, and functional channel regulation. Cysteine residues 12 and 13 within the STREX insert were the only endogenously palmitoylated residues in the entire C terminus of the STREX channel. Palmitoylation of this dicysteine motif was controlled by DHHCs 3, 5, 7, 9, and 17, although DHHC17 showed the greatest specificity for this site upon overexpression of the cognate DHHC. DHHCs that palmitoylated the channel also co-assembled with the channel in co-immunoprecipitation experiments, and knockdown of any of these DHHCs blocked regulation of the channel by protein kinase A-dependent phosphorylation. Taken together our data reveal that a subset of DHHCs controls STREX palmitoylation and function and suggest that DHHC17 may preferentially target cysteine-rich domains. Finally, our approach may prove useful in elucidating the specificity of DHHC palmitoylation of intracellular domains of other ion channels and transmembrane proteins.	[Tian, Lijun; McClafferty, Heather; Jeffries, Owen; Shipston, Michael J.] Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland	University of Edinburgh	Shipston, MJ (corresponding author), Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland.	mike.shipston@ed.ac.uk	Shipston, Mike/C-7309-2013	Shipston, Mike/0000-0001-7544-582X; jeffries, owen/0000-0002-8169-1100	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust.	Chan AW, 2007, CELL CALCIUM, V42, P419, DOI 10.1016/j.ceca.2007.04.009; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2006, METHODS, V40, P177, DOI 10.1016/j.ymeth.2006.05.015; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Gonnord P, 2009, FASEB J, V23, P795, DOI 10.1096/fj.08-114637; Greaves J, 2008, J BIOL CHEM, V283, P25014, DOI 10.1074/jbc.M802140200; Greaves J, 2009, MOL BIOL CELL, V20, P1845, DOI 10.1091/mbc.E08-09-0944; Gubitosi-Klug RA, 2005, P NATL ACAD SCI USA, V102, P5964, DOI 10.1073/pnas.0501999102; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Huang K, 2009, FASEB J, V23, P2605, DOI 10.1096/fj.08-127399; Hurley JF, 2000, P NATL ACAD SCI USA, V97, P9293, DOI 10.1073/pnas.160589697; Jennings BC, 2009, J LIPID RES, V50, P233, DOI 10.1194/jlr.M800270-JLR200; Jindal HK, 2008, AM J PHYSIOL-HEART C, V294, pH2012, DOI 10.1152/ajpheart.01374.2007; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Keller CA, 2004, J NEUROSCI, V24, P5881, DOI 10.1523/JNEUROSCI.1037-04.2004; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Pickering DS, 1995, P NATL ACAD SCI USA, V92, P12090, DOI 10.1073/pnas.92.26.12090; Rathenberg J, 2004, MOL CELL NEUROSCI, V26, P251, DOI 10.1016/j.mcn.2004.01.012; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Resh MD, 2006, METHODS, V40, P191, DOI 10.1016/j.ymeth.2006.04.013; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; SCHMIDT JW, 1987, J BIOL CHEM, V262, P13713; Suzuki H, 2008, BBA-BIOMEMBRANES, V1778, P1181, DOI 10.1016/j.bbamem.2007.12.007; Tian L, 2004, P NATL ACAD SCI USA, V101, P11897, DOI 10.1073/pnas.0402590101; Tian LJ, 2008, P NATL ACAD SCI USA, V105, P21006, DOI 10.1073/pnas.0806700106; Tian LJ, 2003, J BIOL CHEM, V278, P8669, DOI 10.1074/jbc.M211661200; Tian LJ, 2001, J BIOL CHEM, V276, P7717, DOI 10.1074/jbc.C000741200; Uemura T, 2002, BIOCHEM BIOPH RES CO, V296, P492, DOI 10.1016/S0006-291X(02)00900-2; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702	34	57	58	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23954	23962		10.1074/jbc.M110.137802	http://dx.doi.org/10.1074/jbc.M110.137802			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20507996	Green Published, hybrid			2022-12-27	WOS:000280291400046
J	Chuankhayan, P; Hsieh, CY; Huang, YC; Hsieh, YY; Guan, HH; Hsieh, YC; Tien, YC; Chen, CD; Chiang, CM; Chen, CJ				Chuankhayan, Phimonphan; Hsieh, Chih-Yu; Huang, Yen-Chieh; Hsieh, Yi-You; Guan, Hong-Hsiang; Hsieh, Yin-Cheng; Tien, Yueh-Chu; Chen, Chung-De; Chiang, Chien-Min; Chen, Chun-Jung			Crystal Structures of Aspergillus japonicus Fructosyltransferase Complex with Donor/Acceptor Substrates Reveal Complete Subsites in the Active Site for Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHICORY FRUCTAN 1-EXOHYDROLASE; BACILLUS-SUBTILIS LEVANSUCRASE; RAY-DIFFRACTION STRUCTURE; CELL-WALL INVERTASE; HYDROLASE FAMILY 32; MICROBIAL-PRODUCTION; PROTEIN; SUCROSE; INSIGHTS; 6G-FRUCTOSYLTRANSFERASE	Fructosyltransferases catalyze the transfer of a fructose unit from one sucrose/fructan to another and are engaged in the production of fructooligosaccharide/fructan. The enzymes belong to the glycoside hydrolase family 32 (GH32) with a retaining catalytic mechanism. Here we describe the crystal structures of recombinant fructosyltransferase (AjFT) from Aspergillus japonicus CB05 and its mutant D191A complexes with various donor/acceptor substrates, including sucrose, 1-kestose, nystose, and raffinose. This is the first structure of fructosyltransferase of the GH32 with a high transfructosylation activity. The structure of AjFT comprises two domains with an N-terminal catalytic domain containing a five-blade beta-propeller fold linked to a C-terminal beta-sandwich domain. Structures of various mutant AjFT-substrate complexes reveal complete four substrate-binding subsites (-1 to +3) in the catalytic pocket with shapes and characters distinct from those of clan GH-J enzymes. Residues Asp-60, Asp-191, and Glu-292 that are proposed for nucleophile, transition-state stabilizer, and general acid/base catalyst, respectively, govern the binding of the terminal fructose at the -1 subsite and the catalytic reaction. Mutants D60A, D191A, and E292A completely lost their activities. Residues Ile-143, Arg-190, Glu-292, Glu-318, and His-332 combine the hydrophobic Phe-118 and Tyr-369 to define the -1 subsite for its preference of fructosyl and glucosyl moieties. Ile-143 and Gln-327 define the +2 subsite for raffinose, whereas Tyr-404 and Glu-405 define the +2 and +3 subsites for inulin-type substrates with higher structural flexibilities. Structural geometries of 1-kestose, nystose and raffinose are different from previous data. All results shed light on the catalytic mechanism and substrate recognition of AjFT and other clan GH-J fructosyltransferases.	[Hsieh, Chih-Yu; Hsieh, Yi-You; Chiang, Chien-Min] Chia Nan Univ Pharm & Sci, Dept Biotechnol, Tainan 71710, Taiwan; [Chuankhayan, Phimonphan; Huang, Yen-Chieh; Guan, Hong-Hsiang; Hsieh, Yin-Cheng; Tien, Yueh-Chu; Chen, Chung-De; Chen, Chun-Jung] Natl Synchrotron Radiat Res Ctr, Sci Res Div, Life Sci Grp, Hsinchu 30076, Taiwan; [Chen, Chung-De; Chen, Chun-Jung] Natl Tsing Hua Univ, Dept Phys, Hsinchu 30043, Taiwan; [Guan, Hong-Hsiang; Hsieh, Yin-Cheng; Tien, Yueh-Chu] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 30043, Taiwan; [Chen, Chun-Jung] Natl Cheng Kung Univ, Inst Biotechnol, Tainan 701, Taiwan	Chia Nan University of Pharmacy & Science; National Synchrotron Radiation Research Center; National Tsing Hua University; National Tsing Hua University; National Cheng Kung University	Chiang, CM (corresponding author), Chia Nan Univ Pharm & Sci, Dept Biotechnol, Tainan 71710, Taiwan.	cmchiang@mail.chna.edu.tw; cjchen@nsrrc.org.tw	Chen, Chun-Jung/A-6880-2011	Chen, Chun-Jung/0000-0002-5157-4288	National Science Council [94-2313-B-213-001, 95-2313-B-009-001-MY3]; NSRRC [963RSB02, 973RSB02, 983RSB02]; Chia Nan University [CNBT-9502, CNBT-9723]	National Science Council(Ministry of Science and Technology, Taiwan); NSRRC; Chia Nan University	This work was supported by National Science Council Grants 94-2313-B-213-001 and 95-2313-B-009-001-MY3 and NSRRC Grants 963RSB02, 973RSB02, and 983RSB02 (to C.-J.C.) and by Chia Nan University Grants CNBT-9502 and CNBT-9723 (to C.-M.C.).	Alberto F, 2006, BIOCHEM J, V395, P457, DOI [10.1042/BJ20051936, 10.1042/Bj20051936]; Alberto F, 2004, J BIOL CHEM, V279, P18903, DOI 10.1074/jbc.M313911200; Altenbach D, 2009, PLANT MOL BIOL, V69, P47, DOI 10.1007/s11103-008-9404-7; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cairns AJ, 2003, J EXP BOT, V54, P549, DOI 10.1093/jxb/erg056; CHAMBERT R, 1991, BIOCHEM J, V279, P35, DOI 10.1042/bj2790035; COTE GL, 2003, SCI TECHNOLOGY FRUCT, P141; Davies GJ, 2003, BIOCHEM SOC T, V31, P523, DOI 10.1042/BST0310523; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Heyer AG, 2001, APPL ENVIRON MICROB, V67, P363, DOI 10.1128/AEM.67.1.363-370.2001; HIRAYAMA M, 1989, AGR BIOL CHEM TOKYO, V53, P667, DOI 10.1080/00021369.1989.10869350; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Homann A, 2007, BIOCHEM J, V407, P189, DOI 10.1042/BJ20070600; JEFFREY GA, 1972, ACTA CRYSTALL B-STRU, VB 28, P257, DOI 10.1107/S056774087200216X; Lammens W, 2008, J MOL BIOL, V377, P378, DOI 10.1016/j.jmb.2007.12.074; Lammens W, 2009, J EXP BOT, V60, P727, DOI 10.1093/jxb/ern333; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lasseur B, 2009, PLANT PHYSIOL, V149, P327, DOI 10.1104/pp.108.125559; Le Roy K, 2008, NEW PHYTOL, V178, P572, DOI 10.1111/j.1469-8137.2008.02386.x; Le Roy K, 2007, PLANT PHYSIOL, V145, P616, DOI 10.1104/pp.107.105049; Le Roy K, 2007, NEW PHYTOL, V176, P317, DOI 10.1111/j.1469-8137.2007.02174.x; Lindblom-Ylanne S, 2000, EUR J PSYCHOL EDUC, V15, P19, DOI 10.1007/BF03173164; Maiorano AE, 2008, BIOTECHNOL LETT, V30, P1867, DOI 10.1007/s10529-008-9793-3; Martinez-Fleites C, 2005, BIOCHEM J, V390, P19, DOI 10.1042/BJ20050324; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; Meng G, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-16; Meng GY, 2003, NAT STRUCT BIOL, V10, P935, DOI 10.1038/nsb974; Nagem RAP, 2004, J MOL BIOL, V344, P471, DOI 10.1016/j.jmb.2004.09.024; Nishizawa K., 2001, Food Science and Technology Research, V7, P39, DOI 10.3136/fstr.7.39; OKUYAMA K, 1993, B CHEM SOC JPN, V66, P374, DOI 10.1246/bcsj.66.374; Ortiz-Soto ME, 2008, PROTEIN ENG DES SEL, V21, P589, DOI 10.1093/protein/gzn036; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pons T, 2004, PROTEINS, V54, P424, DOI 10.1002/prot.10604; Pool-Zobel BL, 2005, BRIT J NUTR, V93, pS73, DOI 10.1079/BJN20041349; QUIOCHO FA, 1989, PURE APPL CHEM, V61, P1293, DOI 10.1351/pac198961071293; Ritsema T, 2005, PLANT MOL BIOL, V58, P597, DOI 10.1007/s11103-005-6504-5; Ritsema T, 2003, J PLANT PHYSIOL, V160, P811, DOI 10.1078/0176-1617-01029; Ritsema T, 2003, CURR OPIN PLANT BIOL, V6, P223, DOI 10.1016/S1369-5266(03)00034-7; Ritsema T, 2006, PLANT J, V48, P228, DOI 10.1111/j.1365-313X.2006.02862.x; Sangeetha PT, 2005, TRENDS FOOD SCI TECH, V16, P442, DOI 10.1016/j.tifs.2005.05.003; Schroeven L, 2008, NEW PHYTOL, V180, P822, DOI 10.1111/j.1469-8137.2008.02603.x; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Valluru R, 2008, J EXP BOT, V59, P2905, DOI 10.1093/jxb/ern164; Van den Ende W, 2009, FEBS J, V276, P5788, DOI 10.1111/j.1742-4658.2009.07316.x; Vasella A, 2002, CURR OPIN CHEM BIOL, V6, P619, DOI 10.1016/S1367-5931(02)00380-0; Vereyken IJ, 2003, BIOPHYS J, V84, P3147, DOI 10.1016/S0006-3495(03)70039-3; Verhaest M, 2005, PLANT J, V41, P400, DOI 10.1111/j.1365-313X.2004.02304.x; Verhaest M, 2007, NEW PHYTOL, V174, P90, DOI 10.1111/j.1469-8137.2007.01988.x; Verhaest M, 2006, ACTA CRYSTALLOGR D, V62, P1555, DOI 10.1107/S0907444906044489; Vijn I, 1999, PLANT PHYSIOL, V120, P351, DOI 10.1104/pp.120.2.351; Yun JW, 1996, ENZYME MICROB TECH, V19, P107, DOI 10.1016/0141-0229(95)00188-3; Zolotnitsky G, 2004, P NATL ACAD SCI USA, V101, P11275, DOI 10.1073/pnas.0404311101	57	62	69	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23249	23262		10.1074/jbc.M110.113027	http://dx.doi.org/10.1074/jbc.M110.113027			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20466731	hybrid, Green Published			2022-12-27	WOS:000279999900059
J	Friedrich, MW; Aramuni, G; Mank, M; Mackinnon, JAG; Griesbeck, O				Friedrich, Michael W.; Aramuni, Gayane; Mank, Marco; Mackinnon, Jonathan A. G.; Griesbeck, Oliver			Imaging CREB Activation in Living Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; NMDA RECEPTOR ACTIVATION; AKAP SIGNALING COMPLEXES; BINDING PROTEIN; FLUORESCENT PROTEINS; ANCHORING PROTEIN; SPATIOTEMPORAL DYNAMICS; INDUCED TRANSCRIPTION; SUBCELLULAR DYNAMICS; REGULATED KINASE	The Ca2+- and cAMP-responsive element-binding protein (CREB) and the related ATF-1 and CREM are stimulus-inducible transcription factors that link certain forms of cellular activity to changes in gene expression. They are attributed to complex integrative activation characteristics, but current biochemical technology does not allow dynamic imaging of CREB activation in single cells. Using fluorescence resonance energy transfer between mutants of green fluorescent protein we here develop a signal-optimized genetically encoded indicator that enables imaging activation of CREB due to phosphorylation of the critical serine 133. The indicator of CREB activation due to phosphorylation (ICAP) was used to investigate the role of the scaffold and anchoring protein AKAP79/150 in regulating signal pathways converging on CREB. We show that disruption of AKAP79/150-mediated protein kinase A anchoring or knock-down of AKAP150 dramatically reduces the ability of protein kinase A to activate CREB. In contrast, AKAP79/150 regulation of CREB via L-type channels may only have minor importance. ICAP allows dynamic and reversible imaging in living cells and may become useful in studying molecular components and cell-type specificity of activity-dependent gene expression.	[Friedrich, Michael W.; Aramuni, Gayane; Mank, Marco; Mackinnon, Jonathan A. G.; Griesbeck, Oliver] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany	Max Planck Society	Griesbeck, O (corresponding author), Max Planck Inst Neurobiol, Klopferspitz 18, D-82152 Martinsried, Germany.	griesbeck@neuro.mpg.de		Griesbeck, Oliver/0000-0001-5883-5594	Max Planck Society	Max Planck Society(Max Planck Society)	This work was supported by the Max Planck Society.	Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Bauman AL, 2004, NEUROPHARMACOLOGY, V46, P299, DOI 10.1016/j.neuropharm.2003.09.016; Bhattacharyya S, 2009, NAT NEUROSCI, V12, P172, DOI 10.1038/nn.2249; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; CARR DW, 1992, J BIOL CHEM, V267, P13376; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Conkright MD, 2005, TRENDS CELL BIOL, V15, P457, DOI 10.1016/j.tcb.2005.07.007; Conti AC, 2007, NEUROSCIENCE, V146, P713, DOI 10.1016/j.neuroscience.2007.01.045; Dell'Acqua ML, 2006, EUR J CELL BIOL, V85, P627, DOI 10.1016/j.ejcb.2006.01.010; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Dunn TA, 2006, J NEUROSCI, V26, P12807, DOI 10.1523/JNEUROSCI.3238-06.2006; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Gervasi N, 2007, J NEUROSCI, V27, P2744, DOI 10.1523/JNEUROSCI.5352-06.2007; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; Gomez LL, 2002, J NEUROSCI, V22, P7027; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; Green Harry M., 2005, BMC Chemical Biology, V5, P1, DOI 10.1186/1472-6769-5-1; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Griesbeck O, 2004, CURR OPIN NEUROBIOL, V14, P636, DOI 10.1016/j.conb.2004.08.002; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Harada A, 2002, J CELL BIOL, V158, P541, DOI 10.1083/jcb.200110134; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Harvey CD, 2008, P NATL ACAD SCI USA, V105, P19264, DOI 10.1073/pnas.0804598105; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Lee B, 2005, J NEUROSCI, V25, P1137, DOI 10.1523/JNEUROSCI.4288-04.2005; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Li HM, 2004, J MOL BIOL, V342, P1659, DOI 10.1016/j.jmb.2004.07.068; Liu FC, 1996, NEURON, V17, P1133, DOI 10.1016/S0896-6273(00)80245-7; Liu FC, 1998, P NATL ACAD SCI USA, V95, P4708, DOI 10.1073/pnas.95.8.4708; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mank M, 2006, BIOPHYS J, V90, P1790, DOI 10.1529/biophysj.105.073536; Marie H, 2005, NEURON, V45, P741, DOI 10.1016/j.neuron.2005.01.039; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mayr BM, 2001, P NATL ACAD SCI USA, V98, P10936, DOI 10.1073/pnas.191152098; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Miyawaki A, 2005, NEURON, V48, P189, DOI 10.1016/j.neuron.2005.10.003; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Newman RH, 2008, MOL BIOSYST, V4, P496, DOI 10.1039/b720034j; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; Pizzorusso T, 2000, J NEUROSCI, V20, P2809; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Robertson HR, 2009, J NEUROSCI, V29, P7929, DOI 10.1523/JNEUROSCI.6093-08.2009; Sato M, 2007, ANAL CHEM, V79, P2570, DOI 10.1021/ac062171d; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Smith KE, 2006, J NEUROSCI, V26, P2391, DOI 10.1523/JNEUROSCI.3092-05.2006; Spotts JM, 2002, P NATL ACAD SCI USA, V99, P15142, DOI 10.1073/pnas.232565699; Takao K, 2005, J NEUROSCI, V25, P3107, DOI 10.1523/JNEUROSCI.0085-05.2005; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Ting AY, 2001, P NATL ACAD SCI USA, V98, P15003, DOI 10.1073/pnas.211564598; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; VanEngelenburg SB, 2008, CURR OPIN CHEM BIOL, V12, P60, DOI 10.1016/j.cbpa.2008.01.020; Wang HB, 2002, J NEUROCHEM, V83, P946, DOI 10.1046/j.1471-4159.2002.01206.x; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Yasuda R, 2006, CURR OPIN NEUROBIOL, V16, P551, DOI 10.1016/j.conb.2006.08.012; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798; Zhong HN, 2009, NEURON, V62, P363, DOI 10.1016/j.neuron.2009.03.013	72	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23283	23293		10.1074/jbc.M110.124545	http://dx.doi.org/10.1074/jbc.M110.124545			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20484048	Green Published, hybrid			2022-12-27	WOS:000279999900062
J	Fujimura, T; Esteban, R				Fujimura, Tsutomu; Esteban, Rosa			Yeast Double-stranded RNA Virus L-A Deliberately Synthesizes RNA Transcripts with 5 '-Diphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC MESSENGER-RNA; POL FUSION PROTEIN; SACCHAROMYCES-CEREVISIAE; CAPPING ENZYME; CRITICAL RESIDUES; ANTIVIRAL SYSTEM; CAP STRUCTURE; COAT PROTEIN; MOSAIC-VIRUS; VIRAL-RNA	L-A is a persistent double-stranded RNA virus commonly found in the yeast Saccharomyces cerevisiae. Isolated L-A virus synthesizes positive strand transcripts in vitro. We found that the 5' termini of the transcripts are diphosphorylated. The 5'-terminal nucleotide is G, and GDP was the best substrate among those examined to prime the reaction. When GTP was used, the triphosphate of GTP incorporated into the 5'-end was converted to diphosphate. This activity was not dependent on host CTL1 RNA triphosphatase. The 5'-end of the GMP-primed transcript also was converted to diphosphate, the beta-phosphate of which was derived from the beta-phosphate of ATP present in the polymerization reaction. These results demonstrate that L-A virus commands elaborate enzymatic systems to ensure its transcript to be 5'-diphosphorylated. Transcripts of M1, a satellite RNA of L-A virus, also had diphosphate at the 5' termini. Because viral transcripts are released from the virion into the cytoplasm to be translated and encapsidated into a new viral particle, a stage most vulnerable to degradation in the virus replication cycle, our results suggest that the 5'-diphosphate status is important for transcript stability. Consistent with this, L-A transcripts made in vitro are resistant to the affinity-purified Ski1p 5'-exonuclease. We also discuss the implication of these findings on translation of viral RNA. Because the viral transcript has no conventional 5'-cap structure, this work may shed light on the metabolism of non-self-RNA in yeast.	[Fujimura, Tsutomu; Esteban, Rosa] Univ Salamanca, CSIC, Inst Microbiol Bioquim, Dept Genet & Microbiol, Salamanca 37007, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Fujimura, T (corresponding author), Univ Salamanca, CSIC, Inst Microbiol Bioquim, Dept Genet & Microbiol, Avda Campo Charro S-N, Salamanca 37007, Spain.	tfujimura@usal.es	Fujimura, Tsutomu/K-5807-2014; Esteban, Rosa/K-4356-2014	Fujimura, Tsutomu/0000-0002-9457-6769; Esteban, Rosa/0000-0001-6804-7209	Spanish Ministry of Education and Science [BFU2007-60057]	Spanish Ministry of Education and Science(Spanish Government)	This work was supported by Grant BFU2007-60057 from the Spanish Ministry of Education and Science.	Ahola T, 1997, J VIROL, V71, P392, DOI 10.1128/JVI.71.1.392-397.1997; Ahola T, 1999, J VIROL, V73, P10061, DOI 10.1128/JVI.73.12.10061-10069.1999; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; BARBONE FP, 1992, J VIROL, V187, P333; BLANC A, 1994, MOL CELL BIOL, V14, P2664, DOI 10.1128/MCB.14.4.2664; BLANC A, 1992, MOL CELL BIOL, V12, P3390, DOI 10.1128/MCB.12.8.3390; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUENN J, 1976, NUCLEIC ACIDS RES, V3, P2427, DOI 10.1093/nar/3.10.2427; Caston JR, 1997, J CELL BIOL, V138, P975, DOI 10.1083/jcb.138.5.975; Cheng CP, 2006, J VIROL, V80, P2631, DOI 10.1128/JVI.80.6.2631-2640.2006; CHENG RH, 1994, J MOL BIOL, V244, P255, DOI 10.1006/jmbi.1994.1726; DENTE L, 1985, DNA CLONING PRACTICA, V1, P101; DINMAN JD, 1991, P NATL ACAD SCI USA, V88, P174, DOI 10.1073/pnas.88.1.174; ESTEBAN R, 1988, P NATL ACAD SCI USA, V85, P4411, DOI 10.1073/pnas.85.12.4411; Esteban R, 2008, J BIOL CHEM, V283, P25812, DOI 10.1074/jbc.M804400200; FUJIMURA T, 1992, J BIOL CHEM, V267, P2708; FUJIMURA T, 1992, NATURE, V359, P746, DOI 10.1038/359746a0; FUJIMURA T, 1988, CELL, V55, P663, DOI 10.1016/0092-8674(88)90225-5; FUJIMURA T, 1990, CELL, V62, P819, DOI 10.1016/0092-8674(90)90125-X; FUJIMURA T, 1986, P NATL ACAD SCI USA, V83, P4433, DOI 10.1073/pnas.83.12.4433; Furuichi Y, 2000, ADV VIRUS RES, V55, P135, DOI 10.1016/S0065-3527(00)55003-9; GEORGOPOULOS DE, 1987, YEAST, V3, P117, DOI 10.1002/yea.320030208; Huang YL, 2004, J VIROL, V78, P1271, DOI 10.1128/JVI.78.3.1271-1280.2004; ICHO T, 1989, J BIOL CHEM, V264, P6716; Koonin EV, 2010, P NATL ACAD SCI USA, V107, P3283, DOI 10.1073/pnas.0915061107; MASISON DC, 1995, MOL CELL BIOL, V15, P2763; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; NEMEROFF ME, 1987, J BIOL CHEM, V262, P6785; Ogino T, 2010, P NATL ACAD SCI USA, V107, P3463, DOI 10.1073/pnas.0913083107; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Pellegrini O, 2008, METHOD ENZYMOL, V448, P167, DOI 10.1016/S0076-6879(08)02609-8; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; RIDLEY SP, 1984, MOL CELL BIOL, V4, P761, DOI 10.1128/MCB.4.4.761; Rodriguez CR, 1999, NUCLEIC ACIDS RES, V27, P2181, DOI 10.1093/nar/27.10.2181; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Searfoss AW, 2000, P NATL ACAD SCI USA, V97, P9133, DOI 10.1073/pnas.97.16.9133; Shuman S, 2001, PROG NUCLEIC ACID RE, V66, P1; Stevens A, 2001, METHOD ENZYMOL, V342, P251, DOI 10.1016/S0076-6879(01)42549-3; TIPPER DJ, 1984, MICROBIOL REV, V48, P125, DOI 10.1128/MMBR.48.2.125-156.1984; TOHE A, 1978, J BACTERIOL, V136, P1002, DOI 10.1128/JB.136.3.1002-1007.1978; Wickner R.B., 2007, FIELDS VIROLOGY, P737; WICKNER RB, 1980, CELL, V21, P217, DOI 10.1016/0092-8674(80)90129-4; WIDNER WR, 1993, MOL CELL BIOL, V13, P4331, DOI 10.1128/MCB.13.7.4331; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025	45	16	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22909	22916		10.1074/jbc.M110.138982	http://dx.doi.org/10.1074/jbc.M110.138982			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20511225	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000279999900024
J	Idevall-Hagren, O; Barg, S; Gylfe, E; Tengholm, A				Idevall-Hagren, Olof; Barg, Sebastian; Gylfe, Erik; Tengholm, Anders			cAMP Mediators of Pulsatile Insulin Secretion from Glucose-stimulated Single beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; CYCLIC-AMP; PANCREATIC-ISLETS; CYTOPLASMIC CA2+; EXOCYTOSIS; OSCILLATIONS; ATP; PHOSPHORYLATION; ACTIVATION; PATHWAYS	Pulsatile insulin release from glucose-stimulated beta-cells is driven by oscillations of the Ca2+ and cAMP concentrations in the subplasma membrane space ([Ca2+](pm) and [cAMP](pm)). To clarify mechanisms by which cAMP regulates insulin secretion, we performed parallel evanescent wave fluorescence imaging of [cAMP](pm), [Ca2+](pm), and phosphatidylinositol 3,4,5-trisphosphate (PIP3) in the plasma membrane. This lipid is formed by autocrine insulin receptor activation and was used to monitor insulin release kinetics from single MIN6 beta-cells. Elevation of the glucose concentration from 3 to 11 mM induced, after a 2.7-min delay, coordinated oscillations of [Ca2+](pm), [cAMP](pm), and PIP3. Inhibitors of protein kinase A (PKA) markedly diminished the PIP3 response when applied before glucose stimulation, but did not affect already manifested PIP3 oscillations. The reduced PIP3 response could be attributed to accelerated depolarization causing early rise of [Ca2+](pm) that preceded the elevation of [cAMP](pm). However, the amplitude of the PIP3 response after PKA inhibition was restored by a specific agonist to the cAMP-dependent guanine nucleotide exchange factor Epac. Suppression of cAMP formation with adenylyl cyclase inhibitors reduced already established PIP3 oscillations in glucose-stimulated cells, and this effect was almost completely counteracted by the Epac agonist. In cells treated with small interfering RNA targeting Epac2, the amplitudes of the glucose-induced PIP3 oscillations were reduced, and the Epac agonist was without effect. The data indicate that temporal coordination of the triggering [Ca2+](pm) and amplifying [cAMP](pm) signals is important for glucose-induced pulsatile insulin release. Although both PKA and Epac2 partake in initiating insulin secretion, the cAMP dependence of established pulsatility is mediated by Epac2.	[Idevall-Hagren, Olof; Barg, Sebastian; Gylfe, Erik; Tengholm, Anders] Uppsala Univ, Biomed Ctr, Dept Med Cell Biol, SE-75123 Uppsala, Sweden	Uppsala University	Tengholm, A (corresponding author), Uppsala Univ, Biomed Ctr, Dept Med Cell Biol, Box 571, SE-75123 Uppsala, Sweden.	anders.tengholm@mcb.uu.se	Barg, Sebastian/F-9523-2010	Barg, Sebastian/0000-0003-4661-5724; Idevall Hagren, Olof/0000-0002-0241-6304; Gylfe, Erik/0000-0002-8414-2107	Ake Wiberg Foundation; European Foundation for the Study of Diabetes/MSD; Family Ernfors Foundation; Harald and Greta Jeanssons Foundations; Magnus Bergvall Foundation; Novo Nordisk Foundation; Swedish Diabetes Association; Swedish Research Council [32X-14643, 32BI-15333, 32P-15439, 12X-6240]	Ake Wiberg Foundation; European Foundation for the Study of Diabetes/MSD; Family Ernfors Foundation; Harald and Greta Jeanssons Foundations; Magnus Bergvall Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Diabetes Association; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by grants from the Ake Wiberg Foundation, the European Foundation for the Study of Diabetes/MSD, the Family Ernfors Foundation, Harald and Greta Jeanssons Foundations, the Magnus Bergvall Foundation, Novo Nordisk Foundation, the Swedish Diabetes Association, and the Swedish Research Council Grants 32X-14643, 32BI-15333, 32P-15439, and 12X-6240.	Beguin P, 1999, EMBO J, V18, P4722, DOI 10.1093/emboj/18.17.4722; BERGSTEN P, 1994, J BIOL CHEM, V269, P8749; Bratanova-Tochkova TK, 2002, DIABETES, V51, pS83, DOI 10.2337/diabetes.51.2007.S83; CHARLES MA, 1973, SCIENCE, V179, P569, DOI 10.1126/science.179.4073.569; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Dyachok O, 2008, CELL METAB, V8, P26, DOI 10.1016/j.cmet.2008.06.003; Eliasson L, 2003, J GEN PHYSIOL, V121, P181, DOI 10.1085/jgp.20028707; Eliasson L, 1997, J PHYSIOL-LONDON, V503, P399, DOI 10.1111/j.1469-7793.1997.399bh.x; Frech M, 1997, J BIOL CHEM, V272, P8474, DOI 10.1074/jbc.272.13.8474; Fujimoto K, 2002, J BIOL CHEM, V277, P50497, DOI 10.1074/jbc.M210146200; Furman B, 2004, J PHARM PHARMACOL, V56, P1477, DOI 10.1211/0022357044805; GILON P, 1993, J BIOL CHEM, V268, P22265; GRAPENGIESSER E, 1988, BIOCHEM BIOPH RES CO, V151, P1299, DOI 10.1016/S0006-291X(88)80503-5; GRILL V, 1973, FEBS LETT, V33, P311, DOI 10.1016/0014-5793(73)80218-2; Gromada J, 2004, BASIC CLIN PHARMACOL, V95, P252, DOI 10.1111/j.1742-7843.2004.t01-1-pto950502.x; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Harris TE, 1997, BIOCHEM BIOPH RES CO, V232, P648, DOI 10.1006/bbrc.1997.6344; Hatakeyama H, 2006, J PHYSIOL-LONDON, V570, P271, DOI 10.1113/jphysiol.2005.096560; Hatakeyama H, 2007, J PHYSIOL-LONDON, V582, P1087, DOI 10.1113/jphysiol.2007.135228; HELLMAN B, 1974, P NATL ACAD SCI USA, V71, P3405, DOI 10.1073/pnas.71.9.3405; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; HOSKER JP, 1989, METABOLISM, V38, P767, DOI 10.1016/0026-0495(89)90064-4; Idevall-Hagren O, 2006, J BIOL CHEM, V281, P39121; Jones PM, 1998, ENDOCR REV, V19, P429, DOI 10.1210/er.19.4.429; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; Kwan EP, 2007, PANCREAS, V35, pE45, DOI 10.1097/mpa.0b013e318073d1c9; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; LANG DA, 1981, DIABETES, V30, P435, DOI 10.2337/diabetes.30.5.435; Leech CA, 2000, BIOCHEM BIOPH RES CO, V278, P44; Lester LB, 2001, ENDOCRINOLOGY, V142, P1218, DOI 10.1210/en.142.3.1218; Lin YF, 2000, EMBO J, V19, P942, DOI 10.1093/emboj/19.5.942; Michael DJ, 2007, DIABETES, V56, P1277, DOI 10.2337/db06-0367; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Olofsson CS, 2002, PFLUG ARCH EUR J PHY, V444, P43, DOI 10.1007/s00424-002-0781-5; PERSAUD SJ, 1990, BIOCHEM BIOPH RES CO, V173, P833, DOI 10.1016/S0006-291X(05)80862-9; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; Qian WJ, 2004, BIOTECHNIQUES, V37, P922, DOI 10.2144/04376BI01; Renstrom E, 1997, J PHYSIOL-LONDON, V502, P105, DOI 10.1111/j.1469-7793.1997.105bl.x; Rorsman P, 2000, NEWS PHYSIOL SCI, V15, P72; SCHUIT FC, 1985, ENDOCRINOLOGY, V117, P834, DOI 10.1210/endo-117-3-834; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Shibasaki T, 2004, J BIOL CHEM, V279, P7956, DOI 10.1074/jbc.M309068200; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Takahashi N, 1999, P NATL ACAD SCI USA, V96, P760, DOI 10.1073/pnas.96.2.760; Tengholm A, 2009, MOL CELL ENDOCRINOL, V297, P58, DOI 10.1016/j.mce.2008.07.009; Vikman J, 2009, AM J PHYSIOL-ENDOC M, V297, pE452, DOI 10.1152/ajpendo.90585.2008	47	58	60	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23005	23016		10.1074/jbc.M109.095992	http://dx.doi.org/10.1074/jbc.M109.095992			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20498366	Green Published, hybrid			2022-12-27	WOS:000279999900035
J	Kunkel, MT; Newton, AC				Kunkel, Maya T.; Newton, Alexandra C.			Calcium Transduces Plasma Membrane Receptor Signals to Produce Diacylglycerol at Golgi Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; ENCODED FLUORESCENT REPORTER; TRANSPORT; RECRUITMENT; TGN	Protein kinase C and protein kinase D are potently activated by agonist-evoked increases in diacylglycerol. Using live cell-imaging probes for kinase activity, we have shown that both kinases are robustly activated at the Golgi following stimulation of Gq-coupled receptor signaling pathways, displaying activation signatures at the Golgi that are distinct from those at the plasma membrane. Here we report that Ca2+ is the mediator that allows signals received at the plasma membrane to activate these two protein kinases at the Golgi. Specifically, using fluorescence resonance energy transfer-based reporters to image diacylglycerol production, we show that Ca2+ is necessary and sufficient to elevate diacylglycerol levels at the Golgi. First, raising intracellular Ca2+ by treating cells with thapsigargin induces diacylglycerol production at the Golgi. Second, chelation of intracellular Ca2+ prevents UTP-stimulated increases in diacylglycerol at the Golgi. Thus, agonist-evoked increases in intracellular Ca2+ cause increases in Golgi diacylglycerol, allowing this intracellular membrane to serve as a platform for signaling by protein kinases C and D.	[Kunkel, Maya T.; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Newton, AC (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	anewton@ucsd.edu			National Institutes of Health [GM43154, P01 DK54441]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043154, R01GM043154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM43154 and P01 DK54441 (to A.C.N.).	Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Bossard C, 2007, J CELL BIOL, V179, P1123, DOI 10.1083/jcb.200703166; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Fernandez-Ulibarri I, 2007, MOL BIOL CELL, V18, P3250, DOI 10.1091/mbc.E07-04-0334; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Ghanekar Y, 2005, TRENDS CELL BIOL, V15, P511, DOI 10.1016/j.tcb.2005.08.001; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Kunkel MT, 2007, J BIOL CHEM, V282, P6733, DOI 10.1074/jbc.M608086200; Kunkel MT, 2005, J BIOL CHEM, V280, P5581, DOI 10.1074/jbc.M411534200; Liu JW, 1997, J CELL BIOL, V137, P1525, DOI 10.1083/jcb.137.7.1525; Maeda Y, 2001, EMBO J, V20, P5982, DOI 10.1093/emboj/20.21.5982; PAGANO RE, 1988, TRENDS BIOCHEM SCI, V13, P202, DOI 10.1016/0968-0004(88)90082-5; Toker A, 2005, EMBO REP, V6, P310, DOI 10.1038/sj.embor.7400378; van Meer G, 1998, TRENDS CELL BIOL, V8, P29, DOI 10.1016/S0962-8924(97)01196-3; Villani M, 2008, BIOCHEM J, V414, P31, DOI 10.1042/BJ20071240; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Yang CF, 2003, TRENDS PHARMACOL SCI, V24, P602, DOI 10.1016/j.tips.2003.09.003	18	30	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22746	22750		10.1074/jbc.C110.123133	http://dx.doi.org/10.1074/jbc.C110.123133			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20519514	Green Published, hybrid			2022-12-27	WOS:000279999900005
J	Meng, H; Zhang, XJ; Lee, SJ; Strickland, DK; Lawrence, DA; Wang, MM				Meng, He; Zhang, Xiaojie; Lee, Soo Jung; Strickland, Dudley K.; Lawrence, Daniel A.; Wang, Michael M.			Low Density Lipoprotein Receptor-related Protein-1 (LRP1) Regulates Thrombospondin-2 (TSP2) Enhancement of Notch3 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND ENDOCYTOSIS; PLASMINOGEN-ACTIVATOR; DELTA-ENDOCYTOSIS; CELL-MIGRATION; DISULFIDE BOND; DROSOPHILA; CLEAVAGE; PATHWAY; BINDING; DISSOCIATION	Intracellular trafficking of Notch and Notch ligands modulates signaling, suggesting that choreography of ligand and receptor translocation is essential for optimal Notch activity. Indeed, a major model for Notch signaling posits that Notch trans-endocytosis into the ligand-expressing (signal sending) cell is a key driving force for Notch signal transduction. The extracellular protein thrombospondin-2 (TSP2) enhances Notch signaling and binds to both Jagged1 and Notch3 ectodomains, potentially bridging two essential extracellular components of Notch signaling. We investigated the role of low density lipoprotein receptor-related protein-1 (LRP1), a TSP2 receptor, in the regulation of Notch3 signaling. TSP2 potentiation of Notch is blocked by the receptor-associated protein (an inhibitor of low density lipoprotein receptor-related protein function) and requires LRP1 expression in the signal-sending cell. TSP2 stimulates Notch3 endocytosis into wild type fibroblasts but not LRP1-deficient fibroblasts. Finally, recombinant Notch3 and Jagged1 interact with the LRP1 85-kDa B-chain, a subunit that lacks known ligand binding function. Our data suggest that LRP1 and TSP2 stimulate Notch activity by driving trans-endocytosis of the Notch ectodomain into the signal-sending cell and demonstrate a novel, non-cell autonomous function of LRP1 in cell-cell signaling.	[Meng, He; Zhang, Xiaojie; Lee, Soo Jung; Wang, Michael M.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Lawrence, Daniel A.] Univ Michigan, Dept Cardiol, Ann Arbor, MI 48109 USA; [Wang, Michael M.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Strickland, Dudley K.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University System of Maryland; University of Maryland Baltimore	Wang, MM (corresponding author), 7629 Med Sci Bldg 2,Box 5622,1137 Catherine St, Ann Arbor, MI 48109 USA.	micwang@umich.edu		Lawrence, Daniel/0000-0003-3126-1935	National Institutes of Health [NS054724, NS052681, PO1 HL54710, HL50784, HL55374, HL089407]; American Heart Association [0726004Z]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL089407, R01HL050784, P01HL054710, R01HL055374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS052681, K02NS054724] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS054724 (to M. M. W.), NS052681 (to M. M. W.), PO1 HL54710 (to D. K. S. and D. A. L.), HL50784 (to D. K. S.), HL55374 (to D. A. L.), and HL089407 (to D. A. L.). This work was also supported by American Heart Association Fellowship 0726004Z (to H.M.).	Baron M, 2002, MOL MEMBR BIOL, V19, P27, DOI 10.1080/09687680110112929; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Chitnis A, 2006, DEV DYNAM, V235, P886, DOI 10.1002/dvdy.20683; Christensen L, 1996, INT J CANCER, V66, P441; Gaultier A, 2008, J CLIN INVEST, V118, P161, DOI 10.1172/JCI32371; Hagedorn EJ, 2006, J CELL BIOL, V173, P443, DOI 10.1083/jcb.200602054; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; HOGG PJ, 1993, J BIOL CHEM, V268, P7139; Klueg KM, 1999, J CELL SCI, V112, P3289; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Li YH, 2003, FEBS LETT, V555, P346, DOI 10.1016/S0014-5793(03)01272-9; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Lutz C, 2002, J BIOL CHEM, V277, P43143, DOI 10.1074/jbc.M204426200; Meng H, 2009, J BIOL CHEM, V284, P7866, DOI 10.1074/jbc.M803650200; Miyamoto A, 2006, J BIOL CHEM, V281, P10089, DOI 10.1074/jbc.M600298200; Morel V, 2003, DEV GENES EVOL, V213, P65, DOI 10.1007/s00427-003-0296-x; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nichols JT, 2007, TRAFFIC, V8, P959, DOI 10.1111/j.1600-0854.2007.00592.x; Nichols JT, 2007, J CELL BIOL, V176, P445, DOI 10.1083/jcb.200609014; Orr AW, 2003, J CELL SCI, V116, P2917, DOI 10.1242/jcs.00600; Orr AW, 2003, J CELL BIOL, V161, P1179, DOI 10.1083/jcb.200302069; Parks AL, 2000, DEVELOPMENT, V127, P1373; Pimanda JE, 2004, J BIOL CHEM, V279, P21439, DOI 10.1074/jbc.M313560200; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Ranganathan S, 2004, J BIOL CHEM, V279, P40536, DOI 10.1074/jbc.M407592200; Rodrigues RG, 2001, J BIOL CHEM, V276, P27913, DOI 10.1074/jbc.M009518200; Schouwey K, 2007, DEV DYNAM, V236, P282, DOI 10.1002/dvdy.21000; Seugnet L, 1997, DEV BIOL, V192, P585, DOI 10.1006/dbio.1997.8723; SPEZIALE MV, 1991, ARCH BIOCHEM BIOPHYS, V286, P546, DOI 10.1016/0003-9861(91)90077-V; Stefansson S, 1998, J BIOL CHEM, V273, P6358, DOI 10.1074/jbc.273.11.6358; SUN X, 1992, J CELL BIOL, V118, P693, DOI 10.1083/jcb.118.3.693; Takayama Y, 2003, J BIOL CHEM, V278, P22112, DOI 10.1074/jbc.M300894200; TURK JL, 1986, ARCH BIOCHEM BIOPHYS, V245, P446, DOI 10.1016/0003-9861(86)90236-5; Wilkin MB, 2005, MOL MEMBR BIOL, V22, P279, DOI 10.1080/09687860500129778; WILLNOW TE, 1994, J CELL SCI, V107, P719; Yang ZT, 2001, J BIOL CHEM, V276, P8403, DOI 10.1074/jbc.M008925200; Zhang YM, 2007, BIOCHEM BIOPH RES CO, V355, P245, DOI 10.1016/j.bbrc.2007.01.151	40	34	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23045	23053		10.1074/jbc.M110.144634	http://dx.doi.org/10.1074/jbc.M110.144634			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20472562	Green Published, hybrid			2022-12-27	WOS:000279999900039
J	Tegtmeyer, N; Hartig, R; Delahay, RM; Rohde, M; Brandt, S; Conradi, J; Takahashi, S; Smolka, AJ; Sewald, N; Backert, S				Tegtmeyer, Nicole; Hartig, Roland; Delahay, Robin M.; Rohde, Manfred; Brandt, Sabine; Conradi, Jens; Takahashi, Seiichiro; Smolka, Adam J.; Sewald, Norbert; Backert, Steffen			A Small Fibronectin-mimicking Protein from Bacteria Induces Cell Spreading and Focal Adhesion Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; GASTRIC EPITHELIAL-CELLS; PSEUDOTUBERCULOSIS INVASIN PROTEIN; EXTRACELLULAR-MATRIX PROTEINS; IV SECRETION SYSTEMS; HELICOBACTER-PYLORI; CRYSTAL-STRUCTURE; YERSINIA-PSEUDOTUBERCULOSIS; MAMMALIAN-CELLS; TYROSINE PHOSPHORYLATION	Fibronectin, a 250-kDa eukaryotic extracellular matrix protein containing an RGD motif plays crucial roles in cell-cell communication, development, tissue homeostasis, and disease development. The highly complex fibrillar fibronectin meshwork orchestrates the functions of other extracellular matrix proteins, promoting cell adhesion, migration, and intracellular signaling. Here, we demonstrate that CagL, a 26-kDa protein of the gastric pathogen and type I carcinogen Helicobacter pylori, mimics fibronectin in various cellular functions. Like fibronectin, CagL contains a RGD motif and is located on the surface of the bacterial type IV secretion pili as previously shown. CagL binds to the integrin receptor alpha(5)beta(1) and mediates the injection of virulence factors into host target cells. We show that purified CagL alone can directly trigger intracellular signaling pathways upon contact with mammalian cells and can complement the spreading defect of fibronectin(-/-) knock-out cells in vitro. During interaction with various human and mouse cell lines, CagL mimics fibronectin in triggering cell spreading, focal adhesion formation, and activation of several tyrosine kinases in an RGD-dependent manner. Among the activated factors are the nonreceptor tyrosine kinases focal adhesion kinase and Src but also the epidermal growth factor receptor and epidermal growth factor receptor family member Her3/ErbB3. Interestingly, fibronectin activates a similar range of tyrosine kinases but not Her3/ErbB3. These findings suggest that the bacterial protein CagL not only exhibits functional mimicry with fibronectin but is also capable of activating fibronectin-independent signaling events. We thus postulate that CagL may contribute directly to H. pylori pathogenesis by promoting aberrant signaling crosstalk within host cells.	[Backert, Steffen] Natl Univ Ireland Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin 4, Ireland; [Tegtmeyer, Nicole; Brandt, Sabine; Backert, Steffen] Otto Von Guericke Univ, Dept Microbiol, D-39120 Magdeburg, Germany; [Hartig, Roland] Otto Von Guericke Univ, Dept Immunol, D-39120 Magdeburg, Germany; [Delahay, Robin M.] Univ Nottingham, Ctr Biomol Sci, Nottingham NG7 2RD, England; [Rohde, Manfred] Helmholtz Ctr Infect Res, Dept Microbial Pathogenesis, D-38124 Braunschweig, Germany; [Sewald, Norbert] Univ Bielefeld, Dept Chem Organ & Bioorgan Chem, D-33615 Bielefeld, Germany; [Takahashi, Seiichiro] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany; [Smolka, Adam J.] Med Univ S Carolina, Charleston, SC 29425 USA	University College Dublin; Otto von Guericke University; Otto von Guericke University; University of Nottingham; Helmholtz Association; Helmholtz-Center for Infection Research; University of Bielefeld; Max Planck Society; Medical University of South Carolina	Backert, S (corresponding author), Natl Univ Ireland Univ Coll Dublin, Sch Biomol & Biomed Sci, Ardmore House,Belfield Campus, Dublin 4, Ireland.	Steffen.Backert@ucd.ie	Sewald, Norbert/A-2541-2012	Sewald, Norbert/0000-0002-0309-2655; Hartig, Roland/0000-0002-3706-7458; Delahay, Rob/0000-0002-7108-565X	Deutsche Forschungsgemeinschaft [Ba1671/8-1]; University College Dublin [R11408]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University College Dublin	This work was supported by Deutsche Forschungsgemeinschaft Grant Ba1671/8-1 and Research Grant R11408 from University College Dublin (to S. B.).	Aly KA, 2007, MICROBIOL-SGM, V153, P3766, DOI 10.1099/mic.0.2007/010462-0; Amieva MR, 2008, GASTROENTEROLOGY, V134, P306, DOI 10.1053/j.gastro.2007.11.009; AOTA S, 1994, J BIOL CHEM, V269, P24756; Arencibia I, 2002, EUR J IMMUNOL, V32, P1129, DOI 10.1002/1521-4141(200204)32:4<1129::AID-IMMU1129>3.0.CO;2-G; Backert S, 2006, CURR OPIN MICROBIOL, V9, P207, DOI 10.1016/j.mib.2006.02.008; Backert S, 2008, TRENDS MICROBIOL, V16, P409, DOI 10.1016/j.tim.2008.07.001; Bax DV, 2004, J BIOL CHEM, V279, P22377, DOI 10.1074/jbc.M400180200; Bierne H, 2007, MICROBIOL MOL BIOL R, V71, P377, DOI 10.1128/MMBR.00039-06; BOCKHOLT SM, 1993, J BIOL CHEM, V268, P14565; Boyle EC, 2003, CURR OPIN CELL BIOL, V15, P633, DOI 10.1016/S0955-0674(03)00099-1; Brandt S, 2005, P NATL ACAD SCI USA, V102, P9300, DOI 10.1073/pnas.0409873102; Brandt S, 2009, CELL MOTIL CYTOSKEL, V66, P874, DOI 10.1002/cm.20373; Cary LA, 2002, MOL CELL BIOL, V22, P2427, DOI 10.1128/MCB.22.8.2427-2440.2002; Copie V, 1998, J MOL BIOL, V277, P663; Dallas SL, 2006, CURR TOP DEV BIOL, V75, P1, DOI 10.1016/S0070-2153(06)75001-3; Delahay RM, 2008, J MOL BIOL, V377, P956, DOI 10.1016/j.jmb.2008.01.053; Dersch P, 1999, EMBO J, V18, P1199, DOI 10.1093/emboj/18.5.1199; DICKINSON CD, 1994, J MOL BIOL, V236, P1079, DOI 10.1016/0022-2836(94)90013-2; Du YQ, 2007, MICROBES INFECT, V9, P838, DOI 10.1016/j.micinf.2007.03.004; Dubois A, 2007, CELL MICROBIOL, V9, P1108, DOI 10.1111/j.1462-5822.2007.00921.x; Eble J.A., 1997, INTEGRIN LIGAND INTE; Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291; Hauck CR, 2006, EUR J CELL BIOL, V85, P235, DOI 10.1016/j.ejcb.2005.08.002; Humphries MJ, 2004, BIOCHEM SOC T, V32, P822, DOI 10.1042/BST0320822; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Isberg Ralph R., 1994, Trends in Microbiology, V2, P10, DOI 10.1016/0966-842X(94)90338-7; ISBERG RR, 1988, P NATL ACAD SCI USA, V85, P6682, DOI 10.1073/pnas.85.18.6682; ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z; Jimenez-Soto LF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000684; Joh T, 2005, DIGEST DIS SCI, V50, P2081, DOI 10.1007/s10620-005-3011-0; Johansson S, 1997, FRONT BIOSCI, V2, P126; Keates S, 2005, GUT, V54, P1363, DOI 10.1136/gut.2005.066977; Keates S, 2001, J BIOL CHEM, V276, P48127, DOI 10.1074/jbc.M107630200; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kuwada SK, 2000, MOL BIOL CELL, V11, P2485, DOI 10.1091/mbc.11.7.2485; Kwok T, 2002, INFECT IMMUN, V70, P2108, DOI 10.1128/IAI.70.4.2108-2120.2002; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Leiss M, 2008, CURR OPIN CELL BIOL, V20, P502, DOI 10.1016/j.ceb.2008.06.001; LEONG JM, 1990, EMBO J, V9, P1979, DOI 10.1002/j.1460-2075.1990.tb08326.x; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Magnusson MK, 1998, ARTERIOSCL THROM VAS, V18, P1363, DOI 10.1161/01.ATV.18.9.1363; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Matsuo M, 2006, CANCER SCI, V97, P155, DOI 10.1111/j.1349-7006.2006.00152.x; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; NHIEU GTV, 1991, J BIOL CHEM, V266, P24367; Nyberg P, 2004, EMBO J, V23, P2166, DOI 10.1038/sj.emboj.7600214; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Redick SD, 2000, J CELL BIOL, V149, P521, DOI 10.1083/jcb.149.2.521; Rohde M, 2003, MOL MICROBIOL, V49, P219, DOI 10.1046/j.1365-2958.2003.03549.x; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; SAHA A, 2010, GASTROENTER IN PRESS; Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471; Schroder A, 2006, MOL BIOL CELL, V17, P5198, DOI 10.1091/mbc.E06-05-0463; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Sieg DJ, 1999, J CELL SCI, V112, P2677; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Spitzfaden C, 1997, J MOL BIOL, V265, P565, DOI 10.1006/jmbi.1996.0736; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Takahashi S, 2007, J CELL BIOL, V178, P167, DOI 10.1083/jcb.200703021; Tammer I, 2007, GASTROENTEROLOGY, V132, P1309, DOI 10.1053/j.gastro.2007.01.050; Vakonakis L, 2007, CURR OPIN CELL BIOL, V19, P578, DOI 10.1016/j.ceb.2007.09.005; VANNHIEU GT, 1993, EMBO J, V12, P1887, DOI 10.1002/j.1460-2075.1993.tb05837.x; Wallasch C, 2002, BIOCHEM BIOPH RES CO, V295, P695, DOI 10.1016/S0006-291X(02)00740-4; Yan F, 2009, GASTROENTEROLOGY, V136, P1297, DOI 10.1053/j.gastro.2008.12.059; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858	69	87	87	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23513	23524		10.1074/jbc.M109.096214	http://dx.doi.org/10.1074/jbc.M109.096214			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20507990	Green Published, hybrid			2022-12-27	WOS:000279999900083
J	Jacobs, RL; Zhao, Y; Koonen, DPY; Sletten, T; Su, B; Lingrell, S; Cao, GQ; Peake, DA; Kuo, MS; Proctor, SD; Kennedy, BP; Dyck, JRB; Vance, DE				Jacobs, Rene L.; Zhao, Yang; Koonen, Debby P. Y.; Sletten, Torunn; Su, Brian; Lingrell, Susanne; Cao, Guoqing; Peake, David A.; Kuo, Ming-Shang; Proctor, Spencer D.; Kennedy, Brian P.; Dyck, Jason R. B.; Vance, Dennis E.			Impaired de Novo Choline Synthesis Explains Why Phosphatidylethanolamine N-Methyltransferase-deficient Mice Are Protected from Diet-induced Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY LIPOPROTEINS; PLASMA HIGH-DENSITY; PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE-ALPHA; INDUCED INSULIN-RESISTANCE; STEAROYL-COA DESATURASE-1; HEPATIC STEATOSIS; PHOSPHATIDYLCHOLINE SYNTHESIS; TARGETED DELETION; RAT HEPATOCYTES; FATTY LIVER	Phosphatidylcholine (PC) is synthesized from choline via the CDP-choline pathway. Liver cells can also synthesize PC via the sequential methylation of phosphatidylethanolamine, catalyzed by phosphatidylethanolamine N-methyltransferase (PEMT). The current study investigates whether or not hepatic PC biosynthesis is linked to diet-induced obesity. Pemt(+/+) mice fed a high fat diet for 10 weeks increased in body mass by 60% and displayed insulin resistance, whereas Pemt(-/-) mice did not. Compared with Pemt(+/+) mice, Pemt(-/-) mice had increased energy expenditure and maintained normal peripheral insulin sensitivity; however, they developed hepatomegaly and steatosis. In contrast, mice with impaired biosynthesis of PC via the CDP-choline pathway in liver became obese when fed a high fat diet. We, therefore, hypothesized that insufficient choline, rather than decreased hepatic phosphatidylcholine, was responsible for the lack of weight gain in Pemt(-/-) mice despite the presence of 1.3 g of choline/kg high fat diet. Supplementation with an additional 2.7 g of choline (but not betaine)/kg of diet normalized energy metabolism, weight gain, and insulin resistance in high fat diet-fed Pemt(-/-) mice. Furthermore, Pemt(+/+) mice that were fed a choline-deficient diet had increased oxygen consumption, had improved glucose tolerance, and gained less weight. Thus, de novo synthesis of choline via PEMT has a previously unappreciated role in regulating whole body energy metabolism.	[Jacobs, Rene L.; Zhao, Yang; Sletten, Torunn; Su, Brian; Lingrell, Susanne; Proctor, Spencer D.; Vance, Dennis E.] Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada; [Jacobs, Rene L.; Zhao, Yang; Sletten, Torunn; Su, Brian; Lingrell, Susanne; Vance, Dennis E.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada; [Koonen, Debby P. Y.; Dyck, Jason R. B.] Univ Alberta, Cardiovasc Res Ctr, Edmonton, AB T6G 2S2, Canada; [Koonen, Debby P. Y.; Dyck, Jason R. B.] Univ Alberta, Dept Pediat, Edmonton, AB T6G 2S2, Canada; [Cao, Guoqing; Peake, David A.; Kuo, Ming-Shang] Eli Lilly & Co, Lilly Res Labs, Lilly Corp Ctr, Indianapolis, IN 46285 USA; [Jacobs, Rene L.; Proctor, Spencer D.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB T6G 2S2, Canada; [Kennedy, Brian P.] Merck Frosst Ctr Therapeut Res, Dept Biochem Mol Biol, Montreal, PQ H9H 3L1, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; Eli Lilly; University of Alberta; Merck & Company	Vance, DE (corresponding author), Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada.	dennis.vance@ualberta.ca	Proctor, Spencer/F-2774-2012	Dyck, Jason/0000-0002-7045-2884; Proctor, Spencer/0000-0002-7597-5262; Jacobs, Rene/0000-0002-5525-1355	Canadian Institutes for Health Research [MOP 89793, MOP 67053]; Merck Frosst	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Merck Frosst	This work was supported in part by the Canadian Institutes for Health Research (Grants MOP 89793 and MOP 67053) and Merck Frosst.	Abdelmalek MF, 2001, AM J GASTROENTEROL, V96, P2711; Agellon LB, 1999, HEPATOLOGY, V30, P725, DOI 10.1002/hep.510300305; Ahmadian M, 2009, DIABETES, V58, P855, DOI 10.2337/db08-1644; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Bernal-Mizrachi C, 2007, CELL METAB, V5, P91, DOI 10.1016/j.cmet.2006.12.010; BUCHMAN AL, 1995, HEPATOLOGY, V22, P1399, DOI 10.1002/hep.1840220510; Cansev M, 2008, EUR J PHARMACOL, V589, P315, DOI 10.1016/j.ejphar.2008.05.017; Chen YQ, 2008, J BIOL CHEM, V283, P10048, DOI 10.1074/jbc.M708151200; COHEN EL, 1976, SCIENCE, V191, P561, DOI 10.1126/science.1251187; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; da Costa KA, 2006, FASEB J, V20, P1336, DOI 10.1096/fj.06-5734com; Delgado-Reyes CV, 2005, AM J PHYSIOL-REG I, V288, pR182, DOI 10.1152/ajpregu.00406.2004; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; Dobrzyn A, 2005, J BIOL CHEM, V280, P23356, DOI 10.1074/jbc.M502436200; Dyck JRB, 2004, CIRC RES, V94, pE78, DOI 10.1161/01.RES.0000129255.19569.8f; Gautam D, 2006, CELL METAB, V4, P363, DOI 10.1016/j.cmet.2006.09.008; Hartmann J, 2008, NEUROCHEM INT, V52, P972, DOI 10.1016/j.neuint.2007.10.008; Hubbard B, 2006, GASTROENTEROLOGY, V130, P1259, DOI 10.1053/j.gastro.2006.02.012; Ilcol YO, 2003, EUR J BIOCHEM, V270, P991, DOI 10.1046/j.1432-1033.2003.03472.x; Jacobs RL, 2008, J BIOL CHEM, V283, P2147, DOI 10.1074/jbc.M706628200; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; Jacobs RL, 2005, J BIOL CHEM, V280, P28299, DOI 10.1074/jbc.M501971200; Kalaany NY, 2005, CELL METAB, V1, P231, DOI 10.1016/j.cmet.2005.03.001; Karim M, 2003, BBA-MOL CELL BIOL L, V1633, P1, DOI 10.1016/S1388-1981(03)00067-2; Kim SJ, 2008, BIOCHEM BIOPH RES CO, V368, P893, DOI 10.1016/j.bbrc.2008.02.003; Klein J, 1998, NEUROCHEM INT, V32, P479, DOI 10.1016/S0197-0186(97)00127-7; Konstantinova SV, 2008, J NUTR, V138, P914, DOI 10.1093/jn/138.5.914; Koppen A, 1997, J PHARMACOL EXP THER, V282, P1139; KUKSIS A, 1989, ADV CHROMATOGR, V28, P267; Leclercq IA, 2007, LAB INVEST, V87, P56, DOI 10.1038/labinvest.3700489; Li ZQ, 2007, BBA-MOL CELL BIOL L, V1771, P1186, DOI 10.1016/j.bbalip.2007.05.007; Liebisch G, 2004, BBA-MOL CELL BIOL L, V1686, P108, DOI 10.1016/j.bbalip.2004.09.003; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Noga AA, 2003, J BIOL CHEM, V278, P21851, DOI 10.1074/jbc.M301982200; Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; PRITCHARD PH, 1981, BIOCHEM J, V196, P261, DOI 10.1042/bj1960261; Raubenheimer PJ, 2006, DIABETES, V55, P2015, DOI 10.2337/db06-0097; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Rinella ME, 2004, J HEPATOL, V40, P47, DOI 10.1016/j.jhep.2003.09.020; Rizki G, 2006, J LIPID RES, V47, P2280, DOI 10.1194/jlr.M600198-JLR200; Robichaud JC, 2008, J BIOL CHEM, V283, P35496, DOI 10.1074/jbc.M807433200; Schattenberg JRM, 2005, J BIOL CHEM, V280, P9887, DOI 10.1074/jbc.M410310200; Schwahn BC, 2007, ATHEROSCLEROSIS, V195, pE100, DOI 10.1016/j.atherosclerosis.2007.06.030; Song JN, 2005, FASEB J, V19, P1266, DOI 10.1096/fj.04-3580com; Song Z, 2007, AM J PHYSIOL-GASTR L, V293, pG894, DOI 10.1152/ajpgi.00133.2007; Tang W, 1997, J BIOL CHEM, V272, P13146, DOI 10.1074/jbc.272.20.13146; Ueland PM, 2005, CLIN CHEM LAB MED, V43, P1069, DOI 10.1515/CCLM.2005.187; Uno K, 2006, SCIENCE, V312, P1656, DOI 10.1126/science.1126010; Vance DE, 2007, J BIOL CHEM, V282, P33237, DOI 10.1074/jbc.R700028200; Vance DE, 2008, N COMP BIOC, P213, DOI 10.1016/B978-044453219-0.50010-6; Verkade HJ, 2007, J LIPID RES, V48, P2058, DOI 10.1194/jlr.M700278-JLR200; Vetelainen R, 2007, J GASTROEN HEPATOL, V22, P1526, DOI 10.1111/j.1440-1746.2006.04701.x; Walkey CJ, 1997, P NATL ACAD SCI USA, V94, P12880, DOI 10.1073/pnas.94.24.12880; Wunderlich FT, 2008, P NATL ACAD SCI USA, V105, P1297, DOI 10.1073/pnas.0707849104; YAO ZM, 1988, J BIOL CHEM, V263, P2998; Yu XX, 2005, HEPATOLOGY, V42, P362, DOI 10.1002/hep.20783; ZEISEL SH, 1991, FASEB J, V5, P2093, DOI 10.1096/fasebj.5.7.2010061; Zhao Y, 2009, ARTERIOSCL THROM VAS, V29, P1349, DOI 10.1161/ATVBAHA.109.188672	60	137	138	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22403	22413		10.1074/jbc.M110.108514	http://dx.doi.org/10.1074/jbc.M110.108514			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20452975	hybrid, Green Published			2022-12-27	WOS:000279702200053
J	Tando, T; Ishizaka, A; Watanabe, H; Ito, T; Iida, S; Haraguchi, T; Mizutani, T; Izumi, T; Isobe, T; Akiyama, T; Inoue, J; Iba, H				Tando, Toshio; Ishizaka, Aya; Watanabe, Hirotaka; Ito, Taiji; Iida, Shun; Haraguchi, Takeshi; Mizutani, Taketoshi; Izumi, Tomonori; Isobe, Toshiaki; Akiyama, Taishin; Inoue, Jun-ichiro; Iba, Hideo			Requiem Protein Links RelB/p52 and the Brm-type SWI/SNF Complex in a Noncanonical NF-kappa B Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-REMODELING COMPLEX; PANCREATIC-CANCER CELLS; GENE-EXPRESSION; TRANSCRIPTION FACTORS; PROSTATE-CANCER; SNF COMPLEX; ACTIVATION; SUBUNIT; SYSTEM; GROWTH	The SWI/SNF chromatin remodeling complex plays pivotal roles in mammalian transcriptional regulation. In this study, we identify the human requiem protein (REQ/DPF2) as an adaptor molecule that links the NF-kappa B and SWI/SNF chromatin remodeling factor. Through in vitro binding experiments, REQ was found to bind to several SWI/SNF complex subunits and also to the p52 NF-kappa B subunit through its nuclear localization signal containing the N-terminal region. REQ, together with Brm, a catalytic subunit of the SWI/SNF complex, enhances the NF-kappa B dependent transcriptional activation that principally involves the RelB/p52 dimer. Both REQ and Brm were further found to be required for the induction of the endogenous BLC (CXCL13) gene in response to lymphotoxin stimulation, an inducer of the noncanonical NF-kappa B pathway. Upon lymphotoxin treatment, REQ and Brm form a larger complex with RelB/p52 and are recruited to the BLC promoter in a ligand-dependent manner. Moreover, a REQ knockdown efficiently suppresses anchorage-independent growth in several cell lines in which the noncanonical NF-kappa B pathway was constitutively activated. From these results, we conclude that REQ functions as an efficient adaptor protein between the SWI/SNF complex and RelB/p52 and plays important roles in noncanonical NF-kappa B transcriptional activation and its associated oncogenic activity.	[Tando, Toshio; Ishizaka, Aya; Watanabe, Hirotaka; Ito, Taiji; Iida, Shun; Haraguchi, Takeshi; Mizutani, Taketoshi; Iba, Hideo] Univ Tokyo, Dept Microbiol & Immunol, Div Host Parasite Interact, Minato Ku, Tokyo 1088639, Japan; [Akiyama, Taishin; Inoue, Jun-ichiro] Univ Tokyo, Inst Med Sci, Div Cellular & Mol Biol, Minato Ku, Tokyo 1088639, Japan; [Izumi, Tomonori; Isobe, Toshiaki] Univ Tokyo, Div Prote Res, Minato Ku, Tokyo 1088639, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Iba, H (corresponding author), Univ Tokyo, Dept Microbiol & Immunol, Div Host Parasite Interact, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	iba@ims.u-tokyo.ac.jp	Watanabe, Hirotaka/GZA-8002-2022	Ishizaka, Aya/0000-0003-2800-2430	Ministry of Education, Culture, Sports, Science, and Technology of Japan [17016015]; Grants-in-Aid for Scientific Research [21590507, 21390148, 22659094] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research on Priority Areas 17016015 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and in part by the strategic cooperation to control emerging and reemerging infections funded by the Special Coordination Funds for Promoting Science and Technology of the Ministry of Education, Cultures, Sports, Science, and Technology of Japan.	Arai T, 1998, J VIROL, V72, P1115, DOI 10.1128/JVI.72.2.1115-1121.1998; Badenhorst P, 2002, GENE DEV, V16, P3186, DOI 10.1101/gad.1032202; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chestkov AV, 1996, GENOMICS, V36, P174, DOI 10.1006/geno.1996.0440; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eberharter A, 2004, EMBO J, V23, P4029, DOI 10.1038/sj.emboj.7600382; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; GABIG TG, 1994, J BIOL CHEM, V269, P29515; Iba H, 2003, REV MED VIROL, V13, P99, DOI 10.1002/rmv.378; Ito T, 2001, J BIOL CHEM, V276, P2852, DOI 10.1074/jbc.M009633200; Ito T, 2008, BIOCHEM J, V411, P201, DOI 10.1042/BJ20071075; Kayama H, 2008, J BIOL CHEM, V283, P12468, DOI 10.1074/jbc.M709965200; Lange M, 2008, GENE DEV, V22, P2370, DOI 10.1101/gad.471408; LAURENT BC, 1993, GENE DEV, V7, P583, DOI 10.1101/gad.7.4.583; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Lessard L, 2005, BRIT J CANCER, V93, P1019, DOI 10.1038/sj.bjc.6602796; MacKay C, 2009, BIOCHEM BIOPH RES CO, V390, P187, DOI 10.1016/j.bbrc.2009.08.151; Mackay F, 1996, J BIOL CHEM, V271, P24934, DOI 10.1074/jbc.271.40.24934; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; Mizutani T, 2002, J BIOL CHEM, V277, P15859, DOI 10.1074/jbc.M112421200; Mizutani T, 2009, J VIROL, V83, P11569, DOI 10.1128/JVI.00742-09; Muchardt C, 1999, J MOL BIOL, V293, P187, DOI 10.1006/jmbi.1999.2999; Musselman CA, 2009, BIOCHEM J, V423, P179, DOI 10.1042/BJ20090870; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Nishina T, 2009, BIOCHEM BIOPH RES CO, V388, P96, DOI 10.1016/j.bbrc.2009.07.125; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Reisman DN, 2002, ONCOGENE, V21, P1196, DOI 10.1038/sj.onc.1205188; Treand C, 2006, EMBO J, V25, P1690, DOI 10.1038/sj.emboj.7601074; Ui M, 2000, BIOCHEM BIOPH RES CO, V278, P97, DOI 10.1006/bbrc.2000.3777; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Watanabe H, 2006, ONCOGENE, V25, P470, DOI 10.1038/sj.onc.1209068; Wharry CE, 2009, CANCER BIOL THER, V8, P1567, DOI 10.4161/cbt.8.16.8961; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xu Y, 2009, CANCER RES, V69, P3267, DOI 10.1158/0008-5472.CAN-08-4635; Yamamichi N, 2009, EXP CELL RES, V315, P1779, DOI 10.1016/j.yexcr.2009.01.006; Yarnamichi N, 2007, CANCER RES, V67, P10727, DOI 10.1158/0008-5472.CAN-07-2601	40	37	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					21951	21960		10.1074/jbc.M109.087783	http://dx.doi.org/10.1074/jbc.M109.087783			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20460684	hybrid, Green Published			2022-12-27	WOS:000279702200007
J	Herrera, M; Silva, GB; Garvin, JL				Herrera, Marcela; Silva, Guillermo B.; Garvin, Jeffrey L.			Angiotensin II Stimulates Thick Ascending Limb Superoxide Production via Protein Kinase C alpha-dependent NADPH Oxidase Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDULLARY OXIDATIVE STRESS; NAD(P)H OXIDASE; NITRIC-OXIDE; ANTIOXIDANT TREATMENT; NACL ABSORPTION; RENAL MEDULLA; HYPERTENSION; PKC; PRESSURE; KIDNEY	Angiotensin II (Ang II) stimulates thick ascending limb (TAL) O(2)radical anion. production, but the receptor(s) and signaling mechanism(s) involved are unknown. The effect of Ang II on O(2)radical anion is generally attributed to the AT(1) receptor. In some cells, Ang II stimulates protein kinase C (PKC), whose alpha isoform (PKC alpha) can activate NADPH oxidase. We hypothesized that in TALs, Ang II stimulates O(2)radical anion via AT(1) and PKC alpha-dependent NADPH oxidase activation. In rat TALs, 1 nM Ang II stimulated O(2)radical anion from 0.76 +/- 0.17 to 1.97 +/- 0.21 nmol/min/mg (p < 0.001). An AT(1) antagonist blocked the stimulatory effect of Ang II on O(2)radical anion (0.87 +/- 0.25 nmol/min/mg; p < 0.006), whereas an AT(2) antagonist had no effect (2.16 +/- 0.133 nmol/min/mg; p < 0.05 versus vehicle). Apocynin, an NADPH oxidase inhibitor, blocked Ang II-stimulated O(2)radical anion by 90% (p < 0.01). Ang II failed to stimulate O(2)radical anion in TALs from p47(phox-/-) mice (p < 0.02). Monitored by fluorescence resonance energy transfer, Ang II increased PKC activity from 0.02 +/- 0.03 to 0.13 +/- 0.02 arbitrary units (p < 0.03). A general PKC inhibitor, GF109203X, blocked the effect of Ang II on O(2)radical anion (1.47 +/- 0.21 versus 2.72 +/- 0.47 nmol/min/mg with Ang II alone; p < 0.03). A PKC alpha- and beta-selective inhibitor, Go6976, also blocked the stimulatory effect of Ang II on O(2)radical anion (0.59 +/- 0.15 versus 2.05 +/- 0.28 nmol/min/mg with Ang II alone; p < 0.001). To distinguish between PKC alpha and PKC beta, we used tubules expressing dominant-negative PKC alpha or -beta. In control TALs, Ang II stimulated O(2)radical anion by 2.17 +/- 0.44 nmol/min/mg (p < 0.011). In tubules expressing dominant-negative PKC alpha, Ang II failed to stimulate O(2)radical anion (change: -0.30 +/- 0.27 nmol/min/mg). In tubules expressing dominant-negative PKC beta 1, Ang II stimulated O(2)radical anion by 2.08 +/- 0.69 nmol/min/mg (p< 0.002). We conclude that Ang II stimulates TAL O(2)radical anion production via activation of AT1 receptors and PKC alpha-dependent NADPH oxidase.	[Herrera, Marcela; Silva, Guillermo B.; Garvin, Jeffrey L.] Henry Ford Hosp, Hypertens & Vasc Res Div, Dept Internal Med, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital	Herrera, M (corresponding author), Henry Ford Hosp, Hypertens & Vasc Res Div, Dept Internal Med, E&R 7018,2799 W Grand Blvd, Detroit, MI 48202 USA.	mherrer1@hfhs.org			National Institutes of Health [HL-70985, HL-028982]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070985, P01HL028982] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-70985 and HL-028982 (to J.L.G.).	Amlal H, 1998, AM J PHYSIOL-CELL PH, V274, pC1047, DOI 10.1152/ajpcell.1998.274.4.C1047; Aristimuno PC, 1997, AM J PHYSIOL-RENAL, V272, pF624, DOI 10.1152/ajprenal.1997.272.5.F624; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Balla T, 1998, ENDOCR RES, V24, P335, DOI 10.3109/07435809809032613; Costa CA, 2009, AM J HYPERTENS, V22, P1242, DOI 10.1038/ajh.2009.186; Cowley AW, 2008, HYPERTENSION, V52, P777, DOI 10.1161/HYPERTENSIONAHA.107.092858; Evans RG, 2005, CURR OPIN NEPHROL HY, V14, P9, DOI 10.1097/00041552-200501000-00003; Fu YL, 2010, AM J PHYSIOL-REG I, V298, pR707, DOI 10.1152/ajpregu.00762.2009; Herrera M, 2005, AM J PHYSIOL-RENAL, V288, pF58, DOI 10.1152/ajprenal.00209.2004; Herrera M, 2004, AM J PHYSIOL-RENAL, V287, pF231, DOI 10.1152/ajprenal.00413.2003; Herrera M, 2010, J BIOL CHEM, V285, P14932, DOI 10.1074/jbc.M110.109041; Higuchi S, 2007, CLIN SCI, V112, P417, DOI 10.1042/CS20060342; Hong NJ, 2007, AM J PHYSIOL-RENAL, V292, pF993, DOI 10.1152/ajprenal.00383.2006; Hong NJ, 2010, AM J PHYSIOL-RENAL, V298, pF885, DOI 10.1152/ajprenal.00543.2009; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; Inoguchi T, 2003, J AM SOC NEPHROL, V14, pS227, DOI 10.1097/01.ASN.0000077407.90309.65; Jaimes EA, 1998, KIDNEY INT, V54, P775, DOI 10.1046/j.1523-1755.1998.00068.x; Juncos R, 2006, AM J PHYSIOL-REG I, V290, pR79, DOI 10.1152/ajpregu.00447.2005; Juncos R, 2005, AM J PHYSIOL-RENAL, V288, pF982, DOI 10.1152/ajprenal.00348.2004; Kopkan L, 2006, HYPERTENSION, V47, P568, DOI 10.1161/01.HYP.0000200027.34925.93; Li N, 2002, AM J PHYSIOL-RENAL, V282, pF1111, DOI 10.1152/ajprenal.00218.2001; Li NJ, 2005, AM J PHYSIOL-RENAL, V289, pF1048, DOI 10.1152/ajprenal.00416.2004; Liu RS, 2004, KIDNEY INT, V66, P268, DOI 10.1111/j.1523-1755.2004.00727.x; Makino A, 2002, HYPERTENSION, V39, P667, DOI 10.1161/hy0202.103469; Manning RD, 2005, AM J NEPHROL, V25, P311, DOI 10.1159/000086411; Manning RD, 2003, ACTA PHYSIOL SCAND, V179, P243, DOI 10.1046/j.0001-6772.2003.01204.x; Mizuno N, 2009, NEUROSIGNALS, V17, P42, DOI 10.1159/000186689; Mori T, 2003, HYPERTENSION, V42, P588, DOI 10.1161/01.HYP.0000091821.39824.09; Navar LG, 2000, AM J HYPERTENS, V13, p45S, DOI 10.1016/S0895-7061(99)00248-4; Ortiz PA, 2003, HYPERTENSION, V42, P674, DOI 10.1161/01.HYP.0000085561.00001.81; Ortiz PA, 2003, KIDNEY INT, V63, P1141, DOI 10.1046/j.1523-1755.2003.00827.x; Peixoto EBMI, 2009, AM J NEPHROL, V29, P309, DOI 10.1159/000163767; PENG Y, 1995, AM J PHYSIOL-RENAL, V269, pF40, DOI 10.1152/ajprenal.1995.269.1.F40; Seshiah PN, 2002, CIRC RES, V91, P406, DOI 10.1161/01.RES.0000033523.08033.16; Shiose A, 2001, J BIOL CHEM, V276, P1417, DOI 10.1074/jbc.M007597200; Silva GB, 2008, HYPERTENSION, V52, P1091, DOI 10.1161/HYPERTENSIONAHA.108.120212; Silva GB, 2006, HYPERTENSION, V48, P467, DOI 10.1161/01.HYP.0000236646.83354.51; Silva GB, 2010, AM J PHYSIOL-RENAL, V298, pF421, DOI 10.1152/ajprenal.00472.2009; Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097; Taylor NE, 2006, HYPERTENSION, V47, P692, DOI 10.1161/01.HYP.0000203161.02046.8d; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Wilcox CS, 2002, CURR HYPERTENS REP, V4, P160, DOI 10.1007/s11906-002-0041-2; Yang J, 2009, AM J PHYSIOL-RENAL, V297, pF1220, DOI 10.1152/ajprenal.00314.2009; Zhang Z, 2004, AM J PHYSIOL-HEART C, V287, pH773, DOI 10.1152/ajpheart.01135.2003; Zou AP, 2001, HYPERTENSION, V37, P547, DOI 10.1161/01.HYP.37.2.547	45	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21323	21328		10.1074/jbc.M110.109157	http://dx.doi.org/10.1074/jbc.M110.109157			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20448043	hybrid, Green Published			2022-12-27	WOS:000279516100017
J	Aust, S; Brusselbach, F; Putz, S; Hovemann, BT				Aust, Silvia; Bruesselbach, Florian; Puetz, Stefanie; Hovemann, Bernhard T.			Alternative Tasks of Drosophila Tan in Neurotransmitter Recycling Versus Cuticle Sclerotization Disclosed by Kinetic Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOPENICILLIN-N-ACYLTRANSFERASE; ACYL-COENZYME-A; AMINO-ACID SUBSTITUTIONS; PENICILLIUM-CHRYSOGENUM; HISTAMINERGIC PHOTORECEPTOR; MOLECULAR CHARACTERIZATION; PROENZYME CLEAVAGE; ESCHERICHIA-COLI; NERVOUS-SYSTEM; GENE PENDE	Upon a stimulus of light, histamine is released from Drosophila photoreceptor axonal endings. It is taken up into glia where Ebony converts it into beta-alanyl-histamine (carcinine). Carcinine moves into photoreceptor cells and is there cleaved into beta-alanine and histamine by Tan activity. Tan thus provides a key function in the recycling pathway of the neurotransmitter histamine. It is also involved in the process of cuticle formation. There, it cleaves beta-alanyl-dopamine, a major component in cuticle sclerotization. Active Tan enzyme is generated by a self-processing proteolytic cleavage from a pre-protein at a conserved Gly-Cys sequence motif. We confirmed the dependence on the Gly-Cys motif by in vitro mutagenesis. Processing time delays the rise to full Tan activity up to 3 h behind its putative circadian RNA expression in head. To investigate its pleiotropic functions, we have expressed Tan as a His(6) fusion protein in Escherichia coli and have purified it to homogeneity. We found wild type and mutant His(6)-Tan protein co-migrating in size exclusion chromatography with a molecular weight compatible with homodimer formation. We conclude that dimer formation is preceding pre-protein processing. Drosophila tan(1) null mutant analysis revealed that amino acid Arg(217) is absolutely required for processing. Substitution of Met(256) in tan(5), on the contrary, does not affect processing extensively but renders it prone to degradation. This also leads to a strong tan phenotype although His(6)-Tan(5) retains activity. Kinetic parameters of Tan reveal characteristic differences in K-m and k(cat) values of carcinine and beta-alanyl-dopamine cleavage, which conclusively illustrate the divergent tasks met by Tan.	[Aust, Silvia; Bruesselbach, Florian; Puetz, Stefanie; Hovemann, Bernhard T.] Ruhr Univ Bochum, AG Mol Zellbiochem, Fac Chem & Biochem, D-44780 Bochum, Germany	Ruhr University Bochum	Hovemann, BT (corresponding author), NC5-170,Univ Str 150, D-44780 Bochum, Germany.	bernhard.hovemann@rub.de			Deutsche Forschungsgemeinschaft [HO 714/13-2]; International Graduate School of Neuroscience	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Graduate School of Neuroscience	This work was supported by Deutsche Forschungsgemeinschaft Grant HO 714/13-2 (to B. T. H.) and a scholarship of the International Graduate School of Neuroscience (to S. A.).	ALVAREZ E, 1993, EUR J BIOCHEM, V215, P323, DOI 10.1111/j.1432-1033.1993.tb18038.x; ALVAREZ E, 1987, ANTIMICROB AGENTS CH, V31, P1675, DOI 10.1128/AAC.31.11.1675; Barrett AJ, 2001, BIOL CHEM, V382, P727, DOI 10.1515/BC.2001.088; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Bokhove M, 2010, STRUCTURE, V18, P301, DOI 10.1016/j.str.2010.01.005; Borycz J, 2002, J NEUROSCI, V22, P10549; Borycz JA, 2005, J NEUROPHYSIOL, V93, P1611, DOI 10.1152/jn.00894.2004; BURG MG, 1993, EMBO J, V12, P911, DOI 10.1002/j.1460-2075.1993.tb05732.x; FERNANDEZ FJ, 1994, J BACTERIOL, V176, P4941, DOI 10.1128/jb.176.16.4941-4948.1994; Garcia-Estrada C, 2008, FUNGAL GENET BIOL, V45, P1043, DOI 10.1016/j.fgb.2008.03.005; Gavin BA, 2007, PLOS GENET, V3, P2358, DOI 10.1371/journal.pgen.0030206; HEUKESHOVEN J, 1988, ELECTROPHORESIS, V9, P28, DOI 10.1002/elps.1150090106; Hovemann BT, 1998, GENE, V221, P1, DOI 10.1016/S0378-1119(98)00440-5; Keegan KP, 2007, PLOS COMPUT BIOL, V3, P2087, DOI 10.1371/journal.pcbi.0030208; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; McEwen RS, 1918, J EXP ZOOL, V25, P49, DOI 10.1002/jez.1400250103; Michaelis L, 1913, BIOCHEM Z, V49, P333; MORGAN CB, 1925, BIBLIOG GENET, V2, P237; Morgan JR, 1999, J NEUROSCI, V19, P1217; MULLER WH, 1992, BIOCHIM BIOPHYS ACTA, V1116, P210, DOI 10.1016/0304-4165(92)90118-E; Perler FB, 1997, CURR OPIN CHEM BIOL, V1, P292, DOI 10.1016/S1367-5931(97)80065-8; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Richardt A, 2003, J BIOL CHEM, V278, P41160, DOI 10.1074/jbc.M304303200; Richardt A, 2002, J COMP NEUROL, V452, P93, DOI 10.1002/cne.10360; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Stuart AE, 2007, PROG NEUROBIOL, V82, P202, DOI 10.1016/j.pneurobio.2007.03.006; SUGUMARAN M, 1992, ARCH INSECT BIOCHEM, V19, P271, DOI 10.1002/arch.940190406; Suh J, 2007, NEURON, V55, P435, DOI 10.1016/j.neuron.2007.06.038; TOBIN MB, 1990, J BACTERIOL, V172, P5908, DOI 10.1128/jb.172.10.5908-5914.1990; TOBIN MB, 1995, GENE, V162, P29, DOI 10.1016/0378-1119(95)00369-H; TOBIN MB, 1994, FEMS MICROBIOL LETT, V121, P39, DOI 10.1016/0378-1097(94)90143-0; TOBIN MB, 1993, GENE, V132, P199, DOI 10.1016/0378-1119(93)90196-A; True JR, 2005, PLOS GENET, V1, P551, DOI 10.1371/journal.pgen.0010063; True JR, 2003, TRENDS ECOL EVOL, V18, P640, DOI 10.1016/j.tree.2003.09.006; Wagner S, 2007, J COMP NEUROL, V500, P601, DOI 10.1002/cne.21138; WRIGHT TRF, 1987, ADV GENET, V24, P127, DOI 10.1016/s0065-2660(08)60008-5	37	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20740	20747		10.1074/jbc.M110.120170	http://dx.doi.org/10.1074/jbc.M110.120170			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20439462	Green Published, hybrid			2022-12-27	WOS:000279228600038
J	Dange, M; Colman, RF				Dange, Mayura; Colman, Roberta F.			Each Conserved Active Site Tyr in the Three Subunits of Human Isocitrate Dehydrogenase Has a Different Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIG-HEART; ESCHERICHIA-COLI; GAMMA-SUBUNITS; BETA-SUBUNIT; NAD; IDENTIFICATION; RESOLUTION; BINDING; INSIGHTS; COMPLEX	The human NAD-dependent isocitrate dehydrogenase (IDH) is a heterotetrameric mitochondrial enzyme with 2 alpha:1 beta:1 gamma subunit ratio. The three subunits share 40-52% identity in amino acid sequence and each includes a tyrosine in a comparable position: alpha Y126, beta Y137, and gamma Y135. To study the role of the corresponding tyrosines of each of the subunits of human NAD-IDH, the tyrosines were mutated (one subunit at a time) to Ser, Phe, or Glu. Enzymes were expressed with one mutant and two wildtype subunits. The results of characterization of the mutant enzymes suggest that beta Y137 is involved in NAD binding and allosteric activation by ADP. The alpha Y126 is required for catalytic activity and likely acts as a general acid in the reaction. The gamma Y135 is also required for catalytic activity and may be involved in proper folding of the enzyme. The corresponding tyrosines in the three dissimilar subunits of NAD-IDH thus have distinctive functions.	[Dange, Mayura; Colman, Roberta F.] Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA	University of Delaware	Colman, RF (corresponding author), Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA.	rfcolman@udel.edu			National Institutes of Health [HL67774]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL67774.	Bzymek KP, 2007, BIOCHEMISTRY-US, V46, P5391, DOI 10.1021/bi700061t; Ceccarelli C, 2002, J BIOL CHEM, V277, P43454, DOI 10.1074/jbc.M207306200; Cherbavaz DB, 2000, J MOL BIOL, V295, P377, DOI 10.1006/jmbi.1999.3195; COHEN PF, 1972, BIOCHEMISTRY-US, V11, P1501, DOI 10.1021/bi00758a027; EHRLICH RS, 1981, J BIOL CHEM, V256, P1276; EHRLICH RS, 1982, J BIOL CHEM, V257, P4769; EHRLICH RS, 1981, J BIOL CHEM, V256, P560; Hartong DT, 2008, NAT GENET, V40, P1230, DOI 10.1038/ng.223; HUANG YC, 1990, BIOCHEMISTRY-US, V29, P8266, DOI 10.1021/bi00488a010; HURLEY JH, 1993, SCIENCE, V259, P673, DOI 10.1126/science.8430315; Kim TK, 2003, J BIOL CHEM, V278, P49323, DOI 10.1074/jbc.M303781200; Kim YO, 1999, J BIOL CHEM, V274, P36866, DOI 10.1074/jbc.274.52.36866; LEE ME, 1995, BIOCHEMISTRY-US, V34, P378, DOI 10.1021/bi00001a046; RAMACHANDRAN N, 1980, J BIOL CHEM, V255, P8859; RAMACHANDRAN N, 1978, P NATL ACAD SCI USA, V75, P252, DOI 10.1073/pnas.75.1.252; SOUNDAR S, 1993, J BIOL CHEM, V268, P5264; Soundar S, 2003, J BIOL CHEM, V278, P52146, DOI 10.1074/jbc.M306178200; Soundar S, 2006, J BIOL CHEM, V281, P21073, DOI 10.1074/jbc.M602956200; STODDARD BL, 1993, BIOCHEMISTRY-US, V32, P9310, DOI 10.1021/bi00087a008; STODDARD BL, 1993, BIOCHEMISTRY-US, V32, P9317, DOI 10.1021/bi00087a009	20	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20520	20525		10.1074/jbc.M110.115386	http://dx.doi.org/10.1074/jbc.M110.115386			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20435888	Green Published, hybrid			2022-12-27	WOS:000279228600013
J	Cane, DE				Cane, David E.			Programming of Erythromycin Biosynthesis by a Modular Polyketide Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ACYL CARRIER PROTEIN; FATTY-ACID SYNTHASE; BETA-KETOREDUCTASE DOMAINS; 6-DEOXYERYTHRONOLIDE-B SYNTHASE; SACCHAROPOLYSPORA-ERYTHRAEA; CRYSTAL-STRUCTURE; INTERMODULAR COMMUNICATION; MECHANISTIC ANALYSIS; 4-PRO-S HYDRIDE; MOLECULAR-BASIS		Brown Univ, Dept Chem, Providence, RI 02912 USA	Brown University	Cane, DE (corresponding author), Brown Univ, Dept Chem, Providence, RI 02912 USA.	david_cane@brown.edu			National Institutes of Health [GM22172, CA87394]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022172] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM22172 (to D. E. C.) and CA87394 (to C. Khosla).	Alekseyev VY, 2007, PROTEIN SCI, V16, P2093, DOI 10.1110/ps.073011407; Bevitt Debra J., 1993, Biochemical Society Transactions, V21, p30S; BEVITT DJ, 1992, EUR J BIOCHEM, V204, P39, DOI 10.1111/j.1432-1033.1992.tb16603.x; Broadhurst RW, 2003, CHEM BIOL, V10, P723, DOI 10.1016/S1074-5521(03)00156-X; Caffrey P, 2003, CHEMBIOCHEM, V4, P654, DOI 10.1002/cbic.200300581; CAFFREY P, 1992, FEBS LETT, V304, P225, DOI 10.1016/0014-5793(92)80624-P; Castonguay R, 2007, J AM CHEM SOC, V129, P13758, DOI 10.1021/ja0753290; CELMER W D, 1971, Pure and Applied Chemistry, V28, P413, DOI 10.1351/pac197128040413; CELMER WD, 1965, J AM CHEM SOC, V87, P1801, DOI 10.1021/ja01086a038; Chan YA, 2009, NAT PROD REP, V26, P90, DOI 10.1039/b801658p; Chen AY, 2007, CHEM BIOL, V14, P784, DOI 10.1016/j.chembiol.2007.05.015; Chen AY, 2006, J AM CHEM SOC, V128, P3067, DOI 10.1021/ja058093d; CORTES J, 1990, NATURE, V348, P176, DOI 10.1038/348176a0; DONADIO S, 1992, GENE, V111, P51, DOI 10.1016/0378-1119(92)90602-L; DONADIO S, 1993, P NATL ACAD SCI USA, V90, P7119, DOI 10.1073/pnas.90.15.7119; Gokhale RS, 1999, SCIENCE, V284, P482, DOI 10.1126/science.284.5413.482; Hans M, 2003, J AM CHEM SOC, V125, P5366, DOI 10.1021/ja029539i; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; Hopwood DA, 2009, METHOD ENZYMOL, V459, P1; Ikeda H, 1997, CHEM REV, V97, P2591, DOI 10.1021/cr960023p; Joshi AK, 1997, BIOCHEMISTRY-US, V36, P2316, DOI 10.1021/bi9626968; Kallberg Y, 2002, EUR J BIOCHEM, V269, P4409, DOI 10.1046/j.1432-1033.2002.03130.x; Kao CM, 1996, BIOCHEMISTRY-US, V35, P12363, DOI 10.1021/bi9616312; Kao CM, 1998, J AM CHEM SOC, V120, P2478, DOI 10.1021/ja973913a; Katz L, 2009, METHOD ENZYMOL, V459, P113, DOI 10.1016/S0076-6879(09)04606-0; Keatinge-Clay A, 2008, J MOL BIOL, V384, P941, DOI 10.1016/j.jmb.2008.09.084; Keatinge-Clay AT, 2007, CHEM BIOL, V14, P898, DOI 10.1016/j.chembiol.2007.07.009; Keatinge-Clay AT, 2006, STRUCTURE, V14, P737, DOI 10.1016/j.str.2006.01.009; Kellenberger L, 2008, CHEMBIOCHEM, V9, P2740, DOI 10.1002/cbic.200800332; Khosla C, 1999, ANNU REV BIOCHEM, V68, P219, DOI 10.1146/annurev.biochem.68.1.219; Khosla C, 2007, ANNU REV BIOCHEM, V76, P195, DOI 10.1146/annurev.biochem.76.053105.093515; Khosla C, 2009, J ORG CHEM, V74, P6416, DOI 10.1021/jo9012089; Khosla C, 2009, CURR OPIN CHEM BIOL, V13, P135, DOI 10.1016/j.cbpa.2008.12.018; Kim BS, 2004, PROTEIN ENG DES SEL, V17, P277, DOI 10.1093/protein/gzh032; Kim CY, 2004, BIOCHEMISTRY-US, V43, P13892, DOI 10.1021/bi048418n; Kimber MS, 2004, J BIOL CHEM, V279, P52593, DOI 10.1074/jbc.M408105200; Komatsua M, 2010, P NATL ACAD SCI USA, V107, P2646, DOI 10.1073/pnas.0914833107; Kumar P, 2003, J AM CHEM SOC, V125, P4097, DOI 10.1021/ja0297537; Kwan DH, 2008, CHEM BIOL, V15, P1231, DOI 10.1016/j.chembiol.2008.09.012; Lau J, 1999, BIOCHEMISTRY-US, V38, P1643, DOI 10.1021/bi9820311; Leibundgut M, 2007, SCIENCE, V316, P288, DOI 10.1126/science.1138249; Leibundgut M, 2008, CURR OPIN STRUC BIOL, V18, P714, DOI 10.1016/j.sbi.2008.09.008; Liou GF, 2003, BIOCHEMISTRY-US, V42, P200, DOI 10.1021/bi0268100; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; MARSDEN AFA, 1994, SCIENCE, V263, P378, DOI 10.1126/science.8278811; McPherson M, 1998, J AM CHEM SOC, V120, P3267, DOI 10.1021/ja980028z; Meier JL, 2009, CHEM SOC REV, V38, P2012, DOI 10.1039/b805115c; Menzella HG, 2005, NAT BIOTECHNOL, V23, P1171, DOI 10.1038/nbt1128; Ostergaard LH, 2002, BIOCHEMISTRY-US, V41, P2719, DOI 10.1021/bi0117605; Pfeifer BA, 2001, SCIENCE, V291, P1790, DOI 10.1126/science.1058092; Reid R, 2003, BIOCHEMISTRY-US, V42, P72, DOI 10.1021/bi0268706; SEDGWICK B, 1977, EUR J BIOCHEM, V75, P465, DOI 10.1111/j.1432-1033.1977.tb11549.x; SEDGWICK B, 1978, J CHEM SOC CHEM COMM, P193, DOI 10.1039/c39780000193; SEDGWICK B, 1977, EUR J BIOCHEM, V75, P481, DOI 10.1111/j.1432-1033.1977.tb11550.x; Siskos AP, 2005, CHEM BIOL, V12, P1145, DOI 10.1016/j.chembiol.2005.08.017; Starcevic A, 2007, CHEMBIOCHEM, V8, P28, DOI 10.1002/cbic.200600399; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Tang YY, 2006, P NATL ACAD SCI USA, V103, P11124, DOI 10.1073/pnas.0601924103; Tang YY, 2007, CHEM BIOL, V14, P931, DOI 10.1016/j.chembiol.2007.07.012; Tsuji SY, 2001, BIOCHEMISTRY-US, V40, P2326, DOI 10.1021/bi002463n; Valenzano CR, 2009, J AM CHEM SOC, V131, P18501, DOI 10.1021/ja908296m; Van Lanen SG, 2008, CURR OPIN DRUG DISC, V11, P186; von Wettstein-Knowles P, 2006, FEBS J, V273, P695, DOI 10.1111/j.1742-4658.2005.05101.x; Walsh CT, 1997, CURR OPIN CHEM BIOL, V1, P309, DOI 10.1016/S1367-5931(97)80067-1; Weissman KJ, 1997, BIOCHEMISTRY-US, V36, P13849, DOI 10.1021/bi971566b; Witkowski A, 2002, BIOCHEMISTRY-US, V41, P10877, DOI 10.1021/bi0259047; Wu JQ, 2004, BIOCHEMISTRY-US, V43, P16301, DOI 10.1021/bi048147g; Wu N, 2000, J AM CHEM SOC, V122, P4847, DOI 10.1021/ja000023d; Yadav G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000351; Yin YF, 2001, BIOORG MED CHEM LETT, V11, P1477, DOI 10.1016/S0960-894X(00)00529-1	70	50	53	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27517	27523		10.1074/jbc.R110.144618	http://dx.doi.org/10.1074/jbc.R110.144618			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20522551	Green Published, hybrid			2022-12-27	WOS:000281404100005
J	Kosman, DJ				Kosman, Daniel J.			Redox Cycling in Iron Uptake, Efflux, and Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							COPPER-TRANSPORTING ATPASE; WILSON-DISEASE GENE; SACCHAROMYCES-CEREVISIAE; MENKES DISEASE; CHLAMYDOMONAS-REINHARDTII; MULTICOPPER OXIDASE; FERRIC REDUCTASE; CANDIDATE GENE; MOLECULAR CHARACTERIZATION; FERROXIDASE CERULOPLASMIN	Aerobic organisms are faced with a dilemma. Environmental iron is found primarily in the relatively inert Fe(III) form, whereas the more metabolically active ferrous form is a strong pro-oxidant. This conundrum is solved by the redox cycling of iron between Fe(III) and Fe(II) at every step in the iron metabolic pathway. As a transition metal ion, iron can be "metabolized" only by this redox cycling, which is catalyzed in aerobes by the coupled activities of ferric iron reductases (ferrireductases) and ferrous iron oxidases (ferroxidases).	SUNY Buffalo, Dept Biochem, Sch Med & Biomed Sci, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Kosman, DJ (corresponding author), SUNY Buffalo, Dept Biochem, Sch Med & Biomed Sci, Buffalo, NY 14214 USA.	camkos@buffalo.edu			NIDDK, National Institutes of Health [53820, 77826]	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants 53820 and 77826 from NIDDK. This is the first article in the Thematic Minireview Series on Metals in Biology 2010. This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Anderson GJ, 2002, BLOOD CELL MOL DIS, V29, P367, DOI 10.1006/bcmd.2002.0576; ANDERSON GJ, 1994, ADV EXP MED BIOL, V356, P81; ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; AU YPT, 1986, BIOCHIM BIOPHYS ACTA, V883, P242, DOI 10.1016/0304-4165(86)90314-4; BARLOW RM, 1958, P ROY SOC MED, V51, P748, DOI 10.1177/003591575805100914; BENNETTS H. W., 1937, Australian Veterinary Journal, V13, P138, DOI 10.1111/j.1751-0813.1937.tb04108.x; Blank CE, 2010, GEOBIOLOGY, V8, P1, DOI 10.1111/j.1472-4669.2009.00220.x; BODE HP, 1995, EUR J BIOCHEM, V228, P337; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; CHASE MS, 1952, J BIOL CHEM, V199, P757; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; Chen HJ, 2006, J NUTR, V136, P1236, DOI 10.1093/jn/136.5.1236; Chen HJ, 2004, BLOOD, V103, P3933, DOI 10.1182/blood-2003-09-3139; Chen HJ, 2009, J CELL BIOCHEM, V107, P803, DOI 10.1002/jcb.22178; CHIDAMBARAM MV, 1983, FEBS LETT, V159, P137, DOI 10.1016/0014-5793(83)80432-3; Crichton RR, 2001, BIOMETALS, V14, P99, DOI 10.1023/A:1016710810701; CURZON G, 1961, BIOCHEM J, V79, P656, DOI 10.1042/bj0790656; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; DANCIS A, 1992, P NATL ACAD SCI USA, V89, P3869, DOI 10.1073/pnas.89.9.3869; De Domenico I, 2007, EMBO J, V26, P2823, DOI 10.1038/sj.emboj.7601735; DESILVA DM, 1995, J BIOL CHEM, V270, P1098, DOI 10.1074/jbc.270.3.1098; Finegold AA, 1996, J BIOL CHEM, V271, P31021, DOI 10.1074/jbc.271.49.31021; Frazer DM, 2001, AM J PHYSIOL-GASTR L, V281, pG931, DOI 10.1152/ajpgi.2001.281.4.G931; Frieden E, 1974, Adv Exp Med Biol, V48, P235; GAIGER S. H., 1917, Journal of Comparative Pathology and Therapeutics, V30, P185; GUBLER CJ, 1952, BLOOD, V7, P1075, DOI 10.1182/blood.V7.11.1075.1075; Han O, 2007, J CELL BIOCHEM, V101, P1000, DOI 10.1002/jcb.21392; HARRISON PM, 1994, PROGR IRON RES, V356, P1; Hassett RF, 1998, J BIOL CHEM, V273, P23274, DOI 10.1074/jbc.273.36.23274; Herbik A, 2002, PLANT PHYSIOL, V130, P2039, DOI 10.1104/pp.013060; HOLMBERG CG, 1948, ACTA CHEM SCAND, V2, P550, DOI 10.3891/acta.chem.scand.02-0550; Huffman DL, 2001, ANNU REV BIOCHEM, V70, P677, DOI 10.1146/annurev.biochem.70.1.677; Jeong SY, 2003, J BIOL CHEM, V278, P27144, DOI 10.1074/jbc.M301988200; Klomp LWJ, 1997, J BIOL CHEM, V272, P9221, DOI 10.1074/jbc.272.14.9221; Knutson MD, 2007, NUTR REV, V65, P335, DOI 10.1301/nr.2007.jul.335-340; Kono S, 2006, BIOL RES, V39, P15, DOI 10.4067/S0716-97602006000100003; Kosman DJ, 2002, ADV PROTEIN CHEM, V60, P221; Kumar N, 2006, MAYO CLIN PROC, V81, P1371, DOI 10.4065/81.10.1371; Kuo YM, 2004, GUT, V53, P201, DOI 10.1136/gut.2003.019026; Kwok EY, 2006, BIOCHEMISTRY-US, V45, P6317, DOI 10.1021/bi052173c; La Fontaine S, 1998, HUM MOL GENET, V7, P1293, DOI 10.1093/hmg/7.8.1293; La Fontaine S, 2002, EUKARYOT CELL, V1, P736, DOI 10.1128/EC.1.5.736-757.2002; LAHEY ME, 1952, BLOOD, V7, P1053, DOI 10.1182/blood.V7.11.1053.1053; Latunde-Dada GO, 2002, BLOOD CELL MOL DIS, V29, P356, DOI 10.1006/bcmd.2002.0574; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Lin SJ, 1997, J BIOL CHEM, V272, P9215; Lutsenko S, 2002, J BIOENERG BIOMEMBR, V34, P351, DOI 10.1023/A:1021297919034; Mann T, 1938, PROC R SOC SER B-BIO, V126, P303, DOI 10.1098/rspb.1938.0058; MARKOWITZ H, 1955, J CLIN INVEST, V34, P1498, DOI 10.1172/JCI103201; Martins LJ, 1998, J BIOL CHEM, V273, P23716, DOI 10.1074/jbc.273.37.23716; McKie AT, 2001, SCIENCE, V291, P1755, DOI 10.1126/science.1057206; McKie AT, 2002, BIOCHEM SOC T, V30, P722, DOI 10.1042/bst0300722; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; Miyajima H, 2003, NEUROPATHOLOGY, V23, P345, DOI 10.1046/j.1440-1789.2003.00521.x; Miyajima H, 2003, BIOMETALS, V16, P205, DOI 10.1023/A:1020775101654; MIYAJIMA H, 1987, NEUROLOGY, V37, P761, DOI 10.1212/WNL.37.5.761; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Ohgami RS, 2005, BLOOD, V106, P3625, DOI 10.1182/blood-2005-01-0379; OSAKI S, 1969, J BIOL CHEM, V244, P5757; OSAKI S, 1971, J BIOL CHEM, V246, P3018; OSAKI S, 1966, J BIOL CHEM, V241, P5053; OSAKI S, 1966, J BIOL CHEM, V241, P2746; Patel BN, 2000, J BIOL CHEM, V275, P4305, DOI 10.1074/jbc.275.6.4305; Patel BN, 2002, J NEUROSCI, V22, P6578; PETRUKHIN K, 1993, NAT GENET, V5, P338, DOI 10.1038/ng1293-338; RAGUZZI F, 1988, FEBS LETT, V231, P253, DOI 10.1016/0014-5793(88)80742-7; Rasmussen B, 2008, NATURE, V455, P1101, DOI 10.1038/nature07381; Rathore KI, 2008, J NEUROSCI, V28, P12736, DOI 10.1523/JNEUROSCI.3649-08.2008; Rees EM, 2007, J BIOL CHEM, V282, P21629, DOI 10.1074/jbc.M703397200; Sarkar J, 2003, J BIOL CHEM, V278, P44018, DOI 10.1074/jbc.M304926200; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schleper B, 2001, J NEUROL, V248, P705, DOI 10.1007/s004150170118; Shatwell KP, 1996, J BIOL CHEM, V271, P14240, DOI 10.1074/jbc.271.24.14240; Shi XL, 2003, J BIOL CHEM, V278, P50309, DOI 10.1074/jbc.M307019200; Singh A, 2006, J BIOL CHEM, V281, P13355, DOI 10.1074/jbc.M512042200; Singh A, 2007, J BIOL CHEM, V282, P28619, DOI 10.1074/jbc.M703398200; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; Stillman TJ, 2001, J MOL BIOL, V307, P587, DOI 10.1006/jmbi.2001.4475; Stoj C.S., 2006, ENCYCL INORG CHEM, DOI [10.1002/0470862106.ia055, DOI 10.1002/0470862106.IA055]; Sumner JB, 1926, J BIOL CHEM, V69, P435; Syed BA, 2002, PROTEIN ENG, V15, P205, DOI 10.1093/protein/15.3.205; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; Taylor AB, 2005, P NATL ACAD SCI USA, V102, P15459, DOI 10.1073/pnas.0506227102; Terada K, 1998, INT J BIOCHEM CELL B, V30, P1063, DOI 10.1016/S1357-2725(98)00073-9; Terzulli AJ, 2009, J BIOL INORG CHEM, V14, P315, DOI 10.1007/s00775-008-0450-z; Tsivkovskii R, 2002, J BIOL CHEM, V277, P976, DOI 10.1074/jbc.M109368200; Urbanowski JL, 1999, J BIOL CHEM, V274, P38061, DOI 10.1074/jbc.274.53.38061; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; Vulpe CD, 1999, NAT GENET, V21, P195, DOI 10.1038/5979; White C, 2009, J CELL SCI, V122, P1315, DOI 10.1242/jcs.043216; Williams RJP, 2007, J R SOC INTERFACE, V4, P1049, DOI 10.1098/rsif.2007.0225; Yeh KY, 2009, AM J PHYSIOL-GASTR L, V296, pG55, DOI 10.1152/ajpgi.90298.2008; YUAN DS, 1995, P NATL ACAD SCI USA, V92, P2632, DOI 10.1073/pnas.92.7.2632	95	77	81	6	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26729	26735		10.1074/jbc.R110.113217	http://dx.doi.org/10.1074/jbc.R110.113217			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20522542	hybrid, Green Published			2022-12-27	WOS:000281172700002
J	Deacon, K; Knox, AJ				Deacon, Karl; Knox, Alan J.			Endothelin-1 (ET-1) Increases the Expression of Remodeling Genes in Vascular Smooth Muscle through Linked Calcium and cAMP Pathways ROLE OF A PHOSPHOLIPASE A(2)(cPLA(2))/CYCLOOXYGENASE-2 (COX-2)/PROSTACYCLIN RECEPTOR-DEPENDENT AUTOCRINE LOOP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING-PROTEIN; CANCER CELLS; CYCLIC-AMP; IN-VITRO; AMPHIREGULIN EXPRESSION; SIGNAL-TRANSDUCTION; PROSTAGLANDIN E-2; MESSENGER-RNA; UP-REGULATION; NITRIC-OXIDE	Several important genes that are involved in inflammation and tissue remodeling are switched on by virtue of CRE response elements in their promoters. The upstream signaling mechanisms that inflammatory mediators use to activate cAMP response elements (CREs) are poorly understood. Endothelin (ET) is an important vasoactive mediator that plays roles in inflammation, vascular remodeling, angiogenesis, and carcinogenesis by activating 7 transmembrane G protein-coupled receptors (GPCR). Here we characterized the mechanisms ET-1 uses to regulate CRE-dependent remodeling genes in pulmonary vascular smooth muscle cells. These studies revealed activation pathways involving a cyclooxygenase-2 (COX-2)/prostacyclin receptor (IP receptor) autocrine loop and an interlinked calcium-dependent pathway. We found that ET-1 activated several CRE response genes in vascular smooth muscle cells, particularly COX-2, amphiregulin, follistatin, inhibin-beta-A, and CYR61. ET-1 also activated two other genes epiregulin and HB-EGF. Amphiregulin, follistatin, and inhibin-beta-A and epiregulin were activated by an autocrine loop involving cPLA2, arachidonic acid release, COX-2-dependent PGI(2) synthesis, and IP receptor-linked elevation of cAMP leading to CRE transcription activation. In contrast COX-2, CYR61, and HB-EGF transcription were regulated in a calcium-dependent, COX-2 independent, manner. Observations with IP receptor antagonists and COX-2 inhibitors were confirmed with IP receptor or COX-2-specific small interfering RNAs. ET-1 increases in intracellular calcium and gene transcription were dependent upon ETa activation and calcium influx through T type voltage-dependent calcium channels. These studies give important insights into the upstream signaling mechanisms used by G protein-coupled receptor-linked mediators such as ET-1, to activate CRE response genes involved in angiogenesis, vascular remodeling, inflammation, and carcinogenesis.	[Deacon, Karl; Knox, Alan J.] Univ Nottingham, Div Resp Med, Ctr Resp Res, Nottingham NG5 1PB, England	University of Nottingham	Deacon, K (corresponding author), Univ Nottingham, Div Resp Med, Ctr Resp Res, City Hosp Site,Hucknall Rd, Nottingham NG5 1PB, England.	karl.deacon@nottingham.ac.uk		Knox, Alan/0000-0002-5906-4143	British Heart Foundation; Wellcome Trust	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the British Heart Foundation and the Wellcome Trust.	Baba I, 2000, CANCER RES, V60, P6886; Ben-Ami I, 2006, MOL HUM REPROD, V12, P593, DOI 10.1093/molehr/gal068; Bley KR, 2006, BRIT J PHARMACOL, V147, P335, DOI 10.1038/sj.bjp.0706554; BRUNNER F, 1995, AGENT ACTION SUPPL, V45, P269; Castanares C, 2007, J CELL SCI, V120, P1256, DOI 10.1242/jcs.03419; Chansel D, 2006, FASEB J, V20, P1936, DOI 10.1096/fj.05-5328fje; Coleman R A, 1987, Adv Prostaglandin Thromboxane Leukot Res, V17A, P467; Davis A, 2003, CELL SIGNAL, V15, P597, DOI 10.1016/S0898-6568(02)00148-1; Deacon K, 1997, J BIOL CHEM, V272, P14489, DOI 10.1074/jbc.272.22.14489; DellaFazia MA, 1997, FEBS LETT, V410, P22, DOI 10.1016/S0014-5793(97)00445-6; DORLEANSJUSTE P, 1993, J CARDIOVASC PHARM, V22, pS235, DOI 10.1097/00005344-199322008-00063; Egan CG, 2004, CELL SIGNAL, V16, P1387, DOI 10.1016/j.cellsig.2004.04.008; EGUCHI S, 1993, ENDOCRINOLOGY, V132, P524, DOI 10.1210/en.132.2.524; EHRENREICH H, 1990, J EXP MED, V172, P1741, DOI 10.1084/jem.172.6.1741; Endoh M, 1998, LIFE SCI, V62, P1485, DOI 10.1016/S0024-3205(98)00094-0; Feger GI, 1997, RES EXP MED, V196, P327, DOI 10.1007/s004330050042; Freimann S, 2004, BIOCHEM BIOPH RES CO, V324, P829, DOI 10.1016/j.bbrc.2004.09.129; FUTAKI N, 1994, PROSTAGLANDINS, V47, P55, DOI 10.1016/0090-6980(94)90074-4; GREENWALD JE, 1989, J CLIN INVEST, V83, P1061, DOI 10.1172/JCI113948; HAMROUN D, 1995, J CARDIOVASC PHARM, V26, pS156; Harris RC, 2003, EXP CELL RES, V284, P2, DOI 10.1016/S0014-4827(02)00105-2; HIGASHIYAMA S, 1993, J CELL BIOL, V122, P933, DOI 10.1083/jcb.122.4.933; HISLOP AA, 1995, AM J RESP CELL MOL, V12, P557, DOI 10.1165/ajrcmb.12.5.7742018; Kato M, 2003, BIOCHEM BIOPH RES CO, V301, P1109, DOI 10.1016/S0006-291X(03)00093-7; Kiriyama M, 1997, BRIT J PHARMACOL, V122, P217, DOI 10.1038/sj.bjp.0701367; Kitagawa K, 2007, FEBS J, V274, P3210, DOI 10.1111/j.1742-4658.2007.05890.x; Kumari R, 2006, INT J CANCER, V119, P49, DOI 10.1002/ijc.21802; LUSCHER TF, 1992, J HUM HYPERTENS, V6, pS3; Ma WY, 2005, J NEUROCHEM, V93, P664, DOI 10.1111/j.1471-4159.2005.03050.x; MARKEWITZ BA, 1995, AM J PHYSIOL-LUNG C, V268, pL192, DOI 10.1152/ajplung.1995.268.2.L192; MATSUDA H, 1993, HEART VESSELS, V8, P121, DOI 10.1007/BF01744796; Matsumae H, 2008, ARTERIOSCL THROM VAS, V28, P1077, DOI 10.1161/ATVBAHA.108.162362; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; MEHRKE G, 1994, J PHARMACOL EXP THER, V271, P1483; Moens MJU, 2007, FRONT BIOSCI-LANDMRK, V12, P1814; NISHIMURA J, 1992, BIOCHEM BIOPH RES CO, V188, P719, DOI 10.1016/0006-291X(92)91115-7; OHLSTEIN EH, 1992, EUR J PHARM-MOLEC PH, V225, P347, DOI 10.1016/0922-4106(92)90109-9; Ornskov D, 2007, BIOCHEM BIOPH RES CO, V354, P885, DOI 10.1016/j.bbrc.2007.01.047; Ornskov D, 2006, FEBS J, V273, P5479, DOI 10.1111/j.1742-4658.2006.05539.x; Pang LH, 1998, AM J PHYSIOL-LUNG C, V275, pL322, DOI 10.1152/ajplung.1998.275.2.L322; Pang LH, 1997, AM J PHYSIOL-LUNG C, V273, pL1132, DOI 10.1152/ajplung.1997.273.6.L1132; Rodman DM, 2005, CIRC RES, V96, P864, DOI 10.1161/01.RES.0000163066.07472.ff; Rosethorne EM, 2008, BIOCHEM PHARMACOL, V75, P942, DOI 10.1016/j.bcp.2007.10.015; RUSSELL FD, 1995, J CARDIOVASC PHARM, V26, pS346; Schinelli S, 2001, J NEUROSCI, V21, P8842, DOI 10.1523/JNEUROSCI.21-22-08842.2001; Scott MGH, 1999, BRIT J PHARMACOL, V128, P721, DOI 10.1038/sj.bjp.0702829; Seno K, 2000, J MED CHEM, V43, P1041, DOI 10.1021/jm9905155; SHAREFKIN JB, 1991, J VASC SURG, V14, P1; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; SUGIURA M, 1989, BIOCHEM BIOPH RES CO, V161, P1220, DOI 10.1016/0006-291X(89)91372-7; Sun ZJ, 2008, BRIT J CANCER, V99, P1656, DOI 10.1038/sj.bjc.6604712; SUZUKI T, 1993, BIOCHEM BIOPH RES CO, V191, P823, DOI 10.1006/bbrc.1993.1291; TELEMAQUE S, 1993, EUR J PHARMACOL, V237, P275, DOI 10.1016/0014-2999(93)90279-Q; Tirapelli CR, 2005, BRIT J PHARMACOL, V146, P903, DOI 10.1038/sj.bjp.0706388; Trevisi L, 2002, BIOCHEM PHARMACOL, V64, P425, DOI 10.1016/S0006-2952(02)01066-3; Wang SW, 2005, J ALLERGY CLIN IMMUN, V115, P287, DOI 10.1016/j.jaci.2004.11.037; Weinreb M, 2006, PROSTAG LEUKOTR ESS, V75, P81, DOI 10.1016/j.plefa.2006.06.004; Woods M, 1999, MOL PHARMACOL, V55, P902; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; YU JCM, 1995, J CARDIOVASC PHARM, V26, pS348; Zhang WM, 2003, AM J PHYSIOL-LUNG C, V285, pL680, DOI 10.1152/ajplung.00067.2003	62	36	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					25913	25927		10.1074/jbc.M110.139485	http://dx.doi.org/10.1074/jbc.M110.139485			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20452970	Green Published, hybrid			2022-12-27	WOS:000280921000006
J	Gao, P; Bauvy, C; Souquere, S; Tonelli, G; Liu, L; Zhu, YS; Qiao, ZZ; Bakula, D; Proikas-Cezanne, T; Pierron, G; Codogno, P; Chen, QA; Mehrpour, M				Gao, Ping; Bauvy, Chantal; Souquere, Sylvie; Tonelli, Giovanni; Liu, Lei; Zhu, Yushan; Qiao, Zhenzhen; Bakula, Daniela; Proikas-Cezanne, Tassula; Pierron, Gerard; Codogno, Patrice; Chen, Quan; Mehrpour, Maryam			The Bcl-2 Homology Domain 3 Mimetic Gossypol Induces Both Beclin 1-dependent and Beclin 1-independent Cytoprotective Autophagy in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STARVATION-INDUCED AUTOPHAGY; LEUKEMIA-CELLS; DEATH; APOPTOSIS; SURVIVAL; THERAPY; PROTEIN; INHIBITION; GENE; MACROAUTOPHAGY	Gossypol, a natural Bcl-2 homology domain 3 mimetic compound isolated from cottonseeds, is currently being evaluated in clinical trials. Here, we provide evidence that gossypol induces autophagy followed by apoptotic cell death in both the MCF-7 human breast adenocarcinoma and HeLa cell lines. We first show that knockdown of the Bcl-2 homology domain 3-only protein Beclin 1 reduces gossypol-induced autophagy in MCF-7 cells, but not in HeLa cells. Gossypol inhibits the interaction between Beclin 1 and Bcl-2 (B-cell leukemia/lymphoma 2), antagonizes the inhibition of autophagy by Bcl-2, and hence stimulates autophagy. We then show that knockdown of Vps34 reduces gossypol-induced autophagy in both cell lines, and consistent with this, the phosphatidylinositol 3-phosphate-binding protein WIPI-1 is recruited to autophagosomal membranes. Further, Atg5 knockdown also reduces gossypol-mediated autophagy. We conclude that gossypol induces autophagy in both a canonical and a noncanonical manner. Notably, we found that gossypol-mediated apoptotic cell death was potentiated by treatment with the autophagy inhibitor wortmannin or with small interfering RNA against essential autophagy genes (Vps34, Beclin 1, and Atg5). Our findings support the notion that gossypol-induced autophagy is cytoprotective and not part of the cell death process induced by this compound.	[Gao, Ping; Liu, Lei; Chen, Quan] Chinese Acad Sci, Joint Lab Apoptosis & Canc Biol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100101, Peoples R China; [Souquere, Sylvie; Pierron, Gerard] Inst Andre Lwoff, CNRS UPR, Lab Replicat Acide Desoxyribonucle & Ultrastruct, Villejuif, France; [Bauvy, Chantal; Tonelli, Giovanni; Codogno, Patrice; Mehrpour, Maryam] Univ Paris Sud, INSERM, U984, F-92296 Chatenay Malabry, France; [Bakula, Daniela; Proikas-Cezanne, Tassula; Chen, Quan] Univ Tubingen, Inst Cell Biol, Dept Mol Biol, Autophagy Lab, Tubingen, Germany; [Gao, Ping] Chinese Acad Sci, Grad Sch, Beijing 100049, Peoples R China; [Zhu, Yushan; Qiao, Zhenzhen] Nankai Univ, Coll Life Sci, Tianjin 30007, Peoples R China	Chinese Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Eberhard Karls University of Tubingen; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Nankai University	Chen, QA (corresponding author), Chinese Acad Sci, Lab Apoptosis & Canc Biol, IOZ, Beijing 100101, Peoples R China.	chenq@ioz.ac.cn; mehrpourmaryam@yahoo.fr	Mehrpour, Maryam/D-8640-2017; Codogno, Patrice/G-1384-2013	Codogno, Patrice/0000-0002-5492-3180; Chen, Quan/0000-0001-7539-8728; Bakula, Daniela/0000-0003-4107-1414; Proikas-Cezanne, Prof. Dr. Tassula/0000-0001-6934-132X	CAS; INSERM; PHC-PFCC Programme Francais de Cooperation avec la Chine; Ministry of Science and Technology [2007CB914800, 2009CB512800]; NSFC [30771080]; ARC; Deutsche Forschungsgemeinschaft [SFB 773]; Fondation Franco-Chinoise pour la Science et ses Applications	CAS(Chinese Academy of Sciences); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); PHC-PFCC Programme Francais de Cooperation avec la Chine; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); NSFC(National Natural Science Foundation of China (NSFC)); ARC(Australian Research Council); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fondation Franco-Chinoise pour la Science et ses Applications	This work was supported by CAS, INSERM, PHC-PFCC Programme Francais de Cooperation avec la Chine, the 973 program project from the Ministry of Science and Technology Grants 2007CB914800 and 2009CB512800, NSFC Grant 30771080, ARC, Grant SFB 773 from the Deutsche Forschungsgemeinschaft (to T. P.-C.), and the Fondation Franco-Chinoise pour la Science et ses Applications.	ADLAKHA RC, 1989, CANCER RES, V49, P2052; Alva AS, 2004, CELL DEATH DIFFER, V11, P1046, DOI 10.1038/sj.cdd.4401445; Azmi AS, 2009, J CELL PHYSIOL, V218, P13, DOI 10.1002/jcp.21567; Balakrishnan K, 2008, BLOOD, V112, P1971, DOI 10.1182/blood-2007-12-126946; Balci A, 1999, TOHOKU J EXP MED, V189, P51, DOI 10.1620/tjem.189.51; Bauvy C, 2009, METHOD ENZYMOL, V452, P47, DOI 10.1016/S0076-6879(08)03604-5; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Codogno Patrice, 2005, Journal de la Societe de Biologie, V199, P233, DOI 10.1051/jbio:2005024; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Etxebarria A, 2008, BIOCHEM PHARMACOL, V76, P1563, DOI 10.1016/j.bcp.2008.08.003; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Hoyer-Hansen M, 2008, AUTOPHAGY, V4, P574, DOI 10.4161/auto.5921; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kitada S, 2003, J MED CHEM, V46, P4259, DOI 10.1021/jm030190z; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Lei XB, 2006, FASEB J, V20, P2147, DOI 10.1096/fj.05-5665fje; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Ligueros M, 1997, BRIT J CANCER, V76, P21, DOI 10.1038/bjc.1997.330; Lockshin RA, 2001, NAT REV MOL CELL BIO, V2, P545, DOI 10.1038/35080097; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Luo S, 2007, CELL DEATH DIFFER, V14, P1247, DOI 10.1038/sj.cdd.4402149; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mehrpour M, 2010, AM J PHYSIOL-CELL PH, V298, pC776, DOI 10.1152/ajpcell.00507.2009; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Moon DO, 2008, FEBS LETT, V582, P3367, DOI 10.1016/j.febslet.2008.08.029; Moon DO, 2008, CANCER LETT, V264, P192, DOI 10.1016/j.canlet.2008.01.030; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2006, CANCER RES, V66, P2885, DOI 10.1158/0008-5472.CAN-05-4412; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Pattingre S, 2009, AUTOPHAGY, V5, P558, DOI 10.4161/auto.5.4.8390; Proikas-Cezanne T, 2004, ONCOGENE, V23, P9314, DOI 10.1038/sj.onc.1208331; Proikas-Cezanne T, 2007, FEBS LETT, V581, P3396, DOI 10.1016/j.febslet.2007.06.040; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Scarlatti F, 2008, CELL DEATH DIFFER, V15, P1318, DOI 10.1038/cdd.2008.51; Scarlatti F, 2008, AUTOPHAGY, V4, P1083, DOI 10.4161/auto.7068; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; SMITH DM, 2010, CELL DEATH IN PRESS; Vogler M, 2009, CELL DEATH DIFFER, V16, P1030, DOI 10.1038/cdd.2009.48; Warr MR, 2008, CURR ONCOL, V15, P256; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang MC, 2007, LIFE SCI, V80, P767, DOI 10.1016/j.lfs.2006.11.004; Zhang MC, 2007, CLIN EXP PHARMACOL P, V34, P230, DOI 10.1111/j.1440-1681.2007.04577.x; Zhou X, 2010, P NATL ACAD SCI USA, V107, P9424, DOI 10.1073/pnas.0914725107; Zhu JH, 2007, AM J PATHOL, V170, P75, DOI 10.2353/ajpath.2007.060524	54	100	102	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25570	25581		10.1074/jbc.M110.118125	http://dx.doi.org/10.1074/jbc.M110.118125			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20529838	Green Published, hybrid			2022-12-27	WOS:000280682400051
J	Saam, J; Rosini, E; Molla, G; Schulten, K; Pollegioni, L; Ghisla, S				Saam, Jan; Rosini, Elena; Molla, Gianluca; Schulten, Klaus; Pollegioni, Loredano; Ghisla, Sandro			O-2 Reactivity of Flavoproteins DYNAMIC ACCESS OF DIOXYGEN TO THE ACTIVE SITE AND ROLE OF A H+ RELAY SYSTEM IN D-AMINO ACID OXIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; GLUCOSE-OXIDASE; TRIGONOPSIS-VARIABILIS; SOYBEAN LIPOXYGENASE-1; RHODOTORULA-GRACILIS; CHOLESTEROL OXIDASE; OXYGEN ACTIVATION; C-OXIDASE; PATHWAYS; MECHANISM	Molecular dynamics simulations and implicit ligand sampling methods have identified trajectories and sites of high affinity for O-2 in the protein framework of the flavoprotein D-amino-acid oxidase (DAAO). A specific dynamic channel for the diffusion of O-2 leads from solvent to the flavin Si-side ( amino acid substrate and product bind on the Re-side). Based on this, amino acids that flank the putative O-2 high affinity sites have been exchanged with bulky residues to introduce steric constraints. In G52V DAAO, the valine side chain occupies the site that in wild-type DAAO has the highest O-2 affinity. In this variant, the reactivity of the reduced enzyme with O-2 is decreased >= 100-fold and the turnover number approximate to 1000-fold thus verifying the concept. In addition, the simulations have identified a chain of three water molecules that might serve in relaying a H+ from the product imino acid +NH2+ group bound on the flavin Reside to the developing peroxide on the Si-side. This function would be comparable with that of a similarly located histidine in the flavoprotein glucose oxidase.	[Rosini, Elena; Molla, Gianluca; Pollegioni, Loredano; Ghisla, Sandro] Univ Studi Insubria, Dipartimento Biotecnol & Sci Mol, I-21100 Varese, Italy; Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Rosini, Elena; Molla, Gianluca; Pollegioni, Loredano] Politecn Milan, Ctr Ric Interuniv Biotecnol Proteiche Prot Factor, I-21100 Varese, Italy	University of Insubria; University of Illinois System; University of Illinois Urbana-Champaign; Polytechnic University of Milan	Ghisla, S (corresponding author), Univ Studi Insubria, Dipartimento Biotecnol & Sci Mol, Via JH Dunant 3, I-21100 Varese, Italy.	sandro.ghisla@uni-konstanz.de	Rosini, Elena/H-3474-2012; Schulten, Klaus/D-5561-2009	Rosini, Elena/0000-0001-8384-7992; POLLEGIONI, LOREDANO/0000-0003-1733-7243; Molla, Gianluca/0000-0003-3688-3397	Fondo di Ateneo per la Ricerca; National Institutes of Health [NIH P41-RR005969]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005969] Funding Source: NIH RePORTER	Fondo di Ateneo per la Ricerca; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants from Fondo di Ateneo per la Ricerca (to L. P. and G. M.). and by National Institutes of Health Grant NIH P41-RR005969 (to K. S.).	Baron R, 2009, P NATL ACAD SCI USA, V106, P10603, DOI 10.1073/pnas.0903809106; Binda C, 2003, P NATL ACAD SCI USA, V100, P9750, DOI 10.1073/pnas.1633804100; Cohen J, 2006, BIOPHYS J, V91, P1844, DOI 10.1529/biopbysj.106.085746; Coulombe R, 2001, J BIOL CHEM, V276, P30435, DOI 10.1074/jbc.M104103200; FAVAUDON V, 1977, EUR J BIOCHEM, V78, P293, DOI 10.1111/j.1432-1033.1977.tb11740.x; GIBSON QH, 1964, J BIOL CHEM, V239, P3927; HALL LH, 1987, INT J QUANTUM CHEM, V31, P217, DOI 10.1002/qua.560310204; Hofacker I, 1998, PROTEINS, V30, P100, DOI 10.1002/(SICI)1097-0134(199801)30:1<100::AID-PROT9>3.0.CO;2-S; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johnson BJ, 2007, J BIOL CHEM, V282, P17767, DOI 10.1074/jbc.M701308200; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kawazoe T, 2006, PROTEIN SCI, V15, P2708, DOI 10.1110/ps.062421606; KEMAL C, 1977, J AM CHEM SOC, V99, P7272, DOI 10.1021/ja00464a030; Klinman JP, 2007, ACCOUNTS CHEM RES, V40, P325, DOI 10.1021/ar6000507; Knapp MJ, 2003, BIOCHEMISTRY-US, V42, P11466, DOI 10.1021/bi0300884; Knapp MJ, 2001, J AM CHEM SOC, V123, P2931, DOI 10.1021/ja003855k; LAKOWICZ JR, 1973, BIOCHEMISTRY-US, V12, P4161, DOI 10.1021/bi00745a020; Massey V, 2002, INT CONGR SER, V1233, P3, DOI 10.1016/S0531-5131(02)00519-8; Olson JS, 2007, IUBMB LIFE, V59, P552, DOI 10.1080/15216540701230495; Pollegioni L, 2000, EUR J BIOCHEM, V267, P6624, DOI 10.1046/j.1432-1327.2000.01757.x; Pollegioni L, 2007, CELL MOL LIFE SCI, V64, P1373, DOI 10.1007/s00018-007-6558-4; POLLEGIONI L, 1993, J BIOL CHEM, V268, P13850; PORTER DJT, 1977, J BIOL CHEM, V252, P4464; Rosini E, 2009, FEBS J, V276, P4921, DOI 10.1111/j.1742-4658.2009.07191.x; Roth JP, 2004, J AM CHEM SOC, V126, P15120, DOI 10.1021/ja047050e; Saam J, 2007, P NATL ACAD SCI USA, V104, P13319, DOI 10.1073/pnas.0702401104; Scott EE, 2001, J BIOL CHEM, V276, P5177, DOI 10.1074/jbc.M008282200; Son SY, 2008, P NATL ACAD SCI USA, V105, P5739, DOI 10.1073/pnas.0710626105; Soulimane T, 2000, EMBO J, V19, P1766, DOI 10.1093/emboj/19.8.1766; Srajer V, 2001, BIOCHEMISTRY-US, V40, P13802, DOI 10.1021/bi010715u; Su QJ, 1999, BIOCHEMISTRY-US, V38, P8572, DOI 10.1021/bi990044o; Tilocca A, 2002, BIOCHEMISTRY-US, V41, P14111, DOI 10.1021/bi020309q; Todone F, 1997, BIOCHEMISTRY-US, V36, P5853, DOI 10.1021/bi9630570; Umhau S, 2000, P NATL ACAD SCI USA, V97, P12463, DOI 10.1073/pnas.97.23.12463; Vrielink A, 2009, FEBS J, V276, P6826, DOI 10.1111/j.1742-4658.2009.07377.x; Yorita K, 2000, P NATL ACAD SCI USA, V97, P2480, DOI 10.1073/pnas.040559797; Zhao GH, 2008, BIOCHEMISTRY-US, V47, P9124, DOI 10.1021/bi8008642	37	49	52	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24439	24446		10.1074/jbc.M110.131193	http://dx.doi.org/10.1074/jbc.M110.131193			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20498362	Green Published, hybrid			2022-12-27	WOS:000280542100016
J	Zhou, TF; Zhang, YX; Macchiarulo, A; Yang, ZH; Cellanetti, M; Coto, E; Xu, PY; Pellicciari, R; Wang, L				Zhou, Taofeng; Zhang, Yuxia; Macchiarulo, Antonio; Yang, Zhihong; Cellanetti, Marco; Coto, Eliecer; Xu, Pingyi; Pellicciari, Roberto; Wang, Li			Novel Polymorphisms of Nuclear Receptor SHP Associated with Functional and Structural Changes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL HETERODIMER PARTNER; ESTROGEN-RECEPTOR; ANDROGEN RECEPTOR; LIVER RECEPTOR; BIRTH-WEIGHT; GENE; EXPRESSION; REPRESSION; MIR-127; MIR-433	We identified three heterozygous nonsynonymous single nucleotide polymorphisms in the small heterodimer partner (SHP, NROB2) gene in normal subjects and CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy)-like patients, including two novel missense mutations (p.R38H, p.K170N) and one of the previously reported polymorphism (p.G171A). Four novel heterozygous mutations were also identified in the intron ((Intron)1265T -> A), 3'-untranslated region ((3'-UTR)101C -> G, (3'-UTR)186T -> C), and promoter ((Pro)-423C -> T) of the SHP gene. The exonic R38H and K170N mutants exhibited impaired nuclear translocation. K170N made SHP more susceptible to ubiquitination mediated degradation and blocked SHP acetylation, which displayed lost repressive activity on its interacting partners ERR gamma and HNF4 alpha but not LRH-1. In contrast, G171A increased SHP mRNA and protein expression and maintained normal function. In general, the interaction of SHP mutants with LRH-1 and EID1 was enhanced. K170N also markedly impaired the recruitment of SHP, HNF4 alpha, HDAC1, and HDAC3 to the apoCIII promoter. Molecular dynamics simulations of SHP showed that G171A stabilized the nuclear receptor boxes, whereas K170N promoted the conformational destabilization of all the structural elements of the receptor. This study suggests that genetic variations in SHP are common among human subjects and the Lys-170 residue plays a key role in controllingSHPubiquitination and acetylation associated with SHP protein stability and repressive function.	[Wang, Li] Univ Utah, Sch Med, Dept Med, Huntsman Canc Inst, Salt Lake City, UT 84132 USA; [Wang, Li] Univ Utah, Sch Med, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT 84132 USA; [Zhou, Taofeng; Xu, Pingyi] Sun Yat Sen Univ Med Sci, Affiliated Hosp 1, Guangzhou 510080, Guangdong, Peoples R China; [Macchiarulo, Antonio; Cellanetti, Marco; Pellicciari, Roberto] Univ Perugia, Dipartimento Chim & Tecnol Farmaco, I-06123 Perugia, Italy; [Coto, Eliecer] Univ Oviedo, Hosp Cent Asturias, Oviedo 33006, Spain	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Sun Yat Sen University; University of Perugia; Central University Hospital Asturias; University of Oviedo	Wang, L (corresponding author), 30 North,1900 East,SOM 3C310, Salt Lake City, UT 84132 USA.	l.wang@hsc.utah.edu	Macchiarulo, Antonio/L-2846-2017	Macchiarulo, Antonio/0000-0001-9535-4183	University of Utah School of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080440] Funding Source: NIH RePORTER	University of Utah School of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the sequencing core facility at the University of Utah School of Medicine for support. We are very grateful to the generous plasmid gifts from Drs. Frances Sladek, Collin Clyne, John Chiang, Chiwai Wong, Eckardt Treuter, Akiyoshi Fukamizu, Uwe Borgmeyer, Timothy Osborne, and Jianyuan Luo. We thank the neurologists from Hospital University Central Asturias for contribution to this work. We thank Dr. Viswanath Gunda for help in reading the manuscript.	Bavner A, 2002, EMBO REP, V3, P478, DOI 10.1093/embo-reports/kvf087; Boulias K, 2004, NUCLEIC ACIDS RES, V32, P6096, DOI 10.1093/nar/gkh947; Cao HN, 2002, J HUM GENET, V47, P445, DOI 10.1007/s100380200062; Cui Y, 2004, CANCER RES, V64, P9199, DOI 10.1158/0008-5472.CAN-04-2126; Dawson MI, 2008, J MED CHEM, V51, P5650, DOI 10.1021/jm800456k; Echwald SM, 2004, HUM MUTAT, V24, P381, DOI 10.1002/humu.20090; Enya M, 2008, HUM MUTAT, V29, pE271, DOI 10.1002/humu.20865; Fouillade C, 2008, HUM MUTAT, V29, P452, DOI 10.1002/humu.9527; Fu MF, 2000, J BIOL CHEM, V275, P20853, DOI 10.1074/jbc.M000660200; Gaughan L, 2005, NUCLEIC ACIDS RES, V33, P13, DOI 10.1093/nar/gki141; Gobinet J, 2005, BIOCHEMISTRY-US, V44, P6312, DOI 10.1021/bi047308d; He N, 2008, GASTROENTEROLOGY, V134, P793, DOI 10.1053/j.gastro.2008.01.006; Hentschke M, 2002, BIOCHEM BIOPH RES CO, V299, P872, DOI 10.1016/S0006-291X(02)02753-5; Hirota K, 2008, J BIOL CHEM, V283, P32432, DOI 10.1074/jbc.M806179200; Huang JS, 2007, HEPATOLOGY, V46, P147, DOI 10.1002/hep.21632; Hung CCC, 2003, DIABETES, V52, P1288, DOI 10.2337/diabetes.52.5.1288; Hwang-Verslues WW, 2008, MOL ENDOCRINOL, V22, P78, DOI 10.1210/me.2007-0298; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kemper JK, 2004, MOL CELL BIOL, V24, P7707, DOI 10.1128/MCB.24.17.7707-7719.2004; Lee HK, 1998, J BIOL CHEM, V273, P14398, DOI 10.1074/jbc.273.23.14398; Li K, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012286, 10.1371/journal.pone.0010341]; Li Y, 2005, P NATL ACAD SCI USA, V102, P9505, DOI 10.1073/pnas.0501204102; Macchiarulo A, 2006, J MOL GRAPH MODEL, V24, P362, DOI 10.1016/j.jmgm.2005.09.016; Markward Nathan J, 2007, AMIA Annu Symp Proc, P1041; Matsukuma KE, 2007, J BIOL CHEM, V282, P20164, DOI 10.1074/jbc.M702895200; Miao J, 2009, MOL CELL BIOL, V29, P6170, DOI 10.1128/MCB.00825-09; Miao J, 2009, GENE DEV, V23, P986, DOI 10.1101/gad.1773909; Mitchell SMS, 2003, DIABETES, V52, P1276, DOI 10.2337/diabetes.52.5.1276; Nishigori H, 2001, P NATL ACAD SCI USA, V98, P575, DOI 10.1073/pnas.98.2.575; Ortlund EA, 2005, NAT STRUCT MOL BIOL, V12, P357, DOI 10.1038/nsmb910; Sablin EP, 2008, P NATL ACAD SCI USA, V105, P18390, DOI 10.1073/pnas.0808936105; SCHRODINGER LCC, 2009, MAESTRO; Seol W, 1997, MOL CELL BIOL, V17, P7126, DOI 10.1128/MCB.17.12.7126; Shaw D.E., 2009, DESMOND MOL DYNAMICS; Song GS, 2008, NUCLEIC ACIDS RES, V36, P5727, DOI 10.1093/nar/gkn567; Song GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007829; Song GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006880; Song GS, 2009, J BIOL CHEM, V284, P31921, DOI 10.1074/jbc.M109.046862; Song GS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003574; Wang CG, 2001, J BIOL CHEM, V276, P18375, DOI 10.1074/jbc.M100800200; Wang L, 2005, CELL METAB, V2, P227, DOI 10.1016/j.cmet.2005.08.010; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252; Zhang YX, 2008, HEPATOLOGY, V48, P289, DOI 10.1002/hep.22342; Zhang YX, 2010, MOL CELL BIOL, V30, P1341, DOI 10.1128/MCB.01076-09	44	34	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24871	24881		10.1074/jbc.M110.133280	http://dx.doi.org/10.1074/jbc.M110.133280			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20516075	hybrid, Green Published			2022-12-27	WOS:000280542100060
J	Pradipta, AR; Fujimoto, Y; Hasegawa, M; Inohara, N; Fukase, K				Pradipta, Ambara R.; Fujimoto, Yukari; Hasegawa, Mizuho; Inohara, Naohiro; Fukase, Koichi			Characterization of Natural Human Nucleotide-binding Oligomerization Domain Protein 1 (Nod1) Ligands from Bacterial Culture Supernatant for Elucidation of Immune Modulators in the Environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PEPTIDOGLYCAN FRAGMENTS; HOST RECOGNITION; ASSOCIATION; WALL; POLYMORPHISMS; MOLECULES; SUSCEPTIBILITY; RECEPTORS	Nucleotide-binding oligomerization domain protein 1 (Nod1) is an intracellular protein involved in recognition of the bacterial component peptidoglycan. This recognition event induces a host defense response to eliminate invading pathogens. The genetic variation of Nod1 has been linked to several inflammatory diseases and allergies, which are strongly affected by environmental factors. We have found that many of the bacteria that contain DAP-type peptidoglycan release Nod1 ligands into the environment. However, the structures of natural Nod1 ligands in the environment are not well understood. Herein, we report the isolation and structural elucidation of natural human Nod1 (hNod1) ligands from the Escherichia coli K-12 culture supernatant. The supernatant was fractionated with reversed-phase high performance liquid chromatography (RP-HPLC), resulting in the isolation of several hNod1 stimulatory fractions. Structural characterization studies demonstrated that the molecular structure of the most active fraction was the native hNod1 ligand GlcNAc-(beta 1-4)-(anhydro)MurNAc-L-Ala-gamma-D-Glu-meso-DAP. We also found other peptidoglycan fragments using the 7-(diethylamino)coumarin-3-carbonyl labeling method to enhance sensitivity in mass spectroscopy studies. These results suggested that DAP-containing bacteria release certain hNod1 ligands to the environment, and these ligands would accumulate in the environment and regulate the immune system through Nod1.	[Pradipta, Ambara R.; Fujimoto, Yukari; Fukase, Koichi] Osaka Univ, Dept Chem, Grad Sch Sci, Osaka 5600043, Japan; [Hasegawa, Mizuho; Inohara, Naohiro] Univ Michigan, Dept Pathol, Sch Med, Ann Arbor, MI 48109 USA	Osaka University; University of Michigan System; University of Michigan	Fujimoto, Y (corresponding author), Machikaneyama 1-1, Osaka 5600043, Japan.	yukarif@chem.sci.osaka-u.ac.jp; koichi@chem.sci.osaka-u.ac.jp	Pradipta, Ambara Rachmat/E-8344-2016; Fujimoto, Yukari/M-7282-2014	Pradipta, Ambara Rachmat/0000-0002-9056-447X; Fujimoto, Yukari/0000-0001-5320-3192	Japan Society for the Promotion of Science [17510178, 19310144]; Institute for Fermentation, Osaka (IFO); Osaka University; Naito Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018503] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Institute for Fermentation, Osaka (IFO)(Institute for Fermentation (IFO)); Osaka University; Naito Foundation(Naito Memorial Foundation); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by grants-in-aid for scientific research (17510178 and 19310144) from the Japan Society for the Promotion of Science, the Institute for Fermentation, Osaka (IFO), the Osaka University Global Center of Excellence program (Frontier Biomedical Science Underlying Organelle Network Biology), and the Naito Foundation.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Cloud-Hansen KA, 2006, NAT REV MICROBIOL, V4, P710, DOI 10.1038/nrmicro1486; de Pedro MA, 2001, J BACTERIOL, V183, P4115, DOI 10.1128/JB.183.14.4115-4126.2001; Eder W, 2006, ALLERGY, V61, P1117, DOI 10.1111/j.1398-9995.2006.01128.x; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; GOLDMAN WE, 1982, INFECT IMMUN, V36, P782, DOI 10.1128/IAI.36.2.782-794.1982; Hasegawa M, 2007, J BIOL CHEM, V282, P11757, DOI 10.1074/jbc.M700846200; Hasegawa M, 2006, J BIOL CHEM, V281, P29054, DOI 10.1074/jbc.M602638200; Heidrich C, 2002, J BACTERIOL, V184, P6093, DOI 10.1128/JB.184.22.6093-6099.2002; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hysi P, 2005, HUM MOL GENET, V14, P935, DOI 10.1093/hmg/ddi087; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; JACOBS C, 1994, EMBO J, V13, P4684, DOI 10.1002/j.1460-2075.1994.tb06792.x; Kabesch M, 2003, J ALLERGY CLIN IMMUN, V111, P813, DOI 10.1067/mai.2003.1336; Kawasaki A, 2008, CHEM-EUR J, V14, P10318, DOI 10.1002/chem.200801121; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Magalhaes JG, 2005, EMBO REP, V6, P1201, DOI 10.1038/sj.embor.7400552; McGovern DPB, 2005, HUM MOL GENET, V14, P1245, DOI 10.1093/hmg/ddi135; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Meesters RJW, 2008, J CHROMATOGR B, V875, P444, DOI 10.1016/j.jchromb.2008.09.024; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Sansonetti PJ, 2006, NAT IMMUNOL, V7, P1237, DOI 10.1038/ni1420; Scheurwater EM, 2008, J BIOL CHEM, V283, P8363, DOI 10.1074/jbc.M710135200; Suvorov M, 2008, J AM CHEM SOC, V130, P11878, DOI 10.1021/ja805482b; TAYLOR A, 1975, EUR J BIOCHEM, V53, P47, DOI 10.1111/j.1432-1033.1975.tb04040.x; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Weidinger S, 2005, J ALLERGY CLIN IMMUN, V116, P177, DOI 10.1016/j.jaci.2005.02.034; Weidinger S, 2005, CLIN EXP ALLERGY, V35, P866, DOI 10.1111/j.1365-2222.2005.02269.x; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Yoneyama M, 2008, ADV DRUG DELIVER REV, V60, P841, DOI 10.1016/j.addr.2007.12.001; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x	40	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23607	23613		10.1074/jbc.M110.137893	http://dx.doi.org/10.1074/jbc.M110.137893			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20519512	Green Published, hybrid			2022-12-27	WOS:000280291400010
J	Kim, JY; Henrichs, S; Bailly, A; Vincenzetti, V; Sovero, V; Mancuso, S; Pollmann, S; Kim, D; Geisler, M; Nam, HG				Kim, Jun-Young; Henrichs, Sina; Bailly, Aurelien; Vincenzetti, Vincent; Sovero, Valpuri; Mancuso, Stefano; Pollmann, Stephan; Kim, Daehwang; Geisler, Markus; Nam, Hong-Gil			Identification of an ABCB/P-glycoprotein-specific Inhibitor of Auxin Transport by Chemical Genomics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LATERAL ROOT CAP; ARABIDOPSIS-THALIANA; PLASMA-MEMBRANE; P-GLYCOPROTEINS; PIN PROTEINS; EFFLUX; GRAVITROPISM; GROWTH; ACID; IMMUNOPHILIN	Plant development and physiology are widely determined by the polar transport of the signaling molecule auxin. This process is controlled on the cellular efflux level catalyzed by members of the PIN (pin-formed) and ABCB (ATP-binding cassette protein subfamily B)/P-glycoprotein family that can function independently and coordinately. In this study, we have identified by means of chemical genomics a novel auxin transport inhibitor (ATI), BUM (2-[4-(diethylamino)-2-hydroxybenzoyl] benzoic acid), that efficiently blocks auxin-regulated plant physiology and development. In many respects, BUM resembles the functionality of the diagnostic ATI, 1-N-naphtylphtalamic acid (NPA), but it has an IC50 value that is roughly a factor 30 lower. Physiological analysis and binding assays identified ABCBs, primarily ABCB1, as key targets of BUM and NPA, whereas PIN proteins are apparently not directly affected. BUM is complementary to NPA by having distinct ABCB target spectra and impacts on basipetal polar auxin transport in the shoot and root. In comparison with the recently identified ATI, gravacin, it lacks interference with ABCB membrane trafficking. Individual modes or targets of action compared with NPA are reflected by apically shifted root influx maxima that might be the result of altered BUM binding preferences or affinities to the ABCB nucleotide binding folds. This qualifies BUM as a valuable tool for auxin research, allowing differentiation between ABCB- and PIN-mediated efflux systems. Besides its obvious application as a powerful weed herbicide, BUM is a bona fide human ABCB inhibitor with the potential to restrict multidrug resistance during chemotherapy.	[Henrichs, Sina; Bailly, Aurelien; Vincenzetti, Vincent; Sovero, Valpuri; Geisler, Markus] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Henrichs, Sina; Bailly, Aurelien; Vincenzetti, Vincent; Sovero, Valpuri; Geisler, Markus] Zurich Basel Plant Sci Ctr, CH-8008 Zurich, Switzerland; [Nam, Hong-Gil] Pohang Univ Sci & Technol, Lab Plant Syst Biodynam, Pohang 790784, South Korea; [Mancuso, Stefano] Univ Florence, Dept Hort, I-50019 Sesto Fiorentino, Italy; [Pollmann, Stephan] Ruhr Univ Bochum, Lehrstuhl Pflanzenphysiol, D-44801 Bochum, Germany; [Kim, Daehwang] Korea Res Inst Chem Technol, Biomat Res Ctr, Taejon 305600, South Korea	University of Zurich; Pohang University of Science & Technology (POSTECH); University of Florence; Ruhr University Bochum; Korea Research Institute of Chemical Technology (KRICT)	Geisler, M (corresponding author), Univ Zurich, Inst Plant Biol, Zolliker Str 107, CH-8008 Zurich, Switzerland.	markus.geisler@botinst.uzh.ch; nam@postech.ac.kr	Pollmann, Stephan/ABC-8203-2020; Mancuso, Stefano/G-6515-2012; Geisler, Markus M/B-3921-2012; Pollmann, Stephan/C-2776-2009	Pollmann, Stephan/0000-0002-5111-4425; Mancuso, Stefano/0000-0003-1752-3986; Geisler, Markus M/0000-0002-6641-5810; Pollmann, Stephan/0000-0002-5111-4425	Forschungskredit of the University of Zurich [KN57150702]; Novartis Foundation; Swiss National Funds [NF31-125001]; Korea government (MEST) [2009-0091504]; Crop Functional Genomics Frontier Research Program [CG3132]	Forschungskredit of the University of Zurich; Novartis Foundation(Novartis); Swiss National Funds(Swiss National Science Foundation (SNSF)); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Crop Functional Genomics Frontier Research Program	This work was supported by grants from the Forschungskredit of the University of Zurich (KN57150702, to A. B.), from the Novartis Foundation (to M. G.), from the Swiss National Funds (NF31-125001, to M. G.), from the National Research Foundation of Korea (NRF) funded by the Korea government (MEST) (no. 2009-0091504), and from the Crop Functional Genomics Frontier Research Program (CG3132) (to H.-G.N.).; We thank A. Murphy for gravacin, S. pombe strains, and expression plasmids, E. Martinoia for discussion and support, and the Korean Chemical Bank for the chemical library donation.	Achard P, 2003, PLANT CELL, V15, P2816, DOI 10.1105/tpc.015685; Armstrong JI, 2004, P NATL ACAD SCI USA, V101, P14978, DOI 10.1073/pnas.0404312101; Bailly A, 2008, J BIOL CHEM, V283, P21817, DOI 10.1074/jbc.M709655200; Benjamins R, 2008, ANNU REV PLANT BIOL, V59, P443, DOI 10.1146/annurev.arplant.58.032806.103805; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Bernasconi P, 1996, PLANT PHYSIOL, V111, P427, DOI 10.1104/pp.111.2.427; Bhalerao RP, 2002, PLANT J, V29, P325, DOI 10.1046/j.0960-7412.2001.01217.x; Blakeslee JJ, 2005, CURR OPIN PLANT BIOL, V8, P494, DOI 10.1016/j.pbi.2005.07.014; Blakeslee JJ, 2007, PLANT CELL, V19, P131, DOI 10.1105/tpc.106.040782; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Bouchard R, 2006, J BIOL CHEM, V281, P30603, DOI 10.1074/jbc.M604604200; Casimiro I, 2003, TRENDS PLANT SCI, V8, P165, DOI 10.1016/S1360-1385(03)00051-7; COX DN, 1994, PLANT CELL, V6, P1941, DOI 10.1105/tpc.6.12.1941; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Geisler M, 2006, FEBS LETT, V580, P1094, DOI 10.1016/j.febslet.2005.11.054; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Granzin J, 2006, J MOL BIOL, V364, P799, DOI 10.1016/j.jmb.2006.09.052; Jensen PJ, 1998, PLANT PHYSIOL, V116, P455, DOI 10.1104/pp.116.2.455; KATEKAR GF, 1980, PLANT PHYSIOL, V66, P1190, DOI 10.1104/pp.66.6.1190; Kepinski S, 2005, CURR BIOL, V15, pR208, DOI 10.1016/j.cub.2005.03.012; Lewis DR, 2009, NAT PROTOC, V4, P437, DOI 10.1038/nprot.2009.1; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Lomax Terri L., 1995, P509; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; Luschnig C, 2001, CURR BIOL, V11, pR831, DOI 10.1016/S0960-9822(01)00497-3; Mancuso S, 2005, ANAL BIOCHEM, V341, P344, DOI 10.1016/j.ab.2005.03.054; MICHALKE W, 1992, PLANTA, V187, P254, DOI 10.1007/BF00201948; Morris DA, 2000, PLANT GROWTH REGUL, V32, P161, DOI 10.1023/A:1010701527848; Mravec J, 2008, DEVELOPMENT, V135, P3345, DOI 10.1242/dev.021071; Murphy AS, 2002, PLANT PHYSIOL, V128, P935, DOI 10.1104/pp.010519; Nagashima A, 2008, PLANT CELL PHYSIOL, V49, P1250, DOI 10.1093/pcp/pcn092; Nagashima A, 2008, PLANT J, V53, P516, DOI 10.1111/j.1365-313X.2007.03358.x; Noh B, 2001, PLANT CELL, V13, P2441, DOI 10.1105/tpc.13.11.2441; Norambuena Lorena, 2009, V495, P133, DOI 10.1007/978-1-59745-477-3_12; OKADA K, 1991, PLANT CELL, V3, P677, DOI 10.1105/tpc.3.7.677; Ottenschlager I, 2003, P NATL ACAD SCI USA, V100, P2987, DOI 10.1073/pnas.0437936100; Peer WA, 2004, PLANT CELL, V16, P1898, DOI 10.1105/tpc.021501; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Petrasek J, 2003, PLANT PHYSIOL, V131, P254, DOI 10.1104/pp.012740; Rashotte AM, 2000, PLANT PHYSIOL, V122, P481, DOI 10.1104/pp.122.2.481; Rashotte AM, 2001, PLANT CELL, V13, P1683, DOI 10.1105/tpc.13.7.1683; Robert S, 2008, P NATL ACAD SCI USA, V105, P8464, DOI 10.1073/pnas.0711650105; Rojas-Pierce M, 2007, CHEM BIOL, V14, P1366, DOI 10.1016/j.chembiol.2007.10.014; Santelia D, 2005, FEBS LETT, V579, P5399, DOI 10.1016/j.febslet.2005.08.061; Santelia D, 2008, J BIOL CHEM, V283, P31218, DOI 10.1074/jbc.M710122200; Savaldi-Goldstein S, 2008, P NATL ACAD SCI USA, V105, P15190, DOI 10.1073/pnas.0806324105; Surpin M, 2005, P NATL ACAD SCI USA, V102, P4902, DOI 10.1073/pnas.0500222102; SUSSMAN MR, 1980, PLANT PHYSIOL, V66, P1074, DOI 10.1104/pp.66.6.1074; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Terasaka K, 2005, PLANT CELL, V17, P2922, DOI 10.1105/tpc.105.035816; Titapiwatanakun B, 2009, PLANT J, V57, P27, DOI 10.1111/j.1365-313X.2008.03668.x; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Vieten A, 2007, TRENDS PLANT SCI, V12, P160, DOI 10.1016/j.tplants.2007.03.006; Wu G, 2007, PLANT CELL, V19, P1826, DOI 10.1105/tpc.106.048777; Yang HB, 2009, PLANT J, V59, P179, DOI 10.1111/j.1365-313X.2009.03856.x; Zhao YD, 2003, SCIENCE, V301, P1107, DOI 10.1126/science.1084161	57	89	90	3	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23307	23315		10.1074/jbc.M110.105981	http://dx.doi.org/10.1074/jbc.M110.105981			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20472555	hybrid, Green Published			2022-12-27	WOS:000279999900064
J	Darbellay, B; Arnaudeau, S; Ceroni, D; Bader, CR; Konig, S; Bernheim, L				Darbellay, Basile; Arnaudeau, Serge; Ceroni, Dimitri; Bader, Charles R.; Konig, Stephane; Bernheim, Laurent			Human Muscle Economy Myoblast Differentiation and Excitation-Contraction Coupling Use the Same Molecular Partners, STIM1 and STIM2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CA2+ ENTRY; T-CELL-ACTIVATION; CRAC CHANNEL ACTIVATION; PLASMA-MEMBRANE; SKELETAL-MUSCLE; ENDOPLASMIC-RETICULUM; CALCIUM-CHANNEL; ORAI1 CHANNELS; PORE SUBUNIT; MICE LACKING	Our recent work identified store-operated Ca2+ entry (SOCE) as the critical Ca2+ source required for the induction of human myoblast differentiation (Darbellay, B., Arnaudeau, S., Konig, S., Jousset, H., Bader, C., Demaurex, N., and Bernheim, L. (2009) J. Biol. Chem. 284, 5370-5380). The present work indicates that STIM2 silencing, similar to STIM1 silencing, reduces myoblast SOCE amplitude and differentiation. Because myoblasts in culture can be induced to differentiate into myotubes, which spontaneously contract in culture, we used the same molecular tools to explore whether the Ca2+ mechanism of excitation-contraction coupling also relies on STIM1 and STIM2. Live cell imaging of early differentiating myoblasts revealed a characteristic clustering of activated STIM1 and STIM2 during the first few hours of differentiation. Thapsigargin-induced depletion of endoplasmic reticulum Ca2+ content caused STIM1 and STIM2 redistribution into clusters, and co-localization of both STIM proteins. Interaction of STIM1 and STIM2 was revealed by a rapid increase in fluorescence resonance energy transfer between CFP-STIM1 and YFP-STIM2 after SOCE activation and confirmed by co-immunoprecipitation of endogenous STIM1 and STIM2. Although both STIM proteins clearly contribute to SOCE and are required during the differentiation process, STIM1 and STIM2 are functionally largely redundant as overexpression of either STIM1 or STIM2 corrected most of the impact of STIM2 or STIM1 silencing on SOCE and differentiation. With respect to excitation-contraction, we observed that human myotubes rely also on STIM1 and STIM2 to refill their endoplasmic reticulum Ca2+-content during repeated KCl-induced Ca2+ releases. This indicates that STIM2 is a necessary partner of STIM1 for excitation-contraction coupling. Thus, both STIM proteins are required and interact to control SOCE during human myoblast differentiation and human myotube excitation-contraction coupling.	[Darbellay, Basile; Bader, Charles R.] Univ Hosp Geneva, Dept Clin Neurosci, CH-1211 Geneva 4, Switzerland; [Ceroni, Dimitri] Univ Hosp Geneva, Dept Pediat, CH-1211 Geneva 4, Switzerland; [Arnaudeau, Serge; Konig, Stephane; Bernheim, Laurent] Univ Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva 4, Switzerland	University of Geneva; University of Geneva; University of Geneva	Bernheim, L (corresponding author), 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	laurent.bernheim@unige.ch	Darbellay, Basile/B-1708-2018	Koenig, Stephane/0000-0002-0801-279X	Fonds National Suisse pour la Recherche Scientifique [310030-124910]; Fondation Suisse pour la Recherche sur les Maladies Musculaires; Fondation Hans Wilsdorf; Fondation Marcel Levaillant	Fonds National Suisse pour la Recherche Scientifique; Fondation Suisse pour la Recherche sur les Maladies Musculaires; Fondation Hans Wilsdorf; Fondation Marcel Levaillant	This work was supported by the Fonds National Suisse pour la Recherche Scientifique (Grant 310030-124910 to L. B.), the Fondation Suisse pour la Recherche sur les Maladies Musculaires, the Fondation Hans Wilsdorf, and the Fondation Marcel Levaillant.	Arnaudeau S, 2006, J CELL PHYSIOL, V208, P435, DOI 10.1002/jcp.20679; BAROFFIO A, 1993, MUSCLE NERVE, V16, P498, DOI 10.1002/mus.880160511; Berna-Erro A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000522; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Darbellay B, 2009, J BIOL CHEM, V284, P5370, DOI 10.1074/jbc.M806726200; Derler I, 2009, J BIOL CHEM, V284, P24933, DOI 10.1074/jbc.C109.024083; Dziadek MA, 2007, CELL CALCIUM, V42, P123, DOI 10.1016/j.ceca.2007.02.006; Feske S, 2010, CLIN IMMUNOL, V135, P169, DOI 10.1016/j.clim.2010.01.011; Feske S, 2009, IMMUNOL REV, V231, P189, DOI 10.1111/j.1600-065X.2009.00818.x; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; Hewavitharana T, 2008, J BIOL CHEM, V283, P26252, DOI 10.1074/jbc.M802239200; Hinard V, 2008, DEVELOPMENT, V135, P859, DOI 10.1242/dev.011387; Hogan PG, 2007, TRENDS BIOCHEM SCI, V32, P235, DOI 10.1016/j.tibs.2007.03.009; Jousset H, 2007, J BIOL CHEM, V282, P11456, DOI 10.1074/jbc.M609551200; Knapp JR, 2006, DEVELOPMENT, V133, P601, DOI 10.1242/dev.02249; Konig S, 2004, J BIOL CHEM, V279, P28187, DOI 10.1074/jbc.M313932200; Kurebayashi N, 2001, J PHYSIOL-LONDON, V533, P185, DOI 10.1111/j.1469-7793.2001.0185b.x; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Lioudyno MI, 2008, P NATL ACAD SCI USA, V105, P2011, DOI 10.1073/pnas.0706122105; Lorenzon P, 1997, EUR J NEUROSCI, V9, P800, DOI 10.1111/j.1460-9568.1997.tb01429.x; Louis M, 2008, J CELL SCI, V121, P3951, DOI 10.1242/jcs.037218; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Lyfenko AD, 2008, J PHYSIOL-LONDON, V586, P4815, DOI 10.1113/jphysiol.2008.160481; MacLennan DH, 2000, EUR J BIOCHEM, V267, P5291, DOI 10.1046/j.1432-1327.2000.01566.x; McCarl CA, 2009, J ALLERGY CLIN IMMUN, V124, P1311, DOI 10.1016/j.jaci.2009.10.007; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Pan Z, 2002, NAT CELL BIOL, V4, P379, DOI 10.1038/ncb788; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Parvez S, 2008, FASEB J, V22, P752, DOI 10.1096/fj.07-9449com; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Picard C, 2009, NEW ENGL J MED, V360, P1971, DOI 10.1056/NEJMoa0900082; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Rosenberg P, 2004, P NATL ACAD SCI USA, V101, P9387, DOI 10.1073/pnas.0308179101; Schuhmann MK, 2010, J IMMUNOL, V184, P1536, DOI 10.4049/jimmunol.0902161; Smyth JT, 2009, NAT CELL BIOL, V11, P1465, DOI 10.1038/ncb1995; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Stathopulos PB, 2009, J BIOL CHEM, V284, P728, DOI 10.1074/jbc.C800178200; Stiber JA, 2005, DEV BIOL, V287, P213, DOI 10.1016/j.ydbio.2005.06.030; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Wang YJ, 2009, P NATL ACAD SCI USA, V106, P7391, DOI 10.1073/pnas.0900293106; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zheng L, 2008, BIOCHEM BIOPH RES CO, V369, P240, DOI 10.1016/j.bbrc.2007.12.129; Zhou YD, 2009, J BIOL CHEM, V284, P19164, DOI 10.1074/jbc.C109.010900	54	60	64	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22437	22447		10.1074/jbc.M110.118984	http://dx.doi.org/10.1074/jbc.M110.118984			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20436167	hybrid, Green Published			2022-12-27	WOS:000279702200056
J	Lee, S; Miller, M; Shuman, JD; Johnson, PF				Lee, Sook; Miller, Maria; Shuman, Jon D.; Johnson, Peter F.			CCAAT/Enhancer-binding Protein beta DNA Binding Is Auto-inhibited by Multiple Elements That Also Mediate Association with p300/CREB-binding Protein (CBP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROPHOBIC CLUSTER-ANALYSIS; C/EBP-BETA; TRANSCRIPTION FACTOR; STRUCTURAL BASIS; LEUCINE-ZIPPER; NF-M; MYELOMONOCYTIC CELLS; CELLULAR SENESCENCE; V-MYB; PHOSPHORYLATION	Signaling through Ras GTPases controls the activity of many transcription factors including CCAAT/enhancer-binding protein (C/EBP beta), which regulates oncogenic H-Ras(V12)-induced senescence and growth arrest. Here we report that C/EBP beta (LAP) DNA binding is inhibited by N-terminal sequences and derepressed by oncogenic Ras signaling. Sequence and mutational analyses showed that auto-repression involves two LXXLF (phi XX phi phi)-like motifs (LX1 and LX2) and a third element, auto-inhibitory domain (AID), located within conserved region CR5. LX1 is a critical component of the transactivation domain and has been shown to mediate C/EBP beta binding to the TAZ2 region of p300/CREB-binding protein coactivators. C/EBP beta auto-repression also involves a C-terminal regulatory domain (CRD) adjacent to the leucine zipper. CRD contains a third phi XX phi phi motif (LX3) and a short sequence, KQL, which has similarity to a region in the protein-binding site of TAZ2. The C/EBP beta N- and C-terminal domains physically associate in a manner that requires the basic region and CRD. We propose a model in which the regulatory sequences form a hydrophobic core that reciprocally inhibits DNA binding and transactivation. We also suggest a mechanism for C/EBP beta derepression involving several recently identified modifications within AID and CRD. Finally, we show that association of activatedC/EBP beta with p300/CREB-binding protein requires the LX2 and AID auto-inhibitory elements. Thus, the N-terminal regulatory elements have dual roles in auto-inhibition and coactivator binding.	[Lee, Sook; Shuman, Jon D.; Johnson, Peter F.] NCI Frederick, Lab Canc Prevent, NIH, Frederick, MD 21702 USA; [Miller, Maria] NCI Frederick, Macromol Crystallog Lab, NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Johnson, PF (corresponding author), NCI Frederick, Lab Canc Prevent, NIH, Bldg 539,Rm 122, Frederick, MD 21702 USA.	johnsope@mail.nih.gov	Miller, Maria/I-1636-2013; Johnson, Peter/A-1940-2012	Miller, Maria/0000-0003-0252-5348; Johnson, Peter/0000-0002-4145-4725; Shuman, Jon/0000-0001-8412-9087	National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010328, ZIABC010348] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research.	BURK O, 1993, EMBO J, V12, P2027, DOI 10.1002/j.1460-2075.1993.tb05852.x; Burk O, 1997, EMBO J, V16, P1371, DOI 10.1093/emboj/16.6.1371; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; Choi Y, 2000, J BIOL CHEM, V275, P15912, DOI 10.1074/jbc.275.21.15912; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Coeytaux K, 2005, BIOINFORMATICS, V21, P1891, DOI 10.1093/bioinformatics/bti266; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Feng HQ, 2009, STRUCTURE, V17, P202, DOI 10.1016/j.str.2008.12.009; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; GABORIAUD C, 1987, FEBS LETT, V224, P149, DOI 10.1016/0014-5793(87)80439-8; Gao HW, 2002, J BIOL CHEM, V277, P38827, DOI 10.1074/jbc.M206224200; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Graves BJ, 1998, COLD SPRING HARB SYM, V63, P621, DOI 10.1101/sqb.1998.63.621; He B, 2003, MOL CELL BIOL, V23, P2135, DOI 10.1128/MCB.23.6.2135-2150.2003; Hu HM, 2000, J BIOL CHEM, V275, P16373, DOI 10.1074/jbc.M910269199; Jenkins LMM, 2009, BIOCHEMISTRY-US, V48, P1244, DOI 10.1021/bi801716h; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Jonsen MD, 1996, MOL CELL BIOL, V16, P2065; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; KATZ S, 1993, EMBO J, V12, P1321, DOI 10.1002/j.1460-2075.1993.tb05777.x; Kim J, 2002, J BIOL CHEM, V277, P38037, DOI 10.1074/jbc.M207235200; Kovacs KA, 2003, J BIOL CHEM, V278, P36959, DOI 10.1074/jbc.M303147200; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Lee S, 2010, MOL CELL BIOL, V30, P2621, DOI 10.1128/MCB.00782-09; Lee YH, 1997, MOL CELL BIOL, V17, P2038, DOI 10.1128/MCB.17.4.2038; MCKNIGHT SL, 1982, SCIENCE, V217, P316, DOI 10.1126/science.6283634; Miller M, 2003, J BIOL CHEM, V278, P15178, DOI 10.1074/jbc.M300417200; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; NERLOV C, 1995, EMBO J, V14, P4318, DOI 10.1002/j.1460-2075.1995.tb00106.x; NESS SA, 1993, GENE DEV, V7, P749, DOI 10.1101/gad.7.5.749; Podust LM, 2001, J BIOL CHEM, V276, P505, DOI 10.1074/jbc.M005594200; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Rost B, 1996, METHOD ENZYMOL, V266, P525; Sebastian T, 2005, EMBO J, V24, P3301, DOI 10.1038/sj.emboj.7600789; Sebastian T, 2006, CELL CYCLE, V5, P953, DOI 10.4161/cc.5.9.2733; SHUMAN JD, 1990, SCIENCE, V249, P771, DOI 10.1126/science.2202050; Shuman JD, 2004, MOL CELL BIOL, V24, P7380, DOI 10.1128/MCB.24.17.7380-7391.2004; Spooner CJ, 2007, MOL IMMUNOL, V44, P1384, DOI 10.1016/j.molimm.2006.05.004; Tahirov TH, 2002, CELL, V108, P57, DOI 10.1016/S0092-8674(01)00636-5; TRAUTWEIN C, 1995, J BIOL CHEM, V270, P15130, DOI 10.1074/jbc.270.25.15130; Weigel NL, 2007, MOL ENDOCRINOL, V21, P2311, DOI 10.1210/me.2007-0101; Wessells J, 2004, MOL CELL BIOL, V24, P3238, DOI 10.1128/MCB.24.8.3238-3250.2004; Whitmarsh AJ, 2000, CELL MOL LIFE SCI, V57, P1172, DOI 10.1007/PL00000757; WILLIAMS SC, 1995, EMBO J, V14, P3170, DOI 10.1002/j.1460-2075.1995.tb07319.x; WILLIAMS SC, 1991, GENE DEV, V5, P1553, DOI 10.1101/gad.5.9.1553; Wojciak JM, 2009, EMBO J, V28, P948, DOI 10.1038/emboj.2009.30; Yamamoto KR, 1998, COLD SPRING HARB SYM, V63, P587, DOI 10.1101/sqb.1998.63.587; Zahnow CA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001033; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299	55	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21399	21410		10.1074/jbc.M110.128413	http://dx.doi.org/10.1074/jbc.M110.128413			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20452968	Green Published, hybrid			2022-12-27	WOS:000279516100026
J	O'Quin, JB; Bourassa, L; Zhang, DY; Shockey, JM; Gidda, SK; Fosnot, S; Chapman, KD; Mullen, RT; Dyer, JM				O'Quin, Jami B.; Bourassa, Linda; Zhang, Daiyuan; Shockey, Jay M.; Gidda, Satinder K.; Fosnot, Spencer; Chapman, Kent D.; Mullen, Robert T.; Dyer, John M.			Temperature-sensitive Post-translational Regulation of Plant Omega-3 Fatty-acid Desaturases Is Mediated by the Endoplasmic Reticulum-associated Degradation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID DESATURASES; MEMBRANE LIPID-COMPOSITION; STEAROYL-COA DESATURASE; FLUORESCENT PROTEINS; GENE-EXPRESSION; ER; ARABIDOPSIS; STABILITY; ADAPTATION; COMPONENT	Changes in ambient temperature represent a major physiological challenge to membranes of poikilothermic organisms. In plants, the endoplasmic reticulum (ER)-localized omega-3 fatty-acid desaturases (Fad3) increase the production of polyunsaturated fatty acids at cooler temperatures, but the FAD3 genes themselves are typically not up-regulated during this adaptive response. Here, we expressed two closely related plant FAD3 genes in yeast cells and found that their enzymes produced significantly different amounts of omega-3 fatty acids and that these differences correlated to differences in rates of protein turnover. Domain-swapping and mutagenesis experiments revealed that each protein contained a degradation signal in its N terminus and that the charge density of a PEST-like sequence within this region was largely responsible for the differences in rates of protein turnover. The half-life of each Fad3 protein was increased at cooler temperatures, and protein degradation required specific components of the ER-associated degradation pathway including the Cdc48 adaptor proteins Doa1, Shp1, and Ufd2. Expression of the Fad3 proteins in tobacco cells incubated with the proteasomal inhibitor MG132 further confirmed that they were degraded via the proteasomal pathway in plants. Collectively, these findings indicate that Fad3 protein abundance is regulated by a combination of cis-acting degradation signals and the ubiquitin-proteasome pathway and that modulation of Fad3 protein amounts in response to temperature may represent one mechanism of homeoviscous adaptation in plants.	[O'Quin, Jami B.; Bourassa, Linda] Univ New Orleans, Dept Biol Sci, New Orleans, LA 70124 USA; [Zhang, Daiyuan; Chapman, Kent D.] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA; [Zhang, Daiyuan; Fosnot, Spencer; Dyer, John M.] USDA ARS, US Arid Land Agr Res Ctr, Maricopa, AZ 85138 USA; [Shockey, Jay M.] USDA ARS, So Reg Res Ctr, New Orleans, LA 70124 USA; [Gidda, Satinder K.; Mullen, Robert T.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON NWG 2W1, Canada	University of Louisiana System; University of New Orleans; University of North Texas System; University of North Texas Denton; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of Guelph	Dyer, JM (corresponding author), 21881 N Cardon Ln, Maricopa, AZ 85138 USA.	john.dyer@ars.usda.gov		Shockey, Jay/0000-0002-5057-5457; Chapman, Kent/0000-0003-0489-3072	United States Department of Agriculture (USDA); Current Research Information System (CRIS) [5347-21000-009-00D, 6435-41000-087-00D]; Natural Sciences and Engineering Research Council of Canada [217291]; Louisiana Board of Regents Governor's Biotechnology Initiative; University of Guelph Research Chair; USDA; University of North Texas; USDA through South Mountain Community College, Phoenix, AZ [2008-38422-19188]	United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); Current Research Information System (CRIS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Louisiana Board of Regents Governor's Biotechnology Initiative; University of Guelph Research Chair; USDA(United States Department of Agriculture (USDA)); University of North Texas; USDA through South Mountain Community College, Phoenix, AZ	This work was supported by the United States Department of Agriculture (USDA), Current Research Information System (CRIS) Project 5347-21000-009-00D (to J.M.D.), CRIS Project 6435-41000-087-00D (to J.M.S.), Grant 217291 from the Natural Sciences and Engineering Research Council of Canada (to R. T. M.), Specific Cooperative Agreement 5347-21410-004-14S between the USDA and the University of North Texas, a grant from the Louisiana Board of Regents Governor's Biotechnology Initiative (to J.B. O'Q., L. B., and J.M.D.), and a University of Guelph Research Chair (to R. T. M.).; Supported by Cooperative State Research, Education, and Extension Service (CSREES) Grant 2008-38422-19188 from the USDA through the Undergraduate Bioscience Engagement Track (eUBET) program sponsored by South Mountain Community College, Phoenix, AZ.	Adachi S, 2006, PLANT CELL PHYSIOL, V47, P1683, DOI 10.1093/pcp/pcl034; Auesukaree C, 2009, J APPL GENET, V50, P301, DOI 10.1007/BF03195688; Bachmair A, 2001, TRENDS PLANT SCI, V6, P463, DOI 10.1016/S1360-1385(01)02080-5; BARTEL B, 1990, EMBO J, V9, P3179, DOI 10.1002/j.1460-2075.1990.tb07516.x; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Brachmann CB, 1998, YEAST, V14, P115; Brandizzi F, 2003, CURR PROTOC CELL BIO; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; BROWSE J, 1994, PORTL PR P, P141; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Chung SM, 2005, TRENDS PLANT SCI, V10, P357, DOI 10.1016/j.tplants.2005.06.001; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Costa V, 2007, IUBMB LIFE, V59, P293, DOI 10.1080/15216540701225958; Covello PS, 1996, PLANT PHYSIOL, V111, P223, DOI 10.1104/pp.111.1.223; Czabany T, 2007, BBA-MOL CELL BIOL L, V1771, P299, DOI 10.1016/j.bbalip.2006.07.001; Dyer JM, 2004, J AM OIL CHEM SOC, V81, P647, DOI 10.1007/s11746-004-956-x; Dyer JM, 2001, BIOCHEM BIOPH RES CO, V282, P1019, DOI 10.1006/bbrc.2001.4667; Dyer JM, 2001, FEBS LETT, V494, P44, DOI 10.1016/S0014-5793(01)02315-8; Falcone Deane L., 2004, BMC Plant Biology, V4, P17, DOI 10.1186/1471-2229-4-17; Foury F, 2001, J BIOL CHEM, V276, P7762, DOI 10.1074/jbc.M005804200; Garcia-Alai MM, 2006, STRUCTURE, V14, P309, DOI 10.1016/j.str.2005.11.012; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Goder V, 2008, FEBS LETT, V582, P1575, DOI 10.1016/j.febslet.2008.03.056; Guschina IA, 2006, FEBS LETT, V580, P5477, DOI 10.1016/j.febslet.2006.06.066; Halter M, 2007, CYTOM PART A, V71A, P827, DOI 10.1002/cyto.a.20461; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Horiguchi G, 2000, PLANT J, V24, P805, DOI 10.1046/j.1365-313x.2000.00925.x; Horton R M, 1997, Methods Mol Biol, V67, P141; Huang DQ, 2002, MOL CELL BIOL, V22, P5076, DOI 10.1128/MCB.22.14.5076-5088.2002; Hwang YT, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-54; Jackson DD, 1997, J BIOL CHEM, V272, P25928, DOI 10.1074/jbc.272.41.25928; Jaenicke R, 2000, J BIOTECHNOL, V79, P193, DOI 10.1016/S0168-1656(00)00236-4; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Kato H, 2006, J CELL SCI, V119, P2342, DOI 10.1242/jcs.02951; Kinner A, 2003, FEBS LETT, V549, P135, DOI 10.1016/S0014-5793(03)00801-9; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; KODAMA H, 1995, PLANT PHYSIOL, V107, P1177, DOI 10.1104/pp.107.4.1177; KOLODZIEJ PA, 1991, METHOD ENZYMOL, V194, P508; Lis ET, 2006, MOL CELL BIOL, V26, P4122, DOI 10.1128/MCB.01640-05; Lisenbee CS, 2003, TRAFFIC, V4, P491, DOI 10.1034/j.1600-0854.2003.00107.x; Los DA, 1998, BBA-LIPID LIPID MET, V1394, P3, DOI 10.1016/S0005-2760(98)00091-5; Martz F, 2006, J EXP BOT, V57, P897, DOI 10.1093/jxb/erj075; Matsuda O, 2005, J BIOL CHEM, V280, P3597, DOI 10.1074/jbc.M407226200; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; MCCAMMON MT, 1990, J BACTERIOL, V172, P5816, DOI 10.1128/jb.172.10.5816-5827.1990; McCartney AW, 2004, PLANT J, V37, P156, DOI 10.1111/j.1365-313X.2004.01949.x; Mehlmer Norbert, 2009, V479, P235, DOI 10.1007/978-1-59745-289-2_15; Miao YS, 2007, NAT PROTOC, V2, P2348, DOI 10.1038/nprot.2007.360; Mullally JE, 2006, MOL CELL BIOL, V26, P822, DOI 10.1128/MCB.26.3.822-830.2006; Muller J, 2005, PLANT CELL, V17, P149, DOI 10.1105/tpc.104.026625; Mziaut H, 2000, P NATL ACAD SCI USA, V97, P8883, DOI 10.1073/pnas.97.16.8883; Mziaut H, 2002, BBA-MOL CELL BIOL L, V1583, P45, DOI 10.1016/S1388-1981(02)00159-2; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; O'Quin JB, 2009, APPL MICROBIOL BIOT, V83, P117, DOI 10.1007/s00253-008-1826-2; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; OZKAYNAK E, 1987, EMBO J, V6, P1429, DOI 10.1002/j.1460-2075.1987.tb02384.x; Penrose KJ, 2004, J BIOL CHEM, V279, P22430, DOI 10.1074/jbc.M314340200; Rancour DM, 2004, J BIOL CHEM, V279, P54264, DOI 10.1074/jbc.M405498200; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Routaboul JM, 2000, PLANT PHYSIOL, V124, P1697, DOI 10.1104/pp.124.4.1697; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schuberth C, 2004, EMBO REP, V5, P818, DOI 10.1038/sj.embor.7400203; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; SOMERVILLE C, 1995, P NATL ACAD SCI USA, V92, P6215, DOI 10.1073/pnas.92.14.6215; Tang GQ, 2005, PLANT J, V44, P433, DOI 10.1111/j.1365-313X.2005.02535.x; Thompson AR, 2005, CURR OPIN PLANT BIOL, V8, P165, DOI 10.1016/j.pbi.2005.01.013; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; WILLIAMS JP, 1988, PLANT PHYSIOL, V87, P904, DOI 10.1104/pp.87.4.904; Winderickx J, 2008, BBA-MOL CELL RES, V1783, P1381, DOI 10.1016/j.bbamcr.2008.01.020; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Yu C, 2009, PLANT PHYSIOL BIOCH, V47, P1102, DOI 10.1016/j.plaphy.2009.07.008; Zeng G, 1998, BIOTECHNIQUES, V25, P206, DOI 10.2144/98252bm05; Zhang LJ, 2007, BIOTECHNIQUES, V42, P446, DOI 10.2144/000112453; Zhang LP, 2006, J AM CHEM SOC, V128, P4766, DOI 10.1021/ja0580439	81	55	57	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21781	21796		10.1074/jbc.M110.135236	http://dx.doi.org/10.1074/jbc.M110.135236			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20452984	hybrid, Green Submitted, Green Published			2022-12-27	WOS:000279516100063
J	Downie, MJ; El Bissati, K; Bobenchik, AM; Lochlainn, LN; Amerik, A; Zufferey, R; Kirk, K; Mamoun, CB				Downie, Megan J.; El Bissati, Kamal; Bobenchik, April M.; Lochlainn, Laura Nic; Amerik, Alexander; Zufferey, Rachel; Kirk, Kiaran; Mamoun, Choukri Ben			PfNT2, a Permease of the Equilibrative Nucleoside Transporter Family in the Endoplasmic Reticulum of Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAERYTHROCYTIC MALARIA PARASITE; PLASMA-MEMBRANE; FUNCTIONAL-CHARACTERIZATION; SACCHAROMYCES-CEREVISIAE; INTRACELLULAR MEMBRANES; INFECTED ERYTHROCYTES; GENE ENCODES; PROTEIN; LOCALIZATION; YEAST	The survival and proliferation of the obligate intracellular malaria parasite Plasmodium falciparum require salvage of essential purines from the host. Genetic studies have previously shown that the parasite plasma membrane purine permease, PfNT1, plays an essential function in the transport of all naturally occurring purine nucleosides and nucleobases across the parasite plasma membrane. Here, we describe an intracellular permease, PfNT2. PfNT2 is, like PfNT1, a member of the equilibrative nucleoside transporter family. Confocal and immunoelectron microscopic analyses of transgenic parasites harboring green fluorescent protein- or hemagglutinin-tagged PfNT2 demonstrated endoplasmic reticulum localization. This localization was confirmed by colocalization with the endoplasmic reticulum marker PfBiP. Using yeast as a surrogate system, we show that targeting PfNT2 to the plasma membrane of fui1 Delta cells lacking the plasma membrane nucleoside transporter Fui1 confers sensitivity to the toxic nucleoside analog 5-fluorouridine. This study provides the first evidence of an intracellular purine permease in apicomplexan parasites and suggests a novel biological function for the parasite endoplasmic reticulum during malaria infection.	[Downie, Megan J.; Bobenchik, April M.; Lochlainn, Laura Nic; Amerik, Alexander; Mamoun, Choukri Ben] Yale Univ, Sch Med, Infect Dis Sect, New Haven, CT 06512 USA; [Downie, Megan J.; Kirk, Kiaran] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [El Bissati, Kamal; Bobenchik, April M.; Zufferey, Rachel] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA	Yale University; Australian National University; University of Connecticut	Mamoun, CB (corresponding author), Yale Univ, Sch Med, Infect Dis Sect, WWW4,POB 208022, New Haven, CT 06520 USA.	choukri.benmamoun@yale.edu	Kirk, Kiaran/C-8299-2009; Amerik, Alexander/AAM-4167-2020	Kirk, Kiaran/0000-0002-5613-2622; EL BISSATI, KAMAL/0000-0001-9341-4162; Nic Lochlainn, Laura/0000-0001-8095-9892	National Institutes of Health through the NIAID [AI51507]; Department of Defense [PR033005]; Burroughs Wellcome Fund; Australian Research Council; National Health and Medical Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051507] Funding Source: NIH RePORTER	National Institutes of Health through the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Defense(United States Department of Defense); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI51507 through the NIAID (to C. B. M.), Department of Defense Grant PR033005 (to C. B. M.), by the Burroughs Wellcome Fund (to C. B. M), and by grants from the Australian Research Council and National Health and Medical Research Council (to K. K.).	Baldwin SA, 2005, J BIOL CHEM, V280, P15880, DOI 10.1074/jbc.M414337200; Barnes K, 2006, CIRC RES, V99, P510, DOI 10.1161/01.RES.0000238359.18495.42; BENEDETTI H, 1994, MOL BIOL CELL, V5, P1023, DOI 10.1091/mbc.5.9.1023; Carter NS, 2000, J BIOL CHEM, V275, P10683, DOI 10.1074/jbc.275.14.10683; Cliffe ST, 2009, HUM MOL GENET, V18, P2257, DOI 10.1093/hmg/ddp161; DESAI SA, 1993, NATURE, V362, P643, DOI 10.1038/362643a0; Downie MJ, 2008, INT J PARASITOL, V38, P203, DOI 10.1016/j.ijpara.2007.07.005; Downie MJ, 2006, MOL MICROBIOL, V60, P738, DOI 10.1111/j.1365-2958.2006.05125.x; El Bissati K, 2008, MOL BIOCHEM PARASIT, V161, P130, DOI 10.1016/j.molbiopara.2008.06.012; El Bissati K, 2006, P NATL ACAD SCI USA, V103, P9286, DOI 10.1073/pnas.0602590103; Errasti-Murugarren E, 2009, FASEB J, V23, P172, DOI 10.1096/fj.08-113902; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GATI WP, 1990, BIOCHEM J, V272, P277, DOI 10.1042/bj2720277; GERO AM, 1988, MOL BIOCHEM PARASIT, V27, P159, DOI 10.1016/0166-6851(88)90035-7; Henry RI, 2007, BIOCHEM BIOPH RES CO, V363, P288, DOI 10.1016/j.bbrc.2007.08.116; KIRK K, 1994, J BIOL CHEM, V269, P3339; Kirk K, 2009, TRENDS PARASITOL, V25, P246, DOI 10.1016/j.pt.2009.03.006; Ko N, 2008, YEAST, V25, P155, DOI 10.1002/yea.1554; KUMAR N, 1991, MOL BIOCHEM PARASIT, V48, P47, DOI 10.1016/0166-6851(91)90163-Z; Lauer CM, 2008, FEMS MICROBIOL LETT, V285, P79, DOI 10.1111/j.1574-6968.2008.01214.x; Martin RE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r26; Martin RE, 2009, SCIENCE, V325, P1680, DOI 10.1126/science.1175667; Miller CA, 1998, NUCLEIC ACIDS RES, V26, P3577, DOI 10.1093/nar/26.15.3577; Molho-Pessach V, 2008, AM J HUM GENET, V83, P529, DOI 10.1016/j.ajhg.2008.09.013; Mullin KA, 2006, P NATL ACAD SCI USA, V103, P9572, DOI 10.1073/pnas.0602293103; ORTIZ DF, 1992, EMBO J, V11, P3491, DOI 10.1002/j.1460-2075.1992.tb05431.x; Parker MD, 2000, BIOCHEM J, V349, P67, DOI 10.1042/0264-6021:3490067; Quashie NB, 2008, BIOCHEM J, V411, P287, DOI 10.1042/BJ20071460; Quashie NB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-36; Rager N, 2001, J BIOL CHEM, V276, P41095, DOI 10.1074/jbc.M107037200; Riegelhaupt PM, 2010, MOL BIOCHEM PARASIT, V169, P40, DOI 10.1016/j.molbiopara.2009.10.001; Saliba KJ, 2006, NATURE, V443, P582, DOI 10.1038/nature05149; SERRANO R, 1986, NATURE, V319, P689, DOI 10.1038/319689a0; Tonkin CJ, 2006, CURR OPIN MICROBIOL, V9, P381, DOI 10.1016/j.mib.2006.06.015; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; UPSTON JM, 1995, BBA-BIOMEMBRANES, V1236, P249, DOI 10.1016/0005-2736(95)00055-8; van Dooren GG, 2005, MOL MICROBIOL, V57, P405, DOI 10.1111/j.1365-2958.2005.04699.x; Vickers MF, 2000, J BIOL CHEM, V275, P25931, DOI 10.1074/jbc.M000239200	39	23	23	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20827	20833		10.1074/jbc.M110.118489	http://dx.doi.org/10.1074/jbc.M110.118489			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20439460	Green Published, hybrid			2022-12-27	WOS:000279228600046
J	Liu, J; Wang, XN; Cheng, F; Liou, YC; Deng, LW				Liu, Jie; Wang, Xiao Ning; Cheng, Fei; Liou, Yih-Cherng; Deng, Lih-Wen			Phosphorylation of Mixed Lineage Leukemia 5 by Cdc2 Affects Its Cellular Distribution and Is Required for Mitotic Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE METHYLTRANSFERASE COMPLEX; CYCLIN-DEPENDENT KINASES; PROTO-ONCOPROTEIN MLL; HOX GENE-EXPRESSION; H3K4 METHYLATION; DROSOPHILA-TRITHORAX; MYELOID-LEUKEMIA; S-PHASE; MITOSIS; CHROMATIN	The human mixed lineage leukemia-5 (MLL5) gene is frequently deleted in myeloid malignancies. Emerging evidence suggests that MLL5 has important functions in adult hematopoiesis and the chromatin regulatory network, and it participates in regulating the cell cycle machinery. Here, we demonstrate that MLL5 is tightly regulated through phosphorylation on its central domain at the G(2)/M phase of the cell cycle. Upon entry into mitosis, the phosphorylated MLL5 delocalizes from condensed chromosomes, whereas after mitotic exit, MLL5 becomes dephosphorylated and re-associates with the relaxed chromatin. We further identify that the mitotic phosphorylation and subcellular localization of MLL5 are dependent on Cdc2 kinase activity, and Thr-912 is the Cdc2-targeting site. Overexpression of the Cdc2-targeting MLL5 fragment obstructs mitotic entry by competitive inhibition of the phosphorylation of endogenous MLL5. In addition, G(2) phase arrest caused by depletion of endogenous MLL5 can be compensated by exogenously overexpressed full-length MLL5 but not the phosphodomain deletion or MLL5-T912A mutant. Our data provide evidence that MLL5 is a novel cellular target of Cdc2, and the phosphorylation of MLL5 may have an indispensable role in the mitotic progression.	[Liu, Jie; Wang, Xiao Ning; Cheng, Fei; Deng, Lih-Wen] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore; [Liou, Yih-Cherng] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117543, Singapore	National University of Singapore; National University of Singapore	Deng, LW (corresponding author), Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Biochem, 8 Med Dr, Singapore 117597, Singapore.	bchdlw@nus.edu.sg		Deng, Lih-Wen/0000-0002-4985-7844	BMRC-A*STAR, Singapore [R-183-000-164-305]; NMRC-A*STAR, Singapore [R-183-000-149-213]; Ministry of Education [R-183-000-195-112]	BMRC-A*STAR, Singapore(Agency for Science Technology & Research (A*STAR)); NMRC-A*STAR, Singapore(Agency for Science Technology & Research (A*STAR)National Medical Research Council, Singapore); Ministry of Education	This work was supported in part by BMRC-A*STAR, Singapore, Grant R-183-000-164-305, NMRC-A*STAR, Singapore, Grant R-183-000-149-213, and Ministry of Education Academic Research Fund Tier 2 Grant R-183-000-195-112.	Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Brezinova J, 2007, CANCER GENET CYTOGEN, V173, P10, DOI 10.1016/j.cancergencyto.2006.09.003; Chang F, 2008, INT J BIOCHEM CELL B, V40, P2472, DOI 10.1016/j.biocel.2008.04.012; Delcuve GP, 2008, J CELL BIOCHEM, V105, P1, DOI 10.1002/jcb.21806; Deng LW, 2004, P NATL ACAD SCI USA, V101, P757, DOI 10.1073/pnas.2036345100; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Emerling BM, 2002, ONCOGENE, V21, P4849, DOI 10.1038/sj.onc.1205615; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Georgatos SD, 2009, FRONT BIOSCI-LANDMRK, V14, P2017, DOI 10.2741/3360; Georgi AB, 2002, CURR BIOL, V12, P105, DOI 10.1016/S0960-9822(01)00662-5; Glaser S, 2006, DEVELOPMENT, V133, P1423, DOI 10.1242/dev.02302; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; Hasle H, 1999, LEUKEMIA, V13, P376, DOI 10.1038/sj.leu.2401342; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Heuser M, 2009, BLOOD, V113, P1432, DOI [10.1182/blood-2008-02-162263, 10.1182/blood-2008-06-162263]; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Ito T, 2007, J BIOCHEM, V141, P609, DOI 10.1093/jb/mvm091; Johnson EJ, 1996, BLOOD, V87, P3579, DOI 10.1182/blood.V87.9.3579.bloodjournal8793579; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; LeBeau MM, 1996, BLOOD, V88, P1930; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee S, 2006, P NATL ACAD SCI USA, V103, P15392, DOI 10.1073/pnas.0607313103; Liu H, 2007, GENE DEV, V21, P2385, DOI 10.1101/gad.1574507; Liu H, 2009, BLOOD, V113, P1395, DOI 10.1182/blood-2008-11-185801; LUNAFINEMAN S, 1995, BLOOD, V85, P1985, DOI 10.1182/blood.V85.8.1985.bloodjournal8581985; Madan V, 2009, BLOOD, V113, P1444, DOI 10.1182/blood-2008-02-142638; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Mellor J, 2006, CELL, V126, P22, DOI 10.1016/j.cell.2006.06.028; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Mishra BP, 2009, FEBS J, V276, P1629, DOI 10.1111/j.1742-4658.2009.06895.x; MORENO S, 1990, CELL, V61, P549, DOI 10.1016/0092-8674(90)90463-O; Moseley JB, 2009, CURR OPIN CELL BIOL, V21, P82, DOI 10.1016/j.ceb.2008.12.005; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Neef R, 2007, NAT CELL BIOL, V9, P436, DOI 10.1038/ncb1557; Nightingale KP, 2007, J BIOL CHEM, V282, P4408, DOI 10.1074/jbc.M606773200; REYNOLDS JA, 1970, J BIOL CHEM, V245, P5161; Rice JC, 2002, GENE DEV, V16, P2225, DOI 10.1101/gad.1014902; Sambasivan R, 2008, J BIOSCIENCES, V33, P27, DOI 10.1007/s12038-008-0019-6; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Sebastian S, 2009, P NATL ACAD SCI USA, V106, P4719, DOI 10.1073/pnas.0807136106; Takeda S, 2006, GENE DEV, V20, P2397, DOI 10.1101/gad.1449406; Tardat M, 2007, J CELL BIOL, V179, P1413, DOI 10.1083/jcb.200706179; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; YAMASHITA K, 1990, EMBO J, V9, P4331, DOI 10.1002/j.1460-2075.1990.tb07882.x; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yokoyama A, 2002, BLOOD, V100, P3710, DOI 10.1182/blood-2002-04-1015; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zhang Y, 2009, BLOOD, V113, P1455, DOI 10.1182/blood-2008-05-159905; Zhou HL, 2001, NAT BIOTECHNOL, V19, P375, DOI 10.1038/86777	57	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20904	20914		10.1074/jbc.M109.098558	http://dx.doi.org/10.1074/jbc.M109.098558			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20439461	Green Published, hybrid			2022-12-27	WOS:000279228600055
J	McCoy, CE; Sheedy, FJ; Qualls, JE; Doyle, SL; Quinn, SR; Murray, PJ; O'Neill, LAJ				McCoy, Claire E.; Sheedy, Frederick J.; Qualls, Joseph E.; Doyle, Sarah L.; Quinn, Susan R.; Murray, Peter J.; O'Neill, Luke A. J.			IL-10 Inhibits miR-155 Induction by Toll-like Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN-CONTAINING INOSITOL-5-PHOSPHATASE; B-CELL LYMPHOMAS; IMMUNE-RESPONSE; TRANSGENIC MICE; EXPRESSION; MICRORNA; TARGET; TRANSCRIPTION; ACTIVATION; PATHWAY	IL-10 is a potent anti-inflammatory cytokine that is crucial for down-regulating pro-inflammatory genes, which are induced by Toll-like receptor (TLR) signaling. In this study, we have examined whether modulation of microRNAs plays a role in the inhibitory effect of IL-10 on TLR4 signaling. Analyzing microRNAs known to be induced by TLR4, we found that IL-10 could inhibit the expression of miR-155 in response to lipopolysaccharide but had no effect on miR-21 or miR-146a. IL-10 inhibited miR-155 transcription from the BIC gene in a STAT3-dependent manner. This inhibitory effect of IL-10 on miR-155 led to an increase in the expression of the miR-155 target, SHIP1. This is the first example of IL-10 playing a role in microRNA function and suggests that through its inhibitory effect on miR-155, IL-10 has the ability to promote anti-inflammatory gene expression.	[McCoy, Claire E.; Sheedy, Frederick J.; Doyle, Sarah L.; Quinn, Susan R.; O'Neill, Luke A. J.] Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland; [Qualls, Joseph E.; Murray, Peter J.] St Jude Childrens Hosp, Dept Infect Dis, Memphis, TN 38105 USA	Trinity College Dublin; St Jude Children's Research Hospital	McCoy, CE (corresponding author), Monash Inst Med Res, 27-31 Wright St, Clayton, Vic 3168, Australia.	cmccoy@tcd.ie	Murray, Peter J/K-4725-2018; Doyle, Sarah/C-1453-2014	Murray, Peter J/0000-0001-6329-9802; Doyle, Sarah/0000-0002-6294-9380; Qualls, Joseph/0000-0002-0113-2166; Sheedy, Frederick/0000-0003-2645-8493; McCoy, Claire/0000-0001-8710-896X; Sheedy, Frederick/0000-0002-4722-3135; O'Neill, Luke/0000-0002-4333-2748	Science Foundation Ireland; Health Research Board Ireland; Marie Curie Actions	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board Ireland; Marie Curie Actions(European Commission)	This work was supported by grants from the Science Foundation Ireland, Health Research Board Ireland, and Marie Curie Actions.	An HZ, 2005, BLOOD, V105, P4685, DOI 10.1182/blood-2005-01-0191; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Costinean S, 2009, BLOOD, V114, P1374, DOI 10.1182/blood-2009-05-220814; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; El Kasmi KC, 2007, J IMMUNOL, V179, P7215, DOI 10.4049/jimmunol.179.11.7215; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Gantier MP, 2007, IMMUNOL CELL BIOL, V85, P458, DOI 10.1038/sj.icb.7100091; Gantier MP, 2010, J INTERF CYTOK RES, V30, P283, DOI 10.1089/jir.2010.0037; Kanellopoulou C, 2008, SEMIN CANCER BIOL, V18, P79, DOI 10.1016/j.semcancer.2008.01.002; Kluiver J, 2007, ONCOGENE, V26, P3769, DOI 10.1038/sj.onc.1210147; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Liu Z, 2008, INT J MOL SCI, V9, P978, DOI 10.3390/ijms9060978; Mccoy CE, 2008, J BIOL CHEM, V283, P14277, DOI 10.1074/jbc.M709731200; Murray PJ, 2006, BIOCHEM SOC T, V34, P1028, DOI 10.1042/BST0341028; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; O'Garra A, 2008, IMMUNOL REV, V223, P114, DOI 10.1111/j.1600-065X.2008.00635.x; Oikawa T, 2003, GENE, V303, P11, DOI 10.1016/S0378-1119(02)01156-3; Palsson-McDermott EM, 2009, NAT IMMUNOL, V10, P579, DOI 10.1038/ni.1727; Pedersen IM, 2009, EMBO MOL MED, V1, P288, DOI 10.1002/emmm.200900028; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Rai D, 2008, CANCER GENET CYTOGEN, V181, P8, DOI 10.1016/j.cancergencyto.2007.10.008; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Yin QY, 2008, J VIROL, V82, P5295, DOI 10.1128/JVI.02380-07; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200	33	189	205	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20492	20498		10.1074/jbc.M110.102111	http://dx.doi.org/10.1074/jbc.M110.102111			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20435894	Green Published, hybrid			2022-12-27	WOS:000279228600009
J	Wen, KK; McKane, M; Stokasimov, E; Fields, J; Rubenstein, PA				Wen, Kuo-Kuang; McKane, Melissa; Stokasimov, Ema; Fields, Jonathon; Rubenstein, Peter A.			A Potential Yeast Actin Allosteric Conduit Dependent on Hydrophobic Core Residues Val-76 and Trp-79	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; NASCENT MYOFIBRILS; MASS-SPECTROMETRY; BINDING PROTEINS; ARP2/3 COMPLEX; STRESS FIBERS; ALPHA-ACTIN; IN-VITRO; F-ACTIN; DYNAMICS	Intramolecular allosteric interactions responsible for actin conformational regulation are largely unknown. Previous work demonstrated that replacing yeast actin Val-76 with muscle actin Ile caused decreased nucleotide exchange. Residue 76 abuts Trp-79 in a six-residue linear array beginning with Lys-118 on the surface and ending with His-73 in the nucleotide cleft. To test if altering the degree of packing of these two residues would affect actin dynamics, we constructed V76I, W79F, and W79Y single mutants as well as the Ile-76/ Phe-79 and Ile-76/Tyr-79 double mutants. Tyr or Phe should decrease crowding and increase protein flexibility. Subsequent introduction of Ile should restore packing and dampen changes. All mutants showed decreased growth in liquid medium. W79Y alone was severely osmosensitive and exhibited vacuole abnormalities. Both properties were rescued by Ile-76. Phe-79 or Tyr decreased the thermostability of actin and increased its nucleotide exchange rate. These effects, generally greater for Tyr than for Phe, were reversed by introduction of Ile-76. HD exchange showed that the mutations caused propagated conformational changes to all four subdomains. Based on results from phosphate release and light-scattering assays, single mutations affected polymerization in the order of Ile, Phe, and Tyr from least to most. Introduction of Ile-76 partially rescued the polymerization defects caused by either Tyr-79 or Phe-79. Thus, alterations in crowding of the 76-79 residue pair can strongly affect actin conformation and behavior, and these results support the theory that the amino acid array in which they are located may play a central role in actin regulation.	[Wen, Kuo-Kuang; McKane, Melissa; Stokasimov, Ema; Fields, Jonathon; Rubenstein, Peter A.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa	Rubenstein, PA (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA.	peter-rubenstein@uiowa.edu		Rubenstein, Peter/0000-0003-1225-4414	National Institutes of Health [GM33689]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM33689 (to P.A.R.).	Buzan JM, 1996, P NATL ACAD SCI USA, V93, P91, DOI 10.1073/pnas.93.1.91; Carlier M F, 1990, Adv Biophys, V26, P51, DOI 10.1016/0065-227X(90)90007-G; CARLIER MF, 1991, J BIOL CHEM, V266, P1; CHEN X, 1993, J CELL BIOL, V123, P1185, DOI 10.1083/jcb.123.5.1185; COOK RK, 1992, J BIOL CHEM, V267, P9430; Dominguez R, 2009, CRIT REV BIOCHEM MOL, V44, P351, DOI 10.3109/10409230903277340; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Galkin VE, 2001, J CELL BIOL, V153, P75, DOI 10.1083/jcb.153.1.75; GREER C, 1982, MOL CELL BIOL, V2, P1270, DOI 10.1128/MCB.2.10.1270; Guan JQ, 2002, BIOCHEMISTRY-US, V41, P5765, DOI 10.1021/bi0121104; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Hasebe-Kishi F, 2000, J MUSCLE RES CELL M, V21, P717, DOI 10.1023/A:1010374424143; Hill KL, 1996, J CELL BIOL, V135, P1535, DOI 10.1083/jcb.135.6.1535; HITCHCOCK SE, 1980, J BIOL CHEM, V255, P5668; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kim E, 1996, BIOCHEMISTRY-US, V35, P16566, DOI 10.1021/bi9623892; LATTERICH M, 1993, BIOCHEM BIOPH RES CO, V191, P1111, DOI 10.1006/bbrc.1993.1331; McKane M, 2006, J BIOL CHEM, V281, P29916, DOI 10.1074/jbc.M602251200; Melki R, 1996, BIOCHEMISTRY-US, V35, P12038, DOI 10.1021/bi961325o; Nwe TM, 1999, EXP CELL RES, V252, P33, DOI 10.1006/excr.1999.4611; Okamoto K, 2001, METHOD CELL BIOL, V65, P277, DOI 10.1016/S0091-679X(01)65017-9; Page R, 1998, J MOL BIOL, V280, P463, DOI 10.1006/jmbi.1998.1879; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; PRINGLE JR, 1989, METHOD CELL BIOL, V31, P357; Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Shimada Y, 1997, CELL STRUCT FUNCT, V22, P59, DOI 10.1247/csf.22.59; SHU WP, 1992, BIOCHEM J, V283, P567, DOI 10.1042/bj2830567; Stokasimov E, 2009, J BIOL CHEM, V284, P25421, DOI 10.1074/jbc.M109.013078; Suzuki H, 1998, TISSUE CELL, V30, P274, DOI 10.1016/S0040-8166(98)80076-1; Volkmann N, 2001, SCIENCE, V293, P2456, DOI 10.1126/science.1063025; Wang LT, 2002, MOL CELL PROTEOMICS, V1, P132, DOI 10.1074/mcp.M100009-MCP200; Wen KK, 2003, J BIOL CHEM, V278, P48386, DOI 10.1074/jbc.M308980200; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899; Yao XY, 2001, J BIOL CHEM, V276, P25598, DOI 10.1074/jbc.M011797200; Yao XY, 1999, J BIOL CHEM, V274, P37443, DOI 10.1074/jbc.274.52.37443; Zheng B, 2009, FEBS J, V276, P2669, DOI 10.1111/j.1742-4658.2009.06986.x	39	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21185	21194		10.1074/jbc.M110.121426	http://dx.doi.org/10.1074/jbc.M110.121426			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20442407	hybrid, Green Published			2022-12-27	WOS:000279228600081
J	Torres-Quiroz, F; Garcia-Marques, S; Coria, R; Randez-Gil, F; Prieto, JA				Torres-Quiroz, Francisco; Garcia-Marques, Sara; Coria, Roberto; Randez-Gil, Francisca; Prieto, Jose A.			The Activity of Yeast Hog1 MAPK Is Required during Endoplasmic Reticulum Stress Induced by Tunicamycin Exposure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN-RESPONSE; NATURALLY-OCCURRING OSMOLYTES; SACCHAROMYCES-CEREVISIAE; HIGH-OSMOLARITY; KINASE PATHWAY; TYROSINE PHOSPHATASES; TRANSMEMBRANE PROTEIN; TRANSCRIPTION FACTOR; OSMOTIC-STRESS; MESSENGER-RNA	Accumulation of unfolded proteins in the endoplasmic reticulum (ER) triggers the so-called unfolded protein response (UPR), a conserved signaling pathway that drives the transcription of genes such as chaperones and folding enzymes. Nevertheless, the activity of the UPR accounts only for a part of the gene expression program activated upon ER stress. Moreover, the mechanism(s) for how cells adapt and survive to this stress are largely unknown. Here, we show that the yeast high osmolarity glycerol (HOG) pathway plays a role in ER stress resistance. Strains lacking the MAPK Hog1p displayed sensitivity to tunicamycin or beta-mercaptoethanol, whereas hyperactivation of the pathway enhanced their resistance. However, these effects were not due to Hog1p-mediated regulation of the UPR. Northern blot analysis demonstrated that Hog1p controls the tunicamycin-induced transcriptional change of GPD1 and that wild-type cells exposed to the drug accumulated glycerol in a Hog1p-dependent manner. Consistent with this, deletion of genes involved in glycerol synthesis caused increased sensitivity to tunicamycin, whereas overexpression of GPD1 provided higher tolerance to both wildtype and hog1 Delta mutant cells. Quite remarkably, these effects were mediated by the basal activity of the MAPK because tunicamycin exposure does not trigger the phosphorylation of Hog1p or its nuclear import. Hence, our results describe new aspects of the yeast response to ER stress and identify additional functions of glycerol and the Hog1p MAPK to provide stress resistance.	[Garcia-Marques, Sara; Randez-Gil, Francisca; Prieto, Jose A.] Consejo Super Invest Cient, Inst Agroquim & Tecnol Alimentos, Dept Biotechnol, E-46100 Valencia, Spain; [Torres-Quiroz, Francisco; Coria, Roberto] Univ Nacl Autonoma Mexico, Dept Mol Genet, Inst Fisiol Celular, Mexico City 04510, DF, Mexico	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); Universidad Nacional Autonoma de Mexico	Prieto, JA (corresponding author), Consejo Super Invest Cient, Inst Agroquim & Tecnol Alimentos, Dept Biotechnol, POB 73, E-46100 Valencia, Spain.	prieto@iata.csic.es	Torres-Quiroz, Francisco/L-4643-2019; Prieto, Jose A/H-4646-2012; Randez-Gil, Francisca/H-2868-2012; Torres-Quiroz, Francisco/E-3704-2012	Torres-Quiroz, Francisco/0000-0002-3073-8546; Prieto, Jose A/0000-0001-9677-0023; Randez-Gil, Francisca/0000-0001-8217-3156; 	Ministry of Science and Technology of Spain [AGL2007-65498-C02-01]; Instituto de Fisiologia Celular, Universidad Nacional Autonoma de Mexico CONACyT [80343]	Ministry of Science and Technology of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Fisiologia Celular, Universidad Nacional Autonoma de Mexico CONACyT	This work was supported by the Comision Interministerial de Ciencia y Tecnologia project (AGL2007-65498-C02-01) from the Ministry of Science and Technology of Spain. This work was also supported in part by Instituto de Fisiologia Celular, Universidad Nacional Autonoma de Mexico CONACyT Grant 80343.	Aguilera J, 2005, MOL MICROBIOL, V56, P228, DOI 10.1111/j.1365-2958.2005.04533.x; ALBERTYN J, 1994, MOL CELL BIOL, V14, P4135, DOI 10.1128/MCB.14.6.4135; Alepuz PM, 2003, EMBO J, V22, P2433, DOI 10.1093/emboj/cdg243; Alepuz PM, 2001, MOL CELL, V7, P767, DOI 10.1016/S1097-2765(01)00221-0; Ansell R, 1997, EMBO J, V16, P2179, DOI 10.1093/emboj/16.9.2179; Back SH, 2005, METHODS, V35, P395, DOI 10.1016/j.ymeth.2005.03.001; Bahn YS, 2008, EUKARYOT CELL, V7, P2017, DOI 10.1128/EC.00323-08; Bell M, 2003, J BIOL CHEM, V278, P14603, DOI 10.1074/jbc.C300006200; Bermejo C, 2008, MOL BIOL CELL, V19, P1113, DOI 10.1091/mbc.E07-08-0742; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Bolen D W, 2001, Methods Mol Biol, V168, P17; Bolen DW, 2008, ANNU REV BIOCHEM, V77, P339, DOI 10.1146/annurev.biochem.77.061306.131357; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Bonilla M, 2002, EMBO J, V21, P2343, DOI 10.1093/emboj/21.10.2343; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chapman R, 1998, ANNU REV CELL DEV BI, V14, P459, DOI 10.1146/annurev.cellbio.14.1.459; Chen YJ, 2005, MOL CANCER RES, V3, P669, DOI 10.1158/1541-7786.MCR-05-0181; CIRIACY M, 1975, MOL GEN GENET, V138, P157, DOI 10.1007/BF02428119; Cohen TJ, 2008, EUKARYOT CELL, V7, P1191, DOI 10.1128/EC.00059-08; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; de Nadal E, 2010, EMBO J, V29, P4, DOI 10.1038/emboj.2009.346; Dihazi H, 2004, J BIOL CHEM, V279, P23961, DOI 10.1074/jbc.M312974200; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Gacto M, 2003, INT MICROBIOL, V6, P211, DOI 10.1007/s10123-003-0136-x; Garcia-Rodriguez LJ, 2000, J BACTERIOL, V182, P2428, DOI 10.1128/JB.182.9.2428-2437.2000; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Hohmann S, 2007, METHOD ENZYMOL, V428, P29, DOI 10.1016/S0076-6879(07)28002-4; Hohmann S, 2009, FEBS LETT, V583, P4025, DOI 10.1016/j.febslet.2009.10.069; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jacoby T, 1997, J BIOL CHEM, V272, P17749, DOI 10.1074/jbc.272.28.17749; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kim S, 2007, FEBS LETT, V581, P1209, DOI 10.1016/j.febslet.2007.02.032; Krysan Damian J, 2009, Commun Integr Biol, V2, P233; Kumar R, 2009, ARCH BIOCHEM BIOPHYS, V491, P1, DOI 10.1016/j.abb.2009.09.007; Lawrence CL, 2004, MOL CELL BIOL, V24, P3307, DOI 10.1128/MCB.24.8.3307-3323.2004; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Macia J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000056; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; Mattison CP, 2000, GENE DEV, V14, P1229; MORI K, 1993, CELL, V74, P743; Mori K, 1996, GENES CELLS, V1, P803, DOI 10.1046/j.1365-2443.1996.d01-274.x; O'Rourke SM, 2004, MOL BIOL CELL, V15, P532, DOI 10.1091/mbc.E03-07-0521; O'Rourke SM, 2002, TRENDS GENET, V18, P405, DOI 10.1016/S0168-9525(02)02723-3; Panadero J, 2006, J BIOL CHEM, V281, P4638, DOI 10.1074/jbc.M512736200; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; PLATT T, 1972, EXPT MOL GENETICS, P352; Proft M, 2002, MOL CELL, V9, P1307, DOI 10.1016/S1097-2765(02)00557-9; Rassow J, 1997, TRENDS CELL BIOL, V7, P129, DOI 10.1016/S0962-8924(96)10056-8; Reiser V, 1999, MOL BIOL CELL, V10, P1147, DOI 10.1091/mbc.10.4.1147; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Reynolds TB, 1998, J CELL BIOL, V143, P935, DOI 10.1083/jcb.143.4.935; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Saito H, 2004, J BIOCHEM, V136, P267, DOI 10.1093/jb/mvh135; SCHLENSTEDT G, 1995, J CELL BIOL, V129, P979, DOI 10.1083/jcb.129.4.979; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Scrimale T, 2009, MOL BIOL CELL, V20, P164, DOI 10.1091/mbc.E08-08-0809; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sherman F., 1986, METHODS YEAST GENETI; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Thorsen M, 2006, MOL BIOL CELL, V17, P4400, DOI 10.1091/mbc.E06-04-0315; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Westfall PJ, 2008, P NATL ACAD SCI USA, V105, P12212, DOI 10.1073/pnas.0805797105; Westfall PJ, 2006, EUKARYOT CELL, V5, P1215, DOI 10.1128/EC.00037-06; Winkler A, 2002, EUKARYOT CELL, V1, P163, DOI 10.1128/EC.1.2.163-173.2002; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289, DOI 10.1128/MCB.17.3.1289; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	75	45	46	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20088	20096		10.1074/jbc.M109.063578	http://dx.doi.org/10.1074/jbc.M109.063578			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20430884	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000279012000043
J	Whisstock, JC; Silverman, GA; Bird, PI; Bottomley, SP; Kaiserman, D; Luke, CJ; Pak, SC; Reichhart, JM; Huntington, JA				Whisstock, James C.; Silverman, Gary A.; Bird, Phillip I.; Bottomley, Stephen P.; Kaiserman, Dion; Luke, Cliff J.; Pak, Stephen C.; Reichhart, Jean-Marc; Huntington, James A.			Serpins Flex Their Muscle II. STRUCTURAL INSIGHTS INTO TARGET PEPTIDASE RECOGNITION, POLYMERIZATION, AND TRANSPORT FUNCTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CRYSTAL-STRUCTURE; ALPHA(1)-ANTITRYPSIN DEFICIENCY; ALLOSTERIC MECHANISM; PROTEASE COMPLEX; MOLECULAR-BASIS; REVEALS; HEPARIN; MASPIN; FIBRINOLYSIS; SUPERFAMILY	Inhibitory serpins are metastable proteins that undergo a substantial conformational rearrangement to covalently trap target peptidases. The serpin reactive center loop contributes a majority of the interactions that serpins make during the initial binding to target peptidases. However, structural studies on serpin-peptidase complexes reveal a broader set of contacts on the scaffold of inhibitory serpins that have substantial influence on guiding peptidase recognition. Structural and biophysical studies also reveal how aberrant serpin folding can lead to the formation of domain-swapped serpin multimers rather than the monomeric metastable state. Serpin domain swapping may therefore underlie the polymerization events characteristic of the serpinopathies. Finally, recent structural studies reveal how the serpin fold has been adapted for non-inhibitory functions such as hormone binding.	[Whisstock, James C.; Bird, Phillip I.; Bottomley, Stephen P.; Kaiserman, Dion] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Whisstock, James C.; Bird, Phillip I.; Bottomley, Stephen P.; Kaiserman, Dion] Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic 3800, Australia; [Silverman, Gary A.; Luke, Cliff J.; Pak, Stephen C.] Univ Pittsburgh, Dept Pediat & Cell Biol, Childrens Hosp Pittsburgh, Sch Med, Pittsburgh, PA 15201 USA; [Silverman, Gary A.; Luke, Cliff J.; Pak, Stephen C.] Univ Pittsburgh, Dept Physiol, Childrens Hosp Pittsburgh, Sch Med, Pittsburgh, PA 15201 USA; [Silverman, Gary A.; Luke, Cliff J.; Pak, Stephen C.] Univ Pittsburgh, Magee Womens Hosp, Sch Med, Pittsburgh, PA 15201 USA; [Reichhart, Jean-Marc] Univ Strasbourg, CNRS, UPR 9022, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France; [Huntington, James A.] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge CB2 0XY, England	Monash University; Monash University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Cambridge	Silverman, GA (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	james.whisstock@monash.edu.au; gsilverman@upmc.edu	Silverman, Gary/AAJ-1269-2020	Whisstock, James/0000-0003-4200-5611; Pak, Stephen/0000-0002-8089-3237; Bird, Phillip/0000-0002-6695-606X	National Institutes of Health [DK079806, DK081422, HL68629]; National Health and Medical Research Council Australia [490900]; Medical Research Council; Institut Universitaire de France; CNRS; Agence Nationale de la Recherche; Fondation pour la Recherche Medicale; Hartwell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079806, R01DK081422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Institut Universitaire de France; CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Hartwell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK079806 and DK081422 (to G. A. S.) and HL68629 (to J. A. H.); National Health and Medical Research Council Australia Program Grant 490900 (to P. I. B., S. P. B., and J. C. W.); the Medical Research Council (to J. A. H.); The Hartwell Foundation (to G. A. S.); and the Institut Universitaire de France, CNRS, Agence Nationale de la Recherche, and Fondation pour la Recherche Medicale (to J.-M. R.). This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Baglin TP, 2002, P NATL ACAD SCI USA, V99, P11079, DOI 10.1073/pnas.162232399; Bailey CM, 2006, J CELL PHYSIOL, V209, P617, DOI 10.1002/jcp.20782; Bailey CM, 2005, J BIOL CHEM, V280, P34210, DOI 10.1074/jbc.M503523200; Bennett MJ, 2006, STRUCTURE, V14, P811, DOI 10.1016/j.str.2006.03.011; Cabrita LD, 2007, J BIOL CHEM, V282, P26802, DOI 10.1074/jbc.M705020200; Filleur S, 2009, J CELL BIOCHEM, V106, P769, DOI 10.1002/jcb.22072; Fulton KF, 2005, J BIOL CHEM, V280, P8435, DOI 10.1074/jbc.M410206200; Gao F, 2004, DEVELOPMENT, V131, P1479, DOI 10.1242/dev.01048; Gettins PGW, 2009, J BIOL CHEM, V284, P20441, DOI 10.1074/jbc.R800064200; Gooptu B, 2009, EUR RESPIR J, V34, P475, DOI 10.1183/09031936.00096508; GOOPTU B, 2009, BNN REV BIOCH, V78, P147; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Huntington JA, 2006, TRENDS BIOCHEM SCI, V31, P427, DOI 10.1016/j.tibs.2006.06.005; Irving JA, 2003, STRUCTURE, V11, P387, DOI 10.1016/S0969-2126(03)00057-1; Irving JA, 2002, MOL BIOL EVOL, V19, P1881, DOI 10.1093/oxfordjournals.molbev.a004012; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; Kang SH, 2006, MOL MICROBIOL, V60, P1344, DOI 10.1111/j.1365-2958.2006.05182.x; Law RHP, 2008, BLOOD, V111, P2049, DOI 10.1182/blood-2007-09-114215; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; Li W, 2008, P NATL ACAD SCI USA, V105, P4661, DOI 10.1073/pnas.0711055105; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Nagata K, 2003, SEMIN CELL DEV BIOL, V14, P275, DOI 10.1016/j.semcdb.2003.09.020; Perlmutter DH, 2002, J CLIN INVEST, V110, P1579, DOI 10.1172/JCI200216787; Silverman GA, 2010, J BIOL CHEM, V285, P24299, DOI 10.1074/jbc.R110.112771; STEIN PE, 1995, NAT STRUCT BIOL, V2, P96, DOI 10.1038/nsb0295-96; Teoh SSY, 2010, J BIOL CHEM, V285, P10862, DOI 10.1074/jbc.M109.073171; Wei ZQ, 2009, BLOOD, V114, P3662, DOI 10.1182/blood-2009-04-210021; Whisstock JC, 2006, CURR OPIN STRUC BIOL, V16, P761, DOI 10.1016/j.sbi.2006.10.005; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Ye S, 2001, NAT STRUCT BIOL, V8, P979, DOI 10.1038/nsb1101-979; YU MH, 1995, NAT STRUCT BIOL, V2, P363, DOI 10.1038/nsb0595-363; Zhang Q, 2007, EMBO REP, V8, P658, DOI 10.1038/sj.embor.7400986; Zhou AW, 2008, J MOL BIOL, V380, P244, DOI 10.1016/j.jmb.2008.05.012; Zhou AW, 2006, P NATL ACAD SCI USA, V103, P13321, DOI 10.1073/pnas.0604080103; Zhou AW, 2003, NAT STRUCT BIOL, V10, P541, DOI 10.1038/nsb943	36	86	90	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24307	24312		10.1074/jbc.R110.141408	http://dx.doi.org/10.1074/jbc.R110.141408			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20498368	hybrid, Green Published			2022-12-27	WOS:000280542100002
J	Bernal, P; Lemaire, S; Pinho, MG; Mobashery, S; Hinds, J; Taylor, PW				Bernal, Patricia; Lemaire, Sandrine; Pinho, Mariana G.; Mobashery, Shahriar; Hinds, Jason; Taylor, Peter W.			Insertion of Epicatechin Gallate into the Cytoplasmic Membrane of Methicillin-resistant Staphylococcus aureus Disrupts Penicillin-binding Protein (PBP) 2a-mediated beta-Lactam Resistance by Delocalizing PBP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL SYNTHESIS; TEA CATECHINS; EPIGALLOCATECHIN GALLATE; PHOSPHOLIPID-COMPOSITION; LIPID-BILAYERS; GREEN TEA; IN-VITRO; ANTIBIOTICS; DIVISION; SUSCEPTIBILITY	Epicatechin gallate (ECg) sensitizes methicillin-resistant Staphylococcus aureus (MRSA) to oxacillin and other beta-lactam agents; it also reduces the secretion of virulence-associated proteins, prevents biofilm formation, and induces gross morphological changes in MRSA cells without compromising the growth rate. MRSA is resistant to oxacillin because of the presence of penicillin-binding protein 2a (PBP2a), which allows peptidoglycan synthesis to continue after oxacillin-mediated acylation of native PBPs. We show that ECg binds predominantly to the cytoplasmic membrane (CM), initially decreasing the fluidity of the bilayer, and induces changes in gene expression indicative of an attempt to preserve and repair a compromised cell wall. On further incubation, the CM is reorganized; the amount of lysylphosphatidylglycerol is markedly reduced, with a concomitant increase in phosphatidylglycerol, and the proportion of branched chain fatty acids increases, resulting in a more fluid structure. We found no evidence that ECg modulates the enzymatic activity of PBP2a through direct binding to the protein but determined that PBP2 is delocalized from the FtsZ-anchored cell wall biosynthetic machinery at the septal division site following intercalation into the CM. We argue that many features of the ECg-induced phenotype can be explained by changes in the fluid dynamics of the CM.	[Bernal, Patricia; Taylor, Peter W.] Univ London, Sch Pharm, London WC1N 1AX, England; [Lemaire, Sandrine] Catholic Univ Louvain, Unite Pharmacol Cellulaire & Mol, B-1200 Brussels, Belgium; [Pinho, Mariana G.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Bacterial Cell Biol Lab, P-2781901 Oeiras, Portugal; [Mobashery, Shahriar] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Hinds, Jason] Univ London, Dept Cellular & Mol Med, London SW17 0RE, England	University of London; University College London; University of London School of Pharmacy; Universite Catholique Louvain; Universidade Nova de Lisboa; University of Notre Dame; University of London	Taylor, PW (corresponding author), Univ London, Sch Pharm, 29-39 Brunswick Sq, London WC1N 1AX, England.	peter.taylor@pharmacy.ac.uk	Pinho, Mariana/B-9192-2008; Bernal, Patricia/K-6399-2014	Pinho, Mariana/0000-0002-7132-8842; Bernal, Patricia/0000-0002-6228-0496; Hinds, Jason/0000-0002-2739-1908	Medical Research Council [G0600004]; Fundacao para a Ciencia e Tecnologia [PTDC/BIA-MIC/67845/2006]; Wellcome Trust; MRC [G0600004] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Research Grant G0600004 from the Medical Research Council.; Supported by Research Grant PTDC/BIA-MIC/67845/2006 from Fundacao para a Ciencia e Tecnologia.; We acknowledge the Bacterial Microarray Group at St. George's for supply of the microarray and the Wellcome Trust for funding the multicollaborative microbial pathogen microarray facility under its Functional Genomics Resources Initiative. We are grateful to Elena Lastochkin for purification of PBP2a and Yukihiko Hara for supply of [<SUP>3</SUP>H] ECg. We thank Anna Przyborowska (King's College London) for undertaking the fatty acid analyses and Kersti Karu (London School of Pharmacy) for MS identification of lysophosphatidylglycerol. We thank Jeff Errington (University of Newcastle) for the FtsZ antibody.	AMES GF, 1968, J BACTERIOL, V95, P833, DOI 10.1128/JB.95.3.833-843.1968; Baltz RH, 2009, CURR OPIN CHEM BIOL, V13, P144, DOI 10.1016/j.cbpa.2009.02.031; Benfield T, 2007, CLIN MICROBIOL INFEC, V13, P257, DOI 10.1111/j.1469-0691.2006.01589.x; Bernal P, 2007, ENVIRON MICROBIOL, V9, P1135, DOI 10.1111/j.1462-2920.2006.01236.x; Bernal P, 2009, J ANTIMICROB CHEMOTH, V63, P1156, DOI 10.1093/jac/dkp094; Blanco AR, 2005, ANTIMICROB AGENTS CH, V49, P4339, DOI 10.1128/AAC.49.10.4339-4343.2005; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Caturla N, 2003, FREE RADICAL BIO MED, V34, P648, DOI 10.1016/S0891-5849(02)01366-7; Chung M, 2008, ANTIMICROB AGENTS CH, V52, P2709, DOI 10.1128/AAC.00266-08; Denich TJ, 2003, J MICROBIOL METH, V52, P149, DOI 10.1016/S0167-7012(02)00155-0; Deurenberg RH, 2008, INFECT GENET EVOL, V8, P747, DOI 10.1016/j.meegid.2008.07.007; Doyle M, 2009, J ANTIMICROB CHEMOTH, V64, P949, DOI 10.1093/jac/dkp325; Eliopoulos GM, 2009, J INFECTION, V59, pS17, DOI 10.1016/S0163-4453(09)60004-9; Ernst CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000660; Fuda C, 2004, J BIOL CHEM, V279, P40802, DOI 10.1074/jbc.M403589200; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; HAEST CWM, 1972, BIOCHIM BIOPHYS ACTA, V255, P720, DOI 10.1016/0005-2736(72)90385-9; Hamilton-Miller JMT, 1999, FEMS MICROBIOL LETT, V176, P463, DOI 10.1111/j.1574-6968.1999.tb13698.x; Hashimoto T, 1999, BIOSCI BIOTECH BIOCH, V63, P2252, DOI 10.1271/bbb.63.2252; Kajiya K, 2002, BIOSCI BIOTECH BIOCH, V66, P2330, DOI 10.1271/bbb.66.2330; Kajiya K, 2001, BIOSCI BIOTECH BIOCH, V65, P2638, DOI 10.1271/bbb.65.2638; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kumamoto M, 2001, BIOSCI BIOTECH BIOCH, V65, P126, DOI 10.1271/bbb.65.126; Kumazawa S, 2004, BIOSCI BIOTECH BIOCH, V68, P1743, DOI 10.1271/bbb.68.1743; Kuroda M, 2003, MOL MICROBIOL, V49, P807, DOI 10.1046/j.1365-2958.2003.03599.x; Lemaire S, 2008, J BIOL CHEM, V283, P12769, DOI 10.1074/jbc.M800079200; Lennarz W J, 1966, Adv Lipid Res, V4, P175; Martinez JL, 2007, NAT REV MICROBIOL, V5, P958, DOI 10.1038/nrmicro1796; McAleese F, 2006, J BACTERIOL, V188, P1120, DOI 10.1128/JB.188.3.1120-1133.2006; Mukhopadhyay K, 2007, MICROBIOL-SGM, V153, P1187, DOI 10.1099/mic.0.2006/003111-0; Muthaiyan A, 2008, ANTIMICROB AGENTS CH, V52, P980, DOI 10.1128/AAC.01121-07; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Pereira PM, 2007, ANTIMICROB AGENTS CH, V51, P3627, DOI 10.1128/AAC.00431-07; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; Pinho MG, 2005, MOL MICROBIOL, V55, P799, DOI 10.1111/j.1365-2958.2004.04420.x; Pinho MG, 2003, MOL MICROBIOL, V50, P871, DOI 10.1046/j.1365-2958.2003.03719.x; Pinho MG, 2001, P NATL ACAD SCI USA, V98, P10886, DOI 10.1073/pnas.191260798; Pinho MG, 1997, MICROB DRUG RESIST, V3, P409, DOI 10.1089/mdr.1997.3.409; Sass V, 2008, INT J MED MICROBIOL, V298, P619, DOI 10.1016/j.ijmm.2008.01.011; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; Shah S, 2008, LETT APPL MICROBIOL, V46, P181, DOI 10.1111/j.1472-765X.2007.02296.x; Shakil S, 2008, J CHEMOTHERAPY, V20, P411, DOI 10.1179/joc.2008.20.4.411; SHORT SA, 1971, J BACTERIOL, V108, P219, DOI 10.1128/JB.108.1.219-226.1971; Sorlozano A, 2010, EUR J CLIN MICROBIOL, V29, P73, DOI 10.1007/s10096-009-0823-4; Stapleton PD, 2007, MICROBIOL-SGM, V153, P2093, DOI 10.1099/mic.0.2007/007807-0; Stapleton PD, 2006, INT J FOOD MICROBIOL, V111, P276, DOI 10.1016/j.ijfoodmicro.2006.06.005; Stapleton PD, 2006, ANTIMICROB AGENTS CH, V50, P752, DOI 10.1128/AAC.50.2.752-755.2006; Stapleton PD, 2004, INT J ANTIMICROB AG, V23, P462, DOI 10.1016/j.ijantimicag.2003.09.027; SUTTON GC, 1990, BIOCHEM SOC T, V18, P950, DOI 10.1042/bst0180950; Taylor Peter W, 2005, Food Sci Technol Bull, V2, P71, DOI 10.1616/1476-2137.14184; Taylor PW, 2009, PHARM RES SAF TEST, P43; Trevors JT, 2003, J BIOCHEM BIOPH METH, V57, P87, DOI 10.1016/S0165-022X(03)00076-9; Utaida S, 2003, MICROBIOL-SGM, V149, P2719, DOI 10.1099/mic.0.26426-0; Velayutham P, 2008, CURR MED CHEM, V15, P1840; Wilkinson Brian J., 2005, Current Medicinal Chemistry - Anti-Infective Agents, V4, P259, DOI 10.2174/1568012054368119; Witney AA, 2005, APPL ENVIRON MICROB, V71, P7504, DOI 10.1128/AEM.71.11.7504-7514.2005; Zapun A, 2008, FEMS MICROBIOL REV, V32, P345, DOI 10.1111/j.1574-6976.2007.00098.x	59	51	56	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24055	24065		10.1074/jbc.M110.114793	http://dx.doi.org/10.1074/jbc.M110.114793			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20516078	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000280291400056
J	Deghorain, M; Fontaine, L; David, B; Mainardi, JL; Courtin, P; Daniel, R; Errington, J; Sorokin, A; Bolotin, A; Chapot-Chartier, MP; Hallet, B; Hols, P				Deghorain, Marie; Fontaine, Laetitia; David, Blandine; Mainardi, Jean-Luc; Courtin, Pascal; Daniel, Richard; Errington, Jeff; Sorokin, Alexei; Bolotin, Alexander; Chapot-Chartier, Marie-Pierre; Hallet, Bernard; Hols, Pascal			Functional and Morphological Adaptation to Peptidoglycan Precursor Alteration in Lactococcus lactis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL SYNTHESIS; STAPHYLOCOCCUS-AUREUS; VANCOMYCIN RESISTANCE; IDENTIFICATION; MORPHOGENESIS; MUTANTS	Cell wall peptidoglycan assembly is a tightly regulated process requiring the combined action of multienzyme complexes. In this study we provide direct evidence showing that substrate transformations occurring at the different stages of this process play a crucial role in the spatial and temporal coordination of the cell wall synthesis machinery. Peptidoglycan substrate alteration was investigated in the Gram-positive bacterium Lactococcus lactis by substituting the peptidoglycan precursor biosynthesis genes of this bacterium for those of the vancomycin-resistant bacterium Lactobacillus plantarum. A set of L. lactis mutant strains in which the normal D-Ala-ended precursors were partially or totally replaced by D-Lac-ended precursors was generated. Incorporation of the altered precursor into the cell wall induced morphological changes arising from a defect in cell elongation and cell separation. Structural analysis of the muropeptides confirmed that the activity of multiple enzymes involved in peptidoglycan synthesis was altered. Optimization of this altered pathway was necessary to increase the level of vancomycin resistance conferred by the utilization of D-Lac-ended peptidoglycan precursors in the mutant strains. The implications of these findings on the control of bacterial cell morphogenesis and the mechanisms of vancomycin resistance are discussed.	[Hallet, Bernard] Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain La Neuve, Belgium; [Mainardi, Jean-Luc] Ctr Rech Cordeliers, Equipe 12, INSERM, LRMA,U872, F-75006 Paris, France; [Mainardi, Jean-Luc] Univ Paris 06, UMR S 872, F-75006 Paris, France; [Mainardi, Jean-Luc] Univ Paris 05, UMR S872, F-75006 Paris, France; [Mainardi, Jean-Luc] Hop Europeen Georges Pompidou, AP HP, F-75015 Paris, France; [Chapot-Chartier, Marie-Pierre] INRA, Micalis UMR1319, F-78352 Jouy En Josas, France; [Daniel, Richard; Errington, Jeff] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Sorokin, Alexei; Bolotin, Alexander] CRJ INRA, TGU MICALIS, Genome Anal Team ANALGEN, F-78352 Jouy En Josas, France	Universite Catholique Louvain; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Newcastle University - UK; INRAE	Hallet, B (corresponding author), Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain La Neuve, Belgium.	Bernard.Hallet@uclouvain.be	Sorokin, Alexei/AAV-4666-2020; Errington, Jeff/G-1832-2011; Daniel, Richard A./I-2850-2019; MAINARDI, Jean-Luc/E-2714-2014; Bolotine, Alexandre/AAW-1156-2020	Sorokin, Alexei/0000-0002-8653-9896; Errington, Jeff/0000-0002-6977-9388; Daniel, Richard A./0000-0002-6483-5897; MAINARDI, Jean-Luc/0000-0002-4159-0129; Bolotine, Alexandre/0000-0002-5878-8270; Chapot-Chartier, Marie-Pierre/0000-0002-4947-0519	Fonds Speciaux de la Recherche (Universite Catholique de Louvain); Fonds National de la Recherche Scientifique; Actions de Recherche Concertees (Communaute Francaise de Belgique); Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom; European Molecular Biology Organization; INRA	Fonds Speciaux de la Recherche (Universite Catholique de Louvain); Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Actions de Recherche Concertees (Communaute Francaise de Belgique); Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); INRA	This work was supported by Fonds Speciaux de la Recherche (Universite Catholique de Louvain), Fonds National de la Recherche Scientifique, and Actions de Recherche Concertees (Communaute Francaise de Belgique). This work was also supported by a grant from the Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom, and a short-term European Molecular Biology Organization fellowship (to M. D.).; We warmly thank J. Delcour for helpful discussions and scientific advice. We are grateful to M. Arthur for the MS/MS determination of muropeptides I and II and to A. Marnef for the construction of the MD006 strain. We thank Dr. S. Kulakauskas for help in L. lactis MD003-128 sequencing and Dr. S. Kennedy and N. Galleron (MetaQuant sequencing platform) for preparing the amplicon libraries and for preliminary data analysis. Sequencing of MD003-128 was supported in part by the program AIP BioRessources 2009 of INRA (project SOLIMUT).	Arbeloa A, 2004, J BIOL CHEM, V279, P41546, DOI 10.1074/jbc.M407149200; Arthur M, 1996, MOL MICROBIOL, V21, P33, DOI 10.1046/j.1365-2958.1996.00617.x; ARTHUR M, 1992, J BACTERIOL, V174, P2582, DOI 10.1128/jb.174.8.2582-2591.1992; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; BEGG KJ, 1990, J BACTERIOL, V172, P6697, DOI 10.1128/jb.172.12.6697-6703.1990; BillotKlein D, 1996, BIOCHEM J, V313, P711, DOI 10.1042/bj3130711; Bouhss A, 2002, J BIOL CHEM, V277, P45935, DOI 10.1074/jbc.M207449200; Cabeen MT, 2007, J CELL BIOL, V179, P381, DOI 10.1083/jcb.200708001; Carballido-Lopez R, 2007, CURR OPIN MICROBIOL, V10, P611, DOI 10.1016/j.mib.2007.09.008; Courtin P, 2006, J BACTERIOL, V188, P5293, DOI 10.1128/JB.00285-06; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; Deghorain M, 2007, J BACTERIOL, V189, P4332, DOI 10.1128/JB.01829-06; deJonge BLM, 1996, MICROB DRUG RESIST, V2, P225, DOI 10.1089/mdr.1996.2.225; den Blaauwen T, 2008, FEMS MICROBIOL REV, V32, P321, DOI 10.1111/j.1574-6976.2007.00090.x; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Ferain T, 1996, J BACTERIOL, V178, P5431, DOI 10.1128/JB.178.18.5431-5437.1996; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; LLEO MM, 1990, J BACTERIOL, V172, P3758, DOI 10.1128/jb.172.7.3758-3771.1990; Morlot C, 2004, MOL MICROBIOL, V51, P1641, DOI 10.1046/j.1365-2958.2003.03953.x; Ng WL, 2004, MOL MICROBIOL, V53, P1161, DOI 10.1111/j.1365-2958.2004.04196.x; Pinho MG, 2005, MOL MICROBIOL, V55, P799, DOI 10.1111/j.1365-2958.2004.04420.x; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; SCHUSTER C, 1990, J BACTERIOL, V172, P6499, DOI 10.1128/jb.172.11.6499-6505.1990; Seidl K, 2006, ANTIMICROB AGENTS CH, V50, P1183, DOI 10.1128/AAC.50.4.1183-1194.2006; Severin A, 2004, J BIOL CHEM, V279, P3398, DOI 10.1074/jbc.M309593200; Thibessard A, 2002, J BACTERIOL, V184, P2821, DOI 10.1128/JB.184.10.2821-2826.2002; vanKranenburg R, 1997, MOL MICROBIOL, V24, P387, DOI 10.1046/j.1365-2958.1997.3521720.x; Veiga P, 2006, MOL MICROBIOL, V62, P1713, DOI 10.1111/j.1365-2958.2006.05474.x; Veiga P, 2009, J BACTERIOL, V191, P3752, DOI 10.1128/JB.00126-09; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; Zapun A, 2008, FEMS MICROBIOL REV, V32, P345, DOI 10.1111/j.1574-6976.2007.00098.x; Zomer AL, 2007, J BACTERIOL, V189, P1366, DOI 10.1128/JB.01013-06	36	8	9	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24003	24013		10.1074/jbc.M110.143636	http://dx.doi.org/10.1074/jbc.M110.143636			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20525686	hybrid, Green Published			2022-12-27	WOS:000280291400051
J	Yang, JH; Shelat, NY; Bush, CA; Cisar, JO				Yang, Jinghua; Shelat, Nirav Y.; Bush, C. Allen; Cisar, John O.			Structure and Molecular Characterization of Streptococcus pneumoniae Capsular Polysaccharide 10F by Carbohydrate Engineering in Streptococcus oralis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGGREGATION RECEPTOR POLYSACCHARIDES; CELL-SURFACE POLYSACCHARIDE; ACTINOMYCES-NAESLUNDII; WALL POLYSACCHARIDES; BIOSYNTHETIC LOCI; C-POLYSACCHARIDE; NMR; IDENTIFICATION; RECOGNITION; ASSIGNMENT	Although closely related at the molecular level, the capsular polysaccharide (CPS) of serotype 10F Streptococcus pneumoniae and coaggregation receptor polysaccharide (RPS) of Streptococcus oralis C104 have distinct ecological roles. CPS prevents phagocytosis of pathogenic S. pneumoniae, whereas RPS of commensal S. oralis functions as a receptor for lectin-like adhesins on other members of the dental plaque biofilm community. Results from high resolution NMR identified the recognition region of S. oralis RPS (i.e. Galf beta 1-6GalNAc beta 1-3Gal alpha) in the hexasaccharide repeat of S. pneumoniae CPS10F. The failure of this polysaccharide to support fimbriae-mediated adhesion of Actinomyces naeslundii was explained by the position of Galf, which occurred as a branch in CPS10F rather than within the linear polysaccharide chain, as in RPS. Carbohydrate engineering of S. oralis RPS with wzy from S. pneumoniae attributed formation of the Galf branch in CPS10F to the linkage of adjacent repeating units through sub terminal GalNAc in Galf beta 1-6GalNAc beta 1-3Gal alpha rather than through terminal Galf, as in RPS. A gene (wcrD) from serotype 10A S. pneumoniae was then used to engineer a linear surface polysaccharide in S. oralis that was identical to RPS except for the presence of a beta 1-3 linkage between Galf and GalNAc beta 1-3Gal alpha. This polysaccharide also failed to support adhesion of A. naeslundii, thereby establishing the essential role of beta 1-6-linked Galf in recognition of adjacent GalNAc beta 1-3Gal alpha in wild-type RPS. These findings, which illustrate a molecular approach for relating bacterial polysaccharide structure to function, provide insight into the possible evolution of S. oralis RPS from S. pneumoniae CPS.	[Yang, Jinghua; Cisar, John O.] NIDCR, Oral Infect & Immun Branch, NIH, Bethesda, MD 20892 USA; [Shelat, Nirav Y.; Bush, C. Allen] Univ Maryland, Dept Chem & Biochem, Baltimore, MD 21250 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University System of Maryland; University of Maryland Baltimore	Cisar, JO (corresponding author), NIDCR, Oral Infect & Immun Branch, NIH, Bldg 30,Rm 3A-301,30 Convent Dr, Bethesda, MD 20892 USA.	john.cisar@nih.gov		Yang, Jinghua/0000-0001-7140-5548	NIDCR, National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000672] Funding Source: NIH RePORTER	NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by the Intramural Research Program of the NIDCR, National Institutes of Health.	Aanensen DM, 2007, J BACTERIOL, V189, P7856, DOI 10.1128/JB.00837-07; ABEYGUNAWARDANA C, 1991, BIOCHEMISTRY-US, V30, P8568, DOI 10.1021/bi00099a012; ABEYGUNAWARDANA C, 1991, BIOCHEMISTRY-US, V30, P6528, DOI 10.1021/bi00240a025; Abeygunawardana C, 1993, ADV BIOPHYSICAL CHEM, V3, P199; BEIER RC, 1980, CAN J CHEM, V58, P2800, DOI 10.1139/v80-448; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Bishop CJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-3; CISAR JO, 1984, INFECT IMMUN, V46, P453, DOI 10.1128/IAI.46.2.453-458.1984; Cisar JO, 1997, INFECT IMMUN, V65, P5035, DOI 10.1128/IAI.65.12.5035-5041.1997; CISAR JO, 1995, GLYCOBIOLOGY, V5, P655, DOI 10.1093/glycob/5.7.655; CISAR JO, 1979, INFECT IMMUN, V24, P742, DOI 10.1128/IAI.24.3.742-752.1979; Coffey TJ, 1999, MICROBIOL-SGM, V145, P2023, DOI 10.1099/13500872-145-8-2023; Coffey TJ, 1998, MOL MICROBIOL, V27, P73, DOI 10.1046/j.1365-2958.1998.00658.x; DUBOIS M, 1956, ANAL CHEM, V28, P356; JONES C, 1995, CARBOHYD RES, V269, P175, DOI 10.1016/0008-6215(94)00340-L; Kabat E., 1961, EXPT IMMUNOCHEMISTRY; Kamerling J. P., 2000, STREPTOCOCCUS PNEUMO; Karlsson C, 1999, EUR J BIOCHEM, V265, P1091, DOI 10.1046/j.1432-1327.1999.00835.x; Kilian M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002683; Mavroidi A, 2007, J BACTERIOL, V189, P7841, DOI 10.1128/JB.00836-07; MCINTIRE FC, 1988, J BACTERIOL, V170, P2229, DOI 10.1128/jb.170.5.2229-2235.1988; NYVAD B, 1987, SCAND J DENT RES, V95, P369; Palmer RJ, 2003, J BACTERIOL, V185, P3400, DOI 10.1128/JB.185.11.3400-3409.2003; Palmer RJ, 2001, INFECT IMMUN, V69, P5794, DOI 10.1128/IAI.69.9.5794-5804.2001; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; Walz A, 2005, GLYCOBIOLOGY, V15, P700, DOI 10.1093/glycob/cwi049; Xu DQ, 2003, J BACTERIOL, V185, P5419, DOI 10.1128/JB.185.18.5419-5430.2003; Xu QW, 1996, BIOCHEMISTRY-US, V35, P14521, DOI 10.1021/bi961262+; Xu QW, 2005, ANAL BIOCHEM, V336, P262, DOI 10.1016/j.ab.2004.10.019; Yang JH, 2009, J BACTERIOL, V191, P1891, DOI 10.1128/JB.01532-08; Yoshida Y, 2005, MOL MICROBIOL, V58, P244, DOI 10.1111/j.1365-2958.2005.04820.x	31	12	13	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24217	24227		10.1074/jbc.M110.123562	http://dx.doi.org/10.1074/jbc.M110.123562			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20507989	Green Published, hybrid			2022-12-27	WOS:000280291400071
J	Zhai, BB; Yang, HQ; Mancini, A; He, QW; Antoniou, J; Di Battista, JA				Zhai, Beibei; Yang, Huiqing; Mancini, Arturo; He, QingWen; Antoniou, John; Di Battista, John A.			Leukotriene B-4 BLT Receptor Signaling Regulates the Level and Stability of Cyclooxygenase-2 (COX-2) mRNA through Restricted Activation of Ras/Raf/ERK/p42 AUF1 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSCRIPTIONAL GENE-REGULATION; HUMAN SYNOVIAL FIBROBLASTS; NECROSIS-FACTOR-ALPHA; BINDING-PROTEINS; 3'-UNTRANSLATED REGION; RHEUMATOID-ARTHRITIS; THERAPEUTIC TARGET; NUCLEAR EXPORT; KINASE PATHWAY; MAST-CELLS	Recent studies suggest that active resolution of the inflammatory response in animal models of arthritis may involve leukotriene B-4 (LTB4)-dependent stimulation of "intermediate" prostaglandin production, which in turn favors the synthesis of "downstream" anti-inflammatory and pro-resolving lipoxins, resolvins, and protectins. We explored a putative mechanism involving LTB4-dependent control of cyclooxygenase-2 (COX-2) expression, the rate-limiting step in inflammatory prostaglandin biosynthesis. Indeed, LTB4 potently up-regulated/stabilized interleukin-1 beta-induced COX-2 mRNA and protein expression under conditions of COX-2 inhibitor-dependent blockade of PGE(2) release in human synovial fibroblasts (EC50 = 16.5 +/- 1.7 nM for mRNA; 19 +/- 2.4 nM for protein, n = 4). The latter response was pertussis toxin-sensitive, and semi-quantitative reverse transcription-PCR confirmed the quantitative predominance of the BLT2 receptor. Transfection experiments, using human COX-2 promoter plasmids and chimeric luciferase-COX-2 mRNA 3'-untranslated region (3'-UTR) reporter constructs, revealed that LTB4 exerted its stabilizing effect at the post-transcriptional level through a 116-bp adenylate/uridylate-rich sequence in the proximal region of the COX-2 3'-UTR. Using luciferase-COX-2 mRNA 3'-UTR reporter constructs and Ras/c-Raf expression and mutant constructs, we showed that the Ras/c-Raf/MEK1/2/ERK1/2 signaling pathway mediated LTB4-dependent COX-2 mRNA stabilization. Knockdown experiments with specific short hairpin RNAs confirmed that LTB4 stabilization of COX-2 mRNA was apparently mediated through the RNA-binding protein, p42 AUF1. The nuclear export of p42 AUF1 was driven by c-Raf/MEK1/2/ERK1/2 signaling and sensitive to leptomycin B treatment, suggesting a CRM1-dependent mechanism. We conclude that LTB4 may support the resolution phase of the inflammatory response by stabilizing COX-2, ensuring a reservoir of ambient pro-resolution lipid mediators.	[Yang, Huiqing; He, QingWen; Di Battista, John A.] McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada; [Zhai, Beibei] McGill Univ, Dept Expt Med, Montreal, PQ H3A 1A1, Canada; [Mancini, Arturo] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 1A1, Canada; [Antoniou, John] Jewish Gen Hosp, Dept Orthopaed Surg, Montreal, PQ H3T 1E2, Canada	McGill University; McGill University; McGill University; McGill University	Di Battista, JA (corresponding author), McGill Univ, Ctr Hlth, Div Rheumatol & Clin Immunol, Royal Victoria Hosp, 687 Pine Ave,W,Rm M-11-22, Montreal, PQ H3A 1A1, Canada.	john.dibattista@mcgill.ca			Canadian Institutes for Health Research [M11557]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Canadian Institutes for Health Research Grant M11557 (to J.A.D.B.).	ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; APPLEBY SB, 1994, BIOCHEM J, V302, P723, DOI 10.1042/bj3020723; Burg ND, 2001, CLIN IMMUNOL, V99, P7, DOI 10.1006/clim.2001.5007; Campbell EL, 2007, FASEB J, V21, P3162, DOI 10.1096/fj.07-8473com; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Chen CYA, 2004, RNA, V10, P669, DOI 10.1261/rna.5269304; Clark A, 2009, FRONT BIOSCI-LANDMRK, V14, P847, DOI 10.2741/3282; Dean JLE, 2004, CELL SIGNAL, V16, P1113, DOI 10.1016/j.cellsig.2004.04.006; Dixon DA, 2000, J BIOL CHEM, V275, P11750, DOI 10.1074/jbc.275.16.11750; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Faour WH, 2005, J BIOL CHEM, V280, P9536, DOI 10.1074/jbc.M414067200; Faour WH, 2003, J BIOL CHEM, V278, P26897, DOI 10.1074/jbc.M212790200; Faour WH, 2001, J BIOL CHEM, V276, P31720, DOI 10.1074/jbc.M104036200; Faour WH, 2006, J BIOL CHEM, V281, P19849, DOI 10.1074/jbc.M601293200; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Hashimoto A, 2003, J RHEUMATOL, V30, P1712; He W, 2002, J RHEUMATOL, V29, P546; HOCHBERG MC, 1992, ARTHRITIS RHEUM, V35, P498, DOI 10.1002/art.1780350502; Kato K, 2000, J EXP MED, V192, P413, DOI 10.1084/jem.192.3.413; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; MANCINI A, 2008, OSTEOARTHRITIS CA S4, V16, pS16; Mancini A, 2007, INFLAMM RES, V56, pS374; Mazan-Mamczarz K, 2009, NUCLEIC ACIDS RES, V37, P204, DOI 10.1093/nar/gkn929; Meissner T, 2004, FEBS LETT, V576, P27, DOI 10.1016/j.febslet.2004.08.056; Metz M, 2007, IMMUNOL REV, V217, P304, DOI 10.1111/j.1600-065X.2007.00520.x; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; Okuno T, 2005, J BIOL CHEM, V280, P32049, DOI 10.1074/jbc.R500007200; Okuno T, 2008, J EXP MED, V205, P759, DOI 10.1084/jem.20072329; Rocca B, 2002, INT IMMUNOPHARMACOL, V2, P603, DOI 10.1016/S1567-5769(01)00204-1; Saklatvala J, 2004, CURR OPIN PHARMACOL, V4, P372, DOI 10.1016/j.coph.2004.03.009; Sandler H, 2008, BIOCHEM SOC T, V36, P491, DOI 10.1042/BST0360491; Sarkar B, 2003, J BIOL CHEM, V278, P20700, DOI 10.1074/jbc.M301176200; Sawaoka H, 2003, J BIOL CHEM, V278, P13928, DOI 10.1074/jbc.M300016200; Sengupta S, 2003, J BIOL CHEM, V278, P25227, DOI 10.1074/jbc.M301813200; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 1996, FASEB J, V10, P1147, DOI 10.1096/fasebj.10.10.8751717; Smyth EM, 2009, J LIPID RES, V50, pS423, DOI 10.1194/jlr.R800094-JLR200; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Wilson GM, 2003, J BIOL CHEM, V278, P33029, DOI 10.1074/jbc.M305772200; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Yuryev A, 2003, GENOMICS, V81, P112, DOI 10.1016/S0888-7543(02)00008-3; ZHAI B, 2008, OSTEOARTHRITIS CA S4, V16, pS189; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	50	23	26	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23568	23580		10.1074/jbc.M110.107623	http://dx.doi.org/10.1074/jbc.M110.107623			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20489206	hybrid, Green Published			2022-12-27	WOS:000280291400006
J	Ward, JR; West, PW; Ariaans, MP; Parker, LC; Francis, SE; Crossman, DC; Sabroe, I; Wilson, HL				Ward, Jon R.; West, Peter W.; Ariaans, Mark P.; Parker, Lisa C.; Francis, Sheila E.; Crossman, David C.; Sabroe, Ian; Wilson, Heather L.			Temporal Interleukin-1 beta Secretion from Primary Human Peripheral Blood Monocytes by P2X7-independent and P2X7-dependent Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P2X(7) RECEPTOR; IL-1-BETA RELEASE; MICROGLIAL CELLS; P2X7 RECEPTORS; MESSENGER-RNA; DYE UPTAKE; ATP; INFLAMMASOME; EXPRESSION; ACTIVATION	The processing and regulated secretion of IL-1 beta are critical points of control of the biological activity of this important pro-inflammatory cytokine. IL-1 beta is produced by both monocytes and macrophages, but the rate and mechanism of release differ according to the differentiation status and the origin of these cells. We aimed to study the control of processing and release in human blood monocytes and human monocyte-derived macrophages. Toll-like receptor (TLR)-induced IL-1 beta production and release were investigated for dependence upon caspase-1, P2X7 receptor activation, and loss of membrane asymmetry associated with microvesicle shedding. TLR agonists induced P2X7 receptor-dependent IL-1 beta release in both monocytes and macrophages; however, only monocytes also showed P2X7 receptor-independent release of mature IL-1 beta. Furthermore, in monocytes ATP-mediated PS exposure could be activated independently of IL-1 beta production. Release of IL-1 beta from monocytes showed selectivity for specific TLR agonists and was accelerated by P2X7 receptor activation. Human monocytes released more IL-1 beta/cell than macrophages. These data have important implications for inflammatory diseases that involve monocyte activation and IL-1 release.	[Ward, Jon R.; Ariaans, Mark P.; Francis, Sheila E.; Crossman, David C.; Wilson, Heather L.] Univ Sheffield, Royal Hallamshire Hosp, Sch Med, Dept Cardiovasc Sci, Sheffield S10 2RX, S Yorkshire, England; [West, Peter W.; Parker, Lisa C.; Sabroe, Ian] Univ Sheffield, Royal Hallamshire Hosp, Sch Med, Dept Infect & Immun, Sheffield S10 2RX, S Yorkshire, England	University of Sheffield; University of Sheffield	Wilson, HL (corresponding author), Univ Sheffield, Royal Hallamshire Hosp, Sch Med, Dept Cardiovasc Sci, L Floor,Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England.	H.L.Wilson@sheffield.ac.uk	Sabroe, Ian/AAE-5858-2019; Sabroe, Ian/I-5981-2013; Wilson, Heather/O-5909-2019	Sabroe, Ian/0000-0001-9750-8975; Wilson, Heather/0000-0002-7892-3425; Ariaans, Markus/0000-0002-7392-8278; Francis, Sheila/0000-0001-6552-0339; West, Peter/0000-0002-0097-5006	British Heart Foundation [FS/06/004, FS/05/081/19423]; Medical Research Council [G116/170]; Research Councils UK; Novartis; National Institute of Health Research; MRC [G116/170] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Research Councils UK(UK Research & Innovation (UKRI)); Novartis(Novartis); National Institute of Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by British Heart Foundation Grants FS/06/004 (to J. R. W.) and FS/05/081/19423 (to P. W. W.) and funds from the Medical Research Council (to L. C. P.) and Research Councils UK (to H. L. W.).; Supported by Novartis.; Supported by the National Institute of Health Research.; Supported by Medical Research Council Senior Clinical Fellowship G116/170.	Broom DC, 2008, J PHARMACOL EXP THER, V327, P620, DOI 10.1124/jpet.108.141853; Brough D, 2007, J CELL SCI, V120, P772, DOI 10.1242/jcs.03377; Carta S, 2006, BLOOD, V108, P1618, DOI 10.1182/blood-2006-03-014126; Chamberlain J, 2006, AM J PATHOL, V168, P1396, DOI 10.2353/ajpath.2006.051054; CHIN J, 1993, J IMMUNOL, V151, P5574; Di Virgilio F, 2002, BRIT J PHARMACOL, V135, P831, DOI 10.1038/sj.bjp.0704524; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Ferrari D, 1997, J EXP MED, V185, P579, DOI 10.1084/jem.185.3.579; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Gorden KB, 2005, J IMMUNOL, V174, P1259, DOI 10.4049/jimmunol.174.3.1259; Grahames CBA, 1999, BRIT J PHARMACOL, V127, P1915, DOI 10.1038/sj.bjp.0702732; GRIFFITHS RJ, 1995, J IMMUNOL, V154, P2821; HERZYK DJ, 1992, J IMMUNOL, V149, P3052; HOGQUIST KA, 1991, P NATL ACAD SCI USA, V88, P8485, DOI 10.1073/pnas.88.19.8485; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hurst J, 2009, IMMUNOBIOLOGY, V214, P683, DOI 10.1016/j.imbio.2008.12.003; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kleinnijenhuis J, 2009, EUR J IMMUNOL, V39, P1914, DOI 10.1002/eji.200839115; Knofler R, 1997, AM J HEMATOL, V56, P259, DOI 10.1002/(SICI)1096-8652(199712)56:4<259::AID-AJH11>3.0.CO;2-4; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Laupeze B, 1999, HUM IMMUNOL, V60, P591, DOI 10.1016/S0198-8859(99)00025-7; Le Feuvre R, 2002, EUR J PHARMACOL, V447, P261, DOI 10.1016/S0014-2999(02)01848-4; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2007, SEMIN IMMUNOPATHOL, V29, P213, DOI 10.1007/s00281-007-0079-y; Mehta VB, 2001, J BIOL CHEM, V276, P3820, DOI 10.1074/jbc.M006814200; Moore SF, 2007, CELL SIGNAL, V19, P855, DOI 10.1016/j.cellsig.2006.10.010; Morris GE, 2005, AM J RESP CRIT CARE, V171, P814, DOI 10.1164/rccm.200403-406OC; Nelson DW, 2006, J MED CHEM, V49, P3659, DOI 10.1021/jm051202e; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Pelegrin P, 2007, J BIOL CHEM, V282, P2386, DOI 10.1074/jbc.M610351200; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Perregaux DG, 1996, J BIOL CHEM, V271, P29830, DOI 10.1074/jbc.271.47.29830; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Qu Y, 2009, J IMMUNOL, V182, P5052, DOI 10.4049/jimmunol.0802968; Sanz JM, 2000, J IMMUNOL, V164, P4893, DOI 10.4049/jimmunol.164.9.4893; Schilling WP, 1999, AM J PHYSIOL-CELL PH, V277, pC766, DOI 10.1152/ajpcell.1999.277.4.C766; Simpson RJ, 2009, BRAIN BEHAV IMMUN, V23, P232, DOI 10.1016/j.bbi.2008.09.013; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Stockfleth E, 2003, BRIT J DERMATOL, V149, P53, DOI 10.1046/j.0366-077X.2003.05626.x; Tassi S, 2009, J IMMUNOL, V183, P1456, DOI 10.4049/jimmunol.0900578; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; West PW, 2008, IMMUNOLOGY, V125, P101, DOI 10.1111/j.1365-2567.2008.02825.x; Wilson HL, 2004, J IMMUNOL, V173, P1202, DOI 10.4049/jimmunol.173.2.1202; ZOCCHI MR, 2001, FRONTIERS LIFE, P477	55	49	50	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23145	23156		10.1074/jbc.M109.072793	http://dx.doi.org/10.1074/jbc.M109.072793			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20495003	Green Published, hybrid			2022-12-27	WOS:000279999900049
J	Shiraya, K; Hirata, T; Hatano, R; Nagamori, S; Wiriyasermkul, P; Jutabha, P; Matsubara, M; Muto, S; Tanaka, H; Asano, S; Anzai, N; Endou, H; Yamada, A; Sakurai, H; Kanai, Y				Shiraya, Katsuko; Hirata, Taku; Hatano, Ryo; Nagamori, Shushi; Wiriyasermkul, Pattama; Jutabha, Promsuk; Matsubara, Mitsunobu; Muto, Shigeaki; Tanaka, Hidekazu; Asano, Shinji; Anzai, Naohiko; Endou, Hitoshi; Yamada, Akira; Sakurai, Hiroyuki; Kanai, Yoshikatsu			A Novel Transporter of SLC22 Family Specifically Transports Prostaglandins and Co-localizes with 15-Hydroxyprostaglandin Dehydrogenase in Renal Proximal Tubules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGANIC ANION TRANSPORTER; AMINO-ACID TRANSPORTER; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; INTRACELLULAR VOLUME; CATION TRANSPORTERS; EXPRESSION CLONING; CELL LINES; IDENTIFICATION	We identified a novel prostaglandin (PG)-specific organic anion transporter (OAT) in the OAT group of the SLC22 family. The transporter designated OAT-PG from mouse kidney exhibited Na+-independent and saturable transport of PGE(2) when expressed in a proximal tubule cell line (S-2). Unusual for OAT members, OAT-PG showed narrow substrate selectivity and high affinity for a specific subset of PGs, including PGE(2), PGF(2 alpha), and PGD(2). Similar to PGE(2) receptor and PGT, a structurally distinct PG transporter, OAT-PG requires for its substrates an alpha-carboxyl group, with a double bond between C13 and C14 as well as a (S)-hydroxyl group at C15. Unlike the PGE(2) receptor, however, the hydroxyl group at C11 in a cyclopentane ring is not essential for OAT-PG substrates. Addition of a hydroxyl group at C19 or C20 impairs the interaction with OAT-PG, whereas an ethyl group at C20 enhances the interaction, suggesting the importance of hydrophobicity around the omega-tail tip forming a "hydrophobic core" accompanied by a negative charge, which is essential for substrates of OAT members. OAT-PG-mediated transport is concentrative in nature, although OAT-PG mediates both facilitative and exchange transport. OAT-PG is kidney-specific and localized on the basolateral membrane of proximal tubules where a PG-inactivating enzyme, 15-hydroxyprostaglandin dehydrogenase, is expressed. Because of the fact that 15-keto-PGE(2), the metabolite of PGE(2) produced by 15-hydroxyprostaglandin dehydrogenase, is not a substrate of OAT-PG, the transport-metabolism coupling would make unidirectional PGE(2) transport more efficient. By removing extracellular PGE(2), OAT-PG is proposed to be involved in the local PGE(2) clearance and metabolism for the inactivation of PG signals in the kidney cortex.	[Hatano, Ryo; Nagamori, Shushi; Wiriyasermkul, Pattama; Tanaka, Hidekazu; Kanai, Yoshikatsu] Osaka Univ, Grad Sch Med, Dept Pharmacol, Div Biosyst Pharmacol, Suita, Osaka 5650871, Japan; [Shiraya, Katsuko; Hirata, Taku; Wiriyasermkul, Pattama; Jutabha, Promsuk; Anzai, Naohiko; Endou, Hitoshi; Sakurai, Hiroyuki] Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Tokyo 1818611, Japan; [Shiraya, Katsuko; Yamada, Akira] Kyorin Univ, Sch Med, Dept Internal Med, Tokyo 1818611, Japan; [Matsubara, Mitsunobu] Tohoku Univ, Sch Med, Ctr Translat & Adv Anim Res, Div Mol Med, Sendai, Miyagi 9800871, Japan; [Muto, Shigeaki] Jichi Med Univ, Dept Nephrol, Jichi, Tochigi 3290498, Japan; [Asano, Shinji] Ritsumeikan Univ, Coll Pharmaceut Sci, Dept Mol Physiol, Shiga 5258577, Japan	Osaka University; Kyorin University; Kyorin University; Tohoku University; Jichi Medical University; Ritsumeikan University	Kanai, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Pharmacol, Div Biosyst Pharmacol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ykanai@pharma1.med.osaka-u.ac.jp	ANZAI, NAOHIKO/K-9492-2017; Nagamori, Shushi/P-4530-2018; Jutabha, Promsuk/AAE-9872-2022; Jutabha, Promsuk/AFF-4363-2022	ANZAI, NAOHIKO/0000-0003-0605-0458; Nagamori, Shushi/0000-0003-0203-2754; 	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a grant-in-aid for scientific research on priority areas of "transportsomes" from the Ministry of Education, Culture, Sports, Science and Technology of Japan and grants-in-aid for scientific research from the Japan Society for the Promotion of Science.	ADAM SA, 1991, METHOD CELL BIOL, V35, P469; ADEBODUN F, 1993, J CELL PHYSIOL, V154, P199, DOI 10.1002/jcp.1041540123; Anzai N, 2005, J PHARMACOL EXP THER, V315, P534, DOI 10.1124/jpet.105.088583; Apiwattanakul N, 1999, MOL PHARMACOL, V55, P847; Burckhardt G, 2000, AM J PHYSIOL-RENAL, V278, pF853, DOI 10.1152/ajprenal.2000.278.6.F853; Cha SH, 2000, J BIOL CHEM, V275, P4507, DOI 10.1074/jbc.275.6.4507; Chairoungdua A, 1999, J BIOL CHEM, V274, P28845, DOI 10.1074/jbc.274.41.28845; GRUNDEMANN D, 1994, NATURE, V372, P549, DOI 10.1038/372549a0; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P653, DOI 10.1007/s00424-003-1168-y; Hao CM, 2008, ANNU REV PHYSIOL, V70, P357, DOI 10.1146/annurev.physiol.70.113006.100614; Hosoyamada M, 1996, ARCH TOXICOL, V70, P284, DOI 10.1007/s002040050275; Hosoyamada M, 2004, J AM SOC NEPHROL, V15, P261, DOI 10.1097/01.ASN.0000107560.80107.19; ITOH S, 1996, MOL PHARMACOL, V50, P738; Kaler G, 2006, BIOCHEM BIOPH RES CO, V351, P872, DOI 10.1016/j.bbrc.2006.10.136; KANAI N, 1995, SCIENCE, V268, P866, DOI 10.1126/science.7754369; Kanai Y, 2003, EUR J PHARMACOL, V479, P237, DOI 10.1016/j.ejphar.2003.08.073; Kanai Y, 2004, PFLUG ARCH EUR J PHY, V447, P469, DOI 10.1007/s00424-003-1146-4; KANAI Y, 1992, AM J PHYSIOL, V263, pF1087, DOI 10.1152/ajprenal.1992.263.6.F1087; Kimura H, 2002, J PHARMACOL EXP THER, V301, P293, DOI 10.1124/jpet.301.1.293; Koepsell H, 2004, PFLUG ARCH EUR J PHY, V447, P666, DOI 10.1007/s00424-003-1089-9; Kusuhara H, 1999, J BIOL CHEM, V274, P13675, DOI 10.1074/jbc.274.19.13675; LopezNieto CE, 1997, J BIOL CHEM, V272, P6471, DOI 10.1074/jbc.272.10.6471; Morita N, 2005, DRUG METAB DISPOS, V33, P1151, DOI 10.1124/dmd.104.001552; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Nomura T, 2004, MOL PHARMACOL, V65, P973, DOI 10.1124/mol.65.4.973; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; PIPER PJ, 1970, NATURE, V225, P600, DOI 10.1038/225600a0; Pucci ML, 2006, AM J PHYSIOL-RENAL, V290, pF641, DOI 10.1152/ajprenal.00426.2004; Reid G, 2003, P NATL ACAD SCI USA, V100, P9244, DOI 10.1073/pnas.1033060100; Rottenberg H, 1979, Methods Enzymol, V55, P547; Segawa H, 1999, J BIOL CHEM, V274, P19745, DOI 10.1074/jbc.274.28.19745; Sekine T, 1998, FEBS LETT, V429, P179, DOI 10.1016/S0014-5793(98)00585-7; Sekine T, 2000, PFLUG ARCH EUR J PHY, V440, P337, DOI 10.1007/s004240000297; Sekine T, 1997, J BIOL CHEM, V272, P18526, DOI 10.1074/jbc.272.30.18526; Shin HJ, 2007, HEPATOLOGY, V45, P1046, DOI 10.1002/hep.21596; Takeda M, 1999, KIDNEY INT, V56, P2128, DOI 10.1046/j.1523-1755.1999.00789.x; Takeda M, 2002, J PHARMACOL EXP THER, V302, P666, DOI 10.1124/jpet.102.034330; Tamai I, 1997, FEBS LETT, V419, P107, DOI 10.1016/S0014-5793(97)01441-5; UCHIDA S, 1985, PFLUG ARCH EUR J PHY, V404, P278, DOI 10.1007/BF00581251; Uchino H, 2002, MOL PHARMACOL, V61, P729, DOI 10.1124/mol.61.4.729; Ungrin MD, 2001, MOL PHARMACOL, V59, P1446, DOI 10.1124/mol.59.6.1446; UtsunomiyaTate N, 1996, J BIOL CHEM, V271, P14883, DOI 10.1074/jbc.271.25.14883; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; VASQUEZ B, 1982, IN VITRO CELL DEV B, V18, P643; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Wolff NA, 1997, FEBS LETT, V417, P287, DOI 10.1016/S0014-5793(97)01304-5; Yao B, 2008, AM J PHYSIOL-RENAL, V294, pF433, DOI 10.1152/ajprenal.00436.2007; Yokoyama H, 2008, CELL PHYSIOL BIOCHEM, V21, P269, DOI 10.1159/000129385	48	30	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22141	22151		10.1074/jbc.M109.084426	http://dx.doi.org/10.1074/jbc.M109.084426			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20448048	hybrid, Green Published			2022-12-27	WOS:000279702200027
J	Castelle, C; Ilbert, M; Infossi, P; Leroy, G; Giudici-Orticoni, MT				Castelle, Cindy; Ilbert, Marianne; Infossi, Pascale; Leroy, Gisele; Giudici-Orticoni, Marie-Therese			An Unconventional Copper Protein Required for Cytochrome c Oxidase Respiratory Function under Extreme Acidic Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-TRANSFER; COMPLEX-I; RUSTICYANIN; IDENTIFICATION; STABILITY; SEQUENCE; BINDING; SEARCH; MODEL; CHAIN	Very little is known about the processes used by acidophile organisms to preserve stability and function of respiratory pathways. Here, we reveal a potential strategy of these organisms for protecting and keeping functional key enzymes under extreme conditions. Using Acidithiobacillus ferrooxidans, we have identified a protein belonging to a new cupredoxin subfamily, AcoP, for "acidophile CcO partner," which is required for the cytochrome c oxidase (CcO) function. We show that it is a multifunctional copper protein with at least two roles as follows: (i) as a chaperone-like protein involved in the protection of the Cu-A center of the CcO complex and (ii) as a linker between the periplasmic cytochrome c and the inner membrane cytochrome c oxidase. It could represent an interesting model for investigating the multifunctionality of proteins known to be crucial in pathways of energy metabolism.	[Castelle, Cindy; Ilbert, Marianne; Infossi, Pascale; Leroy, Gisele; Giudici-Orticoni, Marie-Therese] IMM CNRS, Lab Bioenerget & Ingn Prot, F-13402 Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Giudici-Orticoni, MT (corresponding author), IMM CNRS, Lab Bioenerget & Ingn Prot, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	giudici@ifr88.cnrs-mrs.fr	Ilbert, marianne/ABG-5015-2021	Castelle, Cindy/0000-0002-0751-9804; ilbert, marianne/0000-0002-9070-2334				Appia-Ayme C, 1999, APPL ENVIRON MICROB, V65, P4781; Arnesano F, 2005, J PROTEOME RES, V4, P63, DOI 10.1021/pr049862f; Balatri E, 2003, STRUCTURE, V11, P1431, DOI 10.1016/j.str.2003.10.004; Bertini I, 2005, J BIOL INORG CHEM, V10, P613, DOI 10.1007/s00775-005-0011-7; Botuyan MV, 1996, J MOL BIOL, V263, P752, DOI 10.1006/jmbi.1996.0613; Castelle C, 2008, J BIOL CHEM, V283, P25803, DOI 10.1074/jbc.M802496200; Cavazza C, 1996, EUR J BIOCHEM, V242, P308, DOI 10.1111/j.1432-1033.1996.0308r.x; Dennison C, 2005, COORDIN CHEM REV, V249, P3025, DOI 10.1016/j.ccr.2005.04.021; Drosou V, 2002, EUR J BIOCHEM, V269, P2980, DOI 10.1046/j.1432-1033.2002.02979.x; Elbehti A, 1996, FEMS MICROBIOL LETT, V136, P51; Elbehti A, 1999, J BIOL CHEM, V274, P16760, DOI 10.1074/jbc.274.24.16760; Erales J, 2009, J BIOL CHEM, V284, P12735, DOI 10.1074/jbc.M808254200; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Giudici-Orticoni MT, 1999, J BIOL CHEM, V274, P30365, DOI 10.1074/jbc.274.43.30365; Giudici-Orticoni MT, 2000, BIOCHEMISTRY-US, V39, P7205, DOI 10.1021/bi992846p; GIUDICIORTICONI MT, 2001, FUNDAMENTALS TECHNOL, P291; GIUDICIORTICONI MT, 1997, BIOHYDROMETALLURGY F, P1; Hakemian AS, 2008, BIOCHEMISTRY-US, V47, P6793, DOI 10.1021/bi800598h; Hakemian AS, 2007, ANNU REV BIOCHEM, V76, P223, DOI 10.1146/annurev.biochem.76.061505.175355; Hinchliffe P, 2006, BIOCHEMISTRY-US, V45, P4413, DOI 10.1021/bi0600998; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Lane Darius J R, 2010, Biochem J, V426, pe1, DOI 10.1042/BJ20091959; Lemos SS, 2000, BIOPHYS J, V79, P1085, DOI 10.1016/S0006-3495(00)76362-4; Ma BY, 2000, PROTEIN ENG, V13, P617, DOI 10.1093/protein/13.9.617; Malarte G, 2005, BIOCHEMISTRY-US, V44, P6471, DOI 10.1021/bi048425b; Maneg O, 2004, BBA-BIOENERGETICS, V1655, P274, DOI 10.1016/j.bbabio.2003.10.010; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Richter OMH, 2009, BBA-BIOENERGETICS, V1787, P626, DOI 10.1016/j.bbabio.2009.02.020; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Schagger H, 2001, IUBMB LIFE, V52, P119, DOI 10.1080/15216540152845911; Siluvai GS, 2009, BIOCHEMISTRY-US, V48, P12133, DOI 10.1021/bi901480g; Stiburek L, 2009, AM J PHYSIOL-CELL PH, V296, pC1218, DOI 10.1152/ajpcell.00564.2008; Tapley TL, 2009, P NATL ACAD SCI USA, V106, P5557, DOI 10.1073/pnas.0811811106; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valdes J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-597; Walter RL, 1996, J MOL BIOL, V263, P730, DOI 10.1006/jmbi.1996.0612; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Witt H, 1998, EUR J BIOCHEM, V251, P367, DOI 10.1046/j.1432-1327.1998.2510367.x	39	17	17	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21519	21525		10.1074/jbc.M110.131359	http://dx.doi.org/10.1074/jbc.M110.131359			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20442397	Green Published, hybrid			2022-12-27	WOS:000279516100038
J	Horne, BE; Li, TF; Genevaux, P; Georgopoulos, C; Landry, SJ				Horne, B. Erin; Li, Tingfeng; Genevaux, Pierre; Georgopoulos, Costa; Landry, Samuel J.			The Hsp40 J-domain Stimulates Hsp70 When Tethered by the Client to the ATPase Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE DNAK; ESCHERICHIA-COLI DNAJ; IN-VIVO; SUBSTRATE-BINDING; MECHANISM; PROTEINS; SPECTROSCOPY; MUTANTS; TEMPERATURES; COCHAPERONE	The Escherichia coli Hsp40 DnaJ uses its J-domain (Jd) to couple ATP hydrolysis and client protein capture in Hsp70 DnaK. Fusion of the Jd to peptide p5 (as in Jdp5) dramatically increases the apparent affinity of the p5 moiety for DnaK in the presence of ATP, and Jdp5 stimulates ATP hydrolysis in DnaK by several orders of magnitude. NMR experiments with [N-15]Jdp5 demonstrated that the peptide tethers the Jd to the ATPase domain. Thus, ATP hydrolysis and client protein binding in DnaK are coupled principally through the association of the client with DnaJ. Overexpression of a recombinant Jd was specifically toxic to cells that simultaneously expressed DnaK. No toxicity was observed when overexpressing Jdp5 or mutant Jd or when co-overexpressing the Jd and the nucleotide exchange factor GrpE. The results suggest that the Jd shifts DnaK to a client-bound form by stimulating the DnaK ATPase but only when the Jd is brought to DnaK by a client-Hsp40 complex.	[Landry, Samuel J.] Tulane Univ, Hlth Sci Ctr, Dept Biochem, New Orleans, LA 70112 USA; [Genevaux, Pierre] Univ Toulouse 3, CNRS, IBCG, Dept Microbiol & Mol Genet, F-31062 Toulouse, France; [Georgopoulos, Costa] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA	Tulane University; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Utah System of Higher Education; University of Utah	Landry, SJ (corresponding author), Tulane Univ, Hlth Sci Ctr, Dept Biochem, SL43,1430 Tulane Ave, New Orleans, LA 70112 USA.	landry@tulane.edu	Li, Tingfeng/B-7890-2010; Genevaux, Pierre/A-4851-2015; Landry, Samuel/AAK-5778-2020	Landry, Samuel/0000-0002-4082-0543; GENEVAUX, Pierre/0000-0001-7539-3126	National Science Foundation; Swiss National Science Foundation; Canton of Geneva; CNRS	National Science Foundation(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Canton of Geneva; CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by grants from the National Science Foundation (to S.J.L.), the Swiss National Science Foundation (to C.G.), the Canton of Geneva (to C.G.), and the CNRS-Action Thematique et Incitative sur Programme (to P.G.).	ANG D, 1989, J BACTERIOL, V171, P2748, DOI 10.1128/jb.171.5.2748-2755.1989; Awad W, 2008, P NATL ACAD SCI USA, V105, P1164, DOI 10.1073/pnas.0702132105; Barthel TK, 2001, J BACTERIOL, V183, P5482, DOI 10.1128/JB.183.19.5482-5490.2001; Buczynski G, 2001, J BIOL CHEM, V276, P27231, DOI 10.1074/jbc.M100237200; BUKAU B, 1989, J BACTERIOL, V171, P6030, DOI 10.1128/jb.171.11.6030-6038.1989; Cajo GC, 2006, J BIOL CHEM, V281, P12436, DOI 10.1074/jbc.M511192200; Chai YH, 1999, J NEUROSCI, V19, P10338; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; COLIGAN JE, 1998, CURRENT PROTOCOLS PR, V2; Davis JE, 1999, P NATL ACAD SCI USA, V96, P9269, DOI 10.1073/pnas.96.16.9269; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Gassler CS, 1998, P NATL ACAD SCI USA, V95, P15229, DOI 10.1073/pnas.95.26.15229; Genevaux P, 2004, EMBO REP, V5, P195, DOI 10.1038/sj.embor.7400067; Genevaux P, 2002, GENETICS, V162, P1045; Genevaux P, 2007, MOL MICROBIOL, V66, P840, DOI 10.1111/j.1365-2958.2007.05961.x; Gisler SM, 1998, J MOL BIOL, V279, P833, DOI 10.1006/jmbi.1998.1815; Greene MK, 1998, P NATL ACAD SCI USA, V95, P6108, DOI 10.1073/pnas.95.11.6108; Greener T, 2001, NAT CELL BIOL, V3, P215, DOI 10.1038/35055137; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Han WJ, 2003, J BIOL CHEM, V278, P19038, DOI 10.1074/jbc.M300756200; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; Karzai AW, 1996, J BIOL CHEM, V271, P11236, DOI 10.1074/jbc.271.19.11236; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kelley WL, 1997, P NATL ACAD SCI USA, V94, P3679, DOI 10.1073/pnas.94.8.3679; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mayer MP, 1999, J MOL BIOL, V289, P1131, DOI 10.1006/jmbi.1999.2844; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; Packschies L, 1997, BIOCHEMISTRY-US, V36, P3417, DOI 10.1021/bi962835l; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Russell R, 1999, BIOCHEMISTRY-US, V38, P4165, DOI 10.1021/bi9824036; Russell R, 1998, BIOCHEMISTRY-US, V37, P596, DOI 10.1021/bi972025p; Slepenkov SV, 2002, BIOCHEMISTRY-US, V41, P12224, DOI 10.1021/bi0263208; Slepenkov SV, 1998, BIOCHEMISTRY-US, V37, P16749, DOI 10.1021/bi981738k; Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223; Swain JF, 2006, J BIOL CHEM, V281, P1605, DOI 10.1074/jbc.M509356200; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Vazquez-Laslop N, 2006, J BACTERIOL, V188, P3494, DOI 10.1128/JB.188.10.3494-3497.2006; Young BP, 2001, EMBO J, V20, P262, DOI 10.1093/emboj/20.1.262; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	42	15	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21679	21688		10.1074/jbc.M110.113118	http://dx.doi.org/10.1074/jbc.M110.113118			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20448033	hybrid, Green Published			2022-12-27	WOS:000279516100055
J	Kondo, MY; Okamoto, DN; Santos, JAN; Juliano, MA; Oda, K; Pillai, B; James, MNG; Juliano, L; Gouvea, IE				Kondo, Marcia Y.; Okamoto, Debora N.; Santos, Jorge A. N.; Juliano, Maria A.; Oda, Kohei; Pillai, Bindu; James, Michael N. G.; Juliano, Luiz; Gouvea, Iuri E.			Studies on the Catalytic Mechanism of a Glutamic Peptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SPECIFICITY; PROTON INVENTORY; ASPERGILLOGLUTAMIC PEPTIDASE; SCYTALIDOGLUTAMIC PEPTIDASE; SCYTALIDIUM-LIGNICOLUM; ASPARTIC PROTEASES; PAPAIN; THERMOLYSIN; INHIBITION; HYDROLYSES	Scytalidoglutamic peptidase (SGP) is the prototype of fungal glutamic peptidases that are characteristically pepstatin insensitive. These enzymes have a unique catalytic dyad comprised of Gln(53) and Glu(136) that activate a bound water molecule for nucleophilic attack on the carbonyl carbon atom of the scissile peptide bond. The hydrolysis by SGP at peptide bonds with proline in the P-1' position is a rare event among peptidases that we investigated using the series of fluorescence resonance energy transfer peptides, Abz-KLXPSKQ-EDDnp, compared with the series Abz-KLXSSKQ-EDDnp. The preference observed in these two series for Phe and His over Leu, Ile, Val, Arg, and Lys, seems to be related to the structure of the S-1 subsite of SGP. These results and the pH profiles of SGP activity showed that its S-1 subsite can accommodate the benzyl group of Phe at pH 4 as well as the positively charged imidazolium group of His. In the pH range 2 to 7, SGP maintains its structure and activity, but at pH 8 or higher it is irreversibly denatured. The intrinsic fluorescence of the Trp residues of SGP were sensitive to the titration of carboxyl groups having low pK values; this can be attributed to the buried Asp(57) and/or Asp(43) as described in SGP three-dimensional structure. The solvent kinetic isotope effects and the proton inventory experiments support a mechanism for the glutamic peptidase SGP that involves the nucleophilic attack of the general base (Glu(136)) activated water, and establish a fundamental role of the S-1 subsite interactions in promoting catalysis.	[Kondo, Marcia Y.; Okamoto, Debora N.; Santos, Jorge A. N.; Juliano, Maria A.; Juliano, Luiz; Gouvea, Iuri E.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Biophys, BR-0404420 Sao Paulo, Brazil; [Oda, Kohei] Kyoto Inst Technol, Dept Appl Biol, Kyoto 6068585, Japan; [Pillai, Bindu; James, Michael N. G.] Univ Alberta, Fac Med & Dent, Sch Mol & Syst Med, Dept Biochem, Edmonton, AB T6G 2H7, Canada	Universidade Federal de Sao Paulo (UNIFESP); Kyoto Institute of Technology; University of Alberta	Gouvea, IE (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Biophys, Rua Tres de Maio 100, BR-0404420 Sao Paulo, Brazil.	iuri.gouvea@unifesp.br	PILLAI, BINDU Raman/ABD-7571-2020; Juliano, Luiz/D-7204-2012; Complexos, INCT Fluidos/H-9172-2013	PILLAI, BINDU Raman/0000-0001-7193-9507; Juliano, Luiz/0000-0002-5589-2822; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil, and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).	BENDER ML, 1962, J AM CHEM SOC, V84, P2582, DOI 10.1021/ja00872a024; COHN EJ, 1943, PROTEINS AMINO ACIDS, P444; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Enyedy EJ, 2004, J AM CHEM SOC, V126, P6017, DOI 10.1021/ja0320166; Ferscht A., 1999, STRUCTURE MECH PROTE, P54; Fujinaga M, 2004, P NATL ACAD SCI USA, V101, P3364, DOI 10.1073/pnas.0400246101; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; Hershcovitz YF, 2007, FEBS J, V274, P3864, DOI 10.1111/j.1742-4658.2007.05912.x; Hirata IY, 1995, LETT PEPT SCI, V1, P299, DOI DOI 10.1007/BF00119771; HYLAND LJ, 1991, BIOCHEMISTRY-US, V30, P8454, DOI 10.1021/bi00098a024; IZQUIERDO MC, 1990, J AM CHEM SOC, V112, P6054, DOI 10.1021/ja00172a023; IZQUIERDOMARTIN M, 1992, J AM CHEM SOC, V114, P325, DOI 10.1021/ja00027a042; James MNG, 2006, BIOL CHEM, V387, P1023, DOI 10.1515/BC.2006.126; KARSTEN WE, 1995, J AM CHEM SOC, V117, P5914, DOI 10.1021/ja00127a002; Kataoka Y, 2005, FEBS LETT, V579, P2991, DOI 10.1016/j.febslet.2005.04.050; Korkmaz B, 2008, NAT PROTOC, V3, P991, DOI 10.1038/nprot.2008.63; Leskovac V., 2003, COMPREHENSIVE ENZYME, P317; MAITA T, 1984, J BIOCHEM-TOKYO, V95, P465, DOI 10.1093/oxfordjournals.jbchem.a134628; MAJIMA E, 1988, AGR BIOL CHEM TOKYO, V52, P787; Murao S., 1985, ASPARTIC PROTEINASES, P379; Northrop DB, 2001, ACCOUNTS CHEM RES, V34, P790, DOI 10.1021/ar000184m; O'Donoghue AJ, 2008, J BIOL CHEM, V283, P29186, DOI 10.1074/jbc.M802366200; ODA K, 2004, HDB PROTEOLYTIC ENZY, P219; Okamoto DN, 2009, BBA-PROTEINS PROTEOM, V1794, P367, DOI 10.1016/j.bbapap.2008.10.017; Pillai B, 2007, J MOL BIOL, V365, P343, DOI 10.1016/j.jmb.2006.09.058; POLGAR L, 1979, EUR J BIOCHEM, V98, P369, DOI 10.1111/j.1432-1033.1979.tb13196.x; Polgar L, 2005, CELL MOL LIFE SCI, V62, P2161, DOI 10.1007/s00018-005-5160-x; POLGAR L, 1987, FEBS LETT, V219, P1, DOI 10.1016/0014-5793(87)81179-1; POLGAR L, 1989, MECH PROTEASE ACTION, P16; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Reshetnyak YK, 2001, BIOPHYS J, V81, P1710, DOI 10.1016/S0006-3495(01)75824-9; Santos JAN, 2009, BIOCHEMISTRY-US, V48, P7948, DOI 10.1021/bi9004446; Sasaki H, 2005, P JPN ACAD B-PHYS, V81, P441, DOI 10.2183/pjab.81.441; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551; Schowen KB, 2000, BBA-BIOENERGETICS, V1458, P43, DOI 10.1016/S0005-2728(00)00059-1; Sims AH, 2004, FEMS MICROBIOL LETT, V239, P95, DOI 10.1016/j.femsle.2004.08.023; SZAWELSKI RJ, 1981, BIOCHEM J, V199, P681, DOI 10.1042/bj1990681; Theodorou LG, 2001, BIOCHEMISTRY-US, V40, P3996, DOI 10.1021/bi001615b; Yabuki Y, 2004, FEBS LETT, V569, P161, DOI 10.1016/j.febslet.2004.05.041	40	21	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21437	21445		10.1074/jbc.M110.122432	http://dx.doi.org/10.1074/jbc.M110.122432			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20442413	Green Published, hybrid			2022-12-27	WOS:000279516100030
J	Lim, ST; Chen, XL; Tomar, A; Miller, NLG; Yoo, J; Schlaepfer, DD				Lim, Ssang-Taek; Chen, Xiao Lei; Tomar, Alok; Miller, Nichol L. G.; Yoo, Jiyeon; Schlaepfer, David D.			Knock-in Mutation Reveals an Essential Role for Focal Adhesion Kinase Activity in Blood Vessel Morphogenesis and Cell Motility-Polarity but Not Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHOA ACTIVITY; FAK; SRC; ANGIOGENESIS; PAXILLIN; SURVIVAL; PYK2; PHOSPHORYLATION; MIGRATION; GAP	Focal adhesion kinase (FAK) associates with both integrins and growth factor receptors in the control of cell motility and survival. Loss of FAK during mouse development results in lethality at embryonic day 8.5 (E8.5) and a block in cell proliferation. Because FAK serves as both a scaffold and signaling protein, gene knock-outs do not provide mechanistic insights in distinguishing between these modes of FAK function. To determine the role of FAK activity during development, a knock-in point mutation (lysine 454 to arginine (R454)) within the catalytic domain was introduced by homologous recombination. Homozygous FAK(R454/R454) mutation was lethal at E9.5 with defects in blood vessel formation as determined by lack of yolk sac primary capillary plexus formation and disorganized endothelial cell patterning in FAK(R454/R454) embryos. In contrast to the inability of embryonic FAK(-/-) cells to proliferate ex vivo, primary FAK(R454/R454) mouse embryo fibroblasts (MEFs) were established from E8.5 embryos. R454 MEFs exhibited no difference in cell growth compared with normal MEFs, and R454 FAK localized to focal adhesions but was not phosphorylated at Tyr-397. In E8.5 embryos and primary MEFs, FAK R454 mutation resulted in decreased c-Src Tyr-416 phosphorylation. R454 MEFs exhibited enhanced focal adhesion formation, decreased migration, and defects in cell polarity. Within immortalized MEFs, FAK activity was required for fibronectin-stimulated FAK-p190RhoGAP association and p190RhoGAP tyrosine phosphorylation linked to decreased RhoA GTPase activity, focal adhesion turnover, and directional motility. Our results establish that intrinsic FAK activity is essential for developmental processes controlling blood vessel formation and cell motility-polarity but not cell proliferation. This work supports the use of FAK inhibitors to disrupt neovascularization.	[Lim, Ssang-Taek; Chen, Xiao Lei; Tomar, Alok; Miller, Nichol L. G.; Yoo, Jiyeon; Schlaepfer, David D.] Univ Calif San Diego, Moores Canc Ctr, Dept Reprod Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Schlaepfer, DD (corresponding author), Univ Calif San Diego, Moores Canc Ctr, Dept Reprod Med, 3855 Hlth Sci Dr, La Jolla, CA 92093 USA.	dschlaepfer@ucsd.edu		Lim, Steve/0000-0003-0323-8607	National Institutes of Health [HL093156, GM087400]; American Heart Association [0540115N, 0725169Y, 0825166F]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087400] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL093156 and GM087400. This work was also supported by American Heart Association Established Investigator Award 0540115N (to D. D. S.).; Supported in part by American Heart Association postdoctoral fellowship 0725169Y.; Supported in part by American Heart Association postdoctoral fellowship 0825166F.	Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Bonnette PC, 2010, J PROTEOMICS, V73, P1306, DOI 10.1016/j.jprot.2010.01.011; Braren R, 2006, J CELL BIOL, V172, P151, DOI 10.1083/jcb.200506184; Brown MC, 2005, MOL BIOL CELL, V16, P4316, DOI 10.1091/mbc.E05-02-0131; Carlson TR, 2008, DEVELOPMENT, V135, P2193, DOI 10.1242/dev.016378; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chen BH, 2002, J BIOL CHEM, V277, P33857, DOI 10.1074/jbc.M204429200; Chikumi H, 2002, J BIOL CHEM, V277, P12463, DOI 10.1074/jbc.M108504200; Corsi JM, 2009, J BIOL CHEM, V284, P34769, DOI 10.1074/jbc.M109.067280; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Ding Q, 2005, J BIOL CHEM, V280, P6802, DOI 10.1074/jbc.M409180200; Eerola I, 2003, AM J HUM GENET, V73, P1240, DOI 10.1086/379793; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; FURUTA Y, 1995, ONCOGENE, V11, P1989; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Golubovskaya VM, 2008, J MED CHEM, V51, P7405, DOI 10.1021/jm800483v; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Han DC, 2000, J BIOL CHEM, V275, P28911, DOI 10.1074/jbc.M001997200; HENKEMEYER M, 1995, NATURE, V377, P695, DOI 10.1038/377695a0; Holinstat M, 2006, J BIOL CHEM, V281, P2296, DOI 10.1074/jbc.M511248200; Hsia DA, 2003, J CELL BIOL, V160, P753, DOI 10.1083/jcb.200212114; Hynes RO, 2007, J THROMB HAEMOST, V5, P32, DOI 10.1111/j.1538-7836.2007.02569.x; Ilic D, 2003, CIRC RES, V92, P300, DOI 10.1161/01.RES.0000055016.36679.23; ILIC D, 1995, BIOCHEM BIOPH RES CO, V209, P300, DOI 10.1006/bbrc.1995.1503; ILLC D, 1995, NATURE, V377, P539; Izaguirre G, 2001, J BIOL CHEM, V276, P28676, DOI 10.1074/jbc.M101678200; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Kulkarni SV, 2000, J CELL BIOL, V149, P457, DOI 10.1083/jcb.149.2.457; Lim ST, 2008, CELL CYCLE, V7, P2306, DOI 10.4161/cc.6367; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Lim ST, 2010, J BIOL CHEM, V285, P1743, DOI 10.1074/jbc.M109.064212; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; Liu E, 2003, EMBO J, V22, P5036, DOI 10.1093/emboj/cdg503; MCGLADE J, 1993, EMBO J, V12, P3073, DOI 10.1002/j.1460-2075.1993.tb05976.x; Mitra SK, 2006, ONCOGENE, V25, P5969, DOI 10.1038/sj.onc.1209588; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Peng X, 2004, CARDIOVASC RES, V64, P421, DOI 10.1016/j.cardiores.2004.07.012; Ren XD, 2000, J CELL SCI, V113, P3673; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Roberts WG, 2008, CANCER RES, V68, P1935, DOI 10.1158/0008-5472.CAN-07-5155; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Schwartz MA, 2001, TRENDS CELL BIOL, V11, P466, DOI 10.1016/S0962-8924(01)02152-3; Serini G, 2006, EXP CELL RES, V312, P651, DOI 10.1016/j.yexcr.2005.10.020; Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155; Sieg DJ, 1998, EMBO J, V17, P5933, DOI 10.1093/emboj/17.20.5933; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Smyth SS, 2002, J CELL BIOL, V158, P17, DOI 10.1083/jcb.200202100; Tanjoni I, 2010, CANCER BIOL THER, V9, P764, DOI 10.4161/cbt.9.10.11434; Tikhmyanova N, 2010, CELL MOL LIFE SCI, V67, P1025, DOI 10.1007/s00018-009-0213-1; Tilghman RW, 2005, J CELL SCI, V118, P2613, DOI 10.1242/jcs.02380; Tomar A, 2009, CURR OPIN CELL BIOL, V21, P676, DOI 10.1016/j.ceb.2009.05.006; Tomar A, 2009, J CELL SCI, V122, P1852, DOI 10.1242/jcs.046870; Walsh C, 2010, CANCER BIOL THER, V9, P776; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wu L, 2008, ONCOGENE, V27, P1439, DOI 10.1038/sj.onc.1210770; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; Zouq NK, 2009, J CELL SCI, V122, P357, DOI 10.1242/jcs.030478	69	85	89	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21526	21536		10.1074/jbc.M110.129999	http://dx.doi.org/10.1074/jbc.M110.129999			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20442405	Green Published, hybrid			2022-12-27	WOS:000279516100039
J	Mohamed, JS; Lopez, MA; Boriek, AM				Mohamed, Junaith S.; Lopez, Michael A.; Boriek, Aladin M.			Mechanical Stretch Up-regulates MicroRNA-26a and Induces Human Airway Smooth Muscle Hypertrophy by Suppressing Glycogen Synthase Kinase-3 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC-HYPERTROPHY; KINASE 3-BETA; SKELETAL-MUSCLE; GENE-EXPRESSION; TRANSCRIPTION; CANCER; MECHANOTRANSDUCTION; PHOSPHORYLATION; DIFFERENTIATION; IDENTIFICATION	Airway smooth muscle hypertrophy is one of the hallmarks of airway remodeling in severe asthma. Several human diseases have been now associated with dysregulated microRNA (miRNA) expression. miRNAs are a class of small non-coding RNAs, which negatively regulate gene expression at the post-transcriptional level. Here, we identify miR-26a as a hypertrophic miRNA of human airway smooth muscle cells (HASMCs). We show that stretch selectively induces the transcription of miR-26a located in the locus 3p21.3 of human chromosome 3. The transcription factor CCAAT enhancer-binding protein alpha (C/EBP alpha) directly activates miR-26a expression through the transcriptional machinery upon stretch. Furthermore, stretch or enforced expression of miR-26a induces HASMC hypertrophy, and miR-26 knockdown reverses this effect, suggesting that miR-26a is a hypertrophic gene. We identify glycogen synthase kinase-3 beta (GSK-3 beta), an anti-hypertrophic protein, as a target gene of miR-26a. Luciferase reporter assays demonstrate that miR-26a directly interact with the 3'-untranslated repeat of the GSK-3 beta mRNA. Stretch or enforced expression of miR-26a attenuates the endogenous GSK-3 beta protein levels followed by the induction of HASMC hypertrophy. miR-26 knockdown reverses this effect, suggesting that miR-26a-induced hypertrophy occurs via its target gene GSK-3 beta. Overall, as a first time, our study unveils that miR-26a is a mechanosensitive gene, and it plays an important role in the regulation of HASMC hypertrophy.	[Mohamed, Junaith S.; Lopez, Michael A.; Boriek, Aladin M.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine	Boriek, AM (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.	boriek@bcm.tmc.edu	Mohamed, Junaith/AAC-4050-2020; Lopez, Michael A./AAT-2145-2021	Lopez, Michael A./0000-0002-3029-0761	NHLBI [HL63134, HL-072839]; National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072839, R01HL063134] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL63134 and HL-072839 from NHLBI. This work was also supported by a grant from the National Science Foundation.	Adachi R, 2003, ZOOL SCI, V20, P557, DOI 10.2108/zsj.20.557; Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Badorff C, 2002, J CLIN INVEST, V109, P373, DOI 10.1172/JCI200213779; Bandi N, 2009, CANCER RES, V69, P5553, DOI 10.1158/0008-5472.CAN-08-4277; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benayoun L, 2003, AM J RESP CRIT CARE, V167, P1360, DOI 10.1164/rccm.200209-1030OC; Bentley JK, 2009, AM J PHYSIOL-LUNG C, V296, pL176, DOI 10.1152/ajplung.90376.2008; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Bottoni A, 2005, J CELL PHYSIOL, V204, P280, DOI 10.1002/jcp.20282; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Deng H, 2008, J BIOL CHEM, V283, P10198, DOI 10.1074/jbc.M800624200; EBINA M, 1993, AM REV RESPIR DIS, V148, P720, DOI 10.1164/ajrccm/148.3.720; Galvin DJ, 2002, AM J PHYSIOL-RENAL, V283, pF1192, DOI 10.1152/ajprenal.00168.2002; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Guo CJ, 2009, APOPTOSIS, V14, P1331, DOI 10.1007/s10495-009-0401-3; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Haq S, 2000, J CELL BIOL, V151, P117, DOI 10.1083/jcb.151.1.117; Hardt SE, 2002, CIRC RES, V90, P1055, DOI 10.1161/01.RES.0000018952.70505.F1; HASANEEN NA, 2005, FASEB J; Hays SR, 2005, THORAX, V60, P226, DOI 10.1136/thx.2004.028340; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hellstrand P, 2005, CAN J PHYSIOL PHARM, V83, P869, DOI 10.1139/Y05-061; Ito S, 2008, AM J RESP CELL MOL, V38, P407, DOI 10.1165/rcmb.2007-0259OC; Ito S, 2006, EUR J PHARMACOL, V552, P135, DOI 10.1016/j.ejphar.2006.08.067; Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061; Kanefsky J, 2006, AM J RESP CELL MOL, V34, P417, DOI 10.1165/rcmb.2005-0326OC; Kashuba VI, 2004, P NATL ACAD SCI USA, V101, P4906, DOI 10.1073/pnas.0401238101; KOMURO I, 1991, J BIOL CHEM, V266, P1265; Komuro I, 2000, JPN HEART J, V41, P117, DOI 10.1536/jhj.41.117; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Kumar A, 2003, J BIOL CHEM, V278, P18868, DOI 10.1074/jbc.M212777200; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lin S. Y., 2006, J BIOMED BIOTECHNOL, V4, P1; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Morisco C, 2001, J BIOL CHEM, V276, P28586, DOI 10.1074/jbc.M103166200; Nicolas FE, 2008, RNA, V14, P2513, DOI 10.1261/rna.1221108; PARKER PJ, 1983, EUR J BIOCHEM, V130, P227; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; Regamey N, 2008, AM J RESP CRIT CARE, V177, P837, DOI 10.1164/rccm.200707-977OC; Rochat A, 2004, MOL BIOL CELL, V15, P4544, DOI 10.1091/mbc.E03-11-0816; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Ruwhof C, 2000, CARDIOVASC RES, V47, P23, DOI 10.1016/S0008-6363(00)00076-6; SADOSHIMA J, 1993, J RECEPTOR RES, V13, P777, DOI 10.3109/10799899309073692; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Sasai N, 2010, MUSCLE NERVE, V41, P100, DOI 10.1002/mus.21473; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Smith PG, 1997, AM J PHYSIOL-LUNG C, V272, pL20, DOI 10.1152/ajplung.1997.272.1.L20; Song B, 2009, ONCOGENE, V28, P4065, DOI 10.1038/onc.2009.274; Sugden PH, 2001, CIRCULATION, V103, P1375, DOI 10.1161/01.CIR.103.10.1375; Tschumperlin DJ, 2001, AM J RESP CRIT CARE, V164, pS90, DOI 10.1164/ajrccm.164.supplement_2.2106060; Tuddenham L, 2006, FEBS LETT, V580, P4214, DOI 10.1016/j.febslet.2006.06.080; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; VAN ROOIJ E, 2006, P NATL ACAD SCI USA, V103, P18255; VANDENBURGH H, 1979, SCIENCE, V203, P265, DOI 10.1126/science.569901; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Vyas DR, 2002, AM J PHYSIOL-CELL PH, V283, pC545, DOI 10.1152/ajpcell.00049.2002; Xi YG, 2006, BIOMARK INSIGHTS, V1, P113; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803	68	169	183	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29336	29347		10.1074/jbc.M110.101147	http://dx.doi.org/10.1074/jbc.M110.101147			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20525681	Green Published, hybrid			2022-12-27	WOS:000281740100036
J	Walstab, J; Hammer, C; Lasitschka, F; Moller, D; Connolly, CN; Rappold, G; Bruss, M; Bonish, H; Niesler, B				Walstab, Jutta; Hammer, Christian; Lasitschka, Felix; Moeller, Dorothee; Connolly, Christopher N.; Rappold, Gudrun; Bruess, Michael; Boenish, Heinz; Niesler, Beate			RIC-3 Exclusively Enhances the Surface Expression of Human Homomeric 5-Hydroxytryptamine Type 3A (5-HT(3)A) Receptors Despite Direct Interactions with 5-HT3A, -C, -D, and -E Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; ENDOPLASMIC-RETICULUM CHAPERONE; FUNCTIONAL EXPRESSION; MOLECULAR-CLONING; SEROTONIN; PROTEIN; GENE; TRAFFICKING; MATURATION	Although five 5-hydroxytryptamine type 3 (5-HT3) subunits (A-E) have been cloned, knowledge on the regulation of their assembly is limited. RIC-3 has been identified as a chaperone specific for the pentameric ligand-gated nicotinic acetylcholine and 5-HT3 receptors. Therefore, we examined the impact of RIC-3 on differently composed 5-HT3 receptors with the focus on 5-HT3C, -D, and -E subunits. The influence of RIC-3 on these receptor subtypes is supported by the presence of RIC3 mRNA in tissues expressing at least one of the subunits 5-HT3C, -D, and -E. Furthermore, immunocytochemical studies on transfected mammalian cells revealed co-localization in the endoplasmic reticulum and direct interaction of RIC-3 with 5-HT3A, -C, -D, and -E. Functional and pharmacological characterization was performed using HEK293 cells expressing 5-HT3A or 5-HT3A + 5-HT3B (or -C, -D, or -E) in the presence or absence of RIC-3. Ca2+ influx analyses revealed that RIC-3 does not influence the 5-HT concentration-response relationship on 5-HT(3)A receptors but leads to differential increases of 5-HT-induced maximum response (E-max) on cells expressing different subunits. Increases of E-max were due to analogously enhanced B-max values for binding of the 5-HT3 receptor antagonist [H-3]GR65630. The observed enhanced cell surface expression of the tested 5-HT3 subunit combinations correlated with the increased surface expression of 5-HT3A as determined by flow cytometry. In conclusion, we showed that RIC-3 can interact with 5-HT3A, -C, -D, and -E subunits and predominantly enhances the surface expression of homomeric 5-HT(3)A receptors in HEK293 cells. These data implicate a possible role of RIC-3 in determining 5-HT3 receptor composition in vivo.	[Niesler, Beate] Heidelberg Univ, Dept Human Mol Genet, Inst Human Genet, D-69120 Heidelberg, Germany; [Walstab, Jutta; Bruess, Michael; Boenish, Heinz] Univ Bonn, Inst Pharmacol & Toxicol, D-53113 Bonn, Germany; [Lasitschka, Felix] Heidelberg Univ, Inst Pathol, D-69120 Heidelberg, Germany; [Connolly, Christopher N.] Univ Dundee, Ninewells Med Sch, Div Med Sci, Ctr Neurosci, Dundee DD1 9SY, Scotland	Ruprecht Karls University Heidelberg; University of Bonn; Ruprecht Karls University Heidelberg; University of Dundee	Niesler, B (corresponding author), Heidelberg Univ, Dept Human Mol Genet, Inst Human Genet, Neuenheimer Feld 366, D-69120 Heidelberg, Germany.	beate.niesler@med.uni-heidelberg.de	Hammer, Christian/C-5827-2014	Hammer, Christian/0000-0003-4548-7548; Connolly, Christopher/0000-0002-0445-8874	German Federal Ministry for Education and Research [BMBF0313320]; National Genome Research Network [NGFN-2 EP-S19T02, 01GS0482]; German Cancer Aid Grants [107229, 107262]; Wellcome Trust [085141]; Biotechnology and Biological Sciences Research Council [C18896] Funding Source: researchfish	German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); National Genome Research Network; German Cancer Aid Grants; Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by German Federal Ministry for Education and Research Grant BMBF0313320 (to B. N.) in the National Genome Research Network (NGFN-2 EP-S19T02; Grant 01GS0482), by German Cancer Aid Grants 107229 (to B. N.) and 107262 (to H. B.), and the Wellcome Trust (to C. N. C.; Grant 085141).	ALEXANDER JK, 2007, ANN M SOC NEUR SAN D; Belelli D, 1995, MOL PHARMACOL, V48, P1054; Ben-Ami HC, 2009, BIOCHEMISTRY-US, V48, P12329, DOI 10.1021/bi901234a; Ben-Ami HC, 2005, J BIOL CHEM, V280, P28053, DOI 10.1074/jbc.M504369200; BLOUNT P, 1991, J CELL BIOL, V113, P1125, DOI 10.1083/jcb.113.5.1125; Boyd GW, 2002, MOL CELL NEUROSCI, V21, P38, DOI 10.1006/mcne.2002.1160; Castillo M, 2005, J BIOL CHEM, V280, P27062, DOI 10.1074/jbc.M503746200; Cheng A, 2007, J BIOL CHEM, V282, P26158, DOI 10.1074/jbc.M703899200; Cheng AX, 2005, J BIOL CHEM, V280, P22502, DOI 10.1074/jbc.M414341200; Chetty N, 2009, NEUROGASTROENT MOTIL, V21, P564, DOI 10.1111/j.1365-2982.2008.01223.x; Chetty N, 2009, NEUROGASTROENT MOTIL, V21, pe14; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Cooper ST, 1997, J NEUROCHEM, V68, P2140; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; Dubin AE, 1999, J BIOL CHEM, V274, P30799, DOI 10.1074/jbc.274.43.30799; Exley R, 2006, J NEUROCHEM, V98, P876, DOI 10.1111/j.1471-4159.2006.03915.x; GELMAN MS, 1995, J BIOL CHEM, V270, P15085, DOI 10.1074/jbc.270.25.15085; GREEN WN, 1995, TRENDS NEUROSCI, V18, P280, DOI 10.1016/0166-2236(95)93915-K; Halevi S, 2003, J BIOL CHEM, V278, P34411, DOI 10.1074/jbc.M300170200; Halevi S, 2002, EMBO J, V21, P1012, DOI 10.1093/emboj/21.5.1012; Holbrook JD, 2009, J NEUROCHEM, V108, P384, DOI 10.1111/j.1471-4159.2008.05775.x; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Jeanclos EM, 2001, J BIOL CHEM, V276, P28281, DOI 10.1074/jbc.M011549200; Karnovsky AM, 2003, GENE, V319, P137, DOI 10.1016/S0378-1119(03)00803-5; Lansdell SJ, 2005, MOL PHARMACOL, V68, P1431, DOI 10.1124/mol.105.017459; Lansdell SJ, 2008, J NEUROCHEM, V105, P1573, DOI 10.1111/j.1471-4159.2008.05235.x; Lo WY, 2008, J BIOL CHEM, V283, P29740, DOI 10.1074/jbc.M802856200; Millar NS, 2008, BRIT J PHARMACOL, V153, pS177, DOI 10.1038/sj.bjp.0707661; MIYAKE A, 1995, MOL PHARMACOL, V48, P407; Monk SA, 2004, BIOCHEM PHARMACOL, V68, P1787, DOI 10.1016/j.bcp.2004.06.034; NGUYEN M, 1995, GENETICS, V140, P527; Niesler B, 2003, GENE, V310, P101, DOI 10.1016/S0378-1119(03)00503-1; Niesler B, 2007, MOL PHARMACOL, V72, P8, DOI 10.1124/mol.106.032144; Seredenina T, 2008, BIOSCIENCE REP, V28, P299, DOI 10.1042/BSR20080055; Severance EG, 2007, NEUROSCIENCE, V148, P454, DOI 10.1016/j.neuroscience.2007.06.008; Shteingauz A, 2009, J CELL SCI, V122, P807, DOI 10.1242/jcs.036343; Thompson AJ, 2007, EXPERT OPIN THER TAR, V11, P527, DOI 10.1517/14728222.11.4.527; Vandenberghe W, 2005, J NEUROSCI, V25, P1095, DOI 10.1523/JNEUROSCI.3568-04.2005; WALSTAB J, 2010, PHARM THER IN PRESS; Walstab J, 2008, PHARMACOGENET GENOM, V18, P793, DOI 10.1097/FPC.0b013e3283050117; Wanamaker CP, 2007, J BIOL CHEM, V282, P31113, DOI 10.1074/jbc.M705369200; Wang Y, 2009, J NEUROSCI, V29, P12625, DOI 10.1523/JNEUROSCI.1776-09.2009; Williams ME, 2005, J BIOL CHEM, V280, P1257, DOI 10.1074/jbc.M410039200	44	22	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26956	26965		10.1074/jbc.M110.122838	http://dx.doi.org/10.1074/jbc.M110.122838			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20522555	hybrid, Green Published			2022-12-27	WOS:000281172700027
J	Gomez, MA; Alisaraie, L; Shio, MT; Berghuis, AM; Lebrun, C; Gautier-Luneau, I; Olivier, M				Gomez, Maria Adelaida; Alisaraie, Laleh; Shio, Marina Tiemi; Berghuis, Albert M.; Lebrun, Colette; Gautier-Luneau, Isabelle; Olivier, Martin			Protein Tyrosine Phosphatases Are Regulated by Mononuclear Iron Dicitrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON(III) CITRATE COMPLEXES; MEMBRANE TRANSPORTER FECA; STRUCTURAL BASIS; NATURAL-RESISTANCE; IMMUNE-RESPONSE; CITRIC-ACID; NRAMP1 GENE; MACROPHAGE; EXPRESSION; PHOSPHORYLATION	The involvement of macrophages (M phi s) as host, accessory, and effector cells in the development of infectious diseases, together with their central role in iron homeostasis, place these immune cells as key players in the interface between iron and infection. Having previously shown that the functional expression of NRAMP-1 results in increased protein phosphorylation mediated in part by an iron-dependent inhibition of M phi protein-tyrosine phosphatase (PTP) activity, we sought to study the mechanism(s) underlying this specific event. Herein we have identified the mononuclear dicitrate iron complex [Fe(cit)(2)H(4-x)]((1+x)-) as the species responsible for the specific inhibition of M phi PTP activity. By using biochemical and computational approaches, we show that [Fe(cit)(2)](5-) targets the catalytic pocket of the PTP SHP-1, competitively inhibiting its interaction with an incoming phosphosubstrate. In vitro and in vivo inhibition of PTP activity by iron-citrate results in protein hyperphosphorylation and enhanced MAPK signaling in response to LPS stimulation. We propose that iron-citrate-mediated PTP inhibition represents a novel and biologically relevant regulatory mechanism of signal transduction.	[Olivier, Martin] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Gomez, Maria Adelaida; Shio, Marina Tiemi; Olivier, Martin] McGill Univ, Ctr Study Host Resistance, Ctr Hlth, Montreal, PQ H3G 1A4, Canada; [Gomez, Maria Adelaida; Shio, Marina Tiemi; Olivier, Martin] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ H3G 1A4, Canada; [Alisaraie, Laleh; Berghuis, Albert M.] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Lebrun, Colette] CEA Grenoble, INAC, Lab Reconnaissance Ion & Chim Coordinat, Serv Chim Inorgan & Biol UMR E CEA UJF 3, F-38054 Grenoble 09, France; [Gautier-Luneau, Isabelle] CNRS, Inst Neel, F-38042 Grenoble 9, France; [Gautier-Luneau, Isabelle] Univ Grenoble 1, F-38042 Grenoble 9, France	McGill University; McGill University; McGill University; McGill University; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Olivier, M (corresponding author), McGill Univ, Dept Microbiol & Immunol, Duff Med Bldg,Rm 610,3775 Univ St, Montreal, PQ H3A 2B4, Canada.	martin.olivier@mcgill.ca	Shio, Marina Tiemi/E-6466-2019; Gautier-Luneau, Isabelle/ABF-7007-2020; Berghuis, Albert M/A-6495-2008; LEBRUN, Colette/I-1695-2014	Shio, Marina Tiemi/0000-0002-2494-6816; Gautier-Luneau, Isabelle/0000-0003-1800-0167; LEBRUN, Colette/0000-0001-7908-2202; Berghuis, Albert/0000-0002-2663-025X; Gomez, Maria Adelaida/0000-0001-8792-1563	Canadian Institute of Health Research (CIHR)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by a Canadian Institute of Health Research (CIHR) operating grant (to M. O.).	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; BAKKEREN DL, 1985, INT J BIOCHEM, V17, P925, DOI 10.1016/0020-711X(85)90177-6; Bilwes AM, 1996, NATURE, V382, P555, DOI 10.1038/382555a0; Bino A, 1998, INORG CHEM, V37, P5168, DOI 10.1021/ic9715658; BLACKWELL JM, 1991, IMMUNOL LETT, V30, P241, DOI 10.1016/0165-2478(91)90032-6; Blanchette J, 1999, EUR J IMMUNOL, V29, P3737, DOI 10.1002/(SICI)1521-4141(199911)29:11&lt;3737::AID-IMMU3737&gt;3.0.CO;2-S; BRAUTIGAN DL, 1981, J BIOL CHEM, V256, P6519; BURRIDGE K, 1995, ANAL BIOCHEM, V232, P56, DOI 10.1006/abio.1995.9961; Canonne-Hergaux F, 2002, BLOOD, V100, P268, DOI 10.1182/blood.V100.1.268; Dadke S, 2001, MOL CELL BIOCHEM, V221, P147, DOI 10.1023/A:1010909031310; Ferguson AD, 2002, SCIENCE, V295, P1715, DOI 10.1126/science.1067313; Forbes JR, 2003, BLOOD, V102, P1884, DOI 10.1182/blood-2003-02-0425; Fritsche G, 2003, J IMMUNOL, V171, P1994, DOI 10.4049/jimmunol.171.4.1994; Gautier-Luneau I, 2005, CHEM-EUR J, V11, P2207, DOI 10.1002/chem.200401087; Gautier-Luneau I, 2007, BIOMETALS, V20, P793, DOI 10.1007/s10534-006-9042-y; Gomez MA, 2007, J BIOL CHEM, V282, P36190, DOI 10.1074/jbc.M703140200; Goswami T, 2001, BIOCHEM J, V354, P511, DOI 10.1042/0264-6021:3540511; Gruenheid S, 1997, J EXP MED, V185, P717, DOI 10.1084/jem.185.4.717; Haase H, 2003, EXP CELL RES, V291, P289, DOI 10.1016/S0014-4827(03)00406-3; HALL BH, 1990, BROOKINGS PAP ECO AC, P85; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Jaramillo M, 2005, J IMMUNOL, V174, P475, DOI 10.4049/jimmunol.174.1.475; Johnson LN, 2001, CHEM REV, V101, P2209, DOI 10.1021/cr000225s; Knutson MD, 2005, P NATL ACAD SCI USA, V102, P1324, DOI 10.1073/pnas.0409409102; LORENZ U, 1994, MOL CELL BIOL, V14, P1824, DOI 10.1128/MCB.14.3.1824; Markova B, 2005, METHODS, V35, P22, DOI 10.1016/j.ymeth.2004.07.004; Matzapetakis M, 1998, J AM CHEM SOC, V120, P13266, DOI 10.1021/ja9807035; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Petrat F, 2002, BIOL CHEM, V383, P489, DOI 10.1515/BC.2002.051; Pierre JL, 2000, BIOMETALS, V13, P91, DOI 10.1023/A:1009225701332; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; ROACH TIA, 1991, INFECT IMMUN, V59, P3935, DOI 10.1128/IAI.59.11.3935-3944.1991; SCHAIBLE UE, 2004, NAT REV MICROBIOL, V2, P946, DOI DOI 10.1038/NRMICR01046; SHWEKY I, 1994, INORG CHEM, V33, P5161, DOI 10.1021/ic00101a001; Strack V, 2002, BIOCHEMISTRY-US, V41, P603, DOI 10.1021/bi011327v; SWARUP G, 1982, BIOCHEM BIOPH RES CO, V107, P1104, DOI 10.1016/0006-291X(82)90635-0; Theurl I, 2005, BIOMETALS, V18, P359, DOI 10.1007/s10534-005-3710-1; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; VIDAL S, 1995, J EXP MED, V182, P655, DOI 10.1084/jem.182.3.655; Wang LJ, 2008, J IMMUNOL, V181, P2723, DOI 10.4049/jimmunol.181.4.2723; Wojciechowski W, 1999, J IMMUNOL, V163, P2688; Yang J, 2000, J BIOL CHEM, V275, P4066, DOI 10.1074/jbc.275.6.4066; Yang J, 1998, J BIOL CHEM, V273, P28199, DOI 10.1074/jbc.273.43.28199; Yue WW, 2003, J MOL BIOL, V332, P353, DOI 10.1016/S0022-2836(03)00855-6	46	18	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24620	24628		10.1074/jbc.M110.107037	http://dx.doi.org/10.1074/jbc.M110.107037			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20519508	Green Published, hybrid			2022-12-27	WOS:000280542100034
J	Hartmann, AM; Wenz, M; Mercado, A; Storger, C; Mount, DB; Friauf, E; Nothwang, HG				Hartmann, Anna-Maria; Wenz, Meike; Mercado, Adriana; Stoerger, Christof; Mount, David B.; Friauf, Eckhard; Nothwang, Hans Gerd			Differences in the Large Extracellular Loop between the K+-Cl- Cotransporters KCC2 and KCC4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITORY NEUROTRANSMISSION; TRANSPORT; DOMAINS; BRAIN; IDENTIFICATION; DISRUPTION; MEMBRANE; TERMINUS; GRADIENT; ISOFORMS	K+Cl- cotransporters (KCCs) play fundamental physiological roles in processes such as inhibitory neurotransmission and cell volume regulation. Mammalian genomes encode four distinct KCC paralogs, which share basic transport characteristics but differ significantly in ion affinity, pharmacology, and relative sensitivity to cell volume. Studies to identify divergence in functional characteristics have thus far focused on the cytoplasmic termini. Here, we investigated sequence requirements of the large extracellular loop (LEL) for function in KCC2 and KCC4. Mutation of all four evolutionarily conserved cysteines abolished KCC2 transport activity. This behavior differs from that of its closest relative, KCC4, which is insensitive to this mutation. Chimeras supported the differences in the LEL of the two cotransporters, because swapping wild-type LEL resulted in functional KCC2 but rendered KCC4 inactive. Insertion of the quadruple cysteine substitution mutant of the KCC4 loop, which was functional in the parental isoform, abolished transport activity in KCC2. Dose-response curves of wild-type and chimeric KCCs revealed that the LEL contributes to the different sensitivity to loop diuretics; a KCC2 chimera containing the KCC4 LEL displayed an IC50 of 396.5 mu M for furosemide, which was closer to KCC4 (548.8 mu M) than to KCC2 (184.4 mu M). Cell surface labeling and immunocytochemistry indicated that mutations do not affect trafficking to the plasma membrane. Taken together, our results show a dramatic and unexpected difference in the sequence requirements of the LEL between the closely related KCC2 and KCC4. Furthermore, they demonstrate that evolutionarily highly conserved amino acids can have different functions within KCC members.	[Nothwang, Hans Gerd] Carl von Ossietzky Univ Oldenburg, Dept Neurogenet, Inst Biol & Environm Sci, D-26111 Oldenburg, Germany; [Wenz, Meike; Stoerger, Christof; Friauf, Eckhard; Nothwang, Hans Gerd] Univ Kaiserslautern, Dept Biol, Anim Physiol Grp, D-67663 Kaiserslautern, Germany; [Mercado, Adriana; Mount, David B.] Harvard Univ, Sch Med, Div Renal, Brigham & Womens Hosp, Boston, MA 02115 USA; [Mount, David B.] Vet Affairs Boston Healthcare Syst, Div Renal, W Roxbury, MA 02132 USA	Carl von Ossietzky Universitat Oldenburg; University of Kaiserslautern; Harvard University; Brigham & Women's Hospital; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Nothwang, HG (corresponding author), Carl von Ossietzky Univ Oldenburg, Dept Neurogenet, Inst Biol & Environm Sci, Carl von Ossietzky Str 9-11, D-26111 Oldenburg, Germany.	hans.g.nothwang@uni-oldenburg.de	Mercado, Adriana/AAR-6143-2021; Nothwang, Hans G/C-5847-2011; Friauf, Eckhard/D-7529-2012	Mercado, Adriana/0000-0002-6881-0160; Friauf, Eckhard/0000-0002-1833-1698; Nothwang, Hans Gerd/0000-0001-7695-6437	National Institutes of Health [DK57708]; Deutsche Forschungsgemeinschaft [428/2-3]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK57708 (to D.B.M.). This work was also supported by Deutsche Forschungsgemeinschaft Grant 428/2-3 (to H.G.N.).	Adragna NC, 2004, J MEMBRANE BIOL, V201, P109, DOI 10.1007/s00232-004-0695-6; Balakrishnan V, 2003, J NEUROSCI, V23, P4134; Bergeron MJ, 2006, J BIOL CHEM, V281, P15959, DOI 10.1074/jbc.M600015200; Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; Boettger T, 2003, EMBO J, V22, P5422, DOI 10.1093/emboj/cdg519; Boettger T, 2002, NATURE, V416, P874, DOI 10.1038/416874a; Casula S, 2001, J BIOL CHEM, V276, P41870, DOI 10.1074/jbc.M107155200; Casula S, 2009, BLOOD CELL MOL DIS, V42, P233, DOI 10.1016/j.bcmd.2009.01.021; CELL P, 1997, AM J PHYSIOL, V273, pC1516; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Delpire E, 2009, P NATL ACAD SCI USA, V106, P5383, DOI 10.1073/pnas.0812756106; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Gagnon KBE, 2006, MOL CELL BIOL, V26, P689, DOI 10.1128/MCB.26.2.689-698.2006; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Gerelsaikhan T, 2000, J BIOL CHEM, V275, P40471, DOI 10.1074/jbc.M007751200; Hartmann AM, 2009, J NEUROCHEM, V111, P321, DOI 10.1111/j.1471-4159.2009.06343.x; Henriksen U, 2005, J BIOL CHEM, V280, P36926, DOI 10.1074/jbc.M502937200; Hershfinkel M, 2009, NAT NEUROSCI, V12, P725, DOI 10.1038/nn.2316; Hewitt SA, 2009, NAT NEUROSCI, V12, P438, DOI 10.1038/nn.2274; Howard HC, 2002, NAT GENET, V32, P384, DOI 10.1038/ng1002; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Isenring P, 1998, J GEN PHYSIOL, V112, P549, DOI 10.1085/jgp.112.5.549; Jacoby SC, 1999, AM J PHYSIOL-CELL PH, V277, pC684, DOI 10.1152/ajpcell.1999.277.4.C684; Karadsheh MF, 2004, NEUROSCIENCE, V123, P381, DOI 10.1016/j.neuroscience.2003.10.004; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; Martinez GQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002746; Mercado A, 2006, J BIOL CHEM, V281, P1016, DOI 10.1074/jbc.M509972200; Mercado A, 2000, J BIOL CHEM, V275, P30326, DOI 10.1074/jbc.M003112200; Mount DB, 1999, J BIOL CHEM, V274, P16355, DOI 10.1074/jbc.274.23.16355; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Reynolds A, 2008, J NEUROSCI, V28, P1588, DOI 10.1523/JNEUROSCI.3791-07.2008; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Saeki T, 2002, BIOSCI BIOTECH BIOCH, V66, P467, DOI 10.1271/bbb.66.467; Simard CF, 2007, J BIOL CHEM, V282, P18083, DOI 10.1074/jbc.M607811200; Song LY, 2002, MOL BRAIN RES, V103, P91, DOI 10.1016/S0169-328X(02)00190-0; Strange K, 2000, AM J PHYSIOL-CELL PH, V279, pC860, DOI 10.1152/ajpcell.2000.279.3.C860; Tanis JE, 2009, J NEUROSCI, V29, P9943, DOI 10.1523/JNEUROSCI.1989-09.2009; Uvarov P, 2009, J BIOL CHEM, V284, P13696, DOI 10.1074/jbc.M807366200; Woo NS, 2002, HIPPOCAMPUS, V12, P258, DOI 10.1002/hipo.10014	40	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23994	24002		10.1074/jbc.M110.144063	http://dx.doi.org/10.1074/jbc.M110.144063			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20516068	Green Published, hybrid			2022-12-27	WOS:000280291400050
J	Pohl, S; Tiede, S; Marschner, K; Encarnacao, M; Castrichini, M; Kollmann, K; Muschol, N; Ullrich, K; Muller-Loennies, S; Braulke, T				Pohl, Sandra; Tiede, Stephan; Marschner, Katrin; Encarnacao, Marisa; Castrichini, Monica; Kollmann, Katrin; Muschol, Nicole; Ullrich, Kurt; Mueller-Loennies, Sven; Braulke, Thomas			Proteolytic Processing of the gamma-Subunit Is Associated with the Failure to Form GlcNAc-1-phosphotransferase Complexes and Mannose 6-Phosphate Residues on Lysosomal Enzymes in Human Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MARROW-TRANSPLANTATION; UDP-N-ACETYLGLUCOSAMINE; CATHEPSIN-D; SANDHOFF-DISEASE; ACID-HYDROLASES; III GAMMA; RECEPTOR; N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE; CELLS; MICE	GlcNAc-1-phosphotransferase is a Golgi-resident 540-kDa complex of three subunits, alpha(2)beta(2)gamma(2), that catalyze the first step in the formation of the mannose 6-phosphate (M6P) recognition marker on lysosomal enzymes. Anti-M6P antibody analysis shows that human primary macrophages fail to generate M6P residues. Here we have explored the sorting and intracellular targeting of cathepsin D as a model, and the expression of the GlcNAc-1-phosphotransferase complex in macrophages. Newly synthesized cathepsin D is transported to lysosomes in an M6P-independent manner in association with membranes whereas the majority is secreted. Realtime PCR analysis revealed a 3-10-fold higher GlcNAc-1-phosphotransferase subunit mRNA levels in macrophages than in fibroblasts or HeLa cells. At the protein level, the gamma-subunit but not the beta-subunit was found to be proteolytically cleaved into three fragments which form irregular 97-kDa disulfide-linked oligomers in macrophages. Size exclusion chromatography showed that the gamma-subunit fragments lost the capability to assemble with other GlcNAc1-phosphotransferase subunits to higher molecular complexes. These findings demonstrate that proteolytic processing of the gamma-subunit represents a novel mechanism to regulate GlcNAc1-phosphotransferase activity and the subsequent sorting of lysosomal enzymes.	[Pohl, Sandra; Tiede, Stephan; Marschner, Katrin; Encarnacao, Marisa; Castrichini, Monica; Kollmann, Katrin; Muschol, Nicole; Ullrich, Kurt; Braulke, Thomas] Childrens Hosp, Dept Biochem, Univ Med Ctr Hamburg Eppendorf, D-20246 Hamburg, Germany; [Mueller-Loennies, Sven] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Med & Biochem Microbiol, D-23845 Borstel, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Forschungszentrum Borstel	Braulke, T (corresponding author), Childrens Hosp, Dept Biochem, Univ Med Ctr Hamburg Eppendorf, Bldg N27,Martinistr 52, D-20246 Hamburg, Germany.	braulke@uke.uni-hamburg.de	Braulke, Thomas/AAV-9121-2020; Pohl, Sandra/AAF-1943-2020; Encarnação, Marisa/AAY-4609-2020; Encarnação, Marisa/P-4261-2016	Braulke, Thomas/0000-0002-2336-8532; Encarnação, Marisa/0000-0002-3726-2851; Tiede, Stephan/0000-0002-6045-3736; Pohl, Sandra/0000-0001-7409-7042	Deutsche Forschungsgemeinschaft [SFB470/C1, 470/C6, SFB877/B3, GRK1459]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB470/C1; 470/C6; SFB877/B3; GRK1459).	AERTS JMFG, 1988, BIOCHIM BIOPHYS ACTA, V964, P303, DOI 10.1016/0304-4165(88)90030-X; Bao M, 1996, J BIOL CHEM, V271, P31437, DOI 10.1074/jbc.271.49.31437; Braulke T, 2008, J INHERIT METAB DIS, V31, P253, DOI 10.1007/s10545-008-0862-5; BRAULKE T, 1987, J CELL BIOL, V104, P1735, DOI 10.1083/jcb.104.6.1735; BRAULKE T, 1987, EUR J CELL BIOL, V43, P316; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; CHAO HHJ, 1990, EMBO J, V9, P3507, DOI 10.1002/j.1460-2075.1990.tb07559.x; DIMENT S, 1989, J BIOL CHEM, V264, P13403; Dittmer F, 1999, J CELL SCI, V112, P1591; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; GABEL CA, 1987, J CELL BIOL, V105, P1561, DOI 10.1083/jcb.105.4.1561; GIESELMANN V, 1985, J BIOL CHEM, V260, P3215; GLICKMAN JN, 1993, J CELL BIOL, V123, P99, DOI 10.1083/jcb.123.1.99; GONZALEZNORIEGA A, 1980, J CELL BIOL, V85, P839, DOI 10.1083/jcb.85.3.839; HASILIK A, 1980, J BIOL CHEM, V255, P4946; HASILIK A, 1980, J BIOL CHEM, V255, P4937; Hiesberger T, 1998, EMBO J, V17, P4617, DOI 10.1093/emboj/17.16.4617; Kollmann K, 2010, EUR J CELL BIOL, V89, P117, DOI 10.1016/j.ejcb.2009.10.008; Kornfeld R, 1998, J BIOL CHEM, V273, P23203, DOI 10.1074/jbc.273.36.23203; Kornfeld S., 2001, METABOLIC MOL BASES, P3421; Krivit W, 1999, Curr Opin Neurol, V12, P167, DOI 10.1097/00019052-199904000-00007; Kudo M, 2006, J BIOL CHEM, V281, P11761, DOI 10.1074/jbc.M513717200; Kudo M, 2005, J BIOL CHEM, V280, P36141, DOI 10.1074/jbc.m509008200; Lee WS, 2007, J BIOL CHEM, V282, P27198, DOI 10.1074/jbc.M704067200; Lefrancois S, 2003, EMBO J, V22, P6430, DOI 10.1093/emboj/cdg629; Mullerr-Loennies S, 2010, AM J PATHOL, V177, P240, DOI 10.2353/ajpath.2010.090954; Muschol N, 2002, BIOCHEM J, V368, P845, DOI 10.1042/BJ20020249; Norflus F, 1998, J CLIN INVEST, V101, P1881, DOI 10.1172/JCI2127; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Oya Y, 2000, ACTA NEUROPATHOL, V99, P161, DOI 10.1007/PL00007420; Pohl S, 2010, AM J MED GENET A, V152A, P124, DOI 10.1002/ajmg.a.33170; Pohl S, 2009, BBA-MOL BASIS DIS, V1792, P221, DOI 10.1016/j.bbadis.2009.01.009; Qian Y, 2010, J BIOL CHEM, V285, P3360, DOI 10.1074/jbc.M109.068650; Raas-Rothschild A, 2000, J CLIN INVEST, V105, P673, DOI 10.1172/JCI5826; Reczek D, 2007, CELL, V131, P770, DOI 10.1016/j.cell.2007.10.018; RIJNBOUTT S, 1991, J BIOL CHEM, V266, P23586; Storch S, 2004, J BIOL CHEM, V279, P53625, DOI 10.1074/jbc.M410930200; Storch S, 2007, TRAFFIC, V8, P431, DOI 10.1111/j.1600-0854.2007.00537.x; Sun PL, 2008, P NATL ACAD SCI USA, V105, P16590, DOI 10.1073/pnas.0807472105; Tiede S, 2005, AM J MED GENET A, V137A, P235, DOI 10.1002/ajmg.a.30868; Tiede S, 2005, NAT MED, V11, P1109, DOI 10.1038/nm1305; Tiede S, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9443; Tiede Stephan, 2004, Hum Mutat, V24, P535, DOI 10.1002/humu.9293; VARKI A, 1980, J BIOL CHEM, V255, P847; Wada R, 2000, P NATL ACAD SCI USA, V97, P10954, DOI 10.1073/pnas.97.20.10954; WAHEED A, 1981, J BIOL CHEM, V256, P4150	46	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23936	23944		10.1074/jbc.M110.129684	http://dx.doi.org/10.1074/jbc.M110.129684			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20489197	Green Published, hybrid			2022-12-27	WOS:000280291400044
J	Bourdin, B; Marger, F; Wall-Lacelle, S; Schneider, T; Klein, H; Sauve, R; Parent, L				Bourdin, Benoite; Marger, Fabrice; Wall-Lacelle, Sebastien; Schneider, Toni; Klein, Helene; Sauve, Remy; Parent, Lucie			Molecular Determinants of the Ca-V beta-induced Plasma Membrane Targeting of the Ca(V)1.2 Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED CALCIUM-CHANNELS; I-II-LINKER; CA2+-ACTIVATED K+ CHANNELS; ENDOPLASMIC-RETICULUM; ALPHA(2)DELTA SUBUNIT; CA-V-BETA(2) SUBUNIT; INTERACTION DOMAIN; TERMINAL DOMAIN; MODULATION; CALMODULIN	Ca-V beta subunits modulate cell surface expression and voltage-dependent gating of high voltage-activated (HVA) Ca(V)1 and Ca(V)2 alpha 1 subunits. High affinity Ca-V beta binding onto the so-called alpha interaction domain of the I-II linker of the Ca-V alpha 1 subunit is required for Ca-V beta modulation of HVA channel gating. It has been suggested, however, that Ca-V beta-mediated plasma membrane targeting could be uncoupled from Ca-V beta-mediated modulation of channel gating. In addition to Ca-V beta, Ca-V alpha 2 delta and calmodulin have been proposed to play important roles in HVA channel targeting. Indeed we show that co-expression of Ca-V alpha 2 delta caused a 5-fold stimulation of the whole cell currents measured with Ca(V)1.2 and Ca-V beta 3. To gauge the synergetic role of auxiliary subunits in the steady-state plasma membrane expression of Ca(V)1.2, extracellularly tagged Ca(V)1.2 proteins were quantified using fluorescence-activated cell sorting analysis. Co-expression of Ca(V)1.2 with either Ca-V alpha 2 delta, calmodulin wild type, or apocalmodulin (alone or in combination) failed to promote the detection of fluorescently labeled Ca(V)1.2 subunits. In contrast, co-expression with Ca-V beta 3 stimulated plasma membrane expression of Ca(V)1.2 by a 10-fold factor. Mutations within the alpha interaction domain of Ca(V)1.2 or within the nucleotide kinase domain of Ca-V beta 3 disrupted the Ca-V beta 3-induced plasma membrane targeting of Ca(V)1.2. Altogether, these data support a model where high affinity binding of Ca-V beta to the I-II linker of Ca-V alpha 1 largely accounts for Ca-V beta-induced plasma membrane targeting of Ca(V)1.2.	[Parent, Lucie] Univ Montreal, Dept Physiol, Downtown Stn, Montreal, PQ H3C 3J7, Canada; [Parent, Lucie] Univ Montreal, Membrane Prot Res Grp, Montreal, PQ H3C 3J7, Canada; [Schneider, Toni] Univ Cologne, Ctr Mol Med, D-50931 Cologne, Germany; [Schneider, Toni] Univ Cologne, Inst Neurophysiol, D-50931 Cologne, Germany	Universite de Montreal; Universite de Montreal; University of Cologne; University of Cologne	Parent, L (corresponding author), Univ Montreal, Dept Physiol, Downtown Stn, POB 6128, Montreal, PQ H3C 3J7, Canada.	lucie.parent@umontreal.ca	Tuluc, Petronel/C-2527-2011		Canadian Institutes of Health Research [MOP13390]; Canadian Heart and Stroke Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Heart and Stroke Foundation(Heart & Stroke Foundation of Canada)	This work was supported by Grant MOP13390 from the Canadian Institutes of Health Research and a grant from the Canadian Heart and Stroke Foundation (to L. P.).	Altier C, 2002, J BIOL CHEM, V277, P33598, DOI 10.1074/jbc.M202476200; Antzelevitch C, 2007, CIRCULATION, V115, P442, DOI 10.1161/CIRCULATIONAHA.106.668392; Barclay J, 2001, J NEUROSCI, V21, P6095, DOI 10.1523/JNEUROSCI.21-16-06095.2001; Bell DC, 2001, J NEUROPHYSIOL, V85, P816, DOI 10.1152/jn.2001.85.2.816; Benmocha A, 2009, CHANNELS, V3, P337, DOI 10.4161/chan.3.5.9686; Berrou L, 2002, BIOPHYS J, V83, P1429, DOI 10.1016/S0006-3495(02)73914-3; Berrou L, 2005, J BIOL CHEM, V280, P494, DOI 10.1074/jbc.M410859200; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Birnbaumer L, 1998, J BIOENERG BIOMEMBR, V30, P357, DOI 10.1023/A:1021989622656; BIRNBAUMER L, 1994, NEURON, V13, P505, DOI 10.1016/0896-6273(94)90021-3; Butcher AJ, 2006, J PHYSIOL-LONDON, V574, P387, DOI 10.1113/jphysiol.2006.109744; Canti C, 2005, P NATL ACAD SCI USA, V102, P11230, DOI 10.1073/pnas.0504183102; Canti C, 2001, BIOPHYS J, V81, P1439, DOI 10.1016/S0006-3495(01)75799-2; CARL SL, 1995, J CELL BIOL, V129, P673, DOI 10.1083/jcb.129.3.673; CASTELLANO A, 1993, J BIOL CHEM, V268, P3450; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Cohen RM, 2005, AM J PHYSIOL-HEART C, V288, pH2363, DOI 10.1152/ajpheart.00348.2004; Cornet V, 2002, EUR J NEUROSCI, V16, P883, DOI 10.1046/j.1460-9568.2002.02168.x; Cribbs LL, 1998, CIRC RES, V83, P103, DOI 10.1161/01.RES.83.1.103; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Dalton S, 2005, J PHYSIOL-LONDON, V567, P757, DOI 10.1113/jphysiol.2005.093195; DeWaard M, 1996, FEBS LETT, V380, P272, DOI 10.1016/0014-5793(96)00007-5; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Fallon JL, 2009, P NATL ACAD SCI USA, V106, P5135, DOI 10.1073/pnas.0807487106; Gao TY, 2000, J BIOL CHEM, V275, P25436, DOI 10.1074/jbc.M003465200; Gao TY, 1997, J BIOL CHEM, V272, P19401, DOI 10.1074/jbc.272.31.19401; Gao TY, 1999, J BIOL CHEM, V274, P2137, DOI 10.1074/jbc.274.4.2137; Gao TY, 2001, J BIOL CHEM, V276, P21089, DOI 10.1074/jbc.M008000200; Geib S, 2002, J BIOL CHEM, V277, P10003, DOI 10.1074/jbc.M106231200; Gerster U, 1999, J PHYSIOL-LONDON, V517, P353, DOI 10.1111/j.1469-7793.1999.0353t.x; Gonzalez-Gutierrez G, 2007, J BIOL CHEM, V282, P2156, DOI 10.1074/jbc.M609071200; Harry JB, 2004, J BIOL CHEM, V279, P46367, DOI 10.1074/jbc.M409523200; He LL, 2007, BIOPHYS J, V93, P834, DOI 10.1529/biophysj.106.101691; Hidalgo P, 2007, CELL CALCIUM, V42, P389, DOI 10.1016/j.ceca.2007.05.009; Hidalgo P, 2006, J BIOL CHEM, V281, P24104, DOI 10.1074/jbc.M605930200; Hulme JT, 2006, J PHYSIOL-LONDON, V576, P87, DOI 10.1113/jphysiol.2006.111799; Hulme JT, 2005, P NATL ACAD SCI USA, V102, P5274, DOI 10.1073/pnas.0409885102; Jarvis SE, 2007, CURR OPIN CELL BIOL, V19, P474, DOI 10.1016/j.ceb.2007.04.020; Joiner WJ, 2001, J BIOL CHEM, V276, P37980; Jones LP, 1998, J GEN PHYSIOL, V112, P125, DOI 10.1085/jgp.112.2.125; Kanevsky N, 2006, J GEN PHYSIOL, V128, P15, DOI 10.1085/jgp.200609485; Kim J, 2004, NEURON, V41, P745, DOI 10.1016/S0896-6273(04)00081-9; Klein H, 1999, J MEMBRANE BIOL, V167, P43, DOI 10.1007/s002329900470; Klugbauer N, 1999, J NEUROSCI, V19, P684; Lao QZ, 2008, J BIOL CHEM, V283, P15577, DOI 10.1074/jbc.M802035200; Lee WS, 2003, J BIOL CHEM, V278, P25940, DOI 10.1074/jbc.M302091200; Leroy J, 2005, J NEUROSCI, V25, P6984, DOI 10.1523/JNEUROSCI.1137-05.2005; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Maltez JM, 2005, NAT STRUCT MOL BIOL, V12, P372, DOI 10.1038/nsmb909; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Obermair GJ, 2010, J BIOL CHEM, V285, P5776, DOI 10.1074/jbc.M109.044271; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Opatowsky Y, 2003, J BIOL CHEM, V278, P52323, DOI 10.1074/jbc.M303564200; Parent L, 1997, J MEMBRANE BIOL, V160, P127, DOI 10.1007/s002329900302; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Platano D, 2000, BIOPHYS J, V78, P2959, DOI 10.1016/S0006-3495(00)76835-4; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Randall A, 1999, MOL CELL NEUROSCI, V14, P255, DOI 10.1006/mcne.1999.0795; Ravindran A, 2008, P NATL ACAD SCI USA, V105, P8154, DOI 10.1073/pnas.0711624105; Raybaud A, 2006, J BIOL CHEM, V281, P39424, DOI 10.1074/jbc.M607405200; Seu L, 2006, J GEN PHYSIOL, V128, P605, DOI 10.1085/jgp.200609631; Snutch T P, 1992, Curr Opin Neurobiol, V2, P247, DOI 10.1016/0959-4388(92)90111-W; Takahashi SX, 2005, J GEN PHYSIOL, V126, P365, DOI 10.1085/jgp.200509354; Tang W, 2003, BIOPHYS J, V85, P1538, DOI 10.1016/S0006-3495(03)74586-X; Tareilus E, 1997, P NATL ACAD SCI USA, V94, P1703, DOI 10.1073/pnas.94.5.1703; Van Petegem F, 2006, BIOCHEM SOC T, V34, P887, DOI 10.1042/BST0340887; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Van Petegem F, 2008, STRUCTURE, V16, P280, DOI 10.1016/j.str.2007.11.010; Wang HG, 2007, J NEUROSCI, V27, P9086, DOI 10.1523/JNEUROSCI.1720-07.2007; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; ZHANG JF, 1993, NEUROPHARMACOLOGY, V32, P1075, DOI 10.1016/0028-3908(93)90003-L; Zuhlke RD, 2000, J BIOL CHEM, V275, P21121, DOI 10.1074/jbc.M002986200; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	78	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22851	22861		10.1074/jbc.M110.111062	http://dx.doi.org/10.1074/jbc.M110.111062			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20478999	Green Published, hybrid			2022-12-27	WOS:000279999900018
J	Graham, S; Ding, M; Ding, YF; Sours-Brothers, S; Luchowski, R; Gryczynski, Z; Yorio, T; Ma, HY; Ma, R				Graham, Sarabeth; Ding, Min; Ding, Yanfeng; Sours-Brothers, Sherry; Luchowski, Rafal; Gryczynski, Zygmunt; Yorio, Thomas; Ma, Haiying; Ma, Rong			Canonical Transient Receptor Potential 6 (TRPC6), a Redox-regulated Cation Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; HYDROGEN-PEROXIDE; ANGIOTENSIN-II; PLASMA-MEMBRANE; C-SRC; GENERATION; ACTIVATION; CELLS; PHOSPHORYLATION; MECHANISMS	This study examined the effect of H2O2 on the TRPC6 channel and its underlying mechanisms using a TRPC6 heterologous expression system. In TRPC6-expressing HEK293T cells, H2O2 significantly stimulated Ca2+ entry in a dose-dependent manner. Electrophysiological experiments showed that H2O2 significantly increased TRPC6 channel open probability and whole-cell currents. H2O2 also evoked a robust inward current in A7r5 vascular smooth muscle cells, which was nearly abolished by knockdown of TRPC6 using a small interfering RNA. Catalase substantially attenuated arginine vasopressin (AVP)-induced Ca2+ entry in cells co-transfected with TRPC6 and AVP V1 receptor. N-Ethylmaleimide and thimerosal were able to simulate the H2O2 response. Dithiothreitol or glutathione-reduced ethyl ester significantly antagonized the response. Furthermore, both N-ethylmaleimide- and H2O2-induced TRPC6 activations were only observed in the cell-attached patches but not in the inside-out patches. Moreover, 1-oleoyl-2-acetyl-sn-glycerol effect on TRPC6 was significantly greater in the presence of H2O2. Biotinylation assays revealed a significant increase in cell surface TRPC6 in response to H2O2. Similarly, in cells transfected with TRPC6-EGFP, confocal microscopy showed a significant increase in fluorescence intensity in the region of the cell membrane and adjacent to the membrane. AVP also increased the fluorescence intensity on the surface of the cells co-transfected with TRPC6-EGFP and V1 receptor, and this response was inhibited by catalase. These data indicate that H2O2 activates TRPC6 channels via modification of thiol groups of intracellular proteins. This cysteine oxidation-dependent pathway not only stimulates the TRPC6 channel by itself but also sensitizes the channels to diacylglycerol and promotes TRPC6 trafficking to the cell surface.	[Ma, Rong] Univ N Texas, Hlth Sci Ctr, Dept Integrat Physiol, Ft Worth, TX 76107 USA; [Ma, Rong] Univ N Texas, Hlth Sci Ctr, Cardiovasc Res Inst, Ft Worth, TX 76107 USA; [Luchowski, Rafal; Gryczynski, Zygmunt] Univ N Texas, Hlth Sci Ctr, Dept Mol Biol & Immunol, Ft Worth, TX 76107 USA; [Yorio, Thomas; Ma, Haiying] Univ N Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA	University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center	Ma, R (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Integrat Physiol, RES 302G,3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.	sherry.sours-brothers@utsouthwestern.edu; rma@hsc.unt.edu	ma, rong/GVU-3096-2022	Sours-Brothers, Sherry/0000-0002-1656-7154; Luchowski, Rafal/0000-0003-1156-8059	NIDDK, National Institutes of Health [1 RO1 DK079968-01A2]; American Diabetes Association [7-07-RA-99]; American Heart Association [09GRNT2260926]; National Science Foundation, Graduate School of Biomedical Science, University of North Texas Health Science Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079968] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); National Science Foundation, Graduate School of Biomedical Science, University of North Texas Health Science Center(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 1 RO1 DK079968-01A2 from NIDDK (to R. M.). This work was also supported by American Diabetes Association Grant 7-07-RA-99 (to R. M.), American Heart Association Grant 09GRNT2260926 (to R. M.), and a National Science Foundation SCORE Fellowship from the Graduate School of Biomedical Science, University of North Texas Health Science Center (to S. G.).	Albert AP, 2008, J PHYSIOL-LONDON, V586, P3087, DOI 10.1113/jphysiol.2008.153676; Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Block K, 2008, J BIOL CHEM, V283, P24061, DOI 10.1074/jbc.M803964200; Cave AC, 2006, ANTIOXID REDOX SIGN, V8, P691, DOI 10.1089/ars.2006.8.691; Cayouette S, 2004, J BIOL CHEM, V279, P7241, DOI 10.1074/jbc.M312042200; Cayouette S, 2007, CELL CALCIUM, V42, P225, DOI 10.1016/j.ceca.2007.01.014; Chaudhuri P, 2008, MOL BIOL CELL, V19, P3203, DOI 10.1091/mbc.E07-08-0765; Chen K, 2001, J BIOL CHEM, V276, P16045, DOI 10.1074/jbc.M011766200; Denu JM, 1998, CURR OPIN CHEM BIOL, V2, P633, DOI 10.1016/S1367-5931(98)80095-1; Dietrich A., 2007, V179, P125; Dietrich A, 2003, J BIOL CHEM, V278, P47842, DOI 10.1074/jbc.M302983200; Dietrich A, 2007, CELL CALCIUM, V42, P233, DOI 10.1016/j.ceca.2007.02.009; Du J, 2008, AM J PHYSIOL-RENAL, V294, pF909, DOI 10.1152/ajprenal.00606.2007; Du J, 2007, J AM SOC NEPHROL, V18, P1437, DOI 10.1681/ASN.2006091067; Edwards DH, 2008, ARTERIOSCL THROM VAS, V28, P1774, DOI 10.1161/ATVBAHA.108.172692; Gervasio OL, 2008, J CELL SCI, V121, P2246, DOI 10.1242/jcs.032003; Gianni D, 2008, MOL BIOL CELL, V19, P2984, DOI 10.1091/mbc.E08-02-0138; Graham S, 2007, AM J PHYSIOL-RENAL, V293, pF1381, DOI 10.1152/ajprenal.00185.2007; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Hecquet CM, 2008, CIRC RES, V102, P347, DOI 10.1161/CIRCRESAHA.107.160176; Hidalgo C, 2008, ANTIOXID REDOX SIGN, V10, P1275, DOI 10.1089/ars.2007.1886; Hisatsune C, 2004, J BIOL CHEM, V279, P18887, DOI 10.1074/jbc.M311274200; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hool LC, 2007, ANTIOXID REDOX SIGN, V9, P409, DOI 10.1089/ars.2006.1446; Hsu MF, 2005, BIOCHEM PHARMACOL, V70, P1320, DOI 10.1016/j.bcp.2005.07.029; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; Inoue R, 2009, CIRC RES, V104, P1399, DOI 10.1161/CIRCRESAHA.108.193227; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Lassegue B, 2004, AM J HYPERTENS, V17, P852, DOI 10.1016/j.amjhyper.2004.02.004; Lemonnier L, 2008, CELL CALCIUM, V43, P506, DOI 10.1016/j.ceca.2007.09.001; Lou YW, 2008, FEBS J, V275, P69, DOI 10.1111/j.1742-4658.2007.06173.x; Ma R, 2005, MOL CELL BIOL, V25, P8285, DOI 10.1128/MCB.25.18.8285-8298.2005; Ma R, 2003, J BIOL CHEM, V278, P52763, DOI 10.1074/jbc.M309610200; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Moeller CC, 2007, J AM SOC NEPHROL, V18, P29, DOI 10.1681/ASN.2006091010; Nishida M, 2010, J BIOL CHEM, V285, P13244, DOI 10.1074/jbc.M109.074104; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Poteser M, 2006, J BIOL CHEM, V281, P13588, DOI 10.1074/jbc.M512205200; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Rhee SG, 2003, J AM SOC NEPHROL, V14, pS211, DOI 10.1097/01.ASN.0000077404.45564.7E; Schnackenberg CG, 2002, CURR OPIN PHARMACOL, V2, P121, DOI 10.1016/S1471-4892(02)00133-9; Schroder E, 2008, CURR OPIN PHARMACOL, V8, P153, DOI 10.1016/j.coph.2007.12.012; Soboloff J, 2005, J BIOL CHEM, V280, P39786, DOI 10.1074/jbc.M506064200; Soulsby M, 2009, PHYSIOLOGY, V24, P281, DOI 10.1152/physiol.00017.2009; Sours S, 2006, AM J PHYSIOL-RENAL, V290, pF1507, DOI 10.1152/ajprenal.00268.2005; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Suzaki Y, 2002, J BIOL CHEM, V277, P9614, DOI 10.1074/jbc.M111790200; Tabet F, 2008, CIRC RES, V103, P149, DOI 10.1161/CIRCRESAHA.108.178608; Tsvilovskyy VV, 2009, GASTROENTEROLOGY, V137, P1415, DOI 10.1053/j.gastro.2009.06.046; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; WARD PA, 1991, AM J MED, V91, pS89, DOI 10.1016/0002-9343(91)90290-E; Watanabe H, 2008, PHARMACOL THERAPEUT, V118, P337, DOI 10.1016/j.pharmthera.2008.03.008; Weibrecht I, 2007, FREE RADICAL BIO MED, V43, P100, DOI 10.1016/j.freeradbiomed.2007.03.021; Wilcox CS, 2002, CURR HYPERTENS REP, V4, P160, DOI 10.1007/s11906-002-0041-2; Winn MP, 2006, J AM SOC NEPHROL, V17, P378, DOI 10.1681/ASN.2005090962; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Yu Y, 2009, CIRCULATION, V119, P2313, DOI 10.1161/CIRCULATIONAHA.108.782458; Zafari AM, 1998, HYPERTENSION, V32, P488, DOI 10.1161/01.HYP.32.3.488; Zhou J, 2008, NAT NEUROSCI, V11, P741, DOI 10.1038/nn.2127	64	70	71	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23464	23474		10.1074/jbc.M109.093500	http://dx.doi.org/10.1074/jbc.M109.093500			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20501650	Green Published, hybrid			2022-12-27	WOS:000279999900078
J	Jadali, A; Ghazizadeh, S				Jadali, Azadeh; Ghazizadeh, Soosan			Protein Kinase D Is Implicated in the Reversible Commitment to Differentiation in Primary Cultures of Mouse Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-SENSING RECEPTOR; PLECKSTRIN HOMOLOGY DOMAIN; ACTIVATION LOOP SER(744); G(Q)-COUPLED RECEPTORS; MAP KINASE; C-MU; GROWTH ARREST; STEM-CELLS; KAPPA-B; EXPRESSION	Although commitment to epidermal differentiation is generally considered to be irreversible, differentiated keratinocytes (KCs) have been shown to maintain a regenerative potential and to reform skin epithelia when placed in a suitable environment. To obtain insights into the mechanism of reinitiation of this proliferative response in differentiated KCs, we examined the reversibility of commitment to Ca2+-induced differentiation. Lowering Ca2+ concentration to micromolar levels triggered culture-wide morphological and biochemical changes, as indicated by derepression of cyclin D1, reinitiation of DNA synthesis, and acquisition of basal cell-like characteristics. These responses were inhibited by Goedecke 6976, an inhibitor of protein kinaseD(PKD) and PKC alpha, but not with GF109203X, a general inhibitor of PKCs, suggesting PKD activation by a PKC-independent mechanism. PKD activation followed complex kinetics with a biphasic early transient phosphorylation within the first 6 h, followed by a sustained and progressive phosphorylation beginning at 24 h. The second phase of PKD activation was followed by prolonged ERK1/2 signaling and progression to DNA synthesis in response to the low Ca2+ switch. Specific knockdown of PKD-1 by RNA interference or expression of a dominant negative form of PKD-1 did not have a significant effect on normal KC proliferation and differentiation but did inhibit Ca2+-mediated reinitiation of proliferation and reversion in differentiated cultures. The present study identifies PKD as a major regulator of a proliferative response in differentiated KCs, probably through sustained activation of the ERK-MAPK pathway, and provides new insights into the process of epidermal regeneration and wound healing.	[Ghazizadeh, Soosan] SUNY Stony Brook, Dept Oral Biol & Pathol, Stony Brook, NY 11794 USA; [Jadali, Azadeh; Ghazizadeh, Soosan] SUNY Stony Brook, Grad Program Mol & Cellular Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Ghazizadeh, S (corresponding author), SUNY Stony Brook, Dept Oral Biol & Pathol, Stony Brook, NY 11794 USA.	sghazizadeh@notes.cc.sunysb.edu			National Institutes of Health [AR056013]; New York State Department of Health [C023053]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR056013] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Department of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR056013 (to S. G.). This work was also supported by New York State Department of Health-New York Stem Cell Science Grant C023053.	Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Bollag WB, 2004, DRUG NEWS PERSPECT, V17, P117, DOI 10.1358/dnp.2004.17.2.829045; Bourcier C, 2006, CANCER RES, V66, P2700, DOI 10.1158/0008-5472.CAN-05-3129; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; CABLE J, 1995, MECH DEVELOP, V50, P139, DOI 10.1016/0925-4773(94)00331-G; CARROLL JM, 1995, CELL, V83, P957, DOI 10.1016/0092-8674(95)90211-2; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Cowell CF, 2009, J CELL BIOCHEM, V106, P714, DOI 10.1002/jcb.22067; Crish JF, 2000, CARCINOGENESIS, V21, P1031, DOI 10.1093/carcin/21.5.1031; Dodd ME, 2005, J INVEST DERMATOL, V125, P294, DOI 10.1111/j.0022-202X.2005.23780.x; Dotto GP, 1999, CRIT REV ORAL BIOL M, V10, P442; Elias PM, 2002, J INVEST DERMATOL, V119, P1128, DOI 10.1046/j.1523-1747.2002.19512.x; Ellwanger K, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-47; Endo K, 2000, J BIOL CHEM, V275, P18476, DOI 10.1074/jbc.M002266200; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fuchs E, 1990, CURR OPIN CELL BIOL, V2, P1028, DOI 10.1016/0955-0674(90)90152-5; Hausser A, 2002, J CELL BIOL, V156, P65, DOI 10.1083/jcb.200110047; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Hobson SA, 2003, MOL CELL ENDOCRINOL, V200, P189, DOI 10.1016/S0303-7207(01)00749-3; Jacamo R, 2008, J BIOL CHEM, V283, P12877, DOI 10.1074/jbc.M800442200; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Jerome-Morais A, 2009, J INVEST DERMATOL, V129, P2365, DOI 10.1038/jid.2009.74; Kifor O, 2001, AM J PHYSIOL-RENAL, V280, pF291, DOI 10.1152/ajprenal.2001.280.2.F291; Kolly C, 2005, J INVEST DERMATOL, V124, P1014, DOI 10.1111/j.0022-202X.2005.23655.x; Lemonnier J, 2004, J BIOL CHEM, V279, P259, DOI 10.1074/jbc.M308665200; Lu Z, 2005, EXP DERMATOL, V14, P727, DOI 10.1111/j.1600-0625.2005.00351.x; Mannik J, 2010, J INVEST DERMATOL, V130, P388, DOI 10.1038/jid.2009.244; MANSBRIDGE JN, 1987, J INVEST DERMATOL, V89, P253, DOI 10.1111/1523-1747.ep12471216; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; MILLER DG, 1990, MOL CELL BIOL, V10, P4239, DOI 10.1128/MCB.10.8.4239; Morasso MI, 2005, BIOL CELL, V97, P173; Owens DM, 2003, NAT REV CANCER, V3, P444, DOI 10.1038/nrc1096; Pajalunga D, 2007, J CELL BIOL, V176, P807, DOI 10.1083/jcb.200608109; Parsa R, 1999, J INVEST DERMATOL, V113, P1099, DOI 10.1046/j.1523-1747.1999.00780.x; Rennecke J, 1999, INT J CANCER, V80, P98, DOI 10.1002/(SICI)1097-0215(19990105)80:1<98::AID-IJC19>3.3.CO;2-4; Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.3.CO;2-Y; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rutberg SE, 1996, ONCOGENE, V13, P167; Rykx A, 2003, FEBS LETT, V546, P81, DOI 10.1016/S0014-5793(03)00487-3; Saidak Z, 2009, ENDOCR REV, V30, P178, DOI 10.1210/er.2008-0041; Scholl FA, 2007, DEV CELL, V12, P615, DOI 10.1016/j.devcel.2007.03.009; Seitz CS, 2000, CANCER RES, V60, P4085; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; Sinnett-Smith J, 2004, J BIOL CHEM, V279, P16883, DOI 10.1074/jbc.M313225200; Sinnett-Smith J, 2009, J BIOL CHEM, V284, P13434, DOI 10.1074/jbc.M806554200; Storz P, 2003, J BIOL CHEM, V278, P17969, DOI 10.1074/jbc.M213224200; Topley GI, 1999, P NATL ACAD SCI USA, V96, P9089, DOI 10.1073/pnas.96.16.9089; Tu CL, 2008, J BIOL CHEM, V283, P3519, DOI 10.1074/jbc.M708318200; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Waldron RT, 1999, J BIOL CHEM, V274, P9224, DOI 10.1074/jbc.274.14.9224; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Watt FM, 1983, J INVEST DERMATOL, V81, P100; YUSPA SH, 1982, CANCER RES, V42, P2344; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x	57	27	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23385	23395		10.1074/jbc.M110.105619	http://dx.doi.org/10.1074/jbc.M110.105619			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20463010	hybrid, Green Published			2022-12-27	WOS:000279999900071
J	Schneider, JG; Yang, Z; Chakravarthy, MV; Lodhi, IJ; Wei, XC; Turk, J; Semenkovich, CF				Schneider, Jochen G.; Yang, Zhen; Chakravarthy, Manu V.; Lodhi, Irfan J.; Wei, Xiaochao; Turk, John; Semenkovich, Clay F.			Macrophage Fatty-acid Synthase Deficiency Decreases Diet-induced Atherosclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER-X-RECEPTORS; MOUSE PERITONEAL-MACROPHAGES; LOW-DENSITY-LIPOPROTEIN; ACTIVATES PPAR-ALPHA; HUMAN AORTIC PLAQUES; PHOSPHOLIPID CONTENT; HYPERLIPIDEMIC MICE; INSULIN-RESISTANCE; BLOOD-PRESSURE; LXR	Fatty acid metabolism is perturbed in atherosclerotic lesions, but whether it affects lesion formation is unknown. To determine whether fatty acid synthesis affects atherosclerosis, we inactivated fatty-acid synthase (FAS) in macrophages of apoE-deficient mice. Serum lipids, body weight, and glucose metabolism were the same in FAS knock-out in macrophages (FASKOM) and control mice, but blood pressure was lower in FASKOM animals. Atherosclerotic extent was decreased 20-40% in different aortic regions of FASKOM as compared with control mice on Western diets. Foam cell formation was diminished in FASKOM as compared with wild type macrophages due to increased apoAI-specific cholesterol efflux and decreased uptake of oxidized low density lipoprotein. Expression of the anti-atherogenic nuclear receptor liver X receptor alpha (LXR alpha; Nr1h3) and its downstream targets, including Abca1, were increased in FASKOM macrophages, whereas expression of the potentially pro-atherogenic type B scavenger receptor CD36 was decreased. Peroxisome proliferator-activated receptor alpha (PPAR alpha) target gene expression was decreased in FASKOM macrophages. PPAR alpha agonist treatment of FASKOM and wild type macrophages normalized PPAR alpha target gene expression as well as Nr1h3 (LXR alpha). Atherosclerotic lesions were more extensive when apoE null mice were transplanted with LXR alpha-deficient/FAS-deficient bone marrow as compared with LXR alpha-replete/FAS-deficient marrow, consistent with anti-atherogenic effects of LXR alpha in the context of FAS deficiency. These results show that macrophage FAS deficiency decreases atherosclerosis through induction of LXR alpha and suggest that FAS, which is induced by LXR alpha, may generate regulatory lipids that cause feedback inhibition of LXR alpha in macrophages.	[Semenkovich, Clay F.] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, Dept Med, St Louis, MO 63110 USA; [Semenkovich, Clay F.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Semenkovich, CF (corresponding author), Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, Dept Med, Campus Box 8127,660 S Euclid Ave, St Louis, MO 63110 USA.	csemenko@wustl.edu	Chakravarthy, Manu/AAD-7553-2021	Chakravarthy, Manu/0000-0002-3699-150X; Lodhi, Irfan/0000-0002-6246-9862; Semenkovich, Clay/0000-0003-1163-1871	National Institutes of Health [DK076729, HL083762, DK56341, DK20579, F32 DK083895, RR00954]; American Diabetes Association and American Heart Association; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL083762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076729, P30DK056341, P30DK020579, F32DK083895, P60DK020579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association and American Heart Association(American Heart AssociationAmerican Diabetes Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK076729, HL083762, DK56341, DK20579, F32 DK083895, and RR00954. This work was also supported by fellowship awards from the American Diabetes Association and American Heart Association.	ARAI H, 1992, J BIOCHEM-TOKYO, V112, P482, DOI 10.1093/oxfordjournals.jbchem.a123925; Bernal-Mizrachi C, 2002, ARTERIOSCL THROM VAS, V22, P961, DOI 10.1161/01.ATV.0000019404.65403.71; Beyea MM, 2007, J BIOL CHEM, V282, P5207, DOI 10.1074/jbc.M611063200; Brunham LR, 2009, ARTERIOSCL THROM VAS, V29, P548, DOI 10.1161/ATVBAHA.108.182303; Chakravarthy MV, 2008, DIABETES, V57, P2698, DOI 10.2337/db08-0404; Chakravarthy MV, 2007, J CLIN INVEST, V117, P2539, DOI 10.1172/JCI31183; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chinetti G, 2004, BIOCHEM BIOPH RES CO, V314, P151, DOI 10.1016/j.bbrc.2003.12.058; Chirala SS, 2003, P NATL ACAD SCI USA, V100, P6358, DOI 10.1073/pnas.0931394100; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Daugherty A, 2008, CIRC RES, V102, P1445, DOI 10.1161/CIRCRESAHA.108.178947; Ecker J, 2010, P NATL ACAD SCI USA, V107, P7817, DOI 10.1073/pnas.0912059107; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; FELTON CV, 1994, LANCET, V344, P1195, DOI 10.1016/S0140-6736(94)90511-8; Felton CV, 1997, ARTERIOSCL THROM VAS, V17, P1337, DOI 10.1161/01.ATV.17.7.1337; HALLBERG A, 1984, BIOCHIM BIOPHYS ACTA, V796, P328, DOI 10.1016/0005-2760(84)90134-6; HOWARD CF, 1968, J LIPID RES, V9, P254; Huby T, 2006, J CLIN INVEST, V116, P2767, DOI 10.1172/JCI26893; Ide T, 2003, MOL ENDOCRINOL, V17, P1255, DOI 10.1210/me.2002-0191; INSULL W, 1966, J CLIN INVEST, V45, P513, DOI 10.1172/JCI105365; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Kalinowska A, 2009, FEBS LETT, V583, P2527, DOI 10.1016/j.febslet.2009.07.008; KANNEL WB, 1985, J AM COLL CARDIOL S6, V0005; Kridel SJ, 2007, EXPERT OPIN INV DRUG, V16, P1817, DOI 10.1517/13543784.16.11.1817; LANG PD, 1970, J CLIN INVEST, V49, P1479, DOI 10.1172/JCI106365; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Li B, 2000, NAT MED, V6, P1115, DOI 10.1038/80450; LOFLAND HB, 1965, J LIPID RES, V6, P112; LOFLAND HB, 1960, ARCH BIOCHEM BIOPHYS, V88, P105, DOI 10.1016/0003-9861(60)90203-4; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Manning-Tobin JJ, 2009, ARTERIOSCL THROM VAS, V29, P19, DOI 10.1161/ATVBAHA.108.176644; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; PEKKANEN J, 1993, CARDIOLOGY, V82, P181, DOI 10.1159/000175867; Rader DJ, 2009, J LIPID RES, V50, pS189, DOI 10.1194/jlr.R800088-JLR200; Rudd JHF, 2008, J NUCL MED, V49, P871, DOI 10.2967/jnumed.107.050294; Schneider JG, 2007, ARTERIOSCL THROM VAS, V27, P2699, DOI 10.1161/ATVBAHA.107.153650; Schneider JG, 2006, CELL METAB, V4, P377, DOI 10.1016/j.cmet.2006.10.002; SEMENKOVICH CF, 1995, J LIPID RES, V36, P1507; Semenkovich CF, 1997, PROG LIPID RES, V36, P43, DOI 10.1016/S0163-7827(97)00003-9; Stachowska E, 2004, EUR J NUTR, V43, P313, DOI 10.1007/s00394-004-0479-x; Stewart ST, 2009, NEW ENGL J MED, V361, P2252, DOI 10.1056/NEJMsa0900459; TABAS I, 1987, J BIOL CHEM, V262, P12175; Taleb S, 2009, J EXP MED, V206, P2067, DOI 10.1084/jem.20090545; Tangirala RK, 2002, P NATL ACAD SCI USA, V99, P11896, DOI 10.1073/pnas.182199799; Teupser D, 2008, ARTERIOSCL THROM VAS, V28, P2009, DOI 10.1161/ATVBAHA.108.175257; Tordjman K, 2001, J CLIN INVEST, V107, P1025, DOI 10.1172/JCI11497; Traves PG, 2007, MOL PHARMACOL, V71, P1545, DOI 10.1124/mol.106.031906; Van Eck M, 2006, ARTERIOSCL THROM VAS, V26, P929, DOI 10.1161/01.ATV.0000208364.22732.16; Whereat A F, 1971, Adv Lipid Res, V9, P119; WHEREAT AF, 1964, J ATHEROSCLER RES, V4, P272, DOI 10.1016/S0368-1319(64)80009-0; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	56	46	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23396	23407		10.1074/jbc.M110.100321	http://dx.doi.org/10.1074/jbc.M110.100321			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20479009	hybrid, Green Published			2022-12-27	WOS:000279999900072
J	Yang, LL; Latchoumycandane, C; McMullen, MR; Pratt, BT; Zhang, RL; Papouchado, BG; Nagy, LE; Feldstein, AE; McIntyre, TM				Yang, Lili; Latchoumycandane, Calivarathan; McMullen, Megan R.; Pratt, Brian T.; Zhang, Renliang; Papouchado, Bettina G.; Nagy, Laura E.; Feldstein, Ariel E.; McIntyre, Thomas M.			Chronic Alcohol Exposure Increases Circulating Bioactive Oxidized Phospholipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-ACTIVATING-FACTOR; TAURINE SUPPLEMENTATION PREVENTS; HIGH-DENSITY-LIPOPROTEIN; TUMOR-NECROSIS-FACTOR; RAT KUPFFER CELLS; OXIDATIVE STRESS; FACTOR ACETYLHYDROLASE; LIPID-PEROXIDATION; REACTIVE OXYGEN; BLOOD-PLASMA	Ethanol metabolism by liver generates short lived reactive oxygen species that damage liver but also affects distal organs through unknown mechanisms. We hypothesized that dissemination of liver oxidative stress proceeds through release of biologically active oxidized lipids to the circulation. We searched for these by tandem mass spectrometry in plasma of rats fed a Lieber-DeCarli ethanol diet or in patients with established alcoholic liver inflammation, steatohepatitis. We found a several-fold increase in plasma peroxidized phosphatidylcholines, inflammatory and pro-apoptotic oxidatively truncated phospholipids, and platelet-activating factor, a remarkably potent and pleiotropic inflammatory mediator, in rats chronically ingesting ethanol. Circulating peroxidized phospholipids also increased in humans with established steatohepatitis. However, reactive oxygen species generated by liver ethanol catabolism were not directly responsible for circulating oxidized phospholipids because the delayed appearance of these lipids did not correlate with ethanol exposure, hepatic oxidative insult, nor plasma alanine transaminase marking hepatocyte damage. Rather, circulating oxidized lipids correlated with steatohepatitis and tumor necrosis factor-alpha deposition in liver. The organic osmolyte 2-aminoethylsulfonic acid (taurine), which reduces liver endoplasmic reticulum stress and inflammation, even though it is not an antioxidant, abolished liver damage and the increase in circulating oxidized phospholipids. Thus, circulating oxidized phospholipids are markers of developing steatohepatitis temporally distinct from oxidant stress associated with hepatic ethanol catabolism. Previously, circulating markers of the critical transition to pathologic steatohepatitis were unknown. Circulating oxidatively truncated phospholipids are pro-inflammatory and pro-apoptotic mediators with the potential to systemically distribute the effect of chronic ethanol exposure. Suppressing hepatic inflammation, not ethanol catabolism, reduces circulating inflammatory and apoptotic agonists.	[Yang, Lili; Latchoumycandane, Calivarathan; Zhang, Renliang; Feldstein, Ariel E.; McIntyre, Thomas M.] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Lerner Res Inst,Dept Cell Biol, Cleveland, OH 44195 USA; [McMullen, Megan R.; Pratt, Brian T.; Nagy, Laura E.] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Lerner Res Inst,Dept Pathobiol, Cleveland, OH 44195 USA; [Papouchado, Bettina G.] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Lerner Res Inst,Dept Pathol, Cleveland, OH 44195 USA; [Nagy, Laura E.] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Lerner Res Inst,Dept Gastroenterol, Cleveland, OH 44195 USA; [Feldstein, Ariel E.] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Lerner Res Inst,Dept Pediat Endocrinol, Cleveland, OH 44195 USA	Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	McIntyre, TM (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cell Biol NE 10, 9500 Euclid Ave, Cleveland, OH 44195 USA.	mcintyt@ccf.org	Latchoumycandane, Calivarathan/GPP-5175-2022	Latchoumycandane, Calivarathan/0000-0002-6637-369X	National Institutes of Health [AA017748, AA011876, AA011975, 1P20 AA017837, DK076852]; CTSA [1UL1RR024989]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported, in whole or in part, by National Institutes of Health Grants AA017748 (to T.M.M.), AA011876 (to L.E.N.), AA011975 (to L.E.N.), 1P20 AA017837 (to L.E.N.), DK076852 (to A.E.F.), and CTSA 1UL1RR024989 (to Pamela Davis).	Adachi J, 2004, J LIPID RES, V45, P967, DOI 10.1194/jlr.M400008-JLR200; Bailey SM, 2002, FREE RADICAL BIO MED, V32, P11, DOI 10.1016/S0891-5849(01)00769-9; BEUTLER BA, 1985, J IMMUNOL, V135, P3972; BOWRY VW, 1992, P NATL ACAD SCI USA, V89, P10316, DOI 10.1073/pnas.89.21.10316; Cahill A, 2002, ALCOHOL CLIN EXP RES, V26, P907, DOI 10.1097/00000374-200206000-00022; CAMUSSI G, 1987, J EXP MED, V166, P1390, DOI 10.1084/jem.166.5.1390; Chen R, 2007, J BIOL CHEM, V282, P24842, DOI 10.1074/jbc.M702865200; Chen R, 2009, J BIOL CHEM, V284, P26297, DOI 10.1074/jbc.M109.018978; Chen R, 2009, ARTERIOSCL THROM VAS, V29, P363, DOI 10.1161/ATVBAHA.108.178731; Chen XC, 2009, HEPATOLOGY, V49, P1554, DOI 10.1002/hep.22811; Czaja MJ, 2004, HEPATOLOGY, V40, P19, DOI 10.1002/hep.20328; Deaciuc IV, 1996, ALCOHOL CLIN EXP RES, V20, P293, DOI 10.1111/j.1530-0277.1996.tb01642.x; Dey A, 2006, HEPATOLOGY, V43, pS63, DOI 10.1002/hep.20957; DIAGNE A, 1984, BIOCHIM BIOPHYS ACTA, V793, P221, DOI 10.1016/0005-2760(84)90324-2; ELSTAD MR, 1988, J IMMUNOL, V140, P1618; Frey B, 2000, J LIPID RES, V41, P1145; Fruhwirth GO, 2007, BBA-MOL BASIS DIS, V1772, P718, DOI 10.1016/j.bbadis.2007.04.009; Harada H, 2000, HYPERTENS RES, V23, P277, DOI 10.1291/hypres.23.277; Hoff HF, 2003, ARTERIOSCL THROM VAS, V23, P275, DOI 10.1161/01.ATV.0000051407.42536.73; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Horkko S, 1997, P NATL ACAD SCI USA, V94, P10356, DOI 10.1073/pnas.94.19.10356; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Itabe H, 1996, J BIOL CHEM, V271, P33208, DOI 10.1074/jbc.271.52.33208; ITABE H, 1988, BIOCHIM BIOPHYS ACTA, V962, P8; Johnson EF, 1996, ANN NY ACAD SCI, V804, P373, DOI 10.1111/j.1749-6632.1996.tb18629.x; Kato Y, 1998, ARCH BIOCHEM BIOPHYS, V351, P106, DOI 10.1006/abbi.1997.0519; Kriska T, 2007, J BIOL CHEM, V282, P100, DOI 10.1074/jbc.M608135200; Lehr HA, 1997, J CLIN INVEST, V99, P2358, DOI 10.1172/JCI119417; Marathe GK, 2003, J BIOL CHEM, V278, P3937, DOI 10.1074/jbc.M211126200; Marathe GK, 1999, J BIOL CHEM, V274, P28395, DOI 10.1074/jbc.274.40.28395; Meagher EA, 1999, J CLIN INVEST, V104, P805, DOI 10.1172/JCI5584; Moumtzi A, 2007, J LIPID RES, V48, P565, DOI 10.1194/jlr.M600394-JLR200; National Research Council, 1996, GUID CAR US LAB AN N; Nonaka H, 2001, CIRCULATION, V104, P1165, DOI 10.1161/hc3601.093976; NORDMANN R, 1990, ALCOHOL ALCOHOLISM, V25, P231, DOI 10.1093/oxfordjournals.alcalc.a044996; Owen JS, 2005, J LIPID RES, V46, P373, DOI 10.1194/jlr.D400029-JLR200; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Rhode S, 2009, J BIOL CHEM, V284, P2258, DOI 10.1074/jbc.M807591200; Roychowdhury S, 2009, HEPATOLOGY, V49, P1326, DOI 10.1002/hep.22776; Schroder H, 2006, FREE RADICAL BIO MED, V40, P1474, DOI 10.1016/j.freeradbiomed.2005.12.014; Shi XL, 1997, ANN CLIN LAB SCI, V27, P365; Smith WL, 2008, J BIOL CHEM, V283, P15513, DOI 10.1074/jbc.R800006200; Stafforini DM, 2009, CARDIOVASC DRUG THER, V23, P73, DOI 10.1007/s10557-008-6133-8; Stafforini DM, 2006, J BIOL CHEM, V281, P4616, DOI 10.1074/jbc.M507340200; STREMLER KE, 1991, J BIOL CHEM, V266, P11095; Subbanagounder G, 2000, ARTERIOSCL THROM VAS, V20, P2248, DOI 10.1161/01.ATV.20.10.2248; Thakur V, 2006, AM J PHYSIOL-GASTR L, V290, pG998, DOI 10.1152/ajpgi.00553.2005; Thakur V, 2006, J LEUKOCYTE BIOL, V79, P1348, DOI 10.1189/jlb.1005613; Thomas CP, 2010, J BIOL CHEM, V285, P6891, DOI 10.1074/jbc.M109.078428	51	47	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22211	22220		10.1074/jbc.M110.119982	http://dx.doi.org/10.1074/jbc.M110.119982			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20460374	Green Published, hybrid			2022-12-27	WOS:000279702200034
J	Cheng, Q; Antholine, WE; Myers, JM; Kalyanaraman, B; Arner, ESJ; Myers, CR				Cheng, Qing; Antholine, William E.; Myers, Judith M.; Kalyanaraman, Balaraman; Arner, Elias S. J.; Myers, Charles R.			The Selenium-independent Inherent Pro-oxidant NADPH Oxidase Activity of Mammalian Thioredoxin Reductase and Its Selenium-dependent Direct Peroxidase Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEXAVALENT CHROMIUM; HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; REACTIVE OXYGEN; IN-VITRO; RADICAL GENERATION; HYDROXYL RADICALS; CELL-DEATH; SPIN-TRAP; SELENOCYSTEINE	Mammalian thioredoxin reductase (TrxR) is an NADPH-dependent homodimer with three redox-active centers per subunit: a FAD, an N-terminal domain dithiol (Cys(59)/Cys(64)), and a C-terminal cysteine/selenocysteine motif (Cys(497)/Sec(498)). TrxR has multiple roles in antioxidant defense. Opposing these functions, it may also assume a pro-oxidant role under some conditions. In the absence of its main electron-accepting substrates (e. g. thioredoxin), wild-type TrxR generates superoxide (O-2(raical anion)), which was here detected and quantified by ESR spin trapping with 5-diethoxyphosphoryl-5-methyl-1-pyrroline-N-oxide (DEPMPO). The peroxidase activity of wild-type TrxR efficiently converted the O2(radical anion). adduct (DEPMPO/HOO center dot) to the hydroxyl radical adduct(DEPMPO/HO center dot). This peroxidase activity was Sec-dependent, although multiple mutants lacking Sec could still generate O-2(radical anion). Variants of TrxR with C59S and/or C64S mutations displayed markedly reduced inherent NADPH oxidase activity, suggesting that the Cys59/Cys64 dithiol is required for O-2(radical anion) generation and that O-2(radical anion) is not derived directly from the FAD. Mutations in the Cys59/Cys64 dithiol also blocked the peroxidase and disulfide reductase activities presumably because of an inability to reduce the Cys497/Sec498 active site. Although the bulk of the DEPMPO/HO center dot signal generated by wild-type TrxR was due to its combined NADPH oxidase and Sec-dependent peroxidase activities, additional experiments showed that some free HO center dot could be generated by the enzyme in an H2O2-dependent and Sec-independent manner. The direct NADPH oxidase and peroxidase activities of TrxR characterized here give insights into the full catalytic potential of this enzyme and may have biological consequences beyond those solely related to its reduction of thioredoxin.	[Myers, Judith M.; Myers, Charles R.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Antholine, William E.; Kalyanaraman, Balaraman; Myers, Charles R.] Med Coll Wisconsin, Free Radical Res Ctr, Milwaukee, WI 53226 USA; [Antholine, William E.; Kalyanaraman, Balaraman] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Cheng, Qing; Arner, Elias S. J.] Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, SE-17177 Stockholm, Sweden	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Karolinska Institutet	Myers, CR (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	cmyers@mcw.edu	Arnér, Elias S.J./J-5832-2012; Arnér, Elias/K-6737-2019	Arnér, Elias S.J./0000-0002-4807-6114; Arnér, Elias/0000-0002-4807-6114; Myers, Charles/0000-0001-7956-3217; Cheng, Qing/0000-0002-3170-9333	National Institutes of Health [R01ES012707]; Swedish Research Council (Medicine); Swedish Cancer Society; Knut and Alice Wallenberg Foundation; Karolinska Institutet; National Institutes of Health National Biomedical ESR Center [EB001980]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012707] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council (Medicine)(Swedish Research Council); Swedish Cancer Society(Swedish Cancer Society); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Karolinska Institutet(Karolinska Institutet); National Institutes of Health National Biomedical ESR Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01ES012707 (to C. R. M.). This work was also supported by grants from the Swedish Research Council (Medicine), the Swedish Cancer Society, the Knut and Alice Wallenberg Foundation, and Karolinska Institutet (to E.S.J.A.). The EPR facilities of the Department of Biophysics of the Medical College of Wisconsin are supported by National Institutes of Health National Biomedical ESR Center Grant EB001980.	Anestal K, 2003, J BIOL CHEM, V278, P15966, DOI 10.1074/jbc.M210733200; Anestal K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001846; Arner ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Arner ESJ, 1999, J MOL BIOL, V292, P1003, DOI 10.1006/jmbi.1999.3085; Arner ESJ, 2002, METHOD ENZYMOL, V347, P226; ARNER ESJ, 1995, J BIOL CHEM, V270, P3479, DOI 10.1074/jbc.270.8.3479; Arner ESJ, 2001, FREE RADICAL BIO MED, V31, P1170, DOI 10.1016/S0891-5849(01)00698-0; Arteel GE, 1999, CHEM RES TOXICOL, V12, P264, DOI 10.1021/tx980223r; BJORNSTEDT M, 1995, J BIOL CHEM, V270, P11761, DOI 10.1074/jbc.270.20.11761; Borthiry GR, 2007, FREE RADICAL BIO MED, V42, P738, DOI 10.1016/j.freeradbiomed.2006.10.055; BRITIGAN BE, 1990, J BIOL CHEM, V265, P2650; Cenas N, 2004, J BIOL CHEM, V279, P2583, DOI 10.1074/jbc.M310292200; Chalier F, 2007, J ORG CHEM, V72, P7886, DOI 10.1021/jo071070s; Cheng Q, 2006, NAT PROTOC, V1, P604, DOI 10.1038/nprot.2006.87; Cheng Q, 2009, J BIOL CHEM, V284, P3998, DOI 10.1074/jbc.M807068200; DULING DR, 1994, J MAGN RESON SER B, V104, P105, DOI 10.1006/jmrb.1994.1062; Eriksson SE, 2009, FREE RADICAL BIO MED, V47, P1661, DOI 10.1016/j.freeradbiomed.2009.09.016; Fang JG, 2005, J BIOL CHEM, V280, P25284, DOI 10.1074/jbc.M414645200; FINKELSTEIN E, 1982, MOL PHARMACOL, V21, P262; FREJAVILLE C, 1995, J MED CHEM, V38, P258, DOI 10.1021/jm00002a007; Gromer S, 2004, MED RES REV, V24, P40, DOI 10.1002/med.10051; Gromer S, 1998, J BIOL CHEM, V273, P20096, DOI 10.1074/jbc.273.32.20096; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; HALLIWELL B, 1989, FREE RADICAL BIO MED, V7, P645, DOI 10.1016/0891-5849(89)90145-7; Hardy M, 2005, J ORG CHEM, V70, P2135, DOI 10.1021/jo0479516; Hardy M, 2007, CHEM RES TOXICOL, V20, P1053, DOI 10.1021/tx700101d; Hashemy SI, 2006, J BIOL CHEM, V281, P10691, DOI 10.1074/jbc.M511373200; HOLMGREN A, 1977, J BIOL CHEM, V252, P4600; Johansson L, 2004, NAT METHODS, V1, P61, DOI 10.1038/NMETH707; Karoui H, 1996, J BIOL CHEM, V271, P6000, DOI 10.1074/jbc.271.11.6000; Khan N, 2003, FREE RADICAL BIO MED, V34, P1473, DOI 10.1016/S0891-5849(03)00182-5; KOSAKA H, 1992, ARCH BIOCHEM BIOPHYS, V293, P401, DOI 10.1016/0003-9861(92)90412-P; KUMAR S, 1992, EUR J BIOCHEM, V207, P435, DOI 10.1111/j.1432-1033.1992.tb17068.x; LIOCHEV SI, 1994, FREE RADICAL BIO MED, V16, P29, DOI 10.1016/0891-5849(94)90239-9; Lothrop AP, 2009, BIOCHEMISTRY-US, V48, P6213, DOI 10.1021/bi802146w; Lu J, 2009, J BIOL CHEM, V284, P723, DOI 10.1074/jbc.R800045200; Millet R, 2005, J MED CHEM, V48, P7024, DOI 10.1021/jm050256l; Myers CR, 2009, TOXICOLOGY, V257, P95, DOI 10.1016/j.tox.2008.12.013; Myers CR, 1998, CARCINOGENESIS, V19, P1029, DOI 10.1093/carcin/19.6.1029; Myers JM, 2008, TOXICOLOGY, V246, P222, DOI 10.1016/j.tox.2008.01.017; Myers JM, 2009, FREE RADICAL BIO MED, V47, P1477, DOI 10.1016/j.freeradbiomed.2009.08.015; Nordberg J, 1998, J BIOL CHEM, V273, P10835, DOI 10.1074/jbc.273.18.10835; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; PERKINS MJ, 1980, ADV PHYS ORG CHEM, V17, P1; Powis G, 2001, ANNU REV BIOPH BIOM, V30, P421, DOI 10.1146/annurev.biophys.30.1.421; Rengby O, 2004, APPL ENVIRON MICROB, V70, P5159, DOI 10.1128/AEM.70.9.5159-5167.2004; Rengby O, 2007, APPL ENVIRON MICROB, V73, P432, DOI 10.1128/AEM.02019-06; Rengby O, 2009, FREE RADICAL BIO MED, V46, P893, DOI 10.1016/j.freeradbiomed.2008.12.017; Rhodes CJ, 2004, SPECTROCHIM ACTA A, V60, P1401, DOI 10.1016/j.saa.2003.10.038; Rigobello MP, 2004, J INORG BIOCHEM, V98, P1634, DOI 10.1016/j.jinorgbio.2004.04.020; Rigobello MP, 1998, FREE RADICAL BIO MED, V24, P370, DOI 10.1016/S0891-5849(97)00216-5; ROSEN GM, 1984, P NATL ACAD SCI-BIOL, V81, P7269, DOI 10.1073/pnas.81.23.7269; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Shi HL, 2005, ARCH BIOCHEM BIOPHYS, V437, P59, DOI 10.1016/j.abb.2005.02.028; SHI XL, 1994, CARCINOGENESIS, V15, P2475, DOI 10.1093/carcin/15.11.2475; SHI XL, 1990, FREE RADICAL RES COM, V10, P17, DOI 10.3109/10715769009145929; SHI XL, 1990, ARCH BIOCHEM BIOPHYS, V277, P342, DOI 10.1016/0003-9861(90)90589-Q; SHI XL, 1992, ARCH BIOCHEM BIOPHYS, V293, P281, DOI 10.1016/0003-9861(92)90396-E; SHI XL, 1994, BBA-MOL BASIS DIS, V1226, P65, DOI 10.1016/0925-4439(94)90060-4; Szadkowski A, 2008, TOXICOLOGY, V243, P164, DOI 10.1016/j.tox.2007.10.004; TORDO P, 1998, ELECT PARAMAGN RESON, V16, P116, DOI DOI 10.1039/9781847553539-00116; Urig S, 2006, SEMIN CANCER BIOL, V16, P452, DOI 10.1016/j.semcancer.2006.09.004; Vasquez-Vivar J, 1999, FREE RADICAL RES, V31, P607, DOI 10.1080/10715769900301181; Villamena FA, 2004, ANTIOXID REDOX SIGN, V6, P619, DOI 10.1089/152308604773934387; Watson WH, 2008, BIOCHEM BIOPH RES CO, V368, P832, DOI 10.1016/j.bbrc.2008.02.006; Witte AB, 2005, FREE RADICAL BIO MED, V39, P696, DOI 10.1016/j.freeradbiomed.2005.04.025; YAMAZAKI I, 1990, J BIOL CHEM, V265, P13589; Zhao HT, 2001, FREE RADICAL BIO MED, V31, P599, DOI 10.1016/S0891-5849(01)00619-0; Zhao R, 2002, P NATL ACAD SCI USA, V99, P8579, DOI 10.1073/pnas.122061399; Zhong LW, 2000, P NATL ACAD SCI USA, V97, P5854, DOI 10.1073/pnas.100114897; Zhong LW, 2000, J BIOL CHEM, V275, P18121, DOI 10.1074/jbc.M000690200	72	50	51	1	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21708	21723		10.1074/jbc.M110.117259	http://dx.doi.org/10.1074/jbc.M110.117259			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20457604	Green Published, hybrid			2022-12-27	WOS:000279516100058
J	Hallows, KR; Bhalla, V; Oyster, NM; Wijngaarden, MA; Lee, JK; Li, H; Chandran, S; Xia, XY; Huang, ZR; Chalkley, RJ; Burlingame, AL; Pearce, D				Hallows, Kenneth R.; Bhalla, Vivek; Oyster, Nicholas M.; Wijngaarden, Marjolein A.; Lee, Jeffrey K.; Li, Hui; Chandran, Sindhu; Xia, Xiaoyu; Huang, Zhirong; Chalkley, Robert J.; Burlingame, Alma L.; Pearce, David			Phosphopeptide Screen Uncovers Novel Phosphorylation Sites of Nedd4-2 That Potentiate Its Inhibition of the Epithelial Na+ Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE NEDD4-2; CELL-SURFACE EXPRESSION; INDUCIBLE KINASE SGK; LIDDLES-SYNDROME; FUNCTIONAL REGULATION; SODIUM-TRANSPORT; ENAC REGULATION; PY MOTIF; SERUM; PROTEIN	The E3 ubiquitin ligase Nedd4-2 regulates several ion transport proteins, including the epithelial Na+ channel (ENaC). Nedd4-2 decreases apical membrane expression and activity of ENaC. Although it is subject to tight hormonal control, the mechanistic basis of Nedd4-2 regulation remains poorly understood. To characterize regulatory inputs to Nedd4-2 function, we screened for novel sites of Nedd4-2 phosphorylation using tandem mass spectrometry. Three of seven identified Xenopus Nedd4-2 Ser/Thr phosphorylation sites corresponded to previously identified target sites for SGK1, whereas four were novel, including Ser-293, which matched the consensus for a MAPK target sequence. Further in vitro and in vivo phosphorylation experiments revealed that Nedd4-2 serves as a target of JNK1, but not of p38 MAPK or ERK1/2. Additional rounds of tandem mass spectrometry identified two other phosphorylated residues within Nedd4-2, including Thr-899, which is present within the catalytic domain. Nedd4-2 with mutations at these sites had markedly inhibited JNK1-dependent phosphorylation, virtually no ENaC inhibitory activity, and significantly reduced ubiquitin ligase activity. These data identify phosphorylatable residues that activate Nedd4-2 and may work together with residues targeted by inhibitory kinases (e.g. SGK1 and protein kinase A) to govern Nedd4-2 regulation of epithelial ion transport.	[Hallows, Kenneth R.; Oyster, Nicholas M.; Lee, Jeffrey K.; Li, Hui] Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15261 USA; [Bhalla, Vivek; Chandran, Sindhu; Xia, Xiaoyu] Stanford Univ, Sch Med, Dept Med, Div Nephrol, Stanford, CA 94305 USA; [Wijngaarden, Marjolein A.] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, NL-2300 RC Leiden, Netherlands; [Huang, Zhirong; Pearce, David] Univ Calif San Francisco, Sch Med, Dept Med, Div Nephrol, San Francisco, CA 94107 USA; [Chalkley, Robert J.; Burlingame, Alma L.] Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Stanford University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bhalla, V (corresponding author), Stanford Univ, Div Nephrol, 780 Welch Rd,Suite 106, Palo Alto, CA 94304 USA.	vbhalla@stanford.edu	Chandran, Sindhu/AAE-6783-2021; Wijngaarden, Marjolein A/F-9438-2010; Hallows, Kenneth/A-8477-2013	Chandran, Sindhu/0000-0003-4547-3381; Wijngaarden, Marjolein A/0000-0002-4697-0286; Bhalla, Vivek/0000-0002-5420-9657; Chalkley, Robert/0000-0002-9757-7302; Hallows, Kenneth/0000-0002-2964-2440	National Institutes of Health [P30 DK079307, R01 DK075048, K08 DK071648, R01 DK056695]; Dutch Kidney Foundation; National Center for Research Resources (NCRR); National Institutes of Health NCRR [RR01614, RR015804]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614, S10RR015804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK071648, R01DK075048, R01DK056695, P30DK079307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Kidney Foundation; National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P30 DK079307 (to the Pittsburgh Kidney Research Center), R01 DK075048 (to K. R. H.), K08 DK071648 (to V. B.), and R01 DK056695 (to D. P.). This work was also supported by a grant from the Dutch Kidney Foundation (to M. A. W.). Mass spectrometry analysis was provided by the University of California San Francisco Mass Spectrometry Facility (A. L. B. and R.J.C.), supported by the Biomedical Research Technology Program of the National Center for Research Resources (NCRR) and National Institutes of Health NCRR Grants RR01614 and RR015804.	Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; Bruce MC, 2008, BIOCHEM J, V415, P155, DOI 10.1042/BJ20071708; Carattino MD, 2005, J BIOL CHEM, V280, P17608, DOI 10.1074/jbc.M501770200; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Edinger RS, 2009, J BIOL CHEM, V284, P150, DOI 10.1074/jbc.M807358200; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Flores SY, 2005, J AM SOC NEPHROL, V16, P2279, DOI 10.1681/ASN.2004100828; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Hryciw DH, 2004, J BIOL CHEM, V279, P54996, DOI 10.1074/jbc.M411491200; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Jespersen T, 2007, CARDIOVASC RES, V74, P64, DOI 10.1016/j.cardiores.2007.01.008; Jiang QS, 1998, J CELL BIOL, V143, P645, DOI 10.1083/jcb.143.3.645; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lee IH, 2007, J BIOL CHEM, V282, P29866, DOI 10.1074/jbc.M701923200; Liang XB, 2006, J BIOL CHEM, V281, P16323, DOI 10.1074/jbc.M601360200; Malik B, 2005, AM J PHYSIOL-RENAL, V289, pF107, DOI 10.1152/ajprenal.00179.2002; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; Schild L, 1996, EMBO J, V15, P2381, DOI 10.1002/j.1460-2075.1996.tb00594.x; Shi HK, 2002, J BIOL CHEM, V277, P13539, DOI 10.1074/jbc.M111717200; Shi PP, 2008, AM J PHYSIOL-RENAL, V295, pF462, DOI 10.1152/ajprenal.90300.2008; Slagsvold T, 2006, EMBO J, V25, P3738, DOI 10.1038/sj.emboj.7601267; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Soundararajan R, 2005, J BIOL CHEM, V280, P39970, DOI 10.1074/jbc.M508658200; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; van Bemmelen MX, 2004, CIRC RES, V95, P284, DOI 10.1161/01.RES.0000136816.05109.89; Yang C, 2006, MOL CELL, V21, P135, DOI 10.1016/j.molcel.2005.11.014	35	33	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21671	21678		10.1074/jbc.M109.084731	http://dx.doi.org/10.1074/jbc.M109.084731			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20466724	Green Published, hybrid			2022-12-27	WOS:000279516100054
J	Prapavorarat, A; Vatanavicharn, T; Soderhall, K; Tassanakajon, A				Prapavorarat, Adisak; Vatanavicharn, Tipachai; Soderhall, Kenneth; Tassanakajon, Anchalee			A Novel Viral Responsive Protein Is Involved in Hemocyte Homeostasis in the Black Tiger Shrimp, Penaeus monodon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WHITE-SPOT SYNDROME; HEMATOPOIETIC-TISSUE; IN-VITRO; APOPTOSIS; CRAYFISH; IDENTIFICATION; ENCAPSULATION; EXPRESSION; MATURATION; CRUSTACEAN	A novel viral responsive protein, namely hemocyte homeostasis-associated protein (HHAP), was characterized for its role in the response of shrimp to white spot syndrome virus infection. The full-length cDNAs of HHAP from the black tiger shrimp (PmHHAP), Penaeus monodon, and the fresh water crayfish (PlHHAP), Pacifastacus leniusculus, were obtained and showed high sequence identity to a hypothetical protein from various organisms, with the highest identity to the hypothetical protein TcasGA2_TC006773 from the red flour beetle, Tribolium castaneum (54% amino acid sequence identity). Transcripts of PmHHAP were expressed in various shrimp tissues with the highest expression in hematopoietic tissue, whereas the transcripts of PlHHAP were found in the hematopoietic and nerve tissues. Upon white spot syndrome virus infection, a high up-regulation level of shrimp hemocytic HHAP mRNA and protein was observed by real-time reverse transcription-PCR and immunofluorescence microscopy, respectively. Gene silencing of PmHHAP by RNA interference resulted in a significant decrease in the number of circulating hemocytes and 100% shrimp mortality within 30 h of the double-stranded PmHHAP RNA injection (but not in control shrimp), indicating that HHAP is essential for shrimp survival. Interestingly, severe damage of hemocytes was observed in vivo in the PmHHAP knockdown shrimp and in vitro in shrimp primary hemocyte cell culture, suggesting that PmHHAP plays an important role in hemocyte homeostasis. Thus, it is speculated that the up-regulation of PmHHAP is an important mechanism to control circulating hemocyte levels in crustaceans during viral infection.	[Tassanakajon, Anchalee] Chulalongkorn Univ, Fac Sci, Dept Biochem, Ctr Excellence Mol Biol & Genom Shrimp, Bangkok 10330, Thailand; [Soderhall, Kenneth] Uppsala Univ, Dept Comparat Physiol, S-75236 Uppsala, Sweden	Chulalongkorn University; Uppsala University	Tassanakajon, A (corresponding author), Chulalongkorn Univ, Fac Sci, Dept Biochem, Ctr Excellence Mol Biol & Genom Shrimp, Bangkok 10330, Thailand.	anchalee.k@chula.ac.th			Commission on Higher Education; Thailand National Center for Genetic Engineering and Biotechnology; Royal Golden Jubilee PhD Program, Thailand Research Fund; Thai Government [TKK2555]	Commission on Higher Education; Thailand National Center for Genetic Engineering and Biotechnology; Royal Golden Jubilee PhD Program, Thailand Research Fund; Thai Government	This work was supported by grants from The Commission on Higher Education, and the Thailand National Center for Genetic Engineering and Biotechnology and by a student fellowship (to A. P. and T. V.) from the Royal Golden Jubilee PhD Program, Thailand Research Fund. This work was also supported by the Thai Government Stimulus Package2 (TKK2555), under the Project for Establishment of Comprehensive Center for Innovative Food, Health Products, and Agriculture.	Ahmad S, 2004, BIOINFORMATICS, V20, P477, DOI 10.1093/bioinformatics/btg432; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bangrak P, 2004, J BIOTECHNOL, V108, P219, DOI 10.1016/j.jbiotec.2003.12.007; Bauchau A.G., 1980, INVERTEBRATE BLOOD C, P385; Chaga Oleg, 1995, Animal Biology, V4, P59; Chang PS, 1996, DIS AQUAT ORGAN, V27, P131, DOI 10.3354/dao027131; Chou HY, 1995, DIS AQUAT ORGAN, V23, P165, DOI 10.3354/dao023165; Du HH, 2007, AQUACULTURE, V262, P532, DOI 10.1016/j.aquaculture.2006.11.002; Ferre F, 2005, NUCLEIC ACIDS RES, V33, pW230, DOI 10.1093/nar/gki412; Flegel TW, 2006, AQUACULTURE, V258, P1, DOI 10.1016/j.aquaculture.2006.05.013; Granja CB, 2003, DIS AQUAT ORGAN, V54, P73, DOI 10.3354/dao054073; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hsiao CY, 2010, FISH SHELLFISH IMMUN, V28, P77, DOI 10.1016/j.fsi.2009.10.016; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; KOBAYASHI M, 1990, CELL TISSUE RES, V260, P13, DOI 10.1007/BF00297485; Lin XH, 2009, EXP CELL RES, V315, P1171, DOI 10.1016/j.yexcr.2009.01.001; Lin XH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-58; Liu HP, 2009, FISH SHELLFISH IMMUN, V27, P79, DOI 10.1016/j.fsi.2009.02.009; Lo CF, 1996, DIS AQUAT ORGAN, V27, P215, DOI 10.3354/dao027215; Lorenzon S, 1999, FISH SHELLFISH IMMUN, V9, P31, DOI 10.1006/fsim.1998.0168; PATERSON WD, 1974, J FISH RES BOARD CAN, V31, P1051, DOI 10.1139/f74-119; Pech LL, 2000, J INSECT PHYSIOL, V46, P1565, DOI 10.1016/S0022-1910(00)00083-4; PERSSON M, 1987, CELL TISSUE RES, V247, P409; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SMITH VJ, 1983, CELL TISSUE RES, V233, P295; SMITH VJ, 1983, BIOL BULL, V164, P299, DOI 10.2307/1541146; Soderhall I, 2005, J IMMUNOL, V174, P6153, DOI 10.4049/jimmunol.174.10.6153; Soderhall I, 2003, DEV COMP IMMUNOL, V27, P661, DOI 10.1016/S0145-305X(03)00039-9; Sung HH, 1998, J INVERTEBR PATHOL, V71, P26, DOI 10.1006/jipa.1997.4703; TSING A, 1989, J INVERTEBR PATHOL, V53, P64, DOI 10.1016/0022-2011(89)90075-X; van de Braak CBT, 2002, DIS AQUAT ORGAN, V51, P149, DOI 10.3354/dao051149; van de Braak CBT, 2002, FISH SHELLFISH IMMUN, V12, P253, DOI 10.1006/fsim.2001.0369; VLAK JM, 2004, 8 INT COMM TAX VIR; Wang CS, 1997, J FISH DIS, V20, P323, DOI 10.1046/j.1365-2761.1997.00301.x; Wang L, 2008, DEV COMP IMMUNOL, V32, P706, DOI 10.1016/j.dci.2007.10.010; Wang W, 2008, FISH SHELLFISH IMMUN, V25, P522, DOI 10.1016/j.fsi.2008.07.016; Yang F, 2001, J VIROL, V75, P11811, DOI 10.1128/JVI.75.23.11811-11820.2001	40	26	27	5	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21467	21477		10.1074/jbc.M110.130526	http://dx.doi.org/10.1074/jbc.M110.130526			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20444692	Green Published, hybrid			2022-12-27	WOS:000279516100033
J	Schieder, M; Rotzer, K; Bruggemann, A; Biel, M; Wahl-Schott, CA				Schieder, Michael; Roetzer, Katrin; Brueggemann, Andrea; Biel, Martin; Wahl-Schott, Christian A.			Characterization of Two-pore Channel 2 (TPCN2)-mediated Ca2+ Currents in Isolated Lysosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXOCYTOSIS; LEADS	Two-pore channels (TPCNs) have been proposed to form lysosomal Ca2+ release channels that are activated by nicotinic acid adenine dinucleotide phosphate. Here, we employ a glass chip-based method to record for the first time nicotinic acid adenine dinucleotide phosphate-dependent currents through a two-pore channel (TPCN2) from intact lysosomes. We show that TPCN2 is a highly selective Ca2+ channel that is regulated by intralysosomal pH. Using site-directed mutagenesis, we identify an amino acid residue in the putative pore region that is crucial for conferring high Ca2+ selectivity. Our glass chip-based method will provide electrophysiological access not only to lysosomal TPCN channels but also to a broad range of other intracellular ion channels.	[Biel, Martin] Univ Munich, Dept Pharm, Ctr Integrated Prot Sci CIPS M, D-81377 Munich, Germany; [Schieder, Michael; Roetzer, Katrin; Biel, Martin; Wahl-Schott, Christian A.] Univ Munich, Dept Pharm, Zentrum Pharmaforsch, D-81377 Munich, Germany; [Brueggemann, Andrea] Nan Technol GmbH, D-80335 Munich, Germany	University of Munich; University of Munich	Biel, M (corresponding author), Univ Munich, Dept Pharm, Ctr Integrated Prot Sci CIPS M, Butenandtstr 5-13, D-81377 Munich, Germany.	martin.biel@cup.uni-muenchen.de; christian.wahl@cup.uni-muenchen.de	Biel, Martin/G-1175-2014; Wahl-Schott, Christian A/J-2623-2015	Biel, Martin/0000-0002-9974-3052; Bruggemann, Andrea/0000-0002-7325-6715	Deutsche Forschungsgemeinschaft; Bayerische Forschungsstiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bayerische Forschungsstiftung	This work was supported by grants from the Deutsche Forschungsgemeinschaft and the Bayerische Forschungsstiftung.	Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cerny J, 2004, EMBO REP, V5, P883, DOI 10.1038/sj.embor.7400243; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Huynh C, 2005, EMBO REP, V6, P843, DOI 10.1038/sj.embor.7400495; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Schenkman J B, 1978, Methods Enzymol, V52, P83; Voets T, 2004, J BIOL CHEM, V279, P15223, DOI 10.1074/jbc.M312076200; Voets T, 2002, J BIOL CHEM, V277, P33704, DOI 10.1074/jbc.M204828200; Zhu MX, 2010, FEBS LETT, V584, P1966, DOI 10.1016/j.febslet.2010.02.028; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	11	106	108	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21219	21222		10.1074/jbc.C110.143123	http://dx.doi.org/10.1074/jbc.C110.143123			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20495006	Green Published, hybrid			2022-12-27	WOS:000279516100006
J	Van Horn, RD; Chu, SY; Fan, L; Yin, TG; Du, JA; Beckmann, R; Mader, M; Zhu, GX; Toth, J; Blanchard, K; Ye, XS				Van Horn, Robert D.; Chu, Shaoyou; Fan, Li; Yin, Tinggui; Du, Jian; Beckmann, Richard; Mader, Mary; Zhu, Guoxin; Toth, John; Blanchard, Kerry; Ye, Xiang S.			Cdk1 Activity Is Required for Mitotic Activation of Aurora A during G(2)/M Transition of Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLO-LIKE KINASE; SMALL-MOLECULE INHIBITOR; HISTONE H3 PHOSPHORYLATION; A KINASE; MAMMALIAN-CELLS; DNA-DAMAGE; CHROMOSOME ALIGNMENT; XENOPUS OOCYTES; B KINASE; S-PHASE	In mammalian cells entry into and progression through mitosis are regulated by multiple mitotic kinases. How mitotic kinases interact with each other and coordinately regulate mitosis remains to be fully understood. Here we employed a chemical biology approach using selective small molecule kinase inhibitors to dissect the relationship between Cdk1 and Aurora A kinases during G(2)/M transition. We find that activation of Aurora A first occurs at centrosomes at late G(2) and is required for centrosome separation independently of Cdk1 activity. Upon entry into mitosis, Aurora A then becomes fully activated downstream of Cdk1 activation. Inactivation of Aurora A or Plk1 individually during a synchronized cell cycle shows no significant effect on Cdk1 activation and entry into mitosis. However, simultaneous inactivation of both Aurora A and Plk1 markedly delays Cdk1 activation and entry into mitosis, suggesting that Aurora A and Plk1 have redundant functions in the feedback activation of Cdk1. Together, our data suggest that Cdk1, Aurora A, and Plk1 mitotic kinases participate in a feedback activation loop and that activation of Cdk1 initiates the feedback loop activity, leading to rapid and timely entry into mitosis in human cells. In addition, live cell imaging reveals that the nuclear cycle of cells becomes uncoupled from cytokinesis upon inactivation of both Aurora A and Aurora B kinases and continues to oscillate in a Cdk1-dependent manner in the absence of cytokinesis, resulting in multinucleated, polyploidy cells.	[Ye, Xiang S.] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Canc Res Div, Indianapolis, IN 46285 USA	Eli Lilly	Ye, XS (corresponding author), Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Canc Res Div, Indianapolis, IN 46285 USA.	Ye_Xiang-s@Lilly.com						Abrieu A, 1998, J CELL SCI, V111, P1751; Adams RR, 2001, J CELL BIOL, V153, P865, DOI 10.1083/jcb.153.4.865; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Cazales M, 2005, CELL CYCLE, V4, P1233, DOI 10.4161/cc.4.9.1964; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Du J, 2004, P NATL ACAD SCI USA, V101, P8975, DOI 10.1073/pnas.0308484101; Eyers PA, 2004, J BIOL CHEM, V279, P9008, DOI 10.1074/jbc.M312424200; Fisher DL, 1996, EMBO J, V15, P850, DOI 10.1002/j.1460-2075.1996.tb00420.x; Geddis AE, 2007, CELL CYCLE, V6, P455, DOI 10.4161/cc.6.4.3836; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Gizatullin F, 2006, CANCER RES, V66, P7668, DOI 10.1158/0008-5472.CAN-05-3353; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Krystyniak A, 2006, ONCOGENE, V25, P338, DOI 10.1038/sj.onc.1209056; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Liu Q, 2006, P NATL ACAD SCI USA, V103, P5811, DOI 10.1073/pnas.0601425103; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8672, DOI 10.1073/pnas.132269599; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Manfredi MG, 2007, P NATL ACAD SCI USA, V104, P4106, DOI 10.1073/pnas.0608798104; Marumoto T, 2002, GENES CELLS, V7, P1173, DOI 10.1046/j.1365-2443.2002.00592.x; Maton G, 2003, J BIOL CHEM, V278, P21439, DOI 10.1074/jbc.M300811200; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; NURSE P, 1994, CELL, V79, P547, DOI 10.1016/0092-8674(94)90539-8; Osmani SA, 1996, BIOCHEM J, V317, P633, DOI 10.1042/bj3170633; Qian YW, 2001, MOL BIOL CELL, V12, P1791, DOI 10.1091/mbc.12.6.1791; Roshak AK, 2000, CELL SIGNAL, V12, P405, DOI 10.1016/S0898-6568(00)00080-2; Sardon T, 2008, EMBO J, V27, P2567, DOI 10.1038/emboj.2008.173; Sarg B, 2006, J BIOL CHEM, V281, P6573, DOI 10.1074/jbc.M508957200; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; WAHL AF, 2003, CURRENT PROTOCOLS CE; Wuarin J, 2002, CELL, V111, P419, DOI 10.1016/S0092-8674(02)01042-5; Yang H, 2005, FEBS LETT, V579, P3385, DOI 10.1016/j.febslet.2005.04.080; YE XS, 1995, EMBO J, V14, P986, DOI 10.1002/j.1460-2075.1995.tb07079.x	40	51	51	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21849	21857		10.1074/jbc.M110.141010	http://dx.doi.org/10.1074/jbc.M110.141010			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20444701	Green Published, hybrid			2022-12-27	WOS:000279516100069
J	Asano, R; Ikoma, K; Sone, Y; Kawaguchi, H; Taki, S; Hayashi, H; Nakanishi, T; Umetsu, M; Katayose, Y; Unno, M; Kudo, T; Kumagai, I				Asano, Ryutaro; Ikoma, Keiko; Sone, Yukiko; Kawaguchi, Hiroko; Taki, Shintaro; Hayashi, Hiroki; Nakanishi, Takeshi; Umetsu, Mitsuo; Katayose, Yu; Unno, Michiaki; Kudo, Toshio; Kumagai, Izumi			Highly Enhanced Cytotoxicity of a Dimeric Bispecific Diabody, the hEx3 Tetrabody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-CHAIN FV; NEURAMINIDASE ANTIBODY NC10; V-L DOMAIN; CRYSTAL-STRUCTURE; TANDEM DIABODY; SCFV MULTIMERS; EFFICIENT INHIBITION; LINKER SEQUENCES; ANTIGEN-BINDING; TUMOR-CELLS	We previously reported the utility for cancer immunotherapy of a humanized bispecific diabody (hEx3) that targets epidermal growth factor receptor and CD3. Here, we used dynamic and static light scattering measurements to show that the multimer fraction observed in hEx3 in solution is a monodisperse tetramer. The multimerization into tetramers increased the inhibition of cancer cell growth by the hEx3 diabody. Furthermore, 1:2 stoichiometric binding for both antigens was observed in a thermodynamic analysis, indicating that the tetramer has bivalent binding activity for each target, and the structure may be in a circular configuration, as is the case for the single-chain Fv tetrabody. In addition to enhanced cytotoxicity, the functional affinity and stability of the hEx3 tetrabody were superior to those of the hEx3 diabody. The increase in molecular weight is also expected to improve the pharmacokinetics of the bispecific diabody, making the hEx3 tetrabody attractive as a therapeutic antibody fragment for cancer immunotherapy.	[Nakanishi, Takeshi; Umetsu, Mitsuo; Kumagai, Izumi] Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Sendai, Miyagi 9808579, Japan; [Hayashi, Hiroki; Katayose, Yu; Unno, Michiaki] Tohoku Univ, Grad Sch Med, Dept Surg, Div Gastroenterol Surg, Sendai, Miyagi 9808574, Japan; [Kudo, Toshio] Tohoku Univ, Inst Dev Aging & Canc, Cell Resource Ctr Biomed Res, Sendai, Miyagi 9808575, Japan	Tohoku University; Tohoku University; Tohoku University	Kumagai, I (corresponding author), Aoba 6-6-11-606,Aoba Ku, Sendai, Miyagi 9808579, Japan.	kmiz@kuma.che.tohoku.ac.jp	Asano, Ryutaro/G-7822-2016; Unno, Michiaki/AAX-5246-2020	Unno, Michiaki/0000-0002-2145-6416; Hayashi, Hiroki/0000-0001-9953-603X	Ministry of Education, Science, Sports, and Culture of Japan; New Energy and Industrial Technology Development Organization (NEDO) of Japan; National Institute of Biomedical Innovation	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation)	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan (to R. A. and I. K.) and by grants from the New Energy and Industrial Technology Development Organization (NEDO) of Japan. This work was also supported by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation.	Adams GP, 1999, J IMMUNOL METHODS, V231, P249, DOI 10.1016/S0022-1759(99)00161-1; Arndt MAE, 1999, BLOOD, V94, P2562, DOI 10.1182/blood.V94.8.2562.420k20_2562_2568; Asano R, 2000, J BIOCHEM-TOKYO, V127, P673, DOI 10.1093/oxfordjournals.jbchem.a022656; Asano R, 2002, J BIOCHEM, V132, P903, DOI 10.1093/oxfordjournals.jbchem.a003303; Asano R, 2008, PROTEIN ENG DES SEL, V21, P597, DOI 10.1093/protein/gzn037; Asano R, 2008, J IMMUNOTHER, V31, P752, DOI 10.1097/CJI.0b013e3181849071; Asano R, 2007, J BIOL CHEM, V282, P27659, DOI 10.1074/jbc.M704719200; Asano R, 2006, CLIN CANCER RES, V12, P4036, DOI 10.1158/1078-0432.CCR-06-0059; Asano R, 2010, FEBS J, V277, P477, DOI 10.1111/j.1742-4658.2009.07499.x; Blanco B, 2003, J IMMUNOL, V171, P1070, DOI 10.4049/jimmunol.171.2.1070; Buhler P, 2008, CANCER IMMUNOL IMMUN, V57, P43, DOI 10.1007/s00262-007-0348-6; Cao Y, 2003, ADV DRUG DELIVER REV, V55, P171, DOI 10.1016/S0169-409X(02)00178-3; Cochlovius B, 2000, CANCER RES, V60, P4336; Dolezal O, 2000, PROTEIN ENG, V13, P565, DOI 10.1093/protein/13.8.565; Dolezal O, 2003, PROTEIN ENG, V16, P47, DOI 10.1093/proeng/gzg006; Gao Y, 2004, LEUKEMIA, V18, P513, DOI 10.1038/sj.leu.2403267; Hudson PJ, 1999, J IMMUNOL METHODS, V231, P177, DOI 10.1016/S0022-1759(99)00157-X; Kipriyanov SM, 1999, J MOL BIOL, V293, P41, DOI 10.1006/jmbi.1999.3156; Kipriyanov SM, 2003, J MOL BIOL, V330, P99, DOI 10.1016/S0022-2836(03)00526-6; Kipriyanov SM, 2002, J IMMUNOL, V169, P137, DOI 10.4049/jimmunol.169.1.137; Kjer-Nielsen L, 2004, P NATL ACAD SCI USA, V101, P7675, DOI 10.1073/pnas.0402295101; Kortt AA, 2001, BIOMOL ENG, V18, P95, DOI 10.1016/S1389-0344(01)00090-9; Kriangkum J, 2001, BIOMOL ENG, V18, P31, DOI 10.1016/S1389-0344(01)00083-1; Kufer P, 2004, TRENDS BIOTECHNOL, V22, P238, DOI 10.1016/j.tibtech.2004.03.006; Le Gall F, 2004, PROTEIN ENG DES SEL, V17, P357, DOI 10.1093/protein/gzh039; Le Gall F, 2004, J IMMUNOL METHODS, V285, P111, DOI 10.1016/j.jim.2003.11.007; Makabe K, 2008, J BIOL CHEM, V283, P1156, DOI 10.1074/jbc.M706190200; Pei XY, 1997, P NATL ACAD SCI USA, V94, P9637, DOI 10.1073/pnas.94.18.9637; PERISIC O, 1994, STRUCTURE, V2, P1217, DOI 10.1016/S0969-2126(94)00123-5; Power BE, 2003, PROTEIN SCI, V12, P734, DOI 10.1110/ps.0228503; RASO V, 1981, CANCER RES, V41, P2073; Ravn P, 2004, J MOL BIOL, V343, P985, DOI 10.1016/j.jmb.2004.08.052; Schlereth B, 2005, CANCER RES, V65, P2882, DOI 10.1158/0008-5472.CAN-04-2637; Shahied LS, 2004, J BIOL CHEM, V279, P53907, DOI 10.1074/jbc.M407888200; SURESH MR, 1986, METHOD ENZYMOL, V121, P210; Volkel T, 2001, PROTEIN ENG, V14, P815, DOI 10.1093/protein/14.10.815; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wu AM, 1996, IMMUNOTECHNOLOGY, V2, P21, DOI 10.1016/1380-2933(95)00027-5; Xiong DS, 2002, CANCER LETT, V177, P29, DOI 10.1016/S0304-3835(01)00758-3	39	21	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20844	20849		10.1074/jbc.M110.120444	http://dx.doi.org/10.1074/jbc.M110.120444			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20444691	Green Published, hybrid			2022-12-27	WOS:000279228600048
J	Chang, YI; Hua, WK; Yao, CL; Hwang, SM; Hung, YC; Kuan, CJ; Leou, JS; Lin, WJ				Chang, Yuan-I; Hua, Wei-Kai; Yao, Chao-Ling; Hwang, Shiaw-Min; Hung, Yi-Chi; Kuan, Chih-Jen; Leou, Jiun-Shyang; Lin, Wey-Jinq			Protein-arginine Methyltransferase 1 Suppresses Megakaryocytic Differentiation via Modulation of the p38 MAPK Pathway in K562 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE SIGNALING PATHWAYS; CYCLIN D1; TRANSCRIPTIONAL ACTIVATION; SUSTAINED ACTIVATION; STROMAL INHIBITION; METHYLATION SITES; ERK/MAPK PATHWAY; REGULATED KINASE; EXPRESSION; PROLIFERATION	Protein-arginine methyltransferase 1 (PRMT1) plays pivotal roles in various cellular processes. However, its role in megakaryocytic differentiation has yet to be investigated. Human leukemia K562 cells have been used as a model to study hematopoietic differentiation. In this study, we report that ectopic expression of HA-PRMT1 in K562 cells suppressed phorbol 12-myristate 13-acetate (PMA)-induced megakaryocytic differentiation as demonstrated by changes in cytological characteristics, adhesive properties, and CD41 expression, whereas knockdown of PRMT1 by small interference RNA promoted differentiation. Impairment of the methyltransferase activity of PRMT1 diminished the suppressive effect. These results provide evidence for a novel role of PRMT1 in negative regulation of megakaryocytic differentiation. Activation of ERK MAPK has been shown to be essential for megakaryocytic differentiation, although the role of p38 MAPK is still poorly understood. We show that knockdown of p38 alpha MAPK or treatment with the p38 inhibitor SB203580 significantly enhanced PMA-induced megakaryocytic differentiation. Further investigation revealed that PRMT1 promotes activation of p38 MAPK without inhibiting activation of ERK MAPK. In p38 alpha knockdown cells, PRMT1 could no longer suppress differentiation. In contrast, enforced expression of p38 alpha MAPK suppressed PMA-induced megakaryocytic differentiation of parental K562 as well as PRMT1-knockdown cells. We propose modulation of the p38 MAPK pathway by PRMT1 as a novel mechanism regulating megakaryocytic differentiation. This study thus provides a new perspective on the promotion of megakaryopoiesis.	[Chang, Yuan-I; Hua, Wei-Kai; Hung, Yi-Chi; Kuan, Chih-Jen; Leou, Jiun-Shyang; Lin, Wey-Jinq] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 11221, Taiwan; [Yao, Chao-Ling] Yuan Ze Univ, Dept Chem Engn & Mat Sci, Chungli 32003, Taiwan; [Hwang, Shiaw-Min] Food Ind Res & Dev Inst, Bioresource Collect & Res Ctr, Hsinchu 30062, Taiwan; [Lin, Wey-Jinq] Taipei City Hosp, Dept Educ & Res, Taipei 10341, Taiwan	National Yang Ming Chiao Tung University; Yuan Ze University; Taipei City Hospital	Lin, WJ (corresponding author), Natl Yang Ming Univ, Inst Biopharmaceut Sci, 155,Sect 2,Linong St, Taipei 11221, Taiwan.	wjlin@ym.edu.tw	Chang, Yuan-I/AAY-1711-2021; Yao, Chao-Ling/HDN-2709-2022	Yao, Chao-Ling/0000-0002-7196-5833	National Science Council, Taiwan [NSC 95-2311-B-010-002]; University System of Taiwan [97DFA2200014]; Ministry of Education	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); University System of Taiwan; Ministry of Education	This work was supported by National Science Council, Taiwan, Grant NSC 95-2311-B-010-002 (to W.-J.L.), University System of Taiwan Grant 97DFA2200014 (to W.-J.L.), and a grant from the Ministry of Education, Aim for the Top University Plan.	ALITALO R, 1990, LEUKEMIA RES, V14, P501, DOI 10.1016/0145-2126(90)90002-Q; Bakker WJ, 2004, J CELL BIOL, V164, P175, DOI 10.1083/jcb.200307056; Balint BL, 2005, MOL CELL BIOL, V25, P5648, DOI 10.1128/MCB.25.13.5648-5663.2005; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Blanchet F, 2005, J EXP MED, V202, P371, DOI 10.1084/jem.20050176; Chiou YY, 2007, PROTEIN J, V26, P87, DOI 10.1007/s10930-006-9049-9; Cimato TR, 2002, J NEUROSCI RES, V67, P435, DOI 10.1002/jnr.10123; Conde I, 2010, EUR J HAEMATOL, V84, P430, DOI 10.1111/j.1600-0609.2010.01416.x; Delehanty LL, 2003, BLOOD, V101, P1744, DOI 10.1182/blood-2002-04-1278; Ding XZ, 2001, BIOCHEM BIOPH RES CO, V282, P447, DOI 10.1006/bbrc.2001.4595; Elagib KE, 2003, BLOOD, V101, P4333, DOI 10.1182/blood-2002-09-2708; Emambokus NR, 2003, IMMUNITY, V19, P33, DOI 10.1016/S1074-7613(03)00173-0; Eriksson M, 2005, EXP CELL RES, V304, P175, DOI 10.1016/j.yexcr.2004.10.017; Fichelson S, 1999, BLOOD, V94, P1601, DOI 10.1182/blood.V94.5.1601.417k19_1601_1613; Garcia J, 2001, MOL CELL BIOL, V21, P2659, DOI 10.1128/MCB.21.8.2659-2670.2001; Goldfarb AN, 2001, J BIOL CHEM, V276, P29526, DOI 10.1074/jbc.M103825200; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; Herrera R, 1998, EXP CELL RES, V238, P407, DOI 10.1006/excr.1997.3847; Jacquel A, 2006, ONCOGENE, V25, P781, DOI 10.1038/sj.onc.1209119; Jiang F, 2002, BLOOD, V99, P3579, DOI 10.1182/blood.V99.10.3579; Kaushansky K, 2005, J CLIN INVEST, V115, P3339, DOI 10.1172/JCI26674; Keeton AB, 2003, ENDOCRINOLOGY, V144, P5402, DOI 10.1210/en.2003-0592; Kirito K, 2003, BLOOD, V102, P3172, DOI 10.1182/blood-2003-03-0944; Klinge CM, 2004, J MOL ENDOCRINOL, V33, P387, DOI 10.1677/jme.1.01541; Kwak YT, 2003, MOL CELL, V11, P1055, DOI 10.1016/S1097-2765(03)00101-1; Lakowski TM, 2009, BIOCHEM J, V421, P253, DOI 10.1042/BJ20090268; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Le Romancer M, 2008, MOL CELL, V31, P212, DOI 10.1016/j.molcel.2008.05.025; Lee CH, 1999, IUBMB LIFE, V48, P585, DOI 10.1080/152165499306450; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Mazharian A, 2009, EXP HEMATOL, V37, P1238, DOI 10.1016/j.exphem.2009.07.006; Meshkini A, 2008, TOXICOL IN VITRO, V22, P1503, DOI 10.1016/j.tiv.2008.05.005; Meyer R, 2007, J STEROID BIOCHEM, V107, P1, DOI 10.1016/j.jsbmb.2007.05.006; Miyata S, 2008, NEUROSCI LETT, V445, P162, DOI 10.1016/j.neulet.2008.08.065; Miyazaki R, 2001, ANN HEMATOL, V80, P284, DOI 10.1007/s002770000285; Navas TA, 2006, BLOOD, V108, P4170, DOI 10.1182/blood-2006-05-023093; Numazawa S, 2003, J BIOCHEM, V133, P599, DOI 10.1093/jb/mvg077; Pawlak MR, 2000, MOL CELL BIOL, V20, P4859, DOI 10.1128/MCB.20.13.4859-4869.2000; Platanias LC, 2003, BLOOD, V101, P4667, DOI 10.1182/blood-2002-12-3647; Qi C, 2002, J BIOL CHEM, V277, P28624, DOI 10.1074/jbc.M201053200; Racke FK, 1997, J BIOL CHEM, V272, P23366, DOI 10.1074/jbc.272.37.23366; Rezai-Zadeh N, 2003, GENE DEV, V17, P1019, DOI 10.1101/gad.1068003; Rouyez MC, 1997, MOL CELL BIOL, V17, P4991, DOI 10.1128/MCB.17.9.4991; Salojin KV, 1999, J IMMUNOL, V163, P844; Severin S, 2010, J THROMB HAEMOST, V8, P17, DOI 10.1111/j.1538-7836.2009.03658.x; Shahjahan M, 2008, AM J CLIN PATHOL, V130, P635, DOI 10.1309/2450EGK3V0XK8D9D; Stassen M, 2007, MOL IMMUNOL, V44, P926, DOI 10.1016/j.molimm.2006.03.019; Sun S, 2001, HAEMATOLOGICA, V86, P17; Tang J, 2000, J BIOL CHEM, V275, P19866, DOI 10.1074/jbc.M000023200; Tang YS, 2008, LEUKEMIA, V22, P1018, DOI 10.1038/leu.2008.20; Towatari M, 2004, HEMATOL J, V5, P262, DOI 10.1038/sj.thj.6200345; Tseng CP, 2001, BIOCHEM BIOPH RES CO, V285, P129, DOI 10.1006/bbrc.2001.5133; Verma A, 2002, J BIOL CHEM, V277, P7726, DOI 10.1074/jbc.M106640200; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Whalen AM, 1997, MOL CELL BIOL, V17, P1947, DOI 10.1128/MCB.17.4.1947; Wolf SS, 2009, CELL MOL LIFE SCI, V66, P2109, DOI 10.1007/s00018-009-0010-x; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Yao CL, 2006, STEM CELLS DEV, V15, P70, DOI 10.1089/scd.2006.15.70; Zhao X, 2008, GENE DEV, V22, P640, DOI 10.1101/gad.1632608	59	29	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20595	20606		10.1074/jbc.M109.092411	http://dx.doi.org/10.1074/jbc.M109.092411			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20442406	Green Published, hybrid			2022-12-27	WOS:000279228600023
J	Oner, SS; Maher, EM; Breton, B; Bouvier, M; Blumer, JB				Oner, Sukru Sadik; Maher, Ellen M.; Breton, Billy; Bouvier, Michel; Blumer, Joe B.			Receptor-regulated Interaction of Activator of G-protein Signaling-4 and G alpha(i)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEROIN-SEEKING BEHAVIOR; G-BETA-GAMMA; GOLOCO MOTIF; INDEPENDENT ACTIVATORS; SURFACE EXPRESSION; AGS3; BINDING; IDENTIFICATION; DISSOCIATION; INHIBITION	Activator of G-protein signaling-4 (AGS4), via its three G-protein regulatory motifs, is well positioned to modulate G-protein signal processing by virtue of its ability to bind G alpha(i)-GDP subunits free of G beta gamma. Apart from initial observations on the biochemical activity of the G-protein regulatory motifs of AGS4, very little is known about the nature of the AGS4-G-protein interaction, how this interaction is regulated, or where the interaction takes place. As an initial approach to these questions, we evaluated the interaction of AGS4 with G alpha(i1) in living cells using bioluminescence resonance energy transfer (BRET). AGS4 and G alpha(i1) reciprocally tagged with either Renilla luciferase (RLuc) or yellow fluorescent protein (YFP) demonstrated saturable, specific BRET signals. BRET signals observed between AGS4-RLuc and G alpha(i1)-YFP were reduced by G-protein-coupled receptor activation, and this agonist-induced reduction in BRET was blocked by pertussis toxin. In addition, specific BRET signals were observed for AGS4-RLuc and alpha(2)-adrenergic receptor-Venus, which were G alpha(i)-dependent and reduced by agonist, indicating that AGS4-G alpha(i) complexes are receptor-proximal. These data suggest that AGS4-G alpha(i) complexes directly couple to a G-protein-coupled receptor and may serve as substrates for agonist-induced G-protein activation.	[Blumer, Joe B.] Med Univ S Carolina, Dept Cell & Mol Pharmacol, Charleston, SC 29425 USA; [Breton, Billy; Bouvier, Michel] Univ Montreal, Dept Biochem, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada	Medical University of South Carolina; Universite de Montreal	Blumer, JB (corresponding author), Med Univ S Carolina, Dept Cell & Mol Pharmacol, 114 Doughty St,STB331, Charleston, SC 29425 USA.	blumerjb@musc.edu	Oner, Sukru/K-8032-2012; Bouvier, Michel/H-2758-2014	Oner, Sukru/0000-0002-8864-7356; Bouvier, Michel/0000-0003-1128-0100; Blumer, Joe/0000-0002-0020-3815	National Institutes of Health [GM086510, NS24821, DA025896]; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086510] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS024821, R01NS024821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025896] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants GM086510 (to J.B.B.) and NS24821 and DA025896 (both to Stephen M. Lanier, Medical University of South Carolina). This work was also supported by grants from the Canadian Institutes of Health Research (to M.B.).	Adhikari A, 2003, J BIOL CHEM, V278, P51825, DOI 10.1074/jbc.M306300200; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; Blumer JB, 2002, J BIOL CHEM, V277, P15897, DOI 10.1074/jbc.M112185200; Blumer JB, 2008, ENDOCRINOLOGY, V149, P3842, DOI 10.1210/en.2008-0050; Blumer JB, 2007, PHARMACOL THERAPEUT, V113, P488, DOI 10.1016/j.pharmthera.2006.11.001; Bowers MS, 2008, P NATL ACAD SCI USA, V105, P12533, DOI 10.1073/pnas.0706999105; Bowers MS, 2004, NEURON, V42, P269, DOI 10.1016/S0896-6273(04)00159-X; Cao XQ, 2004, J BIOL CHEM, V279, P27567, DOI 10.1074/jbc.M312786200; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; DUZIC E, 1992, J BIOL CHEM, V267, P24045; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Ghosh M, 2003, J BIOL CHEM, V278, P34747, DOI 10.1074/jbc.C300271200; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; Groves B, 2007, P NATL ACAD SCI USA, V104, P18103, DOI 10.1073/pnas.0709282104; Kimple RJ, 2004, BIOCHEM J, V378, P801, DOI 10.1042/BJ20031686; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Pattingre S, 2003, J BIOL CHEM, V278, P20995, DOI 10.1074/jbc.M300917200; Peterson YK, 2002, J BIOL CHEM, V277, P6767, DOI 10.1074/jbc.C100699200; Rios C, 2006, BRIT J PHARMACOL, V148, P387, DOI 10.1038/sj.bjp.0706757; Sans N, 2005, NAT CELL BIOL, V7, P1179, DOI 10.1038/ncb1325; SANS N, 2006, NAT CELL BIOL, V8, P100; Sato M, 2006, P NATL ACAD SCI USA, V103, P797, DOI 10.1073/pnas.0507467103; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Willard FS, 2008, J BIOL CHEM, V283, P36698, DOI 10.1074/jbc.M804936200; Wiser O, 2006, NEURON, V50, P561, DOI 10.1016/j.neuron.2006.03.046; Yao L, 2005, P NATL ACAD SCI USA, V102, P8746, DOI 10.1073/pnas.0503419102; Yao LN, 2006, P NATL ACAD SCI USA, V103, P7877, DOI 10.1073/pnas.0602661103	30	32	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20588	20594		10.1074/jbc.C109.088070	http://dx.doi.org/10.1074/jbc.C109.088070			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20452976	Green Published, hybrid			2022-12-27	WOS:000279228600022
J	Mittal, R; Peak-Chew, SY; Sade, RS; Vallis, Y; McMahon, HT				Mittal, Rohit; Peak-Chew, Sew Yeu; Sade, Robert S.; Vallis, Yvonne; McMahon, Harvey T.			The Acetyltransferase Activity of the Bacterial Toxin YopJ of Yersinia Is Activated by Eukaryotic Host Cell Inositol Hexakisphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLOSTRIDIUM-DIFFICILE TOXIN; NF-KAPPA-B; MESSENGER-RNA EXPORT; PROTEIN-KINASE; ACTIN-BINDING; EFFECTOR; ACETYLATION; INHIBITION; MAPK; PYROPHOSPHATES	Plague, one of the most devastating diseases in human history, is caused by the bacterium Yersinia pestis. The bacteria use a syringe-like macromolecular assembly to secrete various toxins directly into the host cells they infect. One such Yersinia outer protein, YopJ, performs the task of dampening innate immune responses in the host by simultaneously inhibiting the MAPK and NF kappa B signaling pathways. YopJ catalyzes the transfer of acetyl groups to serine, threonine, and lysine residues on target proteins. Acetylation of serine and threonine residues prevents them from being phosphorylated thereby preventing the activation of signaling molecules on which they are located. In this study, we describe the requirement of a host-cell factor for full activation of the acetyltransferase activity of YopJ and identify this activating factor to be inositol hexakisphosphate (IP6). We extend the applicability of our results to show that IP6 also stimulates the acetyltransferase activity of AvrA, the YopJ homologue from Salmonella typhimurium. Furthermore, an IP6-induced conformational change in AvrA suggests that IP6 acts as an allosteric activator of enzyme activity. Our results suggest that YopJ-family enzymes are quiescent in the bacterium where they are synthesized, because bacteria lack IP6; once injected into mammalian cells by the pathogen these toxins bind host cell IP6, are activated, and deregulate the MAPK and NF kappa B signaling pathways thereby subverting innate immunity.	[Mittal, Rohit; Peak-Chew, Sew Yeu; Vallis, Yvonne; McMahon, Harvey T.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Sade, Robert S.] MRC Ctr, Ctr Prot Engn, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology; MRC Laboratory Molecular Biology; University of Cambridge	Mittal, R (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	rohit@mrc-lmb.cam.ac.uk			Medical Research Council, UK; MRC [MC_U105178795] Funding Source: UKRI; Medical Research Council [MC_U105178795] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We acknowledge K. Orth (University of Texas Southwestern Medical Center, Dallas, TX) for plasmids encoding YopJ, K.L. Guan (University of Michigan, Ann Arbor, MI) for pCMV-MEK2, and A. Saiardi (MRC-Laboratory for Molecular Cell Biology, University College London, UK) for all the yeast strains used in this study. Finally, we thank E. Boucrot (MRC-Laboratory for Molecular Biology, Cambridge, UK) for S. typhimurium genomic DNA and for his careful reading of the manuscript. This work was supported by the Medical Research Council, UK.	ALI N, 1993, J BIOL CHEM, V268, P6161; Azevedo C, 2006, NAT PROTOC, V1, P2416, DOI 10.1038/nprot.2006.337; Bennett M, 2006, CELL MOL LIFE SCI, V63, P552, DOI 10.1007/s00018-005-5446-z; Bolger Timothy A, 2008, Cell, V134, P624, DOI 10.1016/j.cell.2008.06.027; Brown MT, 2002, J BIOL CHEM, V277, P46298, DOI 10.1074/jbc.M202988200; Choi CH, 2003, NATURE, V424, P965, DOI 10.1038/nature01899; Coaker G, 2005, SCIENCE, V308, P548, DOI 10.1126/science.1108633; Coaker G, 2006, MOL MICROBIOL, V61, P1485, DOI 10.1111/j.1365-2958.2006.05335.x; Du FY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000595; Galimand M, 1997, NEW ENGL J MED, V337, P677, DOI 10.1056/NEJM199709043371004; Guan K L, 1993, Semin Cell Biol, V4, P389, DOI 10.1006/scel.1993.1046; Haefner S, 2005, APPL MICROBIOL BIOT, V68, P588, DOI 10.1007/s00253-005-0005-y; Hanakahi LA, 2002, EMBO J, V21, P2038, DOI 10.1093/emboj/21.8.2038; Iwersen M, 2003, BIOL CHEM, V384, P1035, DOI 10.1515/BC.2003.116; Jones RM, 2008, CELL HOST MICROBE, V3, P233, DOI 10.1016/j.chom.2008.02.016; Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Losito O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005580; Lrhorfi LA, 2007, BIOL CHEM, V388, P297, DOI 10.1515/BC.2007.033; Lupardus PJ, 2008, SCIENCE, V322, P265, DOI 10.1126/science.1162403; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Monack DM, 1997, P NATL ACAD SCI USA, V94, P10385, DOI 10.1073/pnas.94.19.10385; Mueller CA, 2008, MOL MICROBIOL, V68, P1085, DOI 10.1111/j.1365-2958.2008.06237.x; Mukherjee S, 2007, TRENDS BIOCHEM SCI, V32, P210, DOI 10.1016/j.tibs.2007.03.007; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920; Palmer LE, 1998, MOL MICROBIOL, V27, P953, DOI 10.1046/j.1365-2958.1998.00740.x; Prochazkova K, 2008, J BIOL CHEM, V283, P23656, DOI 10.1074/jbc.M803334200; Pruitt RN, 2009, J BIOL CHEM, V284, P21934, DOI 10.1074/jbc.M109.018929; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Saiardi A, 2000, FEBS LETT, V468, P28, DOI 10.1016/S0014-5793(00)01194-7; Santos-Rosa H, 2003, NUCLEIC ACIDS RES, V31, P4285, DOI 10.1093/nar/gkg655; Sarmah B, 2005, DEV CELL, V9, P133, DOI 10.1016/j.devcel.2005.05.002; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Sweet CR, 2007, CELL MICROBIOL, V9, P2700, DOI 10.1111/j.1462-5822.2007.00990.x; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Trasak C, 2007, J BIOL CHEM, V282, P2268, DOI 10.1074/jbc.M610071200; Trosky JE, 2004, J BIOL CHEM, V279, P51953, DOI 10.1074/jbc.M407001200; Trosky JE, 2008, CELL MICROBIOL, V10, P557, DOI 10.1111/j.1462-5822.2007.01109.x; Trosky JE, 2007, J BIOL CHEM, V282, P34299, DOI 10.1074/jbc.M706970200; VANDERKAAY J, 1995, ANAL BIOCHEM, V225, P183, DOI 10.1006/abio.1995.1135; Yang FJ, 2009, J BACTERIOL, V191, P735, DOI 10.1128/JB.01404-08; Ye ZD, 2007, AM J PATHOL, V171, P882, DOI 10.2353/ajpath.2007.070220; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; Zhou HL, 2005, J EXP MED, V202, P1327, DOI 10.1084/jem.20051194	46	55	60	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19927	19934		10.1074/jbc.M110.126581	http://dx.doi.org/10.1074/jbc.M110.126581			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20430892	Green Published, hybrid			2022-12-27	WOS:000279012000026
J	Di Giovanni, J; Iborra, C; Maulet, Y; Leveque, C; El Far, O; Seagar, M				Di Giovanni, Jerome; Iborra, Cecile; Maulet, Yves; Leveque, Christian; El Far, Oussama; Seagar, Michael			Calcium-dependent Regulation of SNARE-mediated Membrane Fusion by Calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENAL CHROMAFFIN CELLS; KISS-AND-RUN; NEUROTRANSMITTER RELEASE; SYNAPTOTAGMIN-I; RAPID ENDOCYTOSIS; LIPID-BINDING; PC12 CELLS; CA2+; EXOCYTOSIS; COMPLEX	Neuroexocytosis requires SNARE proteins, which assemble into trans complexes at the synaptic vesicle/plasma membrane interface and mediate bilayer fusion. Ca2+ sensitivity is thought to be conferred by synaptotagmin, although the ubiquitous Ca2+-effector calmodulin has also been implicated in SNARE-dependent membrane fusion. To examine the molecular mechanisms involved, we examined the direct action of calmodulin and synaptotagmin in vitro, using fluorescence resonance energy transfer to assay lipid mixing between target-and vesicle-SNARE liposomes. Ca2+/calmodulin inhibited SNARE assembly and membrane fusion by binding to two distinct motifs located in the membrane-proximal regions of VAMP2 (K-D = 500 nM) and syntaxin 1 (K-D = 2 mu M). In contrast, fusion was increased by full-length synaptotagmin 1 anchored in vesicle-SNARE liposomes. When synaptotagmin and calmodulin were combined, synaptotagmin overcame the inhibitory effects of calmodulin. Furthermore, synaptotagmin displaced calmodulin binding to target-SNAREs. These findings suggest that two distinct Ca2+ sensors act antagonistically in SNARE-mediated fusion.	[Seagar, Michael] Inst Jean Roche Neurosci, INSERM, UMR641, F-13344 Marseille, France; [Di Giovanni, Jerome; Iborra, Cecile; Maulet, Yves; Leveque, Christian; El Far, Oussama; Seagar, Michael] Univ Mediterrane, F-13344 Marseille, France; [Leveque, Christian] Inst Jean Roche Neurosci, Ctr Anal Prote Marseille, F-13344 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Seagar, M (corresponding author), Inst Jean Roche Neurosci, INSERM, UMR641, Bd P Dramard, F-13344 Marseille, France.	michael.seagar@univmed.fr	Far, Oussama El/D-4225-2017; EL FAR, Oussama/P-9915-2019; leveque, christian/GVU-3567-2022; Maulet, Yves/AAC-3207-2019	Far, Oussama El/0000-0002-7473-8345; EL FAR, Oussama/0000-0002-7473-8345; leveque, christian/0000-0003-2583-2148; Maulet, Yves/0000-0002-3162-0435	Association Francaise Contre les Myopathies; CNRS; INSERM; Ministere de l'Enseignement Superieur et de la Recherche-Action Concertee Incitative Biologie Cellulaire, Moleculaire et Structurale	Association Francaise Contre les Myopathies(Association Francaise contre les Myopathies); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ministere de l'Enseignement Superieur et de la Recherche-Action Concertee Incitative Biologie Cellulaire, Moleculaire et Structurale	This work was supported by the Association Francaise Contre les Myopathies, CNRS, INSERM, and the Ministere de l'Enseignement Superieur et de la Recherche-Action Concertee Incitative Biologie Cellulaire, Moleculaire et Structurale.	Artalejo CR, 2002, P NATL ACAD SCI USA, V99, P6358, DOI 10.1073/pnas.082658499; Artalejo CR, 1996, NEURON, V16, P195, DOI 10.1016/S0896-6273(00)80036-7; Bhalla A, 2005, MOL BIOL CELL, V16, P4755, DOI 10.1091/mbc.E05-04-0277; Burgoyne RD, 2003, BBA-MOL CELL RES, V1641, P137, DOI 10.1016/S0167-4889(03)00089-2; CHAMBERLAIN LH, 1995, J CELL BIOL, V130, P1063, DOI 10.1083/jcb.130.5.1063; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Charvin N, 1997, EMBO J, V16, P4591, DOI 10.1093/emboj/16.15.4591; Chen YA, 1999, J BIOL CHEM, V274, P26469, DOI 10.1074/jbc.274.37.26469; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chen YA, 2001, J BIOL CHEM, V276, P26680, DOI 10.1074/jbc.M103522200; Chicka MC, 2008, NAT STRUCT MOL BIOL, V15, P827, DOI 10.1038/nsmb.1463; Chicka MC, 2009, BIOCHEMISTRY-US, V48, P657, DOI 10.1021/bi801962d; de Haro L, 2004, P NATL ACAD SCI USA, V101, P1578, DOI 10.1073/pnas.0303274101; Elhamdani A, 2006, J NEUROSCI, V26, P3030, DOI 10.1523/JNEUROSCI.5275-05.2006; Fdez E, 2008, MOL BIOL CELL, V19, P3379, DOI 10.1091/mbc.E08-01-0010; Fulop T, 2005, J NEUROSCI, V25, P7324, DOI 10.1523/JNEUROSCI.2042-05.2005; Giraudo CG, 2009, SCIENCE, V323, P512, DOI 10.1126/science.1166500; Harata NC, 2006, J NEUROCHEM, V97, P1546, DOI 10.1111/j.1471-4159.2006.03987.x; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Hu K, 2002, NATURE, V415, P646, DOI 10.1038/415646a; Hu K, 2004, BIOCHEM J, V377, P781, DOI 10.1042/bj20031164; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Junge HJ, 2004, CELL, V118, P389, DOI 10.1016/j.cell.2004.06.029; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; Kim CS, 2002, BIOCHEMISTRY-US, V41, P10928, DOI 10.1021/bi026266v; Kweon DH, 2003, NAT STRUCT BIOL, V10, P440, DOI 10.1038/nsb928; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; LLOBET A, 2008, J GEN PHYSIOL, V132, P3; Mahal LK, 2002, J CELL BIOL, V158, P273, DOI 10.1083/jcb.200203135; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Nishiki T, 2004, J NEUROSCI, V24, P8542, DOI 10.1523/JNEUROSCI.2545-04.2004; Pawlu C, 2004, NEURON, V42, P607, DOI 10.1016/S0896-6273(04)00269-7; Perin MS, 1996, BIOCHEMISTRY-US, V35, P13808, DOI 10.1021/bi960853x; Quetglas S, 2002, EMBO J, V21, P3970, DOI 10.1093/emboj/cdf404; Schaad NC, 1996, P NATL ACAD SCI USA, V93, P9253, DOI 10.1073/pnas.93.17.9253; Schaub JR, 2006, NAT STRUCT MOL BIOL, V13, P748, DOI 10.1038/nsmb1124; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; Siddiqui TJ, 2007, MOL BIOL CELL, V18, P2037, DOI 10.1091/mbc.E07-01-0049; Smith SM, 2008, TRENDS NEUROSCI, V31, P559, DOI 10.1016/j.tins.2008.08.005; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Westerink RHS, 2002, BRAIN RES, V957, P25, DOI 10.1016/S0006-8993(02)03580-1; Williams D, 2009, MOL BIOL CELL, V20, P4910, DOI 10.1091/mbc.E09-04-0284; Wu MN, 1999, NEURON, V23, P593, DOI 10.1016/S0896-6273(00)80811-9; Wu XS, 2009, NAT NEUROSCI, V12, P1003, DOI 10.1038/nn.2355; Yoon TY, 2008, NAT STRUCT MOL BIOL, V15, P707, DOI 10.1038/nsmb.1446; Yoshihara M, 2002, NEURON, V36, P897, DOI 10.1016/S0896-6273(02)01065-6	58	32	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23665	23675		10.1074/jbc.M109.096073	http://dx.doi.org/10.1074/jbc.M109.096073			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20519509	Green Published, hybrid			2022-12-27	WOS:000280291400017
J	Grayfer, L; Garcia, EG; Belosevic, M				Grayfer, Leon; Garcia, Erick Garcia; Belosevic, Miodrag			Comparison of Macrophage Antimicrobial Responses Induced by Type II Interferons of the Goldfish (Carassius auratus L.)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY BURST OXIDASE; TUMOR-NECROSIS-FACTOR; REGULATORY FACTOR-I; GAMMA-INTERFERON; FUNCTIONAL-ANALYSIS; IFN-GAMMA; MOLECULAR CHARACTERIZATION; NADPH OXIDASE; TRANSCRIPTION FACTORS; TARGETED DISRUPTION	Unlike mammals, bony fish have two type II interferons, IFN gamma and IFN gamma rel, whose pro-inflammatory functions have not been fully characterized. To elucidate the distinct roles of these type II interferons of bony fish, we examined the effects of recombinant goldfish (rg) IFN gamma and IFN gamma rel on the macrophage antimicrobial responses, immune gene expression, and their signaling pathways. Our findings indicate that rgIFN gamma and rgIFN gamma rel possess unique capacities to mediate each of the above processes. Q-PCR analysis revealed similar expression of both cytokines in tissues and immune cell populations of the goldfish, although IFN gamma mRNA levels were generally higher in most tissues and cell types. Whereas rgIFN gamma had long-lasting effects on the priming of goldfish monocyte ROI production, the rgIFN gamma rel had relatively short-lived ROI priming potential and eventually down-regulated the priming of ROI production induced by rgIFN gamma or rgTNF alpha 2. Whereas rgIFN gamma induced relatively modest phagocytic and nitric oxide responses of goldfish macrophages, rgIFN gamma rel induced significantly higher phagocytosis, iNOSA and iNOSB gene expression and nitric oxide production compared with rgIFN gamma. The rgIFN gamma and rgIFN gamma rel induced different gene expression profiles in goldfish monocytes. These differences included significantly higher induction of TNF alpha 2, CXCL8, ceruloplasmin, and interferon regulatory factor (IRFs) expression after activation of monocytes with rgIFN gamma rel. The rgIFN gamma rel was more abundant in whole cell lysates compared with rgIFN gamma. Both cytokines induced the phosphorylation of Stat1, while the nuclear localization of Stat1 was only observed following treatment of monocytes with rgIFN gamma. Our findings suggest the presence of functional segregation of the induction of macrophage antimicrobial functions by type II interferons of bony fish.	[Grayfer, Leon; Garcia, Erick Garcia; Belosevic, Miodrag] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Belosevic, Miodrag] Univ Alberta, Sch Publ Hlth, Edmonton, AB T6G 2E9, Canada	University of Alberta; University of Alberta	Belosevic, M (corresponding author), Univ Alberta, Dept Biol Sci, CW 405 Biol Sci Bldg, Edmonton, AB T6G 2E9, Canada.	mike.belosevic@ualberta.ca	Belosevic, Mike/A-2617-2014; Belosevic, Miodrag/G-9396-2018; García García, Erick/H-8793-2013; Belosevic, Miodrag/C-6729-2008	Belosevic, Mike/0000-0001-6512-3587; Belosevic, Miodrag/0000-0002-6412-8236; García García, Erick/0000-0001-7596-9092; Belosevic, Miodrag/0000-0002-6412-8236; Garcia-Garcia, Erick/0000-0002-0861-5611	Natural Sciences and Engineering Council of Canada (NSERC)	Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Sciences and Engineering Council of Canada (NSERC) (to M.B.).	BADER T, 1994, P NATL ACAD SCI USA, V91, P11831, DOI 10.1073/pnas.91.25.11831; BELOSEVIC M, 1988, J IMMUNOL, V141, P890; BELOSEVIC M, 1989, J IMMUNOL, V143, P266; Bernabei P, 2001, EUR CYTOKINE NETW, V12, P6; Bernabei P, 2001, J LEUKOCYTE BIOL, V70, P950; BERTON G, 1986, BIOCHEM BIOPH RES CO, V138, P1276, DOI 10.1016/S0006-291X(86)80421-1; BLUYSSEN HAR, 1995, P NATL ACAD SCI USA, V92, P5645, DOI 10.1073/pnas.92.12.5645; CASSATELLA MA, 1990, J BIOL CHEM, V265, P20241; Castro R, 2008, MOL IMMUNOL, V45, P3454, DOI 10.1016/j.molimm.2008.03.015; Castro R, 2010, FISH SHELLFISH IMMUN, V28, P312, DOI 10.1016/j.fsi.2009.11.010; Chen WQ, 2010, VET IMMUNOL IMMUNOP, V134, P199, DOI 10.1016/j.vetimm.2009.09.007; Collet B, 2009, DEV COMP IMMUNOL, V33, P821, DOI 10.1016/j.dci.2009.01.007; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DRIGGERS PH, 1990, P NATL ACAD SCI USA, V87, P3743, DOI 10.1073/pnas.87.10.3743; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; FERTSCH D, 1984, J IMMUNOL, V132, P2436; Garcia-Garcia E, 2007, J IMMUNOL METHODS, V320, P104, DOI 10.1016/j.jim.2006.12.006; Grayfer L, 2009, DEV COMP IMMUNOL, V33, P235, DOI 10.1016/j.dci.2008.09.001; Grayfer L, 2008, DEV COMP IMMUNOL, V32, P532, DOI 10.1016/j.dci.2007.09.009; Grayfer L, 2009, MOL IMMUNOL, V46, P3050, DOI 10.1016/j.molimm.2009.06.004; GUPTA JW, 1992, CANCER RES, V52, P2530; Han CH, 1998, J BIOL CHEM, V273, P16663, DOI 10.1074/jbc.273.27.16663; HARADA H, 1994, MOL CELL BIOL, V14, P1500, DOI 10.1128/MCB.14.2.1500; He R, 2004, J IMMUNOL, V173, P7462, DOI 10.4049/jimmunol.173.12.7462; Holland JW, 2008, MOL IMMUNOL, V46, P269, DOI 10.1016/j.molimm.2008.08.265; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Igawa D, 2006, MOL IMMUNOL, V43, P999, DOI 10.1016/j.molimm.2005.05.009; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; KERR IM, 1992, J INTERFERON RES, V12, P237, DOI 10.1089/jir.1992.12.237; Levraud JP, 2007, J IMMUNOL, V178, P4385, DOI 10.4049/jimmunol.178.7.4385; Lopez-Munoz A, 2009, J IMMUNOL, V182, P3440, DOI 10.4049/jimmunol.0802528; MARTIN E, 1994, J EXP MED, V180, P977, DOI 10.1084/jem.180.3.977; Matsumoto M, 1999, BIOL CHEM, V380, P699, DOI 10.1515/BC.1999.087; Mazumder B, 1997, J IMMUNOL, V159, P1938; Mazumder B, 1999, MOL CELL BIOL, V19, P6898; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Milev-Milovanovic I, 2006, IMMUNOGENETICS, V58, P70, DOI 10.1007/s00251-006-0081-x; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Nelson N, 1996, J IMMUNOL, V156, P3711; Neumann NF, 2000, FISH SHELLFISH IMMUN, V10, P1, DOI 10.1006/fsim.1999.0221; Neumann NF, 1996, DEV COMP IMMUNOL, V20, P427, DOI 10.1016/S0145-305X(96)00029-8; NEWBURGER PE, 1988, P NATL ACAD SCI USA, V85, P5215, DOI 10.1073/pnas.85.14.5215; Nisimoto Y, 1999, J BIOL CHEM, V274, P22999, DOI 10.1074/jbc.274.33.22999; PERUSSIA B, 1991, CURR OPIN IMMUNOL, V3, P49, DOI 10.1016/0952-7915(91)90076-D; Robertsen B, 2006, FISH SHELLFISH IMMUN, V20, P172, DOI 10.1016/j.fsi.2005.01.010; SAD S, 1995, IMMUNITY, V2, P271, DOI 10.1016/1074-7613(95)90051-9; Sampath P, 2003, MOL CELL BIOL, V23, P1509, DOI 10.1128/MCB.23.5.1509-1519.2003; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sieger D, 2009, DIS MODEL MECH, V2, P571, DOI 10.1242/dmm.003509; Staeheli P, 1990, Adv Virus Res, V38, P147, DOI 10.1016/S0065-3527(08)60862-3; STEVENSON MM, 1990, INFECT IMMUN, V58, P3225, DOI 10.1128/IAI.58.10.3225-3232.1990; Stolte EH, 2008, DEV COMP IMMUNOL, V32, P1467, DOI 10.1016/j.dci.2008.06.012; Subramaniam PS, 2001, CYTOKINE, V15, P175, DOI 10.1006/cyto.2001.0905; Suh CI, 2006, J EXP MED, V203, P1915, DOI 10.1084/jem.20052085; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; TSUNAWAKI S, 1994, BIOCHEM BIOPH RES CO, V199, P1378, DOI 10.1006/bbrc.1994.1383; WANG ZE, 1994, J EXP MED, V179, P1367, DOI 10.1084/jem.179.4.1367; WHEELOCK EF, 1965, SCIENCE, V149, P310, DOI 10.1126/science.149.3681.310; WIENTJES FB, 1993, BIOCHEM J, V296, P557, DOI 10.1042/bj2960557; YOUNG HA, 1995, J LEUKOCYTE BIOL, V58, P373, DOI 10.1002/jlb.58.4.373; Zhang LW, 1997, MOL CELL BIOL, V17, P5748, DOI 10.1128/MCB.17.10.5748; Zou J, 2005, J IMMUNOL, V175, P2484, DOI 10.4049/jimmunol.175.4.2484; Zou J, 2004, FISH SHELLFISH IMMUN, V17, P403, DOI 10.1016/j.fsi.2004.04.015; Zou J, 2007, J IMMUNOL, V179, P3859, DOI 10.4049/jimmunol.179.6.3859	67	79	90	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23537	23547		10.1074/jbc.M109.096925	http://dx.doi.org/10.1074/jbc.M109.096925			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20507977	Green Published, hybrid			2022-12-27	WOS:000280291400003
J	Murata, T; Hotta, N; Toyama, S; Nakayama, S; Chiba, S; Isomura, H; Ohshima, T; Kanda, T; Tsurumi, T				Murata, Takayuki; Hotta, Naoe; Toyama, Shigenori; Nakayama, Sanae; Chiba, Shigeki; Isomura, Hiroki; Ohshima, Takayuki; Kanda, Teru; Tsurumi, Tatsuya			Transcriptional Repression by Sumoylation of Epstein-Barr Virus BZLF1 Protein Correlates with Association of Histone Deacetylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMEDIATE-EARLY PROTEIN; CREB-BINDING-PROTEIN; CONJUGATING ENZYME UBC9; SUMO MODIFICATION; KINASE BGLF4; CELL-LINES; IN-VIVO; K-BZIP; REACTIVATION; LATENCY	The transition from latent to lytic phases of the Epstein-Barr virus life cycle is triggered by expression of a viral transactivator, BZLF1, that then induces expression of the viral immediate-early and early genes. The BZLF1 protein is post-translationally modified by a small ubiquitin-related modifier-1 (SUMO-1). Here we found that BZLF1 is conjugated at lysine 12 not only by SUMO-1 but also by SUMO-2 and 3. The K12R mutant of BZLF1, which no longer becomes sumoylated, exhibits stronger transactivation than the wild-type BZLF1 in a reporter assay system as well as in the context of virus genome with nucleosomal structures. Furthermore, exogenous supply of a SUMO-specific protease, SENP, caused de-sumoylation of BZLF1 and enhanced BZLF1-mediated transactivation. Immunoprecipitation experiments proved that histone deacetylase 3 preferentially associated with the sumoylated form of BZLF1. Levels of the sumoylated BZLF1 increased as lytic replication progressed. Based on these observations, we conclude that sumoylation of BZLF1 regulates its transcriptional activity through histone modification during Epstein-Barr virus productive replication.	[Murata, Takayuki; Hotta, Naoe; Toyama, Shigenori; Nakayama, Sanae; Chiba, Shigeki; Isomura, Hiroki; Kanda, Teru; Tsurumi, Tatsuya] Aichi Canc Ctr Res Inst, Div Virol, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Toyama, Shigenori; Tsurumi, Tatsuya] Nagoya City Univ, Dept Oncol, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Ohshima, Takayuki] Tokushima Bunri Univ, Fac Pharmaceut Sci, Kagawa 7692193, Japan	Aichi Cancer Center; Nagoya City University; Tokushima Bunri University	Tsurumi, T (corresponding author), Aichi Canc Ctr Res Inst, Div Virol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	ttsurumi@aichi-cc.jp	Kanda, Teru/J-7313-2019; Murata, Takayuki/I-2621-2013	Murata, Takayuki/0000-0001-7228-0839; Kanda, Teru/0000-0002-1391-3349; OHSHIMA, Takayuki/0000-0002-1501-6430	Ministry of Education, Science, Sports, Culture, and Technology of Japan [20390137, 21022055, 20790362, 22790448]; Uehara Memorial Research Fund; Japan Leukaemia Research Fund	Ministry of Education, Science, Sports, Culture, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Research Fund(Uehara Memorial Foundation); Japan Leukaemia Research Fund	This work was supported by Grants-in-aid for Scientific Research 20390137 and 21022055 (to T.T.) and 20790362 and 22790448 (to T.M.) from the Ministry of Education, Science, Sports, Culture, and Technology of Japan and in part by the Uehara Memorial Research Fund (to T.T.) and the Japan Leukaemia Research Fund (to T.M.).	Adamson AL, 2005, BIOCHEM BIOPH RES CO, V336, P22, DOI 10.1016/j.bbrc.2005.08.036; Adamson AL, 1999, J VIROL, V73, P6551, DOI 10.1128/JVI.73.8.6551-6558.1999; Adamson AL, 2001, J VIROL, V75, P2388, DOI 10.1128/JVI.75.5.2388-2399.2001; Amon W, 2005, REV MED VIROL, V15, P149, DOI 10.1002/rmv.456; Antoine K, 2005, MOL CELL BIOCHEM, V271, P215, DOI 10.1007/s11010-005-6417-2; Asai R, 2006, J VIROL, V80, P5125, DOI 10.1128/JVI.02674-05; Asai R, 2009, J GEN VIROL, V90, P1575, DOI 10.1099/vir.0.010462-0; Azuma Y, 2003, J CELL BIOL, V163, P477, DOI 10.1083/jcb.200304088; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; Chen CJ, 2001, MOL CELL BIOL, V21, P476, DOI 10.1128/MCB.21.2.476-487.2001; Countryman JK, 2008, J VIROL, V82, P4706, DOI 10.1128/JVI.00116-08; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; Deng Z, 2003, MOL CELL BIOL, V23, P2633, DOI 10.1128/MCB.23.8.2633-2644.2003; Deng Z, 2001, J VIROL, V75, P10334, DOI 10.1128/JVI.75.21.10334-10347.2001; El-Guindy AS, 2006, J BIOL CHEM, V281, P3085, DOI 10.1074/jbc.M506076200; Eloranta JJ, 2002, J BIOL CHEM, V277, P30798, DOI 10.1074/jbc.M202780200; Feng WH, 2007, J VIROL, V81, P10113, DOI 10.1128/JVI.00692-07; Feng WH, 2004, JNCI-J NATL CANCER I, V96, P1691, DOI 10.1093/jnci/djh313; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gruffat H, 2002, EMBO REP, V3, P141, DOI 10.1093/embo-reports/kvf031; Hagemeier SR, 2010, J VIROL, V84, P4383, DOI 10.1128/JVI.02369-09; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Izumiya Y, 2005, J VIROL, V79, P9912, DOI 10.1128/JVI.79.15.9912-9925.2005; Izumiya Y, 2007, J VIROL, V81, P1072, DOI 10.1128/JVI.01473-06; Jacobs AMF, 2007, ONCOGENE, V26, P5866, DOI 10.1038/sj.onc.1210387; Jenkins PJ, 2000, J VIROL, V74, P710, DOI 10.1128/JVI.74.2.710-720.2000; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; JOAB I, 1991, INT J CANCER, V48, P647, DOI 10.1002/ijc.2910480503; Kanamori M, 2000, VIRUS GENES, V20, P117, DOI 10.1023/A:1008110312661; Katsumura KR, 2009, J GEN VIROL, V90, P2331, DOI 10.1099/vir.0.012831-0; Kim JH, 2006, NAT CELL BIOL, V8, P631, DOI 10.1038/ncb1415; Kuo HY, 2005, P NATL ACAD SCI USA, V102, P16973, DOI 10.1073/pnas.0504460102; Liu B, 2008, CURR OPIN CELL BIOL, V20, P288, DOI 10.1016/j.ceb.2008.03.014; Maruo S, 2001, J GEN VIROL, V82, P2373, DOI 10.1099/0022-1317-82-10-2373; Matsumoto J, 2005, ONCOGENE, V24, P1001, DOI 10.1038/sj.onc.1208297; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Miller G, 2007, ADV CANCER RES, V97, P81, DOI 10.1016/S0065-230X(06)97004-3; Muraoka A, 2008, BIOCHEM BIOPH RES CO, V377, P1031, DOI 10.1016/j.bbrc.2008.09.149; Murata T, 2006, J BIOL CHEM, V281, P20788, DOI 10.1074/jbc.M600563200; Murata T, 2009, J BIOL CHEM, V284, P8033, DOI 10.1074/jbc.M808466200; Murata T, 2009, VIROLOGY, V389, P75, DOI 10.1016/j.virol.2009.04.007; Nakayama S, 2009, J BIOL CHEM, V284, P21557, DOI 10.1074/jbc.M109.015685; Nishida T, 2006, BIOCHEM BIOPH RES CO, V345, P1536, DOI 10.1016/j.bbrc.2006.05.065; Nishida T, 2001, J BIOL CHEM, V276, P39060, DOI 10.1074/jbc.M103955200; Ohshima T, 2003, J BIOL CHEM, V278, P50833, DOI 10.1074/jbc.M307533200; Oshima M, 2009, J BIOL CHEM, V284, P11017, DOI 10.1074/jbc.M808694200; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Seeler JS, 2001, ONCOGENE, V20, P7243, DOI 10.1038/sj.onc.1204758; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Speck SH, 1997, TRENDS MICROBIOL, V5, P399, DOI 10.1016/S0966-842X(97)01129-3; Tempera I, 2010, BBA-GENE REGUL MECH, V1799, P236, DOI 10.1016/j.bbagrm.2009.10.004; Tsurumi T, 2005, REV MED VIROL, V15, P3, DOI 10.1002/rmv.441; Wang WL, 2008, NUCLEIC ACIDS RES, V36, P6066, DOI 10.1093/nar/gkn607; Yang SH, 2006, E SCHERING RES FDN W, V57, P193; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Zerby D, 1999, MOL CELL BIOL, V19, P1617	57	31	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23925	23935		10.1074/jbc.M109.095356	http://dx.doi.org/10.1074/jbc.M109.095356			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20516063	Green Published, hybrid			2022-12-27	WOS:000280291400043
J	Ryan, PE; Sivadasan-Nair, N; Nau, MM; Nicholas, S; Lipkowitz, S				Ryan, Philip E.; Sivadasan-Nair, Nina; Nau, Marion M.; Nicholas, Sarah; Lipkowitz, Stanley			The N Terminus of Cbl-c Regulates Ubiquitin Ligase Activity by Modulating Affinity for the Ubiquitin-conjugating Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE PHOSPHORYLATION; EGF RECEPTOR; PROTEIN UBIQUITINATION; ALLOSTERIC ACTIVATION; ANTIGEN RECEPTOR; DOWN-REGULATION; BINDING-SITE; RING-TYPE; V-SRC	Cbl proteins are ubiquitin ligases (E3s) that play a significant role in regulating tyrosine kinase signaling. There are three mammalian family members: Cbl, Cbl-b, and Cbl-c. All have a highly conserved N-terminal tyrosine kinase binding domain, a catalytic RING finger domain, and a C-terminal proline-rich domain that mediates interactions with Src homology 3 (SH3) containing proteins. Although both Cbl and Cbl-b have been studied widely, little is known about Cbl-c. Published reports have demonstrated that the N terminus of Cbl and Cbl-b have an inhibitory effect on their respective E3 activity. However, the mechanism for this inhibition is still unknown. In this study we demonstrate that the N terminus of Cbl-c, like that of Cbl and Cbl-b, inhibits the E3 activity of Cbl-c. Furthermore, we map the region responsible for the inhibition to the EF-hand and SH2 domains. Phosphorylation of a critical tyrosine (Tyr-341) in the linker region of Cbl-c by Src or a phosphomimetic mutation of this tyrosine (Y341E) is sufficient to increase the E3 activity of Cbl-c. We also demonstrate for the first time that phosphorylation of Tyr-341 or the Y341E mutation leads to a decrease in affinity for the ubiquitin-conjugating enzyme (E2), UbcH5b. The decreased affinity of the Y341E mutant Cbl-c for UbcH5b results in a more rapid turnover of bound UbcH5b coincident with the increased E3 activity. These data suggest that the N terminus of Cbl-c contributes to the binding to the E2 and that phosphorylation of Tyr-341 leads to a decrease in affinity and an increase in the E3 activity of Cbl-c.	[Ryan, Philip E.; Sivadasan-Nair, Nina; Nau, Marion M.; Nicholas, Sarah; Lipkowitz, Stanley] NCI, LCMB, CCR, NIH, Bethesda, MD 20892 USA; [Ryan, Philip E.] George Washington Univ, Inst Biomed Sci, Washington, DC 20037 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); George Washington University	Lipkowitz, S (corresponding author), NCI, LCMB, CCR, NIH, Bldg 37,Rm 2066,37 Convent Dr, Bethesda, MD 20892 USA.	lipkowis@mail.nih.gov			National Institutes of Health, NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010977] Funding Source: NIH RePORTER	National Institutes of Health, NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, NCI, Center for Cancer Research.	BLAKE TJ, 1991, ONCOGENE, V6, P653; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Christensen DE, 2009, FEBS J, V276, P5381, DOI 10.1111/j.1742-4658.2009.07249.x; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; Davies GC, 2006, ONCOGENE, V25, P6497, DOI 10.1038/sj.onc.1209662; DONOVAN JA, 1994, J BIOL CHEM, V269, P22921; Duan L, 2004, IMMUNITY, V21, P7, DOI 10.1016/j.immuni.2004.06.012; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Ettenberg SA, 2001, J BIOL CHEM, V276, P27677, DOI 10.1074/jbc.M102641200; Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; Fukazawa T, 1996, J BIOL CHEM, V271, P14554, DOI 10.1074/jbc.271.24.14554; Gao M, 2005, MOL CELL, V19, P581, DOI 10.1016/j.molcel.2005.08.017; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Keane MM, 1999, ONCOGENE, V18, P3365, DOI 10.1038/sj.onc.1202753; KEANE MM, 1995, ONCOGENE, V10, P2367; Kim M, 2004, ONCOGENE, V23, P1645, DOI 10.1038/sj.onc.1207298; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; LANGDON WY, 1990, CURR TOP MICROBIOL, V166, P159; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Lupher ML, 1998, INT J BIOCHEM CELL B, V30, P439, DOI 10.1016/S1357-2725(97)00075-7; Magnifico A, 2003, J BIOL CHEM, V278, P43169, DOI 10.1074/jbc.M308009200; Meisner H, 1997, MOL CELL BIOL, V17, P2217, DOI 10.1128/MCB.17.4.2217; Meng WY, 1999, NATURE, V398, P84, DOI 10.1038/18050; Nau M.M., 2008, CBL PROTEINS, V1, P3; Nau MM, 2003, GENE, V308, P103, DOI 10.1016/S0378-1119(03)00471-2; Odai H, 1995, JPN J CANCER RES, V86, P1119, DOI 10.1111/j.1349-7006.1995.tb03303.x; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Peschard P, 2004, J BIOL CHEM, V279, P29565, DOI 10.1074/jbc.M403954200; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; RIVEROLEZCANO OM, 1994, J BIOL CHEM, V269, P17363; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Ryan PE, 2006, TRENDS BIOCHEM SCI, V31, P79, DOI 10.1016/j.tibs.2005.12.004; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Siepmann TJ, 2003, J BIOL CHEM, V278, P9448, DOI 10.1074/jbc.M211240200; TANAKA S, 1995, J BIOL CHEM, V270, P14347, DOI 10.1074/jbc.270.24.14347; Thien CBF, 2001, MOL CELL, V7, P355, DOI 10.1016/S1097-2765(01)00183-6; Thien CBF, 1997, ONCOGENE, V15, P2909, DOI 10.1038/sj.onc.1201468; Tsui CC, 2008, J NEUROSCI, V28, P8789, DOI 10.1523/JNEUROSCI.2738-08.2008; TSYGANKOV A, 2008, CBL PROTEINS; Tsygankov AY, 2001, ONCOGENE, V20, P6382, DOI 10.1038/sj.onc.1204781; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Yang XA, 2004, PROTEIN EXPRES PURIF, V33, P332, DOI 10.1016/j.pep.2003.10.006; Yokouchi M, 2001, J BIOL CHEM, V276, P35185, DOI 10.1074/jbc.M102219200; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	48	30	36	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23687	23698		10.1074/jbc.M109.091157	http://dx.doi.org/10.1074/jbc.M109.091157			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20525694	Green Published, hybrid			2022-12-27	WOS:000280291400019
J	Shi, WX; Bohon, J; Han, DP; Habte, H; Qin, YL; Cho, MW; Chance, MR				Shi, Wuxian; Bohon, Jen; Han, Dong P.; Habte, Habtom; Qin, Yali; Cho, Michael W.; Chance, Mark R.			Structural Characterization of HIV gp41 with the Membrane-proximal External Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; ANTIBODY 2F5; RADIOLYTIC MODIFICATION; MONOCLONAL-ANTIBODY; ECTODOMAIN REGION; CRYSTAL-STRUCTURE; ATOMIC-STRUCTURE; GLYCOPROTEIN; EPITOPE; FUSION	Human immunodeficiency virus, type 1 (HIV-1) envelope glycoprotein (gp120/gp41) plays a critical role in virus infection and pathogenesis. Three of the six monoclonal antibodies considered to have broadly neutralizing activities (2F5, 4E10, and Z13e1) bind to the membrane-proximal external region (MPER) of gp41. This makes the MPER a desirable template for developing immunogens that can elicit antibodies with properties similar to these monoclonal antibodies, with a long term goal of developing antigens that could serve as novel HIV vaccines. In order to provide a structural basis for rational antigen design, an MPER construct, HR1-54Q, was generated for x-ray crystallographic and x-ray footprinting studies to provide both high resolution atomic coordinates and verification of the solution state of the antigen, respectively. The crystal structure of HR1-54Q reveals a trimeric, coiled-coil six-helical bundle, which probably represents a postfusion form of gp41. The MPER portion extends from HR2 in continuation of a slightly bent long helix and is relatively flexible. The structures observed for the 2F5 and 4E10 epitopes agree well with existing structural data, and enzyme-linked immunosorbent assays indicate that the antigen binds well to antibodies that recognize the above epitopes. Hydroxyl radical-mediated protein footprinting of the antigen in solution reveals specifically protected and accessible regions consistent with the predictions based on the trimeric structure from the crystallographic data. Overall, the HR1-54Q antigen, as characterized by crystallography and footprinting, represents a postfusion, trimeric form of HIV gp41, and its structure provides a rational basis for gp41 antigen design suitable for HIV vaccine development.	[Shi, Wuxian; Bohon, Jen; Chance, Mark R.] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Shi, Wuxian; Bohon, Jen; Chance, Mark R.] Case Western Reserve Univ, Ctr Synchrotron Biosci, Cleveland, OH 44106 USA; [Chance, Mark R.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Han, Dong P.; Habte, Habtom; Qin, Yali; Cho, Michael W.] Iowa State Univ, Coll Vet Med, Dept Biomed Sci, Ames, IA 50011 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Iowa State University	Shi, WX (corresponding author), Case Western Reserve Univ, Ctr Prote & Bioinformat, 930 BRB,10900 Euclid Ave, Cleveland, OH 44106 USA.	wushi@bnl.gov		Cho, Michael/0000-0003-0522-345X; Bohon, Jen/0000-0002-7664-9899	National Institutes of Health [P01-AI-074286]; NIBIB, National Institutes of Health [P30-EB-09998]; office of Basic Energy Sciences of the United States Department of Energy; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI074286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIBIB, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grant P01-AI-074286.; Data for this study were collected at beamlines X29A and X28C of the National Synchrotron Light Source, Brookhaven National Laboratory. Financial support for the operation of these beamlines comes principally from NIBIB, National Institutes of Health, Grant P30-EB-09998, and the office of Basic Energy Sciences of the United States Department of Energy.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Gao F, 2005, J VIROL, V79, P1154, DOI 10.1128/JVI.79.2.1154-1163.2005; Guan JQ, 2005, TRENDS BIOCHEM SCI, V30, P583, DOI 10.1016/j.tibs.2005.08.007; Guan JQ, 2004, ACCOUNTS CHEM RES, V37, P221, DOI 10.1021/ar0302235; Gupta S, 2007, J SYNCHROTRON RADIAT, V14, P233, DOI 10.1107/S0909049507013118; HUNTER E, 1990, CURR TOP MICROBIOL, V157, P187; Julien JP, 2010, J VIROL, V84, P4136, DOI 10.1128/JVI.02357-09; Julien JP, 2008, J MOL BIOL, V384, P377, DOI 10.1016/j.jmb.2008.09.024; Kaur P, 2009, ANAL CHEM, V81, P8141, DOI 10.1021/ac9013644; Kiselar JG, 2002, INT J RADIAT BIOL, V78, P101, DOI 10.1080/09553000110094805; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Liu J, 2010, J VIROL, V84, P201, DOI 10.1128/JVI.01558-09; Liu J, 2009, BIOCHEMISTRY-US, V48, P2915, DOI 10.1021/bi802303b; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Malashkevich VN, 1998, P NATL ACAD SCI USA, V95, P9134, DOI 10.1073/pnas.95.16.9134; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ofek G, 2010, J VIROL, V84, P2955, DOI 10.1128/JVI.02257-09; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pejchal R, 2009, J VIROL, V83, P8451, DOI 10.1128/JVI.00685-09; Penn-Nicholson A, 2008, VIROLOGY, V372, P442, DOI 10.1016/j.virol.2007.11.009; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Scherer EM, 2010, P NATL ACAD SCI USA, V107, P1529, DOI 10.1073/pnas.0909680107; Schibli DJ, 2001, BIOCHEMISTRY-US, V40, P9570, DOI 10.1021/bi010640u; Song LK, 2009, P NATL ACAD SCI USA, V106, P9057, DOI 10.1073/pnas.0901474106; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Sullivan MR, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2839027; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Xu GZ, 2005, ANAL CHEM, V77, P4549, DOI 10.1021/ac050299+; Xu GZ, 2005, ANAL CHEM, V77, P3029, DOI 10.1021/ac048282z; Xu GZ, 2004, ANAL CHEM, V76, P1213, DOI 10.1021/ac035422g; Yu H, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-93; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	45	32	34	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24290	24298		10.1074/jbc.M110.111351	http://dx.doi.org/10.1074/jbc.M110.111351			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20525690	Green Published, hybrid			2022-12-27	WOS:000280291400078
J	Jeon, J; Kim, NY; Kim, S; Kang, NY; Novak, O; Ku, SJ; Cho, C; Lee, DJ; Lee, EJ; Strnad, M; Kim, J				Jeon, Jin; Kim, Nan Young; Kim, Sunmi; Kang, Na Young; Novak, Ondrej; Ku, Su-Jin; Cho, Chuloh; Lee, Dong Ju; Lee, Eun-Jung; Strnad, Miroslav; Kim, Jungmook			A Subset of Cytokinin Two-component Signaling System Plays a Role in Cold Temperature Stress Response in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTIDINE KINASE; GENE-EXPRESSION; NEGATIVE REGULATOR; ABSCISIC-ACID; ENVIRONMENTAL SIGNALS; MEMBRANE-FLUIDITY; MUTANTS REVEAL; RECEPTOR; PERCEPTION; TRANSDUCTION	Amultistep two-component signaling system is established as a key element of cytokinin signaling in Arabidopsis. Here, we provide evidence for a function of the two-component signaling system in cold stress response in Arabidopsis. Cold significantly induced the expression of a subset of A-type ARR genes and of GUS in Pro(ARR7):GUS transgenic Arabidopsis. AHK2 and AHK3 were found to be primarily involved in mediating cold to express A-type ARRs despite cytokinin deficiency. Cold neither significantly induced AHK2 and AHK3 expression nor altered the cytokinin contents of wild type within the 4 h during which the A-type ARR genes exhibited peak expression in response to cold, indicating that cold might induce ARR expression via the AHK2 and AHK3 proteins without alterations in cytokinin levels. The ahk2 ahk3 and ahk3 ahk4 mutants exhibited enhanced freezing tolerance compared with wild type. These ahk double mutants acclimated as efficiently to cold as did wild type. The overexpression of the cold-inducible ARR7 in Arabidopsis resulted in a hypersensitivity response to freezing temperatures under cold-acclimated conditions. The expression of C-repeat/dehydration- responsive element target genes was not affected by ARR7 overexpression as well as in ahk double mutants. By contrast, the arr7 mutants showed increased freezing tolerance. The ahk2 ahk3 and arr7 mutants showed hypersensitive response to abscisic acid (ABA) for germination, whereas ARR7 overexpression lines exhibited insensitive response to ABA. These results suggest that AHK2 and AHK3 and the cold-inducible A-type ARRs play a negative regulatory role in cold stress signaling via inhibition of ABA response, occurring independently of the cold acclimation pathway.	[Kang, Na Young; Cho, Chuloh; Kim, Jungmook] Chonnam Natl Univ, World Class Univ, Dept Bioenergy Sci & Technol, Kwangju 500757, South Korea; [Jeon, Jin; Kim, Nan Young; Kim, Sunmi; Ku, Su-Jin; Lee, Dong Ju; Lee, Eun-Jung] Chonnam Natl Univ, World Class Univ, Dept Plant Biotechnol, Kwangju 500757, South Korea; [Novak, Ondrej; Strnad, Miroslav] Palacky Univ, Lab Growth Regulators, CZ-78371 Olomouc, Czech Republic; [Novak, Ondrej; Strnad, Miroslav] Acad Sci Czech Republ, Inst Expt Bot, CZ-78371 Olomouc, Czech Republic	Chonnam National University; Chonnam National University; Palacky University Olomouc; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences	Kim, J (corresponding author), Chonnam Natl Univ, World Class Univ, Dept Bioenergy Sci & Technol, Kwangju 500757, South Korea.	jungmkim@chonnam.ac.kr	NOVAK, Ondrej/F-7031-2014; Strnad, Miroslav/H-1858-2014	NOVAK, Ondrej/0000-0003-3452-0154; Strnad, Miroslav/0000-0002-2806-794X; Kim, Jungmook/0000-0003-1735-5564	Agricultural Plant Stress Research Center [R11-2001-092-04001-0]; World Class University [R31-2009-000-20025-0, PF06302-01]; Ministry of Education, Science and Technology of Korea	Agricultural Plant Stress Research Center; World Class University; Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Agricultural Plant Stress Research Center Grant R11-2001-092-04001-0, by Plant Diversity Research Center of 21st Century Frontier Research Program Grant PF06302-01, and from the World Class University Project R31-2009-000-20025-0 funded by the Ministry of Education, Science and Technology of Korea (to J.K.).	Abel S, 1996, PLANT PHYSIOL, V111, P9, DOI 10.1104/pp.111.1.9; Argyros RD, 2008, PLANT CELL, V20, P2102, DOI 10.1105/tpc.108.059584; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Bonaventure G, 2003, PLANT CELL, V15, P1020, DOI 10.1105/tpc.008946; Chinnusamy V, 2004, J EXP BOT, V55, P225, DOI 10.1093/jxb/erh005; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Craft J, 2005, PLANT J, V41, P899, DOI 10.1111/j.1365-313X.2005.02342.x; D'Agostino IB, 2000, PLANT PHYSIOL, V124, P1706, DOI 10.1104/pp.124.4.1706; Davies PJ, 2004, PLANT HORMONES: BIOSYNTHESIS, SIGNAL TRANSDUCTION, ACTION, P1; Desikan R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002491; Faiss M, 1997, PLANT J, V12, P401, DOI 10.1046/j.1365-313X.1997.12020401.x; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Gosti F, 1999, PLANT CELL, V11, P1897, DOI 10.1105/tpc.11.10.1897; Hass C, 2004, EMBO J, V23, P3290, DOI 10.1038/sj.emboj.7600337; Hejatko J, 2009, PLANT CELL, V21, P2008, DOI 10.1105/tpc.109.066696; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; Higuchi M, 2004, P NATL ACAD SCI USA, V101, P8821, DOI 10.1073/pnas.0402887101; Hutchison CE, 2006, PLANT CELL, V18, P3073, DOI 10.1105/tpc.106.045674; Hwang D, 2002, PLANT PHYSIOL, V129, P500, DOI 10.1104/pp.005504; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Inoue T, 2001, NATURE, V409, P1060, DOI 10.1038/35059117; Ishitani M, 1998, PLANT CELL, V10, P1151, DOI 10.1105/tpc.10.7.1151; Iwama A, 2007, PLANT CELL PHYSIOL, V48, P375, DOI 10.1093/pcp/pcl065; Jefferson R. A., 1991, PLANT MOL BIOL MAN B, V14, P1; Kiba T, 2003, PLANT CELL PHYSIOL, V44, P868, DOI 10.1093/pcp/pcg108; Kim HJ, 2006, P NATL ACAD SCI USA, V103, P814, DOI 10.1073/pnas.0505150103; Kim HJ, 2002, PLANT J, V29, P693, DOI 10.1046/j.1365-313X.2002.01249.x; Kim J, 2007, J PLANT BIOL, V50, P139, DOI 10.1007/BF03030622; Lee DJ, 2008, PLANTA, V227, P577, DOI 10.1007/s00425-007-0640-x; Lee DJ, 2007, MOL GENET GENOMICS, V277, P115, DOI 10.1007/s00438-006-0177-x; Lohrmann J, 2002, PLANT PHYSIOL, V128, P363, DOI 10.1104/pp.010907; Los DA, 1997, MOL MICROBIOL, V25, P1167, DOI 10.1046/j.1365-2958.1997.5641912.x; Mahonen AP, 2006, SCIENCE, V311, P94, DOI 10.1126/science.1118875; Mason MG, 2005, PLANT CELL, V17, P3007, DOI 10.1105/tpc.105.035451; Mikami K, 2003, PROG LIPID RES, V42, P527, DOI 10.1016/S0163-7827(03)00036-5; Murata N, 1997, PLANT PHYSIOL, V115, P875, DOI 10.1104/pp.115.3.875; Nishimura C, 2004, PLANT CELL, V16, P1365, DOI 10.1105/tpc.021477; Novak O, 2003, ANAL CHIM ACTA, V480, P207, DOI 10.1016/S0003-2670(03)00025-4; Novak O, 2008, PHYTOCHEMISTRY, V69, P2214, DOI 10.1016/j.phytochem.2008.04.022; Orvar BL, 2000, PLANT J, V23, P785, DOI 10.1046/j.1365-313x.2000.00845.x; Osakabe Y, 2002, BIOCHEM BIOPH RES CO, V293, P806, DOI 10.1016/S0006-291X(02)00286-3; Pischke MS, 2002, P NATL ACAD SCI USA, V99, P15800, DOI 10.1073/pnas.232580499; Riefler M, 2006, PLANT CELL, V18, P40, DOI 10.1105/tpc.105.037796; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; Sangwan V, 2001, PLANT J, V27, P1, DOI 10.1046/j.1365-313x.2001.01052.x; Sharma P, 2005, BIOESSAYS, V27, P1048, DOI 10.1002/bies.20307; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Suzuki I, 2000, EMBO J, V19, P1327, DOI 10.1093/emboj/19.6.1327; Suzuki T, 2001, PLANT CELL PHYSIOL, V42, P107, DOI 10.1093/pcp/pce037; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; To JPC, 2008, TRENDS PLANT SCI, V13, P85, DOI 10.1016/j.tplants.2007.11.005; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; Tran LSP, 2007, P NATL ACAD SCI USA, V104, P20623, DOI 10.1073/pnas.0706547105; Ueguchi C, 2001, PLANT CELL PHYSIOL, V42, P751, DOI 10.1093/pcp/pce094; Ueguchi C, 2001, PLANT CELL PHYSIOL, V42, P231, DOI 10.1093/pcp/pce015; Urao T, 1999, PLANT CELL, V11, P1743, DOI 10.1105/tpc.11.9.1743; Vaultier MN, 2006, FEBS LETT, V580, P4218, DOI 10.1016/j.febslet.2006.06.083; VIGH L, 1993, P NATL ACAD SCI USA, V90, P9090, DOI 10.1073/pnas.90.19.9090; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wohlbach DJ, 2008, PLANT CELL, V20, P1101, DOI 10.1105/tpc.107.055871; Yamada H, 2001, PLANT CELL PHYSIOL, V42, P1017, DOI 10.1093/pcp/pce127; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251	63	207	221	8	80	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23369	23384		10.1074/jbc.M109.096644	http://dx.doi.org/10.1074/jbc.M109.096644			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20463025	hybrid, Green Published			2022-12-27	WOS:000279999900070
J	Ono, Y; Ojima, K; Torii, F; Takaya, E; Doi, N; Nakagawa, K; Hata, S; Abe, K; Sorimachi, H				Ono, Yasuko; Ojima, Koichi; Torii, Fukuyo; Takaya, Emi; Doi, Naoko; Nakagawa, Kazuhiro; Hata, Shoji; Abe, Keiko; Sorimachi, Hiroyuki			Skeletal Muscle-specific Calpain Is an Intracellular Na+-dependent Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C PEROXIDASE; DYSTROPHY TYPE 2A; MUSCULAR-DYSTROPHY; BINDING-SITE; FACTOR XA; IN-VIVO; CALCIUM; SODIUM; P94; MUTATIONS	Because intracellular [Na+] is kept low by Na+/K+-ATPase, Na+ dependence is generally considered a property of extracellular enzymes. However, we found that p94/calpain 3, a skeletal-muscle-specific member of the Ca2+-activated intracellular "modulator proteases" that is responsible for a limb-girdle muscular dystrophy ("calpainopathy"), underwent Na+-dependent, but not Cs+-dependent, autolysis in the absence of Ca2+. Furthermore, Na+ and Ca2+ complementarily activated autolysis of p94 at physiological concentrations. By blocking Na+/K+-ATPase, we confirmed intracellular autolysis of p94 in cultured cells. This was further confirmed using inactive p94: C129S knock-in (p94CS-KI) mice as negative controls. Mutagenesis studies showed that much of the p94 molecule contributed to its Na+/Ca2+-dependent autolysis, which is consistent with the scattered location of calpainopathy-associated mutations, and that a conserved Ca2+-binding sequence in the protease acted as a Na+ sensor. Proteomic analyses using Cs+/Mg2+ and p94CS-KI mice as negative controls revealed that Na+ and Ca2+ direct p94 to proteolyze different substrates. We propose three roles for Na+ dependence of p94; 1) to increase sensitivity of p94 to changes in physiological [Ca2+], 2) to regulate substrate specificity of p94, and 3) to regulate contribution of p94 as a structural component in muscle cells. Finally, this is the first example of an intracellular Na+-dependent enzyme.	[Sorimachi, Hiroyuki] Tokyo Metropolitan Inst Med Sci Rinshoken, Calpain Project, Setagaya Ku, Tokyo 1568506, Japan; [Ojima, Koichi; Doi, Naoko; Sorimachi, Hiroyuki] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Torii, Fukuyo; Nakagawa, Kazuhiro; Abe, Keiko] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan	Tokyo Metropolitan Institute of Medical Science; Japan Science & Technology Agency (JST); University of Tokyo	Sorimachi, H (corresponding author), Tokyo Metropolitan Inst Med Sci Rinshoken, Calpain Project, Setagaya Ku, Kamikitazawa 2-1-6, Tokyo 1568506, Japan.	sorimachi-hr@igakuken.or.jp	Sorimachi, Hiroyuki/C-6448-2009; Sorimachi, Hiroyuki/Q-6956-2017	Sorimachi, Hiroyuki/0000-0001-9509-6727; Sorimachi, Hiroyuki/0000-0001-9509-6727; Ojima, Koichi/0000-0002-5973-1073	MEXT.KAKENHI [18076007, 22770139]; JSPS.KAKENHI [18700392, 20500369, 19658057, 20370055]; Ministry of Health, Labour, and Welfare [20B-13]; Takeda Science Foundation	MEXT.KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS.KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by MEXT.KAKENHI Grants 18076007 (to H. S.) and 22770139 (to Y.O.) and JSPS.KAKENHI Grants 18700392 and 20500369 (to K.O.) and 19658057 and 20370055 (to H. S.), by Research Grant 20B-13 for Nervous and Mental Disorders from the Ministry of Health, Labour, and Welfare (to H. S.), and by a Takeda Science Foundation research grant (to H. S.).	Beckmann JS, 2008, NEUROMUSCULAR DISORD, V18, P913, DOI 10.1016/j.nmd.2008.08.005; Bonagura CA, 1996, BIOCHEMISTRY-US, V35, P6107, DOI 10.1021/bi960122x; Bonagura CA, 1999, J BIOL CHEM, V274, P37827, DOI 10.1074/jbc.274.53.37827; Cheng WJ, 2005, P NATL ACAD SCI USA, V102, P19225, DOI 10.1073/pnas.0504334102; Dang QD, 1996, P NATL ACAD SCI USA, V93, P10653, DOI 10.1073/pnas.93.20.10653; Fanin M, 2007, J MED GENET, V44, P38, DOI 10.1136/jmg.2006.044859; Flucher BE, 1996, P NATL ACAD SCI USA, V93, P8101, DOI 10.1073/pnas.93.15.8101; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hanna RA, 2008, NATURE, V456, P409, DOI 10.1038/nature07451; HARAFUJI H, 1980, J BIOCHEM, V87, P1305, DOI 10.1093/oxfordjournals.jbchem.a132868; Hayashi C, 2008, J BIOL CHEM, V283, P14801, DOI 10.1074/jbc.M708262200; Herasse M, 1999, MOL CELL BIOL, V19, P4047; Huebsch KA, 2005, HUM MOL GENET, V14, P2801, DOI 10.1093/hmg/ddi313; Kamata K, 1998, P NATL ACAD SCI USA, V95, P6630, DOI 10.1073/pnas.95.12.6630; Kramerova I, 2004, HUM MOL GENET, V13, P1373, DOI 10.1093/hmg/ddh153; Kramerova I, 2008, HUM MOL GENET, V17, P3271, DOI 10.1093/hmg/ddn223; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Li HQ, 2004, BBA-MOL CELL RES, V1691, P91, DOI 10.1016/j.bbamcr.2003.12.006; Mizushima N, 2007, AUTOPHAGY, V3, P179, DOI 10.4161/auto.4051; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Ojima K, 2007, J BIOL CHEM, V282, P14493, DOI 10.1074/jbc.M610806200; Ono Y, 2004, J BIOL CHEM, V279, P2761, DOI 10.1074/jbc.M308789200; Ono Y, 1998, J BIOL CHEM, V273, P17073, DOI 10.1074/jbc.273.27.17073; Ono Yasuko, 2007, Biotechnology Journal, V2, P565, DOI 10.1002/biot.200700018; Ono Y, 2006, J BIOL CHEM, V281, P18519, DOI 10.1074/jbc.M601029200; Rezaie AR, 2000, BIOCHEMISTRY-US, V39, P1817, DOI 10.1021/bi992006a; Richard I, 1999, AM J HUM GENET, V64, P1524, DOI 10.1086/302426; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Richard I, 2000, J CELL BIOL, V151, P1583, DOI 10.1083/jcb.151.7.1583; Saenz A, 2005, BRAIN, V128, P732, DOI 10.1093/brain/awh408; SAIDO TC, 1993, J BIOL CHEM, V268, P25239; Silva FP, 2006, BIOPHYS CHEM, V119, P282, DOI 10.1016/j.bpc.2005.10.001; SORIMACHI H, 1989, J BIOL CHEM, V264, P20106; Sorimachi H, 2001, J BIOCHEM-TOKYO, V129, P653, DOI 10.1093/oxfordjournals.jbchem.a002903; SORIMACHI H, 1993, J BIOL CHEM, V268, P10593; Sorimachi H, 1995, J BIOL CHEM, V270, P31158, DOI 10.1074/jbc.270.52.31158; Spencer MJ, 2002, P NATL ACAD SCI USA, V99, P8874, DOI 10.1073/pnas.132269299; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; TANABE T, 1990, NATURE, V346, P567, DOI 10.1038/346567a0; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yu XM, 1998, NATURE, V396, P469, DOI 10.1038/24877	43	38	39	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22984	22996		10.1074/jbc.M110.126946	http://dx.doi.org/10.1074/jbc.M110.126946			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20460380	hybrid, Green Published			2022-12-27	WOS:000279999900033
J	Orellana, D; Liu, XY; Wang, GL; Jin, JL; Iakova, P; Timchenko, NA				Orellana, Daniel; Liu, Xiaoying; Wang, Gou-Li; Jin, Jingling; Iakova, Polina; Timchenko, Nikolai A.			Calmodulin Controls Liver Proliferation via Interactions with C/EBP beta-LAP and C/EBP beta-LIP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN-BETA; TRANSCRIPTIONAL INHIBITORY PROTEIN; CELL-CYCLE; INCREASES TRANSLATION; ALPHA; ISOFORM; RNA; PRB; PHOSPHORYLATION; MECHANISMS	A truncated isoform of C/EBP beta, C/EBP beta-LIP, is required for liver proliferation. This isoform is expressed at high levels in proliferating liver and in liver tumors. However, high levels of C/EBP beta-LIP are also observed in non-proliferating livers during acute phase response (APR). In this paper we present mechanisms by which liver regulates activities of C/EBP beta-LIP. We found that calmodulin (CaM) inhibits the ability of C/EBP beta-LIP to promote liver proliferation during APR through direct interactions. This activity of CaM is under negative control of Ca2+, which is reduced in nuclei of livers with APR, whereas it is increased in nuclei of proliferating livers. A mutant CaM, which does not interact with C/EBP beta-LIP, also fails to inhibit the growth promotion activity of C/EBP beta-LIP. Down-regulation of CaM in livers of LPS-treated mice causes liver proliferation via activation of C/EBP beta-LIP. Overexpression of C/EBP beta-LIP above levels of CaM also initiates liver proliferation in LPS-treated mice. In addition, CaM regulates transcriptional activity of another isoform of C/EBP beta, C/EBP beta-LAP, and might control liver biology through the regulation of both isoforms of C/EBP beta. In searching for molecular mechanisms by which C/EBP beta-LIP promotes cell proliferation, we found that C/EBP beta-LIP releases E2F.Rb-dependent repression of cell cycle genes by a disruption of E2F1.Rb complexes and by a direct interaction with E2F-dependent promoters. CaM inhibits these growth promotion activities of C/EBP beta-LIP and, therefore, supports liver quiescence. Thus, our findings discover a new pathway of the regulation of liver proliferation that involves calcium-CaM signaling.	[Timchenko, Nikolai A.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Timchenko, NA (corresponding author), Baylor Coll Med, Dept Pathol, 1 Baylor Plaza, Houston, TX 77030 USA.	nikolait@bcm.tmc.edu		Jin, Jingling/0000-0002-4365-1837; Orellana, Daniel Ignacio/0000-0002-0431-7430	National Institutes of Health [GM55188, CA100070, AG20752]; NATIONAL CANCER INSTITUTE [R01CA100070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG020752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants GM55188, CA100070, and AG20752 (to N.A.T.).	Baldwin BR, 2004, MOL CELL BIOL, V24, P3682, DOI 10.1128/MCB.24.9.3682-3691.2004; Calkhoven CF, 2000, GENE DEV, V14, P1920; Chang HT, 2008, TOXICOL LETT, V179, P53, DOI 10.1016/j.toxlet.2008.04.002; Charles A, 2001, J CELL BIOCHEM, V83, P414, DOI 10.1002/jcb.1239; Chen PL, 1996, P NATL ACAD SCI USA, V93, P465, DOI 10.1073/pnas.93.1.465; Chen PL, 1996, GENE DEV, V10, P2794, DOI 10.1101/gad.10.21.2794; Choi J, 2006, CELL CYCLE, V5, P2183, DOI 10.4161/cc.5.19.3265; Choi J, 2006, CIRC RES, V98, P1273, DOI 10.1161/01.RES.0000223059.19250.91; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Diehl AM, 2005, AM J PHYSIOL-GASTR L, V288, pG1, DOI 10.1152/ajpgi.00376.2004; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Enomoto N, 1999, AM J PHYSIOL-GASTR L, V277, pG1251, DOI 10.1152/ajpgi.1999.277.6.G1251; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Finkler A, 2007, FEBS LETT, V581, P3893, DOI 10.1016/j.febslet.2007.07.051; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Harrison JR, 2005, J BIOL CHEM, V280, P8117, DOI 10.1074/jbc.M410076200; Hata K, 2005, MOL CELL BIOL, V25, P1971, DOI 10.1128/MCB.25.5.1971-1979.2005; Hsieh CC, 1998, MOL BIOL CELL, V9, P1479, DOI 10.1091/mbc.9.6.1479; Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0; Inoue Y, 2007, EMBO J, V26, P2083, DOI 10.1038/sj.emboj.7601652; Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459; Koledova VV, 2006, CIRC RES, V98, P1240, DOI 10.1161/01.RES.0000225860.41648.63; Liu JO, 2009, IMMUNOL REV, V228, P184, DOI 10.1111/j.1600-065X.2008.00756.x; Luedde T, 2004, HEPATOLOGY, V40, P356, DOI 10.1002/hep.20333; MALGAROLI A, 1987, J CELL BIOL, V105, P2145, DOI 10.1083/jcb.105.5.2145; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Monaco S, 2009, CELL CYCLE, V8, P2024, DOI 10.4161/cc.8.13.8813; PORTOLES MT, 1994, EUR J CELL BIOL, V65, P200; Rodriguez-Vilarrupla A, 2005, MOL CELL BIOL, V25, P7364, DOI 10.1128/MCB.25.16.7364-7374.2005; Swulius MT, 2008, CELL MOL LIFE SCI, V65, P2637, DOI 10.1007/s00018-008-8086-2; Taules M, 1999, J BIOL CHEM, V274, P24445, DOI 10.1074/jbc.274.35.24445; Timchenko LT, 2006, J BIOL CHEM, V281, P32806, DOI 10.1074/jbc.M605701200; Timchenko NA, 1999, NUCLEIC ACIDS RES, V27, P4517, DOI 10.1093/nar/27.22.4517; Timchenko NA, 2005, J BIOL CHEM, V280, P20549, DOI 10.1074/jbc.M409563200; Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; Wang GL, 2005, MOL CELL BIOL, V25, P1325, DOI 10.1128/MCB.25.4.1325-1338.2005; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Welm AL, 2000, J BIOL CHEM, V275, P27406; Zahnow CA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001033	41	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23442	23454		10.1074/jbc.M110.129825	http://dx.doi.org/10.1074/jbc.M110.129825			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20498378	Green Published, hybrid			2022-12-27	WOS:000279999900076
J	Bankovich, AJ; Shiow, LR; Cyster, JG				Bankovich, Alexander J.; Shiow, Lawrence R.; Cyster, Jason G.			CD69 Suppresses Sphingosine 1-Phosophate Receptor-1 (S1P(1)) Function through Interaction with Membrane Helix 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; ACTIVATION ANTIGEN CD69; LYMPHOCYTE EGRESS; CALCITONIN RECEPTOR; CRYSTAL-STRUCTURE; EXPRESSION; 1-PHOSPHATE; INTERNALIZATION; TRAFFICKING; AGONISTS	Lymphocyte egress from lymph nodes requires the G-protein-coupled sphingosine 1-phosphate receptor-1 (S1P(1)). The activation antigen CD69 associates with and inhibits the function of S1P(1), inhibiting egress. Here we undertook biochemical characterization of the requirements for S1P(1)-CD69 complex formation. Domain swapping experiments between CD69 and the related type II transmembrane protein, NKRp1A, identified a requirement for the transmembrane and membrane proximal domains for specific interaction. Mutagenesis of S1P(1) showed a lack of requirement for N-linked glycosylation, tyrosine sulfation, or desensitization motifs but identified a requirement for transmembrane helix 4. Expression of CD69 led to a reduction of S1P(1) in cell lysates, likely reflecting degradation. Unexpectedly, the S1P(1)-CD69 complex exhibited a much longer half-life for binding of S1P than v alone. In contrast to wild-type CD69, a non-S1P(1) binding mutant of CD69 failed to inhibit T cell egress from lymph nodes. These findings identify an integral membrane interaction between CD69 and S1P(1) and suggest that CD69 induces an S1P(1) conformation that shares some properties of the ligand-bound state, thereby facilitating S1P(1) internalization and degradation.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cyster, JG (corresponding author), 513 Parnassus Ave,HSE 1001, San Francisco, CA 94143 USA.	Jason.Cyster@ucsf.edu		Bankovich, Alexander/0000-0003-2368-4479	National Institutes of Health [AI074847]; Irvington Institute Fellowship of the Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074847] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irvington Institute Fellowship of the Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI074847.; Supported by an Irvington Institute Fellowship of the Cancer Research Institute.	Armour SL, 1999, J PHARMACOL TOXICOL, V42, P217, DOI 10.1016/S1056-8719(00)00074-5; Christopoulos G, 1999, MOL PHARMACOL, V56, P235, DOI 10.1124/mol.56.1.235; Chu Peter, 2003, J Biol, V2, P21, DOI 10.1186/1475-4924-2-21; Cooray SN, 2009, MOL CELL ENDOCRINOL, V300, P17, DOI 10.1016/j.mce.2008.10.004; DeLano W., 2006, PYMOL MOL GRAPHICS S; ESWAR N, 2006, CURR PROT BIOINFORMA; Feng CG, 2002, INT IMMUNOL, V14, P535, DOI 10.1093/intimm/dxf020; Fieger CB, 2005, FASEB J, V19, P1926, DOI 10.1096/fj.05-4476fje; HALL JG, 1965, BRIT J EXP PATHOL, V46, P450; HAMANN J, 1993, J IMMUNOL, V150, P4920; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Kohno T, 2002, FASEB J, V16, P983, DOI 10.1096/fj.01-0809com; Llera AS, 2001, J BIOL CHEM, V276, P7312, DOI 10.1074/jbc.M008573200; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Metherell LA, 2005, NAT GENET, V37, P166, DOI 10.1038/ng1501; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; Nakayama T, 2002, J IMMUNOL, V168, P87, DOI 10.4049/jimmunol.168.1.87; Natarajan K, 2000, BIOCHEMISTRY-US, V39, P14779, DOI 10.1021/bi0018180; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Parrill AL, 2000, J BIOL CHEM, V275, P39379, DOI 10.1074/jbc.M007680200; Pham THM, 2010, J EXP MED, V207, P17, DOI 10.1084/jem.20091619; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Sebag JA, 2009, J BIOL CHEM, V284, P610, DOI 10.1074/jbc.M804413200; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; SPRENT J, 1971, CELL IMMUNOL, V2, P171, DOI 10.1016/0008-8749(71)90036-0; SWIFT S, 1999, CURR PROT IMM; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Watterson KR, 2002, J BIOL CHEM, V277, P5767, DOI 10.1074/jbc.M110647200; ZIEGLER SF, 1994, J IMMUNOL, V152, P1228; ZIEGLER SF, 1993, EUR J IMMUNOL, V23, P1643, DOI 10.1002/eji.1830230737	32	218	221	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22328	22337		10.1074/jbc.M110.123299	http://dx.doi.org/10.1074/jbc.M110.123299			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20463015	Green Published, hybrid			2022-12-27	WOS:000279702200046
J	Kokhan, O; Shinkarev, VP; Wraight, CA				Kokhan, Oleksandr; Shinkarev, Vladimir P.; Wraight, Colin A.			Binding of Imidazole to the Heme of Cytochrome c(1) and Inhibition of the bc(1) Complex from Rhodobacter sphaeroides II. KINETICS AND MECHANISM OF BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING; FERRICYTOCHROME-C; HORSE HEART; CONFORMATIONAL TRANSITION; ALKALINE ISOMERIZATION; ELECTRONIC-STRUCTURE; PROTEIN DYNAMICS; METHIONINE; EQUILIBRIUM; REACTIVITY	The kinetics of imidazole (Im) and N-methylimidazole (MeIm) binding to oxidized cytochrome (cyt) c(1) of detergent-solubilized bc(1) complex from Rhodobacter sphaeroides are described. The rate of formation of the cyt c(1)-Im complex exhibited three separated regions of dependence on the concentration of imidazole: (i) below 8 mM Im, the rate increased with concentration in a parabolic manner; (ii) above 20 mM, the rate leveled off, indicating a rate-limiting conformational step with lifetime similar to 1 s; and (iii) at Im concentrations above 100 mM, the rate substantially increased again, also parabolically. In contrast, binding of MeIm followed a simple hyperbolic concentration dependence. The temperature dependences of the binding and release kinetics of Im and MeIm were also measured and revealed very large activation parameters for all reactions. The complex concentration dependence of the Im binding rate is not consistent with the popular model for soluble c-type cytochromes in which exogenous ligand binding is preceded by spontaneous opening of the heme cleft, which becomes rate-limiting at high ligand concentrations. Instead, binding of ligand to the heme is explained by a model in which an initial and superficial binding facilitates access to the heme by disruption of hydrogen-bonded structures in the heme domain. For imidazole, two separate pathways of heme access are indicated by the distinct kinetics at low and high concentration. The structural basis for ligand entry to the heme cleft is discussed.	[Kokhan, Oleksandr; Wraight, Colin A.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Shinkarev, Vladimir P.; Wraight, Colin A.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Wraight, CA (corresponding author), Univ Illinois, Ctr Biophys & Computat Biol, 156 Davenport Hall,607 S Mathews Ave, Urbana, IL 61801 USA.	cwraight@illinois.edu		Kokhan, Oleksandr/0000-0001-9867-8044	National Institutes of Health [R01GM053508]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM053508.	Assfalg M, 2003, J AM CHEM SOC, V125, P2913, DOI 10.1021/ja027180s; AXELROD HL, 1994, ACTA CRYSTALLOGR D, V50, P596, DOI 10.1107/S0907444994001319; Banci L, 2001, J BIOL INORG CHEM, V6, P628, DOI 10.1007/s007750100240; Baymann F, 2004, P NATL ACAD SCI USA, V101, P17737, DOI 10.1073/pnas.0407442101; Cieluch E, 2010, BBA-BIOENERGETICS, V1797, P296, DOI 10.1016/j.bbabio.2009.11.003; CREUTZ C, 1974, J BIOL CHEM, V249, P6788; Crofts AR, 2004, ANNU REV PHYSIOL, V66, P689, DOI 10.1146/annurev.physiol.66.032102.150251; Darrouzet E, 1999, BIOCHEMISTRY-US, V38, P7908, DOI 10.1021/bi990211k; DAVIS LA, 1974, J BIOL CHEM, V249, P2624; Dumortier C, 1998, J BIOL CHEM, V273, P25647, DOI 10.1074/jbc.273.40.25647; Dumortier C, 2004, BIOCHEMISTRY-US, V43, P7717, DOI 10.1021/bi0362370; Dumortier C, 1999, ARCH BIOCHEM BIOPHYS, V371, P142, DOI 10.1006/abbi.1999.1440; DYER C, 1979, BIOCHIM BIOPHYS ACTA, V579, P253, DOI 10.1016/0005-2795(79)90053-9; Elberry M, 2006, BIOCHEMISTRY-US, V45, P4991, DOI 10.1021/bi0522246; Esser L, 2006, P NATL ACAD SCI USA, V103, P13045, DOI 10.1073/pnas.0601149103; Fenimore PW, 2004, P NATL ACAD SCI USA, V101, P14408, DOI 10.1073/pnas.0405573101; GEORGE P, 1964, J BIOL CHEM, V239, P1504; GREENWOOD C, 1965, J BIOL CHEM, V240, P3660; Guergova-Kuras M, 1999, PROTEIN EXPRES PURIF, V15, P370, DOI 10.1006/prep.1998.1018; HARBURY HA, 1965, P NATL ACAD SCI USA, V54, P1658, DOI 10.1073/pnas.54.6.1658; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KIHARA H, 1976, BIOCHIM BIOPHYS ACTA, V430, P225, DOI 10.1016/0005-2728(76)90081-5; Kokhan O, 2010, J BIOL CHEM, V285, P22513, DOI 10.1074/jbc.M110.128058; Leskovac V., 2003, COMPREHENSIVE ENZYME, P111; Li J, 2002, BBA-BIOENERGETICS, V1556, P175, DOI 10.1016/S0005-2728(02)00360-2; Lu J, 1999, SPECTROSC LETT, V32, P519, DOI 10.1080/00387019909350003; MARGOLIASH E., 1966, ADVANCE PROTEIN CHEM, V21, P113, DOI 10.1016/S0065-3233(08)60128-X; Osyczka A, 2004, BBA-BIOENERGETICS, V1655, P71, DOI 10.1016/j.bbabio.2003.07.005; Osyczka A, 2001, BIOCHEMISTRY-US, V40, P14547, DOI 10.1021/bi011630w; PERRIN DD, 1972, DISSOCIATION CONST S, P190; Rosell FI, 1998, J AM CHEM SOC, V120, P11234, DOI 10.1021/ja971756+; SALEEM MMM, 1988, INORG CHIM A-BIOINOR, V153, P105, DOI 10.1016/S0020-1693(00)83867-0; SALEEM MMM, 1988, INORG CHIM A-BIOINOR, V153, P99, DOI 10.1016/S0020-1693(00)83866-9; SHAO WP, 1992, ACTA CHIM SINICA, V50, P1129; SHAO WP, 1995, J INORG BIOCHEM, V57, P103; Sivakolundu SG, 2000, J AM CHEM SOC, V122, P1513, DOI 10.1021/ja993225m; SUTIN N, 1972, J BIOL CHEM, V247, P6932; Varhac R, 2009, BIOPHYS CHEM, V144, P21, DOI 10.1016/j.bpc.2009.06.001; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Yao Y, 2003, BIOPHYS CHEM, V104, P459, DOI 10.1016/S0301-4622(03)00031-0; Yao Y, 2002, J BIOL INORG CHEM, V7, P539, DOI 10.1007/s00775-001-0334-y; Zhang HB, 2006, BIOCHEMISTRY-US, V45, P14247, DOI 10.1021/bi061345i	42	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22522	22531		10.1074/jbc.M110.128082	http://dx.doi.org/10.1074/jbc.M110.128082			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20448037	hybrid, Green Published			2022-12-27	WOS:000279702200064
J	Whitney, M; Crisp, JL; Olson, ES; Aguilera, TA; Gross, LA; Ellies, LG; Tsien, RY				Whitney, Mike; Crisp, Jessica L.; Olson, Emilia S.; Aguilera, Todd A.; Gross, Larry A.; Ellies, Lesley G.; Tsien, Roger Y.			Parallel in Vivo and in Vitro Selection Using Phage Display Identifies Protease-dependent Tumor-targeting Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-PENETRATING PEPTIDES; TYPE-1 MATRIX-METALLOPROTEINASE; POLYMORPHONUCLEAR LEUKOCYTE ELASTASE; ENDOGENOUS SERUM-ALBUMIN; PANCREATIC CYSTIC TUMORS; PRIMARY BREAST-CANCER; DRUG-DELIVERY; MOUSE MODEL; EXPRESSION; ACTIVATION	We recently developed activatable cell-penetrating peptides (ACPPs) that target contrast agents to in vivo sites of matrix metalloproteinase activity, such as tumors. Here we use parallel in vivo and in vitro selection with phage display to identify novel tumor-homing ACPPs with no bias for primary sequence or target protease. Specifically, phage displaying a library of ACPPs were either injected into tumor-bearing mice, followed by isolation of cleaved phage from dissected tumor, or isolated based on selective cleavage by extracts of tumor versus normal tissue. Selected sequences were synthesized as fluorescently labeled peptides, and tumor-specific cleavage was confirmed by digestion with tissue extracts. The most efficiently cleaved peptide contained the substrate sequence RLQLKL and labeled tumors and metastases from several cancer models with up to 5-fold contrast. This uniquely identified ACPP was not cleaved by matrix metalloproteinases or various coagulation factors but was efficiently cleaved by plasmin and elastases, both of which have been shown to be aberrantly overexpressed in tumors. The identification of an ACPP that targets tumor expressed proteases without rational design highlights the value of unbiased selection schemes for the development of potential therapeutic agents.	[Whitney, Mike; Olson, Emilia S.; Aguilera, Todd A.; Gross, Larry A.; Tsien, Roger Y.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Crisp, Jessica L.; Tsien, Roger Y.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Ellies, Lesley G.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Gross, Larry A.; Tsien, Roger Y.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Olson, Emilia S.; Aguilera, Todd A.] Univ Calif San Diego, Med Scientist Training Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Tsien, RY (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	rtsien@ucsd.edu		Aguilera, Todd/0000-0002-3734-3758	National Institutes of Health, NCI [CA118182]; DOD [W81XWH-05-1-0183]; NATIONAL CANCER INSTITUTE [K22CA118182] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DOD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grant CA118182 (to L. E.) and DOD grant W81XWH-05-1-0183 (to R. Y. T)	Aguilera TA, 2009, INTEGR BIOL, V1, P371, DOI 10.1039/b904878b; ALLES AJ, 1994, ANN SURG, V219, P131, DOI 10.1097/00000658-199402000-00004; Atwell S, 1999, P NATL ACAD SCI USA, V96, P9497, DOI 10.1073/pnas.96.17.9497; BARBAS CF, 1991, P NATL ACAD SCI USA, V88, P7978, DOI 10.1073/pnas.88.18.7978; Bremer C, 2001, NAT MED, V7, P743, DOI 10.1038/89126; Bremer C, 2001, RADIOLOGY, V221, P523, DOI 10.1148/radiol.2212010368; Brown S, 2000, J AM CHEM SOC, V122, P6799, DOI 10.1021/ja001461n; Cuevas BD, 2006, ONCOGENE, V25, P4998, DOI 10.1038/sj.onc.1209507; Dano K, 2005, THROMB HAEMOSTASIS, V93, P676, DOI 10.1160/TH05-01-0054; Desmedt C, 2006, INT J CANCER, V119, P2539, DOI 10.1002/ijc.22149; Foekens JA, 2003, CANCER RES, V63, P337; Gammon ST, 2003, BIOCONJUGATE CHEM, V14, P368, DOI 10.1021/bc0256291; Goun EA, 2006, BIOCONJUGATE CHEM, V17, P787, DOI 10.1021/bc0503216; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Jessani N, 2002, P NATL ACAD SCI USA, V99, P10335, DOI 10.1073/pnas.162187599; Jiang T, 2004, P NATL ACAD SCI USA, V101, P17867, DOI 10.1073/pnas.0408191101; KOIVUNEN E, 1991, INT J CANCER, V47, P592, DOI 10.1002/ijc.2910470419; Koshikawa N, 1998, AM J PATHOL, V153, P937, DOI 10.1016/S0002-9440(10)65635-0; Kratz F, 2002, J MED CHEM, V45, P5523, DOI 10.1021/jm020276c; Kratz F, 2000, J MED CHEM, V43, P1253, DOI 10.1021/jm9905864; Kridel SJ, 2002, J BIOL CHEM, V277, P23788, DOI 10.1074/jbc.M111574200; La Rocca G, 2004, BRIT J CANCER, V90, P1414, DOI 10.1038/sj.bjc.6601725; Laakkonen P, 2004, P NATL ACAD SCI USA, V101, P9381, DOI 10.1073/pnas.0403317101; Lacroix M, 2008, INT J CANCER, V122, P1, DOI 10.1002/ijc.23233; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Maglione JE, 2001, CANCER RES, V61, P8298; Mi ZB, 2003, MOL THER, V8, P295, DOI 10.1016/S1525-0016(03)00181-3; Miyata S, 1999, J BIOCHEM, V125, P1067, DOI 10.1093/oxfordjournals.jbchem.a022388; Olson ES, 2010, P NATL ACAD SCI USA, V107, P4311, DOI 10.1073/pnas.0910283107; Olson ES, 2009, INTEGR BIOL-UK, V1, P382, DOI 10.1039/b904890a; Paju A, 2004, CLIN CANCER RES, V10, P4761, DOI 10.1158/1078-0432.CCR-0204-03; Ratnikov BI, 2002, LAB INVEST, V82, P1583, DOI 10.1097/01.LAB.0000038555.67772.DB; Rothbard JB, 2002, J MED CHEM, V45, P3612, DOI 10.1021/jm0105676; Sabapathy KT, 1997, J CELL BIOL, V137, P953, DOI 10.1083/jcb.137.4.953; Sidhu SS, 2001, BIOMOL ENG, V18, P57, DOI 10.1016/S1389-0344(01)00087-9; Sounni NE, 2003, MATRIX BIOL, V22, P55, DOI 10.1016/S0945-053X(03)00003-9; Sperti C, 1996, CANCER, V78, P237, DOI 10.1002/(SICI)1097-0142(19960715)78:2<237::AID-CNCR8>3.0.CO;2-I; Talvensaari-Mattila A, 2003, BRIT J CANCER, V89, P1270, DOI 10.1038/sj.bjc.6601238; Thie JA, 2004, J NUCL MED, V45, P1431; Wright LR, 2003, CURR PROTEIN PEPT SC, V4, P105, DOI 10.2174/1389203033487252; YAMASHITA JI, 1994, BRIT J CANCER, V69, P72, DOI 10.1038/bjc.1994.11; Zhang Y, 2006, NANO LETT, V6, P1988, DOI 10.1021/nl0611586; Zou J, 2004, MOL BIOL REP, V31, P121, DOI 10.1023/B:MOLE.0000031459.14448.af	43	57	65	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22532	22541		10.1074/jbc.M110.138297	http://dx.doi.org/10.1074/jbc.M110.138297			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20460372	hybrid, Green Published			2022-12-27	WOS:000279702200065
J	Li, M; Chen, CA; Davies, DR; Chiu, TK				Li, Min; Chen, Changqing; Davies, David R.; Chiu, Thang K.			Induced-fit Mechanism for Prolyl Endopeptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPEPTIDYL-PEPTIDASE-IV; FIBROBLAST ACTIVATION PROTEIN; POSTPROLINE CLEAVING ENZYME; CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; PORPHYROMONAS-GINGIVALIS; SERRATIA-MARCESCENS; GLYCEMIC CONTROL; STRUCTURAL BASIS; RAT-BRAIN	Prolyl peptidases cleave proteins at proline residues and are of importance for cancer, neurological function, and type II diabetes. Prolyl endopeptidase (PEP) cleaves neuropeptides and is a drug target for neuropsychiatric diseases such as post-traumatic stress disorder, depression, and schizophrenia. Previous structural analyses showing little differences between native and substrate-bound structures have suggested a lock-and-key catalytic mechanism. We now directly demonstrate from seven structures of Aeromonus punctata PEP that the mechanism is instead induced fit: the native enzyme exists in a conformationally flexible opened state with a large interdomain opening between the beta-propeller and alpha/beta-hydrolase domains; addition of substrate to preformed native crystals induces a large scale conformational change into a closed state with induced-fit adjustments of the active site, and inhibition of this conformational change prevents substrate binding. Absolute sequence conservation among 28 orthologs of residues at the active site and critical residues at the interdomain interface indicates that this mechanism is conserved in all PEPs. This finding has immediate implications for the use of conformationally targeted drug design to improve specificity of inhibition against this family of proline-specific serine proteases.	[Chiu, Thang K.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Li, Min; Davies, David R.] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Chen, Changqing] Chinese Acad Sci, Shanghai Res Ctr Biotechnol, Shanghai 200233, Peoples R China	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Chinese Academy of Sciences	Chiu, TK (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, 1901 Perdido St, New Orleans, LA 70112 USA.	tchiu@lsuhsc.edu			United States Department of Energy, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK034002] Funding Source: NIH RePORTER	United States Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The use of the Advanced Photon Source was supported by United States Department of Energy, Office of Basic Energy Sciences, Contract W-31-109-Eng-38.	Abbott CA, 2000, EUR J BIOCHEM, V267, P6140, DOI 10.1046/j.1432-1327.2000.01617.x; Aertgeerts K, 2005, J BIOL CHEM, V280, P19441, DOI 10.1074/jbc.C500092200; Aertgeerts K, 2004, PROTEIN SCI, V13, P412, DOI 10.1110/ps.03460604; Ahren B, 2004, J CLIN ENDOCR METAB, V89, P2078, DOI 10.1210/jc.2003-031907; Ansorge S, 2009, CLIN CHEM LAB MED, V47, P253, DOI 10.1515/CCLM.2009.063; Aschner P, 2006, DIABETES CARE, V29, P2632, DOI 10.2337/dc06-0703; ATACK JR, 1991, EUR J PHARMACOL, V205, P157, DOI 10.1016/0014-2999(91)90814-7; Banbula A, 1999, J BIOL CHEM, V274, P9246, DOI 10.1074/jbc.274.14.9246; Bellemere G, 2005, J NEUROENDOCRINOL, V17, P306, DOI 10.1111/j.1365-2826.2005.01308.x; Bellemere G, 2003, J NEUROCHEM, V84, P919, DOI 10.1046/j.1471-4159.2003.01536.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen WT, 2003, ADV EXP MED BIOL, V524, P197; Chiravuri M, 1999, J IMMUNOL, V163, P3092; Chiu TK, 2005, P NATL ACAD SCI USA, V102, P7517, DOI 10.1073/pnas.0502495102; DE MI, 2003, ADV EXP MED BIOL, V524, P3; Drucker DJ, 2003, EXPERT OPIN INV DRUG, V12, P87, DOI 10.1517/13543784.12.1.87; Engel M, 2003, P NATL ACAD SCI USA, V100, P5063, DOI 10.1073/pnas.0230620100; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Fuxreiter M, 2005, PROTEINS, V60, P504, DOI 10.1002/prot.20508; Geiss-Friedlander R, 2009, J BIOL CHEM, V284, P27211, DOI 10.1074/jbc.M109.041871; Hiramatsu H, 2003, BIOCHEM BIOPH RES CO, V302, P849, DOI 10.1016/S0006-291X(03)00258-4; Holst JJ, 2003, ADV EXP MED BIOL, V524, P263; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Irazusta J, 2002, NEUROCHEM INT, V40, P337, DOI 10.1016/S0197-0186(01)00078-X; Ito K, 2000, J BIOCHEM, V128, P673, DOI 10.1093/oxfordjournals.jbchem.a022800; Ito K, 2006, J MOL BIOL, V362, P228, DOI 10.1016/j.jmb.2006.06.083; Jones B, 2003, BLOOD, V102, P1641, DOI 10.1182/blood-2003-01-0208; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; KOIDA M, 1976, J BIOL CHEM, V251, P7593; Kubelka J, 2006, J MOL BIOL, V359, P546, DOI 10.1016/j.jmb.2006.03.034; Lambeir AM, 2002, BIOCHEM PHARMACOL, V64, P1753, DOI 10.1016/S0006-2952(02)01415-6; Lankas GR, 2005, DIABETES, V54, P2988, DOI 10.2337/diabetes.54.10.2988; Lee HJ, 2006, J BIOL CHEM, V281, P38653, DOI 10.1074/jbc.M603895200; Ludwig A, 2002, J LEUKOCYTE BIOL, V72, P183; Lusty CJ, 1999, J APPL CRYSTALLOGR, V32, P106, DOI 10.1107/S002188989801053X; Maes M, 2001, PSYCHONEUROENDOCRINO, V26, P17, DOI 10.1016/S0306-4530(00)00032-9; Maes M, 1999, J AFFECT DISORDERS, V53, P27, DOI 10.1016/S0165-0327(98)00086-X; MAES M, 1995, PSYCHIAT RES, V58, P217, DOI 10.1016/0165-1781(95)02698-V; Medrano FJ, 1998, EMBO J, V17, P1, DOI 10.1093/emboj/17.1.1; Mentlein R, 1999, REGUL PEPTIDES, V85, P9, DOI 10.1016/S0167-0115(99)00089-0; Olsen C, 2002, GENE, V299, P185, DOI 10.1016/S0378-1119(02)01059-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park JE, 1999, J BIOL CHEM, V274, P36505, DOI 10.1074/jbc.274.51.36505; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pitman MR, 2009, FRONT BIOSCI-LANDMRK, V14, P3619, DOI 10.2741/3476; POLGAR L, 1993, FEBS LETT, V322, P227, DOI 10.1016/0014-5793(93)81575-K; POLGAR L, 1992, BIOCHEM J, V283, P647, DOI 10.1042/bj2830647; POLGAR L, 1991, EUR J BIOCHEM, V197, P441, DOI 10.1111/j.1432-1033.1991.tb15930.x; POLGAR L, 1991, BIOMED BIOCHIM ACTA, V50, P721; Portevin B, 1996, J MED CHEM, V39, P2379, DOI 10.1021/jm950858c; Rasmussen HB, 2003, NAT STRUCT BIOL, V10, P19, DOI 10.1038/nsb882; Reinhold D, 2008, FRONT BIOSCI-LANDMRK, V13, P2356, DOI 10.2741/2849; Richard E, 2002, J BIOL CHEM, V277, P19720, DOI 10.1074/jbc.M111901200; Rigolet P, 2002, STRUCTURE, V10, P1383, DOI 10.1016/S0969-2126(02)00851-1; Ristic S, 2005, DIABETES OBES METAB, V7, P692, DOI 10.1111/j.1463-1326.2005.00539.x; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schrag JD, 1997, STRUCTURE, V5, P187, DOI 10.1016/S0969-2126(97)00178-0; Shan L, 2005, P NATL ACAD SCI USA, V102, P3599, DOI 10.1073/pnas.0408286102; Strop P, 2004, J MOL BIOL, V343, P1055, DOI 10.1016/j.jmb.2004.09.003; Szeltner Z, 2004, J MOL BIOL, V340, P627, DOI 10.1016/j.jmb.2004.05.011; Szeltner Z, 2002, J BIOL CHEM, V277, P42613, DOI 10.1074/jbc.M208043200; TAYLOR WL, 1980, BIOCHEM BIOPH RES CO, V94, P9, DOI 10.1016/S0006-291X(80)80179-3; Thoma R, 2003, STRUCTURE, V11, P947, DOI 10.1016/S0969-2126(03)00160-6; WALTER R, 1978, BIOCHEMISTRY-US, V17, P4139, DOI 10.1021/bi00613a006; WELCHES WR, 1993, LIFE SCI, V52, P1461, DOI 10.1016/0024-3205(93)90108-F; Yoshimoto T, 1999, J BIOCHEM, V126, P559, DOI 10.1093/oxfordjournals.jbchem.a022486	67	60	60	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21487	21495		10.1074/jbc.M109.092692	http://dx.doi.org/10.1074/jbc.M109.092692			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20444688	Green Published, hybrid			2022-12-27	WOS:000279516100035
J	Xu, YB; Kershaw, NJ; Luo, CS; Soo, P; Pocock, MJ; Czabotar, PE; Hilton, DJ; Nicola, NA; Garrett, TPJ; Zhang, JG				Xu, Yibin; Kershaw, Nadia J.; Luo, Cindy S.; Soo, Priscilla; Pocock, Michael J.; Czabotar, Peter E.; Hilton, Douglas J.; Nicola, Nicos A.; Garrett, Thomas P. J.; Zhang, Jian-Guo			Crystal Structure of the Entire Ectodomain of gp130 INSIGHTS INTO THE MOLECULAR ASSEMBLY OF THE TALL CYTOKINE RECEPTOR COMPLEXES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROXIMAL EXTRACELLULAR DOMAINS; SIGNAL TRANSDUCER GP130; DIFFRACTION DATA; LIGAND; OLIGOMERIZATION; DIMERIZATION; RECOGNITION; ACTIVATION; REGION	gp130 is the shared signal-transducing receptor subunit for the large and important family of interleukin 6-like cytokines. Previous x-ray structures of ligand-receptor complexes of this family lack the three membrane-proximal domains that are essential for signal transduction. Here we report the crystal structure of the entire extracellular portion of human gp130 (domains 1-6, D1-D6) at 3.6 angstrom resolution, in an unliganded form, as well as a higher resolution structure of the membrane-proximal fibronectin type III domains (D4-D6) at 1.9 angstrom. This represents the first atomic resolution structure of the complete ectodomain of any "tall" cytokine receptor. These structures show that other than a reorientation of the D1 domain, there is little structural change in gp130 upon ligand binding. They also reveal that the interface between the D4 and D5 domains forms an acute bend in the gp130 structure. Key residues at this interface are highly conserved across the entire tall receptor family, suggesting that this acute bend may be a common feature of these receptors. Importantly, this geometry positions the C termini of the membrane-proximal fibronectin type III domains of the tall cytokine receptors in close proximity within the transmembrane complex, favorable for receptor-associated Janus kinases to trans-phosphorylate and activate each other.	[Xu, Yibin; Kershaw, Nadia J.; Luo, Cindy S.; Soo, Priscilla; Pocock, Michael J.; Czabotar, Peter E.; Hilton, Douglas J.; Nicola, Nicos A.; Garrett, Thomas P. J.; Zhang, Jian-Guo] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia	Walter & Eliza Hall Institute	Garrett, TPJ (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia.	tgarrett@wehi.edu.au; zhang@wehi.edu.au	Nicola, Nicos/D-2989-2011; Kershaw, Nadia/G-5770-2014; Hilton, Douglas J/C-7250-2013	Nicola, Nicos/0000-0003-1054-7889; Hilton, Douglas J/0000-0002-7698-2392; Czabotar, Peter/0000-0002-2594-496X; Kershaw, Nadia/0000-0002-3554-2622	Australian National Health and Medical Research Council [257500, 280912, 487922, 461219, 461221, 516730]; Australian Cancer Research Foundation; Victoria Government; Australian Government	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Cancer Research Foundation; Victoria Government; Australian Government(Australian GovernmentCGIAR)	This work was supported by the Australian National Health and Medical Research Council (Grants 257500, 280912, 487922, 461219, 461221, and 516730), the Australian Cancer Research Foundation, the Victoria Government Operational Infrastructure Scheme, and the Australian Government Independent Research Institutes Infrastructure Support Scheme.	Afonine P., 2005, CCP4 NEWSLETTER, V42; Aricescu AR, 2007, SCIENCE, V317, P1217, DOI 10.1126/science.1144646; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blanchard F, 2009, CYTOKINE GROWTH F R, V20, P19, DOI 10.1016/j.cytogfr.2008.11.004; Boulanger MJ, 2004, ADV PROTEIN CHEM, V68, P107; Boulanger MJ, 2003, MOL CELL, V12, P577, DOI 10.1016/S1097-2765(03)00365-4; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Bravo J, 1998, EMBO J, V17, P1665, DOI 10.1093/emboj/17.6.1665; Bravo J, 2000, EMBO J, V19, P2399, DOI 10.1093/emboj/19.11.2399; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; Constantinescu SN, 2001, P NATL ACAD SCI USA, V98, P4379, DOI 10.1073/pnas.081069198; de Pereda JM, 1999, EMBO J, V18, P4087, DOI 10.1093/emboj/18.15.4087; de Pereda JM, 2009, EMBO J, V28, P1180, DOI 10.1038/emboj.2009.48; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Giese B, 2005, J CELL SCI, V118, P5129, DOI 10.1242/jcs.02628; Greiser JS, 2002, J BIOL CHEM, V277, P26959, DOI 10.1074/jbc.M204113200; Hammacher A, 2000, BIOCHEM J, V345, P25, DOI 10.1042/0264-6021:3450025; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Huyton T, 2007, P NATL ACAD SCI USA, V104, P12737, DOI 10.1073/pnas.0705577104; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kurth I, 2000, J IMMUNOL, V164, P273, DOI 10.4049/jimmunol.164.1.273; LEAHY DJ, 1992, SCIENCE, V258, P987, DOI 10.1126/science.1279805; Matadeen R, 2007, STRUCTURE, V15, P441, DOI 10.1016/j.str.2007.02.006; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moritz RL, 2001, J BIOL CHEM, V276, P8244, DOI 10.1074/jbc.M009979200; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pflanz S, 2001, BIOCHEM J, V356, P605, DOI 10.1042/0264-6021:3560605; Sharma A, 1999, EMBO J, V18, P1468, DOI 10.1093/emboj/18.6.1468; Skiniotis G, 2005, NAT STRUCT MOL BIOL, V12, P545, DOI 10.1038/nsmb941; Skiniotis G, 2008, MOL CELL, V31, P737, DOI 10.1016/j.molcel.2008.08.011; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Tamada T, 2006, P NATL ACAD SCI USA, V103, P3135, DOI 10.1073/pnas.0511264103; Tenhumberg S, 2006, BIOCHEM BIOPH RES CO, V346, P649, DOI 10.1016/j.bbrc.2006.05.173; Timmermann A, 2002, EUR J BIOCHEM, V269, P2716, DOI 10.1046/j.1432-1033.2002.02941.x	40	59	61	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21214	21218		10.1074/jbc.C110.129502	http://dx.doi.org/10.1074/jbc.C110.129502			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20489211	Green Published, hybrid			2022-12-27	WOS:000279516100005
J	Martel, G; Hamet, P; Tremblay, J				Martel, Guy; Hamet, Pavel; Tremblay, Johanne			GREBP, a cGMP-response Element-binding Protein Repressing the Transcription of Natriuretic Peptide Receptor 1 (NPR1/GCA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTICULATE GUANYLATE-CYCLASE; VASCULAR ENDOTHELIAL-CELLS; MESSENGER-RNA DEGRADATION; NITRIC-OXIDE SYNTHASE; CYCLIC-GMP; ANGIOTENSIN-II; PHOSPHORYLATION SITES; GENE-EXPRESSION; PORCINE BRAIN; SMOOTH-MUSCLE	NPR1/GCA (natriuretic peptide receptor 1/guanylyl cyclase A) expression is controlled by several agents, including ANP (atrial natriuretic peptide). After ANP stimulation, NPR1/GCA down-regulates the transcriptional activity of its gene via a cGMP-dependent mechanism. Because we previously identified a cis-acting element responsible for this cGMP sensitivity, we proceed here to explore novel putative protein binding to cGMP-response element (cGMP-RE). Using the yeast one-hybrid technique with a human kidney cDNA library, we identified a strong positive clone able to bind cGMP-RE. The clone was derived from 1083-bp-long cDNA of a gene of yet unknown function localized on human chromosome 1 (1p33.36). We named this new protein GREBP (for cGMP-response element-binding protein). DNA binding assays showed 18-fold higher cGMP-RE binding capacity than the controls, whereas an electromobility shift assay indicated a specific binding for the cGMP-RE, and chromatin immunoprecipitation confirmed the binding of GREBP to the element under physiological conditions. By acting on cGMP-RE, GREBP inhibited the expression of a luciferase-coupled NPR1 promoter construct. In H295R cells, ANP heightened GREBP expression by 60% after just 3h of treatment while inhibiting NPR1/GCA expression by 30%. Silencing GREBP with specific small interfering RNA increased the activity of the luciferase-coupled NPR1 promoter and GCA/NPR1 mRNA levels. GREBP is a nuclear protein mainly expressed in the heart. We report here the existence of a human-specific gene that acts as a transcriptional repressor of the NPR1/GCA gene.	[Martel, Guy; Hamet, Pavel; Tremblay, Johanne] Ctr Hosp Univ Montreal CRCHUM, Res Ctr, Montreal, PQ H1W 4A4, Canada	Universite de Montreal	Tremblay, J (corresponding author), CRCHUM, Technopole Angus,2901 Rue Rachel Est,Bur 314, Montreal, PQ H1W 4A4, Canada.	johanne.tremblay@umontreal.ca	Cossette, Suzanne/I-8008-2016; Tremblay, Johanne/E-2154-2013		Canadian Institutes of Health Research [MOP-11463]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP-11463 (to J. T.).	Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; BENNETT BD, 1991, J BIOL CHEM, V266, P23060; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; CAO L, 1995, J BIOL CHEM, V270, P24891, DOI 10.1074/jbc.270.42.24891; Casteel DE, 2002, J BIOL CHEM, V277, P32003, DOI 10.1074/jbc.M112332200; Chan SHH, 2004, MOL PHARMACOL, V65, P319, DOI 10.1124/mol.65.2.319; CHARTIER L, 1984, ENDOCRINOLOGY, V115, P2026, DOI 10.1210/endo-115-5-2026; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Cheng HF, 2000, AM J PHYSIOL-RENAL, V279, pF122, DOI 10.1152/ajprenal.2000.279.1.F122; Cheng LEC, 1997, EMBO J, V16, P1865, DOI 10.1093/emboj/16.8.1865; CURRIE MG, 1983, SCIENCE, V221, P71, DOI 10.1126/science.6857267; DEBOLD AJ, 1981, LIFE SCI, V28, P89, DOI 10.1016/0024-3205(81)90370-2; Duttweiler HM, 1996, TRENDS GENET, V12, P340, DOI 10.1016/S0168-9525(96)80008-4; El Hader C, 2005, AM J PHYSIOL-RENAL, V289, pF1273, DOI 10.1152/ajprenal.00103.2005; GARBERS DL, 1994, J BIOL CHEM, V269, P30741; GARBERS DL, 1992, CELL, V71, P1; Garg R, 2005, PEPTIDES, V26, P1009, DOI 10.1016/j.peptides.2004.09.022; Garg R, 2003, HYPERTENSION, V41, P730, DOI 10.1161/01.HYP.0000051890.68573.94; Gilad Y, 2006, NATURE, V440, P242, DOI 10.1038/nature04559; HAMET P, 1978, J CYCLIC NUCL PROT, V4, P281; HAMET P, 1984, BIOCHEM BIOPH RES CO, V123, P515, DOI 10.1016/0006-291X(84)90260-2; Hazzalin CA, 2002, NAT REV MOL CELL BIO, V3, P30, DOI 10.1038/nrm715; He B, 2003, EUR J BIOCHEM, V270, P2174, DOI 10.1046/j.1432-1033.2003.03574.x; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Hum D, 2004, HYPERTENSION, V43, P1270, DOI 10.1161/01.HYP.0000126920.93207.53; Huo XW, 1999, BIOCHEMISTRY-US, V38, P16941, DOI 10.1021/bi9919448; INAGAMI T, 1989, J BIOL CHEM, V264, P3043; INOUE T, 1995, HYPERTENSION, V25, P711, DOI 10.1161/01.HYP.25.4.711; Isono K, 1999, NUCLEIC ACIDS RES, V27, P3728, DOI 10.1093/nar/27.18.3728; ITOH H, 1992, HYPERTENSION, V19, P758, DOI 10.1161/01.HYP.19.6.758; KATAFUCHI T, 1992, J BIOL CHEM, V267, P7624; Kiemer AK, 1998, J BIOL CHEM, V273, P13444, DOI 10.1074/jbc.273.22.13444; Kiemer AK, 2000, J IMMUNOL, V165, P175, DOI 10.4049/jimmunol.165.1.175; Kopp K, 2005, J CELL BIOCHEM, V95, P217, DOI 10.1002/jcb.20403; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LANIERSMITH KL, 1991, ENDOCRINOLOGY, V129, P2311, DOI 10.1210/endo-129-5-2311; Lee ES, 2007, FEBS LETT, V581, P4325, DOI 10.1016/j.febslet.2007.08.001; Martel G, 2010, MOL CELL BIOCHEM, V334, P53, DOI 10.1007/s11010-009-0326-8; NEYSES L, 1989, BIOCHEM BIOPH RES CO, V163, P1435, DOI 10.1016/0006-291X(89)91139-X; Parenti A, 1998, J BIOL CHEM, V273, P4220, DOI 10.1074/jbc.273.7.4220; Perez-Sala D, 2001, AM J PHYSIOL-RENAL, V280, pF466, DOI 10.1152/ajprenal.2001.280.3.F466; Potter LR, 1999, METHODS, V19, P506, DOI 10.1006/meth.1999.0893; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Sadat S, 2007, BIOCHEM BIOPH RES CO, V363, P674, DOI 10.1016/j.bbrc.2007.09.058; Saeed M, 2007, CLIN GENET, V71, P238, DOI 10.1111/j.1399-0004.2007.00753.x; Sambrook J., 2002, MOL CLONING LAB MANU; Sauzeau V, 2003, J BIOL CHEM, V278, P9472, DOI 10.1074/jbc.M212776200; Schmitzer AR, 2004, PROTEIN ENG DES SEL, V17, P809, DOI 10.1093/protein/gzh090; Sengenes C, 2003, J BIOL CHEM, V278, P48617, DOI 10.1074/jbc.M303713200; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Stein GS, 2000, J CELL SCI, V113, P2527; SUDOH T, 1990, BIOCHEM BIOPH RES CO, V168, P863, DOI 10.1016/0006-291X(90)92401-K; SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0; TREMBLAY J, 1986, FEBS LETT, V194, P210, DOI 10.1016/0014-5793(86)80086-2; Wang X, 1999, EMBO J, V18, P4549, DOI 10.1093/emboj/18.16.4549; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; WINQUIST RJ, 1984, P NATL ACAD SCI-BIOL, V81, P7661, DOI 10.1073/pnas.81.23.7661; Wolf YI, 2009, P NATL ACAD SCI USA, V106, P7273, DOI 10.1073/pnas.0901808106; Yamamoto K, 1997, J MOL CELL CARDIOL, V29, P2375, DOI 10.1006/jmcc.1997.0472; Ye Q, 2003, HYPERTENSION, V41, P675, DOI 10.1161/01.HYP.0000047204.72286.34; Yu XP, 2005, J BIOL CHEM, V280, P35184, DOI 10.1074/jbc.M508138200; Zaragoza C, 2002, MOL PHARMACOL, V62, P927, DOI 10.1124/mol.62.4.927; ZEIDEL ML, 1990, ANNU REV PHYSIOL, V52, P747	63	8	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20926	20939		10.1074/jbc.M109.061622	http://dx.doi.org/10.1074/jbc.M109.061622			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20444705	Green Published, hybrid			2022-12-27	WOS:000279228600057
J	Book, AJ; Gladman, NP; Lee, SS; Scalf, M; Smith, LM; Vierstra, RD				Book, Adam J.; Gladman, Nicholas P.; Lee, Sang-Sook; Scalf, Mark; Smith, Lloyd M.; Vierstra, Richard D.			Affinity Purification of the Arabidopsis 26 S Proteasome Reveals a Diverse Array of Plant Proteolytic Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY PARTICLE SUBUNITS; MASS-SPECTROMETRIC ANALYSIS; 20S PROTEASOME; UBIQUITYLATED PROTEINS; YEAST; IDENTIFICATION; BINDING; PROLIFERATION; DEGRADATION; ASSOCIATION	Selective proteolysis in plants is largely mediated by the ubiquitin (Ub)/proteasome system in which substrates, marked by the covalent attachment of Ub, are degraded by the 26 S proteasome. The 26 S proteasome is composed of two subparticles, the 20 S core protease (CP) that compartmentalizes the protease active sites and the 19 S regulatory particle that recognizes and translocates appropriate substrates into the CP lumen for breakdown. Here, we describe an affinity method to rapidly purify epitope-tagged 26 S proteasomes intact from Arabidopsis thaliana. In-depth mass spectrometric analyses of preparations generated from young seedlings confirmed that the 2.5-MDa CP-regulatory particle complex is actually a heterogeneous set of particles assembled with paralogous pairs for most subunits. A number of these subunits are modified post-translationally by proteolytic processing, acetylation, and/or ubiquitylation. Several proteasome-associated proteins were also identified that likely assist in complex assembly and regulation. In addition, we detected a particle consisting of the CP capped by the single subunit PA200 activator that may be involved in Ub-independent protein breakdown. Taken together, it appears that a diverse and highly dynamic population of proteasomes is assembled in plants, which may expand the target specificity and functions of intracellular proteolysis.	[Book, Adam J.; Gladman, Nicholas P.; Lee, Sang-Sook; Vierstra, Richard D.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Scalf, Mark; Smith, Lloyd M.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Vierstra, RD (corresponding author), Univ Wisconsin, Dept Genet, 425-G Henry Mall, Madison, WI 53706 USA.	vierstra@wisc.edu	Gladman, Nicholas/AAF-7400-2020	Gladman, Nicholas/0000-0002-9000-8377	NHGRI [1P50HG004952]; NIGMS [P01GM081269]; United States Department of Energy [DE-FG02-88ER13968]; National Science Foundation Arabidopsis [MCB-0115870]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM081269] Funding Source: NIH RePORTER	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Energy(United States Department of Energy (DOE)); National Science Foundation Arabidopsis(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The MS facility was supported in part by National Institutes of Health Grants 1P50HG004952 from NHGRI and P01GM081269 from NIGMS (to M.S. and L.M.S.). This work was supported by United States Department of Energy Basic Energy Sciences Program Grant DE-FG02-88ER13968 and National Science Foundation Arabidopsis 2010 Program Grant MCB-0115870 (to R.D.V.).	Boisson B, 2003, J BIOL CHEM, V278, P43418, DOI 10.1074/jbc.M307321200; Book AJ, 2009, PLANT CELL, V21, P460, DOI 10.1105/tpc.108.064444; Book AJ, 2005, PLANT PHYSIOL, V138, P1046, DOI 10.1104/pp.104.057406; Brukhin V, 2005, PLANT CELL, V17, P2723, DOI 10.1105/tpc.105.034975; Chen P, 1996, CELL, V86, P961, DOI 10.1016/S0092-8674(00)80171-3; Denis NJ, 2007, PROTEOMICS, V7, P868, DOI 10.1002/pmic.200600410; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Ermolaeva MD, 2003, PLANT MOL BIOL, V51, P859, DOI 10.1023/A:1023001130337; Farmer LM, 2010, PLANT CELL, V22, P124, DOI 10.1105/tpc.109.072660; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Fu HY, 2001, EMBO J, V20, P7096, DOI 10.1093/emboj/20.24.7096; Fu HY, 1999, PLANT J, V18, P529, DOI 10.1046/j.1365-313X.1999.00479.x; Fu HY, 1998, GENETICS, V149, P677; FUJINAMI K, 1994, J BIOL CHEM, V269, P25905; FUJIWARA T, 1990, J BIOL CHEM, V265, P16604; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Gallois JL, 2009, PLANT CELL, V21, P442, DOI 10.1105/tpc.108.062372; Gomes AV, 2006, CIRC RES, V99, P362, DOI 10.1161/01.RES.0000237386.98506.f7; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Huelsenbeck JP, 2004, J MOL EVOL, V58, P661, DOI 10.1007/s00239-004-2588-9; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Iwanczyk J, 2006, J MOL BIOL, V363, P648, DOI 10.1016/j.jmb.2006.08.010; Kim HJ, 2008, NATURE, V455, P1134, DOI 10.1038/nature07289; Kim YK, 2007, GENE EXPR PATTERNS, V7, P143, DOI 10.1016/j.modgep.2006.06.006; Kimura Y, 2003, ARCH BIOCHEM BIOPHYS, V409, P341, DOI 10.1016/S0003-9861(02)00639-2; Kimura Y, 2000, J BIOL CHEM, V275, P4635, DOI 10.1074/jbc.275.7.4635; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572; Kurepa J, 2008, PLANT J, V53, P102, DOI 10.1111/j.1365-313X.2007.03322.x; Kurepa J, 2009, PLANT PHYSIOL, V150, P178, DOI 10.1104/pp.109.135970; Lee KK, 2005, MOL CELL BIOL, V25, P1173, DOI 10.1128/MCB.25.3.1173-1182.2005; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Paz-Aviram T, 2008, PLANT SIGNAL BEHAV, V3, P409, DOI 10.4161/psb.3.6.5434; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Peng ZH, 2003, CURR BIOL, V13, pR504, DOI 10.1016/S0960-9822(03)00439-1; Perry RH, 2008, MASS SPECTROM REV, V27, P661, DOI 10.1002/mas.20186; Pick E, 2009, MOL CELL, V35, P260, DOI 10.1016/j.molcel.2009.07.009; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Rivett AJ, 2001, BIOCHIMIE, V83, P363; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; ROHRBOUGH JG, J BIOMOL TECHNOL, V17, P327; Rosenzweig R, 2008, BIOCHEM SOC T, V36, P807, DOI 10.1042/BST0360807; Sadre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI 10.1016/j.molcel.2010.02.002; Saeki Y, 2002, BIOCHEM BIOPH RES CO, V296, P813, DOI 10.1016/S0006-291X(02)02002-8; Saracco SA, 2009, PLANT J, V59, P344, DOI 10.1111/j.1365-313X.2009.03862.x; Satoh K, 2001, BIOCHEMISTRY-US, V40, P314, DOI 10.1021/bi001815n; Schmidt M, 2005, BIOL CHEM, V386, P725, DOI 10.1515/BC.2005.085; Schmidt M, 2005, NAT STRUCT MOL BIOL, V12, P294, DOI 10.1038/nsmb914; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Shibahara T, 2002, EUR J BIOCHEM, V269, P1474, DOI 10.1046/j.1432-1033.2002.02792.x; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Smalle J, 2003, PLANT CELL, V15, P965, DOI 10.1105/tpc.009217; Smalle J, 2002, PLANT CELL, V14, P17, DOI 10.1105/tpc.010381; Sonoda Y, 2009, PLANT J, V60, P68, DOI 10.1111/j.1365-313X.2009.03932.x; Ueda M, 2004, DEVELOPMENT, V131, P2101, DOI 10.1242/dev.01096; Ustrell V, 2002, EMBO J, V21, P3516, DOI 10.1093/emboj/cdf333; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Wang XR, 2007, BIOCHEMISTRY-US, V46, P3553, DOI 10.1021/bi061994u; Wenner BR, 2004, J AM SOC MASS SPECTR, V15, P150, DOI 10.1016/j.jasms.2003.10.006; Wiesner J, 2008, PROTEOMICS, V8, P4466, DOI 10.1002/pmic.200800329; Yang PZ, 2004, J BIOL CHEM, V279, P6401, DOI 10.1074/jbc.M311977200	68	90	147	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25554	25569		10.1074/jbc.M110.136622	http://dx.doi.org/10.1074/jbc.M110.136622			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20516081	hybrid, Green Published			2022-12-27	WOS:000280682400050
J	Greaves, J; Gorleku, OA; Salaun, C; Chamberlain, LH				Greaves, Jennifer; Gorleku, Oforiwa A.; Salaun, Christine; Chamberlain, Luke H.			Palmitoylation of the SNAP25 Protein Family SPECIFICITY AND REGULATION BY DHHC PALMITOYL TRANSFERASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-STRING PROTEIN; MEMBRANE INTERACTIONS; CELL-SURFACE; PC12 CELLS; SNAP-25; TRAFFICKING; DOMAIN; EXOCYTOSIS; BINDING; IDENTIFICATION	SNAP25 plays an essential role in neuronal exocytosis pathways. SNAP25a and SNAP25b are alternatively spliced isoforms differing by only nine amino acids, three of which occur within the palmitoylated cysteine-rich domain. SNAP23 is 60% identical to SNAP25 and has a distinct cysteine-rich domain to both SNAP25a and SNAP25b. Despite the conspicuous differences within the palmitoylated domains of these secretory proteins, there is no information on their comparative interactions with palmitoyl transferases. We report that membrane association of all SNAP25/23 proteins is enhanced by Golgi-localized DHHC3, DHHC7, and DHHC17. In contrast, DHHC15 promoted a statistically significant increase in membrane association of only SNAP25b. To investigate the underlying cause of this differential specificity, we examined a SNAP23 point mutant (C79F) designed to mimic the cysteine-rich domain of SNAP25b. DHHC15 promoted a marked increase in membrane binding and palmitoylation of this SNAP23 mutant, demonstrating that the distinct cysteine-rich domains of SNAP25/23 contribute to differential interactions with DHHC15. The lack of activity of DHHC15 toward wild-type SNAP23 was not overcome by replacing its DHHC domain with that from DHHC3, suggesting that substrate specificity is not determined by the DHHC domain alone. Interestingly, DHHC2, which is closely related to DHHC15, associates with the plasma membrane in PC12 cells and can palmitoylate all SNAP25 isoforms. DHHC2 is, thus, a candidate enzyme to regulate SNAP25/23 palmitoylation dynamics at the plasma membrane. Finally, we demonstrate that overexpression of specific Golgi-localized DHHC proteins active against SNAP25/23 proteins perturbs the normal secretion of human growth hormone from PC12 cells.	[Greaves, Jennifer; Gorleku, Oforiwa A.; Chamberlain, Luke H.] Univ Edinburgh, Ctr Integrat Physiol, Sch Biomed Sci, Edinburgh EH8 9XD, Midlothian, Scotland; [Salaun, Christine] Fac Med Paris Descartes, INSERM, U845, F-75730 Paris 15, France	University of Edinburgh; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Chamberlain, LH (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Sch Biomed Sci, Hugh Robson Bldg, Edinburgh EH8 9XD, Midlothian, Scotland.	Luke.Chamberlain@ed.ac.uk		Greaves, Jennifer/0000-0001-8445-789X; Salaun, Christine/0000-0003-3002-6810	Medical Research Council; MRC [G0601597] Funding Source: UKRI; Medical Research Council [G0601597] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Medical Research Council Senior Research fellowship (to L. H. C.).	Aikawa Y, 2006, MOL BIOL CELL, V17, P711, DOI 10.1091/mbc.E05-05-0382; BARK IC, 1994, GENE, V139, P291, DOI 10.1016/0378-1119(94)90773-0; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Gonelle-Gispert C, 2000, J CELL SCI, V113, P3197; Gonzalo S, 1999, J BIOL CHEM, V274, P21313, DOI 10.1074/jbc.274.30.21313; Greaves J, 2008, J BIOL CHEM, V283, P25014, DOI 10.1074/jbc.M802140200; Greaves J, 2006, MOL BIOL CELL, V17, P4748, DOI 10.1091/mbc.E06-03-0183; Greaves J, 2009, MOL BIOL CELL, V20, P1845, DOI 10.1091/mbc.E08-09-0944; Guo ZH, 1998, CELL, V94, P537, DOI 10.1016/S0092-8674(00)81594-9; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Huang K, 2009, FASEB J, V23, P2605, DOI 10.1096/fj.08-127399; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Johansson JU, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000278; Kang RJ, 2004, J BIOL CHEM, V279, P50524, DOI 10.1074/jbc.M404981200; Lane SR, 1997, J NEUROCHEM, V69, P1864; LAWRENCE GW, 1994, EUR J BIOCHEM, V222, P325, DOI 10.1111/j.1432-1033.1994.tb18871.x; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Prescott GR, 2009, J NEUROCHEM, V110, P1135, DOI 10.1111/j.1471-4159.2009.06205.x; Ravichandran V, 1996, J BIOL CHEM, V271, P13300, DOI 10.1074/jbc.271.23.13300; Rea S, 1998, J BIOL CHEM, V273, P18784, DOI 10.1074/jbc.273.30.18784; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; SADOUL K, 1995, J CELL BIOL, V128, P1019, DOI 10.1083/jcb.128.6.1019; Salaun C, 2005, J BIOL CHEM, V280, P19449, DOI 10.1074/jbc.M501923200; Salaun C, 2005, J BIOL CHEM, V280, P1236, DOI 10.1074/jbc.M410674200; Sorensen JB, 2003, CELL, V114, P75, DOI 10.1016/S0092-8674(03)00477-X; Suh YH, 2010, NAT NEUROSCI, V13, P338, DOI 10.1038/nn.2488; Veit M, 1996, FEBS LETT, V385, P119, DOI 10.1016/0014-5793(96)00362-6; Vogel K, 1999, BIOCHEM BIOPH RES CO, V258, P407, DOI 10.1006/bbrc.1999.0652; Wang GY, 1997, J CELL SCI, V110, P505	29	79	81	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24629	24638		10.1074/jbc.M110.119289	http://dx.doi.org/10.1074/jbc.M110.119289			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20519516	Green Published, hybrid			2022-12-27	WOS:000280542100035
J	Koskivirta, I; Kassiri, Z; Rahkonen, O; Kiviranta, R; Oudit, GY; Mckee, TD; Kyto, V; Saraste, A; Jokinen, E; Liu, PP; Vuorio, E; Khokha, R				Koskivirta, Ilpo; Kassiri, Zamaneh; Rahkonen, Otto; Kiviranta, Riku; Oudit, Gavin Y.; Mckee, Trevor D.; Kyto, Ville; Saraste, Antti; Jokinen, Eero; Liu, Peter P.; Vuorio, Eero; Khokha, Rama			Mice with Tissue Inhibitor of Metalloproteinases 4 (Timp4) Deletion Succumb to Induced Myocardial Infarction but Not to Cardiac Pressure Overload	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEART-FAILURE; MATRIX METALLOPROTEINASES; TIMP-1-DEFICIENT MICE; TARGETED DELETION; MMP-INHIBITION; ACTIVATION; ECHOCARDIOGRAPHY; DEFICIENCY; EXPRESSION; MOUSE	Tissue inhibitor of metalloproteinases 4 (TIMP4) is expressed highly in heart and found dysregulated in human cardiovascular diseases. It controls extracellular matrix remodeling by inhibiting matrix metalloproteinases (MMPs) and is implicated in processes including cell proliferation, apoptosis, and angiogenesis. Timp4-deficient mice (Timp4(-/-)) were generated to assess TIMP4 function in normal development and in models of heart disease. We deleted exons 1-3 of the Timp4 gene by homologous recombination. Timp4(-/-) mice are born healthy, develop normally, and produce litters of normal size and gender distribution. These mice show no compensation by overexpression of Timp1, Timp2, or Timp3 in the heart. Following cardiac pressure overload by aortic banding, Timp4(-/-) mice have comparable survival rate, cardiac histology, and cardiac function to controls. In this case, Timp4 deficiency is compensated by increased cardiac Timp2 expression. Strikingly, the induction of myocardial infarction (MI) leads to significantly increased mortality in Timp4(-/-) mice primarily due to left ventricular rupture. The post-MI mortality of Timp4(-/-) mice is reduced by administration of a synthetic MMP inhibitor. Furthermore, combining the genetic deletion of Mmp2 also rescues the higher post-MI mortality of Timp4(-/-) mice. Finally, Timp4(-/-) mice suffer reduced cardiac function at 20 months of age. Timp4 is not essential for murine development, although its loss moderately compromises cardiac function with aging. Timp4(-/-) mice are more susceptible to MI but not to pressure overload, and TIMP4 functions in its capacity as a metalloproteinase inhibitor after myocardial infarction.	[Koskivirta, Ilpo; Kassiri, Zamaneh; Mckee, Trevor D.; Khokha, Rama] Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Koskivirta, Ilpo; Rahkonen, Otto; Kiviranta, Riku; Vuorio, Eero] Univ Turku, Dept Med Biochem & Genet, FI-20520 Turku, Finland; [Rahkonen, Otto; Jokinen, Eero] Univ Helsinki, Dept Pediat, FI-00029 Helsinki, Finland; [Oudit, Gavin Y.; Liu, Peter P.] Univ Toronto, Div Cardiol, Toronto, ON M5G 2N2, Canada; [Koskivirta, Ilpo; Kyto, Ville; Saraste, Antti] Turku Univ Hosp, Dept Med, FI-20521 Turku, Finland	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Turku; University of Helsinki; University of Toronto; University of Turku	Khokha, R (corresponding author), Ontario Canc Inst, 610 Univ Ave,10-330, Toronto, ON M5G 2M9, Canada.	rkhokha@uhnres.utoronto.ca	Kytö, Ville/D-7971-2014; McKee, Trevor David/N-4308-2019	Kytö, Ville/0000-0002-4521-1093; McKee, Trevor David/0000-0002-2195-6146; Khokha, Rama/0000-0002-6028-1524; Vuorio, Eero/0000-0003-3404-2439	Academy of Finland; Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada	Academy of Finland(Academy of Finland); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by research grants from the Academy of Finland, the Canadian Institutes of Health Research, and the Heart and Stroke Foundation of Canada.	Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Broberg CS, 2003, J AM SOC ECHOCARDIOG, V16, P814, DOI 10.1067/S0894-7317(03)00399-7; Caterina JJ, 2000, J BIOL CHEM, V275, P26416, DOI 10.1074/jbc.M001271200; Creemers EEJM, 2003, AM J PHYSIOL-HEART C, V284, pH364, DOI 10.1152/ajpheart.00511.2002; Dollery CM, 1999, CIRC RES, V84, P498, DOI 10.1161/01.RES.84.5.498; Fata JE, 2001, J CLIN INVEST, V108, P831, DOI 10.1172/JCI13171; Fedak PWM, 2004, CIRCULATION, V110, P2401, DOI 10.1161/01.CIR.0000134959.83967.2D; Hayashidani S, 2003, AM J PHYSIOL-HEART C, V285, pH1229, DOI 10.1152/ajpheart.00207.2003; Hoit BD, 2002, MOL CELL BIOCHEM, V238, P145, DOI 10.1023/A:1019988024077; Ikonomidis JS, 2005, AM J PHYSIOL-HEART C, V288, pH149, DOI 10.1152/ajpheart.00370.2004; Jaworski DM, 2006, J NEUROBIOL, V66, P82, DOI 10.1002/neu.20205; Jaworski DM, 2005, BRAIN RES, V1051, P81, DOI 10.1016/j.brainres.2005.05.057; Kassiri Z, 2005, CIRC RES, V97, P380, DOI 10.1161/01.RES.0000178789.16929.cf; Kassiri Z, 2005, THROMB HAEMOSTASIS, V93, P212, DOI 10.1160/TH04-08-0522; Koskivirta I, 2006, HISTOCHEM CELL BIOL, V126, P335, DOI 10.1007/s00418-006-0163-8; Lambert E, 2004, CRIT REV ONCOL HEMAT, V49, P187, DOI 10.1016/j.critrevonc.2003.09.008; Leco KJ, 1997, FEBS LETT, V401, P213, DOI 10.1016/S0014-5793(96)01474-3; Lee MM, 2005, INFECT IMMUN, V73, P661, DOI 10.1128/IAI.73.1.661-665.2005; Li H, 2000, CARDIOVASC RES, V46, P298, DOI 10.1016/S0008-6363(00)00028-6; Li YY, 1998, CIRCULATION, V98, P1728, DOI 10.1161/01.CIR.98.17.1728; Matsumura S, 2005, J CLIN INVEST, V115, P599, DOI 10.1172/JCI200522304; Melendez-Zajgla J, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-85; Mohammed FF, 2004, NAT GENET, V36, P969, DOI 10.1038/ng1413; Morrison CJ, 2001, J BIOL CHEM, V276, P47402, DOI 10.1074/jbc.M108643200; Mukherjee R, 2003, CIRCULATION, V107, P618, DOI 10.1161/01.CIR.0000046449.36178.00; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Nothnick WB, 2001, REPRODUCTION, V122, P923, DOI 10.1530/reprod/122.6.923; Ohta K, 2004, AM J PHYSIOL-HEART C, V287, pH286, DOI 10.1152/ajpheart.00479.2002; Osiewicz K, 1999, ANN NY ACAD SCI, V878, P494, DOI 10.1111/j.1749-6632.1999.tb07706.x; Rahkonen OP, 2002, BBA-GENE STRUCT EXPR, V1577, P45, DOI 10.1016/S0167-4781(02)00404-9; Roten L, 2000, J MOL CELL CARDIOL, V32, P109, DOI 10.1006/jmcc.1999.1052; Saraste A, 2006, AM J PHYSIOL-HEART C, V291, pH871, DOI 10.1152/ajpheart.01375.2005; Schulze CJ, 2003, CIRCULATION, V107, P2487, DOI 10.1161/01.CIR.0000065603.09430.58; Seeland U, 2002, J MOL CELL CARDIOL, V34, P151, DOI 10.1006/jmcc.2001.1497; Soloway PD, 1996, ONCOGENE, V13, P2307; Stracke JO, 2000, J BIOL CHEM, V275, P14809, DOI 10.1074/jbc.275.20.14809; Stratmann B, 2001, BIOL CHEM, V382, P987, DOI 10.1515/BC.2001.124; Tanaka N, 1996, CIRCULATION, V94, P1109, DOI 10.1161/01.CIR.94.5.1109; Tian H, 2007, J MOL CELL CARDIOL, V43, P733, DOI 10.1016/j.yjmcc.2007.09.003; Wang ZP, 2000, J BIOL CHEM, V275, P26411, DOI 10.1074/jbc.M001270200; Wilson EM, 2003, CIRCULATION, V107, P2857, DOI 10.1161/01.CIR.0000068375.40887.FA; Zhao HR, 2004, J BIOL CHEM, V279, P8592, DOI 10.1074/jbc.M308708200	42	64	64	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24487	24493		10.1074/jbc.M110.136820	http://dx.doi.org/10.1074/jbc.M110.136820			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20516072	hybrid, Green Published			2022-12-27	WOS:000280542100021
J	Mirza, S; Chen, JL; Murphy, JM; Young, IG				Mirza, Shamaruh; Chen, Jinglong; Murphy, James M.; Young, Ian G.			The Role of Interchain Heterodisulfide Formation in Activation of the Human Common beta and Mouse beta(IL-3) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; GM-CSF RECEPTORS; COMPLETE EXTRACELLULAR DOMAIN; HIGH-AFFINITY BINDING; IL-5 RECEPTORS; INTERLEUKIN-5 RECEPTOR; EXPRESSION CLONING; SIGNALING COMPLEX; CRYSTAL-STRUCTURE; LIGAND-BINDING	The cytokines, interleukin-3 (IL-3), interleukin-5 (IL-5), and granulocyte-macrophage colony-stimulating factor (GM-CSF), exhibit overlapping activities in the regulation of hematopoietic cells. In humans, the common beta (beta c) receptor is shared by the three cytokines and functions together with cytokine-specific alpha subunits in signaling. A widely accepted hypothesis is that receptor activation requires heterodisulfide formation between the domain 1 D-E loop disulfide in human beta c (h beta c) and unidentified cysteine residues in the N-terminal domains of the alpha receptors. Since the development of this hypothesis, new data have been obtained showing that domain 1 of h beta c is part of the cytokine binding epitope of this receptor and that an IL-3R alpha isoform lacking the N-terminal Ig-like domain (the "SP2" isoform) is competent for signaling. We therefore investigated whether distortion of the domain 1-domain 4 ligand-binding epitope in h beta c and the related mouse receptor, beta(IL-3), could account for the loss of receptor signaling when the domain 1 D-E loop disulfide is disrupted. Indeed, mutation of the disulfide in h beta c led to both a complete loss of high affinity binding with the humanIL-3R alpha SP2 isoform and of downstream signaling. Mutation of the orthologous residues in the mouse IL-3-specific receptor, beta(IL-3), not only precluded direct binding of mouse IL-3 but also resulted in complete loss of high affinity binding and signaling with the mouse IL-3R alpha SP2 isoform. Our data are most consistent with a role for the domain 1 D-E loop disulfide of h beta c and beta(IL-3) in maintaining the precise positions of ligand-binding residues necessary for normal high affinity binding and signaling.	[Murphy, James M.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Mol Med, Parkville, Vic 3050, Australia; [Mirza, Shamaruh; Chen, Jinglong; Young, Ian G.] Australian Natl Univ, Dept Biol Struct, John Curtin Sch Med Res, Canberra, ACT 0200, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; Australian National University; John Curtin School of Medical Research	Murphy, JM (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Mol Med, 1G Royal Parade, Parkville, Vic 3050, Australia.	jamesm@wehi.edu.au; Ian.Young@anu.edu.au	Murphy, James/B-4863-2017	Murphy, James/0000-0003-0195-3949	National Health and Medical Research Council of Australia [471481]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grant number 471481 from the National Health and Medical Research Council of Australia.	BALDWIN GC, 1991, BLOOD, V78, P609, DOI 10.1182/blood.V78.3.609.bloodjournal783609; BERNDT RK, 1996, MOL CELL BIOL, V16, P3035; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Carr PD, 2001, CELL, V104, P291, DOI 10.1016/S0092-8674(01)00213-6; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; CORNELIS S, 1995, EMBO J, V14, P3395, DOI 10.1002/j.1460-2075.1995.tb07345.x; de Groot RP, 1998, CELL SIGNAL, V10, P619, DOI 10.1016/S0898-6568(98)00023-0; DEVOS R, 1994, EUR J BIOCHEM, V225, P635, DOI 10.1111/j.1432-1033.1994.00635.x; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; GEARING DP, 1989, EMBO J, V8, P3667, DOI 10.1002/j.1460-2075.1989.tb08541.x; Gustin SE, 2001, EUR J BIOCHEM, V268, P2905, DOI 10.1046/j.1432-1327.2001.02178.x; Hage T, 1999, CELL, V97, P271, DOI 10.1016/S0092-8674(00)80736-9; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053; HARA T, 1992, EMBO J, V11, P1875, DOI 10.1002/j.1460-2075.1992.tb05239.x; HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; ITOH N, 1990, SCIENCE, V247, P324, DOI 10.1126/science.2404337; Itoh T, 1996, J BIOL CHEM, V271, P7587, DOI 10.1074/jbc.271.13.7587; Itoh T, 1998, MOL CELL BIOL, V18, P742, DOI 10.1128/MCB.18.2.742; KITAMURA T, 1991, CELL, V66, P1165, DOI 10.1016/0092-8674(91)90039-2; Kopf M, 1996, IMMUNITY, V4, P15, DOI 10.1016/S1074-7613(00)80294-0; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Le F, 2000, J BIOL CHEM, V275, P5124, DOI 10.1074/jbc.275.7.5124; Martinez-Moczygemba M, 2008, J EXP MED, V205, P2711, DOI 10.1084/jem.20080759; MCPHERSON GA, 1985, J PHARMACOL METHOD, V14, P213, DOI 10.1016/0160-5402(85)90034-8; METCALF D, 1990, P NATL ACAD SCI USA, V87, P4670, DOI 10.1073/pnas.87.12.4670; MILLER J, 1985, J IMMUNOL, V134, P4212; MIRZA S, 2010, J BIOL CHEM IN PRESS; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Murphy JM, 2008, CYTOKINE, V42, P234, DOI 10.1016/j.cyto.2008.02.010; Murphy JM, 2006, VITAM HORM, V74, P1, DOI 10.1016/S0083-6729(06)74001-8; Murphy JM, 2004, J BIOL CHEM, V279, P26500, DOI 10.1074/jbc.M402705200; Murphy JM, 2003, J BIOL CHEM, V278, P10572, DOI 10.1074/jbc.M211664200; QUELLE FW, 1994, MOL CELL BIOL, V14, P4335, DOI 10.1128/MCB.14.7.4335; SAKAMAKI K, 1992, EMBO J, V11, P3541, DOI 10.1002/j.1460-2075.1992.tb05437.x; SOMERS W, 1994, NATURE, V372, P478, DOI 10.1038/372478a0; Stomski FC, 1998, J BIOL CHEM, V273, P1192, DOI 10.1074/jbc.273.2.1192; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; TAKAKI S, 1993, J EXP MED, V177, P1523, DOI 10.1084/jem.177.6.1523; Tamada T, 2006, P NATL ACAD SCI USA, V103, P3135, DOI 10.1073/pnas.0511264103; TAVERNIER J, 1991, CELL, V66, P1175, DOI 10.1016/0092-8674(91)90040-6; WOODCOCK JM, 1994, EMBO J, V13, P5176, DOI 10.1002/j.1460-2075.1994.tb06848.x; Yoon C, 2000, EMBO J, V19, P3530, DOI 10.1093/emboj/19.14.3530	45	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24759	24768		10.1074/jbc.M109.097881	http://dx.doi.org/10.1074/jbc.M109.097881			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20516062	Green Published, hybrid			2022-12-27	WOS:000280542100048
J	Strijbis, K; van Roermund, CW; van den Burg, J; van den Berg, M; Hardy, GPM; Wanders, RJ; Distel, B				Strijbis, Karin; van Roermund, Carlo W.; van den Burg, Janny; van den Berg, Marlene; Hardy, Guy P. M.; Wanders, Ronald J.; Distel, Ben			Contributions of Carnitine Acetyltransferases to Intracellular Acetyl Unit Transport in Candida albicans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID BETA-OXIDATION; YEAST SACCHAROMYCES-CEREVISIAE; PEROXISOMAL FATTY-ACID; GLYOXYLATE CYCLE; CARBON-SOURCES; COA; PROTEIN; CHAIN; IDENTIFICATION; MITOCHONDRIAL	Transport of acetyl-CoA between intracellular compartments is mediated by carnitine acetyltransferases (Cats) that reversibly link acetyl units to the carrier molecule carnitine. The genome of the opportunistic pathogenic yeast Candida albicans encodes several (putative) Cats: the peroxisomal and mitochondrial Cat2 isoenzymes encoded by a single gene and the carnitine acetyltransferase homologs Yat1 and Yat2. To determine the contributions of the individual Cats, various carnitine acetyltransferase mutant strains were constructed and subjected to phenotypic and biochemical analyses on different carbon sources. We show that mitochondrial Cat2 is required for the intramitochondrial conversion of acetylcarnitine to acetyl-CoA, which is essential for a functional tricarboxylic acid cycle during growth on oleate, acetate, ethanol, and citrate. Yat1 is cytosolic and contributes to acetyl-CoA transport from the cytosol during growth on ethanol or acetate, but its activity is not required for growth on oleate. Yat2 is also cytosolic, but we were unable to attribute any function to this enzyme. Surprisingly, peroxisomal Cat2 is essential neither for export of acetyl units during growth on oleate nor for the import of acetyl units during growth on acetate or ethanol. Oxidation of fatty acids still takes place in the absence of peroxisomal Cat2, but biomass formation is absent, and the strain displays a growth delay on acetate and ethanol that can be partially rescued by the addition of carnitine. Based on our results, we present a model for the intracellular flow of acetyl units under various growth conditions and the roles of each of the Cats in this process.	[Strijbis, Karin; van den Burg, Janny; van den Berg, Marlene; Hardy, Guy P. M.; Distel, Ben] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [van Roermund, Carlo W.; Wanders, Ronald J.] Univ Amsterdam, Acad Med Ctr, Dept Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Distel, B (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	b.distel@amc.uva.nl		Strijbis, Karin/0000-0001-9167-7137	Academic Medical Center, Amsterdam	Academic Medical Center, Amsterdam	This work was supported by a grant from the Academic Medical Center, Amsterdam.	BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; DEJONGGUBBELS P, 1995, YEAST, V11, P407, DOI 10.1002/yea.320110503; ELGERSMA Y, 1995, EMBO J, V14, P3472, DOI 10.1002/j.1460-2075.1995.tb07353.x; Elgersma Y, 1996, J CELL BIOL, V135, P97, DOI 10.1083/jcb.135.1.97; Franken J, 2008, CURR GENET, V53, P347, DOI 10.1007/s00294-008-0191-0; GRUNAU S, 2009, PLOS ONE, V276, P1698; Hammond LE, 2005, J BIOL CHEM, V280, P25629, DOI 10.1074/jbc.M503181200; Hettema EH, 2000, EMBO J, V19, P223, DOI 10.1093/emboj/19.2.223; Hettema EH, 1996, EMBO J, V15, P3813, DOI 10.1002/j.1460-2075.1996.tb00755.x; Hooks MA, 2007, BIOCHEM J, V406, P399, DOI 10.1042/BJ20070258; HOVIK R, 1991, J LIPID RES, V32, P993; KISPAL G, 1993, J BIOL CHEM, V268, P1824; Klein ATJ, 2002, J BIOL CHEM, V277, P25011, DOI 10.1074/jbc.M203254200; Klein ATJ, 2001, J BIOL CHEM, V276, P15034, DOI 10.1074/jbc.M010776200; Kunau WH, 1995, PROG LIPID RES, V34, P267, DOI 10.1016/0163-7827(95)00011-9; Kunze M, 2002, EUR J BIOCHEM, V269, P915, DOI 10.1046/j.0014-2956.2001.02727.x; LEIGHTON F, 1989, J BIOL CHEM, V264, P10347; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; Maeting I, 1999, FEBS LETT, V444, P15, DOI 10.1016/S0014-5793(99)00017-4; NAKANISHI Y, 1994, J BIOCHEM-TOKYO, V115, P328, DOI 10.1093/oxfordjournals.jbchem.a124337; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; OSMUNDSEN H, 1980, INT J BIOCHEM, V12, P625, DOI 10.1016/0020-711X(80)90015-4; Piekarska K, 2008, MICROBIOL-SGM, V154, P3061, DOI 10.1099/mic.0.2008/020289-0; Piekarska K, 2006, EUKARYOT CELL, V5, P1847, DOI 10.1128/EC.00093-06; Prigneau O, 2004, FUNGAL GENET BIOL, V41, P783, DOI 10.1016/j.fgb.2004.04.001; Rokka A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005090; SCHMALIX W, 1993, J BIOL CHEM, V268, P27428; Strijbis K, 2008, EUKARYOT CELL, V7, P610, DOI 10.1128/EC.00017-08; Strijbis K, 2009, FASEB J, V23, P2349, DOI 10.1096/fj.08-127985; Swiegers JH, 2001, YEAST, V18, P585, DOI 10.1002/yea.712; van Roermund CWT, 2001, MOL CELL BIOL, V21, P4321, DOI 10.1128/MCB.21.13.4321-4329.2001; van Roermund CWT, 1998, EMBO J, V17, P677, DOI 10.1093/emboj/17.3.677; Van Vlies N, 2005, BIOCHEM J, V387, P185, DOI 10.1042/BJ20041489; VANROERMUND CWT, 1995, EMBO J, V14, P3480, DOI 10.1002/j.1460-2075.1995.tb07354.x; Velot C, 1999, BIOCHEMISTRY-US, V38, P16195, DOI 10.1021/bi991695n; Visser WF, 2002, BIOCHEM BIOPH RES CO, V299, P494, DOI 10.1016/S0006-291X(02)02663-3; Walther A, 2003, CURR GENET, V42, P339, DOI 10.1007/s00294-002-0349-0; WANDERS RJA, 1990, J INHERIT METAB DIS, V13, P311, DOI 10.1007/BF01799383; Westin MAK, 2008, CELL MOL LIFE SCI, V65, P982, DOI 10.1007/s00018-008-7576-6; Wiese S, 2007, MOL CELL PROTEOMICS, V6, P2045, DOI 10.1074/mcp.M700169-MCP200; WILCKE M, 1994, EUR J BIOCHEM, V222, P803, DOI 10.1111/j.1432-1033.1994.tb18927.x; Zhou H, 2008, MICROBIOL-SGM, V154, P500, DOI 10.1099/mic.0.2007/014555-0	44	17	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24335	24346		10.1074/jbc.M109.094250	http://dx.doi.org/10.1074/jbc.M109.094250			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20522553	hybrid, Green Published			2022-12-27	WOS:000280542100005
J	Malik, M; Shukla, A; Amin, P; Niedelman, W; Lee, J; Jividen, K; Phang, JM; Ding, JH; Suh, KS; Curmi, PMG; Yuspa, SH				Malik, Mariam; Shukla, Anjali; Amin, Palak; Niedelman, Wendy; Lee, Jessica; Jividen, Kasey; Phang, Juanita M.; Ding, Jinhui; Suh, Kwang S.; Curmi, Paul M. G.; Yuspa, Stuart H.			S-Nitrosylation Regulates Nuclear Translocation of Chloride Intracellular Channel Protein CLIC4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; HUMAN BREAST-CANCER; ION CHANNEL; PROTEOMIC ANALYSIS; IN-VITRO; EXPRESSION; GLUTATHIONE; CARCINOMA; MECHANISM; CELLS	Nuclear translocation of chloride intracellular channel protein CLIC4 is essential for its role in Ca2+-induced differentiation, stress-induced apoptosis, and modulating TGF-beta signaling in mouse epidermal keratinocytes. However, post-translational modifications on CLIC4 that govern nuclear translocation and thus these activities remain to be elucidated. The structure of CLIC4 is dependent on the redox environment, in vitro, and translocation may depend on reactive oxygen and nitrogen species in the cell. Here we show that NO directly induces nuclear translocation of CLIC4 that is independent of the NO-cGMP pathway. Indeed, CLIC4 is directly modified by NO through S-nitrosylation of a cysteine residue, as measured by the biotin switch assay. NO enhances association of CLIC4 with the nuclear import proteins importin alpha and Ran. This is likely a result of the conformational change induced by S-nitrosylated CLIC4 that leads to unfolding of the protein, as exhibited by CD spectra analysis and trypsinolysis of the modified protein. Cysteine mutants of CLIC4 exhibit altered nitrosylation, nuclear residence, and stability, compared with the wild type protein likely as a consequence of altered tertiary structure. Moreover, tumor necrosis factor alpha-induced nuclear translocation of CLIC4 is dependent on nitric-oxide synthase activity. Inhibition of nitric-oxide synthase activity inhibits tumor necrosis factor alpha-induced nitrosylation and association with importin alpha and Ran and ablates CLIC4 nuclear translocation. These results suggest that S-nitrosylation governs CLIC4 structure, its association with protein partners, and thus its intracellular distribution.	[Suh, Kwang S.; Yuspa, Stuart H.] NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Phang, Juanita M.; Curmi, Paul M. G.] Univ New S Wales, Sch Phys, Sydney, NSW 2052, Australia; [Phang, Juanita M.; Curmi, Paul M. G.] St Vincents Hosp, Ctr Appl Med Res, Sydney, NSW 2010, Australia; [Ding, Jinhui] NIA, Sect Bioinformat & Computat Biol, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Suh, Kwang S.] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Tissue Bank, Hackensack, NJ 07601 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of New South Wales Sydney; St Vincents Hospital Sydney; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Hackensack University Medical Center	Yuspa, SH (corresponding author), NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bldg 37,Rm 4068A1,37 Convent Dr, Bethesda, MD 20892 USA.	yuspas@mail.nih.gov	Shukla, Anjali/G-4046-2014; Curmi, Paul/G-7185-2011	Curmi, Paul/0000-0001-5762-7638; Amin, Palak/0000-0001-5617-8703; Jividen, Kasey/0000-0003-1022-5038	National Cancer Institute; Australian Research Council; The Australian Nuclear Science and Technology Organization; NATIONAL CANCER INSTITUTE [ZIABC005445] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Australian Research Council(Australian Research Council); The Australian Nuclear Science and Technology Organization; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, by the National Institutes of Health Intramural Program of the National Cancer Institute and by grants from the Australian Research Council (to P.M.G.C.). J.M.P. was supported by a scholarship from The Australian Nuclear Science and Technology Organization.	Ahern GP, 2002, TRENDS NEUROSCI, V25, P510, DOI 10.1016/S0166-2236(02)02254-3; Akool ES, 2005, J BIOL CHEM, V280, P39403, DOI 10.1074/jbc.M504140200; Azad N, 2006, J BIOL CHEM, V281, P34124, DOI 10.1074/jbc.M602551200; Benhar M, 2005, NAT CELL BIOL, V7, P645, DOI 10.1038/ncb0705-645; Berryman M, 2004, J BIOL CHEM, V279, P34794, DOI 10.1074/jbc.M402835200; Bohman S, 2005, J BIOL CHEM, V280, P42397, DOI 10.1074/jbc.M506724200; Chiu C, 2001, INT J MOL MED, V8, P251; Edwards JC, 2006, J BIOL CHEM, V281, P28011, DOI 10.1074/jbc.M605865200; Felley-Bosco E, 2000, P NATL ACAD SCI USA, V97, P14334, DOI 10.1073/pnas.250406797; Fernandez-Salas E, 2002, MOL CELL BIOL, V22, P3610, DOI 10.1128/MCB.22.11.3610-3620.2002; Gatti G, 2004, BREAST, V13, P1, DOI 10.1016/j.breast.2003.09.001; Gius D, 2006, ANTIOXID REDOX SIGN, V8, P1249, DOI 10.1089/ars.2006.8.1249; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; HART TW, 1985, TETRAHEDRON LETT, V26, P2013, DOI 10.1016/S0040-4039(00)98368-0; Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/nrc1046; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Kitamura K, 2001, JPN J PHARMACOL, V85, P351, DOI 10.1254/jjp.85.351; Li CQ, 2005, CANCER LETT, V226, P1, DOI 10.1016/j.canlet.2004.10.021; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Li SM, 2008, CARDIOVASC RES, V77, P107, DOI 10.1093/cvr/cvm022; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Littler DR, 2005, FEBS J, V272, P4996, DOI 10.1111/j.1742-4658.2005.04909.x; Littler DR, 2004, J BIOL CHEM, V279, P9298, DOI 10.1074/jbc.M308444200; Mitchell DA, 2005, NAT CHEM BIOL, V1, P154, DOI 10.1038/nchembio720; Peng HM, 2004, J BIOL CHEM, V279, P52970, DOI 10.1074/jbc.M406926200; Qian ZJ, 1999, J BIOL CHEM, V274, P1621, DOI 10.1074/jbc.274.3.1621; Reveneau S, 1999, LAB INVEST, V79, P1215; Ronnov-Jessen L, 2002, AM J PATHOL, V161, P471, DOI 10.1016/S0002-9440(10)64203-4; Sakai M, 2007, BIOCHEM BIOPH RES CO, V357, P575, DOI 10.1016/j.bbrc.2007.03.174; Santibanez JF, 2007, J CELL PHYSIOL, V210, P456, DOI 10.1002/jcp.20878; Saydam N, 1997, CANCER LETT, V119, P13, DOI 10.1016/S0304-3835(97)00245-0; Schreiter ER, 2007, J BIOL CHEM, V282, P19773, DOI 10.1074/jbc.M701363200; Shiio Y, 2006, J BIOL CHEM, V281, P2750, DOI 10.1074/jbc.M509349200; Shukla A, 2009, NAT CELL BIOL, V11, P777, DOI 10.1038/ncb1885; Singh H, 2007, MOL MEMBR BIOL, V24, P41, DOI 10.1080/09687860600927907; Sirsjo A, 1996, BRIT J DERMATOL, V134, P643, DOI 10.1111/j.1365-2133.1996.tb06963.x; Sliskovic I, 2005, J BIOL CHEM, V280, P8733, DOI 10.1074/jbc.M408080200; Suh KS, 2004, J BIOL CHEM, V279, P4632, DOI 10.1074/jbc.M311632200; Suh KS, 2007, MOL CARCINOGEN, V46, P599, DOI 10.1002/mc.20324; Suh KS, 2007, CLIN CANCER RES, V13, P121, DOI 10.1158/1078-0432.CCR-06-1562; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Tannenbaum SR, 2006, ACS CHEM BIOL, V1, P615, DOI 10.1021/cb600439h; Thomas DD, 2002, METHOD ENZYMOL, V359, P84; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Tschugguel W, 1999, BREAST CANCER RES TR, V56, P145; Tung JJ, 2009, ANGIOGENESIS, V12, P209, DOI 10.1007/s10456-009-9139-3; Ulmasov B, 2009, AM J PATHOL, V174, P1084, DOI 10.2353/ajpath.2009.080625	48	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23818	23828		10.1074/jbc.M109.091611	http://dx.doi.org/10.1074/jbc.M109.091611			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20504765	Green Published, hybrid			2022-12-27	WOS:000280291400032
J	Abd Alla, J; Langer, A; Elzahwy, SS; Arman-Kalcek, G; Streichert, T; Quitterer, U				Abd Alla, Joshua; Langer, Andreas; Elzahwy, Sherif S.; Arman-Kalcek, Goekhan; Streichert, Thomas; Quitterer, Ursula			Angiotensin-converting Enzyme Inhibition Down-regulates the Pro-atherogenic Chemokine Receptor 9 (CCR9)-Chemokine Ligand 25 (CCL25) Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-DEFICIENT MICE; DIET-INDUCED ATHEROSCLEROSIS; ACUTE-MYOCARDIAL-INFARCTION; E-KNOCKOUT MICE; T-CELL; DYSFUNCTION; CAPTOPRIL; TECK; HYPERTENSION; STIMULATION	Many experimental and clinical studies suggest a relationship between enhanced angiotensin II release by the angiotensin-converting enzyme (ACE) and the pathophysiology of atherosclerosis. The atherosclerosis-enhancing effects of angiotensin II are complex and incompletely understood. To identify anti-atherogenic target genes, we performed microarray gene expression profiling of the aorta during atherosclerosis prevention with the ACE inhibitor, captopril. Atherosclerosis-prone apolipoprotein E (apoE)-deficient mice were used as a model to decipher susceptible genes regulated during atherosclerosis prevention with captopril. Microarray gene expression profiling and immunohistology revealed that captopril treatment for 7 months strongly decreased the recruitment of pro-atherogenic immune cells into the aorta. Captopril-mediated inhibition of plaque-infiltrating immune cells involved down-regulation of the C-C chemokine receptor 9 (CCR9). Reduced cell migration correlated with decreased numbers of aorta-resident cells expressing the CCR9-specific chemoattractant factor, chemokine ligand 25 (CCL25). The CCL25-CCR9 axis was pro-atherogenic, because inhibition of CCR9 by RNA interference in hematopoietic progenitors of apoE-deficient mice significantly retarded the development of atherosclerosis. Analysis of coronary artery biopsy specimens of patients with coronary artery atherosclerosis undergoing bypass surgery also showed strong infiltrates of CCR9-positive cells in atherosclerotic lesions. Thus, the C-C chemokine receptor, CCR9, exerts a significant role in atherosclerosis.	[Abd Alla, Joshua; Langer, Andreas; Quitterer, Ursula] Swiss Fed Inst Technol, Mol Pharmacol Unit, CH-8057 Zurich, Switzerland; [Abd Alla, Joshua; Langer, Andreas; Quitterer, Ursula] Univ Zurich, CH-8057 Zurich, Switzerland; [Elzahwy, Sherif S.] Ain Shams Univ Hosp, Cardiol Clin, Cairo, Egypt; [Arman-Kalcek, Goekhan] Univ Hamburg, Heinrich Pette Inst, D-20251 Hamburg, Germany; [Streichert, Thomas] Univ Med Ctr Hamburg Eppendorf, Dept Clin Chem, Cent Labs, D-20246 Hamburg, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Egyptian Knowledge Bank (EKB); Ain Shams University; Heinrich Pette Institute; University of Hamburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Quitterer, U (corresponding author), Y17M70,Winterthurerstr 190, CH-8057 Zurich, Switzerland.	ursula.quitterer@pharma.ethz.ch		elzahwy, sherif/0000-0001-8451-4583	Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported in part by the Swiss National Science Foundation.	AbdAlla S, 2004, CELL, V119, P343, DOI 10.1016/j.cell.2004.10.006; AbdAlla S, 2009, J BIOL CHEM, V284, P6554, DOI 10.1074/jbc.M807746200; Aiello RJ, 1999, ARTERIOSCL THROM VAS, V19, P1518, DOI 10.1161/01.ATV.19.6.1518; Alla JA, 2009, BIOCHEM BIOPH RES CO, V387, P186, DOI 10.1016/j.bbrc.2009.07.011; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Braunersreuther V, 2007, ARTERIOSCL THROM VAS, V27, P373, DOI 10.1161/01.ATV.0000253886.44609.ae; Bursill CA, 2004, CIRCULATION, V110, P2460, DOI 10.1161/01.CIR.0000145122.58420.CO; Caligiuri G, 2002, J CLIN INVEST, V109, P745, DOI 10.1172/JCI200207272; CHOBANIAN AV, 1990, HYPERTENSION, V15, P327, DOI 10.1161/01.HYP.15.3.327; Daugherty A, 2004, CIRCULATION, V110, P3849, DOI 10.1161/01.CIR.0000150540.54220.C4; Eto H, 2008, HYPERTENS RES, V31, P1631, DOI 10.1291/hypres.31.1631; Fu MG, 2003, GENE, V315, P33, DOI 10.1016/S0378-1119(03)00730-3; Fukuda D, 2008, PHARMACOL THERAPEUT, V118, P268, DOI 10.1016/j.pharmthera.2008.02.007; Gautier EL, 2009, ARTERIOSCL THROM VAS, V29, P1412, DOI 10.1161/ATVBAHA.108.180505; Gewaltig J, 2008, HUM PATHOL, V39, P1756, DOI 10.1016/j.humpath.2008.04.018; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Hayek T, 1998, J CARDIOVASC PHARM, V31, P540, DOI 10.1097/00005344-199804000-00011; Hosoe N, 2004, AM J PHYSIOL-GASTR L, V286, pG458, DOI 10.1152/ajpgi.00167.2003; Jayasooriya AP, 2008, P NATL ACAD SCI USA, V105, P6531, DOI 10.1073/pnas.0802690105; Jung YJ, 2008, INT ARCH ALLERGY IMM, V146, P227, DOI 10.1159/000115891; Keidar S, 1997, BIOCHEM BIOPH RES CO, V236, P622, DOI 10.1006/bbrc.1997.6844; KIM SK, 1995, CIRCULATION, V92, P88, DOI 10.1161/01.CIR.92.1.88; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; Kraaijeveld AO, 2007, CIRCULATION, V116, P1931, DOI 10.1161/CIRCULATIONAHA.107.706986; Lean JM, 2002, J CELL BIOCHEM, V87, P386, DOI 10.1002/jcb.10319; Lonn EM, 2001, CIRCULATION, V103, P919; Lorenz K, 2003, NATURE, V426, P574, DOI 10.1038/nature02158; Major TC, 2009, CARDIOVASC DRUG THER, V23, P113, DOI 10.1007/s10557-008-6157-0; McLaren JE, 2009, CYTOKINE GROWTH F R, V20, P125, DOI 10.1016/j.cytogfr.2008.11.003; McMurray J, 2006, J AM COLL CARDIOL, V47, P726, DOI 10.1016/j.jacc.2005.09.055; Olsen MH, 2005, BLOOD PRESSURE, V14, P177, DOI 10.1080/08037050510034185; Parissis JT, 2002, J INTERF CYTOK RES, V22, P223, DOI 10.1089/107999002753536194; SCHINDLER R, 1995, CYTOKINE, V7, P526, DOI 10.1006/cyto.1995.0071; Stumpe Klaus O, 2007, Ther Adv Cardiovasc Dis, V1, P97, DOI 10.1177/1753944707085982; Valdivia-Silva JE, 2009, CANCER LETT, V283, P176, DOI 10.1016/j.canlet.2009.03.040; Vicari AP, 1997, IMMUNITY, V7, P291, DOI 10.1016/S1074-7613(00)80531-2; Wassmann S, 2004, CIRCULATION, V110, P3062, DOI 10.1161/01.CIR.0000137970.47771.AF; Wurbel MA, 2000, EUR J IMMUNOL, V30, P262, DOI 10.1002/1521-4141(200001)30:1<262::AID-IMMU262>3.0.CO;2-0; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Zaballos A, 1999, J IMMUNOL, V162, P5671; Zhou XH, 2000, CIRCULATION, V102, P2919	41	33	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23494	23503		10.1074/jbc.M110.117481	http://dx.doi.org/10.1074/jbc.M110.117481			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20504763	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000279999900081
J	Dutta, T; Deutscher, MP				Dutta, Tanmay; Deutscher, Murray P.			Mode of Action of RNase BN/RNase Z on tRNA Precursors RNase BN DOES NOT REMOVE THE CCA SEQUENCE FROM tRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; TRNASE-Z; EXORIBONUCLEASES; GROWTH; PROTEINS; PLAYS; END	RNase BN, the Escherichia coli homolog of RNase Z, was previously shown to act as both a distributive exoribonuclease and an endoribonuclease on model RNA substrates and to be inhibited by the presence of a 3'-terminal CCA sequence. Here, we examined the mode of action of RNase BN on bacteriophage and bacterial tRNA precursors, particularly in light of a recent report suggesting that RNase BN removes CCA sequences (Takaku, H., and Nashimoto, M. (2008) Genes Cells 13, 1087-1097). We show that purified RNase BN can process both CCA-less and CCA-containing tRNA precursors. On CCA-less precursors, RNase BN cleaved endonucleolytically after the discriminator nucleotide to allow subsequent CCA addition. On CCA-containing precursors, RNase BN acted as either an exoribonuclease or endoribonuclease depending on the nature of the added divalent cation. Addition of Co2+ resulted in higher activity and predominantly exoribonucleolytic activity, whereas in the presence of Mg2+, RNase BN was primarily an endoribonuclease. In no case was any evidence obtained for removal of the CCA sequence. Certain tRNA precursors were extremely poor substrates under any conditions tested. These findings provide important information on the ability of RNase BN to process tRNA precursors and help explain the known physiological properties of this enzyme. In addition, they call into question the removal of CCA sequences by RNase BN.	[Dutta, Tanmay; Deutscher, Murray P.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA	University of Miami	Deutscher, MP (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, POB 016129, Miami, FL 33101 USA.	mdeutsch@med.miami.edu	Dutta, Tanmay/ABH-2431-2021		National Institutes of Health [GM16317]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM016317, R01GM016317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM16317.	ASHA PK, 1983, P NATL ACAD SCI-BIOL, V80, P3301, DOI 10.1073/pnas.80.11.3301; DEUTSCHER MP, 1985, P NATL ACAD SCI USA, V82, P6427, DOI 10.1073/pnas.82.19.6427; Deutscher MP, 2001, PROG NUCLEIC ACID RE, V66, P67; DEUTSCHER MP, 1993, J BACTERIOL, V175, P4577, DOI 10.1128/JB.175.15.4577-4583.1993; DEUTSCHER MP, 1974, J BIOL CHEM, V249, P6696; Deutscher Murray P., 1995, P51; Dubrovsky EB, 2004, NUCLEIC ACIDS RES, V32, P255, DOI 10.1093/nar/gkh182; Dutta T, 2009, J BIOL CHEM, V284, P15425, DOI 10.1074/jbc.M109.005462; Ezraty B, 2005, J BIOL CHEM, V280, P16542, DOI 10.1074/jbc.C500098200; Ishii R, 2005, J BIOL CHEM, V280, P14138, DOI 10.1074/jbc.M500355200; KELLY KO, 1992, J BACTERIOL, V174, P6682, DOI 10.1128/JB.174.20.6682-6684.1992; LI ZW, 1994, J BIOL CHEM, V269, P6064; Li ZW, 1996, CELL, V86, P503, DOI 10.1016/S0092-8674(00)80123-3; Minagawa A, 2004, J BIOL CHEM, V279, P15688, DOI 10.1074/jbc.M313951200; Pellegrini O, 2003, EMBO J, V22, P4534, DOI 10.1093/emboj/cdg435; Perwez T, 2006, MOL MICROBIOL, V60, P723, DOI 10.1111/j.1365-2958.2006.05124.x; Redko Y, 2007, NAT REV MICROBIOL, V5, P278, DOI 10.1038/nrmicro1622; REUVEN NB, 1993, FASEB J, V7, P143, DOI 10.1096/fasebj.7.1.8422961; Schiffer S, 2002, EMBO J, V21, P2769, DOI 10.1093/emboj/21.11.2769; Schilling O, 2004, BIOCHEM BIOPH RES CO, V320, P1365, DOI 10.1016/j.bbrc.2004.05.227; SEIDMAN JG, 1975, P NATL ACAD SCI USA, V72, P1491, DOI 10.1073/pnas.72.4.1491; SEIDMAN JG, 1975, CELL, V5, P389, DOI 10.1016/0092-8674(75)90058-6; Takaku H, 2008, GENES CELLS, V13, P1087, DOI 10.1111/j.1365-2443.2008.01230.x; Vogel A, 2005, BIOL CHEM, V386, P1253, DOI 10.1515/BC.2005.142; Vogel A, 2002, J BIOL CHEM, V277, P29078, DOI 10.1074/jbc.M112047200; Weiner AM, 2004, CURR BIOL, V14, pR883, DOI 10.1016/j.cub.2004.09.069	27	15	16	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22872	22879		10.1074/jbc.M110.141101	http://dx.doi.org/10.1074/jbc.M110.141101			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20489203	Green Published, hybrid			2022-12-27	WOS:000279999900020
J	Tipps, ME; Lawshe, JE; Ellington, AD; Mihic, SJ				Tipps, Megan E.; Lawshe, Jessica E.; Ellington, Andrew D.; Mihic, S. John			Identification of Novel Specific Allosteric Modulators of the Glycine Receptor Using Phage Display	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; MOLECULAR-MECHANISMS; CHANNEL SUPERFAMILY; CHLORIDE CHANNEL; A RECEPTOR; PEPTIDES; ALCOHOL; ETHANOL; BRAIN; NEUROPROTECTION	The glycine receptor (GlyR) is a member of the Cys-loop superfamily of ligand-gated ion channels and the major mediator of inhibitory neurotransmission in the spinal cord and brainstem. Many allosteric modulators affect the functioning of members of this superfamily, with some such as benzodiazepines showing great specificity and others such as zinc, alcohols, and volatile anesthetics acting on multiple members. To date, no potent and efficacious allosteric modulator acting specifically at the GlyR has been identified, hindering both experimental characterization of the receptor and development of GlyR-related therapeutics. We used phage display to identify novel peptides that specifically modulate GlyR function. Peptide D12-116 markedly enhanced GlyR currents at low micromolar concentrations but had no effects on the closely related gamma-aminobutyric acid type A receptors. This approach can readily be adapted for use with other channels that currently lack specific allosteric modulators.	[Mihic, S. John] Univ Texas Austin, Neurobiol Sect, Austin, TX 78712 USA; Univ Texas Austin, Div Pharmacol & Toxicol, Austin, TX 78712 USA; [Ellington, Andrew D.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA; [Tipps, Megan E.; Mihic, S. John] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA; [Ellington, Andrew D.; Mihic, S. John] Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Mihic, SJ (corresponding author), Univ Texas Austin, Neurobiol Sect, A4800,2500 Speedway,MBB 1-148, Austin, TX 78712 USA.	mihic@mail.utexas.edu			National Institutes of Health [1R03AA018197, 1P20AA017838]; National Institute on Alcohol Abuse and Alcoholism [5T32AA007471, F31AA018887]; Welch Foundation [F-1654]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P20AA017838, F31AA018887, R03AA018197, T32AA007471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R03AA018197 and 1P20AA017838 (to S.J.M.) and 5T32AA007471 and F31AA018887 (to M.E.T.) from the National Institute on Alcohol Abuse and Alcoholism. This work was also supported by Welch Foundation Grant F-1654 (to A.D.E.).	Adamian L, 2009, PROTEIN SCI, V18, P2371, DOI 10.1002/pro.247; Azzazy HME, 2002, CLIN BIOCHEM, V35, P425, DOI 10.1016/S0009-9120(02)00343-0; BARNARD EA, 1987, TRENDS NEUROSCI, V10, P502, DOI 10.1016/0166-2236(87)90130-5; Berg T, 2003, ANGEW CHEM INT EDIT, V42, P2462, DOI 10.1002/anie.200200558; BETZ H, 1991, TRENDS NEUROSCI, V14, P458, DOI 10.1016/0166-2236(91)90045-V; BLOOMENTHAL AB, 1994, MOL PHARMACOL, V46, P1156; Colman A., 1984, TRANSCRIPTION TRANSL, P49; Crabbe JC, 2006, ADDICT BIOL, V11, P195, DOI 10.1111/j.1369-1600.2006.00038.x; DOORBAR J, 1994, J MOL BIOL, V244, P361, DOI 10.1006/jmbi.1994.1736; Freshney RI, 2002, CYTOTECHNOLOGY, V39, P55, DOI 10.1023/A:1022949730029; GILBERT DF, 2009, FRONT MOL NEUROSCI, V2, P1; GOODSON RJ, 1994, P NATL ACAD SCI USA, V91, P7129, DOI 10.1073/pnas.91.15.7129; GRENNINGLOH G, 1990, NEURON, V4, P963, DOI 10.1016/0896-6273(90)90149-A; Guzman L, 2009, J PHARMACOL EXP THER, V331, P933, DOI 10.1124/jpet.109.160440; Hamman JH, 2005, BIODRUGS, V19, P165, DOI 10.2165/00063030-200519030-00003; Hou ST, 2004, J NEUROSCI METH, V138, P39, DOI 10.1016/j.jneumeth.2004.03.013; Jensen AA, 2007, CURR NEUROPHARMACOL, V5, P180, DOI 10.2174/157015907781695982; Karatas H, 2009, J NEUROSCI, V29, P13761, DOI 10.1523/JNEUROSCI.4246-09.2009; Krasowski MD, 2000, BRIT J PHARMACOL, V129, P731, DOI 10.1038/sj.bjp.0703087; Ladner RC, 2004, DRUG DISCOV TODAY, V9, P525, DOI 10.1016/S1359-6446(04)03104-6; Li M, 1996, NAT BIOTECHNOL, V14, P986, DOI 10.1038/nbt0896-986; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Mascia MP, 1996, BRIT J PHARMACOL, V119, P1331, DOI 10.1111/j.1476-5381.1996.tb16042.x; May LT, 2004, CURR PHARM DESIGN, V10, P2003, DOI 10.2174/1381612043384303; MIHIC SJ, 1994, J BIOL CHEM, V269, P32768; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Molander A, 2005, ALCOHOL CLIN EXP RES, V29, P27, DOI 10.1097/01.ALC.0000150012.09608.81; Morris MC, 2008, BIOL CELL, V100, P201, DOI 10.1042/BC20070116; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; Rajendra Sundran, 1995, Trends in Neurosciences, V18, P80, DOI 10.1016/0166-2236(95)93880-7; Vengeliene V, 2008, BRIT J PHARMACOL, V154, P299, DOI 10.1038/bjp.2008.30; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Webb TI, 2007, CURR PHARM DESIGN, V13, P2350; Wilkemeyer MF, 2003, P NATL ACAD SCI USA, V100, P8543, DOI 10.1073/pnas.1331636100; Ye JH, 2009, ALCOHOL CLIN EXP RES, V33, P1069, DOI 10.1111/j.1530-0277.2009.00928.x	35	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22838	22843		10.1074/jbc.M110.130815	http://dx.doi.org/10.1074/jbc.M110.130815			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20501662	hybrid, Green Published			2022-12-27	WOS:000279999900016
J	Vecchio, AJ; Simmons, DM; Malkowski, MG				Vecchio, Alex J.; Simmons, Danielle M.; Malkowski, Michael G.			Structural Basis of Fatty Acid Substrate Binding to Cyclooxygenase-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPEROXIDE-H SYNTHASE-1; MOLECULAR-DYNAMICS SIMULATIONS; ACTIVE-SITE RESIDUES; ARACHIDONIC-ACID; LINOLENIC ACID; ARGININE 120; PROSTAGLANDIN; OXYGENATION; CRYSTALLOGRAPHY; COMPLEXES	The cyclooxygenases (COX-1 and COX-2) are membrane-associated heme-containing homodimers that generate prostaglandin H-2 from arachidonic acid (AA). Although AA is the preferred substrate, other fatty acids are oxygenated by these enzymes with varying efficiencies. We determined the crystal structures of AA, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) bound to Co3+-protoporphyrin IX-reconstituted murine COX-2 to 2.1, 2.4, and 2.65 angstrom, respectively. AA, EPA, and docosahexaenoic acid bind in different conformations in each monomer constituting the homodimer in their respective structures such that one monomer exhibits nonproductive binding and the other productive binding of the substrate in the cyclooxygenase channel. The interactions identified between protein and substrate when bound to COX-1 are conserved in our COX-2 structures, with the only notable difference being the lack of interaction of the carboxylate of AA and EPA with the side chain of Arg-120. Leu-531 exhibits a different side chain conformation when the nonproductive and productive binding modes of AA are compared. Unlike COX-1, mutating this residue to Ala, Phe, Pro, or Thr did not result in a significant loss of activity or substrate binding affinity. Determination of the L531F:AA crystal structure resulted in AA binding in the same global conformation in each monomer. We speculate that the mobility of the Leu-531 side chain increases the volume available at the opening of the cyclooxygenase channel and contributes to the observed ability of COX-2 to oxygenate a broad spectrum of fatty acid and fatty ester substrates.	[Vecchio, Alex J.; Simmons, Danielle M.; Malkowski, Michael G.] SUNY Buffalo, Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA; [Vecchio, Alex J.; Simmons, Danielle M.; Malkowski, Michael G.] SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14203 USA	Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Malkowski, MG (corresponding author), SUNY Buffalo, Hauptman Woodward Med Res Inst, 700 Ellicott St, Buffalo, NY 14203 USA.	malkowski@hwi.buffalo.edu	Malkowski, Michael G/G-4939-2011	Malkowski, Michael G/0000-0003-1025-0014; Malkowski, Michael/0000-0002-1203-7463; Vecchio, Alex/0000-0002-4222-7874	NIGMS, National Institutes of Health [R01 GM077176]; Arthritis Foundation; National Science Foundation [DMR-0225180]; NCRR, National Institutes of Health [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115386, R01GM077176] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Arthritis Foundation; National Science Foundation(National Science Foundation (NSF)); NCRR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM077176 (to M. G. M.) from the NIGMS. This work was also supported by an Arthritis Investigator award (to M. G. M.) from the Arthritis Foundation as part of the Segal Osteoarthritis Initiative. This work was based upon research conducted at the Cornell High Energy Synchrotron Source (CHESS), which is supported by the National Science Foundation Award DMR-0225180, using the Macromolecular Diffraction at CHESS (MacCHESS) facility, which is supported by National Institutes of Health Award RR-01646 from NCRR.	Bhattacharyya DK, 1996, J BIOL CHEM, V271, P2179, DOI 10.1074/jbc.271.4.2179; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cohen SX, 2008, ACTA CRYSTALLOGR D, V64, P49, DOI 10.1107/S0907444907047580; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Furse KE, 2006, BIOCHEMISTRY-US, V45, P3189, DOI 10.1021/bi052337p; Furse KE, 2006, BIOCHEMISTRY-US, V45, P3206, DOI 10.1021/bi052338h; Garavito RM, 2002, PROSTAG OTH LIPID M, V68-9, P129; Harman CA, 2004, J BIOL CHEM, V279, P42929, DOI 10.1074/jbc.M403013200; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; Kiefer JR, 2000, NATURE, V405, P97, DOI 10.1038/35011103; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Kozak KR, 2001, J BIOL CHEM, V276, P30072, DOI 10.1074/jbc.M104467200; Kulmacz RJ, 2005, BIOCHEM BIOPH RES CO, V338, P25, DOI 10.1016/j.bbrc.2005.08.030; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; LANEUVILLE O, 1995, J BIOL CHEM, V270, P19330, DOI 10.1074/jbc.270.33.19330; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LECOMTE M, 1994, J BIOL CHEM, V269, P13207; Liu W, 2006, FASEB J, V20, P1097, DOI 10.1096/fj.05-5273com; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; Malkowski MG, 2001, J BIOL CHEM, V276, P37547, DOI 10.1074/jbc.M105982200; Malkowski MG, 2000, ARCH BIOCHEM BIOPHYS, V380, P39, DOI 10.1006/abbi.2000.1906; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OTTO JC, 1993, J BIOL CHEM, V268, P18234; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Prusakiewicz JJ, 2002, BIOCHEM BIOPH RES CO, V296, P612, DOI 10.1016/S0006-291X(02)00915-4; Rieke CJ, 1999, J BIOL CHEM, V274, P17109, DOI 10.1074/jbc.274.24.17109; Rouzer CA, 2003, CHEM REV, V103, P2239, DOI 10.1021/cr000068x; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Rowlinson SW, 2000, J BIOL CHEM, V275, P6586, DOI 10.1074/jbc.275.9.6586; Rowlinson SW, 2003, J BIOL CHEM, V278, P45763, DOI 10.1074/jbc.M305481200; Rowlinson SW, 1999, J BIOL CHEM, V274, P23305, DOI 10.1074/jbc.274.33.23305; Schneider C, 2004, J BIOL CHEM, V279, P4404, DOI 10.1074/jbc.M307431200; Schneider C, 2002, J BIOL CHEM, V277, P478, DOI 10.1074/jbc.M107471200; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SHIMOKAWA T, 1992, J BIOL CHEM, V267, P12387; Smith T, 2000, ARCH BIOCHEM BIOPHYS, V375, P195, DOI 10.1006/abbi.1999.1659; Smith WL, 2008, TRENDS BIOCHEM SCI, V33, P27, DOI 10.1016/j.tibs.2007.09.013; Smith WL, 2001, J CLIN INVEST, V107, P1491, DOI 10.1172/JCI13271; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Smyth EM, 2009, J LIPID RES, V50, pS423, DOI 10.1194/jlr.R800094-JLR200; Tanabe T, 2002, PROSTAG OTH LIPID M, V68-9, P95, DOI 10.1016/S0090-6980(02)00024-2; Thuresson ED, 2001, J BIOL CHEM, V276, P10358, DOI 10.1074/jbc.M009378200; Thuresson ED, 2001, J BIOL CHEM, V276, P10347, DOI 10.1074/jbc.M009377200; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Turman MV, 2009, BIOCHEMISTRY-US, V48, P12233, DOI 10.1021/bi901181z; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103; Yuan C, 2009, J BIOL CHEM, V284, P10046, DOI 10.1074/jbc.M808634200	57	113	118	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22152	22163		10.1074/jbc.M110.119867	http://dx.doi.org/10.1074/jbc.M110.119867			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20463020	Green Published, hybrid			2022-12-27	WOS:000279702200028
J	Dror, AA; Politi, Y; Shahin, H; Lenz, DR; Dossena, S; Nofziger, C; Fuchs, H; de Angelis, MH; Paulmichl, M; Weiner, S; Avraham, KB				Dror, Amiel A.; Politi, Yael; Shahin, Hashem; Lenz, Danielle R.; Dossena, Silvia; Nofziger, Charity; Fuchs, Helmut; de Angelis, Martin Hrabe; Paulmichl, Markus; Weiner, Steve; Avraham, Karen B.			Calcium Oxalate Stone Formation in the Inner Ear as a Result of an Slc26a4 Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAROXYSMAL POSITIONAL VERTIGO; PENDRED-SYNDROME GENE; TARGETED DISRUPTION; OTOCONIAL MEMBRANE; GLOBULAR SUBSTANCE; MAJOR PROTEIN; DEAFNESS; CELLS; TRPV5; CA2+	Calcium oxalate stone formation occurs under pathological conditions and accounts for more than 80% of all types of kidney stones. In the current study, we show for the first time that calcium oxalate stones are formed in the mouse inner ear of a genetic model for hearing loss and vestibular dysfunction in humans. The vestibular system within the inner ear is dependent on extracellular tiny calcium carbonate minerals for proper function. Thousands of these biominerals, known as otoconia, are associated with the utricle and saccule sensory maculae and are vital for mechanical stimulation of the sensory hair cells. We show that a missense mutation within the Slc26a4 gene abolishes the transport activity of its encoded protein, pendrin. As a consequence, dramatic changes in mineral composition, size, and shape occur within the utricle and saccule in a differential manner. Although abnormal giant carbonate minerals reside in the utricle at all ages, in the saccule, a gradual change in mineral composition leads to a formation of calcium oxalate in adult mice. By combining imaging and spectroscopy tools, we determined the profile of mineral composition and morphology at different time points. We propose a novel mechanism for the accumulation and aggregation of oxalate crystals in the inner ear.	[Avraham, Karen B.] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Politi, Yael; Weiner, Steve] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Dossena, Silvia; Nofziger, Charity; Paulmichl, Markus] Paracelsus Med Univ, Inst Pharmacol & Toxicol, A-5020 Salzburg, Austria; [Fuchs, Helmut; de Angelis, Martin Hrabe] Helmholtz Zentrum Munchen, Inst Expt Genet, D-85764 Neuherberg, Germany; [de Angelis, Martin Hrabe] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, D-85354 Freising Weihenstephan, Germany	Tel Aviv University; Sackler Faculty of Medicine; Weizmann Institute of Science; Paracelsus Private Medical University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Avraham, KB (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel.	karena@post.tau.ac.il	Fuchs, Helmut/M-7347-2014; Dossena, Silvia/G-1437-2018; Dror, Amiel/AAD-3348-2022; Dror, Amiel/AAB-7522-2020; de Angelis, Martin Hrabe/F-5531-2012	Fuchs, Helmut/0000-0002-5143-2677; Dror, Amiel/0000-0002-7178-6771; de Angelis, Martin Hrabe/0000-0002-7898-2353; Avraham, Karen B/0000-0002-4913-251X	European Commission [LSHG-CT-2004-512063, 037188]; Fonds zur Forderung der Wissenschaftlichen Forschung (FWF) [P18608-B05, PIRSES-GA-2008-230661, M1108-B11]; Israel Council for Higher Education	European Commission(European CommissionEuropean Commission Joint Research Centre); Fonds zur Forderung der Wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF)); Israel Council for Higher Education	This work was supported by the European Commission FP6 Integrated Projects EuroHear LSHG-CT-2004-512063 and Eumodic 037188 (to K. B. A.) and the Fonds zur Forderung der Wissenschaftlichen Forschung (FWF) Grant P18608-B05 and Grant PIRSES-GA-2008-230661 (to M. P.).; Supported by a Levtzion Fellowship for outstanding doctoral students in the periphery through the Israel Council for Higher Education.; Supported by the Lise Meitner stipend of the Fonds zur Forderung der Wissenschaftlichen Forschung (FWF) (M1108-B11).	Anniko M, 1980, Am J Otolaryngol, V1, P400, DOI 10.1016/S0196-0709(80)80021-4; Beniash E, 1997, P ROY SOC B-BIOL SCI, V264, P461, DOI 10.1098/rspb.1997.0066; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; BERMAN A, 1988, NATURE, V331, P546, DOI 10.1038/331546a0; Beynon GJ, 1997, BRIT J AUDIOL, V31, P11, DOI 10.3109/03005364000000005; CARLSTROM DD, 1963, BIOL BULL, V125, P441, DOI 10.2307/1539358; Cohen-Salmon M, 1997, P NATL ACAD SCI USA, V94, P14450, DOI 10.1073/pnas.94.26.14450; Coyle B, 1996, NAT GENET, V12, P421, DOI 10.1038/ng0496-421; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; DiCiommo DP, 2004, INVEST OPHTH VIS SCI, V45, P3320, DOI 10.1167/iovs.04-0140; Dossena S, 2006, CELL PHYSIOL BIOCHEM, V18, P67, DOI 10.1159/000095164; Dossena S, 2009, J MOL ENDOCRINOL, V43, P93, DOI 10.1677/JME-08-0175; EPLEY JM, 1995, OTOLARYNG HEAD NECK, V112, P154, DOI 10.1016/S0194-5998(95)70315-2; EPLEY JM, 1992, OTOLARYNG HEAD NECK, V107, P399, DOI 10.1177/019459989210700310; ERWAY L C, 1986, Scanning Electron Microscopy, P1681; Everett LA, 2001, HUM MOL GENET, V10, P153, DOI 10.1093/hmg/10.2.153; Frische S, 2003, AM J PHYSIOL-RENAL, V284, pF584, DOI 10.1152/ajprenal.00254.2002; Fugazzola L, 2007, EUR J ENDOCRINOL, V157, P331, DOI 10.1530/EJE-07-0263; HARADA Y, 1977, ACTA OTO-LARYNGOL, V84, P65, DOI 10.3109/00016487709123943; Hertzano R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000207; House MG, 2003, AUDIOL NEURO-OTOL, V8, P91, DOI 10.1159/000068998; Hughes I, 2006, BRAIN RES, V1091, P58, DOI 10.1016/j.brainres.2006.01.074; HUNTERDUVAR IM, 1978, ACTA OTO-LARYNGOL, P3; Jayaraman S, 2000, J BIOL CHEM, V275, P6047, DOI 10.1074/jbc.275.9.6047; Juretic D, 2002, J CHEM INF COMP SCI, V42, P620, DOI 10.1021/ci010263s; Kozel PJ, 1998, J BIOL CHEM, V273, P18693, DOI 10.1074/jbc.273.30.18693; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LIM DJ, 1983, AM J OTOLARYNG, V4, P33, DOI 10.1016/S0196-0709(83)80005-2; Lins U, 2000, J STRUCT BIOL, V131, P67, DOI 10.1006/jsbi.2000.4260; Lowenstam HA, 1989, BIOMINERALIZATION; Lundberg YXW, 2006, BRAIN RES, V1091, P47, DOI 10.1016/j.brainres.2006.02.083; Marquis RE, 1997, P NATL ACAD SCI USA, V94, P11923, DOI 10.1073/pnas.94.22.11923; Moe OW, 2006, LANCET, V367, P333, DOI 10.1016/S0140-6736(06)68071-9; Nakaya K, 2007, AM J PHYSIOL-RENAL, V292, pF1314, DOI 10.1152/ajprenal.00432.2006; Oghalai JS, 2000, OTOLARYNG HEAD NECK, V122, P630, DOI 10.1016/S0194-5998(00)70187-2; Parnes LS, 2003, CAN MED ASSOC J, V169, P681; Pera A, 2008, P NATL ACAD SCI USA, V105, P18608, DOI 10.1073/pnas.0805831105; PIZZOLATO P, 1964, J HISTOCHEM CYTOCHEM, V12, P333, DOI 10.1177/12.5.333; POTE KG, 1993, BIOCHEMISTRY-US, V32, P5017, DOI 10.1021/bi00070a007; POTE KG, 1991, COMP BIOCHEM PHYS B, V98, P287, DOI 10.1016/0305-0491(91)90181-C; Ross M D, 1979, Adv Otorhinolaryngol, V25, P26; ROSS MD, 1976, ANN OTO RHINOL LARYN, V85, P310, DOI 10.1177/000348947608500302; ROSS MD, 1975, ANN OTO RHINOL LARYN, V84, P22, DOI 10.1177/000348947508400105; Royaux IE, 2003, JARO-J ASSOC RES OTO, V4, P394, DOI 10.1007/s10162-002-3052-4; Royaux IE, 2001, P NATL ACAD SCI USA, V98, P4221, DOI 10.1073/pnas.071516798; Scott DA, 1999, NAT GENET, V21, P440, DOI 10.1038/7783; Scott DA, 2000, AM J PHYSIOL-CELL PH, V278, pC207, DOI 10.1152/ajpcell.2000.278.1.C207; Sheffield VC, 1996, NAT GENET, V12, P424, DOI 10.1038/ng0496-424; Shiao JC, 2005, J COMP NEUROL, V488, P331, DOI 10.1002/cne.20578; Simmler MC, 2000, NAT GENET, V24, P139, DOI 10.1038/72793; SJOBERG EL, 1984, GEOCHIM COSMOCHIM AC, V48, P485, DOI 10.1016/0016-7037(84)90276-X; Soleimani M, 2001, AM J PHYSIOL-RENAL, V280, pF356, DOI 10.1152/ajprenal.2001.280.2.F356; Suzuki H, 1997, AM J PHYSIOL-CELL PH, V273, pC1533, DOI 10.1152/ajpcell.1997.273.5.C1533; SUZUKI H, 1995, HEARING RES, V90, P212, DOI 10.1016/0378-5955(95)00168-7; Takumida M, 1997, ACTA OTO-LARYNGOL, V117, P538, DOI 10.3109/00016489709113434; Takumida M, 2009, ACTA OTO-LARYNGOL, V129, P1340, DOI 10.3109/00016480902725254; Thalmann R, 2001, ANN NY ACAD SCI, V942, P162; Verpy E, 1999, P NATL ACAD SCI USA, V96, P529, DOI 10.1073/pnas.96.2.529; Wang YX, 1998, P NATL ACAD SCI USA, V95, P15345, DOI 10.1073/pnas.95.26.15345; Wangemann P, 2007, AM J PHYSIOL-RENAL, V292, pF1345, DOI 10.1152/ajprenal.00487.2006; Yamauchi D, 2005, BIOCHEM BIOPH RES CO, V331, P1353, DOI 10.1016/j.bbrc.2005.04.053; Yeh BI, 2003, J BIOL CHEM, V278, P51044, DOI 10.1074/jbc.M306326200; Zhao X, 2007, DEV BIOL, V304, P508, DOI 10.1016/j.ydbio.2007.01.013	63	57	63	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21724	21735		10.1074/jbc.M110.120188	http://dx.doi.org/10.1074/jbc.M110.120188			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20442411	hybrid, Green Published			2022-12-27	WOS:000279516100059
J	Falk, S; Sinning, I				Falk, Sebastian; Sinning, Irmgard			cpSRP43 Is a Novel Chaperone Specific for Light-harvesting Chlorophyll a,b-binding Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL RECOGNITION PARTICLE; MITOCHONDRIAL INNER MEMBRANE; HEAT-SHOCK-PROTEIN; MOLECULAR CHAPERONES; THYLAKOID MEMBRANE; SECRETORY PATHWAY; ESCHERICHIA-COLI; A/B COMPLEX; IN-VITRO; CHLOROPLAST	The biosynthesis of most membrane proteins is directly coupled to membrane insertion, and therefore, molecular chaperones are not required. The light-harvesting chlorophyll a, b-binding proteins (LHCPs) present a prominent exception as they are synthesized in the cytoplasm, and after import into the chloroplast, they are targeted and inserted into the thylakoid membrane. Upon arrival in the stroma, LHCPs form a soluble transit complex with the chloroplast signal recognition particle (cpSRP) consisting of an SRP54 homolog and the unique cpSRP43 composed of three chromodomains and four ankyrin repeats. Here we describe that cpSRP43 alone prevents aggregation of LHCP by formation of a complex with nanomolar affinity, whereas cpSRP54 is not required for this chaperone activity. Other stromal chaperones like trigger factor cannot replace cpSRP43, which implies that LHCPs require a specific chaperone. Although cpSRP43 does not have an ATPase activity, it can dissolve aggregates of LHCPs similar to chaperones of the Hsp104/ClpB family. We show that the LHCP-cpSRP43 interaction is predominantly hydrophobic but strictly depends on an intact DPLG motif between the second and third transmembrane region. The cpSRP43 ankyrin repeats that provide the binding site for the DPLG motif are sufficient for the chaperone function, whereas the chromodomains are dispensable. Taken together, we define cpSRP43 as a highly specific chaperone for LHCPs in addition to its established function as a targeting factor for this family of membrane proteins.	[Falk, Sebastian; Sinning, Irmgard] Heidelberg Univ, Biochem Ctr BZH, INF 328, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Sinning, I (corresponding author), Heidelberg Univ, Biochem Ctr BZH, INF 328, D-69120 Heidelberg, Germany.	irmi.sinning@bzh.uni-heidelberg.de	Falk, Sebastian/T-4796-2017; Falk, Sebastian/AAG-9706-2019	Falk, Sebastian/0000-0001-7848-4621; Falk, Sebastian/0000-0001-7848-4621	Deutsche Forschungsgemeinschaft [FOR697, SFB638]; Graduiertenkolleg [1188]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduiertenkolleg(German Research Foundation (DFG))	The work was supported by collaborative research grants from the Deutsche Forschungsgemeinschaft (Grants FOR697 and SFB638) and the Graduiertenkolleg 1188.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Barends TRM, 2010, CURR OPIN STRUC BIOL, V20, P46, DOI 10.1016/j.sbi.2009.12.014; Barros T, 2009, BBA-BIOENERGETICS, V1787, P753, DOI 10.1016/j.bbabio.2009.03.012; Booth PJ, 1996, BIOCHEMISTRY-US, V35, P5103, DOI 10.1021/bi953053f; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P1586, DOI 10.1021/bi00220a020; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Ellis RJ, 2006, TRENDS BIOCHEM SCI, V31, P395, DOI 10.1016/j.tibs.2006.05.001; Falk S, 2010, J BIOL CHEM, V285, P5954, DOI 10.1074/jbc.M109.084996; Fersht A, 1998, STRUCTURE MECH PROTE, P103; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Funke S, 2005, J BIOL CHEM, V280, P8912, DOI 10.1074/jbc.M409992200; Goforth RL, 2004, J BIOL CHEM, V279, P43077, DOI 10.1074/jbc.M401600200; Groves MR, 2001, J BIOL CHEM, V276, P27778, DOI 10.1074/jbc.M103470200; Grudnik P, 2009, BIOL CHEM, V390, P775, DOI 10.1515/BC.2009.102; GUTTERIDGE S, 1995, PLANT CELL, V7, P809, DOI 10.1105/tpc.7.7.809; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Herrmann JM, 2003, IUBMB LIFE, V55, P219, DOI 10.1080/1521654031000123349; Herrmann JM, 1997, EMBO J, V16, P2217, DOI 10.1093/emboj/16.9.2217; High S, 1997, J BIOL CHEM, V272, P11622; HOBE S, 1994, EMBO J, V13, P3423, DOI 10.1002/j.1460-2075.1994.tb06647.x; Hoffmann A, 2010, BBA-MOL CELL RES, V1803, P650, DOI 10.1016/j.bbamcr.2010.01.017; Huang GC, 2000, PROTEIN SCI, V9, P1254, DOI 10.1110/ps.9.6.1254; Ito K, 2005, MOL MICROBIOL, V57, P313, DOI 10.1111/j.1365-2958.2005.04696.x; Jaru-Ampornpan P, 2007, MOL BIOL CELL, V18, P2636, DOI 10.1091/mbc.E07-01-0037; Kessler F, 2009, CURR OPIN CELL BIOL, V21, P494, DOI 10.1016/j.ceb.2009.03.004; Klimyuk VI, 1999, PLANT CELL, V11, P87, DOI 10.1105/tpc.11.1.87; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang M, 2001, J BIOL CHEM, V276, P7985, DOI 10.1074/jbc.M006417200; LASKEY RA, 1978, NATURE, V275, P416, DOI 10.1038/275416a0; Liu CM, 2010, NATURE, V463, P197, DOI 10.1038/nature08651; Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246; Nanjo Y, 2006, PLANT CELL, V18, P2582, DOI 10.1105/tpc.105.039891; Nishiyama M, 2008, SCIENCE, V320, P376, DOI 10.1126/science.1154994; PAULSEN H, 1990, PLANTA, V181, P204, DOI 10.1007/BF02411539; PLUMLEY FG, 1995, PLANT CELL, V7, P689, DOI 10.2307/3870172; Radhamony RN, 2006, TRENDS CELL BIOL, V16, P385, DOI 10.1016/j.tcb.2006.06.003; Rehling P, 2003, SCIENCE, V299, P1747, DOI 10.1126/science.1080945; Schmid VHR, 2008, CELL MOL LIFE SCI, V65, P3619, DOI 10.1007/s00018-008-8333-6; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; Soll J, 2004, NAT REV MOL CELL BIO, V5, P198, DOI 10.1038/nrm1333; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Stengel KF, 2008, SCIENCE, V321, P253, DOI 10.1126/science.1158640; Stengel KF, 2007, FEBS LETT, V581, P5671, DOI 10.1016/j.febslet.2007.11.024; Tu CJ, 2000, J BIOL CHEM, V275, P13187, DOI 10.1074/jbc.C000108200; Tzvetkova-Chevolleau T, 2007, PLANT CELL, V19, P1635, DOI 10.1105/tpc.106.048959; Vetsch M, 2004, NATURE, V431, P329, DOI 10.1038/nature02891; Villarejo A, 2005, NAT CELL BIOL, V7, P1224, DOI 10.1038/ncb1330; YALOVSKY S, 1992, P NATL ACAD SCI USA, V89, P5616, DOI 10.1073/pnas.89.12.5616; YUAN JG, 1993, P NATL ACAD SCI USA, V90, P8552, DOI 10.1073/pnas.90.18.8552	55	43	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21655	21661		10.1074/jbc.C110.132746	http://dx.doi.org/10.1074/jbc.C110.132746			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20498370	hybrid, Green Published			2022-12-27	WOS:000279516100052
J	Shirai, R; Gotou, R; Hirano, F; Ikeda, K; Inoue, S				Shirai, Ryoichi; Gotou, Rikiya; Hirano, Fumiyasu; Ikeda, Kiyoshi; Inoue, Seiji			Autologous Extracellular Cytochrome c Is an Endogenous Ligand for Leucine-rich alpha(2)-Glycoprotein and beta-Type Phospholipase A(2) Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGKISTRODON-BLOMHOFFII-SINITICUS; HUMAN-SERUM; CHINESE MAMUSHI; BLOOD-PLASMA; PROTEIN; COMPLEX; EXPRESSION; APOPTOSIS; ALPHA-2-GLYCOPROTEIN; DIFFERENTIATION	beta-Type phospholipase A(2) inhibitory protein (PLI beta) from the serum of the venomous snake Gloydius brevicaudus neutralizes basic phospholipase A(2) (PLA(2)) from its own venom, and it has 33% sequence homology with human leucine-rich alpha(2)-glycoprotein (LRG), which has been recently reported to bind cytochrome c (Cyt c) (Cummings, C., Walder, J., Treeful, A., and Jemmerson, R. (2006) Apoptosis 11, 1121-1129). In the present study, PLI beta was found to bind Cyt c. The interactions of LRG and PLI beta with Cyt c were compared by surface plasmon resonance analysis. Human LRG bound horse and snake Cyt c with dissociation constants of 1.58 x 10(-13) M and 1.65 x 10(-10) M, respectively, but did not bind yeast Cyt c, while G. brevicaudus PLI beta bound horse, snake, and yeast Cyt c with dissociation constants of 1.05 x 10(-10) M, 2.37 x 10(-12) M, and 1.67 x 10(-6) M, respectively. On the other hand, LRG did not show any PLA(2) inhibitory activity and did not bind G. brevicaudus basic PLA(2), whereas PLI beta bound the basic PLA(2) with a dissociation constant of 1.21 x 10(-9) M, which is smaller than those with the Cyt c described above. The PLA(2) inhibitory activity of PLI beta was also found to be suppressed by the binding of Cyt c to PLI beta. These results suggest that autologous Cyt c is an endogeneous ligand for LRG and PLI beta and that these serum proteins neutralize the autologous Cyt c released from the dead cells.	[Shirai, Ryoichi; Gotou, Rikiya; Hirano, Fumiyasu; Ikeda, Kiyoshi; Inoue, Seiji] Osaka Univ Pharmaceut Sci, Biochem Lab, Osaka 5691094, Japan	Osaka University of Pharmaceutical Sciences	Inoue, S (corresponding author), Osaka Univ Pharmaceut Sci, Biochem Lab, 4-20-1 Nasahara, Osaka 5691094, Japan.	inoue@gly.oups.ac.jp	Inoue, Seiji/E-5128-2010	Inoue, Seiji/0000-0003-0760-1047				Ai J, 2008, J LEUKOCYTE BIOL, V83, P1277, DOI 10.1189/jlb.1107751; Codina R, 2010, APOPTOSIS, V15, P139, DOI 10.1007/s10495-009-0412-0; Cummings C, 2006, APOPTOSIS, V11, P1121, DOI 10.1007/s10495-006-8159-3; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HAUPT H, 1977, H-S Z PHYSIOL CHEM, V358, P639, DOI 10.1515/bchm2.1977.358.1.639; Hiraoka Y, 2004, P NATL ACAD SCI USA, V101, P6427, DOI 10.1073/pnas.0401631101; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; INOUE S, 1984, BIOCHIM BIOPHYS ACTA, V790, P188, DOI 10.1016/0167-4838(84)90223-1; Inoue S, 1997, BIOCHEM MOL BIOL INT, V41, P529; Jemmerson R, 2002, CELL DEATH DIFFER, V9, P538, DOI 10.1038/sj.cdd.4400981; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Johnson RJ, 2007, J MOL BIOL, V368, P434, DOI 10.1016/j.jmb.2007.02.005; Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002; Kluck RM, 2000, J BIOL CHEM, V275, P16127, DOI 10.1074/jbc.275.21.16127; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Lambeau G, 1999, TRENDS PHARMACOL SCI, V20, P162, DOI 10.1016/S0165-6147(99)01300-0; Lin ML, 2008, P NATL ACAD SCI USA, V105, P3029, DOI 10.1073/pnas.0712394105; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; MARGOLIASH E, 1959, BIOCHEM J, V71, P570, DOI 10.1042/bj0710570; O'Donnell LC, 2002, J LEUKOCYTE BIOL, V72, P478; Ohkura N, 1997, BIOCHEM J, V325, P527, DOI 10.1042/bj3250527; Okumura K, 1998, J BIOL CHEM, V273, P19469, DOI 10.1074/jbc.273.31.19469; Okumura K, 2002, ARCH BIOCHEM BIOPHYS, V408, P124, DOI 10.1016/S0003-9861(02)00551-9; Okumura K, 1999, BBA-MOL CELL BIOL L, V1441, P51, DOI 10.1016/S1388-1981(99)00141-9; ORNSTEIN L, 1964, ANN NY ACAD SCI, V121, P321, DOI 10.1111/j.1749-6632.1964.tb14207.x; Pullerits R, 2005, RHEUMATOLOGY, V44, P32, DOI 10.1093/rheumatology/keh406; RADVANYI F, 1989, ANAL BIOCHEM, V177, P103, DOI 10.1016/0003-2697(89)90022-5; Renz A, 2001, BLOOD, V98, P1542, DOI 10.1182/blood.V98.5.1542; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Shirai R, 2009, BIOCHEM BIOPH RES CO, V382, P776, DOI 10.1016/j.bbrc.2009.03.104; Shirai R, 2009, TOXICON, V53, P685, DOI 10.1016/j.toxicon.2009.02.001; Stumpp MT, 2003, J MOL BIOL, V332, P471, DOI 10.1016/S0022-2836(03)00897-0; TAKAHASHI N, 1985, P NATL ACAD SCI USA, V82, P1906, DOI 10.1073/pnas.82.7.1906; Weivoda S, 2008, J IMMUNOL METHODS, V336, P22, DOI 10.1016/j.jim.2008.03.004; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	37	14	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21607	21614		10.1074/jbc.M110.122788	http://dx.doi.org/10.1074/jbc.M110.122788			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20442399	Green Published, hybrid			2022-12-27	WOS:000279516100047
J	Wei, LL; Guo, JK; Ouyang, M; Sun, XW; Ma, JF; Chi, W; Lu, CM; Zhang, LX				Wei, Lili; Guo, Jinkui; Ouyang, Min; Sun, Xuwu; Ma, Jinfang; Chi, Wei; Lu, Congming; Zhang, Lixin			LPA19, a Psb27 Homolog in Arabidopsis thaliana, Facilitates D1 Protein Precursor Processing during PSII Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II REACTION-CENTER; PHOTOSYSTEM-II; CHLOROPHYLL-A; COMPLEXES; ACCUMULATION; ARCHITECTURE; RESOLUTION; REPAIR	The biogenesis and assembly of photosystem II (PSII) are mainly regulated by the nuclear-encoded factors. To further identify the novel components involved in PSII biogenesis, we isolated and characterized a high chlorophyll fluorescence low psii accumulation19 (lpa19) mutant, which is defective in PSII biogenesis. LPA19 encodes a Psb27 homolog (At1g05385). Interestingly, another Psb27 homolog (At1g03600) in Arabidopsis was revealed to be required for the efficient repair of photodamaged PSII. These results suggest that the Psb27 homologs play distinct functions in PSII biogenesis and repair in Arabidopsis. Chloroplast protein labeling assays showed that the C-terminal processing of D1 in the lpa19 mutant was impaired. Protein overlay assays provided evidence that LPA19 interacts with D1, and coimmunoprecipitation analysis demonstrated that LPA19 interacts with mature D1 (mD1) and precursor D1 (pD1). Moreover, LPA19 protein was shown to specifically interact with the soluble C terminus present in the precursor and mature D1 through yeast two-hybrid analyses. Thus, these studies suggest that LPA19 is involved in facilitating the D1 precursor protein processing in Arabidopsis.	[Wei, Lili; Guo, Jinkui; Ouyang, Min; Sun, Xuwu; Ma, Jinfang; Chi, Wei; Lu, Congming; Zhang, Lixin] Chinese Acad Sci, Inst Bot, Photosynthesis Res Ctr, Key Lab Photobiol, Beijing 100093, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS	Zhang, LX (corresponding author), Chinese Acad Sci, Inst Bot, Photosynthesis Res Ctr, Key Lab Photobiol, Beijing 100093, Peoples R China.	zhanglixin@ibcas.ac.cn	sun, xuwu/AGR-2370-2022	sun, xuwu/0000-0001-8462-6948	National Natural Science Foundation of China [30630007, 30725003]; Major State Basic Research Development Program [2009CB118500]; Knowledge Innovation Engineering of the Chinese Academy of Sciences [KSCX2-YW-N-042]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program(National Basic Research Program of China); Knowledge Innovation Engineering of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China (30630007, 30725003), the Major State Basic Research Development Program (2009CB118500), the Frontier Project of the Knowledge Innovation Engineering of the Chinese Academy of Sciences (KSCX2-YW-N-042). We are grateful to the Arabidopsis Biological Resource Center for Arabidopsis seeds.	ADIR N, 1990, J BIOL CHEM, V265, P12563; ANBUDURAI PR, 1994, P NATL ACAD SCI USA, V91, P8082, DOI 10.1073/pnas.91.17.8082; Andersson B, 2001, ADV PHOTOSYNTH, V11, P377; Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; Bentley FK, 2008, BIOCHEMISTRY-US, V47, P11637, DOI 10.1021/bi800804h; Chen H, 2006, PLANT MOL BIOL, V61, P567, DOI 10.1007/s11103-006-0031-x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cormann KU, 2009, BIOCHEMISTRY-US, V48, P8768, DOI 10.1021/bi9012726; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Iwata S, 2004, CURR OPIN STRUC BIOL, V14, P447, DOI 10.1016/j.sbi.2004.07.002; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Klinkert B, 2004, J BIOL CHEM, V279, P44639, DOI 10.1074/jbc.M405393200; Kufryk GI, 2003, J BACTERIOL, V185, P6615, DOI 10.1128/JB.185.22.6615-6623.2003; Kufryk GI, 2001, BIOCHEMISTRY-US, V40, P9247, DOI 10.1021/bi0026526; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Lukowitz W, 2000, PLANT PHYSIOL, V123, P795, DOI 10.1104/pp.123.3.795; Ma JF, 2007, PLANT CELL, V19, P1980, DOI 10.1105/tpc.107.050526; Mabbitt PD, 2009, BIOCHEMISTRY-US, V48, P8771, DOI 10.1021/bi901309c; Mamedov F, 2007, BIOCHEMISTRY-US, V46, P5542, DOI 10.1021/bi7000399; Martinez-Garcia JF, 1999, PLANT J, V20, P251, DOI 10.1046/j.1365-313x.1999.00579.x; Meurer J, 1996, PLANTA, V198, P385, DOI 10.1007/BF00620055; Meurer J, 1998, EMBO J, V17, P5286, DOI 10.1093/emboj/17.18.5286; Muller B, 1999, PLANT CELL, V11, P2365, DOI 10.1105/tpc.11.12.2365; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Nowaczyk MM, 2006, PLANT CELL, V18, P3121, DOI 10.1105/tpc.106.042671; Peltier JB, 2002, PLANT CELL, V14, P211, DOI 10.1105/tpc.010304; Peng LW, 2006, PLANT CELL, V18, P955, DOI 10.1105/tpc.105.037689; Plucken H, 2002, FEBS LETT, V532, P85, DOI 10.1016/S0014-5793(02)03634-7; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Rajalahti T, 2007, J PROTEOME RES, V6, P2420, DOI 10.1021/pr0605973; Rokka A, 2005, BIOCHEM J, V388, P159, DOI 10.1042/BJ20042098; Roose JL, 2004, J BIOL CHEM, V279, P45417, DOI 10.1074/jbc.M408458200; Roose JL, 2008, J BIOL CHEM, V283, P4044, DOI 10.1074/jbc.M708960200; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schottkowski M, 2009, J BIOL CHEM, V284, P1813, DOI 10.1074/jbc.M806116200; Sun XW, 2007, PLANT CELL, V19, P1347, DOI 10.1105/tpc.106.049510; Sun XW, 2010, PLANT J, V62, P240, DOI 10.1111/j.1365-313X.2010.04140.x; Suorsa M, 2004, EUR J BIOCHEM, V271, P96, DOI 10.1046/j.1432-1033.2003.03906.x; vanWijk KJ, 1997, BIOCHEMISTRY-US, V36, P6178, DOI 10.1021/bi962921l; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Yamamoto Y, 2001, J BIOL CHEM, V276, P7518, DOI 10.1074/jbc.M008877200; Zhang LX, 1999, J BIOL CHEM, V274, P16062, DOI 10.1074/jbc.274.23.16062; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	46	60	63	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21391	21398		10.1074/jbc.M110.105064	http://dx.doi.org/10.1074/jbc.M110.105064			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20444695	Green Published, hybrid			2022-12-27	WOS:000279516100025
J	Jackman, J; Chen, YM; Huang, A; Moffat, B; Scheer, JM; Leong, SR; Lee, WP; Zhang, JA; Sharma, N; Lu, YM; Iyer, S; Shields, RL; Chiang, N; Bauer, MC; Wadley, D; Roose-Girma, M; Vandlen, R; Yansura, DG; Wu, Y; Wu, LC				Jackman, Janet; Chen, Yongmei; Huang, Arthur; Moffat, Barbara; Scheer, Justin M.; Leong, Steven R.; Lee, Wyne P.; Zhang, Juan; Sharma, Navneet; Lu, Yanmei; Iyer, Suhasini; Shields, Robert L.; Chiang, Nancy; Bauer, Michele C.; Wadley, Diana; Roose-Girma, Merone; Vandlen, Richard; Yansura, Daniel G.; Wu, Yan; Wu, Lawren C.			Development of a Two-part Strategy to Identify a Therapeutic Human Bispecific Antibody That Inhibits IgE Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; GAMMA-RII; MONOCLONAL-ANTIBODIES; CELL ACTIVATION; CANCER-THERAPY; BINDING-SITE; HUMAN IGG1; ALLERGY; EXPRESSION; BASOPHILS	The development of bispecific antibodies as therapeutic agents for human diseases has great clinical potential, but broad application has been hindered by the difficulty of identifying bispecific antibody formats that exhibit favorable pharmacokinetic properties and ease of large-scale manufacturing. Previously, the development of an antibody technology utilizing heavy chain knobs-into-holes mutations and a single common light chain enabled the small-scale generation of human full-length bispecific antibodies. Here we have extended the technology by developing a two-part bispecific antibody discovery strategy that facilitates proof-of-concept studies and clinical candidate antibody generation. Our scheme consists of the efficient small-scale generation of bispecific antibodies lacking a common light chain and the hinge disulfides for proof-of-concept studies coupled with the identification of a common light chain bispecific antibody for large-scale production with high purity and yield. We have applied this technology to generate a bispecific antibody suitable for development as a human therapeutic. This antibody directly inhibits the activation of the high affinity IgE receptor Fc epsilon RI on mast cells and basophils by cross-linking Fc epsilon RI with the inhibitory receptor Fc gamma RIIb, an approach that has strong therapeutic potential for asthma and other allergic diseases. Our approach for producing human bispecific full-length antibodies enables the clinical application of bispecific antibodies to a validated therapeutic pathway in asthma.	[Jackman, Janet; Leong, Steven R.; Lee, Wyne P.; Zhang, Juan; Shields, Robert L.; Wu, Lawren C.] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Chen, Yongmei; Huang, Arthur; Chiang, Nancy; Yansura, Daniel G.; Wu, Yan] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Moffat, Barbara; Scheer, Justin M.; Vandlen, Richard] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Sharma, Navneet; Iyer, Suhasini] Genentech Inc, Dept Pharmacokinet Pharmacodynam & Bioanalyt Sci, San Francisco, CA 94080 USA; [Lu, Yanmei] Genentech Inc, Dept Assay & Automat Technol, San Francisco, CA 94080 USA; [Bauer, Michele C.; Wadley, Diana; Roose-Girma, Merone] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Wu, Lawren C.] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Wu, LC (corresponding author), Genentech Inc, Dept Immunol, 1 DNA Way,MS 34, San Francisco, CA 94080 USA.	lawren@gene.com	Zhang, Juan/GRX-2638-2022		Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	This work was fully supported by Genentech, Inc.	Asano R, 2007, J BIOL CHEM, V282, P27659, DOI 10.1074/jbc.M704719200; Atwell S, 1997, J MOL BIOL, V270, P26, DOI 10.1006/jmbi.1997.1116; Baeuerle PA, 2009, CURR OPIN MOL THER, V11, P22; Bargou R, 2008, SCIENCE, V321, P974, DOI 10.1126/science.1158545; Beck LA, 2004, J ALLERGY CLIN IMMUN, V114, P527, DOI 10.1016/j.jaci.2004.06.032; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Carter P, 2001, J IMMUNOL METHODS, V248, P7, DOI 10.1016/S0022-1759(00)00339-2; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Chang TW, 2007, ADV IMMUNOL, V93, P63, DOI 10.1016/S0065-2776(06)93002-8; DAERON M, 1995, J CLIN INVEST, V95, P577, DOI 10.1172/JCI117701; DAERON M, 1995, IMMUNITY, V3, P635, DOI 10.1016/1074-7613(95)90134-5; Friend PJ, 1999, TRANSPLANTATION, V68, P1632, DOI 10.1097/00007890-199912150-00005; Holgate S, 2005, J ALLERGY CLIN IMMUN, V115, P459, DOI 10.1016/j.jaci.2004.11.053; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Jung ST, 2010, P NATL ACAD SCI USA, V107, P604, DOI 10.1073/pnas.0908590107; Katz HR, 2002, CURR OPIN IMMUNOL, V14, P698, DOI 10.1016/S0952-7915(02)00400-4; Kepley CL, 2000, J ALLERGY CLIN IMMUN, V106, P337, DOI 10.1067/mai.2000.107931; Kriangkum J, 2001, BIOMOL ENG, V18, P31, DOI 10.1016/S1389-0344(01)00083-1; Kufer P, 2004, TRENDS BIOTECHNOL, V22, P238, DOI 10.1016/j.tibtech.2004.03.006; Lee CV, 2004, J MOL BIOL, V340, P1073, DOI 10.1016/j.jmb.2004.05.051; Liang WC, 2007, J MOL BIOL, V366, P815, DOI 10.1016/j.jmb.2006.11.021; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; MacGlashan DW, 1997, J IMMUNOL, V158, P1438; Marvin JS, 2005, ACTA PHARMACOL SIN, V26, P649, DOI 10.1111/j.1745-7254.2005.00119.x; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; Nakamura A, 2005, EXPERT OPIN THER TAR, V9, P169, DOI 10.1517/14728222.9.1.169; Poole JA, 2005, J ALLERGY CLIN IMMUN, V115, pS376, DOI 10.1016/j.jaci.2004.12.1124; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; RISKE F, 1991, J BIOL CHEM, V266, P11245; Saxon A, 2008, J ALLERGY CLIN IMMUN, V121, P320, DOI 10.1016/j.jaci.2007.10.017; Scharenberg AM, 1999, CURR OPIN IMMUNOL, V11, P621, DOI 10.1016/S0952-7915(99)00027-8; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Sidhu SS, 2004, J MOL BIOL, V338, P299, DOI 10.1016/j.jmb.2004.02.050; Simmons LC, 2002, J IMMUNOL METHODS, V263, P133, DOI 10.1016/S0022-1759(02)00036-4; Tam SW, 2004, ALLERGY, V59, P772, DOI 10.1111/j.1398-9995.2004.00332.x; TAO MH, 1989, J IMMUNOL, V143, P2595; van Spriel AB, 2000, IMMUNOL TODAY, V21, P391, DOI 10.1016/S0167-5699(00)01659-5; WALKER MR, 1989, BIOCHEM J, V259, P347, DOI 10.1042/bj2590347; Wu CB, 2007, NAT BIOTECHNOL, V25, P1290, DOI 10.1038/nbt1345; Zhu DC, 2005, NAT MED, V11, P446, DOI 10.1038/nm1219; Zhu DC, 2002, NAT MED, V8, P518, DOI 10.1038/nm0502-518	41	69	126	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20850	20859		10.1074/jbc.M110.113910	http://dx.doi.org/10.1074/jbc.M110.113910			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20444694	Green Published, hybrid			2022-12-27	WOS:000279228600049
J	Mann, FM; Prisic, S; Davenport, EK; Determan, MK; Coates, RM; Peters, RJ				Mann, Francis M.; Prisic, Sladjana; Davenport, Emily K.; Determan, Mara K.; Coates, Robert M.; Peters, Reuben J.			A Single Residue Switch for Mg2+-dependent Inhibition Characterizes Plant Class II Diterpene Cyclases from Primary and Secondary Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPALYL DIPHOSPHATE SYNTHASES; SQUALENE-HOPENE CYCLASE; ENT-COPALYL; ABIETADIENE SYNTHASE; GIBBERELLIN BIOSYNTHESIS; ENZYME MECHANISMS; ENCODES; RICE; INTERMEDIATE; CYCLIZATION	Class II diterpene cyclases mediate the acid-initiated cycloisomerization reaction that serves as the committed step in biosynthesis of the large class of labdane-related diterpenoid natural products, which includes the important gibberellin plant hormones. Intriguingly, these enzymes are differentially susceptible to inhibition by their Mg2+ cofactor, with those involved in gibberellin biosynthesis being more sensitive to such inhibition than those devoted to secondary metabolism, which presumably limits flux toward the potent gibberellin phytohormones. Such inhibition has been suggested to arise from intrasteric Mg2+ binding to the DXDD motif that cooperatively acts as the catalytic acid, whose affinity must then be modulated in some fashion. While further investigating class II diterpene cyclase catalysis, we discovered a conserved basic residue that seems to act as a counter ion to the DXDD motif, enhancing the ability of aspartic acid to carry out the requisite energetically difficult protonation of a carbon-carbon double bond and also affecting inhibitory Mg2+ binding. Notably, this residue is conserved as a histidine in enzymes involved in gibberellin biosynthesis and as an arginine in those dedicated to secondary metabolism. Interchanging the identity of these residues is sufficient to switch the sensitivity of the parent enzyme to inhibition by Mg2+. These striking findings indicate that this is a single residue switch for Mg2+ inhibition, which not only supports the importance of this biochemical regulatory mechanism in limiting gibberellin biosynthesis, but the importance of its release, presumably to enable higher flux, into secondary metabolism.	[Mann, Francis M.; Prisic, Sladjana; Davenport, Emily K.; Determan, Mara K.; Peters, Reuben J.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Coates, Robert M.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	Iowa State University; University of Illinois System; University of Illinois Urbana-Champaign	Peters, RJ (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, 4216 Mol Biol Bldg, Ames, IA 50011 USA.	rjpeters@iastate.edu	Peters, Reuben J./D-1196-2010	Peters, Reuben J./0000-0003-4691-8477; Prisic, Sladjana/0000-0003-3137-4358	National Science Foundation [MCB0919735]; National Institutes of Health [GM076324]; Div Of Molecular and Cellular Bioscience [0919735] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076324] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Science Foundation (MCB0919735) and National Institutes of Health (GM076324) (to R.J.P.).	AitAli T, 1997, PLANT J, V11, P443, DOI 10.1046/j.1365-313X.1997.11030443.x; Alabadi D, 2004, PLANT PHYSIOL, V134, P1050, DOI 10.1104/pp.103.035451; BENSEN RJ, 1995, PLANT CELL, V7, P75, DOI 10.1105/tpc.7.1.75; Bohlmann J, 1998, P NATL ACAD SCI USA, V95, P4126, DOI 10.1073/pnas.95.8.4126; Buckingham J, 2002, DICT NATURAL PRODUCT; CAO R, 2010, PROTEINS IN PRESS; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; Fleet CM, 2005, CURR OPIN PLANT BIOL, V8, P77, DOI 10.1016/j.pbi.2004.11.015; Garcia-Martinez JL, 2001, J PLANT GROWTH REGUL, V20, P354, DOI 10.1007/s003440010033; Harris LJ, 2005, PLANT MOL BIOL, V59, P881, DOI 10.1007/s11103-005-1674-8; Ishijima S, 2003, ARCH BIOCHEM BIOPHYS, V412, P126, DOI 10.1016/S0003-9861(03)00038-9; Keeling CI, 2006, PHYTOCHEMISTRY, V67, P2415, DOI 10.1016/j.phytochem.2006.08.019; Lloyd JC, 2004, J EXP BOT, V55, P1221, DOI 10.1093/jxb/erh143; MCGARVEY DJ, 1995, PLANT CELL, V7, P1015, DOI 10.1105/tpc.7.7.1015; Merkofer T, 1999, TETRAHEDRON LETT, V40, P2121, DOI 10.1016/S0040-4039(99)00145-8; Otomo K, 2004, PLANT J, V39, P886, DOI 10.1111/j.1365-313X.2004.02175.x; Peters RJ, 2006, PHYTOCHEMISTRY, V67, P2307, DOI 10.1016/j.phytochem.2006.08.009; Peters RJ, 2003, BIOCHEMISTRY-US, V42, P2700, DOI 10.1021/bi020492n; Peters RJ, 2002, BIOCHEMISTRY-US, V41, P1836, DOI 10.1021/bi011879d; Peters RJ, 2001, J AM CHEM SOC, V123, P8974, DOI 10.1021/ja010670k; Prisic S, 2004, PLANT PHYSIOL, V136, P4228, DOI 10.1104/pp.104.050567; Prisic S, 2007, CHEMBIOCHEM, V8, P869, DOI 10.1002/cbic.200700045; Prisic S, 2007, PLANT PHYSIOL, V144, P445, DOI 10.1104/pp.106.095208; Sakamoto T, 2004, PLANT PHYSIOL, V134, P1642, DOI 10.1104/pp.103.033696; Sato T, 1999, BIOSCI BIOTECH BIOCH, V63, P2189, DOI 10.1271/bbb.63.2189; Schepmann HG, 2001, ARCH BIOCHEM BIOPHYS, V392, P263, DOI 10.1006/abbi.2001.2438; Silverstone AL, 1997, PLANT J, V12, P9, DOI 10.1046/j.1365-313X.1997.12010009.x; SUN TP, 1994, PLANT CELL, V6, P1509, DOI 10.1105/tpc.6.10.1509; Vogel BS, 1996, J BIOL CHEM, V271, P23262, DOI 10.1074/jbc.271.38.23262; Wendt KU, 2005, ANGEW CHEM INT EDIT, V44, P3966, DOI 10.1002/anie.200500804; Wendt KU, 1998, STRUCTURE, V6, P127, DOI 10.1016/S0969-2126(98)00015-X; Wendt KU, 2000, ANGEW CHEM INT EDIT, V39, P2812, DOI 10.1002/1521-3773(20000818)39:16<2812::AID-ANIE2812>3.0.CO;2-#	32	26	29	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20558	20563		10.1074/jbc.M110.123307	http://dx.doi.org/10.1074/jbc.M110.123307			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20430888	Green Published, hybrid			2022-12-27	WOS:000279228600018
J	Ohtake-Niimi, S; Kondo, S; Ito, T; Kakehi, S; Ohta, T; Habuchi, H; Kimata, K; Habuchi, O				Ohtake-Niimi, Shiori; Kondo, Sachiko; Ito, Tatsuro; Kakehi, Saori; Ohta, Tadayuki; Habuchi, Hiroko; Kimata, Koji; Habuchi, Osami			Mice Deficient in N-Acetylgalactosamine 4-Sulfate 6-O-Sulfotransferase Are Unable to Synthesize Chondroitin/Dermatan Sulfate containing N-Acetylgalactosamine 4,6-Bissulfate Residues and Exhibit Decreased Protease Activity in Bone Marrow-derived Mast Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMOTES NEURITE OUTGROWTH; SIMPLEX-VIRUS INFECTIVITY; CONNECTIVE-TISSUE-TYPE; SECRETORY GRANULES; SERGLYCIN PROTEOGLYCAN; HEPARIN PROTEOGLYCANS; SQUID CARTILAGE; CRITICAL ROLES; GROWTH-FACTOR; MOUSE	Chondroitin sulfate (CS) and dermatan sulfate (DS) containing N-acetylgalactosamine 4,6-bissulfate (GalNAc(4,6-SO4)) show various physiological activities through interacting with numerous functional proteins. N-Acetylgalactosamine 4-sulfate 6-O-sulfotransferase (GalNAc4S-6ST) transfers sulfate from 3'-phosphoadenosine 5'-phosphosulfate to position 6 of N-acetylgalactosamine 4-sulfate in CS or DS to yield GalNAc(4,6-SO4) residues. We here report generation of transgenic mice that lack GalNAc4S-6ST. GalNAc4S-6ST-null mice were born normally and fertile. In GalNAc4S-6ST-null mice, GalNAc(4,6-SO4) residues in CS and DS disappeared completely, indicating that GalNAc4S-6ST should be a sole enzyme responsible for the synthesis of GalNAc(4,6-SO4) residues in both CS and DS. IdoA-GalNAc(4,6-SO4) units that account for similar to 40% of total disaccharide units of DS in the liver of the wild-type mice disappeared in the liver DS of GalNAc4S-6ST-null mice without reduction of IdoA content. Bone marrow-derived mast cells (BMMCs) derived from GalNAc4S-6ST-null mice contained CS without GlcA-GalNAc(4,6-SO4) units. Tryptase and carboxypeptidase A activities of BMMCs derived from GalNAc4S-6ST-null mice were lower than those activities of BMMCs derived from wild-type mice, although mRNA expression of these mast cell proteases was not altered. Disaccharide compositions of heparan sulfate/heparin contained in the mast cells derived from BMMCs in the presence of stem cell factor were much different from those of heparan sulfate/heparin in BMMCs but did not differ significantly between wildtype mice and GalNAc4S-6ST-null mice. These observations suggest that CS containing GalNAc(4,6-SO4) residues in BMMCs may contribute to retain the active proteases in the granules of BMMCs but not for the maturation of BMMCs into connective tissue-type mast cells.	[Ohtake-Niimi, Shiori; Kondo, Sachiko; Ito, Tatsuro; Kakehi, Saori; Habuchi, Osami] Aichi Univ Educ, Dept Chem, Aichi 4488542, Japan; [Ohta, Tadayuki] Aichi Univ Educ, Dept Biol, Aichi 4488542, Japan; [Habuchi, Hiroko; Kimata, Koji] Aichi Med Univ, Res Complex Med Frontiers, Aichi 4801195, Japan	Aichi University Education; Aichi University Education; Aichi Medical University	Habuchi, O (corresponding author), Aichi Univ Educ, Dept Chem, Igaya Cho, Aichi 4488542, Japan.	ohabuchi@auecc.aichi-edu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Seikagaku Corp.; YAMASA Corp.	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Seikagaku Corp.; YAMASA Corp.	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by a special research fund from Seikagaku Corp. and YAMASA Corp.	Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; ANNO K, 1971, BIOCHIM BIOPHYS ACTA, V237, P173, DOI 10.1016/0304-4165(71)90046-8; Asada M, 2009, BBA-GEN SUBJECTS, V1790, P40, DOI 10.1016/j.bbagen.2008.09.001; Bergefall K, 2005, J BIOL CHEM, V280, P32193, DOI 10.1074/jbc.M503645200; BOURIN MC, 1990, J BIOL CHEM, V265, P15424; Bouton MC, 2007, CIRC RES, V100, P1174, DOI 10.1161/01.RES.0000265066.92923.ee; Braga T, 2007, BIOCHEM J, V403, P49, DOI 10.1042/BJ20061257; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; Clement AM, 1999, NEUROSCI LETT, V269, P125, DOI 10.1016/S0304-3940(99)00432-2; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; DAVIDSON S, 1990, J BIOL CHEM, V265, P12324; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; DELFERT DM, 1985, ANAL BIOCHEM, V148, P303, DOI 10.1016/0003-2697(85)90233-7; Dudas J, 2001, AM J CLIN PATHOL, V115, P725; ELIAKIM R, 1986, P NATL ACAD SCI USA, V83, P461, DOI 10.1073/pnas.83.2.461; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Gallai M, 1996, AM J PATHOL, V148, P1463; HABUCHI O, 1993, J BIOL CHEM, V268, P21968; Habuchi O, 2002, ANAL BIOCHEM, V310, P129, DOI 10.1016/S0003-2697(02)00277-4; Halldorsdottir AM, 2006, GLYCOBIOLOGY, V16, P693, DOI 10.1093/glycob/cwj117; Hallgren J, 2000, BIOCHEMISTRY-US, V39, P13068, DOI 10.1021/bi000973b; Henningsson F, 2006, FEBS J, V273, P4901, DOI 10.1111/j.1742-4658.2006.05489.x; Hirose J, 2001, J BIOL CHEM, V276, P5228, DOI 10.1074/jbc.M007542200; Hogemann B, 1997, PATHOL RES PRACT, V193, P747; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Ishii M, 2008, J BIOL CHEM, V283, P32610, DOI 10.1074/jbc.M806331200; Ishii M, 2008, GLYCOBIOLOGY, V18, P602, DOI 10.1093/glycob/cwn040; Ito Y, 2000, J BIOL CHEM, V275, P34728, DOI 10.1074/jbc.M909633199; KATZ HR, 1986, J BIOL CHEM, V261, P3393; Kawashima H, 2000, J BIOL CHEM, V275, P35448, DOI 10.1074/jbc.M003387200; KIMATA K, 2007, COMPREHENSIVE GLYCOS, V3, P159; Kitagawa H, 1997, GLYCOBIOLOGY, V7, P531, DOI 10.1093/glycob/7.4.531; KOBAYASHI S, 1985, BIOCHIM BIOPHYS ACTA, V841, P71, DOI 10.1016/0304-4165(85)90275-2; Koshiishi I, 1999, ARCH BIOCHEM BIOPHYS, V370, P151, DOI 10.1006/abbi.1999.1396; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVISCHAFFER F, 1986, P NATL ACAD SCI USA, V83, P6485, DOI 10.1073/pnas.83.17.6485; Li F, 2008, J BIOL CHEM, V283, P34294, DOI 10.1074/jbc.M806015200; Maccarana M, 2009, MOL CELL BIOL, V29, P5517, DOI 10.1128/MCB.00430-09; MCGEE MP, 1995, J BIOL CHEM, V270, P26109, DOI 10.1074/jbc.270.44.26109; Miller HRP, 1999, BLOOD, V93, P3473, DOI 10.1182/blood.V93.10.3473.410k01_3473_3486; Murer V, 2001, P NATL ACAD SCI USA, V98, P3029, DOI 10.1073/pnas.051630698; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; Ohtake S, 2005, J BIOL CHEM, V280, P39115, DOI 10.1074/jbc.M508816200; Ohtake S, 2003, J BIOL CHEM, V278, P38443, DOI 10.1074/jbc.M306132200; Ohtake S, 2001, J BIOL CHEM, V276, P43894, DOI 10.1074/jbc.M104922200; Ohtake S, 2008, BBA-GEN SUBJECTS, V1780, P687, DOI 10.1016/j.bbagen.2008.01.004; Purushothaman A, 2007, J BIOL CHEM, V282, P19442, DOI 10.1074/jbc.M700630200; Ra HJ, 2009, J BIOL CHEM, V284, P27924, DOI 10.1074/jbc.M109.035147; Raposo G, 1997, MOL BIOL CELL, V8, P2631, DOI 10.1091/mbc.8.12.2631; RAZIN E, 1984, J IMMUNOL, V132, P1479; RAZIN E, 1982, J BIOL CHEM, V257, P7229; Salgueiro AM, 2006, INT J DEV BIOL, V50, P705, DOI 10.1387/ijdb.062168as; SELZMAN HM, 1962, J CELL BIOL, V15, P136, DOI 10.1083/jcb.15.1.136; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Sotogaku N, 2007, J NEUROCHEM, V103, P749, DOI 10.1111/j.1471-4159.2007.04849.x; SPICER SS, 1967, J HISTOCHEM CYTOCHEM, V15, P225, DOI 10.1177/15.4.225; Stevens RL, 2007, IMMUNOL REV, V217, P155, DOI 10.1111/j.1600-065X.2007.00525.x; STEVENS RL, 1983, J BIOL CHEM, V258, P5977; STEVENS RL, 1988, P NATL ACAD SCI USA, V85, P2284, DOI 10.1073/pnas.85.7.2284; Takano H, 2008, FEBS LETT, V582, P1444, DOI 10.1016/j.febslet.2008.03.033; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Tully SE, 2004, J AM CHEM SOC, V126, P7736, DOI 10.1021/ja0484045; Ueoka C, 2000, J BIOL CHEM, V275, P37407, DOI 10.1074/jbc.M002538200; Uyama T, 2006, J BIOL CHEM, V281, P38668, DOI 10.1074/jbc.M609320200; Verkoczy LK, 1998, EUR J IMMUNOL, V28, P2839, DOI 10.1002/(SICI)1521-4141(199809)28:09<2839::AID-IMMU2839>3.0.CO;2-6; Yamaguchi T, 2007, GLYCOBIOLOGY, V17, P1365, DOI 10.1093/glycob/cwm103; YAOITA E, 1990, J BIOL CHEM, V265, P522	67	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20793	20805		10.1074/jbc.M109.084749	http://dx.doi.org/10.1074/jbc.M109.084749			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20439988	hybrid, Green Published			2022-12-27	WOS:000279228600043
J	Sevova, ES; Goren, MA; Schwartz, KJ; Hsu, FF; Turk, J; Fox, BG; Bangs, JD				Sevova, Elitza S.; Goren, Michael A.; Schwartz, Kevin J.; Hsu, Fong-Fu; Turk, John; Fox, Brian G.; Bangs, James D.			Cell-free Synthesis and Functional Characterization of Sphingolipid Synthases from Parasitic Trypanosomatid Protozoa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL PHOSPHORYLCERAMIDE SYNTHASE; FREE TRANSLATION; MEMBRANE; IDENTIFICATION; METABOLISM; PROTEIN; CLONING; TARGET; GROWTH	The Trypanosoma brucei genome has four highly similar genes encoding sphingolipid synthases (TbSLS1-4). TbSLSs are polytopic membrane proteins that are essential for viability of the pathogenic bloodstream stage of this human protozoan parasite and, consequently, can be considered as potential drug targets. TbSLS4 was shown previously to be a bifunctional sphingomyelin/ethanolamine phosphorylceramide synthase, whereas functions of the others were not characterized. Using a recently described liposome-supplemented cell-free synthesis system, which eliminates complications from background cellular activities, we now unambiguously define the enzymatic specificity of the entire gene family. TbSLS1 produces inositol phosphorylceramide, TbSLS2 produces ethanolamine phosphorylceramide, and TbSLS3 is bifunctional, like TbSLS4. These findings indicate that TbSLS1 is uniquely responsible for synthesis of inositol phosphorylceramide in insect stage parasites, in agreement with published expression array data (17). This approach also revealed that the Trypanosoma cruzi ortholog (TcSLS1) is a dedicated inositol phosphorylceramide synthase. The cell-free synthesis system allowed rapid optimization of the reaction conditions for these enzymes and site-specific mutagenesis to alter end product specificity. A single residue at position 252 (TbSLS1, Ser(252); TbSLS3, Phe(252)) strongly influences enzymatic specificity. We also have used this system to demonstrate that aureobasidin A, a potent inhibitor of fungal inositol phosphorylceramide synthases, does not significantly affect any of the TbSLS activities, consistent with the phylogenetic distance of these two clades of sphingolipid synthases. These results represent the first application of cell-free synthesis for the rapid preparation and functional annotation of integral membrane proteins and thus illustrate its utility in studying otherwise intractable enzyme systems.	[Sevova, Elitza S.; Schwartz, Kevin J.; Bangs, James D.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Goren, Michael A.; Fox, Brian G.] Univ Wisconsin, Coll Agr & Life Sci, Dept Biochem, Madison, WI 53706 USA; [Fox, Brian G.] Univ Wisconsin, Ctr Eukaryot Struct Genom, Coll Agr & Life Sci, Madison, WI 53706 USA; [Hsu, Fong-Fu; Turk, John] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Washington University (WUSTL)	Bangs, JD (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Microbiol & Immunol, Madison, WI 53706 USA.	jdbangs@wisc.edu		Hsu, Fong-Fu/0000-0001-5368-0183	United States Public Health Service, NIAID, National Institutes of Health [R01 AI35739]; NIGMS, National Institutes of Health [RO1 GM50853]; NIGMS, National Institutes of Health Protein Structure Initiative [1 U54 GM074901]; United States Public Health Service [P41-RR00954, P60-DK20579, P30-DK56341]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035739, T32AI055397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, P60DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074901, R01GM050853, U54GM094584] Funding Source: NIH RePORTER	United States Public Health Service, NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)United States Public Health Service); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS, National Institutes of Health Protein Structure Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States Public Health Service, NIAID, National Institutes of Health Grant R01 AI35739 (to J.D.B.), NIGMS, National Institutes of Health Grant RO1 GM50853 (to B.G.F.), and NIGMS, National Institutes of Health Protein Structure Initiative Grant 1 U54 GM074901 (to J.L. Markley, G.N. Phillips, Jr., and B.G.F.). The Washington University Department of Medicine Mass Spectroscopy Facility is supported by United States Public Health Service Grants P41-RR00954, P60-DK20579, and P30-DK56341.	Alexander DL, 2002, J CELL SCI, V115, P3253; ANDERSON RL, 1982, CLIN CHIM ACTA, V121, P111, DOI 10.1016/0009-8981(82)90216-9; BERTELLO LE, 1995, BIOCHEM J, V310, P255, DOI 10.1042/bj3100255; Blommel PG, 2006, PROTEIN EXPRES PURIF, V47, P562, DOI 10.1016/j.pep.2005.11.007; DASILVEIRA JF, 1981, BIOCHIM BIOPHYS ACTA, V644, P341, DOI 10.1016/0005-2736(81)90392-8; Denny PW, 2006, J BIOL CHEM, V281, P28200, DOI 10.1074/jbc.M600796200; Figueiredo JM, 2005, BIOCHEM J, V387, P519, DOI 10.1042/BJ20041842; Goren MA, 2008, PROTEIN EXPRES PURIF, V62, P171, DOI 10.1016/j.pep.2008.08.002; Goren MA, 2009, METHOD ENZYMOL, V463, P647, DOI 10.1016/S0076-6879(09)63037-8; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Kabani S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-427; KANESHIRO ES, 1986, J LIPID RES, V27, P1294; Lahiri S, 2007, CELL MOL LIFE SCI, V64, P2270, DOI 10.1007/s00018-007-7076-0; MASTERSON WJ, 1989, CELL, V56, P793, DOI 10.1016/0092-8674(89)90684-3; Mina JG, 2009, MOL BIOCHEM PARASIT, V168, P16, DOI 10.1016/j.molbiopara.2009.06.002; Nagiec MM, 1997, J BIOL CHEM, V272, P9809, DOI 10.1074/jbc.272.15.9809; OLIVEIRA MM, 1977, COMP BIOCHEM PHYS B, V58, P195, DOI 10.1016/0305-0491(77)90109-2; Quinones W, 2004, EXP PARASITOL, V106, P135, DOI 10.1016/j.exppara.2004.03.006; REXACH MF, 1994, J CELL BIOL, V126, P1133, DOI 10.1083/jcb.126.5.1133; Sato K, 2009, MOL BIOL CELL, V20, P4444, DOI 10.1091/mbc.E09-03-0235; Sawasaki T, 2000, Nucleic Acids Symp Ser, P9; Schuck S, 2004, J CELL SCI, V117, P5955, DOI 10.1242/jcs.01596; Sevova ES, 2009, MOL BIOL CELL, V20, P4739, DOI 10.1091/mbc.E09-07-0542; Shea JM, 2006, CURR OPIN MICROBIOL, V9, P352, DOI 10.1016/j.mib.2006.06.003; Sutterwala SS, 2008, MOL MICROBIOL, V70, P281, DOI 10.1111/j.1365-2958.2008.06393.x; Tafesse FG, 2006, J BIOL CHEM, V281, P29421, DOI 10.1074/jbc.R600021200; TAKESAKO K, 1991, J ANTIBIOT, V44, P919, DOI 10.7164/antibiotics.44.919; Ternes P, 2009, J LIPID RES, V50, P2270, DOI 10.1194/jlr.M900230-JLR200; Uhrig ML, 1996, BBA-LIPID LIPID MET, V1300, P233, DOI 10.1016/0005-2760(96)00021-5; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; Zhang K, 2005, MOL MICROBIOL, V55, P1566, DOI 10.1111/j.1365-2958.2005.04493.x; Zhang K, 2003, EMBO J, V22, P6016, DOI 10.1093/emboj/cdg584; Zhang K, 2007, EMBO J, V26, P1094, DOI 10.1038/sj.emboj.7601565	34	32	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20580	20587		10.1074/jbc.M110.127662	http://dx.doi.org/10.1074/jbc.M110.127662			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20457606	Green Published, hybrid			2022-12-27	WOS:000279228600021
J	Vitner, EB; Platt, FM; Futerman, AH				Vitner, Einat B.; Platt, Frances M.; Futerman, Anthony H.			Common and Uncommon Pathogenic Cascades in Lysosomal Storage Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SARCO/ENDOPLASMIC RETICULUM CA2+-ATPASE; LIPID TRAFFICKING DEFECTS; UNFOLDED PROTEIN RESPONSE; NIEMANN-PICK-DISEASE; GAUCHER-DISEASE; OXIDATIVE STRESS; MOUSE MODEL; C DISEASE; SANDHOFF-DISEASE; MITOCHONDRIAL ABERRATIONS	Lysosomal storage diseases (LSDs), of which about 50 are known, are caused by the defective activity of lysosomal proteins, resulting in accumulation of unmetabolized substrates. As a result, a variety of pathogenic cascades are activated such as altered calcium homeostasis, oxidative stress, inflammation, altered lipid trafficking, autophagy, endoplasmic reticulum stress, and autoimmune responses. Some of these pathways are common to many LSDs, whereas others are only altered in a subset of LSDs. Wenow review how these cascades impact upon LSD pathology and suggest how intervention	[Vitner, Einat B.; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Platt, Frances M.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	Weizmann Institute of Science; University of Oxford	Futerman, AH (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tony.futerman@weizmann.ac.il		Platt, Frances/0000-0001-7614-0403; Futerman, Anthony/0000-0003-0013-0115; Bleiberg Vitner, Einat/0000-0001-8578-8551	estate of Louis Uger, Canada; Children's Medical Research Charity UK (Sparks); National Niemann-Pick Disease Foundation (NNPDF); System of Accelerated Research for Niemann-Pick Disease Type C (SOAR-NPC), Newlife; Action Medical Research	estate of Louis Uger, Canada; Children's Medical Research Charity UK (Sparks); National Niemann-Pick Disease Foundation (NNPDF); System of Accelerated Research for Niemann-Pick Disease Type C (SOAR-NPC), Newlife; Action Medical Research	This work was supported by grants from the Children's Gaucher Research Fund, by the estate of Louis Uger, Canada (to A.H.F.), and by the Children's Medical Research Charity UK (Sparks), National Niemann-Pick Disease Foundation (NNPDF), System of Accelerated Research for Niemann-Pick Disease Type C (SOAR-NPC), Newlife, and Action Medical Research (to F.M.P.). This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Allen MJ, 1997, QJM-MON J ASSOC PHYS, V90, P19; Ballabio A, 2009, BBA-MOL CELL RES, V1793, P684, DOI 10.1016/j.bbamcr.2008.12.001; Boot RG, 2004, BLOOD, V103, P33, DOI 10.1182/blood-2003-05-1612; Campeau PM, 2009, BLOOD, V114, P3181, DOI 10.1182/blood-2009-02-205708; Chen CS, 1999, LANCET, V354, P901, DOI 10.1016/S0140-6736(98)10034-X; Deganuto M, 2007, J CELL PHYSIOL, V212, P223, DOI 10.1002/jcp.21023; Dhami R, 2001, LAB INVEST, V81, P987, DOI 10.1038/labinvest.3780311; DiRosario J, 2009, J NEUROSCI RES, V87, P978, DOI 10.1002/jnr.21912; Ehlert Karoline, 2007, Pediatr Rheumatol Online J, V5, P15; Eichler F, 2007, PEDIATR NEUROL, V37, P235, DOI 10.1016/j.pediatrneurol.2007.06.011; Farfel-Becker T, 2009, HUM MOL GENET, V18, P1482, DOI 10.1093/hmg/ddp061; Fukuda T, 2006, AUTOPHAGY, V2, P318, DOI 10.4161/auto.2984; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Ginzburg L, 2005, J NEUROCHEM, V95, P1619, DOI 10.1111/j.1471-4159.2005.03534.x; Ginzburg L, 2008, J NEUROCHEM, V104, P140, DOI 10.1111/j.1471-4159.2007.04983.x; Hachiya Y, 2006, ACTA NEUROPATHOL, V111, P168, DOI 10.1007/s00401-005-0024-x; Heine C, 2003, BIOCHEM J, V376, P369, DOI 10.1042/BJ20030598; Ishibashi S, 2009, J CLIN NEUROSCI, V16, P954, DOI 10.1016/j.jocn.2008.09.020; Jalanko A, 2009, BBA-MOL CELL RES, V1793, P697, DOI 10.1016/j.bbamcr.2008.11.004; Jennings JJ, 2006, J BIOL CHEM, V281, P39041, DOI 10.1074/jbc.M607982200; Jeyakumar M, 2004, ANN NEUROL, V56, P642, DOI 10.1002/ana.20242; Jeyakumar M, 2003, BRAIN, V126, P974, DOI 10.1093/brain/awg089; Jeyakumar Mylvaganam, 2005, Nat Rev Neurosci, V6, P713; Jmoudiak M, 2005, BRIT J HAEMATOL, V129, P178, DOI 10.1111/j.1365-2141.2004.05351.x; Kim SJ, 2006, HUM MOL GENET, V15, P1580, DOI 10.1093/hmg/ddl078; Kim SJ, 2006, HUM MOL GENET, V15, P1826, DOI 10.1093/hmg/ddl105; Ko DC, 2005, PLOS GENET, V1, P81, DOI 10.1371/journal.pgen.0010007; Korkotian E, 1999, J BIOL CHEM, V274, P21673, DOI 10.1074/jbc.274.31.21673; Liao GH, 2007, AM J PATHOL, V171, P962, DOI 10.2353/ajpath.2007.070052; Lim MJ, 2006, NEUROPATH APPL NEURO, V32, P469, DOI 10.1111/j.1365-2990.2006.00738.x; Lloyd-Evans E, 2003, J BIOL CHEM, V278, P23594, DOI 10.1074/jbc.M300212200; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Lloyd-Evans E, 2010, TRAFFIC, V11, P419, DOI 10.1111/j.1600-0854.2010.01032.x; Luiro K, 2006, J NEUROSCI RES, V84, P1124, DOI 10.1002/jnr.21015; Luzi P, 2009, BRAIN RES, V1300, P146, DOI 10.1016/j.brainres.2009.09.017; Marks DL, 2002, TRENDS CELL BIOL, V12, P605, DOI 10.1016/S0962-8924(02)02399-1; Pacheco CD, 2007, HUM MOL GENET, V16, P1495, DOI 10.1093/hmg/ddm100; Pacheco CD, 2007, AUTOPHAGY, V3, P487, DOI 10.4161/auto.4586; Pelled D, 2003, J BIOL CHEM, V278, P29496, DOI 10.1074/jbc.M302964200; Pelled D, 2005, NEUROBIOL DIS, V18, P83, DOI 10.1016/j.nbd.2004.09.004; Raben N, 2007, Acta Myol, V26, P45; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Reddy JV, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000019; Reolon GK, 2009, CELL MOL NEUROBIOL, V29, P443, DOI 10.1007/s10571-008-9335-5; Roversi FM, 2006, CLIN CHIM ACTA, V364, P316, DOI 10.1016/j.cca.2005.07.022; Saftig P, 2008, AUTOPHAGY, V4, P510, DOI 10.4161/auto.5724; Sano R, 2009, MOL CELL, V36, P500, DOI 10.1016/j.molcel.2009.10.021; Settembre C, 2008, AUTOPHAGY, V4, P113, DOI 10.4161/auto.5227; Shen JS, 2008, MOL GENET METAB, V95, P163, DOI 10.1016/j.ymgme.2008.06.016; Sillence DJ, 2004, SEMIN CELL DEV BIOL, V15, P409, DOI 10.1016/j.semcdb.2004.03.004; Sillence DJ, 2002, J LIPID RES, V43, P1837, DOI 10.1194/jlr.M200232-JLR200; Smith D, 2009, NEUROBIOL DIS, V36, P242, DOI 10.1016/j.nbd.2009.07.010; Takamura A, 2008, BIOCHEM BIOPH RES CO, V367, P616, DOI 10.1016/j.bbrc.2007.12.187; Tessitore A, 2004, MOL CELL, V15, P753, DOI 10.1016/j.molcel.2004.08.029; Villani GRD, 2009, BRAIN RES, V1279, P99, DOI 10.1016/j.brainres.2009.03.071; Walkley SU, 2004, SEMIN CELL DEV BIOL, V15, P433, DOI 10.1016/j.semcdb.2004.03.002; Wei H, 2008, HUM MOL GENET, V17, P469, DOI 10.1093/hmg/ddm324; Wu YP, 2004, P NATL ACAD SCI USA, V101, P8425, DOI 10.1073/pnas.0400625101; Yamaguchi A, 2004, J CLIN INVEST, V113, P200, DOI 10.1172/JCI200419639; Zampieri S, 2009, J CELL MOL MED, V13, P3786, DOI 10.1111/j.1582-4934.2008.00493.x	60	250	256	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20423	20427		10.1074/jbc.R110.134452	http://dx.doi.org/10.1074/jbc.R110.134452			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20430897	Green Published, hybrid			2022-12-27	WOS:000279228600001
J	Walsh, CT; Acker, MG; Bowers, AA				Walsh, Christopher T.; Acker, Michael G.; Bowers, Albert A.			Thiazolyl Peptide Antibiotic Biosynthesis: A Cascade of Post-translational Modifications on Ribosomal Nascent Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ELONGATION-FACTOR-TU; POLYTHIAZOLE-CONTAINING PEPTIDE; RENIN INHIBITORY-ACTIVITY; THIOSTREPTON-RESISTANT MUTANTS; IN-VITRO RECONSTITUTION; MICROCIN B17; THIOPEPTIDE ANTIBIOTICS; GENE-CLUSTER; TRANSFER-RNA; EF-TU	Antibiotics of the thiocillin, GE2270A, and thiostrepton class, which block steps in bacterial protein synthesis, contain a trithiazolyl (tetrahydro) pyridine core that provides the architectural constraints for high affinity binding to either the 50 S ribosomal subunit or elongation factor Tu. These mature antibiotic scaffolds arise from a cascade of post-translational modifications on 50-60-residue prepeptide precursors that trim away the N-terminal leader sequences (similar to 40 residues) while the C-terminal 14-18 residues are converted into the mature scaffold. In the producing microbes, the genes encoding the prepeptide open reading frames are flanked in biosynthetic clusters by genes encoding post-translational modification enzymes that carry out lantibiotic-type dehydrations of Ser and Thr residues to dehydroamino acid side chains, cyclodehydration and oxidation of cysteines to thiazoles, and condensation of two dehydroalanine residues en route to the (tetrahydro) pyridine core. The trithiazolyl pyridine framework thus arises from post-translational modification of the peptide backbone of three Cys and two Ser residues of the prepeptide.	[Walsh, Christopher T.; Acker, Michael G.; Bowers, Albert A.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Walsh, CT (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	christopher_walsh@hms.harvard.edu		Acker, Michael/0000-0002-3565-9601	National Institutes of Health [GIM 20011]; New England Regional Center of Excellence, NIAID [U54 AI057 159]; Helen Hay Whitney Foundation; NCI, NIH [CA136283]; NATIONAL CANCER INSTITUTE [F32CA136283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020011] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New England Regional Center of Excellence, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Helen Hay Whitney Foundation; NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GIM 20011 and New England Regional Center of Excellence Grant U54 AI057 159 from NIAID (to C. T. W.).; Supported by a postdoctoral fellowship from the Helen Hay Whitney Foundation.; Supported by National Institutes of Health Postdoctoral Fellowship CA136283 from NCI.	Acker MG, 2009, J AM CHEM SOC, V131, P17563, DOI 10.1021/ja908777t; Agirrezabala X, 2009, Q REV BIOPHYS, V42, P159, DOI 10.1017/S0033583509990060; ANBORGH PH, 1991, EMBO J, V10, P779, DOI 10.1002/j.1460-2075.1991.tb08009.x; ANDERSON B, 1970, NATURE, V225, P233, DOI 10.1038/225233a0; AOKI M, 1991, J ANTIBIOT, V44, P582, DOI 10.7164/antibiotics.44.582; AOKI M, 1991, TETRAHEDRON LETT, V32, P217, DOI 10.1016/0040-4039(91)80859-5; AOKI M, 1991, TETRAHEDRON LETT, V32, P221, DOI 10.1016/0040-4039(91)80860-9; Bagley MC, 2005, CHEM REV, V105, P685, DOI 10.1021/cr0300441; Bagley MC, 2000, J AM CHEM SOC, V122, P3301, DOI 10.1021/ja994247b; Belshaw PJ, 1998, CHEM BIOL, V5, P373, DOI 10.1016/S1074-5521(98)90071-0; Bowers AA, 2010, J AM CHEM SOC, V132, P7519, DOI 10.1021/ja102339q; Brown LCW, 2009, P NATL ACAD SCI USA, V106, P2549, DOI [10.1073/pnas.0900008105, 10.1073/pnas.0900008106]; BYCROFT BW, 1978, J CHEM SOC CHEM COMM, P256, DOI 10.1039/c39780000256; Cameron DM, 2004, NUCLEIC ACIDS RES, V32, P3220, DOI 10.1093/nar/gkh644; Cameron DM, 2002, J MOL BIOL, V319, P27, DOI 10.1016/S0022-2836(02)00235-8; Cane DE, 2010, J BIOL CHEM, V285, P27517, DOI 10.1074/jbc.R110.144618; Carnio MC, 2001, EUR J BIOCHEM, V268, P6390, DOI 10.1046/j.0014-2956.2001.02591.x; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; Chatterjee C, 2005, J AM CHEM SOC, V127, P15332, DOI 10.1021/ja0543043; Constantine KL, 2002, J AM CHEM SOC, V124, P7284, DOI 10.1021/ja026249t; CUNDLIFFE E, 1971, BIOCHEM BIOPH RES CO, V44, P912, DOI 10.1016/0006-291X(71)90798-4; CUNDLIFFE E, 1979, J MOL BIOL, V132, P235, DOI 10.1016/0022-2836(79)90393-0; CUNDLIFFE E, 1981, J GEN MICROBIOL, V126, P185; CUNDLIFFE E, 1979, NATURE, V278, P859, DOI 10.1038/278859a0; Delgado O, 2008, CHEM-EUR J, V14, P2322, DOI 10.1002/chem.200701823; Donia MS, 2008, NAT CHEM BIOL, V4, P341, DOI 10.1038/nchembio.84; Donia MS, 2006, NAT CHEM BIOL, V2, P729, DOI 10.1038/nchembio829; Duerfahrt T, 2004, CHEM BIOL, V11, P261, DOI 10.1016/j.chembiol.2004.01.013; EBATA M, 1969, J ANTIBIOT, V22, P434; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gonzalez RL, 2007, RNA, V13, P2091, DOI 10.1261/rna.499407; Harms JM, 2008, MOL CELL, V30, P26, DOI 10.1016/j.molcel.2008.01.009; Heddle JG, 2001, J MOL BIOL, V307, P1223, DOI 10.1006/jmbi.2001.4562; Heffron SE, 2000, BIOCHEMISTRY-US, V39, P37, DOI 10.1021/bi9913597; Hubbard BK, 2003, ANGEW CHEM INT EDIT, V42, P730, DOI 10.1002/anie.200390202; HUMMEL H, 1987, BIOCHIMIE, V69, P857, DOI 10.1016/0300-9084(87)90212-4; Kelly WL, 2008, ORG BIOMOL CHEM, V6, P4483, DOI 10.1039/b814552k; Kelly WL, 2009, J AM CHEM SOC, V131, P4327, DOI 10.1021/ja807890a; KETTENRING J, 1991, J ANTIBIOT, V44, P702, DOI 10.7164/antibiotics.44.702; Konz D, 1997, CHEM BIOL, V4, P927, DOI 10.1016/S1074-5521(97)90301-X; Leet JE, 2003, J ANTIBIOT, V56, P232, DOI 10.7164/antibiotics.56.232; Lefranc D, 2009, ANGEW CHEM INT EDIT, V48, P4198, DOI 10.1002/anie.200900621; Li B, 2006, SCIENCE, V311, P1464, DOI 10.1126/science.1121422; Li TL, 2004, CHEM BIOL, V11, P107, DOI 10.1016/j.chembiol.2004.01.001; Li YM, 1996, SCIENCE, V274, P1188, DOI 10.1126/science.274.5290.1188; Liao RJ, 2009, CHEM BIOL, V16, P141, DOI 10.1016/j.chembiol.2009.01.007; LIESCH JM, 1977, J AM CHEM SOC, V99, P1645, DOI 10.1021/ja00447a061; Lociuro S, 1997, J ANTIBIOT, V50, P344, DOI 10.7164/antibiotics.50.344; MANKIN AS, 1994, J MOL BIOL, V244, P151, DOI 10.1006/jmbi.1994.1715; McIntosh JA, 2009, NAT PROD REP, V26, P537, DOI 10.1039/b714132g; Miao V, 2005, MICROBIOL-SGM, V151, P1507, DOI 10.1099/mic.0.27757-0; Milne JC, 1998, BIOCHEMISTRY-US, V37, P13250, DOI 10.1021/bi980996e; Milne JC, 1999, BIOCHEMISTRY-US, V38, P4768, DOI 10.1021/bi982975q; MOCEK U, 1993, J AM CHEM SOC, V115, P7992, DOI 10.1021/ja00071a009; MOCEK U, 1993, J AM CHEM SOC, V115, P7557, DOI 10.1021/ja00070a001; MODOLELL J, 1971, P NATL ACAD SCI USA, V68, P1796; Moody CJ, 1998, CHEM COMMUN, P2049, DOI 10.1039/a805762a; Morris RP, 2009, J AM CHEM SOC, V131, P5946, DOI 10.1021/ja900488a; Muller HM, 2007, ANGEW CHEM INT EDIT, V46, P4771, DOI 10.1002/anie.200700684; Mukai A, 2009, J ANTIBIOT, V62, P613, DOI 10.1038/ja.2009.90; Naidu BN, 2005, BIOORG MED CHEM LETT, V15, P2069, DOI 10.1016/j.bmcl.2005.02.046; Naidu BN, 2004, BIOORG MED CHEM LETT, V14, P5573, DOI 10.1016/j.bmcl.2004.08.058; Nicolaou KC, 2008, CHEM COMMUN, P2632, DOI 10.1039/b805069b; Nicolaou KC, 2008, CHEM-ASIAN J, V3, P413, DOI 10.1002/asia.200700361; Nicolaou KC, 2004, ANGEW CHEM INT EDIT, V43, P5092, DOI 10.1002/anie.200461341; Nicolaou KC, 2004, ANGEW CHEM INT EDIT, V43, P5087, DOI 10.1002/anie.200461340; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Nolan EM, 2009, CHEMBIOCHEM, V10, P34, DOI 10.1002/cbic.200800438; NORTHCOTE PT, 1994, J ANTIBIOT, V47, P901, DOI 10.7164/antibiotics.47.901; Oman TJ, 2010, NAT CHEM BIOL, V6, P9, DOI [10.1038/NCHEMBIO.286, 10.1038/nchembio.286]; Parmeggiani A, 2006, FEBS LETT, V580, P4576, DOI 10.1016/j.febslet.2006.07.039; Parmeggiani A, 2006, BIOCHEMISTRY-US, V45, P6846, DOI 10.1021/bi0525122; PASCARD C, 1977, J AM CHEM SOC, V99, P6418, DOI 10.1021/ja00461a039; Patton GC, 2005, CURR OPIN MICROBIOL, V8, P543, DOI 10.1016/j.mib.2005.08.008; Pickens LB, 2010, J BIOL CHEM, V285, P27509, DOI 10.1074/jbc.R110.130419; Porse BT, 1999, J MOL BIOL, V287, P33, DOI 10.1006/jmbi.1999.2600; PRANGE T, 1977, NATURE, V265, P189, DOI 10.1038/265189a0; PUAR MS, 1981, J AM CHEM SOC, V103, P5231, DOI 10.1021/ja00407a047; Puar MS, 1998, J ANTIBIOT, V51, P221, DOI 10.7164/antibiotics.51.221; Robbel L, 2010, J BIOL CHEM, V285, P27501, DOI 10.1074/jbc.R110.128181; ROSENDAHL G, 1994, NUCLEIC ACIDS RES, V22, P357, DOI 10.1093/nar/22.3.357; ROSENDAHL G, 1993, J MOL BIOL, V234, P1013, DOI 10.1006/jmbi.1993.1655; Roy RS, 1999, NAT PROD REP, V16, P249, DOI 10.1039/a806930a; Sattely ES, 2008, NAT PROD REP, V25, P757, DOI 10.1039/b801747f; Schneider TL, 2003, BIOCHEMISTRY-US, V42, P9722, DOI 10.1021/bi034792w; Schofield CJ, 1997, CURR OPIN STRUC BIOL, V7, P857, DOI 10.1016/S0959-440X(97)80158-3; Schoof S, 2009, CHEMBIOCHEM, V10, P242, DOI 10.1002/cbic.200800642; SELVA E, 1991, J ANTIBIOT, V44, P693, DOI 10.7164/antibiotics.44.693; Severinov K, 2007, MOL MICROBIOL, V65, P1380, DOI 10.1111/j.1365-2958.2007.05874.x; SHIMANAKA K, 1994, J ANTIBIOT, V47, P1145, DOI 10.7164/antibiotics.47.1145; SHIMANAKA K, 1994, J ANTIBIOT, V47, P1153, DOI 10.7164/antibiotics.47.1153; SHOJI J, 1981, J ANTIBIOT, V34, P1126, DOI 10.7164/antibiotics.34.1126; Starosta AL, 2009, CHEM BIOL, V16, P1087, DOI 10.1016/j.chembiol.2009.09.016; SU TL, 1948, BRIT J EXP PATHOL, V29, P473; TANAKA T, 1971, J BIOCHEM, V69, P1127, DOI 10.1093/oxfordjournals.jbchem.a129566; Walsh CT, 2010, J AM CHEM SOC, V132, P2469, DOI 10.1021/ja909118a; Walsh CT, 2001, CURR OPIN CHEM BIOL, V5, P525, DOI 10.1016/S1367-5931(00)00235-0; Wang J, 2010, APPL ENVIRON MICROB, V76, P2335, DOI 10.1128/AEM.01790-09; WIENEN B, 1979, J BIOL CHEM, V254, P8031; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501; Xie LL, 2004, SCIENCE, V303, P679, DOI 10.1126/science.1092600; Yu Y, 2009, ACS CHEM BIOL, V4, P855, DOI 10.1021/cb900133x	103	74	75	3	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27525	27531		10.1074/jbc.R110.135970	http://dx.doi.org/10.1074/jbc.R110.135970			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20522549	Green Published, hybrid			2022-12-27	WOS:000281404100006
J	Schultz, IJ; Chen, CY; Paw, BH; Hamza, I				Schultz, Iman J.; Chen, Caiyong; Paw, Barry H.; Hamza, Iqbal			Iron and Porphyrin Trafficking in Heme Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PROTOPORPHYRINOGEN-IX OXIDASE; SULFUR CLUSTER BIOGENESIS; ENDOPLASMIC-RETICULUM; MICROCYTIC ANEMIA; HUMAN FERROCHELATASE; REGULATORY PROTEIN; IDENTIFICATION; MITOCHONDRIA; TRANSPORTER; RECEPTOR	Iron is an essential element for diverse biological functions. In mammals, the majority of iron is enclosed within a single prosthetic group: heme. In metazoans, heme is synthesized via a highly conserved and coordinated pathway within the mitochondria. However, iron is acquired from the environment and subsequently assimilated into various cellular pathways, including heme synthesis. Both iron and heme are toxic but essential cofactors. How is iron transported from the extracellular milieu to the mitochondria? How are heme and heme intermediates coordinated with iron transport? Although recent studies have answered some questions, several pieces of this intriguing puzzle remain unsolved.	[Schultz, Iman J.; Paw, Barry H.] Harvard Univ, Sch Med, Dept Med, Hematol Div,Brigham & Womens Hosp, Boston, MA 02115 USA; [Schultz, Iman J.; Paw, Barry H.] Harvard Univ, Sch Med, Dept Med, Childrens Hosp Boston,Hemat Oncol Div, Boston, MA 02115 USA; [Chen, Caiyong; Hamza, Iqbal] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Chen, Caiyong; Hamza, Iqbal] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Paw, BH (corresponding author), Harvard Univ, Sch Med, Dept Med, Hematol Div,Brigham & Womens Hosp, Boston, MA 02115 USA.	bpaw@rics.bwh.harvard.edu; hamza@umd.edu		Hamza, Iqbal/0000-0003-0045-0610; Paw, Barry/0000-0002-0492-1419	National Institutes of Health [R01 DK74797, R01 DK85035, R01 DK70838, P01 HL032262, P30 DK072437]; Netherlands Organization for Scientific Research (NWO); March of Dimes Foundation; Roche Foundation for Anemia Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL032262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085035, R01DK074797, P30DK072437, R01DK070838] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); March of Dimes Foundation(March of Dimes); Roche Foundation for Anemia Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK74797 and R01 DK85035 (to I. H.) and Grants R01 DK70838, P01 HL032262, and P30 DK072437 (to B. H. P.). This work was also supported by grants from the Netherlands Organization for Scientific Research (NWO; to I. J. S.), the March of Dimes Foundation (to B. H. P. and I. H.), and the Roche Foundation for Anemia Research (to I. H.). This is the fourth article in the Thematic Minireview Series on Metals in Biology 2010. This mini-review will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Achleitner G, 1999, EUR J BIOCHEM, V264, P545, DOI 10.1046/j.1432-1327.1999.00658.x; Ajioka RS, 2006, BBA-MOL CELL RES, V1763, P723, DOI 10.1016/j.bbamcr.2006.05.005; Andrews NC, 2008, BLOOD, V112, P219, DOI 10.1182/blood-2007-12-077388; Andrews NC, 2000, NAT REV GENET, V1, P208, DOI 10.1038/35042073; ASAGAMI H, 1994, BBA-BIOMEMBRANES, V1193, P345, DOI 10.1016/0005-2736(94)90171-6; Bekri S, 2000, BLOOD, V96, P3256; Camaschella C, 2007, BLOOD, V110, P1353, DOI 10.1182/blood-2007-02-072520; Chen W, 2009, P NATL ACAD SCI USA, V106, P16263, DOI 10.1073/pnas.0904519106; Cherradi N, 1997, J BIOL CHEM, V272, P7899, DOI 10.1074/jbc.272.12.7899; Cooperman SS, 2005, BLOOD, V106, P1084, DOI 10.1182/blood-2004-12-4703; COPELAND DE, 1959, J BIOPHYS BIOCHEM CY, V5, P393, DOI 10.1083/jcb.5.3.393; DAILEY HA, 1994, BIOCHEMISTRY-US, V33, P403, DOI 10.1021/bi00168a003; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Delaby C, 2005, EXP CELL RES, V310, P43, DOI 10.1016/j.yexcr.2005.07.002; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Doring F, 1998, J CLIN INVEST, V101, P2761, DOI 10.1172/JCI1909; Feissner RE, 2006, MOL MICROBIOL, V61, P219, DOI 10.1111/j.1365-2958.2006.05221.x; FERREIRA GC, 1988, J BIOL CHEM, V263, P3835; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; Galy B, 2008, CELL METAB, V7, P79, DOI 10.1016/j.cmet.2007.10.006; GRANDCHAMP B, 1978, BIOCHEM J, V176, P97, DOI 10.1042/bj1760097; GRASBECK R, 1982, BIOCHIM BIOPHYS ACTA, V700, P137, DOI 10.1016/0167-4838(82)90089-9; Gruenheid S, 1997, J EXP MED, V185, P717, DOI 10.1084/jem.185.4.717; Guernsey DL, 2009, NAT GENET, V41, P651, DOI 10.1038/ng.359; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; HARBIN BM, 1985, BIOCHEMISTRY-US, V24, P366, DOI 10.1021/bi00323a019; HARVEY JW, 1982, BLOOD, V60, P1227; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; IWAHARA S, 1995, BIOCHEMISTRY-US, V34, P13398, DOI 10.1021/bi00041a017; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; KETTERER B, 1976, BIOCHIM BIOPHYS ACTA, V428, P683, DOI 10.1016/0304-4165(76)90198-7; KINO K, 1980, J BIOL CHEM, V255, P9616; Knutson MD, 2005, P NATL ACAD SCI USA, V102, P1324, DOI 10.1073/pnas.0409409102; Knutson MD, 2003, BLOOD, V102, P4191, DOI 10.1182/blood-2003-04-1250; Koch M, 2004, EMBO J, V23, P1720, DOI 10.1038/sj.emboj.7600189; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Krewulak KD, 2008, BBA-BIOMEMBRANES, V1778, P1781, DOI 10.1016/j.bbamem.2007.07.026; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Kruszewski M, 2003, MUTAT RES-FUND MOL M, V531, P81, DOI 10.1016/j.mrfmmm.2003.08.004; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Lim JE, 2005, NAT GENET, V37, P1270, DOI 10.1038/ng1659; LITWACK G, 1971, NATURE, V234, P466, DOI 10.1038/234466a0; Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255; Masoumi A, 2008, MICROBIOL-SGM, V154, P3707, DOI 10.1099/mic.0.2008/018705-0; MEIER PJ, 1984, J BIOL CHEM, V259, P194; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Mitsuhashi N, 2000, J BIOL CHEM, V275, P17536, DOI 10.1074/jbc.275.23.17536; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; NAUSEEF WM, 1992, BLOOD, V80, P2622; Nemeth E, 2006, ANNU REV NUTR, V26, P323, DOI 10.1146/annurev.nutr.26.061505.111303; Nilsson R, 2009, CELL METAB, V10, P119, DOI 10.1016/j.cmet.2009.06.012; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Paradkar PN, 2009, MOL CELL BIOL, V29, P1007, DOI 10.1128/MCB.01685-08; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; Quigley JG, 2000, BLOOD, V95, P1093, DOI 10.1182/blood.V95.3.1093.003k01_1093_1099; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Roughead ZK, 2000, AM J CLIN NUTR, V72, P982; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Sassa S, 2006, BRIT J HAEMATOL, V135, P281, DOI 10.1111/j.1365-2141.2006.06289.x; Schaer CA, 2006, CIRC RES, V99, P943, DOI 10.1161/01.RES.0000247067.34173.1b; Schranzhofer M, 2006, BLOOD, V107, P4159, DOI 10.1182/blood-2005-05-1809; Sellers VM, 1996, BIOCHEMISTRY-US, V35, P2699, DOI 10.1021/bi952631p; SENIO M, 1985, J BIOL CHEM, V260, P9191; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Shayeghi M, 2005, CELL, V122, P789, DOI 10.1016/j.cell.2005.06.025; Sheftel AD, 2007, BLOOD, V110, P125, DOI 10.1182/blood-2007-01-068148; Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643; Simpson RJ, 2009, CELL METAB, V10, P84, DOI 10.1016/j.cmet.2009.06.009; SMITH A, 1990, EUR J CELL BIOL, V53, P234; Soe-Lin S, 2008, EXP HEMATOL, V36, P929, DOI 10.1016/j.exphem.2008.02.013; Soe-Lin S, 2009, P NATL ACAD SCI USA, V106, P5960, DOI 10.1073/pnas.0900808106; Spielewoy N, 2001, J BIOL CHEM, V276, P5491, DOI 10.1074/jbc.M008853200; Taketani S, 1998, J BIOL CHEM, V273, P31388, DOI 10.1074/jbc.273.47.31388; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Tong WH, 2003, P NATL ACAD SCI USA, V100, P9762, DOI 10.1073/pnas.1732541100; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Wang FD, 2007, NAT GENET, V39, P1025, DOI 10.1038/ng2059; Wingert RA, 2005, NATURE, V436, P1035, DOI 10.1038/nature03887; Worthington MT, 2001, AM J PHYSIOL-GASTR L, V280, pG1172, DOI 10.1152/ajpgi.2001.280.6.G1172; Wu CK, 2001, NAT STRUCT BIOL, V8, P156, DOI 10.1038/84152; Zhang AS, 2009, J BIOL CHEM, V284, P711, DOI 10.1074/jbc.R800017200; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	99	98	100	4	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26753	26759		10.1074/jbc.R110.119503	http://dx.doi.org/10.1074/jbc.R110.119503			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20522548	Green Published, hybrid			2022-12-27	WOS:000281172700005
J	Ouertatani-Sakouhi, H; El-Turk, F; Fauvet, B; Cho, MK; Karpinar, DP; Le Roy, D; Dewor, M; Roger, T; Bernhagen, J; Calandra, T; Zweckstetter, M; Lashuel, HA				Ouertatani-Sakouhi, Hajer; El-Turk, Farah; Fauvet, Bruno; Cho, Min-Kyu; Karpinar, Damla Pinar; Le Roy, Didier; Dewor, Manfred; Roger, Thierry; Bernhagen, Juergen; Calandra, Thierry; Zweckstetter, Markus; Lashuel, Hilal A.			Identification and Characterization of Novel Classes of Macrophage Migration Inhibitory Factor (MIF) Inhibitors with Distinct Mechanisms of Action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAUTOMERASE INHIBITORS; RHEUMATOID-ARTHRITIS; ENZYMATIC-ACTIVITY; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; POTENTIAL ROLE; IN-VITRO; EBSELEN; GLUTATHIONE; SITE	Macrophage migration inhibitory factor (MIF), a proinflammatory cytokine, is considered an attractive therapeutic target in multiple inflammatory and autoimmune disorders. In addition to its known biologic activities, MIF can also function as a tautomerase. Several small molecules have been reported to be effective inhibitors of MIF tautomerase activity in vitro. Herein we employed a robust activity-based assay to identify different classes of novel inhibitors of the catalytic and biological activities of MIF. Several novel chemical classes of inhibitors of the catalytic activity of MIF with IC50 values in the range of 0.2-15.5 mu M were identified and validated. The interaction site and mechanism of action of these inhibitors were defined using structure-activity studies and a battery of biochemical and biophysical methods. MIF inhibitors emerging from these studies could be divided into three categories based on their mechanism of action: 1) molecules that covalently modify the catalytic site at the N-terminal proline residue, Pro(1); 2) a novel class of catalytic site inhibitors; and finally 3) molecules that disrupt the trimeric structure of MIF. Importantly, all inhibitors demonstrated total inhibition of MIF-mediated glucocorticoid overriding and AKT phosphorylation, whereas ebselen, a trimer-disrupting inhibitor, additionally acted as a potent hyperagonist in MIF-mediated chemotactic migration. The identification of biologically active compounds with known toxicity, pharmacokinetic properties, and biological activities in vivo should accelerate the development of clinically relevant MIF inhibitors. Furthermore, the diversity of chemical structures and mechanisms of action of our inhibitors makes them ideal mechanistic probes for elucidating the structure-function relationships of MIF and to further determine the role of the oligomerization state and catalytic activity of MIF in regulating the function(s) of MIF in health and disease.	[Ouertatani-Sakouhi, Hajer; El-Turk, Farah; Fauvet, Bruno; Lashuel, Hilal A.] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Mol Neurobiol & Funct Neuroprote, CH-1015 Lausanne, Switzerland; [Cho, Min-Kyu; Karpinar, Damla Pinar; Zweckstetter, Markus] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany; [Le Roy, Didier; Roger, Thierry; Calandra, Thierry] Univ Lausanne, CH-1011 Lausanne, Switzerland; [Le Roy, Didier; Roger, Thierry; Calandra, Thierry] CHU Vaudois, Dept Med, Infect Dis Serv, CH-1011 Lausanne, Switzerland; [Dewor, Manfred; Bernhagen, Juergen] Tech Hsch RWTH Univ Aachen, Dept Biochem & Mol Cell Biol, Inst Biochem & Mol Biol, D-52074 Aachen, Germany	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Max Planck Society; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); RWTH Aachen University	Lashuel, HA (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Mol Neurobiol & Funct Neuroprote, CH-1015 Lausanne, Switzerland.	hilal.lashuel@epfl.ch	Lashuel, Hilal/M-3500-2017; Roger, Thierry/G-2007-2012; Cho, Min-Kyu/H-1303-2011; Calandra, Thierry/D-9017-2015	Roger, Thierry/0000-0002-9358-0109; Cho, Min-Kyu/0000-0003-0537-2340; Calandra, Thierry/0000-0003-3051-1285; Zweckstetter, Markus/0000-0002-2536-6581; LE ROY, Didier/0000-0001-8954-5442	Swiss Federal Institute of Technology Lausanne; Swiss National Science Foundation [310000-110027, 3100-118266]; German Research Council (DFG) [Be1977/4-1, SFB542-A7]	Swiss Federal Institute of Technology Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); German Research Council (DFG)(German Research Foundation (DFG))	This work was supported by grants from the Swiss Federal Institute of Technology Lausanne (to H. A. L., F. E., and H. O.-S.), Swiss National Science Foundation Grants 310000-110027(to H. A. L.) and 3100-118266 (to T. C.), and German Research Council (DFG) Grants Be1977/4-1 and SFB542-A7 (to J.B.).	Al-Abed Y, 2005, J BIOL CHEM, V280, P36541, DOI 10.1074/jbc.C500243200; Balachandran S, 2009, BIOORG MED CHEM LETT, V19, P4773, DOI 10.1016/j.bmcl.2009.06.052; Beishuizen A, 2001, J CLIN ENDOCR METAB, V86, P2811, DOI 10.1210/jc.86.6.2811; Bendrat K, 1997, BIOCHEMISTRY-US, V36, P15356, DOI 10.1021/bi971153a; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Brown SDM, 2002, MAMM GENOME, V13, P1, DOI 10.1007/s00335-001-0015-8; Bucala R, 2007, IMMUNITY, V26, P281, DOI 10.1016/j.immuni.2007.03.005; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; CHOOK YM, 1994, J MOL BIOL, V240, P476, DOI 10.1006/jmbi.1994.1462; COTGREAVE IA, 1989, BIOCHEM PHARMACOL, V38, P649, DOI 10.1016/0006-2952(89)90211-6; Cournia Z, 2009, J MED CHEM, V52, P416, DOI 10.1021/jm801100v; Crichlow GV, 2009, BIOCHEMISTRY-US, V48, P132, DOI 10.1021/bi8014423; Dabideen DR, 2007, J MED CHEM, V50, P1993, DOI 10.1021/jm061477+; Dagia NM, 2009, EUR J PHARMACOL, V607, P201, DOI 10.1016/j.ejphar.2009.02.031; Daiber A, 2000, BIOCHEM PHARMACOL, V59, P153, DOI 10.1016/S0006-2952(99)00309-3; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dhanasekaran M, 2006, BRAIN RES, V1118, P251, DOI 10.1016/j.brainres.2006.08.020; DIMMELER S, 1991, BIOCHEM PHARMACOL, V42, P1151, DOI 10.1016/0006-2952(91)90303-M; Dios A, 2002, J MED CHEM, V45, P2410, DOI 10.1021/jm010534q; Donnelly SC, 1997, NAT MED, V3, P320, DOI 10.1038/nm0397-320; El-Turk F, 2008, BIOCHEMISTRY-US, V47, P10740, DOI 10.1021/bi800603x; ELTURK F, 2010, BIOCHEMISTR IN PRESS; Emonts M, 2007, CLIN INFECT DIS, V44, P1321, DOI 10.1086/514344; Fingerle-Rowson G, 2009, MOL CELL BIOL, V29, P1922, DOI 10.1128/MCB.01907-08; Garai J, 2009, CURR MED CHEM, V16, P1091, DOI 10.2174/092986709787581842; HURT S, 2010, OPTIMIZATION ALPHASC; Jacob C, 1998, BIOCHEM BIOPH RES CO, V248, P569, DOI 10.1006/bbrc.1998.9026; Kleemann R, 1998, FEBS LETT, V430, P191, DOI 10.1016/S0014-5793(98)00654-1; Kleemann R, 1998, J MOL BIOL, V280, P85, DOI 10.1006/jmbi.1998.1864; Lan HY, 1997, J EXP MED, V185, P1455, DOI 10.1084/jem.185.8.1455; Leech M, 1999, ARTHRITIS RHEUM, V42, P1601, DOI 10.1002/1529-0131(199908)42:8<1601::AID-ANR6>3.0.CO;2-B; Liu M, 2010, BIOCHEMISTRY-US, V49, P2008, DOI 10.1021/bi901851y; Lolis E, 2003, EXPERT OPIN THER TAR, V7, P153, DOI 10.1517/14728222.7.2.153; Lubetsky JB, 2002, J BIOL CHEM, V277, P24976, DOI 10.1074/jbc.M203220200; Lue H, 2007, ONCOGENE, V26, P5046, DOI 10.1038/sj.onc.1210318; Mikulowska A, 1997, J IMMUNOL, V158, P5514; Mizue Y, 2005, P NATL ACAD SCI USA, V102, P14410, DOI 10.1073/pnas.0507189102; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Moussaoui S, 2000, EXP NEUROL, V166, P235, DOI 10.1006/exnr.2000.7516; NIKAWA T, 1994, BIOCHEM PHARMACOL, V47, P1007, DOI 10.1016/0006-2952(94)90411-1; Nishihira J, 1998, BIOCHEM BIOPH RES CO, V243, P538, DOI 10.1006/bbrc.1998.8123; Orita M, 2002, CURR PHARM DESIGN, V8, P1297, DOI 10.2174/1381612023394674; Orita M, 2001, J MED CHEM, V44, P540, DOI 10.1021/jm000386o; Ouertatani-Sakouhi H, 2009, BIOCHEMISTRY-US, V48, P9858, DOI 10.1021/bi900957e; Philo JS, 2004, BIOPHYS CHEM, V108, P77, DOI 10.1016/j.bpc.2003.10.010; Porciuncula LO, 2001, NEUROSCI LETT, V299, P217, DOI 10.1016/S0304-3940(01)01519-1; Rendon BE, 2009, EXP MOL PATHOL, V86, P180, DOI 10.1016/j.yexmp.2009.01.001; Roger T, 2005, EUR J IMMUNOL, V35, P3405, DOI 10.1002/eji.200535413; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; Rosengren E, 1997, FEBS LETT, V417, P85, DOI 10.1016/S0014-5793(97)01261-1; Rossi AG, 1998, J CLIN INVEST, V101, P2869, DOI 10.1172/JCI1524; Saito I, 1998, NEUROSURGERY, V42, P269, DOI 10.1097/00006123-199802000-00038; Sakurai T, 2006, CHEM RES TOXICOL, V19, P1196, DOI 10.1021/tx0601105; SCHEWE T, 1995, GEN PHARMACOL-VASC S, V26, P1153, DOI 10.1016/0306-3623(95)00003-J; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Senter PD, 2002, P NATL ACAD SCI USA, V99, P144, DOI 10.1073/pnas.011569399; SIES H, 1993, FREE RADICAL BIO MED, V14, P313, DOI 10.1016/0891-5849(93)90028-S; SIMONS D, 2010, J CELL MOL IN PRESS; Solano F, 1999, NEUROTOX RES, V1, P153, DOI 10.1007/BF03033287; Stivers JT, 1996, BIOCHEMISTRY-US, V35, P814, DOI 10.1021/bi9510789; Subramanya HS, 1996, BIOCHEMISTRY-US, V35, P792, DOI 10.1021/bi951732k; Sun HW, 1996, P NATL ACAD SCI USA, V93, P5191, DOI 10.1073/pnas.93.11.5191; Suzuki M, 1996, NAT STRUCT BIOL, V3, P259, DOI 10.1038/nsb0396-259; Swope M, 1998, EMBO J, V17, P3534, DOI 10.1093/emboj/17.13.3534; Swope MD, 1998, J BIOL CHEM, V273, P14877, DOI 10.1074/jbc.273.24.14877; Terentis AC, 2010, BIOCHEMISTRY-US, V49, P591, DOI 10.1021/bi901546e; WANG JF, 1992, HEPATOLOGY, V15, P1112, DOI 10.1002/hep.1840150623; WEISER WY, 1989, P NATL ACAD SCI USA, V86, P7522, DOI 10.1073/pnas.86.19.7522; WENDEL A, 1984, BIOCHEM PHARMACOL, V33, P3241, DOI 10.1016/0006-2952(84)90084-4; Winner M, 2008, CANCER RES, V68, P7253, DOI 10.1158/0008-5472.CAN-07-6227; Yabunaka N, 2000, DIABETES CARE, V23, P256, DOI 10.2337/diacare.23.2.256; Yamaguchi T, 1998, STROKE, V29, P12, DOI 10.1161/01.STR.29.1.12; Ying J, 2007, ARTERIOSCL THROM VAS, V27, P783, DOI 10.1161/01.ATV.0000258413.72747.23; Zernecke A, 2010, CARDIOVASC RES, V86, P192, DOI 10.1093/cvr/cvp391; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; ZHANG M, 1995, FEBS LETT, V373, P203, DOI 10.1016/0014-5793(95)01041-C; Zhang XN, 1999, BIOORG MED CHEM LETT, V9, P3193	83	69	71	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26581	26598		10.1074/jbc.M110.113951	http://dx.doi.org/10.1074/jbc.M110.113951			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20516071	Green Published, hybrid			2022-12-27	WOS:000280921000074
J	Pittel, I; Witt-Kehati, D; Degani-Katzav, N; Paas, Y				Pittel, Ilya; Witt-Kehati, Dvora; Degani-Katzav, Nurit; Paas, Yoav			Probing Pore Constriction in a Ligand-gated Ion Channel by Trapping a Metal Ion in the Pore upon Agonist Dissociation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; CYS-LOOP RECEPTORS; X-RAY-STRUCTURE; BINDING-SITE; CRYSTAL-STRUCTURE; GLYCINE RECEPTOR; LOCAL-ANESTHETICS; GATING MECHANISM; NONCOMPETITIVE ANTAGONIST; ALPHA-BUNGAROTOXIN	Eukaryotic pentameric ligand-gated ion channels (pLGICs) are receptors activated by neurotransmitters to rapidly transport ions across cell membranes, down their electrochemical gradients. Recent crystal structures of two prokaryotic pLGICs were interpreted to imply that the extracellular side of the transmembrane pore constricts to close the channel (Hilf, R. J., and Dutzler, R. (2009) Nature 457, 115-118; Bocquet, N., Nury, H., Baaden, M., Le Poupon, C., Changeux, J. P., Delarue, M., and Corringer, P. J. (2009) Nature 457, 111-114). Here, we utilized a eukaryotic acetylcholine (ACh)-serotonin chimeric pLGIC that was engineered with histidines to coordinate a metal ion within the channel pore, at its cytoplasmic side. In a previous study, the access of Zn2+ ions to the engineered histidines had been explored when the channel was either at rest (closed) or active (open) (Paas, Y., Gibor, G., Grailhe, R., Savatier-Duclert, N., Dufresne, V., Sunesen, M., de Carvalho, L. P., Changeux, J. P., and Attali, B. (2005) Proc. Natl. Acad. Sci. U. S. A. 102, 1587715882). In this study, the interactions of Zn2+ with the pore were probed upon agonist (ACh) dissociation that triggers the transition of the receptor from the active conformation to the resting conformation (i.e. during deactivation). Application of Zn2+ onto ACh-bound open receptors obstructed their pore and prevented ionic flow. Removing ACh from its extracellular binding sites to trigger deactivation while Zn2+ is still bound led to tight trapping of Zn2+ within the pore. Together with single-channel recordings, made to explore single pore-blocking events, we show that dissociation of ACh causes the gate to shut on a Zn2+ ion that effectively acts as a "foot in the door." We infer that, upon deactivation, the cytoplasmic side of the pore of the ACh-serotonin receptor chimera constricts to close the channel.	[Pittel, Ilya; Witt-Kehati, Dvora; Degani-Katzav, Nurit; Paas, Yoav] Bar Ilan Univ, Inst Nanotechnol & Adv Mat, Mina & Everard Goodman Fac Life Sci, Lab Ion Channels, IL-52900 Ramat Gan, Israel	Bar Ilan University	Paas, Y (corresponding author), Bar Ilan Univ, Inst Nanotechnol & Adv Mat, Mina & Everard Goodman Fac Life Sci, Lab Ion Channels, IL-52900 Ramat Gan, Israel.	paasyo@mail.biu.ac.il			Wolfson Family Foundation; Israel Science Foundation [812/07, 1645/07]	Wolfson Family Foundation; Israel Science Foundation(Israel Science Foundation)	This work was supported by the Wolfson Family Foundation and the Israel Science Foundation Grants 812/07 and 1645/07.	AIDLEY DJ, 1996, ION CHANNELS MOL ACT, P225; AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; ANAND R, 1993, FEBS LETT, V327, P241, DOI 10.1016/0014-5793(93)80177-V; Betz H, 2006, J NEUROCHEM, V97, P1600, DOI 10.1111/j.1471-4159.2006.03908.x; BLANCHARD SG, 1979, BIOCHEMISTRY-US, V18, P5880, DOI 10.1021/bi00593a019; Blanton MP, 2000, J BIOL CHEM, V275, P3469, DOI 10.1074/jbc.275.5.3469; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Bouzat C, 2008, J NEUROSCI, V28, P7808, DOI 10.1523/JNEUROSCI.0448-08.2008; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; CHANG CC, 1966, BRIT J PHARM CHEMOTH, V28, P172, DOI 10.1111/j.1476-5381.1966.tb01883.x; Changeux JP, 2009, CR BIOL, V332, P421, DOI 10.1016/j.crvi.2009.02.005; CHANGEUX JP, 1970, P NATL ACAD SCI USA, V67, P1241, DOI 10.1073/pnas.67.3.1241; CHARNET P, 1990, NEURON, V4, P87, DOI 10.1016/0896-6273(90)90445-L; Cheng MHY, 2007, PROTEINS, V68, P581, DOI 10.1002/prot.21435; Cheng XL, 2006, PLOS COMPUT BIOL, V2, P1173, DOI 10.1371/journal.pcbi.0020134; CORRINGER PJ, 1995, J BIOL CHEM, V270, P11749, DOI 10.1074/jbc.270.20.11749; Creighton T. E., 1993, PROTEINS STRUCTURES, P141; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Cymes GD, 2008, NAT STRUCT MOL BIOL, V15, P389, DOI 10.1038/nsmb.1407; Dang H, 2000, MOL PHARMACOL, V57, P1114; DAVIES NW, 1989, J PHYSIOL-LONDON, V413, P31, DOI 10.1113/jphysiol.1989.sp017640; del Camino D, 2001, NEURON, V32, P649, DOI 10.1016/S0896-6273(01)00487-1; Diaz N, 2000, CHEM PHYS LETT, V326, P288, DOI 10.1016/S0009-2614(00)00744-2; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dutertre S, 2007, EMBO J, V26, P3858, DOI 10.1038/sj.emboj.7601785; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; Gallagher MJ, 1999, MOL PHARMACOL, V56, P300, DOI 10.1124/mol.56.2.300; Grutter T, 2003, EMBO J, V22, P1990, DOI 10.1093/emboj/cdg197; Gunthorpe MJ, 2001, J BIOL CHEM, V276, P10977, DOI 10.1074/jbc.M009575200; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Harel M, 2001, NEURON, V32, P265, DOI 10.1016/S0896-6273(01)00461-5; HIGAKI JN, 1992, TRENDS BIOCHEM SCI, V17, P100, DOI 10.1016/0968-0004(92)90245-5; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Ivanov I, 2007, J AM CHEM SOC, V129, P8217, DOI 10.1021/ja070778l; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; KARLIN A, 1967, J THEOR BIOL, V16, P306, DOI 10.1016/0022-5193(67)90011-2; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Lape R, 2009, J PHYSIOL-LONDON, V587, P5045, DOI 10.1113/jphysiol.2009.176305; Lee WY, 2009, J NEUROSCI, V29, P3189, DOI 10.1523/JNEUROSCI.6185-08.2009; Leil TA, 2004, J NEUROSCI, V24, P11429, DOI 10.1523/JNEUROSCI.3355-04.2004; LEONARD RJ, 1988, SCIENCE, V242, P1578, DOI 10.1126/science.2462281; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; LESTER HA, 1970, NATURE, V227, P727, DOI 10.1038/227727a0; Liu XL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040019; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Mercado J, 2008, J BIOL CHEM, V283, P15250, DOI 10.1074/jbc.M708638200; Miller PS, 2008, NAT STRUCT MOL BIOL, V15, P1084, DOI 10.1038/nsmb.1492; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Mukhtasimova N, 2009, NATURE, V459, P451, DOI 10.1038/nature07923; NEHER E, 1978, J PHYSIOL-LONDON, V277, P153, DOI 10.1113/jphysiol.1978.sp012267; OGDEN DC, 1981, NATURE, V289, P596, DOI 10.1038/289596a0; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Paas Y, 2005, P NATL ACAD SCI USA, V102, P15877, DOI 10.1073/pnas.0507599102; PAPKE RL, 1989, J GEN PHYSIOL, V93, P785, DOI 10.1085/jgp.93.5.785; Papke RL, 2001, MOL PHARMACOL, V60, P1365, DOI 10.1124/mol.60.6.1365; Pascual JM, 1998, J GEN PHYSIOL, V111, P717, DOI 10.1085/jgp.111.6.717; Pascual JM, 1998, J GEN PHYSIOL, V112, P611, DOI 10.1085/jgp.112.5.611; Perkins DI, 2009, J BIOL CHEM, V284, P27304, DOI 10.1074/jbc.M109.023598; Pless SA, 2009, J BIOL CHEM, V284, P27370, DOI 10.1074/jbc.M109.048405; Pless SA, 2009, J BIOL CHEM, V284, P15847, DOI 10.1074/jbc.M809343200; Purohit Y, 2006, J GEN PHYSIOL, V127, P703, DOI 10.1085/jgp.200509437; Rayes D, 2005, MOL PHARMACOL, V68, P1475, DOI 10.1124/mol.105.015438; Rayes D, 2009, J NEUROSCI, V29, P6022, DOI 10.1523/JNEUROSCI.0627-09.2009; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; Samson AO, 2002, NEURON, V35, P319, DOI 10.1016/S0896-6273(02)00773-0; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Sola M, 2004, EMBO J, V23, P2510, DOI 10.1038/sj.emboj.7600256; Sunesen M, 2006, J BIOL CHEM, V281, P14875, DOI 10.1074/jbc.M511657200; Taly A, 2005, BIOPHYS J, V88, P3954, DOI 10.1529/biophysj.104.050229; Taly A, 2006, P NATL ACAD SCI USA, V103, P16965, DOI 10.1073/pnas.0607477103; Taylor P, 2007, BIOCHEM PHARMACOL, V74, P1164, DOI 10.1016/j.bcp.2007.07.038; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; Webster SM, 2004, NATURE, V428, P864, DOI 10.1038/nature02468; Wilson GG, 2001, P NATL ACAD SCI USA, V98, P1241, DOI 10.1073/pnas.031567798; Wilson GG, 1998, NEURON, V20, P1269, DOI 10.1016/S0896-6273(00)80506-1; Wiltfong RE, 2009, J NEUROSCI, V29, P1626, DOI 10.1523/JNEUROSCI.4121-08.2009	87	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26519	26531		10.1074/jbc.M110.102327	http://dx.doi.org/10.1074/jbc.M110.102327			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20466725	hybrid, Green Published			2022-12-27	WOS:000280921000069
J	Marcucci, H; Paoletti, L; Jackowski, S; Banchio, C				Marcucci, Hebe; Paoletti, Luciana; Jackowski, Suzanne; Banchio, Claudia			Phosphatidylcholine Biosynthesis during Neuronal Differentiation and Its Role in Cell Fate Determination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; RAT SYMPATHETIC NEURONS; NEURITE OUTGROWTH; RETINOIC ACID; PHOSPHOLIPID BIOSYNTHESIS; CHOLINE KINASE; MEMBRANE EXPANSION; ARACHIDONIC-ACID; MAMMALIAN-CELLS; PC12 CELLS	Neuronal differentiation is characterized by neuritogenesis and neurite outgrowth, processes that are dependent on membrane biosynthesis. Thus, the production of phosphatidylcholine (PtdCho), the major membrane phospholipid, should be stimulated during neuronal differentiation. We demonstrate that during retinoic acid (RA)-induced differentiation of Neuro-2a cells, PtdCho synthesis was promoted by an ordered and sequential activation of choline kinase alpha(CK alpha) and choline cytidylyltransferase alpha(CCT alpha). Early after RA stimulation, the increase in PtdCho synthesis is mainly governed by the biochemical activation of CCT alpha. Later, the transcription of CK alpha and CCT alpha-encoding genes was induced. Both PtdCho biosynthesis and neuronal differentiation are dependent on ERK activation. A novel mechanism is proposed by which PtdCho biosynthesis is coordinated during neuronal differentiation. Enforced expression of either CK alpha or CCT alpha increased the rate of synthesis and the amount of PtdCho, and these cells initiated differentiation without RA stimulation, as evidenced by cell morphology and the expression of genes associated with neuritogenesis. The differentiation resulting from enforced expression of CCT alpha or CK alpha was dependent on persistent ERK activation. These results indicate that elevated PtdCho synthesis could mimic the RA signals and thus determine neuronal cell fate. Moreover, they could explain the key role that PtdCho plays during neuronal regeneration.	[Marcucci, Hebe; Paoletti, Luciana; Banchio, Claudia] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Consejo Nacl Invest Cient & Tecn, Inst Biol Mol & Celular Rosario,Dept Ciencias Bio, RA-2000 Rosario, Santa Fe, Argentina; [Jackowski, Suzanne] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; St Jude Children's Research Hospital	Banchio, C (corresponding author), Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Consejo Nacl Invest Cient & Tecn, Inst Biol Mol & Celular Rosario,Dept Ciencias Bio, Suipacha 531, RA-2000 Rosario, Santa Fe, Argentina.	banchio@ibr.gov.ar	Jackowski, Suzanne/N-8168-2018	Jackowski, Suzanne/0000-0002-6855-1429	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina; Agencia de Promocion Cientifica y Tecnologica (ANPCyT), Argentina [PICT 01-38027]; American Lebanese and Syrian Associated Charity; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062896] Funding Source: NIH RePORTER	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia de Promocion Cientifica y Tecnologica (ANPCyT), Argentina(ANPCyT); American Lebanese and Syrian Associated Charity; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina, Agencia de Promocion Cientifica y Tecnologica (ANPCyT), Argentina, Grant PICT 01-38027 (to C. B.), and by the American Lebanese and Syrian Associated Charity (to S. J.).	Adibhatla RM, 2006, AAPS J, V8, pE314; Adibhatla RM, 2006, J BIOL CHEM, V281, P6718, DOI 10.1074/jbc.M512112200; Agassandian M, 2005, J BIOL CHEM, V280, P21577, DOI 10.1074/jbc.M412409200; Anderson DH, 2006, PROG LIPID RES, V45, P102, DOI 10.1016/j.plipres.2005.12.003; Aoyama C, 2004, PROG LIPID RES, V43, P266, DOI 10.1016/j.plipres.2003.12.001; Aoyama C, 2002, BIOCHEM J, V363, P777, DOI 10.1042/0264-6021:3630777; Aoyama C, 2007, BBA-MOL CELL BIOL L, V1771, P1148, DOI 10.1016/j.bbalip.2007.07.003; Araki W, 1997, P NATL ACAD SCI USA, V94, P11946, DOI 10.1073/pnas.94.22.11946; Baburina I, 1999, J BIOL CHEM, V274, P9400, DOI 10.1074/jbc.274.14.9400; Bakovic M, 1999, BBA-MOL CELL BIOL L, V1438, P147, DOI 10.1016/S1388-1981(99)00042-6; Banchio C, 2003, J BIOL CHEM, V278, P32457, DOI 10.1074/jbc.M304810200; Canon E, 2004, MOL BIOL CELL, V15, P5583, DOI 10.1091/mbc.E04-05-0439; Cansev M, 2008, ALZHEIMERS DEMENT, V4, pS153, DOI 10.1016/j.jalz.2007.10.005; Carter JM, 2003, J BIOL CHEM, V278, P44988, DOI 10.1074/jbc.M307336200; Carter JM, 2008, J BIOL CHEM, V283, P202, DOI 10.1074/jbc.M706531200; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; Crowder RJ, 2004, J BIOL CHEM, V279, P42072, DOI 10.1074/jbc.M403726200; Darios F, 2006, NATURE, V440, P813, DOI 10.1038/nature04598; DECHAVES EP, 1995, J CELL BIOL, V128, P913, DOI 10.1083/jcb.128.5.913; DEHAUT F, 1993, NEUROSCI LETT, V161, P133, DOI 10.1016/0304-3940(93)90277-R; EASTER SS, 1993, J NEUROSCI, V13, P285; Fagone P, 2007, J BIOL CHEM, V282, P7591, DOI 10.1074/jbc.M608175200; Futerman AH, 1996, TRENDS NEUROSCI, V19, P144, DOI 10.1016/S0166-2236(96)80025-7; Ikemoto A, 1999, ARCH BIOCHEM BIOPHYS, V364, P67, DOI 10.1006/abbi.1999.1110; INFANTE JP, 1978, BIOCHEM J, V176, P631, DOI 10.1042/bj1760631; INFANTE JP, 1977, BIOCHEM J, V167, P847, DOI 10.1042/bj1670847; Iverson SJ, 2001, LIPIDS, V36, P1283, DOI 10.1007/s11745-001-0843-0; Jackowski S, 2005, J BIOL CHEM, V280, P853, DOI 10.1074/jbc.R400031200; Jackowski S, 2004, MOL CELL BIOL, V24, P4720, DOI 10.1128/MCB.24.11.4720-4733.2004; Jansen SM, 2001, J BIOL CHEM, V276, P18722, DOI 10.1074/jbc.M101817200; Karim M, 2003, BBA-MOL CELL BIOL L, V1633, P1, DOI 10.1016/S1388-1981(03)00067-2; Katsetos CD, 1998, ANAT RECORD, V250, P351; Kent C, 1997, BBA-LIPID LIPID MET, V1348, P79, DOI 10.1016/S0005-2760(97)00112-4; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; Lykidis A, 1998, J BIOL CHEM, V273, P14022, DOI 10.1074/jbc.273.22.14022; Marcucci H, 2008, BBA-MOL CELL BIOL L, V1781, P254, DOI 10.1016/j.bbalip.2008.03.006; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Marszalek JR, 2004, J BIOL CHEM, V279, P23882, DOI 10.1074/jbc.M313460200; OKUDA S, 1994, NEUROSCIENCE, V63, P691, DOI 10.1016/0306-4522(94)90515-0; Pitson SM, 2009, NEUROSIGNALS, V17, P242, DOI 10.1159/000231891; Reynolds CP, 2003, CANCER LETT, V197, P185, DOI 10.1016/S0304-3835(03)00108-3; Sato C, 2002, J BIOL CHEM, V277, P45299, DOI 10.1074/jbc.M206046200; SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6; SHEA TB, 1985, DEV BRAIN RES, V21, P307, DOI 10.1016/0165-3806(85)90220-2; SIDELL N, 1983, EXP CELL RES, V148, P21, DOI 10.1016/0014-4827(83)90184-2; Sriburi R, 2007, J BIOL CHEM, V282, P7024, DOI 10.1074/jbc.M609490200; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Vance DE, 1998, CURR OPIN LIPIDOL, V9, P125, DOI 10.1097/00041433-199804000-00008; Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/o03-073; VANCE JE, 1994, J NEUROCHEM, V62, P329; VANCE JE, 1995, NEUROBIOL AGING, V16, P493, DOI 10.1016/0197-4580(94)00180-9; VANCE JE, 1991, J CELL BIOL, V115, P1061, DOI 10.1083/jcb.115.4.1061; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; WILLIAM WCC, 2003, LIPIDS ANAL; WILLIAMS EJ, 1994, J NEUROCHEM, V62, P1231; YALCIN A, 2010, J ONCOGENE, V29, P139; Yanaka N, 2007, FEBS LETT, V581, P712, DOI 10.1016/j.febslet.2007.01.035	58	55	56	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25382	25393		10.1074/jbc.M110.139477	http://dx.doi.org/10.1074/jbc.M110.139477			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20525991	hybrid, Green Published			2022-12-27	WOS:000280682400031
J	Asari, A; Kanemitsu, T; Kurihara, H				Asari, Akira; Kanemitsu, Tomoyuki; Kurihara, Hitoshi			Oral Administration of High Molecular Weight Hyaluronan (900 kDa) Controls Immune System via Toll-like Receptor 4 in the Intestinal Epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-SELECTIN; CELL-DEATH; EXPRESSION; INFLAMMATION; MICE; LIPOPOLYSACCHARIDE; ARTHRITIS; OLIGOSACCHARIDES; INTERLEUKIN-10; RESPONSIVENESS	Low molecular weight hyaluronan enhances or induces inflammation through toll-like receptor 4 (TLR-4). However, the effects of high molecular weight hyaluronan (HA900) on TLR-4 are unknown. In this study, HA900 (900 kDa) was administered orally to MRL-lpr/lpr mice, a Th-1-type autoimmune disease model. Lymphoaccumulation of double-negative T cells, which is enhanced by proinflammatory cytokines, was suppressed by HA900 treatment. Cytokine array analysis showed that HA900 treatment enhanced production of interleukin-10, an anti-inflammatory cytokine, and down-regulated chemokine production. HA900 colocalized with TLR-4 on the luminal surface of epithelial cells in the large intestine. These cells are parts of the immune system and express cytokines. DNA array analysis of the tissue from the large intestine showed that HA900 treatment up-regulated suppressor of cytokine signaling 3 (SOCS3) expression and down-regulated pleiotrophin expression. Treatment of cultured double-negative T cells from MRL-lpr/lpr mice with pleiotrophin rescued these cells. SOCS3, which is known to suppress inflammation, was enhanced by HA900 treatment. In TLR-4 knockdown HT29 cells (a cell line derived from large intestinal cells), HA900 did not bind to HT29 cells and did not up-regulate SOCS3 expression. Our results suggest that oral administration of HA900 modulates Th-1-type autoimmune disease and inflammation by up-regulating SOCS3 expression and down-regulating pleiotrophin expression via TLR-4 in intestinal epithelial cells.	[Asari, Akira] Hyaluronan Res Inst Inc, Musashino, Tokyo 1800003, Japan; [Asari, Akira] Tokyo Med & Dent Univ, Dept Hard Tissue Engn, Div Biochem, Bunkyo Ku, Tokyo 1138459, Japan; [Kanemitsu, Tomoyuki; Kurihara, Hitoshi] QP Corp, Fuchu, Tokyo 1830034, Japan	Tokyo Medical & Dental University (TMDU)	Asari, A (corresponding author), Hyaluronan Res Inst Inc, 4-5-9 Kichijojiminami Cho, Musashino, Tokyo 1800003, Japan.	a.asari@hyaluronan.co.jp	Asari, Akira/AAU-9212-2021					Abreu MT, 2002, J BIOL CHEM, V277, P20431, DOI 10.1074/jbc.M110333200; Abreu MT, 2003, J ENDOTOXIN RES, V9, P322, DOI 10.1179/096805103225002593; Bocker U, 2003, INT J COLORECTAL DIS, V18, P25, DOI 10.1007/s00384-002-0415-6; Bonder CS, 2005, AM J PATHOL, V167, P1647, DOI 10.1016/S0002-9440(10)61248-5; Cassatella MA, 1999, BLOOD, V94, P2880, DOI 10.1182/blood.V94.8.2880.420k31_2880_2889; Ceponis A, 1998, J RHEUMATOL, V25, P2304; Clavel G, 2007, CLIN IMMUNOL, V124, P158, DOI 10.1016/j.clim.2007.04.014; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jo D, 2005, NAT MED, V11, P892, DOI 10.1038/nm1269; Kikawada E, 2003, J IMMUNOL, V170, P3915, DOI 10.4049/jimmunol.170.7.3915; LEE HG, 1994, ANAL BIOCHEM, V219, P278, DOI 10.1006/abio.1994.1267; Liu X, 1998, GLIA, V24, P390, DOI 10.1002/(SICI)1098-1136(199812)24:4<390::AID-GLIA4>3.0.CO;2-1; Maldonado MA, 1999, J IMMUNOL, V162, P6322; Mihaescu A, 2007, DIS COLON RECTUM, V50, P2194, DOI 10.1007/s10350-007-9065-7; Muto J, 2009, MOL IMMUNOL, V47, P449, DOI 10.1016/j.molimm.2009.08.026; Petit-Bertron AF, 2003, J LEUKOCYTE BIOL, V73, P145, DOI 10.1189/jlb.0802388; Pufe T, 2003, ARTHRITIS RHEUM, V48, P660, DOI 10.1002/art.10839; Qin HW, 2006, J IMMUNOL, V177, P7761, DOI 10.4049/jimmunol.177.11.7761; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; SCHUERERMALY CC, 1994, IMMUNOLOGY, V81, P85; Sivakumar PV, 2002, GUT, V50, P812, DOI 10.1136/gut.50.6.812; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Szczepanik AM, 2003, J ALZHEIMERS DIS, V5, P105, DOI 10.3233/JAD-2003-5205; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; VANHOUTEN N, 1992, J IMMUNOL, V149, P2513; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Xu HP, 2005, J BIOL CHEM, V280, P20879, DOI 10.1074/jbc.M411954200; Xu HP, 2001, J AUTOIMMUN, V16, P87, DOI 10.1006/jaut.2000.0468; Xu HP, 2002, J BIOL CHEM, V277, P17308, DOI 10.1074/jbc.M112371200	30	61	63	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24751	24758		10.1074/jbc.M110.104950	http://dx.doi.org/10.1074/jbc.M110.104950			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20504769	Green Published, hybrid			2022-12-27	WOS:000280542100047
J	Huskens, D; Ferir, G; Vermeire, K; Kehr, JC; Balzarini, J; Dittmann, E; Schols, D				Huskens, Dana; Ferir, Geoffrey; Vermeire, Kurt; Kehr, Jan-Christoph; Balzarini, Jan; Dittmann, Elke; Schols, Dominique			Microvirin, a Novel alpha(1,2)-Mannose-specific Lectin Isolated from Microcystis aeruginosa, Has Anti-HIV-1 Activity Comparable with That of Cyanovirin-N but a Much Higher Safety Profile	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN GP120; CD4 BINDING-SITE; INACTIVATING PROTEIN; GLYCOSYLATION SITES; PRADIMICIN-S; HIV; POTENT; MICROBICIDE; RESISTANCE	Microvirin (MVN), a recently isolated lectin from the cyanobacterium Microcystis aeruginosa PCC7806, shares 33% identity with the potent anti-human immunodeficiency virus (HIV) protein cyanovirin-N (CV-N) isolated from Nostoc ellipsosporum, and both lectins bind to similar carbohydrate structures. MVN is able to inhibit infection by a wide variety of HIV-1 laboratory-adapted strains and clinical isolates of different tropisms and subtypes in peripheral blood mononuclear cells. MVN also inhibits syncytium formation between persistently HIV-1-infected T cells and uninfected CD4(+) T cells and inhibits DC-SIGN-mediated HIV-1 binding and transmission to CD4(+) T cells. Long term passaging of HIV-1 exposed to dose-escalating concentrations of MVN resulted in the selection of a mutant virus with four deleted high mannose-type glycans in the envelope gp120. The MVN-resistant virus was still highly sensitive to various other carbohydrate binding lectins (e.g. CV-N, HHA, GNA, and UDA) but not anymore to the carbohydrate-specific 2G12 monoclonal antibody. Importantly, MVN is more than 50-fold less cytotoxic than CV-N. Also in sharp contrast to CV-N, MVN did not increase the level of the activation markers CD25, CD69, and HLA-DR in CD4(+) T lymphocytes, and subsequently, MVN did not enhance viral replication in pretreated peripheral blood mononuclear cells. Therefore, MVN may qualify as a useful lectin for potential microbicidal use based on its broad and potent antiviral activity and virtual lack of any stimulatory properties and cellular toxicity.	[Huskens, Dana; Ferir, Geoffrey; Vermeire, Kurt; Balzarini, Jan; Schols, Dominique] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium; [Kehr, Jan-Christoph; Dittmann, Elke] Humboldt Univ, Dept Mol Ecol, Inst Biol, D-10115 Berlin, Germany	KU Leuven; Humboldt University of Berlin	Schols, D (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Minderbroedersstr 10, B-3000 Louvain, Belgium.	Dominique.Schols@rega.kuleuven.be	Dittmann, Elke/B-4742-2018; Vermeire, Kurt/P-9992-2017; Schols, Dominique/AAC-1309-2021; Schols, Dominique/S-9057-2017	Dittmann, Elke/0000-0002-7549-7918; Vermeire, Kurt/0000-0003-1123-1907; Schols, Dominique/0000-0003-3256-5850; Schols, Dominique/0000-0003-3256-5850	K.U. Leuven [GOA 10/014]; Center of Excellence [EF/05/15]; Foundation of Scientific Research [FWO G-485-08]; European Commission	K.U. Leuven(KU Leuven); Center of Excellence; Foundation of Scientific Research; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Foundation Dormeur, Concerted Actions of the K.U. Leuven Grant GOA 10/014, Center of Excellence Grant EF/05/15, Foundation of Scientific Research Grant FWO G-485-08, and the CHAARM project of the European Commission.	Balzarini J, 2005, J BIOL CHEM, V280, P41005, DOI 10.1074/jbc.M508801200; Balzarini J, 2007, NAT REV MICROBIOL, V5, P583, DOI 10.1038/nrmicro1707; Balzarini J, 2007, MOL PHARMACOL, V71, P3, DOI 10.1124/mol.106.030155; Balzarini J, 2006, J VIROL, V80, P8411, DOI 10.1128/JVI.00369-06; Balzarini J, 2010, ANTIMICROB AGENTS CH, V54, P1425, DOI 10.1128/AAC.01347-09; Bewley CA, 2002, J MOL BIOL, V322, P881, DOI 10.1016/S0022-2836(02)00842-2; Bewley CA, 1998, NAT STRUCT BIOL, V5, P571, DOI 10.1038/828; Bewley CA, 2001, J AM CHEM SOC, V123, P3892, DOI 10.1021/ja004040e; Bolmstedt AJ, 2001, MOL PHARMACOL, V59, P949, DOI 10.1124/mol.59.5.949; Botos I, 2002, J BIOL CHEM, V277, P34336, DOI 10.1074/jbc.M205909200; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Esser MT, 1999, J VIROL, V73, P4360, DOI 10.1128/JVI.73.5.4360-4371.1999; Gavrovic-Jankulovic M, 2008, INT J BIOCHEM CELL B, V40, P929, DOI 10.1016/j.biocel.2007.10.033; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Huskens D, 2008, INT J BIOCHEM CELL B, V40, P2802, DOI 10.1016/j.biocel.2008.05.023; Huskens D, 2007, VIROLOGY, V360, P294, DOI 10.1016/j.virol.2006.10.027; Huskens D, 2009, ANTIVIR RES, V84, P38, DOI 10.1016/j.antiviral.2009.07.013; Jenabian MA, 2009, J ANTIMICROB CHEMOTH, V64, P1192, DOI 10.1093/jac/dkp380; *JOINT UN PROGR HI, 2008, REP GLOB AIDS EP; Kehr JC, 2006, MOL MICROBIOL, V59, P893, DOI 10.1111/j.1365-2958.2005.05001.x; KOSHTE VL, 1990, BIOCHEM J, V272, P721, DOI 10.1042/bj2720721; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Matei E, 2010, J BIOL CHEM, V285, P13057, DOI 10.1074/jbc.M109.094938; Mori T, 1997, BIOCHEM BIOPH RES CO, V238, P218, DOI 10.1006/bbrc.1997.7202; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; O'Keefe BR, 2009, P NATL ACAD SCI USA, V106, P6099, DOI 10.1073/pnas.0901506106; PAUWELS R, 1990, NATURE, V343, P470, DOI 10.1038/343470a0; Peumans WJ, 2000, PLANTA, V211, P546, DOI 10.1007/s004250000307; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; SAITOH K, 1993, J ANTIBIOT, V46, P580, DOI 10.7164/antibiotics.46.580; Schols D, 1997, J EXP MED, V186, P1383, DOI 10.1084/jem.186.8.1383; Shenoy SR, 2001, J PHARMACOL EXP THER, V297, P704; Swanson MD, 2010, J BIOL CHEM, V285, P8646, DOI 10.1074/jbc.M109.034926; Van Laethem K, 2005, J VIROL METHODS, V123, P25, DOI 10.1016/j.jviromet.2004.09.003; Vermeire K, 2004, AIDS, V18, P2115, DOI 10.1097/00002030-200411050-00003; West AP, 2009, J VIROL, V83, P98, DOI 10.1128/JVI.01564-08; Witvrouw M, 2005, J VIROL, V79, P7777, DOI 10.1128/JVI.79.12.7777-7784.2005; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514	44	91	95	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24845	24854		10.1074/jbc.M110.128546	http://dx.doi.org/10.1074/jbc.M110.128546			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20507987	Green Published, hybrid			2022-12-27	WOS:000280542100057
J	Fujii, S; Sawa, T; Ihara, H; Tong, KI; Ida, T; Okamoto, T; Ahtesham, AK; Ishima, Y; Motohashi, H; Yamamoto, M; Akaike, T				Fujii, Shigemoto; Sawa, Tomohiro; Ihara, Hideshi; Tong, Kit I.; Ida, Tomoaki; Okamoto, Tatsuya; Ahtesham, Ahmed Khandaker; Ishima, Yu; Motohashi, Hozumi; Yamamoto, Masayuki; Akaike, Takaaki			The Critical Role of Nitric Oxide Signaling, via Protein S-Guanylation and Nitrated Cyclic GMP, in the Antioxidant Adaptive Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS-RESPONSE; KEAP1 PROTEIN; DLG MOTIFS; INDUCTION; 8-NITROGUANOSINE; OXIDANTS; GROWTH; NRF2; LOCALIZATION; ACCUMULATION	A nitrated guanine nucleotide, 8-nitroguanosine 3',5'-cyclic monophosphate (8-nitro-cGMP), is formed via nitric oxide (NO) and causes protein S-guanylation. However, intracellular 8-nitro-cGMP levels and mechanisms of formation of 8-nitroc-GMP and S-guanylation are yet to be identified. In this study, we precisely quantified NO-dependent formation of 8-nitroc-GMP in C6 glioma cells via liquid chromatography-tandem mass spectrometry. Treatment of cells with S-nitroso-N-acetylpenicillamine led to a rapid, transient increase in cGMP, after which 8-nitro-cGMP increased linearly up to a peak value comparable with that of cGMP at 24 h and declined thereafter. Markedly high levels (>40 mu M) of 8-nitro-cGMP were also evident in C6 cells that had been stimulated to express inducible NO synthase with excessive NO production. The amount of 8-nitro-cGMP generated was comparable with or much higher than that of cGMP, whose production profile slightly preceded 8-nitro-cGMP formation in the activated inducible NO synthase-expressing cells. These unexpectedly large amounts of 8-nitro-cGMP suggest that GTP ( a substrate of cGMP biosynthesis), rather than cGMP per se, may undergo guanine nitration. Also, 8-nitro-cGMP caused S-guanylation of KEAP1 in cells, which led to Nrf2 activation and subsequent induction of antioxidant enzymes, including heme oxygenase-1; thus, 8-nitro-cGMP protected cells against cytotoxic effects of hydrogen peroxide. Proteomic analysis for endogenously modified KEAP1 with matrix-assisted laser desorption/ionization time-of-flight-tandem mass spectrometry revealed that 8-nitro-cGMP S-guanylated the Cys434 of KEAP1. The present report is therefore the first substantial corroboration of the biological significance of cellular 8-nitro-cGMP formation and potential roles of 8-nitro-cGMP in the Nrf2-dependent antioxidant response.	[Fujii, Shigemoto; Sawa, Tomohiro; Okamoto, Tatsuya; Ahtesham, Ahmed Khandaker; Ishima, Yu; Akaike, Takaaki] Kumamoto Univ, Grad Sch Med Sci, Dept Microbiol, Kumamoto 8608556, Japan; [Ihara, Hideshi; Ida, Tomoaki] Osaka Prefecture Univ, Grad Sch Sci, Dept Biol Sci, Osaka, Japan; [Tong, Kit I.; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi 9808575, Japan; [Motohashi, Hozumi] Tohoku Univ, Grad Sch Med, Ctr Radioisotope Sci, Sendai, Miyagi 9808575, Japan	Kumamoto University; Osaka Metropolitan University; Tohoku University; Tohoku University	Akaike, T (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Microbiol, 1-1-1 Honjo, Kumamoto 8608556, Japan.	takakaik@gpo.kumamoto-u.ac.jp	Motohashi, Hozumi/AAZ-2628-2020; Yamamoto, Masayuki/A-4873-2010; Ahmed, Khandaker Ahtesham/A-5326-2015	Yamamoto, Masayuki/0000-0002-9073-9436; Ahmed, Khandaker Ahtesham/0000-0003-3999-907X	Ministry of Education, Sciences, Sports and Technology (MEXT); Ministry of Health, Labor and Welfare of Japan; Tohoku University Global Centers of Excellence	Ministry of Education, Sciences, Sports and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Tohoku University Global Centers of Excellence	This work was supported in part by grants-in-aid for scientific research and grants-in-aid for scientific research on Innovative Areas (research in a proposed area) from the Ministry of Education, Sciences, Sports and Technology (MEXT) and the Targeted Protein Research Program promoted by MEXT. This work was also supported by grants from the Ministry of Health, Labor and Welfare of Japan and Tohoku University Global Centers of Excellence program for the Conquest of Diseases with Network Medicine.	Akaike T, 2003, P NATL ACAD SCI USA, V100, P685, DOI 10.1073/pnas.0235623100; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; Buckley BJ, 2008, FREE RADICAL BIO MED, V44, P692, DOI 10.1016/j.freeradbiomed.2007.10.055; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Dinkova-Kostova AT, 2005, CHEM RES TOXICOL, V18, P1779, DOI 10.1021/tx050217c; Doi K, 1999, BRIT J CANCER, V80, P1945, DOI 10.1038/sj.bjc.6690624; Eggler AL, 2007, CHEM RES TOXICOL, V20, P1878, DOI 10.1021/tx700217c; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Holland R, 2008, CHEM RES TOXICOL, V21, P2051, DOI 10.1021/tx800226m; Hur J, 2010, BIOCHEM BIOPH RES CO, V391, P1526, DOI 10.1016/j.bbrc.2009.12.114; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Kirkland RA, 2007, J NEUROSCI, V27, P11315, DOI 10.1523/JNEUROSCI.3590-07.2007; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Koppenol WH, 1996, METHOD ENZYMOL, V269, P296; Levonen AL, 2004, BIOCHEM J, V378, P373, DOI 10.1042/BJ20031049; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; MURAD F, 1986, J CLIN INVEST, V78, P1, DOI 10.1172/JCI112536; Ogura T, 2010, P NATL ACAD SCI USA, V107, P2842, DOI 10.1073/pnas.0914036107; Oh JY, 2008, BIOCHEM J, V411, P297, DOI [10.1042/BJ20071189, 10.1042/bj20071189]; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Saito Y, 2008, CHEM COMMUN, P5984, DOI 10.1039/b810771h; Sawa T, 2003, BIOCHEM BIOPH RES CO, V311, P300, DOI 10.1016/j.bbrc.2003.10.003; SAWA T, 2010, BIOCONJUG C IN PRESS; Sawa T, 2007, NAT CHEM BIOL, V3, P727, DOI 10.1038/nchembio.2007.33; Schopfer FJ, 2003, TRENDS BIOCHEM SCI, V28, P646, DOI 10.1016/j.tibs.2003.10.006; Tanaka S, 2003, BRIT J CANCER, V88, P902, DOI 10.1038/sj.bjc.6600830; Terasaki Y, 2006, AM J RESP CRIT CARE, V174, P665, DOI 10.1164/rccm.200510-1580OC; Tomita T, 1997, J BIOCHEM-TOKYO, V122, P531; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Tong KI, 2007, MOL CELL BIOL, V27, P7511, DOI 10.1128/MCB.00753-07; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Watai Y, 2007, GENES CELLS, V12, P1163, DOI 10.1111/j.1365-2443.2007.01118.x; Xu ZL, 2004, AM J PHYSIOL-HEART C, V286, pH1433, DOI 10.1152/ajpheart.00882.2003; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Yoshitake J, 2004, J VIROL, V78, P8709, DOI 10.1128/JVI.78.16.8709-8719.2004; Zaki MH, 2009, J IMMUNOL, V182, P3746, DOI 10.4049/jimmunol.0803363	41	116	121	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23970	23984		10.1074/jbc.M110.145441	http://dx.doi.org/10.1074/jbc.M110.145441			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20498371	Green Published, hybrid			2022-12-27	WOS:000280291400048
J	Mojzita, D; Penttila, M; Richard, P				Mojzita, Dominik; Penttila, Merja; Richard, Peter			Identification of an L-Arabinose Reductase Gene in Aspergillus niger and Its Role in L-Arabinose Catabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-XYLOSE REDUCTASE; HYPOCREA-JECORINA; EXPRESSION; METABOLISM; PATHWAY; PENTOSE; XYLAN; XLNR	The first enzyme in the pathway for L-arabinose catabolism in eukaryotic microorganisms is a reductase, reducing L-arabinose to L-arabitol. The enzymes catalyzing this reduction are in general nonspecific and would also reduce D-xylose to xylitol, the first step in eukaryotic D-xylose catabolism. It is not clear whether microorganisms use different enzymes depending on the carbon source. Here we show that Aspergillus niger makes use of two different enzymes. We identified, cloned, and characterized an L-arabinose reductase, larA, that is different from the D-xylose reductase, xyrA. The larA is up-regulated on L-arabinose, while the xyrA is up-regulated on D-xylose. There is however an initial up-regulation of larA also on D-xylose but that fades away after about 4 h. The deletion of the larA gene in A. niger results in a slow growth phenotype on Larabinose, whereas the growth on D-xylose is unaffected. The L-arabinose reductase can convert L-arabinose and D-xylose to their corresponding sugar alcohols but has a higher affinity for L-arabinose. The K-m for L-arabinose is 54 +/- 6 mM and for D-xylose 155 +/- 15 mM.	[Mojzita, Dominik; Penttila, Merja; Richard, Peter] VTT Tech Res Ctr Finland, Espoo 02044, VTT, Finland	VTT Technical Research Center Finland	Richard, P (corresponding author), VTT Tech Res Ctr Finland, Tietotie 2,POB 1500, Espoo 02044, VTT, Finland.	Peter.Richard@vtt.fi	Richard, Peter/A-4229-2009; Penttilä, Merja E/A-4710-2013	Richard, Peter/0000-0003-0922-6092; Penttila, Merja/0000-0002-6929-1032; Mojzita, Dominik/0000-0001-6078-4503	Academy of Finland through the Finnish Centre of Excellence in White Biotechnology, Green Chemistry; Academy Research Fellowship	Academy of Finland through the Finnish Centre of Excellence in White Biotechnology, Green Chemistry(Academy of Finland); Academy Research Fellowship(Academy of Finland)	This work was supported by the Academy of Finland through the Finnish Centre of Excellence in White Biotechnology, Green Chemistry, and an Academy Research Fellowship (to P. R.).	Akel E, 2009, EUKARYOT CELL, V8, P1837, DOI 10.1128/EC.00162-09; Andersen MR, 2008, P NATL ACAD SCI USA, V105, P4387, DOI 10.1073/pnas.0709964105; BOHREN KM, 1989, J BIOL CHEM, V264, P9547; de Groot MJL, 2007, FOOD TECHNOL BIOTECH, V45, P134; de Groot MJL, 2005, BIOTECHNOL PROGR, V21, P1610, DOI 10.1021/bp050189o; de Groot MJL, 2003, MICROBIOL-SGM, V149, P1183, DOI 10.1099/mic.0.25993-0; DEVRIES RP, 1994, FEMS MICROBIOL LETT, V123, P83, DOI 10.1016/0378-1097(94)90278-X; Hasper AA, 2000, MOL MICROBIOL, V36, P193, DOI 10.1046/j.1365-2958.2000.01843.x; Jorgensen TR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-44; Mojzita D, 2010, APPL ENVIRON MICROB, V76, P169, DOI 10.1128/AEM.02273-09; Noguchi Y, 2009, APPL MICROBIOL BIOT, V85, P141, DOI 10.1007/s00253-009-2236-9; Richard P, 2001, J BIOL CHEM, V276, P40631, DOI 10.1074/jbc.M104022200; Seiboth B, 2003, EUKARYOT CELL, V2, P867, DOI 10.1128/EC.2.5.867-875.2003; Seiboth B, 2007, MOL MICROBIOL, V66, P890, DOI 10.1111/j.1365-2958.2007.05953.x; Sherman F., 1983, METHODS YEAST GENETI; van Peij NNME, 1998, MOL MICROBIOL, V27, P131, DOI 10.1046/j.1365-2958.1998.00666.x; vanKuyk PA, 2001, EUR J BIOCHEM, V268, P5414, DOI 10.1046/j.0014-2956.2001.02482.x; WITTEVEEN CFB, 1989, J GEN MICROBIOL, V135, P2163; WITTEVEEN CFB, 1994, MICROBIOL-SGM, V140, P1679, DOI 10.1099/13500872-140-7-1679	19	34	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23622	23628		10.1074/jbc.M110.113399	http://dx.doi.org/10.1074/jbc.M110.113399			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20511228	Green Published, hybrid			2022-12-27	WOS:000280291400012
J	Sakr, S; Cirinesi, AM; Ullers, RS; Schwager, F; Georgopoulos, C; Genevaux, P				Sakr, Samer; Cirinesi, Anne-Marie; Ullers, Ronald S.; Schwager, Francoise; Georgopoulos, Costa; Genevaux, Pierre			Lon Protease Quality Control of Presecretory Proteins in Escherichia coli and Its Dependence on the SecB and DnaJ (Hsp40) Chaperones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; NEWLY SYNTHESIZED PROTEINS; TRIGGER FACTOR; MOLECULAR CHAPERONES; ATPASE ACTIVITY; SUBSTRATE-SPECIFICITY; PLASMA-MEMBRANE; NASCENT CHAINS; J-DOMAIN; EXPORT	Various environmental insults result in irreversible damage to proteins and protein complexes. To cope, cells have evolved dedicated protein quality control mechanisms involving molecular chaperones and proteases. Here, we provide both genetic and biochemical evidence that the Lon protease and the SecB and DnaJ/Hsp40 chaperones are involved in the quality control of presecretory proteins in Escherichia coli. We showed that mutations in the lon gene alleviate the cold-sensitive phenotype of a secB mutant. Such suppression was not observed with either clpP or clpQ protease mutants. In comparison to the respective single mutants, the double secB lon mutant strongly accumulates aggregates of SecB substrates at physiological temperatures, suggesting that the chaperone and the protease share substrates. These observations were extended in vitro by showing that the main substrates identified in secB lon aggregates, namely proOmpF and proOmpC, are highly sensitive to specific degradation by Lon. In contrast, both substrates are significantly protected from Lon degradation by SecB. Interestingly, the chaperone DnaJ by itself protects substrates better from Lon degradation than SecB or the complete DnaK/DnaJ/GrpE chaperone machinery. In agreement with this finding, a DnaJ mutant protein that does not functionally interact in vivo with DnaK efficiently suppresses the SecB cold-sensitive phenotype, highlighting the role of DnaJ in assisting presecretory proteins. Taken together, our data suggest that when the Sec secretion pathway is compromised, a pool of presecretory proteins is transiently maintained in a translocation-competent state and, thus, protected from Lon degradation by either the SecB or DnaJ chaperones.	[Sakr, Samer; Cirinesi, Anne-Marie; Genevaux, Pierre] CNRS, LMGM, F-31062 Toulouse 9, France; [Sakr, Samer; Cirinesi, Anne-Marie; Genevaux, Pierre] Univ Toulouse 3, F-31062 Toulouse 9, France; [Ullers, Ronald S.; Schwager, Francoise; Georgopoulos, Costa] Ctr Med Univ Geneva, Dept Microbiol & Med Mol, CH-1211 Geneva, Switzerland; [Georgopoulos, Costa] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Geneva; Utah System of Higher Education; University of Utah	Genevaux, P (corresponding author), CNRS, LMGM, 118 Route Narbonne, F-31062 Toulouse 9, France.	genevaux@ibcg.biotoul.fr	Genevaux, Pierre/A-4851-2015	GENEVAUX, Pierre/0000-0001-7539-3126	CNRS; Fond National Swiss [FN-3100A0-114063]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Fond National Swiss	This work was supported by a CNRS ATIP grant (to P. G.) and by Fond National Swiss Grant FN-3100A0-114063 (to C. G. and P. G.).	ALTMAN E, 1991, EMBO J, V10, P239, DOI 10.1002/j.1460-2075.1991.tb07943.x; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Baars L, 2006, J BIOL CHEM, V281, P10024, DOI 10.1074/jbc.M509929200; BACHMANN BJ, 1972, BACTERIOL REV, V36, P525, DOI 10.1128/MMBR.36.4.525-557.1972; Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Bernstein KD, 2001, J BACTERIOL, V183, P2187, DOI 10.1128/JB.183.7.2187-2197.2001; Bochkareva E, 1996, J BIOL CHEM, V271, P22256, DOI 10.1074/jbc.271.36.22256; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Chapman E, 2006, P NATL ACAD SCI USA, V103, P15800, DOI 10.1073/pnas.0607534103; CHUNG CH, 1981, P NATL ACAD SCI-BIOL, V78, P4931, DOI 10.1073/pnas.78.8.4931; CROOKE E, 1987, P NATL ACAD SCI USA, V84, P5216, DOI 10.1073/pnas.84.15.5216; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dekker C, 2003, J STRUCT BIOL, V144, P313, DOI 10.1016/j.jsb.2003.09.012; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Diamond DL, 1997, J BIOL CHEM, V272, P28994, DOI 10.1074/jbc.272.46.28994; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; ELLIS J, 1987, NATURE, V328, P378, DOI 10.1038/328378a0; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Genevaux P, 2004, EMBO REP, V5, P195, DOI 10.1038/sj.embor.7400067; Genevaux P, 2007, MOL MICROBIOL, V66, P840, DOI 10.1111/j.1365-2958.2007.05961.x; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Gottesman S, 1997, GENE DEV, V11, P815, DOI 10.1101/gad.11.7.815; Gouridis G, 2009, NATURE, V462, P363, DOI 10.1038/nature08559; Gur E, 2008, GENE DEV, V22, P2267, DOI 10.1101/gad.1670908; Gur E, 2009, P NATL ACAD SCI USA, V106, P18503, DOI 10.1073/pnas.0910392106; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HOWARDFLANDERS P, 1964, GENETICS, V49, P237; Jong WSP, 2004, EUR J BIOCHEM, V271, P4779, DOI 10.1111/j.1432-1033.2004.04442.x; Jubete Y, 1996, J BIOL CHEM, V271, P30798, DOI 10.1074/jbc.271.48.30798; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; KANG PJ, 1990, J BACTERIOL, V172, P2055, DOI 10.1128/jb.172.4.2055-2064.1990; Karamyshev AL, 2005, J BIOL CHEM, V280, P37930, DOI 10.1074/jbc.M509100200; Kelley WL, 1997, P NATL ACAD SCI USA, V94, P3679, DOI 10.1073/pnas.94.8.3679; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Knoblauch NTM, 1999, J BIOL CHEM, V274, P34219, DOI 10.1074/jbc.274.48.34219; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; KUMAMOTO CA, 1983, J BACTERIOL, V154, P253, DOI 10.1128/JB.154.1.253-260.1983; KUMAMOTO CA, 1985, J BACTERIOL, V163, P267, DOI 10.1128/JB.163.1.267-274.1985; Lee HC, 2002, J BIOL CHEM, V277, P43527, DOI 10.1074/jbc.M205950200; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; LILL R, 1988, CELL, V54, P1013, DOI 10.1016/0092-8674(88)90116-X; Lilly AA, 2009, PROTEIN SCI, V18, P1860, DOI 10.1002/pro.197; Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246; Merz F, 2008, EMBO J, V27, P1622, DOI 10.1038/emboj.2008.89; Miller J.H., 1992, SHORT COURSE BACTERI, P150; OLIVER DB, 1981, CELL, V25, P765, DOI 10.1016/0092-8674(81)90184-7; PAINBENI E, 1993, J MOL BIOL, V234, P1021, DOI 10.1006/jmbi.1993.1656; Qi HY, 2002, J BIOL CHEM, V277, P51077, DOI 10.1074/jbc.M209238200; Randall LL, 2002, CELL MOL LIFE SCI, V59, P1617, DOI 10.1007/PL00012488; RIGGS PD, 1988, GENETICS, V118, P571; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Rotanova TV, 2006, PROTEIN SCI, V15, P1815, DOI 10.1110/ps.052069306; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Scherl A, 2002, MOL BIOL CELL, V13, P4100, DOI 10.1091/mbc.E02-05-0271; Schierle CF, 2003, J BACTERIOL, V185, P5706, DOI 10.1128/JB.185.19.5706-5713.2003; Sharma SK, 2009, CURR PROTEIN PEPT SC, V10, P432, DOI 10.2174/138920309789351930; Shimohata N, 2007, J CELL BIOL, V176, P307, DOI 10.1083/jcb.200611121; Siegenthaler RK, 2006, J BIOL CHEM, V281, P34448, DOI 10.1074/jbc.M606382200; SNYDER WB, 1992, J BACTERIOL, V174, P5661, DOI 10.1128/JB.174.17.5661-5668.1992; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; Tsilibaris V, 2006, RES MICROBIOL, V157, P701, DOI 10.1016/j.resmic.2006.05.004; Ullers RS, 2007, P NATL ACAD SCI USA, V104, P3101, DOI 10.1073/pnas.0608232104; Ullers RS, 2004, P NATL ACAD SCI USA, V101, P7583, DOI 10.1073/pnas.0402398101; van der Sluis EO, 2006, TRENDS MICROBIOL, V14, P105, DOI 10.1016/j.tim.2006.01.009; van Melderen L, 1999, P NATL ACAD SCI USA, V96, P6064, DOI 10.1073/pnas.96.11.6064; WALL D, 1994, J BIOL CHEM, V269, P5446; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; WEI SQ, 1994, J BIOL CHEM, V269, P1648; WILD J, 1992, GENE DEV, V6, P1165, DOI 10.1101/gad.6.7.1165; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; ZYLICZ M, 1987, J BIOL CHEM, V262, P17437	78	23	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23504	23512		10.1074/jbc.M110.133058	http://dx.doi.org/10.1074/jbc.M110.133058			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20504766	Green Published, hybrid			2022-12-27	WOS:000279999900082
J	Heilig, EA; Xia, WM; Shen, J; Kelleher, RJ				Heilig, Elizabeth A.; Xia, Weiming; Shen, Jie; Kelleher, Raymond J., III			A Presenilin-1 Mutation Identified in Familial Alzheimer Disease with Cotton Wool Plaques Causes a Nearly Complete Loss of gamma-Secretase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; TERMINAL PAL MOTIF; A-BETA; INTRACELLULAR DOMAINS; SPASTIC PARAPARESIS; MEMORY IMPAIRMENTS; CATALYTIC SITE; APP; DEPOSITION; STABILIZATION	Mutations in presenilin-1 and presenilin-2 (PS1 and PS2) are the most common cause of familial Alzheimer disease. PS1 and PS2 are the presumptive catalytic components of the multisub-unit gamma-secretase complex, which proteolyzes a number of type I transmembrane proteins, including the amyloid precursor protein (APP) and Notch. APP processing by gamma-secretase produces beta-amyloid peptides (A beta 40 and A beta 42) that accumulate in the Alzheimer disease brain. Here we identify a pathogenic L435F mutation in PS1 in two affected siblings with early-onset familial Alzheimer disease characterized by deposition of cerebral cotton wool plaques. The L435F mutation resides in a conserved C-terminal PAL sequence implicated in active site conformation and catalytic activity. The impact of PS1 mutations in and around the PAL motif on gamma-secretase activity was assessed by expression of mutant PS1 in mouse embryo fibroblasts lacking endogenous PS1 and PS2. Surprisingly, the L435F mutation caused a nearly complete loss of gamma-secretase activity, including > 90% reductions in the generation of A beta 40, A beta 42, and the APP and Notch intracellular domains. Two nonpathogenic PS1 mutations, P433L and L435R, caused essentially complete loss of gamma-secretase activity, whereas two previously identified pathogenic PS1 mutations, P436Q and P436S, caused partial loss of function with substantial reductions in production of A beta 40, A beta 42, and the APP and Notch intracellular domains. These results argue against overproduction of A beta 42 as an essential property of presenilin proteins bearing pathogenic mutations. Rather, our findings provide support for the hypothesis that pathogenic mutations cause a general loss of presenilin function.	[Heilig, Elizabeth A.; Kelleher, Raymond J., III] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Heilig, Elizabeth A.; Kelleher, Raymond J., III] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Xia, Weiming; Shen, Jie] Brigham & Womens Hosp, Dept Neurol, Ctr Neurol Dis, Boston, MA 02115 USA; [Heilig, Elizabeth A.; Xia, Weiming; Shen, Jie; Kelleher, Raymond J., III] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Heilig, Elizabeth A.; Xia, Weiming; Shen, Jie; Kelleher, Raymond J., III] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Kelleher, RJ (corresponding author), MGH Simches Res Ctr, CPZN 6234,185 Cambridge St, Boston, MA 02114 USA.	kelleher@helix.mgh.harvard.edu	xia, weiming/E-5465-2016; Shen, Jie/GXH-9449-2022	xia, weiming/0000-0002-7463-3295; 	Alzheimer's Association; National Institutes of Health (NINDS) [R01 NS41783]; National Institutes of Health Training [T32 AG000222-18]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041783, R01NS075346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000222] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); National Institutes of Health (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by grants from the Alzheimer's Association (to J.S. and R.J.K.) and by National Institutes of Health Grant R01 NS41783 (NINDS; to J.S.).; Supported by National Institutes of Health Training Grant T32 AG000222-18.	Ancolio K, 1999, P NATL ACAD SCI USA, V96, P4119, DOI 10.1073/pnas.96.7.4119; Arduengo PM, 1998, J CELL SCI, V111, P3645; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Brunkan AL, 2005, J NEUROCHEM, V93, P769, DOI 10.1111/j.1471-4159.2005.03099.x; Campbell WA, 2002, BIOCHEMISTRY-US, V41, P3372, DOI 10.1021/bi015810h; Cervantes S, 2004, J BIOL CHEM, V279, P36519, DOI 10.1074/jbc.M404832200; Chen FS, 2002, J BIOL CHEM, V277, P36521, DOI 10.1074/jbc.M205093200; Citron M, 1996, P NATL ACAD SCI USA, V93, P13170, DOI 10.1073/pnas.93.23.13170; Clarke EE, 2006, J BIOL CHEM, V281, P31279, DOI 10.1074/jbc.M605051200; Crook R, 1998, NAT MED, V4, P452, DOI 10.1038/nm0498-452; Dewachter I, 2002, J NEUROSCI, V22, P3445; Durkin JT, 1999, J BIOL CHEM, V274, P20499, DOI 10.1074/jbc.274.29.20499; Guo YQ, 1999, J NEUROSCI, V19, P8435; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Houlden H, 2000, ANN NEUROL, V48, P806, DOI 10.1002/1531-8249(200011)48:5<806::AID-ANA18>3.0.CO;2-F; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Irizarry MC, 1997, J NEUROSCI, V17, P7053; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Jankowsky JL, 2004, NEUROBIOL AGING, V25, P885, DOI 10.1016/j.neurobiolaging.2003.09.008; Karlstrom H, 2008, J NEUROCHEM, V104, P573, DOI 10.1111/j.1471-4159.2007.05038.x; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Kumar-Singh S, 2006, HUM MUTAT, V27, P686, DOI 10.1002/humu.20336; Kwok JBJ, 2003, J BIOL CHEM, V278, P6748, DOI 10.1074/jbc.M211827200; Leem JY, 2002, J BIOL CHEM, V277, P19236, DOI 10.1074/jbc.C200148200; Levitan D, 1996, P NATL ACAD SCI USA, V93, P14940, DOI 10.1073/pnas.93.25.14940; Martoglio B, 2003, HUM MOL GENET, V12, pR201, DOI 10.1093/hmg/ddg303; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; Nakaya Y, 2005, J BIOL CHEM, V280, P19070, DOI 10.1074/jbc.M501130200; Pardossi-Piquard R, 2006, J NEUROCHEM, V97, P1052, DOI 10.1111/j.1471-4159.2006.03822.x; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Rogaeva EA, 2001, NEUROLOGY, V57, P621, DOI 10.1212/WNL.57.4.621; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato T, 2003, J BIOL CHEM, V278, P24294, DOI 10.1074/jbc.M211161200; Saura CA, 2005, J NEUROSCI, V25, P6755, DOI 10.1523/JNEUROSCI.1247-05.2005; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Shimojo M, 2007, NEUROSCI RES, V57, P446, DOI 10.1016/j.neures.2006.12.005; Siman R, 2000, J NEUROSCI, V20, P8717; Steiner H, 1999, J BIOL CHEM, V274, P7615, DOI 10.1074/jbc.274.12.7615; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Sun XY, 2005, NEURODEGENER DIS, V2, P6, DOI 10.1159/000086426; Tandon Anurag, 2000, Current Opinion in Neurology, V13, P377, DOI 10.1097/00019052-200008000-00003; Tolia A, 2008, J BIOL CHEM, V283, P19793, DOI 10.1074/jbc.M802461200; Tomita T, 2001, J BIOL CHEM, V276, P33273, DOI 10.1074/jbc.M011152200; Uemura K, 2006, NEUROSCI LETT, V402, P278, DOI 10.1016/j.neulet.2006.04.018; Walker ES, 2005, J NEUROCHEM, V92, P294, DOI 10.1111/j.1471-4159.2004.02858.x; Wang J, 2006, J NEUROCHEM, V96, P218, DOI 10.1111/j.1471-4159.2005.03548.x; Wang J, 2004, NEUROBIOL DIS, V15, P654, DOI 10.1016/j.nbd.2003.12.008; Wang RS, 2006, J BIOL CHEM, V281, P15330, DOI 10.1074/jbc.M512574200; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P4720, DOI 10.1021/bi982562p; Zhang LL, 2001, BIOCHEMISTRY-US, V40, P5049, DOI 10.1021/bi0028800	58	64	65	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22350	22359		10.1074/jbc.M110.116962	http://dx.doi.org/10.1074/jbc.M110.116962			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20460383	hybrid, Green Published			2022-12-27	WOS:000279702200048
J	Lee, YS; Choi, JW; Hwang, I; Lee, JW; Lee, JH; Kim, AY; Huh, JY; Koh, YJ; Koh, GY; Son, HJ; Masuzaki, H; Hotta, K; Alfadda, AA; Kim, JB				Lee, Yun Sok; Choi, Jin Woo; Hwang, Injae; Lee, Joo Won; Lee, Jae Ho; Kim, A. Young; Huh, Jin Young; Koh, Young Jun; Koh, Gou Young; Son, Hee Jung; Masuzaki, Hiroaki; Hotta, Kikuko; Alfadda, Assim A.; Kim, Jae Bum			Adipocytokine Orosomucoid Integrates Inflammatory and Metabolic Signals to Preserve Energy Homeostasis by Resolving Immoderate Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; ACUTE-PHASE PROTEIN; INSULIN-RESISTANCE; ADIPOSE-TISSUE; ALPHA(1)-ACID GLYCOPROTEIN; 3T3-L1 ADIPOCYTES; OXIDATIVE STRESS; ALPHA-1-ACID GLYCOPROTEIN; GENE-EXPRESSION; BINDING-PROTEIN	Orosomucoid (ORM), also called alpha-1 acid glycoprotein, is an abundant plasma protein that is an immunomodulator induced by stressful conditions such as infections. In this study, we reveal that Orm is induced selectively in the adipose tissue of obese mice to suppress excess inflammation that otherwise disturbs energy homeostasis. Adipose Orm levels were elevated by metabolic signals, including insulin, high glucose, and free fatty acid, as well as by the proinflammatory cytokine tumor necrosis factor-alpha, which is found in increased levels in the adipose tissue of morbid obese subjects. In both adipocytes and macrophages, ORM suppressed proinflammatory gene expression and pathways such as NF-kappa B and mitogen-activated protein kinase signalings and reactive oxygen species generation. Concomitantly, ORM relieved hyperglycemia-induced insulin resistance as well as tumor necrosis factor-alpha-mediated lipolysis in adipocytes. Accordingly, ORM improved glucose and insulin tolerance in obese and diabetic db/db mice. Taken together, our results suggest that ORM integrates inflammatory and metabolic signals to modulate immune responses to protect adipose tissue from excessive inflammation and thereby from metabolic dysfunction.	[Lee, Yun Sok; Choi, Jin Woo; Hwang, Injae; Lee, Joo Won; Lee, Jae Ho; Kim, A. Young; Huh, Jin Young; Kim, Jae Bum] Seoul Natl Univ, Inst Mol Biol & Genet, Seoul 151742, South Korea; [Lee, Yun Sok; Choi, Jin Woo; Hwang, Injae; Lee, Joo Won; Lee, Jae Ho; Kim, A. Young; Huh, Jin Young; Kim, Jae Bum] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Koh, Young Jun; Koh, Gou Young] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Son, Hee Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul 135710, South Korea; [Son, Hee Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Hlth Promot, Seoul 135710, South Korea; [Masuzaki, Hiroaki] Univ Ryukyus, Grad Sch Med, Dept Internal Med 2, Okinawa 9030215, Japan; [Hotta, Kikuko] RIKEN, SNP Res Ctr, Kanagawa 2300045, Japan; [Alfadda, Assim A.] King Saud Univ, Coll Med, Obes Res Ctr, Riyadh 11461, Saudi Arabia; [Alfadda, Assim A.] King Saud Univ, Coll Med, Dept Med, Riyadh 11461, Saudi Arabia; [Kim, Jae Bum] Seoul Natl Univ, Dept Biophys & Chem Biol, Seoul 151742, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST); Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; University of the Ryukyus; RIKEN; King Saud University; King Saud University; Seoul National University (SNU)	Kim, JB (corresponding author), Seoul Natl Univ, Inst Mol Biol & Genet, San 56-1, Seoul 151742, South Korea.	jaebkim@snu.ac.kr	Koh, Gou Young/C-1615-2011; Huh, Jin Young/AAN-5652-2020; Alfadda, Assim/AAF-4499-2020; Lee, Yun Sok/B-3265-2015; Alfadda, Assim/AAT-8023-2020; Lee, Yun Sok/ABC-9195-2021; Song, Minsun/I-5701-2015	Lee, Yun Sok/0000-0001-7967-4734; Alfadda, Assim/0000-0002-4792-5188; Lee, Yun Sok/0000-0001-7967-4734; Hotta, Kikuko/0000-0003-2427-6354; Huh, Jin Young/0000-0002-0980-7199; KIM, Jae Bum/0000-0003-2337-6935	Korea Science and Engineering Foundation; Ministry of Education, Science and Technology [SC-3230, 20090083340, 20090091913]; National Plan of Science and Technology, King Abdulaziz City of Science and Technology, Riyadh, Saudi Arabia	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Plan of Science and Technology, King Abdulaziz City of Science and Technology, Riyadh, Saudi Arabia	This work was supported in part by grants from the Korea Science and Engineering Foundation, Korean Research Foundation Grants SC-3230, 20090083340, and 20090091913 funded by the Ministry of Education, Science and Technology, and by the National Plan of Science and Technology, King Abdulaziz City of Science and Technology, Riyadh, Saudi Arabia.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Atemezem A, 2001, BIOCHEM J, V356, P121, DOI 10.1042/0264-6021:3560121; Boncela J, 2006, J BIOL CHEM, V281, P1066, DOI 10.1074/jbc.M506303200; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; CURRY FE, 1989, AM J PHYSIOL, V257, pH1354, DOI 10.1152/ajpheart.1989.257.5.H1354; Fournier T, 2000, BBA-PROTEIN STRUCT M, V1482, P157, DOI 10.1016/S0167-4838(00)00153-9; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; Ge XM, 2008, FREE RADICAL RES, V42, P582, DOI 10.1080/10715760802158448; Gunnarsson P, 2007, FASEB J, V21, P4059, DOI 10.1096/fj.07-8534com; HARALDSSON B, 1987, ACTA PHYSIOL SCAND, V129, P127, DOI 10.1111/j.1748-1716.1987.tb08047.x; Hochepied T, 2003, CYTOKINE GROWTH F R, V14, P25, DOI 10.1016/S1359-6101(02)00054-0; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2005, DIABETES, V54, pS73, DOI 10.2337/diabetes.54.suppl_2.S73; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Juge-Aubry CE, 2005, CYTOKINE, V29, P270, DOI 10.1016/j.cyto.2004.10.017; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Lee YS, 2003, NUCLEIC ACIDS RES, V31, P7165, DOI 10.1093/nar/gkg934; Lee YS, 2008, MOL ENDOCRINOL, V22, P2176, DOI 10.1210/me.2008-0023; Lee YS, 2007, MOL CELL BIOL, V27, P438, DOI 10.1128/MCB.00490-06; LIBERT C, 1994, J EXP MED, V180, P1571, DOI 10.1084/jem.180.4.1571; Libert C, 1998, TRANSGENIC RES, V7, P429, DOI 10.1023/A:1008810429645; Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200; Lin Y, 2001, J BIOL CHEM, V276, P42077, DOI 10.1074/jbc.M107101200; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; Ojala PJ, 2006, BIOCHEMISTRY-US, V45, P14021, DOI 10.1021/bi061657l; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Park SK, 2004, DIABETES, V53, P2757, DOI 10.2337/diabetes.53.11.2757; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; SCHONRICH G, 1992, EUR J IMMUNOL, V22, P1687, DOI 10.1002/eji.1830220704; Souza SC, 2003, J CELL BIOCHEM, V89, P1077, DOI 10.1002/jcb.10565; Souza SC, 1998, J BIOL CHEM, V273, P24665, DOI 10.1074/jbc.273.38.24665; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2007, CELL, V129, P537, DOI 10.1016/j.cell.2007.02.049; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhang HH, 2002, DIABETES, V51, P2929, DOI 10.2337/diabetes.51.10.2929; Zsila F, 2008, BIOCHEM BIOPH RES CO, V372, P503, DOI 10.1016/j.bbrc.2008.05.090; Zu LX, 2008, MOL PHARMACOL, V73, P215, DOI 10.1124/mol.107.039479	44	95	97	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22174	22185		10.1074/jbc.M109.085464	http://dx.doi.org/10.1074/jbc.M109.085464			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20442402	Green Published, hybrid			2022-12-27	WOS:000279702200030
J	Sakurai, A; Maruyama, F; Funao, J; Nozawa, T; Aikawa, C; Okahashi, N; Shintani, S; Hamada, S; Ooshima, T; Nakagawa, I				Sakurai, Atsuo; Maruyama, Fumito; Funao, Junko; Nozawa, Takashi; Aikawa, Chihiro; Okahashi, Nobuo; Shintani, Seikou; Hamada, Shigeyuki; Ooshima, Takashi; Nakagawa, Ichiro			Specific Behavior of Intracellular Streptococcus pyogenes That Has Undergone Autophagic Degradation Is Associated with Bacterial Streptolysin O and Host Small G Proteins Rab5 and Rab7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCUS; FIBRONECTIN-BINDING PROTEIN; LISTERIA-MONOCYTOGENES; EPITHELIAL-CELLS; MAMMALIAN-CELLS; RECEPTOR; PATHWAYS; SURVIVAL; STRAINS; GROWTH	Streptococcus pyogenes (group A streptococcus (GAS)) is a pathogen that invades non-phagocytic host cells, and causes a variety of acute infections such as pharyngitis. Our group previously reported that intracellular GAS is effectively degraded by the host-cell autophagic machinery, and that a cholesterol-dependent cytolysin, streptolysin O (SLO), is associated with bacterial escape from endosomes in epithelial cells. However, the details of both the intracellular behavior of GAS and the process leading to its autophagic degradation remain unknown. In this study, we found that two host small G proteins, Rab5 and Rab7, were associated with the pathway of autophagosome formation and the fate of intracellular GAS. Rab5 was involved in bacterial invasion and endosome fusion. Rab7 was clearly multifunctional, with roles in bacterial invasion, endosome maturation, and autophagosome formation. In addition, this study showed that the bacterial cytolysin SLO supported the escape of GAS into the cytoplasm from endosomes, and surprisingly, a SLO-deficient mutant of GAS was viable longer than the wild-type strain although it failed to escape the endosomes. This intracellular behavior of GAS is unique and distinct from that of other types of bacterial invaders. Our results provide a new picture of GAS infection and host-cell responses in epithelial cells.	[Sakurai, Atsuo; Funao, Junko; Ooshima, Takashi] Osaka Univ, Grad Sch Dent, Dept Pediat Dent, Suita, Osaka 5650871, Japan; [Sakurai, Atsuo; Shintani, Seikou] Tokyo Dent Coll, Dept Pediat Dent, Mihama Ku, Chiba 2618502, Japan; [Shintani, Seikou] Tokyo Dent Coll, Oral Hlth Sci Ctr, Hrc7, Mihama Ku, Chiba 2618502, Japan; [Maruyama, Fumito] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Nozawa, Takashi; Aikawa, Chihiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Bacterial Pathogenesis, Bunkyo Ku, Tokyo 1138510, Japan; [Nozawa, Takashi; Aikawa, Chihiro; Nakagawa, Ichiro] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba 2778562, Japan; [Okahashi, Nobuo] Osaka Univ, Grad Sch Dent, Dept Oral Frontier Biol, Suita, Osaka 5650871, Japan; [Hamada, Shigeyuki] Minist Publ Hlth, Res Collaborat Ctr Emerging & Reemerging Infect R, Dept Med Sci, Muang Nonthaburi 11000, Thailand	Osaka University; Tokyo Dental College; Tokyo Dental College; Tokyo Institute of Technology; Tokyo Medical & Dental University (TMDU); University of Tokyo; Osaka University; Ministry of Public Health - Thailand	Ooshima, T (corresponding author), Osaka Univ, Grad Sch Dent, Dept Pediat Dent, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ooshima@dent.osaka-u.ac.jp	okahashi, nobuo/A-4032-2010; Maruyama, Fumito/AAK-5928-2020	okahashi, nobuo/0000-0002-8045-7021; Maruyama, Fumito/0000-0003-2347-616X	Japan Society for the Promotion of Science [22390394, 22592032, 21792069]; Uehara Memorial Foundation; Takeda Foundation; Mitsubishi Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Foundation(Takeda Science Foundation (TSF)); Mitsubishi Foundation	This work was supported in part by Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (B) 22390394, for Scientific Research (C) 22592032, for young scientists (B) 21792069, the Uehara Memorial Foundation, the Takeda Foundation, and the Mitsubishi Foundation.	Amano A, 2006, J BIOCHEM, V140, P161, DOI 10.1093/jb/mvj162; Beauregard KE, 1997, J EXP MED, V186, P1159, DOI 10.1084/jem.186.7.1159; Birmingham CL, 2008, NATURE, V451, P350, DOI 10.1038/nature06479; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Ceresa BP, 2001, J BIOL CHEM, V276, P9649, DOI 10.1074/jbc.M010387200; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Eskelinen EL, 2004, MOL BIOL CELL, V15, P3132, DOI 10.1091/mbc.E04-02-0103; FALKOW S, 1991, CELL, V65, P1099, DOI 10.1016/0092-8674(91)90003-H; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Gruenheid S, 2003, NATURE, V422, P775, DOI 10.1038/nature01603; Hara H, 2008, J IMMUNOL, V180, P7859, DOI 10.4049/jimmunol.180.12.7859; Ishikawa S, 2006, MOL MICROBIOL, V60, P1364, DOI 10.1111/j.1365-2958.2006.05184.x; Jadoun J, 1998, J INFECT DIS, V178, P147, DOI 10.1086/515589; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; LI GP, 1993, J BIOL CHEM, V268, P24475; Limbago B, 2000, INFECT IMMUN, V68, P6384, DOI 10.1128/IAI.68.11.6384-6390.2000; Lukomski S, 1997, J CLIN INVEST, V99, P2574, DOI 10.1172/JCI119445; Madden JC, 2001, CELL, V104, P143, DOI 10.1016/S0092-8674(01)00198-2; MERESSE S, 1995, J CELL SCI, V108, P3349; Meyer-Morse N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008610; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Neeman R, 1998, LANCET, V352, P1974, DOI 10.1016/S0140-6736(97)12452-7; Nguyen L, 2005, TRENDS CELL BIOL, V15, P269, DOI 10.1016/j.tcb.2005.03.009; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Ogawa M, 2006, CELL MICROBIOL, V8, P177, DOI 10.1111/j.1462-5822.2005.00652.x; Pfeffer S, 2003, CELL, V112, P507, DOI 10.1016/S0092-8674(03)00118-1; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; Prada-Delgado A, 2005, TRAFFIC, V6, P252, DOI 10.1111/j.1600-0854.2005.00265.x; Press B, 1998, J CELL BIOL, V140, P1075, DOI 10.1083/jcb.140.5.1075; Pust S, 2005, EMBO J, V24, P1287, DOI 10.1038/sj.emboj.7600595; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Romano PS, 2007, CELL MICROBIOL, V9, P891, DOI 10.1111/j.1462-5822.2006.00838.x; Ruiz N, 1998, MOL MICROBIOL, V27, P337, DOI 10.1046/j.1365-2958.1998.00681.x; Sakurai A, 2003, INFECT IMMUN, V71, P6019, DOI 10.1128/IAI.71.10.6019-6026.2003; Sakurai A, 2008, BIOCHEM BIOPH RES CO, V373, P450, DOI 10.1016/j.bbrc.2008.06.061; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Stassen M, 2003, INFECT IMMUN, V71, P6171, DOI 10.1128/IAI.71.11.6171-6177.2003; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; TAO L, 1992, GENE, V120, P105, DOI 10.1016/0378-1119(92)90016-I; Terao Y, 2002, J BIOL CHEM, V277, P47428, DOI 10.1074/jbc.M209133200; Terao Y, 2001, MOL MICROBIOL, V42, P75, DOI 10.1046/j.1365-2958.2001.02579.x; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Timmer AM, 2009, J BIOL CHEM, V284, P862, DOI 10.1074/jbc.M804632200; Wang CW, 2003, MOL MED, V9, P65, DOI 10.1007/BF03402040; Wilkowsky SE, 2002, BIOCHEM BIOPH RES CO, V291, P516, DOI 10.1006/bbrc.2002.6474; Yamaguchi H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000670; Yoshimori T, 2000, MOL BIOL CELL, V11, P747, DOI 10.1091/mbc.11.2.747	59	57	60	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22666	22675		10.1074/jbc.M109.100131	http://dx.doi.org/10.1074/jbc.M109.100131			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20472552	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000279702200077
J	Egloff, S; Szczepaniak, SA; Dienstbier, M; Taylor, A; Knight, S; Murphy, S				Egloff, Sylvain; Szczepaniak, Sylwia Anna; Dienstbier, Martin; Taylor, Alice; Knight, Sophie; Murphy, Shona			The Integrator Complex Recognizes a New Double Mark on the RNA Polymerase II Carboxyl-terminal Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							U2 SNRNA; PROTEIN-KINASE; GENE-EXPRESSION; KU-AUTOANTIGEN; TRANSCRIPTION; IICTD; ELONGATION; CODE; PHOSPHORYLATION; SERINE-7	The carboxyl-terminal domain (CTD) of the largest subunit of RNA polymerase II (pol II) comprises multiple tandem repeats of the heptapeptide Tyr(1)-Ser(2)-Pro(3)-Thr(4)-Ser(5)-Pro(6)-Ser(7). This unusual structure serves as a platform for the binding of factors required for expression of pol II-transcribed genes, including the small nuclear RNA (snRNA) gene-specific Integrator complex. The pol II CTD specifically mediates recruitment of Integrator to the promoter of snRNA genes to activate transcription and direct 3' end processing of the transcripts. Phosphorylation of the CTD and a serine in position 7 are necessary for Integrator recruitment. Here, we have further investigated the requirement of the serines in the CTD heptapeptide and their phosphorylation for Integrator binding. We show that both Ser(2) and Ser(7) of the CTD are required and that phosphorylation of these residues is necessary and sufficient for efficient binding. Using synthetic phosphopeptides, we have determined the pattern of the minimal Ser(2)/Ser(7) double phosphorylation mark required for Integrator to interact with the CTD. This novel double phosphorylation mark is a new addition to the functional repertoire of the CTD code and may be a specific signal for snRNA gene expression.	[Murphy, Shona] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Knight, Sophie] Univ Oxford, Dept Biochem, Oxford OX1 3RE, England	University of Oxford; University of Oxford	Murphy, S (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	shona.murphy@path.ox.ac.uk		EGLOFF, Sylvain/0000-0002-9798-125X; Murphy, Shona/0000-0001-5276-9645	Medical Research Council (UK); Wellcome Trust; MRC [G0400653] Funding Source: UKRI; Medical Research Council [G0400653] Funding Source: researchfish	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a grant from the Medical Research Council (UK) and Wellcome Trust grants (to S.M.).	Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Chapman RD, 2008, TRENDS GENET, V24, P289, DOI 10.1016/j.tig.2008.03.010; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Corden JL, 2007, SCIENCE, V318, P1735, DOI 10.1126/science.1152624; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dominski Z, 2005, MOL CELL BIOL, V25, P1489, DOI 10.1128/MCB.25.4.1489-1500.2005; DVIR A, 1992, P NATL ACAD SCI USA, V89, P11920, DOI 10.1073/pnas.89.24.11920; Egloff S, 2008, BIOCHEM SOC T, V36, P590, DOI 10.1042/BST0360590; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Egloff S, 2008, BIOCHEM SOC T, V36, P537, DOI 10.1042/BST0360537; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Egloff S, 2009, MOL CELL BIOL, V29, P4002, DOI 10.1128/MCB.00189-09; Glover-Cutter K, 2009, MOL CELL BIOL, V29, P5455, DOI 10.1128/MCB.00637-09; Hernandez N, 2001, J BIOL CHEM, V276, P26733, DOI 10.1074/jbc.R100032200; HERNANDEZ N, 1985, EMBO J, V4, P1827, DOI 10.1002/j.1460-2075.1985.tb03857.x; Hirose Y, 2007, J BIOCHEM, V141, P601, DOI 10.1093/jb/mvm090; Izzard RA, 1999, CANCER RES, V59, P2581; Jacobs EY, 2004, MOL CELL BIOL, V24, P846, DOI 10.1128/MCB.24.2.846-855.2004; Kim M, 2009, J BIOL CHEM, V284, P26421, DOI 10.1074/jbc.M109.028993; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; LEESMILLER SP, 1990, MOL CELL BIOL, V10, P6472, DOI 10.1128/MCB.10.12.6472; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Medlin J, 2005, EMBO J, V24, P4154, DOI 10.1038/sj.emboj.7600876; Medlin JE, 2003, EMBO J, V22, P925, DOI 10.1093/emboj/cdg077; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Stiller JW, 2004, EUKARYOT CELL, V3, P735, DOI 10.1128/EC.3.3.735-740.2004; Trigon S, 1998, J BIOL CHEM, V273, P6769, DOI 10.1074/jbc.273.12.6769	29	78	81	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20564	20569		10.1074/jbc.M110.132530	http://dx.doi.org/10.1074/jbc.M110.132530			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20457598	Green Published, hybrid			2022-12-27	WOS:000279228600019
J	Rodriguez, HM; Vaysberg, M; Mikels, A; McCauley, S; Velayo, AC; Garcia, C; Smith, V				Rodriguez, Hector M.; Vaysberg, Maria; Mikels, Amanda; McCauley, Scott; Velayo, Arleene C.; Garcia, Carlos; Smith, Victoria			Modulation of Lysyl Oxidase-like 2 Enzymatic Activity by an Allosteric Antibody Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-AMINOPROPIONITRILE; MONOCLONAL-ANTIBODIES; TUMOR PROGRESSION; PROTEIN; DOMAIN; EXPRESSION; AFFINITY; COLLAGEN; ANCIENT; PATHWAY	In this report, we assessed the steady-state enzymatic activity of lysyl oxidase-like 2 (LOXL2) against the substrates 1,5-diaminopentane (DAP), spermine, and fibrillar type I collagen. We find that both DAP and spermine are capable of activating LOXL2 to the same extent and have similar Michaelis constants (K-m similar to 1 mM) and catalytic rates (k(cat) similar to 0.02 s(-1)). We also show that LOXL2 is capable of being inhibited by a known suicide inhibitor of lysyl oxidase (LOX), beta-aminopropionitrile, which we find is a potent inhibitor of LOXL2 activity. The modality of inhibition of beta-aminopropionitrile was also examined and found to be competitive with respect to the substrates DAP and spermine. In addition, we identified an antibody inhibitor (AB0023) of LOXL2 enzymatic function and have found that the inhibition occurs in a non-competitive manner with respect to both spermine and DAP. The binding epitope of AB0023 was mapped to the scavenger receptor cysteine-rich domain four of human LOXL2. AB0023 binds to a region remote from the catalytic domain making AB0023 an allosteric inhibitor of LOXL2. This affords AB0023 several advantages, because it is specific for LOXL2 and inhibits the enzymatic function of LOXL2 in a noncompetitive manner thereby allowing inhibition of LOXL2 regardless of substrate concentration. These results suggest that antibody allosteric modulators of enzymatic function represent a novel drug development strategy and, in the context of LOXL2, suggest that inhibitors such as these might be useful therapeutics in oncology, fibrosis, and inflammation.	[Rodriguez, Hector M.; Vaysberg, Maria; Mikels, Amanda; McCauley, Scott; Velayo, Arleene C.; Garcia, Carlos; Smith, Victoria] Arresto BioSci, Palo Alto, CA 94304 USA		Rodriguez, HM (corresponding author), Arresto BioSci, Palo Alto, CA 94304 USA.	hrodriguez@arresto.com		McCauley, Scott/0000-0003-4549-5599				Akiri G, 2003, CANCER RES, V63, P1657; BRENNAN C, 1994, PROTEIN ENG, V7, P509, DOI 10.1093/protein/7.4.509; CARROLL SB, 1982, P NATL ACAD SCI-BIOL, V79, P7233, DOI 10.1073/pnas.79.23.7233; CINADER B, 1964, IMMUNOLOGY, V7, P342; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; COPELAND RA, 2005, EVALUATION ENZYME IN, P95; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Fong SFT, 2007, GENE CHROMOSOME CANC, V46, P644, DOI 10.1002/gcc.20444; GACHERU SN, 1990, J BIOL CHEM, V265, P19022; GACHERU SN, 1988, J BIOL CHEM, V263, P16704; Hohenester E, 1999, NAT STRUCT BIOL, V6, P228, DOI 10.1038/6669; Hollosi P, 2009, INT J CANCER, V125, P318, DOI 10.1002/ijc.24308; Jung ST, 2003, PROTEIN EXPRES PURIF, V31, P240, DOI 10.1016/S1046-5928(03)00217-1; KIM YM, MOL BIOL RE IN PRESS; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; Leskovac, 2003, COMPREHENSIVE ENZYME; Martin F, 1997, PROTEIN ENG, V10, P607, DOI 10.1093/protein/10.5.607; McElroy KE, 2000, ANAL BIOCHEM, V284, P382, DOI 10.1006/abio.2000.4740; MINTZ KP, 1985, J NEUROCHEM, V45, P284, DOI 10.1111/j.1471-4159.1985.tb05505.x; Molnar J, 2003, BBA-PROTEINS PROTEOM, V1647, P220, DOI 10.1016/S1570-9639(03)00053-0; NARAYANAN AS, 1972, BIOCHEM BIOPH RES CO, V46, P745; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Palamakumbura AH, 2002, ANAL BIOCHEM, V300, P245, DOI 10.1006/abio.2001.5464; PARK SS, 1982, CANCER RES, V42, P1798; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Peng L, 2009, CARCINOGENESIS, V30, P1660, DOI 10.1093/carcin/bgp178; REISER K, 1992, FASEB J, V6, P2439, DOI 10.1096/fasebj.6.7.1348714; Sarrias MR, 2004, CRIT REV IMMUNOL, V24, P1; Siegel R C, 1979, Int Rev Connect Tissue Res, V8, P73; TANG SS, 1983, J BIOL CHEM, V258, P4331; TANG SS, 1984, J BIOL CHEM, V259, P975; TRACKMAN PC, 1979, J BIOL CHEM, V254, P7831; Vadasz Z, 2005, J HEPATOL, V43, P499, DOI 10.1016/j.jhep.2005.02.052; WILLIAMSON PR, 1986, J BIOL CHEM, V261, P9477	34	104	121	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20964	20974		10.1074/jbc.M109.094136	http://dx.doi.org/10.1074/jbc.M109.094136			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20439985	Green Published, hybrid			2022-12-27	WOS:000279228600060
J	Zheng, C; Fasken, MB; Marshall, NJ; Brockmann, C; Rubinson, ME; Wente, SR; Corbett, AH; Stewart, M				Zheng, Chao; Fasken, Milo B.; Marshall, Neil J.; Brockmann, Christoph; Rubinson, Max E.; Wente, Susan R.; Corbett, Anita H.; Stewart, Murray			Structural Basis for the Function of the Saccharomyces cerevisiae Gfd1 Protein in mRNA Nuclear Export	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; PORE COMPLEX; YEAST; DOMAIN; NAB2P; GLE1; DBP5; RAT8P/DBP5P; INTERACTS; LINK	Following transcription, mRNA is processed, packaged into messenger ribonucleoprotein (mRNP) particles, and transported through nuclear pores (NPCs) to the cytoplasm. At the NPC cytoplasmic face, Dbp5 mediates mRNP remodeling and mRNA export factor dissociation, releasing transcripts for translation. In Saccharomyces cerevisiae, the conserved poly(A) RNA-binding protein, Nab2, facilitates NPC targeting of transcripts and also modulates poly(A) tail length. Dbp5 removes Nab2 from mRNPs at the cytoplasmic face of the pore and, importantly, a Nab2 RNA-binding mutant suppresses the thermosensitive rat8-2 (dbp5) mutant. GFD1 is a multicopy suppressor of rat8-2 (dbp5), and Gfd1 interacts physically with both Dbp5 and the Nab2 N-terminal domain (Nab2-N). Here, we present a structural and functional analysis of the Gfd1/Nab2-N interaction. Crystallography, supported by solution NMR, shows that Gfd1 residues 126-150 form an alpha-helix when bound to Nab2-N. Engineered Nab2-N and Gfd1 mutants that inhibit this interaction in vitro were used to probe its function in vivo using the genetic interaction between GFD1 and NAB2. Although GFD1 is not essential for viability, its deletion severely impairs growth of rat8-2 (dbp5) cells. Moreover, although Gfd1 overexpression suppresses rat8-2 (dbp5), Gfd1 mutants that do not bind Nab2 only partially suppress rat8-2 (dbp5). Furthermore, rat8-2 (dbp5) cells that express nab2-Y34A, in which binding to Gfd1 is impaired, show a synthetic growth phenotype and nuclear accumulation of poly(A) RNA. These data support the importance of the Gfd1/Nab2 interaction for Dbp5 activity and provide further molecular details of the interactions that facilitate Dbp5-mediated mRNP remodeling in the terminal step of mRNA export.	[Stewart, Murray] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Fasken, Milo B.; Rubinson, Max E.; Corbett, Anita H.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Wente, Susan R.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA	MRC Laboratory Molecular Biology; Emory University; Vanderbilt University	Stewart, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	ms@mrc-lmb.cam.ac.uk	Fasken, Milo/K-2177-2019; Corbett, Anita/AAH-6106-2021	Fasken, Milo/0000-0003-4317-7909; Corbett, Anita/0000-0002-0461-6895	National Institutes of Health; Federation of the Societies of Biochemistry and Molecular Biology; Wellcome Trust; MRC [MC_U105178939] Funding Source: UKRI; Medical Research Council [MC_U105178939] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058728, R01GM065442, R37GM051219] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Federation of the Societies of Biochemistry and Molecular Biology; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants (to A. H. C. and S. R. W.). This work was also supported in part by a Federation of the Societies of Biochemistry and Molecular Biology Long Term Fellowship (to C. B.) and a Wellcome Trust Programme Grant (to M. S.).	Adams A, 1997, METHODS YEAST GENETI; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akker SA, 2001, J MOL ENDOCRINOL, V27, P123, DOI 10.1677/jme.0.0270123; Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; ANDERSON JT, 1993, MOL CELL BIOL, V13, P2730, DOI 10.1128/MCB.13.5.2730; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Batisse J, 2009, J BIOL CHEM, V284, P34911, DOI 10.1074/jbc.M109.062034; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Carmody SR, 2009, J CELL SCI, V122, P1933, DOI 10.1242/jcs.041236; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dower K, 2002, RNA, V8, P686, DOI 10.1017/S1355838202024068; Ellisdon AM, 2010, J BIOL CHEM, V285, P3850, DOI 10.1074/jbc.M109.070839; Estruch F, 2005, J BIOL CHEM, V280, P9691, DOI 10.1074/jbc.M413025200; Fairall L, 2001, MOL CELL, V8, P351, DOI 10.1016/S1097-2765(01)00321-5; Fasken MB, 2005, NAT STRUCT MOL BIOL, V12, P482, DOI 10.1038/nsmb945; Fasken MB, 2008, J BIOL CHEM, V283, P27130, DOI 10.1074/jbc.M803649200; Goddard T. D., SPARKY 3; Grant RP, 2008, J MOL BIOL, V376, P1048, DOI 10.1016/j.jmb.2007.11.087; Green DM, 2002, J BIOL CHEM, V277, P7752, DOI 10.1074/jbc.M110053200; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; GRZESIEK S, 1992, J MAGN RESON, V99, P201, DOI 10.1016/0022-2364(92)90169-8; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Guisbert KK, 2005, RNA, V11, P383, DOI 10.1261/rna.7234205; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Hector RE, 2002, EMBO J, V21, P1800, DOI 10.1093/emboj/21.7.1800; Hodge CA, 1999, EMBO J, V18, P5778, DOI 10.1093/emboj/18.20.5778; Jensen TH, 2003, NAT STRUCT BIOL, V10, P10, DOI 10.1038/nsb0103-10; Kelly SM, 2007, P NATL ACAD SCI USA, V104, P12306, DOI 10.1073/pnas.0701244104; Kelly SM, 2009, TRAFFIC, V10, P1199, DOI 10.1111/j.1600-0854.2009.00944.x; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Lange A, 2008, J BIOL CHEM, V283, P12926, DOI 10.1074/jbc.M800898200; LESLIE AGW, 1992, JNT CCP4 ESF EAMCB N, V26, P27; Marfatia KA, 2003, J BIOL CHEM, V278, P6731, DOI 10.1074/jbc.M207571200; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Murphy R, 1996, NATURE, V383, P357, DOI 10.1038/383357a0; Murphy R, 1996, MOL BIOL CELL, V7, P1921, DOI 10.1091/mbc.7.12.1921; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santos-Rosa H, 1998, MOL CELL BIOL, V18, P6826, DOI 10.1128/MCB.18.11.6826; Sarkar S, 1998, MOL BIOL CELL, V9, P3041, DOI 10.1091/mbc.9.11.3041; Shatkin AJ, 2000, NAT STRUCT BIOL, V7, P838, DOI 10.1038/79583; SIKORSKI RS, 1989, GENETICS, V122, P19; Snay-Hodge CA, 1998, EMBO J, V17, P2663, DOI 10.1093/emboj/17.9.2663; Stewart M, 2007, MOL CELL, V25, P327, DOI 10.1016/j.molcel.2007.01.016; Strahm Y, 1999, EMBO J, V18, P5761, DOI 10.1093/emboj/18.20.5761; Strambio-de-Castillia C, 1999, J CELL BIOL, V144, P839, DOI 10.1083/jcb.144.5.839; Stutz F, 2003, TRENDS CELL BIOL, V13, P319, DOI 10.1016/S0962-8924(03)00106-5; Suntharalingam M, 2004, J BIOL CHEM, V279, P35384, DOI 10.1074/jbc.M402044200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019; Tseng SSL, 1998, EMBO J, V17, P2651, DOI 10.1093/emboj/17.9.2651; Vinciguerra P, 2004, CURR OPIN CELL BIOL, V16, P285, DOI 10.1016/j.ceb.2004.03.013; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424; Wong DH, 1997, MOL CELL BIOL, V17, P3755, DOI 10.1128/MCB.17.7.3755	54	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20704	20715		10.1074/jbc.M110.107276	http://dx.doi.org/10.1074/jbc.M110.107276			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20463024	Green Published, hybrid			2022-12-27	WOS:000279228600034
J	Courapied, S; Sellier, H; Trecesson, SD; Vigneron, A; Bernard, AC; Gamelin, E; Barre, B; Coqueret, O				Courapied, Sandy; Sellier, Helene; Trecesson, Sophie de Carne; Vigneron, Arnaud; Bernard, Anne-Charlotte; Gamelin, Erick; Barre, Benjamin; Coqueret, Olivier			The cdk5 Kinase Regulates the STAT3 Transcription Factor to Prevent DNA Damage upon Topoisomerase I Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SIGNAL TRANSDUCER; UNPHOSPHORYLATED STAT3; CONFERS RESISTANCE; INDUCED APOPTOSIS; DRUG-RESISTANCE; GENE-EXPRESSION; C-MYC; ACTIVATION; PATHWAY	The STAT3 transcription factors are cytoplasmic proteins that induce gene activation in response to growth factor stimulation. Following tyrosine phosphorylation, STAT3 proteins dimerize, translocate to the nucleus, and activate specific target genes involved in cell-cycle progression. Despite its importance in cancer cells, the molecular mechanisms by which this protein is regulated in response to DNA damage remain to be characterized. In this study, we show that STAT3 is activated in response to topoisomerase I inhibition. Following treatment, STAT3 is phosphorylated on its C-terminal serine 727 residue but not on its tyrosine 705 site. We also show that topoisomerase I inhibition induced the up-regulation of the cdk5 kinase, a protein initially described in neuronal stress responses. In co-immunoprecipitations, cdk5 was found to associate with STAT3, and pulldown experiments indicated that it associates with the C-terminal activation domain of STAT3 upon DNA damage. Importantly, the cdk5-STAT3 pathway reduced DNA damage in response to topoisomerase I inhibition through the up-regulation of Eme1, an endonuclease involved in DNA repair. ChIP experiments indicated that STAT3 can be found associated with the Eme1 promoter when phosphorylated only on its serine 727 residue and not on tyrosine 705. We therefore propose that the cdk5-STAT3 oncogenic pathway plays an important role in the expression of DNA repair genes and that these proteins could be used as predictive markers of tumors that will fail to respond to chemotherapy.	[Courapied, Sandy; Sellier, Helene; Trecesson, Sophie de Carne; Vigneron, Arnaud; Bernard, Anne-Charlotte; Gamelin, Erick; Barre, Benjamin; Coqueret, Olivier] Paul Papin Canc Ctr, INSERM, U892, F-49933 Angers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut de cancerologie de Lorraine (ICL); Institut de Cancerologie de l'Ouest (ICO); Universite d'Angers	Coqueret, O (corresponding author), Ctr Reg Lutte Contre Canc Paul Papin, INSERM, U892, 2 Rue Moll, F-49033 Angers, France.	olivier.coqueret@univ-angers.fr	Vigneron, Arnaud/ABC-7306-2021; Coqueret, Olivier/K-9660-2015	Vigneron, Arnaud/0000-0003-4161-0676; Coqueret, Olivier/0000-0002-2843-7867	Ligue Contre le Cancer and Institut du Cancer; Inserm-Pays de Loire; Ministere de la Recherche	Ligue Contre le Cancer and Institut du Cancer; Inserm-Pays de Loire; Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France)	This work was supported by fellowships (to S. C. and A. V.), by a grant (Equipe Labelisee) from the Ligue Contre le Cancer and Institut du Cancer, and a fellowship from Inserm-Pays de Loire (to S. C. T.), and by the Ministere de la Recherche (to H. S.).	Alexander K, 2004, MOL CELL BIOL, V24, P2808, DOI 10.1128/MCB.24.7.2808-2819.2004; Barre B, 2005, J BIOL CHEM, V280, P15673, DOI 10.1074/jbc.M413203200; Barre B, 2003, J BIOL CHEM, V278, P2990, DOI 10.1074/jbc.M210422200; Barre B, 2007, TRENDS MOL MED, V13, P4, DOI 10.1016/j.molmed.2006.11.001; Benekli M, 2009, J CLIN ONCOL, V27, P4422, DOI 10.1200/JCO.2008.21.3264; Bienvenu F, 2005, MOL BIOL CELL, V16, P1850, DOI 10.1091/mbc.e04-08-0654; Bowman T, 2001, P NATL ACAD SCI USA, V98, P7319, DOI 10.1073/pnas.131568898; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Campbell KJ, 2006, CANCER RES, V66, P929, DOI 10.1158/0008-5472.CAN-05-2234; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chatterjee-Kishore M, 2000, EMBO J, V19, P4111, DOI 10.1093/emboj/19.15.4111; Dendouga N, 2005, MOL CELL BIOL, V25, P7569, DOI 10.1128/MCB.25.17.7569-7579.2005; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Duan ZF, 2006, CLIN CANCER RES, V12, P5055, DOI 10.1158/1078-0432.CCR-06-0861; Florenes VA, 1999, ONCOGENE, V18, P1023, DOI 10.1038/sj.onc.1202382; Fu AKY, 2004, P NATL ACAD SCI USA, V101, P6728, DOI 10.1073/pnas.0307606100; Giraud S, 2002, J BIOL CHEM, V277, P8004, DOI 10.1074/jbc.M111486200; Giraud S, 2004, ONCOGENE, V23, P7391, DOI 10.1038/sj.onc.1207972; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Gritsko T, 2006, CLIN CANCER RES, V12, P11, DOI 10.1158/1078-0432.CCR-04-1752; Henderson BW, 2007, CLIN CANCER RES, V13, P3156, DOI 10.1158/1078-0432.CCR-06-2950; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kiuchi N, 1999, J EXP MED, V189, P63, DOI 10.1084/jem.189.1.63; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Lee JH, 2008, J BIOL CHEM, V283, P19826, DOI 10.1074/jbc.M706201200; Leslie K, 2006, CANCER RES, V66, P2544, DOI 10.1158/0008-5472.CAN-05-2203; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Lin H, 2007, J BIOL CHEM, V282, P2776, DOI 10.1074/jbc.M607234200; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Niu GL, 2005, MOL CELL BIOL, V25, P7432, DOI 10.1128/MCB.25.17.7432-7440.2005; Osman F, 2007, DNA REPAIR, V6, P1004, DOI 10.1016/j.dnarep.2007.02.019; Paulson M, 1999, J BIOL CHEM, V274, P25343, DOI 10.1074/jbc.274.36.25343; Pommier Y, 2003, MUTAT RES-FUND MOL M, V532, P173, DOI 10.1016/j.mrfmmm.2003.08.016; Qin HR, 2008, CANCER RES, V68, P7736, DOI 10.1158/0008-5472.CAN-08-1125; Sano S, 2005, CANCER RES, V65, P5720, DOI 10.1158/0008-5472.CAN-04-4359; Shen YH, 2001, P NATL ACAD SCI USA, V98, P1543, DOI 10.1073/pnas.041588198; Shields BJ, 2008, CANCER CELL, V14, P166, DOI 10.1016/j.ccr.2008.06.003; Slupianek A, 2001, MOL CELL, V8, P795, DOI 10.1016/S1097-2765(01)00357-4; Slupianek A, 2002, MOL CELL BIOL, V22, P4189, DOI 10.1128/MCB.22.12.4189-4201.2002; Thomas M, 2004, CANCER RES, V64, P8357, DOI 10.1158/0008-5472.CAN-04-1864; Tian B, 2009, NAT CELL BIOL, V11, P211, DOI 10.1038/ncb1829; Townsend PA, 2005, J CELL SCI, V118, P1629, DOI 10.1242/jcs.01728; Turner NC, 2008, EMBO J, V27, P1368, DOI 10.1038/emboj.2008.61; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Van Le H, 2005, J BIOL CHEM, V280, P32018, DOI 10.1074/jbc.M504689200; Vigneron A, 2005, CANCER RES, V65, P8927, DOI 10.1158/0008-5472.CAN-05-0461; Vigneron A, 2008, CANCER RES, V68, P815, DOI 10.1158/0008-5472.CAN-07-5115; Vigneron A, 2006, J BIOL CHEM, V281, P34742, DOI 10.1074/jbc.M602492200; Wang CX, 2006, CELL DEATH DIFFER, V13, P1203, DOI 10.1038/sj.cdd.4401804; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yang HS, 2003, MOL CELL, V11, P1163, DOI 10.1016/S1097-2765(03)00135-7; Yang J, 2005, CANCER RES, V65, P939; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275	57	55	55	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26765	26778		10.1074/jbc.M109.092304	http://dx.doi.org/10.1074/jbc.M109.092304			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20516069	Green Published, hybrid			2022-12-27	WOS:000281172700007
J	Kasahara, T; Kasahara, M				Kasahara, Toshiko; Kasahara, Michihiro			Identification of a Key Residue Determining Substrate Affinity in the Yeast Glucose Transporter Hxt7 A TWO-DIMENSIONAL COMPREHENSIVE STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; COMPREHENSIVE CHIMERIC ANALYSIS; SACCHAROMYCES-CEREVISIAE; HEXOSE TRANSPORTER; ESCHERICHIA-COLI; SCANNING MUTAGENESIS; LACTOSE PERMEASE; BINDING-SITE; HELIX VII; GLUT1	We previously identified Asn(331) in transmembrane segment 7 (TM7) as a key residue determining substrate affinity in Hxt2, a moderately high-affinity facilitative glucose transporter of Saccharomyces cerevisiae. To gain further insight into the structural basis of substrate recognition by yeast glucose transporters, we have now studied Hxt7, whose affinity for glucose is the highest among the major hexose transporters. The functional role of Asp(340) in Hxt7, the residue corresponding to Asn(331) of Hxt2, was examined by replacing it with each of the other 19 amino acids. Such replacement of Asp(340) generated transporters with various affinities for glucose, with the affinity of the Cys(340) mutant surpassing that of the wild-type Hxt7. To examine the structural role of Asp(340) in the substrate translocation pathway, we performed cysteine-scanning mutagenesis of the 21 residues in TM7 of a functional Cys-less Hxt7 mutant in conjunction with exposure to the hydrophilic sulfhydryl reagent p-chloromercuribenzenesulfonate (pCMBS). The transport activity of the D340C mutant of Cys-less Hxt7, in which Asp(340) is replaced with Cys, was completely inhibited by pCMBS, indicating that Asp(340) is located in a water-accessible position. This D340C mutant showed a sensitivity to pCMBS that was similar to 70 times that of the wild-type Hxt7, and it was protected from pCMBS inhibition by the substrates D-glucose and 2-deoxy-D-glucose but not by L-glucose. These results indicate that Asp(340) is situated at or close to a substrate recognition site and is a key residue determining high-affinity glucose transport by Hxt7, supporting the notion that yeast glucose transporters share a common mechanism for substrate recognition.	[Kasahara, Toshiko; Kasahara, Michihiro] Teikyo Univ, Biophys Lab, Sch Med, Tokyo 1920395, Japan; [Kasahara, Michihiro] Teikyo Univ, Genome Res Ctr, Tokyo 1920395, Japan	Teikyo University; Teikyo University	Kasahara, M (corresponding author), Teikyo Univ, Biophys Lab, Sch Med, Tokyo 1920395, Japan.	kasahara@main.teikyo-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Teikyo University	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Teikyo University	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and from Teikyo University.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; AMBERG DC, 2005, METHODS YEAST GENETI, P200; Diderich JA, 2001, YEAST, V18, P1515, DOI 10.1002/yea.779; Elbing K, 2004, APPL ENVIRON MICROB, V70, P5323, DOI 10.1128/AEM.70.9.5323-5330.2004; Hirai T, 2003, J BACTERIOL, V185, P1712, DOI 10.1128/JB.185.5.1712-1718.2003; Hruz PW, 1999, J BIOL CHEM, V274, P36176, DOI 10.1074/jbc.274.51.36176; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Kasahara M, 1997, J BIOL CHEM, V272, P16721, DOI 10.1074/jbc.272.27.16721; Kasahara T, 2004, J BIOL CHEM, V279, P30274, DOI 10.1074/jbc.M403762200; Kasahara T, 2003, BIOCHEM J, V372, P247, DOI 10.1042/BJ20030044; Kasahara T, 1996, BIOCHEM J, V315, P177, DOI 10.1042/bj3150177; Kasahara T, 2007, J BIOL CHEM, V282, P13146, DOI 10.1074/jbc.C700041200; Kasahara T, 2006, J BIOL CHEM, V281, P18532, DOI 10.1074/jbc.M602123200; Kasahara T, 2009, BBA-BIOMEMBRANES, V1788, P1051, DOI 10.1016/j.bbamem.2009.01.014; Kruckeberg AL, 1996, ARCH MICROBIOL, V166, P283, DOI 10.1007/s002030050385; Manolescu A, 2005, J BIOL CHEM, V280, P42978, DOI 10.1074/jbc.M508678200; Mueckler M, 2009, BIOCHEMISTRY-US, V48, P5934, DOI 10.1021/bi900521n; NISHIZAWA K, 1995, J BIOL CHEM, V270, P2423, DOI 10.1074/jbc.270.6.2423; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Reifenberger E, 1997, EUR J BIOCHEM, V245, P324, DOI 10.1111/j.1432-1033.1997.00324.x; Seatter MJ, 1998, BIOCHEMISTRY-US, V37, P1322, DOI 10.1021/bi972322u; Venkatesan P, 2000, BIOCHEMISTRY-US, V39, P10641, DOI 10.1021/bi000438b; Will A, 1998, J BIOL CHEM, V273, P11456, DOI 10.1074/jbc.273.19.11456; YAN RT, 1995, P NATL ACAD SCI USA, V92, P5973, DOI 10.1073/pnas.92.13.5973; Ye L, 2001, YEAST, V18, P1257, DOI 10.1002/yea.771.abs; Ye L, 1999, J BACTERIOL, V181, P4673, DOI 10.1128/JB.181.15.4673-4675.1999; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629	27	17	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26263	26268		10.1074/jbc.M110.149716	http://dx.doi.org/10.1074/jbc.M110.149716			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20525688	hybrid, Green Published			2022-12-27	WOS:000280921000043
J	Bergstroem, B; Johnsen, IB; Nguyen, TT; Hagen, L; Slupphaug, G; Thommesen, L; Anthonsen, MW				Bergstroem, Bjarte; Johnsen, Ingvild B.; Nguyen, Thuy Thanh; Hagen, Lars; Slupphaug, Geir; Thommesen, Liv; Anthonsen, Marit W.			Identification of a Novel in Vivo Virus-targeted Phosphorylation Site in Interferon Regulatory Factor-3 (IRF3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; CRYSTAL-STRUCTURE; KAPPA-B; ACTIVATION; INFECTION; TRANSACTIVATION; RECOGNITION; ASSOCIATION; EPSILON; COMPLEX	The transcription factor interferon regulatory factor-3 (IRF3) regulates expression of type I interferon-beta and plays an important role in antiviral immunity. Despite the biological importance of IRF3, its in vivo phosphorylation pattern has not been reported. In this study, we have identified residues in IRF3 that are phosphorylated in vivo after infection with Sendai virus. We found that Sendai virus induced phosphorylation of the C-terminal residues Thr(390) and Ser(396), in addition to either Ser(385) or Ser(386). Moreover, Ser(173) and Ser(175) were constitutively phosphorylated. Ser(396) has previously been suggested to be the major target of the IRF3-activating kinase TBK1 (TANK-binding kinase-1), whereas Thr(390) has not previously been implicated in IRF3 regulation. Mutagenesis studies indicated that phosphorylation of Thr(390) promotes Ser(396) phosphorylation and binding to the coactivator cAMP-response element-binding protein. Taken together, our results show that IRF3 is subject to multiple interdependent phosphorylations, and we identify Thr(390) as a novel in vivo phosphorylation site that modulates the phosphorylation status of TBK1-targeted Ser(396).	[Anthonsen, Marit W.] Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, Fac Med, N-7006 Trondheim, Norway; [Hagen, Lars; Slupphaug, Geir; Thommesen, Liv] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7006 Trondheim, Norway; [Bergstroem, Bjarte; Thommesen, Liv] Sor Trondelag Univ Coll HiST, Fac Technol, N-7004 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Anthonsen, MW (corresponding author), Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, Fac Med, N-7006 Trondheim, Norway.	Marit.W.Anthonsen@ntnu.no	Bergstrøm, Bjarte/H-8159-2016; Slupphaug, Geir/AAN-3794-2020	Bergstrøm, Bjarte/0000-0002-5042-6697; Bjellmo Johnsen, Ingvild/0000-0002-3520-6776; Slupphaug, Geir/0000-0002-7498-3500	National Programme for Research in Functional Genomics (FUGE) in Norway; Research Council of Norway; Faculty of Medicine, Norwegian University of Science and Technology; Cancer Fund at St. Olavs Hospital; Norwegian Cancer Society	National Programme for Research in Functional Genomics (FUGE) in Norway; Research Council of Norway(Research Council of Norway); Faculty of Medicine, Norwegian University of Science and Technology; Cancer Fund at St. Olavs Hospital; Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by the National Programme for Research in Functional Genomics (FUGE) in Norway (to M.W.A.), FUGE Mid-Norway (to M.W.A.), the Research Council of Norway (to M.W.A.), the Faculty of Medicine, Norwegian University of Science and Technology (to I.B.J. and M.W.A.), the Cancer Fund at St. Olavs Hospital (to M.W.A.), and the Norwegian Cancer Society.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andersen J, 2008, GENES IMMUN, V9, P168, DOI 10.1038/sj.gene.6364449; Chen W, 2008, NAT STRUCT MOL BIOL, V15, P1213, DOI 10.1038/nsmb.1496; Chen WJ, 2008, J MOL BIOL, V379, P251, DOI 10.1016/j.jmb.2008.03.050; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Clement JF, 2008, J VIROL, V82, P3984, DOI 10.1128/JVI.02526-07; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Hagen L, 2008, EMBO J, V27, P51, DOI 10.1038/sj.emboj.7601958; Johnsen IB, 2009, J BIOL CHEM, V284, P19122, DOI 10.1074/jbc.M808233200; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kishore N, 2002, J BIOL CHEM, V277, P13840, DOI 10.1074/jbc.M110474200; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Mori M, 2004, J BIOL CHEM, V279, P9698, DOI 10.1074/jbc.M310616200; Noyce RS, 2009, J VIROL, V83, P4013, DOI 10.1128/JVI.02069-08; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Panne D, 2007, J BIOL CHEM, V282, P22816, DOI 10.1074/jbc.M703019200; Qin BY, 2005, STRUCTURE, V13, P1269, DOI 10.1016/j.str.2005.06.011; Qin BY, 2003, NAT STRUCT BIOL, V10, P913, DOI 10.1038/nsb1002; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Servant MJ, 2003, J BIOL CHEM, V278, P9441, DOI 10.1074/jbc.M209851200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Takahasi K, 2003, NAT STRUCT BIOL, V10, P922, DOI 10.1038/nsb1001; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Weaver BK, 1998, MOL CELL BIOL, V18, P1359, DOI 10.1128/MCB.18.3.1359; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Zhang BH, 2009, CELL RES, V19, P412, DOI 10.1038/cr.2009.8	30	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24904	24914		10.1074/jbc.M109.084822	http://dx.doi.org/10.1074/jbc.M109.084822			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20511230	hybrid, Green Published			2022-12-27	WOS:000280542100063
J	Hosomi, A; Tanabe, K; Hirayama, H; Kim, I; Rao, H; Suzuki, T				Hosomi, Akira; Tanabe, Kaori; Hirayama, Hiroto; Kim, Ikjin; Rao, Hai; Suzuki, Tadashi			Identification of an Htm1 (EDEM)-dependent, Mns1-independent Endoplasmic Reticulum-associated Degradation (ERAD) Pathway in Saccharomyces cerevisiae APPLICATION OF A NOVEL ASSAY FOR GLYCOPROTEIN ERAD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSIDASE-LIKE PROTEIN; PEPTIDE-N-GLYCANASE; QUALITY-CONTROL; MEMBRANE-PROTEIN; MISFOLDED GLYCOPROTEINS; CYTOPLASMIC PEPTIDE; UBIQUITIN-LIGASE; RETRO-TRANSLOCATION; ANCHORED PROTEINS; LUMINAL PROTEIN	Endoplasmic reticulum (ER)-associated degradation (ERAD) is a quality control system for newly synthesized proteins in the ER; nonfunctional proteins, which fail to form their correct folding state, are then degraded. The cytoplasmic peptide: N-glycanase is a deglycosylating enzyme that is involved in the ERAD and releases N-glycans from misfolded glycoproteins/glycopeptides. We have previously identified a mutant plant toxin protein, RTA (ricin A-chain nontoxic mutant), as the first in vivo Png1 (the cytoplasmic peptide: N-glycanase in Saccharomyces cerevisiae)-dependent ERAD substrate. Here, we report a new genetic device to assay the Png1-dependent ERAD pathway using the new model protein designated RTL (RTA-transmembrane-Leu2). Our extensive studies using different yeast mutants identified various factors involved in RTL degradation. The degradation of RTA/RTL was independent of functional Sec61 but was dependent on Der1. Interestingly, ER-mannosidase Mns1 was not involved in RTA degradation, but it was dependent on Htm1 (ERAD-related alpha-mannosidase in yeast) and Yos9 (a putative degradation lectin), indicating that mannose trimming by Mns1 is not essential for efficient ERAD of RTA/RTL. The newly established RTL assay will allow us to gain further insight into the mechanisms involved in the Png1-dependent ERAD-L pathway.	[Hosomi, Akira; Hirayama, Hiroto; Suzuki, Tadashi] RIKEN, Glycometabolome Team, Adv Sci Inst, Wako, Saitama 3510198, Japan; [Tanabe, Kaori] Osaka Univ, Dept Biochem, 21st Century Ctr Excellence Program, Grad Sch Med, Suita, Osaka 5650871, Japan; [Kim, Ikjin; Rao, Hai] Univ Texas San Antonio, Dept Mol Med, Inst Biotechnol, Ctr Hlth, San Antonio, TX 78245 USA; [Suzuki, Tadashi] Japan Sci & Technol Agcy, Core Res Evolutionary Sci & Technol, Kawaguchi, Saitama 3320012, Japan	RIKEN; Osaka University; University of Texas System; University of Texas at San Antonio (UTSA); Japan Science & Technology Agency (JST)	Suzuki, T (corresponding author), RIKEN, Glycometabolome Team, Adv Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tsuzuki_gm@riken.jp	Suzuki, Tadashi/I-4536-2014; Suzuki, Tadashi/AAX-5707-2021; Hosomi, Akira/O-1538-2015; hirayama, hiroto/HCH-9202-2022	Suzuki, Tadashi/0000-0003-1030-7631; RAO, HAI/0000-0002-4235-2210; Hirayama, Hiroto/0000-0003-1909-9488	Global Center of Excellence Program; Ministry of Education, Culture, Sports, Science and Technology of Japan; RIKEN President's Discretionary Fund	Global Center of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN President's Discretionary Fund	This work was supported in part by the Global Center of Excellence Program (to A. H. and T. S.), grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and RIKEN President's Discretionary Fund (Strategic Programs for R&D) (to T. S.).	Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Baker BM, 2007, J BIOL CHEM, V282, P26845, DOI 10.1074/jbc.M704315200; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Buschhorn BA, 2004, FEBS LETT, V577, P422, DOI 10.1016/j.febslet.2004.10.039; Caldwell SR, 2001, J BIOL CHEM, V276, P23296, DOI 10.1074/jbc.M102962200; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Friedmann E, 2002, J BIOL CHEM, V277, P35274, DOI 10.1074/jbc.M201044200; Fujita M, 2006, MOL BIOL CELL, V17, P834, DOI 10.1091/mbc.E05-05-0443; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Heiligenstein S, 2006, EMBO J, V25, P4717, DOI 10.1038/sj.emboj.7601350; Hill K, 2000, EMBO J, V19, P550, DOI 10.1093/emboj/19.4.550; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hirayama H, 2010, J BIOL CHEM, V285, P12390, DOI 10.1074/jbc.M109.082081; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Hosokawa N, 2009, J BIOL CHEM, V284, P17061, DOI 10.1074/jbc.M809725200; Huttunen HJ, 2007, J BIOL CHEM, V282, P28285, DOI 10.1074/jbc.M702951200; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Jakob CA, 1998, J CELL BIOL, V142, P1223, DOI 10.1083/jcb.142.5.1223; Jakob CA, 2001, EMBO REP, V2, P423; Jolliffe NA, 2006, J BIOL CHEM, V281, P23377, DOI 10.1074/jbc.M602678200; Kario E, 2008, J BIOL CHEM, V283, P244, DOI 10.1074/jbc.M706237200; Kim I, 2004, MOL BIOL CELL, V15, P3357, DOI 10.1091/mbc.E03-11-0835; Kim I, 2006, J CELL BIOL, V172, P211, DOI 10.1083/jcb.200507149; Kim I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007604; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Knop M, 1996, YEAST, V12, P1229, DOI 10.1002/(SICI)1097-0061(19960930)12:12<1229::AID-YEA15>3.0.CO;2-H; Kostova Z, 2005, J CELL SCI, V118, P1485, DOI 10.1242/jcs.01740; Kothe M, 2005, J BIOL CHEM, V280, P28127, DOI 10.1074/jbc.M503138200; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Nakatsukasa K, 2001, J BIOL CHEM, V276, P8635, DOI 10.1074/jbc.C100023200; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; Olivari S, 2006, BIOCHEM BIOPH RES CO, V349, P1278, DOI 10.1016/j.bbrc.2006.08.186; Park H, 2001, P NATL ACAD SCI USA, V98, P11163, DOI 10.1073/pnas.201393498; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Plemper RK, 1999, J CELL SCI, V112, P4123; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Sayeed A, 2005, CRIT REV BIOCHEM MOL, V40, P75, DOI 10.1080/10409230590918685; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Schwieger I, 2008, MOL PHARMACOL, V73, P697, DOI 10.1124/mol.107.040931; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Simpson JC, 1999, FEBS LETT, V459, P80, DOI 10.1016/S0014-5793(99)01222-3; Slominska-Wojewodzka M, 2006, MOL BIOL CELL, V17, P1664, DOI 10.1091/mbc.E05-10-0961; Spear ED, 2005, J CELL BIOL, V169, P73, DOI 10.1083/jcb.200411136; Spooner RA, 2008, P NATL ACAD SCI USA, V105, P17408, DOI 10.1073/pnas.0809013105; Steel GJ, 1999, BIOCHEMISTRY-US, V38, P7764, DOI 10.1021/bi990315v; Suzuki T, 2002, FASEB J, V16, DOI 10.1096/fj.01-0889rev; Suzuki T, 2002, GLYCOBIOLOGY, V12, P803, DOI 10.1093/glycob/cwf095; Suzuki T, 2001, J BIOL CHEM, V276, P21601, DOI 10.1074/jbc.M100826200; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; Suzuki T, 2008, ANAL BIOCHEM, V381, P224, DOI 10.1016/j.ab.2008.07.002; Suzuki T, 2007, SEMIN CELL DEV BIOL, V18, P762, DOI 10.1016/j.semcdb.2007.09.010; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Tanabe K, 2006, METHOD ENZYMOL, V415, P46, DOI 10.1016/S0076-6879(06)15004-1; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Taxis C, 2002, MOL BIOL CELL, V13, P1806, DOI 10.1091/mbc.01-08-0399; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Vashist S, 2001, J CELL BIOL, V155, P355, DOI 10.1083/jcb.200106123; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang QQ, 1999, EMBO J, V18, P5972, DOI 10.1093/emboj/18.21.5972; Wilson JD, 2006, TRAFFIC, V7, P1213, DOI 10.1111/j.1600-0854.2006.00460.x; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; [No title captured]	83	31	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24324	24334		10.1074/jbc.M109.095919	http://dx.doi.org/10.1074/jbc.M109.095919			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20511219	hybrid, Green Published			2022-12-27	WOS:000280542100004
J	Geeraert, C; Ratier, A; Pfisterer, SG; Perdiz, D; Cantaloube, I; Rouault, A; Pattingre, S; Proikas-Cezanne, T; Codogno, P; Pous, C				Geeraert, Camille; Ratier, Ameetha; Pfisterer, Simon G.; Perdiz, Daniel; Cantaloube, Isabelle; Rouault, Audrey; Pattingre, Sophie; Proikas-Cezanne, Tassula; Codogno, Patrice; Poues, Christian			Starvation-induced Hyperacetylation of Tubulin Is Required for the Stimulation of Autophagy by Nutrient Deprivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; IN-VIVO; DYNAMIC MICROTUBULES; MAMMALIAN AUTOPHAGY; DEPENDENT MOVEMENT; PUNCTA-FORMATION; KINESIN; FUSION; CELLS; LYSOSOMES	The molecular mechanisms underlying microtubule participation in autophagy are not known. In this study, we show that starvation-induced autophagosome formation requires the most dynamic microtubule subset. Upon nutrient deprivation, labile microtubules specifically recruit markers of autophagosome formation like class III-phosphatidylinositol kinase, WIPI-1, the Atg12-Atg5 conjugate, and LC3-I, whereas mature autophagosomes may bind to stable microtubules. We further found that upon nutrient deprivation, tubulin acetylation increases both in labile and stable microtubules and is required to allow autophagy stimulation. Tubulin hyperacetylation on lysine 40 enhances kinesin-1 and JIP-1 recruitment on microtubules and allows JNK phosphorylation and activation. JNK, in turn, triggers the release of Beclin 1 from Bcl-2-Beclin 1 complexes and its recruitment on microtubules where it may initiate autophagosome formation. Finally, although kinesin-1 functions to carry autophagosomes in basal conditions, it is not involved in motoring autophagosomes after nutrient deprivation. Our results show that the dynamics of microtubules and tubulin post-translational modifications play a major role in the regulation of starvation-induced autophagy.	[Poues, Christian] Univ Paris 11, Fac Pharm, JE 2493, IFR141, F-92296 Chatenay Malabry, France; [Pattingre, Sophie; Codogno, Patrice] Univ Paris 11, Fac Pharm, INSERM, IFR141,U 756, F-92290 Chatenay Malabry, France; [Poues, Christian] Hop Antoine Beclere, AP HP, F-92141 Clamart, France; [Proikas-Cezanne, Tassula] Univ Tubingen, Autophagy Lab, Inst Cell Biol, D-72076 Tubingen, Germany	UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Eberhard Karls University of Tubingen	Pous, C (corresponding author), Univ Paris 11, Fac Pharm, JE 2493, IFR141, 5 Rue JB Clement, F-92296 Chatenay Malabry, France.	christian.pous@u-psud.fr	POÜS, Christian/R-5089-2018; Codogno, Patrice/G-1384-2013; Perdiz, Daniel/R-4471-2018	Codogno, Patrice/0000-0002-5492-3180; Pfisterer, Simon Georg/0000-0001-5606-2102; Proikas-Cezanne, Prof. Dr. Tassula/0000-0001-6934-132X; Perdiz, Daniel/0000-0002-6804-5980; POUS, Christian/0000-0002-2502-7854; Pattingre, Sophie/0000-0001-6284-6050	INSERM; Association pour la Recherche sur le Cancer; Ministere de l'Enseignement Superieur et de la Recherche	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission)	This work was supported in part by institutional funding from INSERM (to P. C.) and a grant from the Association pour la Recherche sur le Cancer (to S. G. P.).; Supported by a grant from the "Ministere de l'Enseignement Superieur et de la Recherche."	APLIN A, 1992, J CELL PHYSIOL, V152, P458, DOI 10.1002/jcp.1041520304; Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Cardoso CMP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004424; Chaumorcel M, 2008, AUTOPHAGY, V4, P46, DOI 10.4161/auto.5184; Cieehomska IA, 2007, AUTOPHAGY, V3, P586, DOI 10.4161/auto.4843; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Daire V, 2009, J BIOL CHEM, V284, P31992, DOI 10.1074/jbc.M109.007906; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Fass E, 2006, J BIOL CHEM, V281, P36303, DOI 10.1074/jbc.M607031200; Giustiniani J, 2009, EXP CELL RES, V315, P3509, DOI 10.1016/j.yexcr.2009.07.018; Giustiniani J, 2009, CELL SIGNAL, V21, P529, DOI 10.1016/j.cellsig.2008.12.004; Gupta V, 2008, TRAFFIC, V9, P1850, DOI 10.1111/j.1600-0854.2008.00811.x; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Horiuchi D, 2007, CURR BIOL, V17, P1313, DOI 10.1016/j.cub.2007.06.062; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Jahreiss L, 2008, TRAFFIC, V9, P574, DOI 10.1111/j.1600-0854.2008.00701.x; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kimura S, 2008, CELL STRUCT FUNCT, V33, P109, DOI 10.1247/csf.08005; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Kochl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x; Kouno T, 2005, J BIOL CHEM, V280, P24610, DOI 10.1074/jbc.M413565200; Kreitzer G, 1999, MOL BIOL CELL, V10, P1105, DOI 10.1091/mbc.10.4.1105; KUZNETSOV SA, 1987, FEBS LETT, V212, P145, DOI 10.1016/0014-5793(87)81574-0; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lee IH, 2009, J BIOL CHEM, V284, P6322, DOI 10.1074/jbc.M807135200; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Longatti A, 2009, CELL DEATH DIFFER, V16, P956, DOI 10.1038/cdd.2009.39; MANN SS, 1994, J BIOL CHEM, V269, P11492; MARKS DL, 1994, J CELL SCI, V107, P2417; Mehrpour M, 2010, AM J PHYSIOL-CELL PH, V298, pC776, DOI 10.1152/ajpcell.00507.2009; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Phung-Koskas T, 2005, J BIOL CHEM, V280, P1123, DOI 10.1074/jbc.M409918200; Pous C, 1998, J CELL BIOL, V142, P153, DOI 10.1083/jcb.142.1.153; Proikas-Cezanne T, 2004, ONCOGENE, V23, P9314, DOI 10.1038/sj.onc.1208331; Proikas-Cezanne T, 2007, FEBS LETT, V581, P3396, DOI 10.1016/j.febslet.2007.06.040; Proikas-Cezanne T, 2009, METHOD ENZYMOL, V452, P247, DOI 10.1016/S0076-6879(08)03616-1; Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Rietdorf J, 2001, NAT CELL BIOL, V3, P992, DOI 10.1038/ncb1101-992; Rubinsztein DC, 2005, AUTOPHAGY, V1, P177, DOI 10.4161/auto.1.3.2050; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Vasquez RJ, 1997, MOL BIOL CELL, V8, P973, DOI 10.1091/mbc.8.6.973; Verhey KJ, 2001, TRENDS BIOCHEM SCI, V26, P545, DOI 10.1016/S0968-0004(01)01931-4; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; VOM DS, 2001, BIOCHEM J, V354, P31; WEBSTER DR, 1987, P NATL ACAD SCI USA, V84, P9040, DOI 10.1073/pnas.84.24.9040; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115	59	128	135	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24184	24194		10.1074/jbc.M109.091553	http://dx.doi.org/10.1074/jbc.M109.091553			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20484055	hybrid, Green Published			2022-12-27	WOS:000280291400068
J	Shiina, N; Tokunaga, M				Shiina, Nobuyuki; Tokunaga, Makio			RNA Granule Protein 140 (RNG140), a Paralog of RNG105 Localized to Distinct RNA Granules in Neuronal Dendrites in the Adult Vertebrate Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; BINDING PROTEINS; TRANSLATION; DOMAIN; PHOSPHORYLATION; RECRUITMENT; STRESS; SITES	RNA granules mediate the transport and local translation of their mRNA cargoes, which regulate cellular processes such as stress response and neuronal synaptic plasticity. RNA granules contain specific RNA-binding proteins, including RNA granule protein 105 (RNG105), which is likely to participate in the transport and translation of mRNAs. In the present report, an RNG105 paralog, RNG140 is described. A homolog of RNG105/RNG140 is found in insects, echinoderms, and urochordates, whereas vertebrates have both of the two genes. RNG140 and RNG105 are similar in that both bind to mRNAs and inhibit translation in vitro, induce the formation of RNA granules, are most highly expressed in the brain, and are localized to dendritic RNA granules, part of which are accumulated at postsynapses. However, they differ in several characteristics; RNG105 is highly expressed in embryonic brains, whereas RNG140 is highly expressed in adult brains. Furthermore, the granules where RNG105 or RNG140 is localized are distinct RNA granules in both cultured cells and neuronal dendrites. Thus, RNG140 is an RNA-binding protein that shows different expression and localization patterns from RNG105. Knockdown experiments in cultured neurons also are performed, which demonstrate that suppression of RNG140 or RNG105 reduces dendrite length and spine density. Knockdown effects of RNG140 were not rescued by RNG105, and vise versa, suggesting distinct roles of RNG105 and RNG140. These results suggest that RNG140 has roles in the maintenance of the dendritic structure in the adult vertebrate brain through localizing to a kind of RNA granules that are distinct from RNG105-containing granules.	[Shiina, Nobuyuki] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Lab Neuronal Cell Biol, Okazaki, Aichi 4448585, Japan; [Shiina, Nobuyuki] Natl Inst Nat Sci, Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; [Shiina, Nobuyuki; Tokunaga, Makio] Res Org Informat & Syst, Struct Biol Ctr, Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; [Shiina, Nobuyuki; Tokunaga, Makio] SOKENDAI, Dept Genet, Okazaki, Aichi 4448585, Japan; [Shiina, Nobuyuki; Tokunaga, Makio] Tokyo Inst Technol, Dept Biol Informat, Grad Sch Biosci & Biotechnol, Kanagawa 2268501, Japan; [Shiina, Nobuyuki] SOKENDAI, Dept Basic Biol, Okazaki, Aichi 4448585, Japan; [Tokunaga, Makio] RIKEN, Res Ctr Allergy & Immunol, Kanagawa 2300045, Japan	National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Tokyo Institute of Technology; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); RIKEN	Shiina, N (corresponding author), Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Lab Neuronal Cell Biol, Nishigonaka 38, Okazaki, Aichi 4448585, Japan.	nshiina@nibb.ac.jp; mtoku@bio.titech.ac.jp		Tokunaga, Makio/0000-0003-4586-8922; Shiina, Nobuyuki/0000-0002-1854-4239	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [20114004] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to N. S. and M. T.).	Aerbajinai W, 2004, J BIOL CHEM, V279, P1916, DOI 10.1074/jbc.M305634200; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Cahuzac B, 2000, EMBO J, V19, P445, DOI 10.1093/emboj/19.3.445; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Ding Y, 2008, J CELL BIOL, V182, P865, DOI 10.1083/jcb.200803147; Forch P, 2002, EMBO J, V21, P6882, DOI 10.1093/emboj/cdf668; Grill B, 2004, J IMMUNOL, V172, P2389, DOI 10.4049/jimmunol.172.4.2389; Innamorati G, 2006, CELL SIGNAL, V18, P761, DOI 10.1016/j.cellsig.2005.11.004; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Kindler S, 2005, ANNU REV CELL DEV BI, V21, P223, DOI 10.1146/annurev.cellbio.21.122303.120653; Kloc M, 2002, CELL, V108, P533, DOI 10.1016/S0092-8674(02)00651-7; Knowles RB, 1996, J NEUROSCI, V16, P7812; NELSON HCM, 1995, CURR OPIN GENET DEV, V5, P180, DOI 10.1016/0959-437X(95)80006-9; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Rupert PB, 2000, STRUCTURE, V8, pR99, DOI 10.1016/S0969-2126(00)00138-6; Shiina N, 2005, J NEUROSCI, V25, P4420, DOI 10.1523/JNEUROSCI.0382-05.2005; Shiina N, 1999, MOL BIOL CELL, V10, P597, DOI 10.1091/mbc.10.3.597; Sossin WS, 2006, TRAFFIC, V7, P1581, DOI 10.1111/j.1600-0854.2006.00500.x; Strom AC, 1996, NUCLEIC ACIDS RES, V24, P1981, DOI 10.1093/nar/24.11.1981; Tacnet P, 2008, BBA-PROTEINS PROTEOM, V1784, P518, DOI 10.1016/j.bbapap.2007.12.005; Yamasaki S, 2008, CURR OPIN CELL BIOL, V20, P222, DOI 10.1016/j.ceb.2008.01.013	23	25	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24260	24269		10.1074/jbc.M110.108944	http://dx.doi.org/10.1074/jbc.M110.108944			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20516077	Green Published, hybrid			2022-12-27	WOS:000280291400075
J	Yamazaki, T; Takata, N; Uemura, M; Kawamura, Y				Yamazaki, Tomokazu; Takata, Naoki; Uemura, Matsuo; Kawamura, Yukio			Arabidopsis Synaptotagmin SYT1, a Type I Signal-anchor Protein, Requires Tandem C2 Domains for Delivery to the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; SYNAPTIC VESICLE; H+-ATPASE; LENGTH; LOCALIZATION; COMPARTMENT; EXOCYTOSIS; MOTIF; VII; TOPOGENESIS	The correct localization of integral membrane proteins to subcellular compartments is important for their functions. Synaptotagmin contains a single transmembrane domain that functions as a type I signal-anchor sequence in its N terminus and two calcium-binding domains (C(2)A and C2B) in its C terminus. Here, we demonstrate that the localization of an Arabidopsis synaptotagmin homolog, SYT1, to the plasma membrane ( PM) is modulated by tandem C2 domains. An analysis of the roots of a transformant-expressing green fluorescent protein-tagged SYT1 driven by native SYT1 promoter suggested that SYT1 is synthesized in the endoplasmic reticulum, and then delivered to the PM via the exocytotic pathway. We transiently expressed a series of truncated proteins in protoplasts, and determined that tandem C(2)A-C2B domains were necessary for the localization of SYT1 to the PM. The PM localization of SYT1 was greatly reduced following mutation of the calcium-binding motifs of the C2B domain, based on sequence comparisons with other homologs, such as endomembrane-localized SYT5. The localization of SYT1 to the PM may have been required for the functional divergence that occurred in the molecular evolution of plant synaptotagmins.	[Uemura, Matsuo; Kawamura, Yukio] Iwate Univ, Fac Agr, Cryobiofrontier Res Ctr, Morioka, Iwate 0208550, Japan; [Yamazaki, Tomokazu; Uemura, Matsuo; Kawamura, Yukio] Iwate Univ, 21st Century Ctr Excellence Program, Morioka, Iwate 0208550, Japan; [Takata, Naoki; Uemura, Matsuo; Kawamura, Yukio] Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 0208550, Japan	Iwate University; Iwate University; Iwate University	Kawamura, Y (corresponding author), Iwate Univ, Fac Agr, Cryobiofrontier Res Ctr, 3-18-8 Ueda, Morioka, Iwate 0208550, Japan.	ykawa@iwate-u.ac.jp	Takata, Naoki/AAD-9822-2020; Uemura, Matsuo/B-1364-2012	Takata, Naoki/0000-0002-8479-8165; Uemura, Matsuo/0000-0003-0436-2976; Kawamura, Yukio/0000-0002-1498-5352	21st Century COE Program [K-03]; Ministry of Education, Culture, Sports, Science and Technology of Japan [18780242, 22780288, 20780229, 17380062]; Japan Society for the Promotion of Science [19.9498]; Iwate University	21st Century COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Iwate University	This work was supported by a grant from the 21st Century COE Program to Iwate University (K-03) and the Tohoku University Ecosystem Adaptive Global COE Program (J03) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Grants-in-Aid for Scientific Research (18780242 and 22780288 to Y. K., 20780229 to T. Y., and 17380062 to M. U.), a grant from the Japan Society for the Promotion of Science (19.9498 to N. T.), and the President Fund of Iwate University.	Bai JH, 2004, TRENDS BIOCHEM SCI, V29, P143, DOI 10.1016/j.tibs.2004.01.008; Baluska F, 2000, DEV BIOL, V227, P618, DOI 10.1006/dbio.2000.9908; Benghezal M, 2000, PLANT CELL, V12, P1179, DOI 10.1105/tpc.12.7.1179; Berton F, 2000, EUR J NEUROSCI, V12, P1294, DOI 10.1046/j.1460-9568.2000.00013.x; Bi GQ, 1995, J CELL BIOL, V131, P1747, DOI 10.1083/jcb.131.6.1747; Bolte S, 2004, J MICROSC-OXFORD, V214, P159, DOI 10.1111/j.0022-2720.2004.01348.x; Brandizzi F, 2002, PLANT CELL, V14, P1077, DOI 10.1105/tpc.000620; Chae YK, 1998, J BIOL CHEM, V273, P25659, DOI 10.1074/jbc.273.40.25659; Chapman ER, 1998, J BIOL CHEM, V273, P13995, DOI 10.1074/jbc.273.22.13995; Craxton M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-43; Creutz CE, 2004, CELL MOL LIFE SCI, V61, P1208, DOI 10.1007/s00018-004-4029-8; Czibener C, 2006, J CELL BIOL, V174, P997, DOI 10.1083/jcb.200605004; daSilva LLP, 2005, PLANT CELL, V17, P132, DOI 10.1105/tpc.104.026351; Dasilva LLP, 2006, PLANT CELL, V18, P1477, DOI 10.1105/tpc.105.040394; Dhonukshe P, 2006, DEV CELL, V10, P137, DOI 10.1016/j.devcel.2005.11.015; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fukuda M, 2004, J BIOL CHEM, V279, P52677, DOI 10.1074/jbc.M409241200; Gaffaney JD, 2008, J BIOL CHEM, V283, P31763, DOI 10.1074/jbc.M803355200; Goder V, 2001, FEBS LETT, V504, P87, DOI 10.1016/S0014-5793(01)02712-0; Grimberg E, 2003, J CELL SCI, V116, P145, DOI 10.1242/jcs.00186; Grise F, 2007, BIOCHEM J, V403, P483, DOI 10.1042/BJ20061182; Gustavsson N, 2008, P NATL ACAD SCI USA, V105, P3992, DOI 10.1073/pnas.0711700105; Hanton SL, 2005, PLANT CELL, V17, P3081, DOI 10.1105/tpc.105.034900; HIGH S, 1991, J CELL BIOL, V113, P25, DOI 10.1083/jcb.113.1.25; Hutt DM, 2002, BIOL REPROD, V66, P50, DOI 10.1095/biolreprod66.1.50; Iezzi M, 2004, J CELL SCI, V117, P3119, DOI 10.1242/jcs.01179; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jimenez JL, 2007, PROTEINS, V68, P770, DOI 10.1002/prot.21449; Kawamura Y, 2003, PLANT J, V36, P141, DOI 10.1046/j.1365-313X.2003.01864.x; Kida Y, 2000, J CELL BIOL, V150, P719, DOI 10.1083/jcb.150.4.719; Lam SK, 2009, PLANT J, V60, P865, DOI 10.1111/j.1365-313X.2009.04007.x; Lee I, 2006, FASEB J, V20, P202, DOI 10.1096/fj.05-4581hyp; Lefebvre B, 2004, PLANT CELL, V16, P1772, DOI 10.1105/tpc.022277; Levius O, 1997, EUR J CELL BIOL, V73, P81; Lewis JD, 2010, P NATL ACAD SCI USA, V107, P2491, DOI 10.1073/pnas.0909080107; Liu JX, 2007, PLANT CELL, V19, P4111, DOI 10.1105/tpc.106.050021; Loewen CA, 2006, MOL BIOL CELL, V17, P5211, DOI 10.1091/mbc.E06-07-0622; Michaut M, 2001, DEV BIOL, V235, P521, DOI 10.1006/dbio.2001.0316; Min SW, 2007, P NATL ACAD SCI USA, V104, P3823, DOI 10.1073/pnas.0611725104; Minami A, 2009, PLANT CELL PHYSIOL, V50, P341, DOI 10.1093/pcp/pcn202; Monterrat C, 2007, HISTOCHEM CELL BIOL, V127, P625, DOI 10.1007/s00418-007-0271-0; Morsomme P, 1998, J BIOL CHEM, V273, P34837, DOI 10.1074/jbc.273.52.34837; Nagase T, 1998, DNA Res, V5, P277, DOI 10.1093/dnares/5.5.277; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Niwa Y, 1999, PLANT J, V18, P455, DOI 10.1046/j.1365-313X.1999.00464.x; Ohshima Y, 2001, PLANT CELL PHYSIOL, V42, P1119, DOI 10.1093/pcp/pce141; Osborne SL, 1999, J BIOL CHEM, V274, P59, DOI 10.1074/jbc.274.1.59; PALMGREN MG, 1990, PLANT PHYSIOL, V92, P871, DOI 10.1104/pp.92.4.871; Pedrazzini E, 1996, P NATL ACAD SCI USA, V93, P4207, DOI 10.1073/pnas.93.9.4207; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Rickman C, 2004, J BIOL CHEM, V279, P12574, DOI 10.1074/jbc.M310710200; Ridge RW, 1999, PLANT CELL PHYSIOL, V40, P1253, DOI 10.1093/oxfordjournals.pcp.a029513; Robinson DG, 2008, TRENDS PLANT SCI, V13, P405, DOI 10.1016/j.tplants.2008.05.010; Rojo E, 2008, PLANT PHYSIOL, V147, P1493, DOI 10.1104/pp.108.124552; Saint-Jore-Dupas C, 2006, PLANT CELL, V18, P3182, DOI 10.1105/tpc.105.036400; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schapire AL, 2008, PLANT CELL, V20, P3374, DOI 10.1105/tpc.108.063859; Seki M, 1998, PLANT J, V15, P707, DOI 10.1046/j.1365-313x.1998.00237.x; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; Takeda S, 2008, SCIENCE, V319, P1241, DOI 10.1126/science.1152505; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Terasaki M, 1997, J CELL BIOL, V139, P63, DOI 10.1083/jcb.139.1.63; Ting JT, 2006, J NEUROSCI, V26, P372, DOI 10.1523/JNEUROSCI.3997-05.2006; UEMURA M, 1995, PLANT PHYSIOL, V109, P15, DOI 10.1104/pp.109.1.15; Watson RT, 2001, AM J PHYSIOL-CELL PH, V281, pC215, DOI 10.1152/ajpcell.2001.281.1.C215; Wirth J, 2007, J BIOL CHEM, V282, P23541, DOI 10.1074/jbc.M700901200; Yamazaki T, 2008, PLANT CELL, V20, P3389, DOI 10.1105/tpc.108.062679; Zhao HB, 2008, DEV CELL, V14, P914, DOI 10.1016/j.devcel.2008.03.022	73	35	36	1	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23163	23174		10.1074/jbc.M109.084046	http://dx.doi.org/10.1074/jbc.M109.084046			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20498364	Green Published, hybrid			2022-12-27	WOS:000279999900051
J	Eylert, E; Herrmann, V; Jules, M; Gillmaier, N; Lautner, M; Buchrieser, C; Eisenreich, W; Heuner, K				Eylert, Eva; Herrmann, Vroni; Jules, Matthieu; Gillmaier, Nadine; Lautner, Monika; Buchrieser, Carmen; Eisenreich, Wolfgang; Heuner, Klaus			Isotopologue Profiling of Legionella pneumophila ROLE OF SERINE AND GLUCOSE AS CARBON SUBSTRATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-REQUIREMENTS; LIQUID-MEDIUM; METABOLISM; GROWTH; VIRULENCE; IDENTIFICATION	Legionella pneumophila (Lp) is commonly found in freshwater habitats but is also the causative agent of Legionnaires' disease when infecting humans. Although various virulence factors have been reported, little is known about the nutrition and the metabolism of the bacterium. Here, we report the application of isotopologue profiling for analyzing the metabolism of L. pneumophila. Cultures of Lp were supplied with [U-C-13(3)] serine, [U-C-13(6)] glucose, or [1,2-C-13(2)] glucose. After growth, C-13 enrichments and isotopologue patterns of protein-derived amino acids and poly-3-hydroxybutyrate were determined by mass spectrometry and/or NMR spectroscopy. The labeling patterns detected in the experiment with [U-C-13(3)] serine showed major carbon flux from serine to pyruvate and from pyruvate to acetyl-CoA, which serves as a precursor of poly-3-hydroxybutyrate or as a substrate of a complete citrate cycle with Si specificity of the citrate synthase. Minor carbon flux was observed between pyruvate and oxaloacetate/malate by carboxylation and decarboxylation, respectively. The apparent lack of label in Val, Ile, Leu, Pro, Phe, Met, Arg, and Tyr confirmed that L. pneumophila is auxotrophic for these amino acids. Experiments with [C-13] glucose showed that the carbohydrate is also used as a substrate to feed the central metabolism. The specific labeling patterns due to [1,2-C-13(2)] glucose identified the Entner-Doudoroff pathway as the predominant route for glucose utilization. In line with these observations, a mutant lacking glucose-6-phosphate dehydrogenase (Delta zwf) did not incorporate label from glucose at significant levels and was slowly outcompeted by the wild type strain in successive rounds of infection in Acanthamoeba castellanii, indicating the importance of this enzyme and of carbohydrate usage in general for the life cycle of Lp.	[Eylert, Eva; Gillmaier, Nadine; Eisenreich, Wolfgang] Tech Univ Munich, Lehrstuhl Biochem, D-85747 Garching, Germany; [Herrmann, Vroni; Lautner, Monika; Heuner, Klaus] Robert Koch Inst, Res Grp Nosocomial Infect Elderly P26, D-13353 Berlin, Germany; [Jules, Matthieu; Buchrieser, Carmen] Inst Pasteur, F-75015 Paris, France; [Jules, Matthieu; Buchrieser, Carmen] CNRS, URA 2171, F-75015 Paris, France	Technical University of Munich; Robert Koch Institute; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Eisenreich, W (corresponding author), Tech Univ Munich, Lehrstuhl Biochem, Lichtenbergstr 4, D-85747 Garching, Germany.	wolfgang.eisenreich@ch.tum.de; heunerk@rki.de	Jules, Matthieu/GVU-5315-2022; Eisenreich, Wolfgang/A-1258-2013	Jules, Matthieu/0000-0003-0817-8949; Eisenreich, Wolfgang/0000-0002-9832-8279; Buchrieser, Carmen/0000-0003-3477-9190	Deutsche Forschungsgemeinschaft DFG, Bonn, Germany [EI 384/4-1, HE 2845/6-1, SPP 1316]; Network of Excellence [LSHB-CT-2005-512061]; Institut Pasteur and Bio-Rad [PTR 185]	Deutsche Forschungsgemeinschaft DFG, Bonn, Germany(German Research Foundation (DFG)); Network of Excellence; Institut Pasteur and Bio-Rad	This work was supported by Grants EI 384/4-1 and HE 2845/6-1 from the Deutsche Forschungsgemeinschaft DFG SPP 1316, Bonn, Germany (to W.E. and K.H., respectively) and by the Network of Excellence "Euro-pathogenomics" Grant LSHB-CT-2005-512061 and the Grant PTR 185 from the Institut Pasteur and Bio-Rad (to C.B.). M.J. received support from the Institut Pasteur-Bio-Rad Grant PTR 185.	ANDERSON AJ, 1990, INT J BIOL MACROMOL, V12, P102, DOI 10.1016/0141-8130(90)90060-N; ANDERSON AJ, 1990, MICROBIOL REV, V54, P450, DOI 10.1128/MMBR.54.4.450-472.1990; Banerji S, 2008, INT J MED MICROBIOL, V298, P169, DOI 10.1016/j.ijmm.2007.11.004; Bruggemann H, 2006, CELL MICROBIOL, V8, P1228, DOI 10.1111/j.1462-5822.2006.00703.x; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; DebRoy S, 2006, P NATL ACAD SCI USA, V103, P19146, DOI 10.1073/pnas.0608279103; Eisenreich W, 2006, P NATL ACAD SCI USA, V103, P2040, DOI 10.1073/pnas.0507580103; Eylert E, 2008, MOL MICROBIOL, V69, P1008, DOI 10.1111/j.1365-2958.2008.06337.x; Flieger A, 2004, INFECT IMMUN, V72, P2648, DOI 10.1128/IAI.72.5.2648-2658.2004; Fonseca Maris V., 2008, P213; Garduno RA, 2002, INFECT IMMUN, V70, P6273, DOI 10.1128/IAI.70.11.6273-6283.2002; GEORGE JR, 1980, J CLIN MICROBIOL, V11, P286, DOI 10.1128/JCM.11.3.286-291.1980; Glockner G, 2008, INT J MED MICROBIOL, V298, P411, DOI 10.1016/j.ijmm.2007.07.012; Greub G, 2003, RES MICROBIOL, V154, P619, DOI 10.1016/j.resmic.2003.08.003; Hammer BK, 2002, MOL MICROBIOL, V44, P107, DOI 10.1046/j.1365-2958.2002.02884.x; Heuner K, 2002, INFECT IMMUN, V70, P1604, DOI 10.1128/IAI.70.3.1604-1608.2002; Hoffman PS, 2008, INFEC AGENT, P113; Hoffman PS, 1984, P 2 INT S LEG, P61; KEEN MG, 1984, CURR MICROBIOL, V11, P81, DOI 10.1007/BF01567708; LEE WNP, 1991, BIOL MASS SPECTROM, V20, P451, DOI 10.1002/bms.1200200804; Molofsky AB, 2004, MOL MICROBIOL, V53, P29, DOI 10.1111/j.1365-2958.2004.04129.x; Molofsky AB, 2003, MOL MICROBIOL, V50, P445, DOI 10.1046/j.1365-2958.2003.03706.x; Pearce MM, 2009, FEMS MICROBIOL LETT, V300, P256, DOI 10.1111/j.1574-6968.2009.01801.x; PINE L, 1979, J CLIN MICROBIOL, V9, P615; REEVES MW, 1981, J CLIN MICROBIOL, V13, P688, DOI 10.1128/JCM.13.4.688-695.1981; RISTROPH JD, 1981, J CLIN MICROBIOL, V13, P115, DOI 10.1128/JCM.13.1.115-119.1981; RISTROPH JD, 1980, J CLIN MICROBIOL, V11, P19, DOI 10.1128/JCM.11.1.19-21.1980; Sauer JD, 2005, P NATL ACAD SCI USA, V102, P9924, DOI 10.1073/pnas.0502767102; Sauer U, 2005, FEMS MICROBIOL REV, V29, P765, DOI 10.1016/j.femsre.2004.11.002; Schunder E, 2010, INT J MED MICROBIOL, V300, P313, DOI 10.1016/j.ijmm.2010.01.002; Steinert M, 1997, APPL ENVIRON MICROB, V63, P2047, DOI 10.1128/AEM.63.5.2047-2053.1997; Swanson MS, 2000, ANNU REV MICROBIOL, V54, P567, DOI 10.1146/annurev.micro.54.1.567; TESH MJ, 1981, J CLIN MICROBIOL, V13, P865, DOI 10.1128/JCM.13.5.865-869.1981; TESH MJ, 1983, J BACTERIOL, V154, P1104, DOI 10.1128/JB.154.3.1104-1109.1983; TESH MJ, 1982, CAN J MICROBIOL, V28, P1055, DOI 10.1139/m82-158; WEISS E, 1984, APPL ENVIRON MICROB, V48, P380, DOI 10.1128/AEM.48.2.380-385.1984; WEISS E, 1980, CURR MICROBIOL, V4, P1, DOI 10.1007/BF02602882; Wieland H, 2005, MOL MICROBIOL, V55, P1528, DOI 10.1111/j.1365-2958.2005.04490.x; Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58	40	75	75	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22232	22243		10.1074/jbc.M110.128678	http://dx.doi.org/10.1074/jbc.M110.128678			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20442401	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000279702200036
J	Hilliard, M; Frohnert, C; Spillner, C; Marcone, S; Nath, A; Lampe, T; Fitzgerald, DJ; Kehlenbach, RH				Hilliard, Mark; Frohnert, Cornelia; Spillner, Christiane; Marcone, Simone; Nath, Annegret; Lampe, Tina; Fitzgerald, Desmond J.; Kehlenbach, Ralph H.			The Anti-inflammatory Prostaglandin 15-Deoxy-Delta(12,14)-PGJ(2) Inhibits CRM1-dependent Nuclear Protein Export	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLOPENTENONE PROSTAGLANDINS; PORE COMPLEX; LEPTOMYCIN-B; CRM1; J(2); IMPORT; BINDING; SIGNAL; TRANSPORT; RECEPTOR	The signaling molecule 15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)) has been described as the "anti-inflammatory prostaglandin." Here we show that substrates of the nuclear export receptor CRM1 accumulate in the nucleus in the presence of 15d-PGJ(2), identifying this prostaglandin as a regulator of CRM1-dependent nuclear protein export that can be produced endogenously. Like leptomycin B (LMB), an established fungal CRM1-inhibitor, 15d-PGJ(2) reacts with a conserved cysteine residue in the CRM1 sequence. This covalent modification prevents the formation of nuclear export complexes. Cells that are transfected with mutant CRM1(C528S) are resistant to the inhibitory effects of LMB and 15d-PGJ(2), demonstrating that the same single amino acid is targeted by the two compounds. Inhibition of the CRM1 pathway by endogenously produced prostaglandin and/or exogenously applied 15d-PGJ(2) may contribute to its anti-inflammatory, anti-proliferative, and anti-viral effects.	[Frohnert, Cornelia; Spillner, Christiane; Nath, Annegret; Lampe, Tina; Kehlenbach, Ralph H.] Univ Gottingen, Fac Med, Dept Biochem 1, D-37073 Gottingen, Germany; [Hilliard, Mark; Marcone, Simone; Fitzgerald, Desmond J.] UCD Conway Inst, Dublin 4, Ireland	University of Gottingen; University College Dublin	Kehlenbach, RH (corresponding author), Univ Gottingen, Fac Med, Dept Biochem 1, Humboldtallee 23, D-37073 Gottingen, Germany.	rkehlen@gwdg.de		Kehlenbach, Ralph/0000-0003-4920-9916; Marcone, Simone/0000-0001-5516-4000	Faculty of Medicine, Georg-August-University, Gottingen; Health Research Board of Ireland; Cancer Research Ireland	Faculty of Medicine, Georg-August-University, Gottingen; Health Research Board of Ireland; Cancer Research Ireland	This work was funded in part by a Research Program Grant, Faculty of Medicine, Georg-August-University, Gottingen ( to R.H.K.) and by the Health Research Board of Ireland and the Cancer Research Ireland (to D.J.F.).	Askjaer P, 1999, MOL CELL BIOL, V19, P6276; Bischoff FR, 1997, FEBS LETT, V419, P249, DOI 10.1016/S0014-5793(97)01467-1; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; Chemnitz J, 2010, IMMUNOBIOLOGY, V215, P370, DOI 10.1016/j.imbio.2009.05.008; Cox B, 2002, BBA-MOL CELL BIOL L, V1584, P37, DOI 10.1016/S1388-1981(02)00267-6; Daelemans D, 2002, P NATL ACAD SCI USA, V99, P14440, DOI 10.1073/pnas.212285299; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Hutten S, 2006, MOL CELL BIOL, V26, P6772, DOI 10.1128/MCB.00342-06; Hutten S, 2009, J CELL SCI, V122, P1100, DOI 10.1242/jcs.040154; Kahle J, 2009, J BIOL CHEM, V284, P9382, DOI 10.1074/jbc.M805694200; Kehlenbach Ralph H, 2002, Methods Mol Biol, V189, P231; Kehlenbach RH, 1999, J CELL BIOL, V145, P645, DOI 10.1083/jcb.145.4.645; Kehlenbach RH, 1998, J CELL BIOL, V141, P863, DOI 10.1083/jcb.141.4.863; Kehlenbach RH, 2001, J BIOL CHEM, V276, P14524, DOI 10.1074/jbc.M011087200; Kim WJ, 2007, EMBO J, V26, P5020, DOI 10.1038/sj.emboj.7601920; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Kondo M, 2002, P NATL ACAD SCI USA, V99, P7367, DOI 10.1073/pnas.112212599; Kondo M, 2001, J BIOL CHEM, V276, P12076, DOI 10.1074/jbc.M009630200; Koster M, 2003, EXP CELL RES, V286, P321, DOI 10.1016/S0014-4827(03)00100-9; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Meissner T, 2004, FEBS LETT, V576, P27, DOI 10.1016/j.febslet.2004.08.056; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; MELCHIOR F, 1995, METHOD ENZYMOL, V257, P279; NARUMIYA S, 1987, J PHARMACOL EXP THER, V242, P306; Oliva JL, 2003, P NATL ACAD SCI USA, V100, P4772, DOI 10.1073/pnas.0735842100; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; PASCHAL BM, 1995, J CELL BIOL, V129, P925, DOI 10.1083/jcb.129.4.925; Perisic O, 1999, J BIOL CHEM, V274, P14979, DOI 10.1074/jbc.274.21.14979; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; Rajakariar R, 2007, P NATL ACAD SCI USA, V104, P20979, DOI 10.1073/pnas.0707394104; Richards SA, 1996, J CELL BIOL, V134, P1157, DOI 10.1083/jcb.134.5.1157; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Ryan AJ, 2008, J BIOL CHEM, V283, P24628, DOI 10.1074/jbc.M801167200; Scher JU, 2005, CLIN IMMUNOL, V114, P100, DOI 10.1016/j.clim.2004.09.008; Schutz S, 2006, J MOL BIOL, V358, P997, DOI 10.1016/j.jmb.2006.02.041; SMITH WL, 1989, BIOCHEM J, V259, P315, DOI 10.1042/bj2590315; Spencer AG, 1998, J BIOL CHEM, V273, P9886, DOI 10.1074/jbc.273.16.9886; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Straus DS, 2001, MED RES REV, V21, P185, DOI 10.1002/med.1006; Turner JG, 2009, CANCER RES, V69, P6899, DOI 10.1158/0008-5472.CAN-09-0484; Uchida K, 2008, CHEM RES TOXICOL, V21, P138, DOI 10.1021/tx700177j; Vunta H, 2007, J BIOL CHEM, V282, P17964, DOI 10.1074/jbc.M703075200; Wang P, 2009, J CELL SCI, V122, P3772, DOI 10.1242/jcs.057026; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X	53	42	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22202	22210		10.1074/jbc.M110.131821	http://dx.doi.org/10.1074/jbc.M110.131821			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20457605	Green Published, hybrid			2022-12-27	WOS:000279702200033
J	Shirai, A; Sadaie, M; Shinmyozu, K; Nakayama, J				Shirai, Atsuko; Sadaie, Mahito; Shinmyozu, Kaori; Nakayama, Jun-ichi			Methylation of Ribosomal Protein L42 Regulates Ribosomal Function and Stress-adapted Cell Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SET DOMAIN METHYLTRANSFERASE; YEAST SCHIZOSACCHAROMYCES-POMBE; MASS-SPECTROMETRIC ANALYSIS; HISTONE LYSINE METHYLATION; LIFE-SPAN EXTENSION; FISSION YEAST; TRANSFER-RNA; CYCLOHEXIMIDE RESISTANCE; SACCHAROMYCES-CEREVISIAE; TRANSLATION INITIATION	Lysine methylation is one of the most common protein modifications. Although lysine methylation of histones has been extensively studied and linked to gene regulation, that of nonhistone proteins remains incompletely understood. Here, we show a novel regulatory role of ribosomal protein methylation. Using an in vitro methyltransferase assay, we found that Schizosaccharomyces pombe Set13, a SET domain protein encoded by SPAC688.14, specifically methylates lysine 55 of ribosomal protein L42 (Rpl42). Mass spectrometric analysis revealed that endogenous Rpl42 is monomethylated at lysine 55 in wild-type S. pombe cells and that the methylation is lost in Delta set13 mutant cells. Delta set13 and Rpl42 methylation-deficient mutant S. pombe cells showed higher cycloheximide sensitivity and defects in stress-responsive growth control compared with wild type. Genetic analyses suggested that the abnormal growth phenotype was distinct from the conserved stress-responsive pathway that modulates translation initiation. Furthermore, the Rpl42 methylation-deficient mutant cells showed a reduced ability to survive after entering stationary phase. These results suggest that Rpl42 methylation plays direct roles in ribosomal function and cell proliferation control independently of the general stress-response pathway.	[Nakayama, Jun-ichi] RIKEN Ctr Dev Biol, Lab Chromatin Dynam, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Shinmyozu, Kaori] RIKEN Ctr Dev Biol, Prote Support Unit, Kobe, Hyogo 6500047, Japan; [Sadaie, Mahito] Canc Res UK, Cambridge Res Inst, Cambridge CB2 0RE, England	RIKEN; RIKEN; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Nakayama, J (corresponding author), RIKEN Ctr Dev Biol, Lab Chromatin Dynam, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	jnakayam@cdb.riken.jp	shirai, atsuko/C-5406-2017; Nakayama, Jun-ichi/C-6003-2011	shirai, atsuko/0000-0003-1344-4746; Nakayama, Jun-ichi/0000-0002-5597-8239	Ministry of Education, Culture, Sports, Science, and Technology of Japan; RIKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.; Supported by a Special Postdoctoral Researchers Program of RIKEN. Both authors contributed equally to this work.	Aguilera J, 2007, FEMS MICROBIOL REV, V31, P327, DOI 10.1111/j.1574-6976.2007.00066.x; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Baouz S, 2009, BIOCHIMIE, V91, P1420, DOI 10.1016/j.biochi.2009.07.013; Blaha G, 2008, J MOL BIOL, V379, P505, DOI 10.1016/j.jmb.2008.03.075; Borovinskaya MA, 2008, RNA, V14, P1590, DOI 10.1261/rna.1076908; Borovinskaya MA, 2007, NAT STRUCT MOL BIOL, V14, P727, DOI 10.1038/nsmb1271; Carroll AJ, 2008, MOL CELL PROTEOMICS, V7, P347, DOI 10.1074/mcp.M700052-MCP200; Chen D, 2007, AGING CELL, V6, P525, DOI 10.1111/j.1474-9726.2007.00305.x; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Clarke SG, 2006, ENZYMES, V24, P1; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; Dunand-Sauthier I, 2005, EUKARYOT CELL, V4, P1785, DOI 10.1128/EC.4.11.1785-1793.2005; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Houtz RL, 2003, ARCH BIOCHEM BIOPHYS, V414, P150, DOI 10.1016/S0003-9861(03)00122-X; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; KAUFER NF, 1983, NUCLEIC ACIDS RES, V11, P3123; Kim JH, 2004, HEPATOLOGY, V39, P129, DOI 10.1002/hep.20017; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Kouskouti A, 2004, MOL CELL, V14, P175, DOI 10.1016/S1097-2765(04)00182-0; Krawchuk MD, 1999, YEAST, V15, P1419, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1419::AID-YEA466>3.0.CO;2-Q; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lee SW, 2002, P NATL ACAD SCI USA, V99, P5942, DOI 10.1073/pnas.082119899; LHOEST J, 1984, EUR J BIOCHEM, V141, P585, DOI 10.1111/j.1432-1033.1984.tb08233.x; LILL R, 1989, EMBO J, V8, P3933, DOI 10.1002/j.1460-2075.1989.tb08574.x; Lyne R, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-27; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Matsuyama A, 2004, YEAST, V21, P1289, DOI 10.1002/yea.1181; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Morris SA, 2005, EUKARYOT CELL, V4, P1446, DOI 10.1128/EC.4.8.1446-1454.2005; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Noma K, 2002, P NATL ACAD SCI USA, V99, P16438, DOI 10.1073/pnas.182436399; Odintsova TI, 2003, J PROTEIN CHEM, V22, P249, DOI 10.1023/A:1025068419698; Pestova TV, 2003, GENE DEV, V17, P181, DOI 10.1101/gad.1040803; Polevoda B, 2000, J BIOL CHEM, V275, P20508, DOI 10.1074/jbc.M001891200; Polevoda B, 2007, MOL MICROBIOL, V65, P590, DOI 10.1111/j.1365-2958.2007.05831.x; Porras-Yakushi TR, 2006, J BIOL CHEM, V281, P35835, DOI 10.1074/jbc.M606578200; Porras-Yakushi TR, 2005, J BIOL CHEM, V280, P34590, DOI 10.1074/jbc.M507672200; Qian C, 2006, CELL MOL LIFE SCI, V63, P2755, DOI 10.1007/s00018-006-6274-5; Roguev A, 2007, NAT METHODS, V4, P861, DOI 10.1038/NMETH1098; Roux AE, 2006, AGING CELL, V5, P345, DOI 10.1111/j.1474-9726.2006.00225.x; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Sadaie M, 2008, J BIOL CHEM, V283, P7185, DOI 10.1074/jbc.M709429200; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Schmeing TM, 2003, RNA, V9, P1345, DOI 10.1261/rna.5120503; Sergiev PV, 2005, NUCLEIC ACIDS RES, V33, P6048, DOI 10.1093/nar/gki910; Shirai A, 2008, J BIOL CHEM, V283, P10745, DOI 10.1074/jbc.M709211200; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Steffen KK, 2008, CELL, V133, P292, DOI 10.1016/j.cell.2008.02.037; Takaku H, 2004, J BIOL CHEM, V279, P23030, DOI 10.1074/jbc.M400888200; VANBOGELEN RA, 1990, P NATL ACAD SCI USA, V87, P5589, DOI 10.1073/pnas.87.15.5589; Vivancos AP, 2006, MOL GENET GENOMICS, V276, P495, DOI 10.1007/s00438-006-0175-z; Webb KJ, 2008, J BIOL CHEM, V283, P35561, DOI 10.1074/jbc.M806006200; Yu YH, 2005, PROTEIN SCI, V14, P1438, DOI 10.1110/ps.041293005	59	18	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22448	22460		10.1074/jbc.M110.132274	http://dx.doi.org/10.1074/jbc.M110.132274			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20444689	hybrid, Green Published			2022-12-27	WOS:000279702200057
J	Merrick, WC				Merrick, William C.			Eukaryotic Protein Synthesis: Still a Mystery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							TRANSLATION INITIATION-FACTORS; RNA SECONDARY STRUCTURE; MESSENGER-RNA; RIBOSOME; VIRUS; REGION; ROLES; CODON		Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA	Case Western Reserve University	Merrick, WC (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	wcm2@case.edu						Berthelot K, 2004, MOL MICROBIOL, V51, P987, DOI 10.1046/j.1365-2958.2003.03898.x; CIGAN AM, 1988, SCIENCE, V242, P93, DOI 10.1126/science.3051379; Dmitriev SE, 2003, FEBS LETT, V533, P99, DOI 10.1016/S0014-5793(02)03776-6; Elroy-Stein O., 2007, TRANSLATIONAL CONTRO, P155; GODEFROYCOLBURN T, 1985, EUR J BIOCHEM, V147, P541; GODEFROYCOLBURN T, 1981, J BIOL CHEM, V256, P1762; Herr AJ, 2001, J MOL BIOL, V309, P1029, DOI 10.1006/jmbi.2001.4717; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; KOZAK M, 1980, CELL, V19, P79, DOI 10.1016/0092-8674(80)90390-6; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KRUSE C, 1985, P NATL ACAD SCI USA, V82, P7515, DOI 10.1073/pnas.82.22.7515; MATHEWS MB, 2007, TRANSLATIONAL CONTRO; Merrick WC, 2003, BIOCHEM MOL BIOL EDU, V31, P378, DOI 10.1002/bmb.2003.494031060274; Mukhopadhyay R, 2008, MOL CELL, V32, P371, DOI 10.1016/j.molcel.2008.09.019; PARKIN NT, 1988, EMBO J, V7, P2831, DOI 10.1002/j.1460-2075.1988.tb03139.x; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; PELLETIER J, 1987, BIOCHEM CELL BIOL, V65, P576, DOI 10.1139/o87-074; PELLETIER J, 1988, MOL CELL BIOL, V8, P1103, DOI 10.1128/MCB.8.3.1103; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Singh CR, 2006, EMBO J, V25, P4537, DOI 10.1038/sj.emboj.7601339; Svitkin YV, 2001, RNA, V7, P1743; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835; Yueh A, 2000, GENE DEV, V14, P414	25	44	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21197	21201		10.1074/jbc.R110.111476	http://dx.doi.org/10.1074/jbc.R110.111476			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20444697	Green Published, hybrid			2022-12-27	WOS:000279516100002
J	Coffinier, C; Jung, HJ; Li, ZW; Nobumori, C; Yun, UJ; Farber, EA; Davies, BS; Weinstein, MM; Yang, SH; Lammerding, J; Farahani, JN; Bentolila, LA; Fong, LG; Young, SG				Coffinier, Catherine; Jung, Hea-Jin; Li, Ziwei; Nobumori, Chika; Yun, Ui Jeong; Farber, Emily A.; Davies, Brandon S.; Weinstein, Michael M.; Yang, Shao H.; Lammerding, Jan; Farahani, Javad N.; Bentolila, Laurent A.; Fong, Loren G.; Young, Stephen G.			Direct Synthesis of Lamin A, Bypassing Prelamin A Processing, Causes Misshapen Nuclei in Fibroblasts but No Detectable Pathology in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUTCHINSON-GILFORD PROGERIA; MUSCULAR-DYSTROPHY; ZMPSTE24-DEFICIENT MICE; RESTRICTIVE DERMOPATHY; DISEASE PHENOTYPES; SYNDROME MUTATION; A PRECURSOR; MOUSE MODEL; ZMPSTE24; GENE	Lamin A, a key component of the nuclear lamina, is generated from prelamin A by four post-translational processing steps: farnesylation, endoproteolytic release of the last three amino acids of the protein, methylation of the C-terminal farnesylcysteine, and finally, endoproteolytic release of the last 15 amino acids of the protein (including the farnesylcysteine methyl ester). The last cleavage step, mediated by ZMPSTE24, releases mature lamin A. This processing scheme has been conserved through vertebrate evolution and is widely assumed to be crucial for targeting lamin A to the nuclear envelope. However, its physiologic importance has never been tested. To address this issue, we created mice with a "mature lamin A-only" allele (Lmna(LAO)), which contains a stop codon immediately after the last codon of mature lamin A. Thus, Lmna(LAO/LAO) mice synthesize mature lamin A directly, bypassing prelamin A synthesis and processing. The levels of mature lamin A in Lmna(LAO/LAO) mice were indistinguishable from those in "prelamin A-only" mice (Lmna(PLAO/PLAO)), where all of the lamin A is produced from prelamin A. Lmna(LAO/LAO) exhibited normal body weights and had no detectable disease phenotypes. A higher frequency of nuclear blebs was observed in Lmna(LAO/LAO) embryonic fibroblasts; however, the mature lamin A in the tissues of Lmna(LAO/LAO) mice was positioned normally at the nuclear rim. We conclude that prelamin A processing is dispensable in mice and that direct synthesis of mature lamin A has little if any effect on the targeting of lamin A to the nuclear rim in mouse tissues.	[Coffinier, Catherine; Jung, Hea-Jin; Li, Ziwei; Nobumori, Chika; Yun, Ui Jeong; Farber, Emily A.; Davies, Brandon S.; Weinstein, Michael M.; Yang, Shao H.; Fong, Loren G.; Young, Stephen G.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; [Weinstein, Michael M.; Young, Stephen G.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Bentolila, Laurent A.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Farahani, Javad N.; Bentolila, Laurent A.] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Lammerding, Jan] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Cambridge, MA 02139 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Harvard University; Brigham & Women's Hospital	Coffinier, C (corresponding author), 695 Charles E Young Dr S, Los Angeles, CA 90095 USA.	coffinie@ucla.edu	Bentolila, Laurent/L-5535-2019; Lammerding, Jan/A-9498-2016	Lammerding, Jan/0000-0003-4335-8611; Young, Stephen/0000-0001-7270-3176; Davies, Brandon/0000-0002-7168-8522	National Institutes of Health [AG035626, HL76839, HL86683, GM66152, HL082792, NS059348]; March of Dimes [6-FY2007-1012]; Ellison Medical Foundation; American Heart Association [0835489N, 0635359N]; American Heart Association, Western States Affiliate; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082792, R01HL076839, R01HL086683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG035626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Ellison Medical Foundation(Lawrence Ellison Foundation); American Heart Association(American Heart Association); American Heart Association, Western States Affiliate(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG035626, HL76839, HL86683, GM66152, HL082792, and NS059348. This work was also supported by March of Dimes Grant 6-FY2007-1012, the Ellison Medical Foundation Senior Scholar Program, two American Heart Association Scientist Development Grants 0835489N and 0635359N, and a postdoctoral fellowship award from the American Heart Association, Western States Affiliate.	Ambroziak P., 2001, ENZYMES, P155; BECK LA, 1990, J CELL BIOL, V110, P1489, DOI 10.1083/jcb.110.5.1489; Bergo MO, 2002, P NATL ACAD SCI USA, V99, P13049, DOI 10.1073/pnas.192460799; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Caron M, 2003, AIDS, V17, P2437, DOI 10.1097/00002030-200311210-00005; Coffinier C, 2007, P NATL ACAD SCI USA, V104, P13432, DOI 10.1073/pnas.0704212104; Corrigan DP, 2005, BIOCHEM J, V387, P129, DOI 10.1042/BJ20041359; Davies BSJ, 2009, ANNU REV GENOM HUM G, V10, P153, DOI 10.1146/annurev-genom-082908-150150; DAVIES BS, 2010, HUM MOL GEN IN PRESS; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fong LG, 2006, SCIENCE, V311, P1621, DOI 10.1126/science.1124875; Fong LG, 2004, P NATL ACAD SCI USA, V101, P18111, DOI 10.1073/pnas.0408558102; Fong LG, 2006, J CLIN INVEST, V116, P743, DOI 10.1172/JCI27125; HENNEKES H, 1994, J CELL SCI, V107, P1019; HOLTZ D, 1989, CELL, V59, P969, DOI 10.1016/0092-8674(89)90753-8; JOYNER AL, 1989, NATURE, V338, P153, DOI 10.1038/338153a0; Kim E, 1999, J BIOL CHEM, V274, P8383, DOI 10.1074/jbc.274.13.8383; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Lammerding J, 2006, J BIOL CHEM, V281, P25768, DOI 10.1074/jbc.M513511200; Lee R, 2010, HUM MOL GENET, V19, P1603, DOI 10.1093/hmg/ddq036; Leung GK, 2001, J BIOL CHEM, V276, P29051, DOI 10.1074/jbc.M102908200; LIN F, 1993, J BIOL CHEM, V268, P16321; LUTZ RJ, 1992, P NATL ACAD SCI USA, V89, P3000, DOI 10.1073/pnas.89.7.3000; Moulson CL, 2005, J INVEST DERMATOL, V125, P913, DOI 10.1111/j.0022-202X.2005.23846.x; Muchir A, 2004, MUSCLE NERVE, V30, P444, DOI 10.1002/mus.20122; Navarro CL, 2005, HUM MOL GENET, V14, P1503, DOI 10.1093/hmg/ddi159; Pendas AM, 2002, NAT GENET, V31, P94, DOI 10.1038/ng871; Rusinol AE, 2006, J CELL SCI, V119, P3265, DOI 10.1242/jcs.03156; SINENSKY M, 1994, J CELL SCI, V107, P61; STEINERT P, 1982, METHOD CELL BIOL, V24, P399; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Toth JI, 2005, P NATL ACAD SCI USA, V102, P12873, DOI 10.1073/pnas.0505767102; Varela I, 2008, NAT MED, V14, P767, DOI 10.1038/nm1786; VORBURGER K, 1989, EMBO J, V8, P4007, DOI 10.1002/j.1460-2075.1989.tb08583.x; Wang Y, 2008, HUM MOL GENET, V17, P2357, DOI 10.1093/hmg/ddn136; WEBER K, 1989, FEBS LETT, V257, P411, DOI 10.1016/0014-5793(89)81584-4; Wolf CM, 2008, J MOL CELL CARDIOL, V44, P293, DOI 10.1016/j.yjmcc.2007.11.008; Worman HJ, 2009, J CLIN INVEST, V119, P1825, DOI 10.1172/JCI37679; Yang SH, 2005, P NATL ACAD SCI USA, V102, P10291, DOI 10.1073/pnas.0504641102; Yang SH, 2008, J BIOL CHEM, V283, P7094, DOI 10.1074/jbc.M708138200; Yang SH, 2006, J CLIN INVEST, V116, P2115, DOI 10.1172/JCI28968; Young SG, 2005, J LIPID RES, V46, P2531, DOI 10.1194/jlr.R500011-JLR200	43	53	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20818	20826		10.1074/jbc.M110.128835	http://dx.doi.org/10.1074/jbc.M110.128835			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20439468	Green Published, hybrid			2022-12-27	WOS:000279228600045
J	Gardner, AM; Cook, MR; Gardner, PR				Gardner, Anne M.; Cook, Matthew R.; Gardner, Paul R.			Nitric-oxide Dioxygenase Function of Human Cytoglobin with Cellular Reductants and in Rat Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERTEBRATE GLOBIN FAMILY; ASCORBATE PEROXIDASE; DEPENDENT METABOLISM; MYOGLOBIN FUNCTION; SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; OXIDATIVE STRESS; MAMMALIAN-CELLS; CYTOCHROME-C	Cytoglobin (Cygb) was investigated for its capacity to function as a NO dioxygenase (NOD) in vitro and in hepatocytes. Ascorbate and cytochrome b(5) were found to support a high NOD activity. Cygb-NOD activity shows respective K-m values for ascorbate, cytochrome b(5), NO, and O-2 of 0.25 mM, 0.3 mu M, 40 nM, and similar to 20 mu M and achieves a k(cat) of 0.5 s(-1). Ascorbate and cytochrome b(5) reduce the oxidized Cygb-NOD intermediate with apparent second order rate constants of 1000 M-1 s(-1) and 3 x 10(6) M-1 s(-1), respectively. In rat hepatocytes engineered to express human Cygb, Cygb-NOD activity shows a similar kcat of 1.2 s(-1), a K-m(NO) of 40 nM, and a k(cat)/K-m(NO) (k'(NOD)) value of 3 x 10(7) M-1 s(-1), demonstrating the efficiency of catalysis. NO inhibits the activity at [NO]/[O-2] ratios > 1:500 and limits catalytic turnover. The activity is competitively inhibited by CO, is slowly inactivated by cyanide, and is distinct from the microsomal NOD activity. Cygb-NOD provides protection to the NO-sensitive aconitase. The results define the NOD function of Cygb and demonstrate roles for ascorbate and cytochrome b(5) as reductants.	[Gardner, Paul R.] Miami Valley Biotech, Dayton, OH 45402 USA; Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; [Cook, Matthew R.; Gardner, Paul R.] Univ Dayton, Dept Chem, Dayton, OH 45469 USA	Cincinnati Children's Hospital Medical Center; University of Dayton	Gardner, PR (corresponding author), Miami Valley Biotech, 1000 E 2nd St,Suite 2445, Dayton, OH 45402 USA.	paul.gardner@mvbiotech.com	Cook, matthew/F-4151-2019	Cook, matthew/0000-0002-3331-9363; Gardner, Paul/0000-0001-8189-0903; Gardner, Anne/0000-0001-7095-772X	National Institutes of Health [GM65090]; American Heart Association Scientist Development [9730193N]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Scientist Development(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM65090. This work was also supported by American Heart Association Scientist Development Grant 9730193N. Part of this work was presented at the 12th Annual Meeting of the Society for Free Radical Biology and Medicine (Gardner, P. R. and Gardner, A. M., Free Radic. Biol. Med. 39, (Suppl. 1) 100 (abstr.)).	BECANA M, 1990, P NATL ACAD SCI USA, V87, P7295, DOI 10.1073/pnas.87.18.7295; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Bentmann A, 2005, J BIOL CHEM, V280, P20660, DOI 10.1074/jbc.M501338200; BRENNER MC, 1989, BIOCHEMISTRY-US, V28, P4656, DOI 10.1021/bi00437a022; Brunori M, 2007, CELL MOL LIFE SCI, V64, P1259, DOI 10.1007/s00018-007-7090-2; Brunori M, 2005, P NATL ACAD SCI USA, V102, P8483, DOI 10.1073/pnas.0408766102; Burmester T, 2002, MOL BIOL EVOL, V19, P416, DOI 10.1093/oxfordjournals.molbev.a004096; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Burmester T, 2009, J EXP BIOL, V212, P1423, DOI 10.1242/jeb.000729; Bursey EH, 2000, BIOCHEMISTRY-US, V39, P7374, DOI 10.1021/bi000446s; Chan TS, 2005, FREE RADICAL BIO MED, V38, P867, DOI 10.1016/j.freeradbiomed.2004.12.006; Coffey MJ, 2001, P NATL ACAD SCI USA, V98, P8006, DOI 10.1073/pnas.141136098; Corpe CP, 2010, J CLIN INVEST, V120, P1069, DOI 10.1172/JCI39191; de Sanctis D, 2004, J MOL BIOL, V336, P917, DOI 10.1016/j.jmb.2003.12.063; Dordas C, 2003, PLANT J, V35, P763, DOI 10.1046/j.1365-313X.2003.01846.x; Dou Y, 2002, BIOPHYS CHEM, V98, P127, DOI 10.1016/S0301-4622(02)00090-X; Fago A, 2006, FEBS LETT, V580, P4884, DOI 10.1016/j.febslet.2006.08.003; Flogel U, 2001, P NATL ACAD SCI USA, V98, P735, DOI 10.1073/pnas.011460298; Fordel E, 2004, IUBMB LIFE, V56, P681, DOI 10.1080/15216540500037406; Fordel E, 2007, GENE, V398, P114, DOI 10.1016/j.gene.2007.03.022; GALARIS D, 1989, ARCH BIOCHEM BIOPHYS, V273, P497, DOI 10.1016/0003-9861(89)90509-2; Gardner AM, 2000, J BIOL CHEM, V275, P12581, DOI 10.1074/jbc.275.17.12581; Gardner PR, 2008, METHOD ENZYMOL, V436, P217, DOI 10.1016/S0076-6879(08)36012-1; Gardner PR, 2006, J INORG BIOCHEM, V100, P542, DOI 10.1016/j.jinorgbio.2005.12.012; Gardner Paul R., 2004, V279, P133; Gardner PR, 2000, J BIOL CHEM, V275, P31581, DOI 10.1074/jbc.M004141200; Gardner PR, 2005, J INORG BIOCHEM, V99, P247, DOI 10.1016/j.jinorgbio.2004.10.003; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Gardner PR, 1997, J BIOL CHEM, V272, P25071, DOI 10.1074/jbc.272.40.25071; Gardner PR, 1998, J BIOL CHEM, V273, P26528, DOI 10.1074/jbc.273.41.26528; Gardner PR, 2001, FREE RADICAL BIO MED, V31, P191, DOI 10.1016/S0891-5849(01)00569-X; Giuffre A, 2008, IUBMB LIFE, V60, P410, DOI 10.1002/iub.88; Godecke A, 2006, CARDIOVASC RES, V69, P309, DOI 10.1016/j.cardiores.2005.10.010; Hall CN, 2009, NITRIC OXIDE-BIOL CH, V21, P92, DOI 10.1016/j.niox.2009.07.002; Hall CN, 2009, BIOCHEM J, V419, P411, DOI 10.1042/BJ20082419; Halligan KE, 2009, J BIOL CHEM, V284, P8539, DOI 10.1074/jbc.M808231200; Hallstrom CK, 2004, FREE RADICAL BIO MED, V37, P216, DOI 10.1016/j.freeradbiomed.2004.04.031; Hankeln T, 2005, J INORG BIOCHEM, V99, P110, DOI 10.1016/j.jinorgbio.2004.11.009; Herold S, 2004, J BIOL CHEM, V279, P22841, DOI 10.1074/jbc.M313732200; Igamberdiev AU, 2006, PLANTA, V223, P1033, DOI 10.1007/s00425-005-0146-3; Kawada N, 2001, J BIOL CHEM, V276, P25318, DOI 10.1074/jbc.M102630200; Kim HS, 2008, AM J PHYSIOL-GASTR L, V295, pG146, DOI 10.1152/ajpgi.00105.2007; Lad L, 2002, BIOCHEMISTRY-US, V41, P13774, DOI 10.1021/bi0261591; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Macdonald IK, 2006, BIOCHEMISTRY-US, V45, P7808, DOI 10.1021/bi0606849; MOREAU S, 1995, PHYTOCHEMISTRY, V39, P1281, DOI 10.1016/0031-9422(95)00161-Y; Nakatani K, 2004, LAB INVEST, V84, P91, DOI 10.1038/labinvest.3700013; Palacios-Callender M, 2007, P NATL ACAD SCI USA, V104, P18508, DOI 10.1073/pnas.0709440104; Pesce A, 2002, EMBO REP, V3, P1146, DOI 10.1093/embo-reports/kvf248; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Schmidt M, 2004, J BIOL CHEM, V279, P8063, DOI 10.1074/jbc.M310540200; Sharp KH, 2003, NAT STRUCT BIOL, V10, P303, DOI 10.1038/nsb913; Smagghe BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002039; Sugimoto H, 2004, J MOL BIOL, V339, P873, DOI 10.1016/j.jmb.2004.04.024; Trandafir F, 2007, GENE, V398, P103, DOI 10.1016/j.gene.2007.02.038; TSCHANK G, 1994, BIOCHEM J, V300, P75, DOI 10.1042/bj3000075; VONBODMAN SB, 1986, P NATL ACAD SCI USA, V83, P9443; Wakasugi K, 2003, J BIOL CHEM, V278, P36505, DOI 10.1074/jbc.M305519200; Weber RE, 2001, PHYSIOL REV, V81, P569, DOI 10.1152/physrev.2001.81.2.569; Weiland TR, 2004, J AM CHEM SOC, V126, P11930, DOI 10.1021/ja046990w; Wittenberg JB, 2003, J EXP BIOL, V206, P2011, DOI 10.1242/jeb.00243; WITTENBERG JB, 1990, ANNU REV BIOPHYS BIO, V19, P217; Zhu H, 2004, J BIOL CHEM, V279, P30316, DOI 10.1074/jbc.M402664200; Zhu H, 1999, P NATL ACAD SCI USA, V96, P14742, DOI 10.1073/pnas.96.26.14742	64	74	76	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23850	23857		10.1074/jbc.M110.132340	http://dx.doi.org/10.1074/jbc.M110.132340			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20511233	Green Published, hybrid			2022-12-27	WOS:000280291400035
J	Li, ZL; Zhang, HQ; Lundin, L; Thullberg, M; Liu, YJ; Wang, YL; Claesson-Welsh, L; Stromblad, S				Li, Zhilun; Zhang, Hongquan; Lundin, Lars; Thullberg, Minna; Liu, Yajuan; Wang, Yunling; Claesson-Welsh, Lena; Stromblad, Staffan			p21-activated Kinase 4 Phosphorylation of Integrin beta 5 Ser-759 and Ser-762 Regulates Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANCHORAGE-INDEPENDENT GROWTH; FOCAL ADHESION KINASE; CYTOPLASMIC DOMAIN; ALPHA-V; TYROSINE PHOSPHORYLATION; IN-VITRO; THREONINE PHOSPHORYLATION; CYTOSKELETAL ASSOCIATION; MELANOMA-CELL; BINDING	Modulation of integrin alpha v beta 5 regulates vascular permeability, angiogenesis, and tumor dissemination. In addition, we previously found a role for p21-activated kinase 4 (PAK4) in selective regulation of integrin alpha v beta 5-mediated cell motility (Zhang, H., Li, Z., Viklund, E. K., and Stromblad, S. (2002) J. Cell Biol. 158, 1287-1297). This report focuses on the molecular mechanisms of this regulation. We here identified a unique PAK4-binding membrane-proximal integrin beta 5-SERS-motif involved in controlling cell attachment and migration. We also mapped the integrin beta 5-binding site within PAK4. We found that PAK4 binding to integrin beta 5 was not sufficient to promote cell migration, but that PAK4 kinase activity was required for PAK4 promotion of cell motility. Importantly, PAK4 specifically phosphorylated the integrin beta 5 subunit at Ser-759 and Ser-762 within the beta 5-SERS-motif. Point mutation of these two serine residues abolished the PAK4-induced cell migration, indicating a functional role for these phosphorylations in migration. Our results may give important leads to the functional regulation of integrin alpha v beta 5, with implications for vascular permeability, angiogenesis, and cancer dissemination.	[Stromblad, Staffan] Karolinska Inst, Ctr Biosci, Dept Biosci & Nutr, S-14183 Huddinge, Sweden; [Stromblad, Staffan] Karolinska Inst, Breast Canc Theme Ctr, S-14183 Huddinge, Sweden; [Liu, Yajuan] Karolinska Inst, Dept Lab Med, S-14183 Huddinge, Sweden; [Lundin, Lars; Claesson-Welsh, Lena] Uppsala Univ, Dept Genet & Pathol, S-75185 Uppsala, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Uppsala University	Zhang, HQ (corresponding author), Peking Univ, Hlth Sci Ctr, Lab Mol Cell Biol & Tumor Biol,Minist Educ, Dept Histol,Key Lab Carcinogenesis & Translat Res, Beijing 100191, Peoples R China.	Hongquan.zhang@bjmu.edu.cn; staffan.stromblad@ki.se		Stromblad, Staffan/0000-0002-1236-6339	Swedish Cancer Society; Swedish Research Council; Center for Biosciences at the Karolinska Institutet; Swedish Strategic Research Foundation; Swedish Society of Medicine; NSFC [30830048]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Center for Biosciences at the Karolinska Institutet(Karolinska Institutet); Swedish Strategic Research Foundation(Swedish Foundation for Strategic Research); Swedish Society of Medicine; NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Swedish Cancer Society, the Swedish Research Council, the Center for Biosciences at the Karolinska Institutet, and the Swedish Strategic Research Foundation (to S. S.), the Swedish Society of Medicine and Grant NSFC # 30830048 to (H.Z.), and the Swedish Research Council (to L.C.-W.).	Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; AEBERSOLD RH, 1987, P NATL ACAD SCI USA, V84, P6970, DOI 10.1073/pnas.84.20.6970; Anthis NJ, 2009, J BIOL CHEM, V284, P36700, DOI 10.1074/jbc.M109.061275; Bao WJ, 2004, J CELL BIOL, V167, P745, DOI 10.1083/jcb.200404018; Barreuther MF, 1996, EXP CELL RES, V222, P10, DOI 10.1006/excr.1996.0002; Bodeau AL, 2001, J CELL SCI, V114, P2795; Boettiger D, 2001, J BIOL CHEM, V276, P31684, DOI 10.1074/jbc.M103997200; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Brooks PC, 1997, J CLIN INVEST, V99, P1390, DOI 10.1172/JCI119298; Buensuceso CS, 2001, J CELL SCI, V114, P1691; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Callow MG, 2005, J CELL SCI, V118, P1861, DOI 10.1242/jcs.02313; Callow MG, 2002, J BIOL CHEM, V277, P550, DOI 10.1074/jbc.M105732200; Cowan KJ, 2000, J BIOL CHEM, V275, P36423, DOI 10.1074/jbc.M004068200; DAHL SC, 1989, J CELL BIOL, V108, P183, DOI 10.1083/jcb.108.1.183; Dan C, 2001, J BIOL CHEM, V276, P32115, DOI 10.1074/jbc.M100871200; Dans M, 2001, J BIOL CHEM, V276, P1494, DOI 10.1074/jbc.M008663200; Datta A, 2002, J BIOL CHEM, V277, P3943, DOI 10.1074/jbc.M109536200; Eliceiri BP, 2002, J CELL BIOL, V157, P149, DOI 10.1083/jcb.200109079; Fagerholm S, 2002, J BIOL CHEM, V277, P1728, DOI 10.1074/jbc.M106856200; Fagerholm SC, 2004, TRENDS BIOCHEM SCI, V29, P504, DOI 10.1016/j.tibs.2004.07.005; FREED E, 1989, EMBO J, V8, P2955, DOI 10.1002/j.1460-2075.1989.tb08445.x; FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; GIMOND C, 1995, EXP CELL RES, V216, P232, DOI 10.1006/excr.1995.1029; Han JW, 2001, J BIOL CHEM, V276, P40903, DOI 10.1074/jbc.M102665200; Hilden TJ, 2003, J IMMUNOL, V170, P4170, DOI 10.4049/jimmunol.170.8.4170; Holly SP, 2000, EXP CELL RES, V261, P69, DOI 10.1006/excr.2000.5040; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ito N, 1998, J BIOL CHEM, V273, P23410, DOI 10.1074/jbc.273.36.23410; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kirk RI, 2000, J BIOL CHEM, V275, P30901, DOI 10.1074/jbc.M001908200; LARJAVA H, 1993, J CLIN INVEST, V92, P1425, DOI 10.1172/JCI116719; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Lewis JM, 1996, J CELL BIOL, V134, P1323, DOI 10.1083/jcb.134.5.1323; Liddington RC, 2002, J CELL BIOL, V158, P833, DOI 10.1083/jcb.200206011; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Liu SC, 2000, J CELL SCI, V113, P3563; Lock JG, 2008, SEMIN CANCER BIOL, V18, P65, DOI 10.1016/j.semcancer.2007.10.001; Millon-Fremillon A, 2008, J CELL BIOL, V180, P427, DOI 10.1083/jcb.200707142; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Novak A, 1998, P NATL ACAD SCI USA, V95, P4374, DOI 10.1073/pnas.95.8.4374; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Phillips DR, 2001, CURR OPIN CELL BIOL, V13, P546, DOI 10.1016/S0955-0674(00)00250-7; Qu J, 2001, MOL CELL BIOL, V21, P3523, DOI 10.1128/MCB.21.10.3523-3533.2001; RESZKA AA, 1992, J CELL BIOL, V117, P1321, DOI 10.1083/jcb.117.6.1321; Sakai T, 1998, J CELL BIOL, V141, P527, DOI 10.1083/jcb.141.2.527; Sakai T, 2001, P NATL ACAD SCI USA, V98, P3808, DOI 10.1073/pnas.240456398; Sheppard D, 2004, CURR OPIN CELL BIOL, V16, P552, DOI 10.1016/j.ceb.2004.06.017; Stromblad S, 1996, CHEM BIOL, V3, P881, DOI 10.1016/S1074-5521(96)90176-3; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tang SQ, 1999, J CELL BIOL, V147, P1073, DOI 10.1083/jcb.147.5.1073; THOMAS L, 1993, J CELL SCI, V105, P191; Valmu L, 1999, BIOCHEM J, V339, P119, DOI 10.1042/0264-6021:3390119; Valmu L, 1999, EUR J IMMUNOL, V29, P2107, DOI 10.1002/(SICI)1521-4141(199907)29:07<2107::AID-IMMU2107>3.0.CO;2-T; WAYNER EA, 1991, J CELL BIOL, V113, P919, DOI 10.1083/jcb.113.4.919; Wegener KL, 2008, MOL MEMBR BIOL, V25, P376, DOI 10.1080/09687680802269886; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Wells CM, 2002, J CELL SCI, V115, P3947, DOI 10.1242/jcs.00080; YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281; Yebra M, 1996, J BIOL CHEM, V271, P29393, DOI 10.1074/jbc.271.46.29393; Zage PE, 1998, CELL ADHES COMMUN, V5, P335, DOI 10.3109/15419069809010780; Zhang HQ, 2004, NAT CELL BIOL, V6, P523, DOI 10.1038/ncb1136; Zhang HQ, 2002, J CELL BIOL, V158, P1287, DOI 10.1083/jcb.200207008	64	45	46	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23699	23710		10.1074/jbc.M110.123497	http://dx.doi.org/10.1074/jbc.M110.123497			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20507994	Green Published, hybrid			2022-12-27	WOS:000280291400020
J	Ponferrada-Marin, MI; Martinez-Macias, MI; Morales-Ruiz, T; Roldan-Arjona, T; Ariza, RR				Isabel Ponferrada-Marin, Maria; Isabel Martinez-Macias, Maria; Morales-Ruiz, Teresa; Roldan-Arjona, Teresa; Ariza, Rafael R.			Methylation-independent DNA Binding Modulates Specificity of Repressor of Silencing 1 (ROS1) and Facilitates Demethylation in Long Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSYLASE/LYASE ROS1; ARABIDOPSIS ENDOSPERM; MUTATIONAL ANALYSIS; PROTEIN; GENE; DEMETER; RECOGNITION; PATTERNS; GENOME; MARK	DNA cytosine methylation is an epigenetic mark that promotes gene silencing and performs critical roles during reproduction and development in both plants and animals. The genomic distribution of DNA methylation is the dynamic outcome of opposing methylation and demethylation processes. In plants, active demethylation occurs through a base excision repair pathway initiated by 5-methycytosine (5-meC) DNA glycosylases of the REPRESSOR OF SILENCING 1 (ROS1)/DEMETER (DME) family. To gain insight into the mechanism by which Arabidopsis ROS1 recognizes and excises 5-meC, we have identified those protein regions that are required for efficient DNA binding and catalysis. We have found that a short N-terminal lysine-rich domain conserved in members of the ROS1/DME family mediates strong methylation-independent binding of ROS1 to DNA and is required for efficient activity on 5-meC center dot G, but not for T center dot G processing. Removal of this domain does not significantly affect 5-meC excision from short molecules, but strongly decreases ROS1 activity on long DNA substrates. This region is not required for product binding and is not involved in the distributive behavior of the enzyme on substrates containing multiple 5-meC residues. Altogether, our results suggest that methylation-independent DNA binding allows ROS1 to perform a highly redundant search for efficient excision of a nondamaged, correctly paired base such as 5-meC in long stretches of DNA. These findings may have implications for understanding the evolution of structure and target specificity in DNA glycosylases.	[Isabel Ponferrada-Marin, Maria; Isabel Martinez-Macias, Maria; Morales-Ruiz, Teresa; Roldan-Arjona, Teresa; Ariza, Rafael R.] Univ Cordoba, Dept Genet, E-14071 Cordoba, Spain	Universidad de Cordoba	Ariza, RR (corresponding author), Univ Cordoba, Dept Genet, E-14071 Cordoba, Spain.	ge1roarr@uco.es	Macias, Maria Isabel Martinez/B-4571-2019; Martinez Macias, Maria Isabel/ACH-3606-2022; Morales-Ruiz, Teresa/L-4842-2014; Roldan-Arjona, Teresa/H-5976-2015	Macias, Maria Isabel Martinez/0000-0001-8611-476X; Martinez Macias, Maria Isabel/0000-0001-8611-476X; Morales-Ruiz, Teresa/0000-0002-6357-6977; Roldan-Arjona, Teresa/0000-0003-2842-3956; Rodriguez Ariza, Rafael/0000-0002-0338-7306	Spanish Ministry of Science and Innovation [BFU2007-60956/BMC]; European Regional Development Fund; Junta de Andalucia, Spain [P07-CVI-02770]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund(European Commission); Junta de Andalucia, Spain(Junta de AndaluciaEuropean Commission)	This work was supported by Grant BFU2007-60956/BMC from the Spanish Ministry of Science and Innovation and the European Regional Development Fund, and Grant P07-CVI-02770 from Junta de Andalucia, Spain.	Agius F, 2006, P NATL ACAD SCI USA, V103, P11796, DOI 10.1073/pnas.0603563103; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Gallinari P, 1996, NATURE, V383, P735, DOI 10.1038/383735a0; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Hardeland U, 2000, J BIOL CHEM, V275, P33449, DOI 10.1074/jbc.M005095200; Hardeland U, 2003, NUCLEIC ACIDS RES, V31, P2261, DOI 10.1093/nar/gkg344; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Ponferrada-Marin MI, 2009, NUCLEIC ACIDS RES, V37, P4264, DOI 10.1093/nar/gkp390; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Liu X, 2002, J MOL BIOL, V321, P265, DOI 10.1016/S0022-2836(02)00623-X; Lloyd RS, 2005, MUTAT RES-FUND MOL M, V577, P77, DOI 10.1016/j.mrfmmm.2005.04.003; Morales-Ruiz T, 2006, P NATL ACAD SCI USA, V103, P6853, DOI 10.1073/pnas.0601109103; Nash HM, 1996, CURR BIOL, V6, P968, DOI 10.1016/S0960-9822(02)00641-3; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Ortega-Galisteo AP, 2008, PLANT MOL BIOL, V67, P671, DOI 10.1007/s11103-008-9346-0; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Porecha RH, 2008, P NATL ACAD SCI USA, V105, P10791, DOI 10.1073/pnas.0801612105; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Roldan-Arjona T., 2009, DNA RNA MODIFICATION, P149; Steinacher R, 2005, CURR BIOL, V15, P616, DOI 10.1016/j.cub.2005.02.054; Tan T, 2002, MOL CELL BIOL, V22, P3247, DOI 10.1128/MCB.22.10.3247-3254.2002; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Weber M, 2007, CURR OPIN CELL BIOL, V19, P273, DOI 10.1016/j.ceb.2007.04.011; Zaika EI, 2004, J BIOL CHEM, V279, P4849, DOI 10.1074/jbc.M310262200; Zharkov DO, 2005, MUTAT RES-FUND MOL M, V577, P24, DOI 10.1016/j.mrfmmm.2005.03.011; Zheng XW, 2008, NATURE, V455, P1259, DOI 10.1038/nature07305; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205; Zhu JH, 2007, CURR BIOL, V17, P54, DOI 10.1016/j.cub.2006.10.059	35	29	30	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23030	23037		10.1074/jbc.M110.124578	http://dx.doi.org/10.1074/jbc.M110.124578			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20489198	hybrid, Green Published			2022-12-27	WOS:000279999900037
J	Li, YR; Xu, W; Tang, Y				Li, Yanran; Xu, Wei; Tang, Yi			Classification, Prediction, and Verification of the Regioselectivity of Fungal Polyketide Synthase Product Template Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-CLUSTER; AROMATIC POLYKETIDES; ENZYMATIC-SYNTHESIS; MOLECULAR ANALYSIS; NATURAL-PRODUCTS; BIOSYNTHESIS; IDENTIFICATION; EXPRESSION; RADICICOL; MECHANISM	The fungal iterative nonreducing polyketide synthases (NRPKSs) synthesize aromatic polyketides, many of which have important biological activities. The product template domains (PT) embedded in the multidomain NRPKSs mediate the regio-selective cyclization of the highly reactive polyketide backbones and dictate the final structures of the products. Understanding the sequence-activity relationships of different PT domains is therefore an important step toward the prediction of polyketide structures from NRPKS sequences and can enable the genome mining of hundreds of cryptic NRPKSs uncovered via genome sequencing. In this work, we first performed phylogenetic analysis of PT domains from NRPKSs of known functions and showed that the PT domains can be classified into five groups, with each group corresponding to a unique product size or cyclization regioselectivity. Group V contains the formerly unverified PT domains that were identified as C6-C11 aldol cyclases. The regioselectivity of PTs from this group were verified by product-based assays using the PT domain excised from the asperthecin AptA NRPKS. When combined with dissociated PKS4 minimal PKS, or replaced the endogenous PKS4 C2-C7 PT domain in a hybrid NRPKS, AptA-PT directed the C6-C11 cyclization of the nonaketide backbone to yield a tetracyclic pyranoanthraquinone 4. Extensive NMR analysis verified that the backbone of 4 was indeed cyclized with the expected regioselectivity. The PT phylogenetic analysis was then expanded to include similar to 100 PT sequences from unverified NRPKSs. Using the assays developed for AptA-PT, the regioselectivities of additional PT domains were investigated and matched to those predicted by the phylogenetic classifications.	[Li, Yanran; Xu, Wei; Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA; [Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Tang, Y (corresponding author), Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA.	yitang@ucla.edu		Li, Yanran/0000-0001-8709-3497	National Institutes of Health [1R01GM085128]; David and Lucile Packard Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David and Lucile Packard Fellowship(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01GM085128 and a David and Lucile Packard Fellowship (to Y.T.).	An JH, 1998, EUR J BIOCHEM, V257, P395, DOI 10.1046/j.1432-1327.1998.2570395.x; Awakawa T, 2009, CHEM BIOL, V16, P613, DOI 10.1016/j.chembiol.2009.04.004; Bailey AM, 2007, CHEM COMMUN, P4053, DOI 10.1039/b708614h; Bok JW, 2009, NAT CHEM BIOL, V5, P462, DOI 10.1038/nchembio.177; Brakhage Axel A., 2008, V66; Breinholt J, 1997, ACTA CHEM SCAND, V51, P855, DOI 10.3891/acta.chem.scand.51-0855; Bringmann G, 2006, NAT CHEM BIOL, V2, P429, DOI 10.1038/nchembio805; Brown DW, 1996, P NATL ACAD SCI USA, V93, P1418, DOI 10.1073/pnas.93.4.1418; Chen HQ, 2007, MOL MICROBIOL, V64, P755, DOI 10.1111/j.1365-2958.2007.05689.x; Chooi YH, 2010, CHEM BIOL, V17, P483, DOI 10.1016/j.chembiol.2010.03.015; Corre C, 2009, NAT PROD REP, V26, P977, DOI 10.1039/b713024b; Cox RJ, 2007, ORG BIOMOL CHEM, V5, P2010, DOI 10.1039/b704420h; Crawford JM, 2008, SCIENCE, V320, P243, DOI 10.1126/science.1154711; Crawford JM, 2006, P NATL ACAD SCI USA, V103, P16728, DOI 10.1073/pnas.0604112103; Crawford JM, 2009, NATURE, V461, P1139, DOI 10.1038/nature08475; Fujii I, 2001, CHEM BIOL, V8, P189, DOI 10.1016/S1074-5521(00)90068-1; Fujii I, 2004, J BIOL CHEM, V279, P44613, DOI 10.1074/jbc.M406758200; Fujii I, 2000, BIOCHEMISTRY-US, V39, P8853, DOI 10.1021/bi000644j; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Hoffmeister D, 2007, NAT PROD REP, V24, P393, DOI 10.1039/b603084j; JESUS A, 1982, J CHEM SOC CHEM COMM, P902; Khosla C, 2007, ANNU REV BIOCHEM, V76, P195, DOI 10.1146/annurev.biochem.76.053105.093515; Kim JE, 2005, APPL ENVIRON MICROB, V71, P1701, DOI 10.1128/AEM.71.4.1701-1708.2005; Kim YT, 2005, MOL MICROBIOL, V58, P1102, DOI 10.1111/j.1365-2958.2005.04884.x; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Linnemannstons P, 2002, FUNGAL GENET BIOL, V37, P134, DOI 10.1016/S1087-1845(02)00501-7; Ma SM, 2008, J AM CHEM SOC, V130, P38, DOI 10.1021/ja078091o; Ma SM, 2007, J AM CHEM SOC, V129, P10642, DOI 10.1021/ja074865p; Ma Y, 2006, CHEMBIOCHEM, V7, P1951, DOI 10.1002/cbic.200600341; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; MCDANIEL R, 1995, NATURE, V375, P549, DOI 10.1038/375549a0; Nielsen KF, 2009, ANAL BIOANAL CHEM, V395, P1225, DOI 10.1007/s00216-009-3081-5; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Pfeifer BA, 2001, SCIENCE, V291, P1790, DOI 10.1126/science.1058092; Rawlings BJ, 1999, NAT PROD REP, V16, P425, DOI 10.1039/a900566h; Reeves CD, 2008, APPL ENVIRON MICROB, V74, P5121, DOI 10.1128/AEM.00478-08; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; Schroeckh V, 2009, P NATL ACAD SCI USA, V106, P14558, DOI 10.1073/pnas.0901870106; Schumann J, 2006, J BIOTECHNOL, V124, P690, DOI 10.1016/j.jbiotec.2006.03.046; Szewczyk E, 2008, APPL ENVIRON MICROB, V74, P7607, DOI 10.1128/AEM.01743-08; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomas R, 2001, CHEMBIOCHEM, V2, P612, DOI 10.1002/1439-7633(20010903)2:9<612::AID-CBIC612>3.0.CO;2-Z; Tominaga M, 2006, APPL ENVIRON MICROB, V72, P484, DOI 10.1128/AEM.72.1.484-490.2006; Tsai HF, 2001, J BIOL CHEM, V276, P29292, DOI 10.1074/jbc.M101998200; Udwary DW, 2007, P NATL ACAD SCI USA, V104, P10376, DOI 10.1073/pnas.0700962104; Udwary DW, 2002, J MOL BIOL, V323, P585, DOI 10.1016/S0022-2836(02)00972-5; Wang SH, 2008, CHEM BIOL, V15, P1328, DOI 10.1016/j.chembiol.2008.10.006; Wattana-Amorn P, 2010, BIOCHEMISTRY-US, V49, P2186, DOI 10.1021/bi902176v; Yoder OC, 2001, CURR OPIN PLANT BIOL, V4, P315, DOI 10.1016/S1369-5266(00)00179-5; Zhang WJ, 2008, P NATL ACAD SCI USA, V105, P20683, DOI 10.1073/pnas.0809084105; Zhou H, 2008, P NATL ACAD SCI USA, V105, P6249, DOI 10.1073/pnas.0800657105; Zhou H, 2010, J AM CHEM SOC, V132, P4530, DOI 10.1021/ja100060k; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	54	73	82	1	39	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22762	22771		10.1074/jbc.M110.128504	http://dx.doi.org/10.1074/jbc.M110.128504			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20479000	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000279999900008
J	Sameshima, T; Iizuka, R; Ueno, T; Wada, J; Aoki, M; Shimamoto, N; Ohdomari, I; Tanii, T; Funatsu, T				Sameshima, Tomoya; Iizuka, Ryo; Ueno, Taro; Wada, Junichi; Aoki, Mutsuko; Shimamoto, Naonobu; Ohdomari, Iwao; Tanii, Takashi; Funatsu, Takashi			Single-molecule Study on the Decay Process of the Football-shaped GroEL-GroES Complex Using Zero-mode Waveguides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE MOLECULES; CHAPERONIN GROEL; FUNCTIONAL CYCLE; FOLDED PROTEIN; ATP; POLYPEPTIDE; CONFORMATION; FLUORESCENCE; CATALYSIS; HEPTAMER	It has been widely believed that an asymmetric GroEL-GroES complex (termed the bullet-shaped complex) is formed solely throughout the chaperonin reaction cycle, whereas we have recently revealed that a symmetric GroEL-(GroES)(2) complex (the football-shaped complex) can form in the presence of denatured proteins. However, the dynamics of the GroEL-GroES interaction, including the football-shaped complex, is unclear. We investigated the decay process of the football-shaped complex at a single-molecule level. Because submicromolar concentrations of fluorescent GroES are required in solution to form saturated amounts of the football-shaped complex, single-molecule fluorescence imaging was carried out using zero-mode waveguides. The single-molecule study revealed two insights into the GroEL-GroES reaction. First, the first GroES to interact with GroEL does not always dissociate from the football-shaped complex prior to the dissociation of a second GroES. Second, there are two cycles, the "football cycle " and the "bullet cycle," in the chaperonin reaction, and the lifetimes of the football-shaped and the bullet-shaped complexes were determined to be 3-5 s and about 6 s, respectively. These findings shed new light on the molecular mechanism of protein folding mediated by the GroEL-GroES chaperonin system.	[Funatsu, Takashi] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Bioanalyt Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Wada, Junichi; Aoki, Mutsuko; Shimamoto, Naonobu; Ohdomari, Iwao; Tanii, Takashi] Waseda Univ, Grad Sch Sci & Engn, Shinjuku Ku, Tokyo 1658555, Japan; [Funatsu, Takashi] Univ Tokyo, Ctr NanoBio Integrat, Bunkyo Ku, Tokyo 1138656, Japan; [Funatsu, Takashi] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020075, Japan	University of Tokyo; Waseda University; University of Tokyo; Japan Science & Technology Agency (JST)	Funatsu, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Bioanalyt Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	funatsu@mail.ecc.u-tokyo.ac.jp	Shimamoto, Naonobu/AGP-3424-2022; Shimamoto, Naonobu/D-6708-2012; Funatsu, Takashi/Q-1404-2015	Funatsu, Takashi/0000-0002-9656-8308; Iizuka, Ryo/0000-0002-9328-5628	Ministry of Education, Science, Sports, and Culture of Japan [21121004, 20059009, 22020006, 21370065]; Japan Society for the Promotion of Science for Young Scientists [20-11078]; Grants-in-Aid for Scientific Research [20310069] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid 21121004 for Scientific Research on Innovative Areas, Grants-in-aid 20059009 (to T. F.) and 22020006 (to R. I.) for Scientific Research on Priority Areas, and Grant-in-aid 21370065 for Scientific Research (B) (to T. F.) from the Ministry of Education, Science, Sports, and Culture of Japan. This work was also supported by Research Fellowship 20-11078 from the Japan Society for the Promotion of Science for Young Scientists (to T.S.).	AZEM A, 1994, SCIENCE, V265, P653, DOI 10.1126/science.7913553; Azem A, 1995, P NATL ACAD SCI USA, V92, P12021, DOI 10.1073/pnas.92.26.12021; Beissinger M, 1999, J MOL BIOL, V289, P1075, DOI 10.1006/jmbi.1999.2780; Chaudhry C, 2003, EMBO J, V22, P4877, DOI 10.1093/emboj/cdg477; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Horwich AL, 2006, CHEM REV, V106, P1917, DOI 10.1021/cr040435v; Koike-Takeshita A, 2008, J BIOL CHEM, V283, P23774, DOI 10.1074/jbc.M802542200; Korlach J, 2008, P NATL ACAD SCI USA, V105, P1176, DOI 10.1073/pnas.0710982105; Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700; Miyake T, 2008, ANAL CHEM, V80, P6018, DOI 10.1021/ac800726g; Motojima F, 2000, BIOCHEM BIOPH RES CO, V267, P842, DOI 10.1006/bbrc.1999.2020; Murai N, 1996, J BIOL CHEM, V271, P28229, DOI 10.1074/jbc.271.45.28229; Nojima T, 2008, J BIOL CHEM, V283, P18385, DOI 10.1074/jbc.M709825200; Nojima T, 2009, J BIOL CHEM, V284, P22834, DOI 10.1074/jbc.M109.020057; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Sakane I, 2007, J MOL BIOL, V367, P1171, DOI 10.1016/j.jmb.2007.01.037; Sameshima T, 2008, J BIOL CHEM, V283, P23765, DOI 10.1074/jbc.M802541200; Sameshima T, 2010, BIOCHEM J, V427, P247, DOI 10.1042/BJ20091845; SCHMIDT M, 1994, SCIENCE, V265, P656, DOI 10.1126/science.7913554; Sparrer H, 1997, P NATL ACAD SCI USA, V94, P1096, DOI 10.1073/pnas.94.4.1096; Suzuki M, 2008, J BIOL CHEM, V283, P23931, DOI 10.1074/jbc.M804090200; Taguchi H, 2004, J BIOL CHEM, V279, P45737, DOI 10.1074/jbc.M406795200; Taguchi H, 2001, NAT BIOTECHNOL, V19, P861, DOI 10.1038/nbt0901-861; Yifrach O, 1996, J MOL BIOL, V255, P356, DOI 10.1006/jmbi.1996.0028	28	30	30	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23157	23162		10.1074/jbc.M110.122101	http://dx.doi.org/10.1074/jbc.M110.122101			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20511221	hybrid, Green Published			2022-12-27	WOS:000279999900050
J	Ariyama, H; Kono, N; Matsuda, S; Inoue, T; Arai, H				Ariyama, Hiroyuki; Kono, Nozomu; Matsuda, Shinji; Inoue, Takao; Arai, Hiroyuki			Decrease in Membrane Phospholipid Unsaturation Induces Unfolded Protein Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; STEAROYL-COA DESATURASE; LIPOTOXIC CELL-DEATH; LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE; GENE-EXPRESSION; FATTY-ACIDS; LYSOPHOSPHOLIPID ACYLTRANSFERASE; PALMITIC ACID; MBOAT FAMILY; LIVER-CELLS	Various kinds of fatty acids are distributed in membrane phospholipids in mammalian cells and tissues. The degree of fatty acid unsaturation in membrane phospholipids affects many membrane-associated functions and can be influenced by diet and by altered activities of lipid-metabolizing enzymes such as fatty acid desaturases. However, little is known about how mammalian cells respond to changes in phospholipid fatty acid composition. In this study we showed that stearoyl-CoA desaturase 1 (SCD1) knockdown increased the amount of saturated fatty acids and decreased that of monounsaturated fatty acids in phospholipids without affecting the amount or the composition of free fatty acid and induced unfolded protein response (UPR), evidenced by increased expression of C/EBP homologous protein (CHOP) and glucose-regulated protein 78 (GRP78) mRNAs and splicing of Xbox-binding protein 1 (XBP1) mRNA. SCD1 knockdown-induced UPR was rescued by various unsaturated fatty acids and was enhanced by saturated fatty acid. Lysophosphatidylcholine acyltransferase 3 (LPCAT3), which incorporates preferentially polyunsaturated fatty acids into phosphatidylcholine, was up-regulated in SCD1 knockdown cells. Knockdown of LPCAT3 synergistically enhanced UPR with SCD1 knockdown. Finally we showed that palmitic acid-induced UPR was significantly enhanced by LPCAT3 knockdown as well as SCD1 knockdown. These results suggest that a decrease in membrane phospholipid unsaturation induces UPR.	[Ariyama, Hiroyuki; Kono, Nozomu; Matsuda, Shinji; Inoue, Takao; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; [Kono, Nozomu; Inoue, Takao; Arai, Hiroyuki] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Arai, H (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan.	harai@mol.f.u-tokyo.ac.jp	KONO, nozomu/AAM-3178-2020		Ministry of Education, Culture, Sports, Science, and Technology of Japan; Core Research for Evolutional Science and Technology	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST))	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by Core Research for Evolutional Science and Technology.	Almaguel FG, 2009, J NEUROSCI RES, V87, P1207, DOI 10.1002/jnr.21918; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bommiasamy H, 2009, J CELL SCI, V122, P1626, DOI 10.1242/jcs.045625; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Borradaile NM, 2006, MOL BIOL CELL, V17, P770, DOI 10.1091/mbc.E05-08-0742; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; CLANDININ MT, 1991, FASEB J, V5, P2761, DOI 10.1096/fasebj.5.13.1916101; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Collins JM, 2010, J BIOL CHEM, V285, P6044, DOI 10.1074/jbc.M109.053280; Dyntar D, 2001, DIABETES, V50, P2105, DOI 10.2337/diabetes.50.9.2105; Flowers MT, 2008, PHYSIOL GENOMICS, V33, P361, DOI 10.1152/physiolgenomics.00139.2007; Flowers MT, 2008, CURR OPIN LIPIDOL, V19, P248, DOI 10.1097/MOL.0b013e3282f9b54d; Guo W, 2007, AM J PHYSIOL-ENDOC M, V293, pE576, DOI 10.1152/ajpendo.00523.2006; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Holub B J, 1978, Adv Lipid Res, V16, P1; Inaba M, 2003, J BIOL CHEM, V278, P12191, DOI 10.1074/jbc.M212204200; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Lands W., 1976, ENZYMES BIOL MEMBRAN, V2, P3; LANDS WEM, 1958, J BIOL CHEM, V231, P883; Lands WEM, 2000, BBA-MOL CELL BIOL L, V1483, P1, DOI 10.1016/S1388-1981(99)00177-8; Lee HC, 2008, MOL BIOL CELL, V19, P1174, DOI 10.1091/mbc.E07-09-0893; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; MACDONALD JIS, 1991, BIOCHIM BIOPHYS ACTA, V1084, P105, DOI 10.1016/0005-2760(91)90209-Z; Matsuda S, 2008, GENES CELLS, V13, P879, DOI 10.1111/j.1365-2443.2008.01212.x; Miyazaki M, 2001, J NUTR, V131, P2260, DOI 10.1093/jn/131.9.2260; Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200; Morgan-Lappe SE, 2007, CANCER RES, V67, P4390, DOI 10.1158/0008-5472.CAN-06-4132; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; NTAMBI JM, 1995, PROG LIPID RES, V34, P139, DOI 10.1016/0163-7827(94)00010-J; Ostrander DB, 2001, J BIOL CHEM, V276, P38061; Peter A, 2008, AM J PHYSIOL-ENDOC M, V295, pE339, DOI 10.1152/ajpendo.00022.2008; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Shindou H, 2009, J LIPID RES, V50, pS46, DOI 10.1194/jlr.R800035-JLR200; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Sparagna GC, 2000, AM J PHYSIOL-HEART C, V279, pH2124, DOI 10.1152/ajpheart.2000.279.5.H2124; SPECTOR AA, 1985, J LIPID RES, V26, P1015; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Sriburi R, 2007, J BIOL CHEM, V282, P7024, DOI 10.1074/jbc.M609490200; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; VIGH L, 1993, P NATL ACAD SCI USA, V90, P9090, DOI 10.1073/pnas.90.19.9090; Wang J, 2005, BIOCHEM BIOPH RES CO, V332, P735, DOI 10.1016/j.bbrc.2005.05.013; Wei Y, 2007, MOL CELL BIOCHEM, V303, P105, DOI 10.1007/s11010-007-9461-2; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhao Y, 2008, J BIOL CHEM, V283, P8258, DOI 10.1074/jbc.M710422200	50	173	181	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22027	22035		10.1074/jbc.M110.126870	http://dx.doi.org/10.1074/jbc.M110.126870			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20489212	Green Published, hybrid			2022-12-27	WOS:000279702200015
J	Dresen, C; Lin, LYC; D'Angelo, I; Tocheva, EI; Strynadka, N; Eltis, LD				Dresen, Carola; Lin, Leo Y. -C.; D'Angelo, Igor; Tocheva, Elitza I.; Strynadka, Natalie; Eltis, Lindsay D.			A Flavin-dependent Monooxygenase from Mycobacterium tuberculosis Involved in Cholesterol Catabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-HYDROXYPHENYLACETATE 3-HYDROXYLASE; ESCHERICHIA-COLI; 3-KETOSTEROID 9-ALPHA-HYDROXYLASE; CHLOROPHENOL 4-MONOOXYGENASE; FUNCTIONAL-CHARACTERIZATION; DIFFRACTION DATA; REDUCED FLAVIN; GENE-CLUSTER; 2-COMPONENT; PURIFICATION	Mycobacterium tuberculosis (Mtb) and Rhodococcus jostii RHA1 have similar cholesterol catabolic pathways. This pathway contributes to the pathogenicity of Mtb. The hsaAB cholesterol catabolic genes have been predicted to encode the oxygenase and reductase, respectively, of a flavin-dependent mono-oxygenase that hydroxylates 3-hydroxy-9,10-seconandrost-1,3,5(10)-triene-9,17- dione (3-HSA) to a catechol. An hsaA deletion mutant of RHA1 did not grow on cholesterol but transformed the latter to 3-HSA and related metabolites in which each of the two keto groups was reduced: 3,9-dihydroxy-9,10-seconandrost-1,3,5(10)-triene- 17-one (3,9-DHSA) and 3,17-dihydroxy-9,10-seconandrost-1,3,5( 10)-triene-9-one (3,17-DHSA). Purified 3-hydroxy-9,10- seconandrost-1,3,5(10)-triene-9,17-dione 4-hydroxylase (HsaAB) from Mtb had higher specificity for 3-HSA than for 3,17-DHSA (apparent k(cat)/K-m =1000 +/- 100 M-1 s(-1) versus 700 +/- 100 M-1 s(-1)). However, 3,9-DHSA was a poorer substrate than 3-hydroxybiphenyl (apparent k(cat)/K-m = 80 +/- 40 M-1 s(-1)). In the presence of 3-HSA the K-mapp for O-2 was 100 +/- 10 mu M. The crystal structure of HsaA to 2.5-angstrom resolution revealed that the enzyme has the same fold, flavin-binding site, and catalytic residues as p-hydroxyphenyl acetate hydroxylase. However, HsaA has a much larger phenol-binding site, consistent with the enzyme's substrate specificity. In addition, a second crystal form of HsaA revealed that a C-terminal flap (Val(367)-Val(394)) could adopt two conformations differing by a rigid body rotation of 25 degrees around Arg(366). This rotation appears to gate the likely flavin entrance to the active site. In docking studies with 3-HSA and flavin, the closed conformation provided a rationale for the enzyme's substrate specificity. Overall, the structural and functional data establish the physiological role of HsaAB and provide a basis to further investigate an important class of monooxygenases as well as the bacterial catabolism of steroids.	[Dresen, Carola; Tocheva, Elitza I.; Eltis, Lindsay D.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Lin, Leo Y. -C.; D'Angelo, Igor; Strynadka, Natalie; Eltis, Lindsay D.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Tocheva, Elitza I.] CALTECH, Pasadena, CA 91125 USA	University of British Columbia; University of British Columbia; California Institute of Technology	Eltis, LD (corresponding author), 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	leltis@interchange.ubc.ca	Eltis, Lindsay D/J-8272-2015	Eltis, Lindsay D/0000-0002-6774-8158	Canadian Institute for Health Research; Michael Smith Foundation for Health Research (MSFHR); Emerging Team programs; Deutsche Forschungsgemeinschaft	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Emerging Team programs; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Canadian Institute for Health Research (to L. D. E. and N.S., respectively) and the Michael Smith Foundation for Health Research (MSFHR) Infrastructure (to N.S.) and Emerging Team programs.; Recipient of a postdoctoral fellowship from the Deutsche Forschungsgemeinschaft.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ballou DP, 2005, BIOCHEM BIOPH RES CO, V338, P590, DOI 10.1016/j.bbrc.2005.09.081; Becker D, 1997, EUR J BIOCHEM, V249, P739, DOI 10.1111/j.1432-1033.1997.t01-1-00739.x; Bhandari P, 1997, J BACTERIOL, V179, P4403, DOI 10.1128/jb.179.13.4403-4406.1997; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Capyk JK, 2009, J BIOL CHEM, V284, P9937, DOI 10.1074/jbc.M900719200; Chaiyen P, 2001, EUR J BIOCHEM, V268, P5550, DOI 10.1046/j.1432-1033.2001.02490.x; Clark-Curtiss JE, 2003, ANNU REV MICROBIOL, V57, P517, DOI 10.1146/annurev.micro.57.030502.090903; Cornish-Bowden A., 1995, ANAL ENZYME KINETIC; DeLano W.L, PYMOL MOL GRAPHICS S; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Eichhorn E, 1999, J BIOL CHEM, V274, P26639, DOI 10.1074/jbc.274.38.26639; ELTIS LD, 1994, PROTEIN ENG, V7, P1145, DOI 10.1093/protein/7.9.1145; FAEDER EJ, 1973, ANAL BIOCHEM, V53, P332, DOI 10.1016/0003-2697(73)90442-9; Galan B, 2000, J BACTERIOL, V182, P627, DOI 10.1128/JB.182.3.627-636.2000; Gisi MR, 2003, J BACTERIOL, V185, P2786, DOI 10.1128/JB.185.9.2786-2792.2003; Hu YM, 2010, MOL MICROBIOL, V75, P107, DOI 10.1111/j.1365-2958.2009.06957.x; Hunter RL, 2006, AM J PATHOL, V168, P1249, DOI 10.2353/ajpath.2006.050848; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kadiyala V, 1998, APPL ENVIRON MICROB, V64, P2479; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Lack NA, 2010, J BIOL CHEM, V285, P434, DOI 10.1074/jbc.M109.058081; Mathieu JM, 2010, APPL ENVIRON MICROB, V76, P352, DOI 10.1128/AEM.02538-09; MAYO SL, 1990, J PHYS CHEM-US, V94, P8897, DOI 10.1021/j100389a010; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakashima N, 2004, APPL ENVIRON MICROB, V70, P5557, DOI 10.1128/AEM.70.9.5557-5568.2004; Nesbitt NM, 2010, INFECT IMMUN, V78, P275, DOI 10.1128/IAI.00893-09; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Payne JW, 1998, J BACTERIOL, V180, P3823, DOI 10.1128/JB.180.15.3823-3827.1998; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rosloniec KZ, 2009, MOL MICROBIOL, V74, P1031, DOI 10.1111/j.1365-2958.2009.06915.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SETO M, 1995, APPL ENVIRON MICROB, V61, P3353, DOI 10.1128/AEM.61.9.3353-3358.1995; Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4; Sucharitakul J, 2005, BIOCHEMISTRY-US, V44, P10434, DOI 10.1021/bi050615e; Sucharitakul J, 2007, BIOCHEMISTRY-US, V46, P8611, DOI 10.1021/bi7006614; Sucharitakul J, 2006, J BIOL CHEM, V281, P17044, DOI 10.1074/jbc.M512385200; THIBAUT D, 1995, J BACTERIOL, V177, P5199, DOI 10.1128/jb.177.18.5199-5205.1995; Vaillancourt FH, 1998, J BIOL CHEM, V273, P34887, DOI 10.1074/jbc.273.52.34887; Valton J, 2008, J BIOL CHEM, V283, P10287, DOI 10.1074/jbc.M709730200; van der Geize R, 2004, CURR OPIN MICROBIOL, V7, P255, DOI 10.1016/j.mib.2004.04.001; van der Geize R, 2000, APPL ENVIRON MICROB, V66, P2029, DOI 10.1128/AEM.66.5.2029-2036.2000; van der Geize R, 2002, MOL MICROBIOL, V45, P1007, DOI 10.1046/j.1365-2958.2002.03069.x; van der Geize R, 2002, MICROBIOL-SGM, V148, P3285, DOI 10.1099/00221287-148-10-3285; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Xu YR, 1997, J BACTERIOL, V179, P1112, DOI 10.1128/jb.179.4.1112-1116.1997; Xun LY, 1996, J BACTERIOL, V178, P2645, DOI 10.1128/jb.178.9.2645-2649.1996; Xun LY, 2000, APPL ENVIRON MICROB, V66, P481, DOI 10.1128/AEM.66.2.481-486.2000; Yam KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000344; Yang XX, 2007, BIOCHEMISTRY-US, V46, P9058, DOI 10.1021/bi700688x; Ying Z, 2005, ANNU REV PHARMACOL, V45, P529, DOI 10.1146/annurev.pharmtox.45.120403.100120	56	80	88	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22264	22275		10.1074/jbc.M109.099028	http://dx.doi.org/10.1074/jbc.M109.099028			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20448045	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000279702200039
J	Watanabe, R; Murai, MJ; Singh, CR; Fox, S; Ii, M; Asano, K				Watanabe, Ryosuke; Murai, Marcelo Jun; Singh, Chingakham Ranjit; Fox, Stephanie; Ii, Miki; Asano, Katsura			The Eukaryotic Initiation Factor (eIF) 4G HEAT Domain Promotes Translation Re-initiation in Yeast Both Dependent on and Independent of eIF4A mRNA Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							START CODON SELECTION; 40S RIBOSOMAL-SUBUNIT; SACCHAROMYCES-CEREVISIAE; PROTEIN-SYNTHESIS; BINDING; GCN4; COMPLEX; ROLES; REINITIATION; REGION	Translation re-initiation provides the molecular basis for translational control of mammalian ATF4 and yeast GCN4 mediated by short upstream open reading (uORFs) in response to eIF2 phosphorylation. eIF4G is the major adaptor subunit of eIF4F that binds the cap-binding subunit eIF4E and the mRNA helicase eIF4A and is also required for re-initiation in mammals. Here we show that the yeast eIF4G2 mutations altering eIF4E-and eIF4A-binding sites increase re-initiation at GCN4 and impair recognition of the start codons of uORF1 or uORF4 located after uORF1. The increase in re-initiation at GCN4 was partially suppressed by increasing the distance between uORF1 and GCN4, suggesting that the mutations decrease the migration rate of the scanning ribosome in the GCN4 leader. Interestingly, eIF4E overexpression suppressed both the phenotypes caused by the mutation altering eIF4E-binding site. Thus, eIF4F is required for accurate AUG selection and re-initiation also in yeast, and the eIF4G interaction with the mRNA-cap appears to promote eIF4F re-acquisition by the re-initiating 40 S subunit. However, eIF4A overexpression suppressed the impaired AUG recognition but not the increase in re-initiation caused by the mutations altering eIF4A-binding site. These results not only provide evidence that mRNA unwinding by eIF4A stimulates start codon recognition, but also suggest that the eIF4A-binding site on eIF4G made of the HEAT domain stimulates the ribosomal scanning independent of eIF4A. Based on the RNA-binding activities identified within the unstructured segments flanking the eIF4G2 HEAT domain, we discuss the role of the HEAT domain in scanning beyond loading eIF4A onto the pre-initiation complex.	[Watanabe, Ryosuke; Murai, Marcelo Jun; Singh, Chingakham Ranjit; Fox, Stephanie; Ii, Miki; Asano, Katsura] Kansas State Univ, Div Biol, Mol Cellular & Dev Biol Program, Manhattan, KS 66506 USA	Kansas State University	Asano, K (corresponding author), Kansas State Univ, Div Biol, Mol Cellular & Dev Biol Program, Ackert Hall, Manhattan, KS 66506 USA.	kasano@ksu.edu			National Institutes of Health [R01 GM64781]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064781] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM64781 (to K.A.).	ABASTADO JP, 1991, MOL CELL BIOL, V11, P486, DOI 10.1128/MCB.11.1.486; Algire MA, 2005, MOL CELL, V20, P251, DOI 10.1016/j.molcel.2005.09.008; Asano K, 1997, J BIOL CHEM, V272, P27042, DOI 10.1074/jbc.272.43.27042; Asano K, 2001, EMBO J, V20, P2326, DOI 10.1093/emboj/20.9.2326; Asano K, 2007, GENE DEV, V21, P1280, DOI 10.1101/gad.1562707; Berset C, 2003, RNA, V9, P871, DOI 10.1261/rna.5380903; Berthelot K, 2004, MOL MICROBIOL, V51, P987, DOI 10.1046/j.1365-2958.2003.03898.x; Cheung YN, 2007, GENE DEV, V21, P1217, DOI 10.1101/gad.1528307; Chuang RY, 1997, SCIENCE, V275, P1468, DOI 10.1126/science.275.5305.1468; delaCruz J, 1997, P NATL ACAD SCI USA, V94, P5201, DOI 10.1073/pnas.94.10.5201; DONAHUE TF, 1988, MOL CELL BIOL, V8, P2955, DOI 10.1128/MCB.8.7.2955; GRANT CM, 1994, MOL CELL BIOL, V14, P2616, DOI 10.1128/MCB.14.4.2616; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; He H, 2003, MOL CELL BIOL, V23, P5431, DOI 10.1128/MCB.23.15.5431-5445.2003; Hinnebusch A.G., 2007, TRANSLATIONAL CONTRO, P225; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Huang HK, 1997, GENE DEV, V11, P2396, DOI 10.1101/gad.11.18.2396; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Laurino JP, 1999, MOL CELL BIOL, V19, P173; LAZAROWITZ SG, 1977, J BIOL CHEM, V252, P7842; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Maag D, 2005, MOL CELL, V17, P265, DOI 10.1016/j.molcel.2004.11.051; Marcotrigiano J, 2001, MOL CELL, V7, P193, DOI 10.1016/S1097-2765(01)00167-8; Marintchev A, 2005, BIOCHEMISTRY-US, V44, P12265, DOI 10.1021/bi051271v; Marintchev A, 2009, CELL, V136, P447, DOI 10.1016/j.cell.2009.01.014; MUELLER PP, 1986, CELL, V45, P201, DOI 10.1016/0092-8674(86)90384-3; Neff CL, 1999, MOL CELL BIOL, V19, P5557; Oberer M, 2005, GENE DEV, V19, P2212, DOI 10.1101/gad.1335305; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Pisarev AV, 2008, EMBO J, V27, P1609, DOI 10.1038/emboj.2008.90; Pisareva VP, 2008, CELL, V135, P1237, DOI 10.1016/j.cell.2008.10.037; Poyry TAA, 2004, GENE DEV, V18, P62, DOI 10.1101/gad.276504; Prevot D, 2003, EMBO J, V22, P1909, DOI 10.1093/emboj/cdg175; Shin BS, 2002, CELL, V111, P1015, DOI 10.1016/S0092-8674(02)01171-6; Singh CR, 2006, EMBO J, V25, P4537, DOI 10.1038/sj.emboj.7601339; Singh CR, 2007, METHOD ENZYMOL, V429, P139, DOI 10.1016/S0076-6879(07)29007-X; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Szamecz B, 2008, GENE DEV, V22, P2414, DOI 10.1101/gad.480508; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Tarun SZ, 1997, MOL CELL BIOL, V17, P6876, DOI 10.1128/MCB.17.12.6876; Udagawa T, 2008, J BIOL CHEM, V283, P22063, DOI 10.1074/jbc.M710017200; WEI CL, 1995, J BIOL CHEM, V270, P5764, DOI 10.1074/jbc.270.11.5764; Yamamoto Y, 2005, P NATL ACAD SCI USA, V102, P16164, DOI 10.1073/pnas.0507960102; Zhou P, 2001, J BIOMOL NMR, V20, P11, DOI 10.1023/A:1011258906244	45	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					21922	21933		10.1074/jbc.M110.132027	http://dx.doi.org/10.1074/jbc.M110.132027			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20463023	Green Published, hybrid			2022-12-27	WOS:000279702200004
J	Zheng, H; Chu, J; Zeng, Y; Loh, HH; Law, PY				Zheng, Hui; Chu, Ji; Zeng, Yan; Loh, Horace H.; Law, Ping-Yee			Yin Yang 1 Phosphorylation Contributes to the Differential Effects of mu-Opioid Receptor Agonists on MicroRNA-190 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR YY1; F-ACTIN; DENDRITIC SPINE; MECHANISMS; NEUROGENESIS; TALIN2; BACE1	mu-Opioid receptor regulates microRNA-190 (miR-190) in an agonist-dependent manner; fentanyl, but not morphine, decreases the miR-190 level in rat primary hippocampal neuron cultures and in mouse hippocampi. In this study, the correlation between the cellular content of miR-190 and the mRNA level of its host gene, talin2, suggested that fentanyl decreases the miR-190 level by inhibiting the transcription of talin2. Fentanyl-induced beta-arrestin2-mediated ERK phosphorylation led to the phosphorylation of Yin Yang 1(YY1). In addition, YY1 phosphorylation impaired the association of YY1 with the -208 to -200 region on the Talin2 promoter, and this association was essential for YY1 to stimulate the transcription of talin2. Thus, fentanyl decreased the transcription of talin2 and subsequently the cellular level of miR-190 by inducing YY1 phosphorylation. In contrast, because morphine induces ERK phosphorylation via the protein kinase C pathway, morphine did not induce YY1 phosphorylation and had no effect on the transcription of talin2 and the cellular content of miR-190. This study therefore delineates a signaling pathway that mediates the effects of fentanyl on miR-190 expression.	[Zheng, Hui; Chu, Ji; Zeng, Yan; Loh, Horace H.; Law, Ping-Yee] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Zheng, H (corresponding author), 6-120 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	zhen0091@umn.edu		Law, Ping-Yee/0000-0002-5364-1093; Zheng, Hui/0000-0001-6801-0529	National Institutes of Health [DA007339, DA016674, DA000564, DA011806, K05-DA70544, K05-DA00513]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016674, K05DA000513, K05DA070554, R56DA000564, R01DA000564, R01DA007339, P50DA011806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA007339, DA016674, DA000564, and DA011806.; Recipient of National Institutes of Health Grant K05-DA70544.; Recipient of National Institutes of Health Grant K05-DA00513.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BECKER KG, 1994, GENE, V150, P259, DOI 10.1016/0378-1119(94)90435-9; Calderwood DA, 2003, NAT CELL BIOL, V5, P694, DOI 10.1038/ncb0803-694; Capani F, 2001, J COMP NEUROL, V435, P156, DOI 10.1002/cne.1199; Christie BR, 2006, HIPPOCAMPUS, V16, P199, DOI 10.1002/hipo.20151; Donohoe ME, 1999, MOL CELL BIOL, V19, P7237; Eisch AJ, 2000, P NATL ACAD SCI USA, V97, P7579, DOI 10.1073/pnas.120552597; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; He Y, 2008, J NEUROCHEM, V106, P1493, DOI 10.1111/j.1471-4159.2008.05486.x; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Liao D, 2005, P NATL ACAD SCI USA, V102, P1725, DOI 10.1073/pnas.0406797102; Ma L, 2007, J CELL SCI, V120, P213, DOI 10.1242/jcs.03338; Monkley SJ, 2001, BIOCHEM BIOPH RES CO, V286, P880, DOI 10.1006/bbrc.2001.5497; Nishizaki T, 2007, NEW DIAM FRONT C TEC, V17, P21; Nowak K, 2006, J NEUROCHEM, V96, P1696, DOI 10.1111/j.1471-4159.2006.03692.x; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Senetar MA, 2007, CELL MOTIL CYTOSKEL, V64, P157, DOI 10.1002/cm.20173; Seo HM, 1996, J NEUROSCI, V16, P4102; Seo S, 2007, EMBO J, V26, P5093, DOI 10.1038/sj.emboj.7601923; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; Stockley JH, 2008, CELL MOL LIFE SCI, V65, P3265, DOI 10.1007/s00018-008-8271-3; Tamada A, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-29; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Tsuchiya S, 2006, J PHARMACOL SCI, V101, P267, DOI 10.1254/jphs.CPJ06013X; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Yue R, 2009, CELL, V139, P535, DOI 10.1016/j.cell.2009.08.038; Zeng Y, 2006, ONCOGENE, V25, P6156, DOI 10.1038/sj.onc.1209908; Zheng H, 2008, P NATL ACAD SCI USA, V105, P9421, DOI 10.1073/pnas.0802253105; Zheng H, 2010, IUBMB LIFE, V62, P112, DOI 10.1002/iub.293; Zheng H, 2010, MOL PHARMACOL, V77, P102, DOI 10.1124/mol.109.060848	37	55	63	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					21994	22002		10.1074/jbc.M110.112607	http://dx.doi.org/10.1074/jbc.M110.112607			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20457614	Green Published, hybrid			2022-12-27	WOS:000279702200012
J	Juul, T; Malolepszy, A; Dybkaer, K; Kidmose, R; Rasmussen, JT; Andersen, GR; Johnsen, HE; Jorgensen, JE; Andersen, SU				Juul, Trine; Malolepszy, Anna; Dybkaer, Karen; Kidmose, Rune; Rasmussen, Jan Trige; Andersen, Gregers Rom; Johnsen, Hans Erik; Jorgensen, Jan-Elo; Andersen, Stig Uggerhoj			The in Vivo Toxicity of Hydroxyurea Depends on Its Direct Target Catalase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBONUCLEOTIDE REDUCTASE-ACTIVITY; RESISTANT HAMSTER-CELLS; ARABIDOPSIS-THALIANA; OXIDATIVE STRESS; GENE-EXPRESSION; DRUG; MOUSE; OVERPRODUCTION; DISEASE; STATE	Hydroxyurea (HU) is a well tolerated ribonucleotide reductase inhibitor effective in HIV, sickle cell disease, and blood cancer therapy. Despite a positive initial response, however, most treated cancers eventually progress due to development of HU resistance. Although RNR properties influence HU resistance in cell lines, the mechanisms underlying cancer HU resistance in vivo remain unclear. To address this issue, we screened for HU resistance in the plant Arabidopsis thaliana and identified seventeen unique catalase mutants, thereby establishing that HU toxicity depends on catalase in vivo. We further demonstrated that catalase is a direct HU target by showing that HU acts as a competitive inhibitor of catalase-mediated hydrogen peroxide decomposition. Considering also that catalase can accelerate HU decomposition in vitro and that co-treatment with another catalase inhibitor alleviates HU effects in vivo, our findings suggests that HU could act as a catalase-activated pro-drug. Clinically, we found high catalase activity in circulating cells from untreated chronic myeloid leukemia, offering a possible explanation for the efficacy of HU against this malignancy.	[Jorgensen, Jan-Elo; Andersen, Stig Uggerhoj] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus, Denmark; [Dybkaer, Karen; Johnsen, Hans Erik] Aarhus Univ Hosp, Aalborg Hosp Sci & Innovat Ctr, Dept Hematol, DK-9000 Aalborg, Denmark	Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University	Andersen, SU (corresponding author), Aarhus Univ, Dept Mol Biol, Gustav Wieds Vej 10, DK-8000 Aarhus, Denmark.	sua@mb.au.dk		Rasmussen, Jan Trige/0000-0002-2809-7225; Andersen, Stig U./0000-0002-1096-1468; Dybkaer, Karen/0000-0003-2488-435X; Malolepszy, Anna/0000-0001-8862-9054; Andersen, Gregers Rom/0000-0001-6292-3319; Johnsen, Hans Erik/0000-0001-8253-2913	Danish Research Council for Technology and Production [274-06-0096]; K.E. Jensen Foundation; Proof-of-Concept grant	Danish Research Council for Technology and Production; K.E. Jensen Foundation; Proof-of-Concept grant(Luxembourg National Research Fund)	This work was supported by The Danish Research Council for Technology and Production (Grant 274-06-0096 to J.-E.J.), the K.E. Jensen Foundation (to H.E.J. and K. D.), and a Proof-of-Concept grant (to T.J., J.-E.J., and S. U. A.).	AKERBLOM L, 1981, P NATL ACAD SCI-BIOL, V78, P2159, DOI 10.1073/pnas.78.4.2159; Bachir D, 2007, HEMOGLOBIN, V31, P417, DOI 10.1080/03630260701587745; BEERS RF, 1952, J BIOL CHEM, V195, P133; Bueso E, 2007, PLANT J, V52, P1052, DOI 10.1111/j.1365-313X.2007.03305.x; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CHOY BK, 1988, CANCER RES, V48, P2029; Cokic VP, 2003, J CLIN INVEST, V111, P231, DOI 10.1172/JCI200316672; Dalziel K, 2004, HEALTH TECHNOL ASSES, V8, P1; ELFORD HL, 1968, BIOCHEM BIOPH RES CO, V33, P129, DOI 10.1016/0006-291X(68)90266-0; Elleingand E, 1998, EUR J BIOCHEM, V258, P485, DOI 10.1046/j.1432-1327.1998.2580485.x; GAO WY, 1994, MOL PHARMACOL, V46, P767; Gigon A, 2004, ANN BOT-LONDON, V94, P345, DOI 10.1093/aob/mch150; Hankins J, 2009, BRIT J HAEMATOL, V145, P296, DOI 10.1111/j.1365-2141.2009.07602.x; Ho YS, 2004, J BIOL CHEM, V279, P32804, DOI 10.1074/jbc.M404800200; Huang JM, 2004, J MED CHEM, V47, P3495, DOI 10.1021/jm030547z; HURTA RAR, 1990, BIOCHIM BIOPHYS ACTA, V1087, P165, DOI 10.1016/0167-4781(90)90201-C; Jong AY, 1998, J BIOMED SCI, V5, P62, DOI 10.1007/BF02253357; LEWIS WH, 1978, J CELL PHYSIOL, V97, P83; LEWIS WH, 1983, MOL CELL BIOL, V3, P1053, DOI 10.1128/MCB.3.6.1053; Lori F, 2007, CURR MED CHEM, V14, P233, DOI 10.2174/092986707779313336; MCCLARTY GA, 1986, SOMAT CELL MOLEC GEN, V12, P121, DOI 10.1007/BF01560659; Navarra P, 1999, CRIT REV ONCOL HEMAT, V29, P249, DOI 10.1016/S1040-8428(98)00032-8; Paton NI, 2002, LANCET, V359, P1667, DOI 10.1016/S0140-6736(02)08557-4; Queval G, 2007, PLANT J, V52, P640, DOI 10.1111/j.1365-313X.2007.03263.x; Rodriguez GI, 1998, BLOOD, V91, P1533, DOI 10.1182/blood.V91.5.1533.1533_1533_1541; Stamatoyannopoulos G, 2005, EXP HEMATOL, V33, P259, DOI 10.1016/j.exphem.2004.11.007; TAGGER AY, 1988, INT J CANCER, V42, P760, DOI 10.1002/ijc.2910420522; TAKAHARA S, 1952, LANCET, V263, P1101; TONIN PN, 1987, CYTOGENET CELL GENET, V45, P102, DOI 10.1159/000132438; WRIGHT JA, 1983, BIOSCIENCE REP, V3, P741, DOI 10.1007/BF01120985	30	39	39	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21411	21415		10.1074/jbc.M110.103564	http://dx.doi.org/10.1074/jbc.M110.103564			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20452979	Green Published, hybrid			2022-12-27	WOS:000279516100027
J	Kumari, A; Minko, IG; Smith, RL; Lloyd, RS; McCullough, AK				Kumari, Anuradha; Minko, Irina G.; Smith, Rebecca L.; Lloyd, R. Stephen; McCullough, Amanda K.			Modulation of UvrD Helicase Activity by Covalent DNA-Protein Cross-links	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; ESCHERICHIA-COLI; GENE-PRODUCT; DAMAGED DNA; BIOLOGICAL CONSEQUENCES; UNWINDING ENZYME-2; MAMMALIAN-CELLS; UVRABC NUCLEASE; POLYMERASE-I; REPLICATION	UvrD (DNA helicase II) has been implicated in DNA replication, DNA recombination, nucleotide excision repair, and methyl-directed mismatch repair. The enzymatic function of UvrD is to translocate along a DNA strand in a 3' to 5' direction and unwind duplex DNA utilizing a DNA-dependent ATPase activity. In addition, UvrD interacts with many other proteins involved in the above processes and is hypothesized to facilitate protein turnover, thus promoting further DNA processing. Although UvrD interactions with proteins bound to DNA have significant biological implications, the effects of covalent DNA-protein cross-links on UvrD helicase activity have not been characterized. Herein, we demonstrate that UvrD-catalyzed strand separation was inhibited on a DNA strand to which a 16-kDa protein was covalently bound. Our sequestration studies suggest that the inhibition of UvrD activity is most likely due to a translocation block and not helicase sequestration on the cross-link-containing DNA substrate. In contrast, no inhibition of UvrD-catalyzed strand separation was apparent when the protein was linked to the complementary strand. The latter result is surprising given the earlier observations that the DNA in this covalent complex is severely bent (similar to 70 degrees), with both DNA strands making multiple contacts with the cross-linked protein. In addition, UvrD was shown to be required for replication of plasmid DNAs containing covalent DNA-protein complexes. Combined, these data suggest a critical role for UvrD in the processing of DNA-protein cross-links.	[Kumari, Anuradha; Minko, Irina G.; Smith, Rebecca L.; Lloyd, R. Stephen; McCullough, Amanda K.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Ctr Res Occupat & Environm Toxicol, Portland, OR 97239 USA	Oregon Health & Science University	McCullough, AK (corresponding author), Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Ctr Res Occupat & Environm Toxicol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	mcculloa@ohsu.edu		Lloyd, R. Stephen/0000-0001-7273-372X	National Institutes of Health [R01 CA106858, PO1 ES05355]; Oregon Health & Science University Center for Research on Occupational & Environmental Toxicology; NATIONAL CANCER INSTITUTE [R01CA106858, P01CA160032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES005355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oregon Health & Science University Center for Research on Occupational & Environmental Toxicology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA106858 (to A. K. M. and R. S. L.) and PO1 ES05355 (to R. S. L.).; Supported by the Oregon Health & Science University Center for Research on Occupational & Environmental Toxicology Summer Internship Program.	ABDELMONEM M, 1977, EUR J BIOCHEM, V79, P33, DOI 10.1111/j.1432-1033.1977.tb11780.x; ABDELMONEM M, 1977, EUR J BIOCHEM, V79, P39, DOI 10.1111/j.1432-1033.1977.tb11781.x; Ail JA, 1999, J MOL BIOL, V293, P815, DOI 10.1006/jmbi.1999.3185; ARTHUR HM, 1980, MOL GEN GENET, V180, P185, DOI 10.1007/BF00267368; Atkinson J, 2009, J BIOL CHEM, V284, P9612, DOI 10.1074/jbc.M808030200; Batty DP, 2000, GENE, V241, P193, DOI 10.1016/S0378-1119(99)00489-8; Bidnenko V, 2006, MOL MICROBIOL, V62, P382, DOI 10.1111/j.1365-2958.2006.05382.x; Cadman CJ, 2006, J MOL BIOL, V362, P18, DOI 10.1016/j.jmb.2006.06.032; CARLSON KM, 1981, MUTAT RES, V84, P257, DOI 10.1016/0027-5107(81)90195-0; CARON PR, 1985, P NATL ACAD SCI USA, V82, P4925, DOI 10.1073/pnas.82.15.4925; Centore RC, 2009, J BACTERIOL, V191, P1429, DOI 10.1128/JB.01415-08; Choudhary S, 2006, J BIOL CHEM, V281, P6000, DOI 10.1074/jbc.M510122200; de Graaf B, 2009, DNA REPAIR, V8, P1207, DOI 10.1016/j.dnarep.2009.06.007; DODSON ML, 1993, BIOCHEMISTRY-US, V32, P8284, DOI 10.1021/bi00083a032; Douki T, 2003, BIOCHEMISTRY-US, V42, P9221, DOI 10.1021/bi034593c; Flores MJ, 2005, MOL MICROBIOL, V57, P1664, DOI 10.1111/j.1365-2958.2005.04753.x; Golan G, 2006, J MOL BIOL, V362, P241, DOI 10.1016/j.jmb.2006.06.059; Hall MC, 1998, EMBO J, V17, P1535, DOI 10.1093/emboj/17.5.1535; HUSAIN I, 1985, P NATL ACAD SCI USA, V82, P6774, DOI 10.1073/pnas.82.20.6774; JOYCE CM, 1984, J BACTERIOL, V158, P636, DOI 10.1128/JB.158.2.636-643.1984; Kanuri M, 2002, J BIOL CHEM, V277, P18257, DOI 10.1074/jbc.M112419200; Khodursky AB, 1998, J BIOL CHEM, V273, P27668, DOI 10.1074/jbc.273.42.27668; KUEMMERLE NB, 1982, MUTAT RES, V94, P285, DOI 10.1016/0027-5107(82)90292-5; KUMURA K, 1985, NUCLEIC ACIDS RES, V13, P1483, DOI 10.1093/nar/13.5.1483; Kuo HK, 2007, CANCER RES, V67, P8248, DOI 10.1158/0008-5472.CAN-07-1038; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; LLOYD RS, 1978, CANCER RES, V38, P3191; MATSON SW, 1986, J BIOL CHEM, V261, P169; McCullough AK, 2001, BIOCHEMISTRY-US, V40, P561, DOI 10.1021/bi002404+; MENDONCA VM, 1993, J BACTERIOL, V175, P4641, DOI 10.1128/JB.175.15.4641-4651.1993; Minko IG, 2005, BIOCHEMISTRY-US, V44, P3000, DOI 10.1021/bi0478805; Minko IG, 2002, P NATL ACAD SCI USA, V99, P1905, DOI 10.1073/pnas.042700399; Minko IG, 2008, CHEM RES TOXICOL, V21, P1983, DOI 10.1021/tx800174a; Moolenaar GF, 2000, J BACTERIOL, V182, P5706, DOI 10.1128/JB.182.20.5706-5714.2000; MORIYA M, 1993, P NATL ACAD SCI USA, V90, P1122, DOI 10.1073/pnas.90.3.1122; Nakano T, 2007, MOL CELL, V28, P147, DOI 10.1016/j.molcel.2007.07.029; OGAWA H, 1968, MOL GEN GENET, V101, P227, DOI 10.1007/BF00271625; OLINSKI R, 1981, RADIAT RES, V86, P102, DOI 10.2307/3575602; OLINSKI R, 1987, CANCER RES, V47, P201; OSSANNA N, 1989, J BACTERIOL, V171, P303, DOI 10.1128/jb.171.1.303-307.1989; Petit C, 1999, BIOCHIMIE, V81, P15, DOI 10.1016/S0300-9084(99)80034-0; Reardon JT, 2006, P NATL ACAD SCI USA, V103, P4056, DOI 10.1073/pnas.0600538103; RUNYON GT, 1989, J BIOL CHEM, V264, P17502; RUNYON GT, 1993, BIOCHEMISTRY-US, V32, P602, DOI 10.1021/bi00053a028; RUNYON GT, 1990, P NATL ACAD SCI USA, V87, P6383, DOI 10.1073/pnas.87.16.6383; Salem AMH, 2009, J BACTERIOL, V191, P5657, DOI 10.1128/JB.00417-09; SCHROCK RD, 1993, J BIOL CHEM, V268, P880; Shen JC, 1998, NUCLEIC ACIDS RES, V26, P2879, DOI 10.1093/nar/26.12.2879; SIEGEL EC, 1983, MOL GEN GENET, V191, P397, DOI 10.1007/BF00425753; Suhasini AN, 2009, J BIOL CHEM, V284, P18458, DOI 10.1074/jbc.M109.012229; Sung JS, 2006, METHOD ENZYMOL, V408, P48, DOI 10.1016/S0076-6879(06)08004-9; VANHOUTEN B, 1988, J BIOL CHEM, V263, P16553; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Venables WN., 2002, MODERN APPL STAT S; Villani G, 2000, J BIOL CHEM, V275, P33185, DOI 10.1074/jbc.R000011200; Wallace SS, 2002, FREE RADICAL BIO MED, V33, P1, DOI 10.1016/S0891-5849(02)00827-4; Yamaguchi M, 1998, J BIOL CHEM, V273, P9197, DOI 10.1074/jbc.273.15.9197; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zhang G, 1998, J BACTERIOL, V180, P377, DOI 10.1128/JB.180.2.377-387.1998; ZWELLING LA, 1979, CANCER RES, V39, P365	61	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21313	21322		10.1074/jbc.M109.078964	http://dx.doi.org/10.1074/jbc.M109.078964			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20444702	Green Published, hybrid			2022-12-27	WOS:000279516100016
J	Moore, SA; Jia, YH				Moore, Stanley A.; Jia, Yunhua			Structure of the Cytoplasmic Domain of the Flagellar Secretion Apparatus Component FlhA from Helicobacter pylori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN EXPORT APPARATUS; CAMPYLOBACTER-JEJUNI; MEMBRANE COMPONENT; MOTOR PROTEIN; SALMONELLA; EXPRESSION; MUTATIONS; VIRULENCE; SYSTEM; FLIF	Using x-ray crystallography we have determined the structure of the cytoplasmic fragment (residues 384-732) of the flagellum secretion system protein FlhA from Helicobacter pylori at 2.4-angstrom resolution (r = 0.224; R-free = 0.263). FlhA proteins and their type III secretion homologues contain an N-terminal integral membrane domain (residues 1-350), a linker segment, and a globular C-terminal cytoplasmic region. The tertiary structure of the cytoplasmic fragment contains a thioredoxin-like domain, an RNA recognition motif-like domain inserted within the thioredoxin-fold, a helical domain, and a C-terminal beta/alpha-domain. Inter-domain contacts are extensive and the H. pylori FlhA structure appears to be in a closed conformation where the C-terminal domain closes against the RNA recognition motif-fold domain. Highly conserved surface residues in FlhA proteins are concentrated on a narrow surface strip comprising the thioredoxin-like and helical domains, possibly close to the export channel opening. The conformation of the FlhA N-terminal linker segment suggests a likely orientation for the FlhA cytoplasmic fragment relative to the membrane-embedded export pore. Comparison with the recently published structures of the Salmonella FlhA cytoplasmic fragment and its type III secretion counterpart InvA highlight a conformational change where the C-terminal beta/alpha domain in H. pylori FlhA moves 15 angstrom relative to Salmonella FlhA. The conformational change is complex but primarily involves hinge-like movements of the helical and C-terminal domains. Interpretation of previous mutational screens suggest that the C-terminal domain of FlhA(C) plays a regulatory role in substrate class switching in flagellum export.	[Moore, Stanley A.; Jia, Yunhua] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada	University of Saskatchewan	Moore, SA (corresponding author), A3 Hlth Sci Bldg,107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	stan.moore@usask.ca			Health Sciences Utilization and Research Committee of Saskatchewan; National Sciences and Engineering Research Council of Canada [RGPIN 262138-05]; Canadian Institutes for Health Research; Canadian Foundation for Innovation; University of Saskatchewan	Health Sciences Utilization and Research Committee of Saskatchewan; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); University of Saskatchewan	This work was supported by a Health Sciences Utilization and Research Committee of Saskatchewan establishment grant and National Sciences and Engineering Research Council of Canada Discovery Grant RGPIN 262138-05.; Stacy McDonald carried out the cloning of the FlhA<INF>C</INF> domain. George Wong and Michael Lane contributed to early protein purification and crystallization efforts of a shorter FlhA<INF>C</INF> construct not presented in this study. Paul W. O'Toole generously provided H. pylori genomic DNA samples. We thank Michel Fojde, James Gorin, and Pawel Grochulski of the Canadian Macromolecular Crystallography (CMCF) beamline at the Canadian Light Source Synchrotron, Saskatoon, Canada, for timely access, advice, and assistance with x-ray data collection. The Canadian Light Source is funded by the Canadian Institutes for Health Research, the National Science and Engineering Research Council of Canada, the Canadian Foundation for Innovation, and the University of Saskatchewan. Many thanks to Dr. Paul W. O'Toole for providing support and encouragement, and for reading the manuscript.	Aizawa SI, 1996, MOL MICROBIOL, V19, P1, DOI 10.1046/j.1365-2958.1996.344874.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carrillo CD, 2004, J BIOL CHEM, V279, P20327, DOI 10.1074/jbc.M401134200; Colland F, 2001, MOL MICROBIOL, V41, P477, DOI 10.1046/j.1365-2958.2001.02537.x; Cover TL, 2009, GASTROENTEROLOGY, V136, P1863, DOI 10.1053/j.gastro.2009.01.073; Douillard FP, 2008, J BACTERIOL, V190, P7975, DOI 10.1128/JB.00879-08; EATON KA, 1992, J MED MICROBIOL, V37, P123, DOI 10.1099/00222615-37-2-123; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ghelardi E, 2002, J BACTERIOL, V184, P6424, DOI 10.1128/JB.184.23.6424-6433.2002; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grunenfelder B, 2003, J BACTERIOL, V185, P1624, DOI 10.1128/JB.185.5.1624-1633.2003; Hirano T, 2009, J BACTERIOL, V191, P3938, DOI 10.1128/JB.01811-08; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Jenal U, 1996, EMBO J, V15, P2393, DOI 10.1002/j.1460-2075.1996.tb00597.x; Josenhans C, 2002, MOL MICROBIOL, V43, P307, DOI 10.1046/j.1365-2958.2002.02765.x; Kavermann H, 2003, J EXP MED, V197, P813, DOI 10.1084/jem.20021531; Kihara M, 2001, J BACTERIOL, V183, P1655, DOI 10.1128/JB.183.5.1655-1662.2001; Konkel ME, 2004, J BACTERIOL, V186, P3296, DOI 10.1128/JB.186.11.3296-3303.2004; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; McMurry JL, 2004, J BACTERIOL, V186, P7586, DOI 10.1128/JB.186.22.7586-7592.2004; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Minamino T, 2003, J BACTERIOL, V185, P3983, DOI 10.1128/JB.185.13.3983-3988.2003; Minamino T, 2008, NATURE, V451, P485, DOI 10.1038/nature06449; Minamino T, 2010, J BACTERIOL, V192, P1929, DOI 10.1128/JB.01328-09; Minamino T, 2009, MOL MICROBIOL, V74, P1471, DOI 10.1111/j.1365-2958.2009.06946.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niehus E, 2004, MOL MICROBIOL, V52, P947, DOI 10.1111/j.1365-2958.2004.04006.x; O'Toole PW, 2000, MICROBES INFECT, V2, P1207, DOI 10.1016/S1286-4579(00)01274-0; OTOOLE PW, 1994, MOL MICROBIOL, V14, P691, DOI 10.1111/j.1365-2958.1994.tb01307.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paul K, 2008, NATURE, V451, P489, DOI 10.1038/nature06497; PLANO GV, 1995, J BACTERIOL, V177, P3843, DOI 10.1128/jb.177.13.3843-3854.1995; PLANO GV, 1993, J BACTERIOL, V175, P3536, DOI 10.1128/jb.175.11.3536-3545.1993; Rust M, 2009, J BACTERIOL, V191, P4824, DOI 10.1128/JB.00018-09; Saijo-Hamano Y, 2005, ACTA CRYSTALLOGR F, V61, P599, DOI 10.1107/S1744309105015745; Saijo-Hamano Y, 2004, J MOL BIOL, V343, P457, DOI 10.1016/j.jmb.2004.08.067; Saijo-Hamano Y, 2010, MOL MICROBIOL, V76, P260, DOI 10.1111/j.1365-2958.2010.07097.x; Schmitz A, 1997, J BACTERIOL, V179, P987, DOI 10.1128/jb.179.4.987-997.1997; Stone CB, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-18; Suzuki H, 2004, J MOL BIOL, V337, P105, DOI 10.1016/j.jmb.2004.01.034; Suzuki H, 1998, J STRUCT BIOL, V124, P104, DOI 10.1006/jsbi.1998.4048; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thomas DR, 2006, J BACTERIOL, V188, P7039, DOI 10.1128/JB.00552-06; VANZANTEN SJOV, 1994, CAN MED ASSOC J, V150, P177; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Worrall LJ, 2010, PROTEIN SCI, V19, P1091, DOI 10.1002/pro.382	52	35	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21060	21069		10.1074/jbc.M110.119412	http://dx.doi.org/10.1074/jbc.M110.119412			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20442410	Green Published, hybrid			2022-12-27	WOS:000279228600069
J	Moriarty, CH; Pursell, B; Mercurio, AM				Moriarty, Charlotte H.; Pursell, Bryan; Mercurio, Arthur M.			miR-10b Targets Tiam1 IMPLICATIONS FOR Rac ACTIVATION AND CARCINOMA MIGRATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICRORNA EXPRESSION; TUMOR INVASION; DEREGULATION; GTPASES; GENES; CELLS; ZEB1	Understanding the mechanisms by which specific microRNAs regulate cell migration and invasion is a timely and significant problem in cancer cell biology. miR-10b is of interest in this regard because its expression is altered in breast and other cancers. Our analysis of potential miR-10b targets identified Tiam1 (T lymphoma invasion and metastasis 1), a guanidine exchange factor for Rac. We demonstrate, using an miR-10b synthetic precursor, expression vector, and antisense oligonucleotide, that miR-10b represses Tiam1 expression in breast carcinoma cells and that it interacts with the 3'-UTR of Tiam1. Consistent with the involvement of Tiam1 in cell motility, we observed that miR-10b suppresses the ability of breast carcinoma cells to migrate and invade. Importantly, we demonstrate that miR-10b also inhibits Tiam1-mediated Rac activation. These data provide a mechanism for the regulation of Tiam1-mediated Rac activation in breast cancer cells and need to be considered in the context of other reported functions for miR-10b.	[Moriarty, Charlotte H.; Pursell, Bryan; Mercurio, Arthur M.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Mercurio, AM (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, 364 Plantat St, Worcester, MA 01605 USA.	arthur.mercurio@umassmed.edu			NCI NIH HHS [R01 CA080789] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA080789] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adam L, 2001, J BIOL CHEM, V276, P28443, DOI 10.1074/jbc.M009769200; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carrio M, 2005, CANCER RES, V65, P7177, DOI 10.1158/0008-5472.CAN-04-1717; Gebeshuber CA, 2009, EMBO REP, V10, P400, DOI 10.1038/embor.2009.9; Gee HE, 2008, NATURE, V455, DOI 10.1038/nature07362; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kleer CG, 2005, BREAST CANCER RES TR, V93, P101, DOI 10.1007/s10549-005-4170-6; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Minard ME, 2004, BREAST CANCER RES TR, V84, P21, DOI 10.1023/B:BREA.0000018421.31632.e6; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Simpson KJ, 2004, CANCER RES, V64, P8694, DOI 10.1158/0008-5472.CAN-04-2247; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tian YY, 2010, J BIOL CHEM, V285, P7986, DOI 10.1074/jbc.M109.062877; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	25	82	86	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20541	20546		10.1074/jbc.M110.121012	http://dx.doi.org/10.1074/jbc.M110.121012			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20444703	Green Published, hybrid			2022-12-27	WOS:000279228600016
J	Liu, RQ; Zhou, QH; Ji, SR; Zhou, Q; Feng, D; Wu, Y; Sui, SF				Liu, Rui-Qin; Zhou, Qing-Hua; Ji, Shang-Rong; Zhou, Qiang; Feng, Du; Wu, Yi; Sui, Sen-Fang			Membrane Localization of beta-Amyloid 1-42 in Lysosomes A POSSIBLE MECHANISM FOR LYSOSOME LABILIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRANEURONAL A-BETA-42 ACCUMULATION; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; PLASMA-MEMBRANE; TRANSGENIC MICE; APOLIPOPROTEIN E4; BILAYER-MEMBRANES; FIBRIL FORMATION; DOWN-SYNDROME; LIPID RAFTS	beta-Amyloid peptide (A beta 42) is the core protein of amyloid plaque in Alzheimer disease. The intracellular accumulation of A beta 42 in the endosomal/lysosomal system has been under investigation for many years, but the direct link between A beta 42 accumulation and dysfunction of the endosomal/lysosomal system is still largely unknown. Here, we found that both in vitro and in vivo, a major portion of A beta 42 was tightly inserted into and a small portion peripherally associated with the lysosomal membrane, whereas its soluble portion was minimal. We also found that the A beta 42 molecules inserted into the membrane tended to form multiple oligomeric aggregates, whereas A beta 40 peptides formed only dimers. Neutralizing lysosomal pH in differentiated PC12 cells decreased the lysosomal membrane insertion of A beta 42 and moderated A beta 42-induced lysosomal labilization and cytotoxicity. Our findings, thus, suggest that the membrane-inserted portion of A beta 42 accumulated in lysosomes may destabilize the lysosomal membrane and induce neurotoxicity.	[Liu, Rui-Qin; Zhou, Qing-Hua; Ji, Shang-Rong; Zhou, Qiang; Feng, Du; Wu, Yi; Sui, Sen-Fang] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Sch Life Sci, Beijing 100084, Peoples R China	Tsinghua University	Sui, SF (corresponding author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Sch Life Sci, Beijing 100084, Peoples R China.	suisf@mail.tsinghua.edu.cn	Zhou, Qinghua/I-2484-2014	Zhou, Qinghua/0000-0003-0468-9266; Wu, Yi/0000-0003-0365-5590; Ji, Shang-Rong/0000-0001-8595-3756	National Natural Science Foundation of China [30830028, 30970591]; National Basic Research program of China [2010CB912400, 2010CD833706]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grant 30830028/30970591 and National Basic Research program of China Grant 2010CB912400/2010CD833706.	Almeida CG, 2006, J NEUROSCI, V26, P4277, DOI 10.1523/JNEUROSCI.5078-05.2006; AMES B, 1996, METHOD ENZYMOL, V8, P115; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P10573, DOI 10.1073/pnas.90.22.10573; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; BONIFACINO JS, 2001, CURR PROTOC CELL BIO; Burdick D, 1997, BRAIN RES, V746, P275, DOI 10.1016/S0006-8993(96)01262-0; Cataldo AM, 2004, NEUROBIOL AGING, V25, P1263, DOI 10.1016/j.neurobiolaging.2004.02.027; ChooSmith LP, 1997, J BIOL CHEM, V272, P22987, DOI 10.1074/jbc.272.37.22987; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; DEMEL RA, 1973, BIOCHIM BIOPHYS ACTA, V311, P507, DOI 10.1016/0005-2736(73)90126-0; DEMEL RA, 1975, BIOCHIM BIOPHYS ACTA, V406, P97, DOI 10.1016/0005-2736(75)90045-0; Ditaranto K, 2001, NEUROBIOL DIS, V8, P19, DOI 10.1006/nbdi.2000.0364; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Gouras GK, 2005, NEUROBIOL AGING, V26, P1235, DOI 10.1016/j.neurobiolaging.2005.05.022; GREEN SA, 1987, J CELL BIOL, V105, P1227, DOI 10.1083/jcb.105.3.1227; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Ji SR, 2002, J BIOL CHEM, V277, P6273, DOI 10.1074/jbc.M104146200; Ji ZS, 2006, J BIOL CHEM, V281, P2683, DOI 10.1074/jbc.M506646200; Ji ZS, 2002, J BIOL CHEM, V277, P21821, DOI 10.1074/jbc.M112109200; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Kim SI, 2006, J CELL BIOCHEM, V99, P878, DOI 10.1002/jcb.20978; KNAUER MF, 1992, P NATL ACAD SCI USA, V89, P7437, DOI 10.1073/pnas.89.16.7437; KNOPS J, 1995, J BIOL CHEM, V270, P2419, DOI 10.1074/jbc.270.6.2419; Koistinaho M, 2001, P NATL ACAD SCI USA, V98, P14675, DOI 10.1073/pnas.261562998; Koo EH, 1996, J CELL SCI, V109, P991; KOO EH, 1994, J BIOL CHEM, V269, P17386; Kremer JJ, 2000, BIOCHEMISTRY-US, V39, P10309, DOI 10.1021/bi0001980; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Langui D, 2004, AM J PATHOL, V165, P1465, DOI 10.1016/S0002-9440(10)63405-0; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Ling DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004201; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Marmagne A, 2004, MOL CELL PROTEOMICS, V3, P675, DOI 10.1074/mcp.M400001-MCP200; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Morelli L, 1999, NEUROSCI LETT, V262, P5, DOI 10.1016/S0304-3940(99)00023-3; Mori C, 2002, AMYLOID, V9, P88, DOI 10.3109/13506120208995241; Morishima-Kawashima M, 1998, BIOCHEMISTRY-US, V37, P15247, DOI 10.1021/bi981843u; NAKAMURA Y, 1989, NEUROSCI LETT, V97, P215, DOI 10.1016/0304-3940(89)90166-3; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2006, J ALZHEIMERS DIS, V9, P277; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Pasternak SH, 2003, J BIOL CHEM, V278, P26687, DOI 10.1074/jbc.M304009200; SEELIG A, 1987, BIOCHIM BIOPHYS ACTA, V899, P196, DOI 10.1016/0005-2736(87)90400-7; SELKOE DJ, 1994, J NEUROPATH EXP NEUR, V53, P438, DOI 10.1097/00005072-199409000-00003; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Smaby JM, 1996, BIOCHEMISTRY-US, V35, P5696, DOI 10.1021/bi953057k; Sun ZX, 2005, NEUROSCI LETT, V391, P71, DOI 10.1016/j.neulet.2005.08.034; SWANSON J, 1987, J CELL BIOL, V104, P1217, DOI 10.1083/jcb.104.5.1217; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Wang SX, 1998, BIOCHEM J, V335, P225, DOI 10.1042/bj3350225; YAMADA H, 1984, J BIOCHEM, V95, P1155, DOI 10.1093/oxfordjournals.jbchem.a134704; Yamazaki T, 2001, J BIOL CHEM, V276, P4454, DOI 10.1074/jbc.M009598200; Yamazaki T, 1996, J CELL SCI, V109, P999; Yang AJ, 1998, J NEUROSCI RES, V52, P691, DOI 10.1002/(SICI)1097-4547(19980615)52:6<691::AID-JNR8>3.0.CO;2-3; YANG AJ, 1995, J BIOL CHEM, V270, P14786, DOI 10.1074/jbc.270.24.14786; Zhang W, 2003, ELECTROPHORESIS, V24, P2855, DOI 10.1002/elps.200305569; Zhao HF, 2005, FEBS LETT, V579, P1551, DOI 10.1016/j.febslet.2005.01.061	68	42	44	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19986	19996		10.1074/jbc.M109.036798	http://dx.doi.org/10.1074/jbc.M109.036798			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20430896	Green Published, hybrid			2022-12-27	WOS:000279012000032
J	Norstrom, MF; Smithback, PA; Rock, RS				Norstrom, Melanie F.; Smithback, Philip A.; Rock, Ronald S.			Unconventional Processive Mechanics of Non-muscle Myosin IIB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE MYOSIN; NEURITE OUTGROWTH; LIGHT-CHAIN; STEP-SIZE; IN-VITRO; MOTOR; ACTIN; FORCE; LOAD; ISOFORMS	Proper tension maintenance in the cytoskeleton is essential for regulated cell polarity, cell motility, and division. Non-muscle myosin IIB (NMIIB) generates tension along actin filaments in many cell types, including neuronal, cardiac, and smooth muscle cells. Using a three-bead optical trapping assay, we recorded NMIIB interactions with actin filaments to determine if a NMIIB dimer cycles along an actin filament in a processive manner. Our results show that NMIIB is the first myosin II to exhibit evidence of processive stepping behavior. Analysis of these data reveals a forward displacement of 5.4 nm and, surprisingly, frequent backward steps of -5.9 nm. Processive stepping along the long pitch helix of actin may provide a mechanism for disassembly of fascin-actin bundles. Forward steps and detachment are weakly force-dependent at all forces, consistent with rate-limiting and force-dependent ADP release. However, backward steps are nearly force-independent. Our data support a model in which NMIIB can readily move in both directions at stall, which may be important for a general regulator of cytoskeleton tension.	[Norstrom, Melanie F.; Smithback, Philip A.; Rock, Ronald S.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago	Rock, RS (corresponding author), GCIS W240R,929 E 57th St, Chicago, IL 60637 USA.	rrock@uchicago.edu			National Institutes of Health [GM078450]; Molecular and Cellular Biology Training [GM008720]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078450, T32GM008720] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular and Cellular Biology Training; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM078450 (to R.S.R.) and Molecular and Cellular Biology Training Grant GM008720 (to M.F.N.).	ADELSTEIN RS, 1982, METHOD ENZYMOL, V85, P298; Ali MY, 2004, BIOPHYS J, V86, P3804, DOI 10.1529/biophysj.103.037416; Ali MY, 2002, NAT STRUCT BIOL, V9, P464, DOI 10.1038/nsb803; Altman D, 2004, CELL, V116, P737, DOI 10.1016/S0092-8674(04)00211-9; Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319; Beausang JF, 2008, BIOPHYS J, V95, P5820, DOI 10.1529/biophysj.108.140319; Bridgman PC, 2001, J NEUROSCI, V21, P6159, DOI 10.1523/JNEUROSCI.21-16-06159.2001; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; FACEMYER KC, 1992, BIOCONJUGATE CHEM, V3, P408, DOI 10.1021/bc00017a009; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; GOPALAKRISHNA R, 1985, Journal of Applied Biochemistry, V7, P311; Guilford WH, 1997, BIOPHYS J, V72, P1006, DOI 10.1016/S0006-3495(97)78753-8; Haviv L, 2008, J MOL BIOL, V375, P325, DOI 10.1016/j.jmb.2007.09.066; Hua W, 1997, NATURE, V388, P390, DOI 10.1038/41118; Ishikawa R, 2003, J NEUROCHEM, V87, P676, DOI 10.1046/j.1471-4159.2003.02058.x; Iwamoto H, 2007, J MOL BIOL, V369, P249, DOI 10.1016/j.jmb.2007.03.031; Kad NM, 2008, J BIOL CHEM, V283, P17477, DOI 10.1074/jbc.M800539200; Kelley CA, 1996, J CELL BIOL, V134, P675, DOI 10.1083/jcb.134.3.675; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Kitamura K, 1999, NATURE, V397, P129, DOI 10.1038/16403; Kolega J, 1998, J CELL SCI, V111, P2085; Kolega J, 2006, MOL BIOL CELL, V17, P4435, DOI 10.1091/mbc.E06-05-0431; Kolomeisky AB, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.031902; Kovacs M, 2007, P NATL ACAD SCI USA, V104, P9994, DOI 10.1073/pnas.0701181104; KRON SJ, 1991, METHOD ENZYMOL, V196, P399; Laakso JM, 2008, SCIENCE, V321, P133, DOI 10.1126/science.1159419; Lo CM, 2004, MOL BIOL CELL, V15, P982, DOI 10.1091/mbc.E03-06-0359; Lofgren M, 2003, J GEN PHYSIOL, V121, P301, DOI 10.1085/jgp.200208720; MAUPIN P, 1994, J CELL SCI, V107, P3077; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Mehta AD, 1997, P NATL ACAD SCI USA, V94, P7927, DOI 10.1073/pnas.94.15.7927; Murphy CT, 2001, NAT CELL BIOL, V3, P311, DOI 10.1038/35060110; Nagy S, 2008, P NATL ACAD SCI USA, V105, P9616, DOI 10.1073/pnas.0802592105; NIEDERMAN R, 1975, J CELL BIOL, V67, P72, DOI 10.1083/jcb.67.1.72; Nishiyama M, 2002, NAT CELL BIOL, V4, P790, DOI 10.1038/ncb857; Palmiter KA, 2000, J MUSCLE RES CELL M, V21, P609, DOI 10.1023/A:1005678905119; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pato MD, 1996, J BIOL CHEM, V271, P2689, DOI 10.1074/jbc.271.5.2689; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; ROCHLIN MW, 1995, J CELL SCI, V108, P3661; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Rosenfeld SS, 2003, J BIOL CHEM, V278, P27449, DOI 10.1074/jbc.M302555200; Sakamoto T, 2000, BIOCHEM BIOPH RES CO, V272, P586, DOI 10.1006/bbrc.2000.2819; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Sweeney HL, 1998, J BIOL CHEM, V273, P6262, DOI 10.1074/jbc.273.11.6262; Takagi Y, 2006, BIOPHYS J, V90, P1295, DOI 10.1529/biophysj.105.068429; TAKAHASHI M, 1992, J BIOL CHEM, V267, P17864; Tsygankov D, 2007, P NATL ACAD SCI USA, V104, P19321, DOI 10.1073/pnas.0709911104; Veigel C, 2003, NAT CELL BIOL, V5, P980, DOI 10.1038/ncb1060; Veigel C, 1999, NATURE, V398, P530, DOI 10.1038/19104; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Vignjevic D, 2006, METHOD ENZYMOL, V406, P727, DOI 10.1016/S0076-6879(06)06057-5; Visscher K, 1998, METHOD ENZYMOL, V298, P460, DOI 10.1016/S0076-6879(98)98040-5; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Wylie SR, 1998, P NATL ACAD SCI USA, V95, P12967, DOI 10.1073/pnas.95.22.12967; Wylie SR, 2001, NAT CELL BIOL, V3, P88, DOI 10.1038/35050613	60	60	61	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26326	26334		10.1074/jbc.M110.123851	http://dx.doi.org/10.1074/jbc.M110.123851			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20511646	Green Published, hybrid			2022-12-27	WOS:000280921000050
J	Shibata, N; Tamagaki, H; Hieda, N; Akita, K; Komori, H; Shomura, Y; Terawaki, S; Mori, K; Yasuoka, N; Higuchi, Y; Toraya, T				Shibata, Naoki; Tamagaki, Hiroko; Hieda, Naoki; Akita, Keita; Komori, Hirofumi; Shomura, Yasuhito; Terawaki, Shin-ichi; Mori, Koichi; Yasuoka, Noritake; Higuchi, Yoshiki; Toraya, Tetsuo			Crystal Structures of Ethanolamine Ammonia-lyase Complexed with Coenzyme B-12 Analogs and Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-STRUCTURE; ADENOSYLCOBALAMIN-DEPENDENT ENZYME; RADICAL PAIR STATE; DIOL-DEHYDRATASE; ACTIVE-SITE; B-12-DEPENDENT ENZYME; CLOSTRIDIAL FERMENTATIONS; POTASSIUM-ION; PROTEIN; INTERMEDIATE	N-terminal truncation of the Escherichia coli ethanolamine ammonia-lyase beta-subunit does not affect the catalytic properties of the enzyme (Akita, K., Hieda, N., Baba, N., Kawaguchi, S., Sakamoto, H., Nakanishi, Y., Yamanishi, M., Mori, K., and Toraya, T. (2010) J. Biochem. 147, 83-93). The binary complex of the truncated enzyme with cyanocobalamin and the ternary complex with cyanocobalamin or adeninylpentylcobalamin and substrates were crystallized, and their x-ray structures were analyzed. The enzyme exists as a trimer of the (alpha beta)(2) dimer. The active site is in the (alpha/beta)(8) barrel of the alpha-subunit; the beta-subunit covers the lower part of the cobalamin that is bound in the interface of the alpha- and beta-subunits. The structure complexed with adeninylpentylcobalamin revealed the presence of an adenine ring-binding pocket in the enzyme that accommodates the adenine moiety through a hydrogen bond network. The substrate is bound by six hydrogen bonds with active-site residues. Arg alpha(160) contributes to substrate binding most likely by hydrogen bonding with the O1 atom. The modeling study implies that marked angular strains and tensile forces induced by tight enzyme-coenzyme interactions are responsible for breaking the coenzyme Co-C bond. The coenzyme adenosyl radical in the productive conformation was modeled by superimposing its adenine ring on the adenine ring-binding site followed by ribosyl rotation around the N-glycosidic bond. A major structural change upon substrate binding was not observed with this particular enzyme. Glu alpha(287), one of the substrate-binding residues, has a direct con-tact with the ribose group of the modeled adenosylcobalamin, which may contribute to the substrate-induced additional labilization of the Co-C bond.	[Shibata, Naoki; Terawaki, Shin-ichi; Yasuoka, Noritake; Higuchi, Yoshiki] Univ Hyogo, Dept Life Sci, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan; [Shibata, Naoki; Higuchi, Yoshiki] RIKEN Harima Inst, SPring Ctr 8, Sayo, Hyogo 6795148, Japan; [Hieda, Naoki; Akita, Keita; Mori, Koichi; Toraya, Tetsuo] Okayama Univ, Grad Sch Nat Sci & Technol, Dept Biosci & Biotechnol, Okayama 7008530, Japan	University of Hyogo; RIKEN; Okayama University	Shibata, N (corresponding author), Univ Hyogo, Dept Life Sci, Grad Sch Life Sci, 3-2-1 Koto, Kamigori, Hyogo 6781297, Japan.	shibach@sci.u-hyogo.ac.jp; toraya@cc.okayama-u.ac.jp	Terawaki, Shin-ichi/V-7082-2019; MORI, Koichi/B-2567-2011; Mori, Koichi/ABC-7268-2021; Shibata, Naoki/AFK-9971-2022	Terawaki, Shin-ichi/0000-0002-2859-0589; Mori, Koichi/0000-0001-8865-2107; Shibata, Naoki/0000-0002-5096-1104; Higuchi, Yoshiki/0000-0001-8284-5709	Global Centers of Excellence (COE); Japan Society for the Promotion of Science [18GS0207, 22370061, 13480195, 17370038, 513]; Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Science and Technology Agency; Asahi Glass Foundation, Tokyo, Japan; Grants-in-Aid for Scientific Research [22570143] Funding Source: KAKEN	Global Centers of Excellence (COE); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Asahi Glass Foundation, Tokyo, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Global Centers of Excellence (COE) Program (to N. S. and Y. H.) and Grants-in-aid for Scientific Research 18GS0207 and (B) 22370061 (to Y. H.) and (B) 13480195, 17370038, and Priority Areas 513 (to T. T.) from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science and Technology, Japan. This work was also supported by a grant from the Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Agency (to Y. H.) and a grant for natural sciences research assistance from the Asahi Glass Foundation, Tokyo, Japan (to T. T.).	ABELES RH, 1976, ACCOUNTS CHEM RES, V9, P114, DOI 10.1021/ar50099a006; Abend A, 1999, ARCH BIOCHEM BIOPHYS, V370, P138, DOI 10.1006/abbi.1999.1382; Akita K, 2010, J BIOCHEM, V147, P83, DOI 10.1093/jb/mvp145; BABIOR B M, 1988, Biofactors, V1, P21; BABIOR BM, 1975, ACCOUNTS CHEM RES, V8, P376, DOI 10.1021/ar50095a003; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bandarian V, 2000, BIOCHEMISTRY-US, V39, P12069, DOI 10.1021/bi001014k; Bandarian V, 2002, BIOCHEMISTRY-US, V41, P8580, DOI 10.1021/bi0201217; BANERJEE R, 1999, CHEMISTRY BIOCH B12; Bender G, 2008, BIOCHEMISTRY-US, V47, P11360, DOI 10.1021/bi801316v; Berkovitch F, 2004, P NATL ACAD SCI USA, V101, P15870, DOI 10.1073/pnas.0407074101; BRADBEER C, 1965, J BIOL CHEM, V240, P4675; BRADBEER C, 1965, J BIOL CHEM, V240, P4669; Canfield JM, 2005, J PHYS CHEM B, V109, P3053, DOI 10.1021/jp046167m; Canfield JM, 2002, J PHYS CHEM B, V106, P8831, DOI 10.1021/jp0207634; CHANG GW, 1975, NATURE, V254, P150, DOI 10.1038/254150a0; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DIZIOL P, 1980, EUR J BIOCHEM, V106, P211; Dolphin D., 1982, B12; DRENNAN CL, 1994, SCIENCE, V266, P1669, DOI 10.1126/science.7992050; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAUST LP, 1992, ARCH BIOCHEM BIOPHYS, V294, P50, DOI 10.1016/0003-9861(92)90135-J; FAUST LRP, 1990, J BIOL CHEM, V265, P12462; GRAVES SW, 1980, BIOCHEMISTRY-US, V19, P3630, DOI 10.1021/bi00556a032; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Harding MM, 2001, ACTA CRYSTALLOGR D, V57, P401, DOI 10.1107/S0907444900019168; Kamachi T, 2004, J AM CHEM SOC, V126, P16207, DOI 10.1021/ja045572o; Ke SC, 1999, BIOCHEMISTRY-US, V38, P12681, DOI 10.1021/bi983067w; Ke SC, 2003, BBA-GEN SUBJECTS, V1620, P267, DOI 10.1016/S0304-4165(03)00006-0; Kofoid E, 1999, J BACTERIOL, V181, P5317, DOI 10.1128/JB.181.17.5317-5329.1999; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Li H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005326; LoBrutto R, 2001, BIOCHEMISTRY-US, V40, P9, DOI 10.1021/bi001865s; Magnusson OT, 2002, BIOCHEMISTRY-US, V41, P1695, DOI 10.1021/bi011947w; Mancia F, 1998, STRUCTURE, V6, P711, DOI 10.1016/S0969-2126(98)00073-2; Mancia F, 1996, STRUCTURE, V4, P339, DOI 10.1016/S0969-2126(96)00037-8; Masuda J, 2001, J SYNCHROTRON RADIAT, V8, P1182, DOI 10.1107/S0909049501015606; Masuda J, 2000, STRUCTURE, V8, P775, DOI 10.1016/S0969-2126(00)00164-7; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OBRIEN RJ, 1985, J BIOL CHEM, V260, P6131; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Penrod JT, 2006, J BACTERIOL, V188, P2865, DOI 10.1128/JB.188.8.2865-2874.2006; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reitzer R, 1999, STRUCTURE, V7, P891, DOI 10.1016/S0969-2126(99)80116-6; Sagermann M, 2009, P NATL ACAD SCI USA, V106, P8883, DOI 10.1073/pnas.0902324106; Schwartz PA, 2007, BIOCHEMISTRY-US, V46, P7293, DOI 10.1021/bi700078z; Shibata N, 2005, STRUCTURE, V13, P1745, DOI 10.1016/j.str.2005.08.011; Shibata N, 1999, STRUCTURE, V7, P997, DOI 10.1016/S0969-2126(99)80126-9; Shibata N, 2002, BIOCHEMISTRY-US, V41, P12607, DOI 10.1021/bi026104z; Sintchak MD, 2002, NAT STRUCT BIOL, V9, P293, DOI 10.1038/nsb774; Sun L, 2008, BIOCHEMISTRY-US, V47, P5523, DOI 10.1021/bi702366e; Sun L, 2006, PROTEINS, V64, P308, DOI 10.1002/prot.20997; Toraya T, 2003, CHEM REV, V103, P2095, DOI 10.1021/cr020428b; TORAYA T, 2010, BIOCHEMISTR IN PRESS; WAGNER OW, 1966, J BIOL CHEM, V241, P1751; WALLIS OC, 1979, FEBS LETT, V97, P196, DOI 10.1016/0014-5793(79)80083-6; Warncke K, 2001, J AM CHEM SOC, V123, P8564, DOI 10.1021/ja003658l; Yamanishi M, 2002, EUR J BIOCHEM, V269, P4484, DOI 10.1046/j.1432-1033.2002.03151.x	59	65	65	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26484	26493		10.1074/jbc.M110.125112	http://dx.doi.org/10.1074/jbc.M110.125112			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20519496	Green Published, hybrid			2022-12-27	WOS:000280921000066
J	Guo, L; Zhou, DQ; Pryse, KM; Okunade, AL; Su, XO				Guo, Lin; Zhou, Dequan; Pryse, Kenneth M.; Okunade, Adewole L.; Su, Xiong			Fatty Acid 2-Hydroxylase Mediates Diffusional Mobility of Raft-associated Lipids, GLUT4 Level, and Lipogenesis in 3T3-L1 Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYTANOYL-COA HYDROXYLASE; ALPHA-OXIDATION; ADIPOSE-TISSUE; LATERAL MOBILITY; GENE-EXPRESSION; CHAIN-LENGTH; INSULIN; DIFFERENTIATION; TRAFFICKING; ORGANIZATION	Straight chain fatty acid alpha-oxidation increases during differentiation of 3T3-L1 adipocytes, leading to a marked accumulation of odd chain length fatty acyl moieties. Potential roles of this pathway in adipocyte differentiation and lipogenesis are unknown. Mammalian fatty acid 2-hydroxylase (FA2H) was recently identified and suggested to catalyze the initial step of straight chain fatty acid alpha-oxidation. Accordingly, we examined whether FA2H modulates adipocyte differentiation and lipogenesis in mature adipocytes. FA2H level markedly increases during differentiation of 3T3-L1 adipocytes, and small interfering RNAs against FA2H inhibit the differentiation process. In mature adipocytes, depletion of FA2H inhibits basal and insulin-stimulated glucose uptake and lipogenesis, which are partially rescued by the enzymatic product of FA2H, 2-hydroxy palmitic acid. Expression of fatty-acid synthase and SCD1 was decreased in FA2H-depleted cells, and levels of GLUT4 and insulin receptor proteins were reduced. 2-Hydroxy fatty acids are enriched in cellular sphingolipids, which are components of membrane rafts. Accelerated diffusional mobility of raft-associated lipids was shown to enhance degradation of GLUT4 and insulin receptor in adipocytes. Consistent with this, depletion of FA2H appeared to increase raft lipid mobility as it significantly accelerated the rates of fluorescence recovery after photo-bleaching measurements of lipid rafts labeled with Alexa 488-conjugated cholera toxin subunit B. Moreover, the enhanced recovery rates were partially reversed by treatment with 2-hydroxy palmitic acid. In conclusion, our findings document the novel role of FA2H in adipocyte lipogenesis possibly by modulation of raft fluidity and level of GLUT4.	[Guo, Lin; Zhou, Dequan; Okunade, Adewole L.; Su, Xiong] Washington Univ, Sch Med, Dept Internal Med, Ctr Human Nutr, St Louis, MO 63110 USA; [Pryse, Kenneth M.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Su, Xiong] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Su, XO (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Ctr Human Nutr, Campus Box 8031,660 S Euclid, St Louis, MO 63110 USA.	xsu@wustl.edu	zhou, dequan/J-9937-2012	zhou, dequan/0000-0002-2662-2882	National Institutes of Health [R21DK082951]; American Heart Association [835140N]; core services of the Nutrition Obesity Research Center at Washington University School of Medicine [P30DK56341]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, R21DK082951] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); core services of the Nutrition Obesity Research Center at Washington University School of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R21DK082951 (to X. S.). This work was also supported by Scientist Development Grant 835140N from the American Heart Association (to X. S.) and by the core services of the Nutrition Obesity Research Center Grant P30DK56341 at Washington University School of Medicine.	Alderson NL, 2004, J BIOL CHEM, V279, P48562, DOI 10.1074/jbc.M406649200; Bacia K, 2002, BIOPHYS J, V83, P1184, DOI 10.1016/S0006-3495(02)75242-9; Bickel PE, 2002, AM J PHYSIOL-ENDOC M, V282, pE1, DOI 10.1152/ajpendo.2002.282.1.E1; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Croes K, 2000, J LIPID RES, V41, P629; Eckhardt M, 2005, BIOCHEM J, V388, P245, DOI 10.1042/BJ20041451; FOUFELLE F, 1992, J BIOL CHEM, V267, P20543; Foulon V, 2005, J BIOL CHEM, V280, P9802, DOI 10.1074/jbc.M413362200; Foulon V, 2003, J LIPID RES, V44, P2349, DOI 10.1194/jlr.M300230-JLR200; Gonzalez-Munoz E, 2009, ENDOCRINOLOGY, V150, P3493, DOI 10.1210/en.2008-1520; Hama H, 2000, FEBS LETT, V478, P26, DOI 10.1016/S0014-5793(00)01821-4; Hama H, 2010, BBA-MOL CELL BIOL L, V1801, P405, DOI 10.1016/j.bbalip.2009.12.004; Hanzal-Bayer MF, 2007, FEBS LETT, V581, P2098, DOI 10.1016/j.febslet.2007.03.019; Hao MM, 2004, J BIOL CHEM, V279, P14171, DOI 10.1074/jbc.M309793200; Herrero AB, 2008, CANCER RES, V68, P9779, DOI 10.1158/0008-5472.CAN-08-1981; Jenske R, 2008, J AGR FOOD CHEM, V56, P11578, DOI 10.1021/jf802772a; Jenske R, 2008, CHEM PHYS LIPIDS, V154, P26, DOI 10.1016/j.chemphyslip.2008.03.010; Koivusalo M, 2007, MOL BIOL CELL, V18, P5113, DOI 10.1091/mbc.E07-04-0330; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Laude AJ, 2004, MOL MEMBR BIOL, V21, P193, DOI 10.1080/09687680410001700517; LAZAR DF, 1995, J BIOL CHEM, V270, P20801, DOI 10.1074/jbc.270.35.20801; Letexier D, 2003, J LIPID RES, V44, P2127, DOI 10.1194/jlr.M300235-JLR200; LEVIS GM, 1964, J BIOL CHEM, V239, P77; Liao W, 2006, ENDOCRINOLOGY, V147, P2245, DOI 10.1210/en.2005-1638; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Liu YQ, 2010, AM J PHYSIOL-CELL PH, V298, pC921, DOI 10.1152/ajpcell.00541.2009; LOFGREN H, 1977, CHEM PHYS LIPIDS, V20, P273, DOI 10.1016/0009-3084(77)90068-8; Lopez JA, 2009, MOL BIOL CELL, V20, P3918, DOI 10.1091/mbc.E09-03-0187; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Maldonado EN, 2008, J LIPID RES, V49, P153, DOI 10.1194/jlr.M700400-JLR200; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Mizutani Y, 2008, J LIPID RES, V49, P2356, DOI 10.1194/jlr.M800158-JLR200; Mukherji M, 2002, CHEM BIOL, V9, P597, DOI 10.1016/S1074-5521(02)00139-4; Nahle Z, 2008, J BIOL CHEM, V283, P14317, DOI 10.1074/jbc.M706478200; Palacios S, 2001, J BIOL CHEM, V276, P3371, DOI 10.1074/jbc.M006739200; Roberts LD, 2009, PHYSIOL GENOMICS, V39, P109, DOI 10.1152/physiolgenomics.90365.2008; Roettger BF, 1999, AM J PHYSIOL-CELL PH, V276, pC539, DOI 10.1152/ajpcell.1999.276.3.C539; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; SHAH J, 1995, J LIPID RES, V36, P1945; Shigematsu S, 2003, J BIOL CHEM, V278, P10683, DOI 10.1074/jbc.M208563200; Singh RD, 2003, MOL BIOL CELL, V14, P3254, DOI 10.1091/mbc.E02-12-0809; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; Su X, 2004, J BIOL CHEM, V279, P21740, DOI 10.1074/jbc.M314166200; Su X, 2004, BIOCHEMISTRY-US, V43, P5033, DOI 10.1021/bi035867z; Su X, 2007, J BIOL CHEM, V282, P21278, DOI 10.1074/jbc.M703725200; Uchida Y, 2007, J BIOL CHEM, V282, P13211, DOI 10.1074/jbc.M611562200; Villena JA, 2002, HORM METAB RES, V34, P664, DOI 10.1055/s-2002-38244; Wanders RJA, 2004, MOL GENET METAB, V83, P16, DOI 10.1016/j.ymgme.2004.08.016; Wanders RJA, 2003, BBA-MOL CELL BIOL L, V1631, P119, DOI 10.1016/S1388-1981(03)00003-9; Yang CZ, 1999, J BIOL CHEM, V274, P25297, DOI 10.1074/jbc.274.36.25297; Zoller I, 2008, J NEUROSCI, V28, P9741, DOI 10.1523/JNEUROSCI.0458-08.2008	52	42	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25438	25447		10.1074/jbc.M110.119933	http://dx.doi.org/10.1074/jbc.M110.119933			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20519515	Green Published, hybrid			2022-12-27	WOS:000280682400037
J	Perry, JJP; Asaithamby, A; Barnebey, A; Kiamanesch, F; Chen, DJ; Han, S; Tainer, JA; Yannone, SM				Perry, J. Jefferson P.; Asaithamby, Aroumougame; Barnebey, Adam; Kiamanesch, Foad; Chen, David J.; Han, Seungil; Tainer, John A.; Yannone, Steven M.			Identification of a Coiled Coil in Werner Syndrome Protein That Facilitates Multimerization and Promotes Exonuclease Processivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4-NITROQUINOLINE 1-OXIDE SENSITIVITY; RECQ HELICASE; DNA HELICASE; HRDC DOMAIN; SUBSTRATE SPECIFICITIES; EXCISION-REPAIR; CELL-LINES; KINASE; WRN; DAMAGE	Werner syndrome (WS) is a rare progeroid disorder characterized by genomic instability, increased cancer incidence, and early onset of a variety of aging pathologies. WS is unique among early aging syndromes in that affected individuals are developmentally normal, and phenotypic onset is in early adulthood. The protein defective in WS (WRN) is a member of the large RecQ family of helicases but is unique among this family in having an exonuclease. RecQ helicases form multimers, but the mechanism and consequence of multimerization remain incompletely defined. Here, we identify a novel heptad repeat coiled coil region between the WRN nuclease and helicase domains that facilitates multimerization of WRN. We mapped a novel and unique DNA-dependent protein kinase phosphorylation site proximal to the WRN multimerization region. However, phosphorylation at this site affected neither exonuclease activity nor multimeric state. We found that WRN nuclease is stimulated by DNA-dependent protein kinase independently of kinase activity or WRN nuclease multimeric status. In addition, WRN nuclease multimerization significantly increased nuclease processivity. We found that the novel WRN coiled coil domain is necessary for multimerization of the nuclease domain and sufficient to multimerize with full-length WRN in human cells. Importantly, correct homomultimerization is required for WRN function in vivo as overexpression of this multimerization domain caused increased sensitivity to camptothecin and 4-nitroquinoline 1-oxide similar to that in cells lacking functional WRN protein.	[Barnebey, Adam; Tainer, John A.; Yannone, Steven M.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Yannone, Steven M.] Buck Inst Age Res, Novato, CA 94945 USA; [Perry, J. Jefferson P.; Tainer, John A.] Scripps Res Inst, Div Mol Radiat Biol, La Jolla, CA 92037 USA; [Asaithamby, Aroumougame; Kiamanesch, Foad; Chen, David J.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Han, Seungil] Pfizer Global Res & Dev, Groton, CT 06340 USA; [Perry, J. Jefferson P.] Amrita Univ, Sch Biotechnol, Kollam 690525, Kerala, India	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Buck Institute for Research on Aging; Scripps Research Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Pfizer; Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Amritapuri	Yannone, SM (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Mail Stop 84-171,1 Cyclotron Rd, Berkeley, CA 94720 USA.	SMYannone@lbl.gov	Yannone, Steven/ABA-3524-2021; Classen, Scott/AAY-8176-2020; Tainer, John/GWQ-4878-2022; Yannone, Steven/G-1927-2011	Tainer, John/0000-0003-1659-2429; 	National Institutes of Health [CA104660, CA92584, CA134991]; United States Department of Energy Office of Science [DE-AC02-05CH11231]; NATIONAL CANCER INSTITUTE [P01CA092584, R01CA134991, R01CA104660] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy Office of Science(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA104660 (to J.J.P. P., J.A.T., and S.M.Y.), CA92584 (to J.A.T. and D.J.C.), and CA134991 (to D.J.C.). This work was also supported by United States Department of Energy Office of Science Contract DE-AC02-05CH11231.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSON CW, 1993, TRENDS BIOCHEM SCI, V18, P433, DOI 10.1016/0968-0004(93)90144-C; Beresten SF, 1999, PROTEIN EXPRES PURIF, V17, P239, DOI 10.1006/prep.1999.1135; Bernstein DA, 2003, EMBO J, V22, P4910, DOI 10.1093/emboj/cdg500; Bernstein DA, 2005, STRUCTURE, V13, P1173, DOI 10.1016/j.str.2005.04.018; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Collis SJ, 2005, ONCOGENE, V24, P949, DOI 10.1038/sj.onc.1208332; Compton SA, 2008, J BIOL CHEM, V283, P24478, DOI 10.1074/jbc.M803370200; Cooper MP, 2000, GENE DEV, V14, P907; Dalhus B, 2009, NAT STRUCT MOL BIOL, V16, P138, DOI 10.1038/nsmb.1538; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Dietschy T, 2007, CELL MOL LIFE SCI, V64, P796, DOI 10.1007/s00018-007-6468-5; Douglas P, 2001, J BIOL CHEM, V276, P18992, DOI 10.1074/jbc.M011703200; Fan L, 2006, MOL CELL, V22, P27, DOI 10.1016/j.molcel.2006.02.017; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893; Garcin ED, 2008, NAT STRUCT MOL BIOL, V15, P515, DOI 10.1038/nsmb.1414; Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100; Grigorova M, 2000, MUTAGENESIS, V15, P303, DOI 10.1093/mutage/15.4.303; Hammel M, 2010, J BIOL CHEM, V285, P1414, DOI 10.1074/jbc.M109.065615; Harmon FG, 1998, GENE DEV, V12, P1134, DOI 10.1101/gad.12.8.1134; Hisama FM, 2000, CANCER RES, V60, P2372; Huang SR, 2000, NUCLEIC ACIDS RES, V28, P2396, DOI 10.1093/nar/28.12.2396; Kamath-Loeb AS, 1998, J BIOL CHEM, V273, P34145, DOI 10.1074/jbc.273.51.34145; Kaneko H, 2004, EXPERT REV MOL DIAGN, V4, P393, DOI 10.1586/14737159.4.3.393; Karmakar P, 2002, J BIOL CHEM, V277, P18291, DOI 10.1074/jbc.M111523200; Karow JK, 1999, CURR BIOL, V9, P597, DOI 10.1016/S0960-9822(99)80264-4; Kawasaki K, 2002, NUCLEIC ACIDS RES, V30, P3682, DOI 10.1093/nar/gkf487; Killoran MP, 2008, NUCLEIC ACIDS RES, V36, P3139, DOI 10.1093/nar/gkn143; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kitano K, 2007, J BIOL CHEM, V282, P2717, DOI 10.1074/jbc.M610142200; Li BM, 2000, J BIOL CHEM, V275, P28349, DOI 10.1074/jbc.C000289200; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MARTIN GM, 1970, LAB INVEST, V23, P86; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Matsumoto Y, 2000, FEBS LETT, V478, P67, DOI 10.1016/S0014-5793(00)01800-7; Meek K, 2008, ADV IMMUNOL, V99, P33, DOI 10.1016/S0065-2776(08)00602-0; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Muftuoglu M, 2008, HUM GENET, V124, P369, DOI 10.1007/s00439-008-0562-0; Oksenych V, 2009, EMBO J, V28, P2971, DOI 10.1038/emboj.2009.230; Oshima J, 2002, CANCER RES, V62, P547; Ozgenc A, 2006, GENOME DYN, V1, P206, DOI 10.1159/000092509; Perry JJP, 2006, NAT STRUCT MOL BIOL, V13, P414, DOI 10.1038/nsmb1088; Pichierri P, 2000, MUTAT RES-FUND MOL M, V456, P45, DOI 10.1016/S0027-5107(00)00109-3; Pike ACW, 2009, P NATL ACAD SCI USA, V106, P1039, DOI 10.1073/pnas.0806908106; Poot M, 2002, FASEB J, V16, P757, DOI 10.1096/fj.01-0906fje; Poot M, 1999, HUM GENET, V104, P10, DOI 10.1007/s004390050903; Popuri V, 2008, J BIOL CHEM, V283, P17766, DOI 10.1074/jbc.M709749200; Prince PR, 1999, HUM GENET, V105, P132, DOI 10.1007/s004390051075; Roberts SA, 2010, NATURE, V464, P1214, DOI 10.1038/nature08926; Rose A, 2004, CELL MOL LIFE SCI, V61, P1996, DOI 10.1007/s00018-004-4039-6; Ruis BL, 2008, MOL CELL BIOL, V28, P6182, DOI 10.1128/MCB.00355-08; SALK D, 1981, CYTOGENET CELL GENET, V30, P92, DOI 10.1159/000131596; Shen JC, 1998, J BIOL CHEM, V273, P34139, DOI 10.1074/jbc.273.51.34139; Sun JZ, 2005, J BIOMOL NMR, V32, P261, DOI 10.1007/s10858-005-7960-6; Tubbs JL, 2009, NATURE, V459, P808, DOI 10.1038/nature08076; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Williams ES, 2009, CANCER RES, V69, P2100, DOI 10.1158/0008-5472.CAN-08-2854; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Williams RS, 2009, CELL, V139, P87, DOI 10.1016/j.cell.2009.07.033; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Xu HQ, 2003, J BIOL CHEM, V278, P34925, DOI 10.1074/jbc.M303581200; Xue Y, 2002, BIOCHEMISTRY-US, V41, P2901, DOI 10.1021/bi0157161; Yannone SM, 2001, J BIOL CHEM, V276, P38242; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	65	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25699	25707		10.1074/jbc.M110.124941	http://dx.doi.org/10.1074/jbc.M110.124941			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20516064	hybrid, Green Published			2022-12-27	WOS:000280682400063
J	Armstrong, SP; Caunt, CJ; Fowkes, RC; Tsaneva-Atanasova, K; McArdle, CA				Armstrong, Stephen P.; Caunt, Christopher J.; Fowkes, Robert C.; Tsaneva-Atanasova, Krasimira; McArdle, Craig A.			Pulsatile and Sustained Gonadotropin-releasing Hormone (GnRH) Receptor Signaling DOES THE ERK SIGNALING PATHWAY DECODE GnRH PULSE FREQUENCY?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; DUAL-SPECIFICITY PHOSPHATASES; PERIFUSED L-BETA-T2 CELLS; SUBUNIT GENE-EXPRESSION; C-TERMINAL TAIL; DIFFERENTIAL REGULATION; SPATIOTEMPORAL REGULATION; IN-VIVO; RECOMBINANT ADENOVIRUS; DEPENDENT ACTIVATION	Gonadotropin-releasing hormone (GnRH) acts via G-protein-coupled receptors on gonadotrophs to stimulate synthesis and secretion of luteinizing hormone and follicle-stimulating hormone. It is secreted in pulses, and its effects depend on pulse frequency, but decoding mechanisms are unknown. Here we have used an extracellular signal regulated kinase-green fluorescent protein (ERK2-GFP) reporter to monitor GnRH signaling. GnRH caused dose-dependent ERK2-GFP translocation to the nucleus, providing a live-cell readout for activation. Pulsatile GnRH caused dose- and frequency-dependent ERK2-GFP translocation. These responses were rapid and transient, showed only digital tracking, and did not desensitize under any condition tested (dose, frequency, and receptor number varied). We also tested for the effects of cycloheximide (to prevent induction of nuclear-inducible MAPK phosphatases) and used GFP fusions containing ERK mutations (D319N, which prevents docking domain-dependent binding to MAPK phosphatases, and K52R, which prevents catalytic activity). These manipulations had little or no effect on the translocation responses, arguing against a role for MAPK phosphatases or ERK-mediated feedback in shaping ERK activation during pulsatile stimulation. GnRH also caused dose- and frequency-dependent activation of the alpha-gonadotropin subunit-, luteinizing hormone beta-, and follicle-stimulating hormone beta-luciferase reporters, and the latter response was inhibited by ERK1/2 knockdown. Moreover, GnRH caused frequency-dependent activation of an Egr1-luciferase reporter, but the response was proportional to cumulative pulse duration. Our data suggest that frequency decoding is not due to negative feedback shaping ERK signaling in this model.	[Armstrong, Stephen P.; McArdle, Craig A.] S Bristol Univ, Labs Integrat Neurosci & Endocrinol, Dept Clin Sci, Bristol BS1 3NY, Avon, England; [Caunt, Christopher J.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Fowkes, Robert C.] Royal Vet Coll, Endocrine Signaling Grp, London NW1 0TU, England; [Tsaneva-Atanasova, Krasimira] Univ Bristol, Bristol Ctr Appl Nonlinear Math, Dept Engn Math, Bristol BS8 1TR, Avon, England	University of Bristol; University of Bath; University of London; University of London Royal Veterinary College; University of Bristol	McArdle, CA (corresponding author), S Bristol Univ, Labs Integrat Neurosci & Endocrinol, Dept Clin Sci, Whitson St, Bristol BS1 3NY, Avon, England.	craig.mcardle@bristol.ac.uk	Fowkes, Robert/HHT-0664-2022; Tsaneva-Atanasova, Krasimira T/AAG-6766-2019; Fowkes, Robert/AAI-4756-2020; McArdle, Craig/AAQ-5660-2021	Tsaneva-Atanasova, Krasimira T/0000-0002-6294-7051; Fowkes, Robert/0000-0002-2222-2056; McArdle, Craig/0000-0003-4836-5351	Wellcome Trust [084588, 078407]; Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Wellcome Trust Grants 084588 and 078407 (to C. A. M.) and a Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom Doctoral Training Grant Award to the University of Bristol Laboratories for Integrative Neuroscience and Endocrinology.	Anderson RD, 2000, GENE THER, V7, P1034, DOI 10.1038/sj.gt.3301197; Armstrong SP, 2009, J BIOL CHEM, V284, P35746, DOI 10.1074/jbc.M109.063917; Armstrong SP, 2009, MOL ENDOCRINOL, V23, P510, DOI 10.1210/me.2008-0333; Bedecarrats GY, 2003, ENDOCRINOLOGY, V144, P1802, DOI 10.1210/en.2002-221140; BELCHETZ PE, 1978, SCIENCE, V202, P631, DOI 10.1126/science.100883; Berridge MJ, 2008, CELL SIGNALLING BIOL; Burger LL, 2008, BIOL REPROD, V79, P947, DOI 10.1095/biolreprod.108.070987; Burger LL, 2009, BIOL REPROD, V81, P1206, DOI 10.1095/biolreprod.109.079426; Burger LL, 2004, J MOL ENDOCRINOL, V33, P559, DOI 10.1677/jme.1.01600; Caunt CJ, 2008, J BIOL CHEM, V283, P26612, DOI 10.1074/jbc.M801500200; Caunt CJ, 2008, J BIOL CHEM, V283, P6241, DOI 10.1074/jbc.M706624200; Caunt CJ, 2006, TRENDS ENDOCRIN MET, V17, P276, DOI 10.1016/j.tem.2006.07.008; Caunt CJ, 2006, TRENDS ENDOCRIN MET, V17, P308, DOI 10.1016/j.tem.2006.08.001; Caunt CJ, 2006, J BIOL CHEM, V281, P2701, DOI 10.1074/jbc.M507242200; Ciccone NA, 2010, MOL CELL BIOL, V30, P1028, DOI 10.1128/MCB.00848-09; CONN PM, 1994, ANNU REV MED, V45, P391, DOI 10.1146/annurev.med.45.1.391; Cullen PJ, 2002, NAT REV MOL CELL BIO, V3, P339, DOI 10.1038/nrm808; DALKIN AC, 1989, ENDOCRINOLOGY, V125, P917, DOI 10.1210/endo-125-2-917; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Durham PL, 2000, MOL ENDOCRINOL, V14, P1570, DOI 10.1210/me.14.10.1570; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Ferris HA, 2006, BIOL REPROD, V74, P993, DOI 10.1095/biolreprod.105.049049; Finch AR, 2004, J CLIN ENDOCR METAB, V89, P1823, DOI 10.1210/jc.2003-030787; Haisenleder DJ, 1998, ENDOCRINOLOGY, V139, P3104, DOI 10.1210/en.139.7.3104; HAISENLEDER DJ, 1991, ENDOCRINOLOGY, V128, P509, DOI 10.1210/endo-128-1-509; Harding A, 2005, CURR BIOL, V15, P869, DOI 10.1016/j.cub.2005.04.020; Heding A, 2000, ENDOCRINOLOGY, V141, P299, DOI 10.1210/en.141.1.299; Hislop JN, 2005, J MOL ENDOCRINOL, V35, P177, DOI 10.1677/jme.1.01809; Hislop JN, 2000, ENDOCRINOLOGY, V141, P4564, DOI 10.1210/en.141.12.4564; Holdstock JG, 1996, MOL ENDOCRINOL, V10, P1308, DOI 10.1210/me.10.11.1308; KAISER UB, 1993, ENDOCRINOLOGY, V133, P931, DOI 10.1210/en.133.2.931; Kaiser UB, 1995, P NATL ACAD SCI USA, V92, P12280, DOI 10.1073/pnas.92.26.12280; Kanasaki H, 2005, ENDOCRINOLOGY, V146, P5503, DOI 10.1210/en.2004-1317; Krakauer DC, 2002, J THEOR BIOL, V218, P457, DOI 10.1006/jtbi.2002.3092; Kupzig S, 2005, P NATL ACAD SCI USA, V102, P7577, DOI 10.1073/pnas.0409611102; Lawson MA, 2007, MOL ENDOCRINOL, V21, P1175, DOI 10.1210/me.2006-0392; Lim S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007244; MacKeigan JP, 2005, MOL CELL BIOL, V25, P4676, DOI 10.1128/MCB.25.11.4676-4682.2005; Maru BS, 2009, BONE, V44, P102, DOI 10.1016/j.bone.2008.09.016; Millar RP, 2004, ENDOCR REV, V25, P235, DOI 10.1210/er.2003-0002; MITCHELL R, 1994, J ENDOCRINOL, V140, pR15, DOI 10.1677/joe.0.140R015; Morgan K, 2008, CANCER RES, V68, P6331, DOI 10.1158/0008-5472.CAN-08-0197; Naor Z, 2009, FRONT NEUROENDOCRIN, V30, P10, DOI 10.1016/j.yfrne.2008.07.001; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; ROBERSON MS, 1995, MOL CELL BIOL, V15, P3531; Ruf F, 2006, J BIOL CHEM, V281, P30967, DOI 10.1074/jbc.M606486200; Schally AV, 1999, PEPTIDES, V20, P1247, DOI 10.1016/S0196-9781(99)00130-8; SHUPNIK MA, 1990, MOL ENDOCRINOL, V4, P1444, DOI 10.1210/mend-4-10-1444; Sim Pauline, 1993, Biochemical Society Transactions, V21, p357S; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tsutsumi R, 2009, ENDOCR J, V56, P729, DOI 10.1507/endocrj.K09E-185; Washington Talitha M, 2004, Theor Biol Med Model, V1, P9, DOI 10.1186/1742-4682-1-9; WEISS J, 1990, MOL ENDOCRINOL, V4, P557, DOI 10.1210/mend-4-4-557; Whitehurst A, 2004, MOL CELL BIOL, V24, P10145, DOI 10.1128/MCB.24.23.10145-10150.2004; Willars GB, 1999, J BIOL CHEM, V274, P30146, DOI 10.1074/jbc.274.42.30146; YASIN M, 1995, ENDOCRINOLOGY, V136, P1559, DOI 10.1210/en.136.4.1559; Zhang T, 2006, J MOL ENDOCRINOL, V36, P41, DOI 10.1677/jme.1.01881; Zhang T, 2001, MOL CELL ENDOCRINOL, V172, P79, DOI 10.1016/S0303-7207(00)00378-6	59	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24360	24371		10.1074/jbc.M110.115964	http://dx.doi.org/10.1074/jbc.M110.115964			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20507982	Green Published, hybrid			2022-12-27	WOS:000280542100007
J	Lacruz, RS; Nanci, A; White, SN; Wen, X; Wang, HJ; Zalzal, SF; Luong, VQ; Schuetter, VL; Conti, PS; Kurtz, I; Paine, ML				Lacruz, Rodrigo S.; Nanci, Antonio; White, Shane N.; Wen, Xin; Wang, HongJun; Zalzal, Sylvia F.; Luong, Vivian Q.; Schuetter, Verna L.; Conti, Peter S.; Kurtz, Ira; Paine, Michael L.			The Sodium Bicarbonate Cotransporter (NBCe1) Is Essential for Normal Development of Mouse Dentition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENTINO-ENAMEL JUNCTION; RENAL TUBULAR-ACIDOSIS; EXPRESSION; LOCALIZATION; MECHANISMS; AE2; PH	Proximal renal tubular acidosis (pRTA) is a syndrome caused by abnormal proximal tubule reabsorption of bicarbonate resulting in metabolic acidosis. Patients with mutations to the SLC4A4 gene (coding for the sodium bicarbonate cotransporter NBCe1), have pRTA, growth delay, ocular defects, and enamel abnormalities. In an earlier report, we provided the first evidence that enamel cells, the ameloblasts, express NBCe1 in a polarized fashion, thereby contributing to trans-cellular bicarbonate transport. To determine whether NBCe1 plays a critical role in enamel development, we studied the expression of NBCe1 at various stages of enamel formation in wild-type mice and characterized the biophysical properties of enamel in NBCe1(-/-) animals. The enamel of NBCe1(-/-) animals was extremely hypomineralized and weak with an abnormal prismatic architecture. The expression profile of amelogenin, a known enamel-specific gene, was not altered in NBCe1(-/-) animals. Our results show for the first time that NBCe1 expression is required for the development of normal enamel. This study provides a mechanistic model to account for enamel abnormalities in certain patients with pRTA.	[Paine, Michael L.] Univ So Calif, Ctr Craniofacial Mol Biol, Sch Dent, Los Angeles, CA 90033 USA; [Nanci, Antonio; Zalzal, Sylvia F.] Univ Montreal, Fac Dent, Lab Study Calcified Tissues & Biomat, Montreal, PQ H3C 3J7, Canada; [White, Shane N.; Luong, Vivian Q.; Schuetter, Verna L.] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90095 USA; [Conti, Peter S.] Univ Calif Los Angeles, Dept Radiol, Mol Imaging Ctr, Keck Sch Med, Los Angeles, CA 90033 USA; [Kurtz, Ira] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of Southern California; Universite de Montreal; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Paine, ML (corresponding author), Univ So Calif, Ctr Craniofacial Mol Biol, Sch Dent, 2250 Alcazar St, Los Angeles, CA 90033 USA.	paine@usc.edu	Lacruz, Rodrigo/AGY-8090-2022	Nanci, Antonio/0000-0003-0616-843X; LACRUZ, RODRIGO/0000-0002-0776-6143	National Institutes of Health [DE013404, DE019629, DK058563, DK077162, S10RR019253]; Canadian Institutes of Health Research; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058563, R01DK077162] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DE013404 and DE019629 (to M. L. P.), DK058563 and DK077162 (to I. K.), and S10RR019253 (to P. S. C.). This work was also supported by the Canadian Institutes of Health Research (to A. N.).; We thank Malcolm L. Snead (University of Southern California) and Charles E. Smith (Universite de Montreal and McGill University) for valuable discussions on this topic and support of this project. We thank Dr. Gary E. Shull (Department of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati College of Medicine, Cincinnati, Ohio) for breeding pairs of the NBCe1<SUP>+/-</SUP> animals and Alicia Thompson from the Scanning Electron Microscope and Analysis Center at University of Southern California. We thank Ryan Park, Archana Tank, and Grant Dagliyan of University of Southern California Molecular Imaging Center for assistance in the collection of the micro-CT data.	ATKINSON ME, 1972, J PERIODONTAL RES, V7, P255, DOI 10.1111/j.1600-0765.1972.tb01112.x; Bevensee MO, 2000, AM J PHYSIOL-CELL PH, V278, pC1200, DOI 10.1152/ajpcell.2000.278.6.C1200; Brandes A, 2007, AM J PHYSIOL-REG I, V293, pR2400, DOI 10.1152/ajpregu.00208.2007; Bronckers A, 2010, BONE, V46, P1188, DOI 10.1016/j.bone.2009.12.002; Dinour D, 2004, J BIOL CHEM, V279, P52238, DOI 10.1074/jbc.M406591200; Elizabeth J, 2007, J ORAL PATHOL MED, V36, P625, DOI 10.1111/j.1600-0714.2007.00615.x; Gawenis LR, 2007, J BIOL CHEM, V282, P9042, DOI 10.1074/jbc.M607041200; Huang Z, 2008, J BONE MINER RES, V23, P1995, DOI 10.1359/JBMR.080705; Inatomi J, 2004, PFLUG ARCH EUR J PHY, V448, P438, DOI 10.1007/s00424-004-1278-1; KOPPANG HS, 1984, SCAND J DENT RES, V92, P489; Lacruz RS, 2010, BIOCHEM BIOPH RES CO, V393, P883, DOI 10.1016/j.bbrc.2010.02.116; Lacruz RS, 2010, CALCIFIED TISSUE INT, V86, P91, DOI 10.1007/s00223-009-9326-7; LIN HM, 1994, CALCIFIED TISSUE INT, V55, P38, DOI 10.1007/BF00310167; Lyaruu DM, 2008, MATRIX BIOL, V27, P119, DOI 10.1016/j.matbio.2007.09.006; NANCI A, 2008, 10 CATES ORAL HISTOL, P147; Paine ML, 2008, J DENT RES, V87, P391, DOI 10.1177/154405910808700415; Paine ML, 2001, MATRIX BIOL, V20, P273, DOI 10.1016/S0945-053X(01)00153-6; Pushkin A, 2006, AM J PHYSIOL-RENAL, V290, pF580, DOI 10.1152/ajprenal.00252.2005; SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; Smith CE, 2006, EUR J ORAL SCI, V114, P147, DOI 10.1111/j.1600-0722.2006.00273.x; Sui W, 2003, J DENT RES, V82, P388, DOI 10.1177/154405910308200512; Tatishchev S, 2003, BIOCHEMISTRY-US, V42, P755, DOI 10.1021/bi026826q; Toyosawa S, 1996, CELL TISSUE RES, V285, P217, DOI 10.1007/s004410050639; Wen X, 2008, ANAT REC, V291, P1246, DOI 10.1002/ar.20751; White SN, 2007, J BIOL CHEM, V282, P5340, DOI 10.1074/jbc.M604814200; White SN, 2005, J PROSTHET DENT, V94, P330, DOI 10.1016/j.prosdent.2005.08.013; White SN, 2000, J AM CERAM SOC, V83, P238, DOI 10.1111/j.1151-2916.2000.tb01181.x; White SN, 2001, J DENT RES, V80, P321, DOI 10.1177/00220345010800010501; WINSNES A, 1979, ACTA PAEDIATR SCAND, V68, P861	30	61	65	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24432	24438		10.1074/jbc.M110.115188	http://dx.doi.org/10.1074/jbc.M110.115188			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529845	Green Published, hybrid			2022-12-27	WOS:000280542100015
J	Tan, L; Varnai, P; Lamport, DTA; Yuan, CH; Xu, JF; Qiu, F; Kieliszewski, MJ				Tan, Li; Varnai, Peter; Lamport, Derek T. A.; Yuan, Chunhua; Xu, Jianfeng; Qiu, Feng; Kieliszewski, Marcia J.			Plant O-Hydroxyproline Arabinogalactans Are Composed of Repeating Trigalactosyl Subunits with Short Bifurcated Side Chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL; GLYCOSYLATION CODES; MOLECULAR-STRUCTURE; NICOTIANA-TABACUM; ACACIA-SENEGAL; PROTEINS; GLYCOPROTEIN; TOBACCO; GUM; POLYSACCHARIDE	Classical arabinogalactan proteins partially defined by type II O-Hyp-linked arabinogalactans (Hyp-AGs) are structural components of the plant extracellular matrix. Recently we described the structure of a small Hyp-AG putatively based on repetitive trigalactosyl subunits and suggested that AGs are less complex and varied than generally supposed. Here we describe three additional AGs with similar subunits. The Hyp-AGs were isolated from two different arabinogalactan protein fusion glycoproteins expressed in tobacco cells; that is, a 22-residue Hyp-AG and a 20-residue Hyp-AG, both isolated from interferon alpha 2b-(Ser-Hyp)(20), and a 14-residue Hyp-AG isolated from (Ala-Hyp)(51)-green fluorescent protein. We used NMR spectroscopy to establish the molecular structure of these Hyp-AGs, which share common features: (i) a galactan main chain composed of two 1 -> 3 beta-linked trigalactosyl blocks linked by a beta-1 -> 6 bond; (ii) bifurcated side chains with Ara, Rha, GlcUA, and a Gal 6-linked to Gal-1 and Gal-2 of the main-chain trigalactosyl repeats; (iii) a common side chain structure composed of up to six residues, the largest consisting of an alpha-L-Rhap-(1 -> 5)-alpha-L-Araf-(1 -> 3)-alpha-L-Araf-(1 -> 3- unit and an alpha-L-Rhap-(1 -> 4)-beta-D-GlcUAp-(1 -> 6)-unit, both linked to Gal. The conformational ensemble obtained by using nuclear Overhauser effect data in structure calculations revealed a galactan main chain with a reverse turn involving the beta-1 -> 6 link between the trigalactosyl blocks, yielding a moderately compact structure stabilized by H-bonds.	[Tan, Li; Xu, Jianfeng; Kieliszewski, Marcia J.] Ohio Univ, Biochem Res Facil, Dept Chem & Biochem, Athens, OH 45701 USA; [Varnai, Peter] Univ Sussex, Dept Chem & Biochem, Brighton BN1 9QG, E Sussex, England; [Lamport, Derek T. A.] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England; [Yuan, Chunhua] Ohio State Univ, Campus Chem Instrument Ctr, Columbus, OH 43210 USA; [Qiu, Feng] Temple Univ, Dept Chem, Philadelphia, PA 19122 USA	University System of Ohio; Ohio University; University of Sussex; University of Sussex; University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Kieliszewski, MJ (corresponding author), Ohio Univ, Biochem Res Facil, Dept Chem & Biochem, 350 W State St, Athens, OH 45701 USA.	kielisze@helios.phy.ohiou.edu	Varnai, Peter/A-6870-2012	Varnai, Peter/0000-0003-4267-4671	National Institutes of Health [2-P41-RR05351-06]; United States Department of Agriculture [2004-34490-14579]; Herman Frasch Foundation [526-HF02]; Ohio University [GC0013845]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture(United States Department of Agriculture (USDA)); Herman Frasch Foundation; Ohio University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant 2-P41-RR05351-06 (to the Complex Carbohydrate Research Center). This work was also funded by United States Department of Agriculture Grants 2004-34490-14579), Herman Frasch Foundation Grant 526-HF02, The Ohio University Biomimetic, Nanoscience, and Nanotechnology Program Grant GC0013845), and by the Ohio University Molecular and Cellular Biology Program.	[Anonymous], 2008, AMBER 10; BACIC A, 1987, CARBOHYD RES, V162, P85, DOI 10.1016/0008-6215(87)80203-3; Cannon MC, 2008, P NATL ACAD SCI USA, V105, P2226, DOI 10.1073/pnas.0711980105; Chaves I, 2002, PHYSIOL PLANTARUM, V116, P548, DOI 10.1034/j.1399-3054.2002.1160414.x; CHURMS SC, 1983, CARBOHYD RES, V123, P267, DOI 10.1016/0008-6215(83)88483-3; CHURMS SC, 1981, CARBOHYD RES, V94, P119, DOI 10.1016/S0008-6215(00)85603-7; CHURMS SC, 1984, CARBOHYD RES, V133, P105, DOI 10.1016/0008-6215(84)85187-3; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DEFAYE J, 1986, CARBOHYD RES, V150, P221, DOI 10.1016/0008-6215(86)80018-0; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FINCHER GB, 1983, ANNU REV PLANT PHYS, V34, P47, DOI 10.1146/annurev.pp.34.060183.000403; GANE AM, 1995, CARBOHYD RES, V277, P67, DOI 10.1016/0008-6215(95)00197-2; Gaspar Y, 2001, PLANT MOL BIOL, V47, P161, DOI 10.1023/A:1010683432529; Gens JS, 2000, PROTOPLASMA, V212, P115, DOI 10.1007/BF01279353; Guan Y, 2004, PLANT PHYSIOL, V135, P1346, DOI 10.1104/pp.104.039370; Hill JM, 2000, EUR J BIOCHEM, V267, P4649, DOI 10.1046/j.1432-1327.2000.01507.x; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KIELISZEWSKI M, 1992, PLANT PHYSIOL, V98, P919, DOI 10.1104/pp.98.3.919; KIELISZEWSKI MJ, 1994, PLANT J, V5, P157, DOI 10.1046/j.1365-313X.1994.05020157.x; Kieliszewski MJ, 2001, PHYTOCHEMISTRY, V57, P319, DOI 10.1016/S0031-9422(01)00029-2; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Lamport DTA, 2006, NEW PHYTOL, V169, P479, DOI 10.1111/j.1469-8137.2005.01591.x; LAMPORT DTA, 1967, NATURE, V216, P1322, DOI 10.1038/2161322a0; LAMPORT DTA, 1971, PLANT PHYSIOL, V48, P454, DOI 10.1104/pp.48.4.454; LAMPORT DTA, 1970, ANN REV PLANT PHYSIO, V21, P235, DOI 10.1146/annurev.pp.21.060170.001315; Lamport DTA, 1977, RECENT ADV PHYTOCHEM, V11, P79; O'Neill MA, 2004, ANNU REV PLANT BIOL, V55, P109, DOI 10.1146/annurev.arplant.55.031903.141750; POPE DG, 1977, PLANT PHYSIOL, V59, P894, DOI 10.1104/pp.59.5.894; Rees DA, 1977, POLYSACCHARIDE SHAPE, P1; Seifert GJ, 2007, ANNU REV PLANT BIOL, V58, P137, DOI 10.1146/annurev.arplant.58.032806.103801; SERPE MD, 1995, PLANT PHYSIOL, V109, P1007, DOI 10.1104/pp.109.3.1007; Serpe MD, 1999, ADV BOT RES, V30, P207; Shpak E, 1999, P NATL ACAD SCI USA, V96, P14736, DOI 10.1073/pnas.96.26.14736; Takahata K, 2004, PLANT CELL PHYSIOL, V45, P1658, DOI 10.1093/pcp/pch188; Tan L, 2003, PLANT PHYSIOL, V132, P1362, DOI 10.1104/pp.103.021766; Tan L, 2004, J BIOL CHEM, V279, P13156, DOI 10.1074/jbc.M311864200; TAN L, 2003, THESIS OHIO U; Xia JC, 2007, J CHEM THEORY COMPUT, V3, P1629, DOI 10.1021/ct700034q; Xu JF, 2005, BIOTECHNOL BIOENG, V90, P578, DOI 10.1002/bit.20441; Xu JF, 2008, PHYTOCHEMISTRY, V69, P1631, DOI 10.1016/j.phytochem.2008.02.006; Xu JF, 2007, BIOTECHNOL BIOENG, V97, P997, DOI 10.1002/bit.21407; Zhao ZD, 2002, PLANT J, V31, P431, DOI 10.1046/j.1365-313X.2002.01365.x	42	79	80	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24575	24583		10.1074/jbc.M109.100149	http://dx.doi.org/10.1074/jbc.M109.100149			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20489210	Green Published, hybrid			2022-12-27	WOS:000280542100029
J	Kovermann, P; Machtens, JP; Ewers, D; Fahlke, C				Kovermann, Peter; Machtens, Jan-Philipp; Ewers, David; Fahlke, Christoph			A Conserved Aspartate Determines Pore Properties of Anion Channels Associated with Excitatory Amino Acid Transporter 4 (EAAT4)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL GLUTAMATE TRANSPORTER; PYROCOCCUS-HORIKOSHII; CHLORIDE CHANNELS; CONDUCTANCE; SUBSTRATE; BINDING; EAAC1; MECHANISM; CURRENTS; HOMOLOG	Excitatory amino acid transporter (EAAT) glutamate transporters function not only as secondary active glutamate transporters but also as anion channels. Recently, a conserved aspartic acid (Asp(112)) within the intracellular loop near to the end of transmembrane domain 2 was proposed as a major determinant of substrate-dependent gating of the anion channel associated with the glial glutamate transporter EAAT1. We studied the corresponding mutation (D117A) in another EAAT isoform, EAAT4, using heterologous expression in mammalian cells, whole cell patch clamp, and noise analysis. In EAAT4, D117A modifies unitary conductances, relative anion permeabilities, as well as gating of associated anion channels. EAAT4 anion channel gating is characterized by two voltage-dependent gating processes with inverse voltage dependence. In wild type EAAT4, external L-glutamate modifies the voltage dependence as well as the minimum open probabilities of both gates, resulting in concentration-dependent changes of the number of open channels. Not only transport substrates but also anions affect wild type EAAT4 channel gating. External anions increase the open probability and slow down relaxation constants of one gating process that is activated by depolarization. D117A abolishes the anion and glutamate dependence of EAAT4 anion currents and shifts the voltage dependence of EAAT4 anion channel activation by more than 200 mV to more positive potentials. D117A is the first reported mutation that changes the unitary conductance of an EAAT anion channel. The finding that mutating a pore-forming residue modifies gating illustrates the close linkage between pore conformation and voltage-and substrate-dependent gating in EAAT4 anion channels.	[Kovermann, Peter; Machtens, Jan-Philipp; Ewers, David; Fahlke, Christoph] Hannover Med Sch, Inst Neurophysiol, D-30625 Hannover, Germany; [Kovermann, Peter; Machtens, Jan-Philipp; Ewers, David; Fahlke, Christoph] Zentrum Syst Neurowissensch, D-30559 Hannover, Germany	Hannover Medical School	Kovermann, P (corresponding author), Hannover Med Sch, Inst Neurophysiol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	kovermann.peter@mh-hannover.de	Ewers, David/AAG-8478-2021; Fahlke, Christoph/G-3635-2013; Kovermann, Peter/AAF-4411-2020; Machtens, Jan-Philipp/M-8659-2013	Ewers, David/0000-0003-1037-1027; Fahlke, Christoph/0000-0001-8602-9952; Machtens, Jan-Philipp/0000-0003-1673-8571; Kovermann, Peter/0000-0001-5296-4918	Deutsche Forschungsgemeinschaft [Fa301/9-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant Fa301/9-1 (to C.F.).	Amara SG, 2002, NEUROCHEM INT, V41, P313, DOI 10.1016/S0197-0186(02)00018-9; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bergles DE, 2002, J NEUROSCI, V22, P10153; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; BOUVIER M, 1992, NATURE, V360, P471, DOI 10.1038/360471a0; DeFelice L. J., 1981, INTRO MEMBRANE NOISE; Fahlke C, 1997, P NATL ACAD SCI USA, V94, P2729, DOI 10.1073/pnas.94.6.2729; Fahlke C, 1997, NATURE, V390, P529, DOI 10.1038/37391; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Fairman WA, 1999, AM J PHYSIOL-RENAL, V277, pF481, DOI 10.1152/ajprenal.1999.277.4.F481; Garcia-Olivares J, 2008, J PHYSIOL-LONDON, V586, P5325, DOI 10.1113/jphysiol.2008.158097; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; Grewer C, 2008, IUBMB LIFE, V60, P609, DOI 10.1002/iub.98; Huang SW, 2007, BIOCHEMISTRY-US, V46, P9685, DOI 10.1021/bi700647f; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; Melzer N, 2005, P NATL ACAD SCI USA, V102, P19214, DOI 10.1073/pnas.0508837103; Melzer N, 2003, J BIOL CHEM, V278, P50112, DOI 10.1074/jbc.M307990200; Mim C, 2005, J GEN PHYSIOL, V126, P571, DOI 10.1085/jgp.200509365; Raunser S, 2006, BIOCHEMISTRY-US, V45, P12796, DOI 10.1021/bi061008+; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Ryan RM, 2007, NAT STRUCT MOL BIOL, V14, P365, DOI 10.1038/nsmb1230; Ryan RM, 2004, J BIOL CHEM, V279, P20742, DOI 10.1074/jbc.M304433200; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Shachnai L, 2005, NEUROPHARMACOLOGY, V49, P862, DOI 10.1016/j.neuropharm.2005.07.005; SIGWORTH FJ, 1992, METHOD ENZYMOL, V207, P746; Tao Z, 2006, J BIOL CHEM, V281, P10263, DOI 10.1074/jbc.M510739200; Tao Z, 2007, J GEN PHYSIOL, V129, P331, DOI 10.1085/jgp.200609678; Torres-Salazar D, 2007, J BIOL CHEM, V282, P34719, DOI 10.1074/jbc.M704118200; Torres-Salazar D, 2006, J NEUROSCI, V26, P7513, DOI 10.1523/JNEUROSCI.4545-05.2006; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Watzke N, 2001, FEBS LETT, V503, P121, DOI 10.1016/S0014-5793(01)02715-6; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018	32	35	35	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23676	23686		10.1074/jbc.M110.126557	http://dx.doi.org/10.1074/jbc.M110.126557			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20519505	Green Published, hybrid			2022-12-27	WOS:000280291400018
J	Thomas, M; Felcht, M; Kruse, K; Kretschmer, S; Deppermann, C; Biesdorf, A; Rohr, K; Benest, AV; Fiedler, U; Augustin, HG				Thomas, Markus; Felcht, Moritz; Kruse, Karoline; Kretschmer, Stella; Deppermann, Carleen; Biesdorf, Andreas; Rohr, Karl; Benest, Andrew V.; Fiedler, Ulrike; Augustin, Hellmut G.			Angiopoietin-2 Stimulation of Endothelial Cells Induces alpha v beta 3 Integrin Internalization and Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; TYROSINE KINASE; RECEPTOR; TIE2; PHOSPHORYLATION; ANGIOGENESIS; ANTAGONIST; ACTIVATION; FAK; REQUIREMENT	The angiopoietins (Ang-1 and Ang-2) have been identified as agonistic and antagonistic ligands of the endothelial receptor tyrosine kinase Tie2, respectively. Both ligands have been demonstrated to induce translocation of Tie2 to cell-cell junctions. However, only Ang-1 induces Tie2-dependent Akt activation and subsequent survival signaling and endothelial quiescence. Ang-2 interferes negatively with Ang-1/Tie2 signaling, thereby antagonizing the Ang-1/Tie2 axis. Here, we show that both Ang-1 and Ang-2 recruit beta 3 integrins to Tie2. This co-localization is most prominent in cell-cell junctions. However, only Ang-2 stimulation resulted in complex formation among Tie2, alpha v beta 3 integrin, and focal adhesion kinase as evidenced by co-immunoprecipitation experiments. Focal adhesion kinase was phosphorylated in the FAT domain at Ser(910) upon Ang-2 stimulation and the adaptor proteins p130Cas and talin dissociated from alpha v beta 3 integrin. The alpha v beta 3 integrin was internalized, ubiquitinylated, and gated toward lysosomes. Taken together, the experiments define Tie2/alpha v beta 3 integrin association-induced integrin internalization and degradation as mechanistic consequences of endothelial Ang-2 stimulation.	[Benest, Andrew V.; Augustin, Hellmut G.] Heidelberg Univ, Res Div Vasc Biol, Med Fac Mannheim CBTM, D-69120 Heidelberg, Germany; [Benest, Andrew V.; Augustin, Hellmut G.] German Canc Res Ctr Heidelberg, DKFZ ZMBH Alliance, D-69120 Heidelberg, Germany; [Biesdorf, Andreas; Rohr, Karl] Heidelberg Univ, Dept Bioinformat & Funct Genom, BIOQUANT, IPMB, D-69120 Heidelberg, Germany; [Fiedler, Ulrike] ProQinase GmbH, D-79106 Freiburg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; ProQinase	Augustin, HG (corresponding author), Heidelberg Univ, Res Div Vasc Biol, Med Fac Mannheim CBTM, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	augustin@angiogenese.de	Augustin, Hellmut/AAA-5246-2020	Augustin, Hellmut/0000-0002-7173-4242; Benest, Andrew/0000-0002-8225-5159	German Research Council (DFG) [SFB-TR23]	German Research Council (DFG)(German Research Foundation (DFG))	This work was supported by grants from the German Research Council (DFG, SFB-TR23, Vascular Differentiation and Remodeling, Project A3).	Abedi H, 1997, J BIOL CHEM, V272, P15442, DOI 10.1074/jbc.272.24.15442; Alghisi GC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004449; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Avraham HK, 2003, J BIOL CHEM, V278, P36661, DOI 10.1074/jbc.M301253200; Bezuidenhout L, 2009, INFLAMMATION, V32, P393, DOI 10.1007/s10753-009-9148-9; Borges E, 2000, J BIOL CHEM, V275, P39867, DOI 10.1074/jbc.M007040200; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Carlson TR, 2001, J BIOL CHEM, V276, P26516, DOI 10.1074/jbc.M100282200; Cascone I, 2005, J CELL BIOL, V170, P993, DOI 10.1083/jcb.200507082; DRAKE CJ, 1995, J CELL SCI, V108, P2655; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Gao BC, 2000, J CELL SCI, V113, P247; Garmy-Susini Barbara, 2008, Lymphatic Research and Biology, V6, P155, DOI 10.1089/lrb.2008.1011; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Hamadi A, 2005, J CELL SCI, V118, P4415, DOI 10.1242/jcs.02565; Hashizume H, 2010, CANCER RES, V70, P2213, DOI 10.1158/0008-5472.CAN-09-1977; Helfrich I, 2009, CLIN CANCER RES, V15, P1384, DOI 10.1158/1078-0432.CCR-08-1615; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Hu B, 2006, CANCER RES, V66, P775, DOI 10.1158/0008-5472.CAN-05-1149; Hunger-Glaser I, 2004, J CELL PHYSIOL, V200, P213, DOI 10.1002/jcp.20018; Imanishi Y, 2007, CANCER RES, V67, P4254, DOI 10.1158/0008-5472.CAN-06-4100; Kumar CC, 1998, ONCOGENE, V17, P1365, DOI 10.1038/sj.onc.1202172; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Masson-Gadais B, 2003, CELL STRESS CHAPERON, V8, P37, DOI 10.1379/1466-1268(2003)8<37:IVRFVA>2.0.CO;2; Nasarre P, 2009, CANCER RES, V69, P1324, DOI 10.1158/0008-5472.CAN-08-3030; Penta K, 1999, J BIOL CHEM, V274, P11101, DOI 10.1074/jbc.274.16.11101; Reiss Y, 2007, CIRC RES, V101, P88, DOI 10.1161/CIRCRESAHA.106.143594; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Scharpfenecker M, 2005, J CELL SCI, V118, P771, DOI 10.1242/jcs.01653; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Serini G, 2008, CARDIOVASC RES, V78, P213, DOI 10.1093/cvr/cvn045; Sheu JR, 1997, BBA-GEN SUBJECTS, V1336, P445, DOI 10.1016/S0304-4165(97)00057-3; Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882; Storgard CM, 1999, J CLIN INVEST, V103, P47, DOI 10.1172/JCI3756; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Thomas M, 2009, ANGIOGENESIS, V12, P125, DOI 10.1007/s10456-009-9147-3; Wu MH, 2005, J PHYSIOL-LONDON, V569, P359, DOI 10.1113/jphysiol.2005.096537	43	71	71	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23842	23849		10.1074/jbc.M109.097543	http://dx.doi.org/10.1074/jbc.M109.097543			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20519501	hybrid, Green Published			2022-12-27	WOS:000280291400034
J	Thompson, JE; Pourhossein, M; Waterhouse, A; Hudson, T; Goldrick, M; Derrick, JP; Roberts, IS				Thompson, James E.; Pourhossein, Meraj; Waterhouse, Amy; Hudson, Thomas; Goldrick, Marie; Derrick, Jeremy P.; Roberts, Ian S.			The K5 Lyase KflA Combines a Viral Tail Spike Structure with a Bacterial Polysaccharide Lyase Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN AC LYASE; PARALLEL BETA-HELIX; GLYCOSAMINOGLYCAN-DEGRADING ENZYMES; PNEUMONIAE HYALURONATE LYASE; P22 TAILSPIKE PROTEIN; ESCHERICHIA-COLI K5; CRYSTAL-STRUCTURE; ACTIVE-SITE; FLAVOBACTERIUM-HEPARINUM; ENZYMATIC DEGRADATION	K5 lyase A (KflA) is a tail spike protein (TSP) encoded by a K5A coliphage, which cleaves K5 capsular polysaccharide, a glycosaminoglycan with the repeat unit [-4)-beta GlcA-(1,4)-alpha GlcNAc(1-], displayed on the surface of Escherichia coli K5 strains. The crystal structure of KflA reveals a trimeric arrangement, with each monomer containing a right-handed, single-stranded parallel beta-helix domain. Stable trimer formation by the intertwining of strands in the C-terminal domain, followed by proteolytic maturation, is likely to be catalyzed by an autochaperone as described for K1F endosialidase. The structure of KflA represents the first bacteriophage tail spike protein combining polysaccharide lyase activity with a single-stranded parallel beta-helix fold. We propose a catalytic site and mechanism representing convergence with the syn-beta-elimination site of heparinase II from Pedobacter heparinus.	[Derrick, Jeremy P.; Roberts, Ian S.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Pourhossein, Meraj] Isfahan Univ Med Sci, Dept Genet & Mol Biol, Sch Med, Motahhari 8174673441, Yasuj, Iran	University of Manchester; Isfahan University Medical Science	Roberts, IS (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg, Manchester M13 9PT, Lancs, England.	i.s.roberts@manchester.ac.uk	Pourhossein, Meraj/W-3666-2017	pourhossein, meraj/0000-0002-9627-8589; Derrick, Jeremy/0000-0002-4350-5354	Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom; Biotechnology and Biological Sciences Research Council [BBS/B/09627] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anandakrishnan R, 2008, J COMPUT BIOL, V15, P165, DOI 10.1089/cmb.2007.0144; Barbirz S, 2008, MOL MICROBIOL, V69, P303, DOI 10.1111/j.1365-2958.2008.06311.x; Blundell CD, 2009, J MOL MICROB BIOTECH, V17, P71, DOI 10.1159/000215933; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CARDIN AD, 1991, METHOD ENZYMOL, V203, P556; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P12067, DOI 10.1073/pnas.182431199; Clarke BR, 2000, J BACTERIOL, V182, P3761, DOI 10.1128/JB.182.13.3761-3766.2000; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fethiere J, 1999, J MOL BIOL, V288, P635, DOI 10.1006/jmbi.1999.2698; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; GUPTA DS, 1983, FEMS MICROBIOL LETT, V16, P13; Han YH, 2009, J BIOL CHEM, V284, P34019, DOI 10.1074/jbc.M109.025338; Hanfling P, 1996, J BACTERIOL, V178, P4747; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Huang WJ, 2003, J MOL BIOL, V328, P623, DOI 10.1016/S0022-2836(03)00345-0; Huang WJ, 1999, J MOL BIOL, V294, P1257, DOI 10.1006/jmbi.1999.3292; Huang WJ, 2001, BIOCHEMISTRY-US, V40, P2359, DOI 10.1021/bi0024254; Jenkins J, 1998, J STRUCT BIOL, V122, P236, DOI 10.1006/jsbi.1998.3985; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; Kreisberg JF, 2002, PROTEIN SCI, V11, P820, DOI 10.1110/ps.3440102; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Legoux R, 1996, J BACTERIOL, V178, P7260, DOI 10.1128/jb.178.24.7260-7264.1996; Leiman PG, 2007, J MOL BIOL, V371, P836, DOI 10.1016/j.jmb.2007.05.083; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Li SL, 2000, EMBO J, V19, P1228, DOI 10.1093/emboj/19.6.1228; Li SL, 2001, J BIOL CHEM, V276, P41407, DOI 10.1074/jbc.M106634200; Lunin VV, 2004, J MOL BIOL, V337, P367, DOI 10.1016/j.jmb.2003.12.071; Mayans O, 1997, STRUCTURE, V5, P677, DOI 10.1016/S0969-2126(97)00222-0; Michel G, 2004, J BIOL CHEM, V279, P32882, DOI 10.1074/jbc.M403421200; MOXON ER, 1990, CURR TOP MICROBIOL, V150, P65; Muhlenhoff M, 2003, J BIOL CHEM, V278, P12634, DOI 10.1074/jbc.M212048200; Muller JJ, 2008, STRUCTURE, V16, P766, DOI 10.1016/j.str.2008.01.019; Murphy KJ, 2004, J BIOL CHEM, V279, P27239, DOI 10.1074/jbc.M401774200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NIMMICH W, 1994, J CLIN MICROBIOL, V32, P2843, DOI 10.1128/JCM.32.11.2843-2845.1994; NIMMICH W, 1991, FEMS MICROBIOL LETT, V82, P137, DOI 10.1016/0378-1097(91)90322-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pojasek K, 2000, BIOCHEMISTRY-US, V39, P4012, DOI 10.1021/bi992514k; Pritchard DG, 2000, PROTEINS, V40, P126; Rek A, 2007, BBA-PROTEINS PROTEOM, V1774, P72, DOI 10.1016/j.bbapap.2006.10.017; Rigden DJ, 2003, J BIOL CHEM, V278, P50596, DOI 10.1074/jbc.M307596200; Rossmann MG, 2004, CURR OPIN STRUC BIOL, V14, P171, DOI 10.1016/j.sbi.2004.02.001; Scavetta RD, 1999, PLANT CELL, V11, P1081, DOI 10.1105/tpc.11.6.1081; Scholl D, 2001, J VIROL, V75, P2509, DOI 10.1128/JVI.75.6.2509-2515.2001; Schulz EC, 2010, NAT STRUCT MOL BIOL, V17, P210, DOI 10.1038/nsmb.1746; Schwarzer D, 2007, J BIOL CHEM, V282, P2821, DOI 10.1074/jbc.M609543200; Shaya D, 2008, GLYCOBIOLOGY, V18, P270, DOI 10.1093/glycob/cwn002; Shaya D, 2006, J BIOL CHEM, V281, P15525, DOI 10.1074/jbc.M512055200; Smith NL, 2005, P NATL ACAD SCI USA, V102, P17652, DOI 10.1073/pnas.0504782102; STEINBACHER S, 1994, SCIENCE, V265, P383, DOI 10.1126/science.8023158; Steinbacher S, 1997, J MOL BIOL, V267, P865, DOI 10.1006/jmbi.1997.0922; Stummeyer K, 2005, NAT STRUCT MOL BIOL, V12, P90, DOI 10.1038/nsmb874; Su HS, 1996, APPL ENVIRON MICROB, V62, P2723, DOI 10.1128/AEM.62.8.2723-2734.1996; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; van Raaij MJ, 2001, J MOL BIOL, V314, P1137, DOI 10.1006/jmbi.2000.5204; VANN WF, 1981, EUR J BIOCHEM, V116, P359, DOI 10.1111/j.1432-1033.1981.tb05343.x; Vitali J, 1998, PLANT PHYSIOL, V116, P69, DOI 10.1104/pp.116.1.69; Warwicker J, 2004, PROTEIN SCI, V13, P2793, DOI 10.1110/ps.04785604; YODER MD, 1995, FASEB J, V9, P335, DOI 10.1096/fasebj.9.5.7896002; YODER MD, 1993, STRUCTURE, V1, P241, DOI 10.1016/0969-2126(93)90013-7	66	38	42	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23963	23969		10.1074/jbc.M110.127571	http://dx.doi.org/10.1074/jbc.M110.127571			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20519506	hybrid, Green Published			2022-12-27	WOS:000280291400047
J	Torii, T; Miyamoto, Y; Sanbe, A; Nishimura, K; Yamauchi, J; Tanoue, A				Torii, Tomohiro; Miyamoto, Yuki; Sanbe, Atsushi; Nishimura, Kohji; Yamauchi, Junji; Tanoue, Akito			Cytohesin-2/ARNO, through Its Interaction with Focal Adhesion Adaptor Protein Paxillin, Regulates Preadipocyte Migration via the Downstream Activation of Arf6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTORS; DOMAIN-CONTAINING PROTEIN; GTP-BINDING PROTEINS; ACTIN CYTOSKELETON; NEURITE OUTGROWTH; VALPROIC ACID; ADIPOCYTE DIFFERENTIATION; INSULIN-RESISTANCE; PLASMA-MEMBRANE; CELL-MIGRATION	The formation of primitive adipose tissue is the initial process in adipose tissue development followed by the migration of preadipocytes into adipocyte clusters. Comparatively little is known about the molecular mechanism controlling preadipocyte migration. Here, we show that cytohesin-2, the guanine-nucleotide exchange factor for the Arf family GTP-binding proteins, regulates migration of mouse preadipocyte 3T3-L1 cells through Arf6. SecinH3, a specific inhibitor of the cytohesin family, markedly inhibits migration of 3T3-L1 cells. 3T3-L1 cells express cytohesin-2 and cytohesin-3, and knockdown of cytohesin-2 with its small interfering RNA effectively decreases cell migration. Cytohesin-2 preferentially acts upstream of Arf6 in this signaling pathway. Furthermore, we find that the focal adhesion protein paxillin forms a complex with cytohesin-2. Paxillin colocalizes with cytohesin-2 at the leading edges of migrating cells. This interaction is mediated by the LIM2 domain of paxillin and the isolated polybasic region of cytohesin-2. Importantly, migration is inhibited by expression of the constructs containing these regions. These results suggest that cytohesin-2, through a previously unexplored complex formation with paxillin, regulates preadipocyte migration and that paxillin plays a previously unknown role as a scaffold protein of Arf guanine-nucleotide exchange factor.	[Torii, Tomohiro; Miyamoto, Yuki; Sanbe, Atsushi; Yamauchi, Junji; Tanoue, Akito] Natl Res Inst Child Hlth & Dev, Dept Pharmacol, Setagaya Ku, Tokyo 1578535, Japan; [Yamauchi, Junji] Tokyo Inst Technol, Dept Biol Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Tanoue, Akito] Japan Hlth Sci Fdn, Chuo Ku, Tokyo 1030001, Japan; [Nishimura, Kohji] Shimane Univ, Dept Mol & Funct Genom, Matsue, Shimane 6908504, Japan	National Center for Child Health & Development - Japan; Tokyo Institute of Technology; Shimane University	Yamauchi, J (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Pharmacol, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	jyamauchi@nch.go.jp		Torii, Tomohiro/0000-0002-0039-923X	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare; Japan Health Science Foundation; Ministry of Human Health and Welfare; Human Health Sciences Foundation; Naito Foundation; Suzuken Foundation; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Health Science Foundation; Ministry of Human Health and Welfare; Human Health Sciences Foundation; Naito Foundation(Naito Memorial Foundation); Suzuken Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to J. Y.) and from the Ministry of Health, Labor, and Welfare, by the Japan Health Science Foundation and the Ministry of Human Health and Welfare (to Y. M., J. Y., and A. T.) and by research grants from the Human Health Sciences Foundation (to J. Y.), the Naito Foundation (to J. Y.), the Suzuken Foundation (to J. Y.), and the Takeda Science Foundation (to J. Y.).	Boehm T, 2003, EMBO J, V22, P1014, DOI 10.1093/emboj/cdg101; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Bryan BA, 2005, MOL CELL BIOL, V25, P11089, DOI 10.1128/MCB.25.24.11089-11101.2005; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; DiNitto JP, 2007, MOL CELL, V28, P569, DOI 10.1016/j.molcel.2007.09.017; Donaldson JG, 2005, BIOCHEM SOC T, V33, P639, DOI 10.1042/BST0330639; Franco M, 1999, EMBO J, V18, P1480, DOI 10.1093/emboj/18.6.1480; Frank SR, 2006, EMBO J, V25, P1848, DOI 10.1038/sj.emboj.7601092; Fuss B, 2006, NATURE, V444, P945, DOI 10.1038/nature05412; Galvez BG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004444; Goda N, 2000, BBA-GENE STRUCT EXPR, V1493, P195, DOI 10.1016/S0167-4781(00)00160-3; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Hofmann I, 2007, CURR BIOL, V17, P711, DOI 10.1016/j.cub.2007.03.007; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; KAHN RA, 1991, J BIOL CHEM, V266, P2606; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Kitano J, 2002, J NEUROSCI, V22, P1280, DOI 10.1523/JNEUROSCI.22-04-01280.2002; Klarlund JK, 2001, J BIOL CHEM, V276, P40065, DOI 10.1074/jbc.M105260200; Koga H, 2004, DNA RES, V11, P293, DOI 10.1093/dnares/11.4.293; Kondo A, 2000, MOL BIOL CELL, V11, P1315, DOI 10.1091/mbc.11.4.1315; LaLonde DP, 2006, CURR BIOL, V16, P1375, DOI 10.1016/j.cub.2006.05.057; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Li CC, 2007, MOL BIOL CELL, V18, P4420, DOI 10.1091/mbc.E07-02-0149; Liu J, 2005, CELL METAB, V2, P165, DOI 10.1016/j.cmet.2005.08.006; Luton F, 2004, MOL BIOL CELL, V15, P1134, DOI 10.1091/mbc.E03-10-0751; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Mansour M, 2002, J BIOL CHEM, V277, P32302, DOI 10.1074/jbc.M202898200; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Miyamoto Y, 2007, J CELL SCI, V120, P4355, DOI 10.1242/jcs.018218; Montagnac G, 2009, CURR BIOL, V19, P184, DOI 10.1016/j.cub.2008.12.043; Murphy JA, 2006, BRAIN RES, V1120, P35, DOI 10.1016/j.brainres.2006.08.096; Nagel WG, 1998, MOL BIOL CELL, V9, P1981, DOI 10.1091/mbc.9.8.1981; Nevrivy DJ, 2000, J BIOL CHEM, V275, P16827, DOI 10.1074/jbc.275.22.16827; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Sheen VL, 2004, NAT GENET, V36, P69, DOI 10.1038/ng1276; Shen X, 2007, P NATL ACAD SCI USA, V104, P1230, DOI 10.1073/pnas.0610535104; Tan I, 2008, CELL, V135, P123, DOI 10.1016/j.cell.2008.09.018; Tang PT, 2002, P NATL ACAD SCI USA, V99, P2625, DOI 10.1073/pnas.052712999; Tsubouchi A, 2002, J CELL BIOL, V159, P673, DOI 10.1083/jcb.200202117; Venkateswarlu K, 2003, J BIOL CHEM, V278, P43460, DOI 10.1074/jbc.M304078200; WASSERMANN F, 1965, HDB PHYSL 5, P87; Yamauchi J, 2008, EXP CELL RES, V314, P2279, DOI 10.1016/j.yexcr.2008.03.019; Yamauchi J, 2008, J CELL BIOL, V181, P351, DOI 10.1083/jcb.200709033; Yamauchi J, 2007, EXP CELL RES, V313, P1886, DOI 10.1016/j.yexcr.2007.02.019; Yamauchi J, 2006, EXP CELL RES, V312, P2954, DOI 10.1016/j.yexcr.2006.05.016; Yamauchi J, 2009, EXP CELL RES, V315, P2043, DOI 10.1016/j.yexcr.2009.03.012; Yano H, 2008, MOL BIOL CELL, V19, P822, DOI 10.1091/mbc.E07-08-0763; Zhang ZWM, 2008, J BIOL CHEM, V283, P18685, DOI 10.1074/jbc.M801274200	57	48	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24270	24281		10.1074/jbc.M110.125658	http://dx.doi.org/10.1074/jbc.M110.125658			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20525696	Green Published, hybrid			2022-12-27	WOS:000280291400076
J	Belouzard, S; Madu, I; Whittaker, GR				Belouzard, Sandrine; Madu, Ikenna; Whittaker, Gary R.			Elastase-mediated Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein at Discrete Sites within the S2 Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARS CORONAVIRUS; CATHEPSIN-L; FUSION PEPTIDE; VIRUS ENTRY; CLEAVAGE; PROTEASES; HEMAGGLUTININ; GLYCOPROTEIN; CELLS	Proteolytic priming is a common method of controlling the activation of membrane fusion mediated by viral glycoproteins. The severe acute respiratory syndrome coronavirus spike protein (SARS-CoV S) can be primed by a variety of host cell proteases, with proteolytic cleavage occurring both as the S1/S2 boundary and adjacent to a fusion peptide in the S2 domain. Here, we studied the priming of SARS-CoV S by elastase and show an important role for residue Thr(795) in the S2 domain. A series of alanine mutants were generated in the vicinity of the S2 cleavage site, with the goal of examining elastase-mediated cleavage within S2. Both proteolytic cleavage and fusion activation were modulated by altering the cleavage site position. We propose a novel mechanism whereby SARS-CoV fusion protein function can be controlled by spatial regulation of the proteolytic priming site, with important implications for viral pathogenesis.	[Belouzard, Sandrine; Madu, Ikenna; Whittaker, Gary R.] Cornell Univ, Dept Microbiol & Immunol, Ithaca, NY 14853 USA	Cornell University	Whittaker, GR (corresponding author), Cornell Univ, Dept Microbiol & Immunol, C4127 VMC, Ithaca, NY 14853 USA.	grw7@cornell.edu	Belouzard, Sandrine/O-8527-2016; Belouzard, Sandrine/AAX-1584-2021	Belouzard, Sandrine/0000-0002-9972-4054; Belouzard, Sandrine/0000-0002-9972-4054	NIAID [R21 AI1076258]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI107258] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM082084] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R21 AI1076258 from NIAID.	Ami Y, 2008, MICROBIOL IMMUNOL, V52, P118, DOI 10.1111/j.1348-0421.2008.00011.x; Belouzard S, 2009, P NATL ACAD SCI USA, V106, P5871, DOI 10.1073/pnas.0809524106; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Bosch BJ, 2008, J VIROL, V82, P8887, DOI 10.1128/JVI.00415-08; Bosch BJ, 2008, NIDOVIRUSES, P157; Callan RJ, 1997, J VIROL, V71, P7579, DOI 10.1128/JVI.71.10.7579-7585.1997; Du LY, 2007, BIOCHEM BIOPH RES CO, V359, P174, DOI 10.1016/j.bbrc.2007.05.092; Huang IC, 2006, J BIOL CHEM, V281, P3198, DOI 10.1074/jbc.M508381200; Kam YW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007870; KLENK HD, 1994, COLD SPRING HARBOR M, P241; Li F, 2006, J VIROL, V80, P6794, DOI 10.1128/JVI.02744-05; Madu IG, 2009, VIROLOGY, V393, P265, DOI 10.1016/j.virol.2009.07.038; Madu IG, 2009, J VIROL, V83, P7411, DOI 10.1128/JVI.00079-09; Matsuyama S, 2005, P NATL ACAD SCI USA, V102, P12543, DOI 10.1073/pnas.0503203102; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Simmons G, 2004, P NATL ACAD SCI USA, V101, P4240, DOI 10.1073/pnas.0306446101; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Woessner JF, 2004, HDB PROTEOLYTIC ENZY	19	59	62	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22756	22761		10.1074/jbc.M110.103275	http://dx.doi.org/10.1074/jbc.M110.103275			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20507992	Green Published, hybrid			2022-12-27	WOS:000279999900007
J	Long, JY; Wang, Y; Wang, WJ; Chang, BHJ; Danesh, FR				Long, Jianyin; Wang, Yin; Wang, Wenjian; Chang, Benny H. J.; Danesh, Farhad R.			Identification of MicroRNA-93 as a Novel Regulator of Vascular Endothelial Growth Factor in Hyperglycemic Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; HIGH GLUCOSE; DIABETIC-NEPHROPATHY; KIDNEY GLOMERULI; MOUSE PODOCYTES; CELL-LINES; VEGF; MICE; REPRESSION; INHIBITION	Vascular endothelial growth factor (VEGF) is a dimeric glycoprotein that plays a crucial role in microvascular complications of diabetes, including diabetic nephropathy. However, the precise regulatory mechanisms governing VEGF expression in the diabetic milieu are still poorly understood. Here, we provide evidence that microRNA-93 (miR-93) regulates VEGF expression in experimental models of diabetes both in vitro and in vivo. Comparative microRNA expression profile arrays identified miR-93 as a signature microRNA in hyperglycemic conditions. We identified VEGF-A as a putative target of miR-93 in the kidney with a perfect complementarity between miR-93 and the 3'-untranslated region of vegfa in several species. When cotransfected with a luciferase reporter construct containing the mouse vegfa 3'-untranslated region, expression of miR-93 markedly decreased the luciferase activity. We showed that forced expression of miR-93 in cells abrogated VEGF protein secretion. Conversely, anti-miR-93 inhibitors increased VEGF release. Transfection of miR-93 also prevented the effect of high glucose on VEGF downstream targets. Using transgenic mice containing VEGF-LacZ bicistronic transcripts, we found that inhibition of glomerular miR-93 by peptide-conjugated morpholino oligomers elicited increased expression of VEGF. Our findings also indicate that high glucose decreases miR-93 expression by down-regulating the promoter of the host MCM7 gene. Taken together, our findings provide new insights into the role of miR-93 in VEGF signaling pathway and offer a potentially novel target in preventing the progression of diabetic nephropathy.	[Long, Jianyin; Wang, Yin; Wang, Wenjian; Danesh, Farhad R.] Baylor Coll Med, Dept Med, Div Nephrol, Houston, TX 77030 USA; [Chang, Benny H. J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Danesh, Farhad R.] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Danesh, FR (corresponding author), Baylor Coll Med, Dept Med, Div Nephrol, 1 Baylor Plaza, Houston, TX 77030 USA.	danesh@bcm.edu	Long, Jianyin/H-8261-2013	Danesh, Farhad/0000-0001-6849-5239	National Institutes of Health through the NIDDK [R01DK067604, R01DK078900]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078900, R01DK091310, R01DK067604] Funding Source: NIH RePORTER	National Institutes of Health through the NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK067604 and R01DK078900 through the NIDDK.	AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Asaumi S, 2003, J DIABETES COMPLICAT, V17, P34, DOI 10.1016/S1056-8727(02)00189-7; Asli NS, 2008, CURR MOL MED, V8, P698, DOI 10.2174/156652408786733739; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Carson JP, 2005, J MICROSC-OXFORD, V217, P275, DOI 10.1111/j.1365-2818.2005.01450.x; Chen S, 2004, DIABETES, V53, P2939, DOI 10.2337/diabetes.53.11.2939; Chen S, 2008, CURR DIABETES REP, V8, P470, DOI 10.1007/s11892-008-0081-3; De Vriese A, 2001, J AM SOC NEPHROL, V12, P993, DOI 10.1681/ASN.V125993; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Du M, 2006, FEBS J, V273, P732, DOI 10.1111/j.1742-4658.2006.05106.x; Enciso JM, 2003, J CELL BIOL, V160, P605, DOI 10.1083/jcb.200209014; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Eremina V, 2007, NEPHRON PHYSIOL, V106, P32, DOI 10.1159/000101798; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Flyvbjerg A, 2002, DIABETES, V51, P3090, DOI 10.2337/diabetes.51.10.3090; Forsburg SL, 2008, BIOCHEM SOC T, V36, P114, DOI 10.1042/BST0360114; Giuliani S, 2008, J UROLOGY, V179, P365, DOI 10.1016/j.juro.2007.08.092; Hoshi S, 2002, BIOCHEM BIOPH RES CO, V290, P177, DOI 10.1006/bbrc.2001.6138; Iglesias-de la Cruz MC, 2002, KIDNEY INT, V62, P901, DOI 10.1046/j.1523-1755.2002.00528.x; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Langley RR, 2003, CANCER RES, V63, P2971; Li FX, 2003, P NATL ACAD SCI USA, V100, P12935, DOI 10.1073/pnas.2231861100; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long JY, 2003, P NATL ACAD SCI USA, V100, P9791, DOI 10.1073/pnas.1733973100; Loureiro RMB, 2005, CYTOKINE GROWTH F R, V16, P77, DOI 10.1016/j.cytogfr.2005.01.005; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Miquerol L, 1999, DEV BIOL, V212, P307, DOI 10.1006/dbio.1999.9355; Monteys AM, 2010, RNA, V16, P495, DOI 10.1261/rna.1731910; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Natarajan R, 1997, AM J PHYSIOL-HEART C, V273, pH2224, DOI 10.1152/ajpheart.1997.273.5.H2224; Nikopoulos GN, 2008, BIOTECHNIQUES, V44, P547, DOI 10.2144/000112725; Olena AF, 2010, J CELL PHYSIOL, V222, P540, DOI 10.1002/jcp.21993; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Suarez Y, 2007, CIRC RES, V100, P1164, DOI 10.1161/01.RES.0000265065.26744.17; Sugimoto H, 2003, J BIOL CHEM, V278, P12605, DOI 10.1074/jbc.C300012200; Suzuki S, 1998, GENE, V216, P85, DOI 10.1016/S0378-1119(98)00323-0; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Varallyay E, 2008, NAT PROTOC, V3, P190, DOI 10.1038/nprot.2007.528; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; WANG J, 2010, GENESIS IN PRESS; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Yao D, 2007, J BIOL CHEM, V282, P31038, DOI 10.1074/jbc.M704703200; Yeung ML, 2008, CANCER RES, V68, P8976, DOI 10.1158/0008-5472.CAN-08-0769; Zeng LX, 2005, FASEB J, V19, P1845, DOI 10.1096/fj.05-4240fje	49	219	239	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23455	23463		10.1074/jbc.M110.136168	http://dx.doi.org/10.1074/jbc.M110.136168			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20501654	Green Published, hybrid			2022-12-27	WOS:000279999900077
J	Twarock, S; Tammi, MI; Savani, RC; Fischer, JW				Twarock, Soeren; Tammi, Markku I.; Savani, Rashmin C.; Fischer, Jens W.			Hyaluronan Stabilizes Focal Adhesions, Filopodia, and the Proliferative Phenotype in Esophageal Squamous Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; RECEPTOR RHAMM; CANCER-CELLS; OVEREXPRESSION; COLON; CD44; TRANSFORMATION; PROMOTES; MOTILITY; SURFACE	Hyaluronan (HA) is a polysaccharide component in the parenchyma and stroma of human esophageal squamous cell carcinoma (ESCC). Clinically, esophageal cancer represents a highly aggressive tumor type with poor prognosis resulting in a 5-year survival rate of 5%. The aim of the present study was the detailed analysis of the role of HA synthesis for ESCC phenotype in vitro using the ESCC cell line OSC1. In OSC1 cells, pericellular HA-matrix surrounding extended actin-dependent filopodia was detected. The small molecule inhibitor of HA synthesis, 4-methylumbelliferone (4-MU, 0.3 mM) caused loss of these filopodia and focal adhesions and inhibited proliferation and migration. In search of the underlying mechanism cleavage of focal adhesion kinase (FAK) was detected by immunoblotting. In addition, displacing HA by an HA-binding peptide (Pep-1, 500 mu g/ml) and digestion of pericellular HA by hyaluronidase resulted in cleavage of focal adhesions. Furthermore, real-time reverse transcription PCR revealed that HA synthase 3 (HAS3) > HAS2 are the predominant HA-synthases in OSC1. Lentiviral transduction with shHAS3, and to a lesser extent with shHAS2, reduced intact FAK protein and filopodia as well as proliferation and migration. Furthermore, down-regulation by lentiviral shRNA of RHAMM (receptor of HA-mediated motility) but not CD44 induced loss of filopodia and caused FAK cleavage. In contrast, knockdown of both HA receptors inhibited proliferation and migration of OSC1. In conclusion, HA synthesis and, in turn, RHAMM and CD44 signaling promoted an activated phenotype of OSC1. Because RHAMM appears to support both filopodia, FAK, and the proliferative and migratory phenotype, it may be promising to explore RHAMM as a potential therapeutic target in esophageal cancer.	[Twarock, Soeren; Fischer, Jens W.] Univ Duisburg Essen, Univ Klinikum Essen, Inst Pharmakol, D-45147 Essen, Germany; [Tammi, Markku I.] Univ Eastern Finland, Inst Biomed, FIN-70211 Kuopio, Finland; [Savani, Rashmin C.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Div Pulm & Vasc Biol, Dallas, TX 75390 USA; [Savani, Rashmin C.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Div Neonatal Perinatal Med, Dallas, TX 75390 USA	University of Duisburg Essen; University of Eastern Finland; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Fischer, JW (corresponding author), Univ Duisburg Essen, Univ Klinikum Essen, Inst Pharmakol, Hufelandstr 55, D-45147 Essen, Germany.	j.fischer@uk-essen.de	Tammi, Markku/AAQ-7878-2021; Rashmin C. Savani, MBChB/AAG-2041-2021; Twarock, Sören/AAB-7705-2020	Rashmin C. Savani, MBChB/0000-0002-9533-5422; Twarock, Sören/0000-0001-9252-1353	Grunderstiftung zur Forderung von Forschung und wissenschaftlichen Nachwuchs an der Heinrich Heine Universitat Dusseldorf; National Institutes of Health [HL073896, HL079090, HL075930]; William Buchanan Chair in Pediatrics of the University of Texas Southwestern Medical Center, Dallas, TX; Academy of Finland; Sigrid Juselius Foundation; EVO Fund of Kuopio University Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079090, R01HL075930, R01HL073896] Funding Source: NIH RePORTER	Grunderstiftung zur Forderung von Forschung und wissenschaftlichen Nachwuchs an der Heinrich Heine Universitat Dusseldorf; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William Buchanan Chair in Pediatrics of the University of Texas Southwestern Medical Center, Dallas, TX; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); EVO Fund of Kuopio University Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a fellowship from the Grunderstiftung zur Forderung von Forschung und wissenschaftlichen Nachwuchs an der Heinrich Heine Universitat Dusseldorf (to S. T.); National Institutes of Health Grants HL073896, HL079090, and HL075930 and the William Buchanan Chair in Pediatrics of the University of Texas Southwestern Medical Center, Dallas, TX (to R. C. S.); and the Academy of Finland, the Sigrid Juselius Foundation, and EVO Fund of Kuopio University Hospital (to M. I. T.).	Maxwell CA, 2008, J CELL SCI, V121, P925, DOI 10.1242/jcs.022038; Amieva MR, 1999, J CELL SCI, V112, P111; Bourguignon LYW, 2000, J BIOL CHEM, V275, P1829, DOI 10.1074/jbc.275.3.1829; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Carragher NO, 2001, J BIOL CHEM, V276, P4270, DOI 10.1074/jbc.M008972200; Dai G, 2007, AM J PATHOL, V171, P1451, DOI 10.2353/ajpath.2007.070136; Fujita Y, 2002, FEBS LETT, V528, P101, DOI 10.1016/S0014-5793(02)03262-3; HALL CL, 1994, J CELL BIOL, V126, P575, DOI 10.1083/jcb.126.2.575; HALL CL, 1995, CELL, V82, P19, DOI 10.1016/0092-8674(95)90048-9; Hamilton SR, 2007, J BIOL CHEM, V282, P16667, DOI 10.1074/jbc.M702078200; Haraguchi N, 2008, ANN SURG ONCOL, V15, P2927, DOI 10.1245/s10434-008-0074-0; Itano N, 2002, P NATL ACAD SCI USA, V99, P3609, DOI 10.1073/pnas.052026799; Kakizaki I, 2004, J BIOL CHEM, V279, P33281, DOI 10.1074/jbc.M405918200; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kovbasnjuk O, 2005, P NATL ACAD SCI USA, V102, P19087, DOI 10.1073/pnas.0506474102; LESLEY J, 1998, FRONT BIOSCI, V3, P616; Levkau B, 1998, J EXP MED, V187, P579, DOI 10.1084/jem.187.4.579; Liu NF, 2001, CANCER RES, V61, P5207; Mummert ME, 2000, J EXP MED, V192, P769, DOI 10.1084/jem.192.6.769; Mylona E, 2008, HUM PATHOL, V39, P1096, DOI 10.1016/j.humpath.2007.12.003; Nakazawa Hideaki, 2006, Cancer Chemother Pharmacol, V57, P165, DOI 10.1007/s00280-005-0016-5; OWENS LV, 1995, CANCER RES, V55, P2752; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Rilla K, 2008, J HISTOCHEM CYTOCHEM, V56, P901, DOI 10.1369/jhc.2008.951665; Ropponen K, 1998, CANCER RES, V58, P342; Sarbia M, 1997, ANTICANCER RES, V17, P2185; SAVANI RC, 1995, J CLIN INVEST, V95, P1158, DOI 10.1172/JCI117764; Schmitt M, 2008, BLOOD, V111, P1357, DOI 10.1182/blood-2007-07-099366; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Sohara Y, 2001, MOL BIOL CELL, V12, P1859, DOI 10.1091/mbc.12.6.1859; Tammi RH, 2008, SEMIN CANCER BIOL, V18, P288, DOI 10.1016/j.semcancer.2008.03.005; Tofuku K, 2006, INT J ONCOL, V29, P175; Tolg C, 2006, J CELL BIOL, V175, P1017, DOI 10.1083/jcb.200511027; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Toole BP, 2002, GLYCOBIOLOGY, V12, p37R, DOI 10.1093/glycob/12.3.37R; Toole BP, 2008, DRUG RESIST UPDATE, V11, P110, DOI 10.1016/j.drup.2008.04.002; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Twarock S, 2009, BRIT J PHARMACOL, V157, P234, DOI 10.1111/j.1476-5381.2009.00138.x; UNDERHILL CB, 1979, J CELL BIOL, V82, P475, DOI 10.1083/jcb.82.2.475; van Nimwegen MJ, 2007, BIOCHEM PHARMACOL, V73, P597, DOI 10.1016/j.bcp.2006.08.011; Wang C, 1998, CLIN CANCER RES, V4, P567; Wang C, 1996, AM J PATHOL, V148, P1861; WASTESON A, 1973, BIOCHEM J, V136, P1069, DOI 10.1042/bj1361069; Yamano Y, 2008, INT J ONCOL, V32, P1001; Yoshihara S, 2005, FEBS LETT, V579, P2722, DOI 10.1016/j.febslet.2005.03.079; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	47	77	80	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23274	23282		10.1074/jbc.M109.093146	http://dx.doi.org/10.1074/jbc.M109.093146			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20463012	Green Published, hybrid			2022-12-27	WOS:000279999900061
J	Wang, XB; Hu, GQ; Zhou, JL				Wang, Xiaobo; Hu, Guoqing; Zhou, Jiliang			Repression of Versican Expression by MicroRNA-143	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; SERUM RESPONSE FACTOR; GENE-EXPRESSION; BALLOON ANGIOPLASTY; VASCULAR-DISEASE; GROWTH; MYOCARDIN; MIGRATION; DIFFERENTIATION; PROLIFERATION	Smooth muscle cells (SMCs) retain remarkable plasticity to undergo phenotypic modulation in which the expression of smooth muscle markers is markedly attenuated while conversely expression of extracellular matrix (ECM) is dramatically up-regulated. Myocardin is perhaps the most potent transcription factor for stimulating expression of smooth muscle-specific genes; little is known, however, about whether myocardin can orchestrate ECM expression to act in concert with smooth muscle differentiation program. In this study, we demonstrated myocardin coordinate smooth muscle differentiation by inducing transcription of microRNA-143 (miR-143), which attenuates ECM versican protein expression. Previous studies have shown that versican is a chondroitin sulfate proteoglycan of the ECM that is produced by synthetic SMCs and promotes SMC migration and proliferation. Our data demonstrated that myocardin significantly represses versican expression in multiple cell lines, and this occurs through the induction of miR-143 by myocardin. By a modified reverse transcribed PCR, we found that miR-143 specifically binds to the 3'-untranslated region of versican mRNA. Reporter assays validated that miR-143 targets versican 3'-untranslated region through an evolutionarily conserved miR-143 binding site. Furthermore, overexpression of miR-143 significantly represses versican expression, whereas conversely, depletion of endogenous miR-143 results in up-regulation of versican expression. In addition, we demonstrated that myocardin represses versican through induction of miR-143. Finally, we found that the regulation of versican by miR-143 is involved in platelet-derived growth factor BB-induced SMC migration. This study provides the first evidence that myocardin, in addition to activating smooth muscle-specific genes, regulates ECM expression through induction of microRNAs during smooth muscle differentiation.	[Wang, Xiaobo; Hu, Guoqing; Zhou, Jiliang] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA	Albany Medical College	Zhou, JL (corresponding author), Albany Med Coll, Ctr Cardiovasc Sci, 47 New Scotland Ave, Albany, NY 12208 USA.	zhouj1@mail.amc.edu	Wang, Xiaobo/S-2476-2019; Wang, Xiaobo/J-4312-2014	Wang, Xiaobo/0000-0001-6044-914X; 	Albany Medical College; American Heart Association	Albany Medical College; American Heart Association(American Heart Association)	This work was supported by a grant from the Albany Medical College start-up fund and an American Heart Association Scientist Development Grant (to J.Z.).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Davis BN, 2009, J BIOL CHEM, V284, P3728, DOI 10.1074/jbc.M808788200; Domenzain-Reyna C, 2009, J BIOL CHEM, V284, P12306, DOI 10.1074/jbc.M807108200; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HOLYCROSS BJ, 1992, CIRC RES, V71, P1525, DOI 10.1161/01.RES.71.6.1525; Huang R, 2006, CIRC RES, V98, P370, DOI 10.1161/01.RES.0000202051.28319.c8; JAWIEN A, 1992, J CLIN INVEST, V89, P507, DOI 10.1172/JCI115613; Kaplan-Albuquerque N, 2003, J BIOL CHEM, V278, P39830, DOI 10.1074/jbc.M305991200; Lee DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004527; Liu XJ, 2009, CIRC RES, V104, P476, DOI 10.1161/CIRCRESAHA.108.185363; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Morton SU, 2008, P NATL ACAD SCI USA, V105, P17830, DOI 10.1073/pnas.0804673105; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Rahmani M, 2005, J BIOL CHEM, V280, P13019, DOI 10.1074/jbc.M411766200; Raines EW, 2000, INT J EXP PATHOL, V81, P173, DOI 10.1046/j.1365-2613.2000.00155.x; Ricciardelli C, 2009, CANCER METAST REV, V28, P233, DOI 10.1007/s10555-009-9182-y; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang XK, 1996, ARTERIOSCL THROM VAS, V16, P1365, DOI 10.1161/01.ATV.16.11.1365; Wight TN, 2008, FRONT BIOSCI, V13, P4933, DOI 10.2741/3052; Wight TN, 2004, CIRC RES, V94, P1158, DOI 10.1161/01.RES.0000126921.29919.51; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; YAO LY, 1994, MATRIX BIOL, V14, P213, DOI 10.1016/0945-053X(94)90185-6; Zhang CX, 2008, CLIN SCI, V114, P699, DOI 10.1042/CS20070211; Zhang M, 2007, J BIOL CHEM, V282, P25708, DOI 10.1074/jbc.M701925200; Zhou JL, 2009, ARTERIOSCL THROM VAS, V29, P921, DOI 10.1161/ATVBAHA.109.187229; Zhou JL, 2005, MOL CELL BIOL, V25, P9874, DOI 10.1128/MCB.25.22.9874-9885.2005; Zhou JL, 2005, J BIOL CHEM, V280, P10861, DOI 10.1074/jbc.M411586200; Zhou JL, 2004, J BIOL CHEM, V279, P15929, DOI 10.1074/jbc.M313822200	35	67	70	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23239	23248		10.1074/jbc.M109.084673	http://dx.doi.org/10.1074/jbc.M109.084673			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20489207	hybrid, Green Published			2022-12-27	WOS:000279999900058
J	Shima, F; Ijiri, Y; Muraoka, S; Liao, JL; Ye, M; Araki, M; Matsumoto, K; Yamamoto, N; Sugimoto, T; Yoshikawa, Y; Kumasaka, T; Yamamoto, M; Tamura, A; Kataoka, T				Shima, Fumi; Ijiri, Yuichi; Muraoka, Shin; Liao, Jingling; Ye, Min; Araki, Mitsugu; Matsumoto, Kousuke; Yamamoto, Naoki; Sugimoto, Takeshi; Yoshikawa, Yoko; Kumasaka, Takashi; Yamamoto, Masaki; Tamura, Atsuo; Kataoka, Tohru			Structural Basis for Conformational Dynamics of GTP-bound Ras Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; MOLECULAR REPLACEMENT; ACTIVATING PROTEIN; P21 RAS; GAMMA-S; BINDING; PROGRAM; SPECTROSCOPY; M-RAS/R-RAS3; COMPLEXES	Ras family small GTPases assume two interconverting conformations, "inactive" state 1 and "active" state 2, in their GTP-bound forms. Here, to clarify the mechanism of state transition, we have carried out x-ray crystal structure analyses of a series of mutant H-Ras and M-Ras in complex with guanosine 5'-(beta,gamma-imido) triphosphate (GppNHp), representing various intermediate states of the transition. Crystallization of H-RasT35S-GppNHp enables us to solve the first complete tertiary structure of H-Ras state 1 possessing two surface pockets unseen in the state 2 or H-Ras-GDP structure. Moreover, determination of the two distinct crystal structures of H-RasT35S-GppNHp, showing prominent polysterism in the switch I and switch II regions, reveals a pivotal role of the guanine nucleotide-mediated interaction between the two switch regions and its rearrangement by a nucleotide positional change in the state 2 to state 1 transition. Furthermore, the P-31 NMR spectra and crystal structures of the GppNHp-bound forms of M-Ras mutants, carrying various H-Ras-type amino acid substitutions, also reveal the existence of a surface pocket in state 1 and support a similar mechanism based on the nucleotide-mediated interaction and its rearrangement in the state 1 to state 2 transition. Intriguingly, the conformational changes accompanying the state transition mimic those that occurred upon GDP/GTP exchange, indicating a common mechanistic basis inherent in the high flexibility of the switch regions. Collectively, these results clarify the structural features distinguishing the two states and provide new insights into the molecular basis for the state transition of Ras protein.	[Shima, Fumi; Ijiri, Yuichi; Muraoka, Shin; Liao, Jingling; Ye, Min; Matsumoto, Kousuke; Sugimoto, Takeshi; Yoshikawa, Yoko; Kataoka, Tohru] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Biol,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Araki, Mitsugu; Yamamoto, Naoki] Kobe Univ, Grad Sch Med, Dept Chem, Nada Ku, Kobe, Hyogo 6578501, Japan; [Kumasaka, Takashi] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan; [Muraoka, Shin; Yamamoto, Masaki] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan	Kobe University; Kobe University; Japan Synchrotron Radiation Research Institute; RIKEN	Kataoka, T (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Biol,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	kataoka@people.kobe-u.ac.jp	Kumasaka, Takashi/D-7428-2018; Yamamoto, Masaki/B-7844-2015; Araki, Mitsugu/C-7470-2016	Kumasaka, Takashi/0000-0001-9289-1557; Yamamoto, Masaki/0000-0002-1311-1768; Tamura, Atsuo/0000-0001-8238-8851	Ministry of Education, Science, Sports, and Culture of Japan [17014061, 18057014, A08]; National Institute of Biomedical Innovation [06-3]	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation)	This work was supported by Grants-in-Aid for Scientific Research in Priority Areas 17014061 and 18057014, and Global Centers of Excellence Program A08 from the Ministry of Education, Science, Sports, and Culture of Japan and by National Institute of Biomedical Innovation Grant for the Program for Promotion of Fundamental Studies of Health Sciences 06-3.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Bellew BF, 1996, BIOCHEMISTRY-US, V35, P12186, DOI 10.1021/bi960594b; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cherfils J, 1997, EMBO J, V16, P5582, DOI 10.1093/emboj/16.18.5582; Corbett KD, 2001, TRENDS BIOCHEM SCI, V26, P710, DOI 10.1016/S0968-0004(01)01974-0; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fabbro D, 2002, PHARMACOL THERAPEUT, V93, P79, DOI 10.1016/S0163-7258(02)00179-1; Fenwick RB, 2009, BIOCHEMISTRY-US, V48, P2192, DOI 10.1021/bi802129d; Ford B, 2005, J BIOL CHEM, V280, P25697, DOI 10.1074/jbc.M502240200; Ford B, 2009, BIOCHEMISTRY-US, V48, P11449, DOI 10.1021/bi901479b; Geyer M, 1999, BIOCHEMISTRY-US, V38, P11250, DOI 10.1021/bi9904306; Geyer M, 1996, BIOCHEMISTRY-US, V35, P10308, DOI 10.1021/bi952858k; Halkides CJ, 1996, BIOCHEMISTRY-US, V35, P12194, DOI 10.1021/bi9605954; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LESLIE AGW, 1992, JOINT CCP4 ESF EACBM; Liao JL, 2008, BIOCHEM BIOPH RES CO, V369, P327, DOI 10.1016/j.bbrc.2008.01.169; Linnemann T, 1999, J BIOL CHEM, V274, P13556, DOI 10.1074/jbc.274.19.13556; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Ohba Y, 2000, J BIOL CHEM, V275, P20020, DOI 10.1074/jbc.M000981200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Phillips MJ, 2008, J BIOL CHEM, V283, P14153, DOI 10.1074/jbc.M706271200; Quilliam LA, 1999, J BIOL CHEM, V274, P23850, DOI 10.1074/jbc.274.34.23850; Spoerner M, 2004, FEBS LETT, V578, P305, DOI 10.1016/j.febslet.2004.11.020; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Spoerner M, 2007, FEBS J, V274, P1419, DOI 10.1111/j.1742-4658.2007.05681.x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Ye M, 2005, J BIOL CHEM, V280, P31267, DOI 10.1074/jbc.M505503200	35	99	102	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22696	22705		10.1074/jbc.M110.125161	http://dx.doi.org/10.1074/jbc.M110.125161			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20479006	Green Published, hybrid			2022-12-27	WOS:000279702200080
J	Berdichevsky, A; Guarente, L; Bose, A				Berdichevsky, Alina; Guarente, Leonard; Bose, Avirup			Acute Oxidative Stress Can Reverse Insulin Resistance by Inactivation of Cytoplasmic JNK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; ACTIVATED PROTEIN-KINASE; HUMAN SKELETAL-MUSCLE; ALPHA-LIPOIC ACID; DIABETES-MELLITUS; GLUCOSE-TRANSPORT; DNA-DAMAGE; EXERCISE; OBESITY; RAT	Chronic oxidative stress results in decreased responsiveness to insulin, eventually leading to diabetes and cardiovascular disease. Activation of the JNK signaling pathway can mediate many of the effects of stress on insulin resistance through inhibitory phosphorylation of insulin receptor substrate 1. By contrast, exercise, which acutely increases oxidative stress in the muscle, improves insulin sensitivity and glucose tolerance in patients with Type 2 diabetes. To elucidate the mechanism underlying the contrasting effects of acute versus chronic oxidative stress on insulin sensitivity, we used a cellular model of insulin-resistant muscle to induce either chronic or acute oxidative stress and investigate their effects on insulin and JNK signaling. Chronic oxidative stress resulted in increased levels of phosphorylated ( activated) JNK in the cytoplasm, whereas acute oxidative stress led to redistribution of JNK-specific phosphatase MKP7 from the nucleus into the cytoplasm, reduction in cytoplasmic phospho-JNK, and a concurrent accumulation of phospho-JNK in the nucleus. Acute oxidative stress restored normal insulin sensitivity and glucose uptake in insulin-resistant muscle cells, and this effect was dependent on MKP7. We propose that the contrasting effects of acute and chronic stress on insulin sensitivity are driven by changes in subcellular distribution of MKP7 and activated JNK.	Novartis Inst Biomed Res, Cardiovasc & Metab Dis Area, Cambridge, MA 02139 USA; [Guarente, Leonard] MIT, Dept Biol, Cambridge, MA 02139 USA	Novartis; Massachusetts Institute of Technology (MIT)	Bose, A (corresponding author), 100 Technol Sq, Cambridge, MA 02139 USA.	Avirup.Bose@novartis.com			National Institutes of Health; Paul F. Glenn Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul F. Glenn Foundation	This work was supported, in whole or in part, by a National Institutes of Health grant and the Paul F. Glenn Foundation (to L. G.).	Aronson D, 1998, BIOCHEM BIOPH RES CO, V251, P106, DOI 10.1006/bbrc.1998.9435; Bjornholm M, 2005, BIOCHEM SOC T, V33, P354; Bloch-Damti A, 2006, DIABETOLOGIA, V49, P2463, DOI 10.1007/s00125-006-0349-6; Demirbag R, 2006, INT J CLIN PRACT, V60, P1187, DOI 10.1111/j.1742-1241.2006.01042.x; Evans JL, 2005, ANTIOXID REDOX SIGN, V7, P1040, DOI 10.1089/ars.2005.7.1040; Fujii N, 2006, AM J PHYSIOL-ENDOC M, V291, pE867, DOI 10.1152/ajpendo.00207.2006; Gao L, 2008, VET CLIN N AM-SMALL, V38, P137, DOI 10.1016/j.cvsm.2007.10.004; Higaki Y, 2008, AM J PHYSIOL-ENDOC M, V294, pE889, DOI 10.1152/ajpendo.00150.2007; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2005, DIABETES, V54, pS73, DOI 10.2337/diabetes.54.suppl_2.S73; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Kaneto H, 2004, NAT MED, V10, P1128, DOI 10.1038/nm1111; Kayatekin BM, 2002, EUR J APPL PHYSIOL, V87, P141, DOI 10.1007/s00421-002-0607-3; Kozlovsky N, 1997, FREE RADICAL BIO MED, V23, P859, DOI 10.1016/S0891-5849(97)00069-5; Kramer HF, 2007, J APPL PHYSIOL, V103, P388, DOI 10.1152/japplphysiol.00085.2007; Lee YH, 2003, J BIOL CHEM, V278, P2896, DOI 10.1074/jbc.M208359200; Maddux BA, 2001, DIABETES, V50, P404, DOI 10.2337/diabetes.50.2.404; Masuda K, 2001, J BIOL CHEM, V276, P39002, DOI 10.1074/jbc.M104600200; McClung JP, 2004, P NATL ACAD SCI USA, V101, P8852, DOI 10.1073/pnas.0308096101; Muellenbach EA, 2008, METABOLISM, V57, P1465, DOI 10.1016/j.metabol.2008.05.018; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rehman A, 1999, FEBS LETT, V448, P120, DOI 10.1016/S0014-5793(99)00339-7; Song FF, 2007, CLIN SCI, V112, P599, DOI 10.1042/CS20060323; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; Villa-Caballero L, 2007, DIABETES RES CLIN PR, V75, P285, DOI 10.1016/j.diabres.2006.07.011; Wang X, 2007, BBA-MOL CELL RES, V1773, P1349, DOI 10.1016/j.bbamcr.2006.10.016; Winnick JJ, 2008, J CLIN ENDOCR METAB, V93, P771, DOI 10.1210/jc.2007-1524	28	46	47	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21581	21589		10.1074/jbc.M109.093633	http://dx.doi.org/10.1074/jbc.M109.093633			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20430894	Green Published, hybrid			2022-12-27	WOS:000279516100044
J	Olshina, MA; Angley, LM; Ramdzan, YM; Tang, JW; Bailey, MF; Hill, AF; Hatters, DM				Olshina, Maya A.; Angley, Lauren M.; Ramdzan, Yasmin M.; Tang, Jinwei; Bailey, Michael F.; Hill, Andrew F.; Hatters, Danny M.			Tracking Mutant Huntingtin Aggregation Kinetics in Cells Reveals Three Major Populations That Include an Invariant Oligomer Pool	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIZE-DISTRIBUTION ANALYSIS; FLUORESCENCE DETECTION; MOLECULAR CHAPERONE; CRYSTAL-STRUCTURE; IN-VITRO; POLYGLUTAMINE; PROTEIN; HSP70; SUPPRESSION; HSP40	Huntington disease is caused by expanded polyglutamine sequences in huntingtin, which procures its aggregation into intracellular inclusion bodies (IBs). Aggregate intermediates, such as soluble oligomers, are predicted to be toxic to cells, yet because of a lack of quantitative methods, the kinetics of aggregation in cells remains poorly understood. We used sedimentation velocity analysis to define and compare the heterogeneity and flux of purified huntingtin with huntingtin expressed in mammalian cells under non-denaturing conditions. Non-pathogenic huntingtin remained as hydrodynamically elongated monomers in vitro and in cells. Purified polyglutamine-expanded pathogenic huntingtin formed elongated monomers (2.4 S) that evolved into a heterogeneous aggregate population of increasing size over time (100-6,000 S). However, in cells, mutant huntingtin formed three major populations: monomers (2.3 S), oligomers (mode s(20,w) = 140 S) and IBs (mode s(20,w) = 320,000 S). Strikingly, the oligomers did not change in size heterogeneity or in their proportion of total huntingtin over 3 days despite continued monomer conversion to IBs, suggesting that oligomers are rate-limiting intermediates to IB formation. We also determined how a chaperone known to modulate huntingtin toxicity, Hsc70, influences in-cell huntingtin partitioning. Hsc70 decreased the pool of 140 S oligomers but increased the overall flux of monomers to IBs, suggesting that Hsc70 reduces toxicity by facilitating transfer of oligomers into IBs. Together, our data suggest that huntingtin aggregation is streamlined in cells and is consistent with the 140 S oligomers, which remain invariant over time, as a constant source of toxicity to cells irrespective of total load of insoluble aggregates.	[Olshina, Maya A.; Angley, Lauren M.; Ramdzan, Yasmin M.; Tang, Jinwei; Bailey, Michael F.; Hill, Andrew F.; Hatters, Danny M.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Hill, Andrew F.; Hatters, Danny M.] Univ Melbourne, Mental Hlth Res Inst, Parkville, Vic 3010, Australia	University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Hatters, DM (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, 30 Flemington Rd, Parkville, Vic 3010, Australia.	dhatters@unimelb.edu.au	Hill, Andrew F/B-4527-2009; Hill, Andrew F./GZL-4124-2022; Hill, Andrew F./AAH-2854-2020	Hill, Andrew F/0000-0001-5581-2354; Hill, Andrew F./0000-0001-5581-2354; Hatters, Danny/0000-0002-9965-2847	National Health and Medical Research Council (NHMRC) [566640]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by a National Health and Medical Research Council (NHMRC) program grant (to A. F. H.) and NHMRC Project Grant 566640 (to D. M. H.). A. F. H. is an NHMRC CDA (Level 2) Fellow.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Bennett MJ, 2002, P NATL ACAD SCI USA, V99, P11634, DOI 10.1073/pnas.182393899; Brignull HR, 2006, METHOD ENZYMOL, V412, P256, DOI 10.1016/S0076-6879(06)12016-9; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Crick SL, 2006, P NATL ACAD SCI USA, V103, P16764, DOI 10.1073/pnas.0608175103; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dougan L, 2009, P NATL ACAD SCI USA, V106, P12605, DOI 10.1073/pnas.0900678106; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hatters DA, 2008, IUBMB LIFE, V60, P724, DOI 10.1002/iub.111; Hatters DM, 2001, J BIOL CHEM, V276, P33755, DOI 10.1074/jbc.M105285200; Hatters DM, 2000, BIOCHEMISTRY-US, V39, P8276, DOI 10.1021/bi000002w; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; JACOB L, 2002, PROTEIN SCI, V11, P2067; Jana NR, 2000, HUM MOL GENET, V9, P2009, DOI 10.1093/hmg/9.13.2009; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; Kingsbury JS, 2008, J BIOL CHEM, V283, P11887, DOI 10.1074/jbc.M709638200; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; Lide DR, 1996, CRC HDB CHEM PHYSICS, P8; Longinotti MP, 2008, J PHYS CHEM REF DATA, V37, P1503, DOI 10.1063/1.2932114; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MacGregor IK, 2004, BIOPHYS CHEM, V108, P165, DOI 10.1016/j.bpc.2003.10.018; MacRaild CA, 2003, BIOPHYS J, V84, P2562, DOI 10.1016/S0006-3495(03)75061-9; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Matsumoto G, 2006, J BIOL CHEM, V281, P4477, DOI 10.1074/jbc.M509201200; Minami Y, 1996, J BIOL CHEM, V271, P19617, DOI 10.1074/jbc.271.32.19617; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Mukai H, 2005, P NATL ACAD SCI USA, V102, P10887, DOI 10.1073/pnas.0409283102; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rosenow MA, 2004, BIOCHEMISTRY-US, V43, P4464, DOI 10.1021/bi0361315; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Rujano MA, 2007, EXP CELL RES, V313, P3568, DOI 10.1016/j.yexcr.2007.07.034; Ryan TM, 2008, J BIOL CHEM, V283, P35118, DOI 10.1074/jbc.M804004200; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Takahashi T, 2008, HUM MOL GENET, V17, P345, DOI 10.1093/hmg/ddm311; Takahashi Y, 2007, J BIOL CHEM, V282, P24039, DOI 10.1074/jbc.M704789200; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; VANHOLDE KE, 1978, BIOPOLYMERS, V17, P1387, DOI 10.1002/bip.1978.360170602; Wacker JL, 2009, J NEUROSCI, V29, P9104, DOI 10.1523/JNEUROSCI.2250-09.2009; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Wang YS, 2009, J EUR ACAD DERMATOL, V23, P451, DOI 10.1111/j.1468-3083.2008.02895.x; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Weiss A, 2008, J NEUROCHEM, V104, P846, DOI 10.1111/j.1471-4159.2007.05032.x; Zhou H, 2001, J BIOL CHEM, V276, P48417, DOI 10.1074/jbc.M104140200	57	88	89	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21807	21816		10.1074/jbc.M109.084434	http://dx.doi.org/10.1074/jbc.M109.084434			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20444706	Green Published, hybrid			2022-12-27	WOS:000279516100065
J	Tomasic, IB; Metcalf, MC; Guce, AI; Clark, NE; Garman, SC				Tomasic, Ivan B.; Metcalf, Matthew C.; Guce, Abigail I.; Clark, Nathaniel E.; Garman, Scott C.			Interconversion of the Specificities of Human Lysosomal Enzymes Associated with Fabry and Schindler Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-N-ACETYLGALACTOSAMINIDASE; 1.9 ANGSTROM STRUCTURE; REPLACEMENT THERAPY; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; GALACTOSIDASE; AGALSIDASE; SAFETY; ANTIBODY	The human lysosomal enzymes alpha-galactosidase (alpha-GAL, EC 3.2.1.22) and alpha-N-acetylgalactosaminidase (alpha-NAGAL, EC 3.2.1.49) share 46% amino acid sequence identity and have similar folds. The active sites of the two enzymes share 11 of 13 amino acids, differing only where they interact with the 2-position of the substrates. Using a rational protein engineering approach, we interconverted the enzymatic specificity of alpha-GAL and alpha-NAGAL. The engineered alpha-GAL (which we call alpha-GAL(SA)) retains the antigenicity of alpha-GAL but has acquired the enzymatic specificity of alpha-NAGAL. Conversely, the engineered alpha-NAGAL (which we call alpha-NAGAL(EL)) retains the antigenicity of alpha-NAGAL but has acquired the enzymatic specificity of the alpha-GAL enzyme. Comparison of the crystal structures of the designed enzyme alpha-GAL(SA) to the wild-type enzymes shows that active sites of alpha-GAL(SA) and alpha-NAGAL superimpose well, indicating success of the rational design. The designed enzymes might be useful as non-immunogenic alternatives in enzyme replacement therapy for treatment of lysosomal storage disorders such as Fabry disease.	[Garman, Scott C.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Guce, Abigail I.; Garman, Scott C.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Garman, SC (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, 710 N Pleasant St, Amherst, MA 01003 USA.	garman@biochem.umass.edu		Metcalf, Matthew/0000-0001-7705-4574	National Institutes of Health [R01 DK76877]; National Science Foundation [0654128]; U.S. Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076877] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK76877 (to S. C. G.). This work was also supported by National Science Foundation Integrative Graduate Education and Research Traineeship 0654128 (to N. E. C.). Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	[Anonymous], 2014, METABOLIC MOL BASES; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benichou B, 2009, MOL GENET METAB, V96, P4, DOI 10.1016/j.ymgme.2008.10.004; Bodensteiner D, 2008, GENET MED, V10, P353, DOI 10.1097/GIM.0b013e318170f868; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Clark NE, 2009, J MOL BIOL, V393, P435, DOI 10.1016/j.jmb.2009.08.021; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Fujimoto Z, 2003, J BIOL CHEM, V278, P20313, DOI 10.1074/jbc.M302292200; Garman SC, 2004, J MOL BIOL, V337, P319, DOI 10.1016/j.jmb.2004.01.035; Garman SC, 2002, STRUCTURE, V10, P425, DOI 10.1016/S0969-2126(02)00726-8; Garman SC, 2006, BIOCATAL BIOTRANSFOR, V24, P129, DOI 10.1080/10242420600598194; Golubev AM, 2004, J MOL BIOL, V339, P413, DOI 10.1016/j.jmb.2004.03.062; Guce AI, 2010, J BIOL CHEM, V285, P3625, DOI 10.1074/jbc.M109.060145; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt GJ, 1997, STRUCTURE, V5, P1557, DOI 10.1016/S0969-2126(97)00305-5; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MAYES JS, 1981, CLIN CHIM ACTA, V112, P247, DOI 10.1016/0009-8981(81)90384-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PERONA JJ, 1995, BIOCHEMISTRY-US, V34, P1489, DOI 10.1021/bi00005a004; Ries M, 2005, PEDIATRICS, V115, pE344, DOI 10.1542/peds.2004-1678; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; Schiffmann R, 2006, NEPHROL DIAL TRANSPL, V21, P345, DOI 10.1093/ndt/gfi152; Spada M, 2006, AM J HUM GENET, V79, P31, DOI 10.1086/504601; Starzyk K, 2007, MOL GENET METAB, V90, P157, DOI 10.1016/j.ymgme.2006.09.003; Tajima Y, 2009, AM J HUM GENET, V85, P569, DOI 10.1016/j.ajhg.2009.09.016; Toscano MD, 2007, ANGEW CHEM INT EDIT, V46, P3212, DOI 10.1002/anie.200604205; Vedder AC, 2008, MOL GENET METAB, V94, P319, DOI 10.1016/j.ymgme.2008.03.003; WANG AM, 1990, J BIOL CHEM, V265, P21859	30	17	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21560	21566		10.1074/jbc.M110.118588	http://dx.doi.org/10.1074/jbc.M110.118588			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20444686	Green Published, hybrid			2022-12-27	WOS:000279516100042
J	Mitra, A; Menezes, ME; Shevde, LA; Samant, RS				Mitra, Aparna; Menezes, Mitchell E.; Shevde, Lalita A.; Samant, Rajeev S.			DNAJB6 Induces Degradation of beta-Catenin and Causes Partial Reversal of Mesenchymal Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; DROSOPHILA TUMOR-SUPPRESSOR; HEAT-SHOCK PROTEINS; WNT SIGNALING PATHWAY; E-CADHERIN; MIR-200 FAMILY; HUMAN HOMOLOG; TRANSCRIPTION FACTORS; MALIGNANT ACTIVITY; MDA-MB-435 CELLS	We showed that expression of MRJ (DNAJB6) protein is lost in invasive ductal carcinoma, and restoration of MRJ(L) restricts malignant behavior of breast cancer and melanoma cells. However, the signaling pathways influenced by MRJ(L) are largely unknown. Our observations revealed that MRJ(L) expression causes changes in cell morphology concomitant with down-regulation of several mesenchymal markers, viz. vimentin, N-cadherin, Twist, and Slug, and up-regulation of epithelial marker keratin 18. Importantly, MRJ(L) expression led to reduced levels of beta-catenin, an epithelial mesenchymal transition marker, and a critical player in the Wnt pathway. We found that MRJ(L) up-regulates expression of DKK1, a well known Wnt/beta-catenin signaling inhibitor, that causes degradation of beta-catenin. Re-expression of DNAJB6 alters the Wnt/beta-catenin signaling in cancer cells, leading to partial reversal of the mesenchymal phenotype. Thus, MRJ(L) may play a role in maintaining an epithelial phenotype, and inhibition of the Wnt/beta-catenin pathway may be one of the potential mechanisms contributing to the restriction of malignant behavior by MRJ(L).	[Mitra, Aparna; Menezes, Mitchell E.; Shevde, Lalita A.; Samant, Rajeev S.] Univ S Alabama, Dept Oncol Sci, Mitchell Canc Inst, Mobile, AL 36604 USA	University of South Alabama	Samant, RS (corresponding author), Univ S Alabama, Dept Oncol Sci, Mitchell Canc Inst, 1660 Springhill Ave, Mobile, AL 36604 USA.	rsamant@usouthal.edu		Samant, Rajeev/0000-0001-5681-4976	National Institutes of Health [1R01CA140472-01A1]; University of South Alabama-Mitchell Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA140472] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of South Alabama-Mitchell Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01CA140472-01A1 (to R. S. S.).; We thank "The Shawn and Leyla Esfahani Breast Cancer Research Endowment" for their invaluable support to breast cancer research at the University of South Alabama-Mitchell Cancer Institute.	Abba MC, 2004, BREAST CANCER RES, V6, pR499, DOI 10.1186/bcr899; Azios NG, 2007, NEOPLASIA, V9, P147, DOI 10.1593/neo.06778; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Buhler H, 2005, MOL CANCER RES, V3, P365, DOI 10.1158/1541-7786.MCR-04-0117; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Chen HW, 2008, CANCER RES, V68, P7428, DOI 10.1158/0008-5472.CAN-07-6734; Cheng H, 2005, MOL CELL BIOL, V25, P44, DOI 10.1128/MCB.25.1.44-59.2005; Cheng XG, 2008, J VIROL, V82, P1229, DOI 10.1128/JVI.00540-07; Chuang JZ, 2002, J BIOL CHEM, V277, P19831, DOI 10.1074/jbc.M109613200; Cowling VH, 2007, CELL CYCLE, V6, P2625, DOI 10.4161/cc.6.21.4880; Cowling VH, 2007, MOL CELL BIOL, V27, P5135, DOI 10.1128/MCB.02282-06; Dai YS, 2005, MOL CELL BIOL, V25, P9936, DOI 10.1128/MCB.25.22.9936-9948.2005; Didelot C, 2007, CURR MED CHEM, V14, P2839, DOI 10.2174/092986707782360079; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Georgakis Georgios V, 2005, Future Oncol, V1, P273; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hatsell S, 2003, J MAMMARY GLAND BIOL, V8, P145, DOI 10.1023/A:1025944723047; Izawa I, 2000, J BIOL CHEM, V275, P34521, DOI 10.1074/jbc.M003492200; Jaattela M, 1999, ANN MED, V31, P261, DOI 10.3109/07853899908995889; Jiang YG, 2007, INT J UROL, V14, P1034, DOI 10.1111/j.1442-2042.2007.01866.x; Jo M, 2009, J BIOL CHEM, V284, P22825, DOI 10.1074/jbc.M109.023960; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kim SW, 2005, CANCER RES, V65, P8784, DOI 10.1158/0008-5472.CAN-04-4422; Kim SW, 2004, CANCER RES, V64, P7732, DOI 10.1158/0008-5472.CAN-04-1323; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lester RD, 2007, J CELL BIOL, V178, P425, DOI 10.1083/jcb.200701092; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Matijasevic Z, 1998, ONCOL RES, V10, P605; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; McInroy L, 2007, BIOCHEM BIOPH RES CO, V360, P109, DOI 10.1016/j.bbrc.2007.06.036; Mikheev AM, 2008, BREAST CANCER RES TR, V112, P263, DOI 10.1007/s10549-007-9867-2; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Mironchik Y, 2005, CANCER RES, V65, P10801, DOI 10.1158/0008-5472.CAN-05-0712; Mitra A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1874; Miyoshi K, 2002, ONCOGENE, V21, P5548, DOI 10.1038/sj.onc.1205686; Moon RT, 1997, CELL, V88, P725, DOI 10.1016/S0092-8674(00)81915-7; Neckers L, 2007, J BIOSCIENCES, V32, P517, DOI 10.1007/s12038-007-0051-y; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Ohtsuka K, 2000, CELL STRESS CHAPERON, V5, P98, DOI 10.1379/1466-1268(2000)005<0098:MHDHCO>2.0.CO;2; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Prasad CP, 2007, ONCOLOGY-BASEL, V73, P112, DOI 10.1159/000120999; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Rae JM, 2004, CLIN EXP METASTAS, V21, P543, DOI 10.1007/s10585-004-3759-1; Rylander MN, 2005, ANN NY ACAD SCI, V1066, P222, DOI 10.1196/annals.1363.009; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Schafer C, 2000, J GASTROENTEROL, V35, P1; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Shevde LA, 2006, CLIN EXP METASTAS, V23, P123, DOI 10.1007/s10585-006-9013-2; Sonna LA, 2002, J APPL PHYSIOL, V92, P1725, DOI 10.1152/japplphysiol.01143.2001; Soti C, 2005, BRIT J PHARMACOL, V146, P769, DOI 10.1038/sj.bjp.0706396; Strickland LB, 2000, BREAST CANCER RES TR, V64, P235, DOI 10.1023/A:1026562720218; Suzuki H, 2008, BRIT J CANCER, V98, P1147, DOI 10.1038/sj.bjc.6604259; Syken J, 2003, ONCOGENE, V22, P4636, DOI 10.1038/sj.onc.1206569; Syken J, 1999, P NATL ACAD SCI USA, V96, P8499, DOI 10.1073/pnas.96.15.8499; Tait LR, 2007, INT J CANCER, V120, P2127, DOI 10.1002/ijc.22572; Trentin GA, 2004, FEBS LETT, V578, P323, DOI 10.1016/j.febslet.2004.11.034; Tsai MF, 2006, JNCI-J NATL CANCER I, V98, P825, DOI 10.1093/jnci/djj229; Tsuruta D, 2003, J CELL SCI, V116, P4977, DOI 10.1242/jcs.00823; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Wang CC, 2005, ONCOGENE, V24, P4081, DOI 10.1038/sj.onc.1208573; Wang CC, 2007, CANCER RES, V67, P4816, DOI 10.1158/0008-5472.CAN-07-0504; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; XIE X, 1992, CLIN EXP METASTAS, V10, P201, DOI 10.1007/BF00132752; Zavadil J, 2008, CANCER RES, V68, P9574, DOI 10.1158/0008-5472.CAN-08-2316	71	43	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24686	24694		10.1074/jbc.M109.094847	http://dx.doi.org/10.1074/jbc.M109.094847			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20522561	Green Published, hybrid			2022-12-27	WOS:000280542100041
J	Rui, Z; Petrickova, K; Skanta, F; Pospisil, S; Yang, YL; Chen, CY; Tsai, SF; Floss, HG; Petricek, M; Yu, TW				Rui, Zhe; Petrickova, Katerina; Skanta, Frantisek; Pospisil, Stanislav; Yang, Yanling; Chen, Chung-Yung; Tsai, Shih-Feng; Floss, Heinz G.; Petricek, Miroslav; Yu, Tin-Wein			Biochemical and Genetic Insights into Asukamycin Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NODOSUS SUBSP ASUKAENSIS; FATTY-ACID SYNTHASE; CRYSTAL-STRUCTURE; MYCOBACTERIUM-TUBERCULOSIS; HETEROLOGOUS EXPRESSION; II THIOESTERASE; STREPTOMYCES; POLYKETIDE; CLUSTER; PATHWAY	Asukamycin, a member of the manumycin family metabolites, is an antimicrobial and potential antitumor agent isolated from Streptomyces nodosus subsp. asukaensis. The entire asukamycin biosynthetic gene cluster was cloned, assembled, and expressed heterologously in Streptomyces lividans. Bioinformatic analysis and mutagenesis studies elucidated the biosynthetic pathway at the genetic and biochemical level. Four gene sets, asuA-D, govern the formation and assembly of the asukamycin building blocks: a 3-amino-4-hydroxybenzoic acid core component, a cyclohexane ring, two triene polyketide chains, and a 2-amino3- hydroxycyclopent-2-enone moiety to form the intermediate protoasukamycin. AsuE1 and AsuE2 catalyze the conversion of protoasukamycin to 4-hydroxyprotoasukamycin, which is epoxidized at C5-C6 by AsuE3 to the final product, asukamycin. Branched acyl CoA starter units, derived from Val, Leu, and Ile, can be incorporated by the actions of the polyketide synthase III (KSIII) AsuC3/C4 as well as the cellular fatty acid synthase FabH to produce the asukamycin congeners A2-A7. In addition, the type II thioesterase AsuC15 limits the cellular level of omega-cyclohexyl fatty acids and likely maintains homeostasis of the cellular membrane.	[Petrickova, Katerina; Skanta, Frantisek; Pospisil, Stanislav; Petricek, Miroslav] Acad Sci Czech Republic, Inst Microbiol, CR-14220 Prague 4, Czech Republic; [Yu, Tin-Wein] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Chen, Chung-Yung] Chung Yuan Christian Univ, Dept Biosci Technol, Chungli 32023, Taiwan; [Tsai, Shih-Feng] Natl Yang Ming Univ, Inst Genet, Taipei 112, Taiwan; [Floss, Heinz G.] Univ Washington, Dept Chem, Seattle, WA 98195 USA	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Louisiana State University System; Louisiana State University; Chung Yuan Christian University; National Yang Ming Chiao Tung University; University of Washington; University of Washington Seattle	Petricek, M (corresponding author), Acad Sci Czech Republic, Inst Microbiol, Videnska 1083, CR-14220 Prague 4, Czech Republic.	petras@biomed.cas.cz; tin.laorchid@gmail.com	Petrickova, Katerina/H-2426-2014; Yang, Yanling/F-5954-2014; Škanta, František/H-7931-2014; Pospisil, Stanislav/H-3051-2014; Chen, Chung-Yung/AAJ-2111-2020; Rui, Zhe/D-9541-2013; Petříček, Miroslav/H-8417-2014; yang, yan/M-2875-2013	Petrickova, Katerina/0000-0003-3719-354X; Rui, Zhe/0000-0001-8113-2694; Petříček, Miroslav/0000-0001-8757-2404; Petrickova, Katerina/0000-0002-0994-4038	National Institutes of Health [CA76461]; Czech Ministry of Education [2B06154]; Institutional Scientific Program [AV0Z50200510]; Louisiana State University; Louisiana State Economic Development; NATIONAL CANCER INSTITUTE [R01CA076461] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Institutional Scientific Program; Louisiana State University; Louisiana State Economic Development; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA76461 (to T.-W.Y.). This work was also supported by Czech Ministry of Education Grant 2B06154, Institutional Scientific Program AV0Z50200510 (to M.P.), a Louisiana State University Faculty Startup Fellowship (to T.-W.Y.), and a Louisiana State Economic Development Assistantship (to T.-W.Y. and Z.R.).	Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; BEALE JM, 1986, J AM CHEM SOC, V108, P331, DOI 10.1021/ja00262a043; Bernier M, 2006, J BIOL CHEM, V281, P2551, DOI 10.1074/jbc.M511878200; Binz TM, 2008, CHEMBIOCHEM, V9, P447, DOI 10.1002/cbic.200700549; Claxton HB, 2009, J BIOL CHEM, V284, P5021, DOI 10.1074/jbc.M808604200; Cohen-Gonsaud M, 2002, J MOL BIOL, V320, P249, DOI 10.1016/S0022-2836(02)00463-1; Cole LJ, 2005, BIOCHEMISTRY-US, V44, P8047, DOI 10.1021/bi050108x; Cropp TA, 2000, NAT BIOTECHNOL, V18, P980, DOI 10.1038/79479; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Ferreras JA, 2008, CHEM BIOL, V15, P51, DOI 10.1016/j.chembiol.2007.11.010; Gerber R, 2009, J AM CHEM SOC, V131, P3148, DOI 10.1021/ja8091054; Groban ES, 2009, J MOL BIOL, V390, P380, DOI 10.1016/j.jmb.2009.05.007; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; Hu YD, 2004, J AM CHEM SOC, V126, P3837, DOI 10.1021/ja039336+; Hu YD, 1997, J AM CHEM SOC, V119, P4301, DOI 10.1021/ja9701016; Hu YD, 2001, J ANTIBIOT, V54, P340, DOI 10.7164/antibiotics.54.340; Hu YD, 2006, HETEROCYCLES, V69, P133; Hu YF, 2008, CHEMBIOCHEM, V9, P1603, DOI 10.1002/cbic.200800029; Huang WJ, 1998, EMBO J, V17, P1183, DOI 10.1093/emboj/17.5.1183; KAKINUMA K, 1979, J AM CHEM SOC, V101, P3402, DOI 10.1021/ja00506a056; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kim BS, 2002, J BIOL CHEM, V277, P48028, DOI 10.1074/jbc.M207770200; Kirchner U, 2003, J BIOL CHEM, V278, P47545, DOI 10.1074/jbc.M307397200; Kitani S, 2008, GENE, V425, P9, DOI 10.1016/j.gene.2008.07.043; Koglin A, 2008, NATURE, V454, P907, DOI 10.1038/nature07161; Kotaka M, 2009, J BIOL CHEM, V284, P15739, DOI 10.1074/jbc.M809669200; Kotowska M, 2009, APPL ENVIRON MICROB, V75, P887, DOI 10.1128/AEM.01371-08; NAKAGAWA A, 1985, J CHEM SOC CHEM COMM, P519, DOI 10.1039/c39850000519; Nasser W, 2007, ANAL BIOANAL CHEM, V387, P381, DOI 10.1007/s00216-006-0702-0; Olsen JG, 1999, FEBS LETT, V460, P46, DOI 10.1016/S0014-5793(99)01303-4; OMURA S, 1976, J ANTIBIOT, V29, P876, DOI 10.7164/antibiotics.29.876; Ostash B, 2007, CHEM BIOL, V14, P257, DOI 10.1016/j.chembiol.2007.01.008; Pacholec M, 2005, BIOCHEMISTRY-US, V44, P4949, DOI 10.1021/bi047303g; Palaniaappan N, 2003, J BIOL CHEM, V278, P35552, DOI 10.1074/jbc.M305082200; Pan H, 2002, STRUCTURE, V10, P1559, DOI 10.1016/S0969-2126(02)00889-4; Petricek M, 2006, J BACTERIOL, V188, P5113, DOI 10.1128/JB.01919-05; Pfennig F, 1999, J BIOL CHEM, V274, P12508, DOI 10.1074/jbc.274.18.12508; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Sacco E, 2007, P NATL ACAD SCI USA, V104, P14628, DOI 10.1073/pnas.0704132104; Sattely ES, 2008, NAT PROD REP, V25, P757, DOI 10.1039/b801747f; Sattler I, 1998, NAT PROD REP, V15, P221, DOI 10.1039/a815221y; Schmutz E, 2003, EUR J BIOCHEM, V270, P4413, DOI 10.1046/j.1432-1033.2003.03830.x; Shipley PR, 2009, INT J MOL MED, V24, P711, DOI 10.3892/ijmm_00000283; Simbahan J, 2004, INT J SYST EVOL MICR, V54, P1703, DOI 10.1099/ijs.0.03012-0; Song F, 2006, J BIOL CHEM, V281, P11028, DOI 10.1074/jbc.M513896200; Suzuki H, 2006, J BIOL CHEM, V281, P36944, DOI 10.1074/jbc.M608103200; Tang Y, 2003, BIOCHEMISTRY-US, V42, P6588, DOI 10.1021/bi0341962; Tang YY, 2006, BIOCHEMISTRY-US, V45, P14085, DOI 10.1021/bi061187v; THIERICKE R, 1989, J CHEM SOC CHEM COMM, P402, DOI 10.1039/c39890000402; THIERICKE R, 1990, J AM CHEM SOC, V112, P3979, DOI 10.1021/ja00166a039; van der Werf MJ, 1999, APPL ENVIRON MICROB, V65, P2092; VINEIS P, 1994, NATURE, V369, P154, DOI 10.1038/369154a0; Webster SP, 2000, BIOCHEMISTRY-US, V39, P516, DOI 10.1021/bi991620j; Wolpert M, 2008, CHEMBIOCHEM, V9, P603, DOI 10.1002/cbic.200700483; Yeh E, 2004, CHEMBIOCHEM, V5, P1290, DOI 10.1002/cbic.200400077; Yu TW, 2002, P NATL ACAD SCI USA, V99, P7968, DOI 10.1073/pnas.092697199; Zhang WJ, 2010, J AM CHEM SOC, V132, P6402, DOI 10.1021/ja1002845; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839; Zheng ZH, 2007, J ENZYM INHIB MED CH, V22, P43, DOI 10.1080/14756360600988781; Zhou Z, 2007, P NATL ACAD SCI USA, V104, P11621, DOI 10.1073/pnas.0705122104	62	47	48	2	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24915	24924		10.1074/jbc.M110.128850	http://dx.doi.org/10.1074/jbc.M110.128850			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20522559	Green Submitted, hybrid, Green Published			2022-12-27	WOS:000280542100064
J	Namgoong, GM; Khanal, P; Cho, HG; Lim, SC; Oh, YK; Kang, BS; Shim, JH; Yoo, JC; Choi, HS				Namgoong, Gwang Mo; Khanal, Prem; Cho, Hae-Guk; Lim, Sung-Chul; Oh, Yoon Kyeong; Kang, Bong Seok; Shim, Jeong-Hyun; Yoo, Jin-Cheol; Choi, Hong Seok			The Prolyl Isomerase Pin1 Induces LC-3 Expression and Mediates Tamoxifen Resistance in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR; ANTIESTROGEN RESISTANCE; REGULATES AUTOPHAGY; ENDOCRINE THERAPY; APOPTOTIC DEATH; CELL-DEATH; IN-VIVO; GROWTH; MACROAUTOPHAGY; INHIBITION	Endocrine therapies, which inhibit estrogen receptor signaling, are the most common and effective treatments for estrogen receptor alpha-positive breast cancer. However, the utility of these agents is limited by the frequent development of resistance, and the precise mechanisms underlying endocrine therapy resistance remain incompletely understood. Here, we demonstrate that peptidyl-prolyl isomerase Pin1 is an important determinant of resistance to tamoxifen and show that Pin1 increases E2F-4- and Egr-1-driven expression of LC-3 as a result of an increased interaction with and phosphorylation of MEK1/2. In human tamoxifen-resistant breast cancer, our results show a significant correlation between Pin1 overexpression and high levels of LC-3. Promoter activity as well as expression levels of Pin1 were drastically higher in tamoxifen-resistant MCF7 cells than control MCF7 cells, as were levels of LC-3 mRNA and protein, an autophagy marker. Pin1(-/-) mouse embryonic fibroblasts showed lower 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced MEK1/2 phosphorylation than Pin1(+/+) mouse embryonic fibroblasts. Silencing of Pin1 expression inhibited TPA-induced MEK1/2 phosphorylation in MCF7 cells. Moreover, PD98059, a specific inhibitor of MEK1/2, and juglone, a potent Pin1 inhibitor, significantly suppressed the TPA-induced expression of E2F-4 as well as Egr-1 transcription factors, which control LC-3 gene expression. Importantly, 4-hydroxy tamoxifen, when used in combination with silencing of Pin1 or LC-3, increased cleaved poly(ADP-ribose) polymerase and DNA fragmentation to inhibit cologenic growth of MCF7 cells. We therefore link the Pin1-MEK pathway and LC-3-mediated tamoxifen resistance and show the therapeutic potential of Pin1 in the treatment of tamoxifen-resistant breast cancer.	[Yoo, Jin-Cheol; Choi, Hong Seok] Chosun Univ, Project Team BK21, Coll Pharm, Kwangju 501759, South Korea; [Lim, Sung-Chul] Chosun Univ, Dept Pathol, Kwangju 501759, South Korea; [Oh, Yoon Kyeong] Chosun Univ, Dept Radiat Oncol, Sch Med, Kwangju 501759, South Korea; [Kang, Bong Seok] Kyungpook Natl Univ Hosp, Biomed Res Inst, Taegu 702701, South Korea; [Shim, Jeong-Hyun] Chonbuk Natl Univ, Sch Dent, Jeonju 561756, South Korea	Chosun University; Chosun University; Chosun University; Kyungpook National University; Kyungpook National University Hospital; Jeonbuk National University	Choi, HS (corresponding author), Chosun Univ, Project Team BK21, Coll Pharm, Kwangju 501759, South Korea.	chs@chosun.ac.kr		Yoo, Jin Cheol/0000-0002-0259-6237	Ministry of Education, Science, and Technology [2009-0066056]	Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (Grant 2009-0066056).	Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Chao SH, 2001, NUCLEIC ACIDS RES, V29, P767, DOI 10.1093/nar/29.3.767; Chen ZH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003316; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; ElAshry D, 1997, ONCOGENE, V15, P423, DOI 10.1038/sj.onc.1201198; Gaddy VT, 2004, CLIN CANCER RES, V10, P5215, DOI 10.1158/1078-0432.CCR-03-0637; Ghayad SE, 2010, INT J CANCER, V126, P545, DOI 10.1002/ijc.24750; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Iorns E, 2008, CANCER CELL, V13, P91, DOI 10.1016/j.ccr.2008.01.001; John S, 2008, CANCER RES, V68, P7855, DOI 10.1158/0008-5472.CAN-07-5875; Joslyn SA, 2002, BREAST CANCER RES TR, V73, P45, DOI 10.1023/A:1015220420400; Lam PB, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-91; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Maddodi N, 2010, J INVEST DERMATOL, V130, P1657, DOI 10.1038/jid.2010.26; Mishima Y, 2008, CANCER SCI, V99, P2200, DOI 10.1111/j.1349-7006.2008.00932.x; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Oesterreich S, 2000, MOL ENDOCRINOL, V14, P369, DOI 10.1210/me.14.3.369; Oh AS, 2001, MOL ENDOCRINOL, V15, P1344, DOI 10.1210/me.15.8.1344; Osborne CK, 2005, CLIN CANCER RES, V11, p865S; Qadir MA, 2008, BREAST CANCER RES TR, V112, P389, DOI 10.1007/s10549-007-9873-4; Ritt DA, 2010, MOL CELL BIOL, V30, P806, DOI 10.1128/MCB.00569-09; Ryo A, 2003, J CELL SCI, V116, P773, DOI 10.1242/jcs.00276; Samaddar JS, 2008, MOL CANCER THER, V7, P2977, DOI 10.1158/1535-7163.MCT-08-0447; Schoenlein PV, 2009, AUTOPHAGY, V5, P400, DOI 10.4161/auto.5.3.7784; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Stanya KJ, 2008, J CELL BIOL, V183, P49, DOI 10.1083/jcb.200806172; Vazquez-Martin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006251; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; Yi P, 2005, MOL CELL BIOL, V25, P9687, DOI 10.1128/MCB.25.21.9687-9699.2005	32	43	44	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23829	23841		10.1074/jbc.M109.092874	http://dx.doi.org/10.1074/jbc.M109.092874			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20479004	Green Published, hybrid			2022-12-27	WOS:000280291400033
J	Santangelo, TJ; Reeve, JN				Santangelo, Thomas J.; Reeve, John N.			Deletion of Switch 3 Results in an Archaeal RNA Polymerase That Is Defective in Transcript Elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMOCOCCUS-KODAKARAENSIS KOD1; DNA HYBRID; HYPERTHERMOPHILIC ARCHAEON; STRUCTURAL BASIS; ANGSTROM RESOLUTION; IN-VITRO; COMPLEX; TERMINATION; HOLOENZYME; INITIATION	Switch 3 is a polypeptide loop conserved in all multisubunit DNA-dependent RNA polymerases (RNAPs) that extends into the main cleft of the RNAP and contacts each base in a nascent transcript as that base is released from the internal DNA-RNA hybrid. Plasmids have been constructed and transformed into Thermococcus kodakaraensis, which direct the constitutive synthesis of the archaeal RNAP subunit RpoB with an N-terminal His(6) tag and the Switch 3 loop either intact (wild-type) or deleted (Delta S3). RNAPs containing these plasmid-encoded RpoB subunits were purified, and, in vitro, the absence of Switch 3 had no negative effects on transcription initiation or elongation complex stability but reduced the rate of transcript elongation. The defect in elongation occurred at every template position and increased the sensitivity of the archaeal RNAP to intrinsic termination. Comparing these properties and those reported for a bacterial RNAP lacking Switch 3 argues that this loop functions differently in the RNAPs from the two prokaryotic domains. The close structural homology of archaeal and eukaryotic RNAPs would predict that eukaryotic Switch 3 loops likely conform to the archaeal rather than bacterial functional paradigm.	[Santangelo, Thomas J.; Reeve, John N.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Santangelo, TJ (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12Th Ave, Columbus, OH 43210 USA.	santangelo.11@osu.edu	Santangelo, Tom/L-8206-2019	Santangelo, Tom/0000-0003-4559-3244	National Institutes of Health [R01GM53185, 1F32-GM073336]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053185, F32GM073336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01GM53185 (to J.N.R.) and 1F32-GM073336 (to T.J.S.).	Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Bell SD, 2001, BIOCHEM SOC T, V29, P392, DOI 10.1042/BST0290392; Bell SD, 2001, CURR OPIN MICROBIOL, V4, P208, DOI 10.1016/S1369-5274(00)00190-9; Brueckner F, 2009, ACTA CRYSTALLOGR D, V65, P112, DOI 10.1107/S0907444908039875; Cramer P, 2004, ADV PROTEIN CHEM, V67, P1; Darst SA, 2001, CURR OPIN STRUC BIOL, V11, P155; Fukui T, 2005, GENOME RES, V15, P352, DOI 10.1101/gr.3003105; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Hirata A, 2009, CURR OPIN STRUC BIOL, V19, P724, DOI 10.1016/j.sbi.2009.10.006; Hirata A, 2008, MOL MICROBIOL, V70, P623, DOI 10.1111/j.1365-2958.2008.06430.x; Keene RG, 1999, NUCLEIC ACIDS RES, V27, P3173, DOI 10.1093/nar/27.15.3173; Kent T, 2009, J BIOL CHEM, V284, P13497, DOI 10.1074/jbc.M901898200; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Komissarova N, 2002, MOL CELL, V10, P1151, DOI 10.1016/S1097-2765(02)00738-4; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Kusser AG, 2008, J MOL BIOL, V376, P303, DOI 10.1016/j.jmb.2007.08.066; Liu XQ, 2009, J BIOL CHEM, V284, P36262, DOI 10.1074/jbc.M109.056820; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Murakami KS, 2003, METHOD ENZYMOL, V370, P42; Naji S, 2008, NUCLEIC ACIDS RES, V36, P676, DOI 10.1093/nar/gkm1086; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Nudler E, 2002, GENES CELLS, V7, P755, DOI 10.1046/j.1365-2443.2002.00563.x; Reeve JN, 1997, CELL, V89, P999, DOI 10.1016/S0092-8674(00)80286-X; Santangelo TJ, 2008, APPL ENVIRON MICROB, V74, P3099, DOI 10.1128/AEM.00305-08; Santangelo TJ, 2007, J MOL BIOL, V367, P344, DOI 10.1016/j.jmb.2006.12.069; Santangelo TJ, 2010, APPL ENVIRON MICROB, V76, P1044, DOI 10.1128/AEM.02497-09; Santangelo TJ, 2009, J BACTERIOL, V191, P7102, DOI 10.1128/JB.00982-09; Santangelo TJ, 2006, J MOL BIOL, V355, P196, DOI 10.1016/j.jmb.2005.10.062; Sato T, 2003, J BACTERIOL, V185, P210, DOI 10.1128/JB.185.1.210-220.2003; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; Soler N, 2007, MOL MICROBIOL, V66, P357, DOI 10.1111/j.1365-2958.2007.05912.x; Spitalny P, 2008, MOL MICROBIOL, V67, P958, DOI 10.1111/j.1365-2958.2007.06084.x; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Werner F, 2002, MOL CELL, V10, P635, DOI 10.1016/S1097-2765(02)00629-9; Werner F, 2008, TRENDS MICROBIOL, V16, P247, DOI 10.1016/j.tim.2008.03.008; Werner F, 2007, MOL MICROBIOL, V65, P1395, DOI 10.1111/j.1365-2958.2007.05876.x; Zhang JW, 2010, NAT STRUCT MOL BIOL, V17, P99, DOI 10.1038/nsmb.1732	40	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23908	23915		10.1074/jbc.M109.094565	http://dx.doi.org/10.1074/jbc.M109.094565			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20511223	Green Published, hybrid			2022-12-27	WOS:000280291400041
J	Korasick, DA; McMichael, C; Walker, KA; Anderson, JC; Bednarek, SY; Heese, A				Korasick, David A.; McMichael, Colleen; Walker, Katie A.; Anderson, Jeffrey C.; Bednarek, Sebastian Y.; Heese, Antje			Novel Functions of Stomatal Cytokinesis-Defective 1 (SCD1) in Innate Immune Responses against Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATTERN-RECOGNITION RECEPTORS; PLANT-DEFENSE; CELL-DEATH; SALICYLIC-ACID; ARABIDOPSIS-THALIANA; DISEASE RESISTANCE; DEPENDENT GROWTH; MPK4 ACTIVATION; PROTEIN; PERCEPTION	Eukaryotes employ complex immune mechanisms for protection against microbial pathogens. Here, we identified SCD1 (Stomatal Cytokinesis-Defective 1), previously implicated in growth and development through its role in cytokinesis and polarized cell expansion (Falbel, T. G., Koch, L. M., Nadeau, J.A., Segui-Simarro, J.M., Sack, F. D., and Bednarek, S.Y. (2003) Development 130, 4011-4024) as a novel component of innate immunity. In Arabidopsis, SCD1 is a unique gene encoding for the only protein containing a complete DENN (Differentially Expressed in Normal and Neoplastic cells) domain. The DENN domain is a largely uncharacterized tripartite protein motif conserved among eukaryotic proteins. We show that conditional scd1-1 plants containing a point mutation in a conserved DENN residue affected a subset of signaling responses to some bacterial pathogen-associated molecular patterns (PAMPs). Consistent with increased transcript accumulation of Pathogen-related (PR) genes, scd1-1 plants were more resistant to Pseudomonas syringae pathovar tomato (Pst) DC3000 infection implicating SCD1 as a negative regulator of basal resistance against bacteria. scd1-1 plants were different from known mutants exhibiting constitutive expressor of PR(cpr)-like phenotypes, in that growth impairment of scd1-1 plants was genetically independent of constitutive immune response activation. For scd1-1, shift to elevated temperature or introduction of a mutant allele in Salicylic acid Induction-Deficient 2 (SID2) suppressed constitutive defense response activation. sid2-2 also repressed the resistance phenotype of scd1-1. Temperature shift and sid2-2, however, did not rescue conditional growth and sterility defects of scd1-1. These results implicate SCD1 in multiple cellular pathways, possibly by affecting different proteins. Overall, our studies identified a novel role for eukaryotic DENN proteins in immunity against bacteria.	[Heese, Antje] Univ Missouri, Div Biochem, Interdisciplinary Plant Grp, Columbia, MO 65211 USA; [McMichael, Colleen; Bednarek, Sebastian Y.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Missouri System; University of Missouri Columbia; University of Wisconsin System; University of Wisconsin Madison	Heese, A (corresponding author), Univ Missouri, Div Biochem, Interdisciplinary Plant Grp, 117 Schweitzer Hall, Columbia, MO 65211 USA.	heesea@missouri.edu	Anderson, Jeff/I-1316-2017; McMichael, Colleen/E-6679-2017	Anderson, Jeff/0000-0001-9446-7100; McMichael, Colleen/0000-0001-5371-9076; Korasick, David/0000-0002-6337-2085	University of Missouri; MU-Life Sciences Undergraduate Research Opportunity Program; Human Frontiers of Science Program [RGP22/2006]; National Science Foundation, Division of Molecular and Cellular Biosciences [0446157]	University of Missouri; MU-Life Sciences Undergraduate Research Opportunity Program; Human Frontiers of Science Program(Human Frontier Science Program); National Science Foundation, Division of Molecular and Cellular Biosciences(National Science Foundation (NSF))	This work was supported in part by start-up funds from the University of Missouri (to A. H.), MU-Life Sciences Undergraduate Research Opportunity Program (to D. A. K. and K. A. W.), Human Frontiers of Science Program Grant (RGP22/2006) (to J.C.A.), and the National Science Foundation, Division of Molecular and Cellular Biosciences (0446157) (to S.Y.B.).	Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; Bartels S, 2009, PLANT CELL, V21, P2884, DOI 10.1105/tpc.109.067678; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Del Villar K, 2004, P NATL ACAD SCI USA, V101, P4210, DOI 10.1073/pnas.0307349101; Denoux C, 2008, MOL PLANT, V1, P423, DOI 10.1093/mp/ssn019; Falbel TG, 2003, DEVELOPMENT, V130, P4011, DOI 10.1242/dev.00619; Fan J, 2008, PLANT J, V53, P393, DOI 10.1111/j.1365-313X.2007.03303.x; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; He K, 2007, CURR BIOL, V17, P1109, DOI 10.1016/j.cub.2007.05.036; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Ichimura K, 2006, J BIOL CHEM, V281, P36969, DOI 10.1074/jbc.M605319200; Jambunathan N, 2001, PLANT CELL, V13, P2225, DOI 10.1105/tpc.13.10.2225; Lee JH, 2008, PLANT CELL, V20, P152, DOI 10.1105/tpc.107.055418; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Levivier E, 2001, BIOCHEM BIOPH RES CO, V287, P688, DOI 10.1006/bbrc.2001.5652; Libault M, 2007, MOL PLANT MICROBE IN, V20, P900, DOI 10.1094/MPMI-20-8-0900; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Loake G, 2007, CURR OPIN PLANT BIOL, V10, P466, DOI 10.1016/j.pbi.2007.08.008; Lorrain S, 2003, TRENDS PLANT SCI, V8, P263, DOI 10.1016/S1360-1385(03)00108-0; Lu X, 2009, P NATL ACAD SCI USA, V106, P22522, DOI 10.1073/pnas.0907711106; Marat AL, 2010, J BIOL CHEM, V285, P10627, DOI 10.1074/jbc.M109.050930; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Miyoshi J, 2004, TRENDS MOL MED, V10, P476, DOI 10.1016/j.molmed.2004.08.002; Mulherkar N, 2007, J BIOL CHEM, V282, P11715, DOI 10.1074/jbc.M701085200; Nakagami H, 2006, J BIOL CHEM, V281, P38697, DOI 10.1074/jbc.M605293200; Nicaise V, 2009, PLANT PHYSIOL, V150, P1638, DOI 10.1104/pp.109.139709; Niwa S, 2008, NAT CELL BIOL, V10, P1269, DOI 10.1038/ncb1785; Nuhse TS, 2007, PLANT J, V51, P931, DOI 10.1111/j.1365-313X.2007.03192.x; Petersen M, 2000, CELL, V103, P1111, DOI 10.1016/S0092-8674(00)00213-0; Rancour DM, 2004, J BIOL CHEM, V279, P54264, DOI 10.1074/jbc.M405498200; Sato M, 2008, EMBO J, V27, P1183, DOI 10.1038/emboj.2008.54; Su SH, 2007, FEBS LETT, V581, P3171, DOI 10.1016/j.febslet.2007.05.083; Suarez-Rodriguez MC, 2007, PLANT PHYSIOL, V143, P661, DOI 10.1104/pp.106.091389; Tanaka M, 2001, MOL BIOL CELL, V12, P1421, DOI 10.1091/mbc.12.5.1421; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Tsuda K, 2008, PLANT J, V53, P763, DOI 10.1111/j.1365-313X.2007.03369.x; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; van Zanten M, 2009, TRENDS PLANT SCI, V14, P214, DOI 10.1016/j.tplants.2009.01.010; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Yang SH, 2004, PLANT CELL, V16, P1060, DOI 10.1105/tpc.020479; Zhang J, 2007, CELL HOST MICROBE, V1, P175, DOI 10.1016/j.chom.2007.03.006; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	45	50	51	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23340	23348		10.1074/jbc.M109.090787	http://dx.doi.org/10.1074/jbc.M109.090787			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20472560	hybrid, Green Published			2022-12-27	WOS:000279999900067
J	Le Clainche, C; Dwivedi, SP; Didry, D; Carlier, MF				Le Clainche, Christophe; Dwivedi, Satya Prakash; Didry, Dominique; Carlier, Marie-France			Vinculin Is a Dually Regulated Actin Filament Barbed End-capping and Side-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION FORMATION; ALPHA-ACTININ; TALIN ROD; INTRAMOLECULAR ASSOCIATION; ACTIVATE VINCULIN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; TAIL DOMAINS; CELLS; SITES	The focal adhesion protein vinculin is an actin-binding protein involved in the mechanical coupling between the actin cytoskeleton and the extracellular matrix. An autoinhibitory interaction between the N-terminal head (Vh) and the C-terminal tail (Vt) of vinculin masks an actin filament side-binding domain in Vt. The binding of several proteins to Vh disrupts this intramolecular interaction and exposes the actin filament side-binding domain. Here, by combining kinetic assays and microscopy observations, we show that Vt inhibits actin polymerization by blocking the barbed ends of actin filaments. In low salt conditions, Vt nucleates actin filaments capped at their barbed ends. We determined that the interaction between vinculin and the barbed end is characterized by slow association and dissociation rate constants. This barbed end capping activity requires C-terminal amino acids of Vt that are dispensable for actin filament side binding. Like the side-binding domain, the capping domain of vinculin is masked by an autoinhibitory interaction between Vh and Vt. In contrast to the side-binding domain, the capping domain is not unmasked by the binding of a talin domain to Vh and requires the dissociation of an additional autoinhibitory interaction. Finally, we show that vinculin and the formin mDia1, which is involved in the processive elongation of actin filaments in focal adhesions, compete for actin filament barbed ends.	[Le Clainche, Christophe; Dwivedi, Satya Prakash; Didry, Dominique; Carlier, Marie-France] CNRS, UPR3082, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Le Clainche, C (corresponding author), CNRS, UPR3082, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France.	Christophe.Leclainche@lebs.cnrs-gif.fr	Le Clainche, Christophe/A-4782-2015	Le Clainche, Christophe/0000-0001-5659-677X	Agence Nationale pour la Recherche [ANR-09-JCJC-0111-01]	Agence Nationale pour la Recherche(French National Research Agency (ANR))	Supported by Agence Nationale pour la Recherche Grant ANR-09-JCJC-0111-01 ADERACTIN. To whom correspondence should be addressed.	Bakolitsa C, 1999, CELL, V99, P603, DOI 10.1016/S0092-8674(00)81549-4; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Bass MD, 1999, BIOCHEM J, V341, P257, DOI 10.1042/0264-6021:3410257; Bass MD, 2002, BIOCHEM J, V362, P761, DOI 10.1042/0264-6021:3620761; Bois PRJ, 2006, J BIOL CHEM, V281, P7228, DOI 10.1074/jbc.M510397200; Borgon RA, 2004, STRUCTURE, V12, P1189, DOI 10.1016/j.str.2004.05.009; Bourdet-Sicard R, 2000, MICROBES INFECT, V2, P813, DOI 10.1016/S1286-4579(00)90366-6; Bourdet-Sicard R, 1999, EMBO J, V18, P5853, DOI 10.1093/emboj/18.21.5853; Breitsprecher D, 2008, EMBO J, V27, P2943, DOI 10.1038/emboj.2008.211; Brown CM, 2006, J CELL SCI, V119, P5204, DOI 10.1242/jcs.03321; BURRIDGE K, 1984, NATURE, V308, P744, DOI 10.1038/308744a0; Chandrasekar I, 2005, J CELL SCI, V118, P1461, DOI 10.1242/jcs.01734; Chen H, 2006, J BIOL CHEM, V281, P40389, DOI 10.1074/jbc.M607324200; CHUANG JZ, 1995, J CELL BIOL, V128, P1095, DOI 10.1083/jcb.128.6.1095; Cohen DM, 2006, J BIOL CHEM, V281, P16006, DOI 10.1074/jbc.M600738200; Cohen DM, 2005, J BIOL CHEM, V280, P17109, DOI 10.1074/jbc.M414704200; COLL JL, 1995, P NATL ACAD SCI USA, V92, P9161, DOI 10.1073/pnas.92.20.9161; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; FUKAMI K, 1994, J BIOL CHEM, V269, P1518; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; GIMONA M, 1988, EMBO J, V7, P2329, DOI 10.1002/j.1460-2075.1988.tb03076.x; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Huttelmaier S, 1997, EUR J BIOCHEM, V247, P1136, DOI 10.1111/j.1432-1033.1997.01136.x; Izard T, 2004, J BIOL CHEM, V279, P27667, DOI 10.1074/jbc.M403076200; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Izard T, 2006, J CELL BIOL, V175, P465, DOI 10.1083/jcb.200605091; Janssen MEW, 2006, MOL CELL, V21, P271, DOI 10.1016/j.molcel.2005.11.020; Ji L, 2008, NAT CELL BIOL, V10, P1393, DOI 10.1038/ncb1797; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; JOHNSON RP, 1994, J BIOL CHEM, V269, P12611; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Kuhn JR, 2007, J BIOL CHEM, V282, P28014, DOI 10.1074/jbc.M705287200; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; MENKEL AR, 1994, J CELL BIOL, V126, P1231, DOI 10.1083/jcb.126.5.1231; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Ramarao N, 2007, FEBS LETT, V581, P853, DOI 10.1016/j.febslet.2007.01.057; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Saunders RM, 2006, EUR J CELL BIOL, V85, P487, DOI 10.1016/j.ejcb.2006.01.014; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; Steimle PA, 1999, J BIOL CHEM, V274, P18414, DOI 10.1074/jbc.274.26.18414; Van Nhieu GT, 2007, EMBO J, V26, P4588; VOLBERG T, 1995, J CELL SCI, V108, P2253; WACHSSTOCK DH, 1987, BIOCHEM BIOPH RES CO, V146, P554, DOI 10.1016/0006-291X(87)90564-X; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Wear MA, 2003, CURR BIOL, V13, P1531, DOI 10.1016/S0960-9822(03)00559-1; Wen KK, 2009, J BIOL CHEM, V284, P30463, DOI 10.1074/jbc.M109.021295; Xu WM, 1998, J CELL SCI, V111, P1535; Zamir E, 2001, J CELL SCI, V114, P3583; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	55	43	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23418	23430		10.1074/jbc.M110.102830	http://dx.doi.org/10.1074/jbc.M110.102830			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20484056	Green Published, hybrid			2022-12-27	WOS:000279999900074
J	Wollers, S; Layer, G; Garcia-Serres, R; Signor, L; Clemancey, M; Latour, JM; Fontecave, M; de Choudens, SO				Wollers, Silke; Layer, Gunhild; Garcia-Serres, Ricardo; Signor, Luca; Clemancey, Martin; Latour, Jean-Marc; Fontecave, Marc; de Choudens, Sandrine Ollagnier			Iron-Sulfur (Fe-S) Cluster Assembly THE SufBCD COMPLEX IS A NEW TYPE OF Fe-S SCAFFOLD WITH A FLAVIN REDOX COFACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CYSTEINE DESULFURASE; CRYSTAL-STRUCTURE; PROTEINS; SUFE; BIOSYNTHESIS; BIOGENESIS; MACHINERY; REDUCTION; SYSTEM	Assembly of iron-sulfur (Fe-S) clusters and maturation of Fe-S proteins in vivo require complex machineries. In Escherichia coli, under adverse stress conditions, this process is achieved by the SUF system that contains six proteins as follows: SufA, SufB, SufC, SufD, SufS, and SufE. Here, we provide a detailed characterization of the SufBCD complex whose function was so far unknown. Using biochemical and spectroscopic analyses, we demonstrate the following: (i) the complex as isolated exists mainly in a 1:2:1 (B:C:D) stoichiometry; (ii) the complex can assemble a [4Fe-4S] cluster in vitro and transfer it to target proteins; and (iii) the complex binds one molecule of flavin adenine nucleotide per SufBC(2)D complex, only in its reduced form (FADH(2)), which has the ability to reduce ferric iron. These results suggest that the SufBC(2)D complex functions as a novel type of scaffold protein that assembles an Fe-S cluster through the mobilization of sulfur from the SufSE cysteine desulfurase and the FADH(2)-dependent reductive mobilization of iron.	[Latour, Jean-Marc; Fontecave, Marc; de Choudens, Sandrine Ollagnier] CEA, iRTSV LCBM, F-38054 Grenoble 09, France; [Wollers, Silke; Layer, Gunhild; Garcia-Serres, Ricardo; Clemancey, Martin; Latour, Jean-Marc; Fontecave, Marc; de Choudens, Sandrine Ollagnier] CNRS, UMR 5249, F-38054 Grenoble, France; [Wollers, Silke; Layer, Gunhild; Garcia-Serres, Ricardo; Clemancey, Martin; Latour, Jean-Marc; de Choudens, Sandrine Ollagnier] Univ Grenoble 1, F-38054 Grenoble, France; [Fontecave, Marc] Coll France, F-75231 Paris 05, France; [Signor, Luca] Univ Grenoble 1, CEA, CNRS, Inst Biol Struct,Lab Spectrometrie Masse Prot, F-38027 Grenoble 1, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; PSL Research University Paris; College de France; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Fontecave, M (corresponding author), CEA, iRTSV LCBM, F-38054 Grenoble 09, France.	mfontecave@cea.fr; sollagnier@cea.fr	Signor, Luca/O-7489-2014; García-Serres, Ricardo/E-4344-2012	Signor, Luca/0000-0003-3880-2466; García-Serres, Ricardo/0000-0001-5203-0568; Ollagnier de Choudens, Sandrine/0000-0002-0080-6659	Region Rhone-Alpes [CIBLE 07 016335]	Region Rhone-Alpes(Region Auvergne-Rhone-Alpes)	This work was supported by the Region Rhone-Alpes, Contract CIBLE 07 016335.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Ayala-Castro C, 2008, MICROBIOL MOL BIOL R, V72, P110, DOI 10.1128/MMBR.00034-07; Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; Balk J, 2005, TRENDS PLANT SCI, V10, P324, DOI 10.1016/j.tplants.2005.05.002; Bedekovics T, 2007, FEMS YEAST RES, V7, P1276, DOI 10.1111/j.1567-1364.2007.00296.x; Chahal HK, 2009, BIOCHEMISTRY-US, V48, P10644, DOI 10.1021/bi901518y; Chandramouli K, 2007, BIOCHEMISTRY-US, V46, P6804, DOI 10.1021/bi6026659; COVES J, 1993, J BIOL CHEM, V268, P18604; COVES J, 1993, EUR J BIOCHEM, V211, P635, DOI 10.1111/j.1432-1033.1993.tb17591.x; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Eccleston JF, 2006, J BIOL CHEM, V281, P8371, DOI 10.1074/jbc.M513455200; FONTECAVE M, 1994, BIOMETALS, V7, P3; Fontecave M, 2008, ARCH BIOCHEM BIOPHYS, V474, P226, DOI 10.1016/j.abb.2007.12.014; Galan B, 2000, J BACTERIOL, V182, P627, DOI 10.1128/JB.182.3.627-636.2000; GARDNER PR, 1992, J BIOL CHEM, V267, P8757; Gupta V, 2009, J AM CHEM SOC, V131, P6149, DOI 10.1021/ja807551e; HALLE F, 1992, EUR J BIOCHEM, V209, P621, DOI 10.1111/j.1432-1033.1992.tb17328.x; Huet G, 2005, J BACTERIOL, V187, P6137, DOI 10.1128/JB.187.17.6137-6146.2005; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Jordan PA, 1999, BIOCHEM J, V344, P739, DOI 10.1042/0264-6021:3440739; Kitaoka S, 2006, FEBS LETT, V580, P137, DOI 10.1016/j.febslet.2005.11.058; Layer G, 2007, J BIOL CHEM, V282, P13342, DOI 10.1074/jbc.M608555200; Layer G, 2006, J BIOL CHEM, V281, P16256, DOI 10.1074/jbc.M513569200; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Loiseau L, 2003, J BIOL CHEM, V278, P38352, DOI 10.1074/jbc.M305953200; Lu JX, 2008, BIOCHEM J, V409, P535, DOI 10.1042/BJ20071166; MASSEY V, 1966, BIOCHEMISTRY-US, V5, P3181, DOI 10.1021/bi00874a016; Mickowska B, 2000, J BIOCHEM BIOPH METH, V44, P95, DOI 10.1016/S0165-022X(00)00073-7; Mihara H, 2000, J BIOCHEM-TOKYO, V127, P559, DOI 10.1093/oxfordjournals.jbchem.a022641; Mihara H, 2002, J BIOCHEM, V131, P679, DOI 10.1093/oxfordjournals.jbchem.a003151; Nachin L, 2003, EMBO J, V22, P427, DOI 10.1093/emboj/cdg061; Ollagnier-de Choudens S, 2003, J BIOL CHEM, V278, P17993, DOI 10.1074/jbc.M300285200; Ollagnier-de-Choudens S, 2004, J BIOL INORG CHEM, V9, P828, DOI 10.1007/s00775-004-0581-9; Ollagnier-De-Choudens S, 2003, FEBS LETT, V555, P263, DOI 10.1016/S0014-5793(03)01244-4; Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x; Outten FW, 2003, J BIOL CHEM, V278, P45713, DOI 10.1074/jbc.M308004200; Petrovic A, 2008, PROTEIN SCI, V17, P1264, DOI 10.1110/ps.034652.108; Ranquet C, 2007, J BIOL CHEM, V282, P30442, DOI 10.1074/jbc.M702519200; Sancho J, 2006, CELL MOL LIFE SCI, V63, P855, DOI 10.1007/s00018-005-5514-4; Sendra M, 2007, FEBS LETT, V581, P1362, DOI 10.1016/j.febslet.2007.02.058; Song SH, 2007, J PHOTOCH PHOTOBIO B, V87, P37, DOI 10.1016/j.jphotobiol.2006.12.007; Takahashi Y, 2002, J BIOL CHEM, V277, P28380, DOI 10.1074/jbc.C200365200; Tokumoto U, 2004, J BIOCHEM, V136, P199, DOI 10.1093/jb/mvh104; Valton J, 2004, J BIOL CHEM, V279, P44362, DOI 10.1074/jbc.M407722200; Vinella D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000497; Wada K, 2009, J MOL BIOL, V387, P245, DOI 10.1016/j.jmb.2009.01.054; Watanabe S, 2005, J MOL BIOL, V353, P1043, DOI 10.1016/j.jmb.2005.09.017	48	100	101	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23329	23339		10.1074/jbc.M110.127449	http://dx.doi.org/10.1074/jbc.M110.127449			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20460376	Green Published, hybrid			2022-12-27	WOS:000279999900066
J	Porubsky, PR; Battaile, KP; Scott, EE				Porubsky, Patrick R.; Battaile, Kevin P.; Scott, Emily E.			Human Cytochrome P450 2E1 Structures with Fatty Acid Analogs Reveal a Previously Unobserved Binding Mode	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLORZOXAZONE HYDROXYLATION; MACROMOLECULAR STRUCTURES; OMEGA-HYDROXYLATION; P450 2E1; PROTEIN; SUBSTRATE; INHIBITORS; MECHANISM; CAVITIES; INSIGHTS	Human microsomal cytochrome P450 (CYP) 2E1 is widely known for its ability to oxidize >70 different, mostly compact, low molecular weight drugs and other xenobiotic compounds. In addition CYP2E1 oxidizes much larger C9-C20 fatty acids that can serve as endogenous signaling molecules. Previously structures of CYP2E1 with small molecules revealed a small, compact CYP2E1 active site, which would be insufficient to accommodate medium and long chain fatty acids without conformational changes in the protein. In the current work we have determined how CYP2E1 can accommodate a series of fatty acid analogs by cocrystallizing CYP2E1 with omega-imidazolyl-octanoic fatty acid, omega-imidazolyl-decanoic fatty acid, and omega-imidazolyl-dodecanoic fatty acid. In each structure direct coordination of the imidazole nitrogen to the heme iron mimics the position required for native fatty acid substrates to yield the omega-1 hydroxylated metabolites that predominate experimentally. In each case rotation of a single Phe(298) side chain merges the active site with an adjacent void, significantly altering the active site size and topology to accommodate fatty acids. The binding of these fatty acid ligands is directly opposite the channel to the protein surface and the binding observed for fatty acids in the bacterial cytochrome P450 BM3 (CYP102A1) from Bacillus megaterium. Instead of the BM3-like binding mode in the CYP2E1 channel, these structures reveal interactions between the fatty acid carboxylates and several residues in the F, G, and B' helices at successive distances from the active site.	[Porubsky, Patrick R.; Scott, Emily E.] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA; [Battaile, Kevin P.] Argonne Natl Lab, Adv Photon Source, Ind Macromol Crystallog Assoc Collaborat Access T, Argonne, IL 60439 USA	University of Kansas; United States Department of Energy (DOE); Argonne National Laboratory	Scott, EE (corresponding author), 1251 Wescoe Hall Dr, Lawrence, KS 66045 USA.	eescott@ku.edu		Battaile, Kevin/0000-0003-0833-3259	National Institutes of Health [GM076343, RR017708]; Department of Energy Office of Biological and Environmental Research; National Institutes of Health National Center for Research Resources Biomedical Technology Program; National Institute of General Medical Sciences; Center for Advanced Radiation Sources at the University of Chicago; Office of Basic Energy Sciences of the United States Department of Energy Office of Science [W-31-109-Eng-38]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076343, R37GM076343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health National Center for Research Resources Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Center for Advanced Radiation Sources at the University of Chicago(University of Chicago); Office of Basic Energy Sciences of the United States Department of Energy Office of Science(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM076343 (to E.E.S.).; Thanks are due to Jennifer Laurence for critical suggestions regarding protein stabilization, to Robert Hanzlik who provided initial samples of the imidazole ligands, and to group members Melanie Blevins and Andria Skinner who attempted to make the unstable CYP2E1 mutant proteins. Crystals were grown using the facilities of the Protein Structure Laboratory core facility at the University of Kansas (supported by National Institutes of Health Grant RR017708). Portions of this research were carried out at the Stanford Synchrotron Radiation Laboratory, a national user facility operated by Stanford University on behalf of the United States Department of Energy Office of Basic Energy Sciences. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research, the National Institutes of Health National Center for Research Resources Biomedical Technology Program, and the National Institute of General Medical Sciences. Use of the Industrial Macromolecular Crystallography Association Collaborative Access Team Beamline 17-BM at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with the Center for Advanced Radiation Sources at the University of Chicago. Use of the Advanced Photon Source was supported by the Office of Basic Energy Sciences of the United States Department of Energy Office of Science under Contract W-31-109-Eng-38.	Adas F, 1999, J LIPID RES, V40, P1990; ALTERMAN MA, 1995, ARCH BIOCHEM BIOPHYS, V320, P289, DOI 10.1016/0003-9861(95)90012-8; Bookser BC, 2001, J COMB CHEM, V3, P205, DOI 10.1021/cc000086s; Carroll MA, 1996, AM J PHYSIOL-REG I, V271, pR863, DOI 10.1152/ajpregu.1996.271.4.R863; Celik A, 2005, ORG BIOMOL CHEM, V3, P2688, DOI 10.1039/b506155e; Cryle MJ, 2008, P NATL ACAD SCI USA, V105, P15696, DOI 10.1073/pnas.0805983105; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FUKUDA T, 1994, J BIOCHEM-TOKYO, V115, P338, DOI 10.1093/oxfordjournals.jbchem.a124339; Gebremedhin D, 2000, CIRC RES, V87, P60, DOI 10.1161/01.RES.87.1.60; Haines DC, 2001, BIOCHEMISTRY-US, V40, P13456, DOI 10.1021/bi011197q; Haines DC, 2008, BIOCHEMISTRY-US, V47, P3662, DOI 10.1021/bi7023964; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; LAETHEM RM, 1993, J BIOL CHEM, V268, P12912; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee DS, 2003, J BIOL CHEM, V278, P9761, DOI 10.1074/jbc.M211575200; Leslie A. G., 1998, MOSFLM 6 0; Li HY, 1997, NAT STRUCT BIOL, V4, P140, DOI 10.1038/nsb0297-140; Lu P, 1997, ARCH BIOCHEM BIOPHYS, V337, P1, DOI 10.1006/abbi.1996.9768; Lucas D, 1998, FUNDAM CLIN PHARM, V12, P553, DOI 10.1111/j.1472-8206.1998.tb00985.x; McCarver DG, 1998, TOXICOL APPL PHARM, V152, P276, DOI 10.1006/taap.1998.8532; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGiff JC, 1999, AM J PHYSIOL-REG I, V277, pR607, DOI 10.1152/ajpregu.1999.277.3.R607; Moran JH, 2000, TOXICOL APPL PHARM, V168, P268, DOI 10.1006/taap.2000.9053; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Porubsky PR, 2008, J BIOL CHEM, V283, P33698, DOI 10.1074/jbc.M805999200; Roy U, 2005, BIOCHEM J, V390, P719, DOI 10.1042/BJ20050681; Smith SV, 2000, BIOCHEMISTRY-US, V39, P5731, DOI 10.1021/bi000129l	31	74	75	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22282	22290		10.1074/jbc.M110.109017	http://dx.doi.org/10.1074/jbc.M110.109017			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20463018	hybrid, Green Published			2022-12-27	WOS:000279702200041
J	Daniels, IS; Zhang, JF; O'Brien, WG; Tao, ZY; Miki, T; Zhao, ZY; Blackburn, MR; Lee, CC				Daniels, Isadora Susan; Zhang, Jianfa; O'Brien, William G., III; Tao, Zhenyin; Miki, Tomoko; Zhao, Zhaoyang; Blackburn, Michael R.; Lee, Cheng Chi			A Role of Erythrocytes in Adenosine Monophosphate Initiation of Hypometabolism in Mammals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICE; HYPOTHERMIA; HYPOXIA; KINASE; MODEL; TIME	Biochemical and mechanistic aspects into how various hypometabolic states are initiated in mammals are poorly understood. Here, we show how a state of hypometabolism is initiated by 5'-AMP uptake by erythrocytes. Wild type, ecto-5'-nucleotidase-deficient, and adenosine receptor-deficient mice undergo 5'-AMP-induced hypometabolism in a similar fashion. Injection of 5'-AMP leads to two distinct declining phases of oxygen consumption (VO2). The phase I response displays a rapid and steep decline in VO2 that is independent of body temperature (T-b) and ambient temperature (T-a). It is followed by a phase II decline that is linked to T-b and moderated by T-a. Altering the dosages of 5'-AMP from 0.25- to 2-fold does not change the phase I response. For mice, a T-a of 15 degrees C is effective for induction of DH with the appropriate dose of 5'-AMP. Erythrocyte uptake of 5'-AMP leads to utilization of ATP to synthesize ADP. This is accompanied by increased glucose but decreased lactate levels, suggesting that glycolysis has slowed. Reduction in glycolysis is known to stimulate erythrocytes to increase intracellular levels of 2,3-bisphosphoglycerate, a potent allosteric inhibitor of hemoglobin's affinity for oxygen. Our studies showed that both 2,3-bisphosphoglycerate and deoxyhemoglobin levels rose following 5'-AMP administration and is in parallel with the phase I decline in VO2. In summary, our investigations reveal that 5'-AMP mediated hypometabolism is probably triggered by reduced oxygen transport by erythrocytes initiated by uptake of 5'-AMP.	[Blackburn, Michael R.; Lee, Cheng Chi] Univ Texas Hlth Sci Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Zhang, Jianfa] Nanjing Univ Sci & Technol, Ctr Mol Metab, Nanjing 210094, Peoples R China	University of Texas System; University of Texas Health Science Center Houston; Nanjing University of Science & Technology	Lee, CC (corresponding author), MSB 6-200,6431 Fannin St, Houston, TX 77030 USA.	cheng.c.lee@uth.tmc.edu		Daniels, Isadora/0000-0002-1351-2908; Blackburn, Michael/0000-0002-1394-9966	National Institutes of Health (NIH/NDPA) [5DP1 OD000895]; NASA; Ministry of Education of P. R. China; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000895] Funding Source: NIH RePORTER	National Institutes of Health (NIH/NDPA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NASA(National Aeronautics & Space Administration (NASA)); Ministry of Education of P. R. China(Ministry of Education, China); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by a National Institutes of Health Director Pioneer award (to C. C. L.) (NIH/NDPA: 5DP1 OD000895).; Supported in part by a NASA/Texas Space Grant Consortium Fellowship.; Supported in part by Ministry of Education of P. R. China.	CHANCE B, 1988, P NATL ACAD SCI USA, V85, P4971, DOI 10.1073/pnas.85.14.4971; Csoka B, 2007, BLOOD, V110, P2685, DOI 10.1182/blood-2007-01-065870; DARK J, 1994, AM J PHYSIOL, V267, P496; EVANS CL, 1967, Q J EXP PHYSIOL CMS, V52, P231, DOI 10.1113/expphysiol.1967.sp001909; HAWKINS CF, 1987, BIOCHEMISTRY-US, V26, P1982, DOI 10.1021/bi00381a030; Heldmaier G, 2004, RESP PHYSIOL NEUROBI, V141, P317, DOI 10.1016/j.resp.2004.03.014; IKEDA S, 1965, TOHOKU J EXP MED, V87, P185, DOI 10.1620/tjem.87.185; KNUDSEN TB, 1992, TERATOLOGY, V45, P91, DOI 10.1002/tera.1420450109; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; Lehninger A L, 1982, PRINCIPLES BIOCH; Mulquiney PJ, 1999, BIOCHEM J, V342, P597, DOI 10.1042/0264-6021:3420597; Noji T, 2004, EUR J PHARMACOL, V495, P1, DOI 10.1016/j.ejphar.2004.05.003; Overton JM, 2004, PHYSIOL BEHAV, V81, P749, DOI 10.1016/j.physbeh.2004.04.025; Pritlove DC, 2006, PLACENTA, V27, P924, DOI 10.1016/j.placenta.2005.08.010; Rhee P, 2000, J TRAUMA, V48, P439, DOI 10.1097/00005373-200003000-00011; Salvatore CA, 2000, J BIOL CHEM, V275, P4429, DOI 10.1074/jbc.275.6.4429; SHEPHERD AP, 1975, J APPL PHYSIOL, V39, P152, DOI 10.1152/jappl.1975.39.1.152; Simpkins CE, 2007, AM J TRANSPLANT, V7, P99, DOI 10.1111/j.1600-6143.2006.01597.x; Sun DQ, 2001, P NATL ACAD SCI USA, V98, P9983, DOI 10.1073/pnas.171317998; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; TSUBOI KK, 1975, J BIOL CHEM, V250, P132; WOOD SC, 1991, ANNU REV PHYSIOL, V53, P71, DOI 10.1146/annurev.physiol.53.1.71; Zhang JF, 2006, NATURE, V439, P340, DOI 10.1038/nature04368	23	38	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20716	20723		10.1074/jbc.M109.090845	http://dx.doi.org/10.1074/jbc.M109.090845			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20430891	hybrid, Green Published			2022-12-27	WOS:000279228600035
J	Pal, K; Kumar, S; Sharma, S; Garg, SK; Alam, MS; Xu, HE; Agrawal, P; Swaminathan, K				Pal, Kuntal; Kumar, Shiva; Sharma, Shikha; Garg, Saurabh Kumar; Alam, Mohammad Suhail; Xu, H. Eric; Agrawal, Pushpa; Swaminathan, Kunchithapadam			Crystal Structure of Full-length Mycobacterium tuberculosis H37Rv Glycogen Branching Enzyme INSIGHTS OF N-TERMINAL beta-SANDWICH IN SUBSTRATE SPECIFICITY AND ENZYMATIC ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL; PROTEIN; POLYSACCHARIDES; BINDING; AMYLOSUCRASE; EXPRESSION; PATTERNS; SUCROSE; COMPLEX; SURFACE	The open reading frame Rv1326c of Mycobacterium tuberculosis (Mtb) H37Rv encodes for an alpha-1,4-glucan branching enzyme (MtbGlgB, EC 2.4.1.18, Uniprot entry Q10625). This enzyme belongs to glycoside hydrolase (GH) family 13 and catalyzes the branching of a linear glucose chain during glycogenesis by cleaving a 1 -> 4 bond and making a new 1 -> 6 bond. Here, we show the crystal structure of full-length MtbGlgB (MtbGlgBWT) at 2.33-angstrom resolution. MtbGlgBWT contains four domains: N1 beta-sandwich, N2 beta-sandwich, a central (beta/alpha)(8) domain that houses the catalytic site, and a C-terminal beta-sandwich. We have assayed the amylase activity with amylose and starch as substrates and the glycogen branching activity using amylose as a substrate for MtbGlgBWT and the N1 domain-deleted (the first 108 residues deleted) Mtb Delta 108GlgB protein. The N1 beta-sandwich, which is formed by the first 105 amino acids and superimposes well with the N2 beta-sandwich, is shown to have an influence in substrate binding in the amylase assay. Also, we have checked and shown that several GH13 family inhibitors are ineffective against MtbGlgBWT and Mtb Delta 108GlgB. We propose a two-step reaction mechanism, for the amylase activity (1 -> 4 bond breakage) and isomerization (1 -> 6 bond formation), which occurs in the same catalytic pocket. The structural and functional properties of MtbGlgB and Mtb Delta 108GlgB are compared with those of the N-terminal 112-amino acid-deleted Escherichia coli GlgB (EC Delta 112GlgB).	[Sharma, Shikha; Garg, Saurabh Kumar; Alam, Mohammad Suhail; Agrawal, Pushpa] Inst Microbial Technol, Council Sci & Ind Res, Chandigarh 160036, India; [Pal, Kuntal; Kumar, Shiva; Swaminathan, Kunchithapadam] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); National University of Singapore; Van Andel Institute	Agrawal, P (corresponding author), Inst Microbial Technol, Council Sci & Ind Res, Chandigarh 160036, India.	pushpa@imtech.res.in; dbsks@nus.edu.sg	Pal, Kuntal/W-6348-2019; Xu, H. Eric/ABD-7487-2021; sarkar, sabyasachi/A-9896-2010	sarkar, sabyasachi/0000-0002-8954-4375; Xu, H. Eric/0000-0002-6829-8144; PAL, KUNTAL/0000-0001-7094-2456	Ministry of Education and Biomedical Research Council, Singapore; Institute of Microbial Technology, India; National University of Singapore; Office of Science of the U.S. Dept. of Energy; CSIR-India [SIP-10]	Ministry of Education and Biomedical Research Council, Singapore(Ministry of Education, Singapore); Institute of Microbial Technology, India; National University of Singapore(National University of Singapore); Office of Science of the U.S. Dept. of Energy(United States Department of Energy (DOE)); CSIR-India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from the Ministry of Education and Biomedical Research Council, Singapore (to K. S.) and Institute of Microbial Technology, India (to P. A.) and scholarships from National University of Singapore (to K. P. and S. K.). Use of the Advanced Photon Source was supported by the Office of Science of the U.S. Dept. of Energy.; Supported by the CSIR-India Network (project SIP-10).; Supported by a fellowship from CSIR, India.	Abad MC, 2002, J BIOL CHEM, V277, P42164, DOI 10.1074/jbc.M205746200; ANDERSEN DH, 1956, LAB INVEST, V5, P11; BESRA GS, 1994, LIPIDS CARBOHYDRATES, P285; Binderup K, 2000, ARCH BIOCHEM BIOPHYS, V374, P73, DOI 10.1006/abbi.1999.1580; BROWN BI, 1966, P NATL ACAD SCI USA, V56, P725, DOI 10.1073/pnas.56.2.725; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzozowski AM, 1997, BIOCHEMISTRY-US, V36, P10837, DOI 10.1021/bi970539i; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CHAPMAN GB, 1959, J BACTERIOL, V77, P205, DOI 10.1128/JB.77.2.205-211.1959; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; Cywes C, 1997, INFECT IMMUN, V65, P4258, DOI 10.1128/IAI.65.10.4258-4266.1997; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Devillers CH, 2003, ARCH BIOCHEM BIOPHYS, V418, P34, DOI 10.1016/S0003-9861(03)00341-2; Dinadayala P, 2004, J BIOL CHEM, V279, P12369, DOI 10.1074/jbc.M308908200; Gagliardi MC, 2007, CELL MICROBIOL, V9, P2081, DOI 10.1111/j.1462-5822.2007.00940.x; Garg SK, 2007, PROTEIN EXPRES PURIF, V51, P198, DOI 10.1016/j.pep.2006.08.005; HANKS J H, 1961, Int J Lepr, V29, P74; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lemassu A, 1996, MICROBIOL-UK, V142, P1513, DOI 10.1099/13500872-142-6-1513; LEMASSU A, 1994, BIOCHEM J, V297, P351, DOI 10.1042/bj2970351; Machovic M, 2006, CELL MOL LIFE SCI, V63, P2710, DOI 10.1007/s00018-006-6246-9; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mirza O, 2001, BIOCHEMISTRY-US, V40, P9032, DOI 10.1021/bi010706l; ORTALOMAGNE A, 1995, MICROBIOL-UK, V141, P1609, DOI 10.1099/13500872-141-7-1609; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palomo M, 2009, APPL ENVIRON MICROB, V75, P1355, DOI 10.1128/AEM.02141-08; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Sambou T, 2008, MOL MICROBIOL, V70, P762, DOI 10.1111/j.1365-2958.2008.06445.x; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sivakumar N, 2006, FEBS LETT, V580, P2646, DOI 10.1016/j.febslet.2006.04.017; Skov LK, 2002, J BIOL CHEM, V277, P47741, DOI 10.1074/jbc.M207860200; Stokes RW, 2004, INFECT IMMUN, V72, P5676, DOI 10.1128/IAI.72.10.5676-5686.2004; Tan TC, 2008, J MOL BIOL, V378, P852, DOI 10.1016/j.jmb.2008.02.041; Tarling CA, 2008, CHEMBIOCHEM, V9, P433, DOI 10.1002/cbic.200700470; Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Valberg SJ, 2001, J VET INTERN MED, V15, P572, DOI 10.1892/0891-6640(2001)015&lt;0572:GBEDIQ&gt;2.3.CO;2; Zhang DH, 2003, J BIOL CHEM, V278, P35428, DOI 10.1074/jbc.M302616200	43	53	55	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20897	20903		10.1074/jbc.M110.121707	http://dx.doi.org/10.1074/jbc.M110.121707			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20444687	hybrid, Green Published			2022-12-27	WOS:000279228600054
J	Lee, J; Jeong, Y; Jeong, S; Rhee, K				Lee, Jungmin; Jeong, Yeontae; Jeong, Saimi; Rhee, Kunsoo			Centrobin/NIP2 Is a Microtubule Stabilizer Whose Activity Is Enhanced by PLK1 Phosphorylation during Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE REGULATION; POLO-LIKE KINASE-1; PROTEIN-KINASES; SUBSTRATE; NEK2; DYNAMICS; MAP4; POLYMERIZATION; ROLES; NIP2/CENTROBIN	Centrobin/NIP2 is a centrosomal protein that is required for centrosome duplication. It is also critical for microtubule organization in both interphase and mitotic cells. In the present study, we observed that centrobin is phosphorylated in a cell cycle stage-specific manner, reaching its maximum at M phase. PLK1 is a kinase that is responsible for M phase-specific phosphorylation of centrobin. The microtubule forming activity of centrobin was enhanced by PLK1 phosphorylation. Furthermore, mitotic spindles were not assembled properly with the phospho-resistant mutant of centrobin. Based on these results, we propose that centrobin functions as a microtubule stabilizing factor and PLK1 enhances centrobin activity for proper spindle formation during mitosis.	[Lee, Jungmin; Jeong, Yeontae; Jeong, Saimi; Rhee, Kunsoo] Seoul Natl Univ, Dept Biol Sci, Seoul 151747, South Korea	Seoul National University (SNU)	Rhee, K (corresponding author), Seoul Natl Univ, Dept Biol Sci, Seoul 151747, South Korea.	rheek@snu.ac.kr			BioImaging Research Center at Gwangju Institute of Science and Technology [R01-2007-000-20116-0]; Science Research Center Program [R11-2005-009-03005-0]; Brain Korea 21 Project	BioImaging Research Center at Gwangju Institute of Science and Technology; Science Research Center Program; Brain Korea 21 Project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported in part by grants from the BioImaging Research Center at Gwangju Institute of Science and Technology, Basic Research Program Grant R01-2007-000-20116-0, and Science Research Center Program Grant R11-2005-009-03005-0.; Supported by the second stage of the Brain Korea 21 Project in 2007.	Avides MD, 2001, NAT CELL BIOL, V3, P421, DOI 10.1038/35070110; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Bondallaz P, 2006, CELL MOTIL CYTOSKEL, V63, P681, DOI 10.1002/cm.20154; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Budde PP, 2001, J CELL BIOL, V153, P149, DOI 10.1083/jcb.153.1.149; Cassey P, 1999, ENVIRONMETRICS, V10, P261, DOI 10.1002/(SICI)1099-095X(199905/06)10:3<261::AID-ENV351>3.0.CO;2-O; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Ebneth A, 1999, CELL MOTIL CYTOSKEL, V44, P209, DOI 10.1002/(SICI)1097-0169(199911)44:3<209::AID-CM6>3.0.CO;2-4; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Fourest-Lieuvin A, 2006, MOL BIOL CELL, V17, P1041, DOI 10.1091/mbc.E05-07-0621; FRY AM, 1995, J BIOL CHEM, V270, P12899, DOI 10.1074/jbc.270.21.12899; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; GOLSTEYN RM, 1995, J CELL BIOL, V129, P1617, DOI 10.1083/jcb.129.6.1617; Jang YJ, 2002, J BIOL CHEM, V277, P44115, DOI 10.1074/jbc.M202172200; Jeong Y, 2007, J CELL SCI, V120, P2106, DOI 10.1242/jcs.03458; Kang YH, 2006, MOL CELL, V24, P409, DOI 10.1016/j.molcel.2006.10.016; Kinoshita K, 2001, SCIENCE, V294, P1340, DOI 10.1126/science.1064629; Kitazawa H, 2000, CELL STRUCT FUNCT, V25, P33, DOI 10.1247/csf.25.33; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lee J, 2009, MOL CELLS, V28, P31, DOI 10.1007/s10059-009-0097-9; Lee KS, 1997, MOL CELL BIOL, V17, P3408, DOI 10.1128/MCB.17.6.3408; Mayor T, 2002, J CELL SCI, V115, P3275; Moores CA, 2006, EMBO J, V25, P4448, DOI 10.1038/sj.emboj.7601335; Nadano D, 2002, BIOCHEM J, V364, P669, DOI 10.1042/BJ20011836; Nakamura M, 2001, CURR BIOL, V11, P1062, DOI 10.1016/S0960-9822(01)00297-4; Ookata K, 1997, BIOCHEMISTRY-US, V36, P15873, DOI 10.1021/bi971251w; OOKATA K, 1995, J CELL BIOL, V128, P849, DOI 10.1083/jcb.128.5.849; Rapley J, 2005, MOL CELL BIOL, V25, P1309, DOI 10.1128/MCB.25.4.1309-1324.2005; Rusan NM, 2002, J CELL BIOL, V158, P997, DOI 10.1083/jcb.200204109; Sonn S, 2009, MOL REPROD DEV, V76, P587, DOI 10.1002/mrd.20990; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; Yarm FR, 2002, MOL CELL BIOL, V22, P6209, DOI 10.1128/MCB.22.17.6209-6221.2002; Yoo JC, 2004, EXP CELL RES, V292, P393, DOI 10.1016/j.yexcr.2003.09.025; Zou CZ, 2005, J CELL BIOL, V171, P437, DOI 10.1083/jcb.200506185	37	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25476	25484		10.1074/jbc.M109.099127	http://dx.doi.org/10.1074/jbc.M109.099127			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20511645	hybrid, Green Published			2022-12-27	WOS:000280682400041
J	Dudek, KA; Lafont, JE; Martinez-Sanchez, A; Murphy, CL				Dudek, Katarzyna A.; Lafont, Jerome E.; Martinez-Sanchez, Aida; Murphy, Christopher L.			Type II Collagen Expression Is Regulated by Tissue-specific miR-675 in Human Articular Chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H19 NONCODING RNA; TRANSCRIPTION FACTORS; GENE; DIFFERENTIATION; PHENOTYPE; CARTILAGE; MICRORNA; SOX9; OSTEOARTHRITIS; ENHANCER	miRNAs have been shown to be essential for normal cartilage development in the mouse. However, the role of specific miRNAs in cartilage function is unknown. Using rarely available healthy human chondrocytes ( obtained from 8 to 50 year old patients), we detected a most highly abundant primary miRNA H19, whose expression was heavily dependent on cartilage master regulator SOX9. Across a range of murine tissues, expression of both H19- and H19-derived miR-675 mirrored that of cartilage-specific SOX9. miR-675 was shown to up-regulate the essential cartilage matrix component COL2A1, and overexpression of miR-675 rescued COL2A1 levels in H19- or SOX9-depleted cells. Wethus provide evidence that SOX9 positively regulates COL2A1 in human articular chondrocytes via a previously unreported miR-675-dependent mechanism. This represents a novel pathway regulating cartilage matrix production and identifies miR-675 as a promising new target for cartilage repair.	[Dudek, Katarzyna A.; Lafont, Jerome E.; Martinez-Sanchez, Aida; Murphy, Christopher L.] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst Rheumatol, London W6 8LH, England	Imperial College London; University of Oxford	Murphy, CL (corresponding author), Univ London Imperial Coll Sci Technol & Med, Kennedy Inst Rheumatol, 65 Aspenlea Rd, London W6 8LH, England.	c.murphy@imperial.ac.uk	Sanchez, Aida Martinez/ABH-5957-2020; Lafont, Jerome E/AAY-2277-2020	Sanchez, Aida Martinez/0000-0001-5142-2527; Lafont, Jerome E/0000-0001-8313-9873	Arthritis Research UK; Biotechnology and Biological Sciences Research Council (United Kingdom) [BB/G006555/1]; BBSRC [BB/G006555/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G006555/1] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Biotechnology and Biological Sciences Research Council (United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Arthritis Research UK and Biotechnology and Biological Sciences Research Council (United Kingdom) Grant BB/G006555/1.	Aigner T, 2003, MATRIX BIOL, V22, P363, DOI 10.1016/S0945-053X(03)00049-0; Aigner T, 2007, NAT CLIN PRACT RHEUM, V3, P391, DOI 10.1038/ncprheum0534; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; GOSHEN R, 1993, MOL REPROD DEV, V34, P374, DOI 10.1002/mrd.1080340405; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Hurst LD, 1999, TRENDS GENET, V15, P134, DOI 10.1016/S0168-9525(99)01696-0; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; Jenkins E, 2005, MATRIX BIOL, V24, P177, DOI 10.1016/j.matbio.2005.02.004; Jones SW, 2009, OSTEOARTHR CARTILAGE, V17, P464, DOI 10.1016/j.joca.2008.09.012; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Lafont JE, 2008, J BIOL CHEM, V283, P4778, DOI 10.1074/jbc.M707729200; Lafont JE, 2007, ARTHRITIS RHEUM, V56, P3297, DOI 10.1002/art.22878; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Lin EA, 2009, J BIOL CHEM, V284, P11326, DOI 10.1074/jbc.M807709200; LUSTIG O, 1994, MOL REPROD DEV, V38, P239, DOI 10.1002/mrd.1080380302; Murphy CL, 2004, J CELL PHYSIOL, V199, P451, DOI 10.1002/jcp.10481; OWEN RD, 1993, CELL GROWTH DIFFER, V4, P1013; RACHMILEWITZ J, 1992, FEBS LETT, V309, P25, DOI 10.1016/0014-5793(92)80731-U; Smits G, 2008, NAT GENET, V40, P971, DOI 10.1038/ng.168; Stokes DG, 2001, BIOCHEM J, V360, P461, DOI 10.1042/0264-6021:3600461; Tuddenham L, 2006, FEBS LETT, V580, P4214, DOI 10.1016/j.febslet.2006.06.080; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yamasaki K, 2009, ARTHRITIS RHEUM-US, V60, P1035, DOI 10.1002/art.24404	31	117	134	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24381	24387		10.1074/jbc.M110.111328	http://dx.doi.org/10.1074/jbc.M110.111328			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529846	Green Published, hybrid			2022-12-27	WOS:000280542100009
J	Ochiai, A; Yamasaki, M; Mikami, B; Hashimoto, W; Murata, K				Ochiai, Akihito; Yamasaki, Masayuki; Mikami, Bunzo; Hashimoto, Wataru; Murata, Kousaku			Crystal Structure of Exotype Alginate Lyase Atu3025 from Agrobacterium tumefaciens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PNEUMONIAE HYALURONATE LYASE; PECTATE LYASE; SUBSTRATE RECOGNITION; MOLECULAR-IDENTIFICATION; ERWINIA-CHRYSANTHEMI; OLIGOALGINATE LYASE; STRAIN C58; COMPLEX; MECHANISM; DISACCHARIDE	Alginate, a major component of the cell wall matrix in brown seaweeds, is degraded by alginate lyases through a beta-elimination reaction. Almost all alginate lyases act endolytically on substrate, thereby yielding unsaturated oligouronic acids having 4-deoxy-L-erythro-hex-4-enepyranosyluronic acid at the nonreducing end. In contrast, Agrobacterium tumefaciens alginate lyase Atu3025, a member of polysaccharide lyase family 15, acts on alginate polysaccharides and oligosaccharides exolytically and releases unsaturated monosaccharides from the substrate terminal. The crystal structures of Atu3025 and its inactive mutant in complex with alginate trisaccharide (H531A/Delta GGG) were determined at 2.10- and 2.99-angstrom resolutions with final R-factors of 18.3 and 19.9%, respectively, by x-ray crystallography. The enzyme is comprised of an alpha/alpha-barrel + anti-parallel beta-sheet as a basic scaffold, and its structural fold has not been seen in alginate lyases analyzed thus far. The structural analysis of H531A/Delta GGG and subsequent site-directed mutagenesis studies proposed the enzyme reaction mechanism, with His(311) and Tyr(365) as the catalytic base and acid, respectively. Two structural determinants, i.e. a short alpha-helix in the central alpha/alpha-barrel domain and a conformational change at the interface between the central and C-terminal domains, are essential for the exolytic mode of action. This is, to our knowledge, the first report on the structure of the family 15 enzyme.	[Murata, Kousaku] Kyoto Univ, Lab Basic & Appl Mol Biotechnol, Kyoto 6110011, Japan; [Yamasaki, Masayuki; Mikami, Bunzo] Kyoto Univ, Lab Appl Struct Biol, Grad Sch Agr, Kyoto 6110011, Japan	Kyoto University; Kyoto University	Murata, K (corresponding author), Kyoto Univ, Lab Basic & Appl Mol Biotechnol, Kyoto 6110011, Japan.	kmurata@kais.kyoto-u.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN) in Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN) in Japan	This work was supported in part by Grants-in-aid from the Japan Society for the Promotion of Science (to K. M. and W. H.), the Targeted Proteins Research Program (to W. H.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, and Research Fellowships from the Japan Society for the Promotion of Science for Young Scientists (to A. O.) and the program (to K. M.) for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN) in Japan.	Abbott DW, 2007, J BIOL CHEM, V282, P35328, DOI 10.1074/jbc.M705511200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROOKS AD, 1990, J BACTERIOL, V172, P6950, DOI 10.1128/jb.172.12.6950-6958.1990; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P12067, DOI 10.1073/pnas.182431199; Creze C, 2008, J BIOL CHEM, V283, P18260, DOI 10.1074/jbc.M709931200; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Doublie S, 1992, CRYSTALLIZATION NUCL; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gimmestad M, 2009, J BACTERIOL, V191, P4845, DOI 10.1128/JB.00455-09; Han YH, 2009, J BIOL CHEM, V284, P34019, DOI 10.1074/jbc.M109.025338; Hashimoto W, 2000, J BACTERIOL, V182, P4572, DOI 10.1128/JB.182.16.4572-4577.2000; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Jedrzejas MJ, 2002, J BIOL CHEM, V277, P28287, DOI 10.1074/jbc.M112009200; Jenkins J, 2004, J BIOL CHEM, V279, P9139, DOI 10.1074/jbc.M311390200; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kluskens LD, 2003, BIOCHEM J, V370, P651, DOI 10.1042/BJ20021595; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LINKER A, 1956, J BIOL CHEM, V219, P13; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lunin VV, 2004, J MOL BIOL, V337, P367, DOI 10.1016/j.jmb.2003.12.071; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; Maruyama Y, 2007, BIOCHEMISTRY-US, V46, P781, DOI 10.1021/bi0619775; Mayans O, 1997, STRUCTURE, V5, P677, DOI 10.1016/S0969-2126(97)00222-0; McDonough MA, 2004, FEBS LETT, V565, P188, DOI 10.1016/j.febslet.2004.03.094; Mishra P, 2009, FEBS J, V276, P3392, DOI 10.1111/j.1742-4658.2009.07065.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Ochiai A, 2006, ACTA CRYSTALLOGR F, V62, P486, DOI 10.1107/S1744309106014333; Ochiai A, 2007, J BIOL CHEM, V282, P37134, DOI 10.1074/jbc.M704663200; Ochiai A, 2007, APPL ENVIRON MICROB, V73, P3803, DOI 10.1128/AEM.00147-07; Ochiai A, 2006, RES MICROBIOL, V157, P642, DOI 10.1016/j.resmic.2006.02.006; Ochiai A, 2009, J BIOL CHEM, V284, P10181, DOI 10.1074/jbc.M807799200; Ogura K, 2008, J MOL BIOL, V380, P373, DOI 10.1016/j.jmb.2008.05.008; Ogura K, 2009, J BIOL CHEM, V284, P35572, DOI 10.1074/jbc.M109.068056; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Rigden DJ, 2003, J BIOL CHEM, V278, P50596, DOI 10.1074/jbc.M307596200; Shaya D, 2006, J BIOL CHEM, V281, P15525, DOI 10.1074/jbc.M512055200; Suda K, 1999, FEMS MICROBIOL LETT, V180, P45, DOI 10.1016/S0378-1097(99)00459-0; Suzuki H, 2006, CARBOHYD RES, V341, P1809, DOI 10.1016/j.carres.2006.04.032; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; WEISSBACH A, 1959, J BIOL CHEM, V234, P705; Wong TY, 2000, ANNU REV MICROBIOL, V54, P289, DOI 10.1146/annurev.micro.54.1.289; Yoon HJ, 2001, J MOL BIOL, V307, P9, DOI 10.1006/jmbi.2000.4509; YOON HJ, 2010, PROTEIN EXPRES PURIF, V19, P84	50	72	76	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24519	24528		10.1074/jbc.M110.125450	http://dx.doi.org/10.1074/jbc.M110.125450			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20507980	hybrid, Green Published			2022-12-27	WOS:000280542100024
J	Lee, WY; Hampson, P; Coulthard, L; Ali, F; Salmon, M; Lord, JM; Scheel-Toellner, D				Lee, Wing-yiu; Hampson, Peter; Coulthard, Lydia; Ali, Farrah; Salmon, Mike; Lord, Janet M.; Scheel-Toellner, Dagmar			Novel Antileukemic Compound Ingenol 3-Angelate Inhibits T Cell Apoptosis by Activating Protein Kinase C theta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; PKC-THETA; CENTRAL MEMORY; LYMPHOCYTES; SURVIVAL; FAMILY; BIM; COSTIMULATION; CHEMOTHERAPY; CD4(+)	Members of the protein kinase C (PKC) family of serine-threonine kinases are important regulators of immune cell survival. Ingenol 3-angelate (PEP005) activates a broad range of PKC isoforms and induces apoptosis in acute myeloid leukemia cells by activating the PKC isoform PKC delta. We show here that, in contrast to its effect on leukemic cells, PEP005 provides a strong survival signal to resting and activated human T cells. The antiapoptotic effect depends upon the activation of PKC theta. This PKC isoform is expressed in T cells but is absent in myeloid cells. Further studies of the mechanism involved in this process showed that PEP005 inhibited activated CD8(+) T cell apoptosis through the activation of NF kappa B downstream of PKC theta, leading to increased expression of the antiapoptotic proteins Mcl-1 and Bcl-x(L). Transfection of CD8(+) T cells with dominant-negative PKC theta diminished the prosurvival effect of PEP005 significantly. Ectopic expression of PKC theta in the acute myeloid leukemia cell line NB4 turned their response to PEP005 from an increased to decreased rate of apoptosis. Therefore, in contrast to myeloid leukemia cells, PEP005 provides a strong survival signal to T cells, and the expression of functional PKC theta influences whether PKC activation leads to an anti-or proapoptotic outcome in the cell types tested.	[Scheel-Toellner, Dagmar] Univ Birmingham, Rheumatol Res Grp, MRC,Inst Biomed Res, Ctr Immune Regulat,Sch Immun & Infect, Birmingham B15 2TT, W Midlands, England; [Coulthard, Lydia] Univ Leeds, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England	University of Birmingham; University of Leeds	Scheel-Toellner, D (corresponding author), Univ Birmingham, Rheumatol Res Grp, MRC,Inst Biomed Res, Ctr Immune Regulat,Sch Immun & Infect, Birmingham B15 2TT, W Midlands, England.	d.scheel@bham.ac.uk	Lee, Wing-Yiu/AAC-8824-2019	Lee, Wing-Yiu/0000-0002-8524-3874; Lord, Janet/0000-0003-1030-6786; Johnson, Lydia/0000-0002-2122-3479	Arthritis Research UK; European Commission [LSHB-CT-2004-503467]; Peplin, Inc.; Birmingham University; Medical Research Council [G9818340B] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); European Commission(European CommissionEuropean Commission Joint Research Centre); Peplin, Inc.; Birmingham University; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by an Arthritis Research UK Career Development Fellowship (to D.S.-T.), an Arthritis Research UK programme grant (to M.S. and J.M.L.), the European Commission (LSHB-CT-2004-503467), a project grant from Peplin, Inc., and a Birmingham University PhD studentship ( to W.-y.L.).	BAIER G, 1993, J BIOL CHEM, V268, P4997; BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842; Barouch-Bentov R, 2005, J IMMUNOL, V175, P5126, DOI 10.4049/jimmunol.175.8.5126; Bosque A, 2007, MOL IMMUNOL, V44, P1446, DOI 10.1016/j.molimm.2006.04.029; Challacombe JM, 2006, J IMMUNOL, V177, P8123, DOI 10.4049/jimmunol.177.11.8123; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Cross T, 2000, ONCOGENE, V19, P2331, DOI 10.1038/sj.onc.1203555; Deacon EM, 1997, J CLIN PATHOL-MOL PA, V50, P124, DOI 10.1136/mp.50.3.124; DUKE RC, 1986, LYMPHOKINE RES, V5, P289; Ersvaer E, 2007, CANCER IMMUNOL IMMUN, V56, P913, DOI 10.1007/s00262-006-0236-5; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; GILLIS S, 1980, J EXP MED, V152, P1709, DOI 10.1084/jem.152.6.1709; Green A C, 1988, Australas J Dermatol, V29, P127, DOI 10.1111/j.1440-0960.1988.tb00383.x; Hampson P, 2005, BLOOD, V106, P1362, DOI 10.1182/blood-2004-10-4117; Hildeman DA, 2002, CURR OPIN IMMUNOL, V14, P354, DOI 10.1016/S0952-7915(02)00335-7; Kedei N, 2004, CANCER RES, V64, P3243, DOI 10.1158/0008-5472.CAN-03-3403; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Lopes AR, 2008, J CLIN INVEST, V118, P1835, DOI 10.1172/JCI33402; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; Manicassamy S, 2006, J IMMUNOL, V176, P6709, DOI 10.4049/jimmunol.176.11.6709; MOHR H, 1987, IMMUNOBIOLOGY, V175, P420, DOI 10.1016/S0171-2985(87)80070-0; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; OSADA S, 1992, MOL CELL BIOL, V12, P3930, DOI 10.1128/MCB.12.9.3930; Saibil SD, 2007, J IMMUNOL, V178, P2932, DOI 10.4049/jimmunol.178.5.2932; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Scheel-Toellner D, 2008, APOPTOSIS, V13, P109, DOI 10.1007/s10495-007-0143-z; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Thuille N, 2005, EMBO J, V24, P3869, DOI 10.1038/sj.emboj.7600856; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; WEEDON D, 1976, MED J AUSTRALIA, V1, P928, DOI 10.5694/j.1326-5377.1976.tb141173.x; Zhu YN, 2004, P NATL ACAD SCI USA, V101, P7681, DOI 10.1073/pnas.0402293101	33	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23889	23898		10.1074/jbc.M109.041962	http://dx.doi.org/10.1074/jbc.M109.041962			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20472553	Green Published, hybrid			2022-12-27	WOS:000280291400039
J	Okada, S; Muto, A; Ogawa, E; Nakanome, A; Katoh, Y; Ikawa, S; Aiba, S; Igarashi, K; Okuyama, R				Okada, Shuko; Muto, Akihiko; Ogawa, Eisaku; Nakanome, Ayako; Katoh, Yasutake; Ikawa, Shuntaro; Aiba, Setsuya; Igarashi, Kazuhiko; Okuyama, Ryuhei			Bach1-dependent and -independent Regulation of Heme Oxygenase-1 in Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION REPRESSOR BACH1; OXIDATIVE STRESS; GENETIC ABLATION; NUCLEAR EXPORT; FACTOR BLIMP-1; SKIN DISEASES; STEM-CELLS; DIFFERENTIATION; EXPRESSION; PSORIASIS	Bach1 is a member of the basic leucine zipper transcription factor family, and the Bach1/small Maf heterodimer specifically represses transcriptional activity directed by the Maf recognition element (MARE). Because Bach1 is a repressor of the oxidative stress response, we examined the function(s) of Bach1 in keratinocytes subjected to oxidative stress. Oxidative stress induced by H2O2 led to an increase in MARE activity and expression of heme oxygenase-1 (HO-1), an inducible antioxidant defense enzyme. Bach1 depletion by small interfering RNAs or by deletion of Bach1 enhanced HO-1 expression in the absence of H2O2, indicating that Bach1 is a critical repressor of HO-1 in keratinocytes. Although Bach1-deficient or -reduced keratinocytes expressed higher levels of HO-1 than control cells in response to H2O2, Bach1 down-regulation did not attenuate the production of reactive oxygen species by H2O2. In contrast, Bach1 overexpression abolished HO-1 induction by H2O2, which led to increased reactive oxygen species accumulation. HO-1 was induced during keratinocyte differentiation, but MARE activity did not change during differentiation. Furthermore, Bach1 overexpression did not inhibit differentiation-associated induction of HO-1 expression, suggesting that HO-1 induction in differentiation is independent of Bach1. Thus, in response to oxidative stress, Bach1 regulates the oxidation state through the negative control of HO-1 expression prior to terminal keratinocyte differentiation. However, Bach1-mediated repression is negated during keratinocyte differentiation.	[Aiba, Setsuya; Okuyama, Ryuhei] Tohoku Univ, Grad Sch Med, Dept Dermatol, Sendai, Miyagi 9808574, Japan; [Muto, Akihiko; Nakanome, Ayako; Katoh, Yasutake; Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Dept Biochem, Sendai, Miyagi 9808574, Japan; [Ikawa, Shuntaro] Tohoku Univ, Ikawa Grp, Interdisciplinary Res Ctr, Sendai, Miyagi 9808578, Japan; [Okuyama, Ryuhei] Shinshu Univ, Sch Med, Dept Dermatol, Matsumoto, Nagano 3908621, Japan	Tohoku University; Tohoku University; Tohoku University; Shinshu University	Okuyama, R (corresponding author), 3-1-1 Asahi, Nagano 3908621, Japan.	rokuyama@shinshu-u.ac.jp	井川, 俊太郎/L-5911-2015	Igarashi, Kazuhiko/0000-0002-2470-2475	Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government	Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government.	Alam J, 2000, J BIOL CHEM, V275, P27694; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; Briganti S, 2003, J EUR ACAD DERMATOL, V17, P663, DOI 10.1046/j.1468-3083.2003.00751.x; Dohi Y, 2008, NAT STRUCT MOL BIOL, V15, P1246, DOI 10.1038/nsmb.1516; Dotto GP, 1999, CRIT REV ORAL BIOL M, V10, P442; Duckers HJ, 2001, NAT MED, V7, P693, DOI 10.1038/89068; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Fuchs E, 2008, J CELL BIOL, V180, P273, DOI 10.1083/jcb.200708185; Hanselmann C, 2001, BIOCHEM J, V353, P459, DOI 10.1042/0264-6021:3530459; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Hintze KJ, 2007, J BIOL CHEM, V282, P34365, DOI 10.1074/jbc.M700254200; Igarashi K, 2006, ANTIOXID REDOX SIGN, V8, P107, DOI 10.1089/ars.2006.8.107; IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0; Ishikawa M, 2005, FREE RADICAL BIO MED, V38, P1344, DOI 10.1016/j.freeradbiomed.2005.01.021; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Kawachi Y, 2008, J INVEST DERMATOL, V128, P1773, DOI 10.1038/sj.jid.5701245; Khor TO, 2006, CANCER RES, V66, P11580, DOI 10.1158/0008-5472.CAN-06-3562; Ma LJ, 2009, ARCH DERMATOL RES, V301, P459, DOI 10.1007/s00403-009-0956-4; Magnusdottir E, 2007, P NATL ACAD SCI USA, V104, P14988, DOI 10.1073/pnas.0707323104; Motohashi H, 2007, CANCER SCI, V98, P135, DOI 10.1111/j.1349-7006.2006.00358.x; Muto A, 2004, NATURE, V429, P566, DOI 10.1038/nature02596; Numata I, 2009, J INVEST DERMATOL, V129, P2594, DOI 10.1038/jid.2009.119; Ochiai K, 2008, INT IMMUNOL, V20, P453, DOI 10.1093/intimm/dxn005; Ochiai K, 2006, J BIOL CHEM, V281, P38226, DOI 10.1074/jbc.M607592200; Odaka Y, 2000, BIOCHEM PHARMACOL, V59, P871, DOI 10.1016/S0006-2952(99)00386-X; Ogawa E, 2008, J BIOL CHEM, V283, P34241, DOI 10.1074/jbc.M804101200; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Okuyama R, 2007, ONCOGENE, V26, P4478, DOI 10.1038/sj.onc.1210235; Okuyama R, 2008, J DERMATOL SCI, V49, P187, DOI 10.1016/j.jdermsci.2007.05.017; Omura S, 2005, GENES CELLS, V10, P277, DOI 10.1111/j.1365-2443.2005.00832.x; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Reichard JF, 2008, J BIOL CHEM, V283, P22363, DOI 10.1074/jbc.M801784200; Shibahara S, 2003, TOHOKU J EXP MED, V200, P167, DOI 10.1620/tjem.200.167; Soares MP, 1998, NAT MED, V4, P1073, DOI 10.1038/2063; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Suzuki H, 2004, EMBO J, V23, P2544, DOI 10.1038/sj.emboj.7600248; Suzuki H, 2003, J BIOL CHEM, V278, P49246, DOI 10.1074/jbc.M306764200; Takahashi T, 2007, MINI-REV MED CHEM, V7, P745; VILE GF, 1994, P NATL ACAD SCI USA, V91, P2607, DOI 10.1073/pnas.91.7.2607; Wagener FADTG, 2003, BLOOD, V102, P521, DOI 10.1182/blood-2002-07-2248; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Wojas-Pelc A, 2007, INT J EXP PATHOL, V88, P95, DOI 10.1111/j.1365-2613.2006.00505.x; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Yano Y, 2006, GENES CELLS, V11, P791, DOI 10.1111/j.1365-2443.2006.00979.x; Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.02415-06; Zenz R, 2006, INT J BIOCHEM CELL B, V38, P1043, DOI 10.1016/j.biocel.2005.11.011; Zhong JL, 2010, FREE RADICAL BIO MED, V48, P196, DOI 10.1016/j.freeradbiomed.2009.10.037	50	21	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23581	23589		10.1074/jbc.M109.068197	http://dx.doi.org/10.1074/jbc.M109.068197			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20501657	hybrid, Green Published			2022-12-27	WOS:000280291400007
J	Ranguelova, K; Chatterjee, S; Ehrenshaft, M; Ramirez, DC; Summers, FA; Kadiiska, MB; Mason, RP				Ranguelova, Kalina; Chatterjee, Saurabh; Ehrenshaft, Marilyn; Ramirez, Dario C.; Summers, Fiona A.; Kadiiska, Maria B.; Mason, Ronald P.			Protein Radical Formation Resulting from Eosinophil Peroxidase-catalyzed Oxidation of Sulfite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELOPEROXIDASE COMPOUND-I; HYDROGEN-PEROXIDE; HORSERADISH-PEROXIDASE; SULFUR-DIOXIDE; MOLYBDENUM COFACTOR; THYROID PEROXIDASE; SO5-RADICALS; OXIDASE; THIOCYANATE; ANION	Eosinophil peroxidase (EPO) is an abundant heme protein in eosinophils that catalyzes the formation of cytotoxic oxidants implicated in asthma, allergic inflammatory disorders, and cancer. It is known that some proteins with peroxidase activity (horseradish peroxidase and prostaglandin hydroperoxidase) can catalyze oxidation of bisulfite (hydrated sulfur dioxide), leading to the formation of sulfur trioxide anion radical ((SO3-)-S-center dot). This free radical further reacts with oxygen to form peroxymonosulfate anion radical ((O3SOO center dot)-O-center dot) and the very reactive sulfate anion radical (SO4(sic)), which is nearly as strong an oxidant as the hydroxyl radical. However, the ability of EPO to generate reactive sulfur radicals has not yet been reported. Here we demonstrate that eosinophil peroxidase/H2O2 is able to oxidize bisulfite, ultimately forming the sulfate anion radical (SO4(sic)), and that these reactive intermediates can oxidize target proteins to protein radicals, thereby initiating protein oxidation. We used immuno-spin trapping and confocal microscopy to study protein oxidation by EPO/H2O2 in the presence of bisulfite in a pure enzymatic system and in human promyelocytic leukemia HL-60 clone 15 cells, maturated to eosinophils. Polyclonal antiserum raised against the spin trap 5,5dimethyl- 1-pyrroline N-oxide (DMPO) detected the presence of DMPO covalently attached to the proteins resulting from the DMPO trapping of protein free radicals. We found that sulfite oxidation mediated by EPO/H2O2 induced the formation of radical-derived DMPO spin-trapped human serum albumin and, to a lesser extent, of DMPO-EPO. These studies suggest that EPO-dependent oxidative damage may play a role in tissue injury in bisulfite-exacerbated eosinophilic inflammatory disorders.	[Ranguelova, Kalina; Kadiiska, Maria B.; Mason, Ronald P.] NIEHS, Pharmacol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Ramirez, Dario C.] Oklahoma Med Res Fdn, Free Radical Biol & Aging Res Program, Oklahoma City, OK 73104 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Oklahoma Medical Research Foundation	Ranguelova, K (corresponding author), NIEHS, Pharmacol Lab, NIH, MD F0-02,POB 12233, Res Triangle Pk, NC 27709 USA.	RanguelovaK@niehs.nih.gov	Mason, Ronald P/G-5967-2019; Kadiiska, Maria B./AAC-9981-2019; RAMIREZ, DARIO C/K-3312-2013	Mason, Ronald P/0000-0002-1859-9109; RAMIREZ, DARIO C/0000-0001-6725-3326	National Institutes of Health, NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050117, ZIAES050139] Funding Source: NIH RePORTER	National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, NIEHS.	ACOSTA R, 1989, ANN ALLERGY, V62, P402; AGOSTI JM, 1987, J ALLERGY CLIN IMMUN, V79, P496, DOI 10.1016/0091-6749(87)90368-X; ARAISO T, 1976, BIOCHEMISTRY-US, V15, P3059, DOI 10.1021/bi00659a019; Arlandson M, 2001, J BIOL CHEM, V276, P215, DOI 10.1074/jbc.M004881200; Arnhold J, 2001, EUR J BIOCHEM, V268, P5142, DOI 10.1046/j.0014-2956.2001.02449.x; Arnhold J, 2006, EUR J INORG CHEM, P3801, DOI 10.1002/ejic.200600436; BOLSCHER BGJM, 1984, BIOCHIM BIOPHYS ACTA, V784, P177, DOI 10.1016/0167-4838(84)90125-0; Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; COHEN HJ, 1973, P NATL ACAD SCI USA, V70, P3655, DOI 10.1073/pnas.70.12.3655; COHEN HJ, 1971, J BIOL CHEM, V246, P359; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Detweiler CD, 2002, FREE RADICAL BIO MED, V33, P364, DOI 10.1016/S0891-5849(02)00895-X; DULING DR, 1994, J MAGN RESON SER B, V104, P105, DOI 10.1006/jmrb.1994.1062; Ehrenshaft M, 2006, FREE RADICAL BIO MED, V41, P422, DOI 10.1016/j.freeradbiomed.2006.02.023; FISCHKOFF SA, 1988, LEUKEMIA RES, V12, P679, DOI 10.1016/0145-2126(88)90103-8; FRIDOVICH I, 1961, J BIOL CHEM, V236, P1836; Furtmuller PG, 2001, BBA-PROTEIN STRUCT M, V1548, P121, DOI 10.1016/S0167-4838(01)00230-8; Furtmuller PG, 2000, BIOCHEMISTRY-US, V39, P15578, DOI 10.1021/bi0020271; Furtmuller PG, 1998, BIOCHEMISTRY-US, V37, P17923, DOI 10.1021/bi9818772; GUNNISON AF, 1974, AM IND HYG ASSOC J, V35, P288, DOI 10.1080/0002889748507036; GUNNISON AF, 1981, FOOD COSMET TOXICOL, V19, P667, DOI 10.1016/0015-6264(81)90519-8; HAYON E, 1972, J AM CHEM SOC, V94, P47, DOI 10.1021/ja00756a009; HOLTZMAN JL, 1976, ANAL CHEM, V48, P229, DOI 10.1021/ac60365a048; HORWITZ RJ, 1995, CLIN CHEST MED, V16, P583; HUIE RE, 1984, J PHYS CHEM-US, V88, P5665, DOI 10.1021/j150667a042; JI AJ, 1995, CLIN CHEM, V41, P897; JOHNSON JL, 1980, P NATL ACAD SCI-BIOL, V77, P3715, DOI 10.1073/pnas.77.6.3715; KOHLER H, 1988, ARCH BIOCHEM BIOPHYS, V264, P438, DOI 10.1016/0003-9861(88)90309-8; LESTER MR, 1995, J AM COLL NUTR, V14, P229; Lu T, 2008, BRIT J PHARMACOL, V154, P1308, DOI 10.1038/bjp.2008.173; MARQUEZ LA, 1994, BIOCHEMISTRY-US, V33, P1447, DOI 10.1021/bi00172a022; Mason RP, 2004, FREE RADICAL BIO MED, V36, P1214, DOI 10.1016/j.freeradbiomed.2004.02.077; Mitsuhashi H, 2001, CLIN CHEM, V47, P1872; MOTTLEY C, 1988, ARCH BIOCHEM BIOPHYS, V267, P681, DOI 10.1016/0003-9861(88)90077-X; MOTTLEY C, 1982, MOL PHARMACOL, V22, P732; MOTTLEY C, 1982, J BIOL CHEM, V257, P5050; Nagy P, 2006, CHEM RES TOXICOL, V19, P587, DOI 10.1021/tx050338c; NETA P, 1988, J PHYS CHEM REF DATA, V17, P1027, DOI 10.1063/1.555808; NETA P, 1985, ENVIRON HEALTH PERSP, V64, P209, DOI 10.2307/3430011; Niknahad H, 2008, CHEM-BIOL INTERACT, V174, P147, DOI 10.1016/j.cbi.2008.05.032; OSHINO N, 1975, ARCH BIOCHEM BIOPHYS, V170, P514, DOI 10.1016/0003-9861(75)90147-2; RALL D P, 1974, Environmental Health Perspectives, V8, P97, DOI 10.2307/3428194; Ramirez DC, 2005, FREE RADICAL BIO MED, V38, P201, DOI 10.1016/j.freeradbiomed.2004.10.008; Ramirez DC, 2003, FREE RADICAL BIO MED, V34, P830, DOI 10.1016/S0891-5849(02)01437-5; Ranguelova K, 2008, BIOCHEMISTRY-US, V47, P11377, DOI 10.1021/bi800952b; Ranguelova K, 2009, FREE RADICAL BIO MED, V47, P128, DOI 10.1016/j.freeradbiomed.2009.04.006; REED GA, 1986, P NATL ACAD SCI USA, V83, P7499, DOI 10.1073/pnas.83.19.7499; ROMAN R, 1973, CAN J CHEM, V51, P588, DOI 10.1139/v73-089; Schwarz G, 2005, CELL MOL LIFE SCI, V62, P2792, DOI 10.1007/s00018-005-5269-y; SHIH VE, 1977, NEW ENGL J MED, V297, P1022, DOI 10.1056/NEJM197711102971902; SLUNGAARD A, 1991, J EXP MED, V173, P117, DOI 10.1084/jem.173.1.117; SLUNGAARD A, 1991, J BIOL CHEM, V266, P4903; STEELE WV, 1982, J CHEM THERMODYN, V14, P337, DOI 10.1016/0021-9614(82)90052-0; WARDLAW AJ, 1994, POSTGRAD MED J, V70, P536, DOI 10.1136/pgmj.70.826.536; WEISS SJ, 1986, SCIENCE, V234, P200, DOI 10.1126/science.3018933; WILKINS JW, 1968, CLIN PHARMACOL THER, V9, P328; YOKOYAMA E, 1971, ARCH ENVIRON HEALTH, V22, P389, DOI 10.1080/00039896.1971.10665861	57	47	47	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24195	24205		10.1074/jbc.M109.069054	http://dx.doi.org/10.1074/jbc.M109.069054			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20501663	Green Published, hybrid			2022-12-27	WOS:000280291400069
J	Venceslau, SS; Lino, RR; Pereira, IAC				Venceslau, Sofia S.; Lino, Rita R.; Pereira, Ines A. C.			The Qrc Membrane Complex, Related to the Alternative Complex III, Is a Menaquinone Reductase Involved in Sulfate Respiration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DESULFOVIBRIO-VULGARIS HILDENBOROUGH; SITE-DIRECTED MUTAGENESIS; GENE-EXPRESSION ANALYSIS; COLI FUMARATE REDUCTASE; ESCHERICHIA-COLI; ELECTRON-TRANSFER; DESULFURICANS ATCC-27774; FORMATE DEHYDROGENASE; BACTERIAL RESPIRATION; RHODOTHERMUS-MARINUS	Biological sulfate reduction is a process with high environmental significance due to its major contribution to the carbon and sulfur cycles in anaerobic environments. However, the respiratory chain of sulfate-reducing bacteria is still poorly understood. Here we describe a new respiratory complex that was isolated as a major protein present in the membranes of Desulfovibrio vulgaris Hildenborough. The complex, which was named Qrc, is the first representative of a new family of redox complexes. It has three subunits related to the complex iron-sulfur molybdoenzyme family and a multiheme cytochrome c and binds six hemes c, one [3Fe-4S](+1/0) cluster, and several interacting [4Fe-4S](2+/1+) clusters but no molybdenum. Qrc is related to the alternative complex III, and we show that it has the reverse catalytic activity, acting as a Type I cytochrome c(3):menaquinone oxidoreductase. The qrc genes are found in the genomes of deltaproteobacterial sulfate reducers, which have periplasmic hydrogenases and formate dehydrogenases that lack a membrane subunit for reduction of the quinone pool. In these organisms, Qrc acts as a menaquinone reductase with electrons from periplasmic hydrogen or formate oxidation. Binding of a menaquinone analogue affects the EPR spectrum of the [3Fe-4S](+1/0) cluster, indicating the presence of a quinone-binding site close to the periplasmic subunits. Qrc is the first respiratory complex from sulfate reducers to have its physiological function clearly elucidated.	[Pereira, Ines A. C.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, EAN, P-2780157 Oeiras, Portugal	Universidade Nova de Lisboa	Pereira, IAC (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, EAN, Av Republ, P-2780157 Oeiras, Portugal.	ipereira@itqb.unl.pt	Pereira, Inês/C-2748-2009; Venceslau, Sofia/M-2882-2016	Pereira, Inês/0000-0003-3283-4520; Venceslau, Sofia/0000-0001-8774-1351	Fundacao para a Ciencia e Tecnologia (FCT, MCTES, Portugal) [PTDC/QUI/68368/2006]; FEDER	Fundacao para a Ciencia e Tecnologia (FCT, MCTES, Portugal)(Portuguese Foundation for Science and Technology); FEDER(European Commission)	This work was supported by Research Grant PTDC/QUI/68368/2006 funded by Fundacao para a Ciencia e Tecnologia (FCT, MCTES, Portugal) and FEDER program.	Baymann F, 2003, PHILOS T ROY SOC B, V358, P267, DOI 10.1098/rstb.2002.1184; Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; Pereira IAC, 2008, MICROBIAL SULFUR METABOLISM, P24, DOI 10.1007/978-3-540-72682-1_3; Cheng VWT, 2005, BIOCHEMISTRY-US, V44, P8068, DOI 10.1021/bi050362p; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Gao XL, 2009, FEBS LETT, V583, P3275, DOI 10.1016/j.febslet.2009.09.022; GUIGLIARELLI B, 1992, EUR J BIOCHEM, V207, P61, DOI 10.1111/j.1432-1033.1992.tb17020.x; Haveman SA, 2003, J BACTERIOL, V185, P4345, DOI 10.1128/JB.185.15.4345-4353.2003; Haveman SA, 2004, J BACTERIOL, V186, P7944, DOI 10.1128/JB.186.23.7944-7950.2004; Heidelberg JF, 2004, NAT BIOTECHNOL, V22, P554, DOI 10.1038/nbt959; Jormakka M, 2003, FEBS LETT, V545, P25, DOI 10.1016/S0014-5793(03)00389-2; Jormakka M, 2002, SCIENCE, V295, P1863, DOI 10.1126/science.1068186; Jormakka M, 2008, NAT STRUCT MOL BIOL, V15, P730, DOI 10.1038/nsmb.1434; Li XZ, 2009, J BACTERIOL, V191, P2675, DOI 10.1128/JB.01814-08; MANODORI A, 1992, BIOCHEMISTRY-US, V31, P2703, DOI 10.1021/bi00125a010; Matias PM, 2005, PROG BIOPHYS MOL BIO, V89, P292, DOI 10.1016/j.pbiomolbio.2004.11.003; McInerney MJ, 2007, P NATL ACAD SCI USA, V104, P7600, DOI 10.1073/pnas.0610456104; Muyzer G, 2008, NAT REV MICROBIOL, V6, P441, DOI 10.1038/nrmicro1892; Oliveira TF, 2008, J BIOL CHEM, V283, P34141, DOI 10.1074/jbc.M805643200; Pereira IAC, 1998, J BIOL INORG CHEM, V3, P494, DOI 10.1007/s007750050259; Pereira IAC, 2007, SULPHATE-REDUCING BACTERIA: ENVIRONMENTAL AND ENGINEERED SYSTEMS, P215, DOI 10.1017/CBO9780511541490.008; Pereira MM, 2007, FEBS LETT, V581, P4831, DOI 10.1016/j.febslet.2007.09.008; Pereira MM, 1999, BIOCHEMISTRY-US, V38, P1268, DOI 10.1021/bi9818063; Pereira PM, 2008, ANTON LEEUW INT J G, V93, P347, DOI 10.1007/s10482-007-9212-0; Pereira PM, 2006, BIOCHEMISTRY-US, V45, P10359, DOI 10.1021/bi0610294; Pires RH, 2006, BIOCHEMISTRY-US, V45, P249, DOI 10.1021/bi0515265; Pires RH, 2003, BBA-BIOENERGETICS, V1605, P67, DOI 10.1016/S0005-2728(03)00065-3; Rabus R, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P659, DOI 10.1007/0-387-30742-7_22; REFOJO PN, 2010, BIOCH BIOPH IN PRESS; Richardson DJ, 2000, MICROBIOL-SGM, V146, P551, DOI 10.1099/00221287-146-3-551; ROSSI M, 1993, J BACTERIOL, V175, P4699, DOI 10.1128/JB.175.15.4699-4711.1993; Rothery RA, 1996, BIOCHEMISTRY-US, V35, P3247, DOI 10.1021/bi951584y; Rothery RA, 2005, FEBS J, V272, P313, DOI 10.1111/j.1742-4658.2004.04469.x; Rothery RA, 1998, J BIOL CHEM, V273, P7462, DOI 10.1074/jbc.273.13.7462; Rothery RA, 2008, BBA-BIOMEMBRANES, V1778, P1897, DOI 10.1016/j.bbamem.2007.09.002; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; SEBBAN C, 1995, FEMS MICROBIOL LETT, V133, P143, DOI 10.1111/j.1574-6968.1995.tb07875.x; Shen YA, 2001, NATURE, V410, P77, DOI 10.1038/35065071; Simon J, 2008, BIOCHEM SOC T, V36, P1011, DOI 10.1042/BST0361011; Simon J, 2008, BBA-BIOENERGETICS, V1777, P1480, DOI 10.1016/j.bbabio.2008.09.008; Stolyar S, 2007, J BACTERIOL, V189, P8944, DOI 10.1128/JB.00284-07; Valente FMA, 2001, CHEMBIOCHEM, V2, P895, DOI 10.1002/1439-7633(20011203)2:12<895::AID-CBIC895>3.0.CO;2-V; Yanyushin MF, 2005, BIOCHEMISTRY-US, V44, P10037, DOI 10.1021/bi047267l; Zhang WW, 2006, PROTEOMICS, V6, P4286, DOI 10.1002/pmic.200500930	44	70	73	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22772	22781		10.1074/jbc.M110.124305	http://dx.doi.org/10.1074/jbc.M110.124305			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20498375	Green Published, hybrid			2022-12-27	WOS:000279999900009
J	Li, G; Shi, Y; Huang, HS; Zhang, YP; Wu, KP; Luo, JS; Sun, Y; Lu, JX; Benovic, JL; Zhou, NM				Li, Guo; Shi, Ying; Huang, Haishan; Zhang, Yaping; Wu, Kuangpei; Luo, Jiansong; Sun, Yi; Lu, Jianxin; Benovic, Jeffrey L.; Zhou, Naiming			Internalization of the Human Nicotinic Acid Receptor GPR109A Is Regulated by G(i), GRK2, and Arrestin3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; BETA-GAMMA-SUBUNITS; MUSCARINIC ACETYLCHOLINE-RECEPTOR; MOLECULAR-IDENTIFICATION; FATTY-ACIDS; DESENSITIZATION; KINASE; SEQUESTRATION; AGONIST; ENDOCYTOSIS	Nicotinic acid (niacin) has been widely used as a favorable lipid-lowering drug for several decades, and the orphan G protein-coupled receptor GPR109A has been identified to be a receptor for niacin. Mechanistic investigations have shown that as a G(i)-coupled receptor, GPR109A inhibits adenylate cyclase activity upon niacin activation, thereby inhibiting free fatty acid liberation. However, the underlying molecular mechanisms that regulate signaling and internalization of GPR109A remain largely unknown. To further characterize GPR109A internalization, we made a construct to express GPR109A fused with enhanced green fluorescent protein (EGFP) at its carboxyl-terminal end. In stable GPR109A-EGFP-expressing HEK-293 cells, GPR109A-EGFP was mainly localized at the plasma membrane and was rapidly internalized in a dose-and time-dependent manner upon agonist stimulation. GPR109A internalization was completely blocked by hypertonic sucrose, indicating that GPR109A internalizes via the clathrin-coated pit pathway. Further investigation demonstrated that internalized GPR109A was recycled to the cell surface after the removal of agonist, and recycling of the internalized receptors was not blocked by treatment with acidotropic agents, NH4Cl and monensin. Pertussis toxin pretreatment not only inhibited forskolin-induced cAMP accumulation and intracellular Ca2+ mobilization; it also significantly attenuated agonist-promoted GPR109A internalization. Moreover, RNA interference experiments showed that knockdown of GRK2 (G protein-coupled receptor kinase 2) and arrestin3 expression significantly impaired receptor internalization. Taken together, these results indicate that the agonist-induced internalization of GPR109A receptors is regulated by GRK2 and arrestin3 in a pertussis toxin-sensitive manner and that internalized receptor recycling is independent of endosomal acidification.	[Li, Guo; Shi, Ying; Huang, Haishan; Zhang, Yaping; Sun, Yi; Zhou, Naiming] Zhejiang Univ, Coll Life Sci, Inst Biochem, Hangzhou 310058, Zhejiang, Peoples R China; [Wu, Kuangpei; Lu, Jianxin] Wenzhou Med Coll, Sch Lab Med & Life Sci, Zhejiang Prov Key Lab Med Genet, Wenzhou 325035, Zhejiang, Peoples R China; [Luo, Jiansong; Benovic, Jeffrey L.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	Zhejiang University; Wenzhou Medical University; Jefferson University	Zhou, NM (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Biochem, Zijingang Campus,388 Yuhang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	znm2000@yahoo.com	Zhou, Naiming/AHC-1121-2022		National Institutes of Health [GM44944, GM47417]; National Natural Science Foundation of China [30670425]; Ministry of Science and Technology [2008AA02Z138]; Zhejiang Natural Science Foundation [Z2080207]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044944, R37GM047417, R01GM047417] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM44944 and GM47417. This work was also supported by National Natural Science Foundation of China Grant 30670425, Ministry of Science and Technology Grant 2008AA02Z138, and Zhejiang Natural Science Foundation Grant Z2080207.	Aramori I, 1997, EMBO J, V16, P4606, DOI 10.1093/emboj/16.15.4606; Bajaj M, 2004, J CLIN ENDOCR METAB, V89, P4649, DOI 10.1210/jc.2004-0224; Barlic J, 1999, J BIOL CHEM, V274, P16287, DOI 10.1074/jbc.274.23.16287; Benyo Z, 2005, J CLIN INVEST, V115, P3634, DOI 10.1172/JCI23626; BLUM CB, 1977, J CLIN INVEST, V60, P795, DOI 10.1172/JCI108833; Boden G, 1998, DIABETES, V47, P1609, DOI 10.2337/diabetes.47.10.1609; BOEKHOFF I, 1994, J BIOL CHEM, V269, P37; Cao TT, 1998, J BIOL CHEM, V273, P24592, DOI 10.1074/jbc.273.38.24592; Carlson LA, 2005, J INTERN MED, V258, P94, DOI 10.1111/j.1365-2796.2005.01528.x; Carman CV, 2000, J BIOL CHEM, V275, P10443, DOI 10.1074/jbc.275.14.10443; Chakrabarti S, 1997, MOL PHARMACOL, V52, P105, DOI 10.1124/mol.52.1.105; Daly CJ, 2003, PHARMACOL THERAPEUT, V100, P101, DOI 10.1016/j.pharmthera.2003.08.001; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; FERGUSON SSG, 1995, J BIOL CHEM, V270, P24782, DOI 10.1074/jbc.270.42.24782; FINK JS, 1988, P NATL ACAD SCI USA, V85, P6662, DOI 10.1073/pnas.85.18.6662; GRADY EF, 1995, MOL BIOL CELL, V6, P509, DOI 10.1091/mbc.6.5.509; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAGA K, 1992, J BIOL CHEM, V267, P2222; HARFORD J, 1983, J CELL BIOL, V96, P1824, DOI 10.1083/jcb.96.6.1824; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Hsieh C, 1999, J NEUROCHEM, V73, P493, DOI 10.1046/j.1471-4159.1999.0730493.x; Iwata K, 2005, J BIOL CHEM, V280, P2197, DOI 10.1074/jbc.M408834200; Kallal L, 2000, TRENDS PHARMACOL SCI, V21, P175, DOI 10.1016/S0165-6147(00)01477-2; Kamanna VS, 2007, AM J CARDIOL, V100, p53N, DOI 10.1016/j.amjcard.2007.09.080; Knopp RH, 1999, NEW ENGL J MED, V341, P498, DOI 10.1056/NEJM199908123410707; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; Liang W, 2004, J CELL SCI, V117, P723, DOI 10.1242/jcs.00878; LippincottSchwartz J, 1997, CURR OPIN NEUROBIOL, V7, P631, DOI 10.1016/S0959-4388(97)80082-7; Lorenzen A, 2001, MOL PHARMACOL, V59, P349, DOI 10.1124/mol.59.2.349; Luo JS, 2008, MOL PHARMACOL, V74, P338, DOI 10.1124/mol.107.044750; MELLMAN I, 1984, J CELL BIOL, V98, P1163, DOI 10.1083/jcb.98.4.1163; Menard L, 1997, MOL PHARMACOL, V51, P800, DOI 10.1124/mol.51.5.800; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; MORO O, 1993, J BIOL CHEM, V268, P6862; Mundell SJ, 2006, TRAFFIC, V7, P1420, DOI 10.1111/j.1600-0854.2006.00469.x; Olli-Lahdesmaki T, 2004, BIOCHEM BIOPH RES CO, V321, P226, DOI 10.1016/j.bbrc.2004.06.131; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; PALSRYLAARSDAM R, 1995, J BIOL CHEM, V270, P29004, DOI 10.1074/jbc.270.48.29004; Pheng LH, 2003, BRIT J PHARMACOL, V139, P695, DOI 10.1038/sj.bjp.0705306; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; RAY A, 1989, MOL CELL BIOL, V9, P5537, DOI 10.1128/MCB.9.12.5537; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Richman JG, 2007, J BIOL CHEM, V282, P18028, DOI 10.1074/jbc.M701866200; Santomauro ATMG, 1999, DIABETES, V48, P1836, DOI 10.2337/diabetes.48.9.1836; SCHVARTZ I, 1987, J BIOL CHEM, V262, P17046; Semple G, 2006, J MED CHEM, V49, P1227, DOI 10.1021/jm051099t; SHEPHERD J, 1979, J CLIN INVEST, V63, P858, DOI 10.1172/JCI109385; Soga T, 2003, BIOCHEM BIOPH RES CO, V303, P364, DOI 10.1016/S0006-291X(03)00342-5; TSUGA H, 1994, J BIOL CHEM, V269, P32522; TSUKADA T, 1987, J BIOL CHEM, V262, P8743; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; VAAG A, 1991, J CLIN INVEST, V88, P1282, DOI 10.1172/JCI115432; VANEPPS DE, 1992, J LEUKOCYTE BIOL, V51, P393, DOI 10.1002/jlb.51.4.393; Walters RW, 2009, J CLIN INVEST, V119, P1312, DOI 10.1172/JCI36806; Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200; Zhang YY, 2005, BIOCHEM BIOPH RES CO, V334, P729, DOI 10.1016/j.bbrc.2005.06.141	58	43	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22605	22618		10.1074/jbc.M109.087213	http://dx.doi.org/10.1074/jbc.M109.087213			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20460384	Green Published, hybrid			2022-12-27	WOS:000279702200071
J	Askew, EB; Bai, SX; Blackwelder, AJ; Wilson, EM				Askew, Emily B.; Bai, Suxia; Blackwelder, Amanda J.; Wilson, Elizabeth M.			Transcriptional Synergy between Melanoma Antigen Gene Protein-A11 (MAGE-11) and p300 in Androgen Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREB-BINDING-PROTEIN; COOH-TERMINAL INTERACTION; ACTIVATION FUNCTION 2; HISTONE ACETYLTRANSFERASE; COREGULATOR MAGE-11; UBIQUITIN LIGASE; PROSTATE-CANCER; DNA-BINDING; CBP; DOMAIN	Androgen receptor (AR)-mediated gene regulation involves interactions with coregulatory proteins that include the melanoma antigen gene protein-A11 (MAGE-11). To understand the functional significance of sequence similarity between MAGE-11 and the adenovirus early protein E1A, we determined whether MAGE-11 contributes to AR transcriptional activity through an interaction with p300, a potent and ubiquitous transcriptional regulator. Here, we report that MAGE-11 interacts with the NH2-terminal region of p300 through the MAGE-11 MXXIF motif (MXXIF189)-M-185, with transcriptional activity depending on the MAGE-11 F-box and MAPK phosphorylation. The MAGE-11- and p300-dependent increase in AR transactivation required the NH2-terminal regions of AR and p300, p300 acetyltransferase activity, and the AR FXXLF motif (23)FQNLF(27) interaction with MAGE-11. MAGE-11 linked AR to p300 and the p160 coactivator, transcriptional intermediary protein 2 (TIF2). The p300 NH2-terminal FXXLF motif (33F)GSLF(37) was required for transcriptional activation by TIF2. Increased expression of p300 decreased the ubiquitinylation of MAGE-11 and transiently increased endogenous MAGE-11 levels. Auto-acetylation of p300 and decreased acetylation of TIF2 were evident in the MAGE-11, p300, and TIF2 complex. The studies suggest that MAGE-11 links NH2-terminal domains of AR and p300 to promote transcriptional synergy through a cadre of FXXLF-related interacting motifs.	[Askew, Emily B.; Bai, Suxia; Blackwelder, Amanda J.; Wilson, Elizabeth M.] Univ N Carolina, Labs Reprod Biol, Chapel Hill, NC 27599 USA; [Askew, Emily B.; Wilson, Elizabeth M.] Univ N Carolina, Curriculum Toxicol, Chapel Hill, NC 27599 USA; [Askew, Emily B.; Bai, Suxia; Blackwelder, Amanda J.; Wilson, Elizabeth M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Bai, Suxia; Blackwelder, Amanda J.; Wilson, Elizabeth M.] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA; [Bai, Suxia; Wilson, Elizabeth M.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Wilson, EM (corresponding author), Univ N Carolina, Labs Reprod Biol, CB7500, Chapel Hill, NC 27599 USA.	emw@med.unc.edu	Askew, Eldon W/F-5347-2014		Eunice Kennedy Shriver NICHD [U54-HD35041]; NICHD (USPHS) [HD16910]; NCI [P01-CA77739]; Department of Defense [PC073586]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD035041, R01HD016910, R37HD016910] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA077739] Funding Source: NIH RePORTER	Eunice Kennedy Shriver NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD (USPHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)United States Public Health Service); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Cooperative Agreement U54-HD35041 from the Eunice Kennedy Shriver NICHD (Specialized Cooperative Centers Program in Reproduction and Infertility Research), Grant HD16910 from NICHD (USPHS), and by P01-CA77739 from the NCI. This work was also supported by Department of Defense PC073586 Fellowship Award.	Aarnisalo P, 1998, P NATL ACAD SCI USA, V95, P2122, DOI 10.1073/pnas.95.5.2122; Ait-Si-Ali S, 1998, NATURE, V396, P184, DOI 10.1038/24190; ARANY Z, 1995, NATURE, V374, P81, DOI 10.1038/374081a0; Askew EB, 2007, J BIOL CHEM, V282, P25801, DOI 10.1074/jbc.M703268200; Askew EB, 2009, J BIOL CHEM, V284, P34793, DOI 10.1074/jbc.M109.065979; Bai S, 2008, MOL HUM REPROD, V14, P107, DOI 10.1093/molehr/gam080; Bai S, 2008, MOL CELL BIOL, V28, P1947, DOI 10.1128/MCB.01672-07; Bai SX, 2005, MOL CELL BIOL, V25, P1238, DOI 10.1128/MCB.25.4.1238-1257.2005; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; Chakravarti D, 1999, CELL, V96, P393, DOI 10.1016/S0092-8674(00)80552-8; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Chen YJ, 2007, J BIOL CHEM, V282, P27215, DOI 10.1074/jbc.M700264200; Debes JD, 2002, CANCER RES, V62, P5632; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Finlan L, 2004, J BIOL CHEM, V279, P49395, DOI 10.1074/jbc.M405974200; Fronsdal K, 1998, J BIOL CHEM, V273, P31853, DOI 10.1074/jbc.273.48.31853; Fu MF, 2000, J BIOL CHEM, V275, P20853, DOI 10.1074/jbc.M000660200; Galbiati L, 2005, CELL CYCLE, V4, P930, DOI 10.4161/cc.4.7.1784; Giordano A, 1999, J CELL PHYSIOL, V181, P218, DOI 10.1002/(SICI)1097-4652(199911)181:2<218::AID-JCP4>3.0.CO;2-5; Goodman RH, 2000, GENE DEV, V14, P1553; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; HAYNES SR, 1992, NUCLEIC ACIDS RES, V20, P2603, DOI 10.1093/nar/20.10.2603; He B, 2002, J BIOL CHEM, V277, P25631, DOI 10.1074/jbc.M202809200; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; He B, 2004, MOL CELL, V16, P425, DOI 10.1016/j.molcel.2004.09.036; He B, 2003, MOL CELL BIOL, V23, P2135, DOI 10.1128/MCB.23.6.2135-2150.2003; He B, 2002, J BIOL CHEM, V277, P10226, DOI 10.1074/jbc.M111975200; He B, 1999, J BIOL CHEM, V274, P37219, DOI 10.1074/jbc.274.52.37219; He B, 2001, J BIOL CHEM, V276, P42293, DOI 10.1074/jbc.M107492200; Heemers HV, 2007, CANCER RES, V67, P3422, DOI 10.1158/0008-5472.CAN-06-2836; Hsu CL, 2003, J BIOL CHEM, V278, P23691, DOI 10.1074/jbc.M211908200; Huang WB, 1999, J BIOL CHEM, V274, P25756, DOI 10.1074/jbc.274.36.25756; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Jeanmougin F, 1997, TRENDS BIOCHEM SCI, V22, P151, DOI 10.1016/S0968-0004(97)01042-6; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Karpf AR, 2009, MOL CANCER RES, V7, P523, DOI 10.1158/1541-7786.MCR-08-0400; Kim J, 2005, J MOL ENDOCRINOL, V34, P107, DOI 10.1677/jme.1.01701; Langley E, 1998, J BIOL CHEM, V273, P92, DOI 10.1074/jbc.273.1.92; Legube G, 2003, EMBO REP, V4, P944, DOI 10.1038/sj.embor.embor941; Levy L, 2004, MOL CELL BIOL, V24, P3404, DOI 10.1128/MCB.24.8.3404-3414.2004; LUBAHN DB, 1988, MOL ENDOCRINOL, V2, P1265, DOI 10.1210/mend-2-12-1265; LUNDBLAD JR, 1995, NATURE, V374, P85, DOI 10.1038/374085a0; Matsuda S, 2004, J BIOL CHEM, V279, P14055, DOI 10.1074/jbc.M310188200; Muraoka M, 1996, ONCOGENE, V12, P1565; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P11, DOI 10.1016/0968-0004(96)80878-4; Rasti M, 2005, J VIROL, V79, P5594, DOI 10.1128/JVI.79.9.5594-5605.2005; Sheppard HM, 2001, MOL CELL BIOL, V21, P39, DOI 10.1128/MCB.21.1.39-50.2001; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Turnell AS, 2006, BRIT J CANCER, V95, P555, DOI 10.1038/sj.bjc.6603304; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Wagner BL, 1998, MOL CELL BIOL, V18, P1369, DOI 10.1128/MCB.18.3.1369; WHYTE P, 1989, CELL, V56, P67, DOI 10.1016/0092-8674(89)90984-7; Yuan LW, 2002, BBA-MOL CELL RES, V1592, P205, DOI 10.1016/S0167-4889(02)00327-0; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P208, DOI 10.1210/me.9.2.208; ZHOU ZX, 1994, J BIOL CHEM, V269, P13115	63	35	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21824	21836		10.1074/jbc.M110.120600	http://dx.doi.org/10.1074/jbc.M110.120600			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20448036	Green Published, hybrid			2022-12-27	WOS:000279516100067
J	Mauk, MR; Mauk, AG				Mauk, Marcia R.; Mauk, A. Grant			Metal Ions and Electrolytes Regulate the Dissociation of Heme from Human Hemopexin at Physiological pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED UPTAKE; PEPTIDE-BOND HYDROLYSIS; POLYMORPHONUCLEAR LEUKOCYTES; CRYSTAL-STRUCTURE; ACUTE HEMOLYSIS; HIGH-AFFINITY; BINDING-SITE; SERUM; LIVER; COMPLEX	The stability of the hemopexin-heme (Hx-heme) complex to dissociation of the heme prosthetic group has been examined in bicarbonate buffers in the presence and absence of various divalent metal ions. In NH4HCO3 buffer (pH 7.4, 20 mM, 25 degrees C) containing Zn2+ (100 mu M), 14% of the heme dissociates from this complex (4.5 mu M) within 10 min, and 50% dissociates within 2 h. In the absence of metal ions, the rate of dissociation of this complex is far lower, is decreased further in KHCO3 solution, and is minimal in NaHCO3. In NH4HCO3 buffer, dissociation of the Hx-heme complex is accelerated by addition of divalent metals with decreasing efficiency in the order Zn2+ > Cu2+ >> Ni2+ > Co2+ >> Mn2+. Addition of Ca2+ prior to addition of Zn2+ stabilizes the Hx-heme complex to dissociation of the heme group, and addition of Ca2+ after Zn2+-induced dissociation of the Hx-heme complex results in re-formation of the Hx-heme complex. These effects are greatly accelerated at 37 degrees C and diminished in other buffers. Overall, the solution conditions that promote formation of the Hx-heme complex are similar to those found in blood plasma, and conditions that promote release of heme are similar to those that the Hx-heme complex should encounter in endosomes following endocytosis of the complex formed with its hepatic receptor.	Univ British Columbia, Dept Biochem & Mol Biol, Life Sci Ctr, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Ctr Blood Res, Life Sci Ctr, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Mauk, AG (corresponding author), 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	mauk@interchange.ubc.ca			CBS-CIHR; Canada Research Chair	CBS-CIHR(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by a CBS-CIHR Partnership grant and by a Canada Research Chair (to A.G.M.).	Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Blindauer CA, 2009, J BIOL CHEM, V284, P23116, DOI 10.1074/jbc.M109.003459; BOWERS GN, 1986, CLIN CHEM, V32, P1437; CAROLI S, 1994, CRIT REV ANAL CHEM, V24, P363, DOI 10.1080/10408349408048824; CARTWRIGHT GE, 1960, AM J MED, V28, P555, DOI 10.1016/0002-9343(60)90150-9; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Clague MJ, 1998, BIOCHEM J, V336, P271, DOI 10.1042/bj3360271; DAVIES DM, 1979, BIOCHEM BIOPH RES CO, V91, P1504, DOI 10.1016/0006-291X(79)91235-X; DEEB RS, 1994, BBA-GEN SUBJECTS, V1200, P161, DOI 10.1016/0304-4165(94)90131-7; Delanghe JR, 2001, CLIN CHIM ACTA, V312, P13, DOI 10.1016/S0009-8981(01)00586-1; FABER HR, 1995, STRUCTURE, V3, P551, DOI 10.1016/S0969-2126(01)00189-7; Flaherty MM, 2008, BIOMETALS, V21, P239, DOI 10.1007/s10534-007-9112-9; Gerasimenko JV, 1998, CURR BIOL, V8, P1335, DOI 10.1016/S0960-9822(07)00565-9; GOLDENTHAL KL, 1988, J HISTOCHEM CYTOCHEM, V36, P391, DOI 10.1177/36.4.2450119; Holt S, 1999, LANCET, V353, P1241, DOI 10.1016/S0140-6736(98)05768-7; HRKAL Z, 1974, EUR J BIOCHEM, V43, P73, DOI 10.1111/j.1432-1033.1974.tb03386.x; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879; KAMBOH MI, 1987, AM J HUM GENET, V41, P645; Krezel A, 2006, ACTA BIOCHIM POL, V53, P721, DOI 10.18388/abp.2006_3299; Krezel A, 2010, J AM CHEM SOC, V132, P3355, DOI 10.1021/ja907567r; Kuzelova K, 1997, BBA-GEN SUBJECTS, V1336, P497, DOI 10.1016/S0304-4165(97)00062-7; LINDER RE, 1978, ANAL BIOCHEM, V90, P474, DOI 10.1016/0003-2697(78)90140-9; Mauk MR, 2007, BIOCHEMISTRY-US, V46, P15033, DOI 10.1021/bi701821a; Mauk MR, 2007, NAT PROD REP, V24, P523, DOI 10.1039/b604184c; Mauk MR, 2009, J AM CHEM SOC, V131, P16976, DOI 10.1021/ja907484j; MAUK MR, 1994, BIOCHEMISTRY-US, V33, P12609, DOI 10.1021/bi00208a011; Mauk MR, 2005, BIOCHEMISTRY-US, V44, P1864, DOI 10.1021/bi0481747; McLEAN FRANKLIN C, 1934, JOUR BIOL CHEM, V107, P337; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Miller YI, 1999, BBA-MOL BASIS DIS, V1454, P153, DOI 10.1016/S0925-4439(99)00027-7; MORGAN WT, 1976, BIOCHIM BIOPHYS ACTA, V434, P311, DOI 10.1016/0005-2795(76)90223-3; MORROW JS, 1974, J BIOL CHEM, V249, P7484; MULLEREBERHARD U, 1988, METHOD ENZYMOL, V163, P536; O'Neil M.J., 2006, MERCK INDEX; OKAZAKI H, 1989, CELL STRUCT FUNCT, V14, P129, DOI 10.1247/csf.14.129; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Paoli M, 1999, NAT STRUCT BIOL, V6, P926; POTTER D, 1993, ARCH BIOCHEM BIOPHYS, V300, P98, DOI 10.1006/abbi.1993.1014; Rosell FI, 2007, BIOCHEMISTRY-US, V46, P9301, DOI 10.1021/bi7008079; Rosell FI, 2005, BIOCHEMISTRY-US, V44, P1872, DOI 10.1021/bi0480077; Rozga M, 2007, J BIOL INORG CHEM, V12, P913, DOI 10.1007/s00775-007-0244-8; SEERY VL, 1972, ARCH BIOCHEM BIOPHYS, V150, P269, DOI 10.1016/0003-9861(72)90035-5; Shipulina NV, 2001, J PROTEIN CHEM, V20, P145, DOI 10.1023/A:1011033625009; SMITH A, 1979, BIOCHEM J, V182, P47, DOI 10.1042/bj1820047; SMITH A, 1990, EUR J CELL BIOL, V53, P234; SMITH A, 1978, BIOCHEM BIOPH RES CO, V84, P151, DOI 10.1016/0006-291X(78)90276-0; Smith A, 2009, BIOMETALS, V22, P421, DOI 10.1007/s10534-008-9178-z; Sonawane ND, 2003, J CELL BIOL, V160, P1129, DOI 10.1083/jcb.200211098; Sonawane ND, 2002, J BIOL CHEM, V277, P5506, DOI 10.1074/jbc.M110818200; Suzuki K, 2003, CELL STRUCT FUNCT, V28, P243, DOI 10.1247/csf.28.243; TAKAHASHI N, 1985, J CHROMATOGR, V326, P373, DOI 10.1016/S0021-9673(01)87463-X; Tolosano E, 1999, BLOOD, V94, P3906, DOI 10.1182/blood.V94.11.3906; Tolosano E, 1996, BIOCHEM BIOPH RES CO, V218, P694, DOI 10.1006/bbrc.1996.0124; Tolosano E, 2002, BLOOD, V100, P4201, DOI 10.1182/blood-2002-04-1270; Tolosano E, 2002, DNA CELL BIOL, V21, P297, DOI 10.1089/104454902753759717; Tolosano E, 2010, ANTIOXID REDOX SIGN, V12, P305, DOI 10.1089/ars.2009.2787; VALLEE BL, 1948, J BIOL CHEM, V176, P445; VANDYKE RW, 1995, AM J PHYSIOL-CELL PH, V269, pC943, DOI 10.1152/ajpcell.1995.269.4.C943; WITTMANN B, 1981, J BIOL CHEM, V256, P8332; Wu A.H.B., 2006, TIETZ CLIN GUIDE LAB; Zak O, 2003, BIOCHEMISTRY-US, V42, P12330, DOI 10.1021/bi034991f	62	3	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20499	20506		10.1074/jbc.M110.123406	http://dx.doi.org/10.1074/jbc.M110.123406			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20430887	hybrid, Green Published			2022-12-27	WOS:000279228600010
J	Gruez, A; Libiad, M; Boschi-Muller, S; Branlant, G				Gruez, Arnaud; Libiad, Marouane; Boschi-Muller, Sandrine; Branlant, Guy			Structural and Biochemical Characterization of Free Methionine-R-sulfoxide Reductase from Neisseria meningitidis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC MECHANISM; GAF DOMAIN; CHEMICAL CATALYSIS; ESCHERICHIA-COLI; AMINO-ACIDS; DIMERIZATION; SPECIFICITY; OXIDATION; BINDING; STEP	A new family of methionine-sulfoxide reductase (Msr) was recently described. The enzyme, named fRMsr, selectively reduces the R isomer at the sulfoxide function of free methionine sulfoxide (Met-R-O). The fRMsrs belong to the GAF fold family. They represent the first GAF domain to show enzymatic activity. Two other Msr families, MsrA and MsrB, were already known. MsrA and MsrB reduce free Met-S-O and Met-R-O, respectively, but exhibit higher catalytic efficiency toward Met-O within a peptide or a protein context. The fold of the three families differs. In the present work, the crystal structure of the fRMsr from Neisseria meningitidis has been determined in complex with S-Met-R-O. Based on biochemical and kinetic data as well as genomic analyses, Cys(118) is demonstrated to be the catalytic Cys on which a sulfenic acid is formed. All of the structural factors involved in the stereoselectivity of the L-Met-R-O binding were identified and account for why Met-S-O, DMSO, and a Met-O within a peptide are not substrates. Taking into account the structural, enzymatic, and biochemical information, a scenario of the catalysis for the reductase step is proposed. Based on the thiol content before and after Met-O reduction and the stoichiometry of Met formed per subunit of wild type and Cys-to-Ala mutants, a scenario of the recycling process of the N. meningitidis fRMsr is proposed. All of the biochemical, enzymatic, and structural properties of the N. meningitidis fRMsr are compared with those of MsrA and MsrB and are discussed in terms of the evolution of function of the GAF domain.	[Gruez, Arnaud; Libiad, Marouane; Boschi-Muller, Sandrine; Branlant, Guy] Nancy Univ, AREMS, CNRS, UMR UHP 7214,Fac Sci & Technol, F-54506 Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Branlant, G (corresponding author), Nancy Univ, AREMS, CNRS, UMR UHP 7214,Fac Sci & Technol, Bld Aiguillettes,BP 70239, F-54506 Vandoeuvre Les Nancy, France.	Guy.Branlant@maem.uhp-nancy.fr		Boschi, Sandrine/0000-0001-8962-4749; Libiad, Marouane/0000-0003-1717-9206	CNRS; University of Nancy I; IFR 111 Bioingenierie; French Ministry of Research	CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Nancy I; IFR 111 Bioingenierie; French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was supported by the CNRS, the University of Nancy I, and the IFR 111 Bioingenierie.; Supported by the French Ministry of Research.	Antoine M, 2003, J BIOL CHEM, V278, P45352, DOI 10.1074/jbc.M307471200; Antoine M, 2006, J BIOL CHEM, V281, P39062, DOI 10.1074/jbc.M608844200; Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; Boschi-Muller S, 2000, J BIOL CHEM, V275, P35908, DOI 10.1074/jbc.M006137200; Boschi-Muller S, 2005, BBA-PROTEINS PROTEOM, V1703, P231, DOI 10.1016/j.bbapap.2004.09.016; Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Heikaus CC, 2008, J BIOL CHEM, V283, P22749, DOI 10.1074/jbc.M801577200; Ho YSJ, 2000, EMBO J, V19, P5288, DOI 10.1093/emboj/19.20.5288; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Le DT, 2009, J BIOL CHEM, V284, P4354, DOI 10.1074/jbc.M805891200; Lin ZD, 2007, P NATL ACAD SCI USA, V104, P9597, DOI 10.1073/pnas.0703774104; Martinez SE, 2005, P NATL ACAD SCI USA, V102, P3082, DOI 10.1073/pnas.0409913102; Moskovitz J, 2005, BBA-PROTEINS PROTEOM, V1703, P213, DOI 10.1016/j.bbapap.2004.09.003; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Neiers F, 2007, J BIOL CHEM, V282, P32397, DOI 10.1074/jbc.M704730200; Olry A, 2002, J BIOL CHEM, V277, P12016, DOI 10.1074/jbc.M112350200; Ranaivoson FM, 2008, J MOL BIOL, V377, P268, DOI 10.1016/j.jmb.2008.01.021; Ranaivoson FM, 2009, J MOL BIOL, V394, P83, DOI 10.1016/j.jmb.2009.08.073; Schoneich C, 2005, BBA-PROTEINS PROTEOM, V1703, P111, DOI 10.1016/j.bbapap.2004.09.009; Sharov VS, 1999, FEBS LETT, V455, P247, DOI 10.1016/S0014-5793(99)00888-1; Stadtman ER, 2005, BBA-PROTEINS PROTEOM, V1703, P135, DOI 10.1016/j.bbapap.2004.08.010; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004	24	28	29	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					25033	25043		10.1074/jbc.M110.134528	http://dx.doi.org/10.1074/jbc.M110.134528			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20489204	Green Published, hybrid			2022-12-27	WOS:000280542100076
J	Zhang, Y; Tang, WW; Jones, MC; Xu, WW; Halene, S; Wu, DQ				Zhang, Yong; Tang, Wenwen; Jones, Matthew C.; Xu, Wenwen; Halene, Stephanie; Wu, Dianqing			Different Roles of G Protein Subunits beta(1) and beta(2) in Neutrophil Function Revealed by Gene Expression Silencing in Primary Mouse Neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA INTERFERENCE; INFLAMMATION	Neutrophils play important roles in host innate immunity and various inflammation-related diseases. In addition, neutrophils represent an excellent system for studying directional cell migration. However, neutrophils are terminally differentiated cells that are short lived and refractory to transfection; thus, they are not amenable for existing gene silencing techniques. Here we describe the development of a method to silence gene expression efficiently in primary mouse neutrophils. A mouse stem cell virus-based retroviral vector was modified to express short hairpin RNAs and fluorescent marker protein at high levels in hematopoietic cells and used to infect mouse bone marrow cells prior to reconstitution of the hematopoietic system in lethally irradiated mice. This method was used successfully to silence the expression of G beta(1) and/or G beta(2) in mouse neutrophils. Knockdown of G beta(2) appeared to affect primarily the directionality of neutrophil chemotaxis rather than motility, whereas knockdown of G beta(1) had no significant effect. However, knockdown of both G beta(1) and G beta(2) led to significant reduction in motility and responsiveness. In addition, knockdown of G beta(1) but not G beta(2) inhibited the ability of neutrophils to kill ingested bacteria, and only double knockdown resulted in significant reduction in bacterial phagocytosis. Therefore, we have developed a short hairpin RNA-based method to effectively silence gene expression in mouse neutrophils for the first time, which allowed us to uncover divergent roles of G beta(1) and G beta(2) in the regulation of neutrophil functions.	[Zhang, Yong; Tang, Wenwen; Jones, Matthew C.; Xu, Wenwen; Wu, Dianqing] Yale Univ, Sch Med, Program Vasc Biol & Therapeut, New Haven, CT 06520 USA; [Zhang, Yong; Tang, Wenwen; Jones, Matthew C.; Xu, Wenwen; Wu, Dianqing] Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA; [Halene, Stephanie] Yale Univ, Sch Med, Dept Med, Sect Hematol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Wu, DQ (corresponding author), Yale Univ, Sch Med, Program Vasc Biol & Therapeut, 333 Cedar St, New Haven, CT 06520 USA.	dan.wu@yale.edu	Tang, Wenwen/J-2011-2012	Jones, Matthew/0000-0003-4723-3277	National Institutes of Health [HL 080706, HL070694]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080706, P01HL070694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054597] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 080706 and HL070694.	Bommakanti RK, 2000, J BIOL CHEM, V275, P38870, DOI 10.1074/jbc.M007403200; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Buonocore S, 2002, TRANSPLANTATION, V73, pS27, DOI 10.1097/00007890-200201151-00010; Colville-Nash Paul, 2003, Methods Mol Biol, V225, P181; Di Lorenzo A, 2009, P NATL ACAD SCI USA, V106, P14552, DOI 10.1073/pnas.0904073106; Dinauer Mary C., 2007, V412, P489, DOI 10.1007/978-1-59745-467-4_30; Dong XM, 2006, METHOD ENZYMOL, V406, P605, DOI 10.1016/S0076-6879(06)06047-2; He WJ, 2006, HUM GENE THER, V17, P949, DOI 10.1089/hum.2006.17.949; Holst J, 2006, NAT METHODS, V3, P191, DOI 10.1038/nmeth858; Hwang JI, 2005, P NATL ACAD SCI USA, V102, P9493, DOI 10.1073/pnas.0503503102; Kay RR, 2008, NAT REV MOL CELL BIO, V9, P455, DOI 10.1038/nrm2419; Kelly M, 2007, J ALLERGY CLIN IMMUN, V120, P3, DOI 10.1016/j.jaci.2007.05.017; Komiya E, 2006, PLACENTA, V27, P934, DOI 10.1016/j.placenta.2006.02.007; Leimig T, 2002, BLOOD, V99, P3169, DOI 10.1182/blood.V99.9.3169; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Owens BM, 2004, METH MOLEC MED, V105, P311; Paddison Patrick J, 2004, Methods Mol Biol, V265, P85; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Stephens L, 2008, CURR BIOL, V18, pR485, DOI 10.1016/j.cub.2008.04.048; Swift S., 2001, CURRENT PROTOCOLS IM; Taher TE, 2008, GENE THER, V15, P998, DOI 10.1038/gt.2008.33; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Wu DQ, 2005, CELL RES, V15, P52, DOI 10.1038/sj.cr.7290265; WU LJ, 1995, J CELL BIOL, V129, P1667, DOI 10.1083/jcb.129.6.1667; Zhu XC, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-98; Zicha D, 1997, Methods Mol Biol, V75, P449; Zwaal RR, 1996, CELL, V86, P619, DOI 10.1016/S0092-8674(00)80135-X	30	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24805	24814		10.1074/jbc.M110.142885	http://dx.doi.org/10.1074/jbc.M110.142885			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20525682	Green Published, hybrid			2022-12-27	WOS:000280542100053
J	Murad, JM; Place, CS; Ran, C; Hekmatyar, SKN; Watson, NP; Kauppinen, RA; Israel, MA				Murad, Joana M.; Place, Chelsea S.; Ran, Cong; Hekmatyar, Shahryar K. N.; Watson, Nathan P.; Kauppinen, Risto A.; Israel, Mark A.			Inhibitor of DNA Binding 4 (ID4) Regulation of Adipocyte Differentiation and Adipose Tissue Formation in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; C/EBP-ALPHA; INSULIN-RESISTANCE; EXPRESSION; ADIPOGENESIS; LIPODYSTROPHY; PROTEINS	Inhibitor of DNA binding 4 (ID4) is a helix-loop-helix protein that heterodimerizes with basic helix-loop-helix transcription factors inhibiting their function. ID4 expression is important for adipogenic differentiation of the 3T3-L1 cell line, and inhibition of ID4 is associated with a concomitant decrease in CCAAT/enhancer-binding protein gamma and peroxisome proliferator-activated receptor gamma mRNA and protein expression. Mice with a homozygous deletion of Id4 (Id4(-/-)) have reduced body fat and gain much less weight compared with wild-type littermates when placed on diets with high fat content. Mouse embryonic fibroblasts (MEFs) isolated from Id4(-/-) mice have reduced adipogenic potential when compared with wild-type MEFs. In agreement with changes in morphological differentiation, the levels of CCAAT/enhancer-binding protein alpha and peroxisome proliferator-activated receptor gamma were also reduced in MEFs from Id4(-/-) mice. Our results demonstrate the importance of ID4 in adipocyte differentiation and the implications of this regulation for adipose tissue formation.	Norris Cotton Canc Ctr, Hanover, NH 03755 USA; [Israel, Mark A.] Dartmouth Med Sch, Dept Pediat, Hanover, NH 03755 USA; [Israel, Mark A.] Dartmouth Med Sch, Dept Genet, Hanover, NH 03755 USA; [Hekmatyar, Shahryar K. N.; Kauppinen, Risto A.] Dartmouth Med Sch, Dept Radiol, Hanover, NH 03755 USA	Norris Cotton Cancer Center; Dartmouth College; Dartmouth College; Dartmouth College	Israel, MA (corresponding author), Norris Cotton Canc Ctr, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	Mark.A.Israel@Dartmouth.edu		Watson, Nathan/0000-0002-9913-5575	Theodora B. Betz Foundation	Theodora B. Betz Foundation	This work was supported by The Theodora B. Betz Foundation (to M. A. I.).	ABATE N, 1994, J LIPID RES, V35, P1490; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Carey JPW, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-173; Chen HC, 2002, J LIPID RES, V43, P986; Chen HP, 1999, BIOCHEM BIOPH RES CO, V256, P614, DOI 10.1006/bbrc.1999.0386; Chen Y, 2009, NAT NEUROSCI, V12, P1398, DOI 10.1038/nn.2410; Ciarapica R, 2009, ONCOGENE, V28, P1881, DOI 10.1038/onc.2009.56; Du Y, 2010, DIFFERENTIATION, V79, P84, DOI 10.1016/j.diff.2009.10.003; Duan SZ, 2007, J CLIN INVEST, V117, P812, DOI 10.1172/JCI28859; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Gronning LM, 2006, AM J PHYSIOL-ENDOC M, V290, pE599, DOI 10.1152/ajpendo.00242.2005; Gulbagci NT, 2009, EMBO REP, V10, P79, DOI 10.1038/embor.2008.207; HAASE A, 1985, PHYS MED BIOL, V30, P341, DOI 10.1088/0031-9155/30/4/008; Havrda MC, 2008, J NEUROSCI, V28, P14074, DOI 10.1523/JNEUROSCI.3188-08.2008; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Hou TY, 2009, J BIOL CHEM, V284, P31735, DOI 10.1074/jbc.M109.013961; Imagawa M, 1999, BIOCHEM BIOPH RES CO, V254, P299, DOI 10.1006/bbrc.1998.9937; Jogi A, 2002, J BIOL CHEM, V277, P9118, DOI 10.1074/jbc.M107713200; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Laclaustra M, 2007, NUTR METAB CARDIOVAS, V17, P125, DOI [10.1016/j.numecd.2006.10.005, 10.1038/ki.2008.517]; Liu CJ, 2002, MOL CELL BIOL, V22, P2893, DOI 10.1128/MCB.22.9.2893-2905.2002; Moldes M, 1997, MOL CELL BIOL, V17, P1796, DOI 10.1128/MCB.17.4.1796; Moldes M, 1999, BIOCHEM J, V344, P873, DOI 10.1042/0264-6021:3440873; Morrison RF, 1999, J CELL BIOCHEM, P59; Park KW, 2008, MOL ENDOCRINOL, V22, P2038, DOI 10.1210/me.2007-0454; Prabhu S, 1997, MOL CELL BIOL, V17, P5888, DOI 10.1128/MCB.17.10.5888; Rahmouni K, 2008, CIRC RES, V103, P565, DOI 10.1161/CIRCRESAHA.108.184366; Reue K, 2006, CURR OPIN CLIN NUTR, V9, P436, DOI 10.1097/01.mco.0000232904.82038.db; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ross DA, 2004, MOL CELL BIOL, V24, P3505, DOI 10.1128/MCB.24.8.3505-3513.2004; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Sattler FR, 2001, AIDS, V15, P2001, DOI 10.1097/00002030-200110190-00013; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Trayhurn P, 2005, ACTA PHYSIOL SCAND, V184, P285, DOI 10.1111/j.1365-201X.2005.01468.x; Tsai YS, 2004, J CLIN INVEST, V114, P240, DOI 10.1172/JCI200420964; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Yun K, 2004, DEVELOPMENT, V131, P5441, DOI 10.1242/dev.01430; Zuo Y, 2006, J BIOL CHEM, V281, P7960, DOI 10.1074/jbc.M510682200	43	21	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24164	24173		10.1074/jbc.M110.128744	http://dx.doi.org/10.1074/jbc.M110.128744			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20460371	Green Published, hybrid			2022-12-27	WOS:000280291400066
J	Wang, JH; Chen, YA				Wang, Jianghai; Chen, Yuan			Role of the Zn2+ Motif of E1 in SUMO Adenylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-ACTIVATING ENZYME; E1-E2 INTERACTION; MODIFIER SUMO-1; PROTEIN; MECHANISM; NUCLEAR; E2; RECRUITMENT; CONJUGATION; INSIGHTS	Post-translational modifications by ubiquitin-like proteins are among the most important mechanisms for regulating a wide variety of cellular functions. In these modifications an E1 enzyme activates each ubiquitin-like protein (Ubl) by adenylation of the Ubl C-terminal COOH group and then forms a thioester bond with the adenylated C-terminal COOH group of the Ubl. Previous x-ray crystallography studies revealed a conserved zinc motif in the SUMO and NEDD8 E1; however, the function of this Zn2+ motif is unclear. In this study, using quantitative ATP:PPi isotope exchange assays in combination with site-directed mutagenesis, we show that the conserved Zn2+ motif in the SUMO E1 is important for SUMO adenylation and is critical for the E1 pseudo-ordered substrate binding mechanism. Furthermore, Zn2+ motif mutants showed significantly reduced k(cat) values for ATP: PPi isotope exchange assays, suggesting that the Zn2+ motif is important in binding and preventing SUMO adenylate from dissociating from E1 before formation of the thioester conjugate. Because the Zn2+ motif is located in a crossover loop that is known to have conformational flexibility, the results described here suggest that this cross-over loop interacts with Ubl in the multistep, dynamic process of Ubl activation by E1s.	[Wang, Jianghai; Chen, Yuan] City Hope Natl Med Ctr, Beckman Res Inst, Div Mol Med, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Chen, YA (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Div Mol Med, Duarte, CA 91010 USA.	ychen@coh.org			National Institutes of Health [R01GM074748, R01GM086171]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074748, R01GM086171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM074748 and R01GM086171.	Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; Bohnsack RN, 2003, J BIOL CHEM, V278, P26823, DOI 10.1074/jbc.M303177200; BURCH TJ, 1994, BIOCHEMISTRY-US, V33, P7300, DOI 10.1021/bi00189a035; Guo B, 2007, BIOCHEM SOC T, V35, P1414, DOI 10.1042/BST0351414; HAAS AL, 1982, J BIOL CHEM, V257, P2543; HAAS AL, 1982, J BIOL CHEM, V257, P329; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Huang DT, 2004, NAT STRUCT MOL BIOL, V11, P927, DOI 10.1038/nsmb826; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Lee GW, 1998, J BIOL CHEM, V273, P6503, DOI 10.1074/jbc.273.11.6503; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mahajan R, 1998, J CELL BIOL, V140, P259, DOI 10.1083/jcb.140.2.259; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Wang JH, 2007, MOL CELL, V27, P228, DOI 10.1016/j.molcel.2007.05.023; Wang JH, 2009, J BIOL CHEM, V284, P20340, DOI 10.1074/jbc.M109.000257; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700	24	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23732	23738		10.1074/jbc.M110.114660	http://dx.doi.org/10.1074/jbc.M110.114660			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20501649	Green Published, hybrid			2022-12-27	WOS:000280291400023
J	Dovas, A; Choi, Y; Yoneda, A; Multhaupt, HAB; Kwon, SH; Kang, D; Oh, ES; Couchman, JR				Dovas, Athanassios; Choi, Youngsil; Yoneda, Atsuko; Multhaupt, Hinke A. B.; Kwon, Seung-Hae; Kang, Dongmin; Oh, Eok-Soo; Couchman, John R.			Serine 34 Phosphorylation of Rho Guanine Dissociation Inhibitor (RhoGDI alpha) Links Signaling from Conventional Protein Kinase C to RhoGTPase in Cell Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; CANINE KIDNEY-CELLS; PKC-ALPHA; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; DEPENDENT ACTIVATION; CYTOPLASMIC DOMAIN; MEMBRANE-BINDING; PLASMA-MEMBRANE; PHOSPHOLIPASE-D; LIVING CELLS	Conventional protein kinase C (PKC) isoforms are essential serine/threonine kinases regulating many signaling networks. At cell adhesion sites, PKC alpha can impact the actin cytoskeleton through its influence on RhoGTPases, but the intermediate steps are not well known. One important regulator of RhoGTPase function is the multifunctional guanine nucleotide dissociation inhibitor RhoGDI alpha that sequesters several related RhoGTPases in an inactive form, but it may also target them through interactions with actin-associated proteins. Here, it is demonstrated that conventional PKC phosphorylates RhoGDI alpha on serine 34, resulting in a specific decrease in affinity for RhoA but not Rac1 or Cdc42. The mechanism of RhoGDI alpha phosphorylation is distinct, requiring the kinase and phosphatidylinositol 4,5-bisphosphate, consistent with recent evidence that the inositide can activate, localize, and orient PKC alpha in membranes. Phosphospecific antibodies reveal endogenous phosphorylation in several cell types that is sensitive to adhesion events triggered, for example, by hepatocyte growth factor. Phosphorylation is also sensitive to PKC inhibition. Together with fluorescence resonance energy transfer microscopy sensing GTP-RhoA levels, the data reveal a common pathway in cell adhesion linking two essential mediators, conventional PKC and RhoA.	[Dovas, Athanassios; Yoneda, Atsuko; Multhaupt, Hinke A. B.; Couchman, John R.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Biomed Sci, London SW7 2AZ, England; [Choi, Youngsil; Kang, Dongmin; Oh, Eok-Soo] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Kwon, Seung-Hae] Chuncheon Ctr, Korea Basic Sci Inst, Chunchon 210701, Gangwon Do, South Korea	Imperial College London; Ewha Womans University; Korea Basic Science Institute (KBSI)	Couchman, JR (corresponding author), Univ Copenhagen, Fac Hlth Sci, Dept Biomed Sci, Bioctr, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	john.couchman@bric.ku.dk		Kang, Dongmin/0000-0001-5997-625X	Wellcome Trust [065940]; Danish National Research Foundation; Haensch Fond; Wilhelm Pedersen Fond; University of Copenhagen; National Core Research Center, Ministry of Education, Science, and Technology Korea [R15-2006-020]; Korea Science and Engineering Foundation through Center for Cell Signaling and Drug Discovery at Ewha Woman's University	Wellcome Trust(Wellcome Trust); Danish National Research Foundation(Danmarks Grundforskningsfond); Haensch Fond; Wilhelm Pedersen Fond; University of Copenhagen; National Core Research Center, Ministry of Education, Science, and Technology Korea; Korea Science and Engineering Foundation through Center for Cell Signaling and Drug Discovery at Ewha Woman's University(Korea Science and Engineering Foundation)	The work was supported in part by Wellcome Trust Programme Grant 065940 (to J.R.C.), Danish National Research Foundation, Haensch Fond, Wilhelm Pedersen Fond, and University of Copenhagen (to J.R.C., H. A. B. M.).; Supported in part by Grant R15-2006-020 from the National Core Research Center program of the Ministry of Education, Science, and Technology Korea and Korea Science and Engineering Foundation through the Center for Cell Signaling and Drug Discovery at Ewha Woman's University.	AKTORIES K, 1995, METHOD ENZYMOL, V256, P184; Balboa MA, 1998, MOL PHARMACOL, V53, P221, DOI 10.1124/mol.53.2.221; Bass MD, 2008, J CELL BIOL, V181, P1013, DOI 10.1083/jcb.200711129; Bass-Zubek AE, 2008, J CELL BIOL, V181, P605, DOI 10.1083/jcb.200712133; Bastiaens PIH, 1996, EMBO J, V15, P4246, DOI 10.1002/j.1460-2075.1996.tb00799.x; Corbalan-Garcia S, 2003, J BIOL CHEM, V278, P4972, DOI 10.1074/jbc.M209385200; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Dovas A, 2006, J CELL SCI, V119, P2837, DOI 10.1242/jcs.03020; Elfenbein A, 2009, J CELL BIOL, V186, P75, DOI 10.1083/jcb.200810179; Faure J, 1999, EUR J BIOCHEM, V262, P879, DOI 10.1046/j.1432-1327.1999.00458.x; Fujii M, 1999, BIOCHEM BIOPH RES CO, V254, P284, DOI 10.1006/bbrc.1998.9936; Fukata Y, 1998, J CELL BIOL, V141, P409, DOI 10.1083/jcb.141.2.409; Fukata Y, 1999, J CELL BIOL, V145, P347, DOI 10.1083/jcb.145.2.347; Genth H, 2003, J BIOL CHEM, V278, P28523, DOI 10.1074/jbc.M301915200; Gentile A, 2008, ONCOGENE, V27, P5590, DOI 10.1038/onc.2008.173; Golovanov AP, 2001, EUR J BIOCHEM, V268, P2253, DOI 10.1046/j.1432-1327.2001.02100.x; Grizot S, 2001, BIOCHEMISTRY-US, V40, P10007, DOI 10.1021/bi010288k; Guerrero-Valero M, 2007, J MOL BIOL, V371, P608, DOI 10.1016/j.jmb.2007.05.086; HOCEVAR BA, 1992, J CELL SCI, V101, P671; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Horowitz A, 1998, J BIOL CHEM, V273, P25548, DOI 10.1074/jbc.273.40.25548; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; Ivaska J, 2003, BIOCHEM SOC T, V31, P90, DOI 10.1042/bst0310090; JAKEN S, 1989, J CELL BIOL, V109, P697, DOI 10.1083/jcb.109.2.697; Keum E, 2004, BIOCHEM J, V378, P1007, DOI 10.1042/BJ20031734; Kitajo H, 2003, ONCOL REP, V10, P1351; Knezevic N, 2007, MOL CELL BIOL, V27, P6323, DOI 10.1128/MCB.00523-07; KOCHS G, 1993, BIOCHEM J, V291, P627, DOI 10.1042/bj2910627; Kodama A, 2000, MOL BIOL CELL, V11, P2565, DOI 10.1091/mbc.11.8.2565; Landgraf KE, 2008, BIOCHEMISTRY-US, V47, P8301, DOI 10.1021/bi800711t; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Lerm M, 2000, FEMS MICROBIOL LETT, V188, P1; Lim ST, 2003, J BIOL CHEM, V278, P13795, DOI 10.1074/jbc.M208300200; Longley RL, 1999, J CELL SCI, V112, P3421; Lub M, 1997, MOL BIOL CELL, V8, P719, DOI 10.1091/mbc.8.4.719; Machesky LM, 1997, J CELL BIOL, V138, P913, DOI 10.1083/jcb.138.4.913; Manna D, 2008, J BIOL CHEM, V283, P26047, DOI 10.1074/jbc.M802617200; Marin-Vicente C, 2008, J MOL BIOL, V377, P1038, DOI 10.1016/j.jmb.2007.12.011; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Mochly-Rosen D, 1998, FASEB J, V12, P35; Mostafavi-Pour Z, 2003, J CELL BIOL, V161, P155, DOI 10.1083/jcb.200210176; Multhaupt HAB, 2009, J PHYSIOL PHARMACOL, V60, P31; NISHIYAMA T, 1994, MOL CELL BIOL, V14, P2447, DOI 10.1128/MCB.14.4.2447; Oh ES, 1998, J BIOL CHEM, V273, P10624, DOI 10.1074/jbc.273.17.10624; Read PW, 2000, METHOD ENZYMOL, V325, P15; Reyland ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2386, DOI 10.2741/3385; RIDLEY AJ, 1994, EMBO J, V13, P2600, DOI 10.1002/j.1460-2075.1994.tb06550.x; Rodriguez P, 2005, BIOTECHNOL LETT, V27, P1869, DOI 10.1007/s10529-005-3895-y; Royal I, 2000, MOL BIOL CELL, V11, P1709, DOI 10.1091/mbc.11.5.1709; Sciorra VA, 1996, J BIOL CHEM, V271, P14226, DOI 10.1074/jbc.271.24.14226; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; SELF AJ, 1995, METHOD ENZYMOL, V256, P3; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Son H, 2006, ARCH BIOCHEM BIOPHYS, V454, P1, DOI 10.1016/j.abb.2006.08.013; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; TAKAISHI K, 1994, ONCOGENE, V9, P273; van Buul JD, 2007, J CELL BIOL, V178, P1279, DOI 10.1083/jcb.200612053; Weekes J, 1996, BIOCHEM J, V314, P827, DOI 10.1042/bj3140827; Yoneda A, 2005, J CELL BIOL, V170, P443, DOI 10.1083/jcb.200412043; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Ziegler WH, 2002, J BIOL CHEM, V277, P7396, DOI 10.1074/jbc.M110008200	67	58	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23294	23306		10.1074/jbc.M109.098129	http://dx.doi.org/10.1074/jbc.M109.098129			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20472934	hybrid, Green Published			2022-12-27	WOS:000279999900063
J	Goddard, AD; Stevens, JM; Rao, F; Mavridou, DAI; Chan, WL; Richardson, DJ; Allen, JWA; Ferguson, SJ				Goddard, Alan D.; Stevens, Julie M.; Rao, Feng; Mavridou, Despoina A. I.; Chan, Weelee; Richardson, David J.; Allen, James W. A.; Ferguson, Stuart J.			c-Type Cytochrome Biogenesis Can Occur via a Natural Ccm System Lacking CcmH, CcmG, and the Heme-binding Histidine of CcmE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CHAPERONE CCME; APOCYTOCHROME-C; ACTIVE-SITE; NITRITE REDUCTASE; COVALENT ATTACHMENT; MATURATION; PROTEIN; REVEALS; PATHWAY	The Ccm cytochrome c maturation System I catalyzes covalent attachment of heme to apocytochromes c in many bacterial species and some mitochondria. A covalent, but transient, bond between heme and a conserved histidine in CcmE along with an interaction between CcmH and the apocytochrome have been previously indicated as core aspects of the Ccm system. Here, we show that in the Ccm system from Desulfovibrio desulfuricans, no CcmH is required, and the holo-CcmE covalent bond occurs via a cysteine residue. These observations call for reconsideration of the accepted models of System I-mediated c-type cytochrome biogenesis.	[Goddard, Alan D.; Stevens, Julie M.; Rao, Feng; Mavridou, Despoina A. I.; Chan, Weelee; Allen, James W. A.; Ferguson, Stuart J.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Richardson, David J.] Univ E Anglia, Ctr Mol & Struct Biochem, Norwich NR4 7TJ, Norfolk, England	University of Oxford; University of East Anglia	Ferguson, SJ (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	stuart.ferguson@bioch.ox.ac.uk	Richardson, David J/E-2275-2011; Mavridou, Despoina/ABG-5940-2020; Goddard, Alan/E-9328-2013	Mavridou, Despoina/0000-0002-7449-1151; Chan, Wee Lee/0000-0001-9672-3841; Goddard, Alan/0000-0003-4950-7470	Biotechnology and Biological Sciences Research Council [BB/D523019/1, BB/E004865/1, BB/D019753/1]; BBSRC [BB/D523019/1, BB/D019753/1, BB/E004865/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grants BB/D523019/1, BB/E004865/1, and BB/D019753/1.	Ahuja U, 2005, J BIOL CHEM, V280, P236, DOI 10.1074/jbc.M410912200; Allen JWA, 2008, FEBS J, V275, P2385, DOI 10.1111/j.1742-4658.2008.06380.x; Allen JWA, 2006, FEBS LETT, V580, P4827, DOI 10.1016/j.febslet.2006.07.073; Allen JWA, 2003, BIOCHEM J, V375, P721, DOI 10.1042/BJ20030752; Allen JWA, 2004, BIOCHEM J, V383, P537, DOI 10.1042/BJ20040832; Allen JWA, 2002, J BIOL CHEM, V277, P33559, DOI 10.1074/jbc.M204963200; Arslan E, 1998, BIOCHEM BIOPH RES CO, V251, P744, DOI 10.1006/bbrc.1998.9549; Bartsch R. G., 1971, METHODS ENZYMOL, V23, P344, DOI [10.1016/S0076-6879(71)23110-4, DOI 10.1016/S0076-6879(71)23110-4]; Bowman SEJ, 2008, NAT PROD REP, V25, P1118, DOI 10.1039/b717196j; Christensen O, 2007, FEBS J, V274, P2322, DOI 10.1111/j.1742-4658.2007.05769.x; Cunha CA, 2003, J BIOL CHEM, V278, P17455, DOI 10.1074/jbc.M211777200; Daltrop O, 2002, P NATL ACAD SCI USA, V99, P9703, DOI 10.1073/pnas.152120699; Di Matteo A, 2007, J BIOL CHEM, V282, P27012, DOI 10.1074/jbc.M702702200; Eaves DJ, 1998, MOL MICROBIOL, V28, P205, DOI 10.1046/j.1365-2958.1998.00792.x; Enggist E, 2003, J BACTERIOL, V185, P175, DOI 10.1128/JB.185.1.175-183.2003; Enggist E, 2002, STRUCTURE, V10, P1551, DOI 10.1016/S0969-2126(02)00885-7; Fabianek RA, 1999, ARCH MICROBIOL, V171, P92, DOI 10.1007/s002030050683; Fabianek RA, 1998, J BACTERIOL, V180, P1947, DOI 10.1128/JB.180.7.1947-1950.1998; Fabianek RA, 2000, FEMS MICROBIOL REV, V24, P303, DOI 10.1111/j.1574-6976.2000.tb00544.x; Feissner RE, 2006, MOL MICROBIOL, V60, P563, DOI 10.1111/j.1365-2958.2006.05132.x; Feissner RE, 2006, MOL MICROBIOL, V61, P219, DOI 10.1111/j.1365-2958.2006.05221.x; Ferguson SJ, 2008, BBA-BIOENERGETICS, V1777, P980, DOI 10.1016/j.bbabio.2008.03.020; Garcia-Rubio I, 2007, BIOPHYS J, V92, P1361, DOI 10.1529/biophysj.106.098277; GODDARD AD, 2010, J FEBS J, V277, P726; Goddard AD, 2008, MOL MICROBIOL, V70, P667, DOI 10.1111/j.1365-2958.2008.06436.x; GOODHEW CF, 1986, BIOCHIM BIOPHYS ACTA, V852, P288, DOI 10.1016/0005-2728(86)90234-3; Hamel P, 2009, BBA-MOL CELL RES, V1793, P125, DOI 10.1016/j.bbamcr.2008.06.017; Hartshorne RS, 2007, MOL MICROBIOL, V64, P1049, DOI 10.1111/j.1365-2958.2007.05712.x; Lee DH, 2005, J AM CHEM SOC, V127, P3716, DOI 10.1021/ja044658e; Meyer EH, 2005, P NATL ACAD SCI USA, V102, P16113, DOI 10.1073/pnas.0503473102; Pattarkine MV, 2006, J MOL BIOL, V358, P1314, DOI 10.1016/j.jmb.2006.03.010; Reid E, 1998, FEMS MICROBIOL LETT, V166, P369, DOI 10.1016/S0378-1097(98)00357-7; Ren Q, 2002, J BIOL CHEM, V277, P7657, DOI 10.1074/jbc.M110979200; Richard-Fogal CL, 2008, J BACTERIOL, V190, P3489, DOI 10.1128/JB.00146-08; Robertson IB, 2008, FEBS LETT, V582, P3067, DOI 10.1016/j.febslet.2008.07.052; SAMBONGI Y, 1994, FEBS LETT, V340, P65, DOI 10.1016/0014-5793(94)80174-6; SAMBONGI Y, 1994, FEBS LETT, V353, P235, DOI 10.1016/0014-5793(94)01053-6; Sanders C, 2008, J BIOL CHEM, V283, P29715, DOI 10.1074/jbc.M805413200; Schulz H, 1998, SCIENCE, V281, P1197, DOI 10.1126/science.281.5380.1197; Setterdahl AT, 2000, BIOCHEMISTRY-US, V39, P10172, DOI 10.1021/bi000663t; Simon J, 2000, MOL MICROBIOL, V35, P686, DOI 10.1046/j.1365-2958.2000.01742.x; Spielewoy N, 2001, J BIOL CHEM, V276, P5491, DOI 10.1074/jbc.M008853200; Stevens JM, 2004, ACCOUNTS CHEM RES, V37, P999, DOI 10.1021/ar030266l; Stevens JM, 2003, J BIOL CHEM, V278, P20500, DOI 10.1074/jbc.M212925200; THONYMEYER L, 1995, J BACTERIOL, V177, P4321; ThroneHolst M, 1997, FEBS LETT, V410, P351, DOI 10.1016/S0014-5793(97)00656-X; Turkarslan S, 2008, MOL MICROBIOL, V70, P652, DOI 10.1111/j.1365-2958.2008.06441.x; Uchida T, 2004, J BIOL CHEM, V279, P51981, DOI 10.1074/jbc.M408963200	48	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22880	22887		10.1074/jbc.M110.133421	http://dx.doi.org/10.1074/jbc.M110.133421			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20466730	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000279999900021
J	Ono, K; Condron, MM; Teplow, DB				Ono, Kenjiro; Condron, Margaret M.; Teplow, David B.			Effects of the English (H6R) and Tottori (D7N) Familial Alzheimer Disease Mutations on Amyloid beta-Protein Assembly and Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; PHOTOINDUCED CROSS-LINKING; IN-VIVO; SYNAPTIC PLASTICITY; PROTOFIBRIL FORMATION; CEREBRAL-HEMORRHAGE; SECRETED OLIGOMERS; MTT REDUCTION; FIBRILLOGENESIS; GENE	Mutations in the amyloid beta-protein (A beta) precursor gene cause autosomal dominant Alzheimer disease in a number of kindreds. In two such kindreds, the English and the Tottori, the mutations produce amyloid beta-proteins containing amino acid substitutions, H6R and D7N, respectively, at the peptide N terminus. To elucidate the structural and biological effects of the mutations, we began by examining monomer conformational dynamics and oligomerization. Relative to their wild type homologues, and in both the A beta 40 and A beta 42 systems, the English and Tottori substitutions accelerated the kinetics of secondary structure change from statistical coil -> alpha/beta -> beta and produced oligomer size distributions skewed to higher order. This skewing was reflected in increases in average oligomer size, as measured using electron microscopy and atomic force microscopy. Stabilization of peptide oligomers using in situ chemical cross-linking allowed detailed study of their properties. Each substitution produced an oligomer that displayed substantial beta-strand (H6R) or alpha/beta (D7N) structure, in contrast to the predominately statistical coil structure of wild type A beta oligomers. Mutant oligomers functioned as fibril seeds, and with efficiencies significantly higher than those of their wild type homologues. Importantly, the mutant forms of both native and chemically stabilized oligomers were significantly more toxic in assays of cell physiology and death. The results show that the English and Tottori mutations alter A beta assembly at its earliest stages, monomer folding and oligomerization, and produce oligomers that are more toxic to cultured neuronal cells than are wild type oligomers.	[Ono, Kenjiro; Condron, Margaret M.; Teplow, David B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Ono, Kenjiro] Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol & Aging, Kanazawa, Ishikawa 9208640, Japan; [Teplow, David B.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Teplow, David B.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Kanazawa University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Teplow, DB (corresponding author), 635 Charles E Young Dr S,Rm 445, Los Angeles, CA 90095 USA.	dteplow@ucla.edu			National Institutes of Health [AG027818]; Japan Human Science Foundation; Mochida Memorial Foundation; Eli Lilly Japan; NATIONAL INSTITUTE ON AGING [P01AG027818] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22790815] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Human Science Foundation; Mochida Memorial Foundation; Eli Lilly Japan(Eli Lilly); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grant AG027818 and the Japan Human Science Foundation, a Pergolide Fellowship (Eli Lilly Japan), and the Mochida Memorial Foundation for Medical and Pharmaceutical Research.	Abe K, 1998, NEUROSCI RES, V31, P295, DOI 10.1016/S0168-0102(98)00055-8; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Betts V, 2008, NEUROBIOL DIS, V31, P442, DOI 10.1016/j.nbd.2008.06.001; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2004, ACCOUNTS CHEM RES, V37, P357, DOI 10.1021/ar000214l; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Bugiani O., 1998, NEUROBIOL AGING, V19, pS238; Fancy DA, 2000, CHEM BIOL, V7, P697, DOI 10.1016/S1074-5521(00)00020-X; Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020; Gardberg A, 2009, BIOCHEMISTRY-US, V48, P5210, DOI 10.1021/bi9001216; Grabowski TJ, 2001, ANN NEUROL, V49, P697, DOI 10.1002/ana.1009; Grant MA, 2007, P NATL ACAD SCI USA, V104, P16522, DOI 10.1073/pnas.0705197104; Groenning Minna, 2010, J Chem Biol, V3, P1, DOI 10.1007/s12154-009-0027-5; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Hori Y, 2007, J BIOL CHEM, V282, P4916, DOI 10.1074/jbc.M608220200; Janssen JC, 2003, NEUROLOGY, V60, P235, DOI 10.1212/01.WNL.0000042088.22694.E3; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; KAMINO K, 1992, AM J HUM GENET, V51, P998; Khurana R, 2003, BIOPHYS J, V85, P1135, DOI 10.1016/S0006-3495(03)74550-0; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Klyubin I, 2004, EUR J NEUROSCI, V19, P2839, DOI 10.1111/j.1460-9568.2004.03389.x; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Lazo ND, 2005, PROTEIN SCI, V14, P1581, DOI 10.1110/ps.041292205; Lazo ND, 2005, AMYLOID PROTEINS: THE BETA SHEET CONFORMATION AND DISEASE, VOLS 1 AND 2, P385; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Lomakin A, 1997, P NATL ACAD SCI USA, V94, P7942, DOI 10.1073/pnas.94.15.7942; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Maji SK, 2009, J BIOL CHEM, V284, P23580, DOI 10.1074/jbc.M109.038133; Maji SK, 2005, BIOCHEMISTRY-US, V44, P13365, DOI 10.1021/bi0508284; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Naiki H, 1996, LAB INVEST, V74, P374; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Ronicke R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003236; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Selkoe DJ, 2004, ANN INTERN MED, V140, P627, DOI 10.7326/0003-4819-140-8-200404200-00047; Sgourakis NG, 2007, J MOL BIOL, V368, P1448, DOI 10.1016/j.jmb.2007.02.093; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Teplow DB, 2006, METHOD ENZYMOL, V413, P20, DOI 10.1016/S0076-6879(06)13002-5; Teplow DB, 2006, ACCOUNTS CHEM RES, V39, P635, DOI 10.1021/ar050063s; Teplow DB, 1998, AMYLOID, V5, P121, DOI 10.3109/13506129808995290; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Tomiyama T, 2008, ANN NEUROL, V63, P377, DOI 10.1002/ana.21321; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Wakutani Y, 2004, J NEUROL NEUROSUR PS, V75, P1039, DOI 10.1136/jnnp.2003.010611; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X; Yang MF, 2008, J MOL BIOL, V384, P450, DOI 10.1016/j.jmb.2008.09.039	57	123	125	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23184	23195		10.1074/jbc.M109.086496	http://dx.doi.org/10.1074/jbc.M109.086496			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20452980	Green Published, hybrid			2022-12-27	WOS:000279999900053
J	Raney, KD; Sharma, SD; Moustafa, IM; Cameron, CE				Raney, Kevin D.; Sharma, Suresh D.; Moustafa, Ibrahim M.; Cameron, Craig E.			Hepatitis C Virus Non-structural Protein 3 (HCV NS3): A Multifunctional Antiviral Target	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							IFN-BETA PROMOTER; PROTEASE INHIBITOR; RIG-I; CRYSTAL-STRUCTURE; SERINE-PROTEASE; ADAPTER PROTEIN; HELICASE ACTIVITY; DRUG-RESISTANCE; BINDING-SITE; DNA HELICASE	Hepatitis C virus non-structural protein 3 contains a serine protease and an RNA helicase. Protease cleaves the genome-encoded polyprotein and inactivates cellular proteins required for innate immunity. Protease has emerged as an important target for the development of antiviral therapeutics, but drug resistance has turned out to be an obstacle in the clinic. Helicase is required for both genome replication and virus assembly. Mechanistic and structural studies of helicase have hurled this enzyme into a prominent position in the field of helicase enzymology. Nevertheless, studies of helicase as an antiviral target remain in their infancy.	[Raney, Kevin D.] Univ Arkansas Med Sci Hosp, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Sharma, Suresh D.; Moustafa, Ibrahim M.; Cameron, Craig E.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	University of Arkansas System; University of Arkansas Medical Sciences; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Raney, KD (corresponding author), Univ Arkansas Med Sci Hosp, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	raneykevind@uams.edu; cec9@psu.edu	SHARMA, Suresh D./AAD-7723-2022; SHARMA, Suresh/C-4431-2008	SHARMA, Suresh D./0000-0002-8633-4145; SHARMA, Suresh/0000-0002-8633-4145	National Institutes of Health [GM089001]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM089001. This is the first article in the Thematic Minireview Series on Hepatitis C Virus. This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Altman MD, 2008, J AM CHEM SOC, V130, P6099, DOI 10.1021/ja076558p; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Behrens SE, 1996, EMBO J, V15, P12, DOI 10.1002/j.1460-2075.1996.tb00329.x; Belon CA, 2009, FUTURE VIROL, V4, P277, DOI 10.2217/FVL.09.7; Belon CA, 2008, BIOTECHNIQUES, V45, P433, DOI 10.2144/000112834; Beran RKF, 2008, J BIOL CHEM, V283, P29929, DOI 10.1074/jbc.M804065200; Beran RKF, 2007, J BIOL CHEM, V282, P34913, DOI 10.1074/jbc.M707165200; Beran RKF, 2009, J VIROL, V83, P3268, DOI 10.1128/JVI.01849-08; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Chao L, 1999, J VIROL, V73, P8798, DOI 10.1128/JVI.73.10.8798-8807.1999; Chen ZL, 2010, ANTIVIR RES, V86, P220, DOI 10.1016/j.antiviral.2010.02.321; Cheng G, 2006, P NATL ACAD SCI USA, V103, P8499, DOI 10.1073/pnas.0602957103; Chockalingam K, 2010, P NATL ACAD SCI USA, V107, P3764, DOI 10.1073/pnas.0915117107; Cicero DO, 1999, J MOL BIOL, V289, P385, DOI 10.1006/jmbi.1999.2746; Cummings MD, 2010, ANGEW CHEM INT EDIT, V49, P1652, DOI 10.1002/anie.200906696; DeFrancesco R, 1996, BIOCHEMISTRY-US, V35, P13282, DOI 10.1021/bi9616458; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Dillingham MS, 2001, P NATL ACAD SCI USA, V98, P8381, DOI 10.1073/pnas.131009598; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; FAILLA C, 1994, J VIROL, V68, P3753, DOI 10.1128/JVI.68.6.3753-3760.1994; Ferreon JC, 2005, J BIOL CHEM, V280, P20483, DOI 10.1074/jbc.M500422200; FERSHT AR, 1973, J MOL BIOL, V74, P137, DOI 10.1016/0022-2836(73)90103-4; FERSHT AR, 1972, J AM CHEM SOC, V94, P293, DOI 10.1021/ja00756a061; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Frick DN, 2004, NUCLEIC ACIDS RES, V32, P5519, DOI 10.1093/nar/gkh891; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; GRAKOUI A, 1993, J VIROL, V67, P2832, DOI 10.1128/JVI.67.5.2832-2843.1993; GRAKOUI A, 1993, P NATL ACAD SCI USA, V90, P10583, DOI 10.1073/pnas.90.22.10583; Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107; Henn A, 2010, P NATL ACAD SCI USA, V107, P4046, DOI 10.1073/pnas.0913081107; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Huang LY, 2005, J BIOL CHEM, V280, P36417, DOI 10.1074/jbc.M508175200; Ingallinella P, 1998, BIOCHEMISTRY-US, V37, P8906, DOI 10.1021/bi980314n; JARVIS TC, 1991, J BIOL CHEM, V266, P1830; Jennings TA, 2009, J BIOL CHEM, V284, P4806, DOI 10.1074/jbc.M805540200; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; Kasprzak A, 2007, FOLIA HISTOCHEM CYTO, V45, P357; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Khu YL, 2001, J VIROL, V75, P205, DOI 10.1128/JVI.75.1.205-214.2001; Kim JL, 1996, CELL, V87, P343, DOI 10.1016/S0092-8674(00)81351-3; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; King NM, 2004, CHEM BIOL, V11, P1333, DOI 10.1016/j.chembiol.2004.08.010; Knipe DM, 2007, FIELDS VIROLOGY; Koev G, 2008, EXPERT OPIN INV DRUG, V17, P303, DOI [10.1517/13543784.17.3.303, 10.1517/13543784.17.3.303 ]; Konan KV, 2003, J VIROL, V77, P7843, DOI 10.1128/JVI.77.14.7843-7855.2003; Lam AMI, 2004, NUCLEIC ACIDS RES, V32, P4060, DOI 10.1093/nar/gkh743; Lam AMI, 2003, J BIOL CHEM, V278, P44514, DOI 10.1074/jbc.M306444200; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Levin MK, 2005, NAT STRUCT MOL BIOL, V12, P429, DOI 10.1038/nsmb920; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Levin MK, 2002, J BIOL CHEM, V277, P29377, DOI 10.1074/jbc.M112315200; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Lin C., 2006, Infectious Disorders - Drug Targets, V6, P3, DOI 10.2174/187152606776056706; Lin TI, 2009, ANTIMICROB AGENTS CH, V53, P1377, DOI 10.1128/AAC.01058-08; Locatelli GA, 2002, BIOCHEMISTRY-US, V41, P10332, DOI 10.1021/bi026082g; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; Love RA, 1996, CELL, V87, P331, DOI 10.1016/S0092-8674(00)81350-1; Lucius AL, 2003, BIOPHYS J, V85, P2224, DOI 10.1016/S0006-3495(03)74648-7; Macdonald A, 2004, J GEN VIROL, V85, P2485, DOI 10.1099/vir.0.80204-0; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Nalam MNL, 2008, CURR OPIN HIV AIDS, V3, P642, DOI 10.1097/COH.0b013e3283136cee; Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168; Patel SS, 2006, J BIOL CHEM, V281, P18265, DOI 10.1074/jbc.R600008200; Perni RB, 2007, BIOORG MED CHEM LETT, V17, P3406, DOI 10.1016/j.bmcl.2007.03.090; Ploss A, 2010, P NATL ACAD SCI USA, V107, P3141, DOI 10.1073/pnas.0915130107; Prabu-Jeyabalan M, 2003, J VIROL, V77, P1306, DOI 10.1128/JVI.77.2.1306-1315.2003; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Rajagopal V, 2008, J MOL BIOL, V376, P69, DOI 10.1016/j.jmb.2007.10.070; Rajagopalan R, 2009, BIOCHEMISTRY-US, V48, P2559, DOI 10.1021/bi900038p; Rajkowitsch L, 2007, RNA BIOL, V4, P118, DOI 10.4161/rna.4.3.5445; ROMANO KP, 2009, PROTEIN SCI, V18, P176; Saikrishnan K, 2008, EMBO J, V27, P2222, DOI 10.1038/emboj.2008.144; Saikrishnan K, 2009, CELL, V137, P849, DOI 10.1016/j.cell.2009.03.036; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Serebrov V, 2004, NATURE, V430, P476, DOI 10.1038/nature02704; Serebrov V, 2009, J BIOL CHEM, V284, P2512, DOI 10.1074/jbc.M805460200; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shimakami T, 2004, J VIROL, V78, P2738, DOI 10.1128/JVI.78.6.2738-2748.2004; Sikora B, 2008, J BIOL CHEM, V283, P11516, DOI 10.1074/jbc.M708125200; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Steinkuhler C, 1998, BIOCHEMISTRY-US, V37, P8899, DOI 10.1021/bi980313v; Sun SY, 2010, CURR OPIN STRUC BIOL, V20, P114, DOI 10.1016/j.sbi.2009.12.006; SUZICH JA, 1993, J VIROL, V67, P6152, DOI 10.1128/JVI.67.10.6152-6158.1993; Tackett AJ, 2005, J BIOL CHEM, V280, P10797, DOI 10.1074/jbc.M407971200; TANJI Y, 1995, J VIROL, V69, P3980, DOI 10.1128/JVI.69.7.3980-3986.1995; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; TOMEI L, 1993, J VIROL, V67, P4017, DOI 10.1128/JVI.67.7.4017-4026.1993; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Venkatraman S, 2006, J MED CHEM, V49, P6074, DOI 10.1021/jm060325b; WALLER H, 2010, J VIROL MET IN PRESS; Wang QX, 2010, NUCLEIC ACIDS RES, V38, P1312, DOI 10.1093/nar/gkp1118; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang RM, 1997, J VIROL, V71, P6208, DOI 10.1128/JVI.71.8.6208-6213.1997	100	130	134	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22725	22731		10.1074/jbc.R110.125294	http://dx.doi.org/10.1074/jbc.R110.125294			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20457607	Green Published, hybrid			2022-12-27	WOS:000279999900002
J	Litherland, GJ; Elias, MS; Hui, W; Macdonald, CD; Catterall, JB; Barter, MJ; Farren, MJ; Jefferson, M; Rowan, AD				Litherland, Gary J.; Elias, Martina S.; Hui, Wang; Macdonald, Christopher D.; Catterall, Jonathon B.; Barter, Matt J.; Farren, Matthew J.; Jefferson, Matthew; Rowan, Andrew D.			Protein Kinase C Isoforms zeta and iota Mediate Collagenase Expression and Cartilage Destruction via STAT3-and ERK-dependent c-fos Induction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; MATRIX-METALLOPROTEINASE EXPRESSION; BOVINE NASAL CARTILAGE; ONCOSTATIN-M; GENE-EXPRESSION; FACTOR-ALPHA; SIGNALING PATHWAYS; RETINOIC ACID; T-CELLS	The protein kinase C (PKC) signaling pathway is a major regulator of cellular functions and is implicated in pathologies involving extracellular matrix remodeling. Inflammatory joint disease is characterized by excessive extracellular matrix catabolism, and here we assess the role of PKC in the induction of the collagenases, matrix metalloproteinase (MMP)-1 and MMP-13, in human chondrocytes by the potent cytokine stimulus interleukin-1 (IL-1) in combination with oncostatin M(OSM). IL-1 + OSM-stimulated collagenolysis and gelatinase activity were ameliorated by pharmacological PKC inhibition in bovine cartilage, as was collagenase gene induction in human chondrocytes. Small interfering RNA-mediated silencing of PKC gene expression showed that both novel (nPKC delta, nPKC eta) and atypical (aPKC zeta, aPKC iota) isoforms were involved in collagenase induction by IL-1. However, MMP1 and MMP13 induction by IL-1 + OSM was inhibited only by aPKC silencing, suggesting that only atypical isoforms play a significant role in complex inflammatory milieus. Silencing of either aPKC led to diminished IL-1 + OSM-dependent extracellular signal-regulated kinase (ERK) and signal transducer and activator of transcription (STAT) 3 phosphorylation, and c-fos expression. STAT3 gene silencing or ERK pathway inhibition also resulted in loss of IL-1 + OSM-stimulated c-fos and collagenase expression. Silencing of c-fos and c-jun expression was sufficient to abrogate IL-1 + OSM-stimulated collagenase gene induction, and overexpression of both c-fos and c-jun was sufficient to drive transcription from the MMP1 promoter in the absence of a stimulus. Our data identify atypical PKC isozymes as STAT and ERK activators that mediate c-fos and collagenase expression during IL-1 + OSM synergy in human chondrocytes. aPKCs may constitute potential therapeutic targets for inflammatory joint diseases involving increased collagenase expression.	[Litherland, Gary J.; Elias, Martina S.; Hui, Wang; Macdonald, Christopher D.; Catterall, Jonathon B.; Barter, Matt J.; Farren, Matthew J.; Jefferson, Matthew; Rowan, Andrew D.] Newcastle Univ, Inst Cellular Med, Cell Signalling Injury & Repair Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Rowan, AD (corresponding author), Newcastle Univ, Inst Cellular Med, Cell Signalling Injury & Repair Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	a.d.rowan@ncl.ac.uk	Litherland, Gary J/K-9755-2015	Litherland, Gary/0000-0001-5264-0219; Elias, Martina S/0000-0003-3352-5391	Arthritis Research UK [18726]; Nuffield Foundation; Dunhill Medical Trust; John G. W. Patterson Foundation; UK National Institute of Health Research Biomedical Research Centre for Aging and Age-Related Disease	Arthritis Research UK(Versus Arthritis); Nuffield Foundation; Dunhill Medical Trust(Dunhill Medical Trust); John G. W. Patterson Foundation; UK National Institute of Health Research Biomedical Research Centre for Aging and Age-Related Disease	This work was supported by Arthritis Research UK Grant 18726, the Nuffield Foundation (Oliver Bird Fund), the Dunhill Medical Trust, the John G. W. Patterson Foundation, and a UK National Institute of Health Research Biomedical Research Centre for Aging and Age-Related Disease award to the Newcastle upon Tyne Hospitals National Health Service Foundation Trust.	Babu GJ, 2000, J MOL CELL CARDIOL, V32, P1447, DOI 10.1006/jmcc.2000.1185; Barksby HE, 2006, ARTHRITIS RHEUM-US, V54, P540, DOI 10.1002/art.21574; BERGMAN I, 1963, ANAL CHEM, V35, P1961, DOI 10.1021/ac60205a053; Bigg HF, 2007, FEBS J, V274, P1246, DOI 10.1111/j.1742-4658.2007.05669.x; Boschelli DH, 2009, CURR TOP MED CHEM, V9, P640, DOI 10.2174/156802609789007372; Botelho FM, 1998, J BIOL CHEM, V273, P5211, DOI 10.1074/jbc.273.9.5211; Budhiraja S, 2008, FUND CLIN PHARMACOL, V22, P231, DOI 10.1111/j.1472-8206.2008.00583.x; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Caraglia M, 2006, ANN ONCOL, V17, pVII124, DOI 10.1093/annonc/mdl964; Carrozza ML, 1997, ONCOGENE, V14, P1083, DOI 10.1038/sj.onc.1200921; Cawston TE, 1998, ARTHRITIS RHEUM-US, V41, P1760, DOI 10.1002/1529-0131(199810)41:10<1760::AID-ART8>3.0.CO;2-M; Chockalingam PS, 2007, ARTHRITIS RHEUM, V56, P4074, DOI 10.1002/art.23043; Chu F, 2004, CARCINOGENESIS, V25, P585, DOI 10.1093/carcin/bgh041; Chu SC, 2004, CONNECT TISSUE RES, V45, P142, DOI 10.1080/03008200490506058; Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006; CLARK IM, 1992, MATRIX, V12, P475, DOI 10.1016/S0934-8832(11)80092-2; Cleaver CS, 2001, ANN RHEUM DIS, V60, P150, DOI 10.1136/ard.60.2.150; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Diaz-Meco MT, 2001, MOL CELL BIOL, V21, P1218, DOI 10.1128/MCB.21.4.1218-1227.2001; Eiseler T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2232; Fields AP, 2007, PHARMACOL RES, V55, P487, DOI 10.1016/j.phrs.2007.04.015; Frederick LA, 2008, ONCOGENE, V27, P4841, DOI 10.1038/onc.2008.119; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Guo Z, 2007, FASEB J, V21, P535, DOI 10.1096/fj.06-6739com; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Hui W, 2003, ARTHRITIS RHEUM-US, V48, P3404, DOI 10.1002/art.11333; Hui W, 2003, ANN RHEUM DIS, V62, P172, DOI 10.1136/ard.62.2.172; Im HJ, 2007, J BIOL CHEM, V282, P11110, DOI 10.1074/jbc.M609040200; Jain N, 1999, J BIOL CHEM, V274, P24392, DOI 10.1074/jbc.274.34.24392; JUBB RW, 1980, J PATHOL, V130, P159, DOI 10.1002/path.1711300304; Keller ET, 2004, BIOCHEM PHARMACOL, V68, P1049, DOI 10.1016/j.bcp.2004.04.024; KOBAYASHI E, 1989, BIOCHEM BIOPH RES CO, V159, P548, DOI 10.1016/0006-291X(89)90028-4; Koenders MI, 2006, ANN RHEUM DIS, V65, P29, DOI 10.1136/ard.2006.058529; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Korzus E, 1997, J BIOL CHEM, V272, P1188, DOI 10.1074/jbc.272.2.1188; Koshy PJ, 2002, ANN RHEUM DIS, V61, P704, DOI 10.1136/ard.61.8.704; Koshy PJT, 1999, ANAL BIOCHEM, V275, P202, DOI 10.1006/abio.1999.4310; Koshy PJT, 2002, ARTHRITIS RHEUM, V46, P961, DOI 10.1002/art.10212; Lacreusette A, 2009, J PATHOL, V217, P665, DOI 10.1002/path.2490; LaVallie ER, 2006, J BIOL CHEM, V281, P24124, DOI 10.1074/jbc.M601905200; Leaman DW, 1996, MOL CELL BIOL, V16, P369; Litherland GJ, 2008, J BIOL CHEM, V283, P14221, DOI 10.1074/jbc.M710136200; Liu JF, 2002, BIOCHEM BIOPH RES CO, V293, P1174, DOI 10.1016/S0006-291X(02)00350-9; Lorenz K, 2003, NATURE, V426, P574, DOI 10.1038/nature02158; Martelli AM, 2006, BBA-MOL CELL BIOL L, V1761, P542, DOI 10.1016/j.bbalip.2006.02.009; Martin P, 2005, P NATL ACAD SCI USA, V102, P9866, DOI 10.1073/pnas.0501202102; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Morgan TG, 2006, ANN RHEUM DIS, V65, P184, DOI 10.1136/ard.2004.033480; Moscat J, 2006, CELL DEATH DIFFER, V13, P702, DOI 10.1038/sj.cdd.4401823; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Perez-Rodriguez R, 2009, J NEUROCHEM, V108, P1083, DOI 10.1111/j.1471-4159.2008.05862.x; Popa-Nita O, 2009, J IMMUNOL, V183, P2104, DOI 10.4049/jimmunol.0900906; Quesnelle KM, 2007, J CELL BIOCHEM, V102, P311, DOI 10.1002/jcb.21475; Regala RP, 2005, J BIOL CHEM, V280, P31109, DOI 10.1074/jbc.M505402200; Robertson MJ, 2007, J CLIN ONCOL, V25, P1741, DOI 10.1200/JCO.2006.09.3146; Rowan AD, 2003, AM J PATHOL, V162, P1975, DOI 10.1016/S0002-9440(10)64330-1; Rowan AD, 2001, ARTHRITIS RHEUM-US, V44, P1620, DOI 10.1002/1529-0131(200107)44:7<1620::AID-ART285>3.0.CO;2-B; Sakkas LI, 2007, ARTHRITIS RHEUM-US, V56, P409, DOI 10.1002/art.22369; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; Scrivo R, 2007, ANN NY ACAD SCI, V1108, P312, DOI 10.1196/annals.1422.033; Shen Garry X., 2003, Current Drug Targets - Cardiovascular & Haematological Disorders, V3, P301, DOI 10.2174/1568006033481375; Shin OS, 2007, CELL MICROBIOL, V9, P1987, DOI 10.1111/j.1462-5822.2007.00929.x; Shingleton WD, 2006, RHEUMATOLOGY, V45, P958, DOI 10.1093/rheumatology/kel024; Shingleton WD, 2000, J CELL BIOCHEM, V79, P519, DOI 10.1002/1097-4644(20001215)79:4<519::AID-JCB10>3.0.CO;2-U; Skvara H, 2008, J CLIN INVEST, V118, P3151, DOI 10.1172/JCI35636; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Staunton D, 1998, PROTEIN ENG, V11, P1093, DOI 10.1093/protein/11.11.1093; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Tanaka S, 1998, SEMIN ARTHRITIS RHEU, V27, P392, DOI 10.1016/S0049-0172(98)80019-X; Tardif G, 1999, ARTHRITIS RHEUM, V42, P1147, DOI 10.1002/1529-0131(199906)42:6<1147::AID-ANR11>3.0.CO;2-Y; Uddin S, 2002, J BIOL CHEM, V277, P14408, DOI 10.1074/jbc.M109671200; Urtreger AJ, 2005, MOL CARCINOGEN, V42, P29, DOI 10.1002/mc.20066; Vincenti MP, 2007, J CELL PHYSIOL, V213, P355, DOI 10.1002/jcp.21208; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Wierenga ATJ, 2003, EXP HEMATOL, V31, P398, DOI 10.1016/S0301-472X(03)00045-6	78	48	50	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22414	22425		10.1074/jbc.M110.120121	http://dx.doi.org/10.1074/jbc.M110.120121			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20463008	hybrid, Green Published			2022-12-27	WOS:000279702200054
J	Shanmugam, D; Wu, B; Ramirez, U; Jaffe, EK; Roos, DS				Shanmugam, Dhanasekaran; Wu, Bo; Ramirez, Ursula; Jaffe, Eileen K.; Roos, David S.			Plastid-associated Porphobilinogen Synthase from Toxoplasma gondii KINETIC AND STRUCTURAL PROPERTIES VALIDATE THERAPEUTIC POTENTIAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY STRUCTURE; PLASMODIUM-FALCIPARUM; HEME-BIOSYNTHESIS; MALARIAL PARASITE; ESCHERICHIA-COLI; ACID DEHYDRATASE; TETRAPYRROLE BIOSYNTHESIS; PSEUDOMONAS-AERUGINOSA; INHIBITION; ASSEMBLIES	Apicomplexan parasites (including Plasmodium spp. and Toxoplasma gondii) employ a four-carbon pathway for de novo heme biosynthesis, but this pathway is distinct from the animal/fungal C4 pathway in that it is distributed between three compartments: the mitochondrion, cytosol, and apicoplast, a plastid acquired by secondary endosymbiosis of an alga. Parasite porphobilinogen synthase (PBGS) resides within the apicoplast, and phylogenetic analysis indicates a plant origin. The PBGS family exhibits a complex use of metal ions (Zn2+ and Mg2+) and oligomeric states (dimers, hexamers, and octamers). Recombinant T. gondii PBGS (TgPBGS) was purified as a stable similar to 320-kDa octamer, and low levels of dimers but no hexamers were also observed. The enzyme displays a broad activity peak (pH 7-8.5), with a K-m for aminolevulinic acid of similar to 150 mu M and specific activity of similar to 24 mu mol of porphobilinogen/mg of protein/h. Like the plant enzyme, TgPBGS responds to Mg2+ but not Zn2+ and shows two Mg2+ affinities, interpreted as tight binding at both the active and allosteric sites. Unlike other Mg2+ -binding PBGS, however, metal ions are not required for TgPBGS octamer stability. A mutant enzyme lacking the C-terminal 13 amino acids distinguishing parasite PBGS from plant and animal enzymes purified as a dimer, suggesting that the C terminus is required for octamer stability. Parasite heme biosynthesis is inhibited (and parasites are killed) by succinylacetone, an active site-directed suicide substrate. The distinct phylogenetic, enzymatic, and structural features of apicomplexan PBGS offer scope for developing selective inhibitors of the parasite enzyme based on its quaternary structure characteristics.	[Shanmugam, Dhanasekaran; Wu, Bo; Roos, David S.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Ramirez, Ursula; Jaffe, Eileen K.] Fox Chase Canc Ctr, Inst Canc Res, Philadelphia, PA 19111 USA	University of Pennsylvania; Fox Chase Cancer Center	Roos, DS (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	droos@sas.upenn.edu		Roos, David Siker/0000-0001-6725-4089	National Institutes of Health Grants [AI28724, ES003654, T32CA00935, AI077577, CA006927]; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI028724, R01AI028724, R56AI077577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003654] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI28724 (to D.S.R.), ES003654 (to E.K.J.), T32CA00935 (to the Institute for Cancer Research), AI077577 (to E.K.J.), and CA006927 (to Fox Chase Cancer Center).	Bollivar David W., 2004, BMC Biochemistry, V5, P17, DOI 10.1186/1471-2091-5-17; Bonday ZQ, 1997, J BIOL CHEM, V272, P21839, DOI 10.1074/jbc.272.35.21839; Breinig S, 2003, NAT STRUCT BIOL, V10, P757, DOI 10.1038/nsb963; Canutescu AA, 2005, BIOINFORMATICS, V21, P2914, DOI 10.1093/bioinformatics/bti438; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Dhanasekaran S, 2004, J BIOL CHEM, V279, P6934, DOI 10.1074/jbc.M311409200; Erskine PT, 2001, FEBS LETT, V503, P196, DOI 10.1016/S0014-5793(01)02721-1; Erskine PT, 2001, J MOL BIOL, V312, P133, DOI 10.1006/jmbi.2001.4947; Frankenberg N, 1999, BIOCHEMISTRY-US, V38, P13976, DOI 10.1021/bi9906470; Gacond S, 2007, CHEM BIODIVERS, V4, P189, DOI 10.1002/cbdv.200790024; Heinemann IU, 2008, ARCH BIOCHEM BIOPHYS, V474, P238, DOI 10.1016/j.abb.2008.02.015; Heinemann IU, 2010, ANTIMICROB AGENTS CH, V54, P267, DOI 10.1128/AAC.00553-09; Jaffe EK, 2007, AM J HUM GENET, V80, P329, DOI 10.1086/511444; Jaffe EK, 2004, BIOORG CHEM, V32, P316, DOI 10.1016/j.bioorg.2004.05.010; Jaffe EK, 2003, CHEM BIOL, V10, P25, DOI 10.1016/S1074-5521(02)00296-X; JAFFE EK, 1995, BIOCHEMISTRY-US, V34, P244, DOI 10.1021/bi00001a029; Jaffe EK, 2000, ACTA CRYSTALLOGR D, V56, P115, DOI 10.1107/S0907444999014894; JAFFE EK, 1995, J BIOENERG BIOMEMBR, V27, P169, DOI 10.1007/BF02110032; Jaffe EK, 2002, J BIOL CHEM, V277, P19792, DOI 10.1074/jbc.M201486200; Jaffe EK, 2005, TRENDS BIOCHEM SCI, V30, P490, DOI 10.1016/j.tibs.2005.07.003; Jarret C, 2000, CHEM BIOL, V7, P185, DOI 10.1016/S1074-5521(00)00089-2; Kervinen J, 2001, BIOCHEMISTRY-US, V40, P8227, DOI 10.1021/bi010656k; Kervinen J, 2000, BIOCHEMISTRY-US, V39, P9018, DOI 10.1021/bi000620c; Kokona B, 2008, BIOCHEMISTRY-US, V47, P10649, DOI 10.1021/bi801128d; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lawrence SH, 2008, CHEM BIOL, V15, P586, DOI 10.1016/j.chembiol.2008.04.012; Lawrence SH, 2009, J BIOL CHEM, V284, P35807, DOI 10.1074/jbc.M109.026294; Matrajt M, 2002, MOL BIOCHEM PARASIT, V120, P285, DOI 10.1016/S0166-6851(02)00014-2; Papenbrock J, 2001, PLANTA, V213, P667, DOI 10.1007/s004250100593; Petrovich RM, 1996, J BIOL CHEM, V271, P8692, DOI 10.1074/jbc.271.15.8692; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Roos DS, 1999, CURR OPIN MICROBIOL, V2, P426, DOI 10.1016/S1369-5274(99)80075-7; Sato S, 2004, PROTIST, V155, P117, DOI 10.1078/1434461000169; Seeber F, 1997, PARASITOL RES, V83, P309, DOI 10.1007/s004360050254; Selwood T, 2008, BIOCHEMISTRY-US, V47, P3245, DOI 10.1021/bi702113z; Senior NM, 1996, BIOCHEM J, V320, P401; Srivastava P, 1998, EXP PARASITOL, V88, P60, DOI 10.1006/expr.1998.4193; SUROLIA N, 1992, BIOCHEM BIOPH RES CO, V187, P744, DOI 10.1016/0006-291X(92)91258-R; Tang L, 2005, J BIOL CHEM, V280, P15786, DOI 10.1074/jbc.M500218200; TSCHUDY DP, 1981, J BIOL CHEM, V256, P9915; van Dooren GG, 2002, J BIOL CHEM, V277, P23612, DOI 10.1074/jbc.M201748200; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; WU B, 2006, THESIS U PENNSYLVANI; Xiang ZX, 2002, P NATL ACAD SCI USA, V99, P7432, DOI 10.1073/pnas.102179699	44	26	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22122	22131		10.1074/jbc.M110.107243	http://dx.doi.org/10.1074/jbc.M110.107243			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20442414	hybrid, Green Published			2022-12-27	WOS:000279702200025
J	Shibata, M; Hakuno, F; Yamanaka, D; Okajima, H; Fukushima, T; Hasegawa, T; Ogata, T; Toyoshima, Y; Chida, K; Kimura, K; Sakoda, H; Takenaka, A; Asano, T; Takahashi, SI				Shibata, Michihiro; Hakuno, Fumihiko; Yamanaka, Daisuke; Okajima, Hiroshi; Fukushima, Toshiaki; Hasegawa, Takashi; Ogata, Tomomi; Toyoshima, Yuka; Chida, Kazuhiro; Kimura, Kumi; Sakoda, Hideyuki; Takenaka, Asako; Asano, Tomoichiro; Takahashi, Shin-Ichiro			Paraquat-induced Oxidative Stress Represses Phosphatidylinositol 3-Kinase Activities Leading to Impaired Glucose Uptake in 3T3-L1 Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; PROTEIN-KINASE; GLUT4 TRANSLOCATION; SIGNALING PATHWAYS; REGULATORY SUBUNIT; TRANSPORT ACTIVITY; TYROSINE KINASE; CELLS; RESISTANCE; GROWTH	Accumulated evidence indicates that oxidative stress causes and/or promotes insulin resistance; however, the mechanism by which this occurs is not fully understood. This study was undertaken to elucidate the molecular mechanism by which oxidative stress induced by paraquat impairs insulin-dependent glucose uptake in 3T3-L1 adipocytes. We confirmed that paraquat-induced oxidative stress decreased glucose transporter 4 (GLUT4) translocation to the cell surface, resulting in repression of insulin-dependent 2-deoxyglucose uptake. Under these conditions, oxidative stress did not affect insulin-dependent tyrosine phosphorylation of insulin receptor, insulin receptor substrate (IRS)-1 and -2, or binding of the phosphatidylinositol 3'-OH kinase (PI 3-kinase) p85 regulatory subunit or p110 alpha catalytic subunit to each IRS. In contrast, we found that oxidative stress induced by paraquat inhibited activities of PI 3-kinase bound to IRSs and also inhibited phosphorylation of Akt, the downstream serine/threonine kinase that has been shown to play an essential role in insulin-dependent translocation of GLUT4 to the plasma membrane. Overexpression of active form Akt (myr-Akt) restored inhibition of insulin-dependent glucose uptake by paraquat, indicating that paraquat-induced oxidative stress inhibits insulin signals upstream of Akt. Paraquat treatment with and without insulin treatment decreased the activity of class Ia PI 3-kinases p110 alpha and p110 beta that are mainly expressed in 3T3-L1 adipocytes. However, paraquat treatment did not repress the activity of the PI 3-kinase p110 alpha mutated at Cys(90) in the p85 binding region. These results indicate that the PI 3-kinase p110 is a possible primary target of paraquat-induced oxidative stress to reduce the PI 3-kinase activity and impaired glucose uptake in 3T3-L1 adipocytes.	[Shibata, Michihiro; Hakuno, Fumihiko; Yamanaka, Daisuke; Okajima, Hiroshi; Fukushima, Toshiaki; Hasegawa, Takashi; Ogata, Tomomi; Toyoshima, Yuka; Chida, Kazuhiro; Takahashi, Shin-Ichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Sci, Lab Cell Regulat,Bunkyo Ku, Tokyo 1138657, Japan; [Shibata, Michihiro; Hakuno, Fumihiko; Yamanaka, Daisuke; Okajima, Hiroshi; Fukushima, Toshiaki; Hasegawa, Takashi; Ogata, Tomomi; Toyoshima, Yuka; Chida, Kazuhiro; Takahashi, Shin-Ichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Kimura, Kumi; Takenaka, Asako] Meiji Univ, Fac Agr, Dept Agr Chem, Kawasaki Ku, Kanagawa 2148571, Japan; [Sakoda, Hideyuki] Asahi Life Fdn, Inst Adult Dis, Dept Internal Med, Chiyoda Ku, Tokyo 1000005, Japan; [Asano, Tomoichiro] Hiroshima Univ, Grad Sch Biomed Sci, Div Mol Med Sci, Hiroshima 7348553, Japan	University of Tokyo; University of Tokyo; Meiji University; Asahi Life Foundation; Hiroshima University	Takahashi, SI (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Sci, Lab Cell Regulat,Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	atkshin@mail.ecc.u-tokyo.ac.jp		Takahashi, Shin-Ichiro/0000-0002-2323-2010; Hakuno, Fumihiko/0000-0002-4447-6225	Ministry of Education, Science, Culture and Sports, Japan [16208028]; Grants-in-Aid for Scientific Research [22780249] Funding Source: KAKEN	Ministry of Education, Science, Culture and Sports, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Scientific Research 16208028 from the Ministry of Education, Science, Culture and Sports, Japan (to S.-I.T.).	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Anderson KE, 2003, INT J BIOCHEM CELL B, V35, P1028, DOI 10.1016/S1357-2725(02)00270-4; Asano T, 2000, J BIOL CHEM, V275, P17671, DOI 10.1074/jbc.M910391199; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; Chang L, 2004, MOL MED, V10, P65, DOI 10.2119/2005-00029.Saltiel; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902; Chen SR, 2000, FREE RADICAL BIO MED, V28, P1266, DOI 10.1016/S0891-5849(00)00265-3; Cho Y, 2006, ENDOCRINOLOGY, V147, P5374, DOI 10.1210/en.2006-0518; Chu F, 2005, CANCER RES, V65, P10478, DOI 10.1158/0008-5472.CAN-05-1989; CLARKE JF, 1994, BIOCHEM J, V300, P631, DOI 10.1042/bj3000631; Dragin N, 2006, FEBS LETT, V580, P3845, DOI 10.1016/j.febslet.2006.06.006; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Ferroni P, 2006, NUTR METAB CARDIOVAS, V16, P222, DOI 10.1016/j.numecd.2005.11.012; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Hakuno F, 2007, J BIOL CHEM, V282, P37747, DOI 10.1074/jbc.M702472200; HALEY TJ, 1979, CLIN TOXICOL, V14, P1; HARA K, 1994, P NATL ACAD SCI USA, V91, P7415, DOI 10.1073/pnas.91.16.7415; Holzenberger M, 2004, HORM RES, V62, P89, DOI 10.1159/000080765; Humphries KM, 2005, J BIOL CHEM, V280, P2750, DOI 10.1074/jbc.M410242200; Inukai K, 1996, J BIOL CHEM, V271, P5317, DOI 10.1074/jbc.271.10.5317; Jacob S, 1996, EXP CLIN ENDOCR DIAB, V104, P284, DOI 10.1055/s-0029-1211455; Kabuta T, 2002, J BIOL CHEM, V277, P6846, DOI 10.1074/jbc.M107058200; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; KANAI F, 1993, BIOCHEM BIOPH RES CO, V195, P762, DOI 10.1006/bbrc.1993.2111; Katagiri H, 1996, J BIOL CHEM, V271, P16987, DOI 10.1074/jbc.271.29.16987; Kimura K, 2007, BIOSCI BIOTECH BIOCH, V71, P16, DOI 10.1271/bbb.60016; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Le Roith D, 2001, DIABETES CARE, V24, P588, DOI 10.2337/diacare.24.3.588; Lee JW, 2004, BIOCHEM J, V382, P631, DOI 10.1042/BJ20040624; Lu L, 2006, J CELL PHYSIOL, V206, P119, DOI 10.1002/jcp.20439; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Mitra P, 2004, J BIOL CHEM, V279, P37431, DOI 10.1074/jbc.C400180200; Nedachi T, 2000, ENDOCRINOLOGY, V141, P2429, DOI 10.1210/en.141.7.2429; Ogihara T, 1997, J BIOL CHEM, V272, P12868, DOI 10.1074/jbc.272.19.12868; OKADA T, 1994, J BIOL CHEM, V269, P3568; PAOLISSO G, 1995, J AM COLL NUTR, V14, P387; PAOLISSO G, 1993, AM J CLIN NUTR, V57, P650, DOI 10.1093/ajcn/57.5.650; Park HS, 2004, J BIOL CHEM, V279, P7584, DOI 10.1074/jbc.M304183200; Peng J, 2005, J BIOL CHEM, V280, P29194, DOI 10.1074/jbc.M500984200; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; Rao AW, 1998, J BIOL CHEM, V273, P25450, DOI 10.1074/jbc.273.39.25450; Rosen P, 2001, DIABETES-METAB RES, V17, P189, DOI 10.1002/dmrr.196; Shigematsu S, 2002, MOL ENDOCRINOL, V16, P1060, DOI 10.1210/me.16.5.1060; Shimada H, 1998, ARCH BIOCHEM BIOPHYS, V351, P75, DOI 10.1006/abbi.1997.0557; Shin BC, 1998, BIOCHEM BIOPH RES CO, V246, P313, DOI 10.1006/bbrc.1998.8606; Tirosh A, 1999, J BIOL CHEM, V274, P10595, DOI 10.1074/jbc.274.15.10595; Wang QH, 1998, BIOCHEM J, V331, P917, DOI 10.1042/bj3310917; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; Wu ZH, 2006, J CELL PHYSIOL, V209, P996, DOI 10.1002/jcp.20819	52	31	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20915	20925		10.1074/jbc.M110.126482	http://dx.doi.org/10.1074/jbc.M110.126482			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20430890	Green Published, hybrid			2022-12-27	WOS:000279228600056
J	Wang, ZP; Bryan, J; Franz, C; Havlioglu, N; Sandell, LJ				Wang, Zhepeng; Bryan, Jennifer; Franz, Carl; Havlioglu, Necat; Sandell, Linda J.			Type IIB Procollagen NH2-propeptide Induces Death of Tumor Cells via Interaction with Integrins alpha(V)beta(3) and alpha(V)beta(5)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-PROPEPTIDE; EXTRACELLULAR-MATRIX; NH2-TERMINAL PROPEPTIDE; C-PROTEINASE; GROWTH-PLATE; EXPRESSION; CARTILAGE; BONE; ANGIOGENESIS; ENDOCYTOSIS	Cartilage is resistant to tumor invasion. In the present study, we found that the NH2-propeptide of the cartilage-characteristic collagen, type IIB, PIIBNP, is capable of killing tumor cells. The NH2-propeptide is liberated into the extracellular matrix prior to deposition of the collagen fibrils. This peptide adheres to and kills cells from chondrosarcoma and cervical and breast cancer cell lines via the integrins alpha(v)beta(5) and alpha(v)beta(3). Adhesion is abrogated by blocking with anti alpha(v)beta(5) and alpha(v)beta(3) antibodies. When alpha(v) is suppressed by small intefering RNA, adhesion and cell killing are blocked. Normal chondrocytes from developing cartilage do not express alpha(v)beta(3) and alpha(v)beta(5) integrins and are thus protected from cell death. Morphological, DNA, and biochemical evidence indicates that the cell death is not by apoptosis but probably by necrosis. In an assay for invasion, PIIBNP reduced the number of cells crossing the membrane. In vivo, in a tumor model for breast cancer, PIIBNP was consistently able to reduce the size of the tumor.	Washington Univ, Sch Med, Barnes Jewish Hosp, Dept Orthoped Surg, St Louis, MO 63110 USA; [Sandell, Linda J.] Washington Univ, Sch Med, Barnes Jewish Hosp, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Barnes-Jewish Hospital; Washington University (WUSTL); Barnes-Jewish Hospital; Washington University (WUSTL)	Sandell, LJ (corresponding author), Washington Univ, Sch Med, Dept Orthopaed Surg, 660 S Euclid Ave,Campus Box 8233, St Louis, MO 63110 USA.	sandelll@wustl.edu			National Institutes of Health [RO1 AR R01 036994]; Siteman Cancer Center; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057235, R01AR036994, R01AR050847] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Siteman Cancer Center; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AR R01 036994. This work was also supported by the Siteman Cancer Center Research Development Award.	Baker EA, 2002, J CLIN PATHOL-MOL PA, V55, P300; Borgne-Sanchez A, 2007, CELL DEATH DIFFER, V14, P422, DOI 10.1038/sj.cdd.4402018; Bornstein P, 2002, MATRIX BIOL, V21, P217, DOI 10.1016/S0945-053X(02)00008-2; BREM H, 1975, J EXP MED, V141, P427, DOI 10.1084/jem.141.2.427; Buckley CD, 1999, NATURE, V397, P534, DOI 10.1038/17409; CANCEDDA R, 1995, INT REV CYTOL, V159, P265, DOI 10.1016/S0074-7696(08)62109-9; Chansky H, 1998, J ORTHOPAED RES, V16, P521, DOI 10.1002/jor.1100160502; CHEAH KSE, 1991, DEVELOPMENT, V111, P945; Cheresh DA, 2002, NAT MED, V8, P193, DOI 10.1038/nm0302-193; Choudhuri T, 2006, VIROLOGY, V351, P58, DOI 10.1016/j.virol.2006.03.031; Fernandes RJ, 2001, J BIOL CHEM, V276, P31502, DOI 10.1074/jbc.M103466200; FISHER LW, 1987, J BIOL CHEM, V262, P13457; Fukui N, 2002, J BIOL CHEM, V277, P2193, DOI 10.1074/jbc.M105485200; Graef Thorsten, 2005, Angiogenesis, V8, P361; Hartigan N, 2003, J BIOL CHEM, V278, P18045, DOI 10.1074/jbc.M211448200; Hausler G, 2002, CALCIFIED TISSUE INT, V71, P212, DOI 10.1007/s00223-001-2083-x; Herard AL, 1996, AM J PHYSIOL-LUNG C, V271, pL726, DOI 10.1152/ajplung.1996.271.5.L726; Hirbe AC, 2007, BLOOD, V109, P3424, DOI 10.1182/blood-2006-09-048686; Hirsch MS, 1997, DEV DYNAM, V210, P249, DOI 10.1002/(SICI)1097-0177(199711)210:3<249::AID-AJA6>3.0.CO;2-G; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Kennedy CL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000516; Kim SY, 2007, ARCH BIOCHEM BIOPHYS, V459, P40, DOI 10.1016/j.abb.2006.11.001; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kubo T, 2006, J ORTHOP RES, V24, P1138, DOI 10.1002/jor.20177; Kusafuka K, 2002, ACTA HISTOCHEM, V104, P167, DOI 10.1078/0065-1281-00642; LANGER R, 1976, SCIENCE, V193, P70, DOI 10.1126/science.935859; Leavesley DI, 1999, NEPHROL DIAL TRANSPL, V14, P1208, DOI 10.1093/ndt/14.5.1208; Magnon C, 2005, CANCER RES, V65, P4353, DOI 10.1158/0008-5472.CAN-04-3536; McBrien NA, 2006, INVEST OPHTH VIS SCI, V47, P4674, DOI 10.1167/iovs.05-1150; McCarty MF, 2006, INTEGR CANCER THER, V5, P252, DOI 10.1177/1534735406291499; McCarty MF, 2006, INTEGR CANCER THER, V5, P150, DOI 10.1177/1534735406288443; Mizejewski GJ, 1999, P SOC EXP BIOL MED, V222, P124, DOI 10.1046/j.1525-1373.1999.d01-122.x; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; Moses MA, 1999, P NATL ACAD SCI USA, V96, P2645, DOI 10.1073/pnas.96.6.2645; Nah HD, 2001, DEV DYNAM, V220, P307, DOI 10.1002/dvdy.1109; NIKKARI L, 1995, J RHEUMATOL, V22, P16; Odrljin TM, 2001, AM J RESP CELL MOL, V24, P12, DOI 10.1165/ajrcmb.24.1.3992; Oganesian A, 1997, J HISTOCHEM CYTOCHEM, V45, P1469, DOI 10.1177/002215549704501104; Oganesian A, 2006, J BIOL CHEM, V281, P38507, DOI 10.1074/jbc.M607536200; Pande P, 2006, TOXICOL APPL PHARM, V210, P70, DOI 10.1016/j.taap.2005.07.017; PANETTI TS, 1995, J BIOL CHEM, V270, P18593, DOI 10.1074/jbc.270.31.18593; Patra D, 2007, J CELL BIOL, V179, P687, DOI 10.1083/jcb.200708092; Prockop DJ, 1998, MATRIX BIOL, V16, P399, DOI 10.1016/S0945-053X(98)90013-0; SALTER DM, 1992, BRIT J RHEUMATOL, V31, P231; SANDELL LJ, 1994, DEV DYNAM, V199, P129, DOI 10.1002/aja.1001990206; SANDELL LJ, 1991, J CELL BIOL, V114, P1307, DOI 10.1083/jcb.114.6.1307; Sanders R, 2008, J ORTHOP TRAUMA, V22, P1, DOI 10.1097/BOT.0b013e3181629441; Teitelbaum SL, 2000, J BONE MINER METAB, V18, P344, DOI 10.1007/s007740070007; Valster A, 2005, METHODS, V37, P208, DOI 10.1016/j.ymeth.2005.08.001; VANDERREST M, 1986, BIOCHEM J, V237, P923, DOI 10.1042/bj2370923; Wang ZP, 2005, J BIOL CHEM, V280, P6840, DOI 10.1074/jbc.M405287200; Zhu Y, 1999, J CELL BIOL, V144, P1069, DOI 10.1083/jcb.144.5.1069	53	34	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20806	20817		10.1074/jbc.M110.118521	http://dx.doi.org/10.1074/jbc.M110.118521			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20439458	Green Published, hybrid			2022-12-27	WOS:000279228600044
J	Robbel, L; Marahiel, MA				Robbel, Lars; Marahiel, Mohamed A.			Daptomycin, a Bacterial Lipopeptide Synthesized by a Nonribosomal Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							STREPTOMYCES-ROSEOSPORUS; NATURAL-PRODUCTS; STAPHYLOCOCCUS-AUREUS; COMBINATORIAL BIOSYNTHESIS; ANTIBIOTIC DAPTOMYCIN; PEPTIDE ANTIBIOTICS; GENE-CLUSTER; CALCIUM; DOMAINS; A21978C	Daptomycin (Cubicin (R)) is a branched cyclic lipopeptide antibiotic of nonribosomal origin and the prototype of the acidic lipopeptide family. It was approved in 2003 for the nontopical treatment of skin structure infections caused by Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA), and in 2006 for the treatment of bacteremia. Understanding the ribosome-independent biosynthesis of daptomycin assembly will provide opportunities for the generation of daptomycin derivatives with an altered pharmaceutical spectrum to address upcoming daptomycin-resistant pathogens. Herein, the structural properties of daptomycin, its biosynthesis, recent efforts for the generation of structural diversity, and its proposed mode of action are discussed.	[Robbel, Lars; Marahiel, Mohamed A.] Univ Marburg, Dept Chem Biochem, D-35043 Marburg, Germany	Philipps University Marburg	Marahiel, MA (corresponding author), Univ Marburg, Dept Chem Biochem, Hans Meerwein Str, D-35043 Marburg, Germany.	marahiel@staff.uni-marburg.de			Deutsche Forschungsgemeinschaft; LOEWE Center for Synthetic Microbiology	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); LOEWE Center for Synthetic Microbiology	This work was supported by the Deutsche Forschungsgemeinschaft and the LOEWE Center for Synthetic Microbiology.	Ball LJ, 2004, ORG BIOMOL CHEM, V2, P1872, DOI 10.1039/b402722a; Baltz RH, 2006, J IND MICROBIOL BIOT, V33, P66, DOI 10.1007/s10295-005-0030-y; Baltz RH, 2005, NAT PROD REP, V22, P717, DOI 10.1039/b416648p; Baltz RH, 2009, CURR OPIN CHEM BIOL, V13, P144, DOI 10.1016/j.cbpa.2009.02.031; Baltz RH, 2009, METHOD ENZYMOL, V458, P511, DOI 10.1016/S0076-6879(09)04820-4; BOECK LD, 1988, J ANTIBIOT, V41, P1085, DOI 10.7164/antibiotics.41.1085; Coeffet-Le Gal MF, 2006, MICROBIOL-SGM, V152, P2993, DOI 10.1099/mic.0.29022-0; COUNTER FT, 1990, J ANTIBIOT, V43, P616, DOI 10.7164/antibiotics.43.616; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DEBONO M, 1987, J ANTIBIOT, V40, P761, DOI 10.7164/antibiotics.40.761; DEBONO M, 1988, J ANTIBIOT, V41, P1093, DOI 10.7164/antibiotics.41.1093; Doekel S, 2008, MICROBIOL-SGM, V154, P2872, DOI 10.1099/mic.0.2008/020685-0; Eisenstein BI, 2010, CLIN INFECT DIS, V50, pS10, DOI 10.1086/647938; Enoch DA, 2007, J INFECTION, V55, P205, DOI 10.1016/j.jinf.2007.05.180; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Friedman L, 2006, ANTIMICROB AGENTS CH, V50, P2137, DOI 10.1128/AAC.00039-06; Grunewald J, 2006, MICROBIOL MOL BIOL R, V70, P121, DOI 10.1128/MMBR.70.1.121-146.2006; Grunewald J, 2004, J AM CHEM SOC, V126, P17025, DOI 10.1021/ja045455t; Gu JQ, 2007, J NAT PROD, V70, P233, DOI 10.1021/np0605135; Hahn M, 2004, P NATL ACAD SCI USA, V101, P15585, DOI 10.1073/pnas.0404932101; Hill J, 2003, BIOORG MED CHEM LETT, V13, P4187, DOI 10.1016/j.bmcl.2003.07.019; Ho SW, 2008, EUR BIOPHYS J BIOPHY, V37, P421, DOI 10.1007/s00249-007-0227-2; Hojati Z, 2002, CHEM BIOL, V9, P1175, DOI 10.1016/S1074-5521(02)00252-1; HUBER FM, 1988, J BIOTECHNOL, V7, P283, DOI 10.1016/0168-1656(88)90040-5; Julia P, 2006, J IND MICROBIOL BIOT, V33, P121, DOI 10.1007/s10295-005-0033-8; Jung D, 2004, CHEM BIOL, V11, P949, DOI 10.1016/j.chembiol.2004.04.020; Kopp F, 2006, BIOCHEMISTRY-US, V45, P10474, DOI 10.1021/bi0609422; LAKEY JH, 1983, J GEN MICROBIOL, V129, P3565; LaPlante KL, 2004, ANTIMICROB AGENTS CH, V48, P4665, DOI 10.1128/AAC.48.12.4665-4672.2004; Mahlert C, 2007, J AM CHEM SOC, V129, P12011, DOI 10.1021/ja074427i; Marahiel MA, 2009, METHOD ENZYMOL, V458, P337, DOI 10.1016/S0076-6879(09)04813-7; Marahiel MA, 2009, J PEPT SCI, V15, P799, DOI 10.1002/psc.1183; McHenney MA, 1996, MICROBIOL-SGM, V142, P2363, DOI 10.1099/00221287-142-9-2363; Miao V, 2005, MICROBIOL-SGM, V151, P1507, DOI 10.1099/mic.0.27757-0; Miao V, 2006, CHEM BIOL, V13, P269, DOI 10.1016/j.chembiol.2005.12.012; Miao V, 2006, J IND MICROBIOL BIOT, V33, P129, DOI 10.1007/s10295-005-0028-5; Montero CI, 2008, ANTIMICROB AGENTS CH, V52, P1167, DOI 10.1128/AAC.00774-07; Murthy MH, 2008, J MED MICROBIOL, V57, P1036, DOI 10.1099/jmm.0.2008/000588-0; Newman D, 2009, BIOORGAN MED CHEM, V17, P2120, DOI 10.1016/j.bmc.2009.03.010; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Newman DJ, 2000, NAT PROD REP, V17, P215, DOI 10.1039/a902202c; Nguyen KT, 2010, ANTIMICROB AGENTS CH, V54, P1404, DOI 10.1128/AAC.01307-09; Nguyen KT, 2006, P NATL ACAD SCI USA, V103, P17462, DOI 10.1073/pnas.0608589103; Nguyen KT, 2006, MOL MICROBIOL, V61, P1294, DOI 10.1111/j.1365-2958.2006.05305.x; Pertel PE, 2008, CLIN INFECT DIS, V46, P1142, DOI 10.1086/533441; Raja A, 2003, NAT REV DRUG DISCOV, V2, P943, DOI 10.1038/nrd1258; Rausch C, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-78; Rotondi KS, 2005, BIOPOLYMERS, V80, P374, DOI 10.1002/bip.20238; Sader HS, 2009, J CHEMOTHERAPY, V21, P500, DOI 10.1179/joc.2009.21.5.500; Sauermann R, 2008, PHARMACOLOGY, V81, P79, DOI 10.1159/000109868; Scott WRP, 2007, BBA-BIOMEMBRANES, V1768, P3116, DOI 10.1016/j.bbamem.2007.08.034; Sieber SA, 2004, ANGEW CHEM INT EDIT, V43, P493, DOI 10.1002/anie.200352787; Sieber SA, 2003, J AM CHEM SOC, V125, P10862, DOI 10.1021/ja0361852; Sieber SA, 2005, CHEM REV, V105, P715, DOI 10.1021/cr0301191; Siedlecki J, 2003, BIOORG MED CHEM LETT, V13, P4245, DOI 10.1016/j.bmcl.2003.07.025; Silverman JA, 2005, J INFECT DIS, V191, P2149, DOI 10.1086/430352; Silverman JA, 2003, ANTIMICROB AGENTS CH, V47, P2538, DOI 10.1128/AAC.47.8.2538-2544.2003; Silverman JA, 2001, ANTIMICROB AGENTS CH, V45, P1799, DOI 10.1128/AAC.45.6.1799-1802.2001; Straus SK, 2006, BBA-BIOMEMBRANES, V1758, P1215, DOI 10.1016/j.bbamem.2006.02.009; TAKAGI T, 1980, BIOCHEM BIOPH RES CO, V96, P377, DOI 10.1016/0006-291X(80)91225-5; Tanovic A, 2008, SCIENCE, V321, P659, DOI 10.1126/science.1159850; Walsh CT, 2010, J AM CHEM SOC, V132, P2469, DOI 10.1021/ja909118a; Walsh CT, 2002, CHEMBIOCHEM, V3, P125; Wittmann M, 2008, FEBS J, V275, P5343, DOI 10.1111/j.1742-4658.2008.06664.x	64	135	149	3	65	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27501	27508		10.1074/jbc.R110.128181	http://dx.doi.org/10.1074/jbc.R110.128181			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20522545	Green Published, hybrid			2022-12-27	WOS:000281404100003
J	Sun, P; Nallar, SC; Raha, A; Kalakonda, S; Velalar, CN; Reddy, SP; Kalvakolanu, DV				Sun, Peng; Nallar, Shreeram C.; Raha, Abhijit; Kalakonda, Sudhakar; Velalar, Chidambaram N.; Reddy, Sekhar P.; Kalvakolanu, Dhananjaya V.			GRIM-19 and p16(INK4a) Synergistically Regulate Cell Cycle Progression and E2F1-responsive Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOIC ACID; TUMOR-SUPPRESSOR; COMPLEX-I; SOMATIC MUTATIONS; SIGNAL TRANSDUCER; EPITHELIAL-CELLS; CDK INHIBITORS; DEATH; E2F; GROWTH	GRIM-19 (Gene associated with Retinoid-IFN-induced Mortality-19) was originally isolated as a growth suppressor in a genome-wide knockdown screen with antisense libraries. Like classical tumor suppressors, mutations, and/or loss of GRIM-19 expression occur in primary human tumors; and it is inactivated by viral gene products. Our search for potential GRIM-19-binding proteins, using mass spectrometry, that permit its antitumor actions led to the inhibitor of cyclin-dependent kinase 4, CDKN2A. The GRIM-19/CDKN2A synergistically suppressed cell cycle progression via inhibiting E2F1-driven gene expression. The N terminus of GRIM-19 and the fourth ankyrin repeat of CDKN2A are crucial for their interaction. The biological relevance of these interactions is underscored by observations that GRIM-19 promotes the inhibitory effect of CDKN2A on CDK4; and mutations from primary tumors disrupt its ability to interact with GRIM-19 and suppress E2F1-driven gene expression.	[Kalvakolanu, Dhananjaya V.] Univ Maryland, Sch Med, Mol & Cellular Canc Biol Grad Program, Baltimore, MD 21201 USA; [Kalvakolanu, Dhananjaya V.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Nallar, Shreeram C.; Raha, Abhijit; Kalakonda, Sudhakar; Velalar, Chidambaram N.; Kalvakolanu, Dhananjaya V.] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Reddy, Sekhar P.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Kalvakolanu, DV (corresponding author), Univ Maryland, Sch Med, Mol & Cellular Canc Biol Grad Program, Baltimore, MD 21201 USA.	dkalvako@umaryland.edu			NCI, National Institutes of Health [CA105005, CA78282]; NATIONAL CANCER INSTITUTE [R01CA078282, R01CA105005] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA105005 and CA78282 from the NCI (to D. V. K.).	Alchanati I, 2006, ONCOGENE, V25, P7138, DOI 10.1038/sj.onc.1209708; Angell JE, 2000, J BIOL CHEM, V275, P33416, DOI 10.1074/jbc.M003929200; Barnich N, 2005, J BIOL CHEM, V280, P19021, DOI 10.1074/jbc.M413776200; BOSTOCK CJ, 1971, EXP CELL RES, V68, P163, DOI 10.1016/0014-4827(71)90599-4; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; CALDAS C, 1994, NAT GENET, V8, P27, DOI 10.1038/ng0994-27; Canepa ET, 2007, IUBMB LIFE, V59, P419, DOI 10.1080/15216540701488358; Choubey D, 1996, EMBO J, V15, P5668, DOI 10.1002/j.1460-2075.1996.tb00951.x; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Fearnley IM, 2001, J BIOL CHEM, V276, P38345, DOI 10.1074/jbc.C100444200; Guerra S, 2003, J VIROL, V77, P6493, DOI 10.1128/JVI.77.11.6493-6506.2003; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HAYASHI N, 1994, BIOCHEM BIOPH RES CO, V202, P1426, DOI 10.1006/bbrc.1994.2090; Hu JD, 2002, J INTERF CYTOK RES, V22, P1017, DOI 10.1089/107999002760624242; Huang GC, 2004, MOL CELL BIOL, V24, P8447, DOI 10.1128/MCB.24.19.8447-8456.2004; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Kalakonda S, 2007, AM J PATHOL, V171, P1352, DOI 10.2353/ajpath.2007.070241; Kalakonda S, 2007, CANCER RES, V67, P6212, DOI 10.1158/0008-5472.CAN-07-0031; Kalvakolanu DV, 2004, CYTOKINE GROWTH F R, V15, P169, DOI 10.1016/j.cytogfr.2004.01.002; KUMAR R, 1992, P NATL ACAD SCI USA, V89, P6599, DOI 10.1073/pnas.89.14.6599; Kyritsis AP, 1996, ONCOGENE, V12, P63; Lee HY, 1998, J CLIN INVEST, V101, P1012, DOI 10.1172/JCI1329; Lindner DJ, 1997, CLIN CANCER RES, V3, P931; Lufei CC, 2003, EMBO J, V22, P1325, DOI 10.1093/emboj/cdg135; Ma X, 2007, ONCOGENE, V26, P4842, DOI 10.1038/sj.onc.1210287; Maximo V, 2005, BRIT J CANCER, V92, P1892, DOI 10.1038/sj.bjc.6602547; MELAMED D, 1993, MOL CELL BIOL, V13, P5255, DOI 10.1128/MCB.13.9.5255; NEVINS JR, 1992, SCIENCE, V258, P424; Reeves MB, 2007, SCIENCE, V316, P1345, DOI 10.1126/science.1142984; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Seo T, 2002, J VIROL, V76, P8797, DOI 10.1128/JVI.76.17.8797-8807.2002; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Simpson RJ, 2003, PROTEINS PROTEOMICS; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Sun P, 2009, ONCOGENE, V28, P1339, DOI 10.1038/onc.2008.480; XU L, 1994, CANCER RES, V54, P5262; Yang J, 2005, CANCER RES, V65, P939; Yuan CH, 2000, PROTEIN SCI, V9, P1120, DOI 10.1110/ps.9.6.1120; Zhang B, 1996, J BIOL CHEM, V271, P28734, DOI 10.1074/jbc.271.46.28734; Zhang J, 2003, P NATL ACAD SCI USA, V100, P9342, DOI 10.1073/pnas.1633516100; Zhang L, 2008, CLIN CANCER RES, V14, P559, DOI 10.1158/1078-0432.CCR-07-1176; Zhou Y, 2009, J INTERF CYTOK RES, V29, P695, DOI 10.1089/jir.2009.0003	45	21	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27545	27552		10.1074/jbc.M110.105767	http://dx.doi.org/10.1074/jbc.M110.105767			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20522552	Green Published, hybrid			2022-12-27	WOS:000281404100009
J	Yadav, V; Kumar, M; Deep, DK; Kumar, H; Sharma, R; Tripathi, T; Tuteja, N; Saxena, AK; Johri, AK				Yadav, Vikas; Kumar, Manoj; Deep, Deepak Kumar; Kumar, Hemant; Sharma, Ruby; Tripathi, Takshashila; Tuteja, Narendra; Saxena, Ajay Kumar; Johri, Atul Kumar			RETRACTED: A Phosphate Transporter from the Root Endophytic Fungus Piriformospora indica Plays a Role in Phosphate Transport to the Host Plant (Retracted article. See vol. 296, 2021)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							MULTIPLE SEQUENCE ALIGNMENT; RNA INTERFERENCE; ANTISENSE RNA; GENE; EXPRESSION; IDENTIFICATION; RESISTANCE; PHOSPHORUS; SOFTWARE; MODEL	Because pure cultures and a stable transformation system are not available for arbuscular mycorrhizal fungi, the role of their phosphate transporters for the symbiotic interaction with the plant up till now could not be studied. Here we report the cloning and the functional analysis of a gene encoding a phosphate transporter (PiPT) from the root endophytic fungus Piriformospora indica, which can be grown axenically. The PiPT polypeptide belongs to the major facilitator superfamily. Homology modeling reveals that PiPT exhibits twelve transmembrane helices divided into two halves connected by a large hydrophilic loop in the middle. The function of the protein encoded by PiPT was confirmed by complementation of a yeast phosphate transporter mutant. The kinetic analysis of PiPT (K-m 25 mu M) reveals that it belongs to the high affinity phosphate transporter family (Pht1). Expression of PiPT was localized to the external hyphae of P. indica colonized with maize plant root, which suggests that external hyphae are the initial site of phosphate uptake from the soil. To understand the physiological role of PiPT, knockdown transformants of the gene were prepared using electroporation and RNA interference. Knockdown transformants transported a significantly lower amount of phosphate to the host plant than wild-type P. indica. Higher amounts of phosphate were found in plants colonized with wild-type P. indica than that of non-colonized and plants colonized with knockdown PiPT P. indica. These observations suggest that PiPT is actively involved in the phosphate transportation and, in turn, P. indica helps improve the nutritional status of the host plant.	[Yadav, Vikas; Kumar, Manoj; Deep, Deepak Kumar; Kumar, Hemant; Sharma, Ruby; Tripathi, Takshashila; Saxena, Ajay Kumar; Johri, Atul Kumar] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Tuteja, Narendra] Int Ctr Genet Engn & Biotechnol, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Johri, AK (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Meharuli Rd, New Delhi 110067, India.	akjohri14@yahoo.com	Sharma, Ruby/GZK-6853-2022; KUMAR, MANOJ/HHC-0782-2022; Tripathi, Ph.D., Takshashila/AAB-1682-2021; Kumar, Arun/C-9149-2009	Sharma, Ruby/0000-0002-8441-0415; Tripathi, Ph.D., Takshashila/0000-0001-6399-9825; Kumar, Arun/0000-0001-8422-0219; Kumar, Hemant/0000-0001-7698-2301	Council of Scientific and Industrial Research (CSIR); Dept. of Science and Technology, Government of India; University Grant Commission; Indian Council of Medical Research; JNU	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Dept. of Science and Technology, Government of India(Department of Science & Technology (India)); University Grant Commission(University Grants Commission, India); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); JNU	This work was supported in part by a grant from the Council of Scientific and Industrial Research (CSIR) and Dept. of Science and Technology, Government of India (to A. K. J. and N. T.).; Supported by a fellowship from the University Grant Commission, Indian Council of Medical Research, CSIR, and JNU.	Abramson J, 2003, FEBS LETT, V555, P96, DOI 10.1016/S0014-5793(03)01087-1; ACHATZ B, 2010, PLANT SOIL IN PRESS; Barazani O, 2005, OECOLOGIA, V146, P234, DOI 10.1007/s00442-005-0193-2; BECARD G, 1988, NEW PHYTOL, V108, P211, DOI 10.1111/j.1469-8137.1988.tb03698.x; Benedetto A, 2005, MYCORRHIZA, V15, P620, DOI 10.1007/s00572-005-0006-9; BIELESKI RL, 1973, ANNU REV PLANT PHYS, V24, P225, DOI 10.1146/annurev.pp.24.060173.001301; BIELESKI RL, 1983, ENCY PLANT PHYSL; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUNYA M, 1991, MOL CELL BIOL, V11, P3229, DOI 10.1128/MCB.11.6.3229; Cameron DD, 2006, NEW PHYTOL, V171, P405, DOI 10.1111/j.1469-8137.2006.01767.x; Cardoza RE, 2006, FUNGAL GENET BIOL, V43, P164, DOI 10.1016/j.fgb.2005.11.002; CHAKRABORTY BN, 1990, NUCLEIC ACIDS RES, V18, P6737, DOI 10.1093/nar/18.22.6737; Chung CC, 2003, APPL ENVIRON MICROB, V69, P754, DOI 10.1128/AEM.69.2.754-759.2003; CIRILLO VP, 1989, METHOD ENZYMOL, V174, P617; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Daram P, 1998, PLANTA, V206, P225, DOI 10.1007/s004250050394; De Backer MD, 2002, CURR OPIN MICROBIOL, V5, P323, DOI 10.1016/S1369-5274(02)00319-3; de Jong JF, 2006, APPL ENVIRON MICROB, V72, P1267, DOI 10.1128/AEM.72.2.1267-1269.2006; Deshmukh S, 2006, P NATL ACAD SCI USA, V103, P18450, DOI 10.1073/pnas.0605697103; Dickson S., 1998, MYCORRHIZA MANUAL, P77; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Fitzgerald A, 2004, FUNGAL GENET BIOL, V41, P963, DOI 10.1016/j.fgb.2004.06.006; Gietz R.D., 1994, MOL GENETICS YEAST P, P121; GRIFFITH J K, 1992, Current Opinion in Cell Biology, V4, P684, DOI 10.1016/0955-0674(92)90090-Y; Hamada W, 1998, MOL GEN GENET, V259, P630, DOI 10.1007/s004380050857; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; HARRISON MJ, 1995, NATURE, V378, P626, DOI 10.1038/378626a0; Henderson PJF, 1993, CURR OPIN CELL BIOL, V5, P708, DOI 10.1016/0955-0674(93)90144-F; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; IRVING GCJ, 1990, COMMUN SOIL SCI PLAN, V21, P2245, DOI 10.1080/00103629009368377; IRVING GCJ, 1984, AUST J EXP AGR, V24, P213, DOI 10.1071/EA9840213; Kadotani N, 2003, MOL PLANT MICROBE IN, V16, P769, DOI 10.1094/MPMI.2003.16.9.769; KAFER E, 1976, GENETICS, V82, P605; Karandashov V, 2004, P NATL ACAD SCI USA, V101, P6285, DOI 10.1073/pnas.0306074101; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar M, 2009, MICROBIOL-SGM, V155, P780, DOI 10.1099/mic.0.019869-0; Leggewie G, 1997, PLANT CELL, V9, P381, DOI 10.1105/tpc.9.3.381; Liu H, 1998, MOL PLANT MICROBE IN, V11, P14, DOI 10.1094/MPMI.1998.11.1.14; Liu H, 2002, GENETICS, V160, P463; Magrini V, 2004, GENOME RES, V14, P1603, DOI 10.1101/gr.2361404; Maldonado-Mendoza IE, 2001, MOL PLANT MICROBE IN, V14, P1140, DOI 10.1094/MPMI.2001.14.10.1140; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; McDonald T, 2005, MOL PLANT MICROBE IN, V18, P539, DOI 10.1094/MPMI-18-0539; Mouyna I, 2004, FEMS MICROBIOL LETT, V237, P317, DOI 10.1016/j.femsle.2004.06.048; Muchhal US, 1996, P NATL ACAD SCI USA, V93, P10519, DOI 10.1073/pnas.93.19.10519; Nakayashiki H, 2005, FUNGAL GENET BIOL, V42, P275, DOI 10.1016/j.fgb.2005.01.002; Nicolas FE, 2003, EMBO J, V22, P3983, DOI 10.1093/emboj/cdg384; Okumura S, 1998, DNA Res, V5, P261, DOI 10.1093/dnares/5.5.261; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Rausch C, 2002, PLANTA, V216, P23, DOI 10.1007/s00425-002-0921-3; Rausch C, 2001, NATURE, V414, P462, DOI 10.1038/35106601; REIZER J, 1994, BBA-REV BIOMEMBRANES, V1197, P133, DOI 10.1016/0304-4157(94)90003-5; RIESMEIER JW, 1992, EMBO J, V11, P4705, DOI 10.1002/j.1460-2075.1992.tb05575.x; Rodriguez-Ortega MJ, 2006, NAT BIOTECHNOL, V24, P191, DOI 10.1038/nbt1179; ROMANO N, 1992, MOL MICROBIOL, V6, P3343, DOI 10.1111/j.1365-2958.1992.tb02202.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 2001, MOL CLONING LAB MANU, Vthird edition; Schachtman DP, 1998, PLANT PHYSIOL, V116, P447, DOI 10.1104/pp.116.2.447; Shahollari B, 2005, J PLANT PHYSIOL, V162, P945, DOI 10.1016/j.jplph.2004.08.012; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOHE A, 1973, J BACTERIOL, V113, P727, DOI 10.1128/JB.113.2.727-738.1973; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Varma A, 1999, APPL ENVIRON MICROB, V65, P2741; VERSAW WK, 1995, GENE, V153, P135, DOI 10.1016/0378-1119(94)00814-9; VONHEIJNE G, 1994, ANNU REV BIOPH BIOM, V301, P616; Waller F, 2005, P NATL ACAD SCI USA, V102, P13386, DOI 10.1073/pnas.0504423102; Walti MA, 2006, EUKARYOT CELL, V5, P732, DOI 10.1128/EC.5.4.732-744.2006; Zuccaro A, 2009, FUNGAL GENET BIOL, V46, P543, DOI 10.1016/j.fgb.2009.03.009	75	186	201	4	63	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26532	26544		10.1074/jbc.M110.111021	http://dx.doi.org/10.1074/jbc.M110.111021			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20479005	Green Published, hybrid			2022-12-27	WOS:000280921000070
J	He, WC; Tan, RY; Dai, CS; Li, YJ; Wang, D; Hao, S; Kahn, M; Liu, YH				He, Weichun; Tan, Ruoyun; Dai, Chunsun; Li, Yingjian; Wang, Dan; Hao, Sha; Kahn, Michael; Liu, Youhua			Plasminogen Activator Inhibitor-1 Is a Transcriptional Target of the Canonical Pathway of Wnt/beta-Catenin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; PODOCYTE DYSFUNCTION; RENAL INJURY; CELL-DEATH; PAI-1; EXPRESSION; TYPE-1; KIDNEY; NEPHROPATHY; SPECIFICITY	Plasminogen activator inhibitor-1 (PAI-1) is a multifunctional glycoprotein that plays a critical role in the pathogenesis of chronic kidney and cardiovascular diseases. Although transforming growth factor (TGF)-beta 1 is a known inducer of PAI-1, how it controls PAI-1 expression remains enigmatic. Here we investigated the mechanism underlying TGF-beta 1 regulation of PAI-1 in kidney tubular epithelial cells (HKC-8). Surprisingly, overexpression of Smad2 or Smad3 in HKC-8 cells blocked PAI-1 induction by TGF-beta 1, whereas knockdown of them sensitized the cells to TGF-beta 1 stimulation, suggesting that Smad signaling is not responsible for PAI-1 induction. Blockade of several TGF-beta 1 downstream pathways such as p38 MAPK or JNK, but not phosphatidylinositol 3-kinase/Akt and ERK1/2, only partially inhibited PAI-1 expression. TGF-beta 1 stimulated beta-catenin activation in tubular epithelial cells, and ectopic expression of beta-catenin induced PAI-1 expression, whereas inhibition of beta-catenin abolished its induction. A functional T cell factor/lymphoid enhancer-binding factor-binding site was identified in the promoter region of the PAI-1 gene, which interacted with T cell factor upon beta-catenin activation. Deletion or site-directed mutation of this site abolished PAI-1 response to beta-catenin or TGF-beta 1 stimulation. Similarly, ectopic expression of Wnt1 also activated PAI-1 expression and promoter activity. In vivo, PAI-1 was induced in kidney tubular epithelia in obstructive nephropathy. Delivery of Wnt1 gene activated beta-catenin and promoted PAI-1 expression after obstructive injury, whereas blockade of Wnt/beta-catenin signaling by Dick-kopf-1 gene inhibited PAI-1 induction. Collectively, these studies identify PAI-1 as a direct downstream target of Wnt/beta-catenin signaling and demonstrate that PAI-1 induction could play a role in mediating the fibrogenic action of this signaling.	[He, Weichun; Tan, Ruoyun; Dai, Chunsun; Li, Yingjian; Wang, Dan; Hao, Sha; Liu, Youhua] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA; Nanjing Med Univ, Dept Med, Affiliated Hosp 1, Nanjing 210029, Peoples R China; [Kahn, Michael] Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Nanjing Medical University; University of Southern California	Liu, YH (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, S-405 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15261 USA.	liuy@upmc.edu		Liu, Youhua/0000-0002-4740-805X	National Institutes of Health [DK061408, DK064005, DK071040]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071040, R01DK061408, R01DK064005] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK061408, DK064005, and DK071040.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bikkavilli RK, 2008, J CELL SCI, V121, P3598, DOI 10.1242/jcs.032854; Bikkavilli Rama Kamesh, 2009, Commun Integr Biol, V2, P46; Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; Dai CS, 2004, J AM SOC NEPHROL, V15, P2637, DOI 10.1097/01.ASN.0000139479.09658.EE; Dai CS, 2003, J BIOL CHEM, V278, P12537, DOI 10.1074/jbc.M300777200; Dai CS, 2002, J AM SOC NEPHROL, V13, P411, DOI 10.1681/ASN.V132411; Eddy AA, 2002, AM J PHYSIOL-RENAL, V283, pF209, DOI 10.1152/ajprenal.00032.2002; Eddy AA, 2006, J AM SOC NEPHROL, V17, P2999, DOI 10.1681/ASN.2006050503; Eddy AA, 2009, THROMB HAEMOSTASIS, V101, P656, DOI 10.1160/TH08-12-0779; Eguchi M, 2005, MED CHEM, V1, P467, DOI 10.2174/1573406054864098; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Fukukawa C, 2009, ONCOGENE, V28, P1110, DOI 10.1038/onc.2008.467; Hamano K, 2002, AM J KIDNEY DIS, V39, P695, DOI 10.1053/ajkd.2002.31986; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Huang YF, 2009, AM J PHYSIOL-RENAL, V297, pF1045, DOI 10.1152/ajprenal.00024.2009; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kitching AR, 2003, J AM SOC NEPHROL, V14, P1487, DOI 10.1097/01.ASN.0000065550.13931.00; Li YJ, 2008, AM J PATHOL, V172, P299, DOI 10.2353/ajpath.2008.070057; Li YJ, 2009, J AM SOC NEPHROL, V20, P1907, DOI 10.1681/ASN.2008090930; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Ma LJ, 2009, FRONT BIOSCI-LANDMRK, V14, P2028, DOI 10.2741/3361; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Matsuo S, 2005, KIDNEY INT, V67, P2221, DOI 10.1111/j.1523-1755.2005.00327.x; Mukai Y, 2007, AM J PHYSIOL-HEART C, V292, pH1937, DOI 10.1152/ajpheart.00868.2006; Nagamine Y, 2008, THROMB HAEMOSTASIS, V100, P1007, DOI 10.1160/TH08-05-0294; Nakamura S, 2000, KIDNEY INT, V58, P251, DOI 10.1046/j.1523-1755.2000.00160.x; Nicholas SB, 2005, KIDNEY INT, V67, P1297, DOI 10.1111/j.1523-1755.2005.00207.x; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Oda T, 2001, KIDNEY INT, V60, P587, DOI 10.1046/j.1523-1755.2001.030002587.x; Paueksakon P, 2002, KIDNEY INT, V61, P2142, DOI 10.1046/j.1523-1755.2002.00384.x; Saadeddin A, 2009, MOL CANCER RES, V7, P1189, DOI 10.1158/1541-7786.MCR-09-0027; Schnaper HW, 2009, FRONT BIOSCI-LANDMRK, V14, P2448, DOI 10.2741/3389; Segarra A, 2001, J AM SOC NEPHROL, V12, P1255, DOI 10.1681/ASN.V1261255; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Surendran K, 2005, J AM SOC NEPHROL, V16, P2373, DOI 10.1681/ASN.2004110949; Surendran K, 2002, AM J PHYSIOL-RENAL, V282, pF431, DOI 10.1152/ajprenal.0009.2001; Tan RY, 2008, AM J PHYSIOL-RENAL, V294, pF1076, DOI 10.1152/ajprenal.00323.2007; Tan XY, 2008, J AM SOC NEPHROL, V19, P1741, DOI 10.1681/ASN.2007060666; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Venugopal J, 2007, J CELL BIOCHEM, V101, P369, DOI 10.1002/jcb.21173; von Toerne C, 2009, AM J TRANSPLANT, V9, P2223, DOI 10.1111/j.1600-6143.2009.02762.x; White BD, 2007, CURR BIOL, V17, pR923, DOI 10.1016/j.cub.2007.08.062; Yang JW, 2005, J AM SOC NEPHROL, V16, P68, DOI 10.1681/ASN.2003090795; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhang XH, 2005, AM J PHYSIOL-RENAL, V288, pF16, DOI 10.1152/ajprenal.00318.2003	50	84	88	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24665	24675		10.1074/jbc.M109.091256	http://dx.doi.org/10.1074/jbc.M109.091256			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20519507	hybrid, Green Published			2022-12-27	WOS:000280542100039
J	Iyer, S; Darley, PI; Acharya, KR				Iyer, Shalini; Darley, Paula I.; Acharya, K. Ravi			Structural Insights into the Binding of Vascular Endothelial Growth Factor-B by VEGFR-1(D2) RECOGNITION AND SPECIFICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; VEGF-B; ANGSTROM RESOLUTION; NEUTRALIZING ANTIBODY; RECEPTOR-BINDING; FAB FRAGMENT; ANGIOGENESIS; COMPLEX; EXPRESSION; MOUSE	The formation of blood vessels ( angiogenesis) is a highly orchestrated sequence of events involving crucial receptor-ligand interactions. Angiogenesis is critical for physiological processes such as development, wound healing, reproduction, tissue regeneration, and remodeling. It also plays a major role in sustaining tumor progression and chronic inflammation. Vascular endothelial growth factor (VEGF)-B, a member of the VEGF family of angiogenic growth factors, effects blood vessel formation by binding to a tyrosine kinase receptor, VEGFR-1. There is growing evidence of the important role played by VEGF-B in physiological and pathological vasculogenesis. Development of VEGF-B antagonists, which inhibit the interaction of this molecule with its cognate receptor, would be important for the treatment of pathologies associated specifically with this growth factor. In this study, we present the crystal structure of the complex of VEGF-B with domain 2 of VEGFR-1 at 2.7 angstrom resolution. Our analysis reveals that each molecule of the ligand engages two receptor molecules using two symmetrical binding sites. Based on these interactions, we identify the receptor-binding determinants on VEGF-B and shed light on the differences in specificity towards VEGFR-1 among the different VEGF homologs.	[Iyer, Shalini; Darley, Paula I.; Acharya, K. Ravi] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Bath	Acharya, KR (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	K.R.Acharya@bath.ac.uk		Acharya, K. Ravi/0000-0002-3009-4058	Wellcome Trust (United Kingdom) [083191]; Royal Society (United Kingdom) Industry Fellowship	Wellcome Trust (United Kingdom)(Wellcome Trust); Royal Society (United Kingdom) Industry Fellowship(Royal Society of London)	This work was supported by the Wellcome Trust (United Kingdom) Programme Grant 083191 and a Royal Society (United Kingdom) Industry Fellowship (to K.R.A.).	Aase K, 1999, DEV DYNAM, V215, P12, DOI 10.1002/(SICI)1097-0177(199905)215:1<12::AID-DVDY3>3.0.CO;2-N; Bellomo D, 2000, CIRC RES, V86, pE29, DOI 10.1161/01.RES.86.2.e29; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cao YH, 1996, J BIOL CHEM, V271, P3154, DOI 10.1074/jbc.271.6.3154; Chen Y, 1999, J MOL BIOL, V293, P865, DOI 10.1006/jmbi.1999.3192; Christinger HW, 2004, J BIOL CHEM, V279, P10382, DOI 10.1074/jbc.M313237200; Davis-Smyth T, 1998, J BIOL CHEM, V273, P3216, DOI 10.1074/jbc.273.6.3216; Detoraki A, 2009, J ALLERGY CLIN IMMUN, V123, P1142, DOI 10.1016/j.jaci.2009.01.044; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Fuh G, 2006, J BIOL CHEM, V281, P6625, DOI 10.1074/jbc.M507783200; Gunningham SP, 2001, J PATHOL, V193, P325, DOI 10.1002/path.814; Hagberg CE, 2010, NATURE, V464, P917, DOI 10.1038/nature08945; Holmes DIR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-209; Iyer S, 2001, J BIOL CHEM, V276, P12153, DOI 10.1074/jbc.M008055200; Iyer S, 2006, J MOL BIOL, V359, P76, DOI 10.1016/j.jmb.2006.03.002; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karpanen T, 2008, CIRC RES, V103, P1018, DOI 10.1161/CIRCRESAHA.108.178459; Keyt BA, 1996, J BIOL CHEM, V271, P5638, DOI 10.1074/jbc.271.10.5638; Lagercrantz J, 1998, BBA-GENE STRUCT EXPR, V1398, P157, DOI 10.1016/S0167-4781(98)00040-2; Leonard P, 2008, J MOL BIOL, V384, P1203, DOI 10.1016/j.jmb.2008.09.076; Leppanen VM, 2010, P NATL ACAD SCI USA, V107, P2425, DOI 10.1073/pnas.0914318107; Li XR, 2001, GROWTH FACTORS, V19, P49, DOI 10.3109/08977190109001075; Louzier V, 2003, AM J PHYSIOL-LUNG C, V284, pL926, DOI 10.1152/ajplung.00247.2002; Makinen T, 1999, J BIOL CHEM, V274, P21217, DOI 10.1074/jbc.274.30.21217; Mousa SA, 2007, SEMIN THROMB HEMOST, V33, P524, DOI 10.1055/s-2007-982084; Muller YA, 1997, STRUCTURE, V5, P1325, DOI 10.1016/S0969-2126(97)00284-0; Muller YA, 1998, STRUCTURE, V6, P1153, DOI 10.1016/S0969-2126(98)00116-6; Neufeld G, 2007, ADV EXP MED BIOL, V600, P118; Olofsson B, 1998, P NATL ACAD SCI USA, V95, P11709, DOI 10.1073/pnas.95.20.11709; Olofsson B, 1996, P NATL ACAD SCI USA, V93, P2576, DOI 10.1073/pnas.93.6.2576; Otrock ZK, 2007, BLOOD CELL MOL DIS, V39, P212, DOI 10.1016/j.bcmd.2007.04.001; Otrock ZK, 2007, BLOOD CELL MOL DIS, V38, P258, DOI 10.1016/j.bcmd.2006.12.003; OTWINOWSKI Z, 1994, ACTA CRYSTALLOGR D, V50, P760; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Scotney PD, 2002, CLIN EXP PHARMACOL P, V29, P1024, DOI 10.1046/j.1440-1681.2002.03769.x; Scrofani SDB, 2000, PROTEIN SCI, V9, P2018, DOI 10.1110/ps.9.10.2018; Stuttfeld E, 2009, IUBMB LIFE, V61, P915, DOI 10.1002/iub.234; Wiesmann C, 1997, CELL, V91, P695, DOI 10.1016/S0092-8674(00)80456-0; Yamazaki Y, 2006, MOL DIVERS, V10, P515, DOI 10.1007/s11030-006-9027-3; Zhang F, 2009, P NATL ACAD SCI USA, V106, P6152, DOI 10.1073/pnas.0813061106	42	45	47	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23779	23789		10.1074/jbc.M110.130658	http://dx.doi.org/10.1074/jbc.M110.130658			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20501651	hybrid, Green Published			2022-12-27	WOS:000280291400028
J	Pakala, SB; Bui-Nguyen, TM; Reddy, SDN; Li, DQ; Peng, SH; Rayala, SK; Behringer, RR; Kumar, R				Pakala, Suresh B.; Bui-Nguyen, Tri M.; Reddy, Sirigiri Divijendra Natha; Li, Da-Qiang; Peng, Shaohua; Rayala, Suresh K.; Behringer, Richard R.; Kumar, Rakesh			Regulation of NF-kappa B Circuitry by a Component of the Nucleosome Remodeling and Deacetylase Complex Controls Inflammatory Response Homeostasis (Publication with Expression of Concern. See vol. 191, pg. 1198, 2016) (Withdrawn Publication. See vol. 292, pg. 4764, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Withdrawn Publication							ESTROGEN-RECEPTOR; MTA1; PROTEIN; GENE; COACTIVATOR; REPRESSION; FAMILY; CANCER; ALPHA; P300	The MTA1 coregulator (metastatic tumor antigen 1), a component of the nucleosome remodeling and deacetylase (NuRD) complex, has been intimately linked with human cancer, but its role in inflammatory responses remains unknown. Here, we discovered that MTA1 is a target of inflammation, and stimulation of macrophages with Escherichia coli lipopolysaccharide (LPS) stimulates MTA1 transcription via the NF-kappa B pathway. Unexpectedly, we found that MTA1 depletion in LPS-stimulated macrophages impairs NF-kappa B signaling and expression of inflammatory molecules. MTA1 itself acts as a transcriptional coactivator of inflammatory cytokines in LPS-stimulated macrophages, and in contrast, it acts as a corepressor in resting primary macrophages as its depletion induced cytokine expression. LPS stimulates S-nitrosylation of histone deacetylase 2 (HDAC2) and interferes with its binding to MTA1, which, in turn, resulted in the loss of corepressor behavior of MTA1.HDAC complex in activated macrophages. Consequently, the net levels of inflammatory cytokines in LPS-stimulated macrophages from MTA1(-/-) mice were high compared with wild-type mice. Accordingly, MTA1(-/-) mice were much more susceptible than control mice to septic shock induced by LPS, revealing that MTA1 protects mice from deregulated host inflammatory response. These findings reveal a previously unrecognized, critical homeostatic role of MTA1, both as a target and as a component of the NF-kappa B circuitry, in the regulation of inflammatory responses.	[Pakala, Suresh B.; Bui-Nguyen, Tri M.; Reddy, Sirigiri Divijendra Natha; Li, Da-Qiang; Kumar, Rakesh] George Washington Univ, Dept Biochem & Mol Biol, Med Ctr, Washington, DC 20037 USA; [Peng, Shaohua; Rayala, Suresh K.; Kumar, Rakesh] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Behringer, Richard R.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA	George Washington University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Kumar, R (corresponding author), George Washington Univ, Dept Biochem & Mol Biol, Med Ctr, Washington, DC 20037 USA.	bcmrxk@gwumc.edu	Kumar, Rakesh/ABD-1065-2020; sirigiri, divijendranathareddy/A-9857-2010	Kumar, Rakesh/0000-0001-7664-0803; Rayala, Suresh/0000-0003-4394-4450	National Institutes of Health [CA98823, CA109379]; NATIONAL CANCER INSTITUTE [R01CA109379, R01CA098823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA98823 and CA109379 (to R.K.).	Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Balasenthil S, 2007, CANCER RES, V67, P7132, DOI 10.1158/0008-5472.CAN-07-0750; Di Marco S, 2005, MOL CELL BIOL, V25, P6533, DOI 10.1128/MCB.25.15.6533-6545.2005; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Good L, 1996, BIOCHEM BIOPH RES CO, V223, P123, DOI 10.1006/bbrc.1996.0856; Gururaj AE, 2006, P NATL ACAD SCI USA, V103, P6670, DOI 10.1073/pnas.0601989103; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; Karin M, 2006, MOL CARCINOGEN, V45, P355, DOI 10.1002/mc.20217; Kumar R, 2003, SEMIN ONCOL, V30, P30, DOI 10.1053/j.seminoncol.2003.08.005; Kumar R, 2002, NATURE, V418, P654, DOI 10.1038/nature00889; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Manavathi B, 2007, P NATL ACAD SCI USA, V104, P13128, DOI 10.1073/pnas.0705878104; Manavathi B, 2007, J BIOL CHEM, V282, P1529, DOI 10.1074/jbc.R600029200; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; TOH Y, 1994, J BIOL CHEM, V269, P22958; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vanden Berghe W, 1999, J BIOL CHEM, V274, P32091, DOI 10.1074/jbc.274.45.32091; Yu CD, 2007, MOL CELL, V25, P765, DOI 10.1016/j.molcel.2007.01.025; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	23	51	54	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23590	23597		10.1074/jbc.M110.139469	http://dx.doi.org/10.1074/jbc.M110.139469			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20519513	hybrid, Green Published			2022-12-27	WOS:000280291400008
J	Hsu, YH; Liao, LJ; Yu, CH; Chiang, CP; Jhan, JR; Chang, LC; Chen, YJ; Lou, PJ; Lin, JJ				Hsu, Yi-Hsin; Liao, Li-Jen; Yu, Chuan-Hang; Chiang, Chun-Pin; Jhan, Jing-Ru; Chang, Lien-Cheng; Chen, Yann-Jang; Lou, Pei-Jen; Lin, Jing-Jer			Overexpression of the Pituitary Tumor Transforming Gene Induces p53-dependent Senescence through Activating DNA Damage Response Pathway in Normal Human Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID SEPARATION; CELLULAR SENESCENCE; HUMAN SECURIN; HUMAN-CELLS; IN-VIVO; P53; TUMORIGENESIS; ARREST; GROWTH; CANCER	Pituitary tumor transforming gene (PTTG1, securin) is involved in cell-cycle control through inhibition of sister-chromatid separation. Elevated levels of PTTG1 were found to be associated with many different tumor types that might be involved in late stage tumor progression. However, the role of PTTG1 in early stage of tumorigenesis is unclear. Here we utilized the adenovirus expression system to deliver PTTG1 into normal human fibroblasts to evaluate the role of PTTG1 in tumorigenesis. Expressing PTTG1 in normal human fibroblasts inhibited cell proliferation. Several senescence-associated (SA) phenotypes including increased SA-beta-galactosidase activities, decreased bromodeoxyuridine incorporation, and increased SA-heterochromatin foci formation were also observed in PTTG1-expressing cells, indicating that PTTG1 overexpression induced a senescent phenotype in normal cells. Significantly, the PTTG1-induced senescence is p53-dependent and telomerase-independent, which is distinctively different from that of replicative senescence. The mechanism of PTTG1-induced senescence was also analyzed. Consistent with its role in regulating sister-chromatid separation, overexpression of PTTG1 inhibited the activation of separase. Consequently, the numbers of cells with abnormal nuclei morphologies and chromosome separations were increased, which resulted in activation of the DNA damage response. Thus, we concluded that PTTG1 overexpression in normal human fibroblasts caused chromosome instability, which subsequently induced p53-dependent senescence through activation of DNA-damage response pathway.	[Lou, Pei-Jen] Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei 110, Taiwan; [Lou, Pei-Jen] Natl Taiwan Univ, Coll Med, Taipei 110, Taiwan; [Hsu, Yi-Hsin; Jhan, Jing-Ru; Chang, Lien-Cheng; Lin, Jing-Jer] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan; [Liao, Li-Jen] Far Eastern Mem Hosp, Dept Otolaryngol, Taipei 110, Taiwan; [Liao, Li-Jen] Natl Taiwan Univ, Coll Publ Hlth, Inst Prevent Med, Taipei 110, Taiwan; [Yu, Chuan-Hang; Chiang, Chun-Pin] Natl Taiwan Univ, Grad Inst Clin Dent, Taipei 110, Taiwan; [Chiang, Chun-Pin] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Dent, Taipei 110, Taiwan; [Chen, Yann-Jang] Natl Yang Ming Univ, Fac Life Sci, Taipei 112, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Yang Ming Chiao Tung University; Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Yang Ming Chiao Tung University	Lou, PJ (corresponding author), Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei 110, Taiwan.	pjlou@ntu.edu.tw; jjlin@ym.edu.tw	Lin, Jing-Jer/G-8068-2015	Chiang, Chun-Pin/0000-0002-6190-7162; LOU, PEI-JEN/0000-0002-3383-8593; LIN, JING-JER/0000-0001-8250-7398	National Science Council [97-2311-B-010-005, 98-3112-B-010-006, 96-2627-B002-010]; National Health Research Institute [NHRI-EX98-9625SI]; Institute of Biopharmaceutical Science	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan); Institute of Biopharmaceutical Science	This work was supported by National Science Council Grants 97-2311-B-010-005 and 98-3112-B-010-006 (to J.-J. L.) and 96-2627-B002-010 (to P.-J. L.) and by the National Health Research Institute Grant NHRI-EX98-9625SI (to J.-J. L.).; We thank members of the Institute of Biopharmaceutical Science for help and support. We thank Y. Su for the adenoviral system, T. H. Cheng for the HCT116 cells, and the National RNAi core facility for the shRNAs.	BAUM P, 1988, MOL CELL BIOL, V8, P5386, DOI 10.1128/MCB.8.12.5386; Bernal JA, 2002, NAT GENET, V32, P306, DOI 10.1038/ng997; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chang BD, 1999, ONCOGENE, V18, P4808, DOI 10.1038/sj.onc.1203078; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dominguez A, 1998, ONCOGENE, V17, P2187, DOI 10.1038/sj.onc.1202140; Escarpe P, 2003, MOL THER, V8, P332, DOI 10.1016/S1525-0016(03)00167-9; Funabiki H, 1996, EMBO J, V15, P6617, DOI 10.1002/j.1460-2075.1996.tb01052.x; Heaney AP, 1999, NAT MED, V5, P1317, DOI 10.1038/15275; Herzig A, 2002, GENE DEV, V16, P2443, DOI 10.1101/gad.242202; Ishikawa H, 2001, J CLIN ENDOCR METAB, V86, P867, DOI 10.1210/jc.86.2.867; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; MCGREW JT, 1992, MOL BIOL CELL, V3, P1443, DOI 10.1091/mbc.3.12.1443; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Olsen CL, 2002, ONCOGENE, V21, P6328, DOI 10.1038/sj.onc.1205780; Pei L, 1997, MOL ENDOCRINOL, V11, P433, DOI 10.1210/me.11.4.433; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Romero F, 2001, NUCLEIC ACIDS RES, V29, P1300, DOI 10.1093/nar/29.6.1300; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shepard JL, 2007, GENE DEV, V21, P55, DOI 10.1101/gad.1470407; Vlotides G, 2007, ENDOCR REV, V28, P165, DOI 10.1210/er.2006-0042; Waizenegger IC, 2002, CURR BIOL, V12, P1368, DOI 10.1016/S0960-9822(02)01073-4; Wei WY, 1999, EXP CELL RES, V253, P519, DOI 10.1006/excr.1999.4665; Yu R, 2003, ENDOCRINOLOGY, V144, P4991, DOI 10.1210/en.2003-0305; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019; Zhang X, 1999, MOL ENDOCRINOL, V13, P156, DOI 10.1210/me.13.1.156; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	32	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22630	22638		10.1074/jbc.M109.096255	http://dx.doi.org/10.1074/jbc.M109.096255			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20452981	hybrid, Green Published			2022-12-27	WOS:000279702200073
J	Maitra, M; Wang, YY; Gerard, RD; Mendelson, CR; Garcia, CK				Maitra, Meenakshi; Wang, Yongyu; Gerard, Robert D.; Mendelson, Carole R.; Garcia, Christine Kim			Surfactant Protein A2 Mutations Associated with Pulmonary Fibrosis Lead to Protein Instability and Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERSTITIAL LUNG-DISEASE; GENE TARGETED MICE; INNATE IMMUNITY; HUMAN SP-A1; SP-C; EXPRESSION; CELLS; OLIGOMERIZATION; TELOMERASE; MECHANISMS	Rare heterozygous mutations in the gene encoding surfactant protein A2 (SP-A2, SFTPA2) are associated with adult-onset pulmonary fibrosis and adenocarcinoma of the lung. We have previously shown that two recombinant SP-A2 mutant proteins (G231V and F198S) remain within the endoplasmic reticulum (ER) of A549 cells and are not secreted into the culture medium. The pathogenic mechanism of the mutant proteins is unknown. Here we analyze all common and rare variants of the surfactant protein A2, SP-A2, in both A549 cells and in primary type II alveolar epithelial cells. We show that, in contrast with all other SP-A2 variants, the mutant proteins are not secreted into the medium with wild-type SP-A isoforms, form fewer intracellular dimer and trimer oligomers, are partially insoluble in 0.5% Nonidet P-40 lysates of transfected A549 cells, and demonstrate greater protein instability in chymotrypsin proteolytic digestions. Both the G231V and F198S mutant SP-A2 proteins are destroyed via the ER-association degradation pathway. Expression of the mutant proteins increases the transcription of a BiP-reporter construct, expression of BiP protein, and production of an ER stress-induced XBP-1 spliced product. Human bronchoalveolar wash samples from individuals who are heterozygous for the G231V mutation have similar levels of total SP-A as normal family members, which suggests that the mechanism of disease does not involve an overt lack of secreted SP-A but instead involves an increase in ER stress of resident type II alveolar epithelial cells.	[Maitra, Meenakshi; Wang, Yongyu; Garcia, Christine Kim] Univ Texas SW Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Gerard, Robert D.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Mendelson, Carole R.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Garcia, CK (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Christine.garcia@utsouthwestern.edu	Wang, Yongyu/F-9039-2011	Wang, Yongyu/0000-0002-8804-3472; Mendelson, Carole Ruth/0000-0003-1696-9791; Wang, Yongyu/0000-0002-6088-8887	National Institutes of Health (NHLBI) [HL093096]; Doris Duke Charitable Foundation; National Institutes of Health [HL050022]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093096, R37HL050022, R01HL050022] Funding Source: NIH RePORTER	National Institutes of Health (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL093096 (NHLBI) (to C. K. G.) and HL050022 (to C. R. M.). This work was also supported by the Doris Duke Charitable Foundation.	Alcorn JL, 1997, AM J RESP CELL MOL, V17, P672, DOI 10.1165/ajrcmb.17.6.2858; Aoki K, 1999, MOL MED, V5, P224, DOI 10.1007/BF03402119; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Beers MF, 2005, ANNU REV PHYSIOL, V67, P663, DOI 10.1146/annurev.physiol.67.040403.101937; Bridges JP, 2006, J CELL BIOL, V172, P395, DOI 10.1083/jcb.200508016; Bridges JP, 2003, J BIOL CHEM, V278, P52739, DOI 10.1074/jbc.M309599200; Cronkhite JT, 2008, AM J RESP CRIT CARE, V178, P729, DOI 10.1164/rccm.200804-550OC; Floros J, 1998, BBA-MOL BASIS DIS, V1408, P312, DOI 10.1016/S0925-4439(98)00077-5; Goss KL, 1998, AM J RESP CELL MOL, V19, P613, DOI 10.1165/ajrcmb.19.4.3155; HAAGSMAN HP, 1989, AM J PHYSIOL, V257, pL421, DOI 10.1152/ajplung.1989.257.6.L421; Han Chao, 2009, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V23, P1409; Head JF, 2003, J BIOL CHEM, V278, P43254, DOI 10.1074/jbc.M305628200; Korfei M, 2008, AM J RESP CRIT CARE, V178, P838, DOI 10.1164/rccm.200802-313OC; Korfhagen TR, 1998, BBA-MOL BASIS DIS, V1408, P296, DOI 10.1016/S0925-4439(98)00075-1; Korfhagen TR, 1996, P NATL ACAD SCI USA, V93, P9594, DOI 10.1073/pnas.93.18.9594; Mason RJ, 2006, RESPIROLOGY, V11, pS12, DOI 10.1111/j.1440-1843.2006.00800.x; McCormack FX, 2002, J CLIN INVEST, V109, P707, DOI 10.1172/JCI200215293; MCCORMICK SM, 1994, AM J PHYSIOL, V266, pL367, DOI 10.1152/ajplung.1994.266.4.L367; Mulugeta S, 2005, AM J RESP CELL MOL, V32, P521, DOI 10.1165/rcmb.2005-0009OC; Mulugeta S, 2007, AM J PHYSIOL-LUNG C, V293, pL720, DOI 10.1152/ajplung.00025.2007; Palaniyar N, 2001, COMP BIOCHEM PHYS A, V129, P109, DOI 10.1016/S1095-6433(01)00309-9; PETITOU M, 1978, ANAL BIOCHEM, V91, P350, DOI 10.1016/0003-2697(78)90849-7; Raghu G, 2004, BRIT J CANCER, V91, pS3, DOI 10.1038/sj.bjc.6602061; Saitoh H, 1998, AM J RESP CELL MOL, V19, P202, DOI 10.1165/ajrcmb.19.2.3239; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Sanchez-Barbero F, 2007, BIOCHEM J, V406, P479, DOI 10.1042/BJ20070275; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Thomas AQ, 2002, AM J RESP CRIT CARE, V165, P1322, DOI 10.1164/rccm.200112-123OC; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Wang GR, 2004, BIOCHEMISTRY-US, V43, P4227, DOI 10.1021/bi036023i; Wang LQ, 2009, TRIBOL T, V52, P59, DOI 10.1080/10402000802105422; Wang WJ, 2003, J CELL SCI, V116, P683, DOI 10.1242/jcs.00267; Whitsett JA, 2002, NEW ENGL J MED, V347, P2141, DOI 10.1056/NEJMra022387; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Zeng XY, 2003, INFECT IMMUN, V71, P1306, DOI 10.1128/IAI.71.3.1306-1315.2003	36	106	108	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22103	22113		10.1074/jbc.M110.121467	http://dx.doi.org/10.1074/jbc.M110.121467			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20466729	hybrid, Green Published			2022-12-27	WOS:000279702200023
J	Vembar, SS; Jonikas, MC; Hendershot, LM; Weissman, JS; Brodsky, JL				Vembar, Shruthi S.; Jonikas, Martin C.; Hendershot, Linda M.; Weissman, Jonathan S.; Brodsky, Jeffrey L.			J Domain Co-chaperone Specificity Defines the Role of BiP during Protein Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST ENDOPLASMIC-RETICULUM; MULTISPANNING MEMBRANE-PROTEIN; HSP70 MOLECULAR CHAPERONE; SACCHAROMYCES-CEREVISIAE; SUBSTRATE-BINDING; DNAJ HOMOLOG; POLYPEPTIDE TRANSLOCATION; DISTINCT FUNCTIONS; UNFOLDED PROTEINS; COCHAPERONE DNAJ	Hsp70 chaperones can potentially interact with one of several J domain-containing Hsp40 co-chaperones to regulate distinct cellular processes. However, features within Hsp70s that determine Hsp40 specificity are undefined. To investigate this question, we introduced mutations into the ER-lumenal Hsp70, BiP/Kar2p, and found that an R217A substitution in the J domain-interacting surface of BiP compromised the physical and functional interaction with Sec63p, an Hsp40 required for ER translocation. In contrast, interaction with Jem1p, an Hsp40 required for ER-associated degradation, was unaffected. Moreover, yeast expressing R217A BiP exhibited defects in translocation but not in ER-associated degradation. Finally, the genetic interactions of the R217A BiP mutant were found to correlate with those of known translocation mutants. Together, our results indicate that residues within the Hsp70 J domain-interacting surface help confer Hsp40 specificity, in turn influencing distinct chaperone-mediated cellular activities.	[Vembar, Shruthi S.; Hendershot, Linda M.; Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Jonikas, Martin C.; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Jonikas, Martin C.; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Jonikas, Martin C.; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Jonikas, Martin C.; Weissman, Jonathan S.] Calif Inst Quantitat Biomed Res, San Francisco, CA 94143 USA; [Hendershot, Linda M.] St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; [Hendershot, Linda M.] Univ Tennessee, Hlth Sci Ctr, Dept Mol Sci, Memphis, TN 38163 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Brodsky, JL (corresponding author), Univ Pittsburgh, Dept Biol Sci, 4249 5th Ave,A320 Langley Hall, Pittsburgh, PA 15260 USA.	jbrodsky@pitt.edu	Vembar, Shruthi Sridhar/AAE-2479-2019; Hendershot, Linda/N-8124-2018	Hendershot, Linda/0000-0002-5473-0274; Weissman, Jonathan/0000-0003-2445-670X	National Institutes of Health [GM75061, GM54068]; Cancer Center [CA21765]; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital; University of Pittsburgh; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054068, R01GM075061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); University of Pittsburgh(University of Pittsburgh); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM75061 (to J. L. B.) and GM54068 (to L. M. H.). This work was also supported by the Cancer Center CORE Grant CA21765 and the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital (to L. M. H.).; Recipient of a Mellon Graduate Fellowship from the University of Pittsburgh.	Alder NN, 2005, J CELL BIOL, V168, P389, DOI 10.1083/jcb.200409174; ANG D, 1991, J BIOL CHEM, V266, P24233; Awad W, 2008, P NATL ACAD SCI USA, V105, P1164, DOI 10.1073/pnas.0702132105; BOHNI PC, 1988, J CELL BIOL, V106, P1035, DOI 10.1083/jcb.106.4.1035; BRODSKY JL, 1993, J CELL BIOL, V120, P95, DOI 10.1083/jcb.120.1.95; BRODSKY JL, 1993, J CELL BIOL, V123, P1355, DOI 10.1083/jcb.123.6.1355; BRODSKY JL, 1995, P NATL ACAD SCI USA, V92, P9643, DOI 10.1073/pnas.92.21.9643; Brodsky JL, 1996, TRENDS BIOCHEM SCI, V21, P122, DOI 10.1016/0968-0004(96)20010-6; BUCHBERGER A, 1994, EMBO J, V13, P1687, DOI 10.1002/j.1460-2075.1994.tb06433.x; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; CAPLAN AJ, 1992, CELL, V71, P1143, DOI 10.1016/S0092-8674(05)80063-7; Corsi AK, 1997, J CELL BIOL, V137, P1483, DOI 10.1083/jcb.137.7.1483; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Craig EA, 2006, REV PHYSIOL BIOCH P, V156, P1, DOI 10.1007/s10254-005-0001-8; CYR DM, 1995, FEBS LETT, V359, P129, DOI 10.1016/0014-5793(95)00024-4; CYR DM, 1992, J BIOL CHEM, V267, P20927; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; FELDHEIM D, 1992, MOL CELL BIOL, V12, P3288, DOI 10.1128/MCB.12.7.3288; FELDHEIM D, 1993, MOL BIOL CELL, V4, P931, DOI 10.1091/mbc.4.9.931; Fernandez-Saiz V, 2006, J BIOL CHEM, V281, P7479, DOI 10.1074/jbc.M512744200; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Gassler CS, 1998, P NATL ACAD SCI USA, V95, P15229, DOI 10.1073/pnas.95.26.15229; HANSEN W, 1986, CELL, V45, P397, DOI 10.1016/0092-8674(86)90325-9; Hennessy F, 2005, PROTEIN SCI, V14, P1697, DOI 10.1110/ps.051406805; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Jiang JW, 2007, MOL CELL, V28, P422, DOI 10.1016/j.molcel.2007.08.022; Jin Y, 2008, EMBO J, V27, P2873, DOI 10.1038/emboj.2008.207; Johnson AE, 1997, TRENDS CELL BIOL, V7, P90, DOI 10.1016/S0962-8924(97)01029-5; Johnson AE, 2009, J CELL BIOL, V185, P765, DOI 10.1083/jcb.200902014; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kabani M, 2003, MOL BIOL CELL, V14, P3437, DOI 10.1091/mbc.E02-12-0847; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Kimata Y, 2003, MOL BIOL CELL, V14, P2559, DOI 10.1091/mbc.E02-11-0708; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McClellan AJ, 1998, MOL BIOL CELL, V9, P3533, DOI 10.1091/mbc.9.12.3533; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; Moro F, 2004, J BIOL CHEM, V279, P19600, DOI 10.1074/jbc.M400921200; Morrow MW, 2001, TRAFFIC, V2, P705, DOI 10.1034/j.1600-0854.2001.21005.x; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; Nishikawa S, 1998, BIOCHEM BIOPH RES CO, V244, P785, DOI 10.1006/bbrc.1998.8342; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Nishikawa S, 1997, J BIOL CHEM, V272, P12889, DOI 10.1074/jbc.272.20.12889; Pierpaoli EV, 1998, BIOCHEMISTRY-US, V37, P16741, DOI 10.1021/bi981762y; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; ROSE M, 1983, METHOD ENZYMOL, V101, P167; SADLER I, 1989, J CELL BIOL, V109, P2665, DOI 10.1083/jcb.109.6.2665; Saibil H, 2000, CURR OPIN STRUC BIOL, V10, P251, DOI 10.1016/S0959-440X(00)00074-9; SCHLENSTEDT G, 1995, J CELL BIOL, V129, P979, DOI 10.1083/jcb.129.4.979; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Shaner L, 2007, CELL STRESS CHAPERON, V12, P1, DOI 10.1379/CSC-245R.1; Silberstein S, 1998, J CELL BIOL, V143, P921, DOI 10.1083/jcb.143.4.921; SIMONS JF, 1995, J CELL BIOL, V130, P41, DOI 10.1083/jcb.130.1.41; Suh WC, 1999, J BIOL CHEM, V274, P30534, DOI 10.1074/jbc.274.43.30534; Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223; Tam A, 2001, J BIOL CHEM, V276, P46798, DOI 10.1074/jbc.M106150200; TEHEESEN S, 1994, EUR J BIOCHEM, V222, P631; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Van Driessche B, 2005, YEAST, V22, P1061, DOI 10.1002/yea.1293; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Youker RT, 2004, MOL BIOL CELL, V15, P4787, DOI 10.1091/mbc.E04-07-0584; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	69	33	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22484	22494		10.1074/jbc.M110.102186	http://dx.doi.org/10.1074/jbc.M110.102186			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20430885	hybrid, Green Published			2022-12-27	WOS:000279702200060
J	Banski, P; Mahboubi, H; Kodiha, M; Shrivastava, S; Kanagaratham, C; Stochaj, U				Banski, Piotr; Mahboubi, Hicham; Kodiha, Mohamed; Shrivastava, Sanhita; Kanagaratham, Cynthia; Stochaj, Ursula			Nucleolar Targeting of the Chaperone Hsc70 Is Regulated by Stress, Cell Signaling, and a Composite Targeting Signal Which Is Controlled by Autoinhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK; HEAT-SHOCK-PROTEIN-70 FAMILY; MOLECULAR CHAPERONES; OXIDATIVE STRESS; NUCLEAR IMPORT; PROTEIN; LOCALIZATION; MECHANISMS; KINASE; HSP70	Hsc70s are constitutively synthesized members of the 70-kDa chaperone family; they are essential for viability and conserved among all organisms. When eukaryotic cells recover from stress, hsc70s accumulate in nucleoli by an unknown mechanism. Our studies were undertaken to characterize the signaling events and the targeting sequence required to concentrate hsc70 in the nucleoli of human cells. Here, we show that pharmacological inhibitors of phosphatidylinositol (PI) 3-kinase and MEK kinases as well as protein-tyrosine phosphatases abolished the stress-dependent nucleolar accumulation of hsc70. Furthermore, to identify the hsc70 nucleolar targeting sequence, green fluorescent protein-tagged fusion proteins with defined segments of hsc70 were generated and their subcellular distribution was analyzed in growing cells. These studies demonstrated that residues 225 to 297 serve as a heat-inducible nucleolar targeting signal. This segment directs green fluorescent protein to nucleoli in response to stress, but fails to do so under nonstress conditions. Fine mapping of the nucleolar targeting signal revealed that it has two separable functions. First, residues 225 to 262 direct reporter proteins constitutively to nucleoli, even without stress. Second, segment 263 to 287 functions as an auto-inhibitory element that prevents hsc70 from concentrating in nucleoli when cells are not stressed. Taken together, PI 3-kinase and MEK kinase signaling as well as tyrosine dephosphorylation are essential for the accumulation of hsc70 in nucleoli of stressed cells. This process relies on a stress-dependent composite targeting signal that combines multiple functions.	[Banski, Piotr; Mahboubi, Hicham; Kodiha, Mohamed; Shrivastava, Sanhita; Kanagaratham, Cynthia; Stochaj, Ursula] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada	McGill University	Stochaj, U (corresponding author), 3655 Promenade Sir William Osler, Montreal, PQ H3G 1Y6, Canada.	ursula.stochaj@mcgill.ca	stochaj, ursula/AAC-1865-2021; Mahboubi, Hicham/E-4294-2015	Mahboubi, Hicham/0000-0001-7643-0769	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Heart and Stroke Foundation of Canada; Fonds de la Recherche en Sante Quebec/Heart and Stroke Foundation of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Fonds de la Recherche en Sante Quebec/Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of CanadaFonds de la Recherche en Sante du Quebec)	This work was supported in part by grants from Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, and Heart and Stroke Foundation of Canada (to U.S.).; Supported by a fellowship from Fonds de la Recherche en Sante Quebec/Heart and Stroke Foundation of Canada.	Ahmad Y, 2009, NUCLEIC ACIDS RES, V37, pD181, DOI 10.1093/nar/gkn804; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; BANSKI P, 2010, TRENDS BIOL IN PRESS; Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Chu A, 2001, FASEB J, V15, P1478, DOI 10.1096/fj.00-0680fje; DANG CV, 1989, J BIOL CHEM, V264, P18019; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Giffard RG, 2004, J NEUROSURG ANESTH, V16, P53, DOI 10.1097/00008506-200401000-00010; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Hiscox JA, 2007, NAT REV MICROBIOL, V5, P119, DOI 10.1038/nrmicro1597; Hishiya A, 2008, ONCOGENE, V27, P6489, DOI 10.1038/onc.2008.314; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; Kodiha M, 2004, CELL DEATH DIFFER, V11, P862, DOI 10.1038/sj.cdd.4401432; Kodiha M, 2005, AM J PHYSIOL-CELL PH, V289, pC1034, DOI 10.1152/ajpcell.00590.2004; Kodiha M, 2007, AM J PHYSIOL-CELL PH, V293, pC1427, DOI 10.1152/ajpcell.00176.2007; Kodiha M, 2009, FEBS LETT, V583, P1987, DOI 10.1016/j.febslet.2009.05.011; Lam YW, 2010, MOL CELL PROTEOMICS, V9, P117, DOI 10.1074/mcp.M900338-MCP200; Lam YW, 2005, J CELL SCI, V118, P1335, DOI 10.1242/jcs.01736; Leung AKL, 2003, BIOCHEM J, V376, P553, DOI 10.1042/BJ20031169; Lo SJ, 2006, CELL RES, V16, P530, DOI 10.1038/sj.cr.7310070; Macario AJL, 2005, NEW ENGL J MED, V353, P1489, DOI 10.1056/NEJMra050111; Marshall KS, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-6; Mayer C, 2005, CELL CYCLE, V4, P1036, DOI 10.4161/cc.4.8.1925; McKeown PC, 2009, CHROMOSOMA, V118, P11, DOI 10.1007/s00412-008-0184-2; Mekhail K, 2007, MOL BIOL CELL, V18, P3966, DOI 10.1091/mbc.E07-03-0295; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morimoto RI, 2009, J GERONTOL A-BIOL, V64, P167, DOI 10.1093/gerona/gln071; Olson MOJ, 2005, HISTOCHEM CELL BIOL, V123, P203, DOI 10.1007/s00418-005-0754-9; Pederson T, 2009, J CELL BIOL, V184, P771, DOI 10.1083/jcb.200812014; PELHAM HRB, 1984, EMBO J, V3, P3095, DOI 10.1002/j.1460-2075.1984.tb02264.x; Porollo A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-316; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Sale EM, 2008, CELL MOL LIFE SCI, V65, P113, DOI 10.1007/s00018-007-7274-9; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Sirri V, 2008, HISTOCHEM CELL BIOL, V129, P13, DOI 10.1007/s00418-007-0359-6; Sorg G, 1999, BIOTECHNIQUES, V26, P858, DOI 10.2144/99265bm12; Tsukahara F, 2004, J BIOL CHEM, V279, P8867, DOI 10.1074/jbc.M308848200; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z	41	28	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21858	21867		10.1074/jbc.M110.117291	http://dx.doi.org/10.1074/jbc.M110.117291			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20457599	hybrid, Green Published			2022-12-27	WOS:000279516100070
J	Gines, S; Paoletti, P; Alberch, J				Gines, Silvia; Paoletti, Paola; Alberch, Jordi			Impaired TrkB-mediated ERK1/2 Activation in Huntington Disease Knock-in Striatal Cells Involves Reduced p52/p46 Shc Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTROPHIC FACTOR; SIGNALING PATHWAYS; OXIDATIVE STRESS; TYROSINE PHOSPHORYLATION; FACTOR RECEPTORS; BRAIN; NEURONS; BDNF; PROTECTS; SURVIVAL	Altered neurotrophic support as a result of reduced brain-derived neurotrophic factor (BDNF) expression and trafficking has been revealed as a key factor in Huntington disease (HD) pathology. BDNF binds to and activates the tyrosine kinase receptor TrkB, leading to activation of intracellular signaling pathways to promote differentiation and cell survival. In order to design new neuroprotective therapies based on BDNF delivery, it is important to define whether BDNF-mediated TrkB signaling is affected in HD. Here, we demonstrate reduced TrkB-mediated Ras/MAPK/ERK1/2 signaling but unchanged phosphatidylinositol 3-kinase/Akt and phospholipase C gamma activation in knock-in HD striatal cells. Altered BDNF-mediated ERK1/2 activation in mutant huntingtin cells is associated with reduced expression of p52/p46 Shc docking proteins. Notably, reduced BDNF-induced ERK1/2 activation increases the sensitivity of mutant huntingtin striatal cells to oxidative damage. Accordingly, pharmacological activation of the MAPK pathway with PMA prevents cell death induced by oxidative stress. Taken together, our results suggest that in addition to reduced BDNF, diminished Ras/MAPK/ERK1/2 activation is involved in neurotrophic deficits associated with HD pathology. Therefore, pharmacological approaches aimed to directly modulate the MAPK/ERK1/2 pathway may represent a valuable therapeutic strategy in HD.	[Gines, Silvia; Paoletti, Paola; Alberch, Jordi] Univ Barcelona, Inst Invest Biomed August Pi i Sunyer, Fac Med, Dept Biol Cellular Immunol & Neurociencies, E-08036 Barcelona, Spain; [Gines, Silvia; Paoletti, Paola; Alberch, Jordi] Ctr Invest Biomed Red Enfermedades Neurodegenerat, E-41013 Seville, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBERNED	Gines, S (corresponding author), Univ Barcelona, Inst Invest Biomed August Pi i Sunyer, Fac Med, Dept Biol Cellular Immunol & Neurociencies, Casanova 143, E-08036 Barcelona, Spain.	silviagines@ub.edu	Alberch, Jordi/K-5702-2014; Gines, Silvia/L-1943-2015	Alberch, Jordi/0000-0002-8684-2721; Gines, Silvia/0000-0002-9479-8185	Ministerio de Ciencia e Innovacion [SAF2008-00644, SAF2009-7077, SAF2008-04360]; Centro de Investigaciones Biomedicas en Red sobre Enfermedades Neuro-degenerativas (CIBERNED) [CB06/05/0054]; Fondo de Investigaciones Sanitarias (Instituto de Salud Carlos III, RETICS) [RD06/0010/0006]; Fundacio La Marato de TV3	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Centro de Investigaciones Biomedicas en Red sobre Enfermedades Neuro-degenerativas (CIBERNED); Fondo de Investigaciones Sanitarias (Instituto de Salud Carlos III, RETICS)(Instituto de Salud Carlos III); Fundacio La Marato de TV3	This work was supported by Ministerio de Ciencia e Innovacion Grants SAF2008-00644 and SAF2009-7077 (to S. G.) and SAF2008-04360 (to J.A.), Centro de Investigaciones Biomedicas en Red sobre Enfermedades Neuro-degenerativas (CIBERNED) Grant CB06/05/0054, Fondo de Investigaciones Sanitarias (Instituto de Salud Carlos III, RETICS) Grant RD06/0010/0006, and the Fundacio La Marato de TV3.	Apostol BL, 2006, HUM MOL GENET, V15, P273, DOI 10.1093/hmg/ddi443; Arany I, 2008, J BIOL CHEM, V283, P6110, DOI 10.1074/jbc.M708799200; Barettino D, 1999, BBA-GENE STRUCT EXPR, V1446, P24, DOI 10.1016/S0167-4781(99)00056-1; Browne SE, 2006, ANTIOXID REDOX SIGN, V8, P2061, DOI 10.1089/ars.2006.8.2061; Butterworth NJ, 1998, NEUROSCIENCE, V87, P49, DOI 10.1016/S0306-4522(98)00129-8; Canals JM, 2004, J NEUROSCI, V24, P7727, DOI 10.1523/JNEUROSCI.1197-04.2004; Cavanaugh JE, 2006, J NEUROSCI RES, V84, P1367, DOI 10.1002/jnr.21024; Deogracias R, 2004, MOL CELL NEUROSCI, V26, P470, DOI 10.1016/j.mcn.2004.03.007; Du J, 2000, J CELL BIOL, V150, P1423, DOI 10.1083/jcb.150.6.1423; Duan WZ, 2003, P NATL ACAD SCI USA, V100, P2911, DOI 10.1073/pnas.0536856100; Ferrer I, 2000, BRAIN RES, V866, P257, DOI 10.1016/S0006-8993(00)02237-X; Fumagalli F, 2008, CNS DRUGS, V22, P1005, DOI 10.2165/0023210-200822120-00004; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Gines S, 2006, EUR J NEUROSCI, V23, P649, DOI 10.1111/j.1460-9568.2006.04590.x; Gines S, 2003, HUM MOL GENET, V12, P497, DOI 10.1093/hmg/ddg046; Gotoh N, 1996, EMBO J, V15, P6197, DOI 10.1002/j.1460-2075.1996.tb01008.x; Gotoh N, 1997, MOL CELL BIOL, V17, P1824, DOI 10.1128/MCB.17.4.1824; Gotoh N, 1995, ONCOGENE, V11, P2525; Gu L, 2009, BIOCHEM BIOPH RES CO, V383, P469, DOI 10.1016/j.bbrc.2009.04.037; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; Huang HY, 2007, NEUROBIOL AGING, V28, P1258, DOI 10.1016/j.neurobiolaging.2006.05.037; Jiang H, 2005, J MOL NEUROSCI, V25, P133, DOI 10.1385/JMN:25:2:133; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Liu YF, 1997, J BIOL CHEM, V272, P8121, DOI 10.1074/jbc.272.13.8121; Luzi L, 2000, CURR OPIN GENET DEV, V10, P668, DOI 10.1016/S0959-437X(00)00146-5; OKADA S, 1995, J BIOL CHEM, V270, P20737, DOI 10.1074/jbc.270.35.20737; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Perez-Navarro E, 2000, J NEUROCHEM, V75, P2190, DOI 10.1046/j.1471-4159.2000.0752190.x; Polidori MC, 1999, NEUROSCI LETT, V272, P53, DOI 10.1016/S0304-3940(99)00578-9; Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Reynolds LF, 2004, J BIOL CHEM, V279, P18239, DOI 10.1074/jbc.M400257200; Rubio I, 2006, BIOCHEM J, V398, P243, DOI 10.1042/BJ20060160; Skaper SD, 2008, CNS NEUROL DISORD-DR, V7, P46, DOI 10.2174/187152708783885174; Stack EC, 2008, ANN NY ACAD SCI, V1147, P79, DOI 10.1196/annals.1427.008; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Velazquez L, 2000, BLOOD, V96, P132, DOI 10.1182/blood.V96.1.132.013k13_132_138; Ventura A, 2002, J BIOL CHEM, V277, P22370, DOI 10.1074/jbc.M200280200; Wu ZL, 2002, J BIOL CHEM, V277, P44208, DOI 10.1074/jbc.M206890200; Yamada M, 1997, J BIOL CHEM, V272, P30334, DOI 10.1074/jbc.272.48.30334; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581; Zuccato C, 2008, BRAIN PATHOL, V18, P225, DOI 10.1111/j.1750-3639.2007.00111.x; Zuccato C, 2007, PROG NEUROBIOL, V81, P294, DOI 10.1016/j.pneurobio.2007.01.003	44	48	48	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21537	21548		10.1074/jbc.M109.084202	http://dx.doi.org/10.1074/jbc.M109.084202			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20442398	Green Published, hybrid			2022-12-27	WOS:000279516100040
J	Lucker, BF; Miller, MS; Dziedzic, SA; Blackmarr, PT; Cole, DG				Lucker, Ben F.; Miller, Mark S.; Dziedzic, Slawomir A.; Blackmarr, Philip T.; Cole, Douglas G.			Direct Interactions of Intraflagellar Transport Complex B Proteins IFT88, IFT52, and IFT46	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINESIN-LIKE PROTEIN; CHLAMYDOMONAS-REINHARDTII; CAENORHABDITIS-ELEGANS; CYTOPLASMIC DYNEIN; SENSORY NEURONS; PRIMARY CILIUM; GENE; FLAGELLA; DISEASE; DISORDERS	Intraflagellar transport (IFT) particles of Chlamydomonas reinhardtii contain two distinct protein complexes, A and B, composed of at least 6 and 15 protein subunits, respectively. As isolated from C. reinhardtii flagella, IFT complex B can be further reduced to a similar to 500-kDa core that contains IFT88, 2 x IFT81, 2 x IFT74/72, IFT52, IFT46, IFT27, IFT25, and IFT22. In this study, yeast-based two-hybrid analysis was combined with bacterial coexpression to show that three of the core B subunits, IFT88, IFT52, and IFT46, interact directly with each other and, together, are capable of forming a ternary complex. Chemical cross-linking results support the IFT52-IFT88 interaction and provide additional evidence of an association between IFT27 and IFT81. With previous studies showing that IFT81 and IFT74/72 interact to form a (IFT81)(2)(IFT74/72)(2) heterotetramer and that IFT27 and IFT25 form a heterodimer, the architecture of complex B is revealing itself. Last, electroporation of recombinant IFT46 was used to rescue flagellar assembly of a newly identified ift46 mutant and to monitor in vivo localization and movement of the IFT particles.	[Cole, Douglas G.] Univ Idaho, Dept Microbiol Mol Biol & Biochem, Moscow, ID 83844 USA; Univ Idaho, Ctr Reprod Biol, Moscow, ID 83844 USA	Idaho; University of Idaho; Idaho; University of Idaho	Cole, DG (corresponding author), Univ Idaho, Dept Microbiol Mol Biol & Biochem, MMBB LSS142, Moscow, ID 83844 USA.	dcole@uidaho.edu	Dziedzic, Slawomir/I-3200-2012	Dziedzic, Slawomir/0000-0003-1721-8594	National Institutes of Health [R01-GM61920]; National Center for Research Resources [P20-RR016454]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061920] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM61920 (to D. G. C.) and P20-RR016454 from the Idea Networks of Biomedical Research Excellence (INBRE) Program of the National Center for Research Resources.	Afzelius BA, 2004, J PATHOL, V204, P470, DOI 10.1002/path.1652; Ahmed NT, 2008, J CELL BIOL, V183, P313, DOI 10.1083/jcb.200802025; Asamiziu E, 2000, DNA RES, V7, P305, DOI 10.1093/dnares/7.5.305; Asamizu E, 1999, DNA Res, V6, P369, DOI 10.1093/dnares/6.6.369; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Baker SA, 2003, J BIOL CHEM, V278, P34211, DOI 10.1074/jbc.M300156200; Bell LR, 2006, GENETICS, V173, P1275, DOI 10.1534/genetics.106.056721; Berthold P, 2002, PROTIST, V153, P401, DOI 10.1078/14344610260450136; Bisgrove BW, 2006, DEVELOPMENT, V133, P4131, DOI 10.1242/dev.02595; BRAY D, 2001, CELL MOVEMENTS MOL M, P3; Brazelton WJ, 2001, CURR BIOL, V11, P1591, DOI 10.1016/S0960-9822(01)00485-7; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; COLE D, 2009, CHLAMYDOMONAS SOURCE, V3, P71; Cole DG, 2003, TRAFFIC, V4, P435, DOI 10.1034/j.1600-0854.2003.t01-1-00103.x; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Collet J, 1998, GENETICS, V148, P187; Davis EE, 2006, DEV CELL, V11, P9, DOI 10.1016/j.devcel.2006.06.009; Deane JA, 2001, CURR BIOL, V11, P1586, DOI 10.1016/S0960-9822(01)00484-5; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; HARLOW E, 1999, USING ANTIBODIES LAB, P276; Hayashi M, 2002, CELL MOTIL CYTOSKEL, V53, P273, DOI 10.1002/cm.10075; Hou YQ, 2007, J CELL BIOL, V176, P653, DOI 10.1083/jcb.200608041; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lechtreck KF, 2009, CELL MOTIL CYTOSKEL, V66, P469, DOI 10.1002/cm.20369; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Lucker BF, 2005, J BIOL CHEM, V280, P27688, DOI 10.1074/jbc.M505062200; Marshall WF, 2008, J CELL BIOL, V180, P17, DOI 10.1083/jcb.200710085; Pan JM, 2005, LAB INVEST, V85, P452, DOI 10.1038/labinvest.3700253; Pazour GJ, 2003, CURR OPIN CELL BIOL, V15, P105, DOI 10.1016/S0955-0674(02)00012-1; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473; Pazour GJ, 2000, METHODS, V22, P285, DOI 10.1006/meth.2000.1081; Pedersen LB, 2005, CURR BIOL, V15, P262, DOI 10.1016/j.cub.2005.01.037; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; Piperno G, 1998, J CELL BIOL, V143, P1591, DOI 10.1083/jcb.143.6.1591; Piperno G, 1997, P NATL ACAD SCI USA, V94, P4457, DOI 10.1073/pnas.94.9.4457; Porter ME, 1999, MOL BIOL CELL, V10, P693, DOI 10.1091/mbc.10.3.693; Praetorius HA, 2005, ANNU REV PHYSIOL, V67, P515, DOI 10.1146/annurev.physiol.67.040403.101353; Qin HM, 2001, CURR BIOL, V11, P457, DOI 10.1016/S0960-9822(01)00122-1; Qin HM, 2007, CURR BIOL, V17, P193, DOI 10.1016/j.cub.2006.12.040; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318; SHAKIR MA, 1993, NEUROREPORT, V4, P891, DOI 10.1097/00001756-199307000-00013; Signor D, 1999, MOL BIOL CELL, V10, P345, DOI 10.1091/mbc.10.2.345; Sizova I, 2001, GENE, V277, P221, DOI 10.1016/S0378-1119(01)00616-3; Taulman PD, 2001, MOL BIOL CELL, V12, P589, DOI 10.1091/mbc.12.3.589; WALTHER Z, 1994, J CELL BIOL, V126, P175, DOI 10.1083/jcb.126.1.175; Wang ZH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005384; Watanabe Y, 2004, CELL STRUCT FUNCT, V29, P67, DOI 10.1247/csf.29.67; Wheatley DN, 1995, PATHOBIOLOGY, V63, P222, DOI 10.1159/000163955; Yoder BK, 2002, AM J PHYSIOL-RENAL, V282, pF541, DOI 10.1152/ajprenal.00273.2001	57	53	58	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21508	21518		10.1074/jbc.M110.106997	http://dx.doi.org/10.1074/jbc.M110.106997			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20435895	hybrid, Green Published			2022-12-27	WOS:000279516100037
J	GuezGuez, A; Prod'homme, V; Mouska, X; Baudot, A; Blin-Wakkach, C; Rottapel, R; Deckert, M				GuezGuez, Amel; Prod'homme, Virginie; Mouska, Xavier; Baudot, Alice; Blin-Wakkach, Claudine; Rottapel, Robert; Deckert, Marcel			3BP2 Adapter Protein Is Required for Receptor Activator of NF kappa B Ligand (RANKL)-induced Osteoclast Differentiation of RAW264.7 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-SRC; REGULATES OSTEOCLASTOGENESIS; SIGNALING PATHWAY; ANTIGEN RECEPTOR; T-CELLS; BONE; EXPRESSION; SH3BP2; NFATC1; KINASE	The adapter protein 3BP2 (also known as SH3BP2 and Abl SH3-binding protein 2) has been involved in leukocyte signaling and activation downstream immunoreceptors. Genetic studies have further associated 3BP2 mutations to the human disease cherubism and to inflammation and bone dysfunction in mouse. However, how wild type 3BP2 functions in macrophage differentiation remains poorly understood. In this study, using small interfering RNA-mediated silencing of 3BP2 in the RAW264.7 monocytic cell line, we show that 3BP2 was required for receptor activator of NF kappa B ligand (RANKL)-induced differentiation of RAW264.7 cells into multinucleated mature osteoclasts but not for granulocyte macrophage-colony stimulating factor/interleukin-4-induced differentiation into dendritic cells. 3BP2 silencing was associated with impaired activation of multiple signaling events downstream of RANK, including actin reorganization; Src, ERK, and JNK phosphorylation; and up-regulation of osteoclastogenic factors. In addition, 3BP2 knockdown cells induced to osteoclast by RANKL displayed a reduced increase of Src and nuclear factor of activated T cells (NFATc1) mRNA and protein expression. Importantly, 3BP2 interacted with Src, Syk, Vav, and Cbl in monocytic cells, and the introduction of constitutively active mutants of Src and NFATc1 in 3BP2-deficient cells restored osteoclast differentiation. Finally, the expression of a 3BP2 cherubism mutant was found to promote increased Src activity and NFAT-dependent osteoclast formation. Together, this study demonstrates that wild type 3BP2 is a key regulator of RANK-mediated macrophage differentiation into osteoclast through Src and NFATc1 activation.	[GuezGuez, Amel; Prod'homme, Virginie; Mouska, Xavier; Baudot, Alice] Hop Archet 1, INSERM, UMR576, F-06202 Nice, France; [GuezGuez, Amel; Prod'homme, Virginie; Baudot, Alice; Blin-Wakkach, Claudine; Deckert, Marcel] Univ Nice Sophia Antipolis, F-06103 Nice, France; [Blin-Wakkach, Claudine] CNRS, Fac Med, FRE2943, F-06107 Nice, France; [Rottapel, Robert] Ontario Canc Inst, Toronto, ON M5G 1L7, Canada	CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); University of Toronto; University Toronto Affiliates; University Health Network Toronto	Deckert, M (corresponding author), Hop Archet 1, INSERM, UMR576, Route St Antoine Ginestiere, F-06202 Nice, France.	deckert@unice.fr	Deckert, Marcel/M-4998-2016; Deckert, Marcel/T-3566-2019; Blin-Wakkach, Claudine/I-1263-2016; WAKKACH, Abdelilah/J-6584-2016; Prod'homme, Virginie/A-3948-2012	Deckert, Marcel/0000-0003-2094-559X; Blin-Wakkach, Claudine/0000-0002-2621-3907; WAKKACH, Abdelilah/0000-0002-6658-8009; Prod'homme, Virginie/0000-0002-9664-4710; Mouska, Xavier/0000-0002-4263-543X; Rottapel, Robert/0000-0002-6024-5558	INSERM; ANR (Agence Nationale pour la Recherche); l'Association pour la Recherche sur le Cancer; Ligue Nationale Contre le Cancer; Fondation pour la Recherche Medicale; Contrat d'Interface Clinique with the Department of Clinical Hematology, Centre Hospitalier Universitaire de Nice (France)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANR (Agence Nationale pour la Recherche)(French National Research Agency (ANR)); l'Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Contrat d'Interface Clinique with the Department of Clinical Hematology, Centre Hospitalier Universitaire de Nice (France)	This work was supported by INSERM, ANR (Agence Nationale pour la Recherche), and l'Association pour la Recherche sur le Cancer.; Recipient of a fellowship from the Ligue Nationale Contre le Cancer.; Supported by the Fondation pour la Recherche Medicale.; Recipient of a Contrat d'Interface Clinique with the Department of Clinical Hematology, Centre Hospitalier Universitaire de Nice (France). To whom correspondence should be addressed: INSERM UMR576, Hopital de l'Archet 1, Route Saint-Antoine de Ginestiere, F-06202, Nice Cedex 3, France. Tel.: 33-492-157-700; Fax: 33-492-157-709; E-mail: deckert@unice.fr.	Aliprantis AO, 2008, J CLIN INVEST, V118, P3775, DOI 10.1172/JCI35711; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Bailet O, 2009, CANCER RES, V69, P2748, DOI 10.1158/0008-5472.CAN-08-2690; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chen G, 2007, MOL CELL BIOL, V27, P3109, DOI 10.1128/MCB.01014-06; de la Fuente MA, 2006, MOL CELL BIOL, V26, P5214, DOI 10.1128/MCB.00087-06; Deckert M, 1998, IMMUNITY, V9, P595, DOI 10.1016/S1074-7613(00)80657-3; Deckert M, 2006, ADV EXP MED BIOL, V584, P107; Faccio R, 2003, J CELL BIOL, V162, P499, DOI 10.1083/jcb.200212082; Faccio R, 2005, NAT MED, V11, P284, DOI 10.1038/nm1194; Foucault I, 2005, BLOOD, V105, P1106, DOI 10.1182/blood-2003-08-2965; Hatani T, 2008, CURR MED CHEM, V15, P549; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Insogna KL, 1997, J CLIN INVEST, V100, P2476, DOI 10.1172/JCI119790; Jevremovic D, 2001, J IMMUNOL, V166, P7219, DOI 10.4049/jimmunol.166.12.7219; Kim HJ, 2009, P NATL ACAD SCI USA, V106, P2325, DOI 10.1073/pnas.0806963106; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kurosaki T, 2002, CURR OPIN IMMUNOL, V14, P341, DOI 10.1016/S0952-7915(02)00344-8; Le Bras S, 2007, FEBS LETT, V581, P967, DOI 10.1016/j.febslet.2007.01.084; Li BJ, 2000, NAT GENET, V24, P304, DOI 10.1038/73542; Lietman SA, 2008, BIOCHEM BIOPH RES CO, V371, P644, DOI 10.1016/j.bbrc.2008.04.080; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; Miyazaki T, 2004, J BIOL CHEM, V279, P17660, DOI 10.1074/jbc.M311032200; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Monticelli S, 2002, EUR J IMMUNOL, V32, P2971, DOI 10.1002/1521-4141(2002010)32:10<2971::AID-IMMU2971>3.0.CO;2-G; Munugalavadla V, 2008, MOL CELL BIOL, V28, P7182, DOI 10.1128/MCB.00920-08; Ory S, 2008, EUR J CELL BIOL, V87, P469, DOI 10.1016/j.ejcb.2008.03.002; Sada K, 2002, BLOOD, V100, P2138, DOI 10.1182/blood-2001-12-0340; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Saltel F, 2008, EUR J CELL BIOL, V87, P459, DOI 10.1016/j.ejcb.2008.01.001; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Shinohara M, 2008, CELL, V132, P794, DOI 10.1016/j.cell.2007.12.037; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Shukla U, 2009, J BIOL CHEM, V284, P33719, DOI 10.1074/jbc.M109.049999; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Southgate J, 1998, J CLIN PATHOL, V51, P831, DOI 10.1136/jcp.51.11.831; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Tanaka S, 1996, NATURE, V383, P528, DOI 10.1038/383528a0; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Ueki Y, 2001, NAT GENET, V28, P125, DOI 10.1038/88832; Ueki Y, 2007, CELL, V128, P71, DOI 10.1016/j.cell.2006.10.047; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Zou W, 2008, MOL CELL, V31, P422, DOI 10.1016/j.molcel.2008.06.023; Zou W, 2007, J CELL BIOL, V176, P877, DOI 10.1083/jcb.200611083	51	30	34	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20952	20963		10.1074/jbc.M109.091124	http://dx.doi.org/10.1074/jbc.M109.091124			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20439986	Green Published, hybrid			2022-12-27	WOS:000279228600059
J	Li, L; Kim, E; Yuan, HX; Inoki, K; Goraksha-Hicks, P; Schiesher, RL; Neufeld, TP; Guan, KL				Li, Li; Kim, Eunjung; Yuan, Haixin; Inoki, Ken; Goraksha-Hicks, Pankuri; Schiesher, Rachel L.; Neufeld, Thomas P.; Guan, Kun-Liang			Regulation of mTORC1 by the Rab and Arf GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE; DIRECT TARGET; CELL-GROWTH; BREFELDIN-A; S6 KINASE; RHEB; TSC2; PHOSPHORYLATION; AUTOPHAGY; PROTEINS	The mammalian target of rapamycin ( mTOR) is a key cell growth regulator, which forms two distinct functional complexes (mTORC1 and mTORC2). mTORC1, which is directly inhibited by rapamycin, promotes cell growth by stimulating protein synthesis and inhibiting autophagy. mTORC1 is regulated by a wide range of extra- and intracellular signals, including growth factors, nutrients, and energy levels. Precise regulation of mTORC1 is important for normal cellular physiology and development, and dysregulation of mTORC1 contributes to hypertrophy and tumorigenesis. In this study, we screened Drosophila small GTPases for their function in TORC1 regulation and found that TORC1 activity is regulated by members of the Rab and Arf family GTPases, which are key regulators of intracellular vesicle trafficking. In mammalian cells, uncontrolled activation of Rab5 and Arf1 strongly inhibit mTORC1 activity. Interestingly, the effect of Rab5 and Arf1 on mTORC1 is specific to amino acid stimulation, whereas glucose-induced mTORC1 activation is not blocked by Rab5 or Arf1. Similarly, active Rab5 selectively inhibits mTORC1 activation by Rag GTPases, which are involved in amino acid signaling, but does not inhibit the effect of Rheb, which directly binds and activates mTORC1. Our data demonstrate a key role of Rab and Arf family small GTPases and intracellular trafficking in mTORC1 activation, particularly in response to amino acids.	[Li, Li; Yuan, Haixin; Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Li, Li; Yuan, Haixin; Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Li, Li] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Inoki, Ken] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Kim, Eunjung] Catholic Univ Daegu, Dept Food Sci & Nutr, Gyongsan 712702, South Korea; [Goraksha-Hicks, Pankuri; Schiesher, Rachel L.; Neufeld, Thomas P.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Catholic University of Daegu; University of Minnesota System; University of Minnesota Twin Cities	Guan, KL (corresponding author), Univ Calif San Diego, Moores Canc Ctr, 3855 Hlth Sci Dr, La Jolla, CA 92093 USA.	kuguan@ucsd.edu	Guan, Kun-Liang/ADK-7088-2022	Neufeld, Thomas/0000-0001-5659-4811	National Institutes of Health [GM62694, GM51586]; United States Department of Defense [DOD W81XWH-09-1-0279]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062694, R01GM062509, R01GM051586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM62694 and GM51586 (to K.-L.G.). This work was also supported by Grant DOD W81XWH-09-1-0279 from the United States Department of Defense (to K.-L.G.).	Arsham AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006068; Chang YY, 2009, BIOCHEM SOC T, V37, P232, DOI 10.1042/BST0370232; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Gomes AQ, 2003, MOL BIOL CELL, V14, P1882, DOI 10.1091/mbc.E02-10-0639; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Lodhi IJ, 2008, MOL BIOL CELL, V19, P2718, DOI 10.1091/mbc.E08-01-0105; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Merithew E, 2001, J BIOL CHEM, V276, P13982, DOI 10.1074/jbc.M009771200; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Thomas G, 2002, BIOL RES, V35, P305, DOI 10.4067/S0716-97602002000200022; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yudin D, 2009, J CELL SCI, V122, P587, DOI 10.1242/jcs.015289; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	30	104	110	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19705	19709		10.1074/jbc.C110.102483	http://dx.doi.org/10.1074/jbc.C110.102483			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20457610	hybrid, Green Published			2022-12-27	WOS:000279012000002
J	Geiduschek, EP				Geiduschek, E. Peter			An Introduction to Transcription and Gene Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							RNA SYNTHESIS; RIBONUCLEIC ACID; DEOXYRIBONUCLEIC ACID; COMPLEMENTARY STRANDS; ENZYMATIC SYNTHESIS; ESCHERICHIA-COLI; BACTERIOPHAGE SP8; T2-SPECIFIC RNA; DIRECTING ROLE; MESSENGER-RNA		Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Geiduschek, EP (corresponding author), Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA.	epg@ucsd.edu						Adams MH, 1959, BACTERIOPHAGES; AURISICCHIO S, 1964, BIOCHIM BIOPHYS ACTA, V80, P514, DOI 10.1016/0926-6550(64)90157-4; BAUTZ EKF, 1963, COLD SPRING HARB SYM, V28, P205, DOI 10.1101/SQB.1963.028.01.033; BECKER EF, 1964, J MOL BIOL, V8, P377, DOI 10.1016/S0022-2836(64)80202-3; BOLLE A, 1968, J MOL BIOL, V33, P339, DOI 10.1016/0022-2836(68)90193-9; BURGESS RR, 1969, NATURE, V221, P43, DOI 10.1038/221043a0; Cairns J., 1966, PHAGE ORIGINS MOL BI; CHAMBERLIN M, 1962, P NATL ACAD SCI USA, V48, P81, DOI 10.1073/pnas.48.1.81; CHAMPE SP, 1962, P NATL ACAD SCI USA, V48, P532, DOI 10.1073/pnas.48.4.532; COLVILL AJE, 1965, P NATL ACAD SCI USA, V53, P1140, DOI 10.1073/pnas.53.5.1140; CORDES S, 1961, NATURE, V191, P1097; DOTY P, 1960, P NATL ACAD SCI USA, V46, P461, DOI 10.1073/pnas.46.4.461; EISERLING FA, 1970, J VIROL, V6, P865, DOI 10.1128/JVI.6.6.865-876.1970; EPSTEIN RH, 1963, COLD SPRING HARB SYM, V28, P375, DOI 10.1101/SQB.1963.028.01.053; EPSTEIN W, 1968, ANNU REV BIOCHEM, V37, P411, DOI 10.1146/annurev.bi.37.070168.002211; FREIFELDER D, 1961, BIOPHYS J, V1, P389, DOI 10.1016/S0006-3495(61)86897-5; FURTH JJ, 1961, BIOCHEM BIOPH RES CO, V4, P362, DOI 10.1016/0006-291X(61)90219-4; FURTH JJ, 1961, BIOCHEM BIOPH RES CO, V4, P431, DOI 10.1016/0006-291X(61)90303-5; GEIDUSCH.E, 1961, P NATL ACAD SCI USA, V47, P950, DOI 10.1073/pnas.47.7.950; GEIDUSCHEK E, 1961, P NATL ACAD SCI USA, V47, P1405, DOI 10.1073/pnas.47.9.1405; Geiduschek EP, 2009, ANNU REV BIOCHEM, V78, P1, DOI 10.1146/annurev.biochem.77.051906.142055; GEIDUSCHEK EP, 1956, J AM CHEM SOC, V78, P879, DOI 10.1021/ja01585a051; GEIDUSCHEK EP, 1962, P NATL ACAD SCI USA, V48, P1078, DOI 10.1073/pnas.48.6.1078; GEIDUSCHEK EP, 1965, B SOC CHIM BIOL, V47, P1571; GEIDUSCHEK EP, 2010, VIROL J IN PRESS; GEIDUSCHEK EP, 1969, RNA POLYMERASE TRANS, P190; GUHA A, 1968, VIROLOGY, V34, P608, DOI 10.1016/0042-6822(68)90082-2; HALL BD, 1961, P NATL ACAD SCI USA, V47, P137, DOI 10.1073/pnas.47.2.137; HALL BD, 1963, COLD SPRING HARB SYM, V28, P201, DOI 10.1101/SQB.1963.028.01.032; HALL BD, 1964, J MOL BIOL, V9, P143, DOI 10.1016/S0022-2836(64)80096-6; HAMAGUCHI K, 1962, J AM CHEM SOC, V84, P1329, DOI 10.1021/ja00867a001; HAYASHI M, 1963, P NATL ACAD SCI USA, V50, P664, DOI 10.1073/pnas.50.4.664; HAYASHI M, 1964, P NATL ACAD SCI USA, V51, P351, DOI 10.1073/pnas.51.2.351; HAYASHI M, 1963, SCIENCE, V140, P1313, DOI 10.1126/science.140.3573.1313; HERSKOVITS T, 1961, ARCH BIOCHEM BIOPHYS, V94, P99, DOI 10.1016/0003-9861(61)90016-9; HURWITZ J, 1960, BIOCHEM BIOPH RES CO, V3, P15, DOI 10.1016/0006-291X(60)90094-2; Jacob Francois, 1987, STATUE INTERIEURE; JOSSE J, 1961, J BIOL CHEM, V236, P864; Judson HF., 1979, 8 DAY CREATION; JURALE C, 1970, NATURE, V226, P1027, DOI 10.1038/2261027a0; KHESIN R. B., 1962, BIOKHIMIYA, V27, P1092; KHESIN RB, 1963, BIOCHEMISTRY-MOSCOW+, V28, P1070; LIAO S, 1968, NATURE, V220, P1336, DOI 10.1038/2201336a0; LURIA SE, 1965, BIOCHEM BIOPH RES CO, V18, P735, DOI 10.1016/0006-291X(65)90847-8; MARMUR J, 1963, COLD SPRING HARB SYM, V28, P191, DOI 10.1101/SQB.1963.028.01.031; MARMUR J, 1960, P NATL ACAD SCI USA, V46, P453, DOI 10.1073/pnas.46.4.453; MARMUR J, 1963, SCIENCE, V142, P387, DOI 10.1126/science.142.3590.387; NYGAARD AP, 1964, J MOL BIOL, V9, P125, DOI 10.1016/S0022-2836(64)80095-4; SPIEGELMAN S, 1963, COLD SPRING HARB SYM, V28, P161, DOI 10.1101/SQB.1963.028.01.029; Stent G., 1963, MOL BIOL BACTERIAL V; STEVENS A, 1960, BIOCHEM BIOPH RES CO, V3, P92, DOI 10.1016/0006-291X(60)90110-8; TOCCHINIVALENTI.GP, 1963, P NATL ACAD SCI USA, V50, P935, DOI 10.1073/pnas.50.5.935; VOLKIN E, 1956, VIROLOGY, V2, P149, DOI 10.1016/0042-6822(56)90016-2; WEISS SB, 1961, P NATL ACAD SCI USA, V47, P1400, DOI 10.1073/pnas.47.9.1400; WEISS SB, 1959, J AM CHEM SOC, V81, P4118, DOI 10.1021/ja01524a087; WEISS SB, 1960, P NATL ACAD SCI USA, V46, P1020, DOI 10.1073/pnas.46.8.1020; WEISS SB, 1961, P NATL ACAD SCI USA, V47, P694, DOI 10.1073/pnas.47.5.694; WEISS SB, 1976, RNA POLYMERASE, P3; WIBERG JS, 1962, P NATL ACAD SCI USA, V48, P293, DOI 10.1073/pnas.48.2.293	59	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					25885	25892		10.1074/jbc.X110.143867	http://dx.doi.org/10.1074/jbc.X110.143867			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20511220	hybrid, Green Published			2022-12-27	WOS:000280921000003
J	Charbonneau, NL; Carlson, EJ; Tufa, S; Sengle, G; Manalo, EC; Carlberg, VM; Ramirez, F; Keene, DR; Sakai, LY				Charbonneau, Noe L.; Carlson, Eric J.; Tufa, Sara; Sengle, Gerhard; Manalo, Elise C.; Carlberg, Valerie M.; Ramirez, Francesco; Keene, Douglas R.; Sakai, Lynn Y.			In Vivo Studies of Mutant Fibrillin-1 Microfibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARFAN-SYNDROME; EXTRACELLULAR-MATRIX; CALCIUM-BINDING; FBN1 MUTATIONS; EXPRESSION; GENE; PATHOGENESIS; PHENOTYPE; COMPONENT; ANEURYSM	In humans, mutations in fibrillin-1 result in a variety of genetic disorders with distinct clinical phenotypes. While most of the known mutations in fibrillin-1 cause Marfan syndrome, a number of other mutations lead to clinical features unrelated to Marfan syndrome. Pathogenesis of Marfan syndrome is currently thought to be driven by mechanisms due to haploinsufficiency of wild-type fibrillin-1. However, haploinsufficiency-driven mechanisms cannot explain the distinct phenotypes found in other fibrillinopathies. To test the hypothesis that mutations in fibrillin-1 cause disorders through primary effects on microfibril structure, two different mutations were generated in Fbn1 in mice. One mutation leads to a truncated fibrillin-1 molecule that is tagged with green fluorescent protein, allowing visualization of mutant fibrillin-1 incorporated into microfibrils. In heterozygosity, these mutant mice demonstrate progressive fragmentation of the aortic elastic lamellae and also display fragmentation of microfibrils in other tissues. Fibrillin-2 epitopes are also progressively revealed in these mice, suggesting that fibrillin-2 immunoreactivity can serve as a marker for microfibril degradation. In contrast, a second mutation (inframe deletion of the first hybrid domain) in fibrillin-1 results in stable microfibrils, demonstrating that fibrillin-1 molecules are not required to be in perfect register for microfibril structure and function and that the first hybrid domain is dispensable for microfibril assembly. Taken together, these results suggest that perturbation of microfibril structure may underlie one of the major features of the Marfan syndrome: fragmentation of aortic elastic lamellae.	[Charbonneau, Noe L.; Carlson, Eric J.; Tufa, Sara; Keene, Douglas R.; Sakai, Lynn Y.] Oregon Hlth & Sci Univ, Shriners Hosp Children, Portland, OR 97239 USA; [Sengle, Gerhard; Manalo, Elise C.; Carlberg, Valerie M.; Sakai, Lynn Y.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Ramirez, Francesco] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Oregon Health & Science University; Oregon Health & Science University; Icahn School of Medicine at Mount Sinai	Sakai, LY (corresponding author), Oregon Hlth & Sci Univ, Shriners Hosp Children, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	lys@shcc.org		Manalo, Elise/0000-0003-2752-5280; Tufa, Sara/0000-0002-6447-8041	National Institutes of Health [RO1 AR46811, RC1HL100608-01, P01 AR049698, RO1 AR42044]; Shriners Hospitals for Children; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR049698, R01AR046811, R01AR042044] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospitals for Children; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 AR46811 and RC1HL100608-01 (to L.Y.S.), P01 AR049698 (to F.R. and L.Y.S.), and RO1 AR42044 (to F.R.). This work was also supported by the Shriners Hospitals for Children (to D.R.K. and to L.Y.S.).	AOYAMA T, 1994, J CLIN INVEST, V94, P130, DOI 10.1172/JCI117298; Arteaga-Solis E, 2001, J CELL BIOL, V154, P275, DOI 10.1083/jcb.200105046; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; Charbonneau NL, 2003, J BIOL CHEM, V278, P2740, DOI 10.1074/jbc.M209201200; Charbonneau NL, 2010, J BIOL CHEM, V285, P20242, DOI 10.1074/jbc.M109.087031; Corson GM, 2004, GENOMICS, V83, P461, DOI 10.1016/j.ygeno.2003.08.023; DIETZ HC, 1993, GENOMICS, V17, P468, DOI 10.1006/geno.1993.1349; Dingemans KP, 2000, ANAT REC, V258, P1; ELDADAH ZA, 1995, J CLIN INVEST, V95, P874, DOI 10.1172/JCI117737; Faivre L, 2007, AM J HUM GENET, V81, P454, DOI 10.1086/520125; Gregory KE, 2005, J BIOL CHEM, V280, P27970, DOI 10.1074/jbc.M504270200; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; HOLLISTER DW, 1990, NEW ENGL J MED, V323, P152, DOI 10.1056/NEJM199007193230303; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; KEENE DR, 1991, J HISTOCHEM CYTOCHEM, V39, P441, DOI 10.1177/39.4.2005373; Kuo CL, 2007, J BIOL CHEM, V282, P4007, DOI 10.1074/jbc.M606370200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeys BL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000488; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ono RN, 2009, J BIOL CHEM, V284, P16872, DOI 10.1074/jbc.M809348200; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Putnam EA, 1996, AM J MED GENET, V62, P233, DOI 10.1002/(SICI)1096-8628(19960329)62:3<233::AID-AJMG7>3.0.CO;2-U; Reinhardt DP, 2000, J BIOL CHEM, V275, P2205, DOI 10.1074/jbc.275.3.2205; Reinhardt DP, 2000, J BIOL CHEM, V275, P12339, DOI 10.1074/jbc.275.16.12339; Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237; Reinhardt DP, 1997, J BIOL CHEM, V272, P7368, DOI 10.1074/jbc.272.11.7368; SAKAI LY, 1994, METHOD ENZYMOL, V245, P29; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Siracusa LD, 1996, GENOME RES, V6, P300, DOI 10.1101/gr.6.4.300; ZHANG H, 1994, J CELL BIOL, V124, P855, DOI 10.1083/jcb.124.5.855	33	64	66	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24943	24955		10.1074/jbc.M110.130021	http://dx.doi.org/10.1074/jbc.M110.130021			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529844	Green Published, hybrid			2022-12-27	WOS:000280542100067
J	Condliffe, SB; Corradini, I; Pozzi, D; Verderio, C; Matteoli, M				Condliffe, Steven B.; Corradini, Irene; Pozzi, Davide; Verderio, Claudia; Matteoli, Michela			Endogenous SNAP-25 Regulates Native Voltage-gated Calcium Channels in Glutamatergic Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ CHANNELS; HIPPOCAMPAL-NEURONS; SUBCELLULAR-DISTRIBUTION; ALPHA(1A) SUBUNITS; PROTEIN SNAP-25; MOUSE; SCHIZOPHRENIA; EXPRESSION; SYNTAXIN; SNARE	In addition to its primary role as a fundamental component of the SNARE complex, SNAP-25 also modulates voltage-gated calcium channels (VGCCs) in various overexpression systems. Although these studies suggest a potential negative regulatory role of SNAP-25 on VGCC activity, the effects of endogenous SNAP-25 on native VGCC function in neurons are unclear. In the present study, we investigated the VGCC properties of cultured glutamatergic and GABAergic rat hippocampal neurons. Glutamatergic currents were dominated by P/Q-type channels, whereas GABAergic cells had a dominant L-type component. Also, glutamatergic VGCC current densities were significantly lower with enhanced inactivation rates and shifts in the voltage dependence of activation and inactivation curves compared with GABAergic cells. Silencing endogenous SNAP-25 in glutamatergic neurons did not alter P/Q-type channel expression or localization but led to increased VGCC current density without changes in the VGCC subtype proportions. Isolation of the P/Qtype component indicated that increased current in the absence of SNAP-25 was correlated with a large depolarizing shift in the voltage dependence of inactivation. Overexpressing SNAP-25 in GABAergic neurons reduced current density without affecting the VGCC subtype proportion. Accordingly, VGCC current densities in glutamatergic neurons from Snap-25(+/-) mice were significantly elevated compared with wild type glutamatergic neurons. Overall, this study demonstrates that endogenous SNAP-25 negatively regulates native VGCCs in glutamatergic neurons which could have important implications for neurological diseases associated with altered SNAP-25 expression.	Univ Milan, Dept Med Pharmacol, I-20129 Milan, Italy; Univ Milan, CNR, Inst Neurosci, I-20129 Milan, Italy; [Matteoli, Michela] IRCCS Fdn Don Gnocchi, I-20122 Milan, Italy	University of Milan; Consiglio Nazionale delle Ricerche (CNR); University of Milan; IRCCS Fondazione Don Carlo Gnocchi Onlus	Condliffe, SB (corresponding author), Univ Otago, Dept Physiol, POB 913, Dunedin 9054, New Zealand.	steven.condliffe@otago.ac.nz	Matteoli, Michela/K-4526-2018; Tuluc, Petronel/C-2527-2011; Pozzi, Davide/A-7021-2016; Verderio, Claudia/K-4415-2016; Corradini, Irene/J-5320-2018	Matteoli, Michela/0000-0002-3569-7843; Pozzi, Davide/0000-0001-6436-0556; Verderio, Claudia/0000-0001-7216-5873; Corradini, Irene/0000-0001-7128-9209	European Union [HEALTH F2-2009-241498, Cariplo 2008.2338, Cariplo 2006.0948]; Compagnia di S.Paolo Program [2005.1964]	European Union(European Commission); Compagnia di S.Paolo Program(Compagnia di San Paolo)	This work was supported by the European Union 7th Framework Program Grant HEALTH F2-2009-241498 (EUROSPIN Project), EUSynapse Integrated Project, Cariplo 2008.2338, Cariplo 2006.0948, and Compagnia di S.Paolo Program 2005.1964 (to M. M.).	Bender KJ, 2009, NEURON, V61, P259, DOI 10.1016/j.neuron.2008.12.004; Bronk P, 2007, J NEUROPHYSIOL, V98, P794, DOI 10.1152/jn.00226.2007; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Delgado-Martinez I, 2007, J NEUROSCI, V27, P9380, DOI 10.1523/JNEUROSCI.5092-06.2007; Fan HP, 2006, J BIOL CHEM, V281, P28174, DOI 10.1074/jbc.M601382200; Garbelli R, 2008, J COMP NEUROL, V506, P373, DOI 10.1002/cne.21505; Grumelli C, 2008, MOL CELL NEUROSCI, V39, P314, DOI 10.1016/j.mcn.2008.07.011; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Hess EJ, 1996, J NEUROSCI, V16, P3104, DOI 10.1523/jneurosci.16-09-03104.1996; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Jeans AF, 2007, P NATL ACAD SCI USA, V104, P2431, DOI 10.1073/pnas.0610222104; Ji JZ, 2002, J BIOL CHEM, V277, P20195, DOI 10.1074/jbc.M201034200; Jonas P, 2004, TRENDS NEUROSCI, V27, P30, DOI 10.1016/j.tins.2003.10.010; Mill J, 2004, MOL PSYCHIATR, V9, P801, DOI 10.1038/sj.mp.4001482; Mott DD, 1997, J NEUROSCI, V17, P3990; PIETRINI G, 1992, P NATL ACAD SCI USA, V89, P8414, DOI 10.1073/pnas.89.18.8414; Pozzi D, 2008, P NATL ACAD SCI USA, V105, P323, DOI 10.1073/pnas.0706211105; Pravettoni E, 2000, DEV BIOL, V227, P581, DOI 10.1006/dbio.2000.9872; Puopolo M, 2007, J NEUROSCI, V27, P645, DOI 10.1523/JNEUROSCI.4341-06.2007; Rettig J, 1996, P NATL ACAD SCI USA, V93, P7363, DOI 10.1073/pnas.93.14.7363; Selak S, 2009, NEURON, V63, P357, DOI 10.1016/j.neuron.2009.07.017; Sheng ZH, 1996, NATURE, V379, P451, DOI 10.1038/379451a0; SUCHER NJ, 1995, NEURON, V14, P1095, DOI 10.1016/0896-6273(95)90257-0; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Tafoya LCR, 2006, J NEUROSCI, V26, P7826, DOI 10.1523/JNEUROSCI.1866-06.2006; Tafoya LCR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-105; Tao-Cheng JH, 2000, J NEUROCYTOL, V29, P67, DOI 10.1023/A:1007168231323; Taverna E, 2002, J CELL SCI, V115, P3909, DOI 10.1242/jcs.00072; Taverna E, 2007, J NEUROCHEM, V100, P664, DOI 10.1111/j.1471-4159.2006.04225.x; Thompson PM, 1998, BIOL PSYCHIAT, V43, P239, DOI 10.1016/S0006-3223(97)00204-7; Thompson PM, 2003, PROG NEURO-PSYCHOPH, V27, P411, DOI 10.1016/S0278-5846(03)00027-7; Timmermann DB, 2002, J NEUROSCI RES, V67, P48, DOI 10.1002/jnr.10074; Verderio C, 2004, NEURON, V41, P599, DOI 10.1016/S0896-6273(04)00077-7; Verderio C, 1999, EUR J NEUROSCI, V11, P2793, DOI 10.1046/j.1460-9568.1999.00697.x; VERDERIO C, 1994, J CELL BIOL, V126, P1527, DOI 10.1083/jcb.126.6.1527; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; Wiser O, 1996, EMBO J, V15, P4100, DOI 10.1002/j.1460-2075.1996.tb00785.x; Wiser O, 1999, P NATL ACAD SCI USA, V96, P248, DOI 10.1073/pnas.96.1.248; Young CE, 1998, CEREB CORTEX, V8, P261, DOI 10.1093/cercor/8.3.261; Zhang Y, 2004, J NEUROSCI, V24, P5239, DOI 10.1523/JNEUROSCI.0992-04.2004; Zhong HJ, 1999, NAT NEUROSCI, V2, P939, DOI 10.1038/14721	42	47	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24968	24976		10.1074/jbc.M110.145813	http://dx.doi.org/10.1074/jbc.M110.145813			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20522554	Green Published, hybrid			2022-12-27	WOS:000280542100069
J	Dejima, K; Murata, D; Mizuguchi, S; Nomura, KH; Izumikawa, T; Kitagawa, H; Gengyo-Ando, K; Yoshina, S; Ichimiya, T; Nishihara, S; Mitani, S; Nomura, K				Dejima, Katsufumi; Murata, Daisuke; Mizuguchi, Souhei; Nomura, Kazuko H.; Izumikawa, Tomomi; Kitagawa, Hiroshi; Gengyo-Ando, Keiko; Yoshina, Sawako; Ichimiya, Tomomi; Nishihara, Shoko; Mitani, Shohei; Nomura, Kazuya			Two Golgi-resident 3 '-Phosphoadenosine 5 '-Phosphosulfate Transporters Play Distinct Roles in Heparan Sulfate Modifications and Embryonic and Larval Development in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSINE 3'-PHOSPHATE 5'-PHOSPHOSULFATE; VULVAL MORPHOGENESIS; EARLY EMBRYOGENESIS; MOLECULAR-CLONING; NERVOUS-SYSTEM; GENE; IDENTIFICATION; EXPRESSION; PAPS; DROSOPHILA	Synthesis of extracellular sulfated molecules requires active 3 '-phosphoadenosine 5 '-phosphosulfate (PAPS). For sulfation to occur, PAPS must pass through the Golgi membrane, which is facilitated by Golgi-resident PAPS transporters. Caenorhabditis elegans PAPS transporters are encoded by two genes, pst-1 and pst-2. Using the yeast heterologous expression system, we characterized PST-1 and PST-2 as PAPS transporters. We created deletion mutants to study the importance of PAPS transporter activity. The pst-1 deletion mutant exhibited defects in cuticle formation, post-embryonic seam cell development, vulval morphogenesis, cell migration, and embryogenesis. The pst-2 mutant exhibited a wildtype phenotype. The defects observed in the pst-1 mutant could be rescued by transgenic expression of pst-1 and hPAPST1 but not pst-2 or hPAPST2. Moreover, the phenotype of a pst-1; pst-2 double mutant were similar to those of the pst-1 single mutant, except that larval cuticle formation was more severely defected. Disaccharide analysis revealed that heparan sulfate from these mutants was undersulfated. Gene expression reporter analysis revealed that these PAPS transporters exhibited different tissue distributions and subcellular localizations. These data suggest that pst-1 and pst-2 play different physiological roles in heparan sulfate modification and development.	[Dejima, Katsufumi; Murata, Daisuke; Mizuguchi, Souhei; Nomura, Kazuko H.; Nomura, Kazuya] Kyushu Univ, Dept Biol, Fac Sci 33, Fukuoka 8128581, Japan; [Dejima, Katsufumi; Murata, Daisuke; Mizuguchi, Souhei; Nomura, Kazuko H.; Izumikawa, Tomomi; Kitagawa, Hiroshi; Gengyo-Ando, Keiko; Yoshina, Sawako; Mitani, Shohei; Nomura, Kazuya] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Izumikawa, Tomomi; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan; [Gengyo-Ando, Keiko; Yoshina, Sawako; Mitani, Shohei] Tokyo Womens Med Univ, Dept Physiol, Sch Med, Tokyo 1628666, Japan; [Ichimiya, Tomomi; Nishihara, Shoko] Soka Univ, Cell Biol Lab, Dept Bioinformat, Fac Engn, Tokyo 1928577, Japan	Kyushu University; Japan Science & Technology Agency (JST); Kobe Pharmaceutical University; Tokyo Women's Medical University; Soka University	Nomura, K (corresponding author), Kyushu Univ, Dept Biol, Fac Sci, Fukuoka 8128581, Japan.	knomuscb@kyushu-u.org	Gengyo-Ando, Keiko/B-2753-2012; Kitagawa, Hiroshi/AAJ-1344-2020; Gengyo-Ando, Keiko/AAC-4504-2019	Kitagawa, Hiroshi/0000-0002-9307-7079; Nishihara, Shoko/0000-0002-1668-2603	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan [B-21390025, B-20370051]; Japan Science and Technology Corp.; National Institutes of Health, NCRR	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Corp.(Japan Science & Technology Agency (JST)); National Institutes of Health, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a grant-in-aid from the Japan Society for the Promotion of Science Fellows (to K. D.), a grant-in-aid for young scientists (B) (to S. M.), and Grant-in-Aid for Scientific Research B-21390025 (to H. K.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan. This research was also supported by MEXT Grant-in-Aid for Scientific Research B-20370051 (to S. N.) and by the Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Corp. (to K. N.).; We thank Dr. K. Fukushima and Prof. K. Yamashita (Tokyo Institute of Technology, Yokohama, Japan) for providing the mammalian total cDNA. We also thank the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health, NCRR, for the worms and E. coli strains. We also thank Adam Kleinschmit for useful comments.	Ali RA, 2005, DEV GENES EVOL, V215, P537, DOI 10.1007/s00427-005-0010-2; Bender AM, 2007, DEV BIOL, V302, P448, DOI 10.1016/j.ydbio.2006.09.051; Berninsone P. M., 2006, WORMBOOK, DOI [10.1895/wormbook.1.125.1, DOI 10.1895/WORMBOOK.1.125.1]; Besset S, 2000, FASEB J, V14, P345, DOI 10.1096/fasebj.14.2.345; Bhattacharya R, 2009, J CELL SCI, V122, P4492, DOI 10.1242/jcs.050732; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; BRENNER S, 1974, GENETICS, V77, P71; Bulow HE, 2008, CURR BIOL, V18, P1978, DOI 10.1016/j.cub.2008.11.023; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; Burdine RD, 1998, DEVELOPMENT, V125, P1083; CAPASSO JM, 1984, P NATL ACAD SCI-BIOL, V81, P7051, DOI 10.1073/pnas.81.22.7051; Carlsson P, 2008, J BIOL CHEM, V283, P20008, DOI 10.1074/jbc.M801652200; Carroll BT, 2006, J BIOL CHEM, V281, P35989, DOI 10.1074/jbc.M606086200; Chisholm A. D., 2005, WORMBOOK, P1, DOI DOI 10.1895/WORMBOOK.1.35.1; Cipollo JF, 2004, J BIOL CHEM, V279, P52893, DOI 10.1074/jbc.M409557200; Clement A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000136; Dejima K, 2006, J BIOL CHEM, V281, P11431, DOI 10.1074/jbc.M601509200; Dejima K, 2009, FASEB J, V23, P2215, DOI 10.1096/fj.08-123737; Dick G, 2008, GLYCOBIOLOGY, V18, P53, DOI 10.1093/glycob/cwm121; Eisenmann D.M., 2005, WORMBOOK, DOI [DOI 10.1895/WORMBOOK.1.7.1, 10.1895/wormbook.1.7.1]; Franks DM, 2006, DEV BIOL, V296, P409, DOI 10.1016/j.ydbio.2006.06.008; Frederick JP, 2008, P NATL ACAD SCI USA, V105, P11605, DOI 10.1073/pnas.0801182105; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; Gengyo-Ando K, 2006, BIOCHEM BIOPH RES CO, V349, P1345, DOI 10.1016/j.bbrc.2006.08.183; Gilleard JS, 1997, MOL CELL BIOL, V17, P2301, DOI 10.1128/MCB.17.4.2301; Goda E, 2006, J BIOL CHEM, V281, P28508, DOI 10.1074/jbc.M605045200; Gravato-Nobre MJ, 2005, GENETICS, V171, P1033, DOI 10.1534/genetics.105.045716; Gumienny TL, 2007, CURR BIOL, V17, P159, DOI 10.1016/j.cub.2006.11.065; Gupta BP, 2002, DEV BIOL, V247, P102, DOI 10.1006/dbio.2002.0688; Hattori K, 2006, J BIOCHEM, V139, P355, DOI 10.1093/jb/mvj041; Herman T, 1999, P NATL ACAD SCI USA, V96, P968, DOI 10.1073/pnas.96.3.968; Hoflich J, 2004, J BIOL CHEM, V279, P30440, DOI 10.1074/jbc.M402429200; Hwang HY, 2003, NATURE, V423, P439, DOI 10.1038/nature01634; Izumikawa T, 2004, J BIOL CHEM, V279, P53755, DOI 10.1074/jbc.M409615200; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; Kamiyama S, 2006, J BIOL CHEM, V281, P10945, DOI 10.1074/jbc.M508991200; Kamiyama S, 2003, J BIOL CHEM, V278, P25958, DOI 10.1074/jbc.M302439200; Kehoe JW, 2000, CHEM BIOL, V7, pR57, DOI 10.1016/S1074-5521(00)00093-4; Kim TH, 2005, FEBS LETT, V579, P53, DOI 10.1016/j.febslet.2004.11.044; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; Kitagawa H, 2007, J BIOL CHEM, V282, P8533, DOI 10.1074/jbc.M611107200; Klaassen CD, 1997, FASEB J, V11, P404, DOI 10.1096/fasebj.11.6.9194521; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Luders F, 2003, EMBO J, V22, P3635, DOI 10.1093/emboj/cdg345; MANDON EC, 1994, P NATL ACAD SCI USA, V91, P10707, DOI 10.1073/pnas.91.22.10707; Mello C, 1995, METHOD CELL BIOL, V48, P451; Miller DM, 1995, METHOD CELL BIOL, V48, P365; Minniti AN, 2004, J CELL SCI, V117, P5179, DOI 10.1242/jcs.01394; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Mizuguchi S, 2009, TRENDS GLYCOSCI GLYC, V21, P179, DOI 10.4052/tigg.21.179; Mohler WA, 1998, CURR BIOL, V8, P1087, DOI 10.1016/S0960-9822(98)70447-6; Morio H, 2003, BIOCHEM BIOPH RES CO, V301, P317, DOI 10.1016/S0006-291X(02)03031-0; Morita I, 2008, J BIOCHEM, V143, P719, DOI 10.1093/jb/mvm221; Nabetani T, 2006, PROTEOMICS, V6, P4456, DOI 10.1002/pmic.200500916; NELSON FK, 1983, J ULTRA MOL STRUCT R, V82, P156; Ozeran JD, 1996, BIOCHEMISTRY-US, V35, P3695, DOI 10.1021/bi951303m; Ozeran JD, 1996, BIOCHEMISTRY-US, V35, P3685, DOI 10.1021/bi951302u; ROBBINS PW, 1958, J BIOL CHEM, V233, P681; ROBBINS PW, 1957, J BIOL CHEM, V229, P837; Sawa H, 1996, GENE DEV, V10, P2189, DOI 10.1101/gad.10.17.2189; SCHWARZ JK, 1984, J BIOL CHEM, V259, P3554; Sherman T, 2005, AM J PHYSIOL-CELL PH, V289, pC341, DOI 10.1152/ajpcell.00071.2005; Silbert JE, 1995, BBA-REV BIOMEMBRANES, V1241, P371, DOI 10.1016/0304-4157(95)00011-9; Sohaskey ML, 2008, DEVELOPMENT, V135, P2215, DOI 10.1242/dev.019950; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; STERNBERG PW, 1988, DEV BIOL, V130, P67, DOI 10.1016/0012-1606(88)90414-9; Strott CA, 2002, ENDOCR REV, V23, P703, DOI 10.1210/er.2001-0040; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Wang X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-213; Yamada S, 1999, FEBS LETT, V459, P327, DOI 10.1016/S0014-5793(99)01286-7; Yano H, 2005, P NATL ACAD SCI USA, V102, P13467, DOI 10.1073/pnas.0506681102; ZARUBA ME, 1988, BIOCHEM BIOPH RES CO, V155, P1271, DOI 10.1016/S0006-291X(88)81278-6; Zhang HQ, 2006, ANN NY ACAD SCI, V1086, P81, DOI 10.1196/annals.1377.014	75	13	15	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24717	24728		10.1074/jbc.M109.088229	http://dx.doi.org/10.1074/jbc.M109.088229			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529843	Green Published, hybrid			2022-12-27	WOS:000280542100044
J	Silverman, GA; Whisstock, JC; Bottomley, SP; Huntington, JA; Kaiserman, D; Luke, CJ; Pak, SC; Reichhart, JM; Bird, PI				Silverman, Gary A.; Whisstock, James C.; Bottomley, Stephen P.; Huntington, James A.; Kaiserman, Dion; Luke, Cliff J.; Pak, Stephen C.; Reichhart, Jean-Marc; Bird, Phillip I.			Serpins Flex Their Muscle I. PUTTING THE CLAMPS ON PROTEOLYSIS IN DIVERSE BIOLOGICAL SYSTEMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PLASMINOGEN-ACTIVATOR INHIBITOR-1; GRANZYME-B INHIBITOR; GENE DEFICIENT MICE; DROSOPHILA TOLL; CAENORHABDITIS-ELEGANS; INTRACELLULAR SERPIN; CRYSTAL-STRUCTURE; FAMILY; MELANIZATION; DEFECTS	Serpins compose the largest superfamily of peptidase inhibitors and are well known as regulators of hemostasis and thrombolysis. Studies using model organisms, from plants to vertebrates, now show that serpins and their unique inhibitory mechanism and conformational flexibility are exploited to control proteolysis in molecular pathways associated with cell survival, development, and host defense. In addition, an increasing number of non-inhibitory serpins are emerging as important elements within a diversity of biological systems by serving as chaperones, hormone transporters, or anti-angiogenic factors.	[Silverman, Gary A.; Luke, Cliff J.; Pak, Stephen C.] Univ Pittsburgh, Dept Pediat & Cell Biol, Childrens Hosp Pittsburgh, Sch Med, Pittsburgh, PA 15201 USA; [Silverman, Gary A.; Luke, Cliff J.; Pak, Stephen C.] Univ Pittsburgh, Dept Physiol, Childrens Hosp Pittsburgh, Sch Med, Pittsburgh, PA 15201 USA; [Silverman, Gary A.; Luke, Cliff J.; Pak, Stephen C.] Univ Pittsburgh, Magee Womens Hosp, Pittsburgh, PA 15201 USA; [Whisstock, James C.; Bottomley, Stephen P.; Kaiserman, Dion; Bird, Phillip I.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Whisstock, James C.; Bottomley, Stephen P.; Kaiserman, Dion; Bird, Phillip I.] Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic 3800, Australia; [Huntington, James A.] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Reichhart, Jean-Marc] Univ Strasbourg, CNRS, UPR 9022, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Monash University; Monash University; University of Cambridge; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Silverman, GA (corresponding author), Univ Pittsburgh, Dept Pediat & Cell Biol, Childrens Hosp Pittsburgh, Sch Med, Pittsburgh, PA 15201 USA.	gsilverman@upmc.edu	Silverman, Gary/AAJ-1269-2020	Pak, Stephen/0000-0002-8089-3237; Whisstock, James/0000-0003-4200-5611; Bird, Phillip/0000-0002-6695-606X	National Institutes of Health [DK079806, DK081422, HL68629]; National Health and Medical Research Council Australia [490900]; Medical Research Council; Hartwell Foundation; Institut Universitaire de France; CNRS; Agence Nationale de la Recherche; Fondation pour la Recherche; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079806, R01DK081422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Hartwell Foundation; Institut Universitaire de France; CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche(Fondation pour la Recherche Medicale); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK079806 and DK081422 (to G. A. S.) and HL68629 (to J. A. H.); National Health and Medical Research Council Australia Program Grant 490900 (to P. I. B., S. P. B., and J. C. W.); the Medical Research Council (to J. A. H.); The Hartwell Foundation (to G. A. S.); and the Institut Universitaire de France, CNRS, Agence Nationale de la Recherche, and Fondation pour la Recherche (to J.-M. R.). This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Ahmad ST, 2009, P NATL ACAD SCI USA, V106, P12168, DOI 10.1073/pnas.0903134106; Ashok Y, 2009, SCI SIGNAL, V1, DOI 10.1126/scisignal.252jc1; Askew DJ, 2007, J BIOL CHEM, V282, P24948, DOI 10.1074/jbc.M703182200; Askew DJ, 2004, GENOMICS, V84, P176, DOI 10.1016/j.ygeno.2004.01.015; ASKEW DJ, 2007, MOL CELLULAR ASPECTS, P101; Askew YS, 2001, J BIOL CHEM, V276, P49320, DOI 10.1074/jbc.M108879200; Bird PI, 1999, IMMUNOL CELL BIOL, V77, P47, DOI 10.1046/j.1440-1711.1999.00787.x; Borner S, 2008, GENE, V415, P23, DOI 10.1016/j.gene.2008.02.004; Bruning M, 2007, BIOCHEM J, V401, P325, DOI 10.1042/BJ20060648; Buchon N, 2009, P NATL ACAD SCI USA, V106, P12442, DOI 10.1073/pnas.0901924106; CARMELIET P, 1993, J CLIN INVEST, V92, P2756, DOI 10.1172/JCI116893; CARMELIET P, 1993, J CLIN INVEST, V92, P2746, DOI 10.1172/JCI116892; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; El Chamy L, 2008, NAT IMMUNOL, V9, P1165, DOI 10.1038/ni.1643; Soukup SF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000532; Gao F, 2004, DEVELOPMENT, V131, P1479, DOI 10.1242/dev.01048; Garrett M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-489; GETTINS PG, 2009, S T J BIOL CHEM, V284, P20441; Gianotten J, 2004, MOL HUM REPROD, V10, P807, DOI 10.1093/molehr/gah109; Grigoryev SA, 1999, J BIOL CHEM, V274, P5626, DOI 10.1074/jbc.274.9.5626; Ha H, 2009, NAT REV NEPHROL, V5, P203, DOI 10.1038/nrneph.2009.15; Hirst CE, 2003, J IMMUNOL, V170, P805, DOI 10.4049/jimmunol.170.2.805; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Huang Q, 2008, EXP EYE RES, V87, P226, DOI 10.1016/j.exer.2008.06.003; Huntington JA, 2006, TRENDS BIOCHEM SCI, V31, P427, DOI 10.1016/j.tibs.2006.06.005; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Jiang R, 2009, J BIOL CHEM, V284, P35652, DOI 10.1074/jbc.M109.071001; Kaiserman D, 2002, GENOMICS, V79, P349, DOI 10.1006/geno.2002.6716; Kaiserman D, 2010, CELL DEATH DIFFER, V17, P586, DOI 10.1038/cdd.2009.169; Kushi A, 2004, EXP ANIM TOKYO, V53, P437, DOI 10.1538/expanim.53.437; Lampl N, 2010, J BIOL CHEM, V285, P13550, DOI 10.1074/jbc.M109.095075; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Ligoxygakis P, 2003, CURR BIOL, V13, P2097, DOI 10.1016/j.cub.2003.10.062; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Loftus SK, 2005, PLOS GENET, V1, P369, DOI 10.1371/journal.pgen.0010038; Luke CJ, 2007, CELL, V130, P1108, DOI 10.1016/j.cell.2007.07.013; McGowan S, 2006, EMBO J, V25, P3144, DOI 10.1038/sj.emboj.7601201; McMahon B, 2007, PATHOPHYSIOL HAEMO T, V36, P184, DOI 10.1159/000175156; Murer V, 2001, P NATL ACAD SCI USA, V98, P3029, DOI 10.1073/pnas.051630698; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; Pak SC, 2006, BIOCHEMISTRY-US, V45, P4474, DOI 10.1021/bi052626d; Pak SC, 2004, J BIOL CHEM, V279, P15448, DOI 10.1074/jbc.M400261200; Pelte N, 2006, INSECT BIOCHEM MOLEC, V36, P37, DOI 10.1016/j.ibmb.2005.10.004; Perlmutter DH, 2007, MOL CELLULAR ASPECTS, P483; Petersen HH, 2006, MOL CELL BIOL, V26, P7236, DOI 10.1128/MCB.00400-06; Reichhart JM, 2005, TRENDS CELL BIOL, V15, P659, DOI 10.1016/j.tcb.2005.10.001; Roberts TH, 2008, FUNCT INTEGR GENOMIC, V8, P1, DOI 10.1007/s10142-007-0059-2; Scarff KL, 2004, MOL CELL BIOL, V24, P4075, DOI 10.1128/MCB.24.9.4075-4082.2004; Scherfer C, 2008, DEV BIOL, V323, P189, DOI 10.1016/j.ydbio.2008.08.030; Silverman G.A., 2007, MOL CELLULAR ASPECTS; Silverman GA, 2004, CELL MOL LIFE SCI, V61, P301, DOI 10.1007/s00018-003-3240-3; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Simonin Y, 2006, J NEUROSCI, V26, P10614, DOI 10.1523/JNEUROSCI.3582-06.2006; Sinnayah P, 2006, CIRC RES, V99, P1125, DOI 10.1161/01.RES.0000250259.66683.f5; Sun JR, 1997, J BIOL CHEM, V272, P15434, DOI 10.1074/jbc.272.24.15434; Suzuki K, 2008, J THROMB HAEMOST, V6, P2017, DOI 10.1111/j.1538-7836.2008.03181.x; Takasawa A, 2008, J BIOL CHEM, V283, P35606, DOI 10.1074/jbc.M804125200; Tang H, 2008, DEV CELL, V15, P617, DOI 10.1016/j.devcel.2008.08.017; Vaillant C, 2007, DEVELOPMENT, V134, P1745, DOI 10.1242/dev.02840; Vercammen D, 2006, J MOL BIOL, V364, P625, DOI 10.1016/j.jmb.2006.09.010; Whisstock JC, 2006, CURR OPIN STRUC BIOL, V16, P761, DOI 10.1016/j.sbi.2006.10.005; Whisstock JC, 2010, J BIOL CHEM, V285, P24307, DOI 10.1074/jbc.R110.141408; WHISSTOCK JC, 2006, MOL CELL BIOL, V4172, P3144; ZELLER R, 2007, DEV CELL, V5, P945	66	114	115	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24299	24305		10.1074/jbc.R110.112771	http://dx.doi.org/10.1074/jbc.R110.112771			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20498369	hybrid, Green Published			2022-12-27	WOS:000280542100001
J	Wang, P; Zhu, F; Lee, NH; Konstantopoulos, K				Wang, Pu; Zhu, Fei; Lee, Norman H.; Konstantopoulos, Konstantinos			Shear-induced Interleukin-6 Synthesis in Chondrocytes ROLES OF E PROSTANOID (EP) 2 AND EP3 IN cAMP/PROTEIN KINASE A-AND PI3-K/Akt-DEPENDENT NF-kappa B ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTAGLANDIN E-2; EXPRESSION; OSTEOARTHRITIS; RECEPTORS; CYCLOOXYGENASE-2; CARTILAGE; STRESS; COX-2; GENE; RAT	Mechanical overloading of cartilage producing hydrostatic stress, tensile strain, and fluid flow can adversely affect chondrocyte function and precipitate osteoarthritis (OA). Application of high fluid shear stress to chondrocytes recapitulates the earmarks of OA, as evidenced by the release of pro-inflammatory mediators, matrix degradation, and chondrocyte apoptosis. Elevated levels of cyclooxygenase-2 (COX-2), prostaglandin (PG) E-2, and interleukin (IL)-6 have been reported in OA cartilage in vivo, and in shear-activated chondrocytes in vitro. Although PGE(2) positively regulates IL-6 synthesis in chondrocytes, the underlying signaling pathway of shear-induced IL-6 expression remains unknown. Using the human T/C-28a2 chondrocyte cell line as a model system, we demonstrate that COX-2-derived PGE(2) signals via up-regulation of E prostanoid (EP) 2 and down-regulation of EP3 receptors to raise intracellular cAMP, and activate protein kinase A (PKA) and phosphatidylinositol 3-kinase (PI3-K)/Akt pathways. PKA and PI3-K/Akt transactivate the NF-kappa B p65 subunit via phosphorylation at Ser-276 and Ser-536, respectively. Binding of p65 to the IL-6 promoter elicits IL-6 synthesis in sheared chondrocytes. Selective knockdown of EP2 or ectopic expression of EP3 blocks PKA- and PI3-K/Akt-dependent p65 activation and markedly diminishes shear-induced IL-6 expression. Similar inhibitory effects on IL-6 synthesis were observed by inhibiting PKA, PI3-K, or NF-kappa B using pharmacological and/or genetic interventions. Reconstructing the signaling network regulating shear-induced IL-6 expression in chondrocytes may provide insights for developing therapeutic strategies for arthritic disorders and for culturing artificial cartilage in bioreactors.	[Konstantopoulos, Konstantinos] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD 21218 USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD 21218 USA; [Lee, Norman H.] George Washington Univ, Med Ctr, Dept Physiol & Pharmacol, Washington, DC 20037 USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; George Washington University; Johns Hopkins University	Konstantopoulos, K (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, 3400 N Charles St, Baltimore, MD 21218 USA.	kkonsta1@jhu.edu	Konstantopoulos, Konstantinos/A-7045-2011		National Institutes of Health NIAMS [R01 AR053358]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053358] Funding Source: NIH RePORTER	National Institutes of Health NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by the National Institutes of Health NIAMS Grant R01 AR053358.	Abulencia JP, 2003, J BIOL CHEM, V278, P28388, DOI 10.1074/jbc.M301378200; Amin AR, 1997, J CLIN INVEST, V99, P1231, DOI 10.1172/JCI119280; Anderson GD, 1996, J CLIN INVEST, V97, P2672, DOI 10.1172/JCI118717; Aoyama T, 2005, J BONE MINER RES, V20, P377, DOI 10.1359/JBMR.041122; Attur M, 2008, J IMMUNOL, V181, P5082, DOI 10.4049/jimmunol.181.7.5082; Brenn D, 2007, ARTHRITIS RHEUM, V56, P351, DOI 10.1002/art.22282; Buckwalter JA, 2006, BIORHEOLOGY, V43, P603; Carter DR, 2004, CLIN ORTHOP RELAT R, pS69, DOI 10.1097/01.blo.0000144970.05107.7e; Chen BC, 2006, J IMMUNOL, V177, P681, DOI 10.4049/jimmunol.177.1.681; Chen LX, 2008, OSTEOARTHR CARTILAGE, V16, P174, DOI 10.1016/j.joca.2007.06.006; Ciullo I, 2001, ONCOGENE, V20, P1186, DOI 10.1038/sj.onc.1204219; Eickelberg O, 1999, J BIOL CHEM, V274, P12933, DOI 10.1074/jbc.274.18.12933; Fujino H, 2002, J BIOL CHEM, V277, P2614, DOI 10.1074/jbc.M109440200; Gerlag DM, 2000, J IMMUNOL, V165, P1652, DOI 10.4049/jimmunol.165.3.1652; Goldring MB, 2004, METH MOLEC MED, V100, P37; GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595; Grassl C, 1999, J AM SOC NEPHROL, V10, P1466; Healy ZR, 2008, AM J PHYSIOL-CELL PH, V294, pC1146, DOI 10.1152/ajpcell.00542.2007; Healy ZR, 2005, P NATL ACAD SCI USA, V102, P14010, DOI 10.1073/pnas.0506620102; Hinson RM, 1996, P NATL ACAD SCI USA, V93, P4885, DOI 10.1073/pnas.93.10.4885; Inoue H, 2002, BRIT J PHARMACOL, V136, P287, DOI 10.1038/sj.bjp.0704705; Kunisch E, 2009, J IMMUNOL, V183, P1328, DOI 10.4049/jimmunol.0900801; Kurihara Y, 2001, CLIN EXP IMMUNOL, V123, P323, DOI 10.1046/j.1365-2249.2001.01442.x; Li X, 2009, ARTHRITIS RHEUM-US, V60, P513, DOI 10.1002/art.24258; Martel-Pelletier Johanne, 2004, Osteoarthritis Cartilage, V12 Suppl A, pS31; Martin JA, 2006, BIORHEOLOGY, V43, P517; Mohtai M, 1996, J ORTHOP RES, V14, P67, DOI 10.1002/jor.1100140112; Noguchi K, 2002, J PERIODONTAL RES, V37, P29, DOI 10.1034/j.1600-0765.2002.00641.x; Notoya K, 2000, J IMMUNOL, V165, P3402, DOI 10.4049/jimmunol.165.6.3402; Papadaki M, 1997, BIOTECHNOL PROGR, V13, P209, DOI 10.1021/bp970029f; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Takaoka Y, 1999, J BIOCHEM-TOKYO, V126, P553, DOI 10.1093/oxfordjournals.jbchem.a022485; Wang P, 2010, AM J PHYSIOL-CELL PH, V298, pC1445, DOI 10.1152/ajpcell.00508.2009; Yokota H, 2003, J BIOL CHEM, V278, P47275, DOI 10.1074/jbc.M304652200; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006; ZHU F, 2010, CELL DEATH IN PRESS	36	72	74	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24793	24804		10.1074/jbc.M110.110320	http://dx.doi.org/10.1074/jbc.M110.110320			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20516073	Green Published, hybrid			2022-12-27	WOS:000280542100052
J	Groskreutz, DJ; Babor, EC; Monick, MM; Varga, SM; Hunninghake, GW				Groskreutz, Dayna J.; Babor, Ellen C.; Monick, Martha M.; Varga, Steven M.; Hunninghake, Gary W.			Respiratory Syncytial Virus Limits alpha Subunit of Eukaryotic Translation Initiation Factor 2 (eIF alpha) Phosphorylation to Maintain Translation and Viral Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE PKR; AIRWAY EPITHELIAL-CELLS; PHOSPHATASE 2A; HEPATITIS-C; CATALYTIC SUBUNIT; GLYCOPROTEIN-G; KAPPA-B; ACTIVATION; RNA; EXPRESSION	The impact of respiratory syncytial virus (RSV) on morbidity and mortality is significant in that it causes bronchiolitis in infants, exacerbations in patients with obstructive lung disease, and pneumonia in immunocompromised hosts. RSV activates protein kinase R (PKR), a cellular kinase relevant to limiting viral replication (Groskreutz, D. J., Monick, M. M., Powers, L. S., Yarovinsky, T. O., Look, D. C., and Hunninghake, G. W. (2006) J. Immunol. 176, 1733-1740). It is activated by autophosphorylation, likely triggered by a double-stranded RNA intermediate during replication of the virus. In most instances, ph-PKR targets the alpha subunit of eukaryotic translation initiation factor 2 (eIF2 alpha) protein via phosphorylation, leading to an inhibition of translation of cellular and viral protein. However, we found that although ph-PKR increases in RSV infection, significant eIF2 alpha phosphorylation is not observed, and inhibition of protein translation does not occur. RSV infection attenuates eIF2 alpha phosphorylation by favoring phosphatase rather than kinase activity. Although PKR is activated, RSV sequesters PKR away from eIF2 alpha by binding of the kinase to the RSV N protein. This occurs in conjunction with an increase in the association of the phosphatase, PP2A, with eIF2 alpha following PKR activation. The result is limited phosphorylation of eIF2 alpha and continued translation of cellular and viral proteins.	[Groskreutz, Dayna J.; Babor, Ellen C.; Monick, Martha M.; Hunninghake, Gary W.] Univ Iowa, Div Pulm Crit Care & Occupat Med, Roy J & Lucille Carver Coll Med, Iowa City, IA 52242 USA; [Groskreutz, Dayna J.; Hunninghake, Gary W.] Univ Iowa, Inst Clin & Translat Sci, Roy J & Lucille Carver Coll Med, Iowa City, IA 52242 USA; [Varga, Steven M.] Univ Iowa, Dept Microbiol, Roy J & Lucille Carver Coll Med, Iowa City, IA 52242 USA; [Varga, Steven M.] Univ Iowa, Interdisciplinary Grad Program Immunol, Roy J & Lucille Carver Coll Med, Iowa City, IA 52242 USA; Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Groskreutz, DJ (corresponding author), Univ Iowa, Div Pulm Crit Care & Occupat Med, Roy J & Lucille Carver Coll Med, 100 EMRB, Iowa City, IA 52242 USA.	dayna-groskreutz@uiowa.edu	Varga, Steven/C-2009-2009	Varga, Steven/0000-0001-7332-4290	National Institutes of Health [HL089392-02, HL073967-01, HL077431-01, HL075559-04, R01 HL079901-01A1, AI 063520]; General Clinical Research Centers [RR00059]; NCRR [UL1RR024979]; Veterans Affairs; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979, M01RR000059] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077431, R01HL096625, R01HL079901, K08HL089392, R01HL073967, R01HL075559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); General Clinical Research Centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants HL089392-02, HL073967-01, HL077431-01, HL075559-04, R01 HL079901-01A1, AI 063520, and RR00059 from the General Clinical Research Centers Program and Grant UL1RR024979 from the NCRR. This work was also supported by a Veterans Affairs Merit Review grant.	Aldallal N, 2002, AM J RESP CRIT CARE, V166, P1248, DOI 10.1164/rccm.200206-627OC; Arroyo JD, 2005, ONCOGENE, V24, P7746, DOI 10.1038/sj.onc.1209038; Azevedo A M N, 2003, Allergol Immunopathol (Madr), V31, P311, DOI 10.1157/13055209; BALL LA, 1986, P NATL ACAD SCI USA, V83, P246, DOI 10.1073/pnas.83.2.246; Bernsmeier C, 2008, J HEPATOL, V49, P429, DOI 10.1016/j.jhep.2008.04.007; Bitko V, 1997, VIROLOGY, V232, P369, DOI 10.1006/viro.1997.8582; Budt M, 2009, J VIROL, V83, P1260, DOI 10.1128/JVI.01558-08; CAMPBELL KS, 1995, J VIROL, V69, P3721, DOI 10.1128/JVI.69.6.3721-3728.1995; Chang KS, 2006, J VIROL, V80, P7364, DOI 10.1128/JVI.00586-06; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Cheng GF, 2003, J VIROL, V77, P10154, DOI 10.1128/JVI.77.18.10154-10161.2003; CHERRIE AH, 1992, J VIROL, V66, P2102, DOI 10.1128/JVI.66.4.2102-2110.1992; Christen V, 2007, HEPATOLOGY, V46, P558, DOI 10.1002/hep.21611; COLLINS PL, 2001, FIELDS VIROLOGY, P1443; Dar AC, 2002, MOL CELL, V10, P295, DOI 10.1016/S1097-2765(02)00590-7; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Duong FHT, 2005, J VIROL, V79, P15342, DOI 10.1128/JVI.79.24.15342-15350.2005; Eigen H, 1999, J PEDIATR-US, V135, pS1; Elde NC, 2009, NATURE, V457, P485, DOI 10.1038/nature07529; Eriksson M, 2000, PEDIAT ALLERG IMM-UK, V11, P193, DOI 10.1034/j.1399-3038.2000.00076.x; Garcia-Bonilla L, 2007, J NEUROCHEM, V103, P1368, DOI 10.1111/j.1471-4159.2007.04844.x; Garofalo R, 1996, J VIROL, V70, P8773, DOI 10.1128/JVI.70.12.8773-8781.1996; Garofalo R, 1996, J IMMUNOL, V157, P2506; Georgopoulou U, 2006, BIOCHIMIE, V88, P651, DOI 10.1016/j.biochi.2005.12.003; Groskreutz DJ, 2007, J IMMUNOL, V179, P2741, DOI 10.4049/jimmunol.179.5.2741; Groskreutz DJ, 2006, J IMMUNOL, V176, P1733, DOI 10.4049/jimmunol.176.3.1733; Haeberle HA, 2002, J INFECT DIS, V186, P1199, DOI 10.1086/344644; Hakki M, 2008, VIROLOGY, V380, P255, DOI 10.1016/j.virol.2008.07.028; Harris J, 2003, CELL MICROBIOL, V5, P671, DOI 10.1046/j.1462-5822.2003.00313.x; Jammi NV, 2001, NUCLEIC ACIDS RES, V29, P3020; Johnson TR, 1998, J VIROL, V72, P2871, DOI 10.1128/JVI.72.4.2871-2880.1998; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Kang JI, 2009, VIRUS RES, V142, P51, DOI 10.1016/j.virusres.2009.01.007; Kimball S R, 2001, Prog Mol Subcell Biol, V26, P155; Lemen Richard J., 1995, Acta Paediatrica Sinica, V36, P78; Mastronarde JG, 1996, J INFECT DIS, V174, P262, DOI 10.1093/infdis/174.2.262; Monick MM, 2006, J IMMUNOL, V177, P1636, DOI 10.4049/jimmunol.177.3.1636; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Parker LM, 2001, J BIOL CHEM, V276, P32522, DOI 10.1074/jbc.M104408200; PETRYSHYN R, 1982, P NATL ACAD SCI-BIOL, V79, P6512, DOI 10.1073/pnas.79.21.6512; Poppers J, 2000, J VIROL, V74, P11215, DOI 10.1128/JVI.74.23.11215-11221.2000; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Rivera J, 2007, J VIROL, V81, P2923, DOI 10.1128/JVI.02077-06; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sadler AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000311; Sawicki DL, 2003, J VIROL, V77, P1801, DOI 10.1128/JVI.77.3.1801-1811.2003; Schneider RJ, 2003, TRENDS BIOCHEM SCI, V28, P130, DOI 10.1016/S0968-0004(03)00029-X; Sharp TV, 1997, EUR J BIOCHEM, V250, P85, DOI 10.1111/j.1432-1033.1997.00085.x; SIGURS N, 1995, PEDIATRICS, V95, P500; Smyth RL, 1999, LANCET, V354, P1997, DOI 10.1016/S0140-6736(05)76769-6; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; SZYSZKA R, 1989, J BIOL CHEM, V264, P3827; Tan SL, 2002, J BIOL CHEM, V277, P36109, DOI 10.1074/jbc.M205109200; Toth AM, 2009, J VIROL, V83, P961, DOI 10.1128/JVI.01669-08; Tung HYL, 1997, FEBS LETT, V401, P197, DOI 10.1016/S0014-5793(96)01470-6; WERTZ GW, 1987, J VIROL, V61, P293, DOI 10.1128/JVI.61.2.293-301.1987; Xu Z, 2000, MOL CELL BIOL, V20, P5285, DOI 10.1128/MCB.20.14.5285-5299.2000; Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07	58	36	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24023	24031		10.1074/jbc.M109.077321	http://dx.doi.org/10.1074/jbc.M109.077321			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20519500	Green Published, hybrid			2022-12-27	WOS:000280291400053
J	Suzuki, Y; Ogawa, K; Koyanagi, Y; Suzuki, Y				Suzuki, Yasutsugu; Ogawa, Kanako; Koyanagi, Yoshio; Suzuki, Youichi			Functional Disruption of the Moloney Murine Leukemia Virus Preintegration Complex by Vaccinia-related Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TO-AUTOINTEGRATION FACTOR; HUMAN VACCINIA-RELATED-KINASE-1 VRK1; CELL-CYCLE PROGRESSION; HIV TYPE-1 INTEGRATION; NUCLEAR-ENVELOPE; RETROVIRAL DNA; IN-VITRO; BINDING-SITE; PROTEIN; BARRIER	Retroviral integration is executed by the preintegration complex (PIC), which contains viral DNA together with a number of proteins. Barrier-to-autointegration factor (BAF), a cellular component of Moloney murine leukemia virus (MMLV) PICs, has been demonstrated to protect viral DNA from autointegration and stimulate the intermolecular integration activity of the PIC by its DNA binding activity. Recent studies reveal that the functions of BAF are regulated by phosphorylation via a family of cellular serine/threonine kinases called vaccinia-related kinases (VRK), and VRK-mediated phosphorylation causes a loss of the DNA binding activity of BAF. These results raise the possibility that BAF phosphorylation may influence the integration activities of the PIC through removal of BAF from viral DNA. In the present study, we report that VRK1 was able to abolish the intermolecular integration activity of MMLV PICs in vitro. This was accompanied by an enhancement of autointegration activity and dissociation of BAF from the PICs. In addition, in vitro phosphorylation of BAF by VRK1 abrogated the activity of BAF in PIC function. Among the VRK family members, VRK1 as well as VRK2, which catalyze hyperphosphorylation of BAF, could abolish PIC function. We also found that treatment of PICs with certain nucleotides such as ATP resulted in the inhibition of the intermolecular integration activity of PICs through the dissociation of BAF. More importantly, the ATP-induced disruption was not observed with the PICs from VRK1 knockdown cells. Our in vitro results therefore suggest the presence of cellular kinases including VRKs that can inactivate the retroviral integration complex via BAF phosphorylation.	[Suzuki, Youichi] Kyoto Univ, Inst Virus Res, Ctr AIDS Res, Lab Viral Pathogenesis,Sakyo Ku, Kyoto 6068507, Japan; Kyoto Univ, Ctr Emerging Virus Res, Lab Host Factors, Kyoto 6068507, Japan; [Suzuki, Yasutsugu] Kyoto Univ, Grad Sch Biostudies, Dept Mammalian Regulatory Network, Kyoto 6068507, Japan	Kyoto University; Kyoto University; Kyoto University	Suzuki, Y (corresponding author), Kyoto Univ, Inst Virus Res, Ctr AIDS Res, Lab Viral Pathogenesis,Sakyo Ku, 53 Shogoin Kawara Cho, Kyoto 6068507, Japan.	ysuzuki@virus.kyoto-u.ac.jp	Suzuki, Yasutsugu/Z-2378-2019	Suzuki, Yasutsugu/0000-0002-8202-3032; Suzuki, Youichi/0000-0003-3554-0755	Ministry of Health, Labor, and Welfare; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Health, Labor, and Welfare and the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Barcia R, 2002, ARCH BIOCHEM BIOPHYS, V399, P1, DOI 10.1006/abbi.2001.2746; Blanco S, 2006, FEBS J, V273, P2487, DOI 10.1111/j.1742-4658.2006.05256.x; Bradley CM, 2005, NAT STRUCT MOL BIOL, V12, P935, DOI 10.1038/nsmb989; BROWN PO, 1989, P NATL ACAD SCI USA, V86, P2525, DOI 10.1073/pnas.86.8.2525; BUSHMAN FD, 1991, P NATL ACAD SCI USA, V88, P1339, DOI 10.1073/pnas.88.4.1339; Chen HM, 2001, MOL CELL BIOL, V21, P6758, DOI 10.1128/MCB.21.20.6758-6767.2001; Chen HM, 1998, P NATL ACAD SCI USA, V95, P15270, DOI 10.1073/pnas.95.26.15270; Dechat T, 2000, J STRUCT BIOL, V129, P335, DOI 10.1006/jsbi.2000.4212; Dorner D, 2006, J CELL BIOL, V173, P83, DOI 10.1083/jcb.200511149; FARNET CM, 1990, P NATL ACAD SCI USA, V87, P4164, DOI 10.1073/pnas.87.11.4164; FARNET CM, 1991, J VIROL, V65, P6942, DOI 10.1128/JVI.65.12.6942-6952.1991; FUJIWARA T, 1988, CELL, V54, P497, DOI 10.1016/0092-8674(88)90071-2; Furukawa K, 1999, J CELL SCI, V112, P2485; Goff SP, 2001, J GENE MED, V3, P517, DOI 10.1002/1521-2254(200111)3:6<517::AID-JGM234>3.0.CO;2-E; Gorjanacz M, 2007, EMBO J, V26, P132, DOI 10.1038/sj.emboj.7601470; Haraguchi T, 2008, J CELL SCI, V121, P2540, DOI 10.1242/jcs.033597; Harris D, 2000, J BIOL CHEM, V275, P39671, DOI 10.1074/jbc.M002626200; Jacque JM, 2006, NATURE, V441, P641, DOI 10.1038/nature04682; Kang TH, 2008, J CELL SCI, V121, P3035, DOI 10.1242/jcs.026757; Kang TH, 2007, MOL CELL BIOL, V27, P8533, DOI 10.1128/MCB.00018-07; Kang TH, 2006, NAT CELL BIOL, V8, P863, DOI 10.1038/ncb1447; Klerkx EPF, 2009, HISTOL HISTOPATHOL, V24, P749, DOI 10.14670/HH-24.749; LEADER DP, 1988, J GEN VIROL, V69, P1441, DOI 10.1099/0022-1317-69-7-1441; LEE MS, 1994, P NATL ACAD SCI USA, V91, P9823, DOI 10.1073/pnas.91.21.9823; Lee MS, 1998, P NATL ACAD SCI USA, V95, P1528, DOI 10.1073/pnas.95.4.1528; Lin CW, 2003, J VIROL, V77, P5030, DOI 10.1128/JVI.77.8.5030-5036.2003; Lopez-Borges S, 2000, ONCOGENE, V19, P3656, DOI 10.1038/sj.onc.1203709; Margalit A, 2005, P NATL ACAD SCI USA, V102, P3290, DOI 10.1073/pnas.0408364102; Margalit A, 2007, TRENDS CELL BIOL, V17, P202, DOI 10.1016/j.tcb.2007.02.004; Nezu J, 1997, GENOMICS, V45, P327, DOI 10.1006/geno.1997.4938; Nichols RJ, 2006, MOL BIOL CELL, V17, P2451, DOI 10.1091/mbc.E05-12-1179; Nichols RJ, 2004, J BIOL CHEM, V279, P7934, DOI 10.1074/jbc.M310813200; Nili E, 2001, J CELL SCI, V114, P3297; Sanz-Garcia M, 2008, MOL CELL PROTEOMICS, V7, P2199, DOI 10.1074/mcp.M700586-MCP200; Scheeff ED, 2009, STRUCTURE, V17, P128, DOI 10.1016/j.str.2008.10.018; Segura-Totten M, 2004, TRENDS CELL BIOL, V14, P261, DOI 10.1016/j.tcb.2004.03.004; Sevilla A, 2004, ONCOGENE, V23, P8950, DOI 10.1038/sj.onc.1208015; Sevilla A, 2004, J BIOL CHEM, V279, P27458, DOI 10.1074/jbc.M401009200; Shun MC, 2007, J VIROL, V81, P166, DOI 10.1128/JVI.01953-06; Suzuki Y, 2004, EMBO J, V23, P4670, DOI 10.1038/sj.emboj.7600452; Suzuki Y, 2002, J VIROL, V76, P12376, DOI 10.1128/JVI.76.23.12376-12380.2002; Suzuki Y, 2007, NAT REV MICROBIOL, V5, P187, DOI 10.1038/nrmicro1579; Valbuena A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001642; Valbuena A, 2007, ARCH BIOCHEM BIOPHYS, V465, P219, DOI 10.1016/j.abb.2007.06.005; Vega FM, 2004, MOL CELL BIOL, V24, P10366, DOI 10.1128/MCB.24.23.10366-10380.2004; Vega FM, 2003, FEBS LETT, V544, P176, DOI 10.1016/S0014-5793(03)00501-5; Vlcek S, 2001, CELL MOL LIFE SCI, V58, P1758, DOI 10.1007/PL00000815; Wiebe MS, 2007, CELL HOST MICROBE, V1, P187, DOI 10.1016/j.chom.2007.03.007; Zelko I, 1998, ARCH BIOCHEM BIOPHYS, V352, P31, DOI 10.1006/abbi.1998.0582; Zheng RL, 2000, P NATL ACAD SCI USA, V97, P8997, DOI 10.1073/pnas.150240197	50	12	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24032	24043		10.1074/jbc.M110.116640	http://dx.doi.org/10.1074/jbc.M110.116640			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20511217	Green Published, hybrid			2022-12-27	WOS:000280291400054
J	Shen, H; Maki, CG				Shen, Hong; Maki, Carl G.			Persistent p21 Expression after Nutlin-3a Removal Is Associated with Senescence-like Arrest in 4N Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC DNA-REPLICATION; CELLULAR SENESCENCE; CDC2 KINASE; IN-VIVO; MDM2; P53; CYCLE; PHOSPHORYLATION; ANTAGONISTS; APOPTOSIS	Nutlin-3a is a preclinical drug that stabilizes p53 by blocking the interaction between p53 and MDM2. In our previous study, Nutlin-3a promoted a tetraploid G(1) arrest in two p53 wild-type cell lines (HCT116 and U2OS), and both cell lines underwent endoreduplication after Nutlin-3a removal. Endoreduplication gave rise to stable tetraploid clones resistant to therapy-induced apoptosis. Prior knowledge of whether cells are susceptible to Nutlin-induced endoreduplication and therapy resistance could help direct Nutlin-3a-based therapies. In the present study, Nutlin-3a promoted a tetraploid G(1) arrest in multiple p53 wildtype cell lines. However, some cell lines underwent endoreduplication to relatively high extents after Nutlin-3a removal whereas other cell lines did not. The resistance to endoreduplication observed in some cell lines was associated with a prolonged 4N arrest after Nutlin-3a removal. Knockdown of either p53 or p21 immediately after Nutlin-3a removal could drive endoreduplication in otherwise resistant 4N cells. Finally, 4N-arrested cells retained persistent p21 expression; expressed senescence-associated beta-galactosidase; displayed an enlarged, flattened phenotype; and underwent a proliferation block that lasted at least 2 weeks after Nutlin-3a removal. These findings demonstrate that transient Nutlin-3a treatment can promote an apparently permanent proliferative block in 4N cells of certain cell lines associated with persistent p21 expression and resistance to endoreduplication.	[Shen, Hong; Maki, Carl G.] Rush Univ, Med Ctr, Dept Anat & Cell Biol, Chicago, IL 60612 USA	Rush University	Maki, CG (corresponding author), Rush Univ, Med Ctr, Dept Anat & Cell Biol, 1750 W Harrison Ave,Jelke Bldg,Rm 1306, Chicago, IL 60612 USA.	Carl_Maki@rush.edu						Badie C, 2000, MOL CELL BIOL, V20, P2358, DOI 10.1128/MCB.20.7.2358-2366.2000; Chang BD, 2000, ONCOGENE, V19, P2165, DOI 10.1038/sj.onc.1203573; Chen JJ, 1996, NUCLEIC ACIDS RES, V24, P1727, DOI 10.1093/nar/24.9.1727; Drakos E, 2009, LEUKEMIA, V23, P2290, DOI 10.1038/leu.2009.180; Efeyan A, 2007, CANCER RES, V67, P7350, DOI 10.1158/0008-5472.CAN-07-0200; Fujita M, 1999, J BIOL CHEM, V274, P25927, DOI 10.1074/jbc.274.36.25927; Fujita M, 1998, J BIOL CHEM, V273, P17095, DOI 10.1074/jbc.273.27.17095; Fujita M, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-22; Ganem NJ, 2007, CELL, V131, P437, DOI 10.1016/j.cell.2007.10.024; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Hasegawa H, 2009, LEUKEMIA, V23, P2090, DOI 10.1038/leu.2009.171; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hendrickson M, 1996, P NATL ACAD SCI USA, V93, P12223, DOI 10.1073/pnas.93.22.12223; Huang BY, 2009, MOL CANCER RES, V7, P1497, DOI 10.1158/1541-7786.MCR-09-0144; Jiang W, 1999, P NATL ACAD SCI USA, V96, P6193, DOI 10.1073/pnas.96.11.6193; Kitagawa M, 2008, ONCOGENE, V27, P5303, DOI 10.1038/onc.2008.164; Kojima K, 2005, BLOOD, V106, P3150, DOI 10.1182/blood-2005-02-0553; Korotchkina LG, 2009, CELL CYCLE, V8, P3777, DOI 10.4161/cc.8.22.10121; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kumamoto K, 2008, CANCER RES, V68, P3193, DOI 10.1158/0008-5472.CAN-07-2780; Lilly MA, 2005, ONCOGENE, V24, P2765, DOI 10.1038/sj.onc.1208610; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Secchiero P, 2006, BLOOD, V107, P4122, DOI 10.1182/blood-2005-11-4465; Shen H, 2008, CANCER RES, V68, P8260, DOI 10.1158/0008-5472.CAN-08-1901; Steelman LS, 2009, CELL CYCLE, V8, P3634, DOI 10.4161/cc.8.22.10165; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Zhao JY, 2000, GENE DEV, V14, P2283, DOI 10.1101/gad.827700; Zou L, 1998, SCIENCE, V280, P593, DOI 10.1126/science.280.5363.593	33	34	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23103	23112		10.1074/jbc.M110.124990	http://dx.doi.org/10.1074/jbc.M110.124990			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20489208	Green Published, hybrid			2022-12-27	WOS:000279999900045
J	Weiner, EM; Robson, S; Marohn, M; Clubb, RT				Weiner, Ethan M.; Robson, Scott; Marohn, Melanie; Clubb, Robert T.			The Sortase A Enzyme That Attaches Proteins to the Cell Wall of Bacillus anthracis Contains an Unusual Active Site Architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; NMR STRUCTURE DETERMINATION; SORTING SIGNAL BINDING; IMIDAZOLIUM ION-PAIR; STAPHYLOCOCCUS-AUREUS; SURFACE-PROTEINS; TRANSPEPTIDASE SRTA; CRYSTAL-STRUCTURES; SUBSTRATE COMPLEX; KINETIC MECHANISM	The pathogen Bacillus anthracis uses the Sortase A (SrtA) enzyme to anchor proteins to its cell wall envelope during vegetative growth. To gain insight into the mechanism of protein attachment to the cell wall in B. anthracis we investigated the structure, backbone dynamics, and function of SrtA. The NMR structure of SrtA has been determined with a backbone coordinate precision of 0.40 +/- 0.07A. SrtA possesses several novel features not previously observed in sortase enzymes including the presence of a structurally ordered amino terminus positioned within the active site and in contact with catalytically essential histidine residue (His126). We propose that this appendage, in combination with a unique flexible active site loop, mediates the recognition of lipid II, the second substrate to which proteins are attached during the anchoring reaction. pKa measurements indicate that His126 is uncharged at physiological pH compatible with the enzyme operating through a "reverse protonation" mechanism. Interestingly, NMR relaxation measurements and the results of a model building study suggest that SrtA recognizes the LPXTG sorting signal through a lock-in-key mechanism in contrast to the prototypical	[Weiner, Ethan M.; Robson, Scott; Marohn, Melanie; Clubb, Robert T.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Clubb, Robert T.] Univ Calif Los Angeles, UCLA DOE Inst Genom & Prote, Los Angeles, CA 90095 USA; [Clubb, Robert T.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clubb, RT (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	rclubb@mbi.ucla.edu		/0000-0002-5800-3672; Robson, Scott/0000-0002-0529-0399	National Institutes of Health [AI52217]; Department of Energy [DE-FC-03-87ER60615]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI52217 and Department of Energy Grant DE-FC-03-87ER60615 (to R. T. C.).	Bentley ML, 2008, J BIOL CHEM, V283, P14762, DOI 10.1074/jbc.M800974200; BRUSCHWEILER R, 1995, SCIENCE, V268, P886, DOI 10.1126/science.7754375; Budzik JM, 2008, J BIOL CHEM, V283, P36676, DOI 10.1074/jbc.M806796200; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; Connolly KM, 2003, J BIOL CHEM, V278, P34061, DOI 10.1074/jbc.M305245200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desvaux M, 2006, FEMS MICROBIOL LETT, V256, P1, DOI 10.1111/j.1574-6968.2006.00122.x; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Frankel BA, 2005, BIOCHEMISTRY-US, V44, P11188, DOI 10.1021/bi050141j; Frankel BA, 2007, BIOCHEMISTRY-US, V46, P7269, DOI 10.1021/bi700448e; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Gaspar AH, 2005, J BACTERIOL, V187, P4646, DOI 10.1128/JB.187.13.4646-4655.2005; Goddard T. D., 2006, SPARKY 3; Grishaev A, 2004, J AM CHEM SOC, V126, P7281, DOI 10.1021/ja0319994; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Huang XY, 2003, BIOCHEMISTRY-US, V42, P11307, DOI 10.1021/bi034391g; Ilangovan U, 2001, P NATL ACAD SCI USA, V98, P6056, DOI 10.1073/pnas.101064198; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; Jung ME, 2005, BIOORG MED CHEM LETT, V15, P5076, DOI 10.1016/j.bmcl.2005.07.073; Keller R., 2004, COMPUTER AIDED RESON, V1; Lee LK, 1997, J BIOMOL NMR, V9, P287, DOI 10.1023/A:1018631009583; Liew CK, 2004, FEBS LETT, V571, P221, DOI 10.1016/j.febslet.2004.06.070; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Manzano C, 2008, STRUCTURE, V16, P1838, DOI 10.1016/j.str.2008.10.007; Maresso AW, 2008, PHARMACOL REV, V60, P128, DOI 10.1124/pr.107.07110; Maresso AW, 2007, J BIOL CHEM, V282, P23129, DOI 10.1074/jbc.M701857200; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Marraffini LA, 2004, J BIOL CHEM, V279, P37763, DOI 10.1074/jbc.M405282200; Marraffini LA, 2007, J BACTERIOL, V189, P6425, DOI 10.1128/JB.00702-07; Marraffini LA, 2006, MOL MICROBIOL, V62, P1402, DOI 10.1111/j.1365-2958.2006.05469.x; Mazmanian SK, 2001, MOL MICROBIOL, V40, P1049, DOI 10.1046/j.1365-2958.2001.02411.x; Naik MT, 2006, J BIOL CHEM, V281, P1817, DOI 10.1074/jbc.M506123200; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Neiers F, 2009, J MOL BIOL, V393, P704, DOI 10.1016/j.jmb.2009.08.058; Palmer III A. G., 1995, PROTEIN NMR SPECTROS; Paterson GK, 2004, TRENDS MICROBIOL, V12, P89, DOI 10.1016/j.tim.2003.12.007; Race PR, 2009, J BIOL CHEM, V284, P6924, DOI 10.1074/jbc.M805406200; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Suree N, 2007, MINI-REV MED CHEM, V7, P991, DOI 10.2174/138955707782110097; Suree N, 2009, BIOORGAN MED CHEM, V17, P7174, DOI 10.1016/j.bmc.2009.08.067; Suree N, 2009, J BIOL CHEM, V284, P24465, DOI 10.1074/jbc.M109.022624; Teng Q., 2005, STRUCTURAL BIOL PRAC; Ton-That H, 2004, BBA-MOL CELL RES, V1694, P269, DOI 10.1016/j.bbamcr.2004.04.014; Ton-That H, 2000, J BIOL CHEM, V275, P9876, DOI 10.1074/jbc.275.13.9876; Ton-That H, 2002, J BIOL CHEM, V277, P7447, DOI 10.1074/jbc.M109945200; Villareal VA, 2008, J BIOL CHEM, V283, P31591, DOI 10.1074/jbc.M801126200; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Zhang RG, 2004, STRUCTURE, V12, P1147, DOI 10.1016/j.str.2004.06.001; Zink SD, 2005, INFECT IMMUN, V73, P5222, DOI 10.1128/IAI.73.8.5222-5228.2005; Zong YN, 2004, J BIOL CHEM, V279, P31383, DOI 10.1074/jbc.M401374200; Zong YN, 2004, STRUCTURE, V12, P105, DOI 10.1016/j.str.2003.11.021	55	48	49	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23431	23441		10.1074/jbc.M110.135434	http://dx.doi.org/10.1074/jbc.M110.135434			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20489200	hybrid, Green Published			2022-12-27	WOS:000279999900075
J	Mirza, S; Chen, JL; Wen, B; Ewens, CL; Dai, J; Murphy, JM; Young, IG				Mirza, Shamaruh; Chen, Jinglong; Wen, Bin; Ewens, Cameron L.; Dai, Jin; Murphy, James M.; Young, Ian G.			Two Modes of beta-Receptor Recognition Are Mediated by Distinct Epitopes on Mouse and Human Interleukin-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; HUMAN GM-CSF; COMPLETE EXTRACELLULAR DOMAIN; HIGH-AFFINITY BINDING; IL-5 RECEPTORS; ALPHA-CHAIN; EXPRESSION CLONING; LIGAND-BINDING; SUBUNIT; ACTIVATION	The cytokine interleukin-3 (IL-3) is a critical regulator of inflammation and immune responses in mammals. IL-3 exerts its effects on target cells via receptors comprising an IL-3-specific alpha-subunit and common beta-subunit (beta c; shared with IL-5 and granulocyte-macrophage colony-stimulating factor) or a beta-subunit that specifically binds IL-3 (beta(IL-3); present in mice but not humans). We recently identified two splice variants of the alpha-subunit of the IL-3 receptor (IL-3R alpha) that are relevant to hematopoietic progenitor cell differentiation or proliferation: the full length ("SP1" isoform) and a novel isoform (denoted "SP2") lacking the N-terminal Ig-like domain. Although our studies demonstrated that each mouse IL-3 (mIL-3) R alpha isoform can direct mIL-3 binding to two distinct sites on the beta(IL-3) sub-unit, it has remained unclear which residues in mIL-3 itself are critical to the two modes of beta(IL-3) recognition and whether the human IL-3R alpha SP1 and SP2 orthologs similarly instruct human IL-3 binding to two distinct sites on the human beta c subunit. Herein, we describe the identification of residues clustering around the highly conserved A-helix residue, Glu(23), in the mIL-3 A- and C-helices as critical for receptor binding and growth stimulation via the beta(IL-3) and mIL-3R alpha SP2 subunits, whereas an overlapping cluster was required for binding and activation of beta(IL-3) in the presence of mIL-3R alpha SP1. Similarly, our studies of human IL-3 indicate that two different modes of beta c binding are utilized in the presence of the hIL-3R alpha SP1 or SP2 isoforms, suggesting a possible conserved mechanism by which the relative orientations of receptor subunits are modulated to achieve distinct signaling outcomes.	[Murphy, James M.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Mirza, Shamaruh; Chen, Jinglong; Wen, Bin; Ewens, Cameron L.; Dai, Jin; Young, Ian G.] Australian Natl Univ, John Curtin Sch Med Res, Dept Biol Struct, Canberra, ACT 0200, Australia	Walter & Eliza Hall Institute; Australian National University; John Curtin School of Medical Research	Murphy, JM (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia.	jamesm@wehi.edu.au; Ian.Young@anu.edu.au	Murphy, James/B-4863-2017	Murphy, James/0000-0003-0195-3949	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the National Health and Medical Research Council of Australia.	Bagley CJ, 1996, J BIOL CHEM, V271, P31922, DOI 10.1074/jbc.271.50.31922; BARRY SC, 1994, J BIOL CHEM, V269, P8488; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; Carr PD, 2001, CELL, V104, P291, DOI 10.1016/S0092-8674(01)00213-6; Chen JL, 2009, J BIOL CHEM, V284, P5763, DOI 10.1074/jbc.M808197200; CORNELIS S, 1995, EMBO J, V14, P3395, DOI 10.1002/j.1460-2075.1995.tb07345.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GEARING DP, 1989, EMBO J, V8, P3667, DOI 10.1002/j.1460-2075.1989.tb08541.x; GRABER P, 1995, J BIOL CHEM, V270, P15762, DOI 10.1074/jbc.270.26.15762; Gustin SE, 2001, EUR J BIOCHEM, V268, P2905, DOI 10.1046/j.1432-1327.2001.02178.x; Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053; HARA T, 1992, EMBO J, V11, P1875, DOI 10.1002/j.1460-2075.1992.tb05239.x; HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655; ITOH N, 1990, SCIENCE, V247, P324, DOI 10.1126/science.2404337; KITAMURA T, 1991, CELL, V66, P1165, DOI 10.1016/0092-8674(91)90039-2; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; LOPEZ AF, 1992, EMBO J, V11, P909, DOI 10.1002/j.1460-2075.1992.tb05129.x; Martinez-Moczygemba M, 2007, J LEUKOCYTE BIOL, V81, P1137, DOI 10.1189/jlb.0706465; MCPHERSON GA, 1985, J PHARMACOL METHOD, V14, P213, DOI 10.1016/0160-5402(85)90034-8; Mirza S, 2010, BIOCHEM J, V426, P307, DOI 10.1042/BJ20091745; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Murphy JM, 2008, CYTOKINE, V42, P234, DOI 10.1016/j.cyto.2008.02.010; Murphy JM, 2010, GROWTH FACTORS, V28, P104, DOI 10.3109/08977190903443048; Murphy JM, 2004, J BIOL CHEM, V279, P26500, DOI 10.1074/jbc.M402705200; Murphy JM, 2003, J BIOL CHEM, V278, P10572, DOI 10.1074/jbc.M211664200; OLINS PO, 1995, J BIOL CHEM, V270, P23754, DOI 10.1074/jbc.270.40.23754; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; QUELLE FW, 1994, MOL CELL BIOL, V14, P4335, DOI 10.1128/MCB.14.7.4335; Robin C, 2006, DEV CELL, V11, P171, DOI 10.1016/j.devcel.2006.07.002; SAKAMAKI K, 1992, EMBO J, V11, P3541, DOI 10.1002/j.1460-2075.1992.tb05437.x; Seubert N, 2003, MOL CELL, V12, P1239, DOI 10.1016/S1097-2765(03)00389-7; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; TAKAKI S, 1993, J EXP MED, V177, P1523, DOI 10.1084/jem.177.6.1523; TAVERNIER J, 1991, CELL, V66, P1175, DOI 10.1016/0092-8674(91)90040-6; TAVERNIER J, 1995, P NATL ACAD SCI USA, V92, P5194, DOI 10.1073/pnas.92.11.5194; Vollmer P, 1999, EUR J BIOCHEM, V263, P438, DOI 10.1046/j.1432-1327.1999.00511.x; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; WOODCOCK JM, 1994, EMBO J, V13, P5176, DOI 10.1002/j.1460-2075.1994.tb06848.x; Woodcock JM, 1996, J BIOL CHEM, V271, P25999, DOI 10.1074/jbc.271.42.25999; Yao SG, 2010, BIOMOL NMR ASSIGN, V4, P73, DOI 10.1007/s12104-010-9213-1; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737	41	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22370	22381		10.1074/jbc.M110.117465	http://dx.doi.org/10.1074/jbc.M110.117465			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20472554	Green Published, hybrid			2022-12-27	WOS:000279702200050
J	Nguyen, TT; Ogbi, M; Yu, QL; Fishman, JB; Thomas, W; Harvey, BJ; Fulton, D; Johnson, JA				Nguyen, Tiffany T.; Ogbi, Mourad; Yu, Qilin; Fishman, Jordan B.; Thomas, Warren; Harvey, Brian J.; Fulton, David; Johnson, John A.			Modulation of the Protein Kinase C delta Interaction with the "d" Subunit of F1F0-ATP Synthase in Neonatal Cardiac Myocytes DEVELOPMENT OF CELL-PERMEABLE, MITOCHONDRIALLY TARGETED INHIBITOR AND FACILITATOR PEPTIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENERGY-METABOLISM; IN-VIVO; INTRACELLULAR RECEPTOR; EPSILON INTERACTS; OXIDASE ACTIVITY; HEART; PKC; REPERFUSION; ISCHEMIA; DOMAIN	The F1F0-ATP synthase provides similar to 90% of cardiac ATP, yet little is known regarding its regulation under normal or pathological conditions. Previously, we demonstrated that protein kinase C delta(PKC delta) inhibits F1F0 activity via an interaction with the "d" subunit of F1F0-ATP synthase (dF(1)F(0)) in neonatal cardiac myocytes (NCMs) (Nguyen, T., Ogbi, M., and Johnson, J.A. (2008) J. Biol. Chem. 283, 29831-29840). We have now identified a dF(1)F(0)-derived peptide (NH2-(2)AGRKLALKTIDWVSF(16-)COOH) that inhibits PKC delta binding to dF(1)F(0) in overlay assays. We have also identified a second dF(1)F(0)-derived peptide (NH2-(111)RVREYEKQLEKIKNMI(126)-COOH) that facilitates PKC delta binding to dF(1)F(0). Incubation of NCMs with versions of these peptides containing HIV-Tat protein transduction and mammalian mitochondrial targeting sequences resulted in their delivery into mitochondria. Preincubation of NCMs, with 10 nM extracellular concentrations of the mitochondrially targeted PKC delta-dF(1)F(0) interaction inhibitor, decreased 100 nM 4 beta-phorbol 12-myristate 13-acetate (4 beta-PMA)-induced co-immuno-precipitation of PKC delta with dF(1)F(0) by 50 +/- 15% and abolished the 30 nM 4 beta-PMA-induced inhibition of F1F0-ATPase activity. A scrambled sequence (inactive) peptide, which contained HIV-Tat and mitochondrial targeting sequences, was without effect. In contrast, the cell-permeable, mitochondrially targeted PKC delta-dF(1)F(0) facilitator peptide by itself induced the PKC delta-dF(1)F(0) co-immunoprecipitation and inhibited F1F0-ATPase activity. In in vitro PKC add-back experiments, the PKC delta-F1F0 inhibitor blocked PKC delta-mediated inhibition of F1F0-ATPase activity, whereas the facilitator induced inhibition. We have developed the first cell-permeable, mitochondrially targeted modulators of the PKC delta-dF(1)F(0) interaction in NCMs. These novel peptides will improve our understanding of cardiac F1F0 regulation and may have potential as therapeutics to attenuate cardiac injury.	[Nguyen, Tiffany T.; Ogbi, Mourad; Yu, Qilin; Fulton, David; Johnson, John A.] Med Coll Georgia, Sch Med, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Nguyen, Tiffany T.; Ogbi, Mourad; Yu, Qilin; Fulton, David; Johnson, John A.] Med Coll Georgia, Program Regenerat Med, Inst Mol Med & Genet, Augusta, GA 30912 USA; [Fulton, David] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA; [Fishman, Jordan B.] 21st Century Biochem Inc, Marlborough, MA 01752 USA; [Thomas, Warren; Harvey, Brian J.] Beaumont Hosp, Royal Coll Surg Ireland, Dept Mol Med, Dublin 9, Ireland	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Royal College of Surgeons - Ireland	Johnson, JA (corresponding author), 1459 Laney Walker Blvd, Augusta, GA 30912 USA.	jjohnson@mail.mcg.edu	Thomas, Warren/A-5477-2010; Harvey, Brian J/A-5120-2010; Harvey, Brian/AAJ-4085-2020	Harvey, Brian J/0000-0002-7388-8034; Harvey, Brian/0000-0002-7388-8034; Thomas, Warren/0000-0003-2706-1770	NHLBI, National Institutes of Health [R01HL76805]; American Heart Association [GSE0855285E, PRE2060572]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076805] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL76805 from NHLBI. This work was also supported by The American Heart Association Grant GSE0855285E ( to J.A.J.) and American Heart Association Greater Southeast Affiliate Predoctoral Fellowship PRE2060572 ( to T.T.N.).	Baines CP, 2003, CIRC RES, V92, P873, DOI 10.1161/01.RES.0000069215.36389.8D; Buchanan SK, 1996, BIOCHEM J, V318, P343, DOI 10.1042/bj3180343; Carbajo RJ, 2005, J MOL BIOL, V351, P824, DOI 10.1016/j.jmb.2005.06.012; Chauhan A, 2007, J CONTROL RELEASE, V117, P148, DOI 10.1016/j.jconrel.2006.10.031; Chen L, 2001, CHEM BIOL, V8, P1123, DOI 10.1016/S1074-5521(01)00076-X; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; Churchill EN, 2005, CIRC RES, V97, P78, DOI 10.1161/01.RES.0000173896.32522.6e; Churchill EN, 2009, TRENDS ENDOCRIN MET, V20, P25, DOI 10.1016/j.tem.2008.10.002; Das AM, 2003, MOL GENET METAB, V79, P71, DOI 10.1016/S1096-7192(03)00069-6; Di Pancrazio F, 2004, BBA-BIOENERGETICS, V1659, P52, DOI 10.1016/j.bbabio.2004.07.009; Gaballo A, 2002, CURR PROTEIN PEPT SC, V3, P451, DOI 10.2174/1389203023380558; Gray MO, 1997, J BIOL CHEM, V272, P30945, DOI 10.1074/jbc.272.49.30945; Green DW, 2000, BBA-BIOENERGETICS, V1458, P343, DOI 10.1016/S0005-2728(00)00085-2; Guo DH, 2007, AM J PHYSIOL-HEART C, V293, pH2219, DOI 10.1152/ajpheart.01306.2006; Gustafsson AB, 2004, J BIOL CHEM, V279, P21233, DOI 10.1074/jbc.M400695200; HARRIS DA, 1991, BIOCHEM J, V280, P561, DOI 10.1042/bj2800561; Inagaki K, 2003, CIRCULATION, V108, P2304, DOI 10.1161/01.CIR.0000101682.24138.36; Inagaki K, 2003, CIRCULATION, V108, P869, DOI 10.1161/01.CIR.0000081943.93653.73; Johnson JA, 1996, CIRC RES, V79, P1086, DOI 10.1161/01.RES.79.6.1086; Johnson JA, 1996, J BIOL CHEM, V271, P24962, DOI 10.1074/jbc.271.40.24962; JOHNSON JA, 1995, CIRC RES, V76, P654, DOI 10.1161/01.RES.76.4.654; LEMIRE BD, 1989, J BIOL CHEM, V264, P20206; Liang BT, 1997, AM J PHYSIOL-HEART C, V273, pH847, DOI 10.1152/ajpheart.1997.273.2.H847; Malhotra A, 2005, AM J PHYSIOL-HEART C, V289, pH1343, DOI 10.1152/ajpheart.01200.2004; Mangat R, 2006, AM J PHYSIOL-HEART C, V291, pH854, DOI 10.1152/ajpheart.01205.2005; Mayr M, 2004, AM J PHYSIOL-HEART C, V287, pH946, DOI 10.1152/ajpheart.00878.2003; Mayr M, 2004, AM J PHYSIOL-HEART C, V287, pH937, DOI 10.1152/ajpheart.00877.2003; Mochly-Rosen D, 2000, CIRC RES, V86, P1173; MOCHLYROSEN D, 1991, P NATL ACAD SCI USA, V88, P3997, DOI 10.1073/pnas.88.9.3997; MOCHLYROSEN D, 1987, J BIOL CHEM, V262, P2291; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Murriel CL, 2004, J BIOL CHEM, V279, P47985, DOI 10.1074/jbc.M405071200; Murriel CL, 2003, ARCH BIOCHEM BIOPHYS, V420, P246, DOI 10.1016/j.abb.2003.08.038; Neubauer S, 1999, J MOL CELL CARDIOL, V31, P1845, DOI 10.1006/jmcc.1999.1016; NGUYEN T, 2007, CURR ENZ INHIB, V3, P143; Nguyen T, 2008, J BIOL CHEM, V283, P29831, DOI 10.1074/jbc.M801642200; Ogbi M, 2006, BIOCHEM J, V393, P191, DOI 10.1042/BJ20050757; Omura T, 1998, J BIOCHEM-TOKYO, V123, P1010; Roe MT, 2008, CIRCULATION, V117, P886, DOI 10.1161/CIRCULATIONAHA.107.759167; RON D, 1995, P NATL ACAD SCI USA, V92, P492, DOI 10.1073/pnas.92.2.492; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Schechtman D, 2002, METHOD ENZYMOL, V345, P470; Schechtman Deborah, 2003, Methods Mol Biol, V233, P345; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Solaini G, 2005, BIOCHEM J, V390, P377, DOI 10.1042/BJ20042006; Takeo S, 1999, CARDIOVASC RES, V43, P32, DOI 10.1016/S0008-6363(99)00079-6; Ventura-Clapier R, 2004, J PHYSIOL-LONDON, V555, P1, DOI 10.1113/jphysiol.2003.055095; Vogt AM, 2005, MOL CELL BIOCHEM, V278, P223, DOI 10.1007/s11010-005-7576-x; VUORINEN K, 1995, CIRCULATION, V91, P2810, DOI 10.1161/01.CIR.91.11.2810; Walker JE, 2006, BBA-BIOENERGETICS, V1757, P286, DOI 10.1016/j.bbabio.2006.01.001; Wang YG, 2001, CIRCULATION, V104, P85, DOI 10.1161/01.CIR.104.1.85; Ylitalo K, 2001, BBA-BIOENERGETICS, V1504, P329, DOI 10.1016/S0005-2728(00)00261-9; Zanotti F, 2004, J BIOENERG BIOMEMBR, V36, P447, DOI 10.1023/B:JOBB.0000047327.68173.9b	53	10	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22164	22173		10.1074/jbc.M109.077578	http://dx.doi.org/10.1074/jbc.M109.077578			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20460381	Green Published, hybrid			2022-12-27	WOS:000279702200029
J	Sanggaard, KW; Scavenius, C; Rasmussen, AJ; Wisniewski, HG; Thgersen, IB; Enghild, JJ				Sanggaard, Kristian W.; Scavenius, Carsten; Rasmussen, Anna Julie; Wisniewski, Hans-Georg; Thgersen, Ida B.; Enghild, Jan J.			The TSG-6/HC2-mediated Transfer Is a Dynamic Process Shuffling Heavy Chains between Glycosaminoglycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTER-ALPHA-INHIBITOR; HYALURONAN-BINDING PROTEINS; COVALENTLY CROSS-LINKS; TRYPSIN-INHIBITOR; EXTRACELLULAR-MATRIX; STIMULATED GENE-6; BIKUNIN PROTEINS; TSG-6; ARTHRITIS; COMPLEX	The heavy chain (HC) subunits of the bikunin proteins are covalently attached to a single chondroitin sulfate (CS) chain originating from bikunin and can be transferred to different hyaluronan (HA) molecules by TSG-6/HC2. In the present study, we demonstrate that HCs transferred to HA may function as HC donors in subsequent transfer reactions, and we show that the CS of bikunin may serve as an HC acceptor, analogous to HA. Our data suggest that TSG-6/HC2 link HCs randomly on the CS chain of bikunin, in contrast to the ordered attachment observed during the biosynthesis. Moreover, the results show that the transfer activity is indifferent to the new HC position, and the relocated HCs are thus prone to further TSG-6/HC2 induced transfer reactions. The data suggest that HCs may be transferred directly from HA to HA without the involvement of the bikunin CS chain. The results demonstrate reversibility of the interactions between HCs and glycosaminoglycans and suggest that a dynamic shuffling of the HCs occur in vivo.	[Sanggaard, Kristian W.; Scavenius, Carsten; Rasmussen, Anna Julie; Thgersen, Ida B.; Enghild, Jan J.] Aarhus Univ, Ctr Insoluble Prot Struct inSPIN, DK-8000 Aarhus C, Denmark; [Sanggaard, Kristian W.; Scavenius, Carsten; Rasmussen, Anna Julie; Thgersen, Ida B.; Enghild, Jan J.] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Dept Mol Biol, DK-8000 Aarhus C, Denmark; [Wisniewski, Hans-Georg] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	Aarhus University; Aarhus University; New York University	Enghild, JJ (corresponding author), Aarhus Univ, Ctr Insoluble Prot Struct inSPIN, Gustav Wiedsvej 10C, DK-8000 Aarhus C, Denmark.	jje@mb.au.dk	Scavenius, Carsten/Q-5941-2017	Scavenius, Carsten/0000-0002-4304-0681; Enghild, Jan Johannes/0000-0001-9292-9172	Carlsberg Foundation; Danish Council for Independent Research, Medical Science	Carlsberg Foundation(Carlsberg Foundation); Danish Council for Independent Research, Medical Science(Det Frie Forskningsrad (DFF))	This work was supported by grants from The Carlsberg Foundation and grants from the Danish Council for Independent Research, Medical Science.	AKO H, 1972, BIOCHEM BIOPH RES CO, V47, P1402, DOI 10.1016/0006-291X(72)90228-8; Bardos T, 2001, AM J PATHOL, V159, P1711, DOI 10.1016/S0002-9440(10)63018-0; BURY AF, 1981, J CHROMATOGR, V213, P491, DOI 10.1016/S0021-9673(00)80500-2; Chi LL, 2008, J AM CHEM SOC, V130, P2617, DOI 10.1021/ja0778500; Colon E, 2009, J BIOL CHEM, V284, P2320, DOI 10.1074/jbc.M807183200; Day AJ, 1999, BIOCHEM SOC T, V27, P115, DOI 10.1042/bst0270115; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; ENGHILD JJ, 1991, J BIOL CHEM, V266, P747; ENGHILD JJ, 1993, J BIOL CHEM, V268, P8711; ENGHILD JJ, 1989, J BIOL CHEM, V264, P15975; Enghild JJ, 1999, BIOCHEMISTRY-US, V38, P11804, DOI 10.1021/bi9908540; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; GEBHARD W, 1990, BIOL CHEM H-S, V371, P13; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Milner CM, 2007, BIOCHEM SOC T, V35, P672, DOI 10.1042/BST0350672; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Mindrescu C, 2000, ARTHRITIS RHEUM, V43, P2668, DOI 10.1002/1529-0131(200012)43:12<2668::AID-ANR6>3.0.CO;2-E; MORELLE W, 1994, EUR J BIOCHEM, V221, P881, DOI 10.1111/j.1432-1033.1994.tb18803.x; Mukhopadhyay D, 2004, J BIOL CHEM, V279, P11119, DOI 10.1074/jbc.M313471200; Ochsner SA, 2003, ENDOCRINOLOGY, V144, P4376, DOI 10.1210/en.2003-0487; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Sanggaard KW, 2008, J BIOL CHEM, V283, P18530, DOI 10.1074/jbc.M800874200; Sanggaard KW, 2006, BIOCHEMISTRY-US, V45, P7661, DOI 10.1021/bi060106s; Sanggaard KW, 2008, J BIOL CHEM, V283, P33919, DOI 10.1074/jbc.M804240200; Sanggaard KW, 2005, J BIOL CHEM, V280, P11936, DOI 10.1074/jbc.M409016200; SAYERS CA, 1980, BIOCHEM J, V189, P255, DOI 10.1042/bj1890255; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; THOGERSEN IB, 1995, J BIOL CHEM, V270, P18700; WISNIEWSKI HG, 1993, J IMMUNOL, V151, P6593; WISNIEWSKI HG, 1994, BIOCHEMISTRY-US, V33, P7423, DOI 10.1021/bi00189a049; Zhuo LS, 2004, J BIOL CHEM, V279, P38079, DOI 10.1074/jbc.R300039200; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	37	16	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					21988	21993		10.1074/jbc.M109.041046	http://dx.doi.org/10.1074/jbc.M109.041046			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20463016	hybrid, Green Published			2022-12-27	WOS:000279702200011
J	Kaspar, JW; Jaiswal, AK				Kaspar, James W.; Jaiswal, Anil K.			An Autoregulatory Loop between Nrf2 and Cul3-Rbx1 Controls Their Cellular Abundance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIOXIDANT RESPONSE ELEMENT; UBIQUITIN-PROTEASOME PATHWAY; TRANSCRIPTION FACTOR NRF2; GENE-EXPRESSION; OXIDOREDUCTASE-1 GENE; MEDIATED EXPRESSION; NUCLEAR IMPORT; ACTIVATION; DEGRADATION; PROTEIN	The INrf2 (Keap1)/Cul3-Rbx1 complex constantly degrades Nrf2 under normal conditions. When a cell encounters oxidative or electrophilic stress, Nrf2 dissociates from the INrf2/Cul3-Rbx1 complex and translocates into the nucleus. In the nucleus, Nrf2 activates a myriad of antioxidant and defensive genes that protect cells. Nrf2 is then exported out of the nucleus and degraded. INrf2 serves as a substrate adaptor to link Nrf2 to Cul3 and Rbx1. Cul3 and Rbx1 make up the ubiquitin ligase complex that is responsible for the ubiquitination and degradation of Nrf2. Previously we have shown a feedback autoregulatory loop between Nrf2 and INrf2 indicating that Nrf2 regulates INrf2 by controlling its transcription. Here we are extending this research by demonstrating the presence of another feedback autoregulatory loop between Cul3-Rbx1 and Nrf2. Experiments using Hepa-1 and HepG2 cells indicate that Nrf2 controls its own degradation by regulating expression and induction of Cul3-Rbx1 genes. Treatment with the antioxidant tert-Butylhydroquinone (t-BHQ) leads to induction of Cul3-Rbx1 genes. Mutagenesis and transfection experiments identified an antioxidant response element in the forward and reverse strands of the proximal Cul3 and Rbx1 promoters, respectively, that Nrf2 binds and regulates expression and antioxidant induction of the Cul3-Rbx1 genes. In addition, short interfering RNA inhibition and overexpression of Nrf2 led to a respective decrease and increase in Cul3-Rbx1 gene expression. The increase in Cul3-Rbx1 leads to ubiquitination and degradation of Nrf2. These data suggest that Nrf2 regulates Cul3-Rbx1 by controlling regulation of expression and induction of Cul3-Rbx1. The induction of Cul3-Rbx1 control Nrf2 by increasing degradation.	[Kaspar, James W.; Jaiswal, Anil K.] Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Jaiswal, AK (corresponding author), Univ Maryland, Sch Med, Dept Pharmacol, 655 W Baltimore St, Baltimore, MD 21201 USA.	ajaiswal@som.umaryland.edu			National Institutes of Health [R01 ES012265]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012265] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 ES012265.	Banning A, 2005, MOL CELL BIOL, V25, P4914, DOI 10.1128/MCB.25.12.4914-4923.2005; Bauer CE, 1999, ANNU REV MICROBIOL, V53, P495, DOI 10.1146/annurev.micro.53.1.495; Bloom DA, 2003, J BIOL CHEM, V278, P44675, DOI 10.1074/jbc.M307633200; BREEN AP, 1995, FREE RADICAL BIO MED, V18, P1033, DOI 10.1016/0891-5849(94)00209-3; Copple IM, 2008, TOXICOLOGY, V246, P24, DOI 10.1016/j.tox.2007.10.029; Dhakshinamoorthy S, 2001, ONCOGENE, V20, P3906, DOI 10.1038/sj.onc.1204506; Dhakshinamoorthy S, 2000, CURR TOP CELL REGUL, V36, P201; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Ikeda H, 2004, BIOCHEM J, V380, P515, DOI 10.1042/BJ20031948; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Jain AK, 2006, J BIOL CHEM, V281, P12132, DOI 10.1074/jbc.M511198200; Jain AK, 2005, J BIOL CHEM, V280, P29158, DOI 10.1074/jbc.M502083200; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; Kim YJ, 2007, CANCER RES, V67, P546, DOI 10.1158/0008-5472.CAN-06-2401; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Maher JM, 2007, HEPATOLOGY, V46, P1597, DOI 10.1002/hep.21831; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; MOHLER J, 1991, MECH DEVELOP, V34, P3, DOI 10.1016/0925-4773(91)90086-L; Nguyen T, 2003, J BIOL CHEM, V278, P4536, DOI 10.1074/jbc.M207293200; Niture SK, 2009, J BIOL CHEM, V284, P13856, DOI 10.1074/jbc.M808084200; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; RUSHMORE TH, 1990, J BIOL CHEM, V265, P14648; Sekhar KR, 2002, ONCOGENE, V21, P6829, DOI 10.1038/sj.onc.1205905; Stewart D, 2003, J BIOL CHEM, V278, P2396, DOI 10.1074/jbc.M209195200; THELEN M, 1993, PHYSIOL REV, V73, P797, DOI 10.1152/physrev.1993.73.4.797; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Wang W, 2006, FREE RADICAL BIO MED, V40, P1119, DOI 10.1016/j.freeradbiomed.2005.10.063; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974	34	48	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21349	21358		10.1074/jbc.M110.121863	http://dx.doi.org/10.1074/jbc.M110.121863			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20452971	hybrid, Green Published			2022-12-27	WOS:000279516100020
J	Lee, YS; Johnson, KA; Molineux, IJ; Yin, YW				Lee, Young-Sam; Johnson, Kenneth A.; Molineux, Ian J.; Yin, Y. Whitney			A Single Mutation in Human Mitochondrial DNA Polymerase Pol gamma A Affects Both Polymerization and Proofreading Activities of Only the Holoenzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACCESSORY SUBUNIT; KLENOW FRAGMENT; EXPRESSION; REPLISOME; EXPLORER	Common causes of human mitochondrial diseases are mutations affecting DNA polymerase (Pol) gamma, the sole polymerase responsible for DNA synthesis in mitochondria. Although the polymerase and exonuclease active sites are located on the catalytic subunit Pol gamma A, in holoenzyme both activities are regulated by the accessory subunit Pol gamma B. Several patients with severe neurological and muscular disorders were reported to carry the Pol gamma A substitutions R232G or R232H, which lie outside of either active site. We report that Arg(232) substitutions have no effect on independent Pol gamma A activities but show major defects in the Pol gamma A-Pol gamma B holoenzyme, including decreased polymerase and increased exonuclease activities, the latter with decreased selectivity for mismatches. We show that Pol gamma B facilitates distinguishing mismatched from base-paired primer termini and that Pol gamma A Arg(232) is essential for mediating this regulatory function of the accessory subunit. This study provides a molecular basis for the disease symptoms exhibited by patients carrying those substitutions.	[Lee, Young-Sam; Johnson, Kenneth A.; Molineux, Ian J.; Yin, Y. Whitney] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Molineux, Ian J.] Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Johnson, Kenneth A.; Yin, Y. Whitney] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Yin, YW (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	whitney.yin@mail.utexas.edu			National Institutes of Health [GM044613, GM032095, GM083703]; Welch Foundation [F-1592]; KinTek Corporation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044613, R01GM032095, R01GM083703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); KinTek Corporation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM044613 (to K. A. J.), GM032095 (to I. J. M.), and GM083703 (to Y. W. Y.). This work was also supported by Welch Foundation Grant F-1592 (to Y. W. Y.). Financial conflict of interest: K. A. J. is President of KinTek Corporation, which provided the RQF-3 rapid quench flow instrument and the KinTek Explorer data fitting software used in this study.	Bailey MF, 2004, J MOL BIOL, V336, P673, DOI 10.1016/j.jmb.2003.11.023; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; BEESE LS, 1993, SCIENCE, V260, P352, DOI 10.1126/science.8469987; Carrodeguas JA, 1999, MOL CELL BIOL, V19, P4039; Chinnery Patrick F, 2008, Neuromuscul Disord, V18, P259, DOI 10.1016/j.nmd.2007.11.005; Farge G, 2007, NUCLEIC ACIDS RES, V35, P902, DOI 10.1093/nar/gkl1116; Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410; FREEMONT PS, 1988, P NATL ACAD SCI USA, V85, P8924, DOI 10.1073/pnas.85.23.8924; Graves SW, 1998, BIOCHEMISTRY-US, V37, P6050, DOI 10.1021/bi972685u; Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805; GUPTA AP, 1984, NUCLEIC ACIDS RES, V12, P5897, DOI 10.1093/nar/12.14.5897; Harrower T, 2008, ARCH NEUROL-CHICAGO, V65, P133, DOI 10.1001/archneurol.2007.4; Jazayeri M, 2003, J BIOL CHEM, V278, P9823, DOI 10.1074/jbc.M211730200; Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w; Johnson AA, 2001, J BIOL CHEM, V276, P38097; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e; Lee YS, 2010, J BIOL CHEM, V285, P1490, DOI 10.1074/jbc.M109.062752; Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050; Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; Taanman JW, 2009, NEUROMUSCULAR DISORD, V19, P151, DOI 10.1016/j.nmd.2008.11.002; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd	26	23	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28105	28116		10.1074/jbc.M110.122283	http://dx.doi.org/10.1074/jbc.M110.122283			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	739TZ	20513922	Green Published, hybrid			2022-12-27	WOS:000288742300009
J	Brown, HJ; Peng, L; Harada, JN; Walker, JR; Cole, S; Lin, SF; Zack, JA; Chanda, SK; Sun, R				Brown, Helen J.; Peng, Li; Harada, Josephine N.; Walker, John R.; Cole, Steven; Lin, Su-Fang; Zack, Jerome A.; Chanda, Sumit K.; Sun, Ren			Gene Expression and Transcription Factor Profiling Reveal Inhibition of Transcription Factor cAMP-response Element-binding Protein by gamma-Herpesvirus Replication and Transcription Activator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; EPSTEIN-BARR-VIRUS; READING FRAME 50; RTA PROMOTES DEGRADATION; LYTIC SWITCH PROTEIN; DNA-BINDING; ENDOTHELIAL-CELLS; CYCLIC-AMP; CREB; REACTIVATION	Herpesvirus replication involves the expression of over 80 viral genes in a well ordered sequence, leading to the production of new virions. Viral genes expressed during the earliest phases of replication often regulate both viral and cellular genes. Therefore, they have the potential to bring about dramatic functional changes within the cell. Replication and transcription activator (RTA) is a potent immediate early transcription activator of the gamma-herpesvirus family. This family includes Epstein-Barr virus and Kaposi sarcoma-associated herpesvirus, human pathogens associated with malignancy. Here we combine gene array technology with transcription factor profiling to identify the earliest DNA promoter and cellular transcription factor targets of RTA in the cellular genome. We find that expression of RTA leads to both activation and inhibition of distinct groups of cellular genes. The identity of the target genes suggests that RTA rapidly changes the cellular environment to counteract cell death pathways, support growth factor signaling, and also promote immune evasion of the infected cell. Transcription factor profiling of the target gene promoters highlighted distinct pathways involved in gene activation at specific time points. Most notable throughout was the high level of cAMP-response element-binding protein (CREB)-response elements in RTA target genes. We find that RTA can function as either an activator or an inhibitor of CREB-response genes, depending on the promoter context. The association with CREB also highlights a novel connection and coordination between viral and cellular "immediate early" responses.	[Brown, Helen J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; [Peng, Li; Sun, Ren] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Cole, Steven; Zack, Jerome A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Harada, Josephine N.; Walker, John R.; Chanda, Sumit K.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Lin, Su-Fang] Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan Town 350, Miaoli County, Taiwan	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Novartis; National Health Research Institutes - Taiwan	Brown, HJ (corresponding author), BSRB 173,615 Charles Young Dr S, Los Angeles, CA 90095 USA.	hjbrown@mednet.ucla.edu	Lin, Su-Fang/B-2666-2010	Lin, Su-Fang/0000-0001-8706-2439	National Institutes of Health [CA091791, CA127042, DE019085, AI070010]; NATIONAL CANCER INSTITUTE [R01CA091791, R21CA127042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [P01DE019085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA091791, CA127042, DE019085, and AI070010.	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; ALBRECHT JC, 1992, J VIROL, V66, P3937, DOI 10.1128/JVI.66.6.3937-3940.1992; Benedict CA, 2002, NAT IMMUNOL, V3, P1013, DOI 10.1038/ni1102-1013; Brown HJ, 2003, J VIROL, V77, P8532, DOI 10.1128/JVI.77.15.8532-8540.2003; BURKE AP, 1990, MODERN PATHOL, V3, P377; Carroll KD, 2007, J VIROL, V81, P8451, DOI 10.1128/JVI.00265-07; Carter KL, 2002, J VIROL, V76, P10427, DOI 10.1128/JVI.76.20.10427-10436.2002; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; Cha-Molstad H, 2004, P NATL ACAD SCI USA, V101, P13572, DOI 10.1073/pnas.0405587101; Chang H, 2005, J VIROL, V79, P4651, DOI 10.1128/JVI.79.8.4651-4663.2005; Chang M, 2005, J VIROL, V79, P13538, DOI 10.1128/JVI.79.21.13538-13547.2005; Chang PJ, 2008, J VIROL, V82, P9700, DOI 10.1128/JVI.00862-08; Chang PJ, 2002, J VIROL, V76, P3168, DOI 10.1128/JVI.76.7.3168-3178.2002; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Cohen A, 2006, J GEN VIROL, V87, P795, DOI 10.1099/vir.0.81619-0; Cole SW, 2003, BIOINFORMATICS, V19, P1808, DOI 10.1093/bioinformatics/btg242; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Deng HY, 2002, J VIROL, V76, P8252, DOI 10.1128/JVI.76.16.8252-8264.2002; Deutsch E, 2004, J VIROL, V78, P10187, DOI 10.1128/JVI.78.18.10187-10192.2004; Du KY, 2000, MOL CELL BIOL, V20, P4320, DOI 10.1128/MCB.20.12.4320-4327.2000; Foreman KE, 1997, NEW ENGL J MED, V336, P163, DOI 10.1056/NEJM199701163360302; Fujimuro M, 2003, NAT MED, V9, P300, DOI 10.1038/nm829; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; Gould F, 2009, J VIROL, V83, P6727, DOI 10.1128/JVI.00351-09; Gwack Y, 2003, MOL CELL BIOL, V23, P2055, DOI 10.1128/MCB.23.6.2055-2067.2003; Gwack Y, 2002, J BIOL CHEM, V277, P6438, DOI 10.1074/jbc.M108289200; Gwack Y, 2001, J VIROL, V75, P1909, DOI 10.1128/JVI.75.4.1909-1917.2001; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; Hottiger MO, 2000, TRENDS MICROBIOL, V8, P560, DOI 10.1016/S0966-842X(00)01874-6; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; JANSEN E, 1995, J BIOL CHEM, V270, P15391, DOI 10.1074/jbc.270.25.15391; Jansen E, 1997, J BIOL CHEM, V272, P2500; Kim S, 2006, J BIOL CHEM, V281, P14066, DOI 10.1074/jbc.M602696200; Liang YY, 2002, GENE DEV, V16, P1977, DOI 10.1101/gad.996502; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Lukac DM, 1998, VIROLOGY, V252, P304, DOI 10.1006/viro.1998.9486; Lukac DM, 2001, J VIROL, V75, P6786, DOI 10.1128/JVI.75.15.6786-6799.2001; Lukac DM, 1999, J VIROL, V73, P9348, DOI 10.1128/JVI.73.11.9348-9361.1999; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; MEDOF ME, 1984, J EXP MED, V160, P1558, DOI 10.1084/jem.160.5.1558; MERI S, 1990, IMMUNOLOGY, V71, P1; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; Naranatt PP, 2004, CANCER RES, V64, P72, DOI 10.1158/0008-5472.CAN-03-2767; Naranatt PP, 2003, J VIROL, V77, P1524, DOI 10.1128/JVI.77.2.1524-1539.2003; Pan HY, 2006, J VIROL, V80, P5371, DOI 10.1128/JVI.02299-05; Peng L, 2010, J GEN VIROL, V91, P463, DOI 10.1099/vir.0.015073-0; Poole LJ, 2002, J VIROL, V76, P3395, DOI 10.1128/JVI.76.7.3395-3420.2002; Qian LW, 2007, J VIROL, V81, P7001, DOI 10.1128/JVI.00016-07; Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776; Renne R, 1998, J VIROL, V72, P5182, DOI 10.1128/JVI.72.6.5182-5188.1998; RICKINSON AB, 2001, FIELDS VIROLOGY, P2817; ROLLINS SA, 1990, J IMMUNOL, V144, P3478; ROTHER RP, 1994, J VIROL, V68, P730, DOI 10.1128/JVI.68.2.730-737.1994; Sakakibara S, 2001, J VIROL, V75, P6894, DOI 10.1128/JVI.75.15.6894-6900.2001; Shepherd EG, 2004, J BIOL CHEM, V279, P54023, DOI 10.1074/jbc.M408444200; SHIBATA D, 1992, AM J PATHOL, V140, P769; SHIBATA D, 1991, AM J PATHOL, V139, P469; Song MJ, 2001, J VIROL, V75, P3129, DOI 10.1128/JVI.75.7.3129-3140.2001; Spiller OB, 2003, J BIOL CHEM, V278, P9283, DOI 10.1074/jbc.M211579200; Spiller OB, 1997, J INFECT DIS, V176, P339, DOI 10.1086/514050; Staudt MR, 2007, CURR TOP MICROBIOL, V312, P71; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; Suzuki Y, 2002, NUCLEIC ACIDS RES, V30, P328, DOI 10.1093/nar/30.1.328; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Wang SS, 2010, VIROLOGY, V397, P311, DOI 10.1016/j.virol.2009.11.031; Wang SZE, 2003, J VIROL, V77, P9590, DOI 10.1128/JVI.77.17.9590-9612.2003; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yang ZL, 2008, J VIROL, V82, P3590, DOI 10.1128/JVI.02229-07; Ye JJ, 2005, J VIROL, V79, P1397, DOI 10.1128/JVI.79.3.1397-1408.2005; Yu FQ, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030044; Yu YX, 2005, IMMUNITY, V22, P59, DOI 10.1016/j.immuni.2004.11.011; Zhang J, 2005, J VIROL, V79, P5640, DOI 10.1128/JVI.79.9.5640-5652.2005; Zhang L, 1998, DNA CELL BIOL, V17, P735; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	75	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25139	25153		10.1074/jbc.M110.137737	http://dx.doi.org/10.1074/jbc.M110.137737			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20516076	Green Published, hybrid			2022-12-27	WOS:000280682400006
J	Ambrosi, C; Gassmann, O; Pranskevich, JN; Boassa, D; Smock, A; Wang, JJ; Dahl, G; Steinem, C; Sosinsky, GE				Ambrosi, Cinzia; Gassmann, Oliver; Pranskevich, Jennifer N.; Boassa, Daniela; Smock, Amy; Wang, Junjie; Dahl, Gerhard; Steinem, Claudia; Sosinsky, Gina E.			Pannexin1 and Pannexin2 Channels Show Quaternary Similarities to Connexons and Different Oligomerization Numbers from Each Other	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE PREDICTION; GAP-JUNCTION PROTEINS; FAMILY; MEMBRANE; INFLAMMASOME; HEXAMER; REVEALS; RELEASE; NEURONS	Pannexins are homologous to innexins, the invertebrate gap junction family. However, mammalian pannexin1 does not form canonical gap junctions, instead forming hexameric oligomers in single plasma membranes and intracellularly. Pannexin1 acts as an ATP release channel, whereas less is known about the function of Pannexin2. We purified cellular membranes isolated from MDCK cells stably expressing rat Pannexin1 or Pannexin2 and identified pannexin channels (pannexons) in single membranes by negative stain and immunogold labeling. Protein gel and Western blot analysis confirmed Pannexin1 (Panx1) or Pannexin2 (Panx2) as the channel-forming proteins. We expressed and purified Panx1 and Panx2 using a baculovirus Sf9 expression system and obtained doughnut-like structures similar to those seen previously in purified connexin hemichannels (connexons) and mammalian membranes. Purified pannexons were comparable in size and overall appearance to Connexin46 and Connexin50 connexons. Pannexons and connexons were further analyzed by single-particle averaging for oligomer and pore diameters. The oligomer diameter increased with increasing monomer molecular mass, and we found that the measured oligomeric pore diameter for Panxs was larger than for Connexin26. Panx1 and Panx2 formed active homomeric channels in Xenopus oocytes and in vitro vesicle assays. Crosslinking and native gels of purified homomeric full-length and a C-terminal Panx2 truncation mutant showed a banding pattern more consistent with an octamer. We purified Panx1/Panx2 heteromeric channels and found that they were unstable over time, possibly because Panx1 and Panx2 homomeric pannexons have different monomer sizes and oligomeric symmetry from each other.	[Sosinsky, Gina E.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, Sch Med, La Jolla, CA 92093 USA; [Sosinsky, Gina E.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Gassmann, Oliver; Steinem, Claudia] Univ Gottingen, Inst Organ & Biomol Chem, D-37077 Gottingen, Germany; [Wang, Junjie; Dahl, Gerhard] Univ Miami, Dept Physiol & Biophys, Sch Med, Miami, FL 33136 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Gottingen; University of Miami	Sosinsky, GE (corresponding author), Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, Sch Med, BSB 1070,9500 Gilman Dr,MC 0608, La Jolla, CA 92093 USA.	gsosinsky@ucsd.edu	Steinem, Claudia/K-7534-2018; Steinem, Claudia/O-4801-2019	Steinem, Claudia/0000-0001-8778-9283	National Institutes of Health [GM072881, GM065937, GM048610, RR04050]; National Science Foundation [MCB0543934]; European Union; Bundesministerium fur Bildung und Forschung [13N9110]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065937, R01GM072881, R01GM048610] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); European Union(European Commission); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM072881 and GM065937 (to G. E. S.) and GM048610 (to G. D.). This work was also supported by National Science Foundation Grant MCB0543934 (to G. E. S.) and the European Union within the framework of the Marie Curie Training Network 019335 Translocation (to C. S.) and by Bundesministerium fur Bildung und Forschung Grant 13N9110 (to C. S.). Most of this work was conducted at the National Center for Microscopy and Imaging Research at San Diego, which is supported by National Institutes of Health Grant RR04050.	Ambrosi C, 2010, BIOPHYS J, V98, P1809, DOI 10.1016/j.bpj.2010.01.019; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Boassa D, 2008, CELL COMMUN ADHES, V15, P119, DOI 10.1080/15419060802013885; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Bunse S, 2009, FEBS J, V276, P6258, DOI 10.1111/j.1742-4658.2009.07334.x; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; D'hondt C, 2009, BIOESSAYS, V31, P953, DOI 10.1002/bies.200800236; DAHL G, 1992, BIOPHYS J, V62, P172, DOI 10.1016/S0006-3495(92)81803-9; Dahl G, 2006, IUBMB LIFE, V58, P409, DOI 10.1080/15216540600794526; DIEZ JA, 1996, HDB NONMEDICAL APPL, P261; Garnier J, 1996, METHOD ENZYMOL, V266, P540; GOODEN M, 1985, BIOCHEM BIOPH RES CO, V128, P993, DOI 10.1016/0006-291X(85)90145-7; Hand GM, 2002, J MOL BIOL, V315, P587, DOI 10.1006/jmbi.2001.5262; Huang Y, 2007, GLIA, V55, P46, DOI 10.1002/glia.20435; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Jiang H, 2007, BRIT J PHARMACOL, V151, P1033, DOI 10.1038/sj.bjp.0707311; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; KNELLER DG, 1990, J MOL BIOL, V214, P171, DOI 10.1016/0022-2836(90)90154-E; Li XL, 2008, J BIOL CHEM, V283, P5748, DOI 10.1074/jbc.M709288200; Locke D, 2004, J BIOL CHEM, V279, P22883, DOI 10.1074/jbc.M401980200; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; MacVicar BA, 2010, TRENDS NEUROSCI, V33, P93, DOI 10.1016/j.tins.2009.11.007; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Oshima A, 2003, J BIOL CHEM, V278, P1807, DOI 10.1074/jbc.M207713200; Oshima A, 2007, P NATL ACAD SCI USA, V104, P10034, DOI 10.1073/pnas.0703704104; Panchin Y, 2000, CURR BIOL, V10, pR473, DOI 10.1016/S0960-9822(00)00576-5; Panchin YV, 2005, J EXP BIOL, V208, P1415, DOI 10.1242/jeb.01547; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; Prochnow N, 2009, NEUROSCIENCE, V162, P1039, DOI 10.1016/j.neuroscience.2009.04.064; Ramundo-Orlando A, 2005, BBA-BIOMEMBRANES, V1668, P33, DOI 10.1016/j.bbamem.2004.11.003; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Southworth DR, 2008, MOL CELL, V32, P631, DOI 10.1016/j.molcel.2008.10.024; Stebbings LA, 2000, MOL BIOL CELL, V11, P2459, DOI 10.1091/mbc.11.7.2459; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Verselis VK, 2002, CURR DRUG TARGETS, V3, P483, DOI 10.2174/1389450023347272; Wang JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1112, DOI 10.1152/ajpcell.00097.2007; Zappala A, 2007, NEUROSCIENCE, V148, P653, DOI 10.1016/j.neuroscience.2007.06.028	45	124	124	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24420	24431		10.1074/jbc.M110.115444	http://dx.doi.org/10.1074/jbc.M110.115444			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20516070	Green Published, hybrid			2022-12-27	WOS:000280542100014
J	Drury, JE; Mindnich, R; Penning, TM				Drury, Jason E.; Mindnich, Rebekka; Penning, Trevor M.			Characterization of Disease-related 5 beta-Reductase (AKR1D1) Mutations Reveals Their Potential to Cause Bile Acid Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDO-KETO REDUCTASE; HUMAN DELTA(4)-3-OXOSTEROID 5-BETA-REDUCTASE; 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE; CRYSTAL-STRUCTURE; GENE ANALYSIS; SRD5B1 AKR1D1; SUPERFAMILY; METABOLISM; RECEPTOR; BINDING	Bile acid deficiency is a serious syndrome in newborns that can result in death if untreated. 5 beta-Reductase deficiency is one form of bile acid deficiency and is characterized by dramatically decreased levels of physiologically active 5 beta-reduced bile acids. AKR1D1 (aldo-keto reductase 1D1) is the only known human enzyme that stereo-specifically reduces the Delta(4) double bond in 3-keto steroids and sterols to yield the 5 beta-hydrogenated product. Analysis of the AKR1D1 gene in five patients with 5 beta-reductase deficiency revealed five different mutations resulting in an amino acid substitution in the protein. To investigate a causal role for these observed point mutations in AKR1D1 in 5 beta-reductase deficiency, we characterized their effect on enzymatic properties. Attempts to purify mutant enzymes by overexpression in Escherichia coli only yielded sufficient amounts of the P133R mutant for further characterization. This enzyme displayed a highly reduced K-m and V-max reminiscent of uncompetitive kinetics with 4-cholesten-7 alpha-ol-3-one as substrate. In addition, this mutant displayed no change in cofactor affinity but was more thermolabile in the absence of NADPH as judged by CD spectroscopy. All mutants were compared following expression in HEK 293 cells. Although these enzymes were equally expressed based on mRNA levels, protein expression and functional activity were dramatically reduced. Cycloheximide treatment also revealed that several of the expressed mutants were less stable. Our findings show that the reported mutations in AKR1D1 in patients with 5 beta-reductase lead to significantly decreased levels of active enzyme and could be causal in the development of bile acid deficiency syndrome.	[Drury, Jason E.; Mindnich, Rebekka; Penning, Trevor M.] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Penning, Trevor M.] Univ Penn, Sch Med, Ctr Excellence Environm Toxicol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Penning, TM (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, 130C John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.	penning@upenn.edu			National Institutes of Health [R01-DK47015, P30 ES013508]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK47015 and P30 ES013508 (to T. M. P.).	Bertilsson G, 1998, P NATL ACAD SCI USA, V95, P12208, DOI 10.1073/pnas.95.21.12208; CLAYTON PT, 1988, LANCET, V1, P1283; DESLYPERE JP, 1992, MOL CELL ENDOCRINOL, V88, P15, DOI 10.1016/0303-7207(92)90004-P; Di Costanzo L, 2008, J BIOL CHEM, V283, P16830, DOI 10.1074/jbc.M801778200; Faucher F, 2008, BIOCHEMISTRY-US, V47, P8261, DOI 10.1021/bi800572s; Gonzales E, 2004, J HEPATOL, V40, P716, DOI 10.1016/j.jhep.2003.12.024; ICHIMIYA H, 1991, J LIPID RES, V32, P829; Inoue T, 1997, ARCH DIS CHILD-FETAL, V77, pF52, DOI 10.1136/fn.77.1.F52; Jez JM, 1998, BIOCHEMISTRY-US, V37, P9695, DOI 10.1021/bi980294p; Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625; Jin Y, 2001, BIOCHEMISTRY-US, V40, P10161, DOI 10.1021/bi010919a; Jin Y, 2006, BIOCHEMISTRY-US, V45, P13054, DOI 10.1021/bi060591r; Kimura A, 1998, EUR J PEDIATR, V157, P386, DOI 10.1007/s004310050835; Komoto J, 2004, BIOCHEMISTRY-US, V43, P2188, DOI 10.1021/bi036046x; KONDO KH, 1994, EUR J BIOCHEM, V219, P357, DOI 10.1111/j.1432-1033.1994.tb19947.x; Lemonde HA, 2003, GUT, V52, P1494, DOI 10.1136/gut.52.10.1494; Moore LB, 2000, J BIOL CHEM, V275, P15122, DOI 10.1074/jbc.M001215200; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Palermo M, 2008, STEROIDS, V73, P417, DOI 10.1016/j.steroids.2007.12.001; Penning TM, 2000, BIOCHEM J, V351, P67, DOI 10.1042/0264-6021:3510067; Qiu W, 2004, MOL ENDOCRINOL, V18, P1798, DOI 10.1210/me.2004-0032; Ratnam K, 1999, BIOCHEMISTRY-US, V38, P7856, DOI 10.1021/bi982838t; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; RUSSELL DW, 1992, BIOCHEMISTRY-US, V31, P4737, DOI 10.1021/bi00135a001; SETCHELL KDR, 1988, J CLIN INVEST, V82, P2148, DOI 10.1172/JCI113837; Steckelbroeck S, 2004, J BIOL CHEM, V279, P10784, DOI 10.1074/jbc.M313308200; Sumazaki R, 1997, LANCET, V349, P329, DOI 10.1016/S0140-6736(05)62828-0; Ueki I, 2009, J GASTROEN HEPATOL, V24, P776, DOI 10.1111/j.1440-1746.2008.05669.x; Wright AS, 1996, J CLIN INVEST, V98, P2558, DOI 10.1172/JCI119074	29	26	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24529	24537		10.1074/jbc.M110.127779	http://dx.doi.org/10.1074/jbc.M110.127779			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20522910	Green Published, hybrid			2022-12-27	WOS:000280542100025
J	Michelow, IC; Dong, MD; Mungall, BA; Yantosca, LM; Lear, C; Ji, X; Karpel, M; Rootes, CL; Brudner, M; Houen, G; Eisen, DP; Kinane, TB; Takahashi, K; Stahl, GL; Olinger, GG; Spear, GT; Ezekowitz, RAB; Schmidt, EV				Michelow, Ian C.; Dong, Mingdong; Mungall, Bruce A.; Yantosca, L. Michael; Lear, Calli; Ji, Xin; Karpel, Marshall; Rootes, Christina L.; Brudner, Matthew; Houen, Gunnar; Eisen, Damon P.; Kinane, T. Bernard; Takahashi, Kazue; Stahl, Gregory L.; Olinger, Gene G.; Spear, Gregory T.; Ezekowitz, R. Alan B.; Schmidt, Emmett V.			A Novel L-ficolin/Mannose-binding Lectin Chimeric Molecule with Enhanced Activity against Ebola Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATTERN-RECOGNITION MOLECULE; CELL-SURFACE CALRETICULIN; SERINE PROTEASES; OPSONIC ACTIVITY; DEFICIENT MICE; HUMAN PLASMA; L-FICOLIN; PROTEIN; COMPLEMENT; SITE	Ebola viruses constitute a newly emerging public threat because they cause rapidly fatal hemorrhagic fevers for which no treatment exists, and they can be manipulated as bioweapons. We targeted conserved N-glycosylated carbohydrate ligands on viral envelope surfaces using novel immune therapies. Mannose-binding lectin (MBL) and L-ficolin (L-FCN) were selected because they function as opsonins and activate complement. Given that MBL has a complex quaternary structure unsuitable for large scale cost-effective production, we sought to develop a less complex chimeric fusion protein with similar ligand recognition and enhanced effector functions. We tested recombinant human MBL and three L-FCN/MBL variants that contained the MBL carbohydrate recognition domain and varying lengths of the L-FCN collagenous domain. Non-reduced chimeric proteins formed predominantly nona-and dodecameric oligomers, whereas recombinant human MBL formed octadecameric and larger oligomers. Surface plasmon resonance revealed that L-FCN/MBL76 had the highest binding affinities for N-acetylglucosamine-bovine serum albumin and mannan. The same chimeric protein displayed superior complement C4 cleavage and binding to calreticulin (cC1qR), a putative receptor for MBL. L-FCN/MBL76 reduced infection by wild type Ebola virus Zaire significantly greater than the other molecules. Tapping mode atomic force microscopy revealed that L-FCN/MBL76 was significantly less tall than the other molecules despite similar polypeptide lengths. We propose that alterations in the quaternary structure of L-FCN/MBL76 resulted in greater flexibility in the collagenous or neck region. Similarly, a more pliable molecule might enhance cooperativity between the carbohydrate recognition domains and their cognate ligands, complement activation, and calreticulin binding dynamics. L-FCN/MBL chimeric proteins should be considered as potential novel therapeutics.	[Michelow, Ian C.; Brudner, Matthew; Kinane, T. Bernard; Takahashi, Kazue] Harvard Univ, Sch Med, Dept Pediat, Massachusetts Gen Hosp,Program Dev Immunol, Boston, MA 02114 USA; [Dong, Mingdong] Univ Aarhus, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus, Denmark; [Mungall, Bruce A.; Rootes, Christina L.] Commonwealth Sci & Ind Res Org Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic 3220, Australia; [Lear, Calli; Olinger, Gene G.] USA, Med Res Inst Infect Dis, Div Virol, Frederick, MD 21702 USA; [Ji, Xin; Spear, Gregory T.] Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA; [Houen, Gunnar] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark; [Eisen, Damon P.] Royal Melbourne Hosp, Victorian Infect Dis Serv, Parkville, Vic 3050, Australia; [Stahl, Gregory L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Aarhus University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Rush University; Statens Serum Institut; Royal Melbourne Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Michelow, IC (corresponding author), Harvard Univ, Sch Med, Dept Pediat, Massachusetts Gen Hosp,Program Dev Immunol, 55 Fruit St,GRJ 1402, Boston, MA 02114 USA.	imichelow@partners.org	Dong, Mingdong/AAC-3023-2020; Michelow, Ian C./AAH-2373-2020; eisen, damon/AAC-7433-2019; dong, mingdong/AAK-9315-2020; Rootes, Christina/AAS-6972-2021; Rootes, Christina L/H-4905-2013; Dong, Mingdong/B-3341-2010	Dong, Mingdong/0000-0002-2025-2171; Michelow, Ian C./0000-0002-8399-480X; Rootes, Christina/0000-0002-7448-8307; Rootes, Christina L/0000-0002-7448-8307; Dong, Mingdong/0000-0002-2025-2171; Olinger, Gene/0000-0001-7338-0292; Mungall, Bruce/0000-0002-6772-1633; Houen, Gunnar/0000-0002-5948-4156; Eisen, Damon/0000-0002-8987-4358; Stahl, Gregory/0000-0002-4805-8119	National Institutes of Health [U01 AI070330, R01 HL52886, R01 HL56086, R21 HL092469, P50 DE016191]; United States Department of Defense, Defense Threat Reduction Agency [4.10006, 4.10007]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052886, R21HL092469, R01HL056086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI077081, U01AI070330, U01AI074503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE016191] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense, Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants U01 AI070330 (to E. V. S.) and R01 HL52886, R01 HL56086, R21 HL092469, and P50 DE016191 (to G. L. S.). This work was also supported by United States Department of Defense, Defense Threat Reduction Agency Biological Therapeutics Program Grants 4.10006 and 4.10007 (to G. G. O.).	Aljofan M, 2008, J VIROL METHODS, V149, P12, DOI 10.1016/j.jviromet.2008.01.016; Bowden TA, 2008, J VIROL, V82, P11628, DOI 10.1128/JVI.01344-08; Cseh S, 2002, J IMMUNOL, V169, P5735, DOI 10.4049/jimmunol.169.10.5735; Dolnik O, 2008, CELL MOL LIFE SCI, V65, P756, DOI 10.1007/s00018-007-7406-2; Dong MD, 2007, J IMMUNOL, V178, P3016, DOI 10.4049/jimmunol.178.5.3016; EDGAR PF, 1995, FEBS LETT, V375, P159, DOI 10.1016/0014-5793(95)01205-S; EZEKOWITZ R A B, 1991, Current Biology, V1, P60; Girija UV, 2007, J IMMUNOL, V179, P455, DOI 10.4049/jimmunol.179.1.455; Hartshorn KL, 2000, AM J PHYSIOL-LUNG C, V278, pL90, DOI 10.1152/ajplung.2000.278.1.L90; HARUMIYA S, 1995, J BIOCHEM-TOKYO, V117, P1029, DOI 10.1093/oxfordjournals.jbchem.a124802; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; Hummelshoj T, 2007, MOL IMMUNOL, V44, P401, DOI 10.1016/j.molimm.2006.02.023; Hyatt AD, 1996, VIRUS RES, V43, P1, DOI 10.1016/0168-1702(96)01307-X; Jensen PH, 2005, J BIOL CHEM, V280, P11043, DOI 10.1074/jbc.M412472200; Jensenius JC, 2003, BIOCHEM SOC T, V31, P763, DOI 10.1042/BST0310763; Ji X, 2005, J GEN VIROL, V86, P2535, DOI 10.1099/vir.0.81199-0; Juozapaitis M, 2007, VIRUS RES, V124, P95, DOI 10.1016/j.virusres.2006.10.008; Kase T, 1999, IMMUNOLOGY, V97, P385; Kilpatrick DC, 1999, IMMUNOL LETT, V67, P109, DOI 10.1016/S0165-2478(98)00147-3; KONGERSLEV L, 2006, Patent No. 20060188963; Krarup A, 2004, J BIOL CHEM, V279, P47513, DOI 10.1074/jbc.M407161200; Lynch NJ, 2004, J IMMUNOL, V172, P1198, DOI 10.4049/jimmunol.172.2.1198; Matsushita M, 1996, J BIOL CHEM, V271, P2448, DOI 10.1074/jbc.271.5.2448; Matsushita M, 2000, J IMMUNOL, V164, P2281, DOI 10.4049/jimmunol.164.5.2281; Meschi J, 2005, J GEN VIROL, V86, P3097, DOI 10.1099/vir.0.80764-0; MESCHI J, LETHON; Moller-Kristensen M, 2007, J INVEST DERMATOL, V127, P1524, DOI 10.1038/sj.jid.5700748; Montalto MC, 2001, J IMMUNOL, V166, P4148, DOI 10.4049/jimmunol.166.6.4148; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Ohashi T, 2004, J BIOL CHEM, V279, P6534, DOI 10.1074/jbc.M310555200; Pagh R, 2008, FEBS J, V275, P515, DOI 10.1111/j.1742-4658.2007.06218.x; Petersen KA, 2006, J CLIN IMMUNOL, V26, P465, DOI 10.1007/s10875-006-9037-z; Petersen SV, 2001, J IMMUNOL METHODS, V257, P107, DOI 10.1016/S0022-1759(01)00453-7; SHERIFF S, 1994, NAT STRUCT BIOL, V1, P789, DOI 10.1038/nsb1194-789; Shi L, 2004, J EXP MED, V199, P1379, DOI 10.1084/jem.20032207; Shiell BJ, 2003, VIRUS RES, V92, P55, DOI 10.1016/S0168-1702(02)00313-1; Stuart GR, 1997, IMMUNOPHARMACOLOGY, V38, P73, DOI 10.1016/S0162-3109(97)00076-3; Tacken PJ, 2004, J IMMUNOL, V172, P4934, DOI 10.4049/jimmunol.172.8.4934; Takahashi K, 2006, CURR OPIN IMMUNOL, V18, P16, DOI 10.1016/j.coi.2005.11.014; Teillet F, 2007, J IMMUNOL, V178, P5710, DOI 10.4049/jimmunol.178.9.5710; Towner JS, 2005, VIROLOGY, V332, P20, DOI 10.1016/j.virol.2004.10.048; Vorup-Jensen T, 2001, INT IMMUNOPHARMACOL, V1, P677, DOI 10.1016/S1567-5769(00)00052-7; Wainberg MA, 2009, ANTIVIR RES, V81, P1, DOI 10.1016/j.antiviral.2008.09.003; WEIS WI, 1994, STRUCTURE, V2, P1227, DOI 10.1016/S0969-2126(94)00124-3; White MR, 2000, J IMMUNOL, V165, P2108, DOI 10.4049/jimmunol.165.4.2108; White MR, 2001, BIOCHEM BIOPH RES CO, V286, P206, DOI 10.1006/bbrc.2001.5373	47	45	57	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24729	24739		10.1074/jbc.M110.106260	http://dx.doi.org/10.1074/jbc.M110.106260			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20516066	Green Published, hybrid			2022-12-27	WOS:000280542100045
J	Sweeney, TR; Cisnetto, V; Bose, D; Bailey, M; Wilson, JR; Zhang, XD; Belsham, GJ; Curry, S				Sweeney, Trevor R.; Cisnetto, Valentina; Bose, Daniel; Bailey, Matthew; Wilson, Jon R.; Zhang, Xiaodong; Belsham, Graham J.; Curry, Stephen			Foot-and-Mouth Disease Virus 2C Is a Hexameric AAA plus Protein with a Coordinated ATP Hydrolysis Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLIOVIRUS RNA REPLICATION; NEGATIVE-STRAND RNA; LARGE TUMOR-ANTIGEN; NUCLEOSIDE TRIPHOSPHATASE; NONSTRUCTURAL PROTEIN-2C; SECRETORY PATHWAY; DNA-REPLICATION; FUSION PROTEINS; POLYPEPTIDE 2C; BINDING	Foot-and-mouth disease virus (FMDV), a positive sense, single-stranded RNA virus, causes a highly contagious disease in cloven-hoofed livestock. Like other picornaviruses, FMDV has a conserved 2C protein assigned to the superfamily 3 helicases, a group of AAA+ ATPases that has a predicted N-terminal membrane-binding amphipathic helix attached to the main ATPase domain. In infected cells, 2C is involved in the formation of membrane vesicles, where it co-localizes with viral RNA replication complexes, but its precise role in virus replication has not been elucidated. We show here that deletion of the predicted N-terminal amphipathic helix enables overexpression in Escherichia coli of a highly soluble truncated protein, 2C(34-318), that has ATPase and RNA binding activity. ATPase activity was abrogated by point mutations in the Walker A (K116A) and B (D160A) motifs and Motif C (N207A) in the active site. Unliganded 2C(34-318) exhibits concentration-dependent self-association to yield oligomeric forms, the largest of which is tetrameric. Strikingly, in the presence of ATP and RNA, FMDV 2C(34-318) containing the N207A mutation, which binds but does not hydrolyze ATP, was found to oligomerize specifically into hexamers. Visualization of FMDV 2C-ATP-RNA complexes by negative stain electron microscopy revealed hexameric ring structures with 6-fold symmetry that are characteristic of AAA+ ATPases. ATPase assays performed by mixing purified active and inactive 2C(34-318) subunits revealed a coordinated mechanism of ATP hydrolysis. Our results provide new insights into the structure and mechanism of picornavirus 2C proteins that will facilitate new investigations of their roles in infection.	[Sweeney, Trevor R.; Cisnetto, Valentina; Curry, Stephen] Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Biophys Sect, Div Cell & Mol Biol, London SW7 2AZ, England; [Bose, Daniel; Zhang, Xiaodong] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England; [Bailey, Matthew; Wilson, Jon R.] Inst Canc Res, Chester Beatty Labs, London SW3 6JB, England; [Belsham, Graham J.] Tech Univ Denmark, Natl Vet Inst, DK-4771 Lindholm, Denmark	Imperial College London; Imperial College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Technical University of Denmark	Curry, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Biophys Sect, Div Cell & Mol Biol, Prince Consort Rd, London SW7 2AZ, England.	s.curry@imperial.ac.uk	Bose, Daniel/AAI-2775-2020; Belsham, Graham/J-3132-2019; Belsham, Graham J./H-8589-2019; Bailey, Matthew A./AAH-3395-2020; Wilson, Jon R/B-7362-2019	Bose, Daniel/0000-0002-0276-6486; Belsham, Graham/0000-0003-1187-4873; Belsham, Graham J./0000-0003-1187-4873; Bailey, Matthew A./0000-0003-4244-5668; Wilson, Jon R/0000-0002-5157-5432; Zhang, Xiaodong/0000-0001-9786-7038; Cisnetto, Valentina/0000-0002-2642-9345; Curry, Stephen/0000-0002-0552-8870; Sweeney, Trevor/0000-0003-4016-7326	Imperial College; Wellcome Trust [076909]; Cancer Research UK	Imperial College; Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK)	Supported by a faculty studentship from Imperial College.; Supported by the Wellcome Trust (Ref. 076909).; Supported by a grant from Cancer Research UK.	Abbate EA, 2004, GENE DEV, V18, P1981, DOI 10.1101/gad.1220104; Adams P, 2009, J BIOL CHEM, V284, P22012, DOI 10.1074/jbc.M109.031807; Banerjee R, 1997, J VIROL, V71, P9570, DOI 10.1128/JVI.71.12.9570-9578.1997; Banerjee R, 2001, VIROLOGY, V280, P41, DOI 10.1006/viro.2000.0770; Banerjee R, 2001, J GEN VIROL, V82, P2621, DOI 10.1099/0022-1317-82-11-2621; Belsham GJ, 2008, J GEN VIROL, V89, P485, DOI 10.1099/vir.0.83385-0; BIENZ K, 1990, J VIROL, V64, P1156, DOI 10.1128/JVI.64.3.1156-1163.1990; Birtley JR, 2005, ACTA CRYSTALLOGR D, V61, P646, DOI 10.1107/S0907444905007924; Braun P, 2002, P NATL ACAD SCI USA, V99, P2654, DOI 10.1073/pnas.042684199; CHO MW, 1994, VIROLOGY, V202, P129, DOI 10.1006/viro.1994.1329; Costa A, 2006, J STRUCT BIOL, V156, P210, DOI 10.1016/j.jsb.2006.04.001; Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; De Palma AM, 2008, J VIROL, V82, P4720, DOI 10.1128/JVI.01338-07; Dodd DA, 2001, J VIROL, V75, P8158, DOI 10.1128/JVI.75.17.8158-8165.2001; Doedens JR, 1997, J VIROL, V71, P9054, DOI 10.1128/JVI.71.12.9054-9064.1997; DOEDENS JR, 1995, EMBO J, V14, P894, DOI 10.1002/j.1460-2075.1995.tb07071.x; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; Echeverri A, 1998, VIRUS RES, V54, P217, DOI 10.1016/S0168-1702(98)00016-1; Edwards AM, 2000, NAT STRUCT BIOL, V7, P970, DOI 10.1038/80751; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; GORBALENYA AE, 1990, FEBS LETT, V262, P145, DOI 10.1016/0014-5793(90)80175-I; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Hammarstrom M, 2002, PROTEIN SCI, V11, P313, DOI 10.1110/ps.22102; Hickman AB, 2005, CURR OPIN STRUC BIOL, V15, P77, DOI 10.1016/j.sbi.2004.12.001; HOHENWALLNER W, 1973, CLIN CHIM ACTA, V45, P169, DOI 10.1016/0009-8981(73)90406-3; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Klein M, 2000, J GEN VIROL, V81, P2481, DOI 10.1099/0022-1317-81-10-2481; Klein M, 2000, J GEN VIROL, V81, P895, DOI 10.1099/0022-1317-81-4-895; Klein M, 1999, VIRUS RES, V65, P155, DOI 10.1016/S0168-1702(99)00110-0; Kusov YY, 1998, ARCH VIROL, V143, P931, DOI 10.1007/s007050050343; Lee SY, 2003, GENE DEV, V17, P2552, DOI 10.1101/gad.1125603; Li DW, 2003, NATURE, V423, P512, DOI 10.1038/nature01691; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Mason PW, 2003, VIRUS RES, V91, P9, DOI 10.1016/S0168-1702(02)00257-5; MASTRANGELO IA, 1989, NATURE, V338, P658, DOI 10.1038/338658a0; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; MIRZAYAN C, 1994, VIROLOGY, V199, P176, DOI 10.1006/viro.1994.1110; MIRZAYAN C, 1992, VIROLOGY, V189, P547, DOI 10.1016/0042-6822(92)90578-D; Moffat K, 2005, J VIROL, V79, P4382, DOI 10.1128/JVI.79.7.4382-4395.2005; Moffat K, 2007, J VIROL, V81, P1129, DOI 10.1128/JVI.00393-06; Monaghan P, 2004, J GEN VIROL, V85, P933, DOI 10.1099/vir.0.19408-0; Murray L, 2009, VIRUS RES, V144, P74, DOI 10.1016/j.virusres.2009.04.001; Pariente N, 2003, J VIROL, V77, P7131, DOI 10.1128/JVI.77.12.7131-7138.2003; Pfister T, 2000, J VIROL, V74, P334, DOI 10.1128/JVI.74.1.334-343.2000; Pfister T, 1999, J BIOL CHEM, V274, P6992, DOI 10.1074/jbc.274.11.6992; Pfister T, 2001, J VIROL, V75, P1611, DOI 10.1128/JVI.75.4.1611-1619.2001; PINCUS SE, 1986, J VIROL, V57, P638, DOI 10.1128/JVI.57.2.638-646.1986; RODRIGUEZ PL, 1995, J BIOL CHEM, V270, P10105, DOI 10.1074/jbc.270.17.10105; RODRIGUEZ PL, 1993, J BIOL CHEM, V268, P8105; Samuilova O, 2006, J VIROL, V80, P1053, DOI 10.1128/JVI.80.2.1053-1058.2006; Sanz-Parra A, 1998, J GEN VIROL, V79, P433, DOI 10.1099/0022-1317-79-3-433; SAUNDERS K, 1982, J VIROL, V42, P389, DOI 10.1128/JVI.42.2.389-394.1982; Schlegel A, 1996, J VIROL, V70, P6576, DOI 10.1128/JVI.70.10.6576-6588.1996; Schuck S, 2005, MOL CELL, V20, P377, DOI 10.1016/j.molcel.2005.09.020; Schumacher J, 2004, J MOL BIOL, V338, P863, DOI 10.1016/j.jmb.2004.02.071; SEO YS, 1993, P NATL ACAD SCI USA, V90, P702, DOI 10.1073/pnas.90.2.702; Shih YP, 2002, PROTEIN SCI, V11, P1714, DOI 10.1110/ps.0205202; Simpson PJ, 2004, STRUCTURE, V12, P1631, DOI 10.1016/j.str.2004.07.008; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Smyth DR, 2003, PROTEIN SCI, V12, P1313, DOI 10.1110/ps.0243403; Teterina NL, 2006, J VIROL, V80, P5327, DOI 10.1128/JVI.02684-05; Teterina NL, 2006, VIROLOGY, V344, P453, DOI 10.1016/j.virol.2005.08.044; TETERINA NL, 1992, J GEN VIROL, V73, P1977, DOI 10.1099/0022-1317-73-8-1977; TOLSKAYA EA, 1994, J MOL BIOL, V236, P1310, DOI 10.1016/0022-2836(94)90060-4; Toth EA, 2003, MOL CELL, V12, P1113, DOI 10.1016/S1097-2765(03)00442-8; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	71	48	49	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24347	24359		10.1074/jbc.M110.129940	http://dx.doi.org/10.1074/jbc.M110.129940			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20507978	Green Published, hybrid			2022-12-27	WOS:000280542100006
J	Gilio, K; Harper, MT; Cosemans, JMEM; Konopatskaya, O; Munnix, ICA; Prinzen, L; Leitges, M; Liu, QH; Molkentin, JD; Heemskerk, JWM; Poole, AW				Gilio, Karen; Harper, Matthew T.; Cosemans, Judith M. E. M.; Konopatskaya, Olga; Munnix, Imke C. A.; Prinzen, Lenneke; Leitges, Michael; Liu, Qinghang; Molkentin, Jeffery D.; Heemskerk, Johan W. M.; Poole, Alastair W.			Functional Divergence of Platelet Protein Kinase C (PKC) Isoforms in Thrombus Formation on Collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED HUMAN PLATELETS; GLYCOPROTEIN-VI; TYROSINE KINASE; SERINE/THREONINE KINASES; PROCOAGULANT ACTIVITY; FIBRINOGEN RECEPTOR; GRANULE SECRETION; ALPHA-GRANULE; EX-VIVO; THETA	Arterial thrombosis, a major cause of myocardial infarction and stroke, is initiated by activation of blood platelets by subendothelial collagen. The protein kinase C (PKC) family centrally regulates platelet activation, and it is becoming clear that the individual PKC isoforms play distinct roles, some of which oppose each other. Here, for the first time, we address all four of the major platelet-expressed PKC isoforms, determining their comparative roles in regulating platelet adhesion to collagen and their subsequent activation under physiological flow conditions. Using mouse gene knock-out and pharmacological approaches in human platelets, we show that collagen-dependent alpha-granule secretion and thrombus formation are mediated by the conventional PKC isoforms, PKC alpha and PKC beta, whereas the novel isoform, PKC theta, negatively regulates these events. PKC delta also negatively regulates thrombus formation but not alpha-granule secretion. In addition, we demonstrate for the first time that individual PKC isoforms differentially regulate platelet calcium signaling and exposure of phosphatidylserine under flow. Although platelet deficient in PKC alpha or PKC beta showed reduced calcium signaling and phosphatidylserine exposure, these responses were enhanced in the absence of PKC theta. In summary therefore, this direct comparison between individual subtypes of PKC, by standardized methodology under flow conditions, reveals that the four major PKCs expressed in platelets play distinct non-redundant roles, where conventional PKCs promote and novel PKCs inhibit thrombus formation on collagen.	[Heemskerk, Johan W. M.] Maastricht Univ, Dept Biochem, Cardiovasc Res Inst Maastricht, Lab Cellular Thrombosis & Haemostasis, NL-6200 MD Maastricht, Netherlands; [Harper, Matthew T.; Konopatskaya, Olga; Poole, Alastair W.] Univ Bristol, Sch Med Sci, Dept Physiol & Pharmacol, Bristol BS8 1TD, Avon, England; [Leitges, Michael] Univ Oslo, Biotechnol Ctr Oslo, N-0317 Oslo, Norway; [Liu, Qinghang; Molkentin, Jeffery D.] Cincinnati Childrens Hosp, Med Ctr, Dept Mol Cardiovasc Biol, Cincinnati, OH 45229 USA	Maastricht University; University of Bristol; University of Oslo; Cincinnati Children's Hospital Medical Center	Heemskerk, JWM (corresponding author), Maastricht Univ, Dept Biochem, Cardiovasc Res Inst Maastricht, Lab Cellular Thrombosis & Haemostasis, POB 616, NL-6200 MD Maastricht, Netherlands.	jwm.heemskerk@bioch.unimaas.nl; a.poole@bris.ac.uk	Leitges, Michael/AAN-1953-2021; Heemskerk, Johan/AAM-8323-2021; Cosemans, Judith MEM/C-8161-2016; Harper, Matthew T/G-5630-2013	Heemskerk, Johan/0000-0002-2848-5121; Cosemans, Judith MEM/0000-0001-7429-0109; Harper, Matthew T/0000-0002-4740-637X; Leitges, Michael/0000-0003-4203-6995; Poole, Alastair/0000-0002-0868-297X; Molkentin, Jeffery/0000-0002-3558-6529; Liu, Qinghang/0000-0003-0638-6509	British Heart Foundation [RG/05/015]; Marie Curie program [2005-020706-2, ZonMW 11.400.0076]	British Heart Foundation(British Heart Foundation); Marie Curie program(European Commission)	This work was supported by the Marie Curie program Early Stage Research Training Grant 2005-020706-2 and ZonMW 11.400.0076 (to J.W.M.H.) and by the British Heart Foundation for program grant support, Grant RG/05/015 (to A. W. P.).	Auger JM, 2005, FASEB J, V19, P825, DOI 10.1096/fj.04-1940fje; BALDASSARE JJ, 1992, J BIOL CHEM, V267, P15585; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Buensuceso CS, 2005, J BIOL CHEM, V280, P644, DOI 10.1074/jbc.M410229200; CAVALLINI L, 1994, EUR J BIOCHEM, V222, P693, DOI 10.1111/j.1432-1033.1994.tb18914.x; Chari R, 2009, ARTERIOSCL THROM VAS, V29, P699, DOI 10.1161/ATVBAHA.109.184010; Cohen S, 2009, BIOCHEM BIOPH RES CO, V385, P22, DOI 10.1016/j.bbrc.2009.05.021; CRABOS M, 1991, BIOCHEM BIOPH RES CO, V178, P878, DOI 10.1016/0006-291X(91)90973-B; Crosby D, 2003, J BIOL CHEM, V278, P24533, DOI 10.1074/jbc.M301847200; Crosby D, 2002, J BIOL CHEM, V277, P9958, DOI 10.1074/jbc.M108965200; Cywin CL, 2007, BIOORG MED CHEM LETT, V17, P225, DOI 10.1016/j.bmcl.2006.09.056; Giuliano S, 2003, BIOCHEM J, V372, P163, DOI 10.1042/BJ20020868; GRABAREK J, 1992, J BIOL CHEM, V267, P10011; Hall KJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003277; Hardy AR, 2005, BLOOD, V105, P3552, DOI 10.1182/blood-2004-07-2893; Harper MT, 2006, J THROMB HAEMOST, V4, P2695, DOI 10.1111/j.1538-7836.2006.02207.x; Harper MT, 2009, BLOOD, V114, P489, DOI 10.1182/blood-2009-03-208454; Heemskerk JWM, 1997, BLOOD, V90, P2615, DOI 10.1182/blood.V90.7.2615.2615_2615_2625; Heemskerk JWM, 2001, J PHYSIOL-LONDON, V535, P625, DOI 10.1111/j.1469-7793.2001.00625.x; Hers I, 1998, ARTERIOSCL THROM VAS, V18, P404, DOI 10.1161/01.ATV.18.3.404; Kahn ML, 2004, SEMIN THROMB HEMOST, V30, P419, DOI 10.1055/s-2004-833477; KHAN WA, 1993, J BIOL CHEM, V268, P5063; Konopatskaya O, 2010, TRENDS PHARMACOL SCI, V31, P8, DOI 10.1016/j.tips.2009.10.006; Konopatskaya O, 2009, J CLIN INVEST, V119, P399, DOI 10.1172/JCI34665; Kuijpers MJE, 2003, FASEB J, V17, P685, DOI 10.1096/fj.02-0381fje; Lecut C, 2004, ARTERIOSCL THROM VAS, V24, P1727, DOI 10.1161/01.ATV.0000137974.85068.93; Mangin P, 2006, BLOOD, V107, P4346, DOI 10.1182/blood-2005-10-4244; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Munnix ICA, 2007, ARTERIOSCL THROM VAS, V27, P2484, DOI 10.1161/ATVBAHA.107.151100; MURPHY CT, 1991, BIOCHEM J, V278, P255, DOI 10.1042/bj2780255; Nagy B, 2009, BLOOD, V113, P2557, DOI 10.1182/blood-2008-07-169268; Nieswandt B, 2001, EMBO J, V20, P2120, DOI 10.1093/emboj/20.9.2120; ORR JW, 1992, J BIOL CHEM, V267, P15263; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; Pears CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003793; Pula G, 2005, J BIOL CHEM, V280, P7194, DOI 10.1074/jbc.M409212200; Pula G, 2006, BLOOD, V108, P4035, DOI 10.1182/blood-2006-05-023739; Quinton TM, 2002, BIOCHEM J, V368, P535, DOI 10.1042/BJ20020226; RINK TJ, 1990, ANNU REV PHYSIOL, V52, P431, DOI 10.1146/annurev.ph.52.030190.002243; SHATTIL SJ, 1987, J BIOL CHEM, V262, P992; Siljander P, 2001, ARTERIOSCL THROM VAS, V21, P618, DOI 10.1161/01.ATV.21.4.618; Siljander PRM, 2004, BLOOD, V103, P1333, DOI 10.1182/blood-2003-03-00869; Soriani A, 2006, J THROMB HAEMOST, V4, P648, DOI 10.1111/j.1538-7836.2006.01806.x; Standaert ML, 1999, ENDOCRINOLOGY, V140, P4470, DOI 10.1210/en.140.10.4470; Strehl A, 2007, J BIOL CHEM, V282, P7046, DOI 10.1074/jbc.M611367200; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Tabuchi A, 2003, J BIOL CHEM, V278, P26374, DOI 10.1074/jbc.M212407200; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; van der Meijden PEJ, 2008, FEBS J, V275, P371, DOI 10.1111/j.1742-4658.2007.06207.x; WALKER TR, 1993, BIOCHEM J, V289, P277, DOI 10.1042/bj2890277; WANG F, 1993, BIOCHEM BIOPH RES CO, V191, P240, DOI 10.1006/bbrc.1993.1208; Yoshioka A, 2001, J BIOL CHEM, V276, P39379, DOI 10.1074/jbc.M102933200	53	80	82	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23408	23417		10.1074/jbc.M110.136176	http://dx.doi.org/10.1074/jbc.M110.136176			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20479008	Green Published, hybrid			2022-12-27	WOS:000279999900073
J	Sugden, C; Ross, S; Bloomfield, G; Ivens, A; Skelton, J; Mueller-Taubenberger, A; Williams, JG				Sugden, Christopher; Ross, Susan; Bloomfield, Gareth; Ivens, Alasdair; Skelton, Jason; Mueller-Taubenberger, Annette; Williams, Jeffrey G.			Two Novel Src Homology 2 Domain Proteins Interact to Regulate Dictyostelium Gene Expression during Growth and Early Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SH2 DOMAIN; MITOCHONDRIAL MORPHOLOGY; DISCOIDEUM; STAT	There are 13 Dictyostelium Src homology 2 (SH2) domain proteins, almost 10-fold fewer than in mammals, and only three are functionally unassigned. One of these, LrrB, contains a novel combination of protein interaction domains: an SH2 domain and a leucine-rich repeat domain. Growth and early development appear normal in the mutant, but expression profiling reveals that three genes active at these stages are greatly under-expressed: the ttdA metallohydrolase, the abcG10 small molecule transporter, and the cinB esterase. In contrast, the multi-gene family encoding the lectin discoidin 1 is overexpressed in the disruptant strain. LrrB binds to 14-3-3 protein, and the level of binding is highest during growth and decreases during early development. Comparative tandem affinity purification tagging shows that LrrB also interacts, via its SH2 domain and in a tyrosine phosphorylation-dependent manner, with two novel proteins: CldA and CldB. Both of these proteins contain a Clu domain, a > 200-amino acid sequence present within highly conserved eukaryotic proteins required for correct mitochondrial dispersal. A functional interaction of LrrB with CldA is supported by the fact that a cldA disruptant mutant also under-expresses ttdA, abcG10, and cinB. Significantly, CldA is itself one of the three functionally unassigned SH2 domain proteins. Thus, just as in metazoa, but on a vastly reduced numerical scale, an interacting network of SH2 domain proteins regulates specific Dictyostelium gene expression.	[Sugden, Christopher; Ross, Susan; Williams, Jeffrey G.] Univ Dundee, Sch Life Sci, Dundee DD1 5EH, Scotland; [Bloomfield, Gareth] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Ivens, Alasdair; Skelton, Jason] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Mueller-Taubenberger, Annette] Univ Munich, Inst Cell Biol, D-80336 Munich, Germany; [Mueller-Taubenberger, Annette] Univ Munich, Ctr Integrated Prot Sci, D-80336 Munich, Germany	University of Dundee; Wellcome Trust Sanger Institute; MRC Laboratory Molecular Biology; University of Munich; University of Munich	Williams, JG (corresponding author), Univ Dundee, Sch Life Sci, Dow St, Dundee DD1 5EH, Scotland.	j.g.williams@dundee.ac.uk	Müller-Taubenberger, Annette/AAM-3671-2021	Bloomfield, Gareth/0000-0003-4269-8059; Ivens, Al/0000-0002-0112-3876; Muller-Taubenberger, Annette/0000-0003-1163-9232	Biotechnology and Biological Sciences Research Council [BB/C500428/1]; Wellcome Trust [06724]; Medical Research Council [MC_U105115237] Funding Source: researchfish; MRC [MC_U105115237] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Biotechnology and Biological Sciences Research Council Project Grant BB/C500428/1 and by Wellcome Trust Program Grant 06724.	Abe T, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng095; Araki T, 2008, DEVELOPMENT, V135, P1347, DOI 10.1242/dev.009936; Bloomfield G, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r75; Cox RT, 2009, DIS MODEL MECH, V2, P490, DOI 10.1242/dmm.002378; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Fields SD, 1998, J CELL SCI, V111, P1717; Gao Q, 2004, MOL CELL PROTEOMICS, V3, P704, DOI 10.1074/mcp.M300131-MCP200; Kibler K, 2003, DEV BIOL, V259, P193, DOI 10.1016/S0012-1606(03)00204-5; Kim L, 1999, CELL, V99, P399, DOI 10.1016/S0092-8674(00)81526-3; King N, 2003, SCIENCE, V301, P361, DOI 10.1126/science.1083853; Knetsch MLW, 1997, BBA-MOL CELL RES, V1357, P243, DOI 10.1016/S0167-4889(97)00060-8; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Langenick J, 2008, J CELL SCI, V121, P3524, DOI 10.1242/jcs.036798; Liu BA, 2006, MOL CELL, V22, P851, DOI 10.1016/j.molcel.2006.06.001; Logan DC, 2003, PLANT J, V36, P500, DOI 10.1046/j.1365-313X.2003.01894.x; LOOMIS WF, 1990, P NATL ACAD SCI USA, V87, P9093, DOI 10.1073/pnas.87.23.9093; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Meima ME, 2007, PROTEIN EXPRES PURIF, V53, P283, DOI 10.1016/j.pep.2007.01.001; Moniakis J, 2001, GENE DEV, V15, P687, DOI 10.1101/gad.871001; Olsen R, 2005, J MOL EVOL, V61, P659, DOI 10.1007/s00239-005-0060-0; Pang KM, 1999, PLASMID, V41, P187, DOI 10.1006/plas.1999.1391; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; SINGLETON CK, 1987, DEV BIOL, V119, P433, DOI 10.1016/0012-1606(87)90047-9; SINGLETON CK, 1989, NUCLEIC ACIDS RES, V17, P9679, DOI 10.1093/nar/17.23.9679; SINGLETON CK, 1991, DEV GENET, V12, P88, DOI 10.1002/dvg.1020120116; Strmecki L, 2007, EUKARYOT CELL, V6, P245, DOI 10.1128/EC.00204-06; WATTS DJ, 1970, BIOCHEM J, V119, P171, DOI 10.1042/bj1190171; Williams JG, 2004, TRENDS PLANT SCI, V9, P161, DOI 10.1016/j.tplants.2004.02.001; WILLIAMS JG, 2003, SIGNAL TRANSDUCERS A, P105; Zhu QL, 1997, P NATL ACAD SCI USA, V94, P7308, DOI 10.1073/pnas.94.14.7308; Zhukovskaya NV, 2004, DEVELOPMENT, V131, P447, DOI 10.1242/dev.00927	31	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22925	22933		10.1074/jbc.M110.139733	http://dx.doi.org/10.1074/jbc.M110.139733			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20457612	Green Published, hybrid			2022-12-27	WOS:000279999900026
J	Dias, MVB; Huang, FL; Chirgadze, DY; Tosin, M; Spiteller, D; Dry, EFV; Leadlay, PF; Spencer, JB; Blundell, TL				Dias, Marcio V. B.; Huang, Fanglu; Chirgadze, Dimitri Y.; Tosin, Manuela; Spiteller, Dieter; Dry, Emily F. V.; Leadlay, Peter F.; Spencer, Jonathan B.; Blundell, Tom L.			Structural Basis for the Activity and Substrate Specificity of Fluoroacetyl-CoA Thioesterase FlK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; 4-HYDROXYBENZOYL-COA THIOESTERASE; FLUOROMETABOLITE BIOSYNTHESIS; FOLD; MECHANISM; ENZYME; ACID; IDENTIFICATION; FLUORINASE; INHIBITOR	The thioesterase FlK from the fluoroacetate-producing Streptomyces cattleya catalyzes the hydrolysis of fluoroacetyl-coenzyme A. This provides an effective self-defense mechanism, preventing any fluoroacetyl-coenzyme A formed from being further metabolized to 4-hydroxy-trans-aconitate, a lethal inhibitor of the tricarboxylic acid cycle. Remarkably, FlK does not accept acetyl-coenzyme A as a substrate. Crystal structure analysis shows that FlK forms a dimer, in which each subunit adopts a hot dog fold as observed for type II thioesterases. Unlike other type II thioesterases, which invariably utilize either an aspartate or a glutamate as catalytic base, we show by site-directed mutagenesis and crystallography that FlK employs a catalytic triad composed of Thr(42), His(76), and a water molecule, analogous to the Ser/Cys-His-acid triad of type I thioesterases. Structural comparison of FlK complexed with various substrate analogues suggests that the interaction between the fluorine of the substrate and the side chain of Arg(120) located opposite to the catalytic triad is essential for correct coordination of the substrate at the active site and therefore accounts for the substrate specificity.	[Huang, Fanglu; Tosin, Manuela; Dry, Emily F. V.; Spencer, Jonathan B.] Univ Cambridge, Univ Chem Lab, Cambridge CB2 1EW, England; [Dias, Marcio V. B.; Chirgadze, Dimitri Y.; Spiteller, Dieter; Leadlay, Peter F.; Blundell, Tom L.] Univ Cambridge, Dept Biochem, Cambridge CB2 1EW, England	University of Cambridge; University of Cambridge	Huang, FL (corresponding author), Univ Cambridge, Univ Chem Lab, Lensfield Rd, Cambridge CB2 1EW, England.	fh223@cam.ac.uk	Dias, Marcio/K-4610-2017	Leadlay, Peter/0000-0002-3247-509X; Tosin, Manuela/0000-0003-4340-9431; Dias, Marcio/0000-0002-5312-0191; Chirgadze, Dimitri/0000-0001-9942-0993	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Biotechnology and Biological Sciences Research Council [BBSB13357]; Wellcome Trust [079281/Z/06/Z]; Herchel Smith Fund	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Herchel Smith Fund	Recipient of a postdoctoral fellowship from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico.; Supported by Biotechnology and Biological Sciences Research Council Grant BBSB13357.; Supported by Wellcome Trust Programme Grant 079281/Z/06/Z.; Recipient of the Herchel Smith Fund Fellowship.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALLAIRE M, 1994, NATURE, V369, P72, DOI 10.1038/369072a0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benning MM, 1998, J BIOL CHEM, V273, P33572, DOI 10.1074/jbc.273.50.33572; DeLano W.L, PYMOL MOL GRAPHICS S; Deng H, 2004, NAT PROD REP, V21, P773, DOI 10.1039/b415087m; Dillon SC, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-109; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; Dong CJ, 2004, NATURE, V427, P561, DOI 10.1038/nature02280; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Hisano T, 2003, J BIOL CHEM, V278, P617, DOI 10.1074/jbc.M205484200; Huang FL, 2006, CHEM BIOL, V13, P475, DOI 10.1016/j.chembiol.2006.02.014; KUHL PW, 1994, BIOCHEM J, V298, P171, DOI 10.1042/bj2980171; Kunishima N, 2005, J MOL BIOL, V352, P212, DOI 10.1016/j.jmb.2005.07.008; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lauble H, 1996, P NATL ACAD SCI USA, V93, P13699, DOI 10.1073/pnas.93.24.13699; Leesong M, 1996, STRUCTURE, V4, P253, DOI 10.1016/S0969-2126(96)00030-5; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li J, 2000, NAT STRUCT BIOL, V7, P555; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; O'Hagan D, 2002, NATURE, V416, P279, DOI 10.1038/416279a; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PETERS R, 1953, PROC R SOC SER B-BIO, V140, P497, DOI 10.1098/rspb.1953.0004; Pidugu LS, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-37; Pleiss J, 1998, CHEM PHYS LIPIDS, V93, P67, DOI 10.1016/S0009-3084(98)00030-9; SANADA M, 1986, J ANTIBIOT, V39, P259, DOI 10.7164/antibiotics.39.259; Schaffrath C, 2003, FEBS LETT, V547, P111, DOI 10.1016/S0014-5793(03)00688-4; SEEMULLER E, 1995, SCIENCE, V268, P579, DOI 10.1126/science.7725107; Song F, 2006, J BIOL CHEM, V281, P11028, DOI 10.1074/jbc.M513896200; Thoden JB, 2003, J BIOL CHEM, V278, P43709, DOI 10.1074/jbc.M308198200; Wang F, 2007, CHEM BIOL, V14, P543, DOI 10.1016/j.chembiol.2007.04.005; Willis MA, 2008, BIOCHEMISTRY-US, V47, P2797, DOI 10.1021/bi702336d; Yokoyama T, 2009, BBA-PROTEINS PROTEOM, V1794, P1073, DOI 10.1016/j.bbapap.2009.03.002; Zhu XF, 2007, J AM CHEM SOC, V129, P14597, DOI 10.1021/ja0731569	39	21	22	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22495	22504		10.1074/jbc.M110.107177	http://dx.doi.org/10.1074/jbc.M110.107177			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20430898	Green Published, hybrid			2022-12-27	WOS:000279702200061
J	Doi, R; Oishi, K; Ishida, N				Doi, Ryosuke; Oishi, Katsutaka; Ishida, Norio			CLOCK Regulates Circadian Rhythms of Hepatic Glycogen Synthesis through Transcriptional Activation of Gys2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; MOLECULAR ANALYSIS; TARGET GENE; PPAR-ALPHA; MOUSE; LIVER; METABOLISM; SYNTHASE; MICE; INSULIN	Hepatic glycogen content is important for glucose homeostasis and exhibits robust circadian rhythms that peak at the end of the active phase in mammals. The activities of the rate-limiting enzymes for glycogenesis and glycogenolysis also show circadian rhythms, and the balance between them forms the circadian rhythm of the hepatic glycogen content. However, no direct evidence has yet implicated the circadian clock in the regulation of glycogen metabolism at the molecular level. We show here that a Clock gene mutation damps the circadian rhythm of the hepatic glycogen content, as well as the circadian mRNA and protein expression of Gys2 (glycogen synthase 2), which is the rate-limiting enzyme of glycogenesis in the liver. Transient reporter assays revealed that CLOCK drives the transcriptional activation of Gys2 via two tandemly located E-boxes. Chromatin immunoprecipitation assays of liver tissues revealed that CLOCK binds to these E-box elements in vivo, and real time reporter assays showed that these elements are sufficient for circadian Gys2 expression in vitro. Thus, CLOCK regulates the circadian rhythms of hepatic glycogen synthesis through transcriptional activation of Gys2.	[Oishi, Katsutaka] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Biol Clock Res Grp, Tsukuba, Ibaraki 3058566, Japan; [Doi, Ryosuke; Ishida, Norio] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Ishida Grp Clock Gene, Tsukuba, Ibaraki 3058566, Japan; [Doi, Ryosuke; Ishida, Norio] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 058572, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba	Oishi, K (corresponding author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Biol Clock Res Grp, 1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	k-ooishi@aist.go.jp; n.ishida@aist.go.jp	; Oishi, Katsutaka/L-6906-2018	DOI, RYOSUKE/0000-0002-1725-2082; Oishi, Katsutaka/0000-0002-4870-0837	Ministry of Education, Culture, Sports, Science and Technology of Japan [18770057]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-Aid for Young Scientists (B) 18770057 (to K.O.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Allaman-Pillet N, 2004, MOL CELL ENDOCRINOL, V226, P59, DOI 10.1016/j.mce.2004.06.001; Ando H, 2009, CLIN EXP HYPERTENS, V31, P201, DOI 10.1080/10641960902822450; Bandsma RHJ, 2004, J BIOL CHEM, V279, P8930, DOI 10.1074/jbc.M310067200; Bertolucci C, 2008, MOL CELL BIOL, V28, P3070, DOI 10.1128/MCB.01931-07; Bollen M, 1998, BIOCHEM J, V336, P19, DOI 10.1042/bj3360019; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; BRYSON JM, 1993, BIOCHEM J, V295, P731, DOI 10.1042/bj2950731; Burcelin R, 2000, J BIOL CHEM, V275, P10930, DOI 10.1074/jbc.275.15.10930; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; Ferrer JC, 2003, FEBS LETT, V546, P127, DOI 10.1016/S0014-5793(03)00565-9; Iitaka C, 2005, J BIOL CHEM, V280, P29397, DOI 10.1074/jbc.M503526200; ISHIKAWA K, 1976, LIFE SCI, V19, P1873, DOI 10.1016/0024-3205(76)90119-3; Kadotani A, 2007, ARCH BIOCHEM BIOPHYS, V466, P283, DOI 10.1016/j.abb.2007.08.006; KASLOW HR, 1985, J BIOL CHEM, V260, P9953; Kennaway DJ, 2007, AM J PHYSIOL-REG I, V293, pR1528, DOI 10.1152/ajpregu.00018.2007; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kobayashi Y, 2000, GENES CELLS, V5, P725, DOI 10.1046/j.1365-2443.2000.00364.x; Krssak M, 2004, DIABETES, V53, P3048, DOI 10.2337/diabetes.53.12.3048; Kudo Takashi, 2009, J Circadian Rhythms, V7, P4, DOI 10.1186/1740-3391-7-4; Kumaki Y, 2008, P NATL ACAD SCI USA, V105, P14946, DOI 10.1073/pnas.0802636105; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Mandard S, 2007, CELL MOL LIFE SCI, V64, P1145, DOI 10.1007/s00018-007-7006-1; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Miyake K, 2002, J CLIN INVEST, V110, P1483, DOI 10.1172/JCI200215880; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; OBRIEN RM, 1990, DIABETES CARE, V13, P327, DOI 10.2337/diacare.13.3.327; Ohno T, 2007, NUCLEIC ACIDS RES, V35, P648, DOI 10.1093/nar/gkl868; Oishi K, 2006, FEBS LETT, V580, P127, DOI 10.1016/j.febslet.2005.11.063; Oishi K, 2003, J BIOL CHEM, V278, P41519, DOI 10.1074/jbc.M304564200; Oishi K, 2005, BIOCHEM J, V386, P575, DOI 10.1042/BJ20041150; Oishi K, 2002, BIOCHEM BIOPH RES CO, V298, P198, DOI 10.1016/S0006-291X(02)02427-0; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pando MP, 2001, NATURE, V410, P311, DOI 10.1038/35066655; Radziuk J, 2001, DIABETES-METAB RES, V17, P250, DOI 10.1002/dmrr.217; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Sakamoto K, 1998, J BIOL CHEM, V273, P27039, DOI 10.1074/jbc.273.42.27039; Tsuchiya Y, 2003, GENES CELLS, V8, P713, DOI 10.1046/j.1365-2443.2003.00669.x; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102	45	91	100	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22114	22121		10.1074/jbc.M110.110361	http://dx.doi.org/10.1074/jbc.M110.110361			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20430893	hybrid, Green Published			2022-12-27	WOS:000279702200024
J	Sanchez, R; Pantoja-Uceda, D; Prieto, J; Diercks, T; Marcaida, MJ; Montoya, G; Campos-Olivas, R; Blanco, FJ				Sanchez, Ricardo; Pantoja-Uceda, David; Prieto, Jesus; Diercks, Tammo; Marcaida, Maria J.; Montoya, Guillermo; Campos-Olivas, Ramon; Blanco, Francisco J.			Solution Structure of Human Growth Arrest and DNA Damage 45 alpha (Gadd45 alpha) and Its Interactions with Proliferating Cell Nuclear Antigen (PCNA) and Aurora A Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53-REGULATED PROTEIN; GADD45A; ACTIVATION; DEMETHYLATION; GADD45-GAMMA; MTK1/MEKK4; ASSIGNMENT; COMPLEX	Gadd45 alpha is a nuclear protein encoded by a DNA damage-inducible gene. Through its interactions with other proteins, Gadd45 alpha participates in the regulation of DNA repair, cell cycle, cell proliferation, and apoptosis. The NMR structure of human Gadd45 alpha has been determined and shows an alpha/beta fold with two long disordered and flexible regions at the N terminus and one of the loops. Human Gadd45 alpha is predominantly monomeric in solution but exists in equilibrium with dimers and other oligomers whose population increases with protein concentration. NMR analysis shows that Aurora A interacts through its N-terminal domain with a region of human Gadd45 alpha encompassing the site of dimerization, suggesting that the oligomerization of Gadd45 alpha could be a regulatory mechanism to modulate its interactions with Aurora A, and possibly with other proteins too. However, Gadd45 alpha appears to interact only weakly with PCNA through its flexible loop, in contrast with previous and contradictory reports.	[Prieto, Jesus; Marcaida, Maria J.; Montoya, Guillermo; Campos-Olivas, Ramon] CNIO, Struct & Computat Biol Programme, E-28029 Madrid, Spain; [Sanchez, Ricardo; Diercks, Tammo; Blanco, Francisco J.] CIC bioGUNE, Struct Biol Unit, E-48160 Derio, Spain; [Pantoja-Uceda, David] CSIC, Inst Quim Fis Rocasolano, Mol Struct & Spect Dept, E-28006 Madrid, Spain; [Blanco, Francisco J.] Basque Fdn Sci, IKERBASQUE, E-48011 Bilbao, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); CIC bioGUNE; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Basque Foundation for Science	Campos-Olivas, R (corresponding author), CNIO, Struct & Computat Biol Programme, Melchor Fernandez Almagro 3, E-28029 Madrid, Spain.	rcampos@cnio.es; fblanco@cicbiogune.es	Pantoja-Uceda, David/J-8097-2014; cancer, biogune/H-7276-2012; Diercks, Tammo/G-1167-2011; Sánchez, Ricardo/AAB-1516-2019; Campos-Olivas, Ramón/L-9173-2014; Marcaida, Maria Jose/I-1644-2017; Blanco, Francisco J/D-4401-2009; Diercks, Tammo/AAT-3731-2021	Diercks, Tammo/0000-0002-5200-0905; Campos-Olivas, Ramón/0000-0002-5743-2221; Marcaida, Maria Jose/0000-0003-0663-5309; Blanco, Francisco J/0000-0003-2545-4319; Diercks, Tammo/0000-0002-5200-0905; Pantoja-Uceda, David/0000-0003-4390-6972	Spanish Ministerio de Ciencia e Innovacion [CTQ2008-03115/BQU, BFU2008-01344, CSD2006-00023]; Consejeria de Educacion of the Basque Government [PI2009-4]; Comunidad Auto noma de Madrid [CAM-P2006/Gen-0166, ETORTEK-2008]; ETORTEK	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Consejeria de Educacion of the Basque Government; Comunidad Auto noma de Madrid(Comunidad de Madrid); ETORTEK	This work was supported by the Spanish Ministerio de Ciencia e Innovacion Grants CTQ2008-03115/BQU (to F.J.B.) and BFU2008-01344 and CSD2006-00023 (to G. M.), Consejeria de Educacion of the Basque Government Grant PI2009-4 (to F.J.B.), Comunidad Auto noma de Madrid Grant CAM-P2006/Gen-0166 (to G. M.), and ETORTEK-2008 Grant to the Structural Biology Unit of CIC bioGUNE.	Azam N, 2001, J BIOL CHEM, V276, P2766, DOI 10.1074/jbc.M005626200; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Bruning JB, 2004, STRUCTURE, V12, P2209, DOI 10.1016/j.str.2004.09.018; Carrier F, 1999, MOL CELL BIOL, V19, P1673; CARRIER F, 1994, J BIOL CHEM, V269, P32672; Clore GM, 1999, J AM CHEM SOC, V121, P9008, DOI 10.1021/ja991789k; FORNACE AJ, 1988, P NATL ACAD SCI USA, V85, P8800, DOI 10.1073/pnas.85.23.8800; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; HALL PA, 1995, ONCOGENE, V10, P2427; Hollander MC, 2002, ONCOGENE, V21, P6228, DOI 10.1038/sj.onc.1205774; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kontopidis G, 2005, P NATL ACAD SCI USA, V102, P1871, DOI 10.1073/pnas.0406540102; Kovalsky O, 2001, J BIOL CHEM, V276, P39330, DOI 10.1074/jbc.M105115200; Miyake Z, 2007, MOL CELL BIOL, V27, P2765, DOI 10.1128/MCB.01435-06; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Sanchez R, 2007, BIOMOL NMR ASSIGN, V1, P245, DOI 10.1007/s12104-007-9068-2; Sanchez R, 2008, BIOMOL NMR ASSIGN, V2, P139, DOI 10.1007/s12104-008-9105-9; Schmitz KM, 2009, MOL CELL, V33, P344, DOI 10.1016/j.molcel.2009.01.015; Schrag JD, 2008, P NATL ACAD SCI USA, V105, P6566, DOI 10.1073/pnas.0800086105; Shao SJ, 2006, J BIOL CHEM, V281, P28943, DOI 10.1074/jbc.M600235200; SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Tornatore L, 2008, J MOL BIOL, V378, P97, DOI 10.1016/j.jmb.2008.01.074; Vairapandi M, 2000, J BIOL CHEM, V275, P16810, DOI 10.1074/jbc.275.22.16810; Wang X, 2008, PROTEIN SCI, V17, P899, DOI 10.1110/ps.073395108; Warbrick E, 1998, BIOESSAYS, V20, P195, DOI 10.1002/(SICI)1521-1878(199803)20:3<195::AID-BIES2>3.0.CO;2-R	28	21	26	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22196	22201		10.1074/jbc.M109.069344	http://dx.doi.org/10.1074/jbc.M109.069344			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20460379	Green Published, hybrid			2022-12-27	WOS:000279702200032
J	Chinnakkannu, P; Samanna, V; Cheng, GM; Ablonczy, Z; Baicu, CF; Bethard, JR; Menick, DR; Kuppuswamy, D; Cooper, G				Chinnakkannu, Panneerselvam; Samanna, Venkatesababa; Cheng, Guangmao; Ablonczy, Zsolt; Baicu, Catalin F.; Bethard, Jennifer R.; Menick, Donald R.; Kuppuswamy, Dhandapani; Cooper, George			Site-specific Microtubule-associated Protein 4 Dephosphorylation Causes Microtubule Network Densification in Pressure Overload Cardiac Hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBULIN MESSENGER-RNAS; CONTRACTILE DYSFUNCTION; ADULT CARDIOCYTES; TAU-PROTEIN; BETA-TUBULIN; TRANSLATIONAL INITIATION; RECEPTOR TRAFFICKING; PHOSPHORYLATION SITE; PROJECTION DOMAIN; ALZHEIMER-DISEASE	In severe pressure overload-induced cardiac hypertrophy, a dense, stabilized microtubule network forms that interferes with cardiocyte contraction and microtubule-based transport. This is associated with persistent transcriptional up-regulation of cardiac alpha- and beta-tubulin and microtubule-stabilizing microtubule-associated protein 4 (MAP4). There is also extensive microtubule decoration by MAP4, suggesting greater MAP4 affinity for microtubules. Because the major determinant of this affinity is site-specific MAP4 dephosphorylation, we characterized this in hypertrophied myocardium and then assessed the functional significance of each dephosphorylation site found by mimicking it in normal cardiocytes. We first isolated MAP4 from normal and pressure overload-hypertrophied feline myocardium; volume-overloaded myocardium, which has an equal degree and duration of hypertrophy but normal functional and cytoskeletal properties, served as a control for any nonspecific growth-related effects. After cloning cDNA-encoding feline MAP4 and obtaining its deduced amino acid sequence, we characterized by mass spectrometry any site-specific MAP4 dephosphorylation. Solely in pressure overload-hypertrophied myocardium, we identified striking MAP4 dephosphorylation at Ser-472 in the MAP4 N-terminal projection domain and at Ser-924 and Ser-1056 in the assembly-promoting region of the C-terminal microtubule-binding domain. Site-directed mutagenesis of MAP4 cDNA was then used to switch each serine to non-phosphorylatable alanine. Wild-type and mutated cDNAs were used to construct adenoviruses; microtubule network density, stability, and MAP4 decoration were assessed in normal cardiocytes following an equivalent level of MAP4 expression. The Ser-924 -> Ala MAP4 mutant produced a microtubule phenotype indistinguishable from that seen in pressure overload hypertrophy, such that Ser-924 MAP4 dephosphorylation during pressure overload hypertrophy may be central to this cytoskeletal abnormality.	[Chinnakkannu, Panneerselvam; Samanna, Venkatesababa; Cheng, Guangmao; Baicu, Catalin F.; Menick, Donald R.; Kuppuswamy, Dhandapani; Cooper, George] Med Univ S Carolina, Gazes Cardiac Res Inst, Div Cardiol, Charleston, SC 29403 USA; [Ablonczy, Zsolt] Med Univ S Carolina, Storm Eye Inst, Dept Ophthalmol, Charleston, SC 29403 USA; [Bethard, Jennifer R.] Med Univ S Carolina, Dept Pharmacol, Charleston, SC 29403 USA; [Kuppuswamy, Dhandapani; Cooper, George] Dept Vet Affairs Med Ctr, Charleston, SC 29401 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Cooper, G (corresponding author), Med Univ S Carolina, Gazes Cardiac Res Inst, Div Cardiol, POB 250773,114 Doughty St, Charleston, SC 29403 USA.	cooperge@musc.edu			National Institutes of Health [HL094545, HL104287, HL48788]; Dept. of Veterans Affairs; NATIONAL EYE INSTITUTE [R01EY019065] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL104287, R01HL094545, P01HL048788] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept. of Veterans Affairs(US Department of Veterans Affairs); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL094545 and HL104287 (to G. C.) and NIH Program Project Grant HL48788 (to G. C., D. K., and D. M.). This work was also supported by a Dept. of Veterans Affairs Merit Review Grant (to G. C.).	Ablonczy Z, 2005, PHOTOCHEM PHOTOBIOL, V81, P541, DOI 10.1562/2004-08-27-RA-294.1; Ablonczy Z, 2002, J BIOL CHEM, V277, P40491, DOI 10.1074/jbc.M205507200; AIZAWA H, 1991, J BIOL CHEM, V266, P9841; AIZAWA H, 1990, J BIOL CHEM, V265, P13849; BACHURSKI CJ, 1994, MOL CELL BIOL, V14, P4076, DOI 10.1128/MCB.14.6.4076; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; BLALOCK A, 1950, SURG GYNECOL OBSTET, V90, P1; Brown NM, 1998, P NATL ACAD SCI USA, V95, P15235, DOI 10.1073/pnas.95.26.15235; Casey LM, 2003, CELL MOTIL CYTOSKEL, V54, P317, DOI 10.1002/cm.10105; Chang W, 2001, J CELL SCI, V114, P2879; CHAPIN SJ, 1991, J CELL SCI, V98, P27; Chen XW, 2007, CIRC RES, V100, P536, DOI 10.1161/01.RES.0000259560.39234.99; Cheng GM, 2005, AM J PHYSIOL-HEART C, V288, pH1193, DOI 10.1152/ajpheart.00109.2004; Cheng GM, 2002, AM J PHYSIOL-HEART C, V283, pH2379, DOI 10.1152/ajpheart.00410.2002; Cheng G, 2008, AM J PHYSIOL-HEART C, V294, pH2231, DOI 10.1152/ajpheart.91515.2007; COOPER G, 1973, CIRC RES, V32, P140, DOI 10.1161/01.RES.32.2.140; COOPER G, 1986, CIRC RES, V58, P692, DOI 10.1161/01.RES.58.5.692; COOPER G, 1973, CIRC RES, V33, P213, DOI 10.1161/01.RES.33.2.213; COOPER G, 1981, CIRC RES, V48, P488, DOI 10.1161/01.RES.48.4.488; COOPER G, 2007, CONGESTIVE HEART FAI, P52; Cooper G, 2006, AM J PHYSIOL-HEART C, V291, pH1003, DOI 10.1152/ajpheart.00132.2006; Drewes G, 1998, TRENDS BIOCHEM SCI, V23, P307, DOI 10.1016/S0968-0004(98)01245-6; Ferrer I, 2002, ACTA NEUROPATHOL, V104, P658, DOI 10.1007/s00401-002-0600-2; HAGESTEDT T, 1989, J CELL BIOL, V109, P1643, DOI 10.1083/jcb.109.4.1643; HASEGAWA M, 1992, J BIOL CHEM, V267, P17047; Hein S, 2000, CARDIOVASC RES, V45, P273, DOI 10.1016/S0008-6363(99)00268-0; Hein S, 2008, AM J PHYSIOL-HEART C, V294, pH1130, DOI 10.1152/ajpheart.91528.2007; Iida J, 2002, J MOL BIOL, V320, P97, DOI 10.1016/S0022-2836(02)00402-3; Illenberger S, 1996, J BIOL CHEM, V271, P10834, DOI 10.1074/jbc.271.18.10834; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; IRMINGERFINGER I, 1990, J CELL BIOL, V111, P2563, DOI 10.1083/jcb.111.6.2563; IVESTER CT, 1995, J BIOL CHEM, V270, P21950, DOI 10.1074/jbc.270.37.21950; Kitazawa H, 2000, CELL STRUCT FUNCT, V25, P33, DOI 10.1247/csf.25.33; Knapp DR, 2002, METHOD ENZYMOL, V343, P157; Leger J, 1997, J BIOL CHEM, V272, P8441, DOI 10.1074/jbc.272.13.8441; LEWIS SA, 1988, SCIENCE, V242, P936, DOI 10.1126/science.3142041; Mangan ME, 1996, DEVELOPMENT, V122, P771; Narishige T, 1999, J BIOL CHEM, V274, P9692, DOI 10.1074/jbc.274.14.9692; NOBLE M, 1989, J CELL BIOL, V109, P3367, DOI 10.1083/jcb.109.6.3367; OLSON KR, 1995, J CELL BIOL, V130, P639, DOI 10.1083/jcb.130.3.639; Ookata K, 1997, BIOCHEMISTRY-US, V36, P15873, DOI 10.1021/bi971251w; OSTLUND RE, 1979, ANAL BIOCHEM, V96, P155, DOI 10.1016/0003-2697(79)90568-2; Ozer RS, 2000, MOL BIOL CELL, V11, P3573, DOI 10.1091/mbc.11.10.3573; PARDEE AB, 1985, BIOESSAYS, V2, P37, DOI 10.1002/bies.950020112; Permana S, 2005, CELL STRUCT FUNCT, V29, P147, DOI 10.1247/csf.29.147; Sato H, 1997, J CELL BIOL, V139, P963, DOI 10.1083/jcb.139.4.963; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; Scholz D, 2008, AM J PHYSIOL-HEART C, V294, pH1135, DOI 10.1152/ajpheart.01275.2007; Schwab C, 2000, NEUROBIOL AGING, V21, P503, DOI 10.1016/S0197-4580(00)00110-X; Tagawa H, 1996, P ASSOC AM PHYSICIAN, V108, P218; Tagawa H, 1996, CIRCULATION, V93, P1230, DOI 10.1161/01.CIR.93.6.1230; Takahashi M, 2003, AM J PHYSIOL-HEART C, V285, pH2072, DOI 10.1152/ajpheart.00396.2003; Terry RD, 1996, J NEUROPATH EXP NEUR, V55, P1023, DOI 10.1097/00005072-199655100-00001; TSUTSUI H, 1993, SCIENCE, V260, P682, DOI 10.1126/science.8097594; TSUTSUI H, 1994, CIRCULATION, V90, P533, DOI 10.1161/01.CIR.90.1.533; Wada H, 1996, J BIOL CHEM, V271, P8359, DOI 10.1074/jbc.271.14.8359; Wang JZ, 2007, EUR J NEUROSCI, V25, P59, DOI 10.1111/j.1460-9568.2006.05226.x; WEST RR, 1991, J BIOL CHEM, V266, P21886; YEN TJ, 1988, NATURE, V334, P580, DOI 10.1038/334580a0	59	24	25	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21837	21848		10.1074/jbc.M110.120709	http://dx.doi.org/10.1074/jbc.M110.120709			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20436166	Green Published, hybrid			2022-12-27	WOS:000279516100068
J	Kim, KS; Park, JY; Jou, I; Park, SM				Kim, Kwang Soo; Park, Ji-Young; Jou, Ilo; Park, Sang Myun			Regulation of Weibel-Palade Body Exocytosis by alpha-Synuclein in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; FAMILIAL PARKINSONS-DISEASE; CHAPERONE-LIKE ACTIVITY; PROTEIN-KINASE-C; IN-VITRO; ALZHEIMERS-DISEASE; MEDIATED RELEASE; PHORBOL ESTERS; LEWY BODIES; WILD-TYPE	alpha-Synuclein is a small presynaptic protein implicated in the pathogenesis of Parkinson disease. Nevertheless, its physiological roles and mechanisms remain incompletely understood. alpha-Synuclein is not only expressed in neurons but also in the vascular endothelium, which contains intracellular granules called Weibel-Palade bodies (WPBs) that contain a number of chemokines, adhesive molecules, and inflammatory cytokines. This study explored whether the exocytosis of WPB is regulated by alpha-synuclein. Phorbol 12-myristate 13-acetate-, thrombin-, or forskolin-induced von Willebrand factor release or translocation of P-selectin from endothelial cells were inhibited by alpha-and alpha-synuclein but not alpha-synuclein. Three point mutants (A30P, A53T, and E46K) found in familial Parkinson disease also inhibited WPB exocytosis similar to that of wild-type alpha-synuclein. Furthermore, the negative regulation of WPB exocytosis required the N terminus or the nonamyloid beta-component of Alzheimer disease amyloid region of alpha-synuclein, but not the C-terminal acidic tail, and alpha-synuclein affected WPB exocytosis through interference with RalA activation by enhancing the interaction of RalGDS-beta-arrestin complexes. Immuno-EM analysis revealed that alpha-synuclein was localized close to WPBs. These findings imply that alpha-synuclein plays as a negative regulator in WPB exocytosis in endothelial cells.	[Park, Sang Myun] Ajou Univ, Sch Med, Dept Pharmacol, Suwon 442721, South Korea; [Kim, Kwang Soo; Park, Ji-Young; Jou, Ilo; Park, Sang Myun] Ajou Univ, Sch Med, Chron Inflammatory Dis Res Ctr, Suwon 442721, South Korea	Ajou University; Ajou University	Park, SM (corresponding author), Ajou Univ, Sch Med, Dept Pharmacol, San 5, Suwon 442721, South Korea.	sangmyun@ajou.ac.kr			Korean Government [KRF-2008-331-E00016]; Korea Science and Engineering Foundation through Chronic Inflammatory Disease Research Center Ajou University [R13-2003-019]	Korean Government(Korean Government); Korea Science and Engineering Foundation through Chronic Inflammatory Disease Research Center Ajou University	This work was supported in part by National Research Foundation of Korea Grant KRF-2008-331-E00016 funded by the Korean Government and the Korea Science and Engineering Foundation through Chronic Inflammatory Disease Research Center Ajou University Grant R13-2003-019.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Ahn BH, 2002, J BIOL CHEM, V277, P12334, DOI 10.1074/jbc.M110414200; Ahn KJ, 2006, J NEUROCHEM, V97, P265, DOI 10.1111/j.1471-4159.2006.03731.x; Baba M, 1998, AM J PATHOL, V152, P879; Bhattacharya M, 2002, NAT CELL BIOL, V4, P547, DOI 10.1038/ncb821; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; Bouley DM, 2001, INFECT IMMUN, V69, P7820, DOI 10.1128/IAI.69.12.7820-7831.2001; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; da Costa CA, 2000, J BIOL CHEM, V275, P24065, DOI 10.1074/jbc.M002413200; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; de Leeuw HPJC, 2001, ARTERIOSCL THROM VAS, V21, P899, DOI 10.1161/01.ATV.21.6.899; Disse J, 2009, BLOOD, V113, P973, DOI 10.1182/blood-2008-06-165282; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; El-Agnaf OMA, 1998, FEBS LETT, V440, P71, DOI 10.1016/S0014-5793(98)01418-5; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Gai WP, 2000, EXP NEUROL, V166, P324, DOI 10.1006/exnr.2000.7527; HAMILTON KK, 1987, J CLIN INVEST, V79, P600, DOI 10.1172/JCI112853; Hashimoto M, 1997, BIOCHEM BIOPH RES CO, V237, P611, DOI 10.1006/bbrc.1997.6978; Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1; Jenco JM, 1998, BIOCHEMISTRY-US, V37, P4901, DOI 10.1021/bi972776r; Kim TD, 2000, PROTEIN SCI, V9, P2489, DOI 10.1110/ps.9.12.2489; Klegeris A, 2008, NEUROBIOL AGING, V29, P739, DOI 10.1016/j.neurobiolaging.2006.11.013; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Lavedan C, 1998, GENOME RES, V8, P871, DOI 10.1101/gr.8.9.871; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee SB, 2009, BIOCHEM BIOPH RES CO, V381, P39, DOI 10.1016/j.bbrc.2009.02.002; Lee SJ, 2008, ACTA NEUROBIOL EXP, V68, P509; LEVINE JD, 1982, BLOOD, V60, P531; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Lowenstein CJ, 2005, TRENDS CARDIOVAS MED, V15, P302, DOI 10.1016/j.tcm.2005.09.005; Lucking CB, 2000, CELL MOL LIFE SCI, V57, P1894, DOI 10.1007/PL00000671; Maehama T, 2008, J BIOL CHEM, V283, P35053, DOI 10.1074/jbc.M805822200; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Matsushita K, 2005, J CELL BIOL, V170, P73, DOI 10.1083/jcb.200502031; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Ostrerova N, 1999, J NEUROSCI, V19, P5782, DOI 10.1523/JNEUROSCI.19-14-05782.1999; Ostrerova-Golts N, 2000, J NEUROSCI, V20, P6048, DOI 10.1523/JNEUROSCI.20-16-06048.2000; Parihar MS, 2009, INT J BIOCHEM CELL B, V41, P2015, DOI 10.1016/j.biocel.2009.05.008; Park JY, 2008, GLIA, V56, P1215, DOI 10.1002/glia.20691; Park SM, 2002, BLOOD, V100, P2506, DOI 10.1182/blood.V100.7.2506; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rondaij MG, 2008, BLOOD, V112, P56, DOI 10.1182/blood-2007-07-099309; Rondaij MG, 2004, ARTERIOSCL THROM VAS, V24, P1315, DOI 10.1161/01.ATV.0000131267.13425.45; Rondaij MG, 2006, ARTERIOSCL THROM VAS, V26, P1002, DOI 10.1161/01.ATV.0000209501.56852.6c; Saha AR, 2000, EUR J NEUROSCI, V12, P3073, DOI 10.1046/j.1460-9568.2000.00210.x; Shin EC, 2000, MOL CELLS, V10, P65, DOI 10.1007/s100590070011; Silinsky EM, 2003, BRIT J PHARMACOL, V138, P1191, DOI 10.1038/sj.bjp.0705213; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Souza JM, 2000, FEBS LETT, V474, P116, DOI 10.1016/S0014-5793(00)01563-5; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Su XM, 2008, NEUROBIOL AGING, V29, P1690, DOI 10.1016/j.neurobiolaging.2007.04.006; Sung JY, 2001, J BIOL CHEM, V276, P27441, DOI 10.1074/jbc.M101318200; Surguchov A, 1999, MOL CELL NEUROSCI, V13, P95, DOI 10.1006/mcne.1999.0735; Tamo W, 2002, NEUROSCI LETT, V326, P5, DOI 10.1016/S0304-3940(02)00297-5; Vischer UM, 1997, THROMB HAEMOSTASIS, V77, P1182; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	59	24	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21416	21425		10.1074/jbc.M110.103499	http://dx.doi.org/10.1074/jbc.M110.103499			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20448034	Green Published, hybrid			2022-12-27	WOS:000279516100028
J	Rah, SY; Mushtaq, M; Nam, TS; Kim, SH; Kim, UH				Rah, So-Young; Mushtaq, Mazhar; Nam, Tae-Sik; Kim, Suhn Hee; Kim, Uh-Hyun			Generation of Cyclic ADP-ribose and Nicotinic Acid Adenine Dinucleotide Phosphate by CD38 for Ca2+ Signaling in Interleukin-8-treated Lymphokine-activated Killer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; CALCIUM-MOBILIZING METABOLITE; PANCREATIC-ACINAR-CELLS; CADP-RIBOSE; NANOMOLAR SENSITIVITY; CYCLASE ACTIVATION; INTRACELLULAR CA2+; HUMAN ERYTHROCYTES; HUMAN NEUTROPHILS; CARDIAC MYOCYTES	We have previously demonstrated that cyclic ADP-ribose (cADPR) is a calcium signaling messenger in interleukin 8 (IL-8)-induced lymphokine-activated killer (LAK) cells. In this study we examined the possibility that IL-8 activates CD38 to produce another messenger, nicotinic acid adenine dinucleotide phosphate (NAADP), in LAK cells, and we showed that IL-8 induced NAADP formation after cADPR production. These calcium signaling messengers were not produced when LAK cells prepared from CD38 knock-out mice were treated with IL-8, indicating that the synthesis of both NAADP and cADPR is catalyzed by CD38 in LAK cells. Application of cADPR to LAK cells induced NAADP production, where as NAADP failed to increase intracellular cADPR levels, confirming that the production of cADPR precedes that of NAADP in IL-8-treated LAK cells. Moreover, NAADP increased intracellular Ca2+ signaling as well as cell migration, which was completely blocked by bafilomycin A1, suggesting that NAADP is generated in lysosome-related organelles after cADPR production. IL-8 or exogenous cADPR, but not NAADP, increased intracellularc AMP levels. cGMP analog, 8-(4-chlorophenylthio)-guanosine 3',5'-cyclic monophosphate, increased both cADPR and NAADP production, whereas the cAMP analog, 8-(4-chlorophenylthio)-cAMP, increased only NAADP production, suggesting that cAMP is essential for IL-8-induced NAADP formation. Furthermore, activation of Rap1, a downstream molecule of Epac, was required for IL-8-induced NAADP formation in LAK cells. Taken together, our data suggest that IL-8-induced NAADP production is mediated by CD38 activation through the actions of cAMP/Epac/proteinkinase A/Rap1 in LAK cells and that NAADP plays a key role in Ca2+ signaling of IL-8-induced LAK cell migration.	[Rah, So-Young; Mushtaq, Mazhar; Nam, Tae-Sik; Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Dept Biochem, Jeonju 561182, South Korea; [Kim, Suhn Hee] Chonbuk Natl Univ, Sch Med, Dept Physiol, Jeonju 561182, South Korea; [Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Inst Cardiovasc Res, Jeonju 561182, South Korea	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University	Kim, UH (corresponding author), Chonbuk Natl Univ, Sch Med, Dept Biochem, Jeonju 561182, South Korea.	uhkim@chonbuk.ac.kr	Mushtaq, Mazhar/L-3366-2019	Mushtaq, Mazhar/0000-0002-2126-924X; Kim, Uh-Hyun/0000-0003-3304-7190; Rah, So-Young/0000-0002-0255-1960	Korea Science and Engineering Foundation [R0A-2007-000-20121-0]; Korea Research Foundation [KRF-2008-359-E00004]; Chonbuk National University [2007]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Korea Research Foundation(National Research Foundation of Korea); Chonbuk National University	This work was supported by Korea Science and Engineering Foundation Grant R0A-2007-000-20121-0 (to U.-H. K.) and by Korea Research Foundation Grant KRF-2008-359-E00004 (to S.-Y.R.).; Supported by the Chonbuk National University Postdoctoral Fellowship Program (2007).	Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; BASSE P, 1991, J EXP MED, V174, P479, DOI 10.1084/jem.174.2.479; Billington RA, 2006, FASEB J, V20, P521, DOI 10.1096/fj.05-5058fje; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Chu H, 2008, J IMMUNOL, V181, P3373, DOI 10.4049/jimmunol.181.5.3373; Churamani D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000797; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/nm1098; DAGNINO L, 1991, J BIOL CHEM, V266, P6308; Franco L, 1998, FASEB J, V12, P1507; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; Gasser A, 2006, J BIOL CHEM, V281, P16906, DOI 10.1074/jbc.M601347200; Genazzani AA, 1996, BIOCHEM J, V315, P721, DOI 10.1042/bj3150721; Gerasimenko JV, 2006, J CELL SCI, V119, P226, DOI 10.1242/jcs.02721; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; Graeff R, 2002, BIOCHEM J, V367, P163, DOI 10.1042/BJ20020644; Graeff RM, 1998, J BIOL CHEM, V273, P118, DOI 10.1074/jbc.273.1.118; Guida L, 2002, J BIOL CHEM, V277, P47097, DOI 10.1074/jbc.M207793200; Gul R, 2008, AM J PHYSIOL-HEART C, V295, pH77, DOI 10.1152/ajpheart.01355.2007; Guo FF, 2001, J BIOL CHEM, V276, P25568, DOI 10.1074/jbc.M101277200; Guse AH, 1999, NATURE, V398, P70, DOI 10.1038/18024; Harmer AR, 2001, BIOCHEM J, V353, P555, DOI 10.1042/0264-6021:3530555; Higashida H, 1997, J BIOL CHEM, V272, P31272, DOI 10.1074/jbc.272.50.31272; Higashida H, 1999, J BIOL CHEM, V274, P33348, DOI 10.1074/jbc.274.47.33348; Hohenegger M, 2002, BIOCHEM J, V367, P423, DOI 10.1042/BJ20020584; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Institute of Laboratory Animal Resources Commission on Life Sciences National Research Council, 1996, GUIDE CARE USE LAB A, P8; Kim BJ, 2008, DIABETES, V57, P868, DOI 10.2337/db07-0443; KIM H, 1993, SCIENCE, V261, P1330, DOI 10.1126/science.8395705; Kim SY, 2008, AM J PHYSIOL-RENAL, V294, pF982, DOI 10.1152/ajprenal.00483.2007; KIM UH, 1993, BIOCHIM BIOPHYS ACTA, V1178, P121, DOI 10.1016/0167-4889(93)90001-6; Lange I, 2008, CELL CALCIUM, V44, P604, DOI 10.1016/j.ceca.2008.05.001; LEE HC, 1991, CELL REGUL, V2, P203, DOI 10.1091/mbc.2.3.203; Lee HC, 2004, CURR MOL MED, V4, P227, DOI 10.2174/1566524043360753; LEE HC, 1995, J BIOL CHEM, V270, P9060, DOI 10.1074/jbc.270.16.9060; Li J, 2007, MOL ENDOCRINOL, V21, P159, DOI 10.1210/me.2006-0340; LUND F, 1995, IMMUNOL TODAY, V16, P469, DOI 10.1016/0167-5699(95)80029-8; Masgrau R, 2003, CURR BIOL, V13, P247, DOI 10.1016/S0960-9822(03)00041-1; McAvoy T, 2009, P NATL ACAD SCI USA, V106, P3531, DOI 10.1073/pnas.0813263106; McLeod SJ, 2002, J IMMUNOL, V169, P1365, DOI 10.4049/jimmunol.169.3.1365; Mehta K, 1996, FASEB J, V10, P1408, DOI 10.1096/fasebj.10.12.8903511; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Podesta M, 2005, J BIOL CHEM, V280, P5343, DOI 10.1074/jbc.M408085200; QUILLIAM LA, 1991, J IMMUNOL, V147, P1628; Rah SY, 2007, J BIOL CHEM, V282, P5653, DOI 10.1074/jbc.M609478200; Rah SY, 2005, J BIOL CHEM, V280, P2888, DOI 10.1074/jbc.M409592200; Rongvaux A, 2003, BIOESSAYS, V25, P683, DOI 10.1002/bies.10297; Sabbatini ME, 2008, J BIOL CHEM, V283, P23884, DOI 10.1074/jbc.M800754200; SEBOK K, 1993, J IMMUNOL, V150, P1524; Shimomura H, 2004, ARCH BIOCHEM BIOPHYS, V431, P124, DOI 10.1016/j.abb.2004.07.021; Soares S, 2007, AM J PHYSIOL-CELL PH, V292, pC227, DOI 10.1152/ajpcell.00638.2005; Somekawa S, 2005, CIRC RES, V97, P655, DOI 10.1161/01.RES.0000183880.49270.f9; Steen M, 2007, J BIOL CHEM, V282, P18864, DOI 10.1074/jbc.M610925200; TSIEN RY, 1982, NATURE, V295, P68, DOI 10.1038/295068a0; Tsygankova OM, 2001, MOL CELL BIOL, V21, P1921, DOI 10.1128/MCB.21.6.1921-1929.2001; Wilson HL, 1998, BIOCHEM J, V331, P837, DOI 10.1042/bj3310837; Xie GH, 2003, BIOCHEM BIOPH RES CO, V307, P713, DOI 10.1016/S0006-291X(03)01240-3; Yamasaki M, 2005, CURR BIOL, V15, P874, DOI 10.1016/j.cub.2005.04.033; ZOCCHI E, 1993, BIOCHEM BIOPH RES CO, V196, P1459, DOI 10.1006/bbrc.1993.2416	60	54	54	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21877	21887		10.1074/jbc.M109.066290	http://dx.doi.org/10.1074/jbc.M109.066290			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20442403	hybrid, Green Published			2022-12-27	WOS:000279516100072
J	Wang, HS; Kim, SS; Zhuo, M				Wang, Hansen; Kim, Susan S.; Zhuo, Min			Roles of Fragile X Mental Retardation Protein in Dopaminergic Stimulation-induced Synapse-associated Protein Synthesis and Subsequent alpha-Amino-3-hydroxyl-5-methyl-4-isoxazole-4-propionate (AMPA) Receptor Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; METABOTROPIC GLUTAMATE RECEPTORS; PREFRONTAL CORTEX NEURONS; MAMMALIAN TARGET; SIGNALING PATHWAY; GENETIC-EVIDENCE; D1 RECEPTORS; TRANSLATIONAL CONTROL; HIPPOCAMPAL-NEURONS; CORTICAL-NEURONS	Fragile X syndrome, the most common form of inherited mental retardation, is caused by the absence of the RNA-binding protein fragile X mental retardation protein (FMRP). FMRP regulates local protein synthesis in dendritic spines. Dopamine (DA) is involved in the modulation of synaptic plasticity. Activation of DA receptors can regulate higher brain functions in a protein synthesis-dependent manner. Our recent study has shown that FMRP acts as a key messenger for DA modulation in forebrain neurons. Here, we demonstrate that FMRP is critical for DA D1 receptor-mediated synthesis of synapse-associated protein 90/PSD-95-associated protein 3 (SAPAP3) in the prefrontal cortex (PFC). DA D1 receptor stimulation induced dynamic changes of FMRP phosphorylation. The changes in FMRP phosphorylation temporally correspond with the expression of SAPAP3 after D1 receptor stimulation. Protein phosphatase 2A, ribosomal protein S6 kinase, and mammalian target of rapamycin are the key signaling molecules for FMRP linking DA D1 receptors to SAPAP3. Knockdown of SAPAP3 did not affect surface expression of alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-4-propionate (AMPA) GluR1 receptors induced by D1 receptor activation but impaired their subsequent internalization in cultured PFC neurons; the subsequent internalization of GluR1 was also impaired in Fmr1 knock-out PFC neurons, suggesting that FMRP may be involved in subsequent internalization of GluR1 through regulating the abundance of SAPAP3 after DA D1 receptor stimulation. Our study thus provides further insights into FMRP involvement in DA modulation and may help to reveal the molecular mechanisms underlying impaired learning and memory in fragile X syndrome.	[Wang, Hansen; Kim, Susan S.; Zhuo, Min] Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto	Zhuo, M (corresponding author), Univ Toronto, Fac Med, Dept Physiol, Med Sci Bldg,Rm 3342,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	min.zhuo@utoronto.ca	Zhuo, Min/A-2072-2008; wang, hansen/I-2510-2019; Cabrera, Mariel/GMX-2706-2022	Zhuo, Min/0000-0001-9062-3241; wang, hansen/0000-0003-4414-3372; 	EJLB Canadian Institutes of Health Research Michael Smith Chair in Neurosciences and Mental Health; Canada Research Chair; NeuroCanada; Canadian Institutes of Health [CIHR66975, CIHR81086]; Fragile X Research Foundation of Canada	EJLB Canadian Institutes of Health Research Michael Smith Chair in Neurosciences and Mental Health(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NeuroCanada; Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Fragile X Research Foundation of Canada	This work was supported by grants from the EJLB Canadian Institutes of Health Research Michael Smith Chair in Neurosciences and Mental Health, Canada Research Chair, and NeuroCanada and by Canadian Institutes of Health Research Operating Grants CIHR66975 and CIHR81086 (to M. Z.). 1 Supported by a postdoctoral fellowship from the Fragile X Research Foundation of Canada.	Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Antion MD, 2008, LEARN MEMORY, V15, P29, DOI 10.1101/lm.661908; Antion MD, 2008, MOL CELL BIOL, V28, P2996, DOI 10.1128/MCB.00201-08; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Banko JL, 2006, J NEUROSCI, V26, P2167, DOI 10.1523/JNEUROSCI.5196-05.2006; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Belmonte MK, 2006, NAT NEUROSCI, V9, P1221, DOI 10.1038/nn1765; Bingol B, 2004, NEUROPHARMACOLOGY, V47, P755, DOI 10.1016/j.neuropharm.2004.07.028; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Calabresi P, 2000, J NEUROSCI, V20, P8443, DOI 10.1523/JNEUROSCI.20-22-08443.2000; Ceman S, 2003, HUM MOL GENET, V12, P3295, DOI 10.1093/hmg/ddg350; Chen GJ, 2004, P NATL ACAD SCI USA, V101, P2596, DOI 10.1073/pnas.0308618100; Chen L, 2007, J NEUROPHYSIOL, V97, P2448, DOI 10.1152/jn.00317.2006; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Cota D, 2008, J NEUROSCI, V28, P7202, DOI 10.1523/JNEUROSCI.1389-08.2008; Dounay AB, 2002, CURR MED CHEM, V9, P1939, DOI 10.2174/0929867023368791; FENG Y, 1995, SCIENCE, V268, P731, DOI 10.1126/science.7732383; Gao WJ, 2001, P NATL ACAD SCI USA, V98, P295, DOI 10.1073/pnas.011524298; Garber K, 2006, CURR OPIN GENET DEV, V16, P270, DOI 10.1016/j.gde.2006.04.010; Garber KB, 2008, EUR J HUM GENET, V16, P666, DOI 10.1038/ejhg.2008.61; Gong B, 2007, EUR J NEUROSCI, V26, P275, DOI 10.1111/j.1460-9568.2007.05669.x; Gong R, 2006, J BIOL CHEM, V281, P18802, DOI 10.1074/jbc.M512524200; Greenough WT, 2001, P NATL ACAD SCI USA, V98, P7101, DOI 10.1073/pnas.141145998; Grossman AW, 2006, J NEUROSCI, V26, P7151, DOI 10.1523/JNEUROSCI.1790-06.2006; Gurden H, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0003.2000; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Huang YY, 2007, LEARN MEMORY, V14, P497, DOI 10.1101/lm.593407; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; Huang YY, 2004, P NATL ACAD SCI USA, V101, P3236, DOI 10.1073/pnas.0308280101; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Jin P, 2003, TRENDS BIOCHEM SCI, V28, P152, DOI 10.1016/S0968-0004(03)00033-1; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Lemon N, 2006, J NEUROSCI, V26, P7723, DOI 10.1523/JNEUROSCI.1454-06.2006; Mao LM, 2005, J BIOL CHEM, V280, P12602, DOI 10.1074/jbc.M411709200; Margolis EB, 2008, J NEUROSCI, V28, P8908, DOI 10.1523/JNEUROSCI.1526-08.2008; Matsuda Y, 2006, J NEUROSCI, V26, P4803, DOI 10.1523/JNEUROSCI.5312-05.2006; Nagai T, 2007, LEARN MEMORY, V14, P117, DOI 10.1101/lm.461407; Narayanan U, 2008, J BIOL CHEM, V283, P18478, DOI 10.1074/jbc.C800055200; Narayanan U, 2007, J NEUROSCI, V27, P14349, DOI 10.1523/JNEUROSCI.2969-07.2007; Nishi A, 2008, J NEUROSCI, V28, P10460, DOI 10.1523/JNEUROSCI.2518-08.2008; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Paspalas CD, 2005, J NEUROSCI, V25, P1260, DOI 10.1523/JNEUROSCI.3436-04.2005; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Polakiewicz RD, 1998, J BIOL CHEM, V273, P23534, DOI 10.1074/jbc.273.36.23534; Price CJ, 1999, J NEUROCHEM, V73, P2441, DOI 10.1046/j.1471-4159.1999.0732441.x; Ronesi JA, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.15pe6; Saitoh M, 2002, J BIOL CHEM, V277, P20104, DOI 10.1074/jbc.M201745200; Santini E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000308; Schicknick H, 2008, CEREB CORTEX, V18, P2646, DOI 10.1093/cercor/bhn026; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Shang YZ, 2009, J NEUROCHEM, V111, P635, DOI 10.1111/j.1471-4159.2009.06314.x; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; Siomi MC, 2002, MOL CELL BIOL, V22, P8438, DOI 10.1128/MCB.22.24.8438-8447.2002; SLOBODYANSKY E, 1995, AM J PHYSIOL-RENAL, V268, pF279, DOI 10.1152/ajprenal.1995.268.2.F279; Smith WB, 2005, NEURON, V45, P765, DOI 10.1016/j.neuron.2005.01.015; Snyder SH, 2006, NEURON, V49, P484, DOI 10.1016/j.neuron.2006.02.002; Sun X, 2005, J NEUROSCI, V25, P7342, DOI 10.1523/JNEUROSCI.4603-04.2005; Swayze RD, 2004, NEUROPHARMACOLOGY, V47, P764, DOI 10.1016/j.neuropharm.2004.07.014; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Terracciano A, 2005, AM J MED GENET C, V137C, P32, DOI 10.1002/ajmg.c.30062; Wang H, 2008, NEURON, V59, P634, DOI 10.1016/j.neuron.2008.06.027; Wang HS, 2008, J NEUROSCI, V28, P4385, DOI 10.1523/JNEUROSCI.0646-08.2008; Wang HS, 2007, J BIOL CHEM, V282, P1507, DOI 10.1074/jbc.M607291200; Wang HS, 2009, J BIOL CHEM, V284, P18953, DOI 10.1074/jbc.M109.019141; Weiler IJ, 2004, P NATL ACAD SCI USA, V101, P17504, DOI 10.1073/pnas.0407533101; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Weinshenker D, 2008, NATURE, V455, P607, DOI 10.1038/455607a; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Welch JM, 2004, J COMP NEUROL, V472, P24, DOI 10.1002/cne.20060; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; Wolf ME, 2003, ANN NY ACAD SCI, V1003, P241, DOI 10.1196/annals.1300.015; Yan Z, 1999, P NATL ACAD SCI USA, V96, P11607, DOI 10.1073/pnas.96.20.11607; Yang CR, 1996, J NEUROSCI, V16, P1922; Zhao MG, 2005, J NEUROSCI, V25, P7385, DOI 10.1523/JNEUROSCI.1520-05.2005	80	43	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21888	21901		10.1074/jbc.M110.116293	http://dx.doi.org/10.1074/jbc.M110.116293			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20457613	hybrid, Green Published			2022-12-27	WOS:000279516100073
J	Tejero, J; Haque, MM; Durra, D; Stuehr, DJ				Tejero, Jesus; Haque, Mohammad Mahfuzul; Durra, Deborah; Stuehr, Dennis J.			A Bridging Interaction Allows Calmodulin to Activate NO Synthase through a Bi-modal Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; INTRAPROTEIN ELECTRON-TRANSFER; LASER FLASH-PHOTOLYSIS; REDUCTASE DOMAIN; CONFORMATIONAL EQUILIBRIUM; 2-DOMAIN CONSTRUCT; CONTROL ELEMENT; SURFACE-CHARGE; FLOW-THROUGH; CATALYSIS	Calmodulin (CaM) activates the nitric-oxide synthases (NOS) by a mechanism that is not completely understood. A recent crystal structure showed that bound CaM engages in a bridging interaction with the NOS FMN subdomain. We investigated its importance in neuronal NOS (nNOS) by mutating the two residues that primarily create the bridging interaction (Arg(752) in the FMN subdomain and Glu(47) in CaM). Mutations designed to completely destroy the bridging interaction prevented bound CaM from increasing electron flux through the FMN subdomain and diminished the FMN-to-heme electron transfer by 90%, whereas mutations that partly preserve the interaction had intermediate effects. The bridging interaction appeared to control FMN subdomain interactions with both its electron donor (NADPH-FAD subdomain) and electron acceptor (heme domain) partner subdomains in nNOS. We conclude that the Arg(752)-Glu(47) bridging interaction is the main feature that enables CaM to activate nNOS. The mechanism is bi-modal and links a single structural aspect of CaM binding to specific changes in nNOS protein conformational and electron transfer properties that are essential for catalysis.	[Tejero, Jesus; Haque, Mohammad Mahfuzul; Durra, Deborah; Stuehr, Dennis J.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Stuehr, DJ (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Pathobiol, NC 22,9500 Euclid Ave, Cleveland, OH 44195 USA.	stuehrd@ccf.org	Tejero, Jesus/G-3953-2017	Tejero, Jesus/0000-0003-3245-9978; HAQUE, MOHAMMAD/0000-0003-0852-6368	National Institutes of Health [CA53914, GM51491, HL76491]; American Heart Association [0625632B]; NATIONAL CANCER INSTITUTE [R01CA053914, R29CA053914] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA53914, GM51491, and HL76491 (to D. J. S.) and American Heart Association Postdoctoral Fellowship 0625632B (to J. T.).	ABUSOUD HM, 1994, J BIOL CHEM, V269, P32047; Adak S, 2001, J BIOL CHEM, V276, P1244, DOI 10.1074/jbc.M006857200; Adak S, 1999, J BIOL CHEM, V274, P22313, DOI 10.1074/jbc.274.32.22313; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Chen PF, 2003, J BIOL CHEM, V278, P52392, DOI 10.1074/jbc.M305469200; Craig DH, 2002, J BIOL CHEM, V277, P33987, DOI 10.1074/jbc.M203118200; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; Dunford AJ, 2007, BIOCHEMISTRY-US, V46, P5018, DOI 10.1021/bi7001339; Feng CJ, 2007, J AM CHEM SOC, V129, P5621, DOI 10.1021/ja068685b; Feng CJ, 2006, BIOCHEMISTRY-US, V45, P6354, DOI 10.1021/bi060223n; Feng CJ, 2009, DALTON T, P6692, DOI 10.1039/b902884f; Feng CJ, 2009, J BIOL INORG CHEM, V14, P133, DOI 10.1007/s00775-008-0431-2; Feng CJ, 2006, J AM CHEM SOC, V128, P3808, DOI 10.1021/ja0578606; Fischmann TO, 1999, NAT STRUCT BIOL, V6, P233, DOI 10.1038/6675; Gachhui R, 1998, J BIOL CHEM, V273, P5451, DOI 10.1074/jbc.273.10.5451; Gachhui R, 1996, J BIOL CHEM, V271, P20594, DOI 10.1074/jbc.271.34.20594; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Gorren ACF, 2007, BBA-GEN SUBJECTS, V1770, P432, DOI 10.1016/j.bbagen.2006.08.019; Gruez A, 2000, J MOL BIOL, V299, P199, DOI 10.1006/jmbi.2000.3748; Guan ZW, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.000810; Hall DA, 2001, P NATL ACAD SCI USA, V98, P9521, DOI 10.1073/pnas.171168898; Haque MM, 2009, J BIOL CHEM, V284, P19237, DOI 10.1074/jbc.M109.013144; Ilagan RP, 2009, BIOCHEMISTRY-US, V48, P3864, DOI 10.1021/bi8021087; Ilagan RP, 2008, J BIOL CHEM, V283, P19603, DOI 10.1074/jbc.M802914200; Jones RJ, 2004, J BIOL CHEM, V279, P36876, DOI 10.1074/jbc.M402808200; Knudsen GM, 2003, J BIOL CHEM, V278, P31814, DOI 10.1074/jbc.M303267200; Konas DW, 2004, J BIOL CHEM, V279, P35412, DOI 10.1074/jbc.M400872200; Lane P, 2002, J BIOL CHEM, V277, P19087, DOI 10.1074/jbc.M200258200; Leys D, 2003, NAT STRUCT BIOL, V10, P219, DOI 10.1038/nsb894; Newman E, 2004, J BIOL CHEM, V279, P33547, DOI 10.1074/jbc.M403892200; Panda K, 2006, J BIOL CHEM, V281, P36819, DOI 10.1074/jbc.M606129200; Pfeiffer S, 1999, ANGEW CHEM INT EDIT, V38, P1715, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1714::AID-ANIE1714>3.0.CO;2-3; Roman LJ, 2006, J BIOL CHEM, V281, P23111, DOI 10.1074/jbc.M603671200; Roman LJ, 2000, J BIOL CHEM, V275, P29225, DOI 10.1074/jbc.M004766200; Roman LJ, 2000, J BIOL CHEM, V275, P21914, DOI 10.1074/jbc.M002449200; Salerno JC, 2009, FEBS J, V276, P6677, DOI 10.1111/j.1742-4658.2009.07382.x; Santolini J, 2001, J BIOL CHEM, V276, P48887, DOI 10.1074/jbc.M108666200; Santolini J, 2001, J BIOL CHEM, V276, P1233, DOI 10.1074/jbc.M006858200; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Spratt DE, 2006, FEBS J, V273, P1759, DOI 10.1111/j.1742-4658.2006.05193.x; Spratt DE, 2007, BIOCHEMISTRY-US, V46, P8288, DOI 10.1021/bi062130b; Stuehr DJ, 2009, FEBS J, V276, P3959, DOI 10.1111/j.1742-4658.2009.07120.x; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; Stuehr DJ, 2000, HANDB EXP PHARMACOL, V143, P33; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; STUEHR DJ, 1992, J BIOL CHEM, V267, P20547; Tiso M, 2005, J BIOL CHEM, V280, P39208, DOI 10.1074/jbc.M507775200; Tiso M, 2007, BIOCHEMISTRY-US, V46, P14418, DOI 10.1021/bi701646k; Toogood HS, 2007, FEBS J, V274, P5481, DOI 10.1111/j.1742-4658.2007.06107.x; Welland A, 2008, BIOCHEMISTRY-US, V47, P9771, DOI 10.1021/bi800787m; Wolthers KR, 2007, BIOCHEMISTRY-US, V46, P6696, DOI 10.1021/bi700339v; Xia CW, 2009, J BIOL CHEM, V284, P30708, DOI 10.1074/jbc.M109.031682	53	30	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					25941	25949		10.1074/jbc.M110.126797	http://dx.doi.org/10.1074/jbc.M110.126797			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20529840	Green Published, hybrid			2022-12-27	WOS:000280921000008
J	Tossidou, I; Teng, B; Drobot, L; Meyer-Schwesinger, C; Worthmann, K; Haller, H; Schiffer, M				Tossidou, Irini; Teng, Beina; Drobot, Lyudmyla; Meyer-Schwesinger, Catherine; Worthmann, Kirstin; Haller, Hermann; Schiffer, Mario			CIN85/Ruk(L) Is a Novel Binding Partner of Nephrin and Podocin and Mediates Slit Diaphragm Turnover in Podocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COILED-COIL DOMAIN; MEMBRANE CURVATURE; DOWN-REGULATION; BAR DOMAINS; PROTEIN; EXPRESSION; UBIQUITIN; KINASE; FAMILY; MONOUBIQUITINATION	Podocyte damage is the basis of many glomerular diseases with ultrastructural changes and decreased expression of components of the slit diaphragm such as nephrin and podocin. Under physiological conditions it is likely that the slit diaphragm underlies permanent renewal processes to indemnify its stability in response to changes in filtration pressure. This would require constant reorganization of the podocyte foot process and the renewal of slit diaphragm components. Thus far, the mechanisms underlying the turnover of slit diaphragm proteins are largely unknown. In this manuscript we examined a mechanism of nephrin endocytosis via CIN85/Ruk(L)-mediated ubiquitination. We can demonstrate that the loss of nephrin expression and onset of the proteinuria in CD2AP(-/-) mice correlates with an increased accumulation of ubiquitinated proteins and expression of CIN85/Ruk(L) in podocytes. In cultured murine podocytes CD2AP deficiency leads to an early ubiquitination of nephrin and podocin after stimulation with fibroblast growth factor-4. Binding assays with different CIN85/Ruk iso-forms and mutants showed that nephrin and podocin are binding to the coiled-coil domain of CIN85/Ruk(L). We found that in the presence of CIN85/Ruk(L), which is involved in down-regulation of receptor-tyrosine kinases, nephrin is internalized after stimulation with fibroblast growth factor-4. Interestingly, co-expression of CIN85/Ruk(L) with CD2AP led to a decreased binding of CIN85/Ruk(L) to nephrin and podocin, which indicates a functional competition between CD2AP and CIN85/Ruk(L). Our results support a novel role for CIN85/Ruk(L) in slit diaphragm turnover and proteinuria.	[Tossidou, Irini; Teng, Beina; Worthmann, Kirstin; Haller, Hermann; Schiffer, Mario] Hannover Med Sch, Div Nephrol, D-30625 Hannover, Germany; [Drobot, Lyudmyla] Palladin Inst Biochem, Inst Cell Biol, UA-01601 Kiev, Ukraine; [Meyer-Schwesinger, Catherine] Univ Hosp Hamburg Eppendorf, Dept Internal Med, D-20251 Hamburg, Germany	Hannover Medical School; National Academy of Sciences Ukraine; Institute of Cell Biology & Genetic Engineering of the National Academy of Sciences of Ukraine; Palladin Institute of Biochemistry of NASU; University of Hamburg; University Medical Center Hamburg-Eppendorf	Tossidou, I (corresponding author), Hannover Med Sch, Div Nephrol, Carl Neuberg St 1, D-30625 Hannover, Germany.	tossidou.irini@mh-hannover.de	Drobot, Liudmyla B/J-8642-2017; Schiffer, Mario/U-7050-2019	Schiffer, Mario/0000-0002-8414-1470	Deutsche Forschungsgemeinschaft [SCHI 587/2-2, SFB 566, B16]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by an Emmy-Noether fellowship from the Deutsche Forschungsgemeinschaft (SCHI 587/2-2) and SFB 566, Project B16 (to M.S.).	Buchman VL, 2002, GENE, V295, P13, DOI 10.1016/S0378-1119(02)00821-1; Dikic I, 2002, FEBS LETT, V529, P110, DOI 10.1016/S0014-5793(02)03188-5; Endlich K, 2001, CURR OPIN NEPHROL HY, V10, P331, DOI 10.1097/00041552-200105000-00006; Gagliardini E, 2003, AM J NEPHROL, V23, P277, DOI 10.1159/000072281; Gaidos G, 2007, J CELL SCI, V120, P2366, DOI 10.1242/jcs.004333; Gout I, 2000, EMBO J, V19, P4015, DOI 10.1093/emboj/19.15.4015; Grunkemeyer JA, 2005, J BIOL CHEM, V280, P29677, DOI 10.1074/jbc.M504004200; Gu F, 2001, CELL MOL LIFE SCI, V58, P1067, DOI 10.1007/PL00000922; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Haglund K, 2002, P NATL ACAD SCI USA, V99, P12191, DOI 10.1073/pnas.192462299; Harita Y, 2009, J BIOL CHEM, V284, P8951, DOI 10.1074/jbc.M806851200; Havrylov S, 2008, TRAFFIC, V9, P798, DOI 10.1111/j.1600-0854.2008.00724.x; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hicke L, 2001, YEAST, V18, pS28; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; Huber TB, 2002, J AM SOC NEPHROL, V13, p124A; Huber TB, 2001, J BIOL CHEM, V276, P41543, DOI 10.1074/jbc.C100452200; Ikezumi Y, 2008, BIOCHEM BIOPH RES CO, V376, P706, DOI 10.1016/j.bbrc.2008.09.049; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Itoh T, 2005, CELL STRUCT FUNCT, V30, P24; Kerjaschki D, 2001, J CLIN INVEST, V108, P1583, DOI 10.1172/JCI200114629; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kirsch KH, 1999, P NATL ACAD SCI USA, V96, P6211, DOI 10.1073/pnas.96.11.6211; Meyer-Schwesinger C, 2009, J PATHOL, V217, P452, DOI 10.1002/path.2446; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Ryan PJ, 1998, BIOCHEM BIOPH RES CO, V244, P763, DOI 10.1006/bbrc.1998.8326; Schiffer M, 2004, J BIOL CHEM, V279, P37004, DOI 10.1074/jbc.M403534200; Schiffer M, 2002, J AM SOC NEPHROL, V13, p43A; Scott PM, 2004, NAT CELL BIOL, V6, P252, DOI 10.1038/ncb1107; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Shih NY, 2001, AM J PATHOL, V159, P2303, DOI 10.1016/S0002-9440(10)63080-5; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Shmuel M, 2006, J BIOL CHEM, V281, P13300, DOI 10.1074/jbc.M513723200; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Tossidou I, 2007, J BIOL CHEM, V282, P7457, DOI 10.1074/jbc.M608519200; Tryggvason K, 2001, CURR OPIN NEPHROL HY, V10, P543, DOI 10.1097/00041552-200107000-00009; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; Xavier S, 2009, J AM SOC NEPHROL, V20, P2127, DOI 10.1681/ASN.2008070806; Zhang J, 2009, CELL RES, V19, P733, DOI 10.1038/cr.2009.51; Zimmerberg J, 2004, CURR BIOL, V14, pR250, DOI 10.1016/j.cub.2004.02.060	42	47	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25285	25295		10.1074/jbc.M109.087239	http://dx.doi.org/10.1074/jbc.M109.087239			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20457601	hybrid, Green Published			2022-12-27	WOS:000280682400021
J	Yang, H; Liu, S; Cai, HW; Wan, L; Li, SF; Li, YP; Cheng, JQ; Lu, XF				Yang, Hao; Liu, Shan; Cai, Huawei; Wan, Lin; Li, Shengfu; Li, Youping; Cheng, Jingqiu; Lu, Xiaofeng			Chondroitin Sulfate as a Molecular Portal That Preferentially Mediates the Apoptotic Killing of Tumor Cells by Penetratin-directed Mitochondria-disrupting Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL PEPTIDE; TARGETED CANCER-THERAPY; IN-VIVO; SURFACE GLYCOSAMINOGLYCANS; BIOLOGICAL ROLE; DRUG-DELIVERY; P53; BINDING; INDUCTION; GROWTH	The use of cell-penetrating peptides (CPPs) as drug carriers for targeted therapy is limited by the unrestricted cellular translocation of CPPs. The preferential induction of tumor cell death by penetratin (Antp)-directed peptides (PNC27 and PNC28), however, suggests that the CPP Antp may contribute to the preferential cytotoxicity of these peptides. Using PNC27 as a molecular model, we constructed three novel peptides (PT, PR9, and PD3) by replacing the leader peptide Antp with one of three distinct CPPs (TAT, R9, or DPV3), respectively. The IC50 values of PNC27 in tumor cells were 2-3 times lower than in normal cells. However, all three engineered peptides demonstrated similar cytotoxic effects in tumor and normal cells. Another three chimeric peptides containing the leader peptide Antp with different mitochondria-disrupting peptides (KLA-Antp (KGA), B27-Antp (BA27), and B28-Antp (BA28)), preferentially induced apoptosis in tumor cells. The IC50 values of these peptides (3-10 mu M) were 3-6 times lower in tumor cells than in normal cells. In contrast, TAT-directed peptides (TAT-KLA (TK), TAT-B27 (TB27), and TAT-B28 (TB28)), were cytotoxic to both tumor and normal cells. These data demonstrate that the leader peptide Antp contributes to the preferential cytotoxicity of Antp-directed peptides. Furthermore, Antp-directed peptides bind chondroitin sulfate (CS), and the removal of endogenous CS reduces the cytotoxic effects of Antp-directed peptides in tumor cells. The overexpression of CS in tumor cells is positively correlated to the cell entry and cytotoxicity of Antp-directed peptides. These results suggest that CS overexpression in tumor cells is an important molecular portal that mediates the preferential cytotoxicity of Antp-directed peptides.	[Yang, Hao; Liu, Shan; Cai, Huawei; Wan, Lin; Li, Shengfu; Li, Youping; Cheng, Jingqiu; Lu, Xiaofeng] Sichuan Univ, W China Hosp, Minist Hlth, Key Lab Transplant Engn & Immunol, Chengdu 610041, Peoples R China	Sichuan University	Lu, XF (corresponding author), 1 Keyuan 4th Rd, Chengdu 610041, Peoples R China.	xiaofenglu@scu.edu.cn	Yang, Hao/ABV-4834-2022; Lu, Xiaofeng/ABD-9075-2021	Yang, Hao/0000-0003-2214-9474; Cai, Huawei/0000-0003-1341-8417	National Basic Research Program of China [2009CB522401]; Natural Science Fund of China [30873184]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China 2009CB522401 (to Y. L.) and Natural Science Fund of China 30873184 (to X. L.).	Asimakopoulou AP, 2008, IN VIVO, V22, P385; Bowne Wilbur B, 2007, Cancer Ther, V5B, P331; Bowne WB, 2008, ANN SURG ONCOL, V15, P3588, DOI 10.1245/s10434-008-0147-0; Chari RVJ, 2008, ACCOUNTS CHEM RES, V41, P98, DOI 10.1021/ar700108g; Console S, 2003, J BIOL CHEM, V278, P35109, DOI 10.1074/jbc.M301726200; De Coupade C, 2005, BIOCHEM J, V390, P407, DOI 10.1042/BJ20050401; Do TN, 2003, ONCOGENE, V22, P1431, DOI 10.1038/sj.onc.1206258; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Foerg C, 2008, J PHARM SCI-US, V97, P144, DOI 10.1002/jps.21117; Gotte M, 2006, CANCER RES, V66, P10233, DOI 10.1158/0008-5472.CAN-06-1464; Jain M, 2005, CANCER RES, V65, P7840, DOI 10.1158/0008-5472.CAN-05-0662; Kanovsky M, 2001, P NATL ACAD SCI USA, V98, P12438, DOI 10.1073/pnas.211280698; Kim AL, 1999, J BIOL CHEM, V274, P34924, DOI 10.1074/jbc.274.49.34924; Kodama J, 2007, EUR J CANCER, V43, P1460, DOI 10.1016/j.ejca.2007.02.007; Kreitman RJ, 2006, AAPS J, V8, pE532, DOI 10.1208/aapsj080363; Law B, 2006, MOL CANCER THER, V5, P1944, DOI 10.1158/1535-7163.MCT-05-0509; Lee CM, 2002, CANCER RES, V62, P4282; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li Y, 2005, INT J CANCER, V115, P55, DOI 10.1002/ijc.20838; Li Y, 2002, BIOCHEM BIOPH RES CO, V298, P439, DOI 10.1016/S0006-291X(02)02470-1; Marty C, 2004, CELL MOL LIFE SCI, V61, P1785, DOI 10.1007/s00018-004-4166-0; Matsuzaki K, 1997, BIOCHEMISTRY-US, V36, P2104, DOI 10.1021/bi961870p; Michl J, 2006, INT J CANCER, V119, P1577, DOI 10.1002/ijc.22029; Mueller J, 2008, BIOCONJUGATE CHEM, V19, P2363, DOI 10.1021/bc800194e; Muller-Tiemann BF, 1998, P NATL ACAD SCI USA, V95, P6079, DOI 10.1073/pnas.95.11.6079; Myrberg H, 2008, BIOCONJUGATE CHEM, V19, P70, DOI 10.1021/bc0701139; Poon GMK, 2007, BIOCHEM SOC T, V35, P788, DOI 10.1042/BST0350788; Prochiantz A, 2000, CURR OPIN CELL BIOL, V12, P400, DOI 10.1016/S0955-0674(00)00108-3; Ram N, 2008, J BIOL CHEM, V283, P24274, DOI 10.1074/jbc.M709971200; Rege K, 2007, CANCER RES, V67, P6368, DOI 10.1158/0008-5472.CAN-06-3658; Rezler EM, 2007, J AM CHEM SOC, V129, P4961, DOI 10.1021/ja066929m; Ricciardelli C, 2009, CANCER METAST REV, V28, P233, DOI 10.1007/s10555-009-9182-y; Risso A, 2002, MOL CELL BIOL, V22, P1926, DOI 10.1128/MCB.22.6.1926-1935.2002; Senatus PB, 2006, MOL CANCER THER, V5, P20, DOI 10.1158/1535-7163.MCT-05-0181; Skerlavaj B, 1996, J BIOL CHEM, V271, P28375, DOI 10.1074/jbc.271.45.28375; Snyder EL, 2005, CANCER RES, V65, P10646, DOI 10.1158/0008-5472.CAN-05-0118; Stewart KM, 2008, ORG BIOMOL CHEM, V6, P2242, DOI 10.1039/b719950c; Tan M, 2006, CANCER RES, V66, P3764, DOI 10.1158/0008-5472.CAN-05-2747; Vives E, 2008, BBA-REV CANCER, V1786, P126, DOI 10.1016/j.bbcan.2008.03.001; Wang ZY, 2003, BLOOD, V102, P1307, DOI 10.1182/blood-2002-09-2753; Yamada Shuhei, 2008, Curr Drug Discov Technol, V5, P289; Ziegler A, 2008, ADV DRUG DELIVER REV, V60, P580, DOI 10.1016/j.addr.2007.10.005	42	33	35	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25666	25676		10.1074/jbc.M109.089417	http://dx.doi.org/10.1074/jbc.M109.089417			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20484051	Green Published, hybrid			2022-12-27	WOS:000280682400060
J	Vigetti, D; Genasetti, A; Karousou, E; Viola, M; Moretto, P; Clerici, M; Deleonibus, S; De Luca, G; Hascall, VC; Passi, A				Vigetti, Davide; Genasetti, Anna; Karousou, Evgenia; Viola, Manuela; Moretto, Paola; Clerici, Moira; Deleonibus, Sara; De Luca, Giancarlo; Hascall, Vincent C.; Passi, Alberto			Proinflammatory Cytokines Induce Hyaluronan Synthesis and Monocyte Adhesion in Human Endothelial Cells through Hyaluronan Synthase 2 (HAS2) and the Nuclear Factor-kappa B (NF-kappa B) Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; INFLAMMATORY DISEASES; IN-VITRO; CD44; ACID; EXTRAVASATION; TRANSCRIPTION; INHIBITORS; EXPRESSION; RECEPTORS	Chronic inflammation is now accepted to have a critical role in the onset of several diseases as well as in vascular pathology, where macrophage transformation into foam cells contributes in atherosclerotic plaque formation. Endothelial cells (EC) have a critical function in recruitment of immune cells, and proinflammatory cytokines drive the specific expression of several adhesion proteins. During inflammatory responses several cells produce hyaluronan matrices that promote monocyte/macrophage adhesion through interactions with the hyaluronan receptor CD44 present on inflammatory cell surfaces. In this study, we used human umbilical chord vein endothelial cells (HUVECs) as a model to study the mechanism that regulates hyaluronan synthesis after treatment with proinflammatory cytokines. We found that interleukin 1 beta and tumor necrosis factors alpha and beta, but not transforming growth factors alpha and beta, strongly induced HA synthesis by NF-kappa B pathway. This signaling pathway mediated hyaluronan synthase 2 (HAS2) mRNA expression without altering other glycosaminoglycan metabolism. Moreover, we verified that U937 monocyte adhesion on stimulated HUVECs depends strongly on hyaluronan, and transfection with short interference RNA of HAS2 abrogates hyaluronan synthesis revealing the critical role of HAS2 in this process.	[Vigetti, Davide; Genasetti, Anna; Karousou, Evgenia; Viola, Manuela; Moretto, Paola; Clerici, Moira; Deleonibus, Sara; De Luca, Giancarlo; Passi, Alberto] Univ Insubria, Dipartimento Sci Biomed Sperimentali & Clin, I-21100 Varese, Italy; [Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA	University of Insubria; Cleveland Clinic Foundation	Passi, A (corresponding author), Univ Insubria, Dipartimento Sci Biomed Sperimentali & Clin, Via JH Dunant 5, I-21100 Varese, Italy.	alberto.passi@uninsubria.it	passi, alberto g/A-1752-2018; Viola, Manuela/B-7120-2011; Vigetti, Davide/C-9861-2010	passi, alberto g/0000-0003-3328-3089; Viola, Manuela/0000-0002-0634-6390; Vigetti, Davide/0000-0002-6339-8453	Fondazione Comunitaria del Varesotto-ONLUS; Centro Insubre di Biotecnologie per la Salute Umana	Fondazione Comunitaria del Varesotto-ONLUS; Centro Insubre di Biotecnologie per la Salute Umana	This work was supported by Fondazione Comunitaria del Varesotto-ONLUS, PRIN 2007 (to G. D. L.) and a young researcher award from the Centro Insubre di Biotecnologie per la Salute Umana (to D. V.).	Alam C. A. S., 2005, Inflammopharmacology, V12, P535; Anderson P, 2009, NAT IMMUNOL, V10, P233, DOI 10.1038/ni0309-233; Campo GM, 2010, BIOCHIMIE, V92, P204, DOI 10.1016/j.biochi.2009.10.006; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de la Motte C, 2009, AM J PATHOL, V174, P2254, DOI 10.2353/ajpath.2009.080831; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; DeGrendele HC, 1996, J EXP MED, V183, P1119, DOI 10.1084/jem.183.3.1119; Estess P, 1999, J EXP MED, V190, P9, DOI 10.1084/jem.190.1.9; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; IALENTI A, 1994, AGENTS ACTIONS, V43, P44, DOI 10.1007/BF02005763; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Johnson Pauline, 2009, Inflammation & Allergy Drug Targets, V8, P208; Kao JJ, 2006, EXP GERONTOL, V41, P641, DOI 10.1016/j.exger.2006.04.003; Kaplan D, 1996, IMMUNOL TODAY, V17, P303, DOI 10.1016/0167-5699(96)30017-0; Karousou EG, 2005, BIOMED CHROMATOGR, V19, P761, DOI 10.1002/bmc.511; Khan AI, 2004, J IMMUNOL, V173, P7594, DOI 10.4049/jimmunol.173.12.7594; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; MACKAY F, 1993, J EXP MED, V177, P1277, DOI 10.1084/jem.177.5.1277; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; MANTOVANI A, 1992, FASEB J, V6, P2591, DOI 10.1096/fasebj.6.8.1592209; Miltner O, 2002, OSTEOARTHR CARTILAGE, V10, P680, DOI 10.1053/joca.2002.0815; Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604; Monslow J, 2006, J BIOL CHEM, V281, P18043, DOI 10.1074/jbc.M510467200; Nandi A, 2000, J BIOL CHEM, V275, P14939, DOI 10.1074/jbc.275.20.14939; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Ren J, 2009, J BIOL CHEM, V284, P16621, DOI 10.1074/jbc.M806430200; Rilla K, 2005, J BIOL CHEM, V280, P31890, DOI 10.1074/jbc.M504736200; RUFFELL B, 2009, SCI HYALURONAN TODAY; Savani RC, 1995, INT J TISSUE REACT, V17, P141; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Termeer CC, 2000, J IMMUNOL, V165, P1863, DOI 10.4049/jimmunol.165.4.1863; Vigetti D, 2008, J BIOL CHEM, V283, P4448, DOI 10.1074/jbc.M709051200; Vigetti D, 2006, FASEB J, V20, P1118, DOI 10.1096/fj.05-4504com; Vigetti D, 2009, J BIOL CHEM, V284, P30684, DOI 10.1074/jbc.M109.040386; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; Vigetti D, 2008, THESCIENTIFICWORLDJO, V8, P1116, DOI 10.1100/tsw.2008.145; Viola M, 2006, J PHARMACEUT BIOMED, V41, P36, DOI 10.1016/j.jpba.2005.10.010	41	99	102	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24639	24645		10.1074/jbc.M110.134536	http://dx.doi.org/10.1074/jbc.M110.134536			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20522558	hybrid, Green Published			2022-12-27	WOS:000280542100036
J	Bubien, JK				Bubien, James K.			Epithelial Na+ Channel (ENaC), Hormones, and Hypertension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							OBESITY-INDUCED HYPERTENSION; SALT-SENSITIVE HYPERTENSION; LIDDLES-SYNDROME; BLOOD-PRESSURE; SODIUM-CHANNEL; RESISTANT HYPERTENSION; METABOLIC SYNDROME; HYPERACTIVE ENAC; BETA-SUBUNIT; PY MOTIF	This minireview examines both the basic science and clinical observations over the past 20 years to show how and why overstimulation of the amiloride-sensitive epithelial Na+ channel (ENaC) expressed by epithelial principal cells of the renal collecting duct may be responsible for a large portion of hypertension in modern society. This idea is based on the finding that, in Liddle syndrome, a mutation of the beta- and/or gamma-subunits of ENaC produces an activated ion channel, in turn resulting in severe hypertension that is resistant to most forms of conventional antihypertensive therapy. ENaC can also be stimulated to conduct sodium by two hormones: aldosterone and insulin. These hormones are both often elevated in obese individuals with therapy-resistant hypertension. Thus, overstimulation of ENaC by metabolic abnormalities in obese individuals may be a likely cause of the hypertension that accompanies obesity. The molecular mechanisms underlying both Liddle syndrome and obesity-related hypertension are different (i.e. genetic and hormonal, respectively), but both have the same end result, namely increased ENaC activity.	Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Bubien, JK (corresponding author), Univ Alabama Birmingham, Dept Physiol & Biophys, UAb Stn, Birmingham, AL 35294 USA.	jbubien@bellsouth.net			Cato Biosciences	Cato Biosciences	This is the fourth article in the "Biochemistry in Medicine: Hypertension Minireview Series." J.K.B. has an equity interest in Hemodynamic Therapeutics, a subsidiary of Cato Biosciences. This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Abcar Antoine C, 2009, Perm J, V13, P73; BERNE RM, 1983, PRINCIPLES PHYSL, P929; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Blazer-Yost BL, 2004, ADV EXP MED BIOL, V559, P359; Blazer-Yost BL, 1998, AM J PHYSIOL-CELL PH, V274, pC1373, DOI 10.1152/ajpcell.1998.274.5.C1373; BOTEROVELEZ M, 1994, NEW ENGL J MED, V330, P178, DOI 10.1056/NEJM199401203300305; Bruce MC, 2008, BIOCHEM J, V415, P155, DOI 10.1042/BJ20071708; Bubien JK, 2003, FASEB J, V17, pA860; Bubien JK, 1996, AM J PHYSIOL-CELL PH, V270, pC208, DOI 10.1152/ajpcell.1996.270.1.C208; Bubien JK, 2001, J BIOL CHEM, V276, P8557, DOI 10.1074/jbc.M008886200; BUBIEN JK, 1994, J BIOL CHEM, V269, P17780; Buck TM, 2010, MOL BIOL CELL, V21, P1047, DOI 10.1091/mbc.E09-11-0944; Butterworth MB, 2009, AM J PHYSIOL-RENAL, V296, pF10, DOI 10.1152/ajprenal.90248.2008; Calhoun DA, 2008, HYPERTENSION, V51, P1403, DOI 10.1161/HYPERTENSIONAHA.108.189141; Carter AR, 2001, AM J PHYSIOL-CELL PH, V281, pC1413, DOI 10.1152/ajpcell.2001.281.5.C1413; de Paula RB, 2004, HYPERTENSION, V43, P41, DOI 10.1161/01.HYP.0000105624.68174.00; DEFRONZO RA, 1975, J CLIN INVEST, V55, P845, DOI 10.1172/JCI107996; Findling JW, 1997, J CLIN ENDOCR METAB, V82, P1071, DOI 10.1210/jc.82.4.1071; Fujita T, 2010, HYPERTENSION, V55, P813, DOI 10.1161/HYPERTENSIONAHA.109.149062; Garovic VD, 2006, NAT CLIN PRACT NEPHR, V2, P624, DOI 10.1038/ncpneph0309; Gonzaga CC, 2008, CURR HYPERTENS REP, V10, P496, DOI 10.1007/s11906-008-0092-0; Goodfriend TL, 2004, HYPERTENSION, V43, P518, DOI 10.1161/01.HYP.0000116223.97436.e5; Haenni A, 2001, J HYPERTENS, V19, P107, DOI 10.1097/00004872-200101000-00014; HALL JE, 1993, HYPERTENSION, V22, P292, DOI 10.1161/01.HYP.22.3.292; Hamm LL, 2010, CURR OPIN NEPHROL HY, V19, P98, DOI 10.1097/MNH.0b013e328332bda4; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; Krug AW, 2008, HYPERTENSION, V51, P1252, DOI 10.1161/HYPERTENSIONAHA.107.109439; LIDDLE GW, 1963, T ASSOC AM PHYSICIAN, V76, P199; Loffing J, 2009, PFLUG ARCH EUR J PHY, V458, P111, DOI 10.1007/s00424-009-0656-0; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Murphy SC, 2009, CLIN CHEM, V55, P2093, DOI 10.1373/clinchem.2009.127506; MUTOH S, 1986, J UROLOGY, V135, P557, DOI 10.1016/S0022-5347(17)45735-1; Oh J, 2000, YONSEI MED J, V41, P276, DOI 10.3349/ymj.2000.41.2.276; PONTIROLI AE, 1992, DIABETOLOGIA, V35, P294, DOI 10.1007/BF00400934; Pratt JH, 2005, J AM SOC NEPHROL, V16, P3154, DOI 10.1681/ASN.2005050460; Pratt JH, 2001, HYPERTENSION, V38, P1124, DOI 10.1161/hy1101.095010; REAVEN GM, 1987, LANCET, V2, P435; Reungjui S, 2008, J AM SOC NEPHROL, V19, P125, DOI 10.1681/ASN.2007030261; Rezkalla L, 2000, CLIN NEPHROL, V53, P66; ROCCHINI AP, 1989, HYPERTENSION, V14, P367, DOI 10.1161/01.HYP.14.4.367; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Saha C, 2005, HYPERTENSION, V46, P481, DOI 10.1161/01.HYP.0000179582.42830.1d; SAWICKI PT, 1992, J AM SOC NEPHROL, V3, pS64; SAWICKI PT, 1992, DIABETOLOGIA, V35, P649, DOI 10.1007/BF00400257; SCHAFER JK, 2003, AM J PHYSIOL-RENAL, V284, pF221; Scholze J, 2007, CIRCULATION, V115, P1991, DOI 10.1161/CIRCULATIONAHA.106.625400; Shi PP, 2008, AM J PHYSIOL-RENAL, V295, pF462, DOI 10.1152/ajprenal.90300.2008; SHIMAMOTO K, 1994, HYPERTENSION, V23, pI29, DOI 10.1161/01.HYP.23.1_Suppl.I29; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Simonsen U, 2009, PHARMACOL REP, V61, P105, DOI 10.1016/S1734-1140(09)70012-X; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Sowers JR, 2009, ANN INTERN MED, V150, P776, DOI 10.7326/0003-4819-150-11-200906020-00005; Staub O, 2005, J AM SOC NEPHROL, V16, P3167, DOI 10.1681/ASN.2005050454; Warnock DG, 2001, AM J MED SCI, V322, P302, DOI 10.1097/00000441-200112000-00002; WARNOCK DG, 1994, HOSP PRACT, V29, P95, DOI 10.1080/21548331.1994.11443050; Weir MR, 2009, CLIN J AM SOC NEPHRO, V4, P2045, DOI 10.2215/CJN.03050509; Weisz OA, 2003, AM J PHYSIOL-RENAL, V285, pF833, DOI 10.1152/ajprenal.00088.2003; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200; Zhou ZH, 2001, AM J PHYSIOL-CELL PH, V281, pC1118, DOI 10.1152/ajpcell.2001.281.4.C1118	61	75	80	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23527	23531		10.1074/jbc.R109.025049	http://dx.doi.org/10.1074/jbc.R109.025049			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20460373	Green Published, hybrid			2022-12-27	WOS:000280291400001
J	Gilio, K; van Kruchten, R; Braun, A; Berna-Erro, A; Feijge, MAH; Stegner, D; van der Meijden, PEJ; Kuijpers, MJE; Varga-Szabo, D; Heemskerk, JWM; Nieswandt, B				Gilio, Karen; van Kruchten, Roger; Braun, Attila; Berna-Erro, Alejandro; Feijge, Marion A. H.; Stegner, David; van der Meijden, Paola E. J.; Kuijpers, Marijke J. E.; Varga-Szabo, David; Heemskerk, Johan W. M.; Nieswandt, Bernhard			Roles of Platelet STIM1 and Orai1 in Glycoprotein VI- and Thrombin-dependent Procoagulant Activity and Thrombus Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STORE-INDEPENDENT MODES; CRAC CHANNEL ACTIVATION; MEDIATED CALCIUM-ENTRY; OPERATED CA2+ ENTRY; IN-VIVO; PHOSPHATIDYLSERINE EXPOSURE; P2Y(12) RECEPTORS; CELL-ACTIVATION; SENSOR STIM1; BLOOD-CELLS	In platelets, STIM1 has been recognized as the key regulatory protein in store-operated Ca2+ entry (SOCE) with Orai1 as principal Ca2+ entry channel. Both proteins contribute to collagen-dependent arterial thrombosis in mice in vivo. It is unclear whether STIM2 is involved. A key platelet response relying on Ca2+ entry is the surface exposure of phosphatidylserine (PS), which accomplishes platelet procoagulant activity. We studied this response in mouse platelets deficient in STIM1, STIM2, or Orai1. Upon high shear flow of blood over collagen, Stim1(-/-) and Orai1(-/-) platelets had greatly impaired glycoprotein (GP) VI-dependent Ca2+ signals, and they were deficient in PS exposure and thrombus formation. In contrast, Stim2(-/-) platelets reacted normally. Upon blood flow in the presence of thrombin generation and coagulation, Ca2+ signals of Stim1(-/-) and Orai1(-/-) platelets were partly reduced, whereas the PS exposure and formation of fibrin-rich thrombi were normalized. Washed Stim1(-/-) and Orai1(-/-) platelets were deficient in GPVI-induced PS exposure and prothrombinase activity, but not when thrombin was present as co-agonist. Markedly, SKF96365, a blocker of (receptor-operated) Ca2+ entry, inhibited Ca2+ and procoagulant responses even in Stim1(-/-) and Orai1(-/-) platelets. These data show for the first time that: (i) STIM1 and Orai1 jointly contribute to GPVI-induced SOCE, procoagulant activity, and thrombus formation; (ii) a compensating Ca2+ entry pathway is effective in the additional presence of thrombin; (iii) platelets contain two mechanisms of Ca2+ entry and PS exposure, only one relying on STIM1-Orai1 interaction.	[Gilio, Karen; van Kruchten, Roger; Feijge, Marion A. H.; van der Meijden, Paola E. J.; Kuijpers, Marijke J. E.; Heemskerk, Johan W. M.] Maastricht Univ, Dept Biochem, CARIM, NL-6200 MD Maastricht, Netherlands; [Braun, Attila; Berna-Erro, Alejandro; Stegner, David; Varga-Szabo, David; Nieswandt, Bernhard] Univ Wurzburg, Rudolf Virchow Ctr Expt Med, D-97080 Wurzburg, Germany	Maastricht University; Maastricht University Medical Centre (MUMC); University of Wurzburg	Heemskerk, JWM (corresponding author), Maastricht Univ, Dept Biochem, CARIM, POB 616, NL-6200 MD Maastricht, Netherlands.	jwm.heemskerk@bioch.unimaas.nl; bernhard.nieswandt@virchow.uni-wuerzburg.de	Kuijpers, Marijke/AAN-9876-2021; Heemskerk, Johan/AAM-8323-2021; Stegner, David/AAA-4948-2019; Erro, Alejandro Berna/S-5909-2019	Heemskerk, Johan/0000-0002-2848-5121; Stegner, David/0000-0003-1059-9865; Erro, Alejandro Berna/0000-0003-1459-6418; van der Meijden, Paola/0000-0002-6532-2583	Nederlandse Organisatie voor Wetenschappelijk Onderzoek [11.400.0076]; Netherlands Heart Foundation [2005-B079]; Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 688, Sonderforschungsbereich 487]; German Excellence Initiative	Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission); Netherlands Heart Foundation(Netherlands Heart Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Excellence Initiative	This work was supported in part by Nederlandse Organisatie voor Wetenschappelijk Onderzoek Grant 11.400.0076, The Netherlands Heart Foundation Grant 2005-B079, and Deutsche Forschungsgemeinschaft Grants Sonderforschungsbereich 688 and 487.; Recipient of a grant from the German Excellence Initiative to the University of Wurzburg.	Auger JM, 2005, FASEB J, V19, P825, DOI 10.1096/fj.04-1940fje; Baba Y, 2008, NAT IMMUNOL, V9, P81, DOI 10.1038/ni1546; Bergmeier W, 2009, BLOOD, V113, P675, DOI 10.1182/blood-2008-08-174516; Berna-Erro A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000522; BEVERS EM, 1982, EUR J BIOCHEM, V122, P429, DOI 10.1111/j.1432-1033.1982.tb05898.x; BEVERS EM, 1996, PRACT APPROACH SER, P319; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Braun A, 2009, BLOOD, V113, P2056, DOI 10.1182/blood-2008-07-171611; DACHARYPRIGENT J, 1995, BIOCHEMISTRY-US, V34, P11625, DOI 10.1021/bi00036a039; Hassock SR, 2002, BLOOD, V100, P2801, DOI 10.1182/blood-2002-03-0723; Heemskerk JWM, 2005, TRENDS CARDIOVAS MED, V15, P86, DOI 10.1016/j.tcm.2005.03.003; Heemskerk JWM, 2002, THROMB HAEMOSTASIS, V88, P186; Heemskerk JWM, 1997, EUR J BIOCHEM, V249, P547, DOI 10.1111/j.1432-1033.1997.00547.x; Heemskerk JWM, 2001, J PHYSIOL-LONDON, V535, P625, DOI 10.1111/j.1469-7793.2001.00625.x; Hewavitharana T, 2008, J BIOL CHEM, V283, P26252, DOI 10.1074/jbc.M802239200; Kuijpers MJE, 2008, MICROCIRCULATION, V15, P269, DOI 10.1080/10739680701653517; Kuijpers MJE, 2003, FASEB J, V17, P685, DOI 10.1096/fj.02-0381fje; Lecut C, 2004, ARTERIOSCL THROM VAS, V24, P1727, DOI 10.1161/01.ATV.0000137974.85068.93; Leon C, 2003, ARTERIOSCL THROM VAS, V23, P1941, DOI 10.1161/01.ATV.0000092127.16125.E6; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Martin S, 2000, BIOCHEM BIOPH RES CO, V279, P639, DOI 10.1006/bbrc.2000.3980; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; Munnix ICA, 2005, ARTERIOSCL THROM VAS, V25, P2673, DOI 10.1161/01.ATV.0000193568.71980.4a; Munnix ICA, 2003, THROMB HAEMOSTASIS, V89, P687, DOI 10.1055/s-0037-1613576; Munnix ICA, 2007, ARTERIOSCL THROM VAS, V27, P2484, DOI 10.1161/ATVBAHA.107.151100; Nieswandt B, 2001, EMBO J, V20, P2120, DOI 10.1093/emboj/20.9.2120; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Parvez S, 2008, FASEB J, V22, P752, DOI 10.1096/fj.07-9449com; Rosado JA, 2002, J BIOL CHEM, V277, P42157, DOI 10.1074/jbc.M207320200; Sage SO, 1997, EXP PHYSIOL, V82, P807, DOI 10.1113/expphysiol.1997.sp004066; Schoenwaelder SM, 2009, BLOOD, V114, P663, DOI 10.1182/blood-2009-01-200345; Siljander P, 2001, ARTERIOSCL THROM VAS, V21, P618, DOI 10.1161/01.ATV.21.4.618; Siljander PRM, 2004, BLOOD, V103, P1333, DOI 10.1182/blood-2003-03-00869; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; THIAGARAJAN P, 1991, J BIOL CHEM, V266, P24302; van der Meijden PEJ, 2009, BLOOD, V114, P881, DOI 10.1182/blood-2008-07-171066; van der Meijden PEJ, 2005, THROMB HAEMOSTASIS, V93, P1128, DOI 10.1160/TH04-09-0597; Vanschoonbeek K, 2008, ARTERIOSCL THROM VAS, V28, P2023, DOI 10.1161/ATVBAHA.107.156992; Varga-Szabo D, 2008, J EXP MED, V205, P1583, DOI 10.1084/jem.20080302; Varga-Szabo D, 2008, PFLUG ARCH EUR J PHY, V457, P377, DOI 10.1007/s00424-008-0531-4; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	44	87	95	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23629	23638		10.1074/jbc.M110.108696	http://dx.doi.org/10.1074/jbc.M110.108696			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20519511	Green Published, hybrid			2022-12-27	WOS:000280291400013
J	Masalkar, P; Wallace, IS; Hwang, JH; Roberts, DM				Masalkar, Pintu; Wallace, Ian S.; Hwang, Jin Ha; Roberts, Daniel M.			Interaction of Cytosolic Glutamine Synthetase of Soybean Root Nodules with the C-terminal Domain of the Symbiosome Membrane Nodulin 26 Aquaglyceroporin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSIC PROTEIN AQUAPORIN-0; WATER CHANNEL AQUAPORIN-2; PERIBACTEROID MEMBRANE; POSTTRANSLATIONAL REGULATION; DIFFERENTIAL EXPRESSION; NITROGEN ASSIMILATION; MEDICAGO-TRUNCATULA; SYMBIOTIC MEMBRANES; PHASEOLUS-VULGARIS; LEGUME NODULES	Nodulin 26 (nod26) is a major intrinsic protein that constitutes the major protein component on the symbiosome membrane (SM) of N-2-fixing soybean nodules. Functionally, nod26 forms a low energy transport pathway for water, osmolytes, and NH3 across the SM. Besides their transport functions, emerging evidence suggests that high concentrations of major intrinsic proteins on membranes provide interaction and docking targets for various cytosolic proteins. Here it is shown that the C-terminal domain peptide of nod26 interacts with a 40-kDa protein from soybean nodule extracts, which was identified as soybean cytosolic glutamine synthetase GS(1)beta 1 by mass spectrometry. Fluorescence spectroscopy assays show that recombinant soybean GS(1)beta 1 binds the nod26 C-terminal domain with a 1:1 stoichiometry (K-d = 266 nM). GS(1)beta 1 also binds to isolated SMs, and this binding can be blocked by preincubation with the C-terminal peptide of nod26. In vivo experiments using either a split ubiquitin yeast two-hybrid system or bimolecular fluorescence complementation show that the four cytosolic GS isoforms expressed in soybean nodules interact with full-length nod26. The binding of GS, the principal ammonia assimilatory enzyme, to the conserved C-terminal domain of nod26, a transporter of NH3, is proposed to promote efficient assimilation of fixed nitrogen, as well as prevent potential ammonia toxicity, by localizing the enzyme to the cytosolic side of the symbiosome membrane.	[Masalkar, Pintu; Wallace, Ian S.; Hwang, Jin Ha; Roberts, Daniel M.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA; [Hwang, Jin Ha; Roberts, Daniel M.] Univ Tennessee, Program Genome Sci & Technol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Roberts, DM (corresponding author), Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA.	drobert2@utk.edu		Roberts, Daniel/0000-0002-0780-7056	National Science Foundation [MCB-0618075]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB-0618075 (to D.M.R.) and by a National Science Foundation Graduate Fellowship (to I.S.W.).	Bernard SM, 2009, NEW PHYTOL, V182, P608, DOI 10.1111/j.1469-8137.2009.02823.x; Britto DT, 2001, P NATL ACAD SCI USA, V98, P4255, DOI 10.1073/pnas.061034698; Brown D, 2008, CURR OPIN NEPHROL HY, V17, P491, DOI 10.1097/MNH.0b013e3283094eb1; Day DA, 2001, CELL MOL LIFE SCI, V58, P61, DOI 10.1007/PL00000778; Dean RM, 1999, BIOCHEMISTRY-US, V38, P347, DOI 10.1021/bi982110c; Fan JG, 2005, MOL VIS, V11, P76; Finnemann J, 2000, PLANT J, V24, P171, DOI 10.1046/j.1365-313x.2000.00863.x; FORDE BG, 1989, PLANT CELL, V1, P391, DOI 10.1105/tpc.1.4.391; FORTIN MG, 1987, NUCLEIC ACIDS RES, V15, P813, DOI 10.1093/nar/15.2.813; FORTIN MG, 1985, EMBO J, V4, P3041, DOI 10.1002/j.1460-2075.1985.tb04043.x; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Gawronski JD, 2004, ANAL BIOCHEM, V327, P114, DOI 10.1016/j.ab.2003.12.024; GEBHARDT C, 1986, EMBO J, V5, P1429, DOI 10.1002/j.1460-2075.1986.tb04379.x; GIRSCH SJ, 1991, CURR EYE RES, V10, P839, DOI 10.3109/02713689109013880; GREFEN C, 2007, CURR PROTOC NEUROSCI, V41; Guenther JF, 2003, PLANT CELL, V15, P981, DOI 10.1105/tpc.009787; Harries WEC, 2004, P NATL ACAD SCI USA, V101, P14045, DOI 10.1073/pnas.0405274101; Jensen ON, 1999, METH MOL B, V112, P513; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li JF, 2007, J BIOL CHEM, V282, P20593, DOI 10.1074/jbc.M700645200; Li JF, 2009, PLANT METHODS, V5, DOI [10.1186/1746-4811-5-6, 10.1371/journal.pcbi.1000450]; Lima L, 2006, J EXP BOT, V57, P2751, DOI 10.1093/jxb/erl036; Liu BF, 2008, J CELL BIOCHEM, V104, P51, DOI 10.1002/jcb.21598; MCPARLAND RH, 1976, BIOCHEM J, V153, P597, DOI 10.1042/bj1530597; Miflin BJ, 2002, J EXP BOT, V53, P979, DOI 10.1093/jexbot/53.370.979; Minet R, 1997, CLIN CHIM ACTA, V268, P121, DOI 10.1016/S0009-8981(97)00173-3; Morey KJ, 2002, PLANT PHYSIOL, V128, P182, DOI 10.1104/pp.010380; Niemietz CM, 2000, FEBS LETT, V465, P110, DOI 10.1016/S0014-5793(99)01729-9; Noda Y, 2005, BIOL CELL, V97, P885; Noda Y, 2004, BIOCHEM BIOPH RES CO, V322, P740, DOI 10.1016/j.bbrc.2004.07.195; Noda Y, 2004, FEBS LETT, V568, P139, DOI 10.1016/j.febslet.2004.05.021; Obermeyer G, 2005, PLANT PHYSIOL, V139, P1015, DOI 10.1104/pp.105.066670; Obrdlik P, 2004, P NATL ACAD SCI USA, V101, P12242, DOI 10.1073/pnas.0404467101; Rivers RL, 1997, J BIOL CHEM, V272, P16256, DOI 10.1074/jbc.272.26.16256; Roberts DM, 2002, PLANT PHYSIOL, V128, P370, DOI 10.1104/pp.010568; Rose KML, 2008, BIOCHEMISTRY-US, V47, P339, DOI 10.1021/bi701980t; Rose KML, 2006, INVEST OPHTH VIS SCI, V47, P1562, DOI 10.1167/iovs.05-1313; Sambrook J., 2001, MOL CLONING LAB MANU; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; STANFORD AC, 1993, PLANT PHYSIOL, V103, P73, DOI 10.1104/pp.103.1.73; STREETER JG, 1989, PLANT PHYSIOL, V90, P779, DOI 10.1104/pp.90.3.779; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Takata K, 2006, CELL MOL BIOL, V52, P34, DOI 10.1170/T747; TEMPLE SJ, 1995, MOL PLANT MICROBE IN, V8, P218, DOI 10.1094/MPMI-8-0218; Temple SJ, 1996, PLANT PHYSIOL, V112, P1723, DOI 10.1104/pp.112.4.1723; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; TYERMAN SD, 1995, NATURE, V378, P629, DOI 10.1038/378629a0; UDVARDI MK, 1990, PLANT PHYSIOL, V94, P71, DOI 10.1104/pp.94.1.71; Udvardi MK, 1997, ANNU REV PLANT PHYS, V48, P493, DOI 10.1146/annurev.arplant.48.1.493; Unno H, 2006, J BIOL CHEM, V281, P29287, DOI 10.1074/jbc.M601497200; Wallace IS, 2006, BBA-BIOMEMBRANES, V1758, P1165, DOI 10.1016/j.bbamem.2006.03.024; WEAVER CD, 1991, PLANT PHYSIOL, V95, P222, DOI 10.1104/pp.95.1.222; WEAVER CD, 1992, BIOCHEMISTRY-US, V31, P8954, DOI 10.1021/bi00152a035; Yu XS, 2005, J BIOL CHEM, V280, P22081, DOI 10.1074/jbc.M414377200; Yu XS, 2004, J CELL SCI, V117, P871, DOI 10.1242/jcs.00945	55	51	55	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23880	23888		10.1074/jbc.M110.135657	http://dx.doi.org/10.1074/jbc.M110.135657			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20504761	Green Published, hybrid			2022-12-27	WOS:000280291400038
J	Zhou, JL; Hu, GQ; Wang, XB				Zhou, Jiliang; Hu, Guoqing; Wang, Xiaobo			Repression of Smooth Muscle Differentiation by a Novel High Mobility Group Box-containing Protein, HMG2L1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM-RESPONSE FACTOR; GENE-EXPRESSION; DNA-BINDING; TRANSCRIPTIONAL ACTIVATION; CELL DIFFERENTIATION; MYOCARDIN; HMG1; ASSOCIATION; INTERACTS; GROWTH	The molecular mechanisms regulating smooth muscle-specific gene expression during smooth muscle development are poorly understood. Myocardin is an extraordinarily powerful cofactor of serum response factor (SRF) that stimulates expression of smooth muscle-specific genes. In an effort to search for proteins that regulate myocardin function, we identified a novel HMG box-containing protein HMG2L1 (high mobility group 2 like 1). We found that HMG2L1 expression is correlated with the smooth muscle cell (SMC) synthetic phenotype. Overexpression of HMG2L1 in SMCs down-regulated smooth muscle marker expression. Conversely, depletion of endogenous HMG2L1 in SMCs increases smooth muscle-specific gene expression. Furthermore, we found HMG2L1 specifically abrogates myocardin-induced activation of smooth muscle-specific genes. By GST pulldown assays, the interaction domains between HMG2L1 and myocardin were mapped to the N termini of each of the proteins. Finally, we demonstrated that HMG2L1 abrogates myocardin function through disrupting its binding to SRF and abolishing SRF-myocardin complex binding to the promoters of smooth muscle-specific genes. This study provides the first evidence of this novel HMG2L1 molecule playing an important role in attenuating smooth muscle differentiation.	[Zhou, Jiliang; Hu, Guoqing; Wang, Xiaobo] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA	Albany Medical College	Zhou, JL (corresponding author), Albany Med Coll, Ctr Cardiovasc Sci, 47 New Scotland Ave, Albany, NY 12208 USA.	zhouj1@mail.amc.edu	Wang, Xiaobo/J-4312-2014; Wang, Xiaobo/S-2476-2019	Wang, Xiaobo/0000-0001-6044-914X	Albany Medical College; American Heart Association	Albany Medical College; American Heart Association(American Heart Association)	This work was supported by funding of Albany Medical College start-up and a Scientist Development Grant from American Heart Association (to J. Z.).	Aidinis V, 1999, MOL CELL BIOL, V19, P6532; Banerjee S, 2003, NUCLEIC ACIDS RES, V31, P3236, DOI 10.1093/nar/gkg412; Bustin M, 2001, TRENDS BIOCHEM SCI, V26, P152, DOI 10.1016/S0968-0004(00)01777-1; Cao DS, 2005, MOL CELL BIOL, V25, P364, DOI 10.1128/MCB.25.1.364-376.2005; Chin MT, 1999, J MOL CELL CARDIOL, V31, P2199, DOI 10.1006/jmcc.1999.1054; Chin MT, 1998, J BIOL CHEM, V273, P9755, DOI 10.1074/jbc.273.16.9755; Doi H, 2005, ARTERIOSCL THROM VAS, V25, P2328, DOI 10.1161/01.ATV.0000185829.47163.32; Garcia-Ramirez M, 2005, ARTERIOSCL THROM VAS, V25, P2398, DOI 10.1161/01.ATV.0000187464.81959.23; Hong CS, 2005, SEMIN CELL DEV BIOL, V16, P694, DOI 10.1016/j.semcdb.2005.06.005; Koopman P, 2005, TRENDS GENET, V21, P367, DOI 10.1016/j.tig.2005.05.006; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Nery FC, 2006, BIOCHEM BIOPH RES CO, V341, P847, DOI 10.1016/j.bbrc.2006.01.036; Oren M, 1997, CELL, V90, P829, DOI 10.1016/S0092-8674(00)80347-5; Pelletier G, 2000, MOL CELL, V6, P1059, DOI 10.1016/S1097-2765(00)00104-0; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Potash JB, 2008, AM J MED GENET B, V147B, P59, DOI 10.1002/ajmg.b.30574; Spencer JA, 1999, J BIOL CHEM, V274, P15686, DOI 10.1074/jbc.274.22.15686; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Yamada M, 2003, GENES CELLS, V8, P677, DOI 10.1046/j.1365-2443.2003.00666.x; Yin F, 2005, J BIOL CHEM, V280, P4745, DOI 10.1074/jbc.M411585200; Zappavigna V, 1996, EMBO J, V15, P4981, DOI 10.1002/j.1460-2075.1996.tb00878.x; Zhang M, 2007, J BIOL CHEM, V282, P25708, DOI 10.1074/jbc.M701925200; Zhou JL, 2009, ARTERIOSCL THROM VAS, V29, P921, DOI 10.1161/ATVBAHA.109.187229; Zhou JL, 2008, J BIOL CHEM, V283, P35383, DOI 10.1074/jbc.M805489200; Zhou JL, 2005, MOL CELL BIOL, V25, P9874, DOI 10.1128/MCB.25.22.9874-9885.2005; Zhou JL, 2005, J BIOL CHEM, V280, P10861, DOI 10.1074/jbc.M411586200; Zhou JL, 2004, J BIOL CHEM, V279, P15929, DOI 10.1074/jbc.M313822200; ZWILLING S, 1995, EMBO J, V14, P1198, DOI 10.1002/j.1460-2075.1995.tb07103.x	30	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23175	23183		10.1074/jbc.M110.109868	http://dx.doi.org/10.1074/jbc.M110.109868			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20511232	hybrid, Green Published			2022-12-27	WOS:000279999900052
J	Mandal, PK; Seiler, A; Perisic, T; Kolle, P; Canak, AB; Forster, H; Weiss, N; Kremmer, E; Lieberman, MW; Bannai, S; Kuhlencordt, P; Sato, H; Bornkamm, GW; Conrad, M				Mandal, Pankaj Kumar; Seiler, Alexander; Perisic, Tamara; Koelle, Pirkko; Canak, Ana Banjac; Foerster, Heidi; Weiss, Norbert; Kremmer, Elisabeth; Lieberman, Michael W.; Bannai, Shiro; Kuhlencordt, Peter; Sato, Hideyo; Bornkamm, Georg W.; Conrad, Marcus			System x(c)(-) and Thioredoxin Reductase 1 Cooperatively Rescue Glutathione Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTINE/GLUTAMATE EXCHANGE TRANSPORTER; EARLY EMBRYONIC LETHALITY; OXIDATIVE STRESS; PROTEIN GLUTATHIONYLATION; PLASMA-MEMBRANE; CELL-DEATH; CYSTINE; GROWTH; RESISTANCE; GLUTAMATE	GSH is the major antioxidant and detoxifier of xenobiotics in mammalian cells. A strong decrease of intracellular GSH has been frequently linked to pathological conditions like ischemia/reperfusion injury and degenerative diseases including diabetes, atherosclerosis, and neurodegeneration. Although GSH is essential for survival, the deleterious effects of GSH deficiency can often be compensated by thiol-containing antioxidants. Using three genetically defined cellular systems, we show here that forced expression of xCT, the substrate-specific subunit of the cystine/glutamate antiporter, in gamma-glutamylcysteine synthetase knock-out cells rescues GSH deficiency by increasing cellular cystine uptake, leading to augmented intracellular and surprisingly high extracellular cysteine levels. Moreover, we provide evidence that under GSH deprivation, the cytosolic thioredoxin/thioredoxin reductase system plays an essential role for the cells to deal with the excess amount of intracellular cystine. Our studies provide first evidence that GSH deficiency can be rescued by an intrinsic genetic mechanism to be considered when designing therapeutic rationales targeting specific redox enzymes to combat diseases linked to GSH deprivation.	[Mandal, Pankaj Kumar; Seiler, Alexander; Perisic, Tamara; Canak, Ana Banjac; Foerster, Heidi; Bornkamm, Georg W.; Conrad, Marcus] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Clin Mol Biol & Tumor Genet, D-81377 Munich, Germany; [Koelle, Pirkko; Weiss, Norbert; Kuhlencordt, Peter] Univ Munich, Med Poliklin Innenstadt, D-80336 Munich, Germany; [Kremmer, Elisabeth] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany; [Lieberman, Michael W.] Methodist Hosp, Res Inst, Dept Pathol, Houston, TX 77030 USA; [Bannai, Shiro; Sato, Hideyo] Yamagata Univ, Dept Bioresource Engn, Yamagata 9978555, Japan	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; The Methodist Hospital System; The Methodist Hospital - Houston; Yamagata University	Conrad, M (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Clin Mol Biol & Tumor Genet, Marchioninistr 25, D-81377 Munich, Germany.	marcus.conrad@helmholtz-muenchen.de	mandal, pankaj/B-4885-2016; Conrad, Marcus/E-8792-2015	Conrad, Marcus/0000-0003-1140-5612; Mandal, Pankaj/0000-0003-1993-9918	Deutsche Forschungsgemeinschaft [SPP 1089, CO 291/2-2]; Deutsche Krebshilfe e.V.; Japan Society for the Promotion of Science (JSPS)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe e.V.(Deutsche Krebshilfe); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Deutsche Forschungsgemeinschaft Grants SPP 1089 (to M.C. and G.W.B.) and CO 291/2-2 (to M.C.), funds from Deutsche Krebshilfe e.V. (to G.W.B.), a JSPS Bilateral Joint Research Project (to H.S. and G.W.B.), and a Japan Society for the Promotion of Science (JSPS) travel fellowship (to M.C.).	Banjac A, 2008, ONCOGENE, V27, P1618, DOI 10.1038/sj.onc.1210796; BANNAI S, 1980, J BIOL CHEM, V255, P2372; BANNAI S, 1986, J BIOL CHEM, V261, P2256; Camier S, 2007, FREE RADICAL BIO MED, V42, P1008, DOI 10.1016/j.freeradbiomed.2006.12.027; Casagrande S, 2002, P NATL ACAD SCI USA, V99, P9745, DOI 10.1073/pnas.152168599; Chung WJ, 2005, J NEUROSCI, V25, P7101, DOI 10.1523/JNEUROSCI.5258-04.2005; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; FAHEY RC, 1984, SCIENCE, V224, P70, DOI 10.1126/science.6322306; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Ghezzi P, 2005, FREE RADICAL RES, V39, P573, DOI 10.1080/10715760500072172; Grant CM, 2001, MOL MICROBIOL, V39, P533, DOI 10.1046/j.1365-2958.2001.02283.x; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; HOLMGREN A, 1977, J BIOL CHEM, V252, P4600; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Jakupoglu C, 2005, MOL CELL BIOL, V25, P1980, DOI 10.1128/MCB.25.5.1980-1988.2005; Jones DP, 2004, FASEB J, V18, P1246, DOI 10.1096/fj.03-0971fje; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lopez-Mirabal HR, 2008, BBA-MOL CELL RES, V1783, P629, DOI 10.1016/j.bbamcr.2007.10.013; Loscalzo J, 2008, CELL METAB, V8, P182, DOI 10.1016/j.cmet.2008.08.004; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; Matsui M, 1996, DEV BIOL, V178, P179, DOI 10.1006/dbio.1996.0208; May JM, 1998, J BIOL CHEM, V273, P23039, DOI 10.1074/jbc.273.36.23039; May JM, 2002, METHOD ENZYMOL, V347, P327; Muller EGD, 1996, MOL BIOL CELL, V7, P1805, DOI 10.1091/mbc.7.11.1805; Niwa T, 2007, J CHROMATOGR B, V855, P59, DOI 10.1016/j.jchromb.2006.12.029; Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; NOVOGRODSKY A, 1979, P NATL ACAD SCI USA, V76, P4932, DOI 10.1073/pnas.76.10.4932; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; Qiang W, 2004, J VIROL, V78, P11926, DOI 10.1128/JVI.78.21.11926-11938.2004; Sato H, 2005, J BIOL CHEM, V280, P37423, DOI 10.1074/jbc.M506439200; SATO H, 1995, BIOCHEM J, V310, P547, DOI 10.1042/bj3100547; Sato H, 2002, J NEUROSCI, V22, P8028; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Savaskan NE, 2008, NAT MED, V14, P629, DOI 10.1038/nm1772; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Shi S, 2007, CYTOM PART A, V71A, P686, DOI 10.1002/cyto.a.20434; Shi ZZ, 2000, P NATL ACAD SCI USA, V97, P5101, DOI 10.1073/pnas.97.10.5101; Sipos K, 2002, J BIOL CHEM, V277, P26944, DOI 10.1074/jbc.M200677200; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Yoo MH, 2006, J BIOL CHEM, V281, P13005, DOI 10.1074/jbc.C600012200	44	129	134	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22244	22253		10.1074/jbc.M110.121327	http://dx.doi.org/10.1074/jbc.M110.121327			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20463017	Green Published, hybrid			2022-12-27	WOS:000279702200037
J	Uriu, Y; Kiyonaka, S; Miki, T; Yagi, M; Akiyama, S; Mori, E; Nakao, A; Beedle, AM; Campbell, KP; Wakamori, M; Mori, Y				Uriu, Yoshitsugu; Kiyonaka, Shigeki; Miki, Takafumi; Yagi, Masakuni; Akiyama, Satoshi; Mori, Emiko; Nakao, Akito; Beedle, Aaron M.; Campbell, Kevin P.; Wakamori, Minoru; Mori, Yasuo			Rab3-interacting Molecule gamma Isoforms Lacking the Rab3-binding Domain Induce Long Lasting Currents but Block Neurotransmitter Vesicle Anchoring in Voltage-dependent P/Q-type Ca2+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-CHANNEL; BETA-SUBUNIT; ACTIVE ZONE; N-TYPE; SYNAPTIC-TRANSMISSION; SKELETAL-MUSCLE; PC12 CELLS; FUNCTIONAL EXPRESSION; INTERACTING MOLECULE; NERVE-TERMINALS	Assembly of voltage-dependent Ca2+ channels (VDCCs) with their associated proteins regulates the coupling of VDCCs with upstream and downstream cellular events. Among the four isoforms of the Rab3-interacting molecule (RIM1 to -4), we have previously reported that VDCC beta-subunits physically interact with the long alpha isoform of the presynaptic active zone scaffolding protein RIM1 (RIM1 alpha) via its C terminus containing the C2B domain. This interaction cooperates with RIM1 alpha-Rab3 interaction to support neurotransmitter exocytosis by anchoring vesicles in the vicinity of VDCCs and by maintaining depolarization-triggered Ca2+ influx as a result of marked inhibition of voltage-dependent inactivation of VDCCs. However, physiological functions have not yet been elucidated for RIM3 and RIM4, which exist only as short gamma isoforms (gamma-RIMs), carrying the C-terminal C2B domain common to RIMs but not the Rab3-binding region and other structural motifs present in the alpha-RIMs, including RIM1 alpha. Here, we demonstrate that gamma-RIMs also exert prominent suppression of VDCC inactivation via direct binding to beta-subunits. In the pheochromocytoma PC12 cells, this common functional feature allows native RIMs to enhance acetylcholine secretion, whereas gamma-RIMs are uniquely different from alpha-RIMs in blocking localization of neurotransmitter-containing vesicles near the plasma membrane. gamma-RIMs as well as alpha-RIMs show wide distribution in central neurons, but knockdown of gamma-RIMs attenuated glutamate release to a lesser extent than that of alpha-RIMs in cultured cerebellar neurons. The results suggest that sustained Ca2+ influx through suppression of VDCC inactivation by RIMs is a ubiquitous property of neurons, whereas the extent of vesicle anchoring to VDCCs at the plasma membrane may depend on the competition of alpha-RIMs with gamma-RIMs for VDCC beta-subunits.	[Uriu, Yoshitsugu; Kiyonaka, Shigeki; Miki, Takafumi; Yagi, Masakuni; Akiyama, Satoshi; Mori, Emiko; Nakao, Akito; Mori, Yasuo] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan; [Kiyonaka, Shigeki; Mori, Yasuo] Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo 1020075, Japan; [Beedle, Aaron M.; Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA; [Beedle, Aaron M.; Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Beedle, Aaron M.; Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Beedle, Aaron M.; Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Neurol, Iowa City, IA 52242 USA; [Wakamori, Minoru] Tohoku Univ, Grad Sch Dent, Dept Oral Biol, Sendai, Miyagi 9808575, Japan	Kyoto University; Japan Science & Technology Agency (JST); Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; University of Iowa; Tohoku University	Mori, Y (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Katsura Campus, Kyoto 6158510, Japan.	mori@sbchem.kyoto-u.ac.jp	Beedle, Aaron/AAI-7014-2020; Beedle, Aaron M/K-1902-2015; Wakamori, Minoru/AAE-2661-2019; Nakao, Akito/AER-2812-2022; Kiyonaka, Shigeki/AAM-7303-2021	Beedle, Aaron M/0000-0002-1019-3235; Wakamori, Minoru/0000-0001-8574-3310; Campbell, Kevin/0000-0003-2066-5889; Nakao, Akito/0000-0002-2296-8245	Ministry of Education, Culture, Sport, Science and Technology of Japan; Grants-in-Aid for Scientific Research [22681033] Funding Source: KAKEN	Ministry of Education, Culture, Sport, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by research grants from the Ministry of Education, Culture, Sport, Science and Technology of Japan.	Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Calakos N, 2004, NEURON, V42, P889, DOI 10.1016/j.neuron.2004.05.014; CASTELLANO A, 1993, J BIOL CHEM, V268, P12359; CASTELLANO A, 1993, J BIOL CHEM, V268, P3450; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Catterall WA, 1998, CELL CALCIUM, V24, P307, DOI 10.1016/S0143-4160(98)90055-0; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200; Craig PJ, 1998, J COMP NEUROL, V397, P251; DEWAARD M, 1994, NEURON, V13, P495, DOI 10.1016/0896-6273(94)90363-8; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Fletcher CF, 2001, FASEB J, V15, P1288, DOI 10.1096/fj.00-0562fje; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Fourcaudot E, 2008, P NATL ACAD SCI USA, V105, P15130, DOI 10.1073/pnas.0806938105; Gebhart M, 2010, MOL CELL NEUROSCI, V44, P246, DOI 10.1016/j.mcn.2010.03.011; Gracheva EO, 2008, NEUROSCI LETT, V444, P137, DOI 10.1016/j.neulet.2008.08.026; Hanson JE, 2002, J COMP NEUROL, V442, P89, DOI 10.1002/cne.10075; Hibino H, 2002, NEURON, V34, P411, DOI 10.1016/S0896-6273(02)00667-0; Hibino H, 2003, P NATL ACAD SCI USA, V100, P307, DOI 10.1073/pnas.0136791100; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; Itakura M, 1999, BIOCHEM BIOPH RES CO, V265, P691, DOI 10.1006/bbrc.1999.1756; Jun K, 1999, P NATL ACAD SCI USA, V96, P15245, DOI 10.1073/pnas.96.26.15245; Kaeser PS, 2008, J NEUROSCI, V28, P13435, DOI 10.1523/JNEUROSCI.3235-08.2008; KAGAWA T, 1994, NEURON, V13, P427, DOI 10.1016/0896-6273(94)90358-1; Kang MG, 2006, P NATL ACAD SCI USA, V103, P5561, DOI 10.1073/pnas.0601289103; Kiyonaka S, 2007, NAT NEUROSCI, V10, P691, DOI 10.1038/nn1904; Koga T, 2002, BRAIN RES, V952, P282, DOI 10.1016/S0006-8993(02)03253-5; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; Lachamp PM, 2009, J NEUROSCI, V29, P381, DOI 10.1523/JNEUROSCI.2354-08.2009; Liang F, 2007, J COMP NEUROL, V503, P501, DOI 10.1002/cne.21403; Liu HY, 1996, J NEUROSCI, V16, P7557; Liu TT, 2005, J PHYSIOL-LONDON, V568, P917, DOI 10.1113/jphysiol.2005.094011; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; Maximov A, 2002, J NEUROSCI, V22, P6939; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; Miki Takafumi, 2007, Channels (Austin), V1, P144; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; NIIDOME T, 1994, BIOCHEM BIOPH RES CO, V203, P1821, DOI 10.1006/bbrc.1994.2399; Nishida M, 1999, BIOCHEM BIOPH RES CO, V262, P350, DOI 10.1006/bbrc.1999.1218; Nishimune H, 2004, NATURE, V432, P580, DOI 10.1038/nature03112; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Patzel V, 2005, NAT BIOTECHNOL, V23, P1440, DOI 10.1038/nbt1151; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; RANDALL A, 1995, J NEUROSCI, V15, P2995; Richards MW, 2007, CHANNELS, V1, P92, DOI 10.4161/chan.4145; RUTH P, 1989, SCIENCE, V245, P1115, DOI 10.1126/science.2549640; Saegusa H, 2007, MOL CELL NEUROSCI, V34, P261, DOI 10.1016/j.mcn.2006.11.006; SATHER WA, 1993, NEURON, V11, P291, DOI 10.1016/0896-6273(93)90185-T; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Schoch S, 2006, EMBO J, V25, P5852, DOI 10.1038/sj.emboj.7601425; Schoch S, 2006, CELL TISSUE RES, V326, P379, DOI 10.1007/s00441-006-0244-y; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; Shibasaki T, 2004, J BIOL CHEM, V279, P7956, DOI 10.1074/jbc.M309068200; Spafford JD, 2003, CURR OPIN NEUROBIOL, V13, P308, DOI 10.1016/S0959-4388(03)00061-8; STANLEY EF, 1991, J NEUROSCI, V11, P985; STANLEY EF, 1993, NEURON, V11, P1007, DOI 10.1016/0896-6273(93)90214-C; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; Toru S, 2000, J BIOL CHEM, V275, P10893, DOI 10.1074/jbc.275.15.10893; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; Tsuboi T, 2006, J CELL SCI, V119, P2196, DOI 10.1242/jcs.02962; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; Vendel AC, 2006, J NEUROSCI, V26, P2635, DOI 10.1523/JNEUROSCI.0067-06.2006; Wadel K, 2007, NEURON, V53, P563, DOI 10.1016/j.neuron.2007.01.021; Wakamori M, 1998, J BIOL CHEM, V273, P34857, DOI 10.1074/jbc.273.52.34857; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wang Y, 2003, GENOMICS, V81, P126, DOI 10.1016/S0888-7543(02)00024-1; Wang Y, 2000, J BIOL CHEM, V275, P20033, DOI 10.1074/jbc.M909008199; Weimer RM, 2006, J NEUROSCI, V26, P8040, DOI 10.1523/JNEUROSCI.2350-06.2006; Westenbroek RE, 1998, J NEUROSCI, V18, P6319; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; Wojcik SM, 2007, NEURON, V55, P11, DOI 10.1016/j.neuron.2007.06.013; Wong FK, 2010, J NEUROCHEM, V112, P463, DOI 10.1111/j.1471-4159.2009.06466.x; Zhai RG, 2004, PHYSIOLOGY, V19, P262, DOI 10.1152/physiol.00014.2004; Zhong HJ, 1999, NAT NEUROSCI, V2, P939, DOI 10.1038/14721; Zhu LJ, 2005, ANAL BIOCHEM, V345, P102, DOI 10.1016/j.ab.2005.07.028	84	37	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21750	21767		10.1074/jbc.M110.101311	http://dx.doi.org/10.1074/jbc.M110.101311			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20452978	Green Published, hybrid			2022-12-27	WOS:000279516100061
J	Yang, J; Bachrati, CZ; Ou, JW; Hickson, ID; Brown, GW				Yang, Jay; Bachrati, Csanad Z.; Ou, Jiongwen; Hickson, Ian D.; Brown, Grant W.			Human Topoisomerase III alpha Is a Single-stranded DNA Decatenase That Is Stimulated by BLM and RMI1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOMS-SYNDROME HELICASE; HOLLIDAY JUNCTION DISSOLVASOME; SISTER-CHROMATID EXCHANGES; SYNDROME GENE-PRODUCT; HOMOLOGOUS RECOMBINATION; GENOME STABILITY; SYNDROME PROTEIN; ESSENTIAL COMPONENT; COMPLEX; REPLICATION	Human topoisomerase III alpha is a type IA DNA topoisomerase that functions with BLM and RMI1 to resolve DNA replication and recombination intermediates. BLM, human topoisomerase III alpha, and RMI1 catalyze the dissolution of double Holliday junctions into noncrossover products via a strand-passage mechanism. We generated single-stranded catenanes that resemble the proposed dissolution intermediate recognized by human topoisomerase III alpha. We demonstrate that human topoisomerase III alpha is a single-stranded DNA decatenase that is specifically stimulated by the BLM-RMI1 pair. In addition, RMI1 interacts with human topoisomerase III alpha, and the interaction is required for the stimulatory effect of RMI1 on decatenase activity. Our data provide direct evidence that human topoisomerase III alpha functions as a decatenase with the assistance of BLM and RMI1 to facilitate the processing of homologous recombination intermediates without crossing over as a mechanism to preserve genome integrity.	[Brown, Grant W.] Univ Toronto, Dept Biochem, Donnelly CCBR, Toronto, ON M5S 3E1, Canada; [Bachrati, Csanad Z.; Hickson, Ian D.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Canc Res UK Labs, Oxford OX3 9DS, England	University of Toronto; Cancer Research UK; University of Oxford	Brown, GW (corresponding author), Univ Toronto, Dept Biochem, Donnelly CCBR, Rm 1230,160 Coll St, Toronto, ON M5S 3E1, Canada.	grant.brown@utoronto.ca	Bachrati, Csanad/ABF-2020-2021; Hickson, Ian/AAJ-7548-2020	Bachrati, Csanad/0000-0003-1703-5894; Hickson, Ian/0000-0002-0583-566X; Brown, Grant/0000-0002-9002-5003	Canadian Institute of Health [MOP-79368]; Cancer Research United Kingdom; Bloom Syndrome Foundation	Canadian Institute of Health(Canadian Institutes of Health Research (CIHR)); Cancer Research United Kingdom(Cancer Research UK); Bloom Syndrome Foundation	This work was supported by the Canadian Institute of Health Research Grant MOP-79368 (to G. W. B.), by Cancer Research United Kingdom, and the Bloom Syndrome Foundation (to I. D. H. and C.Z.B.).	Bachrati CZ, 2009, METHODS MOL BIOL, V582, P91, DOI 10.1007/978-1-60761-340-4_8; Broberg K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-140; Bucka A, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e24; Burgers PMJ, 1999, METHODS, V18, P349, DOI 10.1006/meth.1999.0796; Bussen W, 2007, J BIOL CHEM, V282, P31484, DOI 10.1074/jbc.M706116200; Bylund GO, 2006, METHOD ENZYMOL, V409, P1, DOI 10.1016/S0076-6879(05)09001-4; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Chang M, 2005, EMBO J, V24, P2024, DOI 10.1038/sj.emboj.7600684; Chelysheva L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000309; Chen CF, 2007, J BIOL CHEM, V282, P28971, DOI 10.1074/jbc.M705427200; Cheok CF, 2005, BIOCHEM SOC T, V33, P1456, DOI 10.1042/BST0331456; GERMAN J, 1995, DERMATOL CLIN, V13, P7, DOI 10.1016/S0733-8635(18)30101-3; Goodwin A, 1999, NUCLEIC ACIDS RES, V27, P4050, DOI 10.1093/nar/27.20.4050; Goulaouic H, 1999, NUCLEIC ACIDS RES, V27, P2443, DOI 10.1093/nar/27.12.2443; Hartung F, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000285; HIASA H, 1994, J BIOL CHEM, V269, P32655; HIASA H, 1994, J BIOL CHEM, V269, P2093; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Hu P, 2001, HUM MOL GENET, V10, P1287, DOI 10.1093/hmg/10.12.1287; Johnson FB, 2000, CANCER RES, V60, P1162; Karow JK, 1997, J BIOL CHEM, V272, P30611, DOI 10.1074/jbc.272.49.30611; Liu Y, 2008, GENE DEV, V22, P2737, DOI 10.1101/gad.1732808; Mankouri HW, 2007, TRENDS BIOCHEM SCI, V32, P538, DOI 10.1016/j.tibs.2007.09.009; Mullen JR, 2005, MOL CELL BIOL, V25, P4476, DOI 10.1128/MCB.25.11.4476-4487.2005; Plank JL, 2006, P NATL ACAD SCI USA, V103, P11118, DOI 10.1073/pnas.0604873103; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Raynard S, 2008, J BIOL CHEM, V283, P15701, DOI 10.1074/jbc.M802127200; Raynard S, 2006, J BIOL CHEM, V281, P13861, DOI 10.1074/jbc.C600051200; Seki M, 2006, MOL CELL BIOL, V26, P6299, DOI 10.1128/MCB.00702-06; Singh TR, 2008, GENE DEV, V22, P2856, DOI 10.1101/gad.1725108; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Suski C, 2008, MOL CELL, V30, P779, DOI 10.1016/j.molcel.2008.04.020; Temime-Smaali N, 2008, EMBO J, V27, P1513, DOI 10.1038/emboj.2008.74; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wu L, 2002, NUCLEIC ACIDS RES, V30, P4823, DOI 10.1093/nar/gkf611; Wu L, 2006, P NATL ACAD SCI USA, V103, P4068, DOI 10.1073/pnas.0508295103; Wu L, 2000, J BIOL CHEM, V275, P9636, DOI 10.1074/jbc.275.13.9636; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Xu DY, 2008, GENE DEV, V22, P2843, DOI 10.1101/gad.1708608; Yin JH, 2005, EMBO J, V24, P1465, DOI 10.1038/sj.emboj.7600622	42	54	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21426	21436		10.1074/jbc.M110.123216	http://dx.doi.org/10.1074/jbc.M110.123216			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20445207	Green Published, hybrid			2022-12-27	WOS:000279516100029
J	Qiang, L; Banks, AS; Accili, D				Qiang, Li; Banks, Alexander S.; Accili, Domenico			Uncoupling of Acetylation from Phosphorylation Regulates FoxO1 Function Independent of Its Subcellular Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD TRANSCRIPTION FACTOR; BETA-CELL FUNCTION; FACTOR FKHR; SIGNALING PATHWAY; GENE-EXPRESSION; 14-3-3 BINDING; PROTEIN FOXO1; LIFE-SPAN; INSULIN; DIFFERENTIATION	The activity of transcription factor FoxO1 is regulated by phosphorylation-dependent nuclear exclusion and deacetylation-dependent nuclear retention. It is unclear whether and how these two post-translational modifications affect each other. To answer this question, we expressed FoxO1 cDNAs with combined mutations of phosphorylation and acetylation sites in HEK-293 cells and analyzed their subcellular localization patterns. We show that mutations mimicking the acetylated state (KQ series) render FoxO1 more sensitive to Akt-mediated phosphorylation and nuclear exclusion and can reverse the constitutively nuclear localization of phosphorylation-defective FoxO1. Conversely, mutations mimicking the deacetylated state (KR series) promote FoxO1 nuclear retention. Oxidative stress and the Sirt1 activator resveratrol are thought to promote FoxO1 deacetylation and nuclear retention, thus increasing its activity. Accordingly, FoxO1 deacetylation was required for the effect of oxidative stress (induced by H2O2) to retain FoxO1 in the nucleus. H2O2 also inhibited FoxO1 phosphorylation on Ser-253 and Thr-24, the key insulin-regulated sites, irrespective of its acetylation. In contrast, the effect of resveratrol was independent of FoxO1 acetylation and its phosphorylation on Ser-253 and Thr-24, suggesting that resveratrol acts on FoxO1 in a Sirt1- and Akt-independent manner. The dissociation of deacetylation from dephosphorylation in H2O2-treated cells indicates that the two modifications can occur independently of each other. It can be envisaged that FoxO1 exists in multiple nuclear forms with distinct activities depending on the balance of acetylation and phosphorylation.	[Qiang, Li; Accili, Domenico] Columbia Univ, Dept Med, New York, NY 10032 USA; [Banks, Alexander S.] Harvard Univ, Dana Farber Canc Inst, Sch Med, Boston, MA 02115 USA	Columbia University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Accili, D (corresponding author), 1150 St Nicholas Ave,Rm 238, New York, NY 10032 USA.	da230@columbia.edu	Banks, Alexander/B-4832-2012; Qiang, Li/C-9560-2012	Banks, Alexander/0000-0003-1787-6925; Qiang, Li/0000-0001-8322-1797	National Institutes of Health, Columbia University Diabetes and Endocrinology Research Center [DK57539, DK63608]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057539, P30DK063608] Funding Source: NIH RePORTER	National Institutes of Health, Columbia University Diabetes and Endocrinology Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK57539 and DK63608 from the Columbia University Diabetes and Endocrinology Research Center.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Buteau J, 2007, DIABETES OBES METAB, V9, P140, DOI 10.1111/j.1463-1326.2007.00782.x; Buteau J, 2007, J BIOL CHEM, V282, P287, DOI 10.1074/jbc.M606118200; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Fukuoka M, 2003, INT J MOL MED, V12, P503; Hribal ML, 2003, J CELL BIOL, V162, P535, DOI 10.1083/jcb.200212107; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kawamori D, 2006, J BIOL CHEM, V281, P1091, DOI 10.1074/jbc.M508510200; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kitamura T, 2009, MOL CELL BIOL, V29, P4417, DOI 10.1128/MCB.01622-08; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Logie L, 2007, DIABETES, V56, P2218, DOI 10.2337/db07-0343; Nakae J, 2001, BIOCHEMISTRY-US, V40, P11768, DOI 10.1021/bi015532m; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Obsil T, 2003, BIOCHEMISTRY-US, V42, P15264, DOI 10.1021/bi0352724; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Rena G, 2001, BIOCHEM J, V354, P605, DOI 10.1042/0264-6021:3540605; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Tomizawa M, 2000, J BIOL CHEM, V275, P7289, DOI 10.1074/jbc.275.10.7289; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; Yan L, 2008, J BIOL CHEM, V283, P7411, DOI 10.1074/jbc.M708083200	39	125	128	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27396	27401		10.1074/jbc.M110.140228	http://dx.doi.org/10.1074/jbc.M110.140228			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20519497	hybrid, Green Published			2022-12-27	WOS:000281172700068
J	Heise, CJ; Xu, BE; Deaton, SL; Cha, SK; Cheng, CJ; Earnest, S; Sengupta, S; Juang, YC; Stippec, S; Xu, YD; Zhao, YM; Huang, CL; Cobb, MH				Heise, Charles J.; Xu, Bing-e; Deaton, Staci L.; Cha, Seung-Kuy; Cheng, Chih-Jen; Earnest, Svetlana; Sengupta, Samarpita; Juang, Yu-Chi; Stippec, Steve; Xu, Yingda; Zhao, Yingming; Huang, Chou-Long; Cobb, Melanie H.			Serum and Glucocorticoid-induced Kinase (SGK) 1 and the Epithelial Sodium Channel Are Regulated by Multiple with No Lysine (WNK) Family Members	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA-CL COTRANSPORTER; BLOOD-PRESSURE; ACTIVATES SGK1; IN-VITRO; HYPERTENSION; GENE; K+; PHOSPHORYLATION; HYPERKALEMIA; PATHOGENESIS	The four WNK (with no lysine (K)) protein kinases affect ion balance and contain an unusual protein kinase domain due to the unique placement of the active site lysine. Mutations in two WNKs cause a heritable form of ion imbalance culminating in hypertension. WNK1 activates the serum- and glucocorticoid-induced protein kinase SGK1; the mechanism is noncatalytic. SGK1 increases membrane expression of the epithelial sodium channel (ENaC) and sodium reabsorption via phosphorylation and sequestering of the E3 ubiquitin ligase neural precursor cell expressed, developmentally down-regulated 4-2 (Nedd4-2), which otherwise promotes ENaC endocytosis. Questions remain about the intrinsic abilities of WNK family members to regulate this pathway. We find that expression of the N termini of all four WNKs results in modest to strong activation of SGK1. In reconstitution experiments in the same cell line all four WNKs also increase sodium current blocked by the ENaC inhibitor amiloride. The N termini of the WNKs also have the capacity to interact with SGK1. More detailed analysis of activation by WNK4 suggests mechanisms in common with WNK1. Further evidence for the importance of WNK1 in this process comes from the ability of Nedd4-2 to bind to WNK1 and the finding that endogenous SGK1 has reduced activity if WNK1 is knocked down by small interfering RNA.	[Heise, Charles J.; Xu, Bing-e; Deaton, Staci L.; Earnest, Svetlana; Sengupta, Samarpita; Juang, Yu-Chi; Stippec, Steve; Cobb, Melanie H.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Cha, Seung-Kuy; Cheng, Chih-Jen; Huang, Chou-Long] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Xu, Yingda; Zhao, Yingming] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Cobb, MH (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	melanie.Cobb@utsouthwestern.edu	Cheng, Chih-Jen/AAM-3305-2021	Cobb, Melanie/0000-0003-0833-5473	National Institutes of Health [GM53032, DK59530]; University of Texas Southwestern O'Brien Center [DK79328, CA126832]; Robert A. Welch Foundation [I1243]; NATIONAL CANCER INSTITUTE [R01CA126832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059530, P30DK079328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053032] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas Southwestern O'Brien Center; Robert A. Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM53032 (to M.H.C.) and DK59530 (to C.-L.H.), University of Texas Southwestern O'Brien Center Grant DK79328, Grant CA126832 (to Y.Z.), and Robert A. Welch Foundation Grant I1243 (to M.H.C.).	Anselmo AN, 2006, P NATL ACAD SCI USA, V103, P10883, DOI 10.1073/pnas.0604607103; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; Brickley DR, 2002, J BIOL CHEM, V277, P43064, DOI 10.1074/jbc.M207604200; de la Rosa DA, 1999, J BIOL CHEM, V274, P37834, DOI 10.1074/jbc.274.53.37834; Delaloy C, 2003, MOL CELL BIOL, V23, P9208, DOI 10.1128/MCB.23.24.9208-9221.2003; Dorwart MR, 2007, J PHYSIOL-LONDON, V584, P333, DOI 10.1113/jphysiol.2007.135855; Dowd BFX, 2003, J BIOL CHEM, V278, P27347, DOI 10.1074/jbc.M301899200; Gagnon KBE, 2006, AM J PHYSIOL-CELL PH, V290, pC134, DOI 10.1152/ajpcell.00037.2005; Jiang ZY, 2005, J BIOL CHEM, V280, P21622, DOI 10.1074/jbc.m414464200; Kahle KT, 2004, CURR OPIN NEPHROL HY, V13, P557, DOI 10.1097/00041552-200409000-00012; Kahle KT, 2003, NAT GENET, V35, P372, DOI 10.1038/ng1271; Kamynina E, 2002, AM J PHYSIOL-RENAL, V283, pF377, DOI 10.1152/ajprenal.00143.2002; Lazrak A, 2006, P NATL ACAD SCI USA, V103, P1615, DOI 10.1073/pnas.0510609103; Lee BH, 2007, J BIOL CHEM, V282, P17985, DOI 10.1074/jbc.M702664200; Lenertz LY, 2005, J BIOL CHEM, V280, P26653, DOI 10.1074/jbc.M502598200; Leng Q, 2006, J PHYSIOL-LONDON, V571, P275, DOI 10.1113/jphysiol.2005.102202; McDonald FJ, 2002, AM J PHYSIOL-RENAL, V283, pF431, DOI 10.1152/ajprenal.00080.2002; Min XS, 2004, STRUCTURE, V12, P1303, DOI 10.1016/j.str.2004.04.014; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Newhouse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005003; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Ring AM, 2007, P NATL ACAD SCI USA, V104, P4020, DOI 10.1073/pnas.0611727104; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Rozansky DJ, 2009, J CLIN INVEST, V119, P2601, DOI 10.1172/JCI38323; Subramanya AR, 2006, KIDNEY INT, V70, P630, DOI 10.1038/sj.ki.5001634; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Vitari AC, 2004, BIOCHEM J, V378, P257, DOI 10.1042/BJ20031692; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wilson FH, 2003, P NATL ACAD SCI USA, V100, P680, DOI 10.1073/pnas.242735399; Xie J, 2006, PEDIATR NEPHROL, V21, P1231, DOI 10.1007/s00467-006-0106-6; Xu BE, 2005, J BIOL CHEM, V280, P34218, DOI 10.1074/jbc.M505735200; Xu BE, 2005, P NATL ACAD SCI USA, V102, P10315, DOI 10.1073/pnas.0504422102; Xu BE, 2004, J BIOL CHEM, V279, P7826, DOI 10.1074/jbc.M313465200; Xu BE, 2002, J BIOL CHEM, V277, P48456, DOI 10.1074/jbc.M207917200; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Xu BE, 1999, J BIOL CHEM, V274, P34029, DOI 10.1074/jbc.274.48.34029; Xu Q, 2002, NUCLEIC ACIDS RES, V30, P3754, DOI 10.1093/nar/gkf492; Yang CL, 2007, BIOCHEM BIOPH RES CO, V353, P535, DOI 10.1016/j.bbrc.2006.11.151; Yang CL, 2003, J CLIN INVEST, V111, P1039, DOI 10.1172/JCI200317443; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100	41	58	68	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25161	25167		10.1074/jbc.M110.103432	http://dx.doi.org/10.1074/jbc.M110.103432			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20525693	Green Published, hybrid			2022-12-27	WOS:000280682400008
J	Opacic, M; Vos, EPP; Hesp, BH; Broos, J				Opacic, Milena; Vos, Erwin P. P.; Hesp, Ben H.; Broos, Jaap			Localization of the Substrate-binding Site in the Homodimeric Mannitol Transporter, EIImtl, of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PHOSPHOTRANSFERASE SYSTEM; TRYPTOPHAN PHOSPHORESCENCE SPECTROSCOPY; TRANSIENT STATE KINETICS; 2ND-ORDER RATE CONSTANTS; CYTOPLASMIC B-DOMAIN; ENZYME-IIMTL; FLUORESCENCE DECAY; MEMBRANE TOPOLOGY; NMR-SPECTROSCOPY; ACTIVE-SITE	The mannitol transporter from Escherichia coli, EIImtl, belongs to a class of membrane proteins coupling the transport of substrates with their chemical modification. EIImtl is functional as a homodimer, and it harbors one high affinity mannitol-binding site in the membrane-embedded C domain (IICmtl). To localize this binding site, 19 single Trp-containing mutants of EIImtl were biosynthetically labeled with 5-fluorotryptophan (5-FTrp) and mixed with azi-mannitol, a substrate analog acting as a Forster resonance energy transfer (FRET) acceptor. Typically, for mutants showing FRET, only one 5-FTrp was involved, whereas the 5-FTrp from the other monomer was too distant. This proves that the mannitol-binding site is asymmetrically positioned in dimeric IICmtl. Combined with the available two-dimensional projection maps of IICmtl, it is concluded that a second resting binding site is present in this transporter. Active transport of mannitol only takes place when EIImtl becomes phosphorylated at Cys(384) in the cytoplasmic B domain. Stably phosphorylated EIImtl mutants were constructed, and FRET experiments showed that the position of mannitol in IICmtl remains the same. We conclude that during the transport cycle, the phosphorylated B domain has to move to the mannitol-binding site, located in the middle of the membrane, to phosphorylate mannitol.	[Opacic, Milena; Vos, Erwin P. P.; Broos, Jaap] Univ Groningen, Biophys Chem Lab, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; [Hesp, Ben H.] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Groningen	Broos, J (corresponding author), Univ Groningen, Biophys Chem Lab, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands.	j.broos@rug.nl	Institute, Zernike/W-7033-2019		Netherlands Foundation for Chemical Research; Netherlands Organization for the Advancement of Scientific Research	Netherlands Foundation for Chemical Research; Netherlands Organization for the Advancement of Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Foundation for Chemical Research with financial aid from the Netherlands Organization for the Advancement of Scientific Research.	Barabote RD, 2005, MICROBIOL MOL BIOL R, V69, P608, DOI 10.1128/MMBR.69.4.608-634.2005; BOER H, 1995, BIOCHEMISTRY-US, V34, P3239, DOI 10.1021/bi00010a013; Boer H, 1996, BIOCHEMISTRY-US, V35, P12901, DOI 10.1021/bi9611016; Broos J, 2003, PROTEIN SCI, V12, P1991, DOI 10.1110/ps.03142003; Broos J, 2002, J AM CHEM SOC, V124, P6812, DOI 10.1021/ja017812v; Broos J, 2004, J AM CHEM SOC, V126, P22, DOI 10.1021/ja0385585; Broos J, 2000, BIOCHEMISTRY-US, V39, P10877, DOI 10.1021/bi000803z; Dijkstra DS, 1996, BIOCHEMISTRY-US, V35, P6628; Dijkstra DS, 1996, ANAL BIOCHEM, V240, P142, DOI 10.1006/abio.1996.0341; ELFERINK MGL, 1990, J BACTERIOL, V172, P7119, DOI 10.1128/jb.172.12.7119-7125.1990; ERNI B, 1992, INT REV CYTOL, V137A, P127; Erni B, 2006, J BACTERIOL, V188, P7036, DOI 10.1128/JB.01074-06; HAAS E, 1978, BIOCHEMISTRY-US, V17, P5064, DOI 10.1021/bi00616a032; Koning RI, 1999, J MOL BIOL, V287, P845, DOI 10.1006/jmbi.1999.2650; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE; Legler PM, 2004, J BIOL CHEM, V279, P39115, DOI 10.1074/jbc.M406764200; LEHMANN J, 1993, CARBOHYD RES, V239, P133, DOI 10.1016/0008-6215(93)84209-O; LENGELER JW, 1994, BBA-BIOENERGETICS, V1188, P1, DOI 10.1016/0005-2728(94)90017-5; Liu TQ, 2005, J AM CHEM SOC, V127, P4104, DOI 10.1021/ja043154d; LOLKEMA JS, 1990, BIOCHEMISTRY-US, V29, P10120, DOI 10.1021/bi00495a016; LOLKEMA JS, 1992, BIOCHEMISTRY-US, V31, P5514, DOI 10.1021/bi00139a013; LOLKEMA JS, 1991, BIOCHEMISTRY-US, V30, P6716, DOI 10.1021/bi00241a012; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Meadow ND, 2005, J BIOL CHEM, V280, P41872, DOI 10.1074/jbc.M501440200; MEADOW ND, 1990, ANNU REV BIOCHEM, V59, P497, DOI 10.1146/annurev.biochem.59.1.497; Meadow ND, 2005, BIOCHEMISTRY-US, V44, P12790, DOI 10.1021/bi0502846; Meijberg W, 1998, J BIOL CHEM, V273, P7949, DOI 10.1074/jbc.273.14.7949; Nguyen TX, 2006, J MOL MICROB BIOTECH, V11, P345, DOI 10.1159/000095636; NIKAIDO H, 1992, SCIENCE, V258, P936, DOI 10.1126/science.1279804; Otte S, 2003, J BACTERIOL, V185, P2267, DOI 10.1128/JB.185.7.2267-2276.2003; Otten R, 2004, J BIOMOL NMR, V30, P461, DOI 10.1007/s10858-004-3498-2; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; REMAUT E, 1981, GENE, V15, P81, DOI 10.1016/0378-1119(81)90106-2; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; ROBILLARD GT, 1987, BIOCHEMISTRY-US, V26, P5796, DOI 10.1021/bi00392a032; Robillard GT, 1999, BBA-REV BIOMEMBRANES, V1422, P73, DOI 10.1016/S0304-4157(99)00002-7; ROOSSIEN FF, 1984, BIOCHEMISTRY-US, V23, P211, DOI 10.1021/bi00297a006; SAIER MH, 1992, J BACTERIOL, V174, P1433, DOI 10.1128/jb.174.5.1433-1438.1992; SaraceniRichards CA, 1997, J BACTERIOL, V179, P1135, DOI 10.1128/jb.179.4.1135-1142.1997; SaraceniRichards CA, 1997, J BACTERIOL, V179, P5171, DOI 10.1128/jb.179.16.5171-5177.1997; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; SUGIYAMA JE, 1991, P NATL ACAD SCI USA, V88, P9603, DOI 10.1073/pnas.88.21.9603; Suh JY, 2005, J MOL BIOL, V353, P1129, DOI 10.1016/j.jmb.2005.09.033; Toptygin D, 2002, J PHYS CHEM B, V106, P3724, DOI 10.1021/jp0133889; van Montfort BA, 2002, J BIOL CHEM, V277, P14717, DOI 10.1074/jbc.M201533200; van Montfort RLM, 1998, STRUCTURE, V6, P377, DOI 10.1016/S0969-2126(98)00039-2; Veldhuis G, 2005, J BIOL CHEM, V280, P35148, DOI 10.1074/jbc.M507061200; Veldhuis G, 2005, BIOPHYS J, V89, P201, DOI 10.1529/biophysj.105.062877; Veldhuis G, 2004, BIOPHYS J, V86, P1959, DOI 10.1016/S0006-3495(04)74259-9; Vervoort EB, 2005, J MOL BIOL, V346, P733, DOI 10.1016/j.jmb.2004.12.011; Visser NV, 2009, FEBS LETT, V583, P2785, DOI 10.1016/j.febslet.2009.07.022; Vos EPP, 2009, BIOCHEMISTRY-US, V48, P5284, DOI 10.1021/bi8020668; Vos EPP, 2009, BBA-BIOMEMBRANES, V1788, P581, DOI 10.1016/j.bbamem.2008.10.008; Winkler GR, 2006, J PHYS CHEM B, V110, P7058, DOI 10.1021/jp060043n; Yagur-Kroll S, 2005, J BIOL CHEM, V280, P19306, DOI 10.1074/jbc.M410896200	56	11	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25324	25331		10.1074/jbc.M110.122523	http://dx.doi.org/10.1074/jbc.M110.122523			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20522557	hybrid, Green Published			2022-12-27	WOS:000280682400025
J	Alzamora, R; Thali, RF; Gong, F; Smolak, C; Li, H; Baty, CJ; Bertrand, CA; Auchli, Y; Brunisholz, RA; Neumann, D; Hallows, KR; Pastor-Soler, NM				Alzamora, Rodrigo; Thali, Ramon F.; Gong, Fan; Smolak, Christy; Li, Hui; Baty, Catherine J.; Bertrand, Carol A.; Auchli, Yolanda; Brunisholz, Rene A.; Neumann, Dietbert; Hallows, Kenneth R.; Pastor-Soler, Nuria M.			PKA Regulates Vacuolar H+-ATPase Localization and Activity via Direct Phosphorylation of the A Subunit in Kidney Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDULLARY COLLECTING DUCT; ACTIVATED PROTEIN-KINASE; RENAL EPITHELIAL-CELLS; MALE REPRODUCTIVE-TRACT; TRANSLOCATING ADENOSINE-TRIPHOSPHATASE; INTRACELLULAR PH REGULATION; EPIDIDYMAL CLEAR CELLS; YEAST V-ATPASE; INTERCALATED CELLS; URINARY ACIDIFICATION	The vacuolar H+-ATPase (V-ATPase) is a major contributor to luminal acidification in epithelia of Wolffian duct origin. In both kidney-intercalated cells and epididymal clear cells, cAMP induces V-ATPase apical membrane accumulation, which is linked to proton secretion. We have shown previously that the A subunit in the cytoplasmic V-1 sector of the V-ATPase is phosphorylated by protein kinase A (PKA). Here we have identified by mass spectrometry and mutagenesis that Ser-175 is the major PKA phosphorylation site in the A subunit. Overexpression in HEK-293T cells of either a wild-type (WT) or phosphomimic Ser-175 to Asp (S175D) A subunit mutant caused increased acidification of HCO3--containing culture medium compared with cells expressing vector alone or a PKA phosphorylation-deficient Ser-175 to Ala (S175A) mutant. Moreover, localization of the S175A A subunit mutant expressed in HEK-293T cells was more diffusely cytosolic than that of WT or S175D A subunit. Acute V-ATPase-mediated, bafilomycin-sensitive H+ secretion was up-regulated by a specific PKA activator in HEK-293T cells expressing WTA subunit in HCO3--free buffer. In cells expressing the S175D mutant, V-ATPase activity at the membrane was constitutively up-regulated and unresponsive to PKA activators, whereas cells expressing the S175A mutant had decreased V-ATPase activity that was unresponsive to PKA activation. Finally, Ser-175 was necessary for PKA-stimulated apical accumulation of the V-ATPase in a polarized rabbit cell line of collecting duct A-type intercalated cell characteristics (Clone C). In summary, these results indicate a novel mechanism for the regulation of V-ATPase localization and activity in kidney cells via direct PKA-dependent phosphorylation of the A subunit at Ser-175.	[Hallows, Kenneth R.; Pastor-Soler, Nuria M.] Univ Pittsburgh, Sch Med, Renal Electrolyte Div, Dept Med, Pittsburgh, PA 15263 USA; [Baty, Catherine J.; Bertrand, Carol A.; Hallows, Kenneth R.; Pastor-Soler, Nuria M.] Univ Pittsburgh, Sch Med, Renal Electrolyte Div, Dept Cell Biol & Physiol, Pittsburgh, PA 15263 USA; [Thali, Ramon F.; Neumann, Dietbert] ETH, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Auchli, Yolanda; Brunisholz, Rene A.] Univ Zurich, FGCZ, CH-8057 Zurich, Switzerland	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Hallows, KR (corresponding author), Univ Pittsburgh, Sch Med, Renal Electrolyte Div, Dept Med, S976-1 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15263 USA.	hallows@pitt.edu	gong, fan/K-6004-2013; Hallows, Kenneth/A-8477-2013; gong, fan/F-2376-2010; Li, Hui/J-9884-2013	Hallows, Kenneth/0000-0002-2964-2440; Neumann, Dietbert/0000-0002-4316-684X	National Institutes of Health [P30 DK079307, R01 DK-075048, R01 DK-084184]; American Society of Nephrology Carl W. Gottschalk Research Scholar Award; American Heart Association [09GRNT2060539]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075048, P30DK079307, R01DK084184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Nephrology Carl W. Gottschalk Research Scholar Award; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P30 DK079307 (to the Pittsburgh Kidney Research Center), R01 DK-075048 (to K. R. H.), and R01 DK-084184 (to N. M. P. -S.), the American Society of Nephrology Carl W. Gottschalk Research Scholar Award (to N. M. P. -S.), American Heart Association Grants AHA 09GRNT2060539 (to N. M. P. -S.) and 0825540D (to R. A.), Cystic Fibrosis Foundation Grant CFF R883-CR02 (to C. A. B.), Swiss National Science Foundation Grant 3100A0-11437/1, European Union FP6 contract LSHM-CT-2004-005272 (EXGENESIS), and a graduate training fellowship ETHIIRA from ETH Zurich (to R. F. T.).	Ahlin G, 2009, DRUG METAB DISPOS, V37, P2275, DOI 10.1124/dmd.109.028654; AlAwqati Q, 1996, AM J PHYSIOL-CELL PH, V270, pC1571, DOI 10.1152/ajpcell.1996.270.6.C1571; BASTANI B, 1991, J CLIN INVEST, V88, P126, DOI 10.1172/JCI115268; Beaulieu V, 2005, J BIOL CHEM, V280, P8452, DOI 10.1074/jbc.M412750200; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; Blomqvist SR, 2006, EMBO J, V25, P4131, DOI 10.1038/sj.emboj.7601272; BORON WF, 1986, ANNU REV PHYSIOL, V48, P377; Bouley R, 2005, AM J PHYSIOL-RENAL, V288, pF1103, DOI 10.1152/ajprenal.00337.2004; Breton S, 1996, NAT MED, V2, P470, DOI 10.1038/nm0496-470; BROWN D, 1988, J CLIN INVEST, V82, P2114, DOI 10.1172/JCI113833; Carattino MD, 2005, J BIOL CHEM, V280, P17608, DOI 10.1074/jbc.M501770200; Dames P, 2006, P NATL ACAD SCI USA, V103, P3926, DOI 10.1073/pnas.0600011103; Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339; DOBYAN DC, 1982, ANAT REC, V204, P185, DOI 10.1002/ar.1092040303; EDWARDS JC, 1992, AM J PHYSIOL, V263, pC521, DOI 10.1152/ajpcell.1992.263.2.C521; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gao ZH, 2003, J PHARMACOL EXP THER, V307, P870, DOI 10.1124/jpet.103.055525; GLUCK S, 1988, AM J PHYSIOL, V254, pF71, DOI 10.1152/ajprenal.1988.254.1.F71; GLUCK S, 1982, P NATL ACAD SCI-BIOL, V79, P4327, DOI 10.1073/pnas.79.14.4327; GLUCK S, 1992, J EXP BIOL, V172, P205; GLUCK S, 1984, J CLIN INVEST, V73, P1704, DOI 10.1172/JCI111378; Gong F, 2010, AM J PHYSIOL-RENAL, V298, pF1162, DOI 10.1152/ajprenal.00645.2009; Hallows KR, 2009, AM J PHYSIOL-CELL PH, V296, pC672, DOI 10.1152/ajpcell.00004.2009; Hallows KR, 2006, J BIOL CHEM, V281, P4231, DOI 10.1074/jbc.M511029200; HALLOWS KR, 1994, AM J PHYSIOL-CELL PH, V267, pC1057, DOI 10.1152/ajpcell.1994.267.4.C1057; Hamm L.L, 2008, BRENNER RECTORS KIDN, P248; HAMM LL, 1993, SEMIN NEPHROL, V13, P246; HAYS S, 1986, J CLIN INVEST, V78, P1279, DOI 10.1172/JCI112712; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Lang KS, 2003, CELL PHYSIOL BIOCHEM, V13, P257, DOI 10.1159/000074540; Marshansky V, 2002, CURR OPIN NEPHROL HY, V11, P527, DOI 10.1097/00041552-200209000-00009; MYERS M, 1993, J BIOL CHEM, V268, P9184; Nelson N, 1999, PHYSIOL REV, V79, P361, DOI 10.1152/physrev.1999.79.2.361; OBRIEN MC, 1995, CYTOMETRY, V19, P243, DOI 10.1002/cyto.990190308; Pastor-Soler N, 2005, PHYSIOLOGY, V20, P417, DOI 10.1152/physiol.00036.2005; Pastor-Soler N, 2003, J BIOL CHEM, V278, P49523, DOI 10.1074/jbc.M309543200; Pastor-Soler NM, 2009, FASEB J, V23; Pastor-Soler NM, 2008, AM J PHYSIOL-CELL PH, V294, pC488, DOI 10.1152/ajpcell.00537.2007; Paunescu TG, 2008, AM J PHYSIOL-RENAL, V294, pF130, DOI 10.1152/ajprenal.00406.2007; Paunescu TG, 2010, AM J PHYSIOL-RENAL, V298, pF643, DOI 10.1152/ajprenal.00584.2009; Pech V, 2007, AM J PHYSIOL-RENAL, V292, pF914, DOI 10.1152/ajprenal.00361.2006; Rothenberger F, 2007, J AM SOC NEPHROL, V18, P2085, DOI 10.1681/ASN.2006070753; Sabolic I, 1997, KIDNEY INT, V51, P125, DOI 10.1038/ki.1997.16; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; SCHWARTZ GJ, 1985, J CLIN INVEST, V75, P1638, DOI 10.1172/JCI111871; SCHWARTZ JH, 1994, AM J PHYSIOL, V266, pF94, DOI 10.1152/ajprenal.1994.266.1.F94; Shao E, 2004, J BIOL CHEM, V279, P48663, DOI 10.1074/jbc.M408278200; Shao E, 2003, J BIOL CHEM, V278, P12985, DOI 10.1074/jbc.M212096200; Shum WWC, 2009, J EXP BIOL, V212, P1753, DOI 10.1242/jeb.027284; Smith AN, 2000, NAT GENET, V26, P71, DOI 10.1038/79208; STEINMETZ PR, 1986, AM J PHYSIOL, V251, pF173, DOI 10.1152/ajprenal.1986.251.2.F173; Su Y, 2003, J BIOL CHEM, V278, P20013, DOI 10.1074/jbc.M210077200; Tuerk RD, 2007, J PROTEOME RES, V6, P3266, DOI 10.1021/pr070160a; Tuerk RD, 2009, ANAL BIOCHEM, V390, P141, DOI 10.1016/j.ab.2009.04.015; VANADELSBERG J, 1986, J CELL BIOL, V102, P1638, DOI 10.1083/jcb.102.5.1638; VANADELSBERG J, 1994, CELL, V76, P1053, DOI 10.1016/0092-8674(94)90382-4; Voss M, 2007, J BIOL CHEM, V282, P33735, DOI 10.1074/jbc.M703368200; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; ZEIDEL ML, 1986, J CLIN INVEST, V77, P113, DOI 10.1172/JCI112264; Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje	62	75	75	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24676	24685		10.1074/jbc.M110.106278	http://dx.doi.org/10.1074/jbc.M110.106278			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20525692	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000280542100040
J	Bansal, S; Liu, CP; Sepuri, NBV; Anandatheerthavarada, HK; Selvaraj, V; Hoek, J; Milne, GL; Guengerich, FP; Avadhani, NG				Bansal, Seema; Liu, Chuan-Peng; Sepuri, Naresh B. V.; Anandatheerthavarada, Hindupur K.; Selvaraj, Venkatesh; Hoek, Jan; Milne, Ginger L.; Guengerich, F. Peter; Avadhani, Narayan G.			Mitochondria-targeted Cytochrome P450 2E1 Induces Oxidative Damage and Augments Alcohol-mediated Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; RAT-LIVER; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; LIPID-PEROXIDATION; NADPH OXIDASE; ETHANOL; CYP2E1; ACTIVATION; PHOSPHORYLATION	The ethanol-inducible cytochrome P450 2E1 (CYP2E1) is also induced under different pathological and physiological conditions. Studies including ours have shown that CYP2E1 is bimodally targeted to both the endoplasmic reticulum (microsomes) (mc CYP2E1) and mitochondria (mt CYP2E1). In this study we investigated the role of mtCYP2E1 in ethanol-mediated oxidative stress in stable cell lines expressing predominantly mt CYP2E1 or mc CYP2E1. The ER+ mutation (A2L, A9L), which increases the affinity of the nascent protein for binding to the signal recognition particle, preferentially targets CYP2E1 to the endoplasmic reticulum. The Mt+ (L17G) and Mt++ (I8R, L11R, L17R) mutant proteins, showing progressively lower affinity for signal recognition particle binding, were targeted to mitochondria at correspondingly higher levels. The rate of GSH depletion, used as a measure of oxidative stress, was higher in cells expressing Mt++ and Mt+ proteins as compared with cells expressing ER+ protein. In addition, the cellular level of F-2-isoprostanes, a direct indicator of oxidative stress, was increased markedly in Mt++ cells after ethanol treatment. Notably, expression of Mt++ CYP2E1 protein in yeast cells caused more severe mitochondrial DNA damage and respiratory deficiency than the wild type or ER+ proteins as tested by the inability of cells to grow on glycerol or ethanol. Additionally, liver mitochondria from ethanol-fed rats containing high mt CYP2E1 showed higher levels of F-2-isoprostane production. These results strongly suggest that mt CYP2E1 induces oxidative stress and augments alcohol-mediated cell/tissue injury.	[Selvaraj, Venkatesh; Avadhani, Narayan G.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Selvaraj, Venkatesh; Avadhani, Narayan G.] Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA; [Hoek, Jan] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Jefferson Med Coll, Philadelphia, PA 19107 USA; [Milne, Ginger L.] Vanderbilt Univ, Div Clin Pharmacol, Dept Med, Sch Med, Nashville, TN 37232 USA; [Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	University of Pennsylvania; University of Pennsylvania; Jefferson University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Avadhani, NG (corresponding author), 3800 Spruce St, Philadelphia, PA 19104 USA.	narayan@vet.upenn.edu	Sepuri, Naresh/AAF-2704-2020; Milne, Ginger/D-7648-2014	Milne, Ginger/0000-0003-3890-151X; Hoek, Jan/0000-0001-7127-4218	National Institutes of Health [R01 GM034883, R01 AA017749, R37 CA090426]; NATIONAL CANCER INSTITUTE [R37CA090426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017749] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM034883 and R01 AA017749 (to N. G. A.) and R37 CA090426 (to F. P. G.).	Addya S, 1997, J CELL BIOL, V139, P589, DOI 10.1083/jcb.139.3.589; Albano E, 1996, HEPATOLOGY, V23, P155, DOI 10.1002/hep.510230121; Albano E, 2006, P NUTR SOC, V65, P278, DOI 10.1079/PNS2006496; Anandatheerthavarada HK, 1999, J BIOL CHEM, V274, P6617, DOI 10.1074/jbc.274.10.6617; Anandatheerthavarada HK, 1999, EMBO J, V18, P5494, DOI 10.1093/emboj/18.20.5494; Anandatheerthavarada HK, 1997, ARCH BIOCHEM BIOPHYS, V339, P136, DOI 10.1006/abbi.1996.9855; Bai JX, 2006, J BIOL CHEM, V281, P5128, DOI 10.1074/jbc.M510484200; Bhagwat SV, 1999, TOXICOL APPL PHARM, V156, P231, DOI 10.1006/taap.1999.8646; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; Bondoc FY, 1999, BIOCHEM PHARMACOL, V58, P461, DOI 10.1016/S0006-2952(99)00111-2; Boopathi E, 2000, J BIOL CHEM, V275, P34415, DOI 10.1074/jbc.M004431200; Boopathi E, 2008, MOL CELL, V32, P32, DOI 10.1016/j.molcel.2008.09.008; Bradford BU, 2005, HEPATOLOGY, V41, P336, DOI 10.1002/hep.20532; Butura A, 2009, J HEPATOL, V50, P572, DOI 10.1016/j.jhep.2008.10.020; Caro AA, 2004, ANNU REV PHARMACOL, V44, P27, DOI 10.1146/annurev.pharmtox.44.101802.121704; Dasari VR, 2006, J BIOL CHEM, V281, P30834, DOI 10.1074/jbc.M510725200; Dong HB, 2009, MOL PHARMACOL, V75, P555, DOI 10.1124/mol.108.051888; Dostalek M, 2008, J BIOL CHEM, V283, P17147, DOI 10.1074/jbc.M802447200; Dostalek M, 2007, MOL PHARMACOL, V72, P1419, DOI 10.1124/mol.107.040238; EKSTROM G, 1989, BIOCHEM PHARMACOL, V38, P1313, DOI 10.1016/0006-2952(89)90338-9; Eliasson E, 1996, MOL PHARMACOL, V50, P573; ELIASSON E, 1992, J BIOL CHEM, V267, P15765; Gonzalez FJ, 2007, DRUG METAB DISPOS, V35, P1, DOI 10.1124/dmd.106.012492; GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P168, DOI 10.1021/tx00020a008; Hegde RS, 1998, MOL CELL, V2, P85, DOI 10.1016/S1097-2765(00)80116-1; Kadiiska MB, 2005, FREE RADICAL BIO MED, V38, P711, DOI 10.1016/j.freeradbiomed.2004.10.024; Kono H, 2000, J CLIN INVEST, V106, P867, DOI 10.1172/JCI9020; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; LIEBER CS, 1973, RES COMMUN CHEM PATH, V6, P983; LIEBER CS, 1970, BIOCHEM BIOPH RES CO, V40, P858, DOI 10.1016/0006-291X(70)90982-4; Lieber CS, 1997, PHYSIOL REV, V77, P517, DOI 10.1152/physrev.1997.77.2.517; Morgan K, 2002, HEPATOLOGY, V36, P122, DOI 10.1053/jhep.2002.33720; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Morrow JD, 1999, METHOD ENZYMOL, V300, P3; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; NANJI AA, 1994, ALCOHOL CLIN EXP RES, V18, P1280, DOI 10.1111/j.1530-0277.1994.tb00119.x; Neve EPA, 1999, FEBS LETT, V460, P309, DOI 10.1016/S0014-5793(99)01361-7; Neve EPA, 2000, J BIOL CHEM, V275, P17130, DOI 10.1074/jbc.M000957200; Neve EPA, 1996, ARCH BIOCHEM BIOPHYS, V333, P459, DOI 10.1006/abbi.1996.0415; NIRANJAN BG, 1984, J BIOL CHEM, V259, P2495; OMURA T, 1964, J BIOL CHEM, V239, P2370; Pahan K, 1997, FREE RADICAL BIO MED, V23, P963, DOI 10.1016/S0891-5849(97)00017-8; Prabu SK, 2006, J BIOL CHEM, V281, P2061, DOI 10.1074/jbc.M507741200; Raza H, 2004, DIABETES, V53, P185, DOI 10.2337/diabetes.53.1.185; Robin MA, 2005, FEBS LETT, V579, P6895, DOI 10.1016/j.febslet.2005.11.029; Robin MA, 2002, J BIOL CHEM, V277, P40583, DOI 10.1074/jbc.M203292200; Robin MA, 2001, J BIOL CHEM, V276, P24680, DOI 10.1074/jbc.M100363200; RONIS MJ, 1996, CYTOCHROMES P450 PHA; RONIS MJJ, 1991, EUR J BIOCHEM, V198, P383, DOI 10.1111/j.1432-1033.1991.tb16026.x; Sepuri NBV, 2007, FEBS J, V274, P4615, DOI 10.1111/j.1742-4658.2007.05990.x; Sohn OS, 2001, CANCER RES, V61, P8435; Sumner SCJ, 1999, CHEM RES TOXICOL, V12, P1110, DOI 10.1021/tx990040k; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Wang Y, 2009, HEPATOLOGY, V50, P453, DOI 10.1002/hep.22978; Zaher H, 1998, TOXICOL APPL PHARM, V152, P193, DOI 10.1006/taap.1998.8501	56	75	77	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24609	24619		10.1074/jbc.M110.121822	http://dx.doi.org/10.1074/jbc.M110.121822			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529841	hybrid, Green Published			2022-12-27	WOS:000280542100033
J	Brown, CR; Hung, GC; Dunton, D; Chiang, HL				Brown, C. Randell; Hung, Guo-Chiuan; Dunton, Danielle; Chiang, Hui-Ling			The TOR Complex 1 Is Distributed in Endosomes and in Retrograde Vesicles That Form from the Vacuole Membrane and Plays an Important Role in the Vacuole Import and Degradation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; CATABOLITE INACTIVATION; MOLECULAR MACHINERY; PROTEIN-TRANSPORT; PICHIA-PASTORIS; VID VESICLES; BETA-COP; FRUCTOSE-1,6-BISPHOSPHATASE; AUTOPHAGY; BIOGENESIS	The key gluconeogenic enzyme fructose-1,6-bisphosphatase (FBPase) is induced when Saccharomyces cerevisiae are starved of glucose. However, when glucose is added to cells that have been starved for 3 days, FBPase is degraded in the vacuole. FBPase is first imported to Vid (vacuole import and degradation) vesicles, and these vesicles then merge with the endocytic pathway. In this report we show that two additional gluconeogenic enzymes, isocitrate lyase and phosphoenolpyruvate carboxykinase, were also degraded in the vacuole via the Vid pathway. These new cargo proteins and FBPase interacted with the TORC1 complex during glucose starvation. However, Tor1p was dissociated from FBPase after the addition of glucose. FBPase degradation was inhibited in cells overexpressing TOR1, suggesting that excessive Tor1p is inhibitory. Both Tco89p and Tor1p were found in endosomes coming from the plasma membrane as well as in retrograde vesicles forming from the vacuole membrane. When TORC1 was inactivated by rapamycin, FBPase degradation was inhibited. We suggest that TORC1 interacts with multiple cargo proteins destined for the Vid pathway and plays an important role in the degradation of FBPase in the vacuole.	[Brown, C. Randell; Chiang, Hui-Ling] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Hung, Guo-Chiuan] US FDA, Div Cellular & Gene Therapy, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; US Food & Drug Administration (FDA)	Chiang, HL (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr, Hershey, PA 17033 USA.	hxc32@psu.edu			National Institutes of Health [R01GM 59480]; Pennsylvania Tobacco Settlement Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059480] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Tobacco Settlement Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM 59480. This work was also supported by a grant from the Pennsylvania Tobacco Settlement Fund (to H.-L. C.).	Aniento F, 1996, J CELL BIOL, V133, P29, DOI 10.1083/jcb.133.1.29; Aronova S, 2007, MOL BIOL CELL, V18, P2779, DOI 10.1091/mbc.E07-03-0274; Berchtold D, 2009, MOL BIOL CELL, V20, P1565, DOI 10.1091/mbc.E08-10-1001; Brown CR, 2008, J BIOL CHEM, V283, P26116, DOI 10.1074/jbc.M709922200; Brown CR, 2001, J BIOL CHEM, V276, P48017, DOI 10.1074/jbc.M109222200; Brown CR, 2002, J CELL SCI, V115, P655; Brown CR, 2000, J CELL BIOL, V150, P65, DOI 10.1083/jcb.150.1.65; Bryant NJ, 1998, MICROBIOL MOL BIOL R, V62, P230, DOI 10.1128/MMBR.62.1.230-247.1998; CHIANG HL, 1991, NATURE, V350, P313, DOI 10.1038/350313a0; Chiang HL, 1996, J BIOL CHEM, V271, P9934, DOI 10.1074/jbc.271.17.9934; Chiang MC, 1998, J CELL BIOL, V140, P1347, DOI 10.1083/jcb.140.6.1347; Cui DY, 2004, J BIOL CHEM, V279, P9713, DOI 10.1074/jbc.M310793200; Daro E, 1997, J CELL BIOL, V139, P1747, DOI 10.1083/jcb.139.7.1747; Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020; DUNN WA, 1990, J CELL BIOL, V110, P1923, DOI 10.1083/jcb.110.6.1923; Gabriely G, 2007, MOL CELL BIOL, V27, P526, DOI 10.1128/MCB.00577-06; Gu F, 1997, J CELL BIOL, V139, P1183, DOI 10.1083/jcb.139.5.1183; Hammerle M, 1998, J BIOL CHEM, V273, P25000, DOI 10.1074/jbc.273.39.25000; Hoffman M, 1996, GENETICS, V143, P1555; HOLZER H, 1989, RBC-CELL BIOL REV, V21, P305; Huang PH, 1997, J CELL BIOL, V136, P803, DOI 10.1083/jcb.136.4.803; Huang WP, 2002, CELL STRUCT FUNCT, V27, P409, DOI 10.1247/csf.27.409; Hung GC, 2004, J BIOL CHEM, V279, P49138, DOI 10.1074/jbc.M404544200; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; JONES EW, 1991, J BIOL CHEM, V266, P7963; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Piguet V, 1999, CELL, V97, P63, DOI 10.1016/S0092-8674(00)80715-1; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Regelmann J, 2003, MOL BIOL CELL, V14, P1652, DOI 10.1091/mbc.E02-08-0456; Reggiori F, 2005, CURR OPIN CELL BIOL, V17, P415, DOI 10.1016/j.ceb.2005.06.007; Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; ROTHMAN JH, 1986, CELL, V47, P1041, DOI 10.1016/0092-8674(86)90819-6; SCHORK SM, 1995, J BIOL CHEM, V270, P26446, DOI 10.1074/jbc.270.44.26446; Shieh HL, 1998, J BIOL CHEM, V273, P3381, DOI 10.1074/jbc.273.6.3381; Shieh HL, 2001, J BIOL CHEM, V276, P10398, DOI 10.1074/jbc.M001767200; TUTTLE DL, 1995, J CELL SCI, V108, P25; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wang CW, 2003, MOL MED, V9, P65, DOI 10.1007/BF03402040; Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609; WHITNEY JA, 1995, CELL, V83, P703; Wieland F, 1999, CURR OPIN CELL BIOL, V11, P440, DOI 10.1016/S0955-0674(99)80063-5; Yuan WP, 1999, MOL BIOL CELL, V10, P1353, DOI 10.1091/mbc.10.5.1353	49	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23357	23368		10.1074/jbc.M109.075143	http://dx.doi.org/10.1074/jbc.M109.075143			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20457600	Green Published, hybrid			2022-12-27	WOS:000279999900069
J	Gorbea, C; Makar, KA; Pauschinger, M; Pratt, G; Bersola, JLF; Varela, J; David, RM; Banks, L; Huang, CH; Li, H; Schultheiss, HP; Towbin, JA; Vallejo, JG; Bowles, NE				Gorbea, Carlos; Makar, Kimberly A.; Pauschinger, Matthias; Pratt, Gregory; Bersola, Jeathrina L. F.; Varela, Jacquelin; David, Ryan M.; Banks, Lori; Huang, Chien-Hua; Li, Hua; Schultheiss, Heinz-Peter; Towbin, Jeffrey A.; Vallejo, Jesus G.; Bowles, Neil E.			A Role for Toll-like Receptor 3 Variants in Host Susceptibility to Enteroviral Myocarditis and Dilated Cardiomyopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; ISOLATED RAT HEPATOCYTES; BECLIN 1; PHOSPHATIDYLINOSITOL 3-KINASE; MULTIVESICULAR BODIES; AUTOPHAGIC VACUOLES; FUNCTIONAL ANALYSES; PROTEIN LIPIDATION; ENDOCYTIC PATHWAYS; SIGNALING PATHWAYS	The innate antiviral response is mediated, at least in part, by Toll-like receptors (TLRs). TLR3 signaling is activated in response to viral infection, and the absence of TLR3 in mice significantly increases mortality after infection with enteroviruses that cause myocarditis and/or dilated cardiomyopathy. We screened TLR3 in patients diagnosed with enteroviral myocarditis/cardiomyopathy and identified a rare variant in one patient as well as a significantly increased occurrence of a common polymorphism compared with controls. Expression of either variant resulted in significantly reduced TLR3-mediated signaling after stimulation with synthetic double-stranded RNA. Furthermore, Coxsackievirus B3 infection of cell lines expressing mutated TLR3 abrogated activation of the type I interferon pathway, leading to increased viral replication. TLR3-mediated type I interferon signaling required cellular autophagy and was suppressed by 3-methyladenine and bafilomycin A1, by inhibitors of lysosomal proteolysis, and by reduced expression of Beclin 1, Atg5, or microtubule-associated protein 1 light chain 3 beta (MAP1LC3 beta). However, TLR3-mediated signaling was restored upon exogenous expression of Beclin 1 or a variant MAP1LC3 beta fusion protein refractory to RNA interference. These data suggest that individuals harboring these variants may have a blunted innate immune response to enteroviral infection, leading to reduced viral clearance and an increased risk of cardiac pathology.	Univ Utah, Sch Med, Dept Pediat, Div Cardiol, Salt Lake City, UT 84112 USA; [Pratt, Gregory] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Makar, Kimberly A.; Towbin, Jeffrey A.] Baylor Coll Med, Dept Med, Cardiovasc Sci Sect, Houston, TX 77030 USA; [Bersola, Jeathrina L. F.; Varela, Jacquelin; David, Ryan M.; Li, Hua; Towbin, Jeffrey A.] Baylor Coll Med, Dept Pediat, Cardiol Sect, Houston, TX 77030 USA; [Banks, Lori; Huang, Chien-Hua] Baylor Coll Med, Dept Pediat, Infect Dis Sect, Houston, TX 77030 USA; [Towbin, Jeffrey A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Pauschinger, Matthias; Schultheiss, Heinz-Peter] Charite, Med Clin 2, D-12203 Berlin, Germany	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Bowles, NE (corresponding author), Univ Utah, Sch Med, Eccles Inst Human Genet, Dept Pediat Cardiol, 15 North 2030 East,Rm 7110B, Salt Lake City, UT 84112 USA.	neil.bowles@hsc.utah.edu	Gorbea, Carlos/L-4406-2019; Towbin, Jeffrey A./J-5595-2019	Towbin, Jeffrey A./0000-0002-6585-714X; HUANG, CHIEN-HUA/0000-0003-2981-4537; Banks, Lori/0000-0003-4684-8763	National Institutes of Health, NHLBI [R21-HL091223]; American Heart Association (National Center; Dept. of Human Genetics, University of Utah; Dept. of Pathology, University of Utah; Dept. of Biochemistry, University of Utah; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL091223] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association (National Center(American Heart Association); Dept. of Human Genetics, University of Utah; Dept. of Pathology, University of Utah; Dept. of Biochemistry, University of Utah; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R21-HL091223 (NHLBI, to N. E. B. and J. G. V.). This work was supported by the American Heart Association (National Center and Texas Affiliate (to N. E. B.).; We are grateful to Dr. Mark Leppert (Dept. of Human Genetics, University of Utah), Dr. Robert Fujinami (Dept. of Pathology, University of Utah), and Dr. Martin Rechsteiner (Dept. of Biochemistry, University of Utah) for support and assistance.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Aretz H T, 1987, Am J Cardiovasc Pathol, V1, P3; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Berg TO, 1998, J BIOL CHEM, V273, P21883, DOI 10.1074/jbc.273.34.21883; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Bowles KR, 2000, GENOMICS, V67, P109, DOI 10.1006/geno.2000.6242; Bowles NE, 2003, J AM COLL CARDIOL, V42, P466, DOI 10.1016/S0735-1097(03)00648-X; Bowles NE, 2003, CURR OPIN CARDIOL, V18, P182, DOI 10.1097/00001573-200305000-00002; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Cullen BR, 2006, NAT METHODS, V3, P677, DOI 10.1038/NMETH913; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Drose S, 1997, J EXP BIOL, V200, P1; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Fader CM, 2008, TRAFFIC, V9, P230, DOI 10.1111/j.1600-0854.2007.00677.x; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Funami K, 2004, INT IMMUNOL, V16, P1143, DOI 10.1093/intimm/dxh115; GOODWIN JF, 1983, MYOCARDITIS CARDIOMY, P7; GORDON PB, 1988, BIOCHEM BIOPH RES CO, V151, P40, DOI 10.1016/0006-291X(88)90556-6; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hardarson HS, 2007, AM J PHYSIOL-HEART C, V292, pH251, DOI 10.1152/ajpheart.00398.2006; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Itoh K, 2008, J IMMUNOL, V181, P5522, DOI 10.4049/jimmunol.181.8.5522; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kuhl U, 1996, HEART, V75, P295, DOI 10.1136/hrt.75.3.295; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Liou W, 1997, J CELL BIOL, V136, P61, DOI 10.1083/jcb.136.1.61; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Marino G, 2003, J BIOL CHEM, V278, P3671, DOI 10.1074/jbc.M208247200; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Muenz C, 2009, ANNU REV IMMUNOL, V27, P423, DOI 10.1146/annurev.immunol.021908.132537; Muzio M, 2000, J LEUKOCYTE BIOL, V67, P450, DOI 10.1002/jlb.67.4.450; Negishi H, 2008, P NATL ACAD SCI USA, V105, P20446, DOI 10.1073/pnas.0810372105; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pauschinger M, 1999, CIRCULATION, V99, P1348, DOI 10.1161/01.CIR.99.10.1348; Pei Y, 2006, NAT METHODS, V3, P670, DOI 10.1038/NMETH911; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Pirher N, 2008, NAT STRUCT MOL BIOL, V15, P761, DOI 10.1038/nsmb.1453; Ranjith-Kumar CT, 2007, J BIOL CHEM, V282, P17696, DOI 10.1074/jbc.M700209200; Ranjith-Kumar CT, 2007, J BIOL CHEM, V282, P7668, DOI 10.1074/jbc.M610946200; Richer MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004127; Rudd BD, 2005, J VIROL, V79, P3350, DOI 10.1128/JVI.79.6.3350-3357.2005; Saxena S, 2003, J BIOL CHEM, V278, P44312, DOI 10.1074/jbc.M307089200; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shi CS, 2008, J BIOL CHEM, V283, P33175, DOI 10.1074/jbc.M804478200; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Shoji-Kawata S, 2009, BBA-MOL CELL RES, V1793, P1478, DOI 10.1016/j.bbamcr.2009.02.008; Sun JC, 2006, J BIOL CHEM, V281, P11144, DOI 10.1074/jbc.M510442200; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Virgin HW, 2009, NAT IMMUNOL, V10, P461, DOI 10.1038/ni.1726; Wileman T, 2006, SCIENCE, V312, P875, DOI 10.1126/science.1126766; Wong J, 2008, J VIROL, V82, P9143, DOI 10.1128/JVI.00641-08; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yajima T, 2009, CIRCULATION, V119, P2615, DOI 10.1161/CIRCULATIONAHA.108.766022; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	66	122	133	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23206	23221		10.1074/jbc.M109.047464	http://dx.doi.org/10.1074/jbc.M109.047464			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20472559	Green Published, hybrid			2022-12-27	WOS:000279999900055
J	Kim, BJ; Li, YH; Zhang, JL; Xi, YX; Li, YM; Yang, T; Jung, SY; Pan, XW; Chen, R; Li, W; Wang, Y; Qin, J				Kim, Beom-Jun; Li, Yehua; Zhang, Jinglan; Xi, Yuanxin; Li, Yumei; Yang, Tao; Jung, Sung Yun; Pan, Xuewen; Chen, Rui; Li, Wei; Wang, Yi; Qin, Jun			Genome-wide Reinforcement of Cohesin Binding at Pre-existing Cohesin Sites in Response to Ionizing Radiation in Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; DNA-DAMAGE RESPONSE; DOUBLE-STRAND BREAKS; S-PHASE; ATM; PROTEIN; ACETYLATION; COMPLEX; ROLES; ECO1	The cohesin complex plays a central role in genome maintenance by regulation of chromosome segregation in mitosis and DNA damage response (DDR) in other phases of the cell cycle. The ATM/ATR phosphorylates SMC1 and SMC3, two core components of the cohesin complex to regulate checkpoint signaling and DNA repair. In this report, we show that the genome-wide binding of SMC1 and SMC3 after ionizing radiation (IR) is enhanced by reinforcing pre-existing cohesin binding sites in human cancer cells. We demonstrate that ATM and SMC3 phosphorylation at Ser(1083) regulate this process. We also demonstrate that acetylation of SMC3 at Lys(105) and Lys(106) is induced by IR and this induction depends on the acetyltransferase ESCO1 as well as the ATM/ATR kinases. Consistently, both ESCO1 and SMC3 acetylation are required for intra-S phase checkpoint and cellular survival after IR. Although both IR-induced acetylation and phosphorylation of SMC3 are under the control of ATM/ATR, the two forms of modification are independent of each other and both are required to promote reinforcement of SMC3 binding to cohesin sites. Thus, SMC3 modifications is a mechanism for genome-wide reinforcement of cohesin binding in response to DNA damage response in human cells and enhanced cohesion is a downstream event of DDR.	[Kim, Beom-Jun; Li, Yehua; Zhang, Jinglan; Yang, Tao; Jung, Sung Yun; Pan, Xuewen; Wang, Yi; Qin, Jun] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Ctr Mol Discovery, Houston, TX 77030 USA; [Jung, Sung Yun; Wang, Yi; Qin, Jun] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Li, Yumei; Chen, Rui] Baylor Coll Med, Genome Ctr, Houston, TX 77030 USA; [Xi, Yuanxin; Li, Wei] Baylor Coll Med, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Qin, J (corresponding author), 1 Baylor Plaza, Houston, TX 77030 USA.	jqin@bcm.tmc.edu	Li, Wei/A-8544-2009; Zhang, Jinglan/D-4752-2011; Zhang, Jinglan/AAI-1793-2020	Zhang, Jinglan/0000-0002-4600-7123; Jung, Sung Yun/0000-0003-1521-7977; Li, Wei/0000-0001-9931-5990	National Institutes of Health [CA84199, CA98500]; Welch Foundation; NATIONAL CANCER INSTITUTE [R01CA098500, R01CA084199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA84199 and CA98500 and the Welch Foundation (to J.Q.).	Arumugam P, 2003, CURR BIOL, V13, P1941, DOI 10.1016/j.cub.2003.10.036; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Bernard P, 2008, EMBO J, V27, P111, DOI 10.1038/sj.emboj.7601955; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Heidinger-Pauli JM, 2008, MOL CELL, V31, P47, DOI 10.1016/j.molcel.2008.06.005; Heidinger-Pauli JM, 2009, MOL CELL, V34, P311, DOI 10.1016/j.molcel.2009.04.008; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Luo H, 2008, J BIOL CHEM, V283, P19176, DOI 10.1074/jbc.M802299200; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mishiro T, 2009, EMBO J, V28, P1234, DOI 10.1038/emboj.2009.81; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Onn I, 2008, ANNU REV CELL DEV BI, V24, P105, DOI 10.1146/annurev.cellbio.24.110707.175350; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Schmidt CK, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r52; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Stedman W, 2008, EMBO J, V27, P654, DOI 10.1038/emboj.2008.1; Strom L, 2007, SCIENCE, V317, P242, DOI 10.1126/science.1140649; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; Sutani T, 2009, CURR BIOL, V19, P492, DOI 10.1016/j.cub.2009.01.062; Terret ME, 2009, NATURE, V462, P231, DOI 10.1038/nature08550; Unal E, 2007, SCIENCE, V317, P245, DOI 10.1126/science.1140637; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	45	43	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22782	22790		10.1074/jbc.M110.134577	http://dx.doi.org/10.1074/jbc.M110.134577			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20501661	Green Published, hybrid			2022-12-27	WOS:000279999900010
J	Lazer, G; Pe'er, L; Farago, M; Machida, K; Mayer, BJ; Katzav, S				Lazer, Galit; Pe'er, Liron; Farago, Marganit; Machida, Kazuya; Mayer, Bruce J.; Katzav, Shulamit			Tyrosine Residues at the Carboxyl Terminus of Vav1 Play an Important Role in Regulation of Its Biological Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-RECEPTOR; SIGNAL TRANSDUCER VAV1; ADAPTER PROTEIN; EXCHANGE FACTOR; RHO-FAMILY; PROTOONCOGENE VAV; HUMAN GENOME; LUNG-CANCER; SH2 DOMAINS; ACTIVATION	The guanine nucleotide exchange factor (GEF) Vav1 is an essential signal transducer protein in the hematopoietic system, where it is expressed physiologically. It is also involved in several human malignancies. Tyrosine phosphorylation at the Vav1 amino terminus plays a central role in regulating its activity; however, the role of carboxyl terminal tyrosine residues is unknown. We found that mutation of either Tyr-826 (Y826F) or Tyr-841 (Y841F) to phenylalanine led to loss of Vav1 GEF activity. When these Vav1 mutants were ectopically expressed in pancreatic cancer cells lacking Vav1, they failed to induce growth in agar, indicating loss of transforming potential. Furthermore, although Y841F had no effect on Vav1-stimulated nuclear factor of activated T cells (NFAT) activity, Y826F doubled NFAT activity when compared with Vav1, suggesting that Tyr-826 mediates an autoinhibitory effect on NFAT activity. SH2 profiling revealed that Shc, Csk, Abl, and Sap associate with Tyr-826, whereas SH2-B, Src, Brk, GTPase-activating protein, and phospholipase C-gamma associate with Tyr-841. Although the mutations in the Tyr-826 and Tyr-841 did not affect the binding of the carboxyl SH3 of Vav1 to other proteins, binding to several of the proteins identified by the SH2 profiling was lost. Of interest is Csk, which associates with wild-type Vav1 and Y841F, yet it fails to associate with Y826F, suggesting that loss of binding between Y826F and Csk might relieve an autoinhibitory effect, leading to increased NFAT. Our data indicate that GEF activity is critical for the function of Vav1 as a transforming protein but not for NFAT stimulation. The association of Vav1 with other proteins, detected by SH2 profiling, might affect other Vav1-dependent activities, such as NFAT stimulation.	[Lazer, Galit; Pe'er, Liron; Farago, Marganit; Katzav, Shulamit] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Dept Dev Biol & Canc Res, IL-91120 Jerusalem, Israel; [Machida, Kazuya; Mayer, Bruce J.] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Raymond & Beverly Sackler Lab Genet & Mol Med, Farmington, CT 06030 USA	Hebrew University of Jerusalem; University of Connecticut	Katzav, S (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Dept Dev Biol & Canc Res, POB 12272, IL-91120 Jerusalem, Israel.	shulamitk@ekmd.huji.ac.il			National Institutes of Health [CA107785]; Israel Academy of Sciences; Israel Cancer Research Foundation; Connecticut Breast Health Initiative; NATIONAL CANCER INSTITUTE [R21CA107785, R01CA082258, R33CA107785] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Academy of Sciences; Israel Cancer Research Foundation; Connecticut Breast Health Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA107785 (to B.J.M.). This work was also partially supported by grants from the Israel Academy of Sciences (to S. K.), Israel Cancer Research Foundation (to S. K.), and Connecticut Breast Health Initiative (to K.M.).	Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Bassermann F, 2002, J BIOL CHEM, V277, P12437, DOI 10.1074/jbc.M112397200; Bertagnolo V, 2010, J PROTEOME RES, V9, P752, DOI 10.1021/pr900581y; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Cao YJ, 2002, EMBO J, V21, P4809, DOI 10.1093/emboj/cdf499; Chen RY, 2004, MOL CELL BIOL, V24, P5144, DOI 10.1128/MCB.24.12.5144-5156.2004; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Cui LL, 2009, J IMMUNOL, V182, P3233, DOI 10.4049/jimmunol.0802621; Dierck Kevin, 2009, V527, P131, DOI 10.1007/978-1-60327-834-8_11; Evers EE, 2000, EUR J CANCER, V36, P1269, DOI 10.1016/S0959-8049(00)00091-5; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Fumagalli L, 2007, J IMMUNOL, V178, P3874, DOI 10.4049/jimmunol.178.6.3874; Groysman M, 2002, J BIOL CHEM, V277, P50121, DOI 10.1074/jbc.M204299200; Groysman M, 1998, ONCOGENE, V17, P1597, DOI 10.1038/sj.onc.1202074; Han JW, 1997, MOL CELL BIOL, V17, P1346, DOI 10.1128/MCB.17.3.1346; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harnois T, 2003, ONCOGENE, V22, P6445, DOI 10.1038/sj.onc.1206626; Hehner SP, 2000, J BIOL CHEM, V275, P18160, DOI 10.1074/jbc.275.24.18160; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Hornstein I, 2004, CELL SIGNAL, V16, P1, DOI 10.1016/S0898-6568(03)00110-4; Hornstein I, 2003, J PATHOL, V199, P526, DOI 10.1002/path.1314; Huang JY, 2000, P NATL ACAD SCI USA, V97, P10923, DOI 10.1073/pnas.97.20.10923; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Kaminuma O, 2001, MOL CELL BIOL, V21, P3126, DOI 10.1128/MCB.21.9.3126-3136.2001; KATZAV S, 1991, MOL CELL BIOL, V11, P1912, DOI 10.1128/MCB.11.4.1912; KATZAV S, 1993, ONCOGENE, V8, P1757; KATZAV S, 1989, EMBO J, V8, P2283, DOI 10.1002/j.1460-2075.1989.tb08354.x; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Kuhne MR, 2000, J BIOL CHEM, V275, P2185, DOI 10.1074/jbc.275.3.2185; Lazer G, 2007, CELL SIGNAL, V19, P2479, DOI 10.1016/j.cellsig.2007.07.022; Lazer G, 2009, J PATHOL, V219, P25, DOI 10.1002/path.2579; Li PL, 2008, NAT STRUCT MOL BIOL, V15, P613, DOI 10.1038/nsmb.1428; Liu HH, 2006, ACTA PHYS-CHIM SIN, V22, P868, DOI 10.3866/PKU.WHXB20060720; Lopez-Lago M, 2000, MOL CELL BIOL, V20, P1678, DOI 10.1128/MCB.20.5.1678-1691.2000; Machida K, 2005, BBA-PROTEINS PROTEOM, V1747, P1, DOI 10.1016/j.bbapap.2004.10.005; Machida K, 2007, MOL CELL, V26, P899, DOI 10.1016/j.molcel.2007.05.031; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Maures TJ, 2007, TRENDS ENDOCRIN MET, V18, P38, DOI 10.1016/j.tem.2006.11.007; Michel F, 1998, J BIOL CHEM, V273, P31932, DOI 10.1074/jbc.273.48.31932; Miletic AV, 2006, J BIOL CHEM, V281, P38257, DOI 10.1074/jbc.M608913200; Patrussi L, 2007, BLOOD, V110, P1730, DOI 10.1182/blood-2007-01-068411; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Peterson ME, 2008, IMMUNITY, V29, P578, DOI 10.1016/j.immuni.2008.07.014; Rapley J, 2008, EMBO REP, V9, P655, DOI 10.1038/embor.2008.80; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Saborit-Villarroya I, 2008, MOL IMMUNOL, V45, P3446, DOI 10.1016/j.molimm.2008.03.021; Saborit-Villarroya IN, 2005, J IMMUNOL, V175, P4226, DOI 10.4049/jimmunol.175.7.4226; Saveliev A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000420; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Smit L, 1996, J BIOL CHEM, V271, P8564, DOI 10.1074/jbc.271.15.8564; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Vang T, 2004, EUR J IMMUNOL, V34, P2191, DOI 10.1002/eji.200425036; Walters DK, 2006, LEUKEMIA RES, V30, P1097, DOI 10.1016/j.leukres.2006.01.001; WU J, 1995, MOL CELL BIOL, V15, P4337; Yabana N, 2002, ONCOGENE, V21, P7720, DOI 10.1038/sj.onc.1205927; Yu BK, 2010, CELL, V140, P246, DOI 10.1016/j.cell.2009.12.033; Zugaza JL, 2002, J BIOL CHEM, V277, P45377, DOI 10.1074/jbc.M208039200	63	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23073	23083		10.1074/jbc.M109.094508	http://dx.doi.org/10.1074/jbc.M109.094508			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20457609	hybrid, Green Published			2022-12-27	WOS:000279999900042
J	Liu, J; Majumdar, A; Liu, JL; Thompson, LH; Seidman, MM				Liu, Jia; Majumdar, Alokes; Liu, Jilan; Thompson, Lawrence H.; Seidman, Michael M.			Sequence Conversion by Single Strand Oligonucleotide Donors via Non-homologous End Joining in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELIX-FORMING OLIGONUCLEOTIDES; FANCONI-ANEMIA FIBROBLASTS; ZINC-FINGER NUCLEASES; BREAK REPAIR PATHWAY; HOMOLOGOUS RECOMBINATION; DNA-REPAIR; 2'-O-(2-AMINOETHYL) RESIDUES; MRE11-RAD50-NBS1 COMPLEX; SACCHAROMYCES-CEREVISIAE; RAD51 RECOMBINATION	Double strand breaks (DSBs) can be repaired by homology independent nonhomologous end joining (NHEJ) pathways involving proteins such as Ku70/80, DNAPKcs, Xrcc4/Ligase 4, and the Mre11/Rad50/Nbs1 (MRN) complex. DSBs can also be repaired by homology-dependent pathways (HDR), in which the MRN and CtIP nucleases produce single strand ends that engage homologous sequences either by strand invasion or strand annealing. The entry of ends into HDR pathways underlies protocols for genomic manipulation that combine site-specific DSBs with appropriate informational donors. Most strategies utilize long duplex donors that participate by strand invasion. Work in yeast indicates that single strand oligonucleotide (SSO) donors are also active, over considerable distance, via a single strand annealing pathway. We examined the activity of SSO donors in mammalian cells at DSBs induced either by a restriction nuclease or by a targeted interstrand cross-link. SSO donors were effective immediately adjacent to the break, but activity declined sharply beyond similar to 100 nucleotides. Overexpression of the resection nuclease CtIP increased the frequency of SSO-mediated sequence modulation distal to the break site, but had no effect on the activity of an SSO donor adjacent to the break. Genetic and in vivo competition experiments showed that sequence conversion by SSOs in the immediate vicinity of the break was not by strand invasion or strand annealing pathways. Instead these donors competed for ends that would have otherwise entered NHEJ pathways.	[Liu, Jia; Majumdar, Alokes; Seidman, Michael M.] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA; [Liu, Jilan] Mission Res Inc, Baltimore, MD 21224 USA; [Thompson, Lawrence H.] Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, Livermore, CA 94551 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Seidman, MM (corresponding author), 251 Bayview Blvd,BRC 5B133, Baltimore, MD 21224 USA.	seidmanm@grc.nia.nih.gov			National Institutes of Health; NIA; Fanconi Anemia Research Foundation; NATIONAL INSTITUTE ON AGING [ZIAAG000747] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Fanconi Anemia Research Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, NIA, and by the Fanconi Anemia Research Foundation, through a R&D contract with MedStar Research Institute.	Ahmad A, 2008, MOL CELL BIOL, V28, P5082, DOI 10.1128/MCB.00293-08; Al-Minawi AZ, 2008, NUCLEIC ACIDS RES, V36, P1, DOI 10.1093/nar/gkm888; Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Bell NM, 2009, CHEMBIOCHEM, V10, P2691, DOI 10.1002/cbic.200900341; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; Capp JP, 2007, NUCLEIC ACIDS RES, V35, P3551, DOI 10.1093/nar/gkm243; Capp JP, 2006, NUCLEIC ACIDS RES, V34, P2998, DOI 10.1093/nar/gkl380; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Chen MF, 2006, INT J RADIAT ONCOL, V66, P244, DOI 10.1016/j.ijrobp.2006.03.062; Clerici M, 2005, J BIOL CHEM, V280, P38631, DOI 10.1074/jbc.M508339200; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Delacote F, 2008, CELL CYCLE, V7, P33, DOI 10.4161/cc.7.1.5149; Dinkelmann M, 2009, NAT STRUCT MOL BIOL, V16, P808, DOI 10.1038/nsmb.1639; Donahue SL, 2003, J BIOL CHEM, V278, P29487, DOI 10.1074/jbc.M213251200; Donahue SL, 2002, J BIOL CHEM, V277, P46243, DOI 10.1074/jbc.M207937200; Donoho G, 1998, MOL CELL BIOL, V18, P4070, DOI 10.1128/MCB.18.7.4070; Dupre A, 2008, NAT CHEM BIOL, V4, P119, DOI 10.1038/nchembio.63; Eklund JL, 2007, NUCLEIC ACIDS RES, V35, P5839, DOI 10.1093/nar/gkm624; Garner KM, 2009, NAT CHEM BIOL, V5, P129, DOI 10.1038/nchembio0309-129; Godthelp BC, 2002, NUCLEIC ACIDS RES, V30, P2172, DOI 10.1093/nar/30.10.2172; Gu JF, 2007, EMBO J, V26, P1010, DOI 10.1038/sj.emboj.7601559; Guirouilh-Barbat J, 2007, P NATL ACAD SCI USA, V104, P20902, DOI 10.1073/pnas.0708541104; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; Hefferin ML, 2005, DNA REPAIR, V4, P639, DOI 10.1016/j.dnarep.2004.12.005; Helleday T, 2003, MUTAT RES-FUND MOL M, V532, P103, DOI 10.1016/j.mrfmmm.2003.08.013; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; Jarjour J, 2009, NUCLEIC ACIDS RES, V37, P6871, DOI 10.1093/nar/gkp726; Karanjawala ZE, 2002, CURR BIOL, V12, P397, DOI 10.1016/S0960-9822(02)00684-X; Lambert S, 2000, EMBO J, V19, P3090, DOI 10.1093/emboj/19.12.3090; Lambert S, 2002, ONCOGENE, V21, P4065, DOI 10.1038/sj.onc.1205535; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Lieber MR, 2008, CELL RES, V18, P125, DOI 10.1038/cr.2007.108; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; LIN FL, 1984, COLD SPRING HARB SYM, V49, P139, DOI 10.1101/SQB.1984.049.01.017; Lio YC, 2003, J BIOL CHEM, V278, P2469, DOI 10.1074/jbc.M211038200; Liu N, 2002, NUCLEIC ACIDS RES, V30, P1009, DOI 10.1093/nar/30.4.1009; Liu N, 1998, MOL CELL, V1, P783, DOI 10.1016/S1097-2765(00)80078-7; Majumdar A, 1998, NAT GENET, V20, P212, DOI 10.1038/2530; Majumdar A, 2008, J BIOL CHEM, V283, P11244, DOI 10.1074/jbc.M800607200; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Meulle A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003345; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mirchandani KD, 2006, EXP CELL RES, V312, P2647, DOI 10.1016/j.yexcr.2006.06.014; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Niedernhofer LJ, 2005, CELL, V123, P1191, DOI 10.1016/j.cell.2005.12.009; Nijnik A, 2009, J CLIN INVEST, V119, P1696, DOI 10.1172/JCI32743; Porteus Matthew, 2008, V435, P47, DOI 10.1007/978-1-59745-232-8_4; Puri N, 2004, BIOCHEMISTRY-US, V43, P1343, DOI 10.1021/bi035808l; Puri N, 2002, BIOCHEMISTRY-US, V41, P7716, DOI 10.1021/bi025734y; Radecke F, 2006, MOL THER, V14, P798, DOI 10.1016/j.ymthe.2006.06.008; Rass E, 2009, NAT STRUCT MOL BIOL, V16, P819, DOI 10.1038/nsmb.1641; Richards S, 2005, NUCLEIC ACIDS RES, V33, P5382, DOI 10.1093/nar/gki851; Richardson C, 2000, MOL CELL BIOL, V20, P9068, DOI 10.1128/MCB.20.23.9068-9075.2000; Rodrigue A, 2006, EMBO J, V25, P222, DOI 10.1038/sj.emboj.7600914; Saleh-Gohari N, 2004, NUCLEIC ACIDS RES, V32, P3683, DOI 10.1093/nar/gkh703; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; SAWAI M, 1990, EXP CELL RES, V187, P4, DOI 10.1016/0014-4827(90)90108-M; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Stark JM, 2002, J BIOL CHEM, V277, P20185, DOI 10.1074/jbc.M112132200; Storici F, 2003, P NATL ACAD SCI USA, V100, P14994, DOI 10.1073/pnas.2036296100; Storici F, 2006, MOL CELL BIOL, V26, P7645, DOI 10.1128/MCB.00672-06; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Takeda S, 2007, MOL CELL, V28, P351, DOI 10.1016/j.molcel.2007.10.016; Tebbs RS, 2005, DNA REPAIR, V4, P11, DOI 10.1016/j.dnarep.2004.06.013; Thompson LH, 2009, MUTAT RES-FUND MOL M, V668, P54, DOI 10.1016/j.mrfmmm.2009.02.003; Thorslund T, 2007, ONCOGENE, V26, P7720, DOI 10.1038/sj.onc.1210870; Tsai CJ, 2007, P NATL ACAD SCI USA, V104, P7851, DOI 10.1073/pnas.0702620104; Van Dyck E, 2001, EMBO REP, V2, P905, DOI 10.1093/embo-reports/kve201; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Wang XL, 2008, CHINESE PHYS C, V32, P18, DOI 10.1088/1674-1137/32/1/004; WHITE CI, 1990, EMBO J, V9, P663, DOI 10.1002/j.1460-2075.1990.tb08158.x; Wiegant WW, 2006, MUTAT RES-FUND MOL M, V600, P79, DOI 10.1016/j.mrfmmm.2006.03.001; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Wilson JB, 2008, ONCOGENE, V27, P3641, DOI 10.1038/sj.onc.1211034; Wilson JH, 2008, P NATL ACAD SCI USA, V105, P5653, DOI 10.1073/pnas.0802298105; Xie AY, 2009, NAT STRUCT MOL BIOL, V16, P814, DOI 10.1038/nsmb.1640; Yuan JS, 2010, J BIOL CHEM, V285, P1097, DOI 10.1074/jbc.M109.078436; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zha S, 2009, NAT STRUCT MOL BIOL, V16, P798, DOI 10.1038/nsmb0809-798; Zhuang J, 2009, J BIOL CHEM, V284, P30565, DOI 10.1074/jbc.M109.059444; Zierhut C, 2008, EMBO J, V27, P1875, DOI 10.1038/emboj.2008.111	94	15	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23196	23205		10.1074/jbc.M110.123844	http://dx.doi.org/10.1074/jbc.M110.123844			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20489199	hybrid, Green Published			2022-12-27	WOS:000279999900054
J	Matsuda, JJ; Filali, MS; Moreland, JG; Miller, FJ; Lamb, FS				Matsuda, James J.; Filali, Mohammed S.; Moreland, Jessica G.; Miller, Francis J.; Lamb, Fred S.			Activation of Swelling-activated Chloride Current by Tumor Necrosis Factor-alpha Requires ClC-3-dependent Endosomal Reactive Oxygen Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; SENSITIVE CL-CHANNEL; NADPH OXIDASE; ANION CHANNELS; VOLUME REGULATION; PLASMA-MEMBRANE; VENTRICULAR MYOCYTES; SIGNALING ENDOSOMES; RABBIT VENTRICLE; CLC-3 CHANNELS	ClC-3 is a Cl-/H+ antiporter required for cytokine-induced intraendosomal reactive oxygen species (ROS) generation by Nox1. ClC-3 current is distinct from the swelling-activated chloride current (IClswell), but overexpression of ClC-3 can activate currents that resemble IClswell. Because H2O2 activates IClswell directly, we hypothesized that ClC-3-dependent, endosomal ROS production activates IClswell. Whole-cell perforated patch clamp methods were used to record Cl- currents in cultured aortic vascular smooth muscle cells from wild type (WT) and ClC-3 null mice. Under isotonic conditions, tumor necrosis factor-alpha (TNF-alpha) (10 ng/ml) activated outwardly rectifying Cl- currents with time-dependent inactivation in WT but not ClC-3 null cells. Inhibition by tamoxifen (10 mu M) and by hypertonicity (340 mosM) identified them as IClswell. IClswell was also activated by H2O2 (500 mu M), and the effect of TNF-alpha was completely inhibited by polyethylene glycol-catalase. ClC-3 expression induced IClswell in ClC-3 null cells in the absence of swelling or TNF-alpha, and this effect was also blocked by catalase. IClswell activation by hypotonicity (240 mosM) was only partially inhibited by catalase, and the size of these currents did not differ between WT and ClC-3 null cells. Disruption of endosome trafficking with either mutant Rab5 (S34N) or Rab11 (S25N) inhibited TNF-alpha-mediated activation of IClswell. Thrombin also activates ROS production by Nox1 but not in endosomes. Thrombin caused H2O2-dependent activation of IClswell, but this effect was not ClC-3- or Rab5-dependent. Thus, activation of IClswell by TNF-alpha requires ClC-3-dependent endosomal H2O2 production. This demonstrates a functional link between two distinct anion currents, ClC-3 and IClswell.	Univ Iowa, Dept Pediat, Childrens Hosp, Iowa City, IA 52242 USA; Univ Iowa, Dept Internal Med, Childrens Hosp, Iowa City, IA 52242 USA; Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Lamb, FS (corresponding author), Univ Iowa, Dept Pediat, 7770-F JPP, Iowa City, IA 52242 USA.	fred-lamb@uiowa.edu	Miller Jr, Francis/N-7312-2015	Miller Jr, Francis/0000-0001-5822-0549; Lamb, Fred/0000-0003-2955-5133	National Institutes of Health [HL62483, HL081750, AI067533, DK07690-15]; American Heart Association; Department of Veterans Affairs Office of Research and Development; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081750, R56HL062483, R01HL062483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI067533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Department of Veterans Affairs Office of Research and Development(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL62483 (to F.S.L.), HL081750 (to F.J.M.), AI067533 (to J.G.M.), and DK07690-15 (to J.J.M.). This work was also supported by grants from the American Heart Association (to F.S.L.), and the Department of Veterans Affairs Office of Research and Development (to F.J.M.).	Arreola J, 2002, J PHYSIOL-LONDON, V545, P207, DOI 10.1113/jphysiol.2002.021980; Browe DM, 2006, J GEN PHYSIOL, V127, P237, DOI 10.1085/jgp.200509366; Browe DM, 2004, J GEN PHYSIOL, V124, P273, DOI 10.1085/jgp.200409040; Clempus RE, 2006, CARDIOVASC RES, V71, P216, DOI 10.1016/j.cardiores.2006.02.033; Dai YP, 2005, BRIT J PHARMACOL, V145, P5, DOI 10.1038/sj.bjp.0706135; Dinneen JL, 2004, EXP CELL RES, V294, P509, DOI 10.1016/j.yexcr.2003.12.006; Duan D, 1997, NATURE, V390, P417, DOI 10.1038/37151; Duan DY, 2001, J PHYSIOL-LONDON, V531, P437, DOI 10.1111/j.1469-7793.2001.0437i.x; Faundez Victor, 2004, Sci STKE, V2004, pre8, DOI 10.1126/stke.2332004re8; Friedrich T, 1999, J BIOL CHEM, V274, P896, DOI 10.1074/jbc.274.2.896; Friis MB, 2008, AM J PHYSIOL-CELL PH, V294, pC1552, DOI 10.1152/ajpcell.00571.2007; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Garcia-Regalado A, 2008, MOL BIOL CELL, V19, P4188, DOI 10.1091/mbc.E07-10-1089; Gong WQ, 2004, CELL PHYSIOL BIOCHEM, V14, P213, DOI 10.1159/000080330; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P1241, DOI 10.1074/jbc.M407030200; Hawkins BJ, 2007, MOL BIOL CELL, V18, P2002, DOI 10.1091/mbc.E06-09-0830; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; Huang P, 2001, J BIOL CHEM, V276, P20093, DOI 10.1074/jbc.M009376200; JENTSCH TJ, 1995, J PHYSIOL-LONDON, V482, P19; Lamb FS, 2009, ANTIOXID REDOX SIGN, V11, P1335, DOI [10.1089/ars.2008.2448, 10.1089/ARS.2009.2448]; Lambert S, 2005, J PHYSIOL-LONDON, V567, P191, DOI 10.1113/jphysiol.2005.089888; Lang F, 2007, METHOD ENZYMOL, V428, P209, DOI 10.1016/S0076-6879(07)28011-5; Lemonnier L, 2005, ENDOCR-RELAT CANCER, V12, P335, DOI 10.1677/erc.1.00898; Li XH, 2000, J BIOL CHEM, V275, P35994, DOI 10.1074/jbc.M002712200; Luo SF, 2009, TOXICOL APPL PHARM, V237, P8, DOI 10.1016/j.taap.2009.02.025; Mao JW, 2008, BIOCHEM PHARMACOL, V75, P1706, DOI 10.1016/j.bcp.2008.01.008; Martorell L, 2008, THROMB HAEMOSTASIS, V99, P305, DOI 10.1160/TH07-08-0481; Matsuda JJ, 2008, AM J PHYSIOL-CELL PH, V294, pC251, DOI 10.1152/ajpcell.00338.2007; Matsuda JJ, 2010, J BIOL CHEM, V285, P2569, DOI 10.1074/jbc.M109.018002; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Miller FJ, 2007, CIRC RES, V101, P663, DOI 10.1161/CIRCRESAHA.107.151076; Miller FJ, 2010, ANTIOXID REDOX SIGN, V12, P583, DOI 10.1089/ars.2009.2857; Moreland JG, 2007, J BIOL CHEM, V282, P33958, DOI 10.1074/jbc.M705289200; Moreland JG, 2006, J BIOL CHEM, V281, P12277, DOI 10.1074/jbc.M511030200; Mumbengegwi DR, 2008, MOL CELL BIOL, V28, P3700, DOI 10.1128/MCB.02038-07; Ogura T, 2002, FASEB J, V16, P863, DOI 10.1096/fj.01-0845fje; Okada Y, 2006, J MEMBRANE BIOL, V209, P21, DOI 10.1007/s00232-005-0836-6; Qian JS, 2009, CELL PHYSIOL BIOCHEM, V24, P461, DOI 10.1159/000257485; Reinehr R, 2007, GLIA, V55, P758, DOI 10.1002/glia.20504; Ren ZJ, 2005, AM J PHYSIOL-HEART C, V288, pH2628, DOI 10.1152/ajpheart.00992.2004; Ren Z, 2008, CARDIOVASC RES, V77, P73, DOI 10.1093/cvr/cvm031; Robinson NC, 2004, J PHYSIOL-LONDON, V556, P353, DOI 10.1113/jphysiol.2003.058032; Rossow CF, 2006, ACTA PHYSIOL, V187, P5, DOI 10.1111/j.1748-1716.2006.01550.x; Schlierf B, 2000, EXP CELL RES, V259, P257, DOI 10.1006/excr.2000.4947; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; Shimada K, 2000, AM J PHYSIOL-GASTR L, V279, pG268, DOI 10.1152/ajpgi.2000.279.2.G268; Shimizu T, 2004, P NATL ACAD SCI USA, V101, P6770, DOI 10.1073/pnas.0401604101; Sontheimer H, 2008, EXP BIOL MED, V233, P779, DOI 10.3181/0711-MR-308; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Tang YB, 2008, CELL PROLIFERAT, V41, P775, DOI 10.1111/j.1365-2184.2008.00551.x; Trebak M, 2010, ANTIOXID REDOX SIGN, V12, P657, DOI 10.1089/ars.2009.2842; Varela D, 2004, J BIOL CHEM, V279, P13301, DOI 10.1074/jbc.C400020200; Varela D, 2007, CELL PHYSIOL BIOCHEM, V20, P773, DOI 10.1159/000110437; Volk APD, 2008, J BIOL CHEM, V283, P34315, DOI 10.1074/jbc.M803141200; Wang GL, 2002, CIRC RES, V91, pE28, DOI 10.1161/01.RES.0000042062.69653.E4; Wang GX, 2003, AM J PHYSIOL-HEART C, V285, pH1453, DOI 10.1152/ajpheart.00244.2003; Wang J, 2005, JPN J PHYSIOL, V55, P379, DOI 10.2170/jjphysiol.S655; Wang Li-Wei, 2004, Shengli Xuebao, V56, P230; Wang XQ, 2006, NEURON, V52, P321, DOI 10.1016/j.neuron.2006.08.035; Weinberg F, 2009, CELL MOL LIFE SCI, V66, P3663, DOI 10.1007/s00018-009-0099-y; Weylandt KH, 2001, J BIOL CHEM, V276, P17461, DOI 10.1074/jbc.M011667200; Yamamoto-Mizuma S, 2004, J PHYSIOL-LONDON, V557, P439, DOI 10.1113/jphysiol.2003.059261; Yin ZH, 2008, AM J PHYSIOL-CELL PH, V294, pC535, DOI 10.1152/ajpcell.00291.2007; Zhang HN, 2006, APOPTOSIS, V11, P327, DOI 10.1007/s10495-006-3980-2; Zhou JG, 2005, J BIOL CHEM, V280, P7301, DOI 10.1074/jbc.M412813200	66	49	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22862	22871		10.1074/jbc.M109.099838	http://dx.doi.org/10.1074/jbc.M109.099838			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20479003	Green Published, hybrid			2022-12-27	WOS:000279999900019
J	Pan, R; Zhang, XJ; Zhang, ZJ; Zhou, Y; Tian, WX; He, RQ				Pan, Rong; Zhang, Xue-Jing; Zhang, Zi-Jian; Zhou, Yuan; Tian, Wei-Xi; He, Rong-Qiao			Substrate-induced Changes in Protease Active Site Conformation Impact on Subsequent Reactions with Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED-FIT; SPECIFICITY; FLEXIBILITY; DYNAMICS; ENZYMES; DOCKING; KINASE	Enzymatic catalysis of biochemical reactions is essential to all living systems. The "lock and key" and "induced fit" models were early contributions to our understanding of the mechanisms involved in the reaction between an enzyme and its substrate. However, whether a given substrate-induced conformation is rigid or remains flexible has not yet been determined. By measuring the enzyme activity and intrinsic fluorescence of a nonspecific Eisenia fetida protease-I with different chromogenic substrates, we show that in subsequent reactions of protease with substrates, both the "lock and key" and "induced fit" mechanisms are used depending on the degree of conformational change required. Chromozym-Th-or chromosym-Ch-induced protease conformations were unable to bind chromozym-U. The chromosym-U-induced protease conformation remained flexible and could be further induced by chromozym-Th and chromozym-Ch. When low concentrations of guanidine HCl were used to disturb the conformation of the enzyme, only small changes in intrinsic fluorescence of the chromozym-Th-induced protease were detected, in contrast to the native enzyme whose intrinsic fluorescence markedly increased. This indicates that the substrate-induced enzyme was relatively rigid compared with the native protease. Utilizing a lock and key mechanism for secondary substrate reactions may have adaptive value in that it facilitates high efficiency in enzymatic reactions.	[Pan, Rong; Zhang, Xue-Jing; Zhang, Zi-Jian; Zhou, Yuan; He, Rong-Qiao] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China; [Zhang, Xue-Jing] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Zhang, Zi-Jian; Zhou, Yuan; Tian, Wei-Xi; He, Rong-Qiao] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	He, RQ (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, 15 Da Tun Rd, Beijing 100101, Peoples R China.	herq@sun5.ibp.ac.cn	Pan, Rong/J-4113-2014; Pan, Rong/B-3161-2013; Zhang, Zijian/H-6190-2016		National Natural Science Foundation of China [30870544]; 973 projects of China [2006CB500703, 2010CB912303]; Chinese Academy of Sciences [KSCX2-YW-R-119, KSCX2-YW-R-256]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 projects of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China Grant 30870544, 973 projects of China Grants 2006CB500703 and 2010CB912303, and the Knowledge Innovation Program of the Chinese Academy of Sciences Grants KSCX2-YW-R-119 and KSCX2-YW-R-256.	ANDERSON CM, 1979, SCIENCE, V204, P375, DOI 10.1126/science.220706; Bakan A, 2009, P NATL ACAD SCI USA, V106, P14349, DOI 10.1073/pnas.0904214106; Berger C, 1999, FEBS LETT, V450, P149, DOI 10.1016/S0014-5793(99)00458-5; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Davies DR, 1996, P NATL ACAD SCI USA, V93, P7, DOI 10.1073/pnas.93.1.7; Fischer E., 1894, BER DTSCH CHEM GES, V27, P2985, DOI DOI 10.1002/CBER.18940270364; Hritz J, 2008, J MED CHEM, V51, P7469, DOI 10.1021/jm801005m; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Koska J, 2008, J CHEM INF MODEL, V48, P1965, DOI 10.1021/ci800081s; Li YC, 2008, J BIOL CHEM, V283, P2917, DOI 10.1074/jbc.M707470200; Matsushima N, 2008, CURR PROTEIN PEPT SC, V9, P591, DOI 10.2174/138920308786733886; Nelson DL, 2000, LEHNINGER PRINCIPLES; Okazaki KI, 2008, P NATL ACAD SCI USA, V105, P11182, DOI 10.1073/pnas.0802524105; Somorjai GA, 2004, NATURE, V430, P730, DOI 10.1038/430730a; Sullivan SM, 2008, P NATL ACAD SCI USA, V105, P13829, DOI 10.1073/pnas.0805364105; Sundberg EJ, 2000, STRUCTURE, V8, pR137, DOI 10.1016/S0969-2126(00)00167-2; Swift RV, 2009, J AM CHEM SOC, V131, P5126, DOI 10.1021/ja808064g; TSOU CL, 1993, SCIENCE, V262, P380, DOI 10.1126/science.8211158; Weikl TR, 2009, PROTEINS, V75, P104, DOI 10.1002/prot.22223; Wu JX, 2007, INT J BIOL MACROMOL, V40, P399, DOI 10.1016/j.ijbiomac.2006.10.001; YAO QZ, 1984, BIOCHEMISTRY-US, V23, P2740, DOI 10.1021/bi00307a032; Yaremchuk A, 2001, J MOL BIOL, V309, P989, DOI 10.1006/jmbi.2001.4712; Zhao J, 2007, INT J BIOL MACROMOL, V40, P67, DOI 10.1016/j.ijbiomac.2006.05.007; Zhao J, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/97654	24	17	18	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22948	22954		10.1074/jbc.M110.103549	http://dx.doi.org/10.1074/jbc.M110.103549			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20484054	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000279999900029
J	Xu, K; Zhang, H; Blumwald, E; Xia, T				Xu, Kai; Zhang, Hui; Blumwald, Eduardo; Xia, Tao			A Novel Plant Vacuolar Na+/H+ Antiporter Gene Evolved by DNA Shuffling Confers Improved Salt Tolerance in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS-THALIANA; FUNCTIONAL-ANALYSIS; CATION SELECTIVITY; ION HOMEOSTASIS; C-TERMINUS; IN-VITRO; EXCHANGER; ATNHX1	Plant vacuolar Na+/H+ antiporters play important roles in maintaining cellular ion homeostasis and mediating the transport of Na+ out of the cytosol and into the vacuole. Vacuolar antiporters have been shown to play significant roles in salt tolerance; however the relatively low V-max of the Na+/H+ exchange of the Na+/H+ antiporters identified could limit its application in the molecular breeding of salt tolerant crops. In this study, we applied DNA shuffling methodology to generate and recombine the mutations of Arabidopsis thaliana vacuolar Na+/H+ antiporter gene AtNHX1. Screening using a large scale yeast complementation system identified AtNHXS1, a novel Na+/H+ antiporter. Expression of AtNHXS1 in yeast showed that the antiporter localized to the vacuolar membrane and that its expression improved the tolerance of yeast to NaCl, KCl, LiCl, and hygromycin B. Measurements of the ion transport activity across the intact yeast vacuole demonstrated that the AtNHXS1 protein showed higher Na+/H+ exchange activity and a slightly improved K+/H+ exchange activity.	[Xu, Kai; Zhang, Hui; Xia, Tao] E China Normal Univ, Sch Life Sci, Dept Biochem & Mol Biol, Shanghai 200062, Peoples R China; [Blumwald, Eduardo] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	East China Normal University; University of California System; University of California Davis	Xia, T (corresponding author), B809 Sci Bldg,3663 N Zhongshan Rd, Shanghai, Peoples R China.	txia@bio.ecnu.edu.cn	Blumwald, Eduardo/Y-2751-2019	Xia, Tao/0000-0002-3712-8468	National Natural Science Foundation of China [30671336]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (30671336).	Apse MP, 2007, FEBS LETT, V581, P2247, DOI 10.1016/j.febslet.2007.04.014; Apse MP, 2003, PLANT J, V36, P229, DOI 10.1046/j.1365-313X.2003.01871.x; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; BARLOW DJ, 1988, J MOL BIOL, V201, P601, DOI 10.1016/0022-2836(88)90641-9; Blumwald E, 2000, BBA-BIOMEMBRANES, V1465, P140, DOI 10.1016/S0005-2736(00)00135-8; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; Bowers K, 2000, MOL BIOL CELL, V11, P4277, DOI 10.1091/mbc.11.12.4277; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; Crameri A, 1998, NATURE, V391, P288, DOI 10.1038/34663; Darley CP, 2000, BIOCHEM J, V351, P241, DOI 10.1042/0264-6021:3510241; Dibrov P, 1998, BIOCHEMISTRY-US, V37, P8282, DOI 10.1021/bi9801457; Gaxiola RA, 1999, P NATL ACAD SCI USA, V96, P1480, DOI 10.1073/pnas.96.4.1480; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Hamada A, 2001, PLANT PHYSIOL, V125, P437, DOI 10.1104/pp.125.1.437; Hernandez A, 2009, J BIOL CHEM, V284, P14276, DOI 10.1074/jbc.M806203200; Kamauchi S, 2002, J BIOCHEM, V131, P821, DOI 10.1093/oxfordjournals.jbchem.a003171; Kemp G, 2008, CHANNELS, V2, P329, DOI 10.4161/chan.2.5.6898; Kinclova O, 2001, MOL MICROBIOL, V40, P656, DOI 10.1046/j.1365-2958.2001.02412.x; Kinclova-Zimmermannova O, 2006, MOL MEMBR BIOL, V23, P349, DOI 10.1080/09687860600738908; Landau M, 2007, J BIOL CHEM, V282, P37854, DOI 10.1074/jbc.M705460200; Madrid R, 1998, J BIOL CHEM, V273, P14838, DOI 10.1074/jbc.273.24.14838; Mitsui K, 2004, J BIOCHEM, V135, P139, DOI 10.1093/jb/mvh016; Montiel V, 2007, FEMS YEAST RES, V7, P102, DOI 10.1111/j.1567-1364.2006.00115.x; Nass R, 1997, J BIOL CHEM, V272, P26145, DOI 10.1074/jbc.272.42.26145; Quintero FJ, 2000, FEBS LETT, V471, P224, DOI 10.1016/S0014-5793(00)01412-5; RODRIGUEZNAVARRO A, 1984, J BACTERIOL, V159, P940; Shi HZ, 2003, NAT BIOTECHNOL, V21, P81, DOI 10.1038/nbt766; Simon E, 2003, FEBS LETT, V545, P239, DOI 10.1016/S0014-5793(03)00557-X; Sottosanto JB, 2004, PLANT J, V40, P752, DOI 10.1111/j.1365-313X.2004.02253.x; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Venema K, 2003, J BIOL CHEM, V278, P22453, DOI 10.1074/jbc.M210794200; Venema K, 2002, J BIOL CHEM, V277, P2413, DOI 10.1074/jbc.M105043200; Wiebe CA, 2003, MOL CELL BIOCHEM, V254, P117, DOI 10.1023/A:1027311916247; Wiebe CA, 2001, BIOCHEM J, V357, P1, DOI 10.1042/0264-6021:3570001; Yamaguchi T, 2005, TRENDS PLANT SCI, V10, P615, DOI 10.1016/j.tplants.2005.10.002; Yamaguchi T, 2005, P NATL ACAD SCI USA, V102, P16107, DOI 10.1073/pnas.0504437102; Yamaguchi T, 2003, P NATL ACAD SCI USA, V100, P12510, DOI 10.1073/pnas.2034966100; Yamaguchi T, 2001, PLANT CELL PHYSIOL, V42, P451, DOI 10.1093/pcp/pce080; Zhang HX, 2001, NAT BIOTECHNOL, V19, P765, DOI 10.1038/90824; Zhang HX, 2001, P NATL ACAD SCI USA, V98, P12832, DOI 10.1073/pnas.231476498; Zhao HM, 1997, NUCLEIC ACIDS RES, V25, P1307, DOI 10.1093/nar/25.6.1307	42	16	23	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22997	23004		10.1074/jbc.M109.073783	http://dx.doi.org/10.1074/jbc.M109.073783			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20457597	hybrid, Green Published			2022-12-27	WOS:000279999900034
J	Billet, A; Melin, P; Jollivet, M; Mornon, JP; Callebaut, I; Becq, F				Billet, Arnaud; Melin, Patricia; Jollivet, Mathilde; Mornon, Jean-Paul; Callebaut, Isabelle; Becq, Frederic			C Terminus of Nucleotide Binding Domain 1 Contains Critical Features for Cystic Fibrosis Transmembrane Conductance Regulator Trafficking and Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLORIDE CHANNEL; CYTOPLASMIC DOMAIN; ATPASE ACTIVITY; CFTR CHANNEL; WILD-TYPE; GENISTEIN; CELLS; G551D; DEGRADATION; DERIVATIVES	The cystic fibrosis transmembrane conductance regulator (CFTR) is a Cl- channel physiologically important in fluid-transporting epithelia and pathologically relevant in several human diseases. Here, we show that mutations in the C terminus of the first nucleotide binding domain comprising the latest beta strands (beta(c)5 and beta(c)6) influence the trafficking, channel activity, and pharmacology of CFTR. We mutated CFTR amino acids located in the beta(c)5-beta(c)6 hairpin, within the beta(c)5 strand (H620Q), within the beta-turn linking the two beta strands (E621G, G622D), as well as within (S623A, S624A) and at the extremity (G628R) of the beta(c)6 strand. Functional analysis reveals that the current density was largely reduced for G622D and G628R channels compared with wt CFTR, similar for E621G and S624A, but increased for H620Q and S623A. For G622D and G628R, the abnormal activity is likely due to a defective maturation process, as assessed by the augmented activity and mature C-band observed in the presence of the trafficking corrector miglustat. In addition, in presence of the CFTR activator benzo[c] quinolizinium, the CFTR current density compared with that of wt CFTR was abolished for G622D and G628R channels, but similar for H620Q, S623A, and S624A or slightly increased for E621G. Finally, G622D and G628R were activated by the CFTR agonists genistein, RP-107, and isobutylmethylxanthine. Our results identify the C terminus of the CFTR first nucleotide binding domain as an important molecular site for the trafficking of CFTR protein, for the control of CFTR channel gating, and for the pharmacological effect of a dual activity agent.	[Billet, Arnaud; Melin, Patricia; Jollivet, Mathilde; Becq, Frederic] Univ Poitiers, CNRS, Inst Physiol & Biol Cellulaires, F-86022 Poitiers, France; [Mornon, Jean-Paul; Callebaut, Isabelle] Univ Paris 06 & 07, Inst Mineral & Phys Milieux Condenses, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD)	Becq, F (corresponding author), Univ Poitiers, CNRS, Inst Physiol & Biol Cellulaires, 40 Ave Recteur Pineau, F-86022 Poitiers, France.	frederic.becq@univ-poitiers.fr	Billet, Arnaud/AAZ-3834-2020; Becq, Frederic/P-9233-2016; billet, arnaud/P-9503-2016	Becq, Frederic/0000-0003-3915-0973; Billet, Arnaud/0000-0002-9738-7330	Vaincre La Mucoviscidose; MucoVie; ABCF2; Ministere de l'Enseignement Superieur et de la Recherche	Vaincre La Mucoviscidose; MucoVie; ABCF2; Ministere de l'Enseignement Superieur et de la Recherche	This work was supported by grants from Vaincre La Mucoviscidose, MucoVie, and ABCF2.; Supported by a studentship from the Ministere de l'Enseignement Superieur et de la Recherche.	Aleksandrov AA, 2007, PFLUG ARCH EUR J PHY, V453, P693, DOI 10.1007/s00424-006-0140-z; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; Babenko AP, 1998, ANNU REV PHYSIOL, V60, P667, DOI 10.1146/annurev.physiol.60.1.667; Babenko AP, 2000, J BIOL CHEM, V275, P717, DOI 10.1074/jbc.275.2.717; Becq F, 1999, J BIOL CHEM, V274, P27415, DOI 10.1074/jbc.274.39.27415; Becq F, 2010, DRUGS, V70, P241, DOI 10.2165/11316160-000000000-00000; Callebaut I, 2004, CELL MOL LIFE SCI, V61, P230, DOI 10.1007/s00018-003-3386-z; Chan KM, 2000, J GEN PHYSIOL, V116, P163, DOI 10.1085/jgp.116.2.163; Chappe V, 1998, BRIT J PHARMACOL, V123, P683, DOI 10.1038/sj.bjp.0701648; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Derand R, 2002, J BIOL CHEM, V277, P35999, DOI 10.1074/jbc.M206121200; Derand R, 2001, AM J PHYSIOL-CELL PH, V281, pC1657, DOI 10.1152/ajpcell.2001.281.5.C1657; Dormer RL, 2001, J CELL SCI, V114, P4073; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Gadsby D. C., 1999, PHYSIOL REV, V79, pS77; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; ILLEK B, 1995, AM J PHYSIOL-CELL PH, V268, pC886, DOI 10.1152/ajpcell.1995.268.4.C886; Kidd JF, 2004, J BIOL CHEM, V279, P41664, DOI 10.1074/jbc.M407666200; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Marivingt-Mounir C, 2004, J MED CHEM, V47, P962, DOI 10.1021/jm0308848; Melin P, 2004, BIOCHEM PHARMACOL, V67, P2187, DOI 10.1016/j.bcp.2004.02.022; Melin P, 2007, BBA-BIOMEMBRANES, V1768, P2438, DOI 10.1016/j.bbamem.2007.05.013; Mornon JP, 2008, CELL MOL LIFE SCI, V65, P2594, DOI 10.1007/s00018-008-8249-1; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Moyer BD, 1998, J BIOL CHEM, V273, P21759, DOI 10.1074/jbc.273.34.21759; Noel S, 2006, J PHARMACOL EXP THER, V319, P349, DOI 10.1124/jpet.106.104521; Norez C, 2006, FEBS LETT, V580, P2081, DOI 10.1016/j.febslet.2006.03.010; Norez C, 2009, AM J RESP CELL MOL, V41, P217, DOI 10.1165/rcmb.2008-0285OC; RIORDAN JR, 1989, SCIENCE, V245, P1066; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Stratford FLL, 2003, BIOCHEM BIOPH RES CO, V300, P524, DOI 10.1016/S0006-291X(02)02883-8; Vankeerberghen A, 1998, HUM MOL GENET, V7, P1761, DOI 10.1093/hmg/7.11.1761; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6	34	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22132	22140		10.1074/jbc.M110.120683	http://dx.doi.org/10.1074/jbc.M110.120683			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20435887	Green Published, hybrid			2022-12-27	WOS:000279702200026
J	Dolan, PJ; Johnson, GVW				Dolan, Philip J.; Johnson, Gail V. W.			A Caspase Cleaved Form of Tau Is Preferentially Degraded through the Autophagy Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; ALZHEIMER-DISEASE; QUALITY-CONTROL; HYPERPHOSPHORYLATED TAU; PHOSPHORYLATED TAU; CARBOXYL-TERMINUS; UBIQUITIN LIGASE; PROTEIN CHIP; MOUSE MODEL; CATHEPSIN-D	The microtubule-associated protein tau plays a central role in the pathogenesis of Alzheimer disease (AD) and abnormally accumulates as neurofibrillary tangles; therefore, the pathways by which tau is degraded have been examined extensively. In AD brain tau is abnormally truncated at Asp(421) (tau Delta C), which increases its fibrillogenic properties and results in compromised neuronal function. Given the fact that the accumulation of tau Delta C is a pathogenic process in AD, in this study we examined whether full-length tau and tau Delta Care degraded through similar or different mechanisms. To this end a tetracycline-inducible model was used to show that tau Delta C was degraded significantly faster than full-length tau (FL-tau). Pharmacological inhibition of the proteasome or autophagy pathways demonstrated that although FL-tau is degraded by the proteasome, tau Delta C is cleared predominantly by macroautophagy. We also found that tau Delta C binds C terminus of Hsp70-interacting protein more efficiently than tau. This interaction leads to an increased ubiquitylation of tau Delta C in a reconstituted in vitro assay, but surprisingly, tau (full-length or truncated) was not ubiquitylated in situ. The finding that tau Delta C and FL-tau are differentially processed by these degradation systems provides important insights for the development of therapeutic strategies, which are focused on modulating degradation systems to preferentially clear pathological forms of the proteins.	[Johnson, Gail V. W.] Univ Rochester, Med Ctr, Dept Anesthesiol, Rochester, NY 14642 USA; [Dolan, Philip J.; Johnson, Gail V. W.] Univ Rochester, Dept Pharmacol Physiol, Rochester, NY 14642 USA; [Dolan, Philip J.; Johnson, Gail V. W.] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA	University of Rochester; University of Rochester; University of Alabama System; University of Alabama Birmingham	Johnson, GVW (corresponding author), Univ Rochester, Med Ctr, Dept Anesthesiol, 601 Elmwood Ave,Box 604,Courier Rm4-6314, Rochester, NY 14642 USA.	gail_johnsonvoll@urmc.rochester.edu	Johnson, Gail V.W./K-4723-2012	Johnson, Gail V.W./0000-0003-3464-0404	National Institutes of Health [NS051279]; Alzheimer's Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051279] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS051279. This work was also supported by a grant from the Alzheimer's Association.	AHLBERG J, 1982, LAB INVEST, V47, P523; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Alzheimer A, 1995, Clin Anat, V8, P429; Arnaud LT, 2009, J NEUROCHEM, V110, P328, DOI 10.1111/j.1471-4159.2009.06142.x; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bednarski E, 1996, J NEUROCHEM, V67, P1846, DOI 10.1046/j.1471-4159.1996.67051846.x; Berry RW, 2003, BIOCHEMISTRY-US, V42, P8325, DOI 10.1021/bi027348m; Bi XN, 2000, J NEUROCHEM, V74, P1469, DOI 10.1046/j.1471-4159.2000.0741469.x; Bongarzone ER, 1998, J NEUROSCI RES, V54, P309, DOI 10.1002/(SICI)1097-4547(19981101)54:3<309::AID-JNR2>3.0.CO;2-5; Brady NR, 2007, FEBS J, V274, P3184, DOI 10.1111/j.1742-4658.2007.05849.x; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; Carrettiero DC, 2009, J NEUROSCI, V29, P2151, DOI 10.1523/JNEUROSCI.4660-08.2009; Chung CW, 2001, NEUROBIOL DIS, V8, P162, DOI 10.1006/nbdi.2000.0335; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; David DC, 2002, J NEUROCHEM, V83, P176, DOI 10.1046/j.1471-4159.2002.01137.x; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; DeTure M, 2002, AM J PATHOL, V161, P1711, DOI 10.1016/S0002-9440(10)64448-3; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Dickey CA, 2006, J NEUROSCI, V26, P6985, DOI 10.1523/JNEUROSCI.0746-06.2006; Ding HP, 2006, J BIOL CHEM, V281, P19107, DOI 10.1074/jbc.M511697200; DRUBIN D, 1988, J CELL BIOL, V106, P1583, DOI 10.1083/jcb.106.5.1583; Grelle G, 2006, MOL CELL PROTEOMICS, V5, P234, DOI 10.1074/mcp.M500198-MCP200; GRUNE T, 2010, ARCH BIOCH IN PRESS; Hamano T, 2008, EUR J NEUROSCI, V27, P1119, DOI 10.1111/j.1460-9568.2008.06084.x; Hatakeyama S, 2004, J NEUROCHEM, V91, P299, DOI 10.1111/j.1471-4159.2004.02713.x; HENELL F, 1987, EXP MOL PATHOL, V46, P1, DOI 10.1016/0014-4800(87)90026-8; Jeganathan S, 2008, BIOCHEMISTRY-US, V47, P10526, DOI 10.1021/bi800783d; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; KAWASAKI H, 1987, ACTA NEUROPATHOL, V75, P156, DOI 10.1007/BF00687076; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Li B, 2007, ACTA NEUROPATHOL, V113, P501, DOI 10.1007/s00401-007-0207-8; Li L, 2002, J BIOL CHEM, V277, P41390, DOI 10.1074/jbc.M206334200; Matthews-Roberson TA, 2008, BRAIN RES, V1234, P206, DOI 10.1016/j.brainres.2008.07.111; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Mi KH, 2006, J BIOL CHEM, V281, P4787, DOI 10.1074/jbc.M508657200; Moore DJ, 2008, J NEUROCHEM, V105, P1806, DOI 10.1111/j.1471-4159.2008.05261.x; Morishima Y, 2008, HUM MOL GENET, V17, P3942, DOI 10.1093/hmg/ddn296; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2006, TRENDS NEUROSCI, V29, P528, DOI 10.1016/j.tins.2006.07.003; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Quintanilla RA, 2009, J BIOL CHEM, V284, P18754, DOI 10.1074/jbc.M808908200; Rankin CA, 2005, MOL BRAIN RES, V138, P84, DOI 10.1016/j.molbrainres.2005.04.012; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Sahara N, 2005, J NEUROCHEM, V94, P1254, DOI 10.1111/j.1471-4159.2005.03272.x; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; SCHWORER CM, 1981, J BIOL CHEM, V256, P7652; SELKOE DJ, 1986, NEUROBIOL AGING, V7, P425, DOI 10.1016/0197-4580(86)90055-2; Shelton SB, 2004, J NEUROSCI RES, V76, P110, DOI 10.1002/jnr.20051; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Shringarpure R, 2003, J BIOL CHEM, V278, P311, DOI 10.1074/jbc.M206279200; THORPE GHG, 1986, METHOD ENZYMOL, V133, P331; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; Wong ESP, 2008, HUM MOL GENET, V17, P2570, DOI 10.1093/hmg/ddn157; Zhang CL, 2005, AM J PHYSIOL-HEART C, V288, pH2836, DOI 10.1152/ajpheart.01122.2004	65	112	114	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					21978	21987		10.1074/jbc.M110.110940	http://dx.doi.org/10.1074/jbc.M110.110940			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20466727	Green Published, hybrid			2022-12-27	WOS:000279702200010
J	Rey, FE; Faith, JJ; Bain, J; Muehlbauer, MJ; Stevens, RD; Newgard, CB; Gordon, JI				Rey, Federico E.; Faith, Jeremiah J.; Bain, James; Muehlbauer, Michael J.; Stevens, Robert D.; Newgard, Christopher B.; Gordon, Jeffrey I.			Dissecting the in Vivo Metabolic Potential of Two Human Gut Acetogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFATE-REDUCING BACTERIA; FATTY-ACID PRODUCTION; HUMAN LARGE-INTESTINE; HUMAN FECES; CLOSTRIDIUM-THERMOACETICUM; ANAEROBIC-BACTERIA; MICROBIAL-FLORA; HUMAN COLON; SP-NOV; FERMENTATION	Fermenting microbial communities generate hydrogen; its removal through the production of acetate, methane, or hydrogen sulfide modulates the efficiency of energy extraction from available nutrients in many ecosystems. We noted that pathway components for acetogenesis are more abundantly and consistently represented in the gut microbiomes of monozygotic twins and their mothers than components for methanogenesis or sulfate reduction and subsequently analyzed the metabolic potential of two sequenced human gut acetogens, Blautia hydrogenotrophica and Marvinbryantia formatexigens in vitro and in the intestines of gnotobiotic mice harboring a prominent saccharolytic bacterium. To do so, we developed a generally applicable method for multiplex sequencing of expressed microbial mRNAs (microbial RNA-Seq) and, together with mass spectrometry of metabolites, showed that these organisms have distinct patterns of substrate utilization. B. hydrogenotrophica targets aliphatic and aromatic amino acids. It increases the efficiency of fermentation by consuming reducing equivalents, thereby maintaining a high NAD(+)/NADH ratio and boosting acetate production. In contrast, M. formatexigens consumes oligosaccharides, does not impact the redox state of the gut, and boosts the yield of succinate. These findings have strategic implications for those who wish to manipulate the hydrogen economy of gut microbial communities in ways that modulate energy harvest.	[Rey, Federico E.; Faith, Jeremiah J.; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci, St Louis, MO 63108 USA; [Bain, James; Muehlbauer, Michael J.; Stevens, Robert D.; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27704 USA; [Bain, James; Muehlbauer, Michael J.; Stevens, Robert D.; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27704 USA	Washington University (WUSTL); Duke University; Duke University	Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci, St Louis, MO 63108 USA.	jgordon@wustl.edu		Bain, James R./0000-0002-8917-9187	National Institutes of Health [DK70977, DK078669, DK30292]; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK078669, R01DK070977, R01DK030292, R37DK030292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK70977, DK078669, and DK30292. This work was also supported by the Crohn's and Colitis Foundation of America.	Arendsen AF, 1999, J BACTERIOL, V181, P1489, DOI 10.1128/JB.181.5.1489-1495.1999; Attene-Ramos MS, 2006, MOL CANCER RES, V4, P9, DOI 10.1158/1541-7786.MCR-05-0126; Bernalier A, 1996, ARCH MICROBIOL, V166, P176, DOI 10.1007/s002030050373; BLAXTER KL, 1965, BRIT J NUTR, V19, P511, DOI 10.1079/BJN19650046; BOONE DR, 1989, APPL ENVIRON MICROB, V55, P1735, DOI 10.1128/AEM.55.7.1735-1741.1989; Breznak J.A., 1994, ACETOGENESIS, P303; BREZNAK JA, 1986, APPL ENVIRON MICROB, V52, P623, DOI 10.1128/AEM.52.4.623-630.1986; BREZNAK JA, 1991, ARCH MICROBIOL, V156, P105, DOI 10.1007/BF00290981; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CHRISTL SU, 1992, GUT, V33, P1234, DOI 10.1136/gut.33.9.1234; CORDRUWISCH R, 1988, ARCH MICROBIOL, V149, P350, DOI 10.1007/BF00411655; DORE J, 1995, FEMS MICROBIOL LETT, V130, P7, DOI 10.1016/0378-1097(95)00176-6; DORE J, 1995, FEMS MICROBIOL ECOL, V17, P279, DOI 10.1016/0168-6496(95)00033-7; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Ferchaud-Roucher V, 2005, AM J PHYSIOL-ENDOC M, V289, pE716, DOI 10.1152/ajpendo.00430.2004; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Fonty G, 2007, APPL ENVIRON MICROB, V73, P6391, DOI 10.1128/AEM.00181-07; Frostl JM, 1996, J BACTERIOL, V178, P4597; GIBSON GR, 1988, J APPL BACTERIOL, V65, P241, DOI 10.1111/j.1365-2672.1988.tb01891.x; GIBSON GR, 1988, J APPL BACTERIOL, V65, P103, DOI 10.1111/j.1365-2672.1988.tb01498.x; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Graber JR, 2004, APPL ENVIRON MICROB, V70, P1307, DOI 10.1128/AEM.70.3.1307-1314.2004; HAROLD KKD, 2006, PROKARYOTES, P354; Havlikova M, 2008, SCI TOTAL ENVIRON, V396, P121, DOI 10.1016/j.scitotenv.2008.02.027; KERBY R, 1983, CURR MICROBIOL, V8, P27, DOI 10.1007/BF01567310; LAIMINS LA, 1981, P NATL ACAD SCI-BIOL, V78, P464, DOI 10.1073/pnas.78.1.464; Leclerc M, 1997, ANAEROBE, V3, P307, DOI 10.1006/anae.1997.0117; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; MAI XH, 1994, J BIOL CHEM, V269, P16726; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338; Miller TL, 1996, APPL ENVIRON MICROB, V62, P1589, DOI 10.1128/AEM.62.5.1589-1592.1996; Nakamura N, 2010, ANNU REV FOOD SCI T, V1, P363, DOI 10.1146/annurev.food.102308.124101; ODELSON DA, 1983, APPL ENVIRON MICROB, V45, P1602, DOI 10.1128/AEM.45.5.1602-1613.1983; OUWERKERK D, 2007, ADV ANIM NUTR AUSTR, V16, P101; Passalacqua KD, 2009, J BACTERIOL, V191, P3203, DOI 10.1128/JB.00122-09; Pierce E, 2008, ENVIRON MICROBIOL, V10, P2550, DOI 10.1111/j.1462-2920.2008.01679.x; PRINS RA, 1977, FEMS MICROBIOL LETT, V1, P255, DOI 10.1111/j.1574-6968.1977.tb00627.x; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Stewart JA, 2006, LETT APPL MICROBIOL, V43, P58, DOI 10.1111/j.1472-765X.2006.01906.x; THAUER RK, 1977, BACTERIOL REV, V41, P100, DOI 10.1128/MMBR.41.1.100-180.1977; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Williams YJ, 2009, APPL ENVIRON MICROB, V75, P1860, DOI 10.1128/AEM.02453-08; Wolin MJ, 2003, APPL ENVIRON MICROB, V69, P6321, DOI 10.1128/AEM.69.10.6321-6326.2003; WOLIN MJ, 1993, APPL ENVIRON MICROB, V59, P3551, DOI 10.1128/AEM.59.11.3551-3556.1993; WOLIN MJ, 1983, FED PROC, V42, P109; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106	49	222	248	1	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22082	22090		10.1074/jbc.M110.117713	http://dx.doi.org/10.1074/jbc.M110.117713			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20444704	Green Published, hybrid			2022-12-27	WOS:000279702200021
J	Choi, YJ; Im, E; Pothoulakis, C; Rhee, SH				Choi, Yoon Jeong; Im, Eunok; Pothoulakis, Charalabos; Rhee, Sang Hoon			TRIF Modulates TLR5-dependent Responses by Inducing Proteolytic Degradation of TLR5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR; NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; COLONIC EPITHELIAL-CELLS; HEPATITIS-C VIRUS; ADAPTER PROTEIN; TOLL-LIKE-RECEPTOR-5 ENGAGEMENT; NECROTIZING ENTEROCOLITIS; BACTERIAL FLAGELLIN; NEGATIVE REGULATION	Proteolytic modification of pattern recognition receptors and their signaling adaptor molecules has recently emerged as an essential cellular event to regulate immune and inflammatory responses. Here we show that the TIR domain containing adaptor-inducing interferon-beta (TRIF), an adaptor molecule mediating TLR3 signaling and MyD88-independent signaling of TLR4, plays an inhibitory role in TLR5-elicited responses by inducing proteolytic degradation of TLR5. TRIF overexpression in human embryonic kidney (HEK293) and human colonic epithelial (NCM460) cells abolishes the cellular protein level of TLR5, whereas it does not alter TLR5 mRNA level. Thus, TRIF overexpression dramatically suppresses flagellin/TLR5-deriven NF kappa B activation in NCM460 cells. TRIF-induced TLR5 protein degradation is completely inhibited in the presence of pan-caspase inhibitor (benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone), whereas several specific inhibitors against cathepsin B, reactive oxygen species, or ubiquitin-mediated proteasome activity fail to suppress this degradation. These results indicate that TRIF-induced caspase activity causes TLR5 protein degradation. In addition, we identify that the C terminus of TRIF and extracellular domain of TLR5 are required for TRIF-induced TLR5 degradation. Furthermore, TRIF-induced proteolytic degradation is extended to TLR3, TLR6, TLR7, TLR8, TLR9, and TLR10, whereas the cellular level of TLR1, TLR2, and TLR4 is not affected by TRIF overexpression. These results suggest that, in addition to mediating TLR3- or TLR4-induced signaling as an adaptor molecule, TRIF can participate in proteolytic modification of certain members of TLRs to modulate the functionality of TLRs at post-translational level. Collectively, our findings propose a potential inhibitory role of TRIF at least in regulating host-microbial communication via TLR5 in colonic epithelial cells.	[Choi, Yoon Jeong; Im, Eunok; Pothoulakis, Charalabos; Rhee, Sang Hoon] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Rhee, SH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, MRL 1240,675 Charles E Young Dr S, Los Angeles, CA 90095 USA.	shrhee@mednet.ucla.edu	Lee, Kee-Joon/AAA-4090-2022		NIDDK, National Institutes of Health [DK072471, DK083336, DK079015]; Flight Attendant Medical Research Institute, Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK079015, K01DK083336] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Flight Attendant Medical Research Institute, Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK072471 (NIDDK, to C. P.), DK083336 (NIDDK, to E. I.), and DK079015 (NIDDK, to S. H. R.). This work was also supported by a Young Clinical Scientist Award (to S. H. R. and E. I.) from Flight Attendant Medical Research Institute, Inc.	Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Akashi-Takamura S, 2008, CURR OPIN IMMUNOL, V20, P420, DOI 10.1016/j.coi.2008.07.001; Barrie A, 2006, GASTROENTEROL CLIN N, V35, P883, DOI 10.1016/j.gtc.2006.09.001; Ben Moshe T, 2007, HEPATOLOGY, V45, P1014, DOI 10.1002/hep.21495; Blohmke CJ, 2008, J IMMUNOL, V180, P7764, DOI 10.4049/jimmunol.180.11.7764; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Carvalho FA, 2008, INFLAMM BOWEL DIS, V14, P1051, DOI 10.1002/ibd.20423; Chan KL, 2009, WORLD J GASTROENTERO, V15, P4745, DOI 10.3748/wjg.15.4745; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Fort MM, 2005, J IMMUNOL, V174, P6416, DOI 10.4049/jimmunol.174.10.6416; Funami K, 2008, J BIOL CHEM, V283, P18283, DOI 10.1074/jbc.M801013200; Han KJ, 2004, J BIOL CHEM, V279, P15652, DOI 10.1074/jbc.M311629200; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Honey K, 2003, NAT REV IMMUNOL, V3, P472, DOI 10.1038/nri1110; Hoshimaru M, 1996, P NATL ACAD SCI USA, V93, P1518, DOI 10.1073/pnas.93.4.1518; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kenny EF, 2008, CYTOKINE, V43, P342, DOI 10.1016/j.cyto.2008.07.010; Kovalenko A, 2009, J EXP MED, V206, P2161, DOI 10.1084/jem.20090616; Leaphart CL, 2007, J IMMUNOL, V179, P4808, DOI 10.4049/jimmunol.179.7.4808; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Matsumoto F, 2008, BIOCHEM BIOPH RES CO, V367, P693, DOI 10.1016/j.bbrc.2007.12.130; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Melmed G, 2003, J IMMUNOL, V170, P1406, DOI 10.4049/jimmunol.170.3.1406; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Pan MH, 2008, P NATL ACAD SCI USA, V105, P5862, DOI 10.1073/pnas.0707460104; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Rebsamen M, 2008, CELL DEATH DIFFER, V15, P1804, DOI 10.1038/cdd.2008.119; Rhee SH, 2008, GASTROENTEROLOGY, V135, P518, DOI 10.1053/j.gastro.2008.04.022; Rhee SH, 2006, J BIOL CHEM, V281, P18560, DOI 10.1074/jbc.M513861200; Rhee SH, 2000, J BIOL CHEM, V275, P34035, DOI 10.1074/jbc.M007386200; Rhee SH, 2005, P NATL ACAD SCI USA, V102, P13610, DOI 10.1073/pnas.0502174102; Rhee SH, 2004, J BIOL CHEM, V279, P25179, DOI 10.1074/jbc.M400967200; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Schaefer TM, 2004, IMMUNOLOGY, V112, P428, DOI 10.1111/j.1365-2567.2004.01898.x; Shibolet O, 2007, AM J PHYSIOL-GASTR L, V292, pG1469, DOI 10.1152/ajpgi.00531.2006; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622	46	28	32	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21382	21390		10.1074/jbc.M110.115022	http://dx.doi.org/10.1074/jbc.M110.115022			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20452988	Green Published, hybrid			2022-12-27	WOS:000279516100024
J	Merrick, WC				Merrick, William C.			Introduction to the Thematic Minireview Series on Protein Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material									Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA	Case Western Reserve University	Merrick, WC (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	wcm2@case.edu							0	1	1	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21195	21196		10.1074/jbc.R110.140012	http://dx.doi.org/10.1074/jbc.R110.140012			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20444699	hybrid, Green Published			2022-12-27	WOS:000279516100001
J	Mutschler, H; Reinstein, J; Meinhart, A				Mutschler, Hannes; Reinstein, Jochen; Meinhart, Anton			Assembly Dynamics and Stability of the Pneumococcal Epsilon Zeta Antitoxin Toxin (PezAT) System from Streptococcus pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN ASSOCIATION; MEDIATED CELL-DEATH; ESCHERICHIA-COLI; MULTIDRUG TOLERANCE; COMPLEX-FORMATION; PLASMID; BINDING; ENERGY; DEGRADATION; ENHANCEMENT	The pneumococcal epsilon zeta antitoxin toxin (PezAT) system is a chromosomally encoded, class II toxin antitoxin system from the human pathogen Streptococcus pneumnoniae. Neutralization of the bacteriotoxic protein PezT is carried out by complex formation with its cognate antitoxin PezA. Here we study the stability of the inhibitory complex in vivo and in vitro. We found that toxin release is impeded in Escherichia coli and Bacillus subtilis due to the proteolytic resistance of PezA once bound to PezT. These findings are supported by in vitro experiments demonstrating a strong thermodynamic stabilization of both proteins upon binding. A detailed kinetic analysis of PezAT assembly revealed that these particular features of PezAT are based on a strong, electrostatically guided binding mechanism leading to a stable toxin antitoxin complex with femtomolar affinity. Our data show that PezAT complex formation is distinct to all other conventional toxin antitoxin modules and a controlled mode of toxin release is required for activation.	[Mutschler, Hannes; Reinstein, Jochen; Meinhart, Anton] Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany	Max Planck Society	Meinhart, A (corresponding author), Jahnstr 29, D-69120 Heidelberg, Germany.	anton.meinhart@mpimf-heidelberg.mpg.de	Meinhart, Anton/M-9647-2014; Mutschler, Hannes/K-5148-2015; Mutschler, Hannes/T-1390-2019	Mutschler, Hannes/0000-0001-8005-1657; Mutschler, Hannes/0000-0001-8005-1657				Alsallaq R, 2007, STRUCTURE, V15, P215, DOI 10.1016/j.str.2007.01.005; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bernasconi C. F., 1976, RELAXATION KINETICS; Brown JS, 2004, INFECT IMMUN, V72, P1587, DOI 10.1128/IAI.72.3.1587-1593.2004; Brown JS, 2001, MOL MICROBIOL, V40, P572, DOI 10.1046/j.1365-2958.2001.02414.x; Camacho AG, 2002, BIOL CHEM, V383, P1701, DOI 10.1515/BC.2002.191; CEGLOWSKI P, 1993, MOL GEN GENET, V241, P579, DOI 10.1007/BF00279900; Christensen SK, 2004, MOL MICROBIOL, V51, P1705, DOI 10.1046/j.1365-2958.2003.03941.x; Dao-Thi MH, 2005, J MOL BIOL, V348, P1091, DOI 10.1016/j.jmb.2005.03.049; Debye P., 1942, T ELECTROCHEM SOC, V82, P265, DOI [10.1149/1.3071413, DOI 10.1149/1.3071413]; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Donegan NP, 2010, J BACTERIOL, V192, P1416, DOI 10.1128/JB.00233-09; Gabdoulline RR, 1999, J MOL RECOGNIT, V12, P226, DOI 10.1002/(SICI)1099-1352(199907/08)12:4<226::AID-JMR462>3.0.CO;2-P; Gazit E, 1999, J BIOL CHEM, V274, P16813, DOI 10.1074/jbc.274.24.16813; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Harrison JJ, 2009, ANTIMICROB AGENTS CH, V53, P2253, DOI 10.1128/AAC.00043-09; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; Kenniston JA, 2004, J STRUCT BIOL, V146, P130, DOI 10.1016/j.jsb.2003.10.023; Khoo SK, 2007, J BIOL CHEM, V282, P19606, DOI 10.1074/jbc.M701703200; Kim Y, 2010, ENVIRON MICROBIOL, V12, P1105, DOI 10.1111/j.1462-2920.2009.02147.x; Kolodkin-Gal I, 2007, SCIENCE, V318, P652, DOI 10.1126/science.1147248; Kolodkin-Gal I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006785; Kress W, 2007, BIOCHEMISTRY-US, V46, P6183, DOI 10.1021/bi602616t; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LEE FS, 1989, BIOCHEMISTRY-US, V28, P225, DOI 10.1021/bi00427a031; LEHNHERR H, 1995, P NATL ACAD SCI USA, V92, P3274, DOI 10.1073/pnas.92.8.3274; Lewis K, 2008, CURR TOP MICROBIOL, V322, P107; Lewis K, 2005, BIOCHEMISTRY-MOSCOW+, V70, P267, DOI 10.1007/s10541-005-0111-6; Li W, 2004, J MOL BIOL, V337, P743, DOI 10.1016/j.jmb.2004.02.005; Lioy VS, 2006, MICROBIOL-SGM, V152, P2365, DOI 10.1099/mic.0.28950-0; Lioy VS, 2010, PLASMID, V63, P31, DOI 10.1016/j.plasmid.2009.09.005; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; MCLENDON G, 1978, J BIOL CHEM, V253, P6335; Meinhart A, 2003, P NATL ACAD SCI USA, V100, P1661, DOI 10.1073/pnas.0434325100; Nariya H, 2008, CELL, V132, P55, DOI 10.1016/j.cell.2007.11.044; Nieto C, 2006, MOL MICROBIOL, V59, P1280, DOI 10.1111/j.1365-2958.2006.05027.x; O'Connor EB, 2007, PLASMID, V58, P115, DOI 10.1016/j.plasmid.2007.02.002; Overgaard M, 2009, J MOL BIOL, V394, P183, DOI 10.1016/j.jmb.2009.09.006; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; PARSELL DA, 1989, J BIOL CHEM, V264, P7590; Sat B, 2003, J BACTERIOL, V185, P1803, DOI 10.1128/JB.185.6.1803-1807.2003; SCHREIBER G, 1993, BIOCHEMISTRY-US, V32, P5145, DOI 10.1021/bi00070a025; Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427; Schreiber G, 2009, CHEM REV, V109, P839, DOI 10.1021/cr800373w; Selzer T, 1999, J MOL BIOL, V287, P409, DOI 10.1006/jmbi.1999.2615; Sletvold H, 2008, PLASMID, V60, P75, DOI 10.1016/j.plasmid.2008.04.002; Szekeres S, 2007, MOL MICROBIOL, V63, P1588, DOI 10.1111/j.1365-2958.2007.05613.x; Tsilibaris V, 2007, J BACTERIOL, V189, P6101, DOI 10.1128/JB.00527-07; TSUCHIMOTO S, 1992, J BACTERIOL, V174, P4205, DOI 10.1128/JB.174.13.4205-4211.1992; VANMELDEREN L, 1994, MOL MICROBIOL, V11, P1151; Vijayakumar M, 1998, J MOL BIOL, V278, P1015, DOI 10.1006/jmbi.1998.1747; WALLIS R, 1995, BIOCHEMISTRY-US, V34, P13743, DOI 10.1021/bi00042a004; Werbeck ND, 2009, BIOCHEMISTRY-US, V48, P7240, DOI 10.1021/bi900880c; Wozniak RAF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000439; Zielenkiewicz U, 2005, J BACTERIOL, V187, P6094, DOI 10.1128/JB.187.17.6094-6105.2005	56	20	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21797	21806		10.1074/jbc.M110.126250	http://dx.doi.org/10.1074/jbc.M110.126250			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20442221	hybrid, Green Published			2022-12-27	WOS:000279516100064
J	Sun, WJ; Wang, H; Zhao, XM; Yu, Y; Fan, YH; Wang, H; Wang, XS; Lu, XB; Zhang, GY; Fu, SB; Yang, JH				Sun, Wenjing; Wang, Hao; Zhao, Xiumei; Yu, Yang; Fan, Yihui; Wang, Hao; Wang, Xishan; Lu, Xiongbin; Zhang, Guiyin; Fu, Songbin; Yang, Jianhua			Protein Phosphatase 2A Acts as a Mitogen-activated Protein Kinase Kinase Kinase 3 (MEKK3) Phosphatase to Inhibit Lysophosphatidic Acid-induced I kappa B Kinase beta/Nuclear Factor-kappa B Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IKK-BETA; NEGATIVE REGULATION; S6 KINASE; PHOSPHORYLATION; ALPHA; COMPLEX; DEPHOSPHORYLATION; IDENTIFICATION; SUBUNIT; AKT	MEKK3 is a central intermediate signaling component in lysophosphatidic acid (LPA)-induced activation of the nuclear factor-kappa B (NF-kappa B). However, the precise mechanism for the termination of MEKK3 kinase activity is not fully understood. Using a functional genomic approach, we have identified a protein serine/threonine phosphatase, protein phosphatase 2A (PP2A), as a MEKK3 phosphatase. Overexpression of PP2A catalytic subunit (PP2Ac) beta-isoform results in dephosphorylation of MEKK3 at Thr-516 and Ser-520 and termination of MEKK3-mediated NF-kappa B activation. PP2Ac associates with the phosphorylated form of MEKK3 and the interaction between PP2Ac and MEKK3 is induced by LPA in a transient fashion in the cells. Furthermore, knockdown of PP2Ac expression enhances LPA-induced MEKK3-mediated I kappa B kinase beta (IKK beta) phosphorylation and NF-kappa B activation. These data suggest that PP2A plays an important role in the termination of LPA-mediated NF-kappa B activation through dephosphorylating and inactivating MEKK3.	[Sun, Wenjing; Zhang, Guiyin; Fu, Songbin] Harbin Med Univ, Med Genet Lab, Harbin 150081, Peoples R China; [Sun, Wenjing; Zhao, Xiumei; Yu, Yang; Fan, Yihui; Wang, Hao; Yang, Jianhua] Baylor Coll Med, Dept Pediat, Texas Childrens Canc Ctr, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Wang, Hao] Harbin Med Univ, Affiliated Hosp 2, Dept Gen Surg, Harbin 150086, Peoples R China; [Zhao, Xiumei] Harbin Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Harbin 150001, Peoples R China; [Wang, Xishan] Harbin Med Univ, Affiliated Tumor Hosp, Dept Abdominal Surg, Harbin 150086, Peoples R China; [Lu, Xiongbin] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	Harbin Medical University; Baylor College of Medicine; Texas Children's Cancer Center; Harbin Medical University; Harbin Medical University; Harbin Medical University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Fu, SB (corresponding author), Harbin Med Univ, Med Genet Lab, 157 Baojian Rd, Harbin 150081, Peoples R China.	fusb@ems.hrbmu.edu.cn; jianhuay@bcm.edu			National Institutes of Health/NCI [1R21CA106513-01A2, 5P30CA125123-03]; National Cancer Institute [RSG-06-070-01-TBE]; American Cancer Society; Virginia and L. E. Simmons Family Foundation; National Natural Science Foundation of China [30771198, 30971583]; NATIONAL CANCER INSTITUTE [R21CA106513, P30CA125123] Funding Source: NIH RePORTER	National Institutes of Health/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Virginia and L. E. Simmons Family Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health/NCI Grant 1R21CA106513-01A2 (to J.Y.) from the National Cancer Institute, a research scholar grant RSG-06-070-01-TBE (to J.Y.) from the American Cancer Society, the Virginia and L. E. Simmons Family Foundation Collaborative Research Fund (to J.Y.), the DLDCC pilot study from National Institutes of Health/NCI Grant 5P30CA125123-03(to J.Y.), and the National Natural Science Foundation of China Grants 30771198 and 30971583 (to S. F.).	Adams DG, 2002, ARCH BIOCHEM BIOPHYS, V407, P103, DOI 10.1016/S0003-9861(02)00464-2; Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barr RK, 2008, J BIOL CHEM, V283, P34994, DOI 10.1074/jbc.M804658200; BEG AA, 1993, GENE DEV, V7, P2064, DOI 10.1101/gad.7.11.2064; Chen D, 1999, MOL CELL BIOL, V19, P4684; Cohen PTW, 2003, METHOD ENZYMOL, V366, P135; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Fritz A, 2006, J BIOL CHEM, V281, P6236, DOI 10.1074/jbc.M509249200; Gallego M, 2005, CURR OPIN CELL BIOL, V17, P197, DOI 10.1016/j.ceb.2005.01.002; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Grabiner BC, 2007, GENE DEV, V21, P984, DOI 10.1101/gad.1502507; Heriche JK, 1997, SCIENCE, V276, P952, DOI 10.1126/science.276.5314.952; Ivaska J, 2002, MOL CELL BIOL, V22, P1352, DOI 10.1128/MCB.22.5.1352-1359.2002; Jang YJ, 2007, J BIOL CHEM, V282, P2473, DOI 10.1074/jbc.M605480200; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kim TS, 2009, J BIOL CHEM, V284, P21201, DOI 10.1074/jbc.M109.018168; Klemm S, 2007, P NATL ACAD SCI USA, V104, P134, DOI 10.1073/pnas.0608388103; Kolupaeva V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003447; Lee T, 2003, J CELL PHYSIOL, V194, P349, DOI 10.1002/jcp.10211; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu QH, 2004, AM J PHYSIOL-HEART C, V286, pH2204, DOI 10.1152/ajpheart.01050.2003; Ma J, 2007, ONCOGENE, V26, P5145, DOI 10.1038/sj.onc.1210323; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; McAllister-Lucas LM, 2007, P NATL ACAD SCI USA, V104, P139, DOI 10.1073/pnas.0601947103; Meier R, 1998, EMBO J, V17, P7294, DOI 10.1093/emboj/17.24.7294; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Sun JY, 2008, P NATL ACAD SCI USA, V105, P17085, DOI 10.1073/pnas.0802701105; Sun WJ, 2010, J BIOL CHEM, V285, P7911, DOI 10.1074/jbc.M109.051219; Sun WJ, 2009, CELL SIGNAL, V21, P1488, DOI 10.1016/j.cellsig.2009.05.007; Sun WJ, 2009, CELL SIGNAL, V21, P95, DOI 10.1016/j.cellsig.2008.09.012; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wang DH, 2007, P NATL ACAD SCI USA, V104, P145, DOI 10.1073/pnas.0601894104; Westphal RS, 1999, J BIOL CHEM, V274, P687, DOI 10.1074/jbc.274.2.687; Westphal RS, 1998, SCIENCE, V280, P1258, DOI 10.1126/science.280.5367.1258; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769; Ye RD, 2001, J LEUKOCYTE BIOL, V70, P839; Yellaturu CR, 2002, J BIOL CHEM, V277, P40148, DOI 10.1074/jbc.M206376200; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360; Zhang DY, 2006, EMBO J, V25, P97, DOI 10.1038/sj.emboj.7600913	48	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21341	21348		10.1074/jbc.M110.104224	http://dx.doi.org/10.1074/jbc.M110.104224			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20448038	hybrid, Green Published			2022-12-27	WOS:000279516100019
J	Vignola, MJ; Kashatus, DF; Taylor, GA; Counter, CM; Valdivia, RH				Vignola, Mark J.; Kashatus, David F.; Taylor, Gregory A.; Counter, Christopher M.; Valdivia, Raphael H.			cPLA(2) Regulates the Expression of Type I Interferons and Intracellular Immunity to Chlamydia trachomatis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOST-RESISTANCE; INTERLEUKIN-8 PRODUCTION; INCLUSION MEMBRANE; IFN-BETA; RAS; ACTIVATION; INFECTION; PROTEIN; GTPASE; PATHWAY	Infection with the obligate bacterial intracellular pathogen Chlamydia trachomatis leads to the sustained activation of the small GTPase RAS and many of its downstream signaling components. In particular, the mitogen-activated protein kinase ERK and the calcium-dependent phospholipase cPLA(2) are activated and are important for the onset of inflammatory responses. In this study we tested if activation of ERK and cPLA(2) occurred as a result of RAS signaling during infection and determined the relative contribution of these signaling components to chlamydial replication and survival. We provide genetic and pharmacological evidence that during infection RAS, ERK, and, to a lesser extent, cPLA(2) activation are uncoupled, suggesting that Chlamydia activates individual components of this signaling pathway in a non-canonical manner. In human cell lines, inhibition of ERK or cPLA(2) signaling did not adversely impact C. trachomatis replication. In contrast, in murine cells, inhibition of ERK and cPLA(2) played a significant protective role against C. trachomatis. We determined that cPLA(2)-deficient murine cells are permissive for C. trachomatis replication because of their impaired expression of beta interferon and the induction of immunity-related GTPases (IRG) important for the containment of intracellular pathogens. Furthermore, the MAPK p38 was primarily responsible for cPLA(2) activation in Chlamydia-infected cells and IRG expression. Overall, these findings define a previously unrecognized role for cPLA(2) in the induction of cell autonomous cellular immunity to Chlamydia and highlight the many non-canonical signaling pathways engaged during infection.	[Taylor, Gregory A.; Valdivia, Raphael H.] Duke Univ, Med Ctr, Ctr Microbial Pathogenesis, Durham, NC 27710 USA; Vet Affairs Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Kashatus, David F.; Counter, Christopher M.] Vet Affairs Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Taylor, Gregory A.] Vet Affairs Med Ctr, Dept Med, Ctr Study Aging & Human Dev, Durham, NC 27710 USA; [Taylor, Gregory A.] Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Durham, NC 27710 USA	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Valdivia, RH (corresponding author), Duke Univ, Med Ctr, Ctr Microbial Pathogenesis, 272 Jones Bldg,Res Dr, Durham, NC 27710 USA.	valdi001@mc.duke.edu	Kashatus, David F/D-8299-2012; Valdivia, Raphael/R-5377-2019	Kashatus, David F/0000-0001-8007-0612; Valdivia, Raphael/0000-0003-0961-073X; Counter, Christopher M/0000-0003-0748-3079	National Institutes of Health [AI068032]; Burroughs Wellcome Program on the Pathogenesis of Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057831, R01AI068032] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Program on the Pathogenesis of Infectious Diseases(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI068032 and an award from the Burroughs Wellcome Program on the Pathogenesis of Infectious Diseases.	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Al-Zeer MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004588; Bannantine JP, 1998, INFECT IMMUN, V66, P6017, DOI 10.1128/IAI.66.12.6017-6021.1998; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Bernstein-Hanley I, 2006, P NATL ACAD SCI USA, V103, P14092, DOI 10.1073/pnas.0603338103; Betts HJ, 2009, CURR OPIN MICROBIOL, V12, P81, DOI 10.1016/j.mib.2008.11.009; Bivona TG, 2006, METHOD ENZYMOL, V407, P128, DOI 10.1016/S0076-6879(05)07012-6; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Brown WJ, 2003, TRAFFIC, V4, P214, DOI 10.1034/j.1600-0854.2003.00078.x; Buchholz KR, 2008, INFECT IMMUN, V76, P3150, DOI 10.1128/IAI.00104-08; Buchholz KR, 2007, INFECT IMMUN, V75, P5924, DOI 10.1128/IAI.01029-07; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; Carabeo RA, 2003, P NATL ACAD SCI USA, V100, P6771, DOI 10.1073/pnas.1131289100; Cheng W, 2008, INFECT IMMUN, V76, P942, DOI 10.1128/IAI.01313-07; Coers J, 2008, J IMMUNOL, V180, P6237, DOI 10.4049/jimmunol.180.9.6237; Collazo CM, 2002, INFECT IMMUN, V70, P6933, DOI 10.1128/IAI.70.12.6933-6939.2002; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; Derbigny WA, 2007, INFECT IMMUN, V75, P1280, DOI 10.1128/IAI.01525-06; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Devitt A, 1996, INFECT IMMUN, V64, P3951, DOI 10.1128/IAI.64.10.3951-3956.1996; Donovan S, 2002, BBA-REV CANCER, V1602, P23, DOI 10.1016/S0304-419X(01)00041-5; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Fukuda EY, 2005, INFECT IMMUN, V73, P4017, DOI 10.1128/IAI.73.7.4017-4024.2005; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Gurumurthy RK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000651; Heuer D, 2009, NATURE, V457, P731, DOI 10.1038/nature07578; Howard J, 2008, IMMUNOBIOLOGY, V213, P367, DOI 10.1016/j.imbio.2007.11.005; Johnson RM, 2004, INFECT IMMUN, V72, P3951, DOI 10.1128/IAI.72.7.3951-3960.2004; Krull M, 2004, INFECT IMMUN, V72, P6615, DOI 10.1128/IAI.72.11.6615-6621.2004; Kumar Y, 2008, CELL HOST MICROBE, V4, P159, DOI 10.1016/j.chom.2008.05.018; Lad SP, 2005, J IMMUNOL, V174, P7186, DOI 10.4049/jimmunol.174.11.7186; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; McWhirter SM, 2009, J EXP MED, V206, P1899, DOI 10.1084/jem.20082874; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Monroe KM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000665; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Nagarajan UM, 2005, J IMMUNOL, V175, P450, DOI 10.4049/jimmunol.175.1.450; NAKAFUKU M, 1992, J BIOL CHEM, V267, P19448; Navarini AA, 2006, P NATL ACAD SCI USA, V103, P15535, DOI 10.1073/pnas.0607325103; O'Hayer KM, 2006, METHOD ENZYMOL, V407, P637, DOI 10.1016/S0076-6879(05)07050-3; Omerovic J, 2008, ONCOGENE, V27, P2754, DOI 10.1038/sj.onc.1210925; PETERSON EM, 1988, J BACTERIOL, V170, P1389, DOI 10.1128/jb.170.3.1389-1392.1988; Prantner D, 2010, J IMMUNOL, V184, P2551, DOI 10.4049/jimmunol.0903704; QUILLIAM LA, 1994, MOL CELL BIOL, V14, P1113, DOI 10.1128/MCB.14.2.1113; Rajalingam K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003102; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Robertson DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000664; Rzomp KA, 2006, INFECT IMMUN, V74, P5362, DOI 10.1128/IAI.00539-06; Rzomp KA, 2003, INFECT IMMUN, V71, P5855, DOI 10.1128/IAI.71.10.5855-5870.2003; Saka HA, 2010, CURR OPIN MICROBIOL, V13, P4, DOI 10.1016/j.mib.2009.11.002; San Pietro E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000194; Schachter J, 2001, INT J SYST EVOL MICR, V51, P249, DOI 10.1099/00207713-51-1-249; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Shenoy AR, 2007, IMMUNOBIOLOGY, V212, P771, DOI 10.1016/j.imbio.2007.09.018; Stephens RS, 2003, TRENDS MICROBIOL, V11, P44, DOI 10.1016/S0966-842X(02)00011-2; Su H, 2004, J BIOL CHEM, V279, P9409, DOI 10.1074/jbc.M312008200; Taylor GA, 1996, J BIOL CHEM, V271, P20399, DOI 10.1074/jbc.271.34.20399; Taylor GA, 2007, MICROBES INFECT, V9, P1644, DOI 10.1016/j.micinf.2007.09.004; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Tiwari Sangeeta, 2008, V445, P407, DOI 10.1007/978-1-59745-157-4_26; Uthaiah RC, 2003, J BIOL CHEM, V278, P29336, DOI 10.1074/jbc.M211973200; Valdivia RH, 2008, CURR OPIN MICROBIOL, V11, P53, DOI 10.1016/j.mib.2008.01.003; Verbeke Philippe, 2006, PLoS Pathog, V2, pe45, DOI 10.1371/journal.ppat.0020045; Voice JK, 1999, J BIOL CHEM, V274, P17164, DOI 10.1074/jbc.274.24.17164; Walsh AB, 2001, J BIOL CHEM, V276, P15609, DOI 10.1074/jbc.M010573200; Wylie JL, 1997, J BACTERIOL, V179, P7233, DOI 10.1128/jb.179.23.7233-7242.1997; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhao YO, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000288	71	30	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21625	21635		10.1074/jbc.M110.103010	http://dx.doi.org/10.1074/jbc.M110.103010			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20452986	Green Published, hybrid			2022-12-27	WOS:000279516100049
J	Seng, S; Avraham, HK; Birrane, G; Jiang, SX; Avraham, S				Seng, Seyha; Avraham, Hava Karsenty; Birrane, Gabriel; Jiang, Shuxian; Avraham, Shalom			Nuclear Matrix Protein (NRP/B) Modulates the Nuclear Factor (Erythroid-derived 2)-related 2 (NRF2)-dependent Oxidative Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; DT-DIAPHORASE; ALZHEIMERS-DISEASE; PROCESS ELONGATION; NEURITE OUTGROWTH; HEME OXYGENASE-1; BRAIN-TUMORS; NRF2; GENE; CANCER	Reactive molecules have diverse effects on cells and contribute to several pathological conditions. Cells have evolved complex protective systems to neutralize these molecules and restore redox homeostasis. Previously, we showed that association of nuclear factor (NF)-erythroid-derived 2 (E2)-related factor 2 (NRF2) with the nuclear matrix protein NRP/B was essential for the transcriptional activity of NRF2 target genes in tumor cells. The present study demonstrates the molecular mechanism by which NRP/B, via NRF2, modulates the transcriptional activity of antioxidant response element (ARE)-driven genes. NRP/B is localized in the nucleus of primary brain tissue and human neuroblastoma (SH-SY5Y) cells. Treatment with hydrogen peroxide (H2O2) enhances the nuclear colocalization of NRF2 and NRP/B and induces heme oxygenase 1 (HO1). Treatment of NRP/B or NRF2 knockdowns with H2O2 induced apoptosis. Co-expression of NRF2 with members of the Kelch protein family, NRP/B, MAYVEN, or MAYVEN-related protein 2 (MRP2), revealed that the NRF2-NRP/B complex is important for the transcriptional activity of ARE-driven genes HO1 and NAD(P) H: quinine oxidoreductase 1 (NQO1). NRP/B interaction with Nrf2 was mapped to NRF2 ECH homology 4 (Neh4)/Neh5 regions of NRF2. NRP/B mutations that resulted in low binding affinity to NRF2 were unable to activate NRF2-modulated transcriptional activity of the ARE-driven genes, HO1 and NQO1. Thus, the interaction of NRP/B with the Neh4/Neh5 domains of NRF2 is indispensable for activation of NRF2-mediated ARE-driven antioxidant and detoxifying genes that confer cellular defense against oxidative stress-induced damage.	Beth Israel Deaconess Med Ctr, Div Expt Med, Dept Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Avraham, S (corresponding author), 99 Brookline Ave, Boston, MA 02215 USA.	savraham@bidmc.harvard.edu		Avraham, Hava/0000-0002-7545-3640; Birrane, Gabriel/0000-0002-1759-5499	National Institutes of Health [HL80699, CA096805, CA135226]; Department of Defense Cancer Concept; Flight Attendant Medical Research Institute Young Clinical Scientist Faculty; NATIONAL CANCER INSTITUTE [R21CA135226, R01CA096805] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080699] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Cancer Concept(United States Department of Defense); Flight Attendant Medical Research Institute Young Clinical Scientist Faculty; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL80699 (to S.A.), CA096805 (to H.K.A.), CA135226 (to H.K.A.), a Department of Defense Cancer Concept Award (to S.A.), and Flight Attendant Medical Research Institute Young Clinical Scientist Faculty Award (to S.S.).	Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Begleiter A, 1997, ONCOL RES, V9, P371; Bomont P, 2000, NAT GENET, V26, P370, DOI 10.1038/81701; BORK P, 1994, J MOL BIOL, V236, P1277, DOI 10.1016/0022-2836(94)90056-6; Chung SW, 2005, J BIOL CHEM, V280, P4578, DOI 10.1074/jbc.M409125200; Collins T, 2001, MOL CELL BIOL, V21, P3609, DOI 10.1128/MCB.21.11.3609-3615.2001; Dalton TD, 1999, ANNU REV PHARMACOL, V39, P67, DOI 10.1146/annurev.pharmtox.39.1.67; DEWEINDT C, 1995, CELL GROWTH DIFFER, V6, P1495; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Ghanbari HA, 2004, AGING CELL, V3, P41, DOI 10.1111/j.1474-9728.2004.00083.x; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jackson AL, 2001, MUTAT RES-FUND MOL M, V477, P7, DOI 10.1016/S0027-5107(01)00091-4; Jiang S, 2005, J NEUROCHEM, V92, P1191, DOI 10.1111/j.1471-4159.2004.02946.x; Jiang SX, 2007, J BIOL CHEM, V282, P12319, DOI 10.1074/jbc.M701019200; Katoh Y, 2001, GENES CELLS, V6, P857, DOI 10.1046/j.1365-2443.2001.00469.x; Kim TA, 2005, J CELL SCI, V118, P5537, DOI 10.1242/jcs.02643; Kim TA, 1998, J CELL BIOL, V141, P553, DOI 10.1083/jcb.141.3.553; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Liang XQ, 2004, ONCOGENE, V23, P5890, DOI 10.1038/sj.onc.1207776; Mhatre M, 2004, J ALZHEIMERS DIS, V6, P147; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Nguyen T, 2003, J BIOL CHEM, V278, P4536, DOI 10.1074/jbc.M207293200; Nioi P, 2003, BIOCHEM J, V374, P337, DOI 10.1042/BJ20030754; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; RILEY RJ, 1992, BIOCHEM PHARMACOL, V43, P1657, DOI 10.1016/0006-2952(92)90694-E; ROBINSON DN, 1994, DEVELOPMENT, V120, P2015; ROSS D, 1993, CANCER METAST REV, V12, P83, DOI 10.1007/BF00689803; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Seng S, 2009, ONCOGENE, V28, P378, DOI 10.1038/onc.2008.396; Seng S, 2007, CANCER RES, V67, P8596, DOI 10.1158/0008-5472.CAN-06-3785; Seng S, 2006, MOL CELL BIOL, V26, P8371, DOI 10.1128/MCB.02167-05; Soltysik-Espanola M, 1999, MOL BIOL CELL, V10, P2361, DOI 10.1091/mbc.10.7.2361; Taille C, 2003, J BIOL CHEM, V278, P27160, DOI 10.1074/jbc.M300364200; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; Zhang M, 2002, CELL RES, V12, P123, DOI 10.1038/sj.cr.7290118; Zipper LM, 2002, J BIOL CHEM, V277, P36544, DOI 10.1074/jbc.M206530200	41	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26190	26198		10.1074/jbc.M109.095786	http://dx.doi.org/10.1074/jbc.M109.095786			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20511222	hybrid, Green Published			2022-12-27	WOS:000280921000036
J	Raggatt, LJ; Partridge, NC				Raggatt, Liza J.; Partridge, Nicola C.			Cellular and Molecular Mechanisms of Bone Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							IN-VIVO; PARATHYROID-HORMONE; TERMINAL DIFFERENTIATION; OSTEOPROTEGERIN LIGAND; TISSUE MACROPHAGES; KEY REGULATOR; T-CELLS; EXPRESSION; OSTEOCLASTS; RESORPTION	Physiological bone remodeling is a highly coordinated process responsible for bone resorption and formation and is necessary to repair damaged bone and to maintain mineral homeostasis. In addition to the traditional bone cells (osteoclasts, osteoblasts, and osteocytes) that are necessary for bone remodeling, several immune cells have also been implicated in bone disease. This mini-review discusses physiological bone remodeling, outlining the traditional bone biology dogma in light of emerging osteoimmunology data. Specifically discussed in detail are the cellular and molecular mechanisms of bone remodeling, including events that orchestrate the five sequential phases of bone remodeling: activation, resorption, reversal, formation, and termination.	[Partridge, Nicola C.] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10010 USA; [Raggatt, Liza J.] Univ Queensland, Royal Brisbane Hosp, Clin Res Ctr, Fac Hlth Sci, Herston, Qld 4029, Australia; [Raggatt, Liza J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4062, Australia	New York University; Royal Brisbane & Women's Hospital; University of Queensland; University of Queensland	Partridge, NC (corresponding author), NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10010 USA.	ncp234@nyu.edu	Raggatt, Liza-Jane/S-4530-2016; Raggatt, Liza-Jane/A-5297-2011	Raggatt, Liza-Jane/0000-0002-7920-6225; Partridge, Nicola/0000-0002-5406-4814	National Institutes of Health [DK47420, DK48109]; National Health and Medical Research Council [455941, 631484]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048109, R01DK047420, R56DK047420] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK47420 and DK48109 (to N.C.P.). This work was also supported by National Health and Medical Research Council Grants 455941 and 631484 (to L.J.R.). This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Aguirre JI, 2006, J BONE MINER RES, V21, P605, DOI 10.1359/JBMR.060107; Andersen TL, 2009, AM J PATHOL, V174, P239, DOI 10.2353/ajpath.2009.080627; Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Bonewald LF, 2007, ANN NY ACAD SCI, V1116, P281, DOI 10.1196/annals.1402.018; Burgess TL, 1999, J CELL BIOL, V145, P527, DOI 10.1083/jcb.145.3.527; Corral DA, 1998, P NATL ACAD SCI USA, V95, P13835, DOI 10.1073/pnas.95.23.13835; Everts V, 2002, J BONE MINER RES, V17, P77, DOI 10.1359/jbmr.2002.17.1.77; FERMOR B, 1995, J BONE MINER RES, V10, P1935; Gori F, 2000, ENDOCRINOLOGY, V141, P4768, DOI 10.1210/endo.141.12.7840; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Harmey D, 2004, AM J PATHOL, V164, P1199, DOI 10.1016/S0002-9440(10)63208-7; Hauge EM, 2001, J BONE MINER RES, V16, P1575, DOI 10.1359/jbmr.2001.16.9.1575; Heinemann DEH, 2000, IMMUNOBIOLOGY, V202, P68, DOI 10.1016/S0171-2985(00)80054-6; Hofbauer LC, 2000, J BONE MINER RES, V15, P2, DOI 10.1359/jbmr.2000.15.1.2; Insogna KL, 1997, J CLIN INVEST, V100, P2476, DOI 10.1172/JCI119790; Jacquin C, 2006, J BONE MINER RES, V21, P67, DOI 10.1359/JBMR.051007; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; Kacena MA, 2004, J BONE MINER RES, V19, P652, DOI 10.1359/JBMR.0301254; Kamioka H, 2001, BONE, V28, P145, DOI 10.1016/S8756-3282(00)00421-X; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; KRAAL G, 1987, SCAND J IMMUNOL, V26, P653, DOI 10.1111/j.1365-3083.1987.tb02301.x; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Li X, 2007, J BIOL CHEM, V282, P33098, DOI 10.1074/jbc.M611781200; Li Y, 2007, BLOOD, V109, P3839, DOI 10.1182/blood-2006-07-037994; Lorenzo J, 2008, ENDOCR REV, V29, P403, DOI 10.1210/er.2007-0038; Lowry MB, 2008, ENDOCRINOLOGY, V149, P5735, DOI 10.1210/en.2008-0134; Luchin A, 2000, J BONE MINER RES, V15, P451, DOI 10.1359/jbmr.2000.15.3.451; Ma YFL, 2001, ENDOCRINOLOGY, V142, P4047, DOI 10.1210/en.142.9.4047; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Mizoguchi T, 2009, J CELL BIOL, V184, P541, DOI 10.1083/jcb.200806139; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; PALUMBO C, 1986, CELL TISSUE RES, V246, P125; PARTRIDGE NC, 1987, ENDOCRINOLOGY, V120, P1956, DOI 10.1210/endo-120-5-1956; Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106; Pettit AR, 2008, BONE, V43, P976, DOI 10.1016/j.bone.2008.08.128; Robey P.G., 2008, PRIMER METABOLIC BON, V7, P32; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Swarthout JT, 2002, GENE, V282, P1, DOI 10.1016/S0378-1119(01)00798-3; Takahashi F, 2004, LUNG, V182, P173; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tondravi MM, 1997, NATURE, V386, P81, DOI 10.1038/386081a0; TRAN VP, 1982, CELL TISSUE RES, V225, P283; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; Verborgt O, 2002, J BONE MINER RES, V17, P907, DOI 10.1359/jbmr.2002.17.5.907; Weitzmann MN, 2007, ANN NY ACAD SCI, V1116, P360, DOI 10.1196/annals.1402.068; Yang CM, 2004, J BIOL CHEM, V279, P22158, DOI 10.1074/jbc.M401343200; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	60	736	779	14	169	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25103	25108		10.1074/jbc.R109.041087	http://dx.doi.org/10.1074/jbc.R109.041087			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20501658	Green Published, hybrid			2022-12-27	WOS:000280682400001
J	Cryle, MJ; Meinhart, A; Schlichting, I				Cryle, Max J.; Meinhart, Anton; Schlichting, Ilme			Structural Characterization of OxyD, a Cytochrome P450 Involved in beta-Hydroxytyrosine Formation in Vancomycin Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CO-TRANSCRIBED GENES; GLYCOPEPTIDE ANTIBIOTICS; PROTEIN-STRUCTURE; MOLECULAR CHARACTERIZATION; PEPTIDYL MOIETY; AMINO-ACID; CLUSTER; IDENTIFICATION; INSIGHTS; MODEL	The cytochrome P450 OxyD from the balhimycin glycopeptide antibiotic biosynthetic operon of Amycolatopsis mediterranei is involved in the biosynthesis of the modified amino acid beta-R-hydroxytyrosine,an essential precursor for biosynthesis of the vancomycin-type aglycone. OxyD binds the substrate tyrosine not free in solution, but rather covalently linked to the carrier protein (CP) domain of the non-ribosomal peptide synthase BpsD, exhibiting micromolar binding affinity to a tyrosine-loaded carrier protein construct. The crystal structure of OxyD was determined to 2.1-angstrom resolution, revealing a potential binding site for the carrier protein-bound substrate in a different orientation to that seen with the acyl carrier protein-bound P450(BioI) (Cryle, M. J., and Schlichting, I. (2008) Proc. Natl. Acad. Sci. U. S. A. 105, 15696-15701). A series of residues were identified across known aminoacyl-CP-oxidizing P450s that are highly conserved and cluster in the active site or potential CP binding site of OxyD. These residues appear to be characteristic for aminoacyl-CP-oxidizing P450s, allowing sequence based identification of P450 function for this subgroup of P450s that play vital roles in the biosyntheses of many important natural products in addition to the vancomycin-type antibiotics. The ability to analyze such P450 function based upon sequence data alone should prove an important tool in the analysis and identification of new medicinally relevant biomolecules.	[Cryle, Max J.; Meinhart, Anton; Schlichting, Ilme] Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany	Max Planck Society	Cryle, MJ (corresponding author), Max Planck Inst Med Res, Dept Biomol Mech, Jahnstr 29, D-69120 Heidelberg, Germany.	Max.Cryle@mpimf-heidelberg.mpg.de	Cryle, Max/H-7656-2017; Schlichting, Ilme/I-1339-2013; Meinhart, Anton/M-9647-2014	Cryle, Max/0000-0002-9739-6157; 	Human Frontier Science Program (Cross Disciplinary Fellowship)	Human Frontier Science Program (Cross Disciplinary Fellowship)(Human Frontier Science Program)	Supported by the Human Frontier Science Program (Cross Disciplinary Fellowship). To whom correspondence should be addressed: Max-Planck Institute for Medical Research, Jahnstrasse 29, 69120 Heidelberg, Germany.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bischoff D, 2001, ANGEW CHEM INT EDIT, V40, P4688, DOI 10.1002/1521-3773(20011217)40:24<4688::AID-ANIE4688>3.0.CO;2-M; Bischoff D, 2001, ANGEW CHEM INT EDIT, V40, P1693, DOI 10.1002/1521-3773(20010504)40:9<1693::AID-ANIE16930>3.0.CO;2-8; Bischoff D, 2005, CHEMBIOCHEM, V6, P267, DOI 10.1002/cbic.200400328; Bogomolovas J, 2009, PROTEIN EXPRES PURIF, V64, P16, DOI 10.1016/j.pep.2008.10.003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bruntner C, 1999, MOL GEN GENET, V262, P102; Carter P, 2003, NUCLEIC ACIDS RES, V31, P3293, DOI 10.1093/nar/gkg626; Chen H, 2002, CHEM BIOL, V9, P103, DOI 10.1016/S1074-5521(02)00090-X; Chen HW, 2001, CHEM BIOL, V8, P301, DOI 10.1016/S1074-5521(01)00009-6; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cryle MJ, 2008, P NATL ACAD SCI USA, V105, P15696, DOI 10.1073/pnas.0805983105; Cryle MJ, 2003, AUST J CHEM, V56, P749, DOI 10.1071/CH03040; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DAWSON JH, 1982, J BIOL CHEM, V257, P3606; DeLano W.L, PYMOL MOL GRAPHICS S; DEMONTELLANO PRO, 2008, CYTOCHROME P450 STRU, P183; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Ehmann DE, 2000, CHEM BIOL, V7, P765, DOI 10.1016/S1074-5521(00)00022-3; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Galm U, 2009, MOL BIOSYST, V5, P77, DOI 10.1039/b814075h; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; GOTOH O, 1992, J BIOL CHEM, V267, P83; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Johnston JB, 2009, P NATL ACAD SCI USA, V106, P20687, DOI 10.1073/pnas.0907398106; Jungmann V, 2005, APPL ENVIRON MICROB, V71, P6968, DOI 10.1128/AEM.71.11.6968-6976.2005; Koglin A, 2006, SCIENCE, V312, P273, DOI 10.1126/science.1122928; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lauer B, 2001, MOL GEN GENET, V264, P662, DOI 10.1007/s004380000352; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLean KJ, 2009, J BIOL CHEM, V284, P35524, DOI 10.1074/jbc.M109.032706; Mulyani S, 2010, CHEMBIOCHEM, V11, P266, DOI 10.1002/cbic.200900600; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicolaou KC, 1999, ANGEW CHEM INT EDIT, V38, P2096, DOI 10.1002/(SICI)1521-3773(19990802)38:15<2096::AID-ANIE2096>3.0.CO;2-F; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pelzer S, 1999, ANTIMICROB AGENTS CH, V43, P1565, DOI 10.1128/AAC.43.7.1565; PETERSON JA, 1992, J BIOL CHEM, V267, P14193; Pojer F, 2002, MICROBIOL-SGM, V148, P3901, DOI 10.1099/00221287-148-12-3901; Puk O, 2004, J BACTERIOL, V186, P6093, DOI 10.1128/jb.186.18.6093-6100.2004; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Recktenwald J, 2002, MICROBIOL-SGM, V148, P1105, DOI 10.1099/00221287-148-4-1105; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Solenberg PJ, 1997, CHEM BIOL, V4, P195, DOI 10.1016/S1074-5521(97)90288-X; Steffensky M, 2000, ANTIMICROB AGENTS CH, V44, P1214, DOI 10.1128/AAC.44.5.1214-1222.2000; Stegmann E, 2006, J BIOTECHNOL, V124, P640, DOI 10.1016/j.jbiotec.2006.04.009; Strieker M, 2009, J AM CHEM SOC, V131, P13523, DOI 10.1021/ja9054417; Sussmuth RD, 1999, ANGEW CHEM INT EDIT, V38, P1976, DOI 10.1002/(SICI)1521-3773(19990712)38:13/14<1976::AID-ANIE1976>3.0.CO;2-3; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; van Wageningen AMA, 1998, CHEM BIOL, V5, P155, DOI 10.1016/S1074-5521(98)90060-6; Wang ZX, 2000, ANTIMICROB AGENTS CH, V44, P3040, DOI 10.1128/AAC.44.11.3040-3048.2000; Watanabe K, 2006, NAT CHEM BIOL, V2, P423, DOI 10.1038/nchembio803; Williams DH, 1999, ANGEW CHEM INT EDIT, V38, P1173, DOI 10.1002/(SICI)1521-3773(19990503)38:9<1172::AID-ANIE1172>3.0.CO;2-C; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Woithe K, 2007, J AM CHEM SOC, V129, P6887, DOI 10.1021/ja071038f; YU CA, 1974, J BIOL CHEM, V249, P94; Zerbe K, 2002, J BIOL CHEM, V277, P47476, DOI 10.1074/jbc.M206342200	62	50	50	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24562	24574		10.1074/jbc.M110.131904	http://dx.doi.org/10.1074/jbc.M110.131904			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20519494	Green Published, hybrid			2022-12-27	WOS:000280542100028
J	Kavran, JM; Ward, MD; Oladosu, OO; Mulepati, S; Leahy, DJ				Kavran, Jennifer M.; Ward, Matthew D.; Oladosu, Oyindamola O.; Mulepati, Sabin; Leahy, Daniel J.			All Mammalian Hedgehog Proteins Interact with Cell Adhesion Molecule, Down-regulated by Oncogenes (CDO) and Brother of CDO (BOC) in a Conserved Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRACHYDACTYLY TYPE A1; CRYSTAL-STRUCTURE; PATHWAY; MUTATIONS; DOMAIN; ACTIVATION; COMPLEX; LIGAND; CANCER; ACTS	Hedgehog (Hh) signaling proteins stimulate cell proliferation, differentiation, and tissue patterning at multiple points in animal development. A single Hh homolog is present in Drosophila, but three Hh homologs, Sonic Hh, Indian Hh, and Desert Hh, are present in mammals. Distribution, movement, and reception of Hh signals are tightly regulated, and abnormal Hh signaling is associated with developmental defects and cancer. In addition to the integral membrane proteins Patched and Smoothened, members of the Drosophila Ihog family of adhesion-like molecules have recently been shown to bind Hh proteins with micromolar affinity and positively regulate Hh signaling. Cell adhesion molecule-related, down-regulated by oncogenes (CDO) and Brother of CDO (BOC) are the closest mammalian relatives of Drosophila Ihog, and CDO binds Sonic Hh with micromolar affinity and positively regulates Hh signaling. Despite these similarities, structural and biochemical studies have shown that Ihog and CDO utilize nonorthologous domains and completely different binding modes to interact with cognate Hh proteins. We report here biochemical and x-ray structural studies of Sonic, Indian, and Desert Hh proteins both alone and complexed with active domains of CDO and BOC. These results show that all mammalian Hh proteins bind CDO and BOC in the same manner. We also show that interactions between Hh proteins and CDO are weakened at low pH. Formation of Hh-mediated Hh oligomers is thought to be an important feature of normal Hh signaling, but no conserved self-interaction between Hh proteins is apparent from inspection of 14 independent Hh-containing crystal lattices.	[Kavran, Jennifer M.; Ward, Matthew D.; Oladosu, Oyindamola O.; Mulepati, Sabin; Leahy, Daniel J.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Leahy, DJ (corresponding author), 725 N Wolfe St, Baltimore, MD 21205 USA.	dleahy@jhmi.edu			National Institutes of Health [R01HD055545]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055545] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009110] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HD055545.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bishop B, 2009, NAT STRUCT MOL BIOL, V16, P698, DOI 10.1038/nsmb.1607; Bitgood MJ, 1996, CURR BIOL, V6, P298, DOI 10.1016/S0960-9822(02)00480-3; Bosanac I, 2009, NAT STRUCT MOL BIOL, V16, P691, DOI 10.1038/nsmb.1632; Byrnes AM, 2009, EUR J HUM GENET, V17, P1112, DOI 10.1038/ejhg.2009.18; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Guo SZ, 2010, CELL MOL BIOL LETT, V15, P153, DOI 10.2478/s11658-009-0040-2; HALL TMT, 1995, NATURE, V378, P212, DOI 10.1038/378212a0; Hall TMT, 1997, CELL, V91, P85, DOI 10.1016/S0092-8674(01)80011-8; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Kang JS, 2002, EMBO J, V21, P114, DOI 10.1093/emboj/21.1.114; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Liu MG, 2006, J HUM GENET, V51, P727, DOI 10.1007/s10038-006-0012-6; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLellan JS, 2008, NATURE, V455, P979, DOI 10.1038/nature07358; McLellan JS, 2006, P NATL ACAD SCI USA, V103, P17208, DOI 10.1073/pnas.0606738103; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Valdar WSJ, 2001, J MOL BIOL, V313, P399, DOI 10.1006/jmbi.2001.5034; Vyas N, 2008, CELL, V133, P1214, DOI 10.1016/j.cell.2008.05.026; Yao SQ, 2006, CELL, V125, P343, DOI 10.1016/j.cell.2006.02.040; Zhang W, 2006, DEV CELL, V10, P657, DOI 10.1016/j.devcel.2006.04.005; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang Y, 2001, NATURE, V410, P599, DOI 10.1038/35069099; Zheng XY, 2010, GENE DEV, V24, P57, DOI 10.1101/gad.1870310	40	48	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24584	24590		10.1074/jbc.M110.131680	http://dx.doi.org/10.1074/jbc.M110.131680			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20519495	Green Published, hybrid			2022-12-27	WOS:000280542100030
J	Chuang, TD; Chen, SJ; Lin, FF; Veeramani, S; Kumar, S; Batra, SK; Tu, YP; Lin, MF				Chuang, Tsai-Der; Chen, Siu-Ju; Lin, Fen-Fen; Veeramani, Suresh; Kumar, Satyendra; Batra, Surinder K.; Tu, Yaping; Lin, Ming-Fong			Human Prostatic Acid Phosphatase, an Authentic Tyrosine Phosphatase, Dephosphorylates ErbB-2 and Regulates Prostate Cancer Cell Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANDROGEN-INDEPENDENT PROLIFERATION; SIGNAL TRANSDUCER; IN-VITRO; RECEPTOR; EXPRESSION; PROTEIN; PHOSPHORYLATION; ACTIVATION; KINASE; SITE	Cellular prostatic acid phosphatase (cPAcP), an authentic tyrosine phosphatase, is proposed to function as a negative growth regulator of prostate cancer (PCa) cells in part through its dephosphorylation of ErbB-2. Nevertheless, the direct interaction between cPAcP and ErbB-2 has not been shown nor the specific dephosphorylation site of ErbB-2 by cPAcP. In this report, our data show that the phosphorylation level of ErbB-2 primarily at Tyr(1221/2) correlates with the growth rate of both LNCaP and MDA PCa2b human PCa cells. Further, cPAcP reciprocally co-immunoprecipitated with ErbB-2 in a non-permissive growth condition. Expression of wild type cPAcP, but not inactive mutant, by cDNA in cPAcP-null LNCaP C-81 cells results in decreased tyrosine phosphorylation of ErbB-2 including Tyr(1221/2). Concurrently, Tyr(317) phosphorylation of p52(Shc), proliferating cell nuclear antigen expression, and cell growth are decreased in these cells. Conversely, decreased cPAcP expression by short hairpin RNA in LNCaP C-33 cells was associated with elevated phosphorylation of ErbB-2 initially at Tyr(1221/2). Its downstream p52(Shc), ERK1/2, Akt, Src, STAT-3, and STAT-5 were activated, and cell proliferation, proliferating cell nuclear antigen, and cyclin D1 expression were increased. Stable subclones of C-33 cells by small interfering PAcP had elevated Tyr(1221/2) phosphorylation of ErbB-2 and exhibited androgen-independent growth and increased tumorigenicity in xenograft female animals. In summary, our data together indicate that in prostate epithelia, cPAcP interacts with and dephosphorylates ErbB-2 primarily at Tyr(1221/2) and hence blocks downstream signaling, leading to reduced cell growth. In PCa cells, decreased cPAcP expression is associated with androgen-independent cell proliferation and tumorigenicity as seen in advanced hormone-refractory prostate carcinomas.	[Chuang, Tsai-Der; Chen, Siu-Ju; Lin, Fen-Fen; Veeramani, Suresh; Kumar, Satyendra; Batra, Surinder K.; Lin, Ming-Fong] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Coll Med, Omaha, NE 68198 USA; [Batra, Surinder K.; Lin, Ming-Fong] Univ Nebraska, Med Ctr, Eppley Inst Res Canc, Omaha, NE 68198 USA; [Tu, Yaping] Creighton Univ, Sch Med, Dept Pharmacol, Omaha, NE 68178 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Creighton University	Lin, MF (corresponding author), 985870 Nebraska Med Ctr, Omaha, NE 68198 USA.	mlin@unmc.edu	Veeramani, Suresh/P-7838-2019	Veeramani, Suresh/0000-0001-9217-0872	National Institutes of Health [2R01CA88184, P20RR018759]; United States Department of Defense [PC074289, PC050769]; Nebraska Research Initiative; NATIONAL CANCER INSTITUTE [R01CA088184] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense(United States Department of Defense); Nebraska Research Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants 2R01CA88184 (to M.-F.L.) and P20RR018759 (to S.-J.C.). This study was also supported by United States Department of Defense Grants PC074289 and PC050769 and the Nebraska Research Initiative.	Abdulghani J, 2008, AM J PATHOL, V172, P1717, DOI 10.2353/ajpath.2008.071054; AKIYAMA T, 1991, MOL CELL BIOL, V11, P833, DOI 10.1128/MCB.11.2.833; BENLEVY R, 1994, EMBO J, V13, P3302, DOI 10.1002/j.1460-2075.1994.tb06632.x; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Calvo BF, 2003, CLIN CANCER RES, V9, P1087; Chen L, 2004, NEW ASTRON, V10, P39, DOI 10.1016/j.newast.2004.04.008; Chen SJ, 2007, PROSTATE, V67, P557, DOI 10.1002/pros.20551; Cotarla I, 2004, INT J CANCER, V108, P665, DOI 10.1002/ijc.11619; Craft N, 1999, NAT MED, V5, P280, DOI 10.1038/6495; CULIG Z, 1995, EUR UROL, V27, P45; Dagvadorj A, 2008, CLIN CANCER RES, V14, P1317, DOI 10.1158/1078-0432.CCR-07-2024; FOTI AG, 1977, CLIN CHEM, V23, P95; Frogne T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2230; Gioeli D, 1999, CANCER RES, V59, P279; Huggins C, 1972, CA Cancer J Clin, V22, P232, DOI 10.3322/canjclin.22.4.232; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Igawa T, 2003, PROSTATE, V55, P247, DOI 10.1002/pros.10240; Igawa T, 2002, PROSTATE, V50, P222, DOI 10.1002/pros.10054; Isaacs JT, 2004, NAT MED, V10, P26, DOI 10.1038/nm0104-26; Lee MS, 2004, ONCOGENE, V23, P3048, DOI 10.1038/sj.onc.1207451; Lee MS, 2003, ONCOGENE, V22, P781, DOI 10.1038/sj.onc.1206066; LI HC, 1984, EUR J BIOCHEM, V138, P45, DOI 10.1111/j.1432-1033.1984.tb07879.x; Li HZ, 2005, CLIN CANCER RES, V11, P5863, DOI 10.1158/1078-0432.CCR-05-0562; Lin MF, 1996, BIOCHEM BIOPH RES CO, V226, P206, DOI 10.1006/bbrc.1996.1334; LIN MF, 1986, MOL CELL BIOL, V6, P4753, DOI 10.1128/MCB.6.12.4753; LIN MF, 1986, BIOCHEM J, V235, P351, DOI 10.1042/bj2350351; Lin MF, 1998, J BIOL CHEM, V273, P5939, DOI 10.1074/jbc.273.10.5939; LIN MF, 1993, CELL MOL BIOL RES, V39, P739; LIN MF, 1992, CANCER RES, V52, P4600; LIN MF, 1994, DIFFERENTIATION, V57, P143, DOI 10.1046/j.1432-0436.1994.5720143.x; Lin MF, 2001, J UROLOGY, V166, P1943, DOI 10.1016/S0022-5347(05)65725-4; LIN MF, 1983, BIOCHEMISTRY-US, V22, P1055, DOI 10.1021/bi00274a009; Luchter-Wasylewska E, 2003, J PROTEIN CHEM, V22, P243, DOI 10.1023/A:1025016402860; Luchter-Wasylewska E, 2001, BBA-PROTEIN STRUCT M, V1548, P257, DOI 10.1016/S0167-4838(01)00239-4; Malinowska K, 2009, ENDOCR-RELAT CANCER, V16, P155, DOI 10.1677/ERC-08-0174; Marcotte R, 2009, MOL CELL BIOL, V29, P5858, DOI 10.1128/MCB.01731-08; Meng TC, 2000, ONCOGENE, V19, P2664, DOI 10.1038/sj.onc.1203576; Meng TC, 1998, J BIOL CHEM, V273, P22096, DOI 10.1074/jbc.273.34.22096; MIKAMI Y, 1992, P NATL ACAD SCI USA, V89, P7335, DOI 10.1073/pnas.89.16.7335; Olayioye MA, 1999, J BIOL CHEM, V274, P17209, DOI 10.1074/jbc.274.24.17209; Osman I, 2001, CLIN CANCER RES, V7, P2643; Rahman M, 2004, CLIN CANCER RES, V10, P2208, DOI 10.1158/1078-0432.CCR-0746-3; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Seaton A, 2008, CARCINOGENESIS, V29, P1148, DOI 10.1093/carcin/bgn109; Seidenfeld J, 2000, ANN INTERN MED, V132, P566, DOI 10.7326/0003-4819-132-7-200004040-00009; Sharma S, 2005, PROTEINS, V58, P295, DOI 10.1002/prot.20335; Shi Y, 2006, BJU INT, V97, P170, DOI 10.1111/j.1464-410X.2006.05857.x; Signoretti S, 2000, JNCI-J NATL CANCER I, V92, P1918, DOI 10.1093/jnci/92.23.1918; Stevenson LE, 1998, BREAST CANCER RES TR, V49, P119, DOI 10.1023/A:1006007227747; Sweeney C, 2000, ONCOGENE, V19, P5568, DOI 10.1038/sj.onc.1203913; Tan SH, 2008, CANCER RES, V68, P236, DOI 10.1158/0008-5472.CAN-07-2972; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Toualbi-Abed K, 2008, CARCINOGENESIS, V29, P536, DOI 10.1093/carcin/bgm293; Ursini-Siegel J, 2008, EMBO J, V27, P910, DOI 10.1038/emboj.2008.22; Veeramani S, 2005, ENDOCR-RELAT CANCER, V12, P805, DOI 10.1677/erc.1.00950; Veeramani S, 2009, TRENDS BIOCHEM SCI, V34, P273, DOI 10.1016/j.tibs.2009.03.002; VIHKO P, 1988, FEBS LETT, V236, P275, DOI 10.1016/0014-5793(88)80037-1; Wen Y, 2000, CANCER RES, V60, P6841; Zhang HT, 1998, ONCOGENE, V16, P2835, DOI 10.1038/sj.onc.1201820; Zhang L, 2009, CANCER LETT, V285, P58, DOI 10.1016/j.canlet.2009.04.041; Zhang XQ, 2001, J BIOL CHEM, V276, P2544, DOI 10.1074/jbc.M006661200; Zylka MJ, 2008, NEURON, V60, P111, DOI 10.1016/j.neuron.2008.08.024	64	39	41	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23598	23606		10.1074/jbc.M109.098301	http://dx.doi.org/10.1074/jbc.M109.098301			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20498373	Green Published, hybrid			2022-12-27	WOS:000280291400009
J	Leviatan, S; Sawada, K; Moriyama, Y; Nelson, N				Leviatan, Shani; Sawada, Keisuke; Moriyama, Yoshinori; Nelson, Nathan			Combinatorial Method for Overexpression of Membrane Proteins in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALTOSE-BINDING-PROTEIN; HIGH-LEVEL EXPRESSION; CRYSTAL-STRUCTURE; COUPLED RECEPTOR; FUSION; TRANSPORTER; PURIFICATION; CRYSTALLIZATION; STRATEGIES; CHANNEL	Membrane proteins constitute 20-30% of all proteins encoded by the genome of various organisms. Large amounts of purified proteins are required for activity and crystallization attempts. Thus, there is an unmet need for a heterologous membrane protein overexpression system for purification, crystallization, and activity determination. We developed a combinatorial method for overexpressing and purifying membrane proteins using Escherichia coli. This method utilizes short hydrophilic bacterial proteins, YaiN and YbeL, fused to the ends of the membrane proteins to serve as facilitating factors for expression and purification. Fourteen prokaryotic and mammalian membrane proteins were expressed using this system. Moderate to high expression was obtained for most proteins, and detergent solubilization combined with a short purification process produced stable, monodispersed membrane proteins. Five of the mammalian membrane proteins, overexpressed using our system, were reconstituted into liposomes and exhibited transport activity comparable with the native transporters.	Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel; [Sawada, Keisuke; Moriyama, Yoshinori] Okayama Univ, Dept Membrane Biochem, Okayama 7008530, Japan	Tel Aviv University; Okayama University		nelson@post.tau.ac.il			Japan-Israel Scientific Research cooperation [3-6790]	Japan-Israel Scientific Research cooperation	This work was supported in part by Grant 3-6790 from the Japan-Israel Scientific Research cooperation.	Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Beckwith J, 2000, METHOD ENZYMOL, V326, P3; Begum RR, 2000, J CHROMATOGR B, V737, P119, DOI 10.1016/S0378-4347(99)00480-6; Caffrey M, 2003, J STRUCT BIOL, V142, P108, DOI 10.1016/S1047-8477(03)00043-1; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Davis GD, 1999, BIOTECHNOL BIOENG, V65, P382, DOI 10.1002/(SICI)1097-0290(19991120)65:4<382::AID-BIT2>3.3.CO;2-9; Drew D, 2005, PROTEIN SCI, V14, P2011, DOI 10.1110/ps.051466205; Herring CD, 2004, J BACTERIOL, V186, P6714, DOI 10.1128/JB.186.20.6714-6720.2004; Juge N, 2006, J BIOL CHEM, V281, P39499, DOI 10.1074/jbc.M607670200; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Laage R, 2001, TRAFFIC, V2, P99, DOI 10.1034/j.1600-0854.2001.020204.x; LaVallie ER, 2000, METHOD ENZYMOL, V326, P322; Makrides SC, 1996, MICROBIOL REV, V60, P512, DOI 10.1128/MMBR.60.3.512-538.1996; MICHEL H, 1983, TRENDS BIOCHEM SCI, V8, P56, DOI 10.1016/0968-0004(83)90390-0; Miyaji T, 2008, P NATL ACAD SCI USA, V105, P11720, DOI 10.1073/pnas.0804015105; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Pryor KD, 1997, PROTEIN EXPRES PURIF, V10, P309, DOI 10.1006/prep.1997.0759; Quick M, 2002, P NATL ACAD SCI USA, V99, P8597, DOI 10.1073/pnas.132266599; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Roosild TP, 2005, SCIENCE, V307, P1317, DOI 10.1126/science.1106392; Rudnick G, 2008, P NATL ACAD SCI USA, V105, P5949, DOI 10.1073/pnas.0802774105; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; SHOUFFANI A, 1990, J BIOL CHEM, V265, P6002; White JF, 2004, FEBS LETT, V564, P289, DOI 10.1016/S0014-5793(04)00195-4; Zhan Y, 2001, GENE, V281, P1, DOI 10.1016/S0378-1119(01)00797-1; Zhang YB, 2004, PROTEIN EXPRES PURIF, V36, P207, DOI 10.1016/j.pep.2004.04.020	28	44	50	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23548	23556		10.1074/jbc.M110.125492	http://dx.doi.org/10.1074/jbc.M110.125492			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20525689	hybrid, Green Published			2022-12-27	WOS:000280291400004
J	Nijeholt, JALA; Bulacu, M; Marrink, SJ; Driessen, AJM				Nijeholt, Jelger A. Lycklama A.; Bulacu, Monica; Marrink, Siewert Jan; Driessen, Arnold J. M.			Immobilization of the Plug Domain Inside the SecY Channel Allows Unrestricted Protein Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CROSS-LINKING; CONDUCTING CHANNEL; PRECURSOR PROTEINS; FORCE-FIELD; MEMBRANE; PHENOTYPES; EFFICIENT; COMPLEX; PRLA	The SecYEG complex forms a protein-conducting channel in the inner membrane of Escherichia coli to support the translocation of secretory proteins in their unfolded state. The SecY channel is closed at the periplasmic face of the membrane by a small re-entrance loop that connects transmembrane segment 1 with 2b. This helical domain 2a is termed the plug domain. By the introduction of pairs of cysteines and crosslinkers, the plug domain was immobilized inside the channel and connected to transmembrane segment 10. Translocation was inhibited to various degrees depending on the position and crosslinker spacer length. With one of the crosslinked mutants translocation occurred unrestricted. Biochemical characterization of this mutant as well as molecular dynamics simulations suggest that only a limited movement of the plug domain suffices for translocation.	Univ Groningen, Mol Microbiol Groningen Biomol Sci & Biotechnol I, NL-9751 NN Haren, Netherlands; Univ Groningen, Zernike Inst Adv Mat, NL-9751 NN Haren, Netherlands; [Bulacu, Monica; Marrink, Siewert Jan] Univ Groningen, Mol Dynam Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; [Bulacu, Monica; Marrink, Siewert Jan] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Driessen, AJM (corresponding author), Kerklaan 30, NL-9751 NN Haren, Netherlands.	a.j.m.driessen@rug.nl	Driessen, Arnold J.M./D-1876-2012; Bulacu, Monica/B-4888-2009; Marrink, Siewert J/G-3706-2014; Institute, Zernike/W-7033-2019	Marrink, Siewert J/0000-0001-8423-5277; Driessen, Arnold J.M./0000-0001-9258-9104	Chemical Sciences Division of The Netherlands Organization for Scientific Research (NWO-CW)	Chemical Sciences Division of The Netherlands Organization for Scientific Research (NWO-CW)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Chemical Sciences Division of The Netherlands Organization for Scientific Research (NWO-CW).	BANEYX F, 1990, J BACTERIOL, V172, P491, DOI 10.1128/JB.172.1.491-494.1990; de Keyzer J, 2002, J BIOL CHEM, V277, P46059, DOI 10.1074/jbc.M208449200; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; du Plessis DJF, 2009, J BIOL CHEM, V284, P15805, DOI 10.1074/jbc.M901855200; Duong F, 1999, EMBO J, V18, P3263, DOI 10.1093/emboj/18.12.3263; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; Gumbart J, 2008, J GEN PHYSIOL, V132, P709, DOI 10.1085/jgp.200810062; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Harris CR, 1999, J BACTERIOL, V181, P3438, DOI 10.1128/JB.181.11.3438-3444.1999; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Junne T, 2006, MOL BIOL CELL, V17, P4063, DOI 10.1091/mbc.E06-03-0200; Li WK, 2007, MOL CELL, V26, P511, DOI 10.1016/j.molcel.2007.05.002; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; Maillard AP, 2007, J BIOL CHEM, V282, P1281, DOI 10.1074/jbc.M610060200; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Nouwen N, 2001, FEBS LETT, V508, P103, DOI 10.1016/S0014-5793(01)03033-2; Saparov SM, 2007, MOL CELL, V26, P501, DOI 10.1016/j.molcel.2007.03.022; Sengupta D, 2009, MOL MEMBR BIOL, V26, P422, DOI 10.3109/09687680903321073; Smith MA, 2005, J BACTERIOL, V187, P6454, DOI 10.1128/JB.187.18.6454-6465.2005; Tam PCK, 2005, EMBO J, V24, P3380, DOI 10.1038/sj.emboj.7600804; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Does C, 2003, METHOD ENZYMOL, V372, P86; van der Sluis EO, 2002, FEBS LETT, V527, P159, DOI 10.1016/S0014-5793(02)03202-7; van der Wolk JPW, 1998, EMBO J, V17, P3631, DOI 10.1093/emboj/17.13.3631; Yefimov S, 2008, BIOPHYS J, V94, P2994, DOI 10.1529/biophysj.107.119966; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	27	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23747	23754		10.1074/jbc.M110.124636	http://dx.doi.org/10.1074/jbc.M110.124636			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20489195	Green Published, hybrid			2022-12-27	WOS:000280291400025
J	Alvarez-Curto, E; Ward, RJ; Pediani, JD; Milligan, G				Alvarez-Curto, Elisa; Ward, Richard J.; Pediani, John D.; Milligan, Graeme			Ligand Regulation of the Quaternary Organization of Cell Surface M-3 Muscarinic Acetylcholine Receptors Analyzed by Fluorescence Resonance Energy Transfer (FRET) Imaging and Homogeneous Time-resolved FRET	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; PHARMACOLOGICAL CHAPERONES; CONFORMATIONAL-CHANGES; GPCR OLIGOMERIZATION; CHOLINERGIC-RECEPTOR; MOLECULAR-BASIS; LIVE CELLS; DIMERIZATION; DIMERS; BINDING	Flp-In-TM T-REx(TM) 293 cells expressing a wild type human M-3 muscarinic acetylcholine receptor construct constitutively and able to express a receptor activated solely by synthetic ligand (RASSL) form of this receptor on demand maintained response to the muscarinic agonist carbachol but developed response to clozapine N-oxide only upon induction of the RASSL. The two constructs co-localized at the plasma membrane and generated strong ratiometric fluorescence resonance energy transfer (FRET) signals consistent with direct physical interactions. Increasing levels of induction of the FRET donor RASSL did not alter wild type receptor FRET-acceptor levels substantially. However, ratiometric FRET was modulated in a bell-shaped fashion with maximal levels of the donor resulting in decreased FRET. Carbachol, but not the antagonist atropine, significantly reduced the FRET signal. Cell surface homogeneous time-resolved FRET, based on SNAP-tag technology and employing wild type and RASSL forms of the human M-3 receptor expressed stably in Flp-In-TM TREx(TM) 293 cells, also identified cell surface dimeric/oligomeric complexes. Now, however, signals were enhanced by appropriate selective agonists. At the wild type receptor, large increases in FRET signal to carbachol and acetylcholine were concentration-dependent with EC50 values consistent with the relative affinities of the two ligands. These studies confirm the capacity of the human M-3 muscarinic acetylcholine receptor to exist as dimeric/oligomeric complexes at the surface of cells and demonstrate that the organization of such complexes can be modified by ligand binding. However, conclusions as to the effect of ligands on such complexes may depend on the approach used.	[Alvarez-Curto, Elisa; Ward, Richard J.; Pediani, John D.; Milligan, Graeme] Univ Glasgow, Fac Biomed & Life Sci, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Milligan, G (corresponding author), Univ Glasgow, Fac Biomed & Life Sci, Mol Pharmacol Grp, 253 Wolfson Link Bldg,Univ Ave, Glasgow G12 8QQ, Lanark, Scotland.	g.milligan@bio.gla.ac.uk	Pediani, John/F-2708-2019; Milligan, Graeme/F-9426-2011	Pediani, John/0000-0001-6615-537X; Milligan, Graeme/0000-0002-6946-3519	Biotechnology and Biosciences Research Council [BB/E006302/1]; Medical Research Council [G0900050]; BBSRC [BB/E006302/1] Funding Source: UKRI; MRC [G0900050] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E006302/1] Funding Source: researchfish	Biotechnology and Biosciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biosciences Research Council Grant BB/E006302/1 and the Medical Research Council Grant G0900050.	ALVAREZCURTO E, 2010, G PROTEIN C IN PRESS; Arcemisbehere L, 2010, J BIOL CHEM, V285, P6337, DOI 10.1074/jbc.M109.083477; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; BONNER TI, 1989, TRENDS NEUROSCI, V12, P148, DOI 10.1016/0166-2236(89)90054-4; Bouvier M, 2007, NAT METHODS, V4, P3, DOI 10.1038/nmeth0107-3; Bruysters M, 2005, J BIOL CHEM, V280, P34741, DOI 10.1074/jbc.M504165200; Canals M, 2009, BIOCHEM J, V417, P161, DOI 10.1042/BJ20081227; Claeysen S, 2003, J BIOL CHEM, V278, P699, DOI 10.1074/jbc.C200588200; Conklin BR, 2008, NAT METHODS, V5, P673, DOI 10.1038/nmeth.1232; Cvejic S, 1997, J BIOL CHEM, V272, P26959, DOI 10.1074/jbc.272.43.26959; Dalrymple MB, 2008, PHARMACOL THERAPEUT, V118, P359, DOI 10.1016/j.pharmthera.2008.03.004; del Burgo LS, 2010, EXPERT OPIN DRUG DIS, V5, P461, DOI 10.1517/17460441003720467; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; Fung JJ, 2009, EMBO J, V28, P3315, DOI 10.1038/emboj.2009.267; Gandia J, 2008, BIOESSAYS, V30, P82, DOI 10.1002/bies.20682; Gautier A, 2008, CHEM BIOL, V15, P128, DOI 10.1016/j.chembiol.2008.01.007; Goin JC, 2006, J BIOL CHEM, V281, P5416, DOI 10.1074/jbc.M507476200; Granier S, 2007, J BIOL CHEM, V282, P13895, DOI 10.1074/jbc.M611904200; Granier S, 2009, METHODS MOL BIOL, V552, P253, DOI 10.1007/978-1-60327-317-6_18; Grant M, 2004, J BIOL CHEM, V279, P36179, DOI 10.1074/jbc.M407310200; Guettier JM, 2009, P NATL ACAD SCI USA, V106, P19197, DOI 10.1073/pnas.0906593106; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Harrison Charlotte, 2006, Journal of Pharmacological and Toxicological Methods, V54, P26, DOI 10.1016/j.vascn.2005.11.001; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Ilien B, 2009, J BIOL CHEM, V284, P19533, DOI 10.1074/jbc.M109.017145; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Kang YK, 2003, ARCH PHARM RES, V26, P846, DOI 10.1007/BF02980031; Kobayashi H, 2009, TRAFFIC, V10, P1019, DOI 10.1111/j.1600-0854.2009.00932.x; Kuszak AJ, 2009, J BIOL CHEM, V284, P26732, DOI 10.1074/jbc.M109.026922; Lohse MJ, 2007, CURR OPIN PHARMACOL, V7, P547, DOI 10.1016/j.coph.2007.08.007; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Ma AWS, 2007, BIOCHEMISTRY-US, V46, P7907, DOI 10.1021/bi6026105; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Milligan G, 2008, BRIT J PHARMACOL, V153, pS216, DOI 10.1038/sj.bjp.0707490; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; Milligan G, 2005, FEBS J, V272, P2914, DOI 10.1111/j.1742-4658.2005.04731.x; Milligan G, 2007, TRENDS PHARMACOL SCI, V28, P615, DOI 10.1016/j.tips.2007.11.001; Milligan G, 2007, BBA-BIOMEMBRANES, V1768, P825, DOI 10.1016/j.bbamem.2006.09.021; Milligan G, 2010, CURR OPIN PHARMACOL, V10, P23, DOI 10.1016/j.coph.2009.09.010; Nichols CD, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.016.2009; Novi F, 2004, J BIOL CHEM, V279, P7476, DOI 10.1074/jbc.M306818200; Park PSH, 2003, BIOCHEMISTRY-US, V42, P12960, DOI 10.1021/bi034491m; Savi P, 2006, P NATL ACAD SCI USA, V103, P11069, DOI 10.1073/pnas.0510446103; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Smith NJ, 2009, J BIOL CHEM, V284, P17527, DOI 10.1074/jbc.M109.012849; Stoddart LA, 2008, J BIOL CHEM, V283, P32913, DOI 10.1074/jbc.M805601200; Szidonya L, 2008, J ENDOCRINOL, V196, P435, DOI 10.1677/JOE-07-0573; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Vilardaga JP, 2009, MOL ENDOCRINOL, V23, P590, DOI 10.1210/me.2008-0204; WARD RJ, 2010, METHODS MOL IN PRESS; Wess J, 2007, NAT REV DRUG DISCOV, V6, P721, DOI 10.1038/nrd2379; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Youvan D. C., 1997, BIOTECHNOLOGY, V3, P1; Zeng FY, 1999, J BIOL CHEM, V274, P19487, DOI 10.1074/jbc.274.27.19487; Zeng FY, 2000, NEUROPSYCHOPHARMACOL, V23, pS19, DOI 10.1016/S0893-133X(00)00146-9; Zurn A, 2009, MOL PHARMACOL, V75, P534, DOI 10.1124/mol.108.052399	58	51	51	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23316	23328		10.1074/jbc.M110.122184	http://dx.doi.org/10.1074/jbc.M110.122184			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20489201	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000279999900065
J	de Boussac, H; Ratajewski, M; Sachrajda, I; Koblos, G; Tordai, A; Pulaski, L; Buday, L; Varadi, A; Aranyi, T				de Boussac, Hugues; Ratajewski, Marcin; Sachrajda, Iwona; Koblos, Gabriella; Tordai, Attila; Pulaski, Lukasz; Buday, Laszlo; Varadi, Andras; Aranyi, Tamas			The ERK1/2-Hepatocyte Nuclear Factor 4 alpha Axis Regulates Human ABCC6 Gene Expression in Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAUSE PSEUDOXANTHOMA ELASTICUM; CORONARY-ARTERY-DISEASE; TRANSCRIPTION FACTORS; DNA METHYLATION; PROTEIN; GROWTH; PROMOTER; RECEPTOR; LIVER; IDENTIFICATION	ABCC6 mutations are responsible for the development of pseudoxanthoma elasticum, a rare recessive disease characterized by calcification of elastic fibers. Although ABCC6 is mainly expressed in the liver the disease has dermatologic, ocular, and cardiovascular symptoms. We investigated the transcriptional regulation of the gene and observed that hepatocyte growth factor (HGF) inhibits its expression in HepG2 cells via the activation of ERK1/2. Similarly, other factors activating the cascade also inhibited ABCC6 expression. We identified the ERK1/2 response element in the proximal promoter by luciferase reporter gene assays. This site overlapped with a region conferring the tissue-specific expression pattern to the gene and with a putative hepatocyte nuclear factor 4 alpha (HNF4 alpha) binding site. We demonstrated that HNF4 alpha regulates the expression of ABCC6, acts through the putative binding site, and determines its cell type-specific expression. We also showed that HNF4 alpha is inhibited by the activation of the ERK1/2 cascade. In conclusion we describe here the first regulatory pathway of ABCC6 expression showing that the ERK1/2-HNF4 alpha axis has an important role in regulation of the gene.	[Buday, Laszlo; Varadi, Andras; Aranyi, Tamas] Hungarian Acad Sci, Inst Enzymol, H-1113 Budapest, Hungary; [Ratajewski, Marcin; Sachrajda, Iwona; Pulaski, Lukasz] Polish Acad Sci, Inst Med Biol, Lab Transcript Regulat, PL-93232 Lodz, Poland; [Tordai, Attila] Hungarian Natl Blood Transfus Serv, Lab Mol Diagnost, H-1113 Budapest, Hungary; [Buday, Laszlo] Semmelweis Univ, Dept Med Chem, H-1094 Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences; Semmelweis University	Aranyi, T (corresponding author), Hungarian Acad Sci, Inst Enzymol, Karolina Ut 29, H-1113 Budapest, Hungary.	aranyi@enzim.hu	Varadi, Andras/A-2055-2012; Aranyi, Tamas/AAJ-9629-2021; Ratajewski, Marcin/I-4657-2019	Aranyi, Tamas/0000-0002-2087-6275; Ratajewski, Marcin/0000-0001-5391-5843; Pulaski, Lukasz/0000-0001-8063-801X	National Research Fund of Hungary [NI68950, PD79183]; National Development Agency [KMOP-1.1.2-07/1-2008-0003]; Hungarian Academy of Sciences [KFKT-1-2006-0006]; Polish-Hungarian academic cooperation grant	National Research Fund of Hungary; National Development Agency; Hungarian Academy of Sciences(Hungarian Academy of Sciences); Polish-Hungarian academic cooperation grant	This work was supported in part by National Research Fund of Hungary Grants NI68950 and PD79183, National Development Agency Grant KMOP-1.1.2-07/1-2008-0003, Polanyi Mihaly Grant KFKT-1-2006-0006, a grant called "Lendulet" from the Hungarian Academy of Sciences, and a Polish-Hungarian academic cooperation grant.	Aranyi T, 2005, J BIOL CHEM, V280, P18643, DOI 10.1074/jbc.M501139200; Aranyi T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-431; Bacchelli B, 1999, MODERN PATHOL, V12, P1112; Bergen AAB, 2000, NAT GENET, V25, P228, DOI 10.1038/76109; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Bors A, 2008, ANAL BIOCHEM, V372, P261, DOI 10.1016/j.ab.2007.08.024; Borst P, 2008, CELL CYCLE, V7, P1575, DOI 10.4161/cc.7.11.6005; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; Cai L, 2001, J MOL MED, V79, P536, DOI 10.1007/s001090100275; Czaja MJ, 2003, HEPATOLOGY, V37, P1405, DOI 10.1053/jhep.2003.50233; Douet V, 2007, BIOCHEM BIOPH RES CO, V354, P66, DOI 10.1016/j.bbrc.2006.12.151; Douet V, 2006, BBA-GENE STRUCT EXPR, V1759, P426, DOI 10.1016/j.bbaexp.2006.08.002; Gujdar A, 2004, CELL SIGNAL, V16, P505, DOI 10.1016/j.cellsig.2003.09.009; Hamlin N, 2003, BRIT J HAEMATOL, V122, P852, DOI 10.1046/j.1365-2141.2003.04484.x; Hatzis P, 2006, MOL CELL BIOL, V26, P7017, DOI 10.1128/MCB.00297-06; Hendig D, 2006, CLIN CHEM, V52, P227, DOI 10.1373/clinchem.2005.059253; Hendig D, 2008, CLIN BIOCHEM, V41, P407, DOI 10.1016/j.clinbiochem.2007.12.023; Ilias A, 2002, J BIOL CHEM, V277, P16860, DOI 10.1074/jbc.M110918200; Jiang QJ, 2006, J INVEST DERMATOL, V126, P325, DOI 10.1038/sj.jid.5700065; Jiang QJ, 2009, J INVEST DERMATOL, V129, P348, DOI 10.1038/jid.2008.212; Kermorgant S, 2005, CELL CYCLE, V4, P352, DOI 10.4161/cc.4.3.1519; Koblos G, 2010, GENET TEST MOL BIOMA, V14, P75, DOI 10.1089/gtmb.2009.0094; Kool M, 1999, CANCER RES, V59, P175; Le Saux O, 2000, NAT GENET, V25, P223, DOI 10.1038/76102; Li QL, 2009, EXP DERMATOL, V18, P1, DOI 10.1111/j.1600-0625.2008.00795.x; Lian ZR, 2001, HEPATOLOGY, V34, P146, DOI 10.1053/jhep.2001.25545; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Pasquali-Ronchetti I, 2006, J PATHOL, V208, P54, DOI 10.1002/path.1867; Pfendner Ellen G, 2008, Expert Opin Med Diagn, V2, P63, DOI 10.1517/17530059.2.1.63; Qadri I, 2006, MOL PHARMACOL, V70, P627, DOI 10.1124/mol.106.023499; Qadri I, 2009, TOXICOL APPL PHARM, V234, P281, DOI 10.1016/j.taap.2008.10.005; Ratajewski M, 2006, BIOCHEM BIOPH RES CO, V350, P1082, DOI 10.1016/j.bbrc.2006.10.007; Ratajewski M, 2009, BIOCHEM BIOPH RES CO, V383, P73, DOI 10.1016/j.bbrc.2009.03.131; Ratajewski M, 2008, HUM GENET, V124, P451, DOI 10.1007/s00439-008-0570-0; Reddy S, 1999, J BIOL CHEM, V274, P33050, DOI 10.1074/jbc.274.46.33050; Reyland ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2386, DOI 10.2741/3385; Ringpfeil F, 2000, P NATL ACAD SCI USA, V97, P6001, DOI 10.1073/pnas.100041297; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Schulz V, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9444; Sipeki S, 1999, CELL SIGNAL, V11, P885, DOI 10.1016/S0898-6568(99)00060-1; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Sun K, 2007, MOL ENDOCRINOL, V21, P1297, DOI 10.1210/me.2006-0300; Symmons O, 2008, MOL BIOL EVOL, V25, P2601, DOI 10.1093/molbev/msn202; Trip MD, 2002, CIRCULATION, V106, P773, DOI 10.1161/01.CIR.0000028420.27813.C0; Viollet B, 1997, MOL CELL BIOL, V17, P4208, DOI 10.1128/MCB.17.8.4208; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; You WK, 2008, BMB REP, V41, P833, DOI 10.5483/BMBRep.2008.41.12.833	48	25	29	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22798	22806		10.1074/jbc.M110.105593	http://dx.doi.org/10.1074/jbc.M110.105593			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20463007	Green Published, hybrid			2022-12-27	WOS:000279999900012
J	Jacquot, G; Maidou-Peindara, P; Benichou, S				Jacquot, Guillaume; Maidou-Peindara, Priscilla; Benichou, Serge			Molecular and Functional Basis for the Scaffolding Role of the p50/Dynamitin Subunit of the Microtubule-associated Dynactin Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-RELATED PROTEIN; CYTOPLASMIC DYNEIN; CENTROSOMES; COMPONENT; SPINDLE; CELLS; END; OVEREXPRESSION; PROCESSIVITY; ORIENTATION	p50/dynamitin (DM) is a major subunit of the microtubule-associated dynactin complex that is required for stabilization and attachment of its two distinct structural domains, namely the Arp1 rod and the shoulder/sidearm. Here, we define the determinants of p50/DM required for self-oligomerization of the protein and for interactions with other subunits of the dynactin complex. Whereas the N-terminal 1-91-amino acid region of the protein is required and sufficient for binding to the Arp1 rod, additional determinants contained within the first half of the protein are required for optimal recruitment of the p150(Glued) subunit of the shoulder/sidearm. Overexpression experiments confirmed that the N-terminal 1-91-amino acid region of p50/DM is critical for dynactin functionality, because this fragment acts as a dominant negative to inhibit both dynein-dependent and -independent functions of the complex. Furthermore, the first two predicted coiled-coil motifs of p50/DM contain determinants that mediate self-association of the protein. Interestingly, p50/DM self-association does not contribute to p50/DM-induced disruption of the dynactin complex, but most likely participates in the stabilization of the complex.	[Jacquot, Guillaume; Maidou-Peindara, Priscilla; Benichou, Serge] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, F-75014 Paris, France; [Jacquot, Guillaume; Maidou-Peindara, Priscilla; Benichou, Serge] INSERM, U1016, F-75014 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Benichou, S (corresponding author), Univ Paris 05, Inst Cochin, CNRS, UMR 8104, 27 Rue Faubourg St Jacques, F-75014 Paris, France.	serge.benichou@inserm.fr		Benichou, Serge/0000-0003-3602-3530	INSERM; CNRS; Universite Paris-Descartes; French National Agency for AIDS Research; Sidaction Fondation de France	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paris-Descartes; French National Agency for AIDS Research; Sidaction Fondation de France	This work was supported in part by INSERM, CNRS, Universite Paris-Descartes, the French National Agency for AIDS Research, and Sidaction Fondation de France (to S.B.).	Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Berezuk MA, 2007, TRAFFIC, V8, P124, DOI 10.1111/j.1600-0854.2006.00517.x; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; CLARK SW, 1994, J CELL BIOL, V127, P129, DOI 10.1083/jcb.127.1.129; Coquelle FM, 2002, MOL CELL BIOL, V22, P3089, DOI 10.1128/MCB.22.9.3089-3102.2002; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Eckley DM, 1999, J CELL BIOL, V147, P307, DOI 10.1083/jcb.147.2.307; GILL SR, 1991, J CELL BIOL, V115, P1639, DOI 10.1083/jcb.115.6.1639; Haghnia M, 2007, MOL BIOL CELL, V18, P2081, DOI 10.1091/mbc.E06-08-0695; HARTE PJ, 1982, GENETICS, V101, P477; Hoogenraad CC, 2001, EMBO J, V20, P4041, DOI 10.1093/emboj/20.15.4041; Jacquot G, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-84; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Maier KC, 2008, TRAFFIC, V9, P481, DOI 10.1111/j.1600-0854.2008.00702.x; Melkonian KA, 2007, J BIOL CHEM, V282, P19355, DOI 10.1074/jbc.M700003200; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; MUHUA L, 1994, CELL, V78, P669, DOI 10.1016/0092-8674(94)90531-2; Peden AA, 2002, J CELL BIOL, V156, P327, DOI 10.1083/jcb.200107140; PLAMANN M, 1994, J CELL BIOL, V127, P139, DOI 10.1083/jcb.127.1.139; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Quintyne NJ, 2002, J CELL BIOL, V159, P245, DOI 10.1083/jcb.200203089; SCHAFER DA, 1994, J CELL BIOL, V126, P403, DOI 10.1083/jcb.126.2.403; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; SCHROER TA, 1991, J CELL BIOL, V115, P1309, DOI 10.1083/jcb.115.5.1309; Selig L, 1999, J VIROL, V73, P592, DOI 10.1128/JVI.73.1.592-600.1999; Starr DA, 1998, J CELL BIOL, V142, P763, DOI 10.1083/jcb.142.3.763; Uetake Y, 2004, CELL MOTIL CYTOSKEL, V58, P53, DOI 10.1002/cm.10175; Valetti C, 1999, MOL BIOL CELL, V10, P4107, DOI 10.1091/mbc.10.12.4107; WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634; Watson P, 2006, J CELL SCI, V119, P2758, DOI 10.1242/jcs.02999; Yue LL, 2000, J BIOL CHEM, V275, P23948, DOI 10.1074/jbc.M001845200	33	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23017	23029		10.1074/jbc.M110.100602	http://dx.doi.org/10.1074/jbc.M110.100602			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20463029	Green Published, hybrid			2022-12-27	WOS:000279999900036
J	Robertson, PD; Chagot, B; Chazin, WJ; Eichman, BF				Robertson, Patrick D.; Chagot, Benjamin; Chazin, Walter J.; Eichman, Brandt F.			Solution NMR Structure of the C-terminal DNA Binding Domain of Mcm10 Reveals a Conserved MCM Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL REPLICATION ORIGINS; CYCLIN-DEPENDENT KINASES; POLYMERASE ALPHA-PRIMASE; SACCHAROMYCES-CEREVISIAE; CHROMATIN ASSOCIATION; BUDDING YEAST; BIOCHEMICAL-CHARACTERIZATION; CATALYTIC SUBUNIT; PROTEIN FAMILY; CDC23 MCM10	The eukaryotic DNA replication protein Mcm10 associates with chromatin in early S- phase and is required for assembly and function of the replication fork protein machinery. Xenopus laevis (X) Mcm10bindsDNAvia a highly conserved internal domain (ID) and a C- terminal domain (CTD) that is unique to higher eukaryotes. Although the structural basis of the interactions of the ID with DNA and polymerase similar to is known, little information is available for the CTD. Wehave identified the minimalDNAbinding region of the XMcm10- CTD and determined its three- dimensional structure by solution NMR. The CTD contains a globular domain composed of two zinc binding motifs. NMRchemical shift perturbation and mutational analysis show that ssDNA binds only to the N- terminal (CCCH- type) zinc motif, whose structure is unique to Mcm10. The second (CCCC- type) zinc motif is not involved in DNA binding. However, it is structurally similar to the CCCC zinc ribbon in the N- terminal oligomerization domain of eukaryotic and archaeal MCM helicases. NMR analysis of a construct spanning both the ID and CTD reveals that the two DNA binding domains are structurally independent in solution, supporting a modular architecture for vertebrate Mcm10. Our results provide insight in the action of Mcm10 in the replisome and support a model in which it serves as a central scaffold through coupling of interactions with partner proteins and the DNA.	[Chagot, Benjamin; Chazin, Walter J.; Eichman, Brandt F.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Robertson, Patrick D.; Eichman, Brandt F.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; [Chazin, Walter J.; Eichman, Brandt F.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Chazin, WJ (corresponding author), Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA.	walter.chazin@vanderbilt.edu; brandt.eichman@vanderbilt.edu	Chagot, Benjamin/AAC-6495-2019; Chagot, Benjamin/H-3258-2011	Chagot, Benjamin/0000-0002-9153-0060; 	National Institutes of Health [GM080570]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080570, R01GM065484] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health GrantsGM080570 (to B. F. E.) andGM065484(to W. J. C.) and the Vanderbilt Discovery Grant Program.	Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Brosey CA, 2009, J AM CHEM SOC, V131, P6346, DOI 10.1021/ja9013634; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chattopadhyay S, 2007, MOL BIOL CELL, V18, P4085, DOI 10.1091/mbc.E06-12-1148; Christensen TW, 2003, MOL BIOL CELL, V14, P2206, DOI 10.1091/mbc.E02-11-0706; Dalton S, 1997, MOL CELL BIOL, V17, P5867, DOI 10.1128/MCB.17.10.5867; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Eisenberg S, 2009, J BIOL CHEM, V284, P25412, DOI 10.1074/jbc.M109.033175; Fien K, 2004, J BIOL CHEM, V279, P16144, DOI 10.1074/jbc.M400142200; Fletcher RJ, 2005, J BIOL CHEM, V280, P42405, DOI 10.1074/jbc.M509773200; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; Goddard T. D., 2006, SPARKY 3; Gozuacik D, 2003, NUCLEIC ACIDS RES, V31, P570, DOI 10.1093/nar/gkg136; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Homesley L, 2000, GENE DEV, V14, P913; Hu HT, 2003, J MOL BIOL, V330, P473, DOI 10.1016/S0022-2836(03)00619-3; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Izumi M, 2001, J BIOL CHEM, V276, P48526, DOI 10.1074/jbc.M107190200; Kasiviswanathan R, 2004, J BIOL CHEM, V279, P28358, DOI 10.1074/jbc.M403202200; Kearsey SE, 1998, BBA-GENE STRUCT EXPR, V1398, P113, DOI 10.1016/S0167-4781(98)00033-5; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee C, 2010, MOL CELL BIOL, V30, P423, DOI 10.1128/MCB.01240-09; Lee JK, 2003, P NATL ACAD SCI USA, V100, P2334, DOI 10.1073/pnas.0237384100; Liu W, 2008, NUCLEIC ACIDS RES, V36, P3235, DOI 10.1093/nar/gkn183; Liu Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-60; Lutzmann M, 2005, GENE, V362, P51, DOI 10.1016/j.gene.2005.07.031; MAINE GT, 1984, GENETICS, V106, P365; Merchant AM, 1997, MOL CELL BIOL, V17, P3261, DOI 10.1128/MCB.17.6.3261; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Okorokov AL, 2007, EMBO REP, V8, P925, DOI 10.1038/sj.embor.7401064; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Poplawski A, 2001, J BIOL CHEM, V276, P49371, DOI 10.1074/jbc.M108519200; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Ricke RM, 2004, MOL CELL, V16, P173, DOI 10.1016/j.molcel.2004.09.017; Ricke RM, 2006, J BIOL CHEM, V281, P18414, DOI 10.1074/jbc.M513551200; Robertson PD, 2008, J BIOL CHEM, V283, P3338, DOI 10.1074/jbc.M706267200; Tanaka H, 2009, GENES CELLS, V14, P807, DOI 10.1111/j.1365-2443.2009.01310.x; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tanaka TU, 1998, EMBO J, V17, P5182, DOI 10.1093/emboj/17.17.5182; Tye BK, 1999, ANNU REV BIOCHEM, V68, P649, DOI 10.1146/annurev.biochem.68.1.649; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Warren EM, 2008, STRUCTURE, V16, P1892, DOI 10.1016/j.str.2008.10.005; Warren EM, 2009, J BIOL CHEM, V284, P24662, DOI 10.1074/jbc.M109.020438; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Xu XH, 2009, EMBO J, V28, P3005, DOI 10.1038/emboj.2009.235; YAN H, 1991, GENE DEV, V5, P944, DOI 10.1101/gad.5.6.944; Yang XW, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-13; Yoshida K, 2005, BIOCHEM BIOPH RES CO, V331, P669, DOI 10.1016/j.bbrc.2005.03.222; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000	57	16	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22942	22949		10.1074/jbc.M110.131276	http://dx.doi.org/10.1074/jbc.M110.131276			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20489205	hybrid, Green Published			2022-12-27	WOS:000279999900028
J	Rowley, PA; Kachroo, AH; Ma, CH; Maciaszek, AD; Guga, P; Jayaram, M				Rowley, Paul A.; Kachroo, Aashiq H.; Ma, Chien-Hui; Maciaszek, Anna D.; Guga, Piotr; Jayaram, Makkuni			Electrostatic Suppression Allows Tyrosine Site-specific Recombination in the Absence of a Conserved Catalytic Arginine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOLLIDAY JUNCTION COMPLEX; FLP RECOMBINASE; ACTIVE-SITE; DNA RECOMBINATION; RIBONUCLEASE-ACTIVITIES; FUNCTIONAL-ANALYSIS; INTEGRASE FAMILY; TOPOISOMERASE-I; SIMILARITIES; SUBSTRATE	The active site of the tyrosine family site-specific recombinase Flp contains a conserved catalytic pentad that includes two arginine residues, Arg-191 and Arg-308. Both arginines are essential for the transesterification steps of strand cleavage and strand joining in DNA substrates containing a phosphate group at the scissile position. During strand cleavage, the active site tyrosine supplies the nucleophile to form a covalent 3'-phosphotyrosyl intermediate. The 5'-hydroxyl group produced by cleavage provides the nucleophile to re-form a 3'-5' phosphodiester bond in a recombinant DNA strand. In previous work we showed that substitution of the scissile phosphate (P) by the charge neutral methylphosphonate (MeP) makes Arg-308 dispensable during the catalytic activation of the MeP diester bond. However, in the Flp(R308A) reaction, water out-competes the tyrosine nucleophile (Tyr-343) to cause direct hydrolysis of the MeP diester bond. We now report that for MeP activation Arg-191 is also not required. In contrast to Flp(R308A), Flp(R191A) primarily mediates normal cleavage by Tyr-343 but also exhibits a weaker direct hydrolytic activity. The cleaved MeP-tyrosyl intermediate formed by Flp(R191A) can be targeted for nucleophilic attack by a 5'-hydroxyl or water and channeled toward strand joining or hydrolysis, respectively. In collaboration with wild type Flp, Flp(R191A) promotes strand exchange between MeP- and P-DNA partners. Loss of a catalytically crucial positively charged side chain can thus be suppressed by a compensatory modification in the DNA substrate that neutralizes the negative charge on the scissile phosphate.	[Rowley, Paul A.; Kachroo, Aashiq H.; Ma, Chien-Hui; Jayaram, Makkuni] Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Maciaszek, Anna D.; Guga, Piotr] Polish Acad Sci, Dept Bioorgan Chem, Ctr Mol & Macromol Studies, PL-90363 Lodz, Poland	University of Texas System; University of Texas Austin; Polish Academy of Sciences; Centre of Molecular & Macromolecular Studies of the Polish Academy of Sciences	Jayaram, M (corresponding author), 1 Univ Stn A5000,NMS 2-210, Austin, TX 78712 USA.	Jayaram@icmb.utexas.edu	Kachroo, Aashiq/Z-2505-2019; Guga, Piotr J/Y-5582-2018; Rowley, Paul/I-1265-2019	Kachroo, Aashiq/0000-0001-9770-778X; Rowley, Paul/0000-0002-3590-5139	National Institutes of Health [GM035654]; Robert F. Welch Foundation [F-1274]; University of Texas at Austin; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035654] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert F. Welch Foundation(The Welch Foundation); University of Texas at Austin; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM035654 (to M.J.). This work was also supported in part by Robert F. Welch Foundation Award F-1274 and by a University of Texas at Austin faculty research award.	ARGOS P, 1986, EMBO J, V5, P433, DOI 10.1002/j.1460-2075.1986.tb04229.x; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; CHEN JW, 1992, MOL CELL BIOL, V12, P3757, DOI 10.1128/MCB.12.9.3757; Chen Y, 2000, MOL CELL, V6, P885, DOI 10.1016/S1097-2765(05)00088-2; Chen Y, 2003, ANNU REV BIOPH BIOM, V32, P135, DOI 10.1146/annurev.biophys.32.110601.141732; Chen Y, 2003, J BIOL CHEM, V278, P24800, DOI 10.1074/jbc.M300853200; Cheng CH, 1998, CELL, V92, P841, DOI 10.1016/S0092-8674(00)81411-7; Conway AB, 2003, J MOL BIOL, V326, P425, DOI 10.1016/S0022-2836(02)01370-0; Davies DR, 2006, J MOL BIOL, V357, P1202, DOI 10.1016/j.jmb.2006.01.022; FRIESEN H, 1992, J MOL BIOL, V225, P313, DOI 10.1016/0022-2836(92)90924-9; Ghosh K, 2005, J BIOL CHEM, V280, P8290, DOI 10.1074/jbc.M411668200; Grainge I, 1999, MOL MICROBIOL, V33, P449, DOI 10.1046/j.1365-2958.1999.01493.x; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Guo F, 1997, NATURE, V389, P40, DOI 10.1038/37925; Lee J, 1999, EMBO J, V18, P784, DOI 10.1093/emboj/18.3.784; Ma CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007248; Ma CH, 2009, EMBO J, V28, P1745, DOI 10.1038/emboj.2009.131; PARSONS RL, 1988, MOL CELL BIOL, V8, P3303, DOI 10.1128/MCB.8.8.3303; PARSONS RL, 1990, J BIOL CHEM, V265, P4527; Perry K, 2006, MOL CELL, V23, P343, DOI 10.1016/j.molcel.2006.06.015; PRASAD PV, 1987, P NATL ACAD SCI USA, V84, P2189, DOI 10.1073/pnas.84.8.2189; SERRE MC, 1993, J BIOL CHEM, V268, P455; Tian LG, 2005, STRUCTURE, V13, P513, DOI 10.1016/j.str.2005.02.001; Tian LG, 2003, MOL CELL, V12, P199, DOI 10.1016/S1097-2765(03)00263-6; Xu CJ, 1998, MOL CELL, V1, P729, DOI 10.1016/S1097-2765(00)80072-6; Xu CJ, 1998, J BIOL CHEM, V273, P30591, DOI 10.1074/jbc.273.46.30591	26	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22974	22983		10.1074/jbc.M110.112292	http://dx.doi.org/10.1074/jbc.M110.112292			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20448041	Green Published, hybrid			2022-12-27	WOS:000279999900032
J	Spedale, G; Mischerikow, N; Heck, AJR; Timmers, HTM; Pijnappel, WWMP				Spedale, Gianpiero; Mischerikow, Nikolai; Heck, Albert J. R.; Timmers, H. T. Marc; Pijnappel, W. W. M. Pim			Identification of Pep4p as the Protease Responsible for Formation of the SAGA-related SLIK Protein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TATA-BINDING PROTEIN; MESSENGER-RNA EXPORT; SACCHAROMYCES-CEREVISIAE; HISTONE ACETYLTRANSFERASE; IN-VIVO; COACTIVATOR COMPLEX; CATHEPSIN-D; CELL-DEATH; TRANSCRIPTION; RECRUITMENT	The Saccharomyces cerevisiae Spt-Ada-Gcn5 acetyltransferase (SAGA) protein complex is a coactivator for transcription by RNA polymerase II and has various activities, including acetylation and deubuiqitination of histones and recruitment of TATA-binding protein to promoters. The Spt7p subunit is subject to proteolytic cleavage at its C terminus resulting in removal of the Spt8p-binding domain and generation of the SAGA-related SALSA/SAGA-like (SLIK) protein complex. Here, we report identification of the protease responsible for this cleavage. Screening of a protease knock-out collection revealed PEP4 to be required for cleavage of Spt7p within SAGA in vitro. Endogenous formation of truncated Spt7p was abolished in cells lacking PEP4. Purified Pep4p but not catalytic dead mutant Pep4p or unrelated Prc1p protease specifically cleaved Spt7p within SAGA into SLIK-related Spt7p. Interestingly, SAGA lacking Spt8p was more sensitive to Pep4p-mediated truncation of Spt7p, suggesting that Spt8p counteracted its own release from SAGA. Strains mimicking constitutive SLIK formation showed increased resistance to rapamycin treatment, suggesting a role for SLIK in regulating cellular responses to nutrient stress.	[Pijnappel, W. W. M. Pim] Univ Med Ctr Utrecht, Dept Physiol Chem, NL-3584 CG Utrecht, Netherlands; [Spedale, Gianpiero; Mischerikow, Nikolai; Heck, Albert J. R.; Timmers, H. T. Marc; Pijnappel, W. W. M. Pim] Netherlands Prote Ctr, NL-3584 CH Utrecht, Netherlands; [Mischerikow, Nikolai; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands; [Mischerikow, Nikolai; Heck, Albert J. R.] Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Prote Grp, NL-3584 CH Utrecht, Netherlands; [Heck, Albert J. R.] Ctr Biomed Genet, NL-3584 CH Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University	Pijnappel, WWMP (corresponding author), Univ Weg 100, NL-3584 CG Utrecht, Netherlands.	w.w.m.pijnappel@umcutrecht.nl	Heck, Albert/D-7098-2011	Heck, Albert/0000-0002-2405-4404; Pijnappel, Pim/0000-0002-7042-2482	Netherlands Genomics Initiative [93516050]; Netherlands Proteomics Centre	Netherlands Genomics Initiative; Netherlands Proteomics Centre	This work was financed by Netherlands Genomics Initiative Horizon Program Grant 93516050 and by the Netherlands Proteomics Centre.	Atanassov BS, 2009, MOL CELL, V35, P352, DOI 10.1016/j.molcel.2009.06.015; Baker SP, 2007, ONCOGENE, V26, P5329, DOI 10.1038/sj.onc.1210603; Belotserkovskaya R, 2000, MOL CELL BIOL, V20, P634, DOI 10.1128/MCB.20.2.634-647.2000; Bhaumik SR, 2002, MOL CELL BIOL, V22, P7365, DOI 10.1128/MCB.22.21.7365-7371.2002; Bhaumik SR, 2001, GENE DEV, V15, P1935, DOI 10.1101/gad.911401; Biddick RK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001436; Brown CE, 2001, SCIENCE, V292, P2333, DOI 10.1126/science.1060214; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Coffman JA, 1997, J BACTERIOL, V179, P5609, DOI 10.1128/jb.179.17.5609-5613.1997; Daniel JA, 2004, J BIOL CHEM, V279, P1867, DOI 10.1074/jbc.C300494200; Deiss LP, 1996, EMBO J, V15, P3861, DOI 10.1002/j.1460-2075.1996.tb00760.x; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; EISENMANN DM, 1994, GENETICS, V137, P647; Fournier ML, 2010, MOL CELL PROTEOMICS, V9, P271, DOI 10.1074/mcp.M900415-MCP200; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hoke SM, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-46; Hoke Stephen Mt, 2007, BMC Biochemistry, V8, P16, DOI 10.1186/1471-2091-8-16; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; Ingvarsdottir K, 2005, MOL CELL BIOL, V25, P1162, DOI 10.1128/MCB.25.3.1162-1172.2005; Kohler A, 2006, MOL BIOL CELL, V17, P4228, DOI 10.1091/mbc.E06-02-0098; Kuo MH, 2000, MOL CELL, V6, P1309, DOI 10.1016/S1097-2765(00)00129-5; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Lee KK, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-2; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Marques M, 2006, MICROBIOL-SGM, V152, P3595, DOI 10.1099/mic.0.29040-0; Mason DA, 2005, FEMS YEAST RES, V5, P1237, DOI 10.1016/j.femsyr.2005.07.008; Mischerikow N, 2009, J PROTEOME RES, V8, P5020, DOI 10.1021/pr900449e; Mohibullah N, 2008, GENE DEV, V22, P2994, DOI 10.1101/gad.1724408; Parr CL, 2007, YEAST, V24, P467, DOI 10.1002/yea.1485; Pascual-Garcia P, 2008, GENE DEV, V22, P2811, DOI 10.1101/gad.483308; Pascual-Garcia P, 2009, RNA BIOL, V6, P141, DOI 10.4161/rna.6.2.7793; Pray-Grant MG, 2002, MOL CELL BIOL, V22, P8774, DOI 10.1128/MCB.22.24.8774-8786.2002; Roberg K, 2001, LAB INVEST, V81, P149, DOI 10.1038/labinvest.3780222; Santos-Rosa H, 2009, NAT STRUCT MOL BIOL, V16, P17, DOI 10.1038/nsmb.1534; Sermwittayawong D, 2006, EMBO J, V25, P3791, DOI 10.1038/sj.emboj.7601265; Sterner DE, 2002, P NATL ACAD SCI USA, V99, P11622, DOI 10.1073/pnas.182021199; Timmers HTM, 2005, TRENDS BIOCHEM SCI, V30, P7, DOI 10.1016/j.tibs.2004.11.007; van Oevelen CJC, 2006, J BIOL CHEM, V281, P4523, DOI 10.1074/jbc.M509330200; Warfield L, 2004, GENE DEV, V18, P1022, DOI 10.1101/gad.1192204; Weake VM, 2008, EMBO J, V27, P394, DOI 10.1038/sj.emboj.7601966; WILSON AC, 1995, GENE DEV, V9, P2445, DOI 10.1101/gad.9.20.2445; Wu PYJ, 2002, MOL CELL BIOL, V22, P5367, DOI 10.1128/MCB.22.15.5367-5379.2002; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206; Zhang HS, 2008, J BIOL CHEM, V283, P27360, DOI 10.1074/jbc.M803831200; Zhou HQ, 2006, MOL CELL BIOL, V26, P2728, DOI 10.1128/MCB.26.7.2728-2735.2006	47	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22791	22797		10.1074/jbc.M110.108787	http://dx.doi.org/10.1074/jbc.M110.108787			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20498363	Green Published, hybrid			2022-12-27	WOS:000279999900011
J	Huc, E; Meniche, X; Benz, R; Bayan, N; Ghazi, A; Tropis, M; Daffe, M				Huc, Emilie; Meniche, Xavier; Benz, Roland; Bayan, Nicolas; Ghazi, Alexandre; Tropis, Marielle; Daffe, Mamadou			O-Mycoloylated Proteins from Corynebacterium AN UNPRECEDENTED POST-TRANSLATIONAL MODIFICATION IN BACTERIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL CHANNEL; OUTER-MEMBRANE; MYCOLIC ACIDS; GLUTAMICUM; IDENTIFICATION; MYCOBACTERIA; ENVELOPE; BIOSYNTHESIS; TREHALOSE; REVEAL	O-Acylation of proteins was known only in a few eukaryotic proteins but never in bacteria. We demonstrate, using a combination of protein chemistry and mass spectrometry, the occurrence of three O-acylated polypeptides in Corynebacterium glutamicum, PorA, PorH, and an unknown small protein. The three polypeptides are O-substituted by mycolic acids, long chain alpha-alkyl and beta-hydroxy fatty acids specifically produced by members of the Corynebacterineae suborder. To date these acids were described only as esterifying trehalose and arabinogalactan, and less frequently glycerol, important components of the highly impermeable outer barrier of Corynebacterineae. We show that the post-translational mycoloylation of PorA occurs at Ser-15 and is necessary for the pore-forming activity of C. glutamicum.	[Huc, Emilie; Meniche, Xavier; Tropis, Marielle; Daffe, Mamadou] IPBS, Dept Mecanismes Mol Infect Mycobacteriennes, CNRS, F-31077 Toulouse 04, France; [Huc, Emilie; Meniche, Xavier; Tropis, Marielle; Daffe, Mamadou] Univ Toulouse 3, F-31062 Toulouse, France; [Meniche, Xavier; Bayan, Nicolas; Ghazi, Alexandre] Univ Paris 11, CNRS, UMR8619, Inst Biochim & Biophys Mol & Cellulaire, F-91405 Orsay, France; [Benz, Roland] Jacobs Univ Bremen, Sch Sci & Engn, D-28759 Bremen, Germany	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Jacobs University	Tropis, M (corresponding author), IPBS, Dept Mecanismes Mol Infect Mycobacteriennes, CNRS, 205 Route Narbonne, F-31077 Toulouse 04, France.	marielle.tropis@ipbs.fr; mamadou.daffe@ipbs.fr	Bayan, Nicolas/AAI-5034-2020; Claustre, Emilie Huc/M-6693-2016	Claustre, Emilie Huc/0000-0002-8856-207X; Bayan, Nicolas/0000-0001-7760-0811; Benz, Roland/0000-0002-9510-9265	CNRS; University of Toulouse (Paul Sabatier); Agence Nationale de la Recherche [ANR-07-BLAN-0363]	CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Toulouse (Paul Sabatier); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by grants from the CNRS, the University of Toulouse (Paul Sabatier), and the Agence Nationale de la Recherche (Grant ANR-07-BLAN-0363).	Barth E, 2010, J BACTERIOL, V192, P786, DOI 10.1128/JB.01142-09; BENZ R, 1979, BIOCHIM BIOPHYS ACTA, V551, P238, DOI 10.1016/0005-2736(89)90002-3; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Costa-Riu N, 2003, MOL MICROBIOL, V50, P1295, DOI 10.1046/j.1365-2958.2003.03754.x; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Daffe M., 2005, HDB CORYNEBACTERIUM, P121; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Hunten P, 2005, BBA-BIOMEMBRANES, V1715, P25, DOI 10.1016/j.bbamem.2005.07.011; Kacem R, 2004, MICROBIOL-SGM, V150, P73, DOI 10.1099/mic.0.26583-0; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lichtinger T, 2001, EUR J BIOCHEM, V268, P462; Lichtinger T, 1998, BIOCHEMISTRY-US, V37, P15024, DOI 10.1021/bi980961e; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Portevin D, 2005, J BIOL CHEM, V280, P8862, DOI 10.1074/jbc.M408578200; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Puech V, 2001, MICROBIOL-SGM, V147, P1365, DOI 10.1099/00221287-147-5-1365; Schiffler B, 2007, J BACTERIOL, V189, P7709, DOI 10.1128/JB.00864-07; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; TOWLER DA, 1988, ANNU REV BIOCHEM, V57, P69, DOI 10.1146/annurev.bi.57.070188.000441; Tropis M, 2005, J BIOL CHEM, V280, P26573, DOI 10.1074/jbc.M502104200; Wolf A, 2003, MOL MICROBIOL, V49, P1119, DOI 10.1046/j.1365-2958.2003.03625.x; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	23	29	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					21908	21912		10.1074/jbc.C110.133033	http://dx.doi.org/10.1074/jbc.C110.133033			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20508265	Green Published, hybrid			2022-12-27	WOS:000279702200002
J	Li, PF; Jayarama, S; Ganesh, L; Mordi, D; Carr, R; Kanteti, P; Hay, N; Prabhakar, BS				Li, Peifeng; Jayarama, Shankar; Ganesh, Lakshmy; Mordi, David; Carr, Ryan; Kanteti, Prasad; Hay, Nissim; Prabhakar, Bellur S.			Akt-phosphorylated Mitogen-activated Kinase-activating Death Domain Protein (MADD) Inhibits TRAIL-induced Apoptosis by Blocking Fas-associated Death Domain (FADD) Association with Death Receptor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MADD/DENN SPLICE VARIANT; CELL-SURVIVAL; IG20 GENE; CANCER-CELLS; MITOCHONDRIAL-MEMBRANE; NEOPLASTIC-CELLS; EXCHANGE PROTEIN; CARCINOMA CELLS; DENN-SV; BAX	MADD plays an essential role in cancer cell survival. Abrogation of endogenous MADD expression results in significant spontaneous apoptosis and enhanced susceptibility to tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. However, the regulation of MADD function is largely unknown. Here, we demonstrate that endogenous MADDis phosphorylated at three highly conserved sites by Akt, and only the phosphorylated MADD can directly interact with the TRAIL receptor DR4 thereby preventing Fas-associated death domain recruitment. However, in cells susceptible to TRAIL treatment, TRAIL induces a reduction in MADD phosphorylation levels resulting in MADD dissociation from, and Fas-associated death domain association with DR4, which allows death-inducing signaling complex (DISC) formation leading to apoptosis. Thus, the pro-survival function of MADD is dependent upon its phosphorylation by Akt. Because Akt is active in most cancer cells and phosphorylated MADD confers resistance to TRAIL-induced apoptosis, co-targeting AktMADD axis is likely to increase efficacy of TRAIL-based therapies.	[Li, Peifeng; Jayarama, Shankar; Ganesh, Lakshmy; Mordi, David; Carr, Ryan; Kanteti, Prasad; Prabhakar, Bellur S.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Li, Peifeng; Jayarama, Shankar; Ganesh, Lakshmy; Mordi, David; Carr, Ryan; Kanteti, Prasad; Prabhakar, Bellur S.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60612 USA; [Hay, Nissim] Univ Illinois, Coll Med, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Prabhakar, BS (corresponding author), Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA.	bprabhak@uic.edu	Li, Peifeng/ABD-5663-2021; Li, Peifeng/AHE-6906-2022	Li, Peifeng/0000-0002-0969-9407; Carr, Ryan/0000-0001-5762-367X; Jayarama, Shankar/0000-0003-2996-0470	National Institutes of Health [5R01CA107506]; NATIONAL CANCER INSTITUTE [R01CA090764, R01CA107506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01CA107506.	Al-Zoubi AM, 2001, J BIOL CHEM, V276, P47202, DOI 10.1074/jbc.M104835200; Antignani A, 2006, CURR OPIN CELL BIOL, V18, P685, DOI 10.1016/j.ceb.2006.10.004; Barber MA, 2007, J BIOL CHEM, V282, P29967, DOI 10.1074/jbc.M701877200; Bennett M, 1998, SCIENCE, V282, P290, DOI 10.1126/science.282.5387.290; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Chan SM, 2007, BLOOD, V110, P278, DOI 10.1182/blood-2006-08-039883; Chen XF, 2001, ONCOGENE, V20, P6073, DOI 10.1038/sj.onc.1204736; Chow VTK, 1996, DNA SEQUENCE, V6, P263, DOI 10.3109/10425179609020873; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Coppola T, 2002, BIOCHEM J, V362, P273, DOI 10.1042/0264-6021:3620273; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Delmas D, 2004, ONCOGENE, V23, P8979, DOI 10.1038/sj.onc.1208086; Deng YB, 2002, GENE DEV, V16, P33, DOI 10.1101/gad.949602; Desbarats J, 2003, NAT CELL BIOL, V5, P118, DOI 10.1038/ncb916; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Efimova E, 2003, CANCER RES, V63, P8768; Efimova EV, 2004, ONCOGENE, V23, P1076, DOI 10.1038/sj.onc.1207210; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Guo F, 2002, BLOOD, V99, P3419, DOI 10.1182/blood.V99.9.3419; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kurada BRVVSN, 2009, J BIOL CHEM, V284, P13533, DOI 10.1074/jbc.M808554200; Li LC, 2008, CANCER RES, V68, P7352, DOI 10.1158/0008-5472.CAN-07-6311; Li PF, 1999, EMBO J, V18, P6027, DOI 10.1093/emboj/18.21.6027; Lim KM, 2004, INT J CANCER, V109, P24, DOI 10.1002/ijc.11660; Lim KM, 2002, MOL CARCINOGEN, V35, P110, DOI 10.1002/mc.10082; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Moreau C, 2003, J BIOL CHEM, V278, P19426, DOI 10.1074/jbc.M209472200; Mulherkar N, 2006, ONCOGENE, V25, P6252, DOI 10.1038/sj.onc.1209650; Mulherkar N, 2007, J BIOL CHEM, V282, P11715, DOI 10.1074/jbc.M701085200; Niwa S, 2008, NAT CELL BIOL, V10, P1269, DOI 10.1038/ncb1785; Okano J, 2000, J BIOL CHEM, V275, P30934, DOI 10.1074/jbc.M004112200; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Prabhakar BS, 2008, CLIN CANCER RES, V14, P347, DOI 10.1158/1078-0432.CCR-07-0493; Ramaswamy M, 2004, ONCOGENE, V23, P6083, DOI 10.1038/sj.onc.1207804; Schievella AR, 1997, J BIOL CHEM, V272, P12069, DOI 10.1074/jbc.272.18.12069; Song JH, 2007, CANCER RES, V67, P6946, DOI 10.1158/0008-5472.CAN-06-3896; Subramanian M, 2009, J CLIN ENDOCR METAB, V94, P1467, DOI 10.1210/jc.2008-2378; Tanaka M, 2001, MOL BIOL CELL, V12, P1421, DOI 10.1091/mbc.12.5.1421; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Way TD, 2004, J BIOL CHEM, V279, P4479, DOI 10.1074/jbc.M305529200; Yamaguchi H, 2001, ONCOGENE, V20, P7779, DOI 10.1038/sj.onc.1204984; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	56	30	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22713	22722		10.1074/jbc.M110.105692	http://dx.doi.org/10.1074/jbc.M110.105692			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20484047	Green Published, hybrid			2022-12-27	WOS:000279702200082
J	Oelkrug, R; Kutschke, M; Meyer, CW; Heldmaier, G; Jastroch, M				Oelkrug, Rebecca; Kutschke, Maria; Meyer, Carola W.; Heldmaier, Gerhard; Jastroch, Martin			Uncoupling Protein 1 Decreases Superoxide Production in Brown Adipose Tissue Mitochondria.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE PRODUCTION; NONSHIVERING THERMOGENESIS; FATTY-ACIDS; PROTON CONDUCTANCE; OXIDATIVE STRESS; COMPLEX-I; DEHYDROGENASE; ANTIPORTER; EXPRESSION; GENERATION	In thermogenic brown adipose tissue, uncoupling protein 1 (UCP1) catalyzes the dissipation of mitochondrial proton motive force as heat. In a cellular environment of high oxidative capacity such as brown adipose tissue (BAT), mitochondrial uncoupling could also reduce deleterious reactive oxygen species, but the specific involvement of UCP1 in this process is disputed. By comparing brown adipose tissue mitochondria of wild type mice and UCP1-ablated litter mates, we show that UCP1 potently reduces mitochondrial superoxide production after cold acclimation and during fatty acid oxidation. We address the sites of superoxide production and suggest diminished probability of "reverse electron transport" facilitated by uncoupled respiration as the underlying mechanism of reactive oxygen species suppression in BAT. Furthermore, ablation of UCP1 represses the cold-stimulated increase of substrate oxidation normally seen in active BAT, resulting in lower superoxide production, presumably avoiding deleterious oxidative damage. We conclude that UCP1 allows high oxidative capacity without promoting oxidative damage by simultaneously lowering superoxide production.	[Oelkrug, Rebecca; Kutschke, Maria; Meyer, Carola W.; Heldmaier, Gerhard; Jastroch, Martin] Univ Marburg, Fac Biol, Dept Anim Physiol, D-35043 Marburg, Germany	Philipps University Marburg	Jastroch, M (corresponding author), Buck Inst Age Res, 8001 Redwood Blvd, Novato, CA 94945 USA.	mjastroch@buckinstitute.org	Heldmaier, Gerhard/AAI-3286-2020; Meyer, Carola/N-5874-2014; Jastroch, Martin/I-7494-2017	Meyer, Carola/0000-0001-7959-1218; 	Deutsche Forschungsgemeinschaft [HE 990/15-1, JA 1884/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants HE 990/15-1 (to G.H. and C.W.M.) and JA 1884/2-1.	ANDREYEV AY, 1988, FEBS LETT, V226, P265, DOI 10.1016/0014-5793(88)81436-4; ANDREYEV AY, 1989, EUR J BIOCHEM, V182, P585, DOI 10.1111/j.1432-1033.1989.tb14867.x; Aydin J, 2008, FASEB J, V22, P3919, DOI 10.1096/fj.08-113712; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; CANNON B, 1977, FEBS LETT, V76, P284, DOI 10.1016/0014-5793(77)80169-5; Couplan E, 2002, J BIOL CHEM, V277, P26268, DOI 10.1074/jbc.M202535200; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Drahota Z, 2002, J BIOENERG BIOMEMBR, V34, P105, DOI 10.1023/A:1015123908918; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Granneman JG, 2003, AM J PHYSIOL-ENDOC M, V285, pE1230, DOI 10.1152/ajpendo.00197.2003; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; HARMAN D, 1972, AM J CLIN NUTR, V25, P839; HELDMAIER G, 1990, SEASONAL ADAPTATION; HITTELMAN KJ, 1969, EUR J BIOCHEM, V11, P183, DOI 10.1111/j.1432-1033.1969.tb00759.x; Jastroch M, 2005, PHYSIOL GENOMICS, V22, P150, DOI 10.1152/physiolgenomics.00070.2005; Khailova LS, 2006, BBA-BIOENERGETICS, V1757, P1324, DOI 10.1016/j.bbabio.2006.04.024; Klingenspor M, 2003, EXP PHYSIOL, V88, P141, DOI 10.1113/eph8802508; Klingenspor M, 1996, BIOCHEM J, V316, P607, DOI 10.1042/bj3160607; Koza RA, 1996, ARCH BIOCHEM BIOPHYS, V336, P97, DOI 10.1006/abbi.1996.0536; Lambert AJ, 2008, FEBS LETT, V582, P1711, DOI 10.1016/j.febslet.2008.04.030; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; LOCKE RM, 1982, EUR J BIOCHEM, V129, P373, DOI 10.1111/j.1432-1033.1982.tb07060.x; Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846; Miwa S, 2005, BBA-BIOENERGETICS, V1709, P214, DOI 10.1016/j.bbabio.2005.08.003; Miwa S, 2003, FREE RADICAL BIO MED, V35, P938, DOI 10.1016/S0891-5849(03)00464-7; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Mzilikazi N, 2007, AM J PHYSIOL-REG I, V293, pR2120, DOI 10.1152/ajpregu.00427.2007; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; Raha S, 2001, AM J MED GENET, V106, P62, DOI 10.1002/ajmg.1398; RATNER PL, 1981, J BIOL CHEM, V256, P3576; REYNAFARJE B, 1985, ANAL BIOCHEM, V145, P406, DOI 10.1016/0003-2697(85)90381-1; RICHIERI GV, 1993, BIOCHEMISTRY-US, V32, P7574, DOI 10.1021/bi00080a032; ROTHWELL NJ, 1983, ADV NUTR RES, V5, P201; Rousset S, 2004, DIABETES, V53, pS130, DOI 10.2337/diabetes.53.2007.S130; Shabalina IG, 2006, J BIOL CHEM, V281, P13882, DOI 10.1074/jbc.M601387200; Silva JP, 2005, EMBO J, V24, P4061, DOI 10.1038/sj.emboj.7600866; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Ukropec J, 2006, J BIOL CHEM, V281, P31894, DOI 10.1074/jbc.M606114200; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Zhang L, 1998, J BIOL CHEM, V273, P33972, DOI 10.1074/jbc.273.51.33972	48	63	64	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					21961	21968		10.1074/jbc.M110.122861	http://dx.doi.org/10.1074/jbc.M110.122861			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20466728	Green Published, hybrid			2022-12-27	WOS:000279702200008
J	Yeom, J; Imlay, JA; Park, W				Yeom, Jinki; Imlay, James A.; Park, Woojun			Iron Homeostasis Affects Antibiotic-mediated Cell Death in Pseudomonas Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METALLO-BETA-LACTAMASE; OXIDATIVE STRESS; DNA-DAMAGE; RESISTANCE; AERUGINOSA; MEMBRANE; VIRULENCE	Antibiotics can induce cell death via a variety of action modes, including the inhibition of transcription, ribosomal function, and cell wall biosynthesis. In this study, we demonstrated directly that iron availability is important to the action of antibiotics, and the ferric reductases of Pseudomonas putida and Pseudomonas aeruginosa could accelerate antibiotic-mediated cell death by promoting the Fenton reaction. The modulation of reduced nicotinamide-adenine dinucleotide (NADH) levels and iron chelation affected the actions of antibiotics. Interestingly, the deletion of the ferric reductase gene confers more antibiotic resistance upon cells, and its overexpression accelerates antibiotic-mediated cell death. The results of transcriptome analysis showed that both Pseudomonas species induce many oxidative stress genes under antibiotic conditions, which could not be observed in ferric reductase mutants. Our results indicate that iron homeostasis is crucial for bacterial cell survival under antibiotics and should constitute a significant target for boosting the action of antibiotics.	[Imlay, James A.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Yeom, Jinki; Park, Woojun] Korea Univ, Div Environm Sci & Ecol Engn, Seoul 136713, South Korea	University of Illinois System; University of Illinois Urbana-Champaign; Korea University	Imlay, JA (corresponding author), Univ Illinois, Dept Microbiol, 131 Burrill Hall, Urbana, IL 61801 USA.	jimlay@illinois.edu; wpark@korea.ac.kr		Yeom, Jinki/0000-0002-5332-2658	MEST/NRF, South Korea [20090091491, 2009-0076488]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM049640] Funding Source: NIH RePORTER	MEST/NRF, South Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant 20090091491 from the MEST/NRF to the Environment Biotechnology National Core Research Center and Grant 2009-0076488 from the MEST/NRF program, South Korea.	Albesa I, 2004, BIOCHEM BIOPH RES CO, V317, P605, DOI 10.1016/j.bbrc.2004.03.085; Angrave FE, 2001, ANTIMICROB AGENTS CH, V45, P2939, DOI 10.1128/AAC.45.10.2939-2942.2001; Banerjee R., 2008, REDOX BIOCH; BEERS RF, 1952, J BIOL CHEM, V195, P133; Cabiscol E, 2002, J BIOL CHEM, V277, P44531, DOI 10.1074/jbc.M206525200; Cornelis Pierre, 2008, P213; Davies BW, 2009, MOL CELL, V36, P845, DOI 10.1016/j.molcel.2009.11.024; Docquier JD, 2003, ANTIMICROB AGENTS CH, V47, P1522, DOI 10.1128/AAC.47.5.1522-1528.2003; Dwyer DJ, 2009, CURR OPIN MICROBIOL, V12, P482, DOI 10.1016/j.mib.2009.06.018; ECKERT B, 1989, J BACTERIOL, V171, P3557, DOI 10.1128/JB.171.6.3557-3559.1989; Gomez MI, 2007, CURR OPIN PHARMACOL, V7, P244, DOI 10.1016/j.coph.2006.12.005; Gooderham WJ, 2009, FEMS MICROBIOL REV, V33, P279, DOI 10.1111/j.1574-6976.2008.00135.x; Hassett DJ, 2007, ACS CHEM BIOL, V2, P708, DOI 10.1021/cb700232k; Hernandez ME, 2001, CELL MOL LIFE SCI, V58, P1562, DOI 10.1007/PL00000796; HEYM B, 1992, RES MICROBIOL, V143, P721, DOI 10.1016/0923-2508(92)90067-X; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Jeannot K, 2008, ANTIMICROB AGENTS CH, V52, P2455, DOI 10.1128/AAC.01107-07; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; MICHEAHAMZEHPOUR M, 1991, ANTIMICROB AGENTS CH, V35, P2091, DOI 10.1128/AAC.35.10.2091; NORRIS MJ, 1985, LETT APPL MICROBIOL, V1, P3, DOI 10.1111/j.1472-765X.1985.tb01476.x; Page MGP, 2009, CURR OPIN PHARMACOL, V9, P558, DOI 10.1016/j.coph.2009.08.006; Perz JF, 2005, J CLIN MICROBIOL, V43, P5316, DOI 10.1128/JCM.43.10.5316-5318.2005; Poirel L, 2006, ANTIMICROB AGENTS CH, V50, P2889, DOI 10.1128/AAC.00398-06; Rolston KVI, 2005, DIAGN MICR INFEC DIS, V51, P215, DOI 10.1016/j.diagmicrobio.2004.11.002; Semenza GL, 1999, CELL, V98, P281, DOI 10.1016/S0092-8674(00)81957-1; Singh NP, 1999, MUTAT RES-FUND MOL M, V429, P159, DOI 10.1016/S0027-5107(99)00124-4; THOMAS CM, 1998, PSEUDOMONAS, P133; Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518; Wang XH, 2009, ANTIMICROB AGENTS CH, V53, P1395, DOI 10.1128/AAC.01087-08; Woodmansee AN, 2002, J BIOL CHEM, V277, P34055, DOI 10.1074/jbc.M203977200; Yeom J, 2009, J BIOCHEM, V145, P481, DOI 10.1093/jb/mvn185; Yeom J, 2009, J BACTERIOL, V191, P1472, DOI 10.1128/JB.01473-08	35	85	89	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22689	22695		10.1074/jbc.M110.127456	http://dx.doi.org/10.1074/jbc.M110.127456			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20479007	Green Published, hybrid			2022-12-27	WOS:000279702200079
J	Alibaud, L; Alahari, A; Trivelli, X; Ojha, AK; Hatfull, GF; Guerardel, Y; Kremer, L				Alibaud, Laeticia; Alahari, Anuradha; Trivelli, Xavier; Ojha, Anil K.; Hatfull, Graham F.; Guerardel, Yann; Kremer, Laurent			Temperature-dependent Regulation of Mycolic Acid Cyclopropanation in Saprophytic Mycobacteria ROLE OF THE MYCOBACTERIUM SMEGMATIS 1351 GENE (MSMEG_1351) IN CIS-CYCLOPROPANATION OF alpha-MYCOLATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBERCULOSIS; BIOSYNTHESIS; DRUG; GENE; VIRULENCE; METHYLTRANSFERASE; IDENTIFICATION; THIACETAZONE; ADAPTATION; SMEGMATIS	The cell envelope is a crucial determinant of virulence and drug resistance in Mycobacterium tuberculosis. Several features of pathogenesis and immunomodulation of host responses are attributable to the structural diversity in cell wall lipids, particularly in the mycolic acids. Structural modification of the alpha-mycolic acid by introduction of cyclopropane rings as catalyzed by the methyltransferase, PcaA, is essential for a lethal, persistent infection and the cording phenotype in M. tuberculosis. Here, we demonstrate the presence of cyclopropanated cell wall mycolates in the nonpathogenic strain Mycobacterium smegmatis and identify MSMEG_1351 as a gene encoding a PcaA homologue. Interestingly, alpha-mycolic acid cyclopropanation was inducible in cultures grown at 25 degrees C. The growth temperature modulation of the cyclopropanating activity was determined by high resolution magic angle spinning NMR analyses on whole cells. In parallel, quantitative reverse transcription-PCR analysis showed that MSMEG_1351 gene expression is up-regulated at 25 degrees C compared with 37 degrees C. An MSMEG_1351 knock-out strain of M. smegmatis, generated by recombineering, exhibited a deficiency in cyclopropanation of alpha-mycolates. The functional equivalence of PcaA and MSMEG_1351 was established by cross-complementation in the MSMEG_1351 knock-out mutant and also in a Delta pcaA strain of Mycobacterium bovis BCG. Overexpression of MSMEG_1351 restored the wild-type mycolic acid profile and the cording phenotype in BCG. Although the biological significance of mycolic acid cyclopropanation in nonpathogenic mycobacteria remains unclear, it likely represents a mechanism of adaptation of cell wall structure and composition to cope with environmental factors.	[Alibaud, Laeticia; Alahari, Anuradha; Kremer, Laurent] Univ Montpellier II & I, CNRS, Lab Dynam Interact Membranaires Normales & Pathol, UMR 5235, F-34095 Montpellier 05, France; [Kremer, Laurent] INSERM, F-34095 Montpellier 05, France; [Trivelli, Xavier; Guerardel, Yann] Univ Sci & Technol Lille, Unite Glycobiol Struct & Fonct, F-59650 Villeneuve Dascq, France; [Trivelli, Xavier; Guerardel, Yann] CNRS, UMR 8576, F-59650 Villeneuve Dascq, France; [Ojha, Anil K.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA 15260 USA; [Hatfull, Graham F.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Hatfull, Graham F.] Univ Pittsburgh, Pittsburgh Bacteriophage Inst, Pittsburgh, PA 15260 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kremer, L (corresponding author), Univ Montpellier II & I, CNRS, Lab Dynam Interact Membranaires Normales & Pathol, UMR 5235, Case 107,Pl Eugene Bataillon, F-34095 Montpellier 05, France.	laurent.kremer@univ-montp2.fr	Kremer, Laurent/M-4935-2017	Kremer, Laurent/0000-0002-6604-4458; Guerardel, Yann/0000-0003-4967-9512; Trivelli, Xavier/0000-0001-6775-9650	Tres Grands Equipements Resonnance Magnetique Nucleaire Tres Haut Champs [Fr3050]; CNRS; European Union (FEDER); Ministere Francais de l'Enseignement Superieur et de la Recherche; Region Nord-Pas de Calais; Universite Lille1-Sciences et Technologies	Tres Grands Equipements Resonnance Magnetique Nucleaire Tres Haut Champs; CNRS(Centre National de la Recherche Scientifique (CNRS)); European Union (FEDER)(European Commission); Ministere Francais de l'Enseignement Superieur et de la Recherche; Region Nord-Pas de Calais(Region Hauts-de-FranceEuropean Commission); Universite Lille1-Sciences et Technologies	This work was supported in part by Tres Grands Equipements Resonnance Magnetique Nucleaire Tres Haut Champs Fr3050.; Supported by a grant from the CNRS (Action Thematique Incitative sur Programme "Microbiologie Fondamentale").; We thank W. R. Jacobs and M. Glickman for the kind gift of BCG mc<SUP>2</SUP>2801. We also thank Christophe Biot for help in structural analyses and Benedicte Gauriat-Deroy from Thermo Fisher Scientific Electron for EI analyses of pyrolysis fragments. The 800 MHz NMR spectrometer was funded by European Union (FEDER), Ministere Francais de l'Enseignement Superieur et de la Recherche, Region Nord-Pas de Calais, Universite Lille1-Sciences et Technologies, and CNRS.	Alahari A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001343; Alahari A, 2009, MOL MICROBIOL, V71, P1263, DOI 10.1111/j.1365-2958.2009.06604.x; BABA T, 1989, J BIOCHEM-TOKYO, V106, P81, DOI 10.1093/oxfordjournals.jbchem.a122825; Barkan D, 2009, CHEM BIOL, V16, P499, DOI 10.1016/j.chembiol.2009.04.001; Barry CE, 1996, TRENDS MICROBIOL, V4, P275, DOI 10.1016/0966-842X(96)10031-7; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; Behr MA, 2000, J BACTERIOL, V182, P3394, DOI 10.1128/JB.182.12.3394-3399.2000; Bhowruth V, 2008, BIOCHEM SOC T, V36, P555, DOI 10.1042/BST0360555; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Cronan JE, 2002, CURR OPIN MICROBIOL, V5, P202, DOI 10.1016/S1369-5274(02)00297-7; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Dao DN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000081; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; GEORGE KM, 1995, J BIOL CHEM, V270, P27292, DOI 10.1074/jbc.270.45.27292; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Glickman MS, 2003, J BIOL CHEM, V278, P7844, DOI 10.1074/jbc.M212458200; Glickman MS, 2001, J BIOL CHEM, V276, P2228, DOI 10.1074/jbc.C000652200; Houben ENG, 2009, MOL MICROBIOL, V72, P41, DOI 10.1111/j.1365-2958.2009.06612.x; Huang CC, 2002, J BIOL CHEM, V277, P11559, DOI 10.1074/jbc.M111698200; Iivanainen E, 1999, J APPL MICROBIOL, V86, P673, DOI 10.1046/j.1365-2672.1999.00711.x; Kremer L, 2002, MICROBIOL-SGM, V148, P3145, DOI 10.1099/00221287-148-10-3145; Kremer L, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P173; Kremer L, 2002, BIOCHEM J, V363, P437, DOI 10.1042/0264-6021:3630437; LARSEN MH, 2007, CURR PROTOC MICROBIO, P1; Laval F, 2001, ANAL CHEM, V73, P4537, DOI 10.1021/ac0105181; Laval F, 2008, J BIOL CHEM, V283, P1419, DOI 10.1074/jbc.M708859200; Liu J, 1996, J BIOL CHEM, V271, P29545, DOI 10.1074/jbc.271.47.29545; LORIAN V, 1969, APPL MICROBIOL, V17, P559, DOI 10.1128/AEM.17.4.559-562.1969; Lutfalla G, 2006, METHOD ENZYMOL, V410, P386, DOI 10.1016/S0076-6879(06)10019-1; MINNIKIN DE, 1972, LIPIDS, V7, P398, DOI 10.1007/BF02531510; Mitchison DA, 2004, FRONT BIOSCI-LANDMRK, V9, P1059, DOI 10.2741/1293; Ojha A, 2005, CELL, V123, P861, DOI 10.1016/j.cell.2005.09.012; Ojha AK, 2008, MOL MICROBIOL, V69, P164, DOI 10.1111/j.1365-2958.2008.06274.x; Rao M, 2001, MICROBIOL-UK, V147, P1017, DOI 10.1099/00221287-147-4-1017; Rao V, 2005, J EXP MED, V201, P535, DOI 10.1084/jem.20041668; SINENSKY M, 1974, P NATL ACAD SCI USA, V71, P522, DOI 10.1073/pnas.71.2.522; Stratton HM, 2003, SYST APPL MICROBIOL, V26, P165, DOI 10.1078/072320203322345994; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; TOMIYASU I, 1982, J BACTERIOL, V151, P828, DOI 10.1128/JB.151.2.828-837.1982; TORIYAMA S, 1978, FEBS LETT, V95, P111, DOI 10.1016/0014-5793(78)80063-5; TORIYAMA S, 1980, J BIOCHEM-TOKYO, V88, P211; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; YUAN Y, 1995, P NATL ACAD SCI USA, V92, P6630, DOI 10.1073/pnas.92.14.6630; Yuan Y, 1996, P NATL ACAD SCI USA, V93, P12828, DOI 10.1073/pnas.93.23.12828; Zhang Y, 2006, DRUG DISCOV TODAY, V11, P21, DOI 10.1016/S1359-6446(05)03626-3	45	18	18	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21698	21707		10.1074/jbc.M110.125724	http://dx.doi.org/10.1074/jbc.M110.125724			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20457615	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000279516100057
J	George, EM; Izard, T; Anderson, SD; Brown, DT				George, Eric M.; Izard, Tina; Anderson, Stephen D.; Brown, David T.			Nucleosome Interaction Surface of Linker Histone H1c Is Distinct from That of H1(0)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-STRUCTURE; GLOBULAR DOMAIN; CRYSTAL-STRUCTURE; IN-VIVO; BINDING; DNA; LOCATION; FAMILY; FIBER; H5	The fully organized structure of the eukaryotic nucleosome remains unsolved, in part due to limited information regarding the binding site of the H1 or linker histone. The central globular domain of H1 is believed to interact with the nucleosome core at or near the dyad and to bind at least two strands of DNA. We utilized site-directed mutagenesis and in vivo photobleaching to identify residues that contribute to the binding of the globular domain of the somatic H1 subtype H1c to the nucleosome. As was previously observed for the H1(0) subtype, the binding residues for H1c are clustered on the surface of one face of the domain. Despite considerable structural conservation between the globular domains of these two subtypes, the locations of the binding sites identified for H1c are distinct from those of H1(0). We suggest that the globular domains of these two linker histone subtypes will bind to the nucleosome with distinct orientations that may contribute to higher order chromatin structure heterogeneity or to differences in dynamic interactions with other DNA or chromatin-binding proteins.	[George, Eric M.; Anderson, Stephen D.; Brown, David T.] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA; [Izard, Tina] Scripps Res Inst, Dept Canc Biol, Cell Adhes Lab, Jupiter, FL 33458 USA	University of Mississippi; University of Mississippi Medical Center; Scripps Research Institute	Brown, DT (corresponding author), Univ Mississippi, Med Ctr, Dept Biochem, 2500 N State St, Jackson, MS 39216 USA.	dbrown@umc.edu	George, Eric/ABE-2767-2020	George, Eric/0000-0002-6622-7369	Mississippi Functional Genomics Network, National Institutes of Health [RR016476]; National Center for Research Resources; National Science Foundation [MCB0235800]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016476] Funding Source: NIH RePORTER	Mississippi Functional Genomics Network, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant RR016476 from the Mississippi Functional Genomics Network, IDeA Networks of Biomedical Research Excellence Program of the National Center for Research Resources. This work was also supported by National Science Foundation Grant MCB0235800 (to D. T. B.).	ALLAN J, 1986, J MOL BIOL, V187, P591, DOI 10.1016/0022-2836(86)90337-2; ALLAN J, 1980, NATURE, V288, P675, DOI 10.1038/288675a0; Becker M, 2005, MOL BIOL CELL, V16, P3887, DOI 10.1091/mbc.E05-04-0350; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; Brown DT, 2006, NAT STRUCT MOL BIOL, V13, P250, DOI 10.1038/nsmb1050; Brown DT, 2003, BIOCHEM CELL BIOL, V81, P221, DOI 10.1139/o03-049; Brown DT, 1996, NUCLEIC ACIDS RES, V24, P486, DOI 10.1093/nar/24.3.486; Brown DT, 1997, NUCLEIC ACIDS RES, V25, P5003, DOI 10.1093/nar/25.24.5003; Catez F, 2006, NAT STRUCT MOL BIOL, V13, P305, DOI 10.1038/nsmb1077; Catez F, 2004, MOL CELL BIOL, V24, P4321, DOI 10.1128/MCB.24.10.4321-4328.2004; CERF C, 1994, BIOCHEMISTRY-US, V33, P11079, DOI 10.1021/bi00203a004; Cirillo LA, 1998, EMBO J, V17, P244, DOI 10.1093/emboj/17.1.244; CLARK DJ, 1990, J MOL BIOL, V211, P883, DOI 10.1016/0022-2836(90)90081-V; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Clausell J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007243; COLE RD, 1987, INT J PEPT PROT RES, V30, P433; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Duggan MM, 2000, J MOL BIOL, V304, P21, DOI 10.1006/jmbi.2000.4205; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; FINCH JT, 1976, P NATL ACAD SCI USA, V73, P1897, DOI 10.1073/pnas.73.6.1897; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; Grigoryev SA, 2009, P NATL ACAD SCI USA, V106, P13317, DOI 10.1073/pnas.0903280106; Haab BB, 2001, GENOME BIOL, V2; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; HOROWITZ RA, 1994, J CELL BIOL, V125, P1, DOI 10.1083/jcb.125.1.1; Izzo A, 2008, BIOL CHEM, V389, P333, DOI 10.1515/BC.2008.037; Kepper N, 2008, BIOPHYS J, V95, P3692, DOI 10.1529/biophysj.107.121079; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MCBRYANT SJ, 2010, CELL RES, DOI DOI 10.1038/CR2010.35; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Nikitina T, 2007, J BIOL CHEM, V282, P28237, DOI 10.1074/jbc.M704304200; NOLL M, 1977, J MOL BIOL, V109, P393, DOI 10.1016/S0022-2836(77)80019-3; Parseghian MH, 2001, BIOCHEM CELL BIOL, V79, P289; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Ramakrishnan V, 1997, CRIT REV EUKAR GENE, V7, P215, DOI 10.1615/CritRevEukarGeneExpr.v7.i3.20; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; Robinson PJJ, 2006, CURR OPIN STRUC BIOL, V16, P336, DOI 10.1016/j.sbi.2006.05.007; Routh A, 2008, P NATL ACAD SCI USA, V105, P8872, DOI 10.1073/pnas.0802336105; Sancho M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000227; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; SIMPSON RT, 1978, BIOCHEMISTRY-US, V17, P5524, DOI 10.1021/bi00618a030; STAYNOV DZ, 1988, EMBO J, V7, P3685, DOI 10.1002/j.1460-2075.1988.tb03250.x; Th'ng JPH, 2005, J BIOL CHEM, V280, P27809, DOI 10.1074/jbc.M501627200; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; THOMAS H, 1999, ENTREP REGION DEV, V11, P317; Travers A, 1999, TRENDS BIOCHEM SCI, V24, P4, DOI 10.1016/S0968-0004(98)01339-5; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; van Holde KE., 1989, SPRINGER SERIES MOL; Wolffe A., 1998, CHROMATIN STRUCTURE; Woodcock CL, 2006, CURR OPIN STRUC BIOL, V16, P213, DOI 10.1016/j.sbi.2006.02.005; Woodcock CL, 2005, NAT STRUCT MOL BIOL, V12, P639, DOI 10.1038/nsmb0805-639; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Yellajoshyula D, 2006, P NATL ACAD SCI USA, V103, P18568, DOI 10.1073/pnas.0606478103; Zhou YB, 1998, NATURE, V395, P402, DOI 10.1038/26521; Zlatanova J, 2008, TRENDS BIOCHEM SCI, V33, P247, DOI 10.1016/j.tibs.2008.04.001	56	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20891	20896		10.1074/jbc.M110.108639	http://dx.doi.org/10.1074/jbc.M110.108639			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20444700	Green Published, hybrid			2022-12-27	WOS:000279228600053
J	Krejci, P; Murakami, S; Prochazkova, J; Trantirek, L; Chlebova, K; Ouyang, ZF; Aklian, A; Smutny, J; Bryja, V; Kozubik, A; Wilcox, WR				Krejci, Pavel; Murakami, Shunichi; Prochazkova, Jirina; Trantirek, Lukas; Chlebova, Katarina; Ouyang, Zhufeng; Aklian, Anie; Smutny, Jiri; Bryja, Vitezslav; Kozubik, Alois; Wilcox, William R.			NF449 Is a Novel Inhibitor of Fibroblast Growth Factor Receptor 3 (FGFR3) Signaling Active in Chondrocytes and Multiple Myeloma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERK MAP KINASE; ACTIVATING MUTATIONS; PROLIFERATION; SURAMIN; PATHWAY; DIFFERENTIATION; ACHONDROPLASIA; ASSOCIATION; ANTAGONIST; EXPRESSION	The FGFR3 receptor tyrosine kinase represents an attractive target for therapy due to its role in several human disorders, including skeletal dysplasias, multiple myeloma, and cervical and bladder carcinomas. By using molecular library screening, we identified a compound named NF449 with inhibitory activity toward FGFR3 signaling. In cultured chondrocytes and murine limb organ culture, NF449 rescued FGFR3-mediated extracellular matrix loss and growth inhibition, which represent two major cellular phenotypes of aberrant FGFR3 signaling in cartilage. Similarly, NF449 antagonized FGFR3 action in the multiple myeloma cell lines OPM2 and KMS11, as evidenced by NF449-mediated reversal of ERK MAPK activation and transcript accumulation of CCL3 and CCL4 chemokines, both of which are induced by FGFR3 activation. In cell-free kinase assays, NF449 inhibited the kinase activity of both wild type and a disease-associated FGFR3 mutant (K650E) in a fashion that appeared non-competitive with ATP. Our data identify NF449 as a novel antagonist of FGFR3 signaling, useful for FGFR3 inhibition alone or in combination with inhibitors that target the ATP binding site.	[Krejci, Pavel; Aklian, Anie; Wilcox, William R.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Krejci, Pavel; Prochazkova, Jirina; Chlebova, Katarina; Smutny, Jiri; Bryja, Vitezslav; Kozubik, Alois] Masaryk Univ, Inst Expt Biol, Dept Anim Physiol & Immunol, CS-61137 Brno, Czech Republic; [Krejci, Pavel; Bryja, Vitezslav; Kozubik, Alois] Acad Sci Czech Republic, Inst Biophys, Dept Cytokinet, CS-61265 Brno, Czech Republic; [Murakami, Shunichi; Ouyang, Zhufeng] Case Western Reserve Univ, Dept Orthopaed, Cleveland, OH 44106 USA; [Trantirek, Lukas] Univ Utrecht, Dept Chem, NL-3584 CH Utrecht, Netherlands; [Wilcox, William R.] UCLA Sch Med, Dept Pediat, Los Angeles, CA 90095 USA	Cedars Sinai Medical Center; Masaryk University Brno; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Case Western Reserve University; Utrecht University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Krejci, P (corresponding author), Cedars Sinai Med Ctr, Inst Med Genet, 8727 W 3rd St,Rm 203, Los Angeles, CA 90048 USA.	pavel.krejci@cshs.org	Medalova, Jirina/D-7528-2012; Bryja, Vít?zslav/H-1925-2014; Krejčí, Pavel/I-4285-2014; Trantirek, Lukas/F-9923-2014; Kozubík, Alois/H-1954-2014; Bryja, Vítězslav/P-4217-2019	Bryja, Vít?zslav/0000-0002-9136-5085; Bryja, Vítězslav/0000-0002-9136-5085; Krejci, Pavel/0000-0003-0618-9134	National Institutes of Health [5P01HD022657-21A, 1R01AR055556-01A209]; Multiple Myeloma Research Foundation; Ministry of Education, Youth, and Sports of the Czech Republic [MSM0021622430]; Grant Agency of the Czech Republic [301/09/0587, 204/09/H058]; Academy of Sciences of the Czech Republic [AVOZ50040507, AVOZ50040702]; Winnick Family Research Scholars Award; European Molecular Biology Organization; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE017406] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multiple Myeloma Research Foundation; Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Winnick Family Research Scholars Award; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants 5P01HD022657-21A and 1R01AR055556-01A209 (to S. M.). This work was also supported by the Multiple Myeloma Research Foundation; Ministry of Education, Youth, and Sports of the Czech Republic Grant MSM0021622430; Grant Agency of the Czech Republic Grants 301/09/0587 and 204/09/H058; Academy of Sciences of the Czech Republic Grants AVOZ50040507 and AVOZ50040702; a Winnick Family Research Scholars Award (to W. R. W.); and a European Molecular Biology Organization Installation Grant (to V. B.).	Aikawa T, 2001, J BIOL CHEM, V276, P29347, DOI 10.1074/jbc.M101859200; Aviezer D, 2003, CURR DRUG TARGETS, V4, P353, DOI 10.2174/1389450033490993; Braun K, 2001, N-S ARCH PHARMACOL, V364, P285, DOI 10.1007/s002100100463; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; Chesi M, 1997, NAT GENET, V16, P260, DOI 10.1038/ng0797-260; Dailey L, 2003, J CELL BIOL, V161, P1053, DOI 10.1083/jcb.200302075; FIRSCHING A, 1995, CANCER RES, V55, P4957; Goriely A, 2009, NAT GENET, V41, P1247, DOI 10.1038/ng.470; Guzman-Aranguez A, 2008, EUR J PHARMACOL, V584, P72, DOI 10.1016/j.ejphar.2008.02.002; Hafner C, 2010, BRIT J DERMATOL, V162, P508, DOI 10.1111/j.1365-2133.2009.09488.x; Hafner C, 2006, J CLIN INVEST, V116, P2201, DOI 10.1172/JCI28163; Hausmann R, 2006, MOL PHARMACOL, V69, P2058, DOI 10.1124/mol.106.022665; Hernandez S, 2009, MODERN PATHOL, V22, P848, DOI 10.1038/modpathol.2009.46; Hohenegger M, 1998, P NATL ACAD SCI USA, V95, P346, DOI 10.1073/pnas.95.1.346; Intini D, 2001, BRIT J HAEMATOL, V114, P362, DOI 10.1046/j.1365-2141.2001.02957.x; Kassack MU, 2004, EUR J MED CHEM, V39, P345, DOI 10.1016/j.ejmech.2004.01.007; Kathir KM, 2006, BIOCHEMISTRY-US, V45, P899, DOI 10.1021/bi051389b; Krejci P, 2006, LEUKEMIA, V20, P1165, DOI 10.1038/sj.leu.2404202; Krejci P, 2005, J CELL SCI, V118, P5089, DOI 10.1242/jcs.02618; Krejci P, 2004, EXP CELL RES, V297, P152, DOI 10.1016/j.yexcr.2004.03.011; Krejci P, 2008, J CELL SCI, V121, P272, DOI 10.1242/jcs.017160; Krejci P, 2007, INVEST NEW DRUG, V25, P391, DOI 10.1007/s10637-007-9054-7; Krejci P, 2007, J BIOL CHEM, V282, P2929, DOI 10.1074/jbc.M606144200; L'Hote CGM, 2005, EXP CELL RES, V304, P417, DOI 10.1016/j.yexcr.2004.11.012; Lozano RM, 1998, J MOL BIOL, V281, P899, DOI 10.1006/jmbi.1998.1977; Manetti F, 2000, CURR PHARM DESIGN, V6, P1897, DOI 10.2174/1381612003398528; Masih-Khan E, 2006, BLOOD, V108, P3465, DOI 10.1182/blood-2006-04-017087; Meyer AN, 2008, CANCER RES, V68, P7362, DOI 10.1158/0008-5472.CAN-08-0575; Mohammadi M, 2005, CURR OPIN STRUC BIOL, V15, P506, DOI 10.1016/j.sbi.2005.09.002; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Muenke M, 1997, AM J HUM GENET, V60, P555; Passos-Bueno MR, 1999, HUM MUTAT, V14, P115; Plowright EE, 2000, BLOOD, V95, P992, DOI 10.1182/blood.V95.3.992.003k29_992_998; Qing J, 2009, J CLIN INVEST, V119, P1216, DOI 10.1172/JCI38017; Ronchetti D, 2001, ONCOGENE, V20, P3553, DOI 10.1038/sj.onc.1204465; Sahni M, 1999, GENE DEV, V13, P1361, DOI 10.1101/gad.13.11.1361; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Sola F, 1999, CANCER CHEMOTH PHARM, V43, P241, DOI 10.1007/s002800050890; Soto F, 1999, NEUROPHARMACOLOGY, V38, P141, DOI 10.1016/S0028-3908(98)00158-0; Yasoda A, 2004, NAT MED, V10, P80, DOI 10.1038/nm971; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Yeh BK, 2002, MOL CELL BIOL, V22, P7184, DOI 10.1128/MCB.22.20.7184-7192.2002; Zamai M, 2002, BIOPHYS J, V82, P2652, DOI 10.1016/S0006-3495(02)75607-5	43	33	57	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20644	20653		10.1074/jbc.M109.083626	http://dx.doi.org/10.1074/jbc.M109.083626			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20439987	Green Published, hybrid			2022-12-27	WOS:000279228600028
J	Yoshida, T; Gan, QO; Franke, AS; Ho, RY; Zhang, JF; Chen, YE; Hayashi, M; Majesky, MW; Somlyo, AV; Owens, GK				Yoshida, Tadashi; Gan, Qiong; Franke, Aaron S.; Ho, Ruoya; Zhang, Jifeng; Chen, Y. Eugene; Hayashi, Matsuhiko; Majesky, Mark W.; Somlyo, Avril V.; Owens, Gary K.			Smooth and Cardiac Muscle-selective Knock-out of Kruppel-like Factor 4 Causes Postnatal Death and Growth Retardation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL DIFFERENTIATION MARKERS; PLURIPOTENT STEM-CELLS; IN-VIVO; OXIDIZED PHOSPHOLIPIDS; CONDITIONAL DELETION; GOBLET CELLS; ALPHA-ACTIN; TRANSCRIPTION; KLF4; KRUPPEL-LIKE-FACTOR-4	Kruppel-like factor 4 (Klf4) is a transcription factor involved in differentiation and proliferation in multiple tissues. We demonstrated previously that tamoxifen-induced deletion of the Klf4 gene in mice accelerated neointimal formation but delayed down-regulation of smooth muscle cell differentiation markers in carotid arteries following injury. To further determine the role of Klf4 in the cardiovascular system, we herein derived mice deficient for the Klf4 gene in smooth and cardiac muscle using the SM22 alpha promoter (SM22 alpha-CreKI(+)/Klf4(loxP/loxP) mice). SM22 alpha-CreKI(+)/Klf4(loxP/loxP) mice were born at the expected Mendelian ratio, but they gradually died after birth. Although similar to 40% of SM22 alpha-CreKI(+)/Klf4(loxP/loxP) mice survived beyond postnatal day 28, they exhibited marked growth retardation. In wild-type mice, Klf4 was expressed in the heart from late embryonic development through adulthood, whereas it was not expressed in smooth muscle. No changes were observed in morphology or expression of smooth muscle cell differentiation markers in vessels of SM22 alpha-CreKI(+)/Klf4(loxP/loxP) mice. Of interest, cardiac output was significantly decreased in SM22 alpha-CreKI(+)/Klf4(loxP/loxP) mice, as determined by magnetic resonance imaging. Moreover, a lack of Klf4 in the heart resulted in the reduction in expression of multiple cardiac genes, including Gata4. In vivo chromatin immunoprecipitation assays on the heart revealed that Klf4 bound to the promoter region of the Gata4 gene. Results provide novel evidence that Klf4 plays a key role in late fetal and/or postnatal cardiac development.	[Yoshida, Tadashi; Hayashi, Matsuhiko] Keio Univ, Apheresis & Dialysis Ctr, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan; [Somlyo, Avril V.; Owens, Gary K.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Zhang, Jifeng; Chen, Y. Eugene] Univ Michigan, Ctr Cardiovasc, Dept Internal Med, Med Ctr, Ann Arbor, MI 48109 USA; [Majesky, Mark W.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Majesky, Mark W.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA	Keio University; University of Virginia; University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Yoshida, T (corresponding author), Keio Univ, Apheresis & Dialysis Ctr, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan.	tayoshida-npr@umin.ac.jp	Hayashi, Matsuhiko/J-4748-2013		National Institutes of Health [P01HL19242, R01HL38854, R01HL57353]; American Heart Association [0635253N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093594, R01HL038854, P01HL019242, R01HL057353] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01HL19242, R01HL38854, and R01HL57353 (to G. K. O.). This work was also supported by American Heart Association National Scientist Development Grant 0635253N (to T. Y.)	Adam PJ, 2000, J BIOL CHEM, V275, P37798, DOI 10.1074/jbc.M006323200; BRAUNWALD E, 1997, HEART DIS ATEXTBOOK; Chen XM, 2003, J MOL BIOL, V326, P665, DOI 10.1016/S0022-2836(02)01449-3; Chen XM, 2001, J BIOL CHEM, V276, P30423, DOI 10.1074/jbc.M101194200; Feinberg MW, 2005, J BIOL CHEM, V280, P38247, DOI 10.1074/jbc.M509378200; Guittot SM, 2007, BIOL REPROD, V76, P85, DOI 10.1095/biolreprod.106.055137; Hamik A, 2007, J BIOL CHEM, V282, P13769, DOI 10.1074/jbc.M700078200; Heicklen-Klein A, 2004, DEV BIOL, V267, P490, DOI 10.1016/j.ydbio.2003.09.042; Hendrix JA, 2005, J CLIN INVEST, V115, P418, DOI 10.1172/JCI200522648; Isbell DC, 2007, AM J PHYSIOL-HEART C, V293, pH3372, DOI 10.1152/ajpheart.00997.2007; JONES AW, 1973, J PHYSIOL-LONDON, V232, P247, DOI 10.1113/jphysiol.1973.sp010268; Katz JP, 2005, GASTROENTEROLOGY, V128, P935, DOI 10.1053/j.gastro.2005.02.022; Katz JP, 2002, DEVELOPMENT, V129, P2619; Li L, 1996, CIRC RES, V78, P188, DOI 10.1161/01.RES.78.2.188; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Liu Y, 2003, J BIOL CHEM, V278, P48004, DOI 10.1074/jbc.M301902200; Ohara Y, 2006, BIOL PHARM BULL, V29, P410, DOI 10.1248/bpb.29.410; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Passman JN, 2008, P NATL ACAD SCI USA, V105, P9349, DOI 10.1073/pnas.0711382105; Peterkin T, 2005, SEMIN CELL DEV BIOL, V16, P83, DOI 10.1016/j.semcdb.2004.10.003; Pidkovka NA, 2007, CIRC RES, V101, P792, DOI 10.1161/CIRCRESAHA.107.152736; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shang YT, 2008, J CELL BIOL, V181, P461, DOI 10.1083/jcb.200711145; Shields JM, 1998, NUCLEIC ACIDS RES, V26, P796, DOI 10.1093/nar/26.3.796; SOMLYO AP, 1974, J CELL BIOL, V61, P723, DOI 10.1083/jcb.61.3.723; Swamynathan SK, 2007, MOL CELL BIOL, V27, P182, DOI 10.1128/MCB.00846-06; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Yoshida T, 2005, CIRC RES, V96, P280, DOI 10.1161/01.RES.0000155951.62152.2e; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Yoshida T, 2008, CIRC RES, V102, P1548, DOI 10.1161/CIRCRESAHA.108.176974; Yoshida T, 2008, AM J PHYSIOL-CELL PH, V295, pC1175, DOI 10.1152/ajpcell.00288.2008; Zhang JF, 2006, ARTERIOSCL THROM VAS, V26, pE23, DOI 10.1161/01.ATV.0000202661.61837.93; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200	36	29	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21175	21184		10.1074/jbc.M110.112482	http://dx.doi.org/10.1074/jbc.M110.112482			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20439457	Green Published, hybrid			2022-12-27	WOS:000279228600080
J	Stemmler, TL; Lesuisse, E; Pain, D; Dancis, A				Stemmler, Timothy L.; Lesuisse, Emmanuel; Pain, Debkumar; Dancis, Andrew			Frataxin and Mitochondrial FeS Cluster Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							IRON-SULFUR PROTEINS; YEAST FRATAXIN; FRIEDREICH-ATAXIA; BACTERIAL FRATAXIN; PROCESSING PEPTIDASE; BINDING-PROPERTIES; ESCHERICHIA-COLI; 2FE-2S CLUSTERS; HOMOLOG YFH1; IN-VIVO	Friedreich ataxia is an inherited neurodegenerative disease caused by frataxin deficiency. Frataxin is a conserved mitochondrial protein that plays a role in FeS cluster assembly in mitochondria. FeS clusters are modular cofactors that perform essential functions throughout the cell. They are synthesized by a multistep and multisubunit mitochondrial machinery that includes the scaffold protein Isu for assembling a protein-bound FeS cluster intermediate. Frataxin interacts with Isu, iron, and the cysteine desulfurase Nfs1, which supplies sulfide, thus placing it at the center of mitochondrial FeS cluster biosynthesis.	[Dancis, Andrew] Univ Penn, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA; [Stemmler, Timothy L.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; [Lesuisse, Emmanuel] Univ Paris Diderot, CNRS, Inst Jacques Monod, Lab Mitochondrie Metaux & Stress Oxydant, F-75205 Paris, France; [Pain, Debkumar] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07101 USA	University of Pennsylvania; Wayne State University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Rutgers State University New Brunswick; Rutgers State University Medical Center	Dancis, A (corresponding author), Univ Penn, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA.	adancis@mail.med.upenn.edu		Stemmler, Timothy/0000-0002-6298-088X	National Institutes of Health [DK068139, AG030504, R37DK053953]; Association Francaise de l'Ataxie de Friedreich; American Heart Association [09GRNT2260364]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK053953, R01DK068139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030504] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Association Francaise de l'Ataxie de Friedreich; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants DK068139 (to T. L. S.), AG030504 (to D. P.), and R37DK053953 (to A. D.). This work was also supported by an Association Francaise de l'Ataxie de Friedreich grant (to E. L.) and American Heart Association Grant 09GRNT2260364 (to D. P.). This is the second article in the Thematic Mini-review Series on Metals in Biology 2010. This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Adinolfi S, 2004, BIOCHEMISTRY-US, V43, P6511, DOI 10.1021/bi036049+; Adinolfi S, 2002, HUM MOL GENET, V11, P1865, DOI 10.1093/hmg/11.16.1865; Adinolfi S, 2009, NAT STRUCT MOL BIOL, V16, P390, DOI 10.1038/nsmb.1579; Aloria K, 2004, EMBO REP, V5, P1096, DOI 10.1038/sj.embor.7400272; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Bandyopadhyay S, 2008, BIOCHEM SOC T, V36, P1112, DOI 10.1042/BST0361112; Bencze KZ, 2006, CRIT REV BIOCHEM MOL, V41, P269, DOI 10.1080/10409230600846058; Bou-Abdallah F, 2004, J MOL BIOL, V341, P605, DOI 10.1016/j.jmb.2004.05.072; Branda SS, 1999, J BIOL CHEM, V274, P22763, DOI 10.1074/jbc.274.32.22763; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Bulteau AL, 2007, FREE RADICAL BIO MED, V42, P1561, DOI 10.1016/j.freeradbiomed.2007.02.014; Calmels N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006379; Campanella A, 2004, HUM MOL GENET, V13, P2279, DOI 10.1093/hmg/ddh232; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Chen OS, 2002, P NATL ACAD SCI USA, V99, P12321, DOI 10.1073/pnas.192449599; Condo I, 2010, HUM MOL GENET, V19, P1221, DOI 10.1093/hmg/ddp592; Cook JD, 2006, BIOCHEMISTRY-US, V45, P7767, DOI 10.1021/bi060424r; Correia AR, 2010, BIOCHEM J, V426, P197, DOI 10.1042/BJ20091612; Dhe-Paganon S, 2000, J BIOL CHEM, V275, P30753, DOI 10.1074/jbc.C000407200; Dolezal P, 2007, EUKARYOT CELL, V6, P1431, DOI 10.1128/EC.00027-07; Dutkiewicz R, 2004, J BIOL CHEM, V279, P29167, DOI 10.1074/jbc.M402947200; Dutkiewicz R, 2003, J BIOL CHEM, V278, P29719, DOI 10.1074/jbc.M303527200; Foury F, 1999, FEBS LETT, V456, P281, DOI 10.1016/S0014-5793(99)00961-8; Foury F, 2007, EMBO REP, V8, P194, DOI 10.1038/sj.embor.7400881; Frazzon J, 2002, BIOCHEM SOC T, V30, P680, DOI 10.1042/BST0300680; Gakh O, 2006, HUM MOL GENET, V15, P467, DOI 10.1093/hmg/ddi461; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; Gibson TJ, 1996, TRENDS NEUROSCI, V19, P465, DOI 10.1016/S0166-2236(96)20054-2; Goldberg AV, 2008, NATURE, V452, P624, DOI 10.1038/nature06606; Goncalves S, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-20; Gonzalez-Cabo P, 2005, HUM MOL GENET, V14, P2091, DOI 10.1093/hmg/ddi214; Gordon DM, 1999, HUM MOL GENET, V8, P2255, DOI 10.1093/hmg/8.12.2255; He YN, 2004, BIOCHEMISTRY-US, V43, P16254, DOI 10.1021/bi0488193; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kakhlon O, 2008, BLOOD, V112, P5219, DOI 10.1182/blood-2008-06-161919; Kondapalli KC, 2008, BIOCHEMISTRY-US, V47, P6917, DOI 10.1021/bi800366d; Lange H, 2000, P NATL ACAD SCI USA, V97, P1050, DOI 10.1073/pnas.97.3.1050; Layer G, 2006, J BIOL CHEM, V281, P16256, DOI 10.1074/jbc.M513569200; Leidgens S, 2010, HUM MOL GENET, V19, P276, DOI 10.1093/hmg/ddp495; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Li KY, 2008, HUM MOL GENET, V17, P2265, DOI 10.1093/hmg/ddn127; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012; Muhlenhoff U, 2003, J BIOL CHEM, V278, P40612, DOI 10.1074/jbc.M307847200; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Nair M, 2004, STRUCTURE, V12, P2037, DOI 10.1016/j.str.2004.08.012; Naranuntarat A, 2009, J BIOL CHEM, V284, P22633, DOI 10.1074/jbc.M109.026773; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; Olsson A, 2008, HUM MOL GENET, V17, P1666, DOI 10.1093/hmg/ddn057; Pandolfo M, 2009, J NEUROL, V256, P3, DOI 10.1007/s00415-009-1002-3; Pastore C, 2007, FEBS J, V274, P4199, DOI 10.1111/j.1742-4658.2007.05946.x; Pierik AJ, 2009, NAT PROTOC, V4, P753, DOI 10.1038/nprot.2009.39; Radisky DC, 1999, J BIOL CHEM, V274, P4497, DOI 10.1074/jbc.274.8.4497; Ramazzotti A, 2004, FEBS LETT, V557, P215, DOI 10.1016/S0014-5793(03)01498-4; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Schilke B, 2006, CURR BIOL, V16, P1660, DOI 10.1016/j.cub.2006.06.069; Wang T, 2008, J BIOL CHEM, V283, P12674, DOI 10.1074/jbc.M800399200; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Wilson RB, 1997, NAT GENET, V16, P352, DOI 10.1038/ng0897-352; Yang M, 2006, EMBO J, V25, P1775, DOI 10.1038/sj.emboj.7601064; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i; Zhang Y, 2006, J BIOL CHEM, V281, P22493, DOI 10.1074/jbc.M604246200	68	124	131	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26737	26743		10.1074/jbc.R110.118679	http://dx.doi.org/10.1074/jbc.R110.118679			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20522547	hybrid, Green Submitted, Green Published			2022-12-27	WOS:000281172700003
J	Huang, YT; Liu, TH; Chen, YW; Lee, CH; Chen, HH; Huang, TW; Hsu, SH; Lin, SM; Pan, YJ; Lee, CH; Hsu, IC; Tseng, FG; Fu, CC; Pan, RL				Huang, Yun-Tzu; Liu, Tseng-Huang; Chen, Yen-Wei; Lee, Chien-Hsien; Chen, Hsueh-Hua; Huang, Tsu-Wei; Hsu, Shen-Hsing; Lin, Shih-Ming; Pan, Yih-Jiuan; Lee, Ching-Hung; Hsu, Ian C.; Tseng, Fan-Gang; Fu, Chien-Chung; Pan, Rong-Long			Distance Variations between Active Sites of H+-Pyrophosphatase Determined by Fluorescence Resonance Energy Transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUMPING INORGANIC PYROPHOSPHATASE; ATOMIC-FORCE MICROSCOPY; C-TERMINAL DOMAIN; EVOLUTIONARY CONSERVATION; RADIATION-INACTIVATION; CONFORMATIONAL-CHANGES; MUTAGENESIS; RESIDUES; PURIFICATION; BIOMOLECULES	Homodimeric H+-pyrophosphatase (H+-PPase; EC 3.6.1.1) is a unique enzyme playing a pivotal physiological role in pH homeostasis of organisms. This novel H+-PPase supplies energy at the expense of hydrolyzing metabolic byproduct, pyrophosphate (PPi), for H+ translocation across membrane. The functional unit for the translocation is considered to be a homodimer. Its putative active site on each subunit consists of PPi binding motif, Acidic I and II motifs, and several essential residues. In this investigation structural mapping of these vital regions was primarily determined utilizing single molecule fluorescence resonance energy transfer. Distances between two C termini and also two N termini on homodimeric subunits of H+-PPase are 49.3 +/- 4.0 and 67.2 +/- 5.7 angstrom, respectively. Furthermore, putative PPi binding motifs on individual subunits are found to be relatively far away from each other (70.8 +/- 4.8 angstrom), whereas binding of potassium and substrate analogue led them to closer proximity. Moreover, substrate analogue but not potassium elicits significant distance variations between two Acidic I motifs and two His-622 residues on homodimeric subunits. Taken together, this study provides the first quantitative measurements of distances between various essential motifs, residues, and putative active sites on homodimeric subunits of H+-PPase. A working model is accordingly proposed elucidating the distance variations of dimeric H+-PPase upon substrate binding.	[Huang, Yun-Tzu; Liu, Tseng-Huang; Chen, Yen-Wei; Lee, Chien-Hsien; Hsu, Shen-Hsing; Lin, Shih-Ming; Pan, Yih-Jiuan; Lee, Ching-Hung; Pan, Rong-Long] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 30013, Taiwan; [Huang, Yun-Tzu; Liu, Tseng-Huang; Chen, Yen-Wei; Lee, Chien-Hsien; Hsu, Shen-Hsing; Lin, Shih-Ming; Pan, Yih-Jiuan; Lee, Ching-Hung; Pan, Rong-Long] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Coll Life Sci, Hsinchu 30013, Taiwan; [Chen, Hsueh-Hua; Hsu, Ian C.] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu 30013, Taiwan; [Huang, Tsu-Wei; Tseng, Fan-Gang] Natl Tsing Hua Univ, Dept Engn & Syst Sci, Hsinchu 30013, Taiwan; [Fu, Chien-Chung] Natl Tsing Hua Univ, Inst Nano Engn & Microsyst, Hsinchu 30013, Taiwan	National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; National Tsing Hua University	Pan, RL (corresponding author), Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 30013, Taiwan.	rlpan@life.nthu.edu.tw	Fu, ChienChung/E-6137-2013	Tseng, Fan-Gang/0000-0001-7654-6905; Huang, Tsu-Wei/0000-0002-9982-7248	National Science Council, Republic of China [NSC 98-2627-M-007-002, NSC 98-2627-M-007-001, 97-2311-B-007-003-MY3, NSC 98-2627-M-007-003, NSC-98-2627-M-007-004]	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council, Republic of China Grants NSC 98-2627-M-007-002, NSC 98-2627-M-007-001, and 97-2311-B-007-003-MY3 (to R.-L.P.), NSC 98-2627-M-007-003 (to F.-G.T.), and NSC-98-2627-M-007-004 (to C.-C.F.).	Baltscheffsky M, 1999, FEBS LETT, V452, P121, DOI 10.1016/S0014-5793(99)00617-1; Clerc S, 1998, ANAL BIOCHEM, V259, P104, DOI 10.1006/abio.1998.2639; COOPERMAN BS, 1992, TRENDS BIOCHEM SCI, V17, P262, DOI 10.1016/0968-0004(92)90406-Y; Drozdowicz YM, 2001, TRENDS PLANT SCI, V6, P206, DOI 10.1016/S1360-1385(01)01923-9; EDSTROM RD, 1990, BIOPHYS J, V58, P1437, DOI 10.1016/S0006-3495(90)82489-9; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Gaxiola RA, 2007, FEBS LETT, V581, P2204, DOI 10.1016/j.febslet.2007.03.050; Ginsburg H, 2002, TRENDS PARASITOL, V18, P483, DOI 10.1016/S1471-4922(02)02350-4; GordonWeeks R, 1996, PLANT PHYSIOL, V111, P195, DOI 10.1104/pp.111.1.195; Granier S, 2007, J BIOL CHEM, V282, P13895, DOI 10.1074/jbc.M611904200; Hsiao YY, 2004, BBA-BIOENERGETICS, V1608, P190, DOI 10.1016/j.bbabio.2004.01.001; Hsu SH, 2009, BOT STUD, V50, P291; Ishii Y, 1999, CHEM PHYS, V247, P163, DOI 10.1016/S0301-0104(99)00174-3; KIM EJ, 1995, J BIOL CHEM, V270, P2630, DOI 10.1074/jbc.270.6.2630; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; Lee NK, 2005, BIOPHYS J, V88, P2939, DOI 10.1529/biophysj.104.054114; Lin HH, 2005, ARCH BIOCHEM BIOPHYS, V442, P206, DOI 10.1016/j.abb.2005.08.010; Liu TH, 2009, FEBS J, V276, P4381, DOI 10.1111/j.1742-4658.2009.07146.x; Lopez-Marques RL, 2005, BBA-BIOMEMBRANES, V1716, P69, DOI 10.1016/j.bbamem.2005.08.004; Maeshima M, 2000, BBA-BIOMEMBRANES, V1465, P37, DOI 10.1016/S0005-2736(00)00130-9; Maeshima M, 2001, ANNU REV PLANT PHYS, V52, P469, DOI 10.1146/annurev.arplant.52.1.469; MAESHIMA M, 1991, EUR J BIOCHEM, V196, P11, DOI 10.1111/j.1432-1033.1991.tb15779.x; Mimura H, 2004, J BIOL CHEM, V279, P35106, DOI 10.1074/jbc.M406264200; Nakanishi Y, 2001, J BIOL CHEM, V276, P7654, DOI 10.1074/jbc.M009743200; Pohjanjoki P, 1998, BIOCHEMISTRY-US, V37, P1754, DOI 10.1021/bi971771r; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; SARAFIAN V, 1992, BIOCHEM J, V283, P493, DOI 10.1042/bj2830493; Tomishige M, 2006, NAT STRUCT MOL BIOL, V13, P887, DOI 10.1038/nsmb1151; Tzeng CM, 1996, BIOCHEM J, V316, P143, DOI 10.1042/bj3160143; Weiss S, 2000, NAT STRUCT BIOL, V7, P724, DOI 10.1038/78941; Wu CA, 2005, ACTA CRYSTALLOGR D, V61, P1459, DOI 10.1107/S0907444905025667; Yang SH, 2004, BBA-BIOENERGETICS, V1656, P88, DOI 10.1016/j.bbabio.2004.02.001; Yang SJ, 1998, BIOCHEM J, V331, P395, DOI 10.1042/bj3310395; ZHEN RG, 1994, J BIOL CHEM, V269, P23342	34	11	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23655	23664		10.1074/jbc.M110.134916	http://dx.doi.org/10.1074/jbc.M110.134916			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20511234	hybrid, Green Published			2022-12-27	WOS:000280291400016
J	Kasaragod, P; Venkatesan, R; Kiema, TR; Hiltunen, JK; Wierenga, RK				Kasaragod, Prasad; Venkatesan, Rajaram; Kiema, Tiila R.; Hiltunen, J. Kalervo; Wierenga, Rik K.			Crystal Structure of Liganded Rat Peroxisomal Multifunctional Enzyme Type 1 A FLEXIBLE MOLECULE WITH TWO INTERCONNECTED ACTIVE SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENOYL-COA HYDRATASE; BETA-OXIDATION; DELTA(3)-DELTA(2)-ENOYL-COA ISOMERASE; DELTA-3,DELTA-2-ENOYL-COA ISOMERASE; 3-HYDROXYACYL-COA DEHYDROGENASE; CROTONASE SUPERFAMILY; 2-ENOYL-COA HYDRATASE; ANGSTROM RESOLUTION; BIFUNCTIONAL ENZYME; LIVER PEROXISOMES	The crystal structure of the full-length rat peroxisomal multifunctional enzyme, type 1 (rpMFE1), has been determined at 2.8 angstrom resolution. This enzyme has three catalytic activities and two active sites. The N-terminal part has the crotonase fold, which builds the active site for the Delta(3),Delta(2)-enoyl-CoA isomerase and the Delta(2)-enoyl-CoA hydratase-1 catalytic activities, and the C-terminal part has the (3S)-hydroxyacyl-CoA dehydrogenase fold and makes the (3S)-hydroxyacyl-CoA dehydrogenase active site. rpMFE1 is a multidomain protein having five domains (A-E). The crystal structure of full-length rpMFE1 shows a flexible arrangement of the A-domain with respect to the B-E-domains. Because of a hinge region near the end of the A-domain, two different positions of the A-domain were observed for the two protein molecules (A and B) of the asymmetric unit. In the most closed conformation, the mode of binding of CoA is stabilized by domains A and B (helix-10), as seen in other crotonase fold members. Domain B, although functionally belonging to the N-terminal part, is found tightly associated with the C-terminal part, i.e. fixed to the E-domain. The two active sites of rpMFE1 are similar to 40 angstrom apart, separated by a tunnel, characterized by an excess of positively charged side chains. Comparison of the structures of rpMFE1 with the monofunctional crotonase and (3S)-hydroxyacyl-CoA dehydrogenase superfamily enzymes, as well as with the bacterial alpha(2)beta(2)-fatty acid oxidation multienzyme complex, reveals that this tunnel could be important for substrate channeling, as observed earlier on the basis of the kinetics of rpMFE1 purified from rat liver.	[Wierenga, Rik K.] Univ Oulu, Bioctr Oulu, FI-90014 Oulu, Finland; Univ Oulu, Dept Biochem, FI-90014 Oulu, Finland	University of Oulu; Finland National Institute for Health & Welfare; University of Oulu	Wierenga, RK (corresponding author), Univ Oulu, Bioctr Oulu, POB 3000, FI-90014 Oulu, Finland.	rik.wierenga@oulu.fi		Venkatesan, Rajaram/0000-0002-7257-1211	Academy of Finland; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work has been supported by a grant from the Academy of Finland and the Sigrid Juselius Foundation.	Atreya CE, 2003, J BIOL CHEM, V278, P28901, DOI 10.1074/jbc.M212689200; Bahnson BJ, 2002, BIOCHEMISTRY-US, V41, P2621, DOI 10.1021/bi015844p; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barycki JJ, 1999, PROTEIN SCI, V8, P2010, DOI 10.1110/ps.8.10.2010; Barycki JJ, 2000, J BIOL CHEM, V275, P27186; Bhaumik P, 2005, CURR OPIN STRUC BIOL, V15, P621, DOI 10.1016/j.sbi.2005.10.010; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Elcock AH, 1996, J MOL BIOL, V262, P370, DOI 10.1006/jmbi.1996.0520; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel CK, 1998, J MOL BIOL, V275, P847, DOI 10.1006/jmbi.1997.1491; Engel CK, 1996, EMBO J, V15, P5135, DOI 10.1002/j.1460-2075.1996.tb00897.x; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ferdinandusse S, 2004, J LIPID RES, V45, P1104, DOI 10.1194/jlr.M300512-JLR200; Filppula SA, 1998, J BIOL CHEM, V273, P349, DOI 10.1074/jbc.273.1.349; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gurvitz A, 1998, J BIOL CHEM, V273, P31366, DOI 10.1074/jbc.273.47.31366; Hamed RB, 2008, CELL MOL LIFE SCI, V65, P2507, DOI 10.1007/s00018-008-8082-6; Hiltunen JK, 2000, BBA-MOL CELL BIOL L, V1484, P117, DOI 10.1016/S1388-1981(00)00013-5; Hofstein HA, 1999, BIOCHEMISTRY-US, V38, P9508, DOI 10.1021/bi990506y; Holden HM, 1998, CURR OPIN STRUC BIOL, V8, P679, DOI 10.1016/S0959-440X(98)80086-9; Holden HM, 2001, ACCOUNTS CHEM RES, V34, P145, DOI 10.1021/ar000053l; HYDE CC, 1988, J BIOL CHEM, V263, P17857; Ishikawa M, 2004, EMBO J, V23, P2745, DOI 10.1038/sj.emboj.7600298; Kiema TR, 1999, BIOCHEMISTRY-US, V38, P2991, DOI 10.1021/bi981646v; Kiema TR, 2002, BIOCHEM J, V367, P433, DOI 10.1042/BJ20020292; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kurosawa T, 2001, STEROIDS, V66, P107, DOI 10.1016/S0039-128X(00)00217-8; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Manjasetty BA, 2003, P NATL ACAD SCI USA, V100, P6992, DOI 10.1073/pnas.1236794100; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Miles EW, 1999, J BIOL CHEM, V274, P12193, DOI 10.1074/jbc.274.18.12193; Modis Y, 1998, STRUCTURE, V6, P957, DOI 10.1016/S0969-2126(98)00098-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mursula AM, 2004, FEBS LETT, V557, P81, DOI 10.1016/S0014-5793(03)01450-9; Nguyen SD, 2008, BBA-MOL CELL BIOL L, V1781, P400, DOI 10.1016/j.bbalip.2008.06.004; PALOSAARI PM, 1990, J BIOL CHEM, V265, P2446; PALOSAARI PM, 1991, J BIOL CHEM, V266, P10750; Partanen ST, 2004, J MOL BIOL, V342, P1197, DOI 10.1016/j.jmb.2004.07.039; Raushel FM, 2003, ACCOUNTS CHEM RES, V36, P539, DOI 10.1021/ar020047k; Savolainen K, 2004, HUM MOL GENET, V13, P955, DOI 10.1093/hmg/ddh107; Taskinen JP, 2006, J MOL BIOL, V355, P734, DOI 10.1016/j.jmb.2005.10.085; Taskinen JP, 2002, ACTA CRYSTALLOGR D, V58, P690, DOI 10.1107/S0907444902001890; Tsuchiya D, 2006, STRUCTURE, V14, P237, DOI 10.1016/j.str.2005.10.011; Xu RF, 1996, BIOCHEM BIOPH RES CO, V221, P271, DOI 10.1006/bbrc.1996.0585; YANG SY, 1986, J BIOL CHEM, V261, P5390; Zhang DY, 2002, J BIOL CHEM, V277, P9127, DOI 10.1074/jbc.M112228200	47	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24089	24098		10.1074/jbc.M110.117606	http://dx.doi.org/10.1074/jbc.M110.117606			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20463028	Green Published, hybrid			2022-12-27	WOS:000280291400059
J	Raftos, JE; Whillier, S; Kuchel, PW				Raftos, Julia E.; Whillier, Stephney; Kuchel, Philip W.			Glutathione Synthesis and Turnover in the Human Erythrocyte ALIGNMENT OF A MODEL BASED ON DETAILED ENZYME KINETICS WITH EXPERIMENTAL DATA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEXOSE-MONOPHOSPHATE SHUNT; AMINO-ACID-TRANSPORT; INSIDE-OUT VESICLES; SICKLE-CELL-ANEMIA; GAMMA-GLUTAMYLCYSTEINE; N-ACETYLCYSTEINE; RED-CELL; ELECTROCHEMICAL MODEL; OXIDIZED GLUTATHIONE; MATHEMATICAL-MODEL	The erythrocyte is exposed to reactive oxygen species in the circulation and also to those produced by autoxidation of hemoglobin. Consequently, erythrocytes depend on protection by the antioxidant glutathione. Mathematical models based on realistic kinetic data have provided valuable insights into the regulation of biochemical pathways within the erythrocyte but none have satisfactorily accounted for glutathione metabolism. In the current model, rate equations were derived for the enzyme-catalyzed reactions, and for each equation the nonlinear algebraic relationship between the steady-state kinetic parameters and the unitary rate constants was derived. The model also includes the transport processes that supply the amino acid constituents of glutathione and the export of oxidized glutathione. Values of the kinetic parameters for the individual reactions were measured predominately using isolated enzymes under conditions that differed from the intracellular environment. By comparing the experimental and simulated results, the values of the enzyme-kinetic parameters of the model were refined to yield conformity between model simulations and experimental data. Model output accurately represented the steady-state concentrations of metabolites in erythrocytes suspended in plasma and the changing glutathione concentrations in whole and hemolyzed erythrocytes under specific experimental conditions. Analysis indicated that feedback inhibition of gamma-glutamate-cysteine ligase by glutathione had a limited effect on steady-state glutathione concentrations and was not sufficiently potent to return glutathione concentrations to normal levels in erythrocytes exposed to sustained increases in oxidative load.	[Raftos, Julia E.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Kuchel, Philip W.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Kuchel, Philip W.] Univ Sydney, Ctr Math Biol, Sydney, NSW 2006, Australia	Macquarie University; University of Sydney; University of Sydney	Raftos, JE (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	julia.raftos@mq.edu.au	Whillier, Stephney/AAC-8550-2020	Whillier, Stephney/0000-0002-5093-4376; Kuchel, Philip/0000-0003-4100-7332	Macquarie University; Commonwealth of Australia; Australian Research Council	Macquarie University; Commonwealth of Australia(Australian Government); Australian Research Council(Australian Research Council)	Supported by a Macquarie University Research Development Grant.; Recipient of a Commonwealth of Australia Postgraduate Award.; Recipient of a Discovery Project Grant from the Australian Research Council.	Aguilo A, 2000, J NUTR BIOCHEM, V11, P81, DOI 10.1016/S0955-2863(99)00073-X; AKERBOOM TPM, 1992, BIOCHIM BIOPHYS ACTA, V1103, P115, DOI 10.1016/0005-2736(92)90064-S; BANNAI S, 1984, BIOCHIM BIOPHYS ACTA, V779, P289, DOI 10.1016/0304-4157(84)90014-5; Barbaro MPF, 2005, FREE RADICAL RES, V39, P1111, DOI 10.1080/10715760500250257; BEUTLER E, 1989, GLUTATHIONE CHEM BIO, P291; Blanco RA, 2007, AM J CLIN NUTR, V86, P1016, DOI 10.1093/ajcn/86.4.1016; BURGUNDER JM, 1989, EUR J CLIN PHARMACOL, V36, P127, DOI 10.1007/BF00609183; CLELAND WW, 1967, ANNU REV BIOCHEM, V36, P77, DOI 10.1146/annurev.bi.36.070167.000453; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P104, DOI 10.1016/0926-6569(63)90211-6; CORNISHBOWDEN A, 1977, BIOCHEM J, V165, P55, DOI 10.1042/bj1650055; DIMANT E, 1955, J BIOL CHEM, V213, P769; Ellory J.C., 2003, RED CELL MEMBRANE TR, DOI [10.1007/978-3-662-05181-8_12, DOI 10.1007/978-3-662-05181-8_12]; ELLORY JC, 1983, BIOMED BIOCHIM ACTA, V42, pS48; Forni LG, 2005, CRIT CARE, V9, pR591, DOI 10.1186/cc3806; Friesen RW, 2007, J NUTR, V137, P2641; Griffith OW, 1999, ADV ENZYMOL RAMB, V73, P209, DOI 10.1002/9780470123195.ch7; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; GRIFFITH OW, 1981, J BIOL CHEM, V256, P4900; GRIMES AJ, 1980, HUMAN RED CELL METAB; HAGENFELDT L, 1978, CLIN CHIM ACTA, V85, P167, DOI 10.1016/0009-8981(78)90236-X; Halliwell B, 2004, FREE RADICALS BIOL M; HEBBEL RP, 1988, P NATL ACAD SCI USA, V85, P237, DOI 10.1073/pnas.85.1.237; HOLZHUTTER HG, 1985, EUR J BIOCHEM, V149, P101, DOI 10.1111/j.1432-1033.1985.tb08899.x; HSIEH HS, 1975, RED BLOOD CELL, V2, P799; JACKSON RC, 1969, BIOCHEM J, V111, P309, DOI 10.1042/bj1110309; JAFFE ER, 1981, FUNCTION RED BLOOD C, P133; Johnson JM, 2008, CLIN CHIM ACTA, V396, P43, DOI 10.1016/j.cca.2008.06.020; JOSHI A, 1989, J THEOR BIOL, V141, P515, DOI 10.1016/S0022-5193(89)80233-4; Kiessling K, 2000, Hematol J, V1, P243, DOI 10.1038/sj.thj.6200033; KING EL, 1956, J PHYS CHEM-US, V60, P1375, DOI 10.1021/j150544a010; KING GF, 1985, BIOCHEM J, V227, P833, DOI 10.1042/bj2270833; Klokouzas A, 2001, EUR J BIOCHEM, V268, P6569, DOI 10.1046/j.0014-2956.2001.02611.x; KONDO T, 1980, P NATL ACAD SCI-BIOL, V77, P6359, DOI 10.1073/pnas.77.11.6359; KONDO T, 1987, P NATL ACAD SCI USA, V84, P7373, DOI 10.1073/pnas.84.21.7373; KUCHEL PW, 1982, BIOCHEM MED METAB B, V27, P95, DOI 10.1016/0006-2944(82)90012-6; LEW VL, 1986, J MEMBRANE BIOL, V92, P57, DOI 10.1007/BF01869016; Liu HL, 2005, J NEUROSCI RES, V79, P861, DOI 10.1002/jnr.20424; LOVRIC VA, 1981, MED J AUSTRALIA, V1, P635, DOI 10.5694/j.1326-5377.1981.tb135893.x; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; LUNN G, 1979, BLOOD, V54, P238; MAJERUS PW, 1971, J CLIN INVEST, V50, P1637, DOI 10.1172/JCI106652; MAK IT, 1994, AM J PHYSIOL-CELL PH, V267, pC1366; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Mills BJ, 1996, BIOCHEM PHARMACOL, V52, P401, DOI 10.1016/0006-2952(96)00241-9; MINNICH V, 1971, J CLIN INVEST, V50, P507, DOI 10.1172/JCI106519; MULQUINEY P, 2003, MODELLING METABOLISM; Mulquiney PJ, 1999, BIOCHEM J, V342, P597, DOI 10.1042/0264-6021:3420597; Nakayama Y, 2005, THEOR BIOL MED MODEL, V2, DOI 10.1186/1742-4682-2-18; Niihara Y, 1997, J LAB CLIN MED, V130, P83, DOI 10.1016/S0022-2143(97)90062-7; Niihara Y, 1998, AM J HEMATOL, V58, P117, DOI 10.1002/(SICI)1096-8652(199806)58:2<117::AID-AJH5>3.0.CO;2-V; Oakley AJ, 2008, J BIOL CHEM, V283, P22031, DOI 10.1074/jbc.M803623200; OWENS CWI, 1965, BIOCHEM J, V94, P705, DOI 10.1042/bj0940705; Pace BS, 2003, AM J HEMATOL, V73, P26, DOI 10.1002/ajh.10321; PHELPS DT, 1992, AM J RESP CELL MOL, V7, P293, DOI 10.1165/ajrcmb/7.3.293; RAE C, 1990, EUR J BIOCHEM, V193, P83, DOI 10.1111/j.1432-1033.1990.tb19307.x; Raftos JE, 2006, REDOX REP, V11, P9, DOI 10.1179/135100006X100986; RAFTOS JE, 1986, HAEMATOLOGIA, V19, P251; RAFTOS JE, 1990, J GEN PHYSIOL, V95, P1183, DOI 10.1085/jgp.95.6.1183; Raftos JE, 2007, INT J BIOCHEM CELL B, V39, P1698, DOI 10.1016/j.biocel.2007.04.014; RAPOPORT S, 1961, Folia Haematol Int Mag Klin Morphol Blutforsch, V78, P364; RAPOPORT SM, 1988, ROOTS OF MODERN BIOCHEMISTRY, P157; Reed MC, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-8; RHOADS DG, 1968, J BIOL CHEM, V243, P3963; Rice-Evans C., 1990, BLOOD CELL BIOCH, P429; Richie JP, 1996, CLIN CHEM, V42, P1100; RICHMAN PG, 1975, J BIOL CHEM, V250, P1422; Ristoff E, 2000, BLOOD, V95, P2193; Salvador A, 2003, P NATL ACAD SCI USA, V100, P14463, DOI 10.1073/pnas.2335687100; SCHUSTER R, 1988, BIOSYSTEMS, V22, P19, DOI 10.1016/0303-2647(88)90047-0; SMITH JE, 1980, ENZYME, V25, P236, DOI 10.1159/000459258; SRIVASTA.SK, 1969, J BIOL CHEM, V244, P9; Stein W., 1990, CHANNELS CARRIERS PU; THORBURN DR, 1985, EUR J BIOCHEM, V150, P371, DOI 10.1111/j.1432-1033.1985.tb09030.x; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Tunnicliff G, 2003, J BIOMED SCI, V10, P30, DOI 10.1159/000068084; TUNNICLIFF G, 1994, COMP BIOCHEM PHYS A, V108, P471, DOI 10.1016/0300-9629(94)90329-8; van Thien H, 2004, CLIN NUTR, V23, P59, DOI 10.1016/S0261-5614(03)00089-X; Verrey F, 2003, PFLUG ARCH EUR J PHY, V445, P529, DOI 10.1007/S00424-002-0973-Z; WAGNER TC, 1994, ANAL BIOCHEM, V222, P417, DOI 10.1006/abio.1994.1511; Whillier S, 2009, REDOX REP, V14, P115, DOI 10.1179/135100009X392539; WINTER CG, 1964, J BIOL CHEM, V239, P872; WORTHINGTON DJ, 1976, EUR J BIOCHEM, V67, P231, DOI 10.1111/j.1432-1033.1976.tb10654.x; YOUNG JD, 1980, PROC R SOC SER B-BIO, V209, P355, DOI 10.1098/rspb.1980.0100; Zhang HQ, 2009, ARCH BIOCHEM BIOPHYS, V481, P110, DOI 10.1016/j.abb.2008.10.020	84	59	59	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23557	23567		10.1074/jbc.M109.067017	http://dx.doi.org/10.1074/jbc.M109.067017			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20498365	Green Published, hybrid			2022-12-27	WOS:000280291400005
J	Agarwal, V; Asmat, TM; Luo, SS; Jensch, I; Zipfel, PF; Hammerschmidt, S				Agarwal, Vaibhav; Asmat, Tauseef M.; Luo, Shanshan; Jensch, Inga; Zipfel, Peter F.; Hammerschmidt, Sven			Complement Regulator Factor H Mediates a Two-step Uptake of Streptococcus pneumoniae by Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOLYTIC-UREMIC SYNDROME; PNEUMOCOCCAL SURFACE PROTEIN; HEPARIN-BINDING DOMAIN; EPITHELIAL-CELLS; ENDOTHELIAL-CELLS; MYCOBACTERIUM-AVIUM; RHO GTPASES; HOST-CELLS; C-TERMINUS; PSPC	Streptococcus pneumoniae, a human pathogen, recruits complement regulator factor H to its bacterial cell surface. The bacterial PspC protein binds Factor H via short consensus repeats (SCR) 8-11 and SCR19-20. In this study, we define how bacterially bound Factor H promotes pneumococcal adherence to and uptake by epithelial cells or human polymorphonuclear leukocytes (PMNs) via a two-step process. First, pneumococcal adherence to epithelial cells was significantly reduced by heparin and dermatan sulfate. However, none of the glycosaminoglycans affected binding of Factor H to pneumococci. Adherence of pneumococci to human epithelial cells was inhibited by monoclonal antibodies recognizing SCR19-20 of Factor H suggesting that the C-terminal glycosaminoglycan-binding region of Factor H mediates the contact between pneumococci and human cells. Blocking of the integrin CR3 receptor, i.e. CD11b and CD18, of PMNs or CR3-expressing epithelial cells reduced significantly the interaction of pneumococci with both cell types. Similarly, an additional CR3 ligand, Pra1, derived from Candida albicans, blocked the interaction of pneumococci with PMNs. Strikingly, Pra1 inhibited also pneumococcal uptake by lung epithelial cells but not adherence. In addition, invasion of Factor H-coated pneumococci required the dynamics of host-cell actin microfilaments and was affected by inhibitors of protein-tyrosine kinases and phosphatidylinositol 3-kinase. In conclusion, pneumococcal entry into host cells via Factor H is based on a two-step mechanism. The first and initial contact of Factor H-coated pneumococci is mediated by glycosaminoglycans expressed on the surface of human cells, and the second step, pneumococcal uptake, is integrin-mediated and depends on host signaling molecules such as phosphatidylinositol 3-kinase.	[Hammerschmidt, Sven] Ernst Moritz Arndt Univ Greifswald, Inst Genet & Funct Genom, Dept Genet Microorganisms, D-17487 Greifswald, Germany; [Agarwal, Vaibhav; Hammerschmidt, Sven] Univ Munich, Max von Pettenkofer Inst Hyg & Med Microbiol, D-80336 Munich, Germany; [Luo, Shanshan; Zipfel, Peter F.] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, D-07745 Jena, Germany; [Zipfel, Peter F.] Univ Jena, D-07745 Jena, Germany	Ernst Moritz Arndt Universitat Greifswald; University of Munich; Hans Knoll Institute (HKI); Friedrich Schiller University of Jena	Hammerschmidt, S (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Genet & Funct Genom, Dept Genet Microorganisms, Friedrich Ludwig Jahn Str 15A, D-17487 Greifswald, Germany.	sven.hammerschmidt@uni-greifswald.de	Asmat, Tauseef M/Q-3801-2019; Hammerschmidt, Sven/G-2598-2010	Hammerschmidt, Sven/0000-0002-6382-6681	Deutsche Forschungsgemeinschaft [DFG Ha 3125/2-1, 3125/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by Deutsche Forschungsgemeinschaft Grants DFG Ha 3125/2-1 and 3125/4-1.	Agarwal V, 2009, J BIOL CHEM, V284, P19427, DOI 10.1074/jbc.M109.003442; AUSTRIAN R, 1986, J ANTIMICROB CHEMOTH, V18, P35, DOI 10.1093/jac/18.Supplement_A.35; Bergmann S, 2006, MICROBIOL-SGM, V152, P295, DOI 10.1099/mic.0.28610-0; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; Bermudez LE, 1999, INFECT IMMUN, V67, P4912, DOI 10.1128/IAI.67.9.4912-4916.1999; BERRY L, 1991, AM J RESP CELL MOL, V4, P338, DOI 10.1165/ajrcmb/4.4.338; Blackmore TK, 1996, J IMMUNOL, V157, P5422; Blackmore TK, 1998, J IMMUNOL, V160, P3342; Burnham CAD, 2007, FEMS MICROBIOL LETT, V272, P8, DOI 10.1111/j.1574-6968.2007.00768.x; Cartwright K, 2002, EUR J PEDIATR, V161, P188, DOI 10.1007/s00431-001-0907-3; Cheng ZZ, 2006, MOL IMMUNOL, V43, P972, DOI 10.1016/j.molimm.2005.05.011; Dave S, 2004, J IMMUNOL, V173, P471, DOI 10.4049/jimmunol.173.1.471; Dave S, 2001, INFECT IMMUN, V69, P3435, DOI 10.1128/IAI.69.5.3435-3437.2001; Dieudonne-Vatran A, 2009, J IMMUNOL, V182, P7865, DOI 10.4049/jimmunol.0802376; DiScipio RG, 1998, J IMMUNOL, V160, P4057; Duthy TG, 2002, INFECT IMMUN, V70, P5604, DOI 10.1128/IAI.70.10.5604-5611.2002; Elm C, 2004, J BIOL CHEM, V279, P6296, DOI 10.1074/jbc.M310528200; Genth H, 2008, INT J BIOCHEM CELL B, V40, P592, DOI 10.1016/j.biocel.2007.12.014; Hammerschmidt S, 2006, CURR OPIN MICROBIOL, V9, P12, DOI 10.1016/j.mib.2005.11.001; Hammerschmidt S, 2000, MOL MICROBIOL, V36, P726, DOI 10.1046/j.1365-2958.2000.01897.x; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Hellwage J, 2002, J IMMUNOL, V169, P6935, DOI 10.4049/jimmunol.169.12.6935; Hellwage J, 1997, BIOCHEM J, V326, P321, DOI 10.1042/bj3260321; Iannelli F, 2002, GENE, V284, P63, DOI 10.1016/S0378-1119(01)00896-4; Ingalls RR, 1997, J IMMUNOL, V159, P433; Iozzo RV, 1996, FASEB J, V10, P598, DOI 10.1096/fasebj.10.5.8621059; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Ireton K, 1996, SCIENCE, V274, P780, DOI 10.1126/science.274.5288.780; Janulczyk R, 2000, J BIOL CHEM, V275, P37257, DOI 10.1074/jbc.M004572200; Jarva H, 2004, J IMMUNOL, V172, P3111, DOI 10.4049/jimmunol.172.5.3111; Jarva H, 2002, J IMMUNOL, V168, P1886, DOI 10.4049/jimmunol.168.4.1886; Jokiranta TS, 2006, EMBO J, V25, P1784, DOI 10.1038/sj.emboj.7601052; Jokiranta TS, 2000, J BIOL CHEM, V275, P27657; Jokiranta TS, 2005, AM J PATHOL, V167, P1173, DOI 10.1016/S0002-9440(10)61205-9; Jozsi M, 2006, J AM SOC NEPHROL, V17, P170, DOI 10.1681/ASN.2005080868; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kazmierczak BI, 2001, CELL MICROBIOL, V3, P85, DOI 10.1046/j.1462-5822.2001.00091.x; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Kraiczy P, 2006, MOL IMMUNOL, V43, P31, DOI 10.1016/j.molimm.2005.06.016; Krause-Gruszczynska M, 2007, CELL MICROBIOL, V9, P2431, DOI 10.1111/j.1462-5822.2007.00971.x; Kwok T, 2002, INFECT IMMUN, V70, P2108, DOI 10.1128/IAI.70.4.2108-2120.2002; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Lu L, 2006, J BIOL CHEM, V281, P15464, DOI 10.1074/jbc.M602404200; Luo SS, 2009, MOL IMMUNOL, V47, P541, DOI 10.1016/j.molimm.2009.07.017; Manuelian T, 2003, J CLIN INVEST, V111, P1181, DOI 10.1172/JCI200316651; MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982; MUSHER DM, 1992, CLIN INFECT DIS, V14, P801, DOI 10.1093/clinids/14.4.801; Neeleman C, 1999, INFECT IMMUN, V67, P4517, DOI 10.1128/IAI.67.9.4517-4524.1999; Oppermann M, 2006, CLIN EXP IMMUNOL, V144, P342, DOI 10.1111/j.1365-2249.2006.03071.x; PANGBURN MK, 1991, J BIOL CHEM, V266, P16847; Pelish HE, 2006, NAT CHEM BIOL, V2, P221, DOI 10.1038/nchembio0406-221b; Pracht D, 2005, INFECT IMMUN, V73, P2680, DOI 10.1128/IAI.73.5.2680-2689.2005; Reddy MA, 2000, J BIOL CHEM, V275, P36769, DOI 10.1074/jbc.M007382200; Rennemeier C, 2007, FASEB J, V21, P3118, DOI 10.1096/fj.06-7992com; RIPOCHE J, 1986, BIOSCIENCE REP, V6, P65, DOI 10.1007/BF01145180; Rooijakkers SHM, 2007, MOL IMMUNOL, V44, P23, DOI 10.1016/j.molimm.2006.06.011; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; Saito A, 2005, J BIOCHEM, V137, P225, DOI 10.1093/jb/mvi025; Sangari FJ, 2000, CELL MICROBIOL, V2, P561, DOI 10.1046/j.1462-5822.2000.00080.x; Soloviev DA, 2007, J IMMUNOL, V178, P2038, DOI 10.4049/jimmunol.178.4.2038; Van Nhieu GT, 1999, EMBO J, V18, P3249, DOI 10.1093/emboj/18.12.3249; Xu B, 2006, ORG BIOMOL CHEM, V4, P4149, DOI 10.1039/b609143a; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4; Zipfel PF, 2007, MOL IMMUNOL, V44, P3850, DOI 10.1016/j.molimm.2007.06.149; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620; Zipfel PF, 2008, VACCINE, V26, pI67, DOI 10.1016/j.vaccine.2008.11.015; Zipfel PF, 2002, BIOCHEM SOC T, V30, P971, DOI 10.1042/bst0300971	68	65	68	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23484	23493		10.1074/jbc.M110.142703	http://dx.doi.org/10.1074/jbc.M110.142703			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20504767	Green Published, hybrid			2022-12-27	WOS:000279999900080
J	Foti, JJ; DeLucia, AM; Joyce, CM; Walker, GC				Foti, James J.; DeLucia, Angela M.; Joyce, Catherine M.; Walker, Graham C.			UmuD(2) Inhibits a Non-covalent Step during DinB-mediated Template Slippage on Homopolymeric Nucleotide Runs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY DNA-POLYMERASE; ERROR-FREE BYPASS; Y-FAMILY; ESCHERICHIA-COLI; FRAMESHIFT MUTATION; ABASIC LESION; MUTAGENESIS; FIDELITY; MISALIGNMENT; REPLICATION	Escherichia coli DinB (DNA polymerase IV) possesses an enzyme architecture resulting in specialized lesion bypass function and the potential for creating -1 frameshifts in homopolymeric nucleotide runs. We have previously shown that the mutagenic potential of DinB is regulated by the DNA damage response protein UmuD(2). In the current study, we employ a pre-steady-state fluorescence approach to gain a mechanistic understanding of DinB regulation by UmuD(2). Our results suggest that DinB, like its mammalian and archaeal orthologs, uses a template slippage mechanism to create single base deletions on homopolymeric runs. With 2-aminopurine as a fluorescent reporter in the DNA substrate, the template slippage reaction results in a prechemistry fluorescence change that is inhibited by UmuD(2). We propose a model in which DNA templates containing homopolymeric nucleotide runs, when bound to DinB, are in an equilibrium between non-slipped and slipped conformations. UmuD(2), when bound to DinB, displaces the equilibrium in favor of the non-slipped conformation, thereby preventing frameshifting and potentially enhancing DinB activity on non-slipped substrates.	[Foti, James J.; Walker, Graham C.] MIT, Dept Biol, Cambridge, MA 02139 USA; [DeLucia, Angela M.; Joyce, Catherine M.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Massachusetts Institute of Technology (MIT); Yale University	Walker, GC (corresponding author), MIT, Dept Biol, 68-633,77 Massachusetts Ave, Cambridge, MA 02139 USA.	gwalker@mit.edu		/0000-0001-7243-8261	National Institutes of Health [R01 GM28550, R01 CA021615, F32 GM079885, P30 ES002019]; NATIONAL CANCER INSTITUTE [R01CA021615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028550, F32GM079885] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM28550 (to C.M.J.), R01 CA021615 (to G. C. W.), F32 GM079885 (to J.J.F.), and P30 ES002019 (to the MIT Center for Environmental Health Sciences).	Bauer J, 2007, P NATL ACAD SCI USA, V104, P14905, DOI 10.1073/pnas.0700717104; BEBENEK K, 1990, P NATL ACAD SCI USA, V87, P4946, DOI 10.1073/pnas.87.13.4946; Bebenek K, 2008, EMBO REP, V9, P459, DOI 10.1038/embor.2008.33; Bloom LB, 1997, J BIOL CHEM, V272, P27919, DOI 10.1074/jbc.272.44.27919; Boudsocq F, 2004, J BIOL CHEM, V279, P32932, DOI 10.1074/jbc.M405249200; CAIRNS J, 1991, GENETICS, V128, P695; CUPPLES CG, 1990, GENETICS, V125, P275; DeLucia AM, 2007, BIOCHEMISTRY-US, V46, P10790, DOI 10.1021/bi7006756; Efrati E, 1997, J BIOL CHEM, V272, P2559; FRIEDBERG EC, 2005, DNA REPAIR MUTAGENES, P509; Godoy VG, 2007, MOL CELL, V28, P1058, DOI 10.1016/j.molcel.2007.10.025; Irimia A, 2009, J BIOL CHEM, V284, P22467, DOI 10.1074/jbc.M109.003905; Jarosz DF, 2009, P NATL ACAD SCI USA, V106, P21137, DOI 10.1073/pnas.0907257106; Jarosz DF, 2006, NATURE, V439, P225, DOI 10.1038/nature04318; Jia L, 2008, NUCLEIC ACIDS RES, V36, P6571, DOI 10.1093/nar/gkn719; Kim SR, 1997, P NATL ACAD SCI USA, V94, P13792, DOI 10.1073/pnas.94.25.13792; Kobayashi S, 2002, J BIOL CHEM, V277, P34198, DOI 10.1074/jbc.M204826200; Kokoska RJ, 2002, J BIOL CHEM, V277, P19633, DOI 10.1074/jbc.M202021200; KUNKEL TA, 1986, J BIOL CHEM, V261, P3581; KUNKEL TA, 1988, J BIOL CHEM, V263, P14784; Ling H, 2004, MOL CELL, V13, P751, DOI 10.1016/S1097-2765(04)00101-7; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; Ogi T, 1999, GENES CELLS, V4, P607, DOI 10.1046/j.1365-2443.1999.00289.x; Ohashi E, 2000, GENE DEV, V14, P1589; Ohashi E, 2000, J BIOL CHEM, V275, P39678, DOI 10.1074/jbc.M005309200; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Potapova O, 2002, J BIOL CHEM, V277, P28157, DOI 10.1074/jbc.M202607200; Rachofsky EL, 2001, BIOCHEMISTRY-US, V40, P946, DOI 10.1021/bi001664o; Rechkoblit O, 2006, PLOS BIOL, V4, P25, DOI 10.1371/journal.pbio.0040011; Shen X, 2002, J BIOL CHEM, V277, P5265, DOI 10.1074/jbc.M109575200; SIMMONS LA, 2008, ECOSAL ESCHERICHIA C; Simon SM, 2008, P NATL ACAD SCI USA, V105, P1152, DOI 10.1073/pnas.0706067105; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; Sutton MD, 2001, P NATL ACAD SCI USA, V98, P8342, DOI 10.1073/pnas.111036998; Tippin B, 2004, J BIOL CHEM, V279, P45360, DOI 10.1074/jbc.M408600200; Washington MT, 2004, MOL CELL BIOL, V24, P5687, DOI 10.1128/MCB.24.13.5687-5693.2004; Wilson RC, 2008, MOL CELL, V29, P767, DOI 10.1016/j.molcel.2008.01.014; Wolfle WT, 2003, GENE DEV, V17, P2191, DOI 10.1101/gad.1108603; WOODGATE R, 1991, MOL GEN GENET, V229, P10, DOI 10.1007/BF00264207; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4138, DOI 10.1093/nar/28.21.4138; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4147, DOI 10.1093/nar/28.21.4147	42	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23084	23093		10.1074/jbc.M110.115774	http://dx.doi.org/10.1074/jbc.M110.115774			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20467052	hybrid, Green Published			2022-12-27	WOS:000279999900043
J	Berube, J; Roussel, L; Nattagh, L; Rousseau, S				Berube, Julie; Roussel, Lucie; Nattagh, Leila; Rousseau, Simon			Loss of Cystic Fibrosis Transmembrane Conductance Regulator Function Enhances Activation of p38 and ERK MAPKs, Increasing Interleukin-6 Synthesis in Airway Epithelial Cells Exposed to Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOKINE PRODUCTION; SIGNALING PATHWAYS; KINASE CASCADE; PHOSPHORYLATION; MYD88; INFECTIONS; GENERATION; EXPRESSION; TRANSPORT; TARGETS	In cystic fibrosis (CF), the absence of functional cystic fibrosis transmembrane conductance regulator (CFTR) translates into chronic bacterial infection, excessive inflammation, tissue damage, impaired lung function and eventual death. Understanding the mechanisms underlying this vicious circle of inflammation is important to design better therapies for CF. We found in CF lung biopsies increased immunoreactivity for p38 MAPK activity markers. Moreover, when compared with their non-CF counterpart, airway epithelial cells expressing the most common mutation in CF (CFTR Delta F508) were more potent at inducing neutrophil chemotaxis through increased interleukin (IL)-6 synthesis when challenged with Pseudomonas aeruginosa diffusible material. We then discovered that in CFTR Delta F508cells, the p38 and ERK MAPKs are hyperactivated in response to P. aeruginosa diffusible material, leading to increased IL-6 mRNA expression and stability. Moreover, although TLR5 contributes to p38 MAPK activation upon P. aeruginosa challenge, it only played a weak role in IL-6 synthesis. Instead, we found that the production of reactive oxygen species is essential for IL-6 synthesis in response to P. aeruginosa diffusible material. Finally, we uncovered that in CFTR Delta F508 cells, the extracellular glutathione levels are decreased, leading to a greater sensitivity to reactive oxygen species, providing an explanation for the hyperactivation of the p38 and ERK MAPKs and increased IL-6 synthesis. Taken together, our study has characterized a mechanism whereby the CFTR Delta F508 mutation in airway epithelial cells contributes to increase inflammation of the airways.	[Berube, Julie; Roussel, Lucie; Nattagh, Leila; Rousseau, Simon] McGill Univ, Meakins Christie Labs, Heath Ctr, Res Inst, Montreal, PQ H2X 2P2, Canada	McGill University	Rousseau, S (corresponding author), McGill Univ, Meakins Christie Labs, Heath Ctr, Res Inst, 3626 St Urbain St, Montreal, PQ H2X 2P2, Canada.	simon.rousseau@mcgill.ca	Rousseau, Simon/A-1800-2009	Rousseau, Simon/0000-0002-8773-575X	Canadian Cystic Fibrosis Foundation; Department of Medicine, McGill University; McGill University Health Centre Research Institute (MUHC-RI); Canadian Foundation for Innovation-leaders; Les Fonds de la Recherche en Sante du Quebec (FRSQ)	Canadian Cystic Fibrosis Foundation; Department of Medicine, McGill University; McGill University Health Centre Research Institute (MUHC-RI); Canadian Foundation for Innovation-leaders; Les Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This work was supported by a Canadian Cystic Fibrosis Foundation research grant (to S.R.); the Department of Medicine, McGill University; the McGill University Health Centre Research Institute (MUHC-RI); and the Canadian Foundation for Innovation-leaders opportunities funds. The Meakins-Christie Laboratories, MUHC-RI, are supported by a Centre grant from Les Fonds de la Recherche en Sante du Quebec (FRSQ).; Recipient of a postdoctoral fellowship from the FRSQ.; Recipient of a salary award from the FRSQ. To whom correspondence should be addressed: Meakins-Christie Laboratories, 3626 St-Urbain, Montreal, Quebec H2X 2P2, Canada. Tel.: 514-398-3864; Fax: 514-398-7483; E-mail: simon.rousseau@mcgill.ca.	Allen RG, 2000, FREE RADICAL BIO MED, V28, P463, DOI 10.1016/S0891-5849(99)00242-7; BALTIMORE RS, 1989, AM REV RESPIR DIS, V140, P1650, DOI 10.1164/ajrccm/140.6.1650; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Becker MN, 2004, AM J RESP CRIT CARE, V169, P645, DOI 10.1164/rccm.200207-765OC; Berube J, 2009, CELL SIGNAL, V21, P448, DOI 10.1016/j.cellsig.2008.12.001; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Beyaert R, 1996, EMBO J, V15, P1914, DOI 10.1002/j.1460-2075.1996.tb00542.x; Bonfield TL, 1999, J ALLERGY CLIN IMMUN, V104, P72, DOI 10.1016/S0091-6749(99)70116-8; BONFIELD TL, 1995, AM J RESP CRIT CARE, V152, P2111, DOI 10.1164/ajrccm.152.6.8520783; Briata P, 2005, MOL CELL, V20, P891, DOI 10.1016/j.molcel.2005.10.021; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Gao L, 1999, AM J PHYSIOL-LUNG C, V277, pL113, DOI 10.1152/ajplung.1999.277.1.L113; Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Kelley TJ, 1998, J CLIN INVEST, V102, P1200, DOI 10.1172/JCI2357; Kube D, 2001, AM J PHYSIOL-LUNG C, V280, pL493, DOI 10.1152/ajplung.2001.280.3.L493; Kufer TA, 2006, INFECT IMMUN, V74, P3115, DOI 10.1128/IAI.00035-06; Kuma Y, 2005, J BIOL CHEM, V280, P19472, DOI 10.1074/jbc.M414221200; Lee J, 2000, J LEUKOCYTE BIOL, V68, P909; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Liu CN, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000382; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ratner AJ, 2001, J BIOL CHEM, V276, P19267, DOI 10.1074/jbc.M007703200; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Rousseau S, 2002, EMBO J, V21, P6505, DOI 10.1093/emboj/cdf639; Roussel L, 2010, J IMMUNOL, V184, P4531, DOI 10.4049/jimmunol.0903162; Schwiebert LM, 1999, AM J PHYSIOL-CELL PH, V276, pC700, DOI 10.1152/ajpcell.1999.276.3.C700; Shapiro L, 1995, P NATL ACAD SCI USA, V92, P12230, DOI 10.1073/pnas.92.26.12230; Stecenko AA, 2001, INFLAMMATION, V25, P145, DOI 10.1023/A:1011080229374; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Wedzicha JA, 2002, CHEST, V121, p136S, DOI 10.1378/chest.121.5_suppl.136S; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; WHITE MB, 1990, NATURE, V344, P665, DOI 10.1038/344665a0; Windheim M, 2007, BIOCHEM J, V404, P179, DOI 10.1042/BJ20061704; Wu Q, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-26; Yan FG, 2008, BIOCHEM BIOPH RES CO, V366, P513, DOI 10.1016/j.bbrc.2007.11.172; Yang HT, 2008, CELL SIGNAL, V20, P375, DOI 10.1016/j.cellsig.2007.10.025	47	62	64	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22299	22307		10.1074/jbc.M109.098566	http://dx.doi.org/10.1074/jbc.M109.098566			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20460375	Green Published, hybrid			2022-12-27	WOS:000279702200043
J	Chou, S; Jensen, BC; Parsons, M; Alber, T; Grundner, C				Chou, Seemay; Jensen, Bryan C.; Parsons, Marilyn; Alber, Tom; Grundner, Christoph			The Trypanosoma brucei Life Cycle Switch TbPTP1 Is Structurally Conserved and Dephosphorylates the Nucleolar Protein NOPP44/46	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHORYLATED PROTEINS; RIBOSOME BIOGENESIS; KINASE; PHOSPHATASE; PESCADILLO; BINDING; DIFFERENTIATION; LOCALIZATION; PURIFICATION; SPECIFICITY	Trypanosoma brucei adapts to changing environments as it cycles through arrested and proliferating stages in the human and tsetse fly hosts. Changes in protein tyrosine phosphorylation of several proteins, including NOPP44/46, accompany T. brucei development. Moreover, inactivation of T. brucei protein-tyrosine phosphatase 1 (TbPTP1) triggers differentiation of bloodstream stumpy forms into tsetse procyclic forms through unknown downstream effects. Here, we link these events by showing that NOPP44/46 is a major substrate of TbPTP1. TbPTP1 substrate-trapping mutants selectively enrich NOPP44/46 from procyclic stage cell lysates, and TbPTP1 efficiently and selectively dephosphorylates NOPP44/46 in vitro. To provide insights into the mechanism of NOPP44/46 recognition, we determined the crystal structure of TbPTP1. The TbPTP1 structure, the first of a kinetoplastid protein-tyrosine phosphatase (PTP), emphasizes the conservation of the PTP fold, extending to one of the most diverged eukaryotes. The structure reveals surfaces that may mediate substrate specificity and affords a template for the design of selective inhibitors to interfere with T. brucei transmission.	[Chou, Seemay; Alber, Tom] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Chou, Seemay; Alber, Tom] Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA; [Jensen, Bryan C.; Parsons, Marilyn; Grundner, Christoph] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Parsons, Marilyn; Grundner, Christoph] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Center for Infectious Disease Research; University of Washington; University of Washington Seattle	Grundner, C (corresponding author), 307 Westlake Ave N,Ste 500, Seattle, WA 98109 USA.	christoph.grundner@sbri.org		Parsons, Marilyn/0000-0003-3994-8096	National Institutes of Health [R01 AI31077]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI31077 (to M. P.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Allende ML, 1996, GENE DEV, V10, P3141, DOI 10.1101/gad.10.24.3141; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Das A, 1996, J BIOL CHEM, V271, P15675, DOI 10.1074/jbc.271.26.15675; Das A, 1998, J CELL SCI, V111, P2615; Dean S, 2009, NATURE, V459, P213, DOI 10.1038/nature07997; Du YCN, 2002, CELL, V109, P835, DOI 10.1016/S0092-8674(02)00773-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fenn K, 2007, CURR OPIN MICROBIOL, V10, P539, DOI 10.1016/j.mib.2007.09.014; Fevre EM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000333; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Garcia-Salcedo JA, 2002, MOL MICROBIOL, V45, P307, DOI 10.1046/j.1365-2958.2002.03019.x; Goldschmidt L, 2007, PROTEIN SCI, V16, P1569, DOI 10.1110/ps.072914007; Hellman K, 2007, EUKARYOT CELL, V6, P2206, DOI 10.1128/EC.00176-07; Inder KL, 2009, J BIOL CHEM, V284, P28410, DOI 10.1074/jbc.M109.001537; Jensen BC, 2005, EUKARYOT CELL, V4, P30, DOI 10.1128/EC.4.1.30-35.2005; Jensen BC, 2007, MOL BIOCHEM PARASIT, V151, P28, DOI 10.1016/j.molbiopara.2006.10.002; Kinoshita Y, 2001, J BIOL CHEM, V276, P6656, DOI 10.1074/jbc.M008536200; Lerch-Gaggl A, 2002, J BIOL CHEM, V277, P45347, DOI 10.1074/jbc.M208338200; Li ZY, 2006, EUKARYOT CELL, V5, P1026, DOI 10.1128/EC.00129-06; Maiorana A, 2004, ONCOGENE, V23, P7116, DOI 10.1038/sj.onc.1207916; Montalibet J, 2005, METHODS, V35, P2, DOI 10.1016/j.ymeth.2004.07.002; Muller IB, 2002, MOL BIOL CELL, V13, P3787, DOI 10.1091/mbc.E02-02-0093; Nett IRE, 2009, EUKARYOT CELL, V8, P617, DOI 10.1128/EC.00366-08; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panigrahi AK, 2001, MOL CELL BIOL, V21, P6833, DOI 10.1128/MCB.21.20.6833-6840.2001; Park JH, 2002, MOL BIOCHEM PARASIT, V119, P97, DOI 10.1016/S0166-6851(01)00407-8; Park JH, 2001, J CELL SCI, V114, P173; PARSONS M, 1991, MOL BIOCHEM PARASIT, V45, P241, DOI 10.1016/0166-6851(91)90091-J; PARSONS M, 1994, MOL BIOCHEM PARASIT, V63, P69, DOI 10.1016/0166-6851(94)90009-4; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Salmeen A, 2000, MOL CELL, V6, P1401, DOI 10.1016/S1097-2765(00)00137-4; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Szoor B, 2006, J CELL BIOL, V175, P293, DOI 10.1083/jcb.200605090; White NJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S8; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Worthen C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000678; ZHANG ZY, 1992, J BIOL CHEM, V267, P23759; Zhang ZY, 2002, ANNU REV PHARMACOL, V42, P209, DOI 10.1146/annurev.pharmtox.42.083001.144616	44	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22075	22081		10.1074/jbc.M110.108860	http://dx.doi.org/10.1074/jbc.M110.108860			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20444707	Green Published, hybrid			2022-12-27	WOS:000279702200020
J	Cogoi, S; Paramasivam, M; Membrino, A; Yokoyama, KK; Xodo, LE				Cogoi, Susanna; Paramasivam, Manikandan; Membrino, Alexandro; Yokoyama, Kazunari K.; Xodo, Luigi E.			The KRAS Promoter Responds to Myc-associated Zinc Finger and Poly(ADP-ribose) Polymerase 1 Proteins, Which Recognize a Critical Quadruplex-forming GA-element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEASE HYPERSENSITIVE ELEMENT; C-MYC; DNA-STRUCTURE; GENE-EXPRESSION; P2 PROMOTER; G4 DNA; BINDING; MAZ; TRANSCRIPTION; PARP-1	The murine KRAS promoter contains a G-rich nuclease hypersensitive element (GA-element) upstream of the transcription start site that is essential for transcription. Pulldown and chromatin immunoprecipitation assays demonstrate that this GA-element is bound by the Myc-associated zinc finger (MAZ) and poly(ADP-ribose) polymerase 1 (PARP-1) proteins. These proteins are crucial for transcription, because when they are knocked down by short hairpin RNA, transcription is down-regulated. This is also the case when the poly(ADP-ribosyl) ation activity of PARP-1 is inhibited by 3,4-dihydro-5-[ 4-(1-piperidinyl) butoxyl]-1(2H) isoquinolinone. We found that MAZ specifically binds to the duplex and quadruplex conformations of the GA-element, whereas PARP-1 shows specificity only for the G-quadruplex. On the basis of fluorescence resonance energy transfer melting and polymerase stop assays we saw that MAZ stabilizes the KRAS quadruplex. When the capacity of folding in the GA-element is abrogated by specific G -> T or G -> A point mutations, KRAS transcription is down-regulated. Conversely, guanidine-modified phthalocyanines, which specifically interact with and stabilize the KRAS G-quadruplex, push the promoter activity up to more than double. Collectively, our data support a transcription mechanism for murine KRAS that involves MAZ, PARP-1 and duplex-quadruplex conformational changes in the promoter GA-element.	[Cogoi, Susanna; Paramasivam, Manikandan; Membrino, Alexandro; Xodo, Luigi E.] Univ Udine, Sch Med, Dept Biomed Sci & Technol, I-33100 Udine, Italy; [Yokoyama, Kazunari K.] Kaohsiung Med Univ, Ctr Excellence Environm Med, Kaohsiung 80708, Taiwan	University of Udine; Kaohsiung Medical University	Xodo, LE (corresponding author), Univ Udine, Sch Med, Dept Biomed Sci & Technol, Piazzale Kolbe 4, I-33100 Udine, Italy.	luigi.xodo@uniud.it	Xodo, Luigi/W-6350-2019	Xodo, Luigi/0000-0003-3344-7207	Associazione Italiana per la Ricerca sul Cancro; Italian Ministry of Scientific Research [PRIN 2007]	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Scientific Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by Associazione Italiana per la Ricerca sul Cancro 2008 and Italian Ministry of Scientific Research (PRIN 2007).	Alzeer J, 2009, CHEM COMMUN, P1970, DOI 10.1039/b822985f; Bonicalzi ME, 2005, CELL MOL LIFE SCI, V62, P739, DOI 10.1007/s00018-004-4505-1; BOSSONE SA, 1992, P NATL ACAD SCI USA, V89, P7452, DOI 10.1073/pnas.89.16.7452; Brooks TA, 2009, NAT REV CANCER, V9, P849, DOI 10.1038/nrc2733; Cahoon LA, 2009, SCIENCE, V325, P764, DOI 10.1126/science.1175653; Caiafa P, 2009, J CELL PHYSIOL, V219, P265, DOI 10.1002/jcp.21691; Chasovskikh S, 2005, CYTOM PART A, V68A, P21, DOI 10.1002/cyto.a.20187; Choi EW, 2010, NUCLEIC ACIDS RES, V38, P1623, DOI 10.1093/nar/gkp1088; Choi HS, 2009, BIOCHEM BIOPH RES CO, V380, P431, DOI 10.1016/j.bbrc.2009.01.136; Cogoi S, 2008, NUCLEIC ACIDS RES, V36, P3765, DOI 10.1093/nar/gkn120; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; DEMURCIA G, 1994, TRENDS BIOCHEM SCI, V19, P172, DOI 10.1016/0968-0004(94)90280-1; Eddy J, 2006, NUCLEIC ACIDS RES, V34, P3887, DOI 10.1093/nar/gkl529; Freyer MW, 2007, BIOPHYS J, V92, P2007, DOI 10.1529/biophysj.106.097246; Green JJ, 2003, J AM CHEM SOC, V125, P3763, DOI 10.1021/ja029149w; Her S, 2003, MOL PHARMACOL, V64, P1180, DOI 10.1124/mol.64.5.1180; Hershman SG, 2008, NUCLEIC ACIDS RES, V36, P144, DOI 10.1093/nar/gkm986; Himeda CL, 2008, MOL CELL BIOL, V28, P6521, DOI 10.1128/MCB.00306-08; HOFFMAN EK, 1990, P NATL ACAD SCI USA, V87, P2705, DOI 10.1073/pnas.87.7.2705; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Izzo MW, 1999, J BIOL CHEM, V274, P19498, DOI 10.1074/jbc.274.27.19498; Jordan-Sciutto KL, 2000, BIOCHEMISTRY-US, V39, P3206, DOI 10.1021/bi992211q; Karantzoulis-Fegaras F, 1999, J BIOL CHEM, V274, P3076, DOI 10.1074/jbc.274.5.3076; Kouzine F, 2008, NAT STRUCT MOL BIOL, V15, P146, DOI 10.1038/nsmb.1372; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Lee SK, 1999, SCIENCE, V286, P2339, DOI 10.1126/science.286.5448.2339; Leroy C, 2004, J MOL ENDOCRINOL, V32, P99, DOI 10.1677/jme.0.0320099; Lew A, 2000, P NATL ACAD SCI USA, V97, P12508, DOI 10.1073/pnas.97.23.12508; Lonskaya I, 2005, J BIOL CHEM, V280, P17076, DOI 10.1074/jbc.M413483200; Maizels N, 2006, NAT STRUCT MOL BIOL, V13, P1055, DOI 10.1038/nsmb1171; Martin-Oliva D, 2006, CANCER RES, V66, P5744, DOI 10.1158/0008-5472.CAN-05-3050; Membrino A, 2010, CHEM COMMUN, V46, P625, DOI 10.1039/b918964e; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350, DOI 10.1128/mcb.16.5.2350; Ogino H, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-41; Palumbo SL, 2008, NUCLEIC ACIDS RES, V36, P1755, DOI 10.1093/nar/gkm1069; Parks CL, 1997, J VIROL, V71, P9600, DOI 10.1128/JVI.71.12.9600-9607.1997; Parks CL, 1996, J BIOL CHEM, V271, P4417; PESTOV DG, 1991, NUCLEIC ACIDS RES, V19, P6527, DOI 10.1093/nar/19.23.6527; Potaman VN, 2005, J MOL BIOL, V348, P609, DOI 10.1016/j.jmb.2005.03.010; Qin Y, 2007, NUCLEIC ACIDS RES, V35, P7698, DOI 10.1093/nar/gkm538; Rankin S, 2005, J AM CHEM SOC, V127, P10584, DOI 10.1021/ja050823u; Ren JS, 1999, BIOCHEMISTRY-US, V38, P16067, DOI 10.1021/bi992070s; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Soldatenkov VA, 2008, ACS CHEM BIOL, V3, P214, DOI 10.1021/cb700234f; Song J, 1998, J BIOL CHEM, V273, P20603, DOI 10.1074/jbc.273.32.20603; Song J, 2001, J BIOL CHEM, V276, P19897, DOI 10.1074/jbc.M010658200; Sun D, 2008, MOL CANCER THER, V7, P880, DOI 10.1158/1535-7163.MCT-07-2119; Sun D, 2009, J MED CHEM, V52, P2863, DOI 10.1021/jm900055s; Teng Y, 2007, CANCER RES, V67, P10491, DOI 10.1158/0008-5472.CAN-06-4206; Thakur RK, 2009, NUCLEIC ACIDS RES, V37, P172, DOI 10.1093/nar/gkn919; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Tomonaga T, 1996, P NATL ACAD SCI USA, V93, P5830, DOI 10.1073/pnas.93.12.5830; Tsutsui H, 1996, BIOCHEM BIOPH RES CO, V226, P801, DOI 10.1006/bbrc.1996.1432; Tsutsui H, 1999, BIOCHEM BIOPH RES CO, V262, P198, DOI 10.1006/bbrc.1999.1130; Ugai H, 2001, BIOCHEM BIOPH RES CO, V286, P1087, DOI 10.1006/bbrc.2001.5469; Wacker DA, 2007, MOL CELL BIOL, V27, P7475, DOI 10.1128/MCB.01314-07	58	97	98	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22003	22016		10.1074/jbc.M110.101923	http://dx.doi.org/10.1074/jbc.M110.101923			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20457603	Green Published, hybrid			2022-12-27	WOS:000279702200013
J	Han, SJ; Makareeva, E; Kuznetsova, NV; DeRidder, AM; Sutter, MB; Losert, W; Phillips, CL; Visse, R; Nagase, H; Leikin, S				Han, Sejin; Makareeva, Elena; Kuznetsova, Natalia V.; DeRidder, Angela M.; Sutter, Mary Beth; Losert, Wolfgang; Phillips, Charlotte L.; Visse, Robert; Nagase, Hideaki; Leikin, Sergey			Molecular Mechanism of Type I Collagen Homotrimer Resistance to Mammalian Collagenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELICAL COLLAGEN; PEPTIDE-BOND HYDROLYSIS; EHLERS-DANLOS-SYNDROME; C-TERMINAL DOMAIN; OSTEOGENESIS IMPERFECTA; FIBROBLAST COLLAGENASE; EXTRACELLULAR-MATRIX; ALPHA-2(I) CHAIN; OSTEO-SARCOMA; GELATINASE-A	Type I collagen cleavage is crucial for tissue remodeling, but its homotrimeric isoform is resistant to all collagenases. The homotrimers occur in fetal tissues, fibrosis, and cancer, where their collagenase resistance may play an important physiological role. To understand the mechanism of this resistance, we studied interactions of alpha 1(I)(3) homotrimers and normal alpha 1(I)(2)alpha 2(I) heterotrimers with fibroblast collagenase (MMP-1). Similar MMP-1 binding to the two isoforms and similar cleavage efficiency of unwound alpha 1(I) and alpha 2(I) chains suggested increased stability and less efficient unwinding of the homotrimer triple helix at the collagenase cleavage site. The unwinding, necessary for placing individual chains inside the catalytic cleft of the enzyme, was the rate-limiting cleavage step for both collagen isoforms. Comparative analysis of the homo-and heterotrimer cleavage kinetics revealed that MMP-1 binding promotes stochastic helix unwinding, resolving the controversy between different models of collagenase action.	[Han, Sejin; Makareeva, Elena; Kuznetsova, Natalia V.; DeRidder, Angela M.; Sutter, Mary Beth; Leikin, Sergey] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA; [Han, Sejin; Losert, Wolfgang] Univ Maryland, Inst Phys Sci & Technol, Dept Phys, College Pk, MD 20742 USA; [Han, Sejin; Losert, Wolfgang] Univ Maryland, Inst Res Elect & Appl Phys, College Pk, MD 20742 USA; [Phillips, Charlotte L.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Visse, Robert; Nagase, Hideaki] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst, Div Rheumatol, London W6 8LH, England	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of Missouri System; University of Missouri Columbia; Imperial College London; University of Oxford	Leikin, S (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bldg 9,Rm 1E-127, Bethesda, MD 20892 USA.	leikins@mail.nih.gov	Makareeva, Elena/F-5183-2011; Leikin, Sergey/A-5518-2008	Makareeva, Elena/0000-0002-5815-0760; Leikin, Sergey/0000-0001-7095-0739; Phillips, Charlotte/0000-0002-7761-3783	National Institutes of Health NICHD; NIDDK [DK069522]; National Science Foundation [PHY-0750371]; Wellcome Trust [075473]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000256] Funding Source: NIH RePORTER	National Institutes of Health NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Science Foundation(National Science Foundation (NSF)); Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health NICHD Intramural Research Program grant (to S.L.) and NIDDK Grant DK069522 (to C.L.P.). This work was also supported by National Science Foundation Grant PHY-0750371 (to W.L.) and Wellcome Trust Program Grant 075473 (to H.N.).	ASOKAN R, 1993, MOL CELL BIOCHEM, V121, P99, DOI 10.1007/BF00925968; Bailey AJ, 2002, INT J BIOCHEM CELL B, V34, P176, DOI 10.1016/S1357-2725(01)00107-8; Barbolina MV, 2008, SEMIN CELL DEV BIOL, V19, P24, DOI 10.1016/j.semcdb.2007.06.008; Beare AHM, 2003, J INVEST DERMATOL, V120, P153, DOI 10.1046/j.1523-1747.2003.12019.x; Brodeur AC, 2007, KIDNEY INT, V71, P985, DOI 10.1038/sj.ki.5002173; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; CLARK IM, 1989, BIOCHEM J, V263, P201, DOI 10.1042/bj2630201; Collier IE, 2001, BIOPHYS J, V81, P2370, DOI 10.1016/S0006-3495(01)75883-3; DECLERCK YA, 1987, CANCER RES, V47, P6505; EHRLICH HP, 1982, BIOCHEM MED METAB B, V28, P273, DOI 10.1016/0006-2944(82)90080-1; Han S, 2008, J MOL BIOL, V383, P122, DOI 10.1016/j.jmb.2008.08.008; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; JIMENEZ SA, 1977, BIOCHEM BIOPH RES CO, V78, P1354, DOI 10.1016/0006-291X(77)91441-3; Kuznetsova NV, 2003, J MOL BIOL, V331, P191, DOI 10.1016/S0022-2836(03)00715-0; LEHEUP BP, 1989, LAB INVEST, V60, P791; LESOT H, 1981, BIOCHIM BIOPHYS ACTA, V656, P206, DOI 10.1016/0005-2787(81)90088-5; LITTLE CD, 1977, CELL, V10, P287, DOI 10.1016/0092-8674(77)90222-7; LIU X, 1995, J CELL BIOL, V130, P227, DOI 10.1083/jcb.130.1.227; Makareeva E, 2006, J BIOL CHEM, V281, P6463, DOI 10.1074/jbc.M511830200; Makareeva E, 2008, J BIOL CHEM, V283, P4787, DOI 10.1074/jbc.M705773200; Makareeva E, 2010, CANCER RES, V70, P4366, DOI 10.1158/0008-5472.CAN-09-4057; Malfait F, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.038224; Mann V, 2001, J CLIN INVEST, V107, P899, DOI 10.1172/JCI10347; Miles CA, 2002, J MOL BIOL, V321, P797, DOI 10.1016/S0022-2836(02)00703-9; MILLER EJ, 1982, METHOD ENZYMOL, V82, P33; MINAFRA IP, 1985, CELL BIOL INT REP, V9, P291, DOI 10.1016/0309-1651(85)90047-5; MINAFRA S, 1988, CELL BIOL INT REP, V12, P895, DOI 10.1016/0309-1651(88)90053-7; MORO L, 1977, ARCH BIOCHEM BIOPHYS, V182, P33, DOI 10.1016/0003-9861(77)90280-6; MURPHY G, 1992, J BIOL CHEM, V267, P9612; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; NARAYANAN AS, 1984, COLLAGEN REL RES, V4, P289; NARAYANAN AS, 1980, BIOCHEMISTRY-US, V19, P5037, DOI 10.1021/bi00563a016; Nerenberg PS, 2008, J MOL BIOL, V382, P246, DOI 10.1016/j.jmb.2008.07.009; Nerenberg PS, 2008, PROTEINS, V70, P1154, DOI 10.1002/prot.21687; Pace JM, 2008, J BIOL CHEM, V283, P16061, DOI 10.1074/jbc.M801982200; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; ROJKIND M, 1979, GASTROENTEROLOGY, V76, P710; RUPARD JH, 1988, AM J PATHOL, V133, P316; Saffarian S, 2004, SCIENCE, V306, P108, DOI 10.1126/science.1099179; Schwarze U, 2004, AM J HUM GENET, V74, P917, DOI 10.1086/420794; SHAPIRO FD, 1982, J NATL CANCER I, V69, P1009; Tam EM, 2004, J BIOL CHEM, V279, P43336, DOI 10.1074/jbc.M407186200; UITTO J, 1979, ARCH BIOCHEM BIOPHYS, V192, P371, DOI 10.1016/0003-9861(79)90105-X; WELGUS HG, 1981, J BIOL CHEM, V256, P9511; YAMAGATA S, 1984, J BIOCHEM-TOKYO, V96, P17, DOI 10.1093/oxfordjournals.jbchem.a134809; Zhao WG, 2000, J CLIN INVEST, V106, P941, DOI 10.1172/JCI10158	48	83	88	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22276	22281		10.1074/jbc.M110.102079	http://dx.doi.org/10.1074/jbc.M110.102079			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20463013	Green Published, hybrid			2022-12-27	WOS:000279702200040
J	Ohashi, K; Ouchi, N; Higuchi, A; Shaw, RJ; Walsh, K				Ohashi, Koji; Ouchi, Noriyuki; Higuchi, Akiko; Shaw, Reuben J.; Walsh, Kenneth			LKB1 Deficiency in Tie2-Cre-expressing Cells Impairs Ischemia-induced Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; PEUTZ-JEGHERS-SYNDROME; ADIPONECTIN STIMULATES ANGIOGENESIS; ENDOTHELIAL GROWTH-FACTOR; SKELETAL-MUSCLE; GLUCOSE-HOMEOSTASIS; TUMOR-SUPPRESSOR; CANCER CELLS; NO SYNTHASE; EXPRESSION	LKB1 is a tumor suppressor protein whose loss leads to HIF1 alpha-mediated activation of a proangiogenic program in intestinal polyps. LKB1 is also protein kinase regulator of AMP-activated protein kinase (AMPK) signaling, which is essential for endothelial cell responses to tissue ischemia. To discern whether LKB1 signaling is either pro- or antiangiogenic, we investigated ischemia-induced revascularization in mice that were deficient for LKB1 in Tie2-Cre-expressing cells. Whereas homozygous deletion of LKB1 led to embryonic lethality, heterozygous LKB1-knock-out (KO) (Lkb1(flox/+); Tie2(Tg/+)) mice were viable. Unchallenged heterozygous LKB1-KO mice displayed normal capillary density, but the revascularization of hind limb following ischemic surgery was significantly impaired as evaluated by laser Doppler flow and capillary density measurements. Reduction of LKB1 in cultured endothelial cells, using either small interfering RNA or an adenovirus expressing nonfunctional kinase-dead LKB1 protein, attenuated endothelial proliferation, migration, and differentiation into network structures on Matrigel that was accompanied by diminished AMPK phosphorylation at Thr-172. Conversely, adenovirus-mediated LKB1 overexpression (Ad-LKB1) augmented network structure formation, and this was associated with elevated AMPK phosphorylation. The augmented differentiation of endothelial cells into network structures induced by Ad-LKB1 was abrogated by the co-transduction of a dominant negative mutant of AMPK. These observations suggest that the LKB1-AMPK signaling axis in endothelial cells is a positive regulator of the revascularization response to tissue ischemia.	[Walsh, Kenneth] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Dept Mol Cardiol, Boston, MA 02118 USA; [Shaw, Reuben J.] Salk Inst Biol Studies, Mol & Cell Biol Lab, Dulbecco Ctr Canc Res, La Jolla, CA 92037 USA	Boston University; Salk Institute	Walsh, K (corresponding author), Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Dept Mol Cardiol, 715 Albany St,W611, Boston, MA 02118 USA.	kxwalsh@bu.edu	OHASHI, Koji/I-7307-2014; OUCHI, Noriyuki/I-7306-2014	Walsh, Kenneth/0000-0001-7580-2276	National Institutes of Health [AG15052, HL91949, HL81587]; Manpei Suzuki Diabetes Foundation; American Heart Association Scientist Development, Northeast Affiliate; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091949, P01HL081587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015052, R37AG015052] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Manpei Suzuki Diabetes Foundation; American Heart Association Scientist Development, Northeast Affiliate(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG15052, HL91949, and HL81587 (to K.W.).; Supported by the Manpei Suzuki Diabetes Foundation.; Supported by an American Heart Association Scientist Development grant, Northeast Affiliate.	Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; Arras M, 1998, J CLIN INVEST, V101, P40, DOI 10.1172/JCI119877; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349; Galasso G, 2006, CIRC RES, V98, P254, DOI 10.1161/01.RES.0000200740.57764.52; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hemminki A, 1997, NAT GENET, V15, P87, DOI 10.1038/ng0197-87; Ikeda Y, 2009, J BIOL CHEM, V284, P35839, DOI 10.1074/jbc.M109.057273; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Karuman P, 2001, MOL CELL, V7, P1307, DOI 10.1016/S1097-2765(01)00258-1; Koh HJ, 2006, MOL CELL BIOL, V26, P8217, DOI 10.1128/MCB.00979-06; KUDO N, 1995, J BIOL CHEM, V270, P17513, DOI 10.1074/jbc.270.29.17513; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Londesborough A, 2008, DEVELOPMENT, V135, P2331, DOI 10.1242/dev.017038; Miyoshi H, 2002, CANCER RES, V62, P2261; Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200; Noga AA, 2007, AM J PHYSIOL-HEART C, V292, pH1460, DOI 10.1152/ajpheart.01133.2006; Ohashi K, 2009, MOL CELL BIOL, V29, P3487, DOI 10.1128/MCB.00126-09; Ouchi N, 2005, CIRC RES, V96, P838, DOI 10.1161/01.RES.0000163633.10240.3b; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Shackelford DB, 2009, P NATL ACAD SCI USA, V106, P11137, DOI 10.1073/pnas.0900465106; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Skurk C, 2005, CIRC RES, V96, P308, DOI 10.1161/01.RES.0000156273.30274.f7; Stabile E, 2006, CIRCULATION, V113, P118, DOI 10.1161/CIRCULATIONAHA.105.576702; Stahmann N, 2006, MOL CELL BIOL, V26, P5933, DOI 10.1128/MCB.00383-06; Tiainen M, 1999, P NATL ACAD SCI USA, V96, P9248, DOI 10.1073/pnas.96.16.9248; Tiainen M, 2002, HUM MOL GENET, V11, P1497, DOI 10.1093/hmg/11.13.1497; Witczak CA, 2008, CELL MOL LIFE SCI, V65, P3737, DOI 10.1007/s00018-008-8244-6; Xie ZL, 2009, MOL CELL BIOL, V29, P3582, DOI 10.1128/MCB.01417-08; Xie ZL, 2006, J BIOL CHEM, V281, P6366, DOI 10.1074/jbc.M511178200; Ylikorkala A, 2001, SCIENCE, V293, P1323, DOI 10.1126/science.1062074; Zhang YJ, 2006, ARTERIOSCL THROM VAS, V26, P1281, DOI 10.1161/01.ATV.0000221230.08596.98; Zhou J, 2009, ONCOGENE, V28, P1993, DOI 10.1038/onc.2009.63; Zhuang ZG, 2006, MOL CANCER RES, V4, P843, DOI 10.1158/1541-7786.MCR-06-0118; Zou MH, 2003, J BIOL CHEM, V278, P34003, DOI 10.1074/jbc.M300215200; Zou MH, 2002, J BIOL CHEM, V277, P32552, DOI 10.1074/jbc.M204512200	41	33	34	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22291	22298		10.1074/jbc.M110.123794	http://dx.doi.org/10.1074/jbc.M110.123794			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20489196	hybrid, Green Published			2022-12-27	WOS:000279702200042
J	Tadevosyan, A; Maguy, A; Villeneuve, LR; Babin, J; Bonnefoy, A; Allen, BG; Nattel, S				Tadevosyan, Artavazd; Maguy, Ange; Villeneuve, Louis R.; Babin, Judith; Bonnefoy, Arnaud; Allen, Bruce G.; Nattel, Stanley			Nuclear-delimited Angiotensin Receptor-mediated Signaling Regulates Cardiomyocyte Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; SMOOTH-MUSCLE-CELLS; END-POINT REDUCTION; II-BINDING SITES; NF-KAPPA-B; CARDIAC MYOCYTES; ANG-II; CARDIOVASCULAR MORBIDITY; LOSARTAN INTERVENTION; TRANSCRIPTION FACTOR	Angiotensin-II (Ang-II) from extracardiac sources and intra-cardiac synthesis regulates cardiac homeostasis, with mitogenic and growth-promoting effects largely due to altered gene expression. Here, we assessed the possibility that angiotensin-1 (AT1R) or angiotensin-2 (AT2R) receptors on the nuclear envelope mediate effects on cardiomyocyte gene expression. Immunoblots of nucleus-enriched fractions from isolated cardiomyocytes indicated the presence of AT1R and AT2R proteins that copurified with the nuclear membrane marker nucleoporin-62 and histone-3, but not markers of plasma (calpactin-I), Golgi (GRP-78), or endoplasmic reticulum (GM130) membranes. Confocal microscopy revealed AT1R and AT2R proteins on nuclear membranes. Microinjected Ang-II preferentially bound to nuclear sites of isolated cardiomyocytes. AT1R and AT2R ligands enhanced de novo RNA synthesis in isolated cardiomyocyte nuclei incubated with [alpha-P-32]UTP (e.g. 36.0 +/- 6.0 cpm/ng of DNA control versus 246.4 +/- 15.4 cpm/ng of DNA Ang-II, 390.1 +/- 15.5 cpm/ng of DNA L-162313 (AT1), 180.9 +/- 7.2 cpm/ng of DNA CGP42112A (AT2), p < 0.001). Ang-II application to cardiomyocyte nuclei enhanced NF kappa B mRNA expression, a response that was suppressed by co-administration of AT1R (valsartan) and/or AT2R (PD123177) blockers. Dose-response experiments with Ang-II applied to purified cardiomyocyte nuclei versus intact cardiomyocytes showed greater increases in NF kappa B mRNA levels at saturating concentrations with similar to 2-fold greater affinity upon nuclear application, suggesting preferential nuclear signaling. AT1R, but not AT2R, stimulation increased [Ca2+] in isolated cardiomyocyte nuclei. Inositol 1,4,5-trisphosphate receptor blockade by 2-aminoethoxydiphenyl borate prevented AT1R-mediated Ca2+ release and attenuated AT1R-mediated transcription initiation responses. We conclude that cardiomyocyte nuclear membranes possess angiotensin receptors that couple to nuclear signaling pathways and regulate transcription. Signaling within the nuclear envelope (e.g. from intracellularly synthesized Ang-II) may play a role in Ang-II-mediated changes in cardiac gene expression, with potentially important mechanistic and therapeutic implications.	[Tadevosyan, Artavazd; Babin, Judith; Bonnefoy, Arnaud; Allen, Bruce G.; Nattel, Stanley] Montreal Heart Inst, Dept Med, Montreal, PQ H1T 1C8, Canada; [Allen, Bruce G.] Montreal Heart Inst, Dept Biochem, Montreal, PQ H1T 1C8, Canada; [Bonnefoy, Arnaud] Univ Montreal, INSERM, U743, Montreal, PQ H3T 1J4, Canada; [Allen, Bruce G.; Nattel, Stanley] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada	Universite de Montreal; Universite de Montreal; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montreal; McGill University	Nattel, S (corresponding author), 5000 Belanger St E, Montreal, PQ H1T 1C8, Canada.	stanley.nattel@icm-mhi.org	Maguy, Ange/ABG-9298-2021; Allen, Bruce G/B-4693-2008	Allen, Bruce G/0000-0001-9000-9495; Maguy, Ange/0000-0003-0170-7430; Nattel, Stanley/0000-0002-5565-3311	Canadian Institutes of Health Research [MGP 6957]; Fondation Leducq	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fondation Leducq(Leducq Foundation)	This work was supported by Canadian Institutes of Health Research Grant MGP 6957 and the European-North American Atrial Fibrillation Research Alliance (ENAFRA) award from Fondation Leducq.	AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; Baker KM, 2004, REGUL PEPTIDES, V120, P5, DOI 10.1016/j.regpep.2004.04.004; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; BATTLE T, 1994, TISSUE CELL, V26, P943, DOI 10.1016/0040-8166(94)90043-4; Bezin S, 2008, J BIOL CHEM, V283, P27859, DOI 10.1074/jbc.M804701200; Bhattacharya M, 1998, P NATL ACAD SCI USA, V95, P15792, DOI 10.1073/pnas.95.26.15792; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Boivin B, 2003, J BIOL CHEM, V278, P29153, DOI 10.1074/jbc.M301738200; Boivin B, 2006, CARDIOVASC RES, V71, P69, DOI 10.1016/j.cardiores.2006.03.015; BOOZ GW, 1992, ENDOCRINOLOGY, V130, P3641, DOI 10.1210/en.130.6.3641; CHEN L, 1991, P SOC EXP BIOL MED, V196, P280; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; De Mello WC, 2006, REGUL PEPTIDES, V133, P10, DOI 10.1016/j.regpep.2005.09.020; De Mello WC, 1998, HYPERTENSION, V32, P976, DOI 10.1161/01.HYP.32.6.976; Filipeanu CM, 2001, BRIT J PHARMACOL, V132, P1590, DOI 10.1038/sj.bjp.0703984; Gerasimenko O, 2004, J CELL SCI, V117, P3087, DOI 10.1242/jcs.01295; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Groth W, 2003, J HYPERTENS, V21, P2175, DOI 10.1097/00004872-200311000-00028; Haller H, 1996, CIRC RES, V79, P765, DOI 10.1161/01.RES.79.4.765; Ichihara A, 2006, HYPERTENSION, V47, P894, DOI 10.1161/01.HYP.0000215838.48170.0b; Juillerat-Jeanneret L, 2004, BRIT J CANCER, V90, P1059, DOI 10.1038/sj.bjc.6601646; Kang NL, 2002, J MOL MED, V80, P359, DOI 10.1007/s00109-002-0326-6; Kusnier C, 2006, BIOL RES, V39, P541, DOI 10.4067/S0716-97602006000300015; Li XC, 2008, AM J PHYSIOL-CELL PH, V294, pC1034, DOI 10.1152/ajpcell.00432.2007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malviya AN, 1998, CELL, V92, P17, DOI 10.1016/S0092-8674(00)80895-8; Martini JS, 2008, P NATL ACAD SCI USA, V105, P12457, DOI 10.1073/pnas.0803153105; Meberg PJ, 1996, MOL BRAIN RES, V38, P179, DOI 10.1016/0169-328X(95)00229-L; Peters J, 2002, CIRC RES, V90, P1135, DOI 10.1161/01.RES.0000019242.51541.99; Re RN, 2008, J CLIN PHARMACOL, V48, P344, DOI 10.1177/0091270007312155; Re RN, 2007, NAT CLIN PRACT CARD, V4, P549, DOI 10.1038/ncpcardio0985; Reudelhuber TL, 2007, HYPERTENSION, V49, P1196, DOI 10.1161/HYPERTENSIONAHA.106.075085; ROBERTSON AL, 1971, SCIENCE, V172, P1138, DOI 10.1126/science.172.3988.1138; SADOSHIMA J, 1993, CELL, V75, P977, DOI 10.1016/0092-8674(93)90541-W; Shao J, 2007, J HYPERTENS, V25, P1643, DOI 10.1097/HJH.0b013e328165d159; Singh VP, 2007, AM J PHYSIOL-HEART C, V293, pH939, DOI 10.1152/ajpheart.00391.2007; Singh VP, 2008, DIABETES, V57, P3297, DOI 10.2337/db08-0805; Sorriento D, 2008, P NATL ACAD SCI USA, V105, P17818, DOI 10.1073/pnas.0804446105; TANG SS, 1992, ENDOCRINOLOGY, V131, P374, DOI 10.1210/en.131.1.374; Wachtell K, 2005, J AM COLL CARDIOL, V45, P705, DOI 10.1016/j.jacc.2004.06.080; Willard FS, 2000, IMMUNOL CELL BIOL, V78, P387, DOI 10.1046/j.1440-1711.2000.00927.x; Wright CD, 2008, CIRC RES, V103, P992, DOI 10.1161/CIRCRESAHA.108.176024; Xu J, 2007, AM J PHYSIOL-HEART C, V293, pH1900, DOI 10.1152/ajpheart.00379.2007; Zima AV, 2007, J PHYSIOL-LONDON, V584, P601, DOI 10.1113/jphysiol.2007.140731	44	89	89	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22338	22349		10.1074/jbc.M110.121749	http://dx.doi.org/10.1074/jbc.M110.121749			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20463030	hybrid, Green Published			2022-12-27	WOS:000279702200047
J	Daniels, C; Daddaoua, A; Lu, D; Zhang, XD; Ramos, JL				Daniels, Craig; Daddaoua, Abdelali; Lu, Duo; Zhang, Xiaodong; Ramos, Juan-Luis			Domain Cross-talk during Effector Binding to the Multidrug Binding TTGR Regulator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-PUTIDA DOT-T1E; EFFLUX PUMPS; ESCHERICHIA-COLI; RESISTANCE; EXPRESSION; TOLERANCE; BACTERIA; PROTEIN; TTGABC	A major mechanism of antibiotic resistance in bacteria is the active extrusion of toxic compounds through membrane-bound efflux pumps. The TtgR protein represses transcription of ttgABC, a key efflux pump in Pseudomonas putida DOT-T1E capable of extruding antibiotics, solvents, and flavonoids. TtgR contains two distinct and overlapping ligand binding sites, one is broad and contains mainly hydrophobic residues, whereas the second is deep and contains polar residues. Mutants in the ligand binding pockets were generated and characterized using electrophoretic mobility shift assays, isothermal titration calorimetry, and promoter expression. Several mutants were affected in their response to effectors in vitro: mutants H70A, H72A, and R75A did not dissociate from promoter DNA in the presence of chloramphenicol. Other mutants exhibited altered binding to the operator: L66A and L66AV96A mutants bound 3- and 15-fold better than the native protein, whereas the H67A mutant bound with 3- fold lower affinity. In vivo expression assays using a fusion of the promoter of ttgA to lacZ and antibiotic tolerance correlated with the in vitro observations, namely that mutant H67A leads to increased basal expression levels and enhances antibiotic tolerance, whereas mutants L66A and L66AV96A exhibit lower basal expression levels and decreased resistance to antibiotics. The crystal structure of TtgR H67A was resolved. The data provide evidence for the inter-domain communication that is predicted to be required for the transmission of the effector binding signal to the DNA binding domain and provide important information to understand TtgR/DNA/effector interactions.	[Ramos, Juan-Luis] CSIC, EEZ, Environm Protect Dept, E-18008 Granada, Spain; [Lu, Duo; Zhang, Xiaodong] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); Imperial College London	Ramos, JL (corresponding author), CSIC, EEZ, Environm Protect Dept, C Prof Albareda 1, E-18008 Granada, Spain.	jlramos@eez.csic.es	Daddaoua, Abdelali/D-6930-2014	Zhang, Xiaodong/0000-0001-9786-7038; Ramos, Juan L./0000-0002-8731-7435; Daddaoua, Abdelali/0000-0002-7348-6393	Junta de Andalucia FEDER Proyecto de Excelencia [CVI1912]; FEDER [BIO2006-05668]; Spanish Ministry of Science and Innovation [PSYSMO GEN2006-27750-C5-5-E/SYS]; Consejo Superior de Investigaciones Cientificas; MRC [G0501723] Funding Source: UKRI; Medical Research Council [G0501723] Funding Source: researchfish	Junta de Andalucia FEDER Proyecto de Excelencia; FEDER(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejo Superior de Investigaciones Cientificas; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by Junta de Andalucia FEDER Proyecto de Excelencia Grant CVI1912, FEDER Consolider C Grant BIO2006-05668, and Grant PSYSMO GEN2006-27750-C5-5-E/SYS from the Spanish Ministry of Science and Innovation.; Recipient of an I3P fellowship from Consejo Superior de Investigaciones Cientificas.	Alguel Y, 2007, J MOL BIOL, V369, P829, DOI 10.1016/j.jmb.2007.03.062; Amsterdam D., 1991, ANTIBIOTICS LAB MED, P72; Bernal P, 2007, ENVIRON MICROBIOL, V9, P1658, DOI 10.1111/j.1462-2920.2007.01283.x; Chuanchuen R, 2002, J BACTERIOL, V184, P5036, DOI 10.1128/JB.184.18.5036-5044.2002; Duque E, 2001, MOL MICROBIOL, V39, P1100, DOI 10.1046/j.1365-2958.2001.02310.x; Grkovic S, 1998, J BIOL CHEM, V273, P18665, DOI 10.1074/jbc.273.29.18665; Kieboom J, 2001, MICROBIOL-SGM, V147, P43, DOI 10.1099/00221287-147-1-43; Krell T, 2007, J MOL BIOL, V369, P1188, DOI 10.1016/j.jmb.2007.04.025; LOMOVSKAYA O, 1995, J BACTERIOL, V177, P2328, DOI 10.1128/jb.177.9.2328-2334.1995; MILLER JH, 1972, EXPT MOL GENETICS, pCH48; Nikaido H, 2001, J MOL MICROB BIOTECH, V3, P215; Nikaido H, 2001, SEMIN CELL DEV BIOL, V12, P215, DOI 10.1006/scdb.2000.0247; POOLE K, 2003, PSEUDOMONAS; Ramos JL, 2002, ANNU REV MICROBIOL, V56, P743, DOI 10.1146/annurev.micro.56.012302.161038; Ramos JL, 1998, J BACTERIOL, V180, P3323, DOI 10.1128/JB.180.13.3323-3329.1998; RAMOS JL, 1995, J BACTERIOL, V177, P3911, DOI 10.1128/jb.177.14.3911-3916.1995; SPAINK HP, 1987, PLANT MOL BIOL, V9, P27, DOI 10.1007/BF00017984; Teran W, 2003, ANTIMICROB AGENTS CH, V47, P3067, DOI 10.1128/AAC.47.10.3067-3072.2003; Teran W, 2006, J BIOL CHEM, V281, P7102, DOI 10.1074/jbc.M511095200	19	22	23	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21372	21381		10.1074/jbc.M110.113282	http://dx.doi.org/10.1074/jbc.M110.113282			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20435893	Green Published, hybrid			2022-12-27	WOS:000279516100023
J	Peng, FW; Yao, HH; Bai, XT; Zhu, XH; Reiner, BC; Beazely, M; Funa, K; Xiong, HG; Buch, S				Peng, Fuwang; Yao, Honghong; Bai, Xuetao; Zhu, Xuhui; Reiner, Benjamin C.; Beazely, Michael; Funa, Keiko; Xiong, Huangui; Buch, Shilpa			Platelet-derived Growth Factor-mediated Induction of the Synaptic Plasticity Gene Arc/Arg3.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; IMMEDIATE-EARLY GENE; METABOTROPIC GLUTAMATE RECEPTORS; PROTEASE-ACTIVATED LIGAND; CENTRAL-NERVOUS-SYSTEM; PDGF B-CHAIN; HIPPOCAMPAL-NEURONS; MESSENGER-RNA; IN-VITRO; INTRACELLULAR CALCIUM	Platelet-derived growth factor (PDGF) is a pleiotropic protein with critical roles in both developmental as well as pathogenic processes. In the central nervous system specifically, PDGF is critical for neuronal proliferation and differentiation and has also been implicated as a neuroprotective agent. Whether PDGF also plays a role in synaptic plasticity, however, remains poorly understood. In the present study we demonstrated that in the rat hippocampal neurons PDGF regulated the expression of Arc/Arg3.1 gene that has been implicated in both synapse plasticity and long term potentiation. Relevance of these findings was further confirmed in vivo by injecting mice with intracerebral inoculations of PDGF, which resulted in a rapid induction of Arc in the hippocampus of the injected mice. PDGF induced long term potentiation in rat hippocampal slices, which was abolished by PDGF receptor-tyrosine kinase inhibitor STI-571. We also present evidence that PDGF-mediated induction of Arc/Arg3.1 involved activation of the MAPK/ERK (MEK) pathway. Additionally, induction of Arc/Arg3.1 also involved the upstream release of intracellular calcium stores, an effect that could be blocked by thapsigargin but not by EGTA. Pharmacological approach using inhibitors specific for either MAPK/ERK phosphorylation or calcium release demonstrated that the two pathways converged downstream at a common point involving activation of the immediate early gene Egr-1. Chromatin immunoprecipitation assays demonstrated the binding of Egr-1, but not Egr-3, to the Arc promoter. These findings for the first time, thus, suggest an additional role of PDGF, that of induction of Arc.	[Xiong, Huangui; Buch, Shilpa] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA; [Bai, Xuetao] Univ Kansas, Med Ctr, Dept Pathol, Kansas City, KS 66160 USA; [Beazely, Michael] Univ Waterloo, Sch Pharm, Kitchener, ON N2G 1C5, Canada; [Funa, Keiko] Gothenburg Univ, SE-40530 Gothenburg, Sweden	University of Nebraska System; University of Nebraska Medical Center; University of Kansas; University of Kansas Medical Center; University of Waterloo; University of Gothenburg	Buch, S (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, 985880 Nebraska Med Ctr,DRC 8011, Omaha, NE 68198 USA.	sbuch@unmc.edu	Reiner, Benjamin/ABG-1618-2020	Reiner, Benjamin/0000-0001-7796-587X; Beazely, Michael/0000-0002-8722-460X; Buch, Shilpa/0000-0002-3103-6685	National Institutes of Health [MH-068212, DA020392, DA023397, DA024442, DA027729]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068212, P30MH062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020392, R21DA023397, R01DA027729, R01DA024442] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants MH-068212, DA020392, DA023397, DA024442, and DA027729 (to S. B.).	ABRAHAM WC, 1991, MOL NEUROBIOL, V5, P297, DOI 10.1007/BF02935553; Beazely MA, 2009, J BIOL CHEM, V284, P8054, DOI 10.1074/jbc.M805384200; BENITO M, 1993, GROWTH REGULAT, V3, P172; Bergsten E, 2001, NAT CELL BIOL, V3, P512, DOI 10.1038/35074588; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; CHENG B, 1995, J NEUROSCI, V15, P7095; Coogan AN, 1999, NEUROSCIENCE, V93, P57, DOI 10.1016/S0306-4522(99)00100-1; Cottrell JR, 2004, NEURON, V44, P677, DOI 10.1016/j.neuron.2004.10.025; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Egawa-Tsuzuki T, 2004, EXP NEUROL, V186, P89, DOI 10.1016/j.expneurol.2003.11.001; Enarsson M, 2002, MOL CANCER RES, V1, P147; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Erlandsson A, 2001, J NEUROSCI, V21, P3483, DOI 10.1523/JNEUROSCI.21-10-03483.2001; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Gozal D, 2000, J NEUROCHEM, V74, P310, DOI 10.1046/j.1471-4159.2000.0740310.x; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Heldin CH, 2002, ARCH BIOCHEM BIOPHYS, V398, P284, DOI 10.1006/abbi.2001.2707; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hynds DL, 1997, J NEUROSCI RES, V47, P617, DOI 10.1002/(SICI)1097-4547(19970315)47:6<617::AID-JNR7>3.0.CO;2-G; Iihara K, 1997, J CEREBR BLOOD F MET, V17, P1097, DOI 10.1097/00004647-199710000-00012; Ishii Y, 2006, J NEUROCHEM, V98, P588, DOI 10.1111/j.1471-4159.2006.03922.x; Kuhl D, 1998, CURR OPIN NEUROBIOL, V8, P600, DOI 10.1016/S0959-4388(98)80087-1; Lanahan A, 1998, NEUROBIOL LEARN MEM, V70, P37, DOI 10.1006/nlme.1998.3836; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Li L, 2005, MOL CELL BIOL, V25, P10286, DOI 10.1128/MCB.25.23.10286-10300.2005; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; Machado HB, 2008, J NEUROSCI RES, V86, P593, DOI 10.1002/jnr.21529; Mayer SI, 2009, EUR J CELL BIOL, V88, P19, DOI 10.1016/j.ejcb.2008.07.002; Mellor J, 2001, NAT NEUROSCI, V4, P125, DOI 10.1038/83941; Mohapel P, 2005, NEUROSCIENCE, V132, P767, DOI 10.1016/j.neuroscience.2004.11.056; Moon Y, 2007, TOXICOL APPL PHARM, V223, P155, DOI 10.1016/j.taap.2007.04.018; Nunes-de-Souza RL, 2002, BRAIN RES, V927, P87, DOI 10.1016/S0006-8993(01)03335-2; Oak JN, 2001, MOL PHARMACOL, V60, P92, DOI 10.1124/mol.60.1.92; OTHBERG A, 1995, EXP BRAIN RES, V105, P111; Peng FW, 2008, J NEUROVIROL, V14, P62, DOI 10.1080/13550280701809084; Pietz K, 1996, NEUROSCI LETT, V204, P101, DOI 10.1016/0304-3940(96)12326-0; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Pratsinis H, 2007, EUR SPINE J, V16, P1858, DOI 10.1007/s00586-007-0408-9; Rosenblum K, 2000, J NEUROSCI, V20, P977, DOI 10.1523/JNEUROSCI.20-03-00977.2000; Rosengart MR, 2000, SHOCK, V13, P183, DOI 10.1097/00024382-200003000-00003; RUPPRECHT HD, 1993, AM J PHYSIOL, V265, pF351, DOI 10.1152/ajprenal.1993.265.3.F351; Saqr HE, 1999, NEUROCHEM INT, V35, P411, DOI 10.1016/S0197-0186(99)00092-3; SASAHARA A, 1992, DEV BRAIN RES, V68, P41, DOI 10.1016/0165-3806(92)90246-S; SASAHARA M, 1991, CELL, V64, P217, DOI 10.1016/0092-8674(91)90223-L; SMITS A, 1991, P NATL ACAD SCI USA, V88, P8159, DOI 10.1073/pnas.88.18.8159; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Steward O, 2002, NEUROBIOL LEARN MEM, V78, P508, DOI 10.1006/nlme.2002.4102; Sung JY, 2001, J NEUROCHEM, V78, P1044, DOI 10.1046/j.1471-4159.2001.00491.x; Tseng HC, 2005, NEUROBIOL DIS, V19, P77, DOI 10.1016/j.nbd.2004.11.007; Tsui CC, 1996, J NEUROSCI, V16, P2463; Valenzuela CF, 1995, MOL PHARMACOL, V48, P1099; Valenzuela CF, 1997, BRAIN RES REV, V24, P77; Waltereit R, 2001, J NEUROSCI, V21, P5484, DOI 10.1523/JNEUROSCI.21-15-05484.2001; Williams BP, 1997, NEURON, V18, P553, DOI 10.1016/S0896-6273(00)80297-4; WILLIAMS S, 1989, NEURON, V3, P583, DOI 10.1016/0896-6273(89)90268-7; Xiong HG, 1996, BRAIN RES, V737, P188, DOI 10.1016/0006-8993(96)00731-7; Yao HH, 2005, J NEUROCHEM, V92, P948, DOI 10.1111/j.1471-4159.2004.02937.x; Yin Y, 2002, P NATL ACAD SCI USA, V99, P2368, DOI 10.1073/pnas.042693699; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984; Zheng F, 2009, J NEUROSCI RES, V87, P380, DOI 10.1002/jnr.21863	65	41	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21615	21624		10.1074/jbc.M110.107003	http://dx.doi.org/10.1074/jbc.M110.107003			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20452974	Green Published, hybrid			2022-12-27	WOS:000279516100048
J	Wang, Z; Ginnan, R; Abdullaev, IF; Trebak, M; Vincent, PA; Singer, HA				Wang, Zhen; Ginnan, Roman; Abdullaev, Iskandar F.; Trebak, Mohamed; Vincent, Peter A.; Singer, Harold A.			Calcium/Calmodulin-dependent Protein Kinase II Delta 6 (CaMKII delta(6)) and RhoA Involvement in Thrombin-induced Endothelial Barrier Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; CELL PROLIFERATION; ISOFORM REGULATION; ERK ACTIVATION; TRP CHANNELS; HEART-TISSUE; PERMEABILITY; CAMKII; MECHANISM; ENTRY	Multiple Ca2+ release and entry mechanisms and potential cytoskeletal targets have been implicated in vascular endothelial barrier dysfunction; however, the immediate downstream effectors of Ca2+ signals in the regulation of endothelial permeability still remain unclear. In the present study, we evaluated the contribution of multifunctional Ca2+/calmodulin-dependent protein kinase II (CaMKII) as a mediator of thrombin-stimulated increases in human umbilical vein endothelial cell (HUVEC) monolayer permeability. For the first time, we identified the CaMKII delta(6) isoform as the predominant CaMKII isoform expressed in endothelium. As little as 2.5 nM thrombin maximally increased CaMKII delta(6) activation assessed by Thr(287) autophosphorylation. Electroporation of siRNA targeting endogenous CaMKII delta (siCaMKII delta) suppressed expression of the kinase by >80% and significantly inhibited 2.5 nM thrombin-induced increases in monolayer permeability assessed by electrical cell-substrate impedance sensing (ECIS). siCaMKII delta inhibited 2.5 nM thrombin-induced activation of RhoA, but had no effect on thrombin-induced ERK1/2 activation. Although Rho kinase inhibition strongly suppressed thrombin-induced HUVEC hyperpermeability, inhibiting ERK1/2 activation had no effect. In contrast to previous reports, these results indicate that thrombin-induced ERK1/2 activation in endothelial cells is not mediated by CaMKII and is not involved in endothelial barrier hyperpermeability. Instead, CaMKII delta(6) mediates thrombin-induced HUVEC barrier dysfunction through RhoA/Rho kinase as downstream intermediates. Moreover, the relative contribution of the CaMKII delta(6)/RhoA pathway(s) diminished with increasing thrombin stimulation, indicating recruitment of alternative signaling pathways mediating endothelial barrier dysfunction, dependent upon thrombin concentration.	[Wang, Zhen; Ginnan, Roman; Abdullaev, Iskandar F.; Trebak, Mohamed; Vincent, Peter A.; Singer, Harold A.] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA	Albany Medical College	Singer, HA (corresponding author), Albany Med Coll MC8, Ctr Cardiovasc Sci, 47 New Scotland Ave, Albany, NY 12208 USA.	singerh@mail.amc.edu	Abdullaev, Iskandar/AAH-2478-2021; Trebak, Mohamed/E-7405-2014		National Institutes of Health [R01 HL-049426, RO1 HL-077870]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097111, R01HL049426, R01HL077870] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL-049426 (to H. A. S.) and RO1 HL-077870 (to P. A. V.).	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Abraham ST, 1996, J BIOL CHEM, V271, P2506, DOI 10.1074/jbc.271.5.2506; Amerongen GPV, 2004, CIRC RES, V94, P1041, DOI 10.1161/01.RES.0000125627.77235.0C; Bayer KM, 2001, BIOCHEM BIOPH RES CO, V289, P917, DOI 10.1006/bbrc.2001.6063; Birnbaumer L, 2002, CIRC RES, V91, P1, DOI 10.1161/01.RES.0000026600.67226.92; Birukova AA, 2004, MICROVASC RES, V67, P64, DOI 10.1016/j.mvr.2003.09.007; Borbiev T, 2003, AM J PHYSIOL-LUNG C, V285, pL43, DOI 10.1152/ajplung.00460.2001; Borbiev T, 2001, AM J PHYSIOL-LUNG C, V280, pL983, DOI 10.1152/ajplung.2001.280.5.L983; Cai H, 2008, CARDIOVASC RES, V77, P30, DOI 10.1093/cvr/cvm010; Chew CS, 2008, AM J PHYSIOL-GASTR L, V295, pG1159, DOI 10.1152/ajpgi.90345.2008; Chiasson CM, 2009, MOL BIOL CELL, V20, P1970, DOI 10.1091/mbc.E08-07-0735; Cioffi DL, 2009, ANTIOXID REDOX SIGN, V11, P765, DOI 10.1089/ARS.2008.2221; Clements RT, 2005, AM J PHYSIOL-LUNG C, V288, pL294, DOI 10.1152/ajplung.00213.2004; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Gao L, 2006, BIOCHEM BIOPH RES CO, V345, P1606, DOI 10.1016/j.bbrc.2006.05.066; Gavard J, 2008, J BIOL CHEM, V283, P29888, DOI 10.1074/jbc.M803880200; GEISTERFER AAT, 1988, CIRC RES, V62, P749, DOI 10.1161/01.RES.62.4.749; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; Ginnan R, 2002, AM J PHYSIOL-CELL PH, V282, pC754, DOI 10.1152/ajpcell.00335.2001; House SJ, 2008, ARTERIOSCL THROM VAS, V28, P441, DOI 10.1161/ATVBAHA.107.156810; House SJ, 2007, AM J PHYSIOL-CELL PH, V292, pC2276, DOI 10.1152/ajpcell.00606.2006; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Jin M, 2005, J NEUROSCI, V25, P2338, DOI 10.1523/JNEUROSCI.4889-04.2005; Lu KK, 2005, AM J PHYSIOL-CELL PH, V289, pC1343, DOI 10.1152/ajpcell.00064.2005; MAYER P, 1995, BASIC RES CARDIOL, V90, P372, DOI 10.1007/BF00788498; MAYER P, 1994, BIOCHEM J, V298, P757, DOI 10.1042/bj2980757; Mercure MZ, 2008, AM J PHYSIOL-CELL PH, V294, pC1465, DOI 10.1152/ajpcell.90638.2007; Pfleiderer PJ, 2004, AM J PHYSIOL-CELL PH, V286, pC1238, DOI 10.1152/ajpcell.00536.2003; Rezazadeh S, 2006, J PHARMACOL EXP THER, V317, P292, DOI 10.1124/jpet.105.097618; Rokolya A, 2000, AM J PHYSIOL-CELL PH, V278, pC537, DOI 10.1152/ajpcell.2000.278.3.C537; Sandoval R, 2001, AM J PHYSIOL-LUNG C, V280, pL239, DOI 10.1152/ajplung.2001.280.2.L239; SCHWORER CM, 1993, J BIOL CHEM, V268, P14443; SHUMAN MA, 1976, J CLIN INVEST, V58, P1249, DOI 10.1172/JCI108579; SHUMAN MA, 1978, J CLIN INVEST, V61, P1102, DOI 10.1172/JCI109010; Singer HA, 1997, J BIOL CHEM, V272, P9393; Soderling TR, 2001, CHEM REV, V101, P2341, DOI 10.1021/cr0002386; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Tiruppathi C, 2006, MICROCIRCULATION, V13, P693, DOI 10.1080/10739680600930347; TOBIMATSU T, 1989, J BIOL CHEM, V264, P17907; Van Riper DA, 2000, MOL CELL BIOCHEM, V213, P83, DOI 10.1023/A:1007116231678; Wojciak-Stothard B, 2001, J CELL SCI, V114, P1343	41	41	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21303	21312		10.1074/jbc.M110.120790	http://dx.doi.org/10.1074/jbc.M110.120790			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20442409	Green Published, hybrid			2022-12-27	WOS:000279516100015
J	Zhang, JD; Qian, XS; Ning, HA; Yang, JJ; Xiong, HB; Liu, JG				Zhang, Jidong; Qian, Xuesong; Ning, Huan; Yang, Jianjun; Xiong, Huabao; Liu, Jianguo			Activation of IL-27 p28 Gene Transcription by Interferon Regulatory Factor 8 in Cooperation with Interferon Regulatory Factor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENCE-BINDING-PROTEIN; CENTRAL-NERVOUS-SYSTEM; NATURAL-KILLER-CELLS; CD4(+) T-CELLS; NF-KAPPA-B; FACTOR-I; DENDRITIC CELLS; LEISHMANIA-MAJOR; CARCINOMA-CELLS; TH1 RESPONSES	Interferon regulatory factor (IRF) family members, especially interferon regulatory factor-1 (IRF-1) and interferon regulatory factor-8 (IRF-8 or ICSBP), play important roles in interferon signaling in a wide range of host responses to infection and tumor growth. Interleukin-27 (IL-27), as a member of the IL-12 cytokine family, not only acts as a proinflammatory cytokine that regulates the differentiation of naive T helper cells but also possesses anti-inflammatory properties. IL-27 consists of EBI3 (Epstein-Barr virus-induced gene 3) and p28 subunits. Our previous work has shown that IRF-1 regulates IL-27 p28 gene transcription by specifically binding to the IRF-1 response element in the p28 promoter. In this study, we found that IRF-8-deficient macrophages were highly defective in the production of IL-27 p28 at both mRNA and protein levels. Circulating IL-27 p28 in serum was also decreased in IRF-8(-/-) mice in a septic shock model. Lipopolysaccharide, as a potent inducer of IL-27 p28 expression, could activate IRF-8 expression in a MyD88-dependent pathway, which in turn induced p28 gene transcription through NF-kappa B and/or IRF-8. Transcriptional analyses revealed that IRF-8 activated p28 gene transcription through binding to a site located at -57 to -48 in the p28 promoter overlapping the IRF-1 binding site. Consistent with this observation, overexpression of both IRF-8 and IRF-1 additively activated IL-27 p28 promoter. This study provides further mechanistic information regarding how signals initiated during innate and adaptive immune responses synergize to yield greater IL-27 production and sustained cellular immunity.	[Zhang, Jidong; Qian, Xuesong; Ning, Huan; Liu, Jianguo] St Louis Univ, Sch Med, Dept Internal Med, Div Immunobiol, St Louis, MO 63104 USA; [Yang, Jianjun; Xiong, Huabao] Mt Sinai Sch Med, Immunobiol Ctr, New York, NY 10029 USA	Saint Louis University; Icahn School of Medicine at Mount Sinai	Liu, JG (corresponding author), St Louis Univ, Sch Med, Dept Internal Med, Div Immunobiol, 1100 S Grand Blvd,DRC Rm 811, St Louis, MO 63104 USA.	jliu9@slu.edu	NING, HUAN/R-4786-2018; yang, jian/HIK-0188-2022		Vasculitis Foundation	Vasculitis Foundation	This work was supported in part by the Vasculitis Foundation.	Artis D, 2004, J IMMUNOL, V172, P4672, DOI 10.4049/jimmunol.172.8.4672; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Chiyo M, 2004, ANTICANCER RES, V24, P3763; Chiyo M, 2005, INT J CANCER, V115, P437, DOI 10.1002/ijc.20848; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Diveu C, 2009, J IMMUNOL, V182, P5748, DOI 10.4049/jimmunol.0801162; Duncan GS, 1996, J EXP MED, V184, P2043, DOI 10.1084/jem.184.5.2043; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Hamano S, 2003, IMMUNITY, V19, P657, DOI 10.1016/S1074-7613(03)00298-X; Hibbert L, 2003, J INTERF CYTOK RES, V23, P513, DOI 10.1089/10799900360708632; Hisada M, 2004, CANCER RES, V64, P1152, DOI 10.1158/0008-5472.CAN-03-2084; Holscher C, 2005, J IMMUNOL, V174, P3534, DOI 10.4049/jimmunol.174.6.3534; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Levi BZ, 2002, J INTERF CYTOK RES, V22, P153, DOI 10.1089/107999002753452764; Liu JG, 2004, J BIOL CHEM, V279, P55609, DOI 10.1074/jbc.M406565200; Liu JG, 2003, J EXP MED, V198, P1265, DOI 10.1084/jem.20030026; Liu JG, 2007, J EXP MED, V204, P141, DOI 10.1084/jem.20061440; Liu JG, 2006, J BIOL CHEM, V281, P19188, DOI 10.1074/jbc.M602059200; Liu JG, 2006, INFECT IMMUN, V74, P4750, DOI 10.1128/IAI.00287-06; Lohoff M, 2000, J EXP MED, V192, P325, DOI 10.1084/jem.192.3.325; Lucas S, 2003, P NATL ACAD SCI USA, V100, P15047, DOI 10.1073/pnas.2536517100; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; Miyazaki Y, 2005, J IMMUNOL, V175, P2401, DOI 10.4049/jimmunol.175.4.2401; Molle C, 2007, J IMMUNOL, V178, P7607, DOI 10.4049/jimmunol.178.12.7607; Nieuwenhuis EES, 2002, P NATL ACAD SCI USA, V99, P16951, DOI 10.1073/pnas.252648899; Nozawa H, 1999, GENE DEV, V13, P1240, DOI 10.1101/gad.13.10.1240; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Ogasawara K, 1998, NATURE, V391, P700, DOI 10.1038/35636; Ohteki T, 1998, J EXP MED, V187, P967, DOI 10.1084/jem.187.6.967; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pirhonen J, 2007, J LEUKOCYTE BIOL, V82, P1185, DOI 10.1189/jlb.0307157; Remoli ME, 2007, EUR J IMMUNOL, V37, P3499, DOI 10.1002/eji.200737566; Salcedo R, 2004, J IMMUNOL, V173, P7170, DOI 10.4049/jimmunol.173.12.7170; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shimizu M, 2006, J IMMUNOL, V176, P7317, DOI 10.4049/jimmunol.176.12.7317; Stumhofer JS, 2008, IMMUNOL LETT, V117, P123, DOI 10.1016/j.imlet.2008.01.011; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Sun DX, 2006, NAT IMMUNOL, V7, P375, DOI 10.1038/ni1308; Taki S, 1997, IMMUNITY, V6, P673, DOI 10.1016/S1074-7613(00)80443-4; Tamura T, 2002, J INTERF CYTOK RES, V22, P145, DOI 10.1089/107999002753452755; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tsujimura H, 2004, J IMMUNOL, V172, P6820, DOI 10.4049/jimmunol.172.11.6820; Tsujimura H, 2003, J IMMUNOL, V170, P1131, DOI 10.4049/jimmunol.170.3.1131; Tsujimura H, 2003, BLOOD, V101, P961, DOI 10.1182/blood-2002-05-1327; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Yoshida H, 2001, IMMUNITY, V15, P569, DOI 10.1016/S1074-7613(01)00206-0; Zahn S, 2005, EUR J IMMUNOL, V35, P1106, DOI 10.1002/eji.200425926; Zhao J, 2006, J BIOL CHEM, V281, P10073, DOI 10.1074/jbc.M507788200	56	47	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21269	21281		10.1074/jbc.M110.100818	http://dx.doi.org/10.1074/jbc.M110.100818			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20435892	Green Published, hybrid			2022-12-27	WOS:000279516100012
J	Nagano, M; Hoshino, D; Sakamoto, T; Kawasaki, N; Koshikawa, N; Seiki, M				Nagano, Makoto; Hoshino, Daisuke; Sakamoto, Takeharu; Kawasaki, Noritaka; Koshikawa, Naohiko; Seiki, Motoharu			ZF21 Protein Regulates Cell Adhesion and Motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE SHP-2; FOCAL ADHESION; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; EXTRACELLULAR-MATRIX; ALPHA-ACTININ; FYVE FINGER; MIGRATION; KINASE; CYTOSKELETON; INTEGRINS	Cell migration on an extracellular matrix (ECM) requires continuous formation and turnover of focal adhesions (FAs) along the direction of cell movement. However, our knowledge of the components of FAs and the mechanism of their regulation remains limited. Here, we identify ZF21, a member of a protein family characterized by the presence of a phosphatidylinositol 3-phosphate-binding FYVE domain, to be a new regulator of FAs and cell movement. Knockdown of ZF21 expression in cells increased the number of FAs and suppressed cell migration. Knockdown of ZF21 expression also led to a significant delay in FA disassembly following induction of synchronous disassembly of FAs by nocodazole treatment. ZF21 bound to focal adhesion kinase, localized to FAs, and was necessary for dephosphorylation of FAK at Tyr(397), which is important for disassembly of FAs. Thus, ZF21 represents a new component of FAs, mediates disassembly of FAs, and thereby regulates cell motility.	[Nagano, Makoto; Hoshino, Daisuke; Sakamoto, Takeharu; Kawasaki, Noritaka; Koshikawa, Naohiko] Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo 1088639, Japan	University of Tokyo	Seiki, M (corresponding author), 4-6-1 Shirokanedai,Minato Ku, Tokyo 1088639, Japan.	mseiki@ims.u-tokyo.ac.jp	Koshikawa, Naohiko/S-7306-2017; Nagano, Makoto/J-7050-2015; Sakamoto, Takeharu/Y-6062-2019; Seiki, Motoharu/K-9443-2015	Koshikawa, Naohiko/0000-0002-4539-888X; Nagano, Makoto/0000-0002-1948-1591; Sakamoto, Takeharu/0000-0002-1225-1902; 	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Specific Coordination Fund for Promoting Science (to T. S.), by a grant-in-aid for scientific research on priority areas ("Integrative Research toward the Conquest of Cancer") (to M. S.), and by Global COE Program (to T. S. and M. S.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Carlucci A, 2008, J BIOL CHEM, V283, P10919, DOI 10.1074/jbc.M707248200; Chao WT, 2009, FEBS LETT, V583, P1337, DOI 10.1016/j.febslet.2009.03.037; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; Dourdin N, 2001, J BIOL CHEM, V276, P48382, DOI 10.1074/jbc.M108893200; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Galbraith CG, 1998, CURR OPIN CELL BIOL, V10, P566, DOI 10.1016/S0955-0674(98)80030-6; Gaullier JM, 2000, J BIOL CHEM, V275, P24595, DOI 10.1074/jbc.M906554199; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Gillooly DJ, 2001, BIOCHEM J, V355, P249, DOI 10.1042/0264-6021:3550249; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; GLUCK U, 1994, J CELL SCI, V107, P1773; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; ILIAE D, 1995, NATURE, V377, P539; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Iwahara T, 2004, P NATL ACAD SCI USA, V101, P17693, DOI 10.1073/pnas.0408413102; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Krylyshkina O, 2002, J CELL BIOL, V156, P349, DOI 10.1083/jcb.200105051; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee SA, 2005, P NATL ACAD SCI USA, V102, P13052, DOI 10.1073/pnas.0503900102; Liu SC, 2000, J CELL SCI, V113, P3563; Manes S, 1999, MOL CELL BIOL, V19, P3125; Meighan CM, 2008, CURR OPIN CELL BIOL, V20, P520, DOI 10.1016/j.ceb.2008.05.010; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; Uekita T, 2004, J BIOL CHEM, V279, P12734, DOI 10.1074/jbc.M309957200; Westhoff MA, 2004, MOL CELL BIOL, V24, P8113, DOI 10.1128/MCB.24.18.8113-8133.2004; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; Zhang ZY, 2006, J BIOL CHEM, V281, P1746, DOI 10.1074/jbc.M509590200	42	16	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21013	21022		10.1074/jbc.M110.106443	http://dx.doi.org/10.1074/jbc.M110.106443			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20439989	Green Published, hybrid			2022-12-27	WOS:000279228600065
J	Li, CM; Qi, YF; Teng, X; Yang, ZC; Wei, P; Zhang, CS; Tan, L; Zhou, L; Liu, Y; Lai, LH				Li, Chunmei; Qi, Yifei; Teng, Xin; Yang, Zongchang; Wei, Ping; Zhang, Changsheng; Tan, Lei; Zhou, Lu; Liu, Ying; Lai, Luhua			Maturation Mechanism of Severe Acute Respiratory Syndrome (SARS) Coronavirus 3C-like Proteinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; DIMER INTERFACE; SUBSTRATE-SPECIFICITY; HIV-1 PROTEASE; VIRUS; DIMERIZATION; INHIBITOR; DESIGN; DOMAIN; POLYPROTEIN	The 3C-like proteinase (3CL(pro)) of the severe acute respiratory syndrome (SARS) coronavirus plays a vital role in virus maturation and is proposed to be a key target for drug design against SARS. Various in vitro studies revealed that only the dimer of the matured 3CL(pro) is active. However, as the internally encoded 3CL(pro) gets matured from the replicase polyprotein by autolytic cleavage at both the N-terminal and the C-terminal flanking sites, it is unclear whether the polyprotein also needs to dimerize first for its auto-cleavage reaction. We constructed a large protein containing the cyan fluorescent protein (C), the N-terminal flanking substrate peptide of SARS 3CL(pro) (XX), SARS 3CL(pro) (3CLP), and the yellow fluorescent protein (Y) to study the autoprocessing of 3CL(pro) using fluorescence resonance energy transfer. In contrast to the matured 3CL(pro), the polyprotein, as well as the one-step digested product, 3CLP-Y-His, were shown to be monomeric in gel filtration and analytic ultracentrifuge analysis. However, dimers can still be induced and detected when incubating these large proteins with a substrate analog compound in both chemical cross-linking experiments and analytic ultracentrifuge analysis. We also measured enzyme activity under different enzyme concentrations and found a clear tendency of substrate-induced dimer formation. Based on these discoveries, we conclude that substrate-induced dimerization is essential for the activity of SARS-3CL(pro) in the polyprotein, and a modified model for the 3CL(pro) maturation process was proposed. As many viral proteases undergo a similar maturation process, this model might be generally applicable.	[Liu, Ying; Lai, Luhua] Peking Univ, Coll Chem & Mol Engn, State Key Lab Struct Chem Unstable & Stable Speci, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China; [Li, Chunmei; Qi, Yifei; Wei, Ping; Zhang, Changsheng; Lai, Luhua] Peking Univ, Ctr Theoret Biol, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Peking University; Peking University	Lai, LH (corresponding author), Peking Univ, Coll Chem & Mol Engn, State Key Lab Struct Chem Unstable & Stable Speci, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China.	lhlai@pku.edu.cn	Teng, Xin/L-7614-2018	Teng, Xin/0000-0002-8354-0090	Ministry of Science and Technology of China; National Natural Science Foundation of China	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported, in part, by the Ministry of Science and Technology of China and the National Natural Science Foundation of China.	Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; Anand K, 2002, EMBO J, V21, P3213, DOI 10.1093/emboj/cdf327; CAMERON CE, 1993, J BIOL CHEM, V268, P11711; Chen H, 2006, J BIOL CHEM, V281, P13894, DOI 10.1074/jbc.M510745200; Chen S, 2008, J BIOL CHEM, V283, P554, DOI 10.1074/jbc.M705240200; Darke PL, 1996, J BIOL CHEM, V271, P7445, DOI 10.1074/jbc.271.13.7445; Fan KQ, 2005, BIOCHEM BIOPH RES CO, V329, P934, DOI 10.1016/j.bbrc.2005.02.061; Fan KQ, 2004, J BIOL CHEM, V279, P1637, DOI 10.1074/jbc.M310875200; Hsu MF, 2005, J BIOL CHEM, V280, P31257, DOI 10.1074/jbc.M502577200; Hu TC, 2009, VIROLOGY, V388, P324, DOI 10.1016/j.virol.2009.03.034; Huang CK, 2004, BIOCHEMISTRY-US, V43, P4568, DOI 10.1021/bi036022q; Lai LH, 2006, CURR PHARM DESIGN, V12, P4555, DOI 10.2174/138161206779010396; Lorenz IC, 2006, NATURE, V442, P831, DOI 10.1038/nature04975; LOUIS JM, 1994, P NATL ACAD SCI USA, V91, P7970, DOI 10.1073/pnas.91.17.7970; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; Marnett AB, 2004, P NATL ACAD SCI USA, V101, P6870, DOI 10.1073/pnas.0401613101; Pinon JD, 1997, VIROLOGY, V230, P309, DOI 10.1006/viro.1997.8503; Schiller JJ, 1998, VIROLOGY, V242, P288, DOI 10.1006/viro.1997.9010; Shan YF, 2004, BIOCHEM BIOPH RES CO, V324, P579, DOI 10.1016/j.bbrc.2004.09.088; Shi JH, 2008, J VIROL, V82, P4620, DOI 10.1128/JVI.02680-07; Tang C, 2008, NATURE, V455, P693, DOI 10.1038/nature07342; Thiel V, 2003, J GEN VIROL, V84, P2305, DOI 10.1099/vir.0.19424-0; Tibbles KW, 1996, J VIROL, V70, P1923, DOI 10.1128/JVI.70.3.1923-1930.1996; Wei P, 2006, BIOCHEM BIOPH RES CO, V339, P865, DOI 10.1016/j.bbrc.2005.11.102; Wei P, 2010, ACTA PHYS-CHIM SIN, V26, P1093, DOI 10.3866/PKU.WHXB20100449; WLODAWER A, 1989, SCIENCE, V245, P616, DOI 10.1126/science.2548279; Yang HT, 2006, CURR PHARM DESIGN, V12, P4573, DOI 10.2174/138161206779010369; Zhou L, 2006, J MED CHEM, V49, P3440, DOI 10.1021/jm0602357; Ziebuhr J, 2005, CURR TOP MICROBIOL, V287, P57, DOI 10.1007/3-540-26765-4_3; Ziebuhr J, 2000, J GEN VIROL, V81, P853, DOI 10.1099/0022-1317-81-4-853	30	36	37	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28134	28140		10.1074/jbc.M109.095851	http://dx.doi.org/10.1074/jbc.M109.095851			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20489209	Green Published, hybrid			2022-12-27	WOS:000281404100056
J	Wang, C; Chen, SH; Wang, X; Wang, L; Wallis, AK; Freedman, RB; Wang, CC				Wang, Chao; Chen, Sihong; Wang, Xi; Wang, Lei; Wallis, A. Katrine; Freedman, Robert B.; Wang, Chih-chen			Plasticity of Human Protein Disulfide Isomerase EVIDENCE FOR MOBILITY AROUND THE X-LINKER REGION AND ITS FUNCTIONAL SIGNIFICANCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; RIBONUCLEASE-A; BINDING SITE; B' DOMAIN; THIOREDOXIN; CATALYSIS	Protein disulfide isomerase (PDI), which consists of multiple domains arranged as abb'xa'c, is a key enzyme responsible for oxidative folding in the endoplasmic reticulum. In this work we focus on the conformational plasticity of this enzyme. Proteolysis of native human PDI (hPDI) by several proteases consistently targets sites in the C-terminal half of the molecule (x-linker and a' domain) leaving large fragments in which the N terminus is intact. Fluorescence studies on the W111F/W390F mutant of full-length PDI show that its fluorescence is dominated by Trp-347 in the x-linker which acts as an intrinsic reporter and indicates that this linker can move between "capped" and "uncapped" conformations in which it either occupies or exposes the major ligand binding site on the b' domain of hPDI. Studies with a range of constructs and mutants using intrinsic fluorescence, collision quenching, and extrinsic probe fluorescence (1-anilino-8-naphthalene sulfonate) show that the presence of the a' domain in full-length hPDI moderates the ability of the x-linker to generate the capped conformation (compared with shorter fragments) but does not abolish it. Hence, unlike yeast PDI, the major conformational plasticity of full-length hPDI concerns the mobility of the a' domain "arm" relative to the bb' "trunk" mediated by the x-linker. The chaperone and enzymatic activities of these constructs and mutants are consistent with the interpretation that the reversible interaction of the x-linker with the ligand binding site mediates access of protein substrates to this site.	[Chen, Sihong; Wallis, A. Katrine; Freedman, Robert B.] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [Wang, Chih-chen] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Wang, Chao] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China	University of Warwick; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Freedman, RB (corresponding author), Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England.	R.B.Freedman@warwick.ac.uk; chihwang@sun5.ibp.ac.cn	Wang, Chao/AGP-7000-2022	Wang, Lei/0000-0002-5071-5800; Wallis, Katrine/0000-0002-2162-6454; Wang, Chao/0000-0002-3048-8559	Chinese Ministry of Science and Technology [2006CB806508, 2006CB910903]; Chinese Academy of Science [KSCX2-YW-R-119, KSCX2-YW-R-256]; Biotechnology and Biological Sciences Funding Council [BB/D017807, CPA1339]; Wellcome Trust; Biotechnology and Biological Sciences Research Council [BB/D017807/1] Funding Source: researchfish; BBSRC [BB/D017807/1] Funding Source: UKRI	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Academy of Science(Chinese Academy of Sciences); Biotechnology and Biological Sciences Funding Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Chinese Ministry of Science and Technology Grants 2006CB806508 and 2006CB910903, Chinese Academy of Science Grants KSCX2-YW-R-119 and KSCX2-YW-R-256, and Biotechnology and Biological Sciences Funding Council Project Grant BB/D017807 and partnering award CPA1339 (to R. B. F.) and by Wellcome Trust VIP fellowships (to S. C. and A. K. W.).	Alanen HI, 2003, ANTIOXID REDOX SIGN, V5, P367, DOI 10.1089/152308603768295096; BIRKS JB, 1970, PHOTOPHYSICS AROMATI, P443; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Byrne LJ, 2009, BIOCHEM J, V423, P209, DOI 10.1042/BJ20090565; Chalton DA, 2010, ANAL CHEM, V82, P3073, DOI 10.1021/ac902932c; DARBY NJ, 1995, BIOCHEMISTRY-US, V34, P11725, DOI 10.1021/bi00037a009; Darby NJ, 1998, J MOL BIOL, V276, P239, DOI 10.1006/jmbi.1997.1504; Denisov AY, 2009, FEBS J, V276, P1440, DOI 10.1111/j.1742-4658.2009.06884.x; EFTINK MR, 1976, J PHYS CHEM-US, V80, P486, DOI 10.1021/j100546a014; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Forster ML, 2009, J BIOL CHEM, V284, P13045, DOI 10.1074/jbc.M808352200; Freedman RB, 2002, EMBO REP, V3, P136, DOI 10.1093/embo-reports/kvf035; Freedman RB, 1998, BIOL CHEM, V379, P321, DOI 10.1515/bchm.1998.379.3.321; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; HAWKINS HC, 1991, BIOCHEM J, V275, P349, DOI 10.1042/bj2750349; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Lappi AK, 2004, J MOL BIOL, V335, P283, DOI 10.1016/j.jmb.2003.10.051; Li SJ, 2006, J BIOL CHEM, V281, P6581, DOI 10.1074/jbc.M508422200; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; Mainathambika BS, 2008, ANNU REV CELL DEV BI, V24, P211, DOI 10.1146/annurev.cellbio.24.110707.175333; MARTINEZGALISTEO E, 1993, BIOCHIMIE, V75, P803, DOI 10.1016/0300-9084(93)90131-B; Nguyen VD, 2008, J MOL BIOL, V383, P1144, DOI 10.1016/j.jmb.2008.08.085; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; Pirneskoski A, 2001, J BIOL CHEM, V276, P11287, DOI 10.1074/jbc.M010656200; Shin HC, 2000, J MOL BIOL, V300, P995, DOI 10.1006/jmbi.2000.3928; SONG JL, 1995, EUR J BIOCHEM, V231, P312, DOI 10.1111/j.1432-1033.1995.tb20702.x; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Tian G, 2008, J BIOL CHEM, V283, P33630, DOI 10.1074/jbc.M806026200; Wallis AK, 2009, PROTEIN SCI, V18, P2569, DOI 10.1002/pro.270; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200; Wang LK, 2008, EMBO REP, V9, P642, DOI 10.1038/embor.2008.88; WEISSMAN JS, 1993, NATURE, V365, P185, DOI 10.1038/365185a0; Yao Y, 1997, EMBO J, V16, P651, DOI 10.1093/emboj/16.3.651	36	55	56	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26788	26797		10.1074/jbc.M110.107839	http://dx.doi.org/10.1074/jbc.M110.107839			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20516074	Green Published, hybrid			2022-12-27	WOS:000281172700009
J	Inberg, A; Linial, M				Inberg, Alex; Linial, Michal			Protection of Pancreatic beta-Cells from Various Stress Conditions Is Mediated by DJ-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; TFII-I; ER STRESS; UP-REGULATION; PROTEIN; ACTIVATION; PROMOTER; FAILURE; NEURONS; BINDING	Pancreatic beta-cells are vulnerable to multiple stresses, leading to dysfunction and apoptotic death. Deterioration in beta-cells function and mass is associated with type 2 diabetes. Comparative two-dimensional gel electrophoresis from pancreatic MIN6 cells that were maintained at varying glucose concentrations was carried out. An induced expression of a protein spot, detected in MIN6 cells experiencing high glucose concentration, was identified by mass spectrometry as the oxidized form of DJ-1. DJ-1 (park7) is a multifunctional protein implicated in familial Parkinsonism and neuroprotection in response to oxidative damage. The DJ-1 protein and its oxidized form were also induced following exposure to oxidative and endoplasmic reticulum stress in MIN6 and beta TC-6 cells and also in mouse pancreatic islets. Suppression of DJ-1 levels by small interfering RNA led to an accelerated cell death, whereas an increase in DJ-1 levels by adenovirus-based infection attenuated cell death induced by H2O2 and thapsigargin in beta-cell lines and mouse pancreatic islets. Furthermore, DJ-1 improved regulated insulin secretion under basal as well as oxidative and endoplasmic reticulum stress conditions in a dose-dependent manner. We identified TFII-I (Gtf2i) as DJ-1 partner in the cytosol, whereas the binding of TFII-I to DJ-1 prevented TFII-I translocation to the nucleus. The outcome was attenuation of the stress response. Our results suggest that DJ-1 together with TFII-I operate in concert to cope with various insults and to sustain pancreatic beta-cell function.	Hebrew Univ Jerusalem, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Linial, Michal] Hebrew Univ Jerusalem, Sudarsky Ctr Computat Biol, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem		michall@cc.huji.ac.il	Linial, Michal/B-9143-2011; Linial, Michal/AAQ-9259-2020	Linial, Michal/0000-0002-9357-4526	Sudarsky Center for Computational Biology; European Commission Framework VII Prospects consortium; ISF [592/07]; Israeli Council for Higher Education	Sudarsky Center for Computational Biology; European Commission Framework VII Prospects consortium; ISF(Israel Science Foundation); Israeli Council for Higher Education	The initial phase of this work was supported by the Sudarsky Center for Computational Biology. This work was supported in part by the European Commission Framework VII Prospects consortium and a grant from ISF 592/07.; Recipient of a Lev-Zion fellowship of the Israeli Council for Higher Education.	Bast A, 2002, DIABETOLOGIA, V45, P867, DOI 10.1007/s00125-002-0846-1; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bonora E, 2008, NUTR METAB CARDIOVAS, V18, P74, DOI 10.1016/j.numecd.2007.05.004; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Choi J, 2006, J BIOL CHEM, V281, P10816, DOI 10.1074/jbc.M509079200; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hong M, 2005, J BIOL CHEM, V280, P16821, DOI 10.1074/jbc.M413753200; Inberg A, 2007, PROTEOMICS, V7, P910, DOI 10.1002/pmic.200600547; Inden M, 2006, NEUROBIOL DIS, V24, P144, DOI 10.1016/j.nbd.2006.06.004; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Ishikawa S, 2009, J BIOL CHEM, V284, P28832, DOI 10.1074/jbc.M109.019950; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Junn E, 2009, J NEUROSCI RES, V87, P123, DOI 10.1002/jnr.21831; Kahle PJ, 2009, FREE RADICAL BIO MED, V47, P1354, DOI 10.1016/j.freeradbiomed.2009.08.003; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kim YC, 2009, J NEUROCHEM, V110, P192; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; KNAACK D, 1994, DIABETES, V43, P1413, DOI 10.2337/diabetes.43.12.1413; Lev N, 2008, NEUROTOXICOLOGY, V29, P397, DOI 10.1016/j.neuro.2008.01.007; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Misra UK, 2009, J CELL BIOCHEM, V106, P381, DOI 10.1002/jcb.22016; Miyazaki S, 2008, J NEUROCHEM, V105, P2418, DOI 10.1111/j.1471-4159.2008.05327.x; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Parker R, 2001, MOL CELL BIOL, V21, P3220, DOI 10.1128/MCB.21.9.3220-3233.2001; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Racek T, 2008, J BIOL CHEM, V283, P34305, DOI 10.1074/jbc.M803925200; Robertson RP, 2009, TRENDS ENDOCRIN MET, V20, P388, DOI 10.1016/j.tem.2009.05.004; Roy AL, 2006, ACS CHEM BIOL, V1, P619, DOI 10.1021/cb6004323; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Tanaka Y, 1999, P NATL ACAD SCI USA, V96, P10857, DOI 10.1073/pnas.96.19.10857; Tussie-Luna MI, 2002, J BIOL CHEM, V277, P43185, DOI 10.1074/jbc.M207635200; Waanders LF, 2009, P NATL ACAD SCI USA, V106, P18902, DOI 10.1073/pnas.0908351106; Wang HY, 2005, J CELL SCI, V118, P3905, DOI 10.1242/jcs.02513; Zhong N, 2008, HUM MOL GENET, V17, P3357, DOI 10.1093/hmg/ddn230	43	41	43	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25686	25698		10.1074/jbc.M110.109751	http://dx.doi.org/10.1074/jbc.M110.109751			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20516060	Green Published, hybrid			2022-12-27	WOS:000280682400062
J	Sen, S; Talukdar, I; Liu, Y; Tam, J; Reddy, S; Webster, NJG				Sen, Supriya; Talukdar, Indrani; Liu, Ying; Tam, Joseph; Reddy, Sita; Webster, Nicholas J. G.			Muscleblind-like 1 (Mbnl1) Promotes Insulin Receptor Exon 11 Inclusion via Binding to a Downstream Evolutionarily Conserved Intronic Enhancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; MYOTONIC-DYSTROPHY TYPE-2; SPLICING FACTORS; SKELETAL-MUSCLE; CUG REPEATS; PROTEINS; EXPRESSION; MECHANISMS; DISEASE; CELLS	The insulin receptor exists as two isoforms, IR-A and IR-B, which result from alternative splicing of exon 11 in the primary transcript. These two isoforms show a cell-specific distribution, and their relative proportions also vary during development, aging, and in different disease states. We have previously demonstrated that both intron 10 and the alternatively spliced exon 11 contain regulatory sequences that affect insulin receptor splicing both positively and negatively and that these sequences bind the serine/arginine-rich (SR) proteins SRp20 and SF2/ASF and the CELF protein CUG-BP1. In this study, we describe a new intronic splicing element within intron 11 that is highly conserved across species. Using minigenes carrying deletion mutations within intron 11, we demonstrated that this sequence functions as an intronic splicing enhancer. We subsequently used RNA affinity chromatography to identify Mbnl1 as a splicing factor that recognizes this enhancer. By ribonucleoprotein immunoprecipitation, we also established that Mbnl1 binds specifically to the INSR (insulin receptor gene) RNA. Overexpression or knockdown of Mbnl1 in hepatoma and embryonic kidney cells altered the levels of exon 11 inclusion. Finally, we showed that deletion of the intronic enhancer eliminates the ability of Mbnl1 to promote exon inclusion. Collectively, these findings demonstrate a role for Mbnl1 in controlling insulin receptor exon 11 inclusion via binding to a downstream intronic enhancer element.	[Sen, Supriya; Talukdar, Indrani; Webster, Nicholas J. G.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Sen, Supriya; Talukdar, Indrani; Webster, Nicholas J. G.] Vet Affairs San Diego Healthcare Syst, Med Res Serv, San Diego, CA USA; [Liu, Ying; Tam, Joseph] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Reddy, Sita] Univ So Calif, Keck Sch Med, Inst Med Genet, Los Angeles, CA 90089 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of Hong Kong; University of Southern California	Webster, NJG (corresponding author), Univ Calif San Diego, Dept Med, Stein Clin Res Bldg 201,0673,9500 Gilman Dr, La Jolla, CA 92093 USA.	nwebster@ucsd.edu	Webster, Nick/AAI-8410-2021; Sen, Supriya/J-1750-2015	Sen, Supriya/0000-0002-0417-9322	Department of Veterans Affairs; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD012303, U54HD012303] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047400] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000130] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a Merit Review award from the Department of Veterans Affairs.	Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BROOK, 1992, CELL, V69, P385; Buratti E, 2006, NUCLEIC ACIDS RES, V34, P3494, DOI 10.1093/nar/gkl498; Caputi M, 1999, EMBO J, V18, P4060, DOI 10.1093/emboj/18.14.4060; Castle JC, 2008, NAT GENET, V40, P1416, DOI 10.1038/ng.264; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Dansithong W, 2005, J BIOL CHEM, V280, P5773, DOI 10.1074/jbc.M410781200; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Goers ES, 2010, NUCLEIC ACIDS RES, V38, P2467, DOI 10.1093/nar/gkp1209; Graveley BR, 2005, CELL, V123, P65, DOI 10.1016/j.cell.2005.07.028; Gromak N, 2003, RNA, V9, P443, DOI 10.1261/rna.2191903; Hernandez-Sanchez C, 2008, MOL BIOL EVOL, V25, P1043, DOI 10.1093/molbev/msn036; Hiller M, 2007, PLOS GENET, V3, P2147, DOI 10.1371/journal.pgen.0030204; Hino S, 2007, HUM MOL GENET, V16, P2834, DOI 10.1093/hmg/ddm239; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Kanadia RN, 2006, P NATL ACAD SCI USA, V103, P11748, DOI 10.1073/pnas.0604970103; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Kosaki A, 1998, J BIOL CHEM, V273, P10331, DOI 10.1074/jbc.273.17.10331; KOSAKI A, 1993, J BIOL CHEM, V268, P21990; Kramer A, 1996, ANNU REV BIOCHEM, V65, P367, DOI 10.1146/annurev.biochem.65.1.367; Ladd AN, 2001, MOL CELL BIOL, V21, P1285, DOI 10.1128/MCB.21.4.1285-1296.2001; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Lopez AJ, 1998, ANNU REV GENET, V32, P279, DOI 10.1146/annurev.genet.32.1.279; Lopez-Bigas N, 2005, FEBS LETT, V579, P1900, DOI 10.1016/j.febslet.2005.02.047; Louvi A, 1997, DEV BIOL, V189, P33, DOI 10.1006/dbio.1997.8666; Mahadevan MS, 2006, NAT GENET, V38, P1066, DOI 10.1038/ng1857; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; MOLLER DE, 1989, MOL ENDOCRINOL, V3, P1263, DOI 10.1210/mend-3-8-1263; MOSTHAF L, 1990, EMBO J, V9, P2409, DOI 10.1002/j.1460-2075.1990.tb07416.x; MOSTHAF L, 1991, P NATL ACAD SCI USA, V88, P4728, DOI 10.1073/pnas.88.11.4728; NORGREN S, 1993, DIABETES, V42, P675, DOI 10.2337/diabetes.42.5.675; NORGREN S, 1994, BIOCHEM BIOPH RES CO, V199, P277, DOI 10.1006/bbrc.1994.1225; Paul S, 2006, EMBO J, V25, P4271, DOI 10.1038/sj.emboj.7601296; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; RIO D C, 1992, Current Opinion in Cell Biology, V4, P444, DOI 10.1016/0955-0674(92)90010-A; Sanford JR, 2005, BIOCHEM SOC T, V33, P443, DOI 10.1042/BST0330443; Santos AN, 2008, ENDOCRINOLOGY, V149, P515, DOI 10.1210/en.2007-0821; Savkur RS, 2004, AM J HUM GENET, V74, P1309, DOI 10.1086/421528; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; SEINO S, 1989, BIOCHEM BIOPH RES CO, V159, P312, DOI 10.1016/0006-291X(89)92439-X; Sen S, 2009, MOL CELL BIOL, V29, P871, DOI 10.1128/MCB.01709-08; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; VIDAL H, 1995, DIABETES, V44, P1196, DOI 10.2337/diabetes.44.10.1196; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Warf MB, 2007, RNA, V13, P2238, DOI 10.1261/rna.610607; Warf MB, 2009, P NATL ACAD SCI USA, V106, P18551, DOI 10.1073/pnas.0903234106; Warf MB, 2009, P NATL ACAD SCI USA, V106, P9203, DOI 10.1073/pnas.0900342106; Webster N J, 1999, Front Horm Res, V25, P1; Yuan Y, 2007, NUCLEIC ACIDS RES, V35, P5474, DOI 10.1093/nar/gkm601; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108	55	46	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25426	25437		10.1074/jbc.M109.095224	http://dx.doi.org/10.1074/jbc.M109.095224			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20519504	hybrid, Green Published			2022-12-27	WOS:000280682400036
J	Guzzo, C; Mat, NFC; Gee, K				Guzzo, Christina; Mat, Nor Fazila Che; Gee, Katrina			Interleukin-27 Induces a STAT1/3-and NF-kappa B-dependent Proinflammatory Cytokine Profile in Human Monocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CD4(+) T-CELLS; CHEMOKINE RECEPTORS; INTERFERON-GAMMA; IL-10 PRODUCTION; DENDRITIC CELLS; CUTTING EDGE; IL-27; EXPRESSION; INDUCTION; STAT1	IL-27 is a heterodimeric cytokine bridging innate and adaptive immunity by playing a role in the activation of naive T cells and in development of Th1 cells. Additionally, recent evidence supports a role for IL-27 in the activation of monocytic cells. Both pro-inflammatory and anti-inflammatory activities have been attributed to IL-27; however, the role played by IL-27 in the activation of human monocytic cells in terms of cytokine production has not been well described. Our results show that IL-27 is a strong inducer of proinflammatory cytokine and chemokine expression, including enhancement of IL-6, IP- 10, MIP-1 alpha, MIP-1 beta, and TNF-alpha expression in human primary monocytes. Furthermore, we observed that IL-27-induced cytokine and chemokine production was mediated by STAT1, STAT3, and NF-kappa B activation. Understanding how IL-27 exerts its effects on monocytic cells will identify important molecular mechanisms in the regulation of immune responses, particularly in the modulation of monocyte activation.	[Guzzo, Christina; Mat, Nor Fazila Che; Gee, Katrina] Queens Univ, Dept Microbiol & Immunol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Gee, K (corresponding author), Queens Univ, Dept Microbiol & Immunol, Rm 739 Botterell Hall, Kingston, ON K7L 3N6, Canada.	kgee@queensu.ca	Gee, Katrina/H-3093-2016; MAT, NOR FAZILA CHE/M-3349-2015	MAT, NOR FAZILA CHE/0000-0002-1698-3633; Guzzo, Christina/0000-0002-3042-0976; Gee, Katrina/0000-0002-7535-2882	Canada Foundation of Innovation; Natural Sciences and Engineering Research Council of Canada; Ontario HIV Treatment Network Studentship; Canadian Institutes of Health Research Vanier Award; Ministry of Higher Education, Malasia; Universiti Sains Malaysia	Canada Foundation of Innovation(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario HIV Treatment Network Studentship; Canadian Institutes of Health Research Vanier Award(Canadian Institutes of Health Research (CIHR)); Ministry of Higher Education, Malasia; Universiti Sains Malaysia(Universiti Sains Malaysia)	This work was supported by grants from the Canada Foundation of Innovation and Natural Sciences and Engineering Research Council of Canada.; Supported by an Ontario HIV Treatment Network Studentship and a Canadian Institutes of Health Research Vanier Award.; Supported by the Ministry of Higher Education, Malasia and Universiti Sains Malaysia.	Al-Hanbali M, 2009, NEUROENDOCRINOL LETT, V30, P131; Aste-Amezaga M, 1998, J IMMUNOL, V160, P5936; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Batten M, 2007, J MOL MED-JMM, V85, P661, DOI 10.1007/s00109-007-0164-7; Bernardino ALF, 2009, J INFECT DIS, V199, P1379, DOI 10.1086/597807; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Cao YX, 2008, J IMMUNOL, V180, P922, DOI 10.4049/jimmunol.180.2.922; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Dagia NM, 2010, AM J PHYSIOL-CELL PH, V298, pC929, DOI 10.1152/ajpcell.00461.2009; Feng XM, 2008, BIOCHEM BIOPH RES CO, V367, P553, DOI 10.1016/j.bbrc.2007.12.154; GUBLER U, 1991, P NATL ACAD SCI USA, V88, P4143, DOI 10.1073/pnas.88.10.4143; Holscher C, 2005, J IMMUNOL, V174, P3534, DOI 10.4049/jimmunol.174.6.3534; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Imamichi T, 2008, AIDS, V22, P39, DOI 10.1097/QAD.0b013e3282f3356c; Kalliolias GD, 2008, J IMMUNOL, V180, P6325, DOI 10.4049/jimmunol.180.9.6325; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Liu JG, 2007, J EXP MED, V204, P141, DOI 10.1084/jem.20061440; Martinasso G, 2010, CANCER LETT, V287, P62, DOI 10.1016/j.canlet.2009.05.036; Molle C, 2007, J IMMUNOL, V178, P7607, DOI 10.4049/jimmunol.178.12.7607; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Pearson AL, 2008, J NEPHROL, V21, P887; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Robinson CM, 2008, J INFECT DIS, V198, P359, DOI 10.1086/589774; Ruckerl D, 2006, IMMUNOBIOLOGY, V211, P427, DOI 10.1016/j.imbio.2006.05.008; Sato T, 1997, BLOOD, V90, P4749, DOI 10.1182/blood.V90.12.4749.4749_4749_4758; Sheikh F, 2004, J IMMUNOL, V172, P2006, DOI 10.4049/jimmunol.172.4.2006; Shimizu M, 2006, J IMMUNOL, V176, P7317, DOI 10.4049/jimmunol.176.12.7317; Siegernund S, 2007, IMMUNOBIOLOGY, V212, P739, DOI 10.1016/j.imbio.2007.09.004; Sprecher CA, 1998, BIOCHEM BIOPH RES CO, V246, P82, DOI 10.1006/bbrc.1998.8576; Stancato LF, 1996, J BIOL CHEM, V271, P4134; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Takeda A, 2005, INT IMMUNOL, V17, P889, DOI 10.1093/intimm/dxh268; Veckman V, 2004, J LEUKOCYTE BIOL, V75, P764, DOI 10.1189/jlb.1003461; Villarino AV, 2004, J IMMUNOL, V173, P715, DOI 10.4049/jimmunol.173.2.715; Wirtz S, 2005, J IMMUNOL, V174, P2814, DOI 10.4049/jimmunol.174.5.2814; Yoshimura T, 2006, J IMMUNOL, V177, P5377, DOI 10.4049/jimmunol.177.8.5377	37	81	83	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24404	24411		10.1074/jbc.M110.112599	http://dx.doi.org/10.1074/jbc.M110.112599			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20519510	hybrid, Green Published			2022-12-27	WOS:000280542100012
J	Lee, JH; You, J; Dobrota, E; Skalnik, DG				Lee, Jeong-Heon; You, Jinsam; Dobrota, Erika; Skalnik, David G.			Identification and Characterization of a Novel Human PP1 Phosphatase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR TARGETING SUBUNIT; CPG-BINDING PROTEIN; C-TERMINAL DOMAIN; HISTONE H3; WD-REPEAT; TRANSCRIPTION TERMINATION; METHYLTRANSFERASE COMPLEX; SACCHAROMYCES-CEREVISIAE; POLYADENYLATION FACTOR; STRUCTURAL BASIS	Mammalian Wdr82 is a regulatory component of the Setd1a and Setd1b histone H3-lysine 4 methyltransferase complexes and is implicated in the tethering of Setd1 complexes to transcriptional start sites of active genes. In the studies reported here, immunoprecipitation and mass spectrometry analyses reveal that Wdr82 additionally associates with multiple protein complexes, including an RNA polymerase II complex, four distinct histone H3-Lys(4) methyltransferase complexes, protein phosphatase 1 (PP1)-associated proteins, a chaperonin-containing Tcp1 complex, and other uncharacterized proteins. Further characterization of the PP1-associated proteins identified a stable multimeric complex composed of regulatory subunits PNUTS, Tox4, and Wdr82 and a PP1 catalytic subunit (denoted as the PTW/PP1 phosphatase complex). The PTW/PP1 complex exhibits in vitro phosphatase activity in a PP1-dependent manner. Analysis of protein-protein interactions reveals that PNUTS mediates phosphatase complex formation by providing a binding platform to each component. The PNUTS and Tox4 subunits are predominantly associated with the PTW/PP1 phosphatase complex in HEK293 cells, and the integrity of this complex remains intact throughout cell cycle progression. Inducible expression of a PP1 interaction-defective form of PNUTS (W401A) or small interfering RNA-mediated depletion of PNUTS in HEK293 cells causes cell cycle arrest at mitotic exit and apoptotic cell death. PNUTS ( W401A) shows normal association with chromosomes but causes defects in the process of chromosome decondensation at late telophase. These data reveal that mammalian Wdr82 functions in a variety of cellular processes and reveal a potential role of the PTW/PP1 phosphatase complex in the regulation of chromatin structure during the transition from mitosis into interphase.	Indiana Univ, Sch Med, Wells Ctr Pediat Res, Sect Pediat Hematol Oncol,Dept Pediat & Biochem, Indianapolis, IN 46202 USA; [You, Jinsam] Monarch LifeSci, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Lee, JH (corresponding author), Indiana Univ, Sch Med, Dept Pediat, Wells Ctr Pediat Res, Indianapolis, IN 46202 USA.	jeonglee@iupui.edu			Riley Children's Foundation; Lilly Endowment; National Science Foundation [MCB-0641851]; Showalter Trust	Riley Children's Foundation; Lilly Endowment; National Science Foundation(National Science Foundation (NSF)); Showalter Trust	This work was supported in part by the Riley Children's Foundation, the Lilly Endowment, National Science Foundation Grant MCB-0641851 (to D. G. S.), and a Showalter Trust award (to J.-H. L.).	Aggen JB, 2000, CHEM BIOL, V7, pR13, DOI 10.1016/S1074-5521(00)00069-7; Allen PB, 1998, J BIOL CHEM, V273, P4089, DOI 10.1074/jbc.273.7.4089; Andreassen PR, 1998, J CELL BIOL, V141, P1207, DOI 10.1083/jcb.141.5.1207; Bennett D, 2005, BIOCHEM SOC T, V33, P1444, DOI 10.1042/BST0331444; Beullens M, 1999, J BIOL CHEM, V274, P14053, DOI 10.1074/jbc.274.20.14053; Bollen M, 2009, TRENDS CELL BIOL, V19, P531, DOI 10.1016/j.tcb.2009.06.005; Booth V, 2000, J BIOL CHEM, V275, P31266, DOI 10.1074/jbc.M002595200; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Cheng AY, 2000, J BIOL CHEM, V275, P1846, DOI 10.1074/jbc.275.3.1846; Cheng HL, 2004, MOL CELL BIOL, V24, P2932, DOI 10.1128/MCB.24.7.2932-2943.2004; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Cohen PTW, 2002, J CELL SCI, V115, P241; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; De Leon G, 2008, CANCER BIOL THER, V7, P833, DOI 10.4161/cbt.7.6.5839; De Wulf P, 2009, CURR OPIN CELL BIOL, V21, P806, DOI 10.1016/j.ceb.2009.08.003; Dichtl E, 2004, RNA, V10, P965, DOI 10.1261/rna.7090104; DOHADWALA M, 1994, P NATL ACAD SCI USA, V91, P6408, DOI 10.1073/pnas.91.14.6408; Dunn AY, 2001, J STRUCT BIOL, V135, P176, DOI 10.1006/jsbi.2001.4380; FERNANDEZ A, 1992, J CELL BIOL, V116, P1421, DOI 10.1083/jcb.116.6.1421; Hurley TD, 2007, J BIOL CHEM, V282, P28874, DOI 10.1074/jbc.M703472200; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Kim YM, 2003, J BIOL CHEM, V278, P13819, DOI 10.1074/jbc.M209621200; Kreivi JP, 1997, FEBS LETT, V420, P57, DOI 10.1016/S0014-5793(97)01485-3; Krucher NA, 2006, EXP CELL RES, V312, P2757, DOI 10.1016/j.yexcr.2006.05.002; Kwon YG, 1997, P NATL ACAD SCI USA, V94, P2168, DOI 10.1073/pnas.94.6.2168; Landsverk HB, 2005, BIOCHEM J, V390, P709, DOI 10.1042/BJ20050678; Lee H, 2009, PATHOLOGY, V41, P200, DOI 10.1080/00313020802593566; Lee JH, 2008, MOL CELL BIOL, V28, P609, DOI 10.1128/MCB.01356-07; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Lee JH, 2002, J BIOL CHEM, V277, P42259, DOI 10.1074/jbc.M205054200; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee SJ, 2007, CELL DEATH DIFFER, V14, P1106, DOI 10.1038/sj.cdd.4402111; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Nedea E, 2003, J BIOL CHEM, V278, P33000, DOI 10.1074/jbc.M304454200; Nedea E, 2008, MOL CELL, V29, P577, DOI 10.1016/j.molcel.2007.12.031; O'Flaherty E, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-13; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Raha-Chowdhury R, 2005, MOL BRAIN RES, V138, P70, DOI 10.1016/j.molbrainres.2005.04.001; Roguev A, 2004, MOL CELL PROTEOMICS, V3, P125, DOI 10.1074/mcp.M300081-MCP200; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; SHENOLIKAR S, 1994, ANNU REV CELL BIOL, V10, P55, DOI 10.1146/annurev.cellbio.10.1.55; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Simon VR, 2001, CELL PROLIFERAT, V34, P15, DOI 10.1046/j.1365-2184.2001.00192.x; Skoufias DA, 2007, J CELL BIOL, V179, P671, DOI 10.1083/jcb.200704117; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Trinkle-Mulcahy L, 2006, J CELL BIOL, V172, P679, DOI 10.1083/jcb.200508154; Trinkle-Mulcahy L, 2001, J CELL SCI, V114, P4219; Trinkle-Mulcahy L, 2003, MOL BIOL CELL, V14, P107, DOI 10.1091/mbc.E02-07-0376; Udho E, 2002, BIOCHEM BIOPH RES CO, V297, P463, DOI 10.1016/S0006-291X(02)02236-2; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Vitaliano-Prunier A, 2008, NAT CELL BIOL, V10, P1365, DOI 10.1038/ncb1796; Washington K, 2002, J BIOL CHEM, V277, P40442, DOI 10.1074/jbc.M205687200; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu JQ, 2009, NAT CELL BIOL, V11, P644, DOI 10.1038/ncb1871; Wu M, 2008, MOL CELL BIOL, V28, P7337, DOI 10.1128/MCB.00976-08; Yeo M, 2003, J BIOL CHEM, V278, P26078, DOI 10.1074/jbc.M301791200; Yi CL, 2006, INT J BIOCHEM CELL B, V38, P1076, DOI 10.1016/j.biocel.2005.12.019	59	73	80	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24466	24476		10.1074/jbc.M110.109801	http://dx.doi.org/10.1074/jbc.M110.109801			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20516061	hybrid, Green Published			2022-12-27	WOS:000280542100019
J	Sergeeva, OA; Kletke, O; Kragler, A; Poppek, A; Fleischer, W; Schubring, SR; Gorg, B; Haas, HL; Zhu, XR; Lubbert, H; Gisselmann, G; Hatt, H				Sergeeva, Olga A.; Kletke, Olaf; Kragler, Andrea; Poppek, Anja; Fleischer, Wiebke; Schubring, Stephan R.; Goerg, Boris; Haas, Helmut L.; Zhu, Xin-Ran; Luebbert, Hermann; Gisselmann, Guenter; Hatt, Hanns			Fragrant Dioxane Derivatives Identify beta 1-Subunit-containing GABA(A) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOBUTYRIC ACID(A) RECEPTORS; GENERAL ANESTHETIC ETOMIDATE; A RECEPTOR; EPSILON-SUBUNIT; NEURONS; GAMMA; PROPOFOL; SITES; SLEEP; RAT	Nineteen GABA(A) receptor (GABA(A)R) subunits are known in mammals with only a restricted number of functionally identified native combinations. The physiological role of beta 1-subunit-containing GABA(A)Rs is unknown. Here we report the discovery of a new structural class of GABA(A)R positive modulators with unique beta 1-subunit selectivity: fragrant dioxane derivatives (FDD). At heterologously expressed alpha 1 beta x gamma 2L (x-for 1,2,3) GABAAR FDD were 6 times more potent at beta 1-versus beta 2- and beta 3-containing receptors. Serine at position 265 was essential for the high sensitivity of the beta 1-subunit to FDD and the beta 1N286W mutation nearly abolished modulation; vice versa the mutation beta 3N265S shifted FDD sensitivity toward the beta 1-type. In posterior hypothalamic neurons controlling wakefulness GABA-mediated whole-cell responses and GABAergic synaptic currents were highly sensitive to FDD, in contrast to beta 1-negative cerebellar Purkinje neurons. Immunostaining for the beta 1-subunit and the potency of FDD to modulate GABA responses in cultured hypothalamic neurons was drastically diminished by beta 1-siRNA treatment. In conclusion, with the help of FDDs we reveal a functional expression of beta 1-containing GABA(A)Rs in the hypothalamus, offering a new tool for studies on the functional diversity of native GABA(A)Rs.	[Sergeeva, Olga A.] Univ Dusseldorf, Inst Neurophysiol, D-40001 Dusseldorf, Germany; [Kletke, Olaf; Kragler, Andrea; Poppek, Anja; Gisselmann, Guenter; Hatt, Hanns] Ruhr Univ, Lehrstuhl Zellphysiol, D-44780 Bochum, Germany; [Zhu, Xin-Ran; Luebbert, Hermann] Ruhr Univ, Lehrstuhl Tierphysiol, D-44780 Bochum, Germany; [Goerg, Boris] Univ Dusseldorf, Klin Gastroenterol Hepatol & Infektiol, D-40001 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Ruhr University Bochum; Ruhr University Bochum; Heinrich Heine University Dusseldorf	Sergeeva, OA (corresponding author), Univ Dusseldorf, Inst Neurophysiol, D-40001 Dusseldorf, Germany.	olga.sergeeva@uni-duesseldorf.de	Sergeeva, Olga/AAE-1869-2019	Zhu, Xinran/0000-0003-2352-0853; Kletke, Olaf/0000-0002-7825-1278; Luebbert, Herrmann/0000-0003-3429-5233; Gorg, Boris/0000-0002-4630-9420	Deutsche Forschungsgemeinschaft [SFB 575/TP 1, 3, and 8]; Heisenberg stipend	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Heisenberg stipend	This work was supported by Deutsche Forschungsgemeinschaft SFB 575/TP 1, 3, and 8 and a Heisenberg stipend (to O.A.S.).	Bateson AN, 2004, SLEEP MED, V5, pS9, DOI 10.1016/S1389-9457(04)90002-0; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Belelli D, 1997, P NATL ACAD SCI USA, V94, P11031, DOI 10.1073/pnas.94.20.11031; Belujon P, 2009, J NEUROPHYSIOL, V102, P2312, DOI 10.1152/jn.00227.2009; Bencsits E, 1999, J BIOL CHEM, V274, P19613, DOI 10.1074/jbc.274.28.19613; Bonin RP, 2008, PHARMACOL BIOCHEM BE, V90, P105, DOI 10.1016/j.pbb.2007.12.011; DREWE JA, 1988, SCIENCE, V241, P1810, DOI 10.1126/science.2459774; HillVenning C, 1997, BRIT J PHARMACOL, V120, P749, DOI 10.1038/sj.bjp.0700927; Hosie AM, 2003, NAT NEUROSCI, V6, P362, DOI 10.1038/nn1030; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; Krasowski MD, 1998, MOL PHARMACOL, V53, P530, DOI 10.1124/mol.53.3.530; Lam DW, 1998, BRAIN RES, V784, P179, DOI 10.1016/S0006-8993(97)01334-6; Li XQ, 2005, WORLD J GASTROENTERO, V11, P3319, DOI 10.3748/wjg.v11.i21.3319; Mangan PS, 2005, MOL PHARMACOL, V67, P775, DOI 10.1124/mol.104.007385; Meera P, 2009, NEUROPHARMACOLOGY, V56, P155, DOI 10.1016/j.neuropharm.2008.08.011; Nelson LE, 2002, NAT NEUROSCI, V5, P979, DOI 10.1038/nn913; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Olsen RW, 2004, BIOCHEM PHARMACOL, V68, P1675, DOI 10.1016/j.bcp.2004.07.026; Parmentier R, 2009, J NEUROSCI, V29, P4471, DOI 10.1523/JNEUROSCI.2976-08.2009; Rudolph U, 2004, ANNU REV PHARMACOL, V44, P475, DOI 10.1146/annurev.pharmtox.44.101802.121429; Rudolph U, 2006, CURR OPIN PHARMACOL, V6, P18, DOI 10.1016/j.coph.2005.10.003; Sergeeva OA, 2005, J NEUROSCI, V25, P88, DOI 10.1523/JNEUROSCI.3209-04.2005; Sergeeva OA, 2002, EUR J NEUROSCI, V16, P1472, DOI 10.1046/j.1460-9568.2002.02221.x; Sergeeva OA, 2007, CELL MOL NEUROBIOL, V27, P669, DOI 10.1007/s10571-007-9153-1; Sergeeva OA, 2006, EUR J NEUROSCI, V24, P1413, DOI 10.1111/j.1460-9568.2006.05027.x; Sherin JE, 1998, J NEUROSCI, V18, P4705; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Siegwart R, 2002, J NEUROCHEM, V80, P140, DOI 10.1046/j.0022-3042.2001.00682.x; Sigel Erwin, 2002, Current Topics in Medicinal Chemistry, V2, P833, DOI 10.2174/1568026023393444; Thompson SA, 2004, BRIT J PHARMACOL, V142, P97, DOI 10.1038/sj.bjp.0705689; Ueno S, 1997, J NEUROSCI, V17, P625; VONECONOMO C, 1926, HDB NORMALEN PATHOLO, V17, P591; VOROBJEV VS, 1991, J NEUROSCI METH, V38, P145, DOI 10.1016/0165-0270(91)90164-U; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; WISDEN W, 1992, J NEUROSCI, V12, P1040; Zecharia AY, 2009, J NEUROSCI, V29, P2177, DOI 10.1523/JNEUROSCI.4997-08.2009	37	34	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23985	23993		10.1074/jbc.M110.103309	http://dx.doi.org/10.1074/jbc.M110.103309			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20511229	Green Published, hybrid			2022-12-27	WOS:000280291400049
J	Kimura, Y; Kurabe, N; Ikegami, K; Tsutsumi, K; Konishi, Y; Kaplan, OI; Kunitomo, H; Iino, Y; Blacque, OE; Setou, M				Kimura, Yoshishige; Kurabe, Nobuya; Ikegami, Koji; Tsutsumi, Koji; Konishi, Yoshiyuki; Kaplan, Oktay Ismail; Kunitomo, Hirofumi; Iino, Yuichi; Blacque, Oliver E.; Setou, Mitsutoshi			Identification of Tubulin Deglutamylase among Caenorhabditis elegans and Mammalian Cytosolic Carboxypeptidases (CCPs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-TUBULIN; BETA-TUBULIN; POLYGLUTAMYLATION; POLYGLYCYLATION; MICROTUBULES; SUBFAMILY; LIGASE; TTLL10	Tubulin polyglutamylation is a reversible post-translational modification, serving important roles in microtubule (MT)-related processes. Polyglutamylases of the tubulin tyrosine ligase-like (TTLL) family add glutamate moieties to specific tubulin glutamate residues, whereas as yet unknown deglutamylases shorten polyglutamate chains. First we investigated regulatory machinery of tubulin glutamylation in MT-based sensory cilia of the roundworm Caenorhabditis elegans. We found that ciliary MTs were polyglutamylated by a process requiring ttll-4. Conversely, loss of ccpp-6 gene function, which encodes one of two cytosolic carboxypeptidases (CCPs), resulted in elevated levels of ciliary MT polyglutamylation. Consistent with a deglutamylase function for ccpp-6, overexpression of this gene in ciliated cells decreased polyglutamylation signals. Similarly, we confirmed that overexpression of murine CCP5, one of two sequence orthologs of nematode ccpp-6, caused a dramatic loss of MT polyglutamylation in cultured mammalian cells. Finally, using an in vitro assay for tubulin glutamylation, we found that recombinantly expressed Myc-tagged CCP5 exhibited deglutamylase biochemical activities. Together, these data from two evolutionarily divergent systems identify C. elegans CCPP-6 and its mammalian ortholog CCP5 as a tubulin deglutamylase.	[Kimura, Yoshishige; Kurabe, Nobuya; Ikegami, Koji; Tsutsumi, Koji; Konishi, Yoshiyuki; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Mol Anat, Hamamatsu, Shizuoka 4313192, Japan; [Kaplan, Oktay Ismail; Blacque, Oliver E.] Univ Coll Dublin, UCD Conway Inst, Sch Biomol & Biomed Sci, Dublin 4, Ireland; [Kunitomo, Hirofumi; Iino, Yuichi] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan	Hamamatsu University School of Medicine; University College Dublin; University of Tokyo	Setou, M (corresponding author), Hamamatsu Univ Sch Med, Dept Mol Anat, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	setou@hama-med.ac.jp	IINO, YUICHI/G-4962-2014; Blacque, Oliver/AAL-8860-2021; Kaplan, Oktay Ismail/F-8531-2015; KUNITOMO, HIROFUMI/G-4963-2014	Kaplan, Oktay Ismail/0000-0002-8733-0920; KUNITOMO, HIROFUMI/0000-0001-7312-7051; Blacque, Oliver/0000-0003-1598-2695	Japan Science and Technology Agency; Japan Society for the Promotion of Science	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a SENTAN grant from the Japan Science and Technology Agency and WAKATE grants from the Japan Society for the Promotion of Science (Grant WAKATE S to M. S. and Grant WAKATE B to Y. Konishi).	ARGARANA CE, 1978, MOL CELL BIOCHEM, V19, P17; AUDEBERT S, 1993, MOL BIOL CELL, V4, P615, DOI 10.1091/mbc.4.6.615; BRE MH, 1994, CELL MOTIL CYTOSKEL, V27, P337, DOI 10.1002/cm.970270406; BRENNER S, 1974, GENETICS, V77, P71; de la Vega MR, 2007, FASEB J, V21, P851, DOI 10.1096/fj.06-7330com; EDDE B, 1990, SCIENCE, V247, P83, DOI 10.1126/science.1967194; Fernandez-Gonzalez A, 2002, SCIENCE, V295, P1904, DOI 10.1126/science.1068912; Gagnon C, 1996, J CELL SCI, V109, P1545; GUNDERSEN GG, 1984, CELL, V38, P779, DOI 10.1016/0092-8674(84)90273-3; Ikegami K, 2008, FEBS LETT, V582, P1129, DOI 10.1016/j.febslet.2008.02.079; Ikegami K, 2007, P NATL ACAD SCI USA, V104, P3213, DOI 10.1073/pnas.0611547104; Ikegami K, 2006, J BIOL CHEM, V281, P30707, DOI 10.1074/jbc.M603984200; Ikegami K, 2010, P NATL ACAD SCI USA, V107, P10490, DOI 10.1073/pnas.1002128107; Ikegami K, 2010, CELL STRUCT FUNCT, V35, P15, DOI 10.1247/csf.09027; Ikegami K, 2009, FEBS LETT, V583, P1957, DOI 10.1016/j.febslet.2009.05.003; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Kalinina E, 2007, FASEB J, V21, P836, DOI 10.1096/fj.06-7329com; Nonet ML, 1997, J NEUROSCI, V17, P8061; REDEKER V, 1994, SCIENCE, V266, P1688, DOI 10.1126/science.7992051; Regnard C, 1999, J CELL SCI, V112, P4281; Rogowski K, 2009, CELL, V137, P1076, DOI 10.1016/j.cell.2009.05.020; van Dijk J, 2007, MOL CELL, V26, P437, DOI 10.1016/j.molcel.2007.04.012; Wloga D, 2009, DEV CELL, V16, P867, DOI 10.1016/j.devcel.2009.04.008	23	74	88	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22934	22939		10.1074/jbc.C110.128280	http://dx.doi.org/10.1074/jbc.C110.128280			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20519502	hybrid, Green Published			2022-12-27	WOS:000279999900027
J	Mizuno, N; Jao, CC; Langen, R; Steven, AC				Mizuno, Naoko; Jao, Christine C.; Langen, Ralf; Steven, Alasdair C.			Multiple Modes of Endophilin-mediated Conversion of Lipid Vesicles into Coated Tubes IMPLICATIONS FOR SYNAPTIC ENDOCYTOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIN/AMPHIPHYSIN/RVS BAR DOMAIN; MEMBRANE CURVATURE; STRUCTURAL BASIS; ELECTRON-MICROSCOPY; MICELLE TRANSITION; DYNAMIN; AMPHIPHYSIN; MECHANISM; INVAGINATION; SYNAPTOJANIN	Endophilin A1 is a BAR (Bin/amphiphysin/Rvs) protein abundant in neural synapses that senses and induces membrane curvature, contributing to neck formation in presynaptic endocytic vesicles. To investigate its role in membrane remodeling, we used cryoelectron microscopy to characterize structural changes induced in lipid vesicles by exposure to endophilin. The vesicles convert rapidly to coated tubules whose morphology reflects the local concentration of endophilin. Their diameters and curvature resemble those of synaptic vesicles in situ. Three-dimensional reconstructions of quasicylindrical tubes revealed arrays of BAR dimers, flanked by densities that we equate with amphipathic helices whose folding and membrane insertion were attested by EPR. We also observed the compression of bulbous coated tubes into 70-angstrom-wide cylindrical micelles, which appear to mimic the penultimate (hemi-fission) stage of endocytosis. Our findings suggest that the adaptability of endophilin-lipid interactions underlies dynamic changes of endocytic membranes.	[Mizuno, Naoko; Steven, Alasdair C.] NIAMSD, Struct Biol Lab, NIH, Bethesda, MD 20892 USA; [Jao, Christine C.; Langen, Ralf] Univ So Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Southern California	Steven, AC (corresponding author), NIAMS, Struct Biol Res Lab, NIH, Bldg 50,Rm 1517, Bethesda, MD 20892 USA.	stevena@mail.nih.gov	Mizuno, Naoko/AAY-1926-2021	Mizuno, Naoko/0000-0002-1594-2821	NIAMS; National Institutes of Health [GM063915]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR027015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063915] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the Intramural Research Program of NIAMS, National Institutes of Health and by National Institutes of Health Grant GM063915 (to R. L.).	Anggono V, 2007, J NEUROCHEM, V102, P931, DOI 10.1111/j.1471-4159.2007.04574.x; Arkhipov A, 2008, BIOPHYS J, V95, P2806, DOI 10.1529/biophysj.108.132563; Arkhipov A, 2009, BIOPHYS J, V97, P2727, DOI 10.1016/j.bpj.2009.08.051; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Bhatia VK, 2009, EMBO J, V28, P3303, DOI 10.1038/emboj.2009.261; Blood PD, 2006, P NATL ACAD SCI USA, V103, P15068, DOI 10.1073/pnas.0603917103; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Chou JJ, 2004, J BIOMOL NMR, V29, P299, DOI 10.1023/B:JNMR.0000032560.43738.6a; CUL H, 2009, BIOPHYS J, V97, P2746; DECAMILLI P, 1995, CURR OPIN NEUROBIOL, V5, P559, DOI 10.1016/0959-4388(95)80059-X; Dickman DK, 2005, CELL, V123, P521, DOI 10.1016/j.cell.2005.09.026; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Fernandez-Busnadiego R, 2010, J CELL BIOL, V188, P145, DOI 10.1083/jcb.200908082; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Frost A, 2007, STRUCTURE, V15, P751, DOI 10.1016/j.str.2007.06.006; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jao CC, 2010, J BIOL CHEM, V285, P20164, DOI 10.1074/jbc.M110.127811; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Mears JA, 2008, METHOD CELL BIOL, V88, P237, DOI 10.1016/S0091-679X(08)00413-5; Millard TH, 2005, EMBO J, V24, P240, DOI 10.1038/sj.emboj.7600535; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rigoni M, 2005, SCIENCE, V310, P1678, DOI 10.1126/science.1120640; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Saarikangas J, 2009, CURR BIOL, V19, P95, DOI 10.1016/j.cub.2008.12.029; Schuske KR, 2003, NEURON, V40, P749, DOI 10.1016/S0896-6273(03)00667-6; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; VINSON PK, 1989, BIOPHYS J, V56, P669, DOI 10.1016/S0006-3495(89)82714-6; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; WALTER A, 1991, BIOPHYS J, V60, P1315, DOI 10.1016/S0006-3495(91)82169-5; Wang Q, 2009, P NATL ACAD SCI USA, V106, P12700, DOI 10.1073/pnas.0902974106; Weissenhorn W, 2005, J MOL BIOL, V351, P653, DOI 10.1016/j.jmb.2005.06.013; Yin Y, 2009, STRUCTURE, V17, P882, DOI 10.1016/j.str.2009.03.016	49	41	41	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23349	23356		10.1074/jbc.M110.143776	http://dx.doi.org/10.1074/jbc.M110.143776			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20484046	Green Published, hybrid			2022-12-27	WOS:000279999900068
J	Chen, WH; Gao, F; Chu, FL; Zhang, JH; Gao, GF; Xia, C				Chen, Weihong; Gao, Feng; Chu, Fuliang; Zhang, Jianhua; Gao, George F.; Xia, Chun			Crystal Structure of a Bony Fish beta(2)-Microglobulin INSIGHTS INTO THE EVOLUTIONARY ORIGIN OF IMMUNOGLOBULIN SUPERFAMILY CONSTANT MOLECULES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; 3-DIMENSIONAL STRUCTURE; T-CELL; BETA-2-MICROGLOBULIN; SYSTEM; GENES; CRYSTALLOGRAPHY; RECOGNITION; AMPHIOXUS; RECEPTOR	Three-dimensional structures of beta(2)-microglobulin (beta 2m) from chicken and various mammals have been described previously, but aside from genomic sequences, very little is known about the three-dimensional structures of beta 2m in species other than warm-blooded vertebrates. Here, we present the first three-dimensional structure of beta 2m from bony fish grass carp (Ctid-beta 2m), resolved at 2.1 angstrom. The key structural differences between this new structure and previously published structures are two new hydrogen bonds at positions Ile(37) and Glu(38) in strand C and Lys(66) in strand E, and a hydrophobic pocket around the center of the protein found in Ctid-beta 2m. Importantly, Ctid-beta 2m has a short D strand and a long loop between stands C and D, rather than the flexible region found in other beta 2m structures that serves as a putative binding region for the major histocompatibility complex heavy chain. Comparing the Ctid-beta 2m structure with those of bovine and human beta 2ms, the C alpha root mean square deviation of the latter are 1.3 angstrom and 1.8 angstrom, respectively. Compared with the constant domains of Lamprey T cell receptor-like receptor (Lamp-TCRLC) and Amphioxus V and C domain-bearing protein (Amphi-VCPC), Ctid-beta 2m exhibits very different topology. The three-dimensional structures of domains predicted from Amphi-VCPC/Lamp-TCRLC are distinctly lacking in strand A of beta 2ms. There are 18 amino acids at the N terminus of Amphi-VCPC that may have evolved into strand A of beta 2ms. A mutation in the BC loops of Amphi-VCPC may have led to the novel topology found in beta 2m. Based on these results, Ctid-beta 2m may well reflect evolutionary characteristics of ancestral C set molecules.	[Chen, Weihong; Zhang, Jianhua; Xia, Chun] China Agr Univ, Coll Vet Med, Dept Microbiol & Immunol, Beijing 100094, Peoples R China; [Chen, Weihong; Gao, Feng; Chu, Fuliang; Zhang, Jianhua; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Gao, George F.] Chinese Acad Sci, Inst Microbiol, China Japan Joint Lab Mol Microbiol & Mol Immunol, Beijing 100101, Peoples R China; [Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, Beijing 100101, Peoples R China; [Xia, Chun] Minist Agr China, Key Lab Prevent Vet Med, Beijing 100094, Peoples R China	China Agricultural University; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Ministry of Agriculture & Rural Affairs	Xia, C (corresponding author), China Agr Univ, Coll Vet Med, Dept Microbiol & Immunol, Beijing 100094, Peoples R China.	xiachun@cau.edu.cn	Gao, George Fu/ABD-5229-2021; Chu, Fuliang/F-6925-2011		National Basic Research Program of China [2007CB815805]; National Natural Science Foundation of China [30371098]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program (Project 973) of China (2007CB815805) and the National Natural Science Foundation of China (Grant 30371098).	Achour A, 1998, IMMUNITY, V9, P199, DOI 10.1016/S1074-7613(00)80602-0; BECKER JW, 1985, P NATL ACAD SCI USA, V82, P4225, DOI 10.1073/pnas.82.12.4225; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen WH, 2008, ACTA CRYSTALLOGR F, V64, P200, DOI 10.1107/S1744309107068388; Chu FL, 2007, J IMMUNOL, V178, P944, DOI 10.4049/jimmunol.178.2.944; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; Criscitiello MF, 1998, IMMUNOGENETICS, V48, P339, DOI 10.1007/s002510050441; DIXON B, 1993, IMMUNOGENETICS, V38, P27, DOI 10.1007/BF00216387; Hao HF, 2006, FISH SHELLFISH IMMUN, V20, P118, DOI 10.1016/j.fsi.2005.04.003; Hao HF, 2007, PROTEIN EXPRES PURIF, V51, P120, DOI 10.1016/j.pep.2006.08.003; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Koch M, 2007, IMMUNITY, V27, P885, DOI 10.1016/j.immuni.2007.11.007; LANCET D, 1979, P NATL ACAD SCI USA, V76, P3844, DOI 10.1073/pnas.76.8.3844; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lundqvist ML, 1999, IMMUNOGENETICS, V50, P79, DOI 10.1007/s002510050690; Magor KE, 2004, J IMMUNOL, V172, P3635, DOI 10.4049/jimmunol.172.6.3635; Michaelsson J, 2001, J IMMUNOL, V166, P7327, DOI 10.4049/jimmunol.166.12.7327; Mosyak L, 2006, J BIOL CHEM, V281, P36378, DOI 10.1074/jbc.M607314200; ONO H, 1993, IMMUNOGENETICS, V38, P1, DOI 10.1007/BF00216384; Pancer Z, 2004, P NATL ACAD SCI USA, V101, P13273, DOI 10.1073/pnas.0405529101; Persson AC, 1999, IMMUNOGENETICS, V50, P49, DOI 10.1007/s002510050685; Prada JAH, 2006, NAT IMMUNOL, V7, P875, DOI 10.1038/ni1359; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Rosano C, 2005, BBA-PROTEINS PROTEOM, V1753, P85, DOI 10.1016/j.bbapap.2005.07.010; Smith KJ, 1996, IMMUNITY, V4, P215, DOI 10.1016/S1074-7613(00)80430-6; Trinh CH, 2002, P NATL ACAD SCI USA, V99, P9771, DOI 10.1073/pnas.152337399; Yu CL, 2005, J IMMUNOL, V174, P3493, DOI 10.4049/jimmunol.174.6.3493; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	30	22	22	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22505	22512		10.1074/jbc.M109.095000	http://dx.doi.org/10.1074/jbc.M109.095000			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20444690	hybrid, Green Published			2022-12-27	WOS:000279702200062
J	Kabil, O; Banerjee, R				Kabil, Omer; Banerjee, Ruma			Redox Biochemistry of Hydrogen Sulfide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CYSTATHIONINE BETA-SYNTHASE; MERCAPTOPYRUVATE SULFURTRANSFERASE; 3-MERCAPTOPYRUVATE SULFURTRANSFERASE; RAT-LIVER; H2S; OXIDATION; CYSTEINE; SULFUR; SUBSTRATE; OXIDASE	H2S, the most recently discovered gasotransmitter, might in fact be the evolutionary matriarch of this family, being both ancient and highly reduced. Disruption of gamma-cystathionase in mice leads to cardiovascular dysfunction and marked hypertension, suggesting a key role for this enzyme in H2S production in the vasculature. However, patients with inherited deficiency in gamma-cystathionase apparently do not present vascular pathology. A mitochondrial pathway disposes sulfide and couples it to oxidative phosphorylation while also exposing cytochrome c oxidase to this metabolic poison. This report focuses on the biochemistry of H2S biogenesis and clearance, on the molecular mechanisms of its action, and on its varied biological effects.	[Kabil, Omer; Banerjee, Ruma] Univ Michigan, Dept Biol Chem, Med Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Dept Biol Chem, Med Ctr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Kabil, Omer/AAJ-1435-2020		National Institutes of Health [HL58984]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL58984 (to R.B.). This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Abe K, 1996, J NEUROSCI, V16, P1066; Agrawal N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004032; AKAGI R, 1982, ACTA MED OKAYAMA, V36, P187; BARTHOLOMEW TC, 1980, BIOCHEM PHARMACOL, V29, P2431, DOI 10.1016/0006-2952(80)90346-9; BEAUCHAMP RO, 1984, CRC CR REV TOXICOL, V13, P25, DOI 10.3109/10408448409029321; Benavides GA, 2007, P NATL ACAD SCI USA, V104, P17977, DOI 10.1073/pnas.0705710104; Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; Calvert JW, 2010, ANTIOXID REDOX SIGN, V12, P1203, DOI 10.1089/ars.2009.2882; Celano L, 2009, ARCH BIOCHEM BIOPHYS, V491, P96, DOI 10.1016/j.abb.2009.08.022; Chen XL, 2004, J BIOL CHEM, V279, P52082, DOI 10.1074/jbc.C400481200; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Collman J, 2009, P NATL ACAD SCI USA, V106, P22090, DOI 10.1073/pnas.0904082106; Cooper CE, 2008, J BIOENERG BIOMEMBR, V40, P533, DOI 10.1007/s10863-008-9166-6; CRAWHALL JC, 1968, SCIENCE, V160, P419, DOI 10.1126/science.160.3826.419; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Eto K, 2002, J BIOL CHEM, V277, P42680, DOI 10.1074/jbc.M205835200; Flores JF, 2005, P NATL ACAD SCI USA, V102, P2713, DOI 10.1073/pnas.0407455102; Furne J, 2008, AM J PHYSIOL-REG I, V295, pR1479, DOI 10.1152/ajpregu.90566.2008; GADALLA MM, 2010, J NEUROCHEM IN PRESS; Goubern M, 2007, FASEB J, V21, P1699, DOI 10.1096/fj.06-7407com; Grice K, 2005, SCIENCE, V307, P706, DOI 10.1126/science.1104323; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; JARABAK R, 1978, ARCH BIOCHEM BIOPHYS, V185, P458, DOI 10.1016/0003-9861(78)90189-3; Kimura H, 2010, ANTIOXID REDOX SIGN, V12, P1111, DOI 10.1089/ars.2009.2919; Li C, 2010, SCIENCE, V328, P80, DOI 10.1126/science.1182369; Li L, 2008, TRENDS PHARMACOL SCI, V29, P84, DOI 10.1016/j.tips.2007.11.003; Mathai JC, 2009, P NATL ACAD SCI USA, V106, P16633, DOI 10.1073/pnas.0902952106; Mosharov E, 2000, BIOCHEMISTRY-US, V39, P13005, DOI 10.1021/bi001088w; Mudd S., 2001, METABOLIC MOL BASES, P2007; MUDD SH, 1967, SCIENCE, V156, P1599, DOI 10.1126/science.156.3782.1599; Muller FH, 2004, MOL MICROBIOL, V53, P1147, DOI 10.1111/j.1365-2958.2004.04193.x; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268re2; Nagahara N, 2005, J BIOL CHEM, V280, P34569, DOI 10.1074/jbc.M505643200; NAGAHARA N, 1995, J BIOL CHEM, V270, P16230, DOI 10.1074/jbc.270.27.16230; Nagahara N, 1998, HISTOCHEM CELL BIOL, V110, P243, DOI 10.1007/s004180050286; Nandi DL, 1998, INT J BIOCHEM CELL B, V30, P973, DOI 10.1016/S1357-2725(98)00050-8; NICHOLLS P, 1982, CAN J BIOCHEM CELL B, V60, P613, DOI 10.1139/o82-076; Nicoletti FP, 2010, BIOCHEMISTRY-US, V49, P2269, DOI 10.1021/bi901671d; Olson KR, 2009, BBA-BIOENERGETICS, V1787, P856, DOI 10.1016/j.bbabio.2009.03.019; Pietri R, 2009, BIOCHEMISTRY-US, V48, P4881, DOI 10.1021/bi801738j; POWELL MA, 1986, SCIENCE, V233, P563, DOI 10.1126/science.233.4763.563; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Taoka S, 2001, J INORG BIOCHEM, V87, P245, DOI 10.1016/S0162-0134(01)00335-X; Tiranti V, 2004, AM J HUM GENET, V74, P239, DOI 10.1086/381653; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; Vorobets VS, 2002, RUSS J APPL CHEM+, V75, P229, DOI 10.1023/A:1016152117662; Wang J, 2003, HUM GENET, V112, P404, DOI 10.1007/s00439-003-0906-8; Weber RE, 2001, PHYSIOL REV, V81, P569, DOI 10.1152/physrev.2001.81.2.569; Westrop GD, 2009, J BIOL CHEM, V284, P33485, DOI 10.1074/jbc.M109.054320; Whitfield NL, 2008, AM J PHYSIOL-REG I, V294, pR1930, DOI 10.1152/ajpregu.00025.2008; Williams RAM, 2003, J BIOL CHEM, V278, P1480, DOI 10.1074/jbc.M209395200; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	54	581	603	2	131	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					21903	21907		10.1074/jbc.R110.128363	http://dx.doi.org/10.1074/jbc.R110.128363			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20448039	hybrid, Green Published			2022-12-27	WOS:000279702200001
J	Lee, SM; Vasishtha, M; Prywes, R				Lee, Seung-Min; Vasishtha, Mansi; Prywes, Ron			Activation and Repression of Cellular Immediate Early Genes by Serum Response Factor Cofactors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR ELK-1; TERNARY COMPLEX FACTORS; C-FOS GENE; GROWTH-FACTOR; HISTONE DEACETYLASES; BINDING PROTEIN; ACTIN DYNAMICS; MAP KINASES; DOMAIN; MYOCARDIN	The induction of expression of many cellular immediate early genes (IEG) involves the transcription factor serum response factor (SRF). Two families of SRF coactivators have also been implicated in IEG induction, the ternary complex factors (TCFs), ELK1, Sap1, and Net, and the myocardin-related factors, MKL1 and MKL2. We found that serum induction of some SRF target genes is preferentially regulated by MKL1/2, whereas others are redundantly activated by both TCFs and MKL1/2. Yet ELK1 can also repress transcription. Binding of ELK1 and MKL1 to SRF has been found to be mutually exclusive in vitro, suggesting that ELK1 could repress expression of IEGs by blocking MKL1 binding. We characterized the in vivo binding of MKL1 and ELK1 to target genes and found an inverse relationship of serum-induced MKL1 binding and serum-decreased ELK1 binding. However, experiments with short hairpin RNA-mediated MKL1/2 depletion and expression of a nuclear MKL1 (N100) variant in stably transfected cells failed to alter ELK1 binding, suggesting that ELK1 binding to target genes is regulated independently of MKL1/2. Nevertheless, we found that short interfering RNA-mediated depletion of TCFs increased target gene expression in cells containing the N100 MKL1 activator, most notably in cells under continuous growth conditions. These results indicate that the TCFs can function both as activators and repressors of target gene expression depending upon the cellular growth conditions.	[Lee, Seung-Min; Vasishtha, Mansi; Prywes, Ron] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Prywes, R (corresponding author), Columbia Univ, Dept Biol Sci, Fairchild 813A,MC 2420,1212 Amsterdam Ave, New York, NY 10027 USA.	mrp6@columbia.edu			National Institutes of Health [CA50329]; NATIONAL CANCER INSTITUTE [R01CA050329] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA50329 (to R. P.).	ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; Boros J, 2009, GENOME RES, V19, P1963, DOI 10.1101/gr.093047.109; Brandt DT, 2009, NAT CELL BIOL, V11, P557, DOI 10.1038/ncb1862; BRAVO R, 1990, CELL GROWTH DIFFER, V1, P305; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Cen B, 2004, J CELL BIOCHEM, V93, P74, DOI 10.1002/jcb.20199; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Cesari F, 2004, MOL CELL BIOL, V24, P294, DOI 10.1128/MCB.24.1.294-305.2004; COCHRAN BH, 1984, SCIENCE, V226, P1080, DOI 10.1126/science.6093261; Criqui-Filipe P, 1999, EMBO J, V18, P3392, DOI 10.1093/emboj/18.12.3392; Descot A, 2008, MOL CELL BIOL, V28, P6171, DOI 10.1128/MCB.00303-08; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Ducret C, 2000, ONCOGENE, V19, P5063, DOI 10.1038/sj.onc.1203892; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; GIOVANE A, 1994, GENE DEV, V8, P1502, DOI 10.1101/gad.8.13.1502; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; Guettler S, 2008, MOL CELL BIOL, V28, P732, DOI 10.1128/MCB.01623-07; Hassler M, 2001, EMBO J, V20, P3018, DOI 10.1093/emboj/20.12.3018; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; HERRERA RE, 1989, NATURE, V340, P68, DOI 10.1038/340068a0; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x; JANKNECHT R, 1994, ONCOGENE, V9, P1273; Janknecht R, 1996, BIOCHEM BIOPH RES CO, V228, P831, DOI 10.1006/bbrc.1996.1740; Kasza A, 2005, J BIOL CHEM, V280, P1149, DOI 10.1074/jbc.M411161200; Li QJ, 2003, EMBO J, V22, P281, DOI 10.1093/emboj/cdg028; Ling Y, 1997, EMBO J, V16, P2431, DOI 10.1093/emboj/16.9.2431; Ma ZG, 2001, NAT GENET, V28, P220, DOI 10.1038/90054; Maira SM, 1996, EMBO J, V15, P5849, DOI 10.1002/j.1460-2075.1996.tb00972.x; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Mercher T, 2001, P NATL ACAD SCI USA, V98, P5776, DOI 10.1073/pnas.101001498; Messenguy F, 2003, GENE, V316, P1, DOI 10.1016/S0378-1119(03)00747-9; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Mo Y, 2000, NAT STRUCT BIOL, V7, P292; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Muehlich S, 2008, MOL CELL BIOL, V28, P6302, DOI 10.1128/MCB.00427-08; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; Nakagawa K, 2005, GENES CELLS, V10, P835, DOI 10.1111/j.1365-2443.2005.00880.x; Nissen LJ, 2001, J BIOL CHEM, V276, P5213, DOI 10.1074/jbc.M007824200; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Posern G, 2004, EMBO J, V23, P3973, DOI 10.1038/sj.emboj.7600404; PRICE MA, 1995, EMBO J, V14, P2589, DOI 10.1002/j.1460-2075.1995.tb07257.x; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Sasazuki T, 2002, J BIOL CHEM, V277, P28853, DOI 10.1074/jbc.M203190200; Selvaraj A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-13; Selvaraj A, 2003, J BIOL CHEM, V278, P41977, DOI 10.1074/jbc.M305679200; Sharrocks AD, 1997, INT J BIOCHEM CELL B, V29, P1371, DOI 10.1016/S1357-2725(97)00086-1; SHORE P, 1995, EUR J BIOCHEM, V229, P1, DOI 10.1111/j.1432-1033.1995.tb20430.x; Shore P, 1996, MOL CELL BIOL, V16, P3338; SHORE P, 1994, MOL CELL BIOL, V14, P3283, DOI 10.1128/MCB.14.5.3283; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Spencer JA, 1999, MOL CELL BIOL, V19, P3977; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tanaka T, 2008, MOL CELL BIOL, V28, P1147, DOI 10.1128/MCB.01771-07; TREISMAN R, 1992, EMBO J, V11, P4631, DOI 10.1002/j.1460-2075.1992.tb05565.x; TREISMAN R, 1987, EMBO J, V6, P2711, DOI 10.1002/j.1460-2075.1987.tb02564.x; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang J, 2007, MOL CELL BIOL, V27, P622, DOI 10.1128/MCB.01160-06; Wang Y, 2000, ONCOGENE, V19, P1379, DOI 10.1038/sj.onc.1203443; Wang Y, 1998, CELL GROWTH DIFFER, V9, P513; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Yang SH, 1999, EMBO J, V18, P5666, DOI 10.1093/emboj/18.20.5666; Yang SH, 2002, MOL CELL BIOL, V22, P5036, DOI 10.1128/MCB.22.14.5036-5046.2002; Yang SH, 1998, EMBO J, V17, P1740, DOI 10.1093/emboj/17.6.1740; Yang SH, 1998, MOL CELL BIOL, V18, P710, DOI 10.1128/MCB.18.2.710; Yang SH, 2001, MOL CELL BIOL, V21, P2802, DOI 10.1128/MCB.21.8.2802-2814.2001; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X; Yoshida T, 2007, AM J PHYSIOL-CELL PH, V292, pC886, DOI 10.1152/ajpcell.00449.2006; Yoshida T, 2008, AM J PHYSIOL-CELL PH, V295, pC1175, DOI 10.1152/ajpcell.00288.2008; Zaromytidou AI, 2006, MOL CELL BIOL, V26, P4134, DOI 10.1128/MCB.01902-05; Zhou JL, 2005, MOL CELL BIOL, V25, P9874, DOI 10.1128/MCB.25.22.9874-9885.2005; Zhou JL, 2005, J BIOL CHEM, V280, P10861, DOI 10.1074/jbc.M411586200	78	51	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22036	22049		10.1074/jbc.M110.108878	http://dx.doi.org/10.1074/jbc.M110.108878			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20466732	Green Published, hybrid			2022-12-27	WOS:000279702200016
J	Qamar, I; Gong, EY; Kim, Y; Song, CH; Lee, HJ; Chun, SY; Lee, K				Qamar, Imteyaz; Gong, Eun-Yeung; Kim, Yeawon; Song, Chin-Hee; Lee, Hyun Joo; Chun, Sang-Young; Lee, Keesook			Anti-steroidogenic Factor ARR19 Inhibits Testicular Steroidogenesis through the Suppression of Nur77 Transactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR NUR77; PROTEIN-KINASE-A; P450C17 GENE-TRANSCRIPTION; NECROSIS-FACTOR-ALPHA; RAT LEYDIG-CELLS; NGFI-B; COACTIVATOR RECRUITMENT; ANDROGEN RECEPTOR; MEDIATES TRANSACTIVATION; INDEPENDENT MECHANISMS	ARR19 (androgen receptor corepressor-19 kDa), a leucine-rich protein whose expression is down-regulated by luteinizing hormone and cAMP, is differentially expressed during the development of Leydig cells and inhibits testicular steroidogenesis by reducing the expression of steroidogenic enzymes. However, the molecular events behind the suppression of testicular steroidogenesis are unknown. In the present study, we demonstrate that ARR19 inhibits the transactivation of orphan nuclear receptor Nur77, which is one of the major transcription factors that regulate the expression of steroidogenic enzyme genes in Leydig cells. ARR19 physically interacts with Nur77 and suppresses Nur77-induced promoter activity of steroidogenic enzyme genes including StAR, P450c17, and 3 beta-HSD in Leydig cells. Transient transfection and chromatin immunoprecipitation assays revealed that ARR19-mediated reduced expression of steroidogenic enzyme genes was likely due to the interference of SRC-1 recruitment to Nur77 protein on the promoter of steroidogenic enzyme genes. These findings suggest that ARR19 acts as a novel coregulator of Nur77, in turn regulating Nur77-induced testicular steroidogenesis, and may play an important role in the development and function of testicular Leydig cells.	[Qamar, Imteyaz; Gong, Eun-Yeung; Kim, Yeawon; Song, Chin-Hee; Lee, Hyun Joo; Chun, Sang-Young; Lee, Keesook] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea	Chonnam National University	Lee, K (corresponding author), Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea.	klee@chonnam.ac.kr		Qamar, Imteyaz/0000-0003-2390-1808	Ministry of Education, Science and Technology [2009-0065629]	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Education, Science and Technology Grant 2009-0065629.	Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141; Cooke BA, 1999, MOL CELL ENDOCRINOL, V151, P25, DOI 10.1016/S0303-7207(98)00255-X; COOKE BA, 1996, LEYDIG CELL, P352; DAVIS IJ, 1993, MOL ENDOCRINOL, V7, P953, DOI 10.1210/me.7.8.953; FAHRNER TJ, 1990, MOL CELL BIOL, V10, P6454, DOI 10.1128/MCB.10.12.6454; Fan WQ, 2007, J BIOL CHEM, V282, P7329, DOI 10.1074/jbc.M610447200; Ge RS, 2006, P NATL ACAD SCI USA, V103, P2719, DOI 10.1073/pnas.0507692103; Ge RS, 2005, BIOL REPROD, V72, P1405, DOI 10.1095/biolreprod.104.037499; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Haddad JJ, 2002, CYTOKINE, V17, P301, DOI 10.1006/cyto.2002.1017; HAIDER S, 1986, GEN COMP ENDOCR, V64, P321, DOI 10.1016/0016-6480(86)90065-1; Han YQ, 1997, J BIOL CHEM, V272, P9825; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; HAZEL TG, 1991, MOL CELL BIOL, V11, P3239, DOI 10.1128/MCB.11.6.3239; HIRATA Y, 1993, J BIOL CHEM, V268, P24808; Hong CY, 2004, MOL CELL BIOL, V24, P2593, DOI 10.1128/MCB.24.7.2593-2604.2004; Jeong BC, 2004, MOL ENDOCRINOL, V18, P13, DOI 10.1210/me.2003-0065; Kim JY, 2004, MOL ENDOCRINOL, V18, P2880, DOI 10.1210/me.2004-0211; Kovalovsky D, 2002, MOL ENDOCRINOL, V16, P1638, DOI 10.1210/me.16.7.1638; Ladner KJ, 2003, J BIOL CHEM, V278, P2294, DOI 10.1074/jbc.M207129200; Li T, 2006, INT J BIOCHEM CELL B, V38, P420, DOI 10.1016/j.biocel.2005.10.003; Maira M, 2003, MOL CELL BIOL, V23, P763, DOI 10.1128/MCB.23.3.763-776.2003; Manna P. R., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P93, DOI 10.2174/1568008053174714; Mellon SH, 1998, ENDOCR RES, V24, P505, DOI 10.3109/07435809809032639; Mendis-Handagama SMLC, 2001, BIOL REPROD, V65, P660, DOI 10.1095/biolreprod65.3.660; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; Mohan S, 2003, ENDOCRINOLOGY, V144, P929, DOI 10.1210/en.2002-220948; Moraga PF, 1997, J ENDOCRINOL, V154, P201, DOI 10.1677/joe.0.1540201; Park JI, 2001, ENDOCRINOLOGY, V142, P3051, DOI 10.1210/en.142.7.3051; Parker KL, 1997, ENDOCR REV, V18, P361, DOI 10.1210/er.18.3.361; Payne A., 1996, LEYDIG CELL PP, P259; Pekarsky Y, 2001, P NATL ACAD SCI USA, V98, P3690, DOI 10.1073/pnas.051003198; Qamar I, 2009, J BIOL CHEM, V284, P18021, DOI 10.1074/jbc.M900896200; Sadie H, 2003, ENDOCRINOLOGY, V144, P1958, DOI 10.1210/en.2002-220874; Sadovsky Y, 2000, REV REPROD, V5, P136; Sohn YC, 2001, J BIOL CHEM, V276, P43734, DOI 10.1074/jbc.M107208200; Song KH, 2001, ENDOCRINOLOGY, V142, P5116, DOI 10.1210/en.142.12.5116; Song KH, 2004, MOL ENDOCRINOL, V18, P1929, DOI 10.1210/me.2004-0043; Steinmetz ACU, 2001, ANNU REV BIOPH BIOM, V30, P329, DOI 10.1146/annurev.biophys.30.1.329; Stocco CO, 2000, J BIOL CHEM, V275, P37202, DOI 10.1074/jbc.M006016200; Teerds KJ, 2007, J ENDOCRINOL, V194, P579, DOI 10.1677/JOE-06-0084; Wansa KDSA, 2002, J BIOL CHEM, V277, P33001, DOI 10.1074/jbc.M203572200; Wansa KDSA, 2003, J BIOL CHEM, V278, P24776, DOI 10.1074/jbc.M300088200; Wells J, 2002, METHODS, V26, P48, DOI 10.1016/S1046-2023(02)00007-5; WILSON TE, 1993, MOL CELL BIOL, V13, P861, DOI 10.1128/MCB.13.2.861; Zhang PL, 1997, MOL ENDOCRINOL, V11, P891, DOI 10.1210/me.11.7.891; Zhang PL, 1996, MOL ENDOCRINOL, V10, P147, DOI 10.1210/me.10.2.147	47	28	30	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22360	22369		10.1074/jbc.M109.059949	http://dx.doi.org/10.1074/jbc.M109.059949			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20472563	Green Published, hybrid			2022-12-27	WOS:000279702200049
J	Halterman, MW; Gill, M; DeJesus, C; Ogihara, M; Schor, NF; Federoff, HJ				Halterman, Marc W.; Gill, Molly; DeJesus, Chris; Ogihara, Mitsunori; Schor, Nina F.; Federoff, Howard J.			The Endoplasmic Reticulum Stress Response Factor CHOP-10 Protects against Hypoxia-induced Neuronal Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL CEREBRAL-ISCHEMIA; PROGRAMMED CELL-DEATH; TRANSCRIPTION FACTOR; UP-REGULATION; BRAIN; EXPRESSION; ACTIVATION; PROMOTES; GADD153; PATHWAY	Hypoxia-induced gene expression is a critical determinant of neuron survival after stroke. Understanding the cell autonomous genetic program controlling adaptive and pathological transcription could have important therapeutic implications. To identify the factors that modulate delayed neuronal apoptosis after hypoxic injury, we developed an in vitro culture model that recapitulates these divergent responses and characterized the sequence of gene expression changes using microarrays. Hypoxia induced a disproportionate number of bZIP transcription factors and related targets involved in the endoplasmic reticulum stress response. Although the temporal and spatial aspects of ATF4 expression correlated with neuron loss, our results did not support the anticipated pathological role for delayed CHOP expression. Rather, CHOP deletion enhanced neuronal susceptibility to both hypoxic and thapsigargin-mediated injury and attenuated brain-derived neurotrophic factor-induced neuroprotection. Also, enforced expression of CHOP prior to the onset of hypoxia protected wild-type cultures against subsequent injury. Collectively, these findings indicate CHOP serves a more complex role in the neuronal response to hypoxic stress with involvement in both ischemic preconditioning and delayed neuroprotection.	[Halterman, Marc W.; Gill, Molly; Schor, Nina F.] Univ Rochester, Med Ctr, Ctr Neural Dev & Dis, Rochester, NY 14642 USA; [Halterman, Marc W.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Halterman, Marc W.; DeJesus, Chris; Schor, Nina F.] Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA; [Ogihara, Mitsunori] Univ Miami, Dept Comp Sci, Coral Gables, FL 33124 USA; [Federoff, Howard J.] Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20007 USA	University of Rochester; University of Rochester; University of Rochester; University of Miami; Georgetown University	Halterman, MW (corresponding author), Univ Rochester, Med Ctr, Ctr Neural Dev & Dis, 601 Elmwood Ave,Box 645, Rochester, NY 14642 USA.	marc_halterman@urmc.rochester.edu	Ogihara, Mitsunori/AAB-8275-2020	Ogihara, Mitsunori/0000-0002-5690-7854; Schor, Nina/0000-0002-3817-7376	NINDS NIH HHS [R00 NS060764-04, R00 NS060764] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS060764] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aldridge JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000874; Bert AG, 2006, RNA, V12, P1074, DOI 10.1261/rna.2320506; Bredesen DE, 2007, STROKE, V38, P652, DOI 10.1161/01.STR.0000257802.82826.a7; Chen G, 2007, J NEUROSCI RES, V85, P1674, DOI 10.1002/jnr.21292; Dave KR, 2004, BRAIN RES, V1024, P89, DOI 10.1016/j.brainres.2004.07.050; DeGracia DJ, 2004, J NEUROCHEM, V91, P1, DOI 10.1111/j.1471-4159.2004.02703.x; Du C, 1996, J CEREBR BLOOD F MET, V16, P195, DOI 10.1097/00004647-199603000-00003; GESCHWIND MD, 1994, METH NEUROSCI, V21, P462; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Halterman MW, 2008, MOL CELL NEUROSCI, V38, P125, DOI 10.1016/j.mcn.2008.01.014; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Jin KL, 2001, ANN NEUROL, V50, P93, DOI 10.1002/ana.1073; Khot S, 2006, SEMIN NEUROL, V26, P422, DOI 10.1055/s-2006-948323; Kim JB, 2004, J NEUROCHEM, V89, P1271, DOI 10.1111/j.1471-4159.2004.02429.x; Kirino T, 2000, NEUROPATHOLOGY, V20, pS95; KIRINO T, 1984, ACTA NEUROPATHOL, V64, P139, DOI 10.1007/BF00695577; Konaka Kuni, 2007, J Stroke Cerebrovasc Dis, V16, P82, DOI 10.1016/j.jstrokecerebrovasdis.2006.10.007; KRAJEWSKI S, 1995, J NEUROSCI, V15, P6364; Lange PS, 2008, J EXP MED, V205, P1227, DOI 10.1084/jem.20071460; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu SM, 2004, J CEREBR BLOOD F MET, V24, P343, DOI 10.1097/01.WCB.0000110047.43905.01; Ma YJ, 2004, J BIOL CHEM, V279, P13792, DOI 10.1074/jbc.M313724200; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Oida Y, 2008, NEUROSCIENCE, V151, P111, DOI 10.1016/j.neuroscience.2007.10.047; ROSENBAUM DM, 1994, ANN NEUROL, V36, P864, DOI 10.1002/ana.410360610; ROSS DT, 1993, J CEREBR BLOOD F MET, V13, P558, DOI 10.1038/jcbfm.1993.73; Schabitz WR, 2000, STROKE, V31, P2212, DOI 10.1161/01.STR.31.9.2212; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SHIGENO T, 1990, NEUROSCI LETT, V120, P117, DOI 10.1016/0304-3940(90)90182-9; Southwood CM, 2002, NEURON, V36, P585, DOI 10.1016/S0896-6273(02)01045-0; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Tajiri S, 2004, CELL DEATH DIFFER, V11, P403, DOI 10.1038/sj.cdd.4401365; Tajiri S, 2006, FEBS LETT, V580, P3462, DOI 10.1016/j.febslet.2006.05.021; Teschendorf P, 2008, NEUROSCI LETT, V448, P194, DOI 10.1016/j.neulet.2008.10.030; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Zhu Y, 2008, J NEUROSCI, V28, P2168, DOI 10.1523/JNEUROSCI.5232-07.2008; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	41	50	52	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21329	21340		10.1074/jbc.M109.095299	http://dx.doi.org/10.1074/jbc.M109.095299			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20448044	Green Published, hybrid			2022-12-27	WOS:000279516100018
J	Loomis, WF; Behrens, MM; Williams, ME; Anjard, C				Loomis, William F.; Behrens, M. Margarita; Williams, Megan E.; Anjard, Christophe			Pregnenolone Sulfate and Cortisol Induce Secretion of Acyl-CoA-binding Protein and Its Conversion into Endozepines from Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED RAT ASTROCYTES; TERMINAL DIFFERENTIATION; UNCONVENTIONAL SECRETION; OCTADECANEUROPEPTIDE ODN; PROCESSING PRODUCTS; CEREBROSPINAL-FLUID; PRESYNAPTIC ACTION; INHIBITOR DBI; DICTYOSTELIUM; MECHANISMS	Acyl-CoA-binding protein (ACBP) functions both intracellularly as part of fatty acid metabolism and extracellularly as diazepam binding inhibitor, the precursor of endozepine peptides. Two of these peptides, ODN and TTN, bind to the GABA(A) receptor and modulate its sensitivity to gamma-aminobutyric acid (GABA). We have found that depolarization of mouse primary astrocytes induces the rapid release and processing of ACBP to the active peptides. We previously showed that ODN can trigger the rapid sporulation of the social amoeba Dictyostelium. Using this bioassay, we now show that astrocytes release the endozepine peptides within 10 min of exposure to the steroids cortisol, pregnenolone, pregnenolone sulfate, or progesterone. ACBP lacks a signal sequence for secretion through the endoplasmic reticulum/Golgi pathway and its secretion is not affected by addition of brefeldin A, a well known inhibitor of the classical secretion pathway, suggesting that it follows an unconventional pathway for secretion. Moreover, induction of autophagy by addition of rapamycin also resulted in rapid release of ACBP indicating that this protein uses components of the autophagy pathway for secretion. Following secretion, ACBP is proteolytically cleaved to the active neuropeptides by protease activity on the surface of astrocytes. Neurosteroids, such as pregnenolone sulfate, were previously shown to modulate the excitatory/inhibitory balance in brain through increased release of glutamate and decreased release of GABA. These effects of steroids in neurons will be reinforced by the release of endozepines from astrocytes shown here, and suggest an orchestrated astrocyte-neuron cross-talk that can affect a broad spectrum of behavioral functions.	[Loomis, William F.; Williams, Megan E.; Anjard, Christophe] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Behrens, M. Margarita] Salk Inst Biol Studies, La Jolla, CA 92037 USA	University of California System; University of California San Diego; Salk Institute	Loomis, WF (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	wloomis@UCSD.edu; canjard@ucsd.edu	Behrens, M. Margarita/K-2576-2014; Anjard, Christophe/H-5012-2017	Anjard, Christophe/0000-0002-6905-1493	National Institutes of Health [GM78175]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078175] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM78175.	ANJARD C, 1992, DEVELOPMENT, V115, P785; Anjard C, 2005, P NATL ACAD SCI USA, V102, P7607, DOI 10.1073/pnas.0501820102; Anjard C, 1998, DEV BIOL, V193, P146, DOI 10.1006/dbio.1997.8804; Anjard C, 2008, DEVELOPMENT, V135, P819, DOI 10.1242/dev.018051; Anjard C, 2006, DEVELOPMENT, V133, P2253, DOI 10.1242/dev.02399; Anjard C, 2009, DEVELOPMENT, V136, P803, DOI 10.1242/dev.032607; BERKOVICH A, 1990, MOL PHARMACOL, V37, P164; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; CABRAL M, 2010, EUKARYOTIC IN PRESS; Cuervo P, 2009, J PROTEOMICS, V73, P79, DOI 10.1016/j.jprot.2009.08.006; Do-Rego JL, 2001, J NEUROCHEM, V76, P128, DOI 10.1046/j.1471-4159.2001.00053.x; Dong Y, 2005, CELL MOL LIFE SCI, V62, P1003, DOI 10.1007/s00018-005-5004-8; Duran JM, 2010, J CELL BIOL, V188, P527, DOI 10.1083/jcb.200911154; Faergeman NJ, 2007, MOL CELL BIOCHEM, V299, P55, DOI 10.1007/s11010-005-9040-3; FERRERO P, 1986, P NATL ACAD SCI USA, V83, P827, DOI 10.1073/pnas.83.3.827; Garcia-Ovejero D, 2005, BRAIN RES REV, V48, P273, DOI 10.1016/j.brainresrev.2004.12.018; Gibbs TT, 2006, PHARMACOL BIOCHEM BE, V84, P555, DOI 10.1016/j.pbb.2006.07.031; GUARNERI P, 1990, NEUROPHARMACOLOGY, V29, P419, DOI 10.1016/0028-3908(90)90162-K; GUIDOTTI A, 1983, P NATL ACAD SCI-BIOL, V80, P3531, DOI 10.1073/pnas.80.11.3531; Hwang J, 2010, BRIT J PHARMACOL, V159, P586, DOI 10.1111/j.1476-5381.2009.00563.x; Kinney JW, 2006, J NEUROSCI, V26, P1604, DOI 10.1523/JNEUROSCI.4722-05.2006; Kinseth MA, 2007, CELL, V130, P524, DOI 10.1016/j.cell.2007.06.029; KNECHT DA, 1987, SCIENCE, V236, P1081, DOI 10.1126/science.3576221; KNUDSEN J, 1993, MOL CELL BIOCHEM, V123, P129, DOI 10.1007/BF01076484; Lafon-Cazal M, 2003, J BIOL CHEM, V278, P24438, DOI 10.1074/jbc.M211980200; Levi S, 2000, PLASMID, V44, P231, DOI 10.1006/plas.2000.1487; MAJEWSKA MD, 1988, NEUROSCI LETT, V90, P279, DOI 10.1016/0304-3940(88)90202-9; Manjithaya R, 2010, J CELL BIOL, V188, P537, DOI 10.1083/jcb.200911149; Masmoudi O, 2005, J NEUROCHEM, V94, P561, DOI 10.1111/j.1471-4159.2005.03076.x; Masmoudi O, 2003, FASEB J, V17, P17, DOI 10.1096/fj.02-0317com; Memmott RM, 2009, CELL SIGNAL, V21, P656, DOI 10.1016/j.cellsig.2009.01.004; Mtchedlishvili Z, 2003, MOL PHARMACOL, V64, P857, DOI 10.1124/mol.64.4.857; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Nitz I, 2005, INT J BIOCHEM CELL B, V37, P2395, DOI 10.1016/j.biocel.2005.06.008; PAPADOPOULOS V, 1991, NEUROPHARMACOLOGY, V30, P1417, DOI 10.1016/S0028-3908(11)80011-0; Prager EM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.286re5; Qian ZY, 2008, J NEUROCHEM, V105, P1287, DOI 10.1111/j.1471-4159.2008.05229.x; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; SLOBODYANSKY E, 1989, J NEUROCHEM, V53, P1276, DOI 10.1111/j.1471-4159.1989.tb07425.x; Smith JL, 2008, STEROIDS, V73, P1160, DOI 10.1016/j.steroids.2008.05.003; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; Teschemacher A, 1997, BRAIN RES, V772, P226, DOI 10.1016/S0006-8993(97)00872-X; TONON MC, 1990, NEUROPEPTIDES, V15, P17, DOI 10.1016/0143-4179(90)90155-R; Wang N, 1999, MOL CELL BIOL, V19, P4750; Yanase H, 2002, ARCH HISTOL CYTOL, V65, P27, DOI 10.1679/aohc.65.27; Yuen EY, 2009, P NATL ACAD SCI USA, V106, P14075, DOI 10.1073/pnas.0906791106; Zheng P, 2009, PROG NEUROBIOL, V89, P134, DOI 10.1016/j.pneurobio.2009.07.001; Zinder O, 1999, ACTA PHYSIOL SCAND, V167, P181	48	42	42	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21359	21365		10.1074/jbc.M110.105858	http://dx.doi.org/10.1074/jbc.M110.105858			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20452969	hybrid, Green Published			2022-12-27	WOS:000279516100021
J	Mateyak, MK; Kinzy, TG				Mateyak, Maria K.; Kinzy, Terri Goss			eEF1A: Thinking Outside the Ribosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ELONGATION-FACTOR 1A; DEPENDENT RNA-POLYMERASE; FACTOR-I-ALPHA; TRANSLATION ELONGATION; NUCLEOTIDE EXCHANGE; ACTIN CYTOSKELETON; PROTEIN-SYNTHESIS; F-ACTIN; GUANINE-NUCLEOTIDE; BINDING PROTEIN	Eukaryotic translation elongation factor 1A (eEF1A) is one of the most abundant protein synthesis factors. eEF1A is responsible for the delivery of all aminoacyl-tRNAs to the ribosome, aside from initiator and selenocysteine tRNAs. In addition to its roles in polypeptide chain elongation, unique cellular and viral activities have been attributed to eEF1A in eukaryotes from yeast to plants and mammals. From preliminary, speculative associations to well characterized biochemical and biological interactions, it is clear that eEF1A, of all the translation factors, has been ascribed the most functions outside of protein synthesis. A mechanistic understanding of these non-canonical functions of eEF1A will shed light on many important biological questions, including viral-host interaction, subcellular organization, and the integration of key cellular pathways.	[Mateyak, Maria K.; Kinzy, Terri Goss] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Kinzy, TG (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA.	kinzytg@umdnj.edu		Kinzy, Terri/0000-0003-1394-9226; Mateyak, Maria/0000-0003-0859-1901	National Institutes of Health [GM057483]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057483] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM057483 (to T. G. K.). This is the sixth article in the Thematic Minireview Series on Protein Synthesis. This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Amiri A, 2007, ONCOGENE, V26, P3027, DOI 10.1038/sj.onc.1210101; Andersen GR, 2000, MOL CELL, V6, P1261, DOI 10.1016/S1097-2765(00)00122-2; Andersen GR, 2003, TRENDS BIOCHEM SCI, V28, P434, DOI 10.1016/S0968-0004(03)00162-2; Andersen GR, 2001, NAT STRUCT BIOL, V8, P531, DOI 10.1038/88598; Blackwell JL, 1997, J VIROL, V71, P6433, DOI 10.1128/JVI.71.9.6433-6444.1997; Calado A, 2002, EMBO J, V21, P6216, DOI 10.1093/emboj/cdf620; Chang RY, 2007, J CELL BIOCHEM, V100, P267, DOI 10.1002/jcb.20969; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; Davis WG, 2007, J VIROL, V81, P10172, DOI 10.1128/JVI.00531-07; DEMMA M, 1990, J BIOL CHEM, V265, P2286; DURSO NA, 1994, PLANT CELL, V6, P893, DOI 10.1105/tpc.6.6.893; Duttaroy A, 1998, EXP CELL RES, V238, P168, DOI 10.1006/excr.1997.3819; Edmonds BT, 1998, J BIOL CHEM, V273, P10288, DOI 10.1074/jbc.273.17.10288; GONEN H, 1994, P NATL ACAD SCI USA, V91, P7648, DOI 10.1073/pnas.91.16.7648; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Gross SR, 2007, MOL CELL BIOL, V27, P1974, DOI 10.1128/MCB.00832-06; Grosshans H, 2000, J STRUCT BIOL, V129, P288, DOI 10.1006/jsbi.2000.4226; Hotokezaka Y, 2002, J BIOL CHEM, V277, P18545, DOI 10.1074/jbc.M201022200; Jeganathan S, 2008, MOL CELL BIOL, V28, P4549, DOI 10.1128/MCB.00150-08; Johnson CM, 2001, J GEN VIROL, V82, P2935, DOI 10.1099/0022-1317-82-12-2935; Kahns S, 1998, NUCLEIC ACIDS RES, V26, P1884, DOI 10.1093/nar/26.8.1884; Khacho M, 2008, MOL BIOL CELL, V19, P5296, DOI 10.1091/mbc.E08-06-0562; Kim S, 2010, NAT REV MOL CELL BIO, V11, P75, DOI 10.1038/nrm2818; Kinzy TG, 2000, COLD SPRING HARBOR M, V39, P973; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; LEE S, 1992, J BIOL CHEM, V267, P24064; Li ZH, 2009, VIROLOGY, V385, P245, DOI 10.1016/j.virol.2008.11.041; Liu G, 1996, J CELL BIOL, V135, P953, DOI 10.1083/jcb.135.4.953; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Matsuda D, 2004, VIROLOGY, V321, P47, DOI 10.1016/j.virol.2003.10.028; Moore RC, 1998, CELL MOTIL CYTOSKEL, V41, P168, DOI 10.1002/(SICI)1097-0169(1998)41:2<168::AID-CM7>3.0.CO;2-A; Munshi R, 2001, GENETICS, V157, P1425; Murthi A, 2010, MOL BIOL CELL, V21, P639, DOI 10.1091/mbc.E09-07-0551; Nishikiori M, 2006, J VIROL, V80, P8459, DOI 10.1128/JVI.00545-06; OHTA K, 1990, J BIOL CHEM, V265, P3240; Pittman YR, 2009, J BIOL CHEM, V284, P4739, DOI 10.1074/jbc.M807945200; Qanungo KR, 2004, P NATL ACAD SCI USA, V101, P5952, DOI 10.1073/pnas.0401449101; Rodnina MV, 2009, CURR OPIN CELL BIOL, V21, P435, DOI 10.1016/j.ceb.2009.01.023; Ruest LB, 2002, J BIOL CHEM, V277, P5418, DOI 10.1074/jbc.M110685200; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; SHIINA N, 1994, SCIENCE, V266, P282, DOI 10.1126/science.7939665; Stapulionis R, 1997, J BIOL CHEM, V272, P24980, DOI 10.1074/jbc.272.40.24980; Talapatra S, 2002, CELL DEATH DIFFER, V9, P856, DOI 10.1038/sj.cdd.4401078; TAYLOR DR, 2006, TRANSLATIONAL CONTRO, P59; Thivierge K, 2008, VIROLOGY, V377, P216, DOI 10.1016/j.virol.2008.04.015; Yamaji Y, 2006, VIROLOGY, V347, P100, DOI 10.1016/j.virol.2005.11.031; Yamaji Y, 2010, ARCH VIROL, V155, P263, DOI 10.1007/s00705-009-0571-x; YANG F, 1990, NATURE, V347, P494, DOI 10.1038/347494a0; Zeenko VV, 2002, J VIROL, V76, P5678, DOI 10.1128/JVI.76.11.5678-5691.2002	50	185	196	4	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21209	21213		10.1074/jbc.R110.113795	http://dx.doi.org/10.1074/jbc.R110.113795			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20444696	Green Published, hybrid			2022-12-27	WOS:000279516100004
J	Goswami, S; Tarapore, RS; TeSlaa, JJ; Grinblat, Y; Setaluri, V; Spiegelman, VS				Goswami, Srikanta; Tarapore, Rohinton S.; TeSlaa, Jessica J.; Grinblat, Yevgenya; Setaluri, Vijayasaradhi; Spiegelman, Vladimir S.			MicroRNA-340-mediated Degradation of Microphthalmia-associated Transcription Factor mRNA Is Inhibited by the Coding Region Determinant-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MELANOMA-CELL LINES; CRD-BP; MASTER REGULATOR; MITF; EXPRESSION; GENE; MELANOCYTES; FAMILY; ZEBRAFISH; TRANSLATION	Alternative cleavage and polyadenylation generate multiple transcript variants of mRNA isoforms with different length of 3'-untranslated region (UTR). Alternative cleavage and polyadenylation enable differential post-transcriptional regulation of transcripts via the availability of different cis-acting elements in 3'-UTRs. Microphthalmia-associated transcription factor ( MITF) is a master regulator of melanocyte development and melanogenesis. It has also been implicated in melanoma development. Here we show that melanoma cells favor the expression of MITF mRNA with shorter 3'-UTR. This isoform of mRNA is regulated by microRNA, miR-340. miR-340 interacts with two of its target sites on the 3'-UTR of MITF mRNA, causing mRNA degradation and decreased expression and activity of MITF. On the other hand, the RNA-binding protein coding region determinant-binding protein, shown to be highly expressed in melanoma, directly binds to the 3'-UTR of MITF mRNA and prevents the binding of miR-340 to its target sites, resulting in stabilization of the MITF transcript and elevated expression and transcriptional activity of MITF. This interplay between RNA-binding protein and miRNA describes the important mechanism of regulation of MITF in melanocytes and malignant melanomas.	[Goswami, Srikanta; Tarapore, Rohinton S.; Setaluri, Vijayasaradhi; Spiegelman, Vladimir S.] Univ Wisconsin, Dept Dermatol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Goswami, Srikanta; Tarapore, Rohinton S.; Setaluri, Vijayasaradhi; Spiegelman, Vladimir S.] Univ Wisconsin, Paul P Carbone Comprehens Canc Ctr, Sch Med & Publ Hlth, Madison, WI 53706 USA; [TeSlaa, Jessica J.; Grinblat, Yevgenya] Univ Wisconsin, Dept Zool, Sch Med & Publ Hlth, Madison, WI 53706 USA; [TeSlaa, Jessica J.; Grinblat, Yevgenya] Univ Wisconsin, Dept Anat, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Spiegelman, VS (corresponding author), Univ Wisconsin, Dept Dermatol, Sch Med & Publ Hlth, 1300 Univ Ave,MSC 417, Madison, WI 53706 USA.	spiegelman@dermatology.wisc.edu	Tarapore, Rohinton/J-8300-2012	Spiegelman, Vladimir S/0000-0003-4847-155X	National Institutes of Health [CA121851, CA12509, GM076244]; NATIONAL CANCER INSTITUTE [R01CA121851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA121851 (to V.S.S.), CA12509 (to V.S.), and GM076244 (to Y.G.).	Atlas R, 2004, J NEUROCHEM, V89, P613, DOI 10.1111/j.1471-4159.2004.02371.x; Bemis LT, 2008, CANCER RES, V68, P1362, DOI 10.1158/0008-5472.CAN-07-2912; BENTLEY NJ, 1994, MOL CELL BIOL, V14, P7996, DOI 10.1128/MCB.14.12.7996; Carreira S, 2000, J BIOL CHEM, V275, P21920, DOI 10.1074/jbc.M000035200; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Dorsky RI, 2000, GENE DEV, V14, P158; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Elcheva I, 2008, ONCOGENE, V27, P5069, DOI 10.1038/onc.2008.141; Elcheva I, 2009, MOL CELL, V35, P240, DOI 10.1016/j.molcel.2009.06.007; Fang D, 2002, NUCLEIC ACIDS RES, V30, P3096, DOI 10.1093/nar/gkf424; Hallsson JH, 2004, GENETICS, V167, P233, DOI 10.1534/genetics.167.1.233; Hansen TVO, 2004, MOL CELL BIOL, V24, P4448, DOI 10.1128/MCB.24.10.4448-4464.2004; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Kawakami Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1811, DOI 10.1271/bbb.90185; Kedde M, 2008, CELL CYCLE, V7, P899, DOI 10.4161/cc.7.7.5644; Khaled M, 2002, J BIOL CHEM, V277, P33690, DOI 10.1074/jbc.M202939200; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; McGill GG, 2006, J BIOL CHEM, V281, P10365, DOI 10.1074/jbc.M513094200; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Mueller DW, 2009, J INVEST DERMATOL, V129, P1740, DOI 10.1038/jid.2008.452; Munro TP, 2006, J CELL BIOL, V172, P577, DOI 10.1083/jcb.200510044; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nielsen FC, 2001, SCAND J CLIN LAB INV, V61, P93; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Noubissi FK, 2006, NATURE, V441, P898, DOI 10.1038/nature04839; Noubissi FK, 2009, CANCER RES, V69, P8572, DOI 10.1158/0008-5472.CAN-09-1500; Price ER, 1998, J BIOL CHEM, V273, P17983, DOI 10.1074/jbc.273.29.17983; PROKIPCAK RD, 1994, J BIOL CHEM, V269, P9261; Runge S, 2000, J BIOL CHEM, V275, P29562, DOI 10.1074/jbc.M001156200; Saito H, 2003, PIGM CELL RES, V16, P261, DOI 10.1034/j.1600-0749.2003.00039.x; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Spiegelman VS, 2000, MOL CELL, V5, P877, DOI 10.1016/S1097-2765(00)80327-5; Takeda K, 2000, J BIOL CHEM, V275, P14013, DOI 10.1074/jbc.C000113200; Tessier CR, 2004, CANCER RES, V64, P209, DOI 10.1158/0008-5472.CAN-03-2927; Vance KW, 2005, CANCER RES, V65, P2260, DOI 10.1158/0008-5472.CAN-04-3045; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Watanabe A, 1998, NAT GENET, V18, P283, DOI 10.1038/ng0398-283; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wu M, 2000, GENE DEV, V14, P301; Yasumoto K, 2002, EMBO J, V21, P2703, DOI 10.1093/emboj/21.11.2703; Yasumoto K, 1997, J BIOL CHEM, V272, P503; YASUMOTO KI, 1994, MOL CELL BIOL, V14, P8058, DOI 10.1128/MCB.14.12.8058	51	62	64	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20532	20540		10.1074/jbc.M110.109298	http://dx.doi.org/10.1074/jbc.M110.109298			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20439467	Green Published, hybrid			2022-12-27	WOS:000279228600015
J	Hanson, HH; Kang, S; Fernandez-Monreal, M; Oung, T; Yildirim, M; Lee, R; Suyama, K; Hazan, RB; Phillips, GR				Hanson, Hugo H.; Kang, Semie; Fernandez-Monreal, Monica; Oung, Twethida; Yildirim, Murat; Lee, Rebecca; Suyama, Kimita; Hazan, Rachel B.; Phillips, Greg R.			LC3-dependent Intracellular Membrane Tubules Induced by gamma-Protocadherins A3 and B2 A ROLE FOR INTRALUMINAL INTERACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC DOMAIN; CORRELATIVE LIGHT; CELL-ADHESION; N-CADHERIN; LC3; PROTEIN; ALPHA; REVEALS; FAMILY; ULTRASTRUCTURE	Clustered protocadherins (Pcdhs) are a family of cadherin-like molecules arranged in gene clusters (alpha, beta, and gamma). gamma-Protocadherins (Pcdh-gamma s) are involved in cell-cell interactions, but their prominent intracellular distribution in vivo and different knock-out phenotypes suggest that these molecules participate in still unidentified processes. We found using correlative light and electron microscopy that Pcdh-gamma A3 and -gamma B2, but not -gamma C4, -alpha 1, or N-cadherin, generate intracellular juxtanuclear membrane tubules when expressed in cells. These tubules recruit the autophagy marker MAP1A/1B LC3 (LC3) but are not associated with autophagic vesicles. Lipidation of LC3 is required for its coclustering with Pcdh-gamma tubules, suggesting the involvement of an autophagic-like molecular cascade. Expression of wild-type LC3 with Pcdh-gamma A3 increased tubule length whereas expression of lipidation-defective LC3 decreased tubule length relative to Pcdh-gamma A3 expressed alone. The tubules were found to emanate from lysosomes. Deletion of the luminal/extracellular domain of Pcdh-gamma A3 preserved lysosomal targeting but eliminated tubule formation whereas cytoplasmic deletion eliminated both lysosomal targeting and tubule formation. Deletion of the membrane-proximal three cadherin repeats resulted in tubes that were narrower than those produced by full-length molecules. These results suggest that Pcdh-gamma A and -gamma B families can influence the shape of intracellular membranes by mediating intraluminal interactions within organelles.	[Hanson, Hugo H.; Kang, Semie; Fernandez-Monreal, Monica; Oung, Twethida; Yildirim, Murat; Lee, Rebecca; Phillips, Greg R.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Suyama, Kimita; Hazan, Rachel B.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA	Icahn School of Medicine at Mount Sinai; Yeshiva University; Albert Einstein College of Medicine	Phillips, GR (corresponding author), Mt Sinai Sch Med, Dept Neurosci, Box 1065,1 Gustave L Levy Pl, New York, NY 10029 USA.	greg.phillips@mssm.edu	Monreal, Monica Fernandez/P-6685-2019; Fernandez-Monreal, Mónica/I-7954-2012	Monreal, Monica Fernandez/0000-0001-7278-448X; Fernandez-Monreal, Mónica/0000-0001-7278-448X	National Institutes of Health [NS051238]; Irma T. Hirschl award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irma T. Hirschl award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant NS051238 and an Irma T. Hirschl award (to G. R. P.).	Baisamy L, 2009, J BIOL CHEM, V284, P28232, DOI 10.1074/jbc.M109.054668; Chen ZW, 2007, J NEUROSCI, V27, P6655, DOI 10.1523/JNEUROSCI.0919-07.2007; Elazar Z, 2003, BBA-MOL CELL RES, V1641, P145, DOI 10.1016/S0167-4889(03)00086-7; Emond MR, 2008, DEV BIOL, V321, P175, DOI 10.1016/j.ydbio.2008.06.011; Fernandez-Monreal M, 2009, MOL CELL NEUROSCI, V40, P344, DOI 10.1016/j.mcn.2008.12.002; Frank M, 2005, MOL CELL NEUROSCI, V29, P603, DOI 10.1016/j.mcn.2005.05.001; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Gao WT, 2010, J BIOL CHEM, V285, P1371, DOI 10.1074/jbc.M109.054197; Garrett AM, 2009, J NEUROSCI, V29, P11723, DOI 10.1523/JNEUROSCI.2818-09.2009; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Jontes JD, 2006, TRENDS NEUROSCI, V29, P186, DOI 10.1016/j.tins.2006.02.002; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Koch AW, 2004, STRUCTURE, V12, P793, DOI 10.1016/j.str.2004.02.034; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; KUZNETSOV SA, 1987, FEBS LETT, V212, P145, DOI 10.1016/0014-5793(87)81574-0; Lefebvre JL, 2008, DEVELOPMENT, V135, P4141, DOI 10.1242/dev.027912; Leil TA, 2004, J NEUROSCI, V24, P11429, DOI 10.1523/JNEUROSCI.3355-04.2004; Lingwood D, 2009, J BIOL CHEM, V284, P12041, DOI 10.1074/jbc.M900220200; Marsden KC, 2007, J NEUROSCI, V27, P14326, DOI 10.1523/JNEUROSCI.4433-07.2007; Morishita H, 2006, J BIOL CHEM, V281, P33650, DOI 10.1074/jbc.M603298200; Mutoh T, 2004, EXP CELL RES, V294, P494, DOI 10.1016/j.yexcr.2003.11.019; OBATA S, 1995, J CELL SCI, V108, P3765; OZAWA M, 1990, J CELL BIOL, V111, P1645, DOI 10.1083/jcb.111.4.1645; Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; Phillips GR, 2003, J NEUROSCI, V23, P5096; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Polishchuk RS, 2000, J CELL BIOL, V148, P45, DOI 10.1083/jcb.148.1.45; Prasad T, 2008, DEVELOPMENT, V135, P4153, DOI 10.1242/dev.026807; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; Razi M, 2009, METHOD ENZYMOL, V452, P261, DOI 10.1016/S0076-6879(08)03617-3; Scherz-Shouval R, 2003, J BIOL CHEM, V278, P14053, DOI 10.1074/jbc.M212108200; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Su H, 2010, DEV BIOL, V339, P38, DOI 10.1016/j.ydbio.2009.12.010; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Tanida I, 2008, AUTOPHAGY, V4, P131, DOI 10.4161/auto.5233; Tasic B, 2002, MOL CELL, V10, P21, DOI 10.1016/S1097-2765(02)00578-6; Triana-Baltzer GB, 2006, J NEUROBIOL, V66, P393, DOI 10.1002/neu.20228; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wang XZ, 2002, NEURON, V36, P843, DOI 10.1016/S0896-6273(02)01090-5; Wang Y, 2006, NEUROSCIENCE, V140, P1265, DOI 10.1016/j.neuroscience.2006.03.013; Weiner JA, 2005, P NATL ACAD SCI USA, V102, P8, DOI 10.1073/pnas.0407931101; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Xie ZP, 2009, AUTOPHAGY, V5, P217, DOI 10.4161/auto.5.2.7201	49	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20982	20992		10.1074/jbc.M109.092031	http://dx.doi.org/10.1074/jbc.M109.092031			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20439459	hybrid, Green Published			2022-12-27	WOS:000279228600062
J	Shirogane, Y; Takeda, M; Tahara, M; Ikegame, S; Nakamura, T; Yanagi, Y				Shirogane, Yuta; Takeda, Makoto; Tahara, Maino; Ikegame, Satoshi; Nakamura, Takanori; Yanagi, Yusuke			Epithelial-Mesenchymal Transition Abolishes the Susceptibility of Polarized Epithelial Cell Lines to Measles Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SNAIL; MEDIATED EXPRESSION CLONING; E-CADHERIN; TIGHT JUNCTION; CLONED CDNA; ADENOVIRUS RECEPTOR; RECYCLING ENDOSOMES; SYNCYTIUM FORMATION; GENE-EXPRESSION; TUMOR-CELLS	Measles virus (MV), an enveloped negative-strand RNA virus, remains a major cause of morbidity and mortality in developing countries. MV predominantly infects immune cells by using signaling lymphocyte activation molecule (SLAM; also called CD150) as a receptor, but it also infects polarized epithelial cells, forming tight junctions in a SLAM-independent manner. Although the ability of MV to infect polarized epithelial cells is thought to be important for its transmission, the epithelial cell receptor for MV has not been identified. A transcriptional repressor, Snail, induces epithelial-mesenchymal transition (EMT), in which epithelial cells lose epithelial cell phenotypes, such as adherens and tight junctions. In this study, EMT was induced by expressing Snail in a lung adenocarcinoma cell line, II-18, which is highly susceptible to wild-type MV. Snail-expressing II-18 cells lost adherens and tight junctions. Microarray analysis confirmed the induction of EMT in II-18 cells and suggested a novel function of Snail in protein degradation and distribution. Importantly, wild-type MV no longer entered EMT-induced II-18 cells, suggesting that the epithelial cell receptor is down-regulated by the induction of EMT. Other polarized cell lines, NCI-H358 and HT-29, also lost susceptibility to wild-type MV when EMT was induced. However, the complete formation of tight junctions rather reduced MV entry into HT-29 cells. Taken together, these data suggest that the unidentified epithelial cell receptor for MV is involved in the formation of epithelial intercellular junctions.	[Shirogane, Yuta] Kyushu Univ, Fac Med, Dept Virol, Higashi Ku, Fukuoka 8128582, Japan; [Nakamura, Takanori] Kyushu Univ, Res Support Ctr, Fac Med, Higashi Ku, Fukuoka 8128582, Japan	Kyushu University; Kyushu University	Shirogane, Y (corresponding author), Kyushu Univ, Fac Med, Dept Virol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yuuta@virology.med.kyushu-u.ac.jp	Shirogane, Yuta/AAO-1073-2021; Takeda, Makoto/J-2550-2018; ikegame, satoshi/AAC-6305-2022	Shirogane, Yuta/0000-0002-4284-0310; Takeda, Makoto/0000-0002-8194-7727; Yanagi, Yusuke/0000-0001-7815-1667	Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labor, and Welfare of Japan	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology and the Ministry of Health, Labor, and Welfare of Japan.	Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; BROWER M, 1986, CANCER RES, V46, P798; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Casanova JE, 1999, MOL BIOL CELL, V10, P47, DOI 10.1091/mbc.10.1.47; Cheng T, 2006, J BIOL CHEM, V281, P15893, DOI 10.1074/jbc.M600694200; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; Craighead J. E., 2000, PATHOLOGY PATHOGENES, P397; De Craene B, 2005, CANCER RES, V65, P6237, DOI 10.1158/0008-5472.CAN-04-3545; de Marco MC, 2002, J CELL BIOL, V159, P37, DOI 10.1083/jcb.200206033; de Swart RL, 2007, PLOS PATHOG, V3, P1771, DOI 10.1371/journal.ppat.0030178; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; Fogh J., 1975, HUMAN TUMOR CELLS IN, P115, DOI 10.1007/978-1-4757-1647-4_5; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Hales CM, 2001, J BIOL CHEM, V276, P39067, DOI 10.1074/jbc.M104831200; Hashimoto K, 2002, J VIROL, V76, P6743, DOI 10.1128/JVI.76.13.6743-6749.2002; Hunziker W, 1998, J BIOL CHEM, V273, P15734, DOI 10.1074/jbc.273.25.15734; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Janda E, 2006, ONCOGENE, V25, P7117, DOI 10.1038/sj.onc.1209701; KIMURA A, 1975, ARCH VIROL, V47, P295, DOI 10.1007/BF01347970; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kitamura T, 2000, METH MOL B, V134, P143; KOBAYASHI S, 1990, KOKENSHI, V42, P73; Lacher MD, 2006, CANCER RES, V66, P1648, DOI 10.1158/0008-5472.CAN-05-2328; Leonard VHJ, 2008, J CLIN INVEST, V118, P2448, DOI 10.1172/JCI35454; LIGHTWOOD R, 1970, J PEDIATR-US, V77, P59, DOI 10.1016/S0022-3476(70)80045-2; Martinez-Estrada OM, 2006, BIOCHEM J, V394, P449, DOI 10.1042/BJ20050591; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Mee CJ, 2008, J VIROL, V82, P461, DOI 10.1128/JVI.01894-07; MOENCH TR, 1988, J INFECT DIS, V158, P433, DOI 10.1093/infdis/158.2.433; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakatsu Y, 2006, J VIROL METHODS, V137, P152, DOI 10.1016/j.jviromet.2006.05.029; NANICHE D, 1993, J VIROL, V67, P6025, DOI 10.1128/JVI.67.10.6025-6032.1993; NII S, 1964, BIKEN J, V6, P271; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; NOMMENSEN FE, 1981, J MED VIROL, V7, P157, DOI 10.1002/jmv.1890070210; Ohkubo T, 2004, J CELL SCI, V117, P1675, DOI 10.1242/jcs.01004; OLDINGSTENKVIST E, 1976, J INFECT DIS, V134, P463, DOI 10.1093/infdis/134.5.463; Onishi M, 1996, EXP HEMATOL, V24, P324; Ono N, 2001, J VIROL, V75, P4399, DOI 10.1128/JVI.75.9.4399-4401.2001; RICHARDSON CD, 1980, VIROLOGY, V105, P205, DOI 10.1016/0042-6822(80)90168-3; Rodriguez-Gabin AG, 2004, J NEUROSCI RES, V76, P758, DOI 10.1002/jnr.20121; Saito RA, 2009, CANCER RES, V69, P2783, DOI 10.1158/0008-5472.CAN-08-3490; SAKAGUCHI M, 1986, MICROBIOL IMMUNOL, V30, P1067, DOI 10.1111/j.1348-0421.1986.tb03036.x; SIDORENKO SP, 1993, J IMMUNOL, V151, P4614; SILICIANO JD, 1988, J CELL BIOL, V107, P2389, DOI 10.1083/jcb.107.6.2389; Tahara M, 2008, J VIROL, V82, P4630, DOI 10.1128/JVI.02691-07; Tahara M, 2007, J VIROL, V81, P2564, DOI 10.1128/JVI.02449-06; Takeda M, 2005, J VIROL, V79, P14346, DOI 10.1128/JVI.79.22.14346-14354.2005; Takeda M, 2000, J VIROL, V74, P6643, DOI 10.1128/JVI.74.14.6643-6647.2000; Takeda M, 2005, VIRUS RES, V108, P161, DOI 10.1016/j.virusres.2004.09.002; Takeda M, 2007, J VIROL, V81, P12091, DOI 10.1128/JVI.01264-07; Takeuchi K, 2003, VIRUS RES, V94, P11, DOI 10.1016/S0168-1702(03)00117-5; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Vetter G, 2009, BIOCHEM BIOPH RES CO, V385, P485, DOI 10.1016/j.bbrc.2009.05.025; Whiteman EL, 2008, ONCOGENE, V27, P3875, DOI 10.1038/onc.2008.9; Yanagi Y, 2009, CURR TOP MICROBIOL, V329, P13; Zacchi P, 1998, J CELL BIOL, V140, P1039, DOI 10.1083/jcb.140.5.1039; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	65	28	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20882	20890		10.1074/jbc.M110.102590	http://dx.doi.org/10.1074/jbc.M110.102590			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20435897	hybrid, Green Published			2022-12-27	WOS:000279228600052
J	Wiles, KG; Panizzi, P; Kroh, HK; Bock, PE				Wiles, Karen G.; Panizzi, Peter; Kroh, Heather K.; Bock, Paul E.			Skizzle Is a Novel Plasminogen- and Plasmin-binding Protein from Streptococcus agalactiae That Targets Proteins of Human Fibrinolysis to Promote Plasmin Generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UROKINASE-CATALYZED ACTIVATION; ANTIFIBRINOLYTIC AMINO-ACIDS; EPSILON-AMINOCAPROIC ACID; SITE-SPECIFIC MUTAGENESIS; ACTIVE-SITE; LIGAND-BINDING; CONFORMATIONAL ACTIVATION; STREPTOKINASE BINDS; FLUORESCENCE PROBES; KINETIC MECHANISM	Skizzle (SkzL), secreted by Streptococcus agalactiae, has moderate sequence identity to streptokinase and staphylokinase, bacterial activators of human plasminogen (Pg). SkzL binds [Glu]Pg with low affinity (K-D 3-16 mu M) and [Lys]Pg and plasmin (Pm) with indistinguishable high affinity (K-D 80 and 50 nM, respectively). Binding of SkzL to Pg and Pm is completely lysine-binding site-dependent, as shown by the effect of the lysine analog, 6-aminohexanoic acid. Deletion of the COOH-terminal SkzL Lys(415) residue reduces affinity for [Lys] Pg and active site-blocked Pm 30-fold, implicating Lys(415) in a lysine-binding site interaction with a Pg/Pm kringle. SkzL binding to active site fluorescein-labeled Pg/Pm analogs demonstrates distinct high and low affinity interactions. High affinity binding is mediated by Lys(415), whereas the source of low affinity binding is unknown. SkzL enhances the activation of [Glu] Pg by urokinase (uPA) similar to 20-fold, to a maximum rate indistinguishable from that for [Lys]Pg and [Glu]Pg activation in the presence of 6-aminohexanoic acid. SkzL binds preferentially to the partially extended beta-conformation of [Glu] Pg, which is in unfavorable equilibrium with the compact alpha-conformation, thereby converting [Glu]Pg to the fully extended gamma-conformation and accelerating the rate of its activation by uPA. SkzL enhances [Lys]Pg and [Glu]Pg activation by single-chain tissue-type Pg activator, similar to 42- and similar to 650-fold, respectively. SkzL increases the rate of plasma clot lysis by uPA and single-chain tissue-type Pg activator similar to 2-fold, confirming its cofactor activity in a physiological model system. The results suggest a role for SkzL in S. agalactiae pathogenesis through fibrinolytic enhancement.	[Wiles, Karen G.; Panizzi, Peter; Kroh, Heather K.; Bock, Paul E.] Vanderbilt Univ, Dept Pathol, Sch Med, Nashville, TN 37232 USA	Vanderbilt University	Bock, PE (corresponding author), Vanderbilt Univ, Dept Pathol, Sch Med, C3321A Med Ctr N, Nashville, TN 37232 USA.	paul.bock@vanderbilt.edu	Panizzi, Peter/A-6072-2019	Panizzi, Peter/0000-0003-0141-8807	NHLBI [RO1 HL056181]; American Heart Association [0715393B]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056181, R00HL094533] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in whole or in part by National Institutes of Health Grant RO1 HL056181 from the NHLBI (to P. E. B.).; Supported in part by Predoctoral Fellowship 0715393B from the American Heart Association, Greater SE Affiliate.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bachmann F., 1994, HEMOSTASIS THROMBOSI, V3rd, P1592; Bean RR, 2005, J BIOL CHEM, V280, P7504, DOI 10.1074/jbc.M411637200; Bergmann S, 2003, MOL MICROBIOL, V49, P411, DOI 10.1046/j.1365-2958.2003.03557.x; Blumberg HM, 1996, J INFECT DIS, V173, P365, DOI 10.1093/infdis/173.2.365; Bock PE, 1996, J BIOL CHEM, V271, P1072, DOI 10.1074/jbc.271.2.1072; Bock PE, 1997, J BIOL CHEM, V272, P19837, DOI 10.1074/jbc.272.32.19837; BOCK PE, 1992, J BIOL CHEM, V267, P14963; BODE W, 1976, FEBS LETT, V68, P231, DOI 10.1016/0014-5793(76)80443-7; Boxrud PD, 2000, J BIOL CHEM, V275, P14579, DOI 10.1074/jbc.275.19.14579; Boxrud PD, 2000, BIOCHEMISTRY-US, V39, P13974, DOI 10.1021/bi000594i; Boxrud PD, 2004, J BIOL CHEM, V279, P36633, DOI 10.1074/jbc.M405264200; Boxrud PD, 2004, J BIOL CHEM, V279, P36642, DOI 10.1074/jbc.M405265200; Boxrud PD, 2001, J BIOL CHEM, V276, P26084, DOI 10.1074/jbc.M101966200; Brochet M, 2006, MICROBES INFECT, V8, P1227, DOI 10.1016/j.micinf.2005.11.010; BROCKWAY WJ, 1972, ARCH BIOCHEM BIOPHYS, V151, P194, DOI 10.1016/0003-9861(72)90488-2; CASTELLINO FJ, 1981, METHOD ENZYMOL, V80, P365; CASTELLINO FJ, 1973, BIOCHEMISTRY-US, V12, P2787, DOI 10.1021/bi00739a002; Chang Y, 1998, BIOCHEMISTRY-US, V37, P3258, DOI 10.1021/bi972284e; Cockell CS, 1998, BIOCHEM J, V333, P99, DOI 10.1042/bj3330099; Cork AJ, 2009, J BIOL CHEM, V284, P17129, DOI 10.1074/jbc.M109.004317; CUMMINGS HS, 1985, ARCH BIOCHEM BIOPHYS, V236, P612, DOI 10.1016/0003-9861(85)90665-4; DEMUNK GAW, 1993, THROMB HAEMOSTASIS, V70, P481; DEMUNK GAW, 1989, BIOCHEMISTRY-US, V28, P7318, DOI 10.1021/bi00444a026; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; Esmon CT, 1998, NAT STRUCT BIOL, V5, P933, DOI 10.1038/2906; Fluegge K, 2004, EUR J CLIN MICROBIOL, V23, P818, DOI 10.1007/s10096-004-1229-y; FREDENBURGH JC, 1992, J BIOL CHEM, V267, P26150; Grella DK, 1997, BLOOD, V89, P1585, DOI 10.1182/blood.V89.5.1585.1585_1585_1589; HENKIN J, 1991, PROG CARDIOVASC DIS, V34, P135, DOI 10.1016/0033-0620(91)90010-J; HOCHSCHWENDER SM, 1981, J BIOL CHEM, V256, P1172; Jespers L, 1999, THROMB HAEMOSTASIS, V81, P479; Johnsen LB, 2000, BIOCHEMISTRY-US, V39, P6440, DOI 10.1021/bi9922502; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LERCH PG, 1980, EUR J BIOCHEM, V107, P7, DOI 10.1111/j.1432-1033.1980.tb04617.x; LIJNEN HR, 1988, EUR J BIOCHEM, V177, P575, DOI 10.1111/j.1432-1033.1988.tb14409.x; LIJNEN HR, 1990, J BIOL CHEM, V265, P5232; LIJNEN HR, 1994, EUR J BIOCHEM, V224, P567, DOI 10.1111/j.1432-1033.1994.00567.x; Magalhaes V, 2007, MICROBES INFECT, V9, P1276, DOI 10.1016/j.micinf.2007.06.001; Markus G, 1996, FIBRINOLYSIS, V10, P75, DOI 10.1016/S0268-9499(96)80082-8; MARKUS G, 1979, J BIOL CHEM, V254, P1211; MARKUS G, 1978, J BIOL CHEM, V253, P727; MARSHALL JM, 1994, BIOCHEMISTRY-US, V33, P3599, DOI 10.1021/bi00178a017; MCCANCE SG, 1995, BIOCHEMISTRY-US, V34, P9581, DOI 10.1021/bi00029a035; NELLES L, 1987, J BIOL CHEM, V262, P5682; NOVOKHATNY V, 1995, J BIOL CHEM, V270, P8680, DOI 10.1074/jbc.270.15.8680; NOVOKHATNY VV, 1989, THROMB RES, V53, P243, DOI 10.1016/0049-3848(89)90099-6; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Panizzi P, 2004, CELL MOL LIFE SCI, V61, P2793, DOI 10.1007/s00018-004-4285-7; Panizzi P, 2006, J BIOL CHEM, V281, P26774, DOI 10.1074/jbc.C600171200; PETROS AM, 1989, BIOCHEMISTRY-US, V28, P1368, DOI 10.1021/bi00429a064; Pietrocola G, 2005, BLOOD, V105, P1052, DOI 10.1182/blood-2004-06-2149; PLOPLIS VA, 1982, BIOCHEMISTRY-US, V21, P5891, DOI 10.1021/bi00266a025; PLOW EF, 1981, J BIOL CHEM, V256, P864; PONTING CP, 1992, BLOOD COAGUL FIBRIN, V3, P605, DOI 10.1097/00001721-199210000-00012; Rajamohan G, 2002, BIOCHEM J, V365, P379, DOI 10.1042/BJ20011647; ROBBINS KC, 1975, J BIOL CHEM, V250, P4044; Sazonova IY, 2001, J BIOL CHEM, V276, P12609, DOI 10.1074/jbc.M009265200; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schuchat A, 1999, LANCET, V353, P51, DOI 10.1016/S0140-6736(98)07128-1; SJOHOLM I, 1973, EUR J BIOCHEM, V39, P471, DOI 10.1111/j.1432-1033.1973.tb03146.x; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; Tharp AC, 2009, J BIOL CHEM, V284, P19511, DOI 10.1074/jbc.M109.005512; Tordai H, 1999, FEBS LETT, V461, P63, DOI 10.1016/S0014-5793(99)01416-7; URANO T, 1987, J BIOL CHEM, V262, P15959; URANO T, 1987, P NATL ACAD SCI USA, V84, P4031, DOI 10.1073/pnas.84.12.4031; URANO T, 1988, BIOCHEMISTRY-US, V27, P6522, DOI 10.1021/bi00417a049; VALI Z, 1982, J BIOL CHEM, V257, P2104; VIOLAND BN, 1976, J BIOL CHEM, V251, P3906; VIOLAND BN, 1978, J BIOL CHEM, V253, P5395; Wang SG, 1999, BIOCHEMISTRY-US, V38, P5232, DOI 10.1021/bi981915h; Wang SG, 2000, EUR J BIOCHEM, V267, P3994, DOI 10.1046/j.1432-1327.2000.01434.x; Ward PN, 2004, INDIAN J MED RES, V119, P136; Ward PN, 2004, J MOL BIOL, V342, P1101, DOI 10.1016/j.jmb.2004.07.079; Ward PN, 2002, J BACTERIOL, V184, P119, DOI 10.1128/JB.184.1.119-125.2002; WEISEL JW, 1994, J MOL BIOL, V235, P1117, DOI 10.1006/jmbi.1994.1061; Whiting GC, 2002, J MED MICROBIOL, V51, P837, DOI 10.1099/0022-1317-51-10-837	80	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21153	21164		10.1074/jbc.M110.107730	http://dx.doi.org/10.1074/jbc.M110.107730			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20435890	Green Published, hybrid			2022-12-27	WOS:000279228600078
J	Sharir, H; Zinger, A; Nevo, A; Sekler, I; Hershfinkel, M				Sharir, Haleli; Zinger, Anna; Nevo, Andrey; Sekler, Israel; Hershfinkel, Michal			Zinc Released from Injured Cells Is Acting via the Zn2+-sensing Receptor, ZnR, to Trigger Signaling Leading to Epithelial Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; NA+/H+ EXCHANGER NHE1; PROSTATE-CANCER CELLS; GROWTH-FACTOR-I; SENSING RECEPTOR; EXTRACELLULAR ZINC; INTERCELLULAR COMMUNICATION; EPIDERMAL-KERATINOCYTES; BIOLOGICAL APPLICATIONS; DEPENDENT ACTIVATION	A role for Zn2+ in accelerating wound healing is established, yet, the signaling pathways linking Zn2+ to tissue repair are not well known. We show that in the human HaCaT keratinocytes extracellular Zn2+ induces a metabotropic Ca2+ response that is abolished by silencing the expression of the G-protein-coupled receptor GPR39, suggesting that this Zn2+-sensing receptor, ZnR, is mediating the response. Keratinocytic-ZnR signaling is highly selective for Zn2+ and can be triggered by nanomolar concentrations of this ion. Interestingly, Zn2+ was also released following cellular injury, as monitored by a specific non-permeable fluorescent Zn2+ probe, ZnAF-2. Chelation of Zn2+ and scavenging of ATP from conditioned medium, collected from injured epithelial cultures, was sufficient to eliminate the metabotropic Ca2+ signaling. The signaling triggered by Zn2+, via ZnR, or by ATP further activated MAP kinase and induced up-regulation of the sodium/proton exchanger NHE1 activity. Finally, activation of ZnR/GPR39 signaling or application of ATP enhanced keratinocytes scratch closure in an in vitro model. Thus our results indicate that extracellular Zn2+, which is either applied or released following injury, activates ZnR/GPR39 to promote signaling leading to epithelial repair.	[Sharir, Haleli; Zinger, Anna; Nevo, Andrey; Hershfinkel, Michal] Ben Gurion Univ Negev, Dept Morphol, Fac Hlth Sci, IL-84105 Beer Sheva, Israel; [Sekler, Israel] Ben Gurion Univ Negev, Dept Physiol, Fac Hlth Sci, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Hershfinkel, M (corresponding author), Ben Gurion Univ Negev, Dept Morphol, Fac Hlth Sci, IL-84105 Beer Sheva, Israel.	hmichal@bgu.ac.il	Hershfinkel, Michal/F-1548-2012	Hershfinkel, Michal/0000-0003-1652-1989	Israel Science Foundation [585/05]; German Israeli Foundation [912-90.11/2006]	Israel Science Foundation(Israel Science Foundation); German Israeli Foundation(German-Israeli Foundation for Scientific Research and Development)	This work was supported by the Israel Science Foundation (Grant 585/05, to M.H.) and by the German Israeli Foundation (Grant 912-90.11/2006, to M.H.).	Andrews GK, 2008, BIOCHEM SOC T, V36, P1242, DOI 10.1042/BST0361242; Azriel-Tamir H, 2004, J BIOL CHEM, V279, P51804, DOI 10.1074/jbc.M406581200; Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P279, DOI 10.1081/CLT-100102426; Baumgartner M, 2004, AM J PHYSIOL-CELL PH, V287, pC844, DOI 10.1152/ajpcell.00094.2004; Besecker B, 2008, AM J PHYSIOL-LUNG C, V294, pL1127, DOI 10.1152/ajplung.00057.2008; Besser L, 2009, J NEUROSCI, V29, P2890, DOI 10.1523/JNEUROSCI.5093-08.2009; Boucher I, 2007, EXP EYE RES, V85, P130, DOI 10.1016/j.exer.2007.03.009; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Breitkreutz D, 2007, J CANCER RES CLIN, V133, P793, DOI 10.1007/s00432-007-0280-3; Campbell M, 2005, CIRC RES, V96, P197, DOI 10.1161/01.RES.0000152966.88353.9d; Chiu T, 2005, AM J PHYSIOL-GASTR L, V288, pG182, DOI 10.1152/ajpgi.00200.2004; Crivat G, 2006, ANAL CHEM, V78, P5799, DOI 10.1021/ac060764i; Darlenski R, 2009, EUR J PHARM BIOPHARM, V72, P295, DOI 10.1016/j.ejpb.2008.11.013; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Dubi N, 2008, CARCINOGENESIS, V29, P1692, DOI 10.1093/carcin/bgn027; Fitsialos G, 2007, J BIOL CHEM, V282, P15090, DOI 10.1074/jbc.M606094200; Fliegel L, 2005, INT J BIOCHEM CELL B, V37, P33, DOI 10.1016/j.biocel.2004.02.006; Gazel A, 2008, J CELL PHYSIOL, V215, P292, DOI 10.1002/jcp.21394; Gomes P, 2005, INVEST OPHTH VIS SCI, V46, P104, DOI 10.1167/iovs.04-0846; Greco S, 2006, J ENDOCRINOL, V188, P79, DOI 10.1677/joe.1.06433; Hachem JR, 2005, J INVEST DERMATOL, V125, P790, DOI 10.1111/j.0022-202X.2005.23836.x; Han WN, 2009, PHOTOCHEM PHOTOBIOL, V85, P997, DOI 10.1111/j.1751-1097.2008.00531.x; Haworth RS, 2003, J BIOL CHEM, V278, P31676, DOI 10.1074/jbc.M304400200; Hershfinkel M, 2001, P NATL ACAD SCI USA, V98, P11749, DOI 10.1073/pnas.201193398; Hershfinkel M, 2007, MOL MED, V13, P331, DOI 10.2119/2006-00038.Hershfinkel; HERSHLINKEL M, 2006, MOL BIOL METAL HOMEO; Hirano T, 2002, J AM CHEM SOC, V124, P6555, DOI 10.1021/ja025567p; Hirano T, 2000, ANGEW CHEM INT EDIT, V39, P1052, DOI 10.1002/(SICI)1521-3773(20000317)39:6<1052::AID-ANIE1052>3.0.CO;2-5; Ho Y, 2008, MOL PHARMACOL, V74, P1141, DOI 10.1124/mol.108.049064; Hogstrand C, 2009, TRENDS MOL MED, V15, P101, DOI 10.1016/j.molmed.2009.01.004; Huang JS, 1999, EUR J BIOCHEM, V266, P943, DOI 10.1046/j.1432-1327.1999.00932.x; Jacinto A, 2001, NAT CELL BIOL, V3, pE117, DOI 10.1038/35074643; Jensen SL, 2008, J CUTAN PATHOL, V35, P1, DOI 10.1111/j.1600-0560.2008.00981.x; Kaisman-Elbaz T, 2009, J CELL PHYSIOL, V220, P222, DOI 10.1002/jcp.21754; Kambe T, 2008, GENESIS, V46, P214, DOI 10.1002/dvg.20382; Kay Alan R, 2004, BMC Physiol, V4, P4, DOI 10.1186/1472-6793-4-4; Kiss Z, 1997, FEBS LETT, V415, P71, DOI 10.1016/S0014-5793(97)01095-8; Knoell DL, 2009, CRIT CARE MED, V37, P1380, DOI 10.1097/CCM.0b013e31819cefe4; Kohout TA, 2003, MOL PHARMACOL, V63, P9, DOI 10.1124/mol.63.1.9; Lang F, 2007, METHOD ENZYMOL, V428, P209, DOI 10.1016/S0076-6879(07)28011-5; Lansdown ABG, 1996, LANCET, V347, P706, DOI 10.1016/S0140-6736(96)90072-0; Lansdown ABG, 2007, WOUND REPAIR REGEN, V15, P2, DOI 10.1111/j.1524-475X.2006.00179.x; Lasithiotakis KG, 2008, J INVEST DERMATOL, V128, P2013, DOI 10.1038/jid.2008.44; MacDonald RS, 1998, J NUTR, V128, P1600, DOI 10.1093/jn/128.10.1600; Malo ME, 2007, J BIOL CHEM, V282, P6292, DOI 10.1074/jbc.M611073200; Micallef L, 2009, EXP DERMATOL, V18, P143, DOI 10.1111/j.1600-0625.2008.00775.x; Murakami M, 2008, CANCER SCI, V99, P1515, DOI 10.1111/j.1349-7006.2008.00854.x; O'Toole EA, 1997, J CLIN INVEST, V100, P2881, DOI 10.1172/JCI119837; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Pirila E, 2007, WOUND REPAIR REGEN, V15, P47, DOI 10.1111/j.1524-475X.2006.00184.x; Putney LK, 2003, J BIOL CHEM, V278, P44645, DOI 10.1074/jbc.M308099200; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Ravanti L, 2000, INT J MOL MED, V6, P391; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Sammak PJ, 1997, J CELL SCI, V110, P465; Sarangarajan R, 2001, BBA-BIOMEMBRANES, V1511, P181, DOI 10.1016/S0005-2736(01)00273-5; Sarfaraz S, 2006, J BIOL CHEM, V281, P39480, DOI 10.1074/jbc.M603495200; Schneider L, 2009, J CELL BIOL, V185, P163, DOI 10.1083/jcb.200806019; Schwartz JR, 2005, DERMATOL SURG, V31, P837; Sharir H, 2005, BIOCHEM BIOPH RES CO, V332, P845, DOI 10.1016/j.bbrc.2005.05.036; Sinnberg T, 2009, J INVEST DERMATOL, V129, P1500, DOI 10.1038/jid.2008.379; Snabaitis AK, 2000, CIRC RES, V86, P214, DOI 10.1161/01.RES.86.2.214; Stock C, 2008, EUR J CELL BIOL, V87, P591, DOI 10.1016/j.ejcb.2008.01.007; Stuwe L, 2007, J PHYSIOL-LONDON, V585, P351, DOI 10.1113/jphysiol.2007.145185; Taboubi S, 2007, FASEB J, V21, P4047, DOI 10.1096/fj.06-7476com; Takahashi H, 2008, J DERMATOL SCI, V50, P31, DOI 10.1016/j.jdermsci.2007.11.002; Taniguchi M, 2004, BIOORGAN MED CHEM, V12, P3125, DOI 10.1016/j.bmc.2004.04.006; Taylor KM, 2008, BIOCHEM SOC T, V36, P1247, DOI 10.1042/BST0361247; Taylor KM, 2004, BIOCHEM J, V377, P131, DOI 10.1042/BJ20031183; Tenaud I, 2000, EXP DERMATOL, V9, P407, DOI 10.1034/j.1600-0625.2000.009006407.x; Tenaud I, 2009, J DERMATOL TREAT, V20, P91, DOI 10.1080/09546630802509089; Thuraisingam T, 2010, J INVEST DERMATOL, V130, P278, DOI 10.1038/jid.2009.209; Wesley UV, 2007, J BIOL CHEM, V282, P3213, DOI 10.1074/jbc.M606533200; Yang LL, 2004, J CELL BIOCHEM, V91, P938, DOI 10.1002/jcb.10774; Yasuda SI, 2007, J RECEPT SIG TRANSD, V27, P235, DOI 10.1080/10799890701506147; Yin J, 2007, J CELL SCI, V120, P815, DOI 10.1242/jcs.03389; Zhao L, 2007, BIOCHEM BIOPH RES CO, V363, P82, DOI 10.1016/j.bbrc.2007.08.127	78	80	84	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26097	26106		10.1074/jbc.M110.107490	http://dx.doi.org/10.1074/jbc.M110.107490			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20522546	Green Published, hybrid			2022-12-27	WOS:000280921000026
J	Nambi, S; Basu, N; Visweswariah, SS				Nambi, Subhalaxmi; Basu, Nirmalya; Visweswariah, Sandhya S.			cAMP-regulated Protein Lysine Acetylases in Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARYLAMINE N-ACETYLTRANSFERASES; ADENYLYL CYCLASES; NUCLEOTIDE PHOSPHODIESTERASE; CHROMATIN PROTEIN; CYCLIC-AMP; BINDING; TUBERCULOSIS; MECHANISM; KINASE; GENE	Cyclic AMP synthesized by Mycobacterium tuberculosis has been shown to play a role in pathogenesis. However, the high levels of intracellular cAMP found in both pathogenic and nonpathogenic mycobacteria suggest that additional and important biological processes are regulated by cAMP in these organisms. We describe here the biochemical characterization of novel cAMP-binding proteins in M. smegmatis and M. tuberculosis (MSMEG_5458 and Rv0998, respectively) that contain a cyclic nucleotide binding domain fused to a domain that shows similarity to the GNAT family of acetyltransferases. We detect protein lysine acetylation in mycobacteria and identify a universal stress protein (USP) as a substrate of MSMEG_5458. Acetylation of a lysine residue in USP is regulated by cAMP, and using a strain deleted for MSMEG_5458, we show that USP is indeed an in vivo substrate for MSMEG_5458. The Rv0998 protein shows a strict cAMP-dependent acetylation of USP, despite a lower affinity for cAMP than MSMEG_5458. Thus, this report not only represents the first demonstration of protein lysine acetylation in mycobacteria but also describes a unique functional interplay between a cyclic nucleotide binding domain and a protein acetyltransferase.	[Nambi, Subhalaxmi; Basu, Nirmalya; Visweswariah, Sandhya S.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Visweswariah, SS (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	sandhya@mrdg.iisc.ernet.in	Visweswariah, Sandhya/Q-7500-2019	Visweswariah, Sandhya/0000-0003-2786-7344; Basu, Nirmalya/0000-0003-3041-2826; Nambi, Subhalaxmi/0000-0001-7104-659X	Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Department of Biotechnology, Government of India.; Recipient of a Senior Research Fellowship from the Council of Scientific and Industrial Research, Government of India.; Recipient of a Junior Research Fellowship from the Council of Scientific and Industrial Research, Government of India.	Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; BARZU O, 1994, PROG NUCLEIC ACID RE, V49, P241; Basu A, 2009, P NATL ACAD SCI USA, V106, P13785, DOI 10.1073/pnas.0906801106; Bell SD, 2002, SCIENCE, V296, P148, DOI 10.1126/science.1070506; Berman HM, 2005, P NATL ACAD SCI USA, V102, P45, DOI 10.1073/pnas.0408579102; Berndsen CE, 2005, METHODS, V36, P321, DOI 10.1016/j.ymeth.2005.03.002; Brent MM, 2009, J BIOL CHEM, V284, P19412, DOI 10.1074/jbc.M109.014951; BUBIS J, 1988, J BIOL CHEM, V263, P9668; Canaves JM, 2002, J MOL EVOL, V54, P17, DOI 10.1007/s00239-001-0013-1; Chang PA, 2010, MOL CELL BIOCHEM, V339, P181, DOI 10.1007/s11010-009-0382-0; Dass BKM, 2008, J BACTERIOL, V190, P3824, DOI 10.1128/JB.00138-08; DOSTMANN WRG, 1990, J BIOL CHEM, V265, P10484; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Festa RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008589; Gallagher DT, 2009, J BIOL CHEM, V284, P8228, DOI 10.1074/jbc.C800215200; Hodawadekar SC, 2007, ONCOGENE, V26, P5528, DOI 10.1038/sj.onc.1210619; Kannan N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r264; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Korner H, 2003, FEMS MICROBIOL REV, V27, P559, DOI 10.1016/S0168-6445(03)00066-4; Linder JU, 2003, CELL SIGNAL, V15, P1081, DOI 10.1016/S0898-6568(03)00130-X; Marsh VL, 2005, J BIOL CHEM, V280, P21122, DOI 10.1074/jbc.M501280200; McCue LA, 2000, GENOME RES, V10, P204, DOI 10.1101/gr.10.2.204; Mehler EL, 2002, PROTEINS, V48, P283, DOI 10.1002/prot.10153; O'Toole R, 2003, RES MICROBIOL, V154, P387, DOI 10.1016/S0923-2508(03)00081-0; O'Toole R, 2003, J BACTERIOL, V185, P1543, DOI 10.1128/JB.185.5.1543-1554.2003; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Podobnik M, 2009, J BIOL CHEM, V284, P32846, DOI 10.1074/jbc.M109.049635; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Shenoy AR, 2005, BIOCHEMISTRY-US, V44, P15695, DOI 10.1021/bi0512391; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; Shenoy AR, 2007, J MOL BIOL, V365, P211, DOI 10.1016/j.jmb.2006.10.005; Shenoy AR, 2006, FEBS LETT, V580, P3344, DOI 10.1016/j.febslet.2006.05.034; Shenoy AR, 2006, TRENDS MICROBIOL, V14, P543, DOI 10.1016/j.tim.2006.10.005; Sim E, 2008, CURR DRUG METAB, V9, P510, DOI 10.2174/138920008784892100; Stapleton M, 2010, J BIOL CHEM, V285, P7016, DOI 10.1074/jbc.M109.047720; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanner KG, 1999, J BIOL CHEM, V274, P18157, DOI 10.1074/jbc.274.26.18157; Taylor SS, 2008, BBA-PROTEINS PROTEOM, V1784, P16, DOI 10.1016/j.bbapap.2007.10.002; Trievel RC, 1999, P NATL ACAD SCI USA, V96, P8931, DOI 10.1073/pnas.96.16.8931; Vagena E, 2008, CURR DRUG METAB, V9, P628, DOI 10.2174/138920008785821729; Vetting MW, 2008, ACTA CRYSTALLOGR F, V64, P978, DOI 10.1107/S1744309108031679; Vetting MW, 2004, CHEM BIOL, V11, P565, DOI 10.1016/j.chembiol.2004.03.017; Wang L, 2008, CURR OPIN STRUC BIOL, V18, P741, DOI 10.1016/j.sbi.2008.09.004; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; WEBER IT, 1989, BIOCHEMISTRY-US, V28, P6122, DOI 10.1021/bi00440a059; Yan JS, 2008, J MOL BIOL, V376, P1260, DOI 10.1016/j.jmb.2007.12.070; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yu JJ, 2010, PHARMACOL RES, V62, P35, DOI 10.1016/j.phrs.2009.12.006; Zaunbrecher MA, 2009, P NATL ACAD SCI USA, V106, P20004, DOI 10.1073/pnas.0907925106; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	53	86	89	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24313	24323		10.1074/jbc.M110.118398	http://dx.doi.org/10.1074/jbc.M110.118398			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20507997	hybrid, Green Published			2022-12-27	WOS:000280542100003
J	Peng, YJ; He, WQ; Tang, J; Tao, T; Chen, C; Gao, YQ; Zhang, WC; He, XY; Dai, YY; Zhu, NC; Lv, N; Zhang, CH; Qiao, YN; Zhao, LP; Gao, XA; Zhu, MS				Peng, Ya-Jing; He, Wei-Qi; Tang, Jing; Tao, Tao; Chen, Chen; Gao, Yun-Qian; Zhang, Wen-Cheng; He, Xue-Yan; Dai, Yu-Yuan; Zhu, Nian-Chun; Lv, Ning; Zhang, Cheng-Hai; Qiao, Yan-Ning; Zhao, Li-Ping; Gao, Xiang; Zhu, Min-Sheng			Trio Is a Key Guanine Nucleotide Exchange Factor Coordinating Regulation of the Migration and Morphogenesis of Granule Cells in the Developing Cerebellum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-GTPASES; GROWTH-CONE; NEURONAL MIGRATION; GUIDANCE CUES; AXON GUIDANCE; OLFACTORY SYSTEM; IN-VIVO; RAC1; MOTILITY; DOMAIN	Orchestrated regulation of neuronal migration and morphogenesis is critical for neuronal development and establishment of functional circuits, but its regulatory mechanism is incompletely defined. We established and analyzed mice with neural-specific knock-out of Trio, a guanine nucleotide exchange factor with multiple guanine nucleotide exchange factor domains. Knock-out mice showed defective cerebella and severe signs of ataxia. Mutant cerebella had no granule cells in the internal granule cell layer due to aberrant granule cell migration as well as abnormal neurite growth. Trio-deficient granule cells showed reduced extension of neurites and highly branched and misguided processes with perturbed stabilization of actin and microtubules. Trio deletion caused down-regulation of the activation of Rac1, RhoA, and Cdc42, and mutant granule cells appeared to be unresponsive to neurite growth-promoting molecules such as Netrin-1 and Semaphorin 6A. These results suggest that Trio may be a key signal module for the orchestrated regulation of neuronal migration and morphogenesis during cerebellar development. Trio may serve as a signal integrator decoding extrinsic signals to Rho GTPases for cytoskeleton organization.	[Peng, Ya-Jing; He, Wei-Qi; Tang, Jing; Tao, Tao; Chen, Chen; Gao, Yun-Qian; Zhang, Wen-Cheng; He, Xue-Yan; Dai, Yu-Yuan; Zhu, Nian-Chun; Lv, Ning; Zhang, Cheng-Hai; Qiao, Yan-Ning; Gao, Xiang; Zhu, Min-Sheng] Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Peoples R China; [Peng, Ya-Jing; He, Wei-Qi; Tang, Jing; Tao, Tao; Chen, Chen; Gao, Yun-Qian; Zhang, Wen-Cheng; He, Xue-Yan; Dai, Yu-Yuan; Zhu, Nian-Chun; Lv, Ning; Zhang, Cheng-Hai; Qiao, Yan-Ning; Gao, Xiang; Zhu, Min-Sheng] Nanjing Univ, Moe Key Lab Model Anim Dis Study, Nanjing 210061, Peoples R China; [Zhao, Li-Ping] Natl Inst Biol Sci, Beijing 102206, Peoples R China	Nanjing University; Nanjing University; National Institute of Biological Sciences, Beijing	Zhu, MS (corresponding author), 12 Xue Fu Rd, Nanjing 210061, Peoples R China.	zhums@nju.edu.cn	He, Weiqi/I-7935-2013; Zhang, Wencheng/AAO-8445-2020; Dai, Yuyuan/D-6485-2016; Lv, Ning/V-5706-2019; He, Weiqi/L-2502-2019; He, Xue-Yan/AAK-8453-2021	He, Weiqi/0000-0003-3137-8420; He, Weiqi/0000-0003-3137-8420; He, Xue-Yan/0000-0001-5423-5997; Chen, Chen/0000-0001-7075-8501; Qiao, Yanning/0000-0002-8092-4662	National Basic Research Program of China (973 Program) [2009CB941602, 2007CB947100, 2005CB522501]; National Natural Science Funding of China [30570911]; Scientific Research Foundation of Graduate School of Nanjing University	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Funding of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation of Graduate School of Nanjing University(Nanjing University)	This work was supported by the National Basic Research Program of China (973 Program) (Grants 2009CB941602, 2007CB947100, and 2005CB522501), National Natural Science Funding of China (Grant 30570911), and the Scientific Research Foundation of Graduate School of Nanjing University.	Alcantara S, 2000, DEVELOPMENT, V127, P1359; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Backer S, 2007, J NEUROSCI, V27, P10323, DOI 10.1523/JNEUROSCI.1102-07.2007; Bagri A, 2002, ADV EXP MED BIOL, V515, P13; Barallobre MJ, 2005, BRAIN RES REV, V49, P22, DOI 10.1016/j.brainresrev.2004.11.003; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; Bateman J, 2001, J CELL SCI, V114, P1973; Bellanger JM, 2000, NAT CELL BIOL, V2, P888, DOI 10.1038/35046533; Bielas SL, 2007, CELL, V129, P579, DOI 10.1016/j.cell.2007.03.023; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Briancon-Marjollet A, 2008, MOL CELL BIOL, V28, P2314, DOI 10.1128/MCB.00998-07; Chen L, 2007, J NEUROSCI, V27, P3884, DOI 10.1523/JNEUROSCI.3509-06.2007; COHENCORY S, 1991, J NEUROSCI, V11, P462; Colomer V, 1997, HUM MOL GENET, V6, P1519, DOI 10.1093/hmg/6.9.1519; Corbetta S, 2005, MOL CELL BIOL, V25, P5763, DOI 10.1128/MCB.25.13.5763-5776.2005; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Donald S, 2008, P NATL ACAD SCI USA, V105, P4483, DOI 10.1073/pnas.0712324105; Estrach S, 2002, CURR BIOL, V12, P307, DOI 10.1016/S0960-9822(02)00658-9; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Gallo G, 2004, J NEUROBIOL, V58, P92, DOI 10.1002/neu.10282; Garvalov BK, 2007, J NEUROSCI, V27, P13117, DOI 10.1523/JNEUROSCI.3322-07.2007; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Homma N, 2003, CELL, V114, P229, DOI 10.1016/S0092-8674(03)00522-1; Hongo T, 2000, BIOL NEONATE, V78, P293, DOI 10.1159/000014282; Huang J, 2007, J CELL BIOL, V179, P539, DOI 10.1083/jcb.200702036; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kalil K, 2005, CURR OPIN NEUROBIOL, V15, P521, DOI 10.1016/j.conb.2005.08.005; Kassai H, 2008, EUR J NEUROSCI, V28, P257, DOI 10.1111/j.1460-9568.2008.06343.x; Kerjan G, 2005, NAT NEUROSCI, V8, P1516, DOI 10.1038/nn1555; Komuro H, 2003, CELL MOL LIFE SCI, V60, P1084, DOI 10.1007/s00018-003-2248-z; Lalli G, 2005, J CELL BIOL, V171, P857, DOI 10.1083/jcb.200507061; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Ma XM, 2008, J NEUROSCI, V28, P12368, DOI 10.1523/JNEUROSCI.4269-08.2008; Ma XM, 2005, J COMP NEUROL, V482, P333, DOI 10.1002/cne.20404; NAGATA I, 1990, DEV BRAIN RES, V52, P63, DOI 10.1016/0165-3806(90)90222-K; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Ng JL, 2004, NEURON, V44, P779, DOI 10.1016/j.neuron.2004.11.014; O'Brien SP, 2000, P NATL ACAD SCI USA, V97, P12074, DOI 10.1073/pnas.97.22.12074; Park HT, 2002, BIOESSAYS, V24, P821, DOI 10.1002/bies.10141; Rakic Pasko, 1994, Current Opinion in Neurobiology, V4, P63, DOI 10.1016/0959-4388(94)90033-7; Renaud J, 2008, NAT NEUROSCI, V11, P440, DOI 10.1038/nn2064; Robertson SP, 2004, CLIN DYSMORPHOL, V13, P123, DOI 10.1097/01.mcd.0000130235.95356.40; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sanes DH, 2006, DEV NERVOUS SYSTEM; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Shekarabi M, 2002, MOL CELL NEUROSCI, V19, P1, DOI 10.1006/mcne.2001.1075; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Vastrik I, 1999, CURR BIOL, V9, P991, DOI 10.1016/S0960-9822(99)80447-3; Wang VY, 2001, NAT REV NEUROSCI, V2, P484, DOI 10.1038/35081558; Watabe-Uchida M, 2006, J NEUROSCI, V26, P10633, DOI 10.1523/JNEUROSCI.4084-06.2006; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Wingate RJT, 2001, CURR OPIN NEUROBIOL, V11, P82, DOI 10.1016/S0959-4388(00)00177-X; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Yacubova E, 2003, CELL BIOCHEM BIOPHYS, V37, P213; Yue Q, 2005, DEVELOPMENT, V132, P3281, DOI 10.1242/dev.01891; Zhu Y, 2002, NAT NEUROSCI, V5, P719, DOI 10.1038/nn881	73	57	57	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24834	24844		10.1074/jbc.M109.096537	http://dx.doi.org/10.1074/jbc.M109.096537			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20516067	hybrid, Green Published			2022-12-27	WOS:000280542100056
J	Karousou, E; Kamiryo, M; Skandalis, SS; Ruusala, A; Asteriou, T; Passi, A; Yamashita, H; Hellman, U; Heldin, CH; Heldin, P				Karousou, Eugenia; Kamiryo, Masaru; Skandalis, Spyros S.; Ruusala, Aino; Asteriou, Trias; Passi, Alberto; Yamashita, Hidetoshi; Hellman, Ulf; Heldin, Carl-Henrik; Heldin, Paraskevi			The Activity of Hyaluronan Synthase 2 Is Regulated by Dimerization and Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; MOLECULAR-CLONING; ACTIVATION; BIOSYNTHESIS; EXPRESSION; TRANSPORT; PATHWAY	Hyaluronan is a component of the extracellular matrix, which affects tissue homeostasis. In this study, we investigated the regulatory mechanisms of one of the hyaluronan-synthesizing enzymes, HAS2. Ectopic expression of Flag-and 6myc-HAS2 in COS-1 cells followed by immunoprecipitation and immunoblotting revealed homodimers; after co-transfection with Flag-HAS3, also heterodimers were seen. Furthermore, the expressed HAS2 was ubiquitinated. We identified one acceptor site for ubiquitin on lysine residue 190. Mutation of this residue led to inactivation of the enzymatic activity of HAS2. Interestingly, K190R-mutated HAS2 formed dimers with wt HAS2 and quenched the activity of wt HAS2, thus demonstrating a functional role of the dimeric configuration.	[Hellman, Ulf; Heldin, Carl-Henrik; Heldin, Paraskevi] Uppsala Univ, Biomed Ctr, Ludwig Inst Canc Res, SE-75124 Uppsala, Sweden; [Passi, Alberto] Univ Insubria, DSBSC, I-21100 Varese, Italy; [Yamashita, Hidetoshi] Yamagata Univ, Sch Med, Dept Ophthalmol & Visual Sci, Yamagata 9909585, Japan	Ludwig Institute for Cancer Research; Uppsala University; University of Insubria; Yamagata University	Heldin, P (corresponding author), Uppsala Univ, Biomed Ctr, Ludwig Inst Canc Res, Box 595, SE-75124 Uppsala, Sweden.	Evi.Heldin@LICR.uu.se	passi, alberto g/A-1752-2018; Skandalis, Spyros/F-6815-2010	passi, alberto g/0000-0003-3328-3089; Skandalis, Spyros/0000-0003-1156-2896	Swedish Cancer Society; Wenner-Gren Foundation; Mizoutani Foundation for Glycoscience; FEBS	Swedish Cancer Society(Swedish Cancer Society); Wenner-Gren Foundation; Mizoutani Foundation for Glycoscience; FEBS	This work was supported in part by grants from the Swedish Cancer Society, Wenner-Gren Foundation, and Mizoutani Foundation for Glycoscience.; Recipient of FEBS Fellowships.	Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; Asplund T, 1998, BBA-GEN SUBJECTS, V1380, P377, DOI 10.1016/S0304-4165(98)00010-5; Berdiaki A, 2008, BBA-GEN SUBJECTS, V1780, P194, DOI 10.1016/j.bbagen.2007.10.005; Bourguignon LYW, 2007, J BIOL CHEM, V282, P19426, DOI 10.1074/jbc.M610054200; Ghosh A, 2009, J BIOL CHEM, V284, P18840, DOI 10.1074/jbc.M109.013813; Goentzel BJ, 2006, BIOCHEM J, V396, P347, DOI 10.1042/BJ20051782; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; HELDIN P, 1989, BIOCHEM J, V258, P919, DOI 10.1042/bj2580919; HELDIN P, 1992, BIOCHEM J, V283, P165, DOI 10.1042/bj2830165; HELDIN P, 1993, EXP CELL RES, V208, P422, DOI 10.1006/excr.1993.1264; Hellman U, 2000, EXS, V88, P43; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Itano N, 2008, SEMIN CANCER BIOL, V18, P268, DOI 10.1016/j.semcancer.2008.03.006; Jacobson A, 2000, BIOCHEM J, V348, P29, DOI 10.1042/0264-6021:3480029; Karvinen S, 2003, J BIOL CHEM, V278, P49495, DOI 10.1074/jbc.M310445200; KLEWES L, 1994, J CELL PHYSIOL, V160, P539, DOI 10.1002/jcp.1041600317; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Leithe E, 2004, J BIOL CHEM, V279, P50089, DOI 10.1074/jbc.M402006200; Li LL, 2007, BIOCHEM J, V404, P327, DOI 10.1042/BJ20061757; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Mullegger J, 2003, BIOL CHEM, V384, P175, DOI 10.1515/BC.2003.019; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Recklies AD, 2001, BIOCHEM J, V354, P17, DOI 10.1042/0264-6021:3540017; Rilla K, 2005, J BIOL CHEM, V280, P31890, DOI 10.1074/jbc.M504736200; Salmena L, 2007, NAT REV CANCER, V7, P409, DOI 10.1038/nrc2145; Sayo T, 2002, J INVEST DERMATOL, V118, P43, DOI 10.1046/j.0022-202x.2001.01613.x; Schevchenko VA, 1996, MUTAT RES-ENVIR MUTA, V361, P29, DOI 10.1016/S0165-1161(96)90226-5; Schulz T, 2007, J BIOL CHEM, V282, P20999, DOI 10.1074/jbc.M700915200; Spicer AP, 1998, J BIOL CHEM, V273, P1923, DOI 10.1074/jbc.273.4.1923; Spicer AP, 1998, J BIOL CHEM, V273, P25117, DOI 10.1074/jbc.273.39.25117; Spicer AP, 1996, J BIOL CHEM, V271, P23400, DOI 10.1074/jbc.271.38.23400; Spicer AP, 1997, J BIOL CHEM, V272, P8957; Stuhlmeier KM, 2006, WIEN MED WOCHENSCHR, V156, P563, DOI 10.1007/s10354-006-0351-0; Stuhlmeier KM, 2004, J BIOL CHEM, V279, P8753, DOI 10.1074/jbc.M303945200; SUZUKI M, 1995, BIOCHEM J, V307, P817, DOI 10.1042/bj3070817; Tlapak-Simmons VL, 1999, J BIOL CHEM, V274, P4239, DOI 10.1074/jbc.274.7.4239; Toole BP, 2008, SEMIN CANCER BIOL, V18, P244, DOI 10.1016/j.semcancer.2008.03.009; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997	40	90	90	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23647	23654		10.1074/jbc.M110.127050	http://dx.doi.org/10.1074/jbc.M110.127050			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20507985	hybrid, Green Published			2022-12-27	WOS:000280291400015
J	Ladiwala, ARA; Lin, JC; Bale, SS; Marcelino-Cruz, AM; Bhattacharya, M; Dordick, JS; Tessier, PM				Ladiwala, Ali Reza A.; Lin, Jason C.; Bale, Shyam Sundhar; Marcelino-Cruz, Anna Marie; Bhattacharya, Moumita; Dordick, Jonathan S.; Tessier, Peter M.			Resveratrol Selectively Remodels Soluble Oligomers and Fibrils of Amyloid A beta into Off-pathway Conformers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMISSIBLE MINK ENCEPHALOPATHY; POLYGLUTAMINE AGGREGATION NUCLEATION; SMALL-MOLECULE ACTIVATORS; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; PRION PROTEIN; HUNTINGTONS-DISEASE; PARKINSONS-DISEASE; ASSEMBLY PATHWAYS; STRAIN VARIATION	Misfolded proteins associated with diverse aggregation disorders assemble not only into a single toxic conformer but rather into a suite of aggregated conformers with unique biochemical properties and toxicities. To what extent small molecules can target and neutralize specific aggregated conformers is poorly understood. Therefore, we have investigated the capacity of resveratrol to recognize and remodel five conformers (monomers, soluble oligomers, non-toxic oligomers, fibrillar intermediates, and amyloid fibrils) of the A beta 1-42 peptide associated with Alzheimer disease. We find that resveratrol selectively remodels three of these conformers (soluble oligomers, fibrillar intermediates, and amyloid fibrils) into an alternative aggregated species that is non-toxic, high molecular weight, and unstructured. Surprisingly, resveratrol does not remodel non-toxic oligomers or accelerate A beta monomer aggregation despite that both conformers possess random coil secondary structures indistinguishable from soluble oligomers and significantly different from their beta-sheet rich, fibrillar counterparts. We expect that resveratrol and other small molecules with similar conformational specificity will aid in illuminating the conformational epitopes responsible for A beta-mediated toxicity.	[Dordick, Jonathan S.; Tessier, Peter M.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Chem & Biol Engn, Troy, NY 12180 USA; [Dordick, Jonathan S.] Rensselaer Polytech Inst, Dept Biol, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Tessier, PM (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Chem & Biol Engn, 110 8th St, Troy, NY 12180 USA.	tessier@rpi.edu	Tessier, Peter/GPP-3396-2022; Tessier, Peter/I-5730-2013	Tessier, Peter/0000-0002-3220-007X	Alzheimer's Association [NIRG-08-90967]	Alzheimer's Association(Alzheimer's Association)	This work was supported by Alzheimer's Association Grant NIRG-08-90967 (to P. M. T.).	Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Amijee H, 2009, J ALZHEIMERS DIS, V17, P33, DOI 10.3233/JAD-2009-1044; Auer S, 2007, HFSP J, V1, P137, DOI 10.2976/1.2760023; Bates G, 2003, LANCET, V361, P1642, DOI 10.1016/S0140-6736(03)13304-1; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Baxa U, 2005, J STRUCT BIOL, V150, P170, DOI 10.1016/j.jsb.2005.02.007; Bernacki JP, 2009, BIOPHYS J, V96, P2871, DOI 10.1016/j.bpj.2008.12.3903; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BESSEN RA, 1992, J GEN VIROL, V73, P329, DOI 10.1099/0022-1317-73-2-329; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; BESSEN RA, 1995, NATURE, V375, P698, DOI 10.1038/375698a0; Bhattacharyya AM, 2005, P NATL ACAD SCI USA, V102, P15400, DOI 10.1073/pnas.0501651102; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Blanchard BJ, 2004, P NATL ACAD SCI USA, V101, P14326, DOI 10.1073/pnas.0405941101; Bousset L, 2003, J STRUCT BIOL, V141, P132, DOI 10.1016/S1047-8477(02)00606-8; BRUCE M, 1994, PHILOS T R SOC B, V343, P405, DOI 10.1098/rstb.1994.0036; BRUCE ME, 1991, J GEN VIROL, V72, P595, DOI 10.1099/0022-1317-72-3-595; Bulic B, 2009, ANGEW CHEM INT EDIT, V48, P1741, DOI 10.1002/anie.200802621; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Chen M, 2007, J BIOL CHEM, V282, P24970, DOI 10.1074/jbc.M700368200; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Chien P, 2003, NATURE, V424, P948, DOI 10.1038/nature01894; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen E, 2009, CELL, V139, P1157, DOI 10.1016/j.cell.2009.11.014; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Crick SL, 2006, P NATL ACAD SCI USA, V103, P16764, DOI 10.1073/pnas.0608175103; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; DICKINSON AG, 1969, GENET RES, V13, P213, DOI 10.1017/S0016672300002895; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Feng Y, 2009, NEUROTOXICOLOGY, V30, P986, DOI 10.1016/j.neuro.2009.08.013; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Goldsbury C, 2005, J MOL BIOL, V352, P282, DOI 10.1016/j.jmb.2005.07.029; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Herbst M, 2006, CURR PHARM DESIGN, V12, P2543, DOI 10.2174/138161206777698828; Hill SE, 2009, BIOPHYS J, V96, P3781, DOI 10.1016/j.bpj.2009.01.044; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hudson SA, 2009, J MOL BIOL, V392, P689, DOI 10.1016/j.jmb.2009.07.031; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jiang Y, 2004, J BIOL CHEM, V279, P3361, DOI 10.1074/jbc.M310494200; KATZMAN R, 1986, NEW ENGL J MED, V314, P964, DOI 10.1056/NEJM198604103141506; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kayed R, 2006, METHOD ENZYMOL, V413, P326, DOI 10.1016/S0076-6879(06)13017-7; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Lee CH, 2006, J BIOL CHEM, V281, P3463, DOI 10.1074/jbc.M505307200; Lee EN, 2004, BIOCHEMISTRY-US, V43, P3704, DOI 10.1021/bi0356707; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Margittai M, 2006, METHOD ENZYMOL, V413, P122, DOI 10.1016/S0076-6879(06)13007-4; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Moretto N, 2007, J BIOL CHEM, V282, P11436, DOI 10.1074/jbc.M609690200; Mukhopadhyay S, 2006, J MOL BIOL, V358, P935, DOI 10.1016/j.jmb.2006.02.006; Necula M, 2007, BIOCHEMISTRY-US, V46, P8850, DOI 10.1021/bi700411k; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Ono K, 2003, J NEUROCHEM, V87, P172, DOI 10.1046/j.1471-4159.2003.01976.x; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Pallitto MM, 1999, BIOCHEMISTRY-US, V38, P3570, DOI 10.1021/bi982119e; Paravastu AK, 2006, BIOPHYS J, V90, P4618, DOI 10.1529/biophysj.105.076927; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; PATTISON IH, 1968, RES VET SCI, V9, P408; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Plakoutsi G, 2005, J MOL BIOL, V351, P910, DOI 10.1016/j.jmb.2005.06.043; Porat Y, 2004, BIOCHEMISTRY-US, V43, P14454, DOI 10.1021/bi048582a; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Radovan D, 2009, FEBS LETT, V583, P1439, DOI 10.1016/j.febslet.2009.03.059; Reinke AA, 2007, CHEM BIOL DRUG DES, V70, P206, DOI 10.1111/j.1747-0285.2007.00557.x; Riviere C, 2007, BIOORGAN MED CHEM, V15, P1160, DOI 10.1016/j.bmc.2006.09.069; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Scott MR, 1997, J VIROL, V71, P9032, DOI 10.1128/JVI.71.12.9032-9044.1997; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Stains CI, 2007, CHEMMEDCHEM, V2, P1674, DOI 10.1002/cmdc.200700140; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; Tessier PM, 2007, NATURE, V447, P556, DOI 10.1038/nature05848; Trojanowski JQ, 2001, PARKINSONISM RELAT D, V7, P247, DOI 10.1016/S1353-8020(00)00065-1; Walling HW, 1998, J NEUROSCI RES, V54, P301, DOI 10.1002/(SICI)1097-4547(19981101)54:3<301::AID-JNR1>3.0.CO;2-W; Wang H, 2008, P NATL ACAD SCI USA, V105, P7159, DOI 10.1073/pnas.0801934105; Wang J, 2008, J NEUROSCI, V28, P6388, DOI 10.1523/JNEUROSCI.0364-08.2008; Wetzel R, 2006, ACCOUNTS CHEM RES, V39, P671, DOI 10.1021/ar050069h; Wu JW, 2010, J BIOL CHEM, V285, P6071, DOI 10.1074/jbc.M109.069542; Yamaguchi K, 2005, J MOL BIOL, V352, P952, DOI 10.1016/j.jmb.2005.07.061; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200	94	241	250	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24228	24237		10.1074/jbc.M110.133108	http://dx.doi.org/10.1074/jbc.M110.133108			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20511235	hybrid, Green Published			2022-12-27	WOS:000280291400072
J	Mrinal, N; Nagaraju, J				Mrinal, Nirotpal; Nagaraju, Javaregowda			Dynamic Repositioning of Dorsal to Two Different kappa B Motifs Controls Its Autoregulation during Immune Response in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED REPRESSION; HOST-DEFENSE; GENES; EMBRYO; ACTIVATION; PATHWAYS; ENHANCER; TOLL; EXPRESSION; CONVERSION	Autoregulation is one of the mechanisms of imparting feedback control on gene expression. Positive autoregulatory feedback results in induction of a gene, and negative feedback leads to its suppression. Here, we report an interesting mechanism of autoregulation operating on Drosophila Rel gene dorsal that can activate as well as repress its expression. Using biochemical and genetic approaches, we show that upon immune challenge Dorsal regulates its activation as well as repression by dynamically binding to two different kappa B motifs, kappa B-I (intronic kappa B) and kappa B-P (promoter kappa B), present in the dorsal gene. Although the kappa B-I motif functions as an enhancer, the kappa B-P motif acts as a transcriptional repressor. Interestingly, Dorsal binding to these two motifs is dynamic; immediately upon immune challenge, Dorsal binds to the kappa B-I leading to auto-activation, whereas at the terminal phase of the immune response, it is removed from the kappa B-I and repositioned at the kappa B-P, resulting in its repression. Furthermore, we show that repression of Dorsal as well as its binding to the kappa B-P depends on the transcription factor AP1. Depletion of AP1 by RNA interference resulted in constitutive expression of Dorsal. In conclusion, this study suggests that during acute phase response dorsal is regulated by following two subcircuits: (i) Dl-kappa B-I for activation and (ii) Dl-AP1-kappa B-P for repression. These two subcircuits are temporally delineated and bring about overall regulation of dorsal during immune response. These results suggest the presence of a previously unknown mechanism of Dorsal autoregulation in immune-challenged Drosophila.	[Mrinal, Nirotpal; Nagaraju, Javaregowda] Ctr DNA Fingerprinting & Diagnost, Mol Genet Lab, Hyderabad 500001, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)	Nagaraju, J (corresponding author), Ctr DNA Fingerprinting & Diagnost, Mol Genet Lab, Hyderabad 500001, Andhra Pradesh, India.	jnagaraju@cdfd.org.in			Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	Supported by a Centre of Excellence grant from Department of Biotechnology, Government of India. To whom correspondence should be addressed. E-mail: jnagaraju@cdfd.org.in.	Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Brennan CA, 2004, ANNU REV IMMUNOL, V22, P457, DOI 10.1146/annurev.immunol.22.012703.104626; CHEN SM, 1993, MOL CELL BIOL, V13, P831, DOI 10.1128/MCB.13.2.831; Dushay MS, 1998, AM J HUM GENET, V62, P10, DOI 10.1086/301694; Dushay MS, 1996, P NATL ACAD SCI USA, V93, P10343, DOI 10.1073/pnas.93.19.10343; ENGSTROM Y, 1993, J MOL BIOL, V232, P327, DOI 10.1006/jmbi.1993.1392; GOVIND S, 1991, TRENDS GENET, V7, P119, DOI 10.1016/0168-9525(91)90456-Z; Hizver J, 2001, P NATL ACAD SCI USA, V98, P8490, DOI 10.1073/pnas.151247298; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Hong JW, 2008, P NATL ACAD SCI USA, V105, P20072, DOI 10.1073/pnas.0806476105; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; IP YT, 1992, GENE DEV, V6, P1518, DOI 10.1101/gad.6.8.1518; IP YT, 1991, CELL, V64, P439; JIANG J, 1992, EMBO J, V11, P3147, DOI 10.1002/j.1460-2075.1992.tb05387.x; JIANG J, 1993, EMBO J, V12, P3201, DOI 10.1002/j.1460-2075.1993.tb05989.x; KIROV N, 1993, EMBO J, V12, P3193, DOI 10.1002/j.1460-2075.1993.tb05988.x; Lemaitre B, 2004, NAT REV IMMUNOL, V4, P521, DOI 10.1038/nri1390; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Levashina EA, 1998, J MOL BIOL, V278, P515, DOI 10.1006/jmbi.1998.1705; Manfruelli P, 1999, EMBO J, V18, P3380, DOI 10.1093/emboj/18.12.3380; Meng XJ, 1999, GENE DEV, V13, P792, DOI 10.1101/gad.13.7.792; Minakhina S, 2006, ONCOGENE, V25, P6749, DOI 10.1038/sj.onc.1209940; Moussian B, 2005, CURR BIOL, V15, pR887, DOI 10.1016/j.cub.2005.10.026; Mrinal N, 2008, J BIOL CHEM, V283, P23376, DOI 10.1074/jbc.M801080200; PAN D, 1992, EMBO J, V11, P1837, DOI 10.1002/j.1460-2075.1992.tb05235.x; Ratnaparkhi GS, 2006, DEVELOPMENT, V133, P4409, DOI 10.1242/dev.02643; RUSHLOW C, 1992, BIOESSAYS, V14, P89, DOI 10.1002/bies.950140204; Senger K, 2004, MOL CELL, V13, P19, DOI 10.1016/S1097-2765(03)00500-8; Senger K, 2006, P NATL ACAD SCI USA, V103, P15957, DOI 10.1073/pnas.0607608103; Stathopoulos A, 2002, DEV BIOL, V246, P57, DOI 10.1006/dbio.2002.0652; Taylor BS, 1998, J BIOL CHEM, V273, P15148, DOI 10.1074/jbc.273.24.15148; Tingvall TO, 2001, P NATL ACAD SCI USA, V98, P3884, DOI 10.1073/pnas.061230198; Tzou P, 2002, CURR OPIN MICROBIOL, V5, P102, DOI 10.1016/S1369-5274(02)00294-1; Uvell H, 2007, TRENDS GENET, V23, P342, DOI 10.1016/j.tig.2007.05.003	36	4	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24206	24216		10.1074/jbc.M109.097196	http://dx.doi.org/10.1074/jbc.M109.097196			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20504768	Green Published, hybrid			2022-12-27	WOS:000280291400070
J	Lam, CKL; Chari, M; Su, BB; Cheung, GWC; Kokorovic, A; Yang, CS; Wang, PYT; Lai, TYY; Lam, TKT				Lam, Carol K. L.; Chari, Madhu; Su, Brenda B.; Cheung, Grace W. C.; Kokorovic, Andrea; Yang, Clair S.; Wang, Penny Y. T.; Lai, Teresa Y. Y.; Lam, Tony K. T.			Activation of N-Methyl-D-aspartate (NMDA) Receptors in the Dorsal Vagal Complex Lowers Glucose Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOOD-INTAKE; INSULIN ACTION; GLYCINE RECEPTORS; NR1 SUBUNIT; BRAIN; HOMEOSTASIS; HORN; INHIBITION; METABOLISM; MECHANISMS	Diabetes is characterized by hyperglycemia due partly to increased hepatic glucose production. The hypothalamus regulates hepatic glucose production in rodents. However, it is currently unknown whether other regions of the brain are sufficient in glucose production regulation. The N-methyl-D-aspartate (NMDA) receptor is composed of NR1 and NR2 subunits, which are activated by co-agonist glycine and glutamate or aspartate, respectively. Here we report that direct administration of either co-agonist glycine or NMDA into the dorsal vagal complex (DVC), targeting the nucleus of the solitary tract, lowered glucose production in vivo. Direct infusion of the NMDA receptor blocker MK-801 into the DVC negated the metabolic effect of glycine. To evaluate whether NR1 subunit of the NMDA receptor mediates the effect of glycine, NR1 in the DVC was inhibited by DVC NR1 antagonist 7-chlorokynurenic acid or DVC shRNA-NR1. Pharmacological and molecular inhibition of DVC NR1 negated the metabolic effect of glycine. To evaluate whether the NMDA receptors mediate the effects of NR2 agonist NMDA, DVC NMDA receptors were inhibited by antagonist D-2-amino-5-phosphonovaleric acid (D-APV). DVC D-APV fully negated the ability of DVC NMDA to lower glucose production. Finally, hepatic vagotomy negated the DVC glycine ability to lower glucose production. These findings demonstrate that activation of NR1 and NR2 subunits of the NMDA receptors in the DVC is sufficient to trigger a brain-liver axis to lower glucose production, and suggest that DVC NMDA receptors serve as a therapeutic target for diabetes and obesity.	[Lam, Tony K. T.] Univ Hlth Network, Toronto Gen Res Inst, MaRS Ctr, Toronto, ON M5G 1L7, Canada; [Lam, Carol K. L.; Chari, Madhu; Cheung, Grace W. C.; Kokorovic, Andrea; Yang, Clair S.; Lam, Tony K. T.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Lam, Tony K. T.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto	Lam, TKT (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, MaRS Ctr, Toronto Med Discovery Tower,Rm 10-705,101 Coll St, Toronto, ON M5G 1L7, Canada.	tony.lam@uhnres.utoronto.ca		Lam, Carol/0000-0002-9736-3347	Canadian Institute of Health Research [MOP-86554]; Ontario Graduate Scholarship; Banting and Best Diabetes Centre at the University of Toronto (BBDC)	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Banting and Best Diabetes Centre at the University of Toronto (BBDC)	This work was supported by a research grant (to T.K.T.L.) from the Canadian Institute of Health Research (MOP-86554).; Supported by the Canadian Institute of Health Research graduate scholarship.; Supported by the Ontario Graduate Scholarship and a graduate scholarship from the Banting and Best Diabetes Centre at the University of Toronto (BBDC).; Supported by the Canadian Institute of Health Research and BBDC graduate scholarships.	Baptista V, 2005, J NEUROPHYSIOL, V94, P147, DOI 10.1152/jn.00927.2004; Bergeron R, 1998, P NATL ACAD SCI USA, V95, P15730, DOI 10.1073/pnas.95.26.15730; Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; BUDAI D, 1992, NEUROSCI LETT, V135, P265, DOI 10.1016/0304-3940(92)90452-D; Caspi L, 2007, CELL METAB, V6, P99, DOI 10.1016/j.cmet.2007.07.005; Chari M, 2008, DIABETES, V57, P836, DOI 10.2337/db07-1464; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; Cheung GWC, 2009, CELL METAB, V10, P99, DOI 10.1016/j.cmet.2009.07.005; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Erreger K, 2007, MOL PHARMACOL, V72, P907, DOI 10.1124/mol.107.037333; Erreger Kevin, 2004, Critical Reviews in Neurobiology, V16, P187; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; Garraway SM, 2007, J PHARMACOL EXP THER, V322, P982, DOI 10.1124/jpet.107.123125; Gelling RW, 2006, CELL METAB, V3, P67, DOI 10.1016/j.cmet.2005.11.013; Grill HJ, 2006, OBESITY, V14, P216, DOI 10.1038/oby.2006.312; Inoue H, 2006, CELL METAB, V3, P267, DOI 10.1016/j.cmet.2006.02.009; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; Kievit P, 2006, CELL METAB, V4, P123, DOI 10.1016/j.cmet.2006.06.010; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Lam CKL, 2009, PHYSIOLOGY, V24, P159, DOI 10.1152/physiol.00003.2009; Lam TKT, 2005, SCIENCE, V309, P943, DOI 10.1126/science.1112085; Lam TKT, 2010, NAT MED, V16, P392, DOI 10.1038/nm0410-392; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; MCGALE EHF, 1977, J NEUROCHEM, V29, P291, DOI 10.1111/j.1471-4159.1977.tb09621.x; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Morton GJ, 2005, J CLIN INVEST, V115, P703, DOI 10.1172/JCI200522081; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Obici S, 2003, NAT MED, V9, P756, DOI 10.1038/nm873; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Pocai A, 2005, NATURE, V434, P1026, DOI 10.1038/nature03439; Ross R, 2008, DIABETES, V57, P2061, DOI 10.2337/db08-0206; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Shimoyama N, 2005, J PHARMACOL EXP THER, V312, P834, DOI 10.1124/jpet.104.074856; South SM, 2003, J NEUROSCI, V23, P5031; Taylor SI, 1999, CELL, V97, P9, DOI 10.1016/S0092-8674(00)80709-6; Turecek R, 2001, NATURE, V411, P587, DOI 10.1038/35079084; Wang PYT, 2008, NATURE, V452, P1012, DOI 10.1038/nature06852; Whitehead KJ, 2001, BRAIN RES, V910, P192, DOI 10.1016/S0006-8993(01)02684-1	40	57	60	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					21913	21921		10.1074/jbc.M109.087338	http://dx.doi.org/10.1074/jbc.M109.087338			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20448042	Green Published, hybrid			2022-12-27	WOS:000279702200003
J	Li, TB; Yang, YS; Canessa, CM				Li, Tianbo; Yang, Youshan; Canessa, Cecilia M.			Leu(85) in the beta 1-beta 2 Linker of ASIC1 Slows Activation and Decreases the Apparent Proton Affinity by Stabilizing a Closed Conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING ION-CHANNEL; ION-CHANNEL-1; PH	Acid-sensing ion channels (ASICs) are proton-activated channels expressed in neurons of the central and peripheral nervous systems where they modulate neuronal activity in response to external increases in proton concentration. The size of ASIC1 currents evoked by a given local acidification is determined by the number of channels in the plasma membrane and by the apparent proton affinities for activation and steady-state desensitization of the channel. Thus, the magnitude of the pH drop and the value of the baseline pH both are functionally important. Recent characterization of ASIC1s from an increasing number of species has made evident that proton affinities of these channels vary across vertebrates. We found that in species with high baseline plasma pH, e. g. frog, shark, and fish, ASIC1 has high proton affinity compared with the mammalian channel. The beta 1-beta 2 linker in the extracellular domain, specifically by the substitution M85L, determines the interspecies differences in proton affinities and also the time course of ASIC1 macroscopic currents. The mechanism underlying these observations is a delay in channel opening after application of protons, most likely by stabilizing a closed conformation that decreases the apparent affinity to protons and also slows the rise and decay phases of the current. Together, the results suggest evolutionary adaptation of ASIC1 to match the value of the species-specific plasma pH. At the molecular level, adaptation is achieved by substitutions of nonionizable residues rather than by modification of the channel proton sensor.	[Li, Tianbo; Yang, Youshan; Canessa, Cecilia M.] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University	Canessa, CM (corresponding author), Yale Univ, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06520 USA.	Cecilia.canessa@yale.edu	Li, Tianbo/C-6118-2012					Burton RF, 2002, J EXP BIOL, V205, P641; Coric T, 2005, J PHYSIOL-LONDON, V568, P725, DOI 10.1113/jphysiol.2005.087734; Coric T, 2003, J BIOL CHEM, V278, P45240, DOI 10.1074/jbc.M304441200; de la Rosa DA, 2002, P NATL ACAD SCI USA, V99, P2326, DOI 10.1073/pnas.042688199; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; HUGHES MK, 1993, MOL BIOL EVOL, V10, P1360; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; LI T, 2010, AM J PHYSL IN PRESS; Springauf A, 2010, J PHYSIOL-LONDON, V588, P809, DOI 10.1113/jphysiol.2009.182931; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Zhang P, 2006, J GEN PHYSIOL, V127, P109, DOI 10.1085/jgp.200509396	14	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22706	22712		10.1074/jbc.M110.134114	http://dx.doi.org/10.1074/jbc.M110.134114			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20479002	Green Published, hybrid			2022-12-27	WOS:000279702200081
J	Wang, Q; Rajshankar, D; Laschinger, C; Talior-Volodarsky, I; Wang, YQ; Downey, GP; McCulloch, CA				Wang, Qin; Rajshankar, Dhaarmini; Laschinger, Carol; Talior-Volodarsky, Ilana; Wang, Yongqiang; Downey, Gregory P.; McCulloch, Christopher A.			Importance of Protein-tyrosine Phosphatase-alpha Catalytic Domains for Interactions with SHP-2 and Interleukin-1-induced Matrix Metalloproteinase-3 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC-FAMILY KINASES; FOCAL ADHESIONS; PTP-ALPHA; ENDOPLASMIC-RETICULUM; HUMAN FIBROBLASTS; DOWN-REGULATION; ERK ACTIVATION; RPTP-ALPHA; PHOSPHORYLATION; INTEGRIN	Interleukin-1 (IL-1) induces extracellular matrix degradation as a result of increased expression of matrix metalloproteinases (MMPs). We examined adhesion-restricted signaling pathways that enable IL-1-induced MMP release in human gingival and murine fibroblasts. Of the seven MMPs and three tissue inhibitors of MMPs screened, IL-1 enhanced release only of MMP3 when cells formed focal adhesions. Inhibition of protein-tyrosine phosphatases (PTPs), which are enriched in focal adhesions, blocked IL-1-induced MMP3 release. Accordingly, in contrast to wild-type cells, fibroblasts null for PTP alpha did not exhibit IL-1-induced MMP3 release. IL-1 treatment enhanced the recruitment of SHP-2 and PTP alpha to focal adhesions and the association of PTP alpha with SHP-2. Pulldown assays confirmed a direct interaction between PTP alpha and SHP-2, which was dependent on the intact, membrane-proximal phosphatase domain of PTP alpha. Interactions between SHP-2 and PTP alpha, recruitment of SHP-2 to focal adhesions, IL-1-induced ERK activation, and MMP3 expression were all blocked by point mutations in the phosphatase domains of PTP alpha. These data indicate that IL-1-induced signaling through focal adhesions leading to MMP3 release and interactions between SHP-2 and PTP alpha are dependent on the integrity of the catalytic domains of PTP alpha.	[Wang, Qin; Rajshankar, Dhaarmini; Laschinger, Carol; Talior-Volodarsky, Ilana; Wang, Yongqiang; McCulloch, Christopher A.] Univ Toronto, Matrix Dynam Grp, Toronto, ON M5S 3E2, Canada; [Downey, Gregory P.] Natl Jewish Hlth, Div Pulm & Crit Care Med, Dept Med, Denver, CO 80206 USA; [Downey, Gregory P.] Natl Jewish Hlth, Div Pulm & Crit Care Med, Dept Pediat, Denver, CO 80206 USA; [Downey, Gregory P.] Univ Colorado Denver, Div Pulm Sci & Crit Care Med, Dept Med, Aurora, CO 80045 USA; [Downey, Gregory P.] Univ Colorado Denver, Integrated Dept Immunol, Aurora, CO 80045 USA	University of Toronto; National Jewish Health; National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	McCulloch, CA (corresponding author), Univ Toronto, Matrix Dynam Grp, Rm 244,Fitzgerald Bldg,150 Coll St, Toronto, ON M5S 3E2, Canada.	christopher.mcculloch@utoronto.ca		Downey, Gregory P/0000-0003-3253-5862	Canadian Institutes of Health Research [MOP 84254]; National Institutes of Health [HL090669]; Harold and Mary Zirin Chair in Pulmonary Biology at National Jewish Health; Canada Research Chair [Tier 1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090669] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harold and Mary Zirin Chair in Pulmonary Biology at National Jewish Health; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the Canadian Institutes of Health Research (MOP 84254; to C.A.M. and G.P.D.). This work was also supported in part by National Institutes of Health Grant HL090669 (to G.P.D.) and funds from the Harold and Mary Zirin Chair in Pulmonary Biology at National Jewish Health (to G.P.D.).; Supported by a Canada Research Chair (Tier 1). To whom correspondence should be addressed: Rm.244, Fitzgerald Bldg., University of Toronto, 150 College St., Toronto, Ontario M5S 3E2, Canada. Tel.: 416-978-1258; Fax: 416-978-5956; E-mail: christopher.mcculloch@utoronto.ca.	Abreu MTH, 2008, AM J PHYSIOL-CELL PH, V294, pC931, DOI 10.1152/ajpcell.00359.2007; Abreu MTH, 2006, J CELL PHYSIOL, V207, P132, DOI 10.1002/jcp.20544; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; ARORA PD, 1995, J BIOL CHEM, V270, P6042, DOI 10.1074/jbc.270.11.6042; Bhandari V, 1998, J BIOL CHEM, V273, P8691, DOI 10.1074/jbc.273.15.8691; Bilwes AM, 1996, NATURE, V382, P555, DOI 10.1038/382555a0; Blanchetot C, 2000, J BIOL CHEM, V275, P12446, DOI 10.1074/jbc.275.17.12446; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Chen M, 2006, J BIOL CHEM, V281, P11972, DOI 10.1074/jbc.M600561200; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DIBATTISTA JA, 1995, J RHEUMATOL, V22, P123; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; Harder KW, 1998, J BIOL CHEM, V273, P31890, DOI 10.1074/jbc.273.48.31890; HavemosePoulsen A, 1997, CRIT REV ORAL BIOL M, V8, P217, DOI 10.1177/10454411970080020801; ILLC D, 1995, NATURE, V377, P539; Jones Matthew L, 2004, Methods Mol Biol, V273, P169; Kirchner J, 2003, J CELL SCI, V116, P975, DOI 10.1242/jcs.00284; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kodama A, 2000, MOL BIOL CELL, V11, P2565, DOI 10.1091/mbc.11.8.2565; Lammers R, 2000, J BIOL CHEM, V275, P3391, DOI 10.1074/jbc.275.5.3391; Lo YYC, 1998, J BIOL CHEM, V273, P7059, DOI 10.1074/jbc.273.12.7059; Luo L, 1997, BIOCHEM J, V324, P653, DOI 10.1042/bj3240653; MacGillivray M, 2003, J BIOL CHEM, V278, P27190, DOI 10.1074/jbc.M213083200; MAUVIEL A, 1992, J CELL BIOCHEM, V50, P53, DOI 10.1002/jcb.240500110; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; Oh ES, 1999, MOL CELL BIOL, V19, P3205; Osteen KG, 1999, GYNECOL OBSTET INVES, V48, P2, DOI 10.1159/000052863; Ostman A, 2001, TRENDS CELL BIOL, V11, P258, DOI 10.1016/S0962-8924(01)01990-0; Panetti TS, 2002, FRONT BIOSCI-LANDMRK, V7, pD143, DOI 10.2741/panetti; PLOPPER G, 1993, BIOCHEM BIOPH RES CO, V193, P571, DOI 10.1006/bbrc.1993.1662; Ponniah S, 1999, CURR BIOL, V9, P535, DOI 10.1016/S0960-9822(99)80238-3; Poole AW, 2005, CELL SIGNAL, V17, P1323, DOI 10.1016/j.cellsig.2005.05.016; QWARNSTROM EE, 1988, J BIOL CHEM, V263, P8261; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Segal G, 2001, J CELL SCI, V114, P119; Su J, 1999, CURR BIOL, V9, P505, DOI 10.1016/S0960-9822(99)80234-6; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Tsuda M, 1998, J BIOL CHEM, V273, P13223, DOI 10.1074/jbc.273.21.13223; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; von Wichert G, 2003, EMBO J, V22, P5023, DOI 10.1093/emboj/cdg492; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061; Wang Q, 2005, J BIOL CHEM, V280, P8397, DOI 10.1074/jbc.M410462200; Wang Q, 2006, J BIOL CHEM, V281, P31093, DOI 10.1074/jbc.M606392200; Wang Q, 2009, J BIOL CHEM, V284, P20763, DOI 10.1074/jbc.M808828200; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zheng XM, 2000, EMBO J, V19, P964, DOI 10.1093/emboj/19.5.964; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0	52	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22308	22317		10.1074/jbc.M110.102426	http://dx.doi.org/10.1074/jbc.M110.102426			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20472558	Green Published, hybrid			2022-12-27	WOS:000279702200044
J	Darwanto, A; Curtis, MP; Schrag, M; Kirsch, W; Liu, P; Xu, GL; Neidigh, JW; Zhang, KL				Darwanto, Agus; Curtis, Matthew P.; Schrag, Matthew; Kirsch, Wolff; Liu, Peng; Xu, Guoliang; Neidigh, Jonathan W.; Zhang, Kangling			A Modified "Cross-talk" between Histone H2B Lys-120 Ubiquitination and H3 Lys-79 Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRY; ABSOLUTE QUANTIFICATION; CHROMATIN MODIFICATIONS; GENE-EXPRESSION; ACETYLATION; FUSION; YEAST; MONOUBIQUITINATION; ELONGATION; PROTEOMICS	Western blot analysis is currently the major method utilized for quantitatively assessing histone global modifications. However, there is a growing need to develop a highly specific, accurate, and multisite quantitative method. Herein, we report a liquid chromatography-tandem mass spectrometry-multiple reaction monitoring method to simultaneously quantify multisite modifications with unmatched specificity, sensitivity, and throughput. With one set of purification of histones by high pressure liquid chromatography or SDS-PAGE, nearly 20 modification sites including acetylation, propionylation, methylation, and ubiquitination were quantified within 2 h for two samples to be compared. Using this method, the relative levels of H2B ubiquitination and H3 Lys-79 methylation were quantified in the U937 human leukemia cell line, U937 derivative cell lines overexpressing anti-secretory factor 10 (AF10) and mutant AF10 with the deletion of the hDot1 binding domain OM-LZ. We found that H2B ubiquitination is inversely correlated with H3 Lys-79 methylation. Therefore, we propose that a catalytic and inhibitory loop mechanism may better describe the crosstalk relationship between H2B ubiquitination and H3 Lys-79 methylation.	[Neidigh, Jonathan W.; Zhang, Kangling] Loma Linda Univ, Sch Med, Dept Basic Sci, Div Biochem, Loma Linda, CA 92350 USA; [Schrag, Matthew; Kirsch, Wolff] Loma Linda Univ, Neurosurg Ctr Res, Loma Linda, CA 92350 USA; [Liu, Peng; Xu, Guoliang] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China	Loma Linda University; Loma Linda University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhang, KL (corresponding author), Loma Linda Univ, Sch Med, Dept Basic Sci, Div Biochem, Loma Linda, CA 92350 USA.	kzhang@llu.edu		Liu, Peng/0000-0002-6469-6460	Department of Basic Sciences, Biochemistry Division, Loma Linda University	Department of Basic Sciences, Biochemistry Division, Loma Linda University	This work was supported by the Department of Basic Sciences, Biochemistry Division, Loma Linda University.	Asnafi V, 2003, BLOOD, V102, P1000, DOI 10.1182/blood-2002-09-2913; Bitoun E, 2007, HUM MOL GENET, V16, P92, DOI 10.1093/hmg/ddl444; Bohlander SK, 2000, LEUKEMIA, V14, P93, DOI 10.1038/sj.leu.2401614; Dehe PM, 2005, J MOL BIOL, V353, P477, DOI 10.1016/j.jmb.2005.08.059; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Huang ZP, 2006, TETRAHEDRON LETT, V47, P5997, DOI 10.1016/j.tetlet.2006.05.190; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Keshishian H, 2007, MOL CELL PROTEOMICS, V6, P2212, DOI 10.1074/mcp.M700354-MCP200; Kim K, 2009, EXPERT REV PROTEOMIC, V6, P225, DOI 10.1586/EPR.09.11; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Lin YH, 2009, BLOOD, V114, P651, DOI 10.1182/blood-2009-03-209395; Liu B, 2009, J BIOL CHEM, V284, P32288, DOI 10.1074/jbc.M109.045856; Matysiak S, 1998, TETRAHEDRON LETT, V39, P1733, DOI 10.1016/S0040-4039(98)00055-0; Mayya V, 2006, MOL CELL PROTEOMICS, V5, P1146, DOI 10.1074/mcp.T500029-MCP200; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Ong SE, 2004, NAT METHODS, V1, P119, DOI 10.1038/NMETH715; Pan S, 2009, J PROTEOME RES, V8, P787, DOI 10.1021/pr800538n; Shahbazian MD, 2005, MOL CELL, V19, P271, DOI 10.1016/j.molcel.2005.06.010; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Smith CM, 2003, ANAL BIOCHEM, V316, P23, DOI 10.1016/S0003-2697(03)00032-0; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Yang XJ, 2005, ONCOGENE, V24, P1653, DOI 10.1038/sj.onc.1208173; Yocum Anastasia K., 2009, Briefings in Functional Genomics & Proteomics, V8, P145, DOI 10.1093/bfgp/eln056; Zhang KL, 2008, INT J MASS SPECTROM, V278, P89, DOI 10.1016/j.ijms.2008.08.018; Zhang KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001210; Zhang KL, 2008, INT J MASS SPECTROM, V269, P101, DOI 10.1016/j.ijms.2007.09.010; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	38	51	53	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21868	21876		10.1074/jbc.M110.126813	http://dx.doi.org/10.1074/jbc.M110.126813			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20442396	Green Published, hybrid			2022-12-27	WOS:000279516100071
J	Pene-Dumitrescu, T; Smithgall, TE				Pene-Dumitrescu, Teodora; Smithgall, Thomas E.			Expression of a Src Family Kinase in Chronic Myelogenous Leukemia Cells Induces Resistance to Imatinib in a Kinase-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC MYELOID-LEUKEMIA; ABL TYROSINE KINASE; REGULATES BCR-ABL; C-ABL; PROTEIN-KINASE; SIGNALING PATHWAY; BETA-CATENIN; SH2 DOMAIN; LYN KINASE; FOLLOW-UP	The Bcr-Abl kinase inhibitor imatinib is remarkably effective in chronic myelogenous leukemia (CML), although drug resistance is an emerging problem. Myeloid Src family kinases such as Hck and Lyn are often overexpressed in imatinib-resistant CML cells that lack Bcr-Abl mutations. Here we tested whether Hck overexpression is sufficient to induce imatinib resistance using both wild-type Hck and a mutant (Hck-T338A) that is uniquely sensitive to the pyrazolo-pyrimidine inhibitor, NaPP1. Expression of either kinase in K562 CML cells caused resistance to imatinib-induced apoptosis and inhibition of soft-agar colony formation. Treatment with NaPP1 restored sensitivity to imatinib in cells expressing T338A but not wild-type Hck, demonstrating that resistance requires Hck kinase activity. NaPP1 also reduced Hck-mediated phosphorylation of Bcr-Abl at sites that may affect imatinib sensitivity exclusively in cells expressing Hck-T338A. These data show that elevated Src family kinase activity is sufficient to induce imatinib resistance through a mechanism that may involve phosphorylation of Bcr-Abl.	[Pene-Dumitrescu, Teodora; Smithgall, Thomas E.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Smithgall, TE (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Bridgeside Point 2,Suite 523,450 Technol Dr, Pittsburgh, PA 15219 USA.	tsmithga@pitt.edu			National Institutes of Health [CA101828, GM077629]; NATIONAL CANCER INSTITUTE [R01CA101828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA101828 and GM077629 (to T. E. S.).	Alaimo PJ, 2005, BIOORGAN MED CHEM, V13, P2825, DOI 10.1016/j.bmc.2005.02.021; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bishop AC, 1998, CURR BIOL, V8, P257, DOI 10.1016/S0960-9822(98)70198-8; Bishop AC, 2001, TRENDS CELL BIOL, V11, P167, DOI 10.1016/S0962-8924(01)01928-6; Blencke S, 2004, CHEM BIOL, V11, P691, DOI 10.1016/j.chembiol.2004.02.029; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Briggs SD, 1997, J BIOL CHEM, V272, P17899, DOI 10.1074/jbc.272.29.17899; Briggs SD, 1999, J BIOL CHEM, V274, P26579, DOI 10.1074/jbc.274.37.26579; Chen S, 2008, J MOL BIOL, V383, P414, DOI 10.1016/j.jmb.2008.08.040; Choi HJ, 2004, J MOL BIOL, V343, P1255, DOI 10.1016/j.jmb.2004.09.015; Cortez D, 1996, ONCOGENE, V13, P2589; DanhauserRiedl S, 1996, CANCER RES, V56, P3589; Danial NN, 2000, ONCOGENE, V19, P2523, DOI 10.1038/sj.onc.1203484; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Donato NJ, 2004, CANCER RES, V64, P672, DOI 10.1158/0008-5472.CAN-03-1484; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Faderl S, 1999, NEW ENGL J MED, V341, P164, DOI 10.1056/NEJM199907153410306; Furstoss O, 2002, EMBO J, V21, P514, DOI 10.1093/emboj/21.4.514; GOGA A, 1995, CELL, V82, P981, DOI 10.1016/0092-8674(95)90277-5; Goldman JM, 2003, NEW ENGL J MED, V349, P1451, DOI 10.1056/NEJMra020777; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Hochhaus A, 2002, LEUKEMIA, V16, P2190, DOI 10.1038/sj.leu.2402741; Hochhaus A, 2008, BLOOD, V111, P1039, DOI 10.1182/blood-2007-07-103523; Howlett CJ, 1999, BIOCHEM BIOPH RES CO, V257, P129, DOI 10.1006/bbrc.1999.0427; Iacob RE, 2009, P NATL ACAD SCI USA, V106, P1386, DOI 10.1073/pnas.0811912106; Kawano T, 2007, CANCER RES, V67, P11576, DOI 10.1158/0008-5472.CAN-07-2756; Kirchner D, 2003, EXP HEMATOL, V31, P504, DOI 10.1016/S0301-472X(03)00069-9; Klejman A, 2002, EMBO J, V21, P5766, DOI 10.1093/emboj/cdf562; Lakshmikuttyamma A, 2008, ONCOGENE, V27, P3831, DOI 10.1038/onc.2008.8; Lerner EC, 2005, J BIOL CHEM, V280, P40832, DOI 10.1074/jbc.M508782200; Lerner EC, 2002, NAT STRUCT BIOL, V9, P365, DOI 10.1038/nsb782; Li YQ, 2001, J BIOL CHEM, V276, P6061, DOI 10.1074/jbc.C000754200; Lionberger JM, 2000, J BIOL CHEM, V275, P18581, DOI 10.1074/jbc.C000126200; Liu Y, 1999, CHEM BIOL, V6, P671, DOI 10.1016/S1074-5521(99)80118-5; LOZZIO BB, 1981, P SOC EXP BIOL MED, V166, P546; MACAULEY A, 1993, ONCOGENE, V8, P117; Mahon FX, 2008, CANCER RES, V68, P9809, DOI 10.1158/0008-5472.CAN-08-1008; Meyn MA, 2006, J BIOL CHEM, V281, P30907, DOI 10.1074/jbc.M605902200; MULLER AJ, 1991, MOL CELL BIOL, V11, P1785, DOI 10.1128/MCB.11.4.1785; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; PENDERGAST AM, 1993, CELL, V75, P175, DOI 10.1016/S0092-8674(05)80094-7; Pene-Dumitrescu T, 2008, ONCOGENE, V27, P7055, DOI 10.1038/onc.2008.330; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Porter M, 2000, J BIOL CHEM, V275, P2721, DOI 10.1074/jbc.275.4.2721; PUIL L, 1994, EMBO J, V13, P764, DOI 10.1002/j.1460-2075.1994.tb06319.x; Raitano A. B., 1997, BIOCHIM BIOPHYS ACTA, V1333, P201, DOI 10.1016/S0304-419X(97)00023-1; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Sattler M, 1996, ONCOGENE, V12, P839; Sattler Martin, 1997, Cytokine and Growth Factor Reviews, V8, P63, DOI 10.1016/S1359-6101(96)00047-0; Satyamoorthy K, 2001, CANCER RES, V61, P7318; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Trible RP, 2006, J BIOL CHEM, V281, P27029, DOI 10.1074/jbc.M601128200; Voss J, 2000, ONCOGENE, V19, P1684, DOI 10.1038/sj.onc.1203467; Warmuth M, 1997, J BIOL CHEM, V272, P33260, DOI 10.1074/jbc.272.52.33260; Wilson MB, 2002, ONCOGENE, V21, P8075, DOI 10.1038/sj.onc.1206008; Wong S, 2004, P NATL ACAD SCI USA, V101, P17456, DOI 10.1073/pnas.0407061101; Wu J, 2008, J NATL CANCER I, V100, P926, DOI 10.1093/jnci/djn188; Wu J, 2008, BLOOD, V111, P3821, DOI 10.1182/blood-2007-08-109330; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1	66	50	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21446	21457		10.1074/jbc.M109.090043	http://dx.doi.org/10.1074/jbc.M109.090043			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20452982	Green Published, hybrid			2022-12-27	WOS:000279516100031
J	Maio, N; Polticelli, F; De Francesco, G; Rizzo, G; di Patti, MCB; Musci, G				Maio, Nunziata; Polticelli, Fabio; De Francesco, Giovanni; Rizzo, Gianluca; di Patti, Maria Carmela Bonaccorsi; Musci, Giovanni			Role of External Loops of Human Ceruloplasmin in Copper Loading by ATP7B and Ccc2p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PICHIA-PASTORIS; ACERULOPLASMINEMIA; EXPRESSION; DISORDER; ATPASES; PROTEIN; SYSTEM	Ceruloplasmin is a multicopper oxidase required for correct iron homeostasis. Previously, we have identified a ceruloplasmin mutant associated with the iron overload disease aceruloplasminemia, which was unable to acquire copper from themammalian pump ATP7B but could be produced in an enzymatically active form in yeast. Here, we report the expression of recombinant ceruloplasmin in the yeast Pichia pastoris and the study of the role of five surface-exposed loops in copper incorporation by comparing the efficiencies of mammalian ATP7B and yeast Ccc2p. The possibility to "mix and match" mammalian and yeast multicopper oxidases and copper ATPases can provide clues on the molecular features underlying the process of copper loading in multicopper oxidases.	[De Francesco, Giovanni; di Patti, Maria Carmela Bonaccorsi] Univ Roma La Sapienza, Dept Sci Biochim, I-00185 Rome, Italy; [Musci, Giovanni] Univ ROMA TRE, Dipartimento Biol, I-00146 Rome, Italy; [Musci, Giovanni] Univ Molise, Dipartimento Sci & Tecnol Agroalimentari, I-86100 Campobasso, Italy	Sapienza University Rome; Roma Tre University; University of Molise	di Patti, MCB (corresponding author), Univ Roma La Sapienza, Dept Sci Biochim, Ple A Moro 5, I-00185 Rome, Italy.	mariacarmela.bonaccorsi@uniroma1.it; musci@unimol.it	Rizzo, Gianluca/J-6540-2019; Bonaccorsi di Patti, Maria Carmela/F-1198-2011; Musci, Giovanni/H-2862-2012; Polticelli, Fabio/A-4573-2009	Rizzo, Gianluca/0000-0002-5540-0621; Bonaccorsi di Patti, Maria Carmela/0000-0002-4794-7037; Musci, Giovanni/0000-0002-5196-709X; Polticelli, Fabio/0000-0002-7657-2019; Maio, Nunziata/0000-0002-6225-6058	Telethon-Italy [GGP06173]	Telethon-Italy(Fondazione Telethon)	This work was supported by Telethon-Italy Grant GGP06173 (to G.M.).	Bielli P, 2001, J BIOL CHEM, V276, P2678, DOI 10.1074/jbc.M007176200; di Patti MC, 2009, J BIOL CHEM, V284, P4545, DOI 10.1074/jbc.M805688200; Cereghino GPL, 2001, GENE, V263, P159, DOI 10.1016/S0378-1119(00)00576-X; De Domenico I, 2007, EMBO J, V26, P2823, DOI 10.1038/sj.emboj.7601735; di Patti MCB, 1999, ARCH BIOCHEM BIOPHYS, V372, P295, DOI 10.1006/abbi.1999.1493; Hsi G, 2008, HUM MUTAT, V29, P491, DOI 10.1002/humu.20674; Hung IH, 1997, J BIOL CHEM, V272, P21461, DOI 10.1074/jbc.272.34.21461; Kuhn J, 2005, J NEUROL, V252, P111, DOI 10.1007/s00415-005-0608-3; Lutsenko S, 2008, ARCH BIOCHEM BIOPHYS, V476, P22, DOI 10.1016/j.abb.2008.05.005; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Miyajima H, 2003, NEUROPATHOLOGY, V23, P345, DOI 10.1046/j.1440-1789.2003.00521.x; Patel BN, 1997, J BIOL CHEM, V272, P20185, DOI 10.1074/jbc.272.32.20185; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; SCHOSINSKY KH, 1975, CLIN CHEM, V21, P757; Sears IB, 1998, YEAST, V14, P783, DOI 10.1002/(SICI)1097-0061(19980615)14:8<783::AID-YEA272>3.0.CO;2-Y; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Wu SX, 2004, BIOTECHNIQUES, V36, P152, DOI 10.2144/04361DD02	17	7	8	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20507	20513		10.1074/jbc.M109.090027	http://dx.doi.org/10.1074/jbc.M109.090027			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20430895	Green Published, hybrid			2022-12-27	WOS:000279228600011
J	Patel, N; Kalra, VK				Patel, Nitin; Kalra, Vijay K.			Placenta Growth Factor-induced Early Growth Response 1 (Egr-1) Regulates Hypoxia-inducible Factor-1 alpha (HIF-1 alpha) in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE FACTOR; KAPPA-B; TRANSCELLULAR BIOSYNTHESIS; 5-LIPOXYGENASE PATHWAY; CYSTEINYL LEUKOTRIENES; INDUCED EXPRESSION; COREPRESSOR NAB2; THP-1 MONOCYTES; GENE-EXPRESSION; UP-REGULATION	Leukotrienes, the lipid inflammatory products derived from arachidonic acid, are involved in the pathogenesis of respiratory and cardiovascular diseases and reactive airway disease in sickle cell disease. Placenta growth factor (PlGF), elaborated from erythroid cells, increased the mRNA expression of 5-lipoxygenase and 5-lipoxygenase-activating protein (FLAP) in human pulmonary microvascular endothelial cells. PlGF-induced both promoter activity and mRNA expression of hypoxia-inducible factor-1 alpha (HIF-1 alpha), which was abrogated by early growth response-1 (EGR-1) small interfering RNA. PlGF showed a temporal reciprocal relationship in the mRNA levels of EGR-1 and NAB2, the latter a repressor of Egr-1. Moreover, Nab2, but not mutant Nab2, significantly reduced promoter activity and mRNA expression of HIF-1 alpha and also reduced expression of the HIF-1 alpha target gene FLAP. Furthermore, overexpression of Egr-1 led to increased promoter activities for both HIF-1 alpha and FLAP in the absence of PlGF. Additionally, the Egr-1-mediated induction of HIF-1 alpha and FLAP promoters was reduced to basal levels by EGR-1 small interfering RNA. The binding of Egr-1 to HIF-1 alpha promoter was corroborated by electrophoretic mobility shift assay and chromatin immunoprecipitation assay, which showed increased Egr-1 binding to the HIF-1 alpha promoter in response to PlGF stimulation. These studies provide a novel mechanism for PlGF-mediated regulation of HIF-1 alpha via Egr-1, which results in increased FLAP expression. This study provides a new therapeutic target, namely Egr-1, for attenuation of elevated leukotriene levels in patients with sickle cell disease and other inflammatory diseases.	[Kalra, Vijay K.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, HMR 611, Los Angeles, CA 90033 USA	University of Southern California	Kalra, VK (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, HMR 611, Los Angeles, CA 90033 USA.	vkalra@usc.edu	Patel, Nitin/C-9625-2010		National Institutes of Health [R01-HL-079916, HL-070595]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079916, U54HL070595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HL-079916 and HL-070595.	BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc; FEINMARK SJ, 1986, J BIOL CHEM, V261, P6466; Ferguson AD, 2007, SCIENCE, V317, P510, DOI 10.1126/science.1144346; Folco G, 2006, PHARMACOL REV, V58, P375, DOI 10.1124/pr.58.3.8; Frede S, 2006, BIOCHEM J, V396, P517, DOI 10.1042/BJ20051839; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Giri RK, 2004, J NEUROCHEM, V91, P1199, DOI 10.1111/j.1471-4159.2004.02800.x; Giri RK, 2003, J IMMUNOL, V170, P5281, DOI 10.4049/jimmunol.170.10.5281; Gronert K, 1999, METH MOL B, V120, P119; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Houston P, 2001, BIOCHEM BIOPH RES CO, V283, P480, DOI 10.1006/bbrc.2001.4810; Iyer NV, 1998, GENOMICS, V52, P159, DOI 10.1006/geno.1998.5416; Jennings JE, 2008, AM J HEMATOL, V83, P640, DOI 10.1002/ajh.21199; Kanaoka Y, 2004, J IMMUNOL, V173, P1503, DOI 10.4049/jimmunol.173.3.1503; Kang J, 2009, ANAL BIOCHEM, V386, P251, DOI 10.1016/j.ab.2008.12.021; KHACHIGIAN LM, 1995, J BIOL CHEM, V270, P27679, DOI 10.1074/jbc.270.46.27679; Kim KS, 2006, J IMMUNOL, V177, P7211, DOI 10.4049/jimmunol.177.10.7211; Kumbrink J, 2005, J BIOL CHEM, V280, P42785, DOI 10.1074/jbc.M511079200; LEWIS RA, 1990, NEW ENGL J MED, V323, P645; Lucerna M, 2003, J BIOL CHEM, V278, P11433, DOI 10.1074/jbc.M204937200; MACKMAN N, 1989, BIOCHEMISTRY-US, V28, P1755, DOI 10.1021/bi00430a050; Mechtcheriakova D, 2001, FASEB J, V15, P230, DOI 10.1096/fj.00-0247com; MILLER DK, 1985, J BIOL CHEM, V260, P1006; Minet E, 1999, BIOCHEM BIOPH RES CO, V261, P534, DOI 10.1006/bbrc.1999.0995; Patel N, 2008, BLOOD, V112, P856, DOI 10.1182/blood-2007-12-130567; Patel N, 2009, BLOOD, V113, P1129, DOI 10.1182/blood-2008-07-169821; Perelman N, 2003, BLOOD, V102, P1506, DOI 10.1182/blood-2002-11-3422; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; RADMARK O, 2005, AM J PHYSIOL-CELL PH, V288, pC1125; Reddy KV, 2003, J BIOL CHEM, V278, P13810, DOI 10.1074/jbc.M211102200; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Rong Y, 2006, CANCER RES, V66, P7067, DOI 10.1158/0008-5472.CAN-06-0346; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Selvaraj SK, 2003, BLOOD, V102, P1515, DOI 10.1182/blood-2002-11-3423; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Silverman ES, 1998, AM J RESP CELL MOL, V19, P316, DOI 10.1165/ajrcmb.19.2.3154; Srinivasan R, 2006, J BIOL CHEM, V281, P15129, DOI 10.1074/jbc.M600775200; Stins MF, 2001, J NEUROVIROL, V7, P125; Svaren J, 1996, MOL CELL BIOL, V16, P3545; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Voelkel NF, 1996, J CLIN INVEST, V97, P2491, DOI 10.1172/JCI118696; Wright L, 1998, AM J RESP CRIT CARE, V157, P219, DOI 10.1164/ajrccm.157.1.9704003; Wu SQ, 2002, BLOOD, V100, P4454, DOI 10.1182/blood-2002-02-0415; Yan SF, 1998, P NATL ACAD SCI USA, V95, P8298, DOI 10.1073/pnas.95.14.8298; Yan SF, 2000, NAT MED, V6, P1355, DOI 10.1038/82168; Zarini S, 2009, P NATL ACAD SCI USA, V106, P8296, DOI 10.1073/pnas.0903851106; Zhang YY, 2002, BIOCHEM J, V361, P267, DOI 10.1042/0264-6021:3610267; Zhao L, 2004, NAT MED, V10, P966, DOI 10.1038/nm1099	52	33	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20570	20579		10.1074/jbc.M110.119495	http://dx.doi.org/10.1074/jbc.M110.119495			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20448047	hybrid, Green Published			2022-12-27	WOS:000279228600020
J	Tselnicker, I; Tsemakhovich, VA; Dessauer, CW; Dascal, N				Tselnicker, Isabella; Tsemakhovich, Vladimir A.; Dessauer, Carmen W.; Dascal, Nathan			Stargazin Modulates Neuronal Voltage-dependent Ca2+ Channel Ca(v)2.2 by a G beta gamma-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED CALCIUM-CHANNELS; ACTIVATED K+ CHANNELS; G-PROTEIN INHIBITION; XENOPUS OOCYTES; POTASSIUM CHANNEL; ADENYLYL-CYCLASE; SUBUNITS; MOUSE; EXPRESSION; RECEPTORS	Loss of neuronal protein stargazin (gamma(2)) is associated with recurrent epileptic seizures and ataxia in mice. Initially, due to homology to the skeletal muscle calcium channel gamma(1) subunit, stargazin and other family members (gamma(3-8)) were classified as gamma subunits of neuronal voltage-gated calcium channels (such as Ca(V)2.1-Ca(V)2.3). Here, we report that stargazin interferes with G protein modulation of Ca(V)2.2 (N-type) channels expressed in Xenopus oocytes. Stargazin counteracted the G beta gamma-induced inhibition of Ca(V)2.2 channel currents, caused either by coexpression of the G beta gamma dimer or by activation of a G protein-coupled receptor. Expression of high doses of G beta gamma overcame the effects of stargazin. High affinity G beta gamma scavenger proteins m-c beta ARK and m-phosducin produced effects similar to stargazin. The effects of stargazin and m-c beta ARK were not additive, suggesting a common mechanism of action, and generally independent of the presence of the Ca-V beta(3) subunit. However, in some cases, coexpression of Ca-V beta(3) blunted the modulation by stargazin. Finally, the G beta gamma-opposing action of stargazin was not unique to Ca(V)2.2, as stargazin also inhibited the G beta gamma-mediated activation of the G protein-activated K+ channel. Purified cytosolic C-terminal part of stargazin bound G beta gamma in vitro. Our results suggest that the regulation by stargazin of biophysical properties of Ca(V)2.2 are not exerted by direct modulation of the channel but via a G beta gamma-dependent mechanism.	[Tselnicker, Isabella; Tsemakhovich, Vladimir A.; Dascal, Nathan] Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Dessauer, Carmen W.] Univ Texas Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	Tel Aviv University; Sackler Faculty of Medicine; University of Texas System; University of Texas Health Science Center Houston	Tselnicker, I (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	isabell1@post.tau.ac.il; dascaln@post.tau.ac.il	Farhy, Isabella/P-1367-2018; Dascal, Nathan/O-3915-2015; Dessauer, Carmen/N-6933-2018	Dascal, Nathan/0000-0002-5397-4146; Dessauer, Carmen/0000-0003-1210-4280	Israeli Ministry of Health [3-4879]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060419] Funding Source: NIH RePORTER	Israeli Ministry of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Israeli Ministry of Health Grant 3-4879.	Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bauer PH, 1998, J BIOL CHEM, V273, P9465, DOI 10.1074/jbc.273.16.9465; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; Berlin S, 2010, J BIOL CHEM, V285, P6179, DOI 10.1074/jbc.M109.085944; Blumenstein Y, 2004, J PHYSIOL-LONDON, V556, P121, DOI 10.1113/jphysiol.2003.056168; Bourinet E, 1996, P NATL ACAD SCI USA, V93, P1486, DOI 10.1073/pnas.93.4.1486; Canti C, 2001, BIOPHYS J, V81, P1439, DOI 10.1016/S0006-3495(01)75799-2; Canti C, 2000, J PHYSIOL-LONDON, V527, P419, DOI 10.1111/j.1469-7793.2000.t01-1-00419.x; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Choi J, 2002, J BIOL CHEM, V277, P12359, DOI 10.1074/jbc.M200528200; Dascal N, 2001, TRENDS ENDOCRIN MET, V12, P391, DOI 10.1016/S1043-2760(01)00475-1; Dascal N., 1992, METHODS MOL BIOL VOL, VVolume 13, P205; De Waard M, 2005, TRENDS PHARMACOL SCI, V26, P427, DOI 10.1016/j.tips.2005.06.008; Deng F, 2006, J NEUROSCI, V26, P7875, DOI 10.1523/JNEUROSCI.1851-06.2006; Dessauer CW, 1998, J BIOL CHEM, V273, P25831, DOI 10.1074/jbc.273.40.25831; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Dolphin AC, 2003, PHARMACOL REV, V55, P607, DOI 10.1124/pr.55.4.3; Ferron L, 2008, J NEUROSCI, V28, P10604, DOI 10.1523/JNEUROSCI.2709-08.2008; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; IKEDA SR, 1991, J PHYSIOL-LONDON, V439, P181, DOI 10.1113/jphysiol.1991.sp018663; IKEDA SR, 1996, NATURE, V380, P258; Kang MG, 2001, J BIOL CHEM, V276, P32917, DOI 10.1074/jbc.M100787200; Khosravani H, 2006, PHYSIOL REV, V86, P941, DOI 10.1152/physrev.00002.2006; KIM CM, 1993, J BIOL CHEM, V268, P15412; Klugbauer N, 2000, FEBS LETT, V470, P189, DOI 10.1016/S0014-5793(00)01306-5; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; Meir A, 2000, BIOPHYS J, V79, P731, DOI 10.1016/S0006-3495(00)76331-4; Meir A, 2002, PFLUG ARCH EUR J PHY, V444, P263, DOI 10.1007/s00424-002-0803-3; Moss FJ, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-23; Moss FJ, 2002, EMBO J, V21, P1514, DOI 10.1093/emboj/21.7.1514; Osten P, 2006, CURR OPIN NEUROBIOL, V16, P275, DOI 10.1016/j.conb.2006.04.002; Peleg S, 2002, NEURON, V33, P87, DOI 10.1016/S0896-6273(01)00567-0; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Rishal I, 2005, J BIOL CHEM, V280, P16685, DOI 10.1074/jbc.M412196200; Rishal I, 2003, J BIOL CHEM, V278, P3840, DOI 10.1074/jbc.C200605200; ROCHE JP, 1995, FEBS LETT, V371, P43, DOI 10.1016/0014-5793(95)00860-C; Roche JP, 1998, J NEUROSCI, V18, P4883; Roche JP, 1998, J NEUROSCI, V18, P878; Rousset M, 2001, J PHYSIOL-LONDON, V532, P583, DOI 10.1111/j.1469-7793.2001.0583e.x; Rubinstein M, 2007, J PHYSIOL-LONDON, V581, P17, DOI 10.1113/jphysiol.2006.125864; Rubinstein M, 2009, J PHYSIOL-LONDON, V587, P3473, DOI 10.1113/jphysiol.2009.173229; Sandoval A, 2007, J NEUROSCI, V27, P3317, DOI 10.1523/JNEUROSCI.4566-06.2007; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; SCHREIBMAYER W, 1994, PFLUG ARCH EUR J PHY, V426, P453, DOI 10.1007/BF00388310; Sharp AH, 2001, NEUROSCIENCE, V105, P599, DOI 10.1016/S0306-4522(01)00220-2; Tedford HW, 2006, PHARMACOL REV, V58, P837, DOI 10.1124/pr.58.4.11; Wakamori M, 1998, J NEUROPHYSIOL, V79, P622, DOI 10.1152/jn.1998.79.2.622; Wakamori M, 1999, J PHYSIOL-LONDON, V517, P659, DOI 10.1111/j.1469-7793.1999.0659s.x; Zamponi GW, 1998, CURR OPIN NEUROBIOL, V8, P351, DOI 10.1016/S0959-4388(98)80060-3; Zhang Y, 2008, J NEUROSCI, V28, P14176, DOI 10.1523/JNEUROSCI.1350-08.2008	54	16	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20462	20471		10.1074/jbc.M110.121277	http://dx.doi.org/10.1074/jbc.M110.121277			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20435886	hybrid, Green Published			2022-12-27	WOS:000279228600006
J	Sharma, AK; Pallesen, LJ; Spang, RJ; Walden, WE				Sharma, Anil K.; Pallesen, Leif J.; Spang, Robert J.; Walden, William E.			Cytosolic Iron-Sulfur Cluster Assembly (CIA) System: Factors, Mechanism, and Relevance to Cellular Iron Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SACCHAROMYCES-CEREVISIAE; PROTEIN BIOGENESIS; CYSTEINE DESULFURASE; MOLECULAR CONTROL; CRYSTAL-STRUCTURE; OXIDATIVE STRESS; MESSENGER-RNA; FE/S PROTEINS; YEAST; MITOCHONDRIAL	FeS cluster biogenesis is an essential process in virtually all forms of life. Complex protein machineries that are conserved from bacteria through higher eukaryotes facilitate assembly of the FeS cofactor in proteins. In the last several years, significant strides have been made in our understanding of FeS cluster assembly and the functional overlap of this process with cellular iron homeostasis. This minireview summarizes the present understanding of the cytosolic iron-sulfur cluster assembly (CIA) system in eukaryotes, with a focus on information gained from studies in budding yeast and mammalian systems.	[Sharma, Anil K.; Pallesen, Leif J.; Spang, Robert J.; Walden, William E.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Walden, WE (corresponding author), Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA.	wwalden@uic.edu	Sharma, Anil K./AAP-1909-2020	Sharma, Anil K./0000-0002-9768-1644	National Institutes of Health [DK047281]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK047281. This is the third article in the Thematic Minireview Series on Metals in Biology 2010. This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Alseth I, 1999, MOL CELL BIOL, V19, P3779; Ayala-Castro C, 2008, MICROBIOL MOL BIOL R, V72, P110, DOI 10.1128/MMBR.00034-07; Balk J, 2005, MOL CELL BIOL, V25, P10833, DOI 10.1128/MCB.25.24.10833-10841.2005; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Bandyopadhyay S, 2008, J BIOL CHEM, V283, P14092, DOI 10.1074/jbc.M709161200; Bandyopadhyay S, 2008, BIOCHEM SOC T, V36, P1112, DOI 10.1042/BST0361112; Barthelme D, 2007, J BIOL CHEM, V282, P14598, DOI 10.1074/jbc.M700825200; Barton RM, 1999, J BIOL CHEM, V274, P30008, DOI 10.1074/jbc.274.42.30008; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; BIGELIS R, 1976, J BIOL CHEM, V251, P3545; Boal AK, 2007, J INORG BIOCHEM, V101, P1913, DOI 10.1016/j.jinorgbio.2007.05.001; Boyd JM, 2008, BIOCHEMISTRY-US, V47, P8195, DOI 10.1021/bi800551y; Boyd JM, 2009, J BACTERIOL, V191, P1490, DOI 10.1128/JB.01469-08; Bych K, 2008, EMBO J, V27, P1736, DOI 10.1038/emboj.2008.98; Bych K, 2008, J BIOL CHEM, V283, P35797, DOI 10.1074/jbc.M807303200; Chen OS, 2004, J BIOL CHEM, V279, P29513, DOI 10.1074/jbc.M403209200; Condo I, 2010, HUM MOL GENET, V19, P1221, DOI 10.1093/hmg/ddp592; Conlan AR, 2009, J MOL BIOL, V392, P143, DOI 10.1016/j.jmb.2009.06.079; Dupuy J, 2006, STRUCTURE, V14, P129, DOI 10.1016/j.str.2005.09.009; Duschene KS, 2010, FEBS LETT, V584, P1263, DOI 10.1016/j.febslet.2010.02.041; Eisenstein RS, 2000, ANNU REV NUTR, V20, P627, DOI 10.1146/annurev.nutr.20.1.627; Fontecave M, 2008, ARCH BIOCHEM BIOPHYS, V474, P226, DOI 10.1016/j.abb.2007.12.014; Fujii M, 2009, GENES CELLS, V14, P457, DOI 10.1111/j.1365-2443.2009.01282.x; Gelling C, 2008, MOL CELL BIOL, V28, P1851, DOI 10.1128/MCB.01963-07; Hassett RF, 1998, J BIOL CHEM, V273, P7628, DOI 10.1074/jbc.273.13.7628; Hausmann A, 2005, P NATL ACAD SCI USA, V102, P3266, DOI 10.1073/pnas.0406447102; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Huang QQ, 2008, FEBS LETT, V582, P1431, DOI 10.1016/j.febslet.2008.03.028; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Kohbushi H, 2009, BIOCHEM BIOPH RES CO, V378, P810, DOI 10.1016/j.bbrc.2008.11.138; Kuhn LC, 2009, CELL METAB, V10, P439, DOI 10.1016/j.cmet.2009.11.005; Kuhnke G, 2006, MOL MEMBR BIOL, V23, P173, DOI 10.1080/09687860500473630; Kumanovics A, 2008, J BIOL CHEM, V283, P10276, DOI 10.1074/jbc.M801160200; Land T, 1998, MOL CELL, V2, P807, DOI 10.1016/S1097-2765(00)80295-6; Lange H, 2001, EMBO REP, V2, P715, DOI 10.1093/embo-reports/kve161; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Lezhneva L, 2004, PLANT J, V37, P174, DOI 10.1046/j.1365-313X.2003.01952.x; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Li HR, 2009, BIOCHEMISTRY-US, V48, P9569, DOI 10.1021/bi901182w; Li J, 2001, J BIOL CHEM, V276, P1503, DOI 10.1074/jbc.M007198200; Li KY, 2006, J BIOL CHEM, V281, P12344, DOI 10.1074/jbc.M600582200; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Luo M, 2010, J MOL BIOL, V398, P614, DOI 10.1016/j.jmb.2010.03.029; Miao BJ, 1997, J MOL BIOL, V265, P541, DOI 10.1006/jmbi.1996.0762; Muhlenhoff U, 2007, EUKARYOT CELL, V6, P495, DOI 10.1128/EC.00191-06; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; Muhlenhoff U, 2003, J BIOL CHEM, V278, P40612, DOI 10.1074/jbc.M307847200; Naamati A, 2009, J BIOL CHEM, V284, P30200, DOI 10.1074/jbc.M109.034694; Nakai Y, 2004, J BIOL CHEM, V279, P12363, DOI 10.1074/jbc.M312448200; Netz DJA, 2007, NAT CHEM BIOL, V3, P278, DOI 10.1038/nchembio872; Nicolet Y, 2002, J INORG BIOCHEM, V91, P1, DOI 10.1016/S0162-0134(02)00392-6; Nishino T, 2000, J INORG BIOCHEM, V82, P43, DOI 10.1016/S0162-0134(00)00165-3; Ojeda L, 2006, J BIOL CHEM, V281, P17661, DOI 10.1074/jbc.M602165200; Peyssonnaux C, 2008, CELL CYCLE, V7, P28, DOI 10.4161/cc.7.1.5145; Pilon Marinus, 2006, Genet Eng (N Y), V27, P101, DOI 10.1007/0-387-25856-6_7; Puig S, 2008, CELL METAB, V7, P555, DOI 10.1016/j.cmet.2008.04.010; Pujol-Carrion N, 2006, J CELL SCI, V119, P4554, DOI 10.1242/jcs.03229; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Rouhier N, 2007, P NATL ACAD SCI USA, V104, P7379, DOI 10.1073/pnas.0702268104; Roy A, 2003, EMBO J, V22, P4826, DOI 10.1093/emboj/cdg455; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Schindelin N, 1997, NATURE, V387, P370, DOI 10.1038/387370a0; Schlenzka W, 1996, FEBS LETT, V385, P197, DOI 10.1016/0014-5793(96)00384-5; Schnackerz KD, 2004, BBA-PROTEINS PROTEOM, V1701, P61, DOI 10.1016/j.bbapap.2004.06.009; Schwenkert S, 2010, BIOCHEM J, V425, P207, DOI 10.1042/BJ20091290; Sheftel AD, 2009, MOL CELL BIOL, V29, P6059, DOI 10.1128/MCB.00817-09; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Sipos K, 2002, J BIOL CHEM, V277, P26944, DOI 10.1074/jbc.M200677200; Skovran E, 2003, J BACTERIOL, V185, P98, DOI 10.1128/JB.185.1.98-106.2003; Song DS, 2008, J BIOL CHEM, V283, P9231, DOI 10.1074/jbc.M708077200; Song DS, 2009, J BIOL CHEM, V284, P35297, DOI 10.1074/jbc.M109.040014; Srinivasan V, 2007, STRUCTURE, V15, P1246, DOI 10.1016/j.str.2007.08.009; Stehling O, 2008, MOL CELL BIOL, V28, P5517, DOI 10.1128/MCB.00545-08; Theil EC, 2000, BIOCHEM PHARMACOL, V59, P87, DOI 10.1016/S0006-2952(99)00300-7; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Urzica E, 2009, BIOCHEMISTRY-US, V48, P4946, DOI 10.1021/bi900312x; Vernis L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004376; Vitale G, 1996, GENE, V178, P97, DOI 10.1016/0378-1119(96)00341-1; Voisine C, 2000, MOL CELL BIOL, V20, P3677, DOI 10.1128/MCB.20.10.3677-3684.2000; Voisine C, 2001, P NATL ACAD SCI USA, V98, P1483, DOI 10.1073/pnas.98.4.1483; Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116; Wu XL, 2005, P NATL ACAD SCI USA, V102, P14058, DOI 10.1073/pnas.0506714102; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x; Yeeles JTP, 2009, J BIOL CHEM, V284, P7746, DOI 10.1074/jbc.M808526200; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08; Zhang Y, 2006, J BIOL CHEM, V281, P22493, DOI 10.1074/jbc.M604246200; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031	93	82	84	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26745	26751		10.1074/jbc.R110.122218	http://dx.doi.org/10.1074/jbc.R110.122218			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20522543	hybrid, Green Published			2022-12-27	WOS:000281172700004
J	Takahashi, N; Kobayashi, R; Kono, T				Takahashi, Nozomi; Kobayashi, Ryota; Kono, Tomohiro			Restoration of Dlk1 and Rtl1 Is Necessary but Insufficient to Rescue Lethality in Intergenic Differentially Methylated Region (IG-DMR)-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPRINTED GENE; STEM-CELLS; MOUSE; MOUSE-CHROMOSOME-12; IDENTIFICATION; PLACENTA; DEFECTS; GENOMES; EMBRYO; DOMAIN	In the Dlk1-Dio3 imprinted domain, an intergenic differentially methylated region (IG-DMR) regulates the parental allele-specific expression of imprinted genes. The maternally inherited deletion of IG-DMR (IG-DMR((-/+))) results in perinatal lethality because of the overexpression of paternally expressed genes and repression of maternally expressed noncoding RNAs (ncRNAs), including Gtl2. To better understand the possible contribution of paternally expressed genes to the lethality, we attempted to rescue the lethality of IG-DMR((-/+)) mutants by restoring the paternally expressed genes. Because the paternally inherited Gtl2 deletion (Gtl2((+/-))) induced a decrease in the expression of paternally expressed genes, we crossed female IG-DMR heterozygous mice and male Gtl2 heterozygous mutant mice. The resultant IG-DMR((-/+))/Gtl2((+/-)) double mutant mice had normal expression levels of paternally expressed genes, and none of them showed perinatal lethality; however, most mice showed postnatal lethality with decreased expression of the maternally expressed ncRNAs. Thus, we inferred that paternally expressed genes are necessary for perinatal survivability and that maternally expressed ncRNAs are involved in postnatal lethality.	[Takahashi, Nozomi; Kobayashi, Ryota; Kono, Tomohiro] Tokyo Univ Agr, Dept Biosci, Setagaya Ku, Tokyo 1560054, Japan	Tokyo University of Agriculture	Kono, T (corresponding author), Tokyo Univ Agr, Dept Biosci, Setagaya Ku, Tokyo 1560054, Japan.	tomohiro@nodai.ac.jp	liang, yan/H-3894-2011		Ministry of Education, Science, Culture and Sports of Japan	Ministry of Education, Science, Culture and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Scientific Research on Priority Area and for Scientific Research A from the Ministry of Education, Science, Culture and Sports of Japan (to T. K.).	Allegrucci C, 2005, REPRODUCTION, V129, P137, DOI 10.1530/rep.1.00360; BARTON SC, 1984, NATURE, V311, P374, DOI 10.1038/311374a0; Cavaille J, 2002, HUM MOL GENET, V11, P1527, DOI 10.1093/hmg/11.13.1527; da Rocha ST, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000392; Georgiades P, 2000, DEVELOPMENT, V127, P4719; Hatada I, 2001, J BIOCHEM, V130, P187, DOI 10.1093/oxfordjournals.jbchem.a002971; Kawahara M, 2007, NAT BIOTECHNOL, V25, P1045, DOI 10.1038/nbt1331; Kono T, 2004, NATURE, V428, P860, DOI 10.1038/nature02402; Lin SP, 2007, DEVELOPMENT, V134, P417, DOI 10.1242/dev.02726; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Pearsall RS, 1999, GENOMICS, V55, P194, DOI 10.1006/geno.1998.5660; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Schmidt JV, 2000, GENE DEV, V14, P1997; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Sekita Y, 2008, NAT GENET, V40, P243, DOI 10.1038/ng.2007.51; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi N, 2009, HUM MOL GENET, V18, P1879, DOI 10.1093/hmg/ddp108; Tierling S, 2006, GENOMICS, V87, P225, DOI 10.1016/j.ygeno.2005.09.018; TREMBLAY KD, 1995, NAT GENET, V9, P407, DOI 10.1038/ng0495-407; Tsai CE, 2002, CURR BIOL, V12, P1221, DOI 10.1016/S0960-9822(02)00951-X	23	5	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26121	26125		10.1074/jbc.M109.075325	http://dx.doi.org/10.1074/jbc.M109.075325			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20511218	Green Published, hybrid			2022-12-27	WOS:000280921000029
J	Bong, SM; Kwak, GH; Moon, JH; Lee, KS; Kim, HS; Kim, HY; Chi, YM				Bong, Seoung Min; Kwak, Geun-Hee; Moon, Jin Ho; Lee, Ki Seog; Kim, Hong Seok; Kim, Hwa-Young; Chi, Young Min			Structural and Kinetic Analysis of Free Methionine-R-sulfoxide Reductase from Staphylococcus aureus CONFORMATIONAL CHANGES DURING CATALYSIS AND IMPLICATIONS FOR THE CATALYTIC AND INHIBITORY MECHANISMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE METHIONINE-(R)-SULFOXIDE REDUCTASE; ALZHEIMERS-DISEASE; MOLECULAR-GRAPHICS; GAF DOMAIN; OXIDATION; PEPTIDE; PROTEIN; VIRULENCE; EXPRESSION; REVEALS	Free methionine-R-sulfoxide reductase (fRMsr) reduces free methionine R-sulfoxide back to methionine, but its catalytic mechanism is poorly understood. Here, we have determined the crystal structures of the reduced, substrate-bound, and oxidized forms of fRMsr from Staphylococcus aureus. Our structural and biochemical analyses suggest the catalytic mechanism of fRMsr in which Cys(102) functions as the catalytic residue and Cys(68) as the resolving Cys that forms a disulfide bond with Cys(102).Cys(78), previously thought to be a catalytic Cys, is a non-essential residue for catalytic function. Additionally, our structures provide insights into the enzyme-substrate interaction and the role of active site residues in substrate binding. Structural comparison reveals that conformational changes occur in the active site during catalysis, particularly in the loop of residues 97-106 containing the catalytic Cys(102). We have also crystallized a complex between fRMsr and isopropyl alcohol, which acts as a competitive inhibitor for the enzyme. This isopropyl alcohol-bound structure helps us to understand the inhibitory mechanism of fRMsr. Our structural and enzymatic analyses suggest that a branched methyl group in alcohol seems important for competitive inhibition of the fRMsr due to its ability to bind to the active site.	[Kwak, Geun-Hee; Kim, Hwa-Young] Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, Taegu 705717, South Korea; [Bong, Seoung Min; Chi, Young Min] Korea Univ, Coll Life Sci, Div Biotechnol, Seoul 136713, South Korea; [Moon, Jin Ho] Korea Univ, Inst Life Sci & Nat Resources, Seoul 136713, South Korea; [Lee, Ki Seog] Catholic Univ Pusan, Coll Hlth Sci, Dept Clin Lab Sci, Pusan 609757, South Korea; [Kim, Hong Seok] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA	Yeungnam University; Korea University; Korea University; Catholic University Pusan; University of Texas System; University of Texas Health San Antonio	Kim, HY (corresponding author), Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, Taegu 705717, South Korea.	hykim@ynu.ac.kr; ezeg@korea.ac.kr			Korea University [2009]; Ministry for Health, Welfare, and Family Affairs [A090181]	Korea University; Ministry for Health, Welfare, and Family Affairs	This work was supported by a Korea University Grant 2009 (to Y. M. C.) and by Korea Healthcare Technology R&D Project (Ministry for Health, Welfare, and Family Affairs) Grant A090181 (to H. -Y. K.).	Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barnham KJ, 2003, J BIOL CHEM, V278, P42959, DOI 10.1074/jbc.M305494200; Bong SM, 2009, ACTA CRYSTALLOGR F, V65, P1120, DOI 10.1107/S1744309109037105; Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007; Dhandayuthapani S, 2001, J BACTERIOL, V183, P5645, DOI 10.1128/JB.183.19.5645-5650.2001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Ho YSJ, 2000, EMBO J, V19, P5288, DOI 10.1093/emboj/19.20.5288; Hou LM, 2002, J BIOL CHEM, V277, P40173, DOI 10.1074/jbc.C200338200; Kim HY, 2007, BIOCHEM J, V407, P321, DOI 10.1042/BJ20070929; Kim YK, 2009, MOL MICROBIOL, V72, P699, DOI 10.1111/j.1365-2958.2009.06680.x; Koc A, 2004, P NATL ACAD SCI USA, V101, P7999, DOI 10.1073/pnas.0307929101; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwak GH, 2010, BIOCHEM BIOPH RES CO, V395, P412, DOI 10.1016/j.bbrc.2010.04.036; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le DT, 2009, J BIOL CHEM, V284, P4354, DOI 10.1074/jbc.M805891200; Lee BC, 2009, BBA-GEN SUBJECTS, V1790, P1471, DOI 10.1016/j.bbagen.2009.04.014; Lin ZD, 2007, P NATL ACAD SCI USA, V104, P9597, DOI 10.1073/pnas.0703774104; Lowther WT, 2002, NAT STRUCT BIOL, V9, P348, DOI 10.1038/nsb783; Minniti AN, 2009, AGING CELL, V8, P690, DOI 10.1111/j.1474-9726.2009.00521.x; Moskovitz J, 2005, BBA-PROTEINS PROTEOM, V1703, P213, DOI 10.1016/j.bbapap.2004.09.003; Olry A, 2002, J BIOL CHEM, V277, P12016, DOI 10.1074/jbc.M112350200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; Sasindran SJ, 2007, FUTURE MICROBIOL, V2, P619, DOI 10.2217/17460913.2.6.619; Schoneich C, 2005, BBA-PROTEINS PROTEOM, V1703, P111, DOI 10.1016/j.bbapap.2004.09.009; Singh VK, 2003, MICROBIOL-SGM, V149, P2739, DOI 10.1099/mic.0.26442-0; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Tete-Favier F, 2000, STRUCTURE, V8, P1167, DOI 10.1016/S0969-2126(00)00526-8; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wassef R, 2007, J NEUROSCI, V27, P12808, DOI 10.1523/JNEUROSCI.0322-07.2007; Weissbach H, 2002, ARCH BIOCHEM BIOPHYS, V397, P172, DOI 10.1006/abbi.2001.2664; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004; Zoraghi R, 2004, MOL PHARMACOL, V65, P267, DOI 10.1124/mol.65.2.267	36	10	12	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					25044	25052		10.1074/jbc.M110.103119	http://dx.doi.org/10.1074/jbc.M110.103119			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20504774	Green Published, hybrid			2022-12-27	WOS:000280542100077
J	Chai, GL; Ma, CX; Bao, K; Zheng, LA; Wang, XQ; Sun, ZR; Salo, E; Adell, T; Wu, W				Chai, Guoliang; Ma, Changxin; Bao, Kai; Zheng, Liang; Wang, Xinquan; Sun, Zhirong; Salo, Emili; Adell, Teresa; Wu, Wei			Complete Functional Segregation of Planarian beta-Catenin-1 and-2 in Mediating Wnt Signaling and Cell Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; CRYSTAL-STRUCTURE; PROTEIN INTERACTIONS; ACTIN-BINDING; REGENERATION; PLAKOGLOBIN; ARMADILLO; DISTINCT; PHOSPHORYLATION; MAINTENANCE	beta-Catenin is a bifunctional protein participating in both cell adhesion and canonical Wnt signaling. In cell adhesion, it bridges the transmembrane cadherin and the actin-binding protein alpha-catenin and is essential for adherens junction formation, whereas in canonical Wnt signaling, it shuttles between the cytosol and nucleus and functions as an essential transcriptional activator. Schmidtea mediterranea beta-catenin-1 was identified as a determinant of antero-posterior polarity during body regeneration by mediating Wnt signaling. Here we show that S. mediterranea beta-catenin-2 is specifically expressed in epithelial cells in the gut and pharynx, where it has a putative role in mediating cell adhesion. We show evidence that planarian beta-catenin-1 and -2 have distinct biochemical properties. beta-Catenin-1 can interact with the components of the canonical Wnt signaling pathway but not with alpha-catenin, whereas beta-catenin-2 interacts with cell adhesion molecules, including E-cadherin and alpha-catenin, but not with Wnt signaling components. Consistent with their specific function, beta-catenin-1 is a potent transcriptional activator, whereas beta-catenin-2 has no transcriptional activity. Protein sequence alignment also indicates that the planarian beta-catenin-1 and -2 retain distinct critical residues and motifs, which are in agreement with the differences in their biochemical properties. At last, phylogenetic analysis reveals a probable Platyhelminthes-specific structural and functional segregation from which the monofunctional beta-catenins evolved. Our results thus identify the first two monofunctional beta-catenins in metazoans.	[Salo, Emili; Adell, Teresa] Univ Barcelona, Dept Genet, E-08028 Barcelona, Spain; [Salo, Emili; Adell, Teresa] Univ Barcelona, Inst Biomed, E-08028 Barcelona, Spain; [Wu, Wei] Tsinghua Univ, Minist Educ, Prot Sci Lab, Beijing 100084, Peoples R China; [Bao, Kai; Sun, Zhirong] Tsinghua Univ, Minist Educ, Bioinformat Lab, Sch Life Sci, Beijing 100084, Peoples R China	University of Barcelona; University of Barcelona; Tsinghua University; Chinese Academy of Sciences; Tsinghua University	Adell, T (corresponding author), Univ Barcelona, Dept Genet, E-08028 Barcelona, Spain.	tadellc@ub.edu; wwu@mail.tsinghua.edu.cn	Salo, Emili/M-3928-2014; Creixell, Teresa Adell/C-5100-2017	Salo, Emili/0000-0001-5460-9223; Creixell, Teresa Adell/0000-0002-5446-1510; Chai, Guoliang/0000-0001-9658-6381	National Natural Science Foundation of China [30670225]; Major Science Programs of China [2006CB943402]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Science Programs of China	This work was supported by National Natural Science Foundation of China Grant 30670225 and Major Science Programs of China Grant 2006CB943402 (to W. W.).	Adell T, 2009, DEVELOPMENT, V136, P905, DOI 10.1242/dev.033761; Ben-Ze'ev A, 1998, CURR OPIN CELL BIOL, V10, P629, DOI 10.1016/S0955-0674(98)80039-2; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; BUTZ S, 1992, SCIENCE, V257, P1142, DOI 10.1126/science.257.5073.1142-a; Cebria F, 2005, DEVELOPMENT, V132, P3691, DOI 10.1242/dev.01941; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Grimson MJ, 2000, NATURE, V408, P727, DOI 10.1038/35047099; Gurley KA, 2008, SCIENCE, V319, P323, DOI 10.1126/science.1150029; Hartz DT, 1999, AM J DRUG ALCOHOL AB, V25, P207, DOI 10.1081/ADA-100101856; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Iglesias M, 2008, DEVELOPMENT, V135, P1215, DOI 10.1242/dev.020289; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Kobayashi C, 2007, DEV BIOL, V306, P714, DOI 10.1016/j.ydbio.2007.04.010; Korswagen HC, 2000, NATURE, V406, P527, DOI 10.1038/35020099; Liu CM, 1999, P NATL ACAD SCI USA, V96, P6273, DOI 10.1073/pnas.96.11.6273; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Molina MD, 2007, DEV BIOL, V311, P79, DOI 10.1016/j.ydbio.2007.08.019; Natarajan L, 2001, GENETICS, V159, P159; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Orsulic S, 1996, J CELL BIOL, V134, P1283, DOI 10.1083/jcb.134.5.1283; Oviedo NJ, 2010, DEV BIOL, V339, P188, DOI 10.1016/j.ydbio.2009.12.012; PEIFER M, 1992, J CELL BIOL, V118, P681, DOI 10.1083/jcb.118.3.681; Perego C, 2000, EMBO J, V19, P3978, DOI 10.1093/emboj/19.15.3978; Petersen CP, 2008, SCIENCE, V319, P327, DOI 10.1126/science.1149943; Petersen CP, 2009, P NATL ACAD SCI USA, V106, P17061, DOI 10.1073/pnas.0906823106; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Schneider SQ, 2003, J EXP ZOOL PART B, V295B, P25, DOI 10.1002/jez.b.00006; Simcha I, 1998, J CELL BIOL, V141, P1433, DOI 10.1083/jcb.141.6.1433; Stadeli R, 2006, CURR BIOL, V16, pR378, DOI 10.1016/j.cub.2006.04.019; Vleminckx K, 1999, MECH DEVELOP, V81, P65, DOI 10.1016/S0925-4773(98)00225-1; Xing Y, 2004, MOL CELL, V15, P523, DOI 10.1016/j.molcel.2004.08.001; Xing Y, 2003, GENE DEV, V17, P2753, DOI 10.1101/gad.1142603; Xing Y, 2008, STRUCTURE, V16, P478, DOI 10.1016/j.str.2007.12.021	40	24	27	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24120	24130		10.1074/jbc.M110.113662	http://dx.doi.org/10.1074/jbc.M110.113662			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20511647	Green Published, hybrid			2022-12-27	WOS:000280291400062
J	Feng, HJ; Macdonald, RL				Feng, Hua-Jun; Macdonald, Robert L.			Barbiturates Require the N Terminus and First Transmembrane Domain of the delta Subunit for Enhancement of alpha 1 beta 3 delta GABA(A) Receptor Currents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOBUTYRIC ACID(A) RECEPTORS; ACETYLCHOLINE-RECEPTOR; A RECEPTORS; NEUROACTIVE STEROIDS; ALPHA-SUBUNIT; L929 CELLS; M2 DOMAIN; CHANNEL; MODULATION; ACTIVATION	GABA(A) receptors are composed predominantly of alpha beta gamma receptors, which mediate primarily synaptic inhibition, and alpha beta delta receptors, which mediate primarily extrasynaptic inhibition. At saturating GABA concentrations, the barbiturate pentobarbital substantially increased the amplitude and desensitization of the alpha 1 beta 3 delta receptor but not the alpha 1 beta 3 gamma 2L receptor currents. To explore the structural domains of the delta subunit that are involved in pentobarbital potentiation and increased desensitization of alpha 1 beta 3 delta currents, chimeric cDNAs were constructed by progressive replacement of gamma 2L subunit sequence with a delta subunit sequence or a delta subunit sequence with a gamma 2L subunit sequence, and HEK293T cells were co-transfected with alpha 1 and beta 3 subunits or alpha 1 and beta 3 subunits and a gamma 2L, delta, or chimeric subunit. Currents evoked by a saturating concentration of GABA or by co-application of GABA and pentobarbital were recorded using the patch clamp technique. By comparing the extent of enhancement and changes in kinetic properties produced by pentobarbital among chimeric and wild type receptors, we concluded that although potentiation of alpha 1 beta 3 delta currents by pentobarbital required the delta subunit sequence from the N terminus to proline 241 in the first transmembrane domain (M1), increasing desensitization of alpha 1 beta 3 delta currents required a delta subunit sequence from the N terminus to isoleucine 235 in M1. These findings suggest that the delta subunit N terminus and N-terminal portion of the M1 domain are, at least in part, involved in transduction of the allosteric effect of pentobarbital to enhance alpha 1 beta 3 delta currents and that this effect involves a distinct but overlapping structural domain from that involved in altering desensitization.	[Feng, Hua-Jun; Macdonald, Robert L.] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37232 USA; [Macdonald, Robert L.] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Macdonald, Robert L.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Feng, HJ (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurol, 6140 MRB 3,465 21st Ave S, Nashville, TN 37232 USA.	huajun.feng@vanderbilt.edu		Feng, Huajun/0000-0003-1544-4248	National Institutes of Health [NSR0I 33300]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051590] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NSR0I 33300 (to R. L. M.).	Adkins CE, 2001, J BIOL CHEM, V276, P38934, DOI 10.1074/jbc.M104318200; AKABAS MH, 1995, BIOCHEMISTRY-US, V34, P12496, DOI 10.1021/bi00039a002; Akk G, 2004, J PHYSIOL-LONDON, V556, P387, DOI 10.1113/jphysiol.2003.058230; Belelli D, 2009, J NEUROSCI, V29, P12757, DOI 10.1523/JNEUROSCI.3340-09.2009; Bianchi MT, 2007, J PHYSIOL-LONDON, V584, P769, DOI 10.1113/jphysiol.2007.142364; Bianchi MT, 2003, J NEUROSCI, V23, P10934; Bianchi MT, 2001, J NEUROSCI, V21, P1127; Campagna-Slater V, 2007, NEUROSCI LETT, V418, P28, DOI 10.1016/j.neulet.2007.02.091; Carlson BX, 2000, MOL PHARMACOL, V57, P474, DOI 10.1124/mol.57.3.474; England PM, 1999, CELL, V96, P89, DOI 10.1016/S0092-8674(00)80962-9; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Feng HJ, 2004, J NEUROPHYSIOL, V92, P1577, DOI 10.1152/jn.00285.2004; Feng HJ, 2004, MOL PHARMACOL, V66, P988, DOI 10.1124/mol.104.002543; Feng HJ, 2004, MOL PHARMACOL, V66, P1517, DOI 10.1124/mol.104.003426; FILATOV GN, 1995, MOL PHARMACOL, V48, P379; Fisher JL, 1997, J PHYSIOL-LONDON, V505, P283, DOI 10.1111/j.1469-7793.1997.283bb.x; Greenfield LJ, 1997, NEUROPHARMACOLOGY, V36, P63, DOI 10.1016/S0028-3908(96)00150-5; Greenfield LJ, 2002, NEUROPHARMACOLOGY, V42, P502, DOI 10.1016/S0028-3908(01)00196-4; Haas KF, 1999, J PHYSIOL-LONDON, V514, P27, DOI 10.1111/j.1469-7793.1999.027af.x; Hevers W, 1998, MOL NEUROBIOL, V18, P35, DOI 10.1007/BF02741459; JONES MV, 1995, NEURON, V15, P181, DOI 10.1016/0896-6273(95)90075-6; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Lees G, 1998, ANESTHESIOLOGY, V88, P206, DOI 10.1097/00000542-199801000-00029; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Li XS, 2000, J NEUROSCI, V20, P899, DOI 10.1523/JNEUROSCI.20-03-00899.2000; McKernan RM, 1996, TRENDS NEUROSCI, V19, P139, DOI 10.1016/S0166-2236(96)80023-3; Meera P, 2009, NEUROPHARMACOLOGY, V56, P155, DOI 10.1016/j.neuropharm.2008.08.011; Mihalek RM, 1999, P NATL ACAD SCI USA, V96, P12905, DOI 10.1073/pnas.96.22.12905; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002; Nishikawa K, 2003, ANESTHESIOLOGY, V99, P678, DOI 10.1097/00000542-200309000-00024; Olsen R. W., 2002, GLUTAMATE GABA RECEP, P202; Richardson JE, 2007, ANESTHESIOLOGY, V107, P412, DOI 10.1097/01.anes.0000278875.36639.2c; SAXENA NC, 1994, J NEUROSCI, V14, P7077; SCHULZ DW, 1981, BRAIN RES, V209, P177, DOI 10.1016/0006-8993(81)91179-3; Steinbach JH, 2001, J PHYSIOL-LONDON, V537, P715; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Stewart D, 2008, MOL PHARMACOL, V74, P1687, DOI 10.1124/mol.108.050500; Sundstrom-Poromaa I, 2002, NAT NEUROSCI, V5, P721, DOI 10.1038/nn888; Thompson SA, 2002, MOL PHARMACOL, V61, P861, DOI 10.1124/mol.61.4.861; Wallner M, 2003, P NATL ACAD SCI USA, V100, P15218, DOI 10.1073/pnas.2435171100; Wilson GG, 2001, P NATL ACAD SCI USA, V98, P1241, DOI 10.1073/pnas.031567798; Wilson GG, 1998, NEURON, V20, P1269, DOI 10.1016/S0896-6273(00)80506-1; Wohlfarth KM, 2002, J NEUROSCI, V22, P1541, DOI 10.1523/JNEUROSCI.22-05-01541.2002; Zhang H, 1998, BIOCHEMISTRY-US, V37, P7952, DOI 10.1021/bi980143m	46	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23614	23621		10.1074/jbc.M110.122564	http://dx.doi.org/10.1074/jbc.M110.122564			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20525684	Green Published, hybrid			2022-12-27	WOS:000280291400011
J	Tonic, I; Yu, WN; Park, Y; Chen, CC; Hay, N				Tonic, Ivana; Yu, Wan-Ni; Park, Youngku; Chen, Chia-Chen; Hay, Nissim			Akt Activation Emulates Chk1 Inhibition and Bcl2 Overexpression and Abrogates G2 Cell Cycle Checkpoint by Inhibiting BRCA1 Foci	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; KINASE; COMPLEX; 3-KINASE/AKT; SENESCENCE; PATHWAY; REPAIR	Akt is perhaps the most frequently activated oncoprotein in human cancers. Overriding cell cycle checkpoint in combination with the inhibition of apoptosis are two principal requirements for predisposition to cancer. Here we show that the activation of Akt is sufficient to promote these two principal processes, by inhibiting Chk1 activation with concomitant inhibition of apoptosis. These activities of Akt cannot be recapitulated by the knockdown of Chk1 alone or by overexpression of Bcl2. Rather the combination of Chk1 knockdown and Bcl2 overexpression is required to recapitulate Akt activities. Akt was shown to directly phosphorylate Chk1. However, we found that Chk1 mutants in the Akt phosphorylation sites behave like wildtype Chk1 in mediating G2 arrest, suggesting that the phosphorylation of Chk1 by Akt is either dispensable for Chk1 activity or insufficient by itself to exert an effect on Chk1 activity. Here we report a new mechanism by which Akt affects G2 cell cycle arrest. We show that Akt inhibits BRCA1 function that induces G2 cell cycle arrest. Akt prevents the translocation of BRCA1 to DNA damage foci and, thereby, inhibiting the activation of Chk1 following DNA damage.	[Hay, Nissim] Univ Illinois, Dept Biochem & Mol Genet, Coll Med, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Hay, N (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Coll Med, M-C 669,900 S Ashland Ave, Chicago, IL 60607 USA.	nhay@uic.edu			National Institutes of Health [CA090764, AG016927, AG025953]; ACS-IL [06-24]; NATIONAL CANCER INSTITUTE [R01CA090764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016927, R01AG025953] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ACS-IL; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants CA090764, AG016927, and AG025953 (to N.H.) and by ACS-IL 06-24 (to Y.P.).	Allan LA, 2000, MOL CELL BIOL, V20, P1291, DOI 10.1128/MCB.20.4.1291-1298.2000; Altiok S, 1999, J BIOL CHEM, V274, P32274, DOI 10.1074/jbc.274.45.32274; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Feng L, 2009, GENE DEV, V23, P719, DOI 10.1101/gad.1770609; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; HUEN MS, 2009, NAT REV MOL CELL BIO, V11, P529; Kandel ES, 2002, MOL CELL BIOL, V22, P7831, DOI 10.1128/MCB.22.22.7831-7841.2002; Karran P, 2006, BRIT MED BULL, V79-80, P153, DOI 10.1093/bmb/ldl020; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Kennedy SG, 1999, MOL CELL BIOL, V19, P5800; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; King FW, 2004, CELL CYCLE, V3, P634; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lam MH, 2004, CANCER CELL, V6, P45, DOI 10.1016/j.ccr.2004.06.015; Liu QH, 2000, GENE DEV, V14, P1448; MacLachlan TK, 2000, J BIOL CHEM, V275, P2777, DOI 10.1074/jbc.275.4.2777; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; PERRY ME, 1993, CURR OPIN GENET DEV, V3, P50, DOI 10.1016/S0959-437X(05)80340-5; Polyak K, 1996, GENE DEV, V10, P1945, DOI 10.1101/gad.10.15.1945; Robey RB, 2009, SEMIN CANCER BIOL, V19, P25, DOI 10.1016/j.semcancer.2008.11.010; Shao G, 2009, GENE DEV, V23, P740, DOI 10.1101/gad.1739609; Shtivelman E, 2002, CURR BIOL, V12, P919, DOI 10.1016/S0960-9822(02)00843-6; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Solyom S, 2010, BREAST CANCER RES TR, V120, P165, DOI 10.1007/s10549-009-0453-7; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Xiang T, 2008, CANCER RES, V68, P10040, DOI 10.1158/0008-5472.CAN-08-3009; Yamane K, 2007, CANCER RES, V67, P6286, DOI 10.1158/0008-5472.CAN-06-2205; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029	34	31	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23790	23798		10.1074/jbc.M110.104372	http://dx.doi.org/10.1074/jbc.M110.104372			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20495005	hybrid, Green Published			2022-12-27	WOS:000280291400029
J	Auton, M; Sowa, KE; Smith, SM; Sedlak, E; Vijayan, KV; Cruz, MA				Auton, Matthew; Sowa, Katie E.; Smith, Scott M.; Sedlak, Erik; Vijayan, K. Vinod; Cruz, Miguel A.			Destabilization of the A1 Domain in von Willebrand Factor Dissociates the A1A2A3 Tri-domain and Provokes Spontaneous Binding to Glycoprotein Ib alpha and Platelet Activation under Shear Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VONWILLEBRAND-FACTOR BINDING; CONFORMATIONAL-CHANGE; ADAMTS-13 ACTIVITY; A2 DOMAIN; ADHESION; COLLAGEN; 2B; IDENTIFICATION; AGGREGATION; STABILITY	This study used recombinant A1A2A3 tri-domain proteins to demonstrate that A domain association in von Willebrand factor (VWF) regulates the binding to platelet glycoprotein Ib alpha (GPIb alpha). We performed comparative studies between wild type (WT) A1 domain and the R1450E variant that dissociates the tri-domain complex by destabilizing the A1 domain. Using urea denaturation and differential scanning calorimetry, we demonstrated the destabilization of the A1 domain structure concomitantly results in a reduced interaction among the three A domains. This dissociation results in spontaneous binding of R1450E to GPIb alpha without ristocetin with an apparent K-D of 85 +/- 34 nM, comparable with that of WT (36 +/- 12 nM) with ristocetin. The mutant blocked 100% ristocetin-induced platelet agglutination, whereas WT failed to inhibit. The mutant enhanced shear-induced platelet aggregation at 500 and 5000 s(-1) shear rates, reaching 42 and 66%, respectively. Shear-induced platelet aggregation did not exceed 18% in the presence of WT. A1A2A3 variants were added before perfusion over a fibrin(ogen)-coated surface. At 1500 s(-1), platelets from blood containing WT adhered <10% of the surface area, whereas the mutant induced platelets to rapidly bind, covering 100% of the fibrin(ogen) surface area. Comparable results were obtained with multimeric VWF when ristocetin (0.5 mg/ml) was added to blood before perfusion. EDTA or antibodies against GPIb alpha and alpha IIb beta 3 blocked the effect of the mutant and ristocetin on platelet activation/adhesion. Therefore, the termination of A domain association within VWF in solution results in binding to GPIba and platelet activation under high shear stress.	[Auton, Matthew; Sowa, Katie E.; Smith, Scott M.; Sedlak, Erik; Vijayan, K. Vinod; Cruz, Miguel A.] Baylor Coll Med, Thrombosis Res Sect, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine	Cruz, MA (corresponding author), Baylor Coll Med, Thrombosis Res Sect, Dept Med, 1 Baylor Plaza,N1319, Houston, TX 77030 USA.	miguelc@bcm.tmc.edu	Auton, Matthew/A-2960-2008	Auton, Matthew/0000-0002-4446-6932; Sedlak, Erik/0000-0003-1290-5774	National Institutes of Health [HL72886]; Mary R. Gibson Foundation; Alkek Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072886] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mary R. Gibson Foundation; Alkek Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL72886 (to M. A. C.). This work was also supported by the Mary R. Gibson Foundation and Alkek Foundation.	Ajzenberg N, 2000, BLOOD, V95, P3796; Auton M, 2007, J MOL BIOL, V366, P986, DOI 10.1016/j.jmb.2006.10.067; Auton M, 2009, BIOPHYS J, V97, P618, DOI 10.1016/j.bpj.2009.05.009; AZUMA H, 1993, THROMB HAEMOSTASIS, V69, P192; Borthakur G, 2003, J THROMB HAEMOST, V1, P1288, DOI 10.1046/j.1538-7836.2003.00156.x; CHOW TW, 1992, BLOOD, V80, P113; Cruz MA, 2000, J BIOL CHEM, V275, P19098, DOI 10.1074/jbc.M002292200; Cruz MA, 2005, BLOOD, V105, P1986, DOI 10.1182/blood-2004-04-1365; Cruz MA, 2003, THROMB HAEMOSTASIS, V90, P1204, DOI 10.1160/TH03-06-0398; CRUZ MA, 1995, J BIOL CHEM, V270, P10822, DOI 10.1074/jbc.270.18.10822; de Romeuf C, 1998, THROMB HAEMOSTASIS, V79, P211; DENT JA, 1990, P NATL ACAD SCI USA, V87, P6306, DOI 10.1073/pnas.87.16.6306; ENDENBURG SC, 1995, BLOOD, V86, P4158, DOI 10.1182/blood.V86.11.4158.bloodjournal86114158; ENDENBURG SC, 1993, BLOOD COAGUL FIBRIN, V4, P139, DOI 10.1097/00001721-199304010-00024; Federici AB, 2009, BLOOD, V113, P526, DOI 10.1182/blood-2008-04-152280; Gardiner EE, 2010, PLATELETS, V21, P244, DOI 10.3109/09537101003695339; Goto S, 1998, J CLIN INVEST, V101, P479, DOI 10.1172/JCI973; IKEDA Y, 1993, THROMB HAEMOSTASIS, V69, P496; Keuren JFW, 2004, BLOOD, V103, P1741, DOI 10.1182/blood-2003-07-2267; Lankhof H, 1996, THROMB HAEMOSTASIS, V75, P950; Lyubarev AE, 1998, BIOCHEMISTRY-MOSCOW+, V63, P434; Martin C, 2007, J THROMB HAEMOST, V5, P1363, DOI 10.1111/j.1538-7836.2007.02536.x; Mazzucato M, 1999, J BIOL CHEM, V274, P3033, DOI 10.1074/jbc.274.5.3033; Mazzucato M, 2002, BLOOD, V100, P2793, DOI 10.1182/blood-2002-02-0514; Miura S, 1999, BRIT J HAEMATOL, V105, P1092, DOI 10.1046/j.1365-2141.1999.01454.x; MOHRI H, 1989, J BIOL CHEM, V264, P17361; MOHRI H, 1988, J BIOL CHEM, V263, P17901; Morales LD, 2006, J THROMB HAEMOST, V4, P417, DOI 10.1111/j.1538-7836.2006.01742.x; Nakayama T, 2002, J BIOL CHEM, V277, P22063, DOI 10.1074/jbc.M201327200; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; Sedlak E, 2008, BIOPHYS J, V94, P1384, DOI 10.1529/biophysj.107.113696; Shankaran H, 2003, BLOOD, V101, P2637, DOI 10.1182/blood-2002-05-1550; SHELTONINLOES BB, 1986, BIOCHEMISTRY-US, V25, P3164, DOI 10.1021/bi00359a014; Tsai HM, 1997, BLOOD, V89, P1954, DOI 10.1182/blood.V89.6.1954; Ulrichts H, 2006, J BIOL CHEM, V281, P4699, DOI 10.1074/jbc.M513314200; Whitelock JL, 2004, J THROMB HAEMOST, V2, P485, DOI 10.1111/j.1538-7836.2004.00601.x; Wu T, 2010, BLOOD, V115, P370, DOI 10.1182/blood-2009-03-210369; Yago T, 2008, J CLIN INVEST, V118, P3195, DOI 10.1172/JCI35754; Zaidi TN, 1996, BLOOD, V88, P2967, DOI 10.1182/blood.V88.8.2967.bloodjournal8882967; Zhang JN, 2003, THROMB HAEMOSTASIS, V90, P672, DOI 10.1160/TH03-03-0145; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P9226, DOI 10.1073/pnas.0903679106	42	32	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22829	22837		10.1074/jbc.M110.103358	http://dx.doi.org/10.1074/jbc.M110.103358			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20498367	Green Published, hybrid			2022-12-27	WOS:000279999900015
J	Lacal, J; Alfonso, C; Liu, XX; Parales, RE; Morel, B; Conejero-Lara, F; Rivas, G; Duque, E; Ramos, JL; Krell, T				Lacal, Jesus; Alfonso, Carlos; Liu, Xianxian; Parales, Rebecca E.; Morel, Bertrand; Conejero-Lara, Francisco; Rivas, German; Duque, Estrella; Ramos, Juan L.; Krell, Tino			Identification of a Chemoreceptor for Tricarboxylic Acid Cycle Intermediates DIFFERENTIAL CHEMOTACTIC RESPONSE TOWARDS RECEPTOR LIGANDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGANIC-ACIDS; PSEUDOMONAS-AERUGINOSA; CONFORMATIONAL-CHANGES; ESCHERICHIA-COLI; BINDING DOMAIN; RHIZOSPHERE; CLONING; CITRATE; COLONIZATION; PREDICTION	We report the identification of McpS as the specific chemoreceptor for 6 tricarboxylic acid (TCA) cycle intermediates and butyrate in Pseudomonas putida. The analysis of the bacterial mutant deficient in mcpS and complementation assays demonstrate that McpS is the only chemoreceptor of TCA cycle intermediates in the strain under study. TCA cycle intermediates are abundantly present in root exudates, and taxis toward these compounds is proposed to facilitate the access to carbon sources. McpS has an unusually large ligand-binding domain (LBD) that is un-annotated in InterPro and is predicted to contain 6 helices. The ligand profile of McpS was determined by isothermal titration calorimetry of purified recombinant LBD (McpS-LBD). McpS recognizes TCA cycle intermediates but does not bind very close structural homologues and derivatives like maleate, aspartate, or tricarballylate. This implies that functional similarity of ligands, such as being part of the same pathway, and not structural similarity is the primary element, which has driven the evolution of receptor specificity. The magnitude of chemotactic responses toward these 7 chemoattractants, as determined by qualitative and quantitative chemotaxis assays, differed largely. Ligands that cause a strong chemotactic response (malate, succinate, and fumarate) were found by differential scanning calorimetry to increase significantly the midpoint of protein unfolding (T-m) and unfolding enthalpy (Delta H) of McpS-LBD. Equilibrium sedimentation studies show that malate, the chemoattractant that causes the strongest chemotactic response, stabilizes the dimeric state of McpS-LBD. In this respect clear parallels exist to the Tar receptor and other eukaryotic receptors, which are discussed.	[Lacal, Jesus; Duque, Estrella; Ramos, Juan L.; Krell, Tino] CSIC, Estn Expt Zaidin, Environm Protect Dept, E-18008 Granada, Spain; [Alfonso, Carlos; Rivas, German] CSIC, Ctr Invest Biol, E-28040 Madrid, Spain; [Liu, Xianxian; Parales, Rebecca E.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA; [Morel, Bertrand; Conejero-Lara, Francisco] Univ Granada, Fac Ciencias, Dept Quim Fis, E-18071 Granada, Spain; [Morel, Bertrand; Conejero-Lara, Francisco] Univ Granada, Fac Ciencias, Inst Biotecnol, E-18071 Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of California System; University of California Davis; University of Granada; University of Granada	Krell, T (corresponding author), CSIC, Estn Expt Zaidin, Environm Protect Dept, Prof Albareda 1, E-18008 Granada, Spain.	tino.krell@eez.csic.es	Rivas, German/AAG-7458-2022; Rivas, German/AFL-7528-2022; Alfonso, Carlos/K-1316-2014; Lacal Romero, Jesus/G-8041-2015; Lara, Francisco Conejero/F-2962-2016; Lacal, Jesus/B-1511-2019; Krell, Tino/G-7296-2015	Rivas, German/0000-0003-3450-7478; Rivas, German/0000-0003-3450-7478; Alfonso, Carlos/0000-0001-7165-4800; Lacal Romero, Jesus/0000-0002-2751-7291; Lara, Francisco Conejero/0000-0002-8282-2168; Lacal, Jesus/0000-0002-2751-7291; Krell, Tino/0000-0002-9040-3166; Morel, Bertrand/0000-0002-2708-8589; Ramos, Juan L./0000-0002-8731-7435; Duque, Estrella/0000-0002-4857-8974	Spanish Ministry of Science and Education [CICYT BIO-2006-05668, BFU 2005-0487-C02-02, CSD 2007-00010, BIO2008-04478-C03-03]; Junta de Andalucia [CIV344, CIV1912, P09-RNM-4509]; BBVA foundation	Spanish Ministry of Science and Education(Spanish Government); Junta de Andalucia(Junta de Andalucia); BBVA foundation(BBVA Foundation)	This work was supported by Spanish Ministry of Science and Education Grants CICYT BIO-2006-05668, BFU 2005-0487-C02-02, CSD 2007-00010, and BIO2008-04478-C03-03, Junta de Andalucia Grant CIV344 (to J.L.R.), CIV1912 and P09-RNM-4509 (to T. K.), and the BBVA foundation.	Alvarez-Ortega C, 2007, APPL ENVIRON MICROB, V73, P7793, DOI 10.1128/AEM.01898-07; Anantharaman V, 2000, TRENDS BIOCHEM SCI, V25, P535, DOI 10.1016/S0968-0004(00)01672-8; BIEMANN HP, 1994, BIOCHEMISTRY-US, V33, P629, DOI 10.1021/bi00169a002; Bjorkman AM, 2001, J BIOL CHEM, V276, P2808, DOI 10.1074/jbc.M009593200; BORKOVICH KA, 1992, P NATL ACAD SCI USA, V89, P6756, DOI 10.1073/pnas.89.15.6756; Busch A, 2007, P NATL ACAD SCI USA, V104, P13774, DOI 10.1073/pnas.0701547104; Chaudhry C, 2009, P NATL ACAD SCI USA, V106, P12329, DOI 10.1073/pnas.0904175106; Cole JL, 2004, METHOD ENZYMOL, V384, P212; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; de Weert S, 2002, MOL PLANT MICROBE IN, V15, P1173, DOI 10.1094/MPMI.2002.15.11.1173; Deleage G, 1997, BIOCHIMIE, V79, P681, DOI 10.1016/S0300-9084(97)83524-9; DUQUE E, 2007, PSEUDOMONAS, V5; Garcia JAL, 2001, PHYTOCHEM ANALYSIS, V12, P305, DOI 10.1002/pca.596; Guazzaroni ME, 2007, J BIOL CHEM, V282, P16308, DOI 10.1074/jbc.M610032200; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; HUGDAHL MB, 1988, INFECT IMMUN, V56, P1560, DOI 10.1128/IAI.56.6.1560-1566.1988; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; JOHNSON JF, 1994, PLANT PHYSIOL, V85, P315; Kamilova F, 2006, MOL PLANT MICROBE IN, V19, P250, DOI 10.1094/MPMI-19-0250; Kato J, 2008, J BIOSCI BIOENG, V106, P1, DOI 10.1263/jbb.106.1; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Krell T, 2008, MICROB BIOTECHNOL, V1, P126, DOI 10.1111/j.1751-7915.2007.00013.x; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Levit MN, 2002, J BIOL CHEM, V277, P36760, DOI 10.1074/jbc.M204325200; Liao H, 2006, PLANT PHYSIOL, V141, P674, DOI 10.1104/pp.105.076497; LIN LN, 1994, BIOCHEMISTRY-US, V33, P6564, DOI 10.1021/bi00187a025; LIPTON DS, 1987, PLANT PHYSIOL, V85, P315, DOI 10.1104/pp.85.2.315; Liu XX, 2009, J BACTERIOL, V191, P2909, DOI 10.1128/JB.01708-08; Lugtenberg BJJ, 2001, ANNU REV PHYTOPATHOL, V39, P461, DOI 10.1146/annurev.phyto.39.1.461; MILLIGAN DL, 1993, J BIOL CHEM, V268, P19991; MINTON AP, 1996, MODERN ANAL ULTRACEN, P81; Molina L, 2000, SOIL BIOL BIOCHEM, V32, P315, DOI 10.1016/S0038-0717(99)00156-X; Murphy OJ, 2001, BIOCHEMISTRY-US, V40, P1358, DOI 10.1021/bi0015109; Ottemann KM, 1999, SCIENCE, V285, P1751, DOI 10.1126/science.285.5434.1751; Ottemann KM, 1998, BIOCHEMISTRY-US, V37, P7062, DOI 10.1021/bi980305e; Parales RE, 2000, APPL ENVIRON MICROB, V66, P4098, DOI 10.1128/AEM.66.9.4098-4104.2000; REINHOLD B, 1985, J BACTERIOL, V162, P190, DOI 10.1128/JB.162.1.190-195.1985; ROBINSON JB, 1993, J BACTERIOL, V175, P2284, DOI 10.1128/JB.175.8.2284-2291.1993; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Seedorf H, 2008, P NATL ACAD SCI USA, V105, P2128, DOI 10.1073/pnas.0711093105; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Spink CH, 2008, METHOD CELL BIOL, V84, P115, DOI 10.1010/S0091-679X(07)84005-2; Stock J, 1996, CURR BIOL, V6, P825, DOI 10.1016/S0960-9822(02)00605-X; Tikhonov D B, 2009, Neurosci Behav Physiol, V39, P763, DOI 10.1007/s11055-009-9195-6; Ulrich LE, 2005, BIOINFORMATICS, V21, P45, DOI 10.1093/bioinformatics/bti1204; Vaknin A, 2008, J MOL BIOL, V382, P573, DOI 10.1016/j.jmb.2008.07.026; Velazquez-Campoy Adrian, 2004, Methods Mol Biol, V261, P35; Vilchez S, 2000, J BACTERIOL, V182, P91, DOI 10.1128/JB.182.1.91-99.2000; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Warner JB, 2002, MICROBIOL-SGM, V148, P3405, DOI 10.1099/00221287-148-11-3405; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; YAMAMOTO K, 1993, P NATL ACAD SCI USA, V90, P217, DOI 10.1073/pnas.90.1.217; Yeh JI, 1996, J MOL BIOL, V262, P186, DOI 10.1006/jmbi.1996.0507; Yu EW, 2001, P NATL ACAD SCI USA, V98, P9517, DOI 10.1073/pnas.161239298; Yurgel SN, 2004, FEMS MICROBIOL REV, V28, P489, DOI 10.1016/j.femsre.2004.04.002; Zhulin IB, 2003, J BACTERIOL, V185, P285, DOI 10.1128/JB.185.1.285-294.2003; Zhulin IB, 2001, ADV MICROB PHYSIOL, V45, P157, DOI 10.1016/S0065-2911(01)45004-1	58	77	79	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23124	23134		10.1074/jbc.M110.110403	http://dx.doi.org/10.1074/jbc.M110.110403			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20498372	Green Published, hybrid			2022-12-27	WOS:000279999900047
J	Chen, YC; Bathula, SR; Li, J; Huang, L				Chen, Yunching; Bathula, Surendar Reddy; Li, Jun; Huang, Leaf			Multifunctional Nanoparticles Delivering Small Interfering RNA and Doxorubicin Overcome Drug Resistance in Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-GLYCOPROTEIN; MULTIDRUG-RESISTANCE; DOWN-REGULATION; GUANIDINO COMPOUNDS; TUMOR-CELLS; C-MYC; SIRNA; OVEREXPRESSION; EXPRESSION; LIPOSOME	Drug resistance is a major challenge to the effective treatment of cancer. We have developed two nanoparticle formulations, cationic liposome-polycation-DNA (LPD) and anionic liposome-polycation-DNA (LPD-II), for systemic co-delivery of doxorubicin (Dox) and a therapeutic small interfering RNA (siRNA) to multiple drug resistance (MDR) tumors. In this study, we have provided four strategies to overcome drug resistance. First, we formed the LPD nanoparticles with a guanidinium-containing cationic lipid, i.e. N,N-distearyl-N-methyl-N-2-(N'-arginyl) aminoethyl ammonium chloride, which can induce reactive oxygen species, down-regulate MDR transporter expression, and increase Dox uptake. Second, to block angiogenesis and increase drug penetration, we have further formulated LPD nanoparticles to co-deliver vascular endothelial growth factor siRNA and Dox. An enhanced Dox uptake and a therapeutic effect were observed when combined with vascular endothelial growth factor siRNA in the nanoparticles. Third, to avoid P-glycoprotein-mediated drug efflux, we further designed another delivery vehicle, LPD-II, which showed much higher entrapment efficiency of Dox than LPD. Finally, we delivered a therapeutic siRNA to inhibit MDR transporter. We demonstrated the first evidence of c-Myc siRNA delivered by the LPD-II nanoparticles down-regulating MDR expression and increasing Dox uptake in vivo. Three daily intravenous injections of therapeutic siRNA and Dox (1.2 mg/kg) co-formulated in either LPD or LPD-II nanoparticles showed a significant improvement in tumor growth inhibition. This study highlights a potential clinical use for the multifunctional nanoparticles with an effective delivery property and a function to overcome drug resistance in cancer. The activity and the toxicity of LPD- and LPD-II-mediated therapy are compared.	[Chen, Yunching; Bathula, Surendar Reddy; Li, Jun; Huang, Leaf] Univ N Carolina, Eshelman Sch Pharm, Div Mol Pharmaceut, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Chen, YC (corresponding author), Univ N Carolina, Eshelman Sch Pharm, Div Mol Pharmaceut, 1319 Kerr Hall, Chapel Hill, NC 27599 USA.	yunching@email.unc.edu		Chen, Yunching/0000-0001-6228-5169	National Institutes of Health [CA129825]; NATIONAL CANCER INSTITUTE [R01CA129825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA129825.	Almubarak M, 2008, J ONCOL, V2008, DOI 10.1155/2008/942618; BANERJEE S, 1992, CELL MOL BIOL, V38, P561; Cai Y, 2007, CANCER BIOL THER, V6, P1794, DOI 10.4161/cbt.6.11.4860; Calcabrini A, 2000, HISTOCHEM J, V32, P599, DOI 10.1023/A:1026732405381; Chen YC, 2010, MOL THER, V18, P828, DOI 10.1038/mt.2009.291; Chen YC, 2009, MOL PHARMACEUT, V6, P696, DOI 10.1021/mp800136v; Cui ZR, 2005, MOL PHARMACEUT, V2, P22, DOI 10.1021/mp049907k; Devi GR, 2006, CANCER GENE THER, V13, P819, DOI 10.1038/sj.cgt.7700931; GERVASONI JE, 1991, CANCER RES, V51, P4955; Goren D, 2000, CLIN CANCER RES, V6, P1949; GRANDJEANFOREST.F, 2009, ABC TRANSPORTERS MUL, P17; He Y, 2000, CHINESE MED J-PEKING, V113, P848; Hiramatsu M, 2003, MOL CELL BIOCHEM, V244, P57, DOI 10.1023/A:1022491419813; Hollo Z, 1996, FEBS LETT, V383, P99, DOI 10.1016/0014-5793(96)00237-2; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; Lee RJ, 1996, J BIOL CHEM, V271, P8481, DOI 10.1074/jbc.271.14.8481; Mishima Y, 2002, J NATL CANCER I, V94, P1020; MORI A, 1987, PAVLOVIAN J BIOL SCI, V22, P85; Nakahara T, 2006, CANCER RES, V66, P1434, DOI 10.1158/0008-5472.CAN-05-0923; Nakamura Y, 2006, INT J CANCER, V118, P2448, DOI 10.1002/ijc.21691; Puhlmann U, 2005, J PHARMACOL EXP THER, V312, P346, DOI 10.1124/jpet.104.071571; Shah N, 2009, J DRUG TARGET, V17, P533, DOI 10.1080/10611860903046628; Shen Y, 2008, IDRUGS, V11, P572; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; TSURUO T, 1981, J ANTIBIOT, V34, P1206, DOI 10.7164/antibiotics.34.1206; Vlahovic G, 2007, BRIT J CANCER, V97, P735, DOI 10.1038/sj.bjc.6603941; Wartenberg M, 2001, J BIOL CHEM, V276, P17420, DOI 10.1074/jbc.M100141200; Xu DH, 2008, PHARMAZIE, V63, P646, DOI 10.1691/ph.2008.8082; Yan WL, 2007, MOL IMMUNOL, V44, P3672, DOI 10.1016/j.molimm.2007.04.009	30	195	205	4	113	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22639	22650		10.1074/jbc.M110.125906	http://dx.doi.org/10.1074/jbc.M110.125906			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20460382	Green Published, hybrid			2022-12-27	WOS:000279702200074
J	Shinohara, M; Sato, N; Kurinami, H; Takeuchi, D; Takeda, S; Shimamura, M; Yamashita, T; Uchiyama, Y; Rakugi, H; Morishita, R				Shinohara, Mitsuru; Sato, Naoyuki; Kurinami, Hitomi; Takeuchi, Daisuke; Takeda, Shuko; Shimamura, Munehisa; Yamashita, Toshihide; Uchiyama, Yasuo; Rakugi, Hiromi; Morishita, Ryuichi			Reduction of Brain beta-Amyloid (A beta) by Fluvastatin, a Hydroxymethylglutaryl-CoA Reductase Inhibitor, through Increase in Degradation of Amyloid Precursor Protein C-terminal Fragments (APP-CTFs) and A beta Clearance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN-1; GAMMA-SECRETASE INHIBITOR; ALZHEIMERS-DISEASE; IN-VITRO; EFFLUX TRANSPORT; ALPHA-SECRETASE; STATIN THERAPY; PEPTIDE; ACCUMULATION; SIMVASTATIN	Epidemiological studies suggest that statins (hydroxymethylglutaryl-CoA reductase inhibitors) could reduce the risk of Alzheimer disease. Although one possible explanation is through an effect on beta-amyloid (A beta) metabolism, its effect remains to be elucidated. Here, we explored the molecular mechanisms of how statins influence A beta metabolism. Fluvastatin at clinical doses significantly reduced A beta and amyloid precursor protein C-terminal fragment (APP-CTF) levels among APP metabolites in the brain of C57BL/6 mice. Chronic intracerebroventricular infusion of lysosomal inhibitors blocked these effects, indicating that up-regulation of the lysosomal degradation of endogenous APP-CTFs is involved in reduced A beta production. Biochemical analysis suggested that this was mediated by enhanced trafficking of APP-CTFs from endosomes to lysosomes, associated with marked changes of Rab proteins, which regulate endosomal function. In primary neurons, fluvastatin enhanced the degradation of APP-CTFs through an isoprenoid-dependent mechanism. Because our previous study suggests additive effects of fluvastatin on A beta metabolism, we examined A beta clearance rates by using the brain efflux index method and found its increased rates at high A beta levels from brain. As LRP1 in brain microvessels was increased, up-regulation of LRP1-mediated A beta clearance at the blood-brain barrier might be involved. In cultured brain microvessel endothelial cells, fluvastatin increased LRP1 and the uptake of A beta, which was blocked by LRP1 antagonists, through an isoprenoid-dependent mechanism. Overall, the present study demonstrated that fluvastatin reduced A beta level by an isoprenoid-dependent mechanism. These results have important implications for the development of disease-modifying therapy for Alzheimer disease as well as understanding of A beta metabolism.	[Shinohara, Mitsuru; Sato, Naoyuki; Kurinami, Hitomi; Takeuchi, Daisuke; Takeda, Shuko; Shimamura, Munehisa; Morishita, Ryuichi] Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, Suita, Osaka 5650871, Japan; [Shinohara, Mitsuru; Sato, Naoyuki; Kurinami, Hitomi; Takeuchi, Daisuke; Takeda, Shuko; Shimamura, Munehisa; Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr Med, Suita, Osaka 5650871, Japan; [Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka 5650871, Japan; [Uchiyama, Yasuo] Juntendo Univ, Grad Sch Med, Dept Cell Biol & Neurosci, Bunkyo Ku, Tokyo 1138421, Japan	Osaka University; Osaka University; Osaka University; Juntendo University	Morishita, R (corresponding author), 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	morishit@cgt.med.osaka-u.ac.jp		Rakugi, Hiromi/0000-0001-6508-4338; Yamashita, Toshihide/0000-0003-4559-7018	Japan Promotion of Science; Japanese Ministry of Education, Culture, Sports, Science and Technology; Japan Science and Technology Agency; Takeda Science Foundation; Novartis Pharma AG; Chiyoda; Kanae Foundation	Japan Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Novartis Pharma AG; Chiyoda; Kanae Foundation	This work was supported in part by grants-in-aid from Japan Promotion of Science, the Japanese Ministry of Education, Culture, Sports, Science and Technology (to R. M. and N. S.), the Japan Science and Technology Agency (to N. S.), the Takeda Science Foundation (to R. M.), Novartis Pharma AG, Chiyoda, and the Kanae Foundation (to N. S.).	Akanuma SI, 2008, NEUROCHEM INT, V52, P956, DOI 10.1016/j.neuint.2007.12.002; Boche D, 2008, BRAIN, V131, P3299, DOI 10.1093/brain/awn261; Burns A, 2009, LANCET NEUROL, V8, P4, DOI 10.1016/S1474-4422(08)70271-0; Burns MP, 2006, NEUROMOL MED, V8, P319, DOI 10.1385/NMM:8:3:319; Chauhan NB, 2004, NEUROCHEM RES, V29, P1897, DOI 10.1023/B:NERE.0000042217.90204.8d; Cole SL, 2005, J BIOL CHEM, V280, P18755, DOI 10.1074/jbc.M413895200; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Eckert GP, 2009, NEUROBIOL DIS, V35, P251, DOI 10.1016/j.nbd.2009.05.005; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Gauthier SA, 2012, METHODS MOL BIOL, V849, P261, DOI 10.1007/978-1-61779-551-0_18; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Grbovic OM, 2003, J BIOL CHEM, V278, P31261, DOI 10.1074/jbc.M304122200; Guardia-Laguarta C, 2009, J NEUROCHEM, V110, P220, DOI 10.1111/j.1471-4159.2009.06126.x; Haag MDM, 2009, J NEUROL NEUROSUR PS, V80, P13, DOI 10.1136/jnnp.2008.150433; Hellstrom-Lindahl E, 2009, NEUROCHEM INT, V55, P243, DOI 10.1016/j.neuint.2009.03.007; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Ito S, 2006, NEUROSCI RES, V56, P246, DOI 10.1016/j.neures.2006.07.006; IVY GO, 1984, SCIENCE, V226, P985, DOI 10.1126/science.6505679; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Kakee A, 1996, J PHARMACOL EXP THER, V277, P1550; Kandiah N, 2009, J NEUROL SCI, V283, P230, DOI 10.1016/j.jns.2009.02.352; Koike M, 2000, J NEUROSCI, V20, P6898, DOI 10.1523/JNEUROSCI.20-18-06898.2000; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Kurinami H, 2008, INT J MOL MED, V21, P531; Lanz TA, 2003, J PHARMACOL EXP THER, V305, P864, DOI 10.1124/jpet.102.048280; Li G, 2004, NEUROLOGY, V63, P1624, DOI 10.1212/01.WNL.0000142963.90204.58; Li L, 2006, ANN NEUROL, V60, P729, DOI 10.1002/ana.21053; Liao JK, 2002, J CLIN INVEST, V110, P285, DOI 10.1172/JCI200216421; Masters CL, 2006, BRAIN, V129, P2823, DOI 10.1093/brain/awl251; McGuinness B, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003160.pub2; Morishita R, 2002, CURR DRUG TARGETS, V3, P379, DOI 10.2174/1389450023347434; Nazer B, 2008, NEUROBIOL DIS, V30, P94, DOI 10.1016/j.nbd.2007.12.005; Nishitomi K, 2006, J NEUROCHEM, V99, P1555, DOI 10.1111/j.1471-4159.2006.04178.x; Nixon RA, 2005, NEUROBIOL AGING, V26, P373, DOI 10.1016/j.neurobiolaging.2004.09.018; Ostrowski SM, 2007, J BIOL CHEM, V282, P26832, DOI 10.1074/jbc.M702640200; Park IH, 2003, NEUROBIOL AGING, V24, P637, DOI 10.1016/S0197-4580(02)00155-0; Parsons RB, 2006, BIOCHEM J, V399, P205, DOI 10.1042/BJ20060655; Parvathy S, 2004, J NEUROCHEM, V90, P1005, DOI 10.1111/j.1471-4159.2004.02521.x; Pedrini S, 2005, PLOS MED, V2, P69, DOI 10.1371/journal.pmed.0020018; Petanceska SS, 2002, J MOL NEUROSCI, V19, P155, DOI 10.1007/s12031-002-0026-2; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Roensch J, 2007, NEUROCHEM INT, V50, P800, DOI 10.1016/j.neuint.2007.02.001; Rojas R, 2008, J CELL BIOL, V183, P513, DOI 10.1083/jcb.200804048; Saito Y, 2008, J BIOL CHEM, V283, P35763, DOI 10.1074/jbc.M801353200; Schmidt Stephen D., 2004, V299, P279; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Shiiki T, 2004, J NEUROSCI, V24, P9632, DOI 10.1523/JNEUROSCI.2236-04.2004; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Tabaton M, 2005, INT J EXP PATHOL, V86, P139, DOI 10.1111/j.0959-9673.2005.00428.x; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; TAKEI N, 1994, BRAIN RES, V652, P65, DOI 10.1016/0006-8993(94)90317-4; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Wolozin B, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-20; Won JS, 2008, J NEUROCHEM, V105, P1536, DOI 10.1111/j.1471-4159.2008.05283.x; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Yamada K, 2008, J BIOL CHEM, V283, P34554, DOI 10.1074/jbc.M801487200; Yang DS, 2008, AM J PATHOL, V173, P665, DOI 10.2353/ajpath.2008.071176; Zhou Y, 2008, FASEB J, V22, P47, DOI 10.1096/fj.07-8175com; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	62	85	92	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22091	22102		10.1074/jbc.M110.102277	http://dx.doi.org/10.1074/jbc.M110.102277			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20472556	Green Published, hybrid			2022-12-27	WOS:000279702200022
J	Lorsch, JR; Dever, TE				Lorsch, Jon R.; Dever, Thomas E.			Molecular View of 43 S Complex Formation and Start Site Selection in Eukaryotic Translation Initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							40S RIBOSOMAL-SUBUNIT; GTP EXCHANGE FACTORS; TRANSFER-RNA; CODON SELECTION; CRYSTAL-STRUCTURE; BETA-SUBUNIT; IN-VIVO; SACCHAROMYCES-CEREVISIAE; CONFORMATIONAL-CHANGE; ELONGATION-FACTORS	A central step to high fidelity protein synthesis is selection of the proper start codon. Recent structural, biochemical, and genetic analyses have provided molecular insights into the coordinated activities of the initiation factors in start codon selection. A molecular model is emerging in which start codon recognition is linked to dynamic reorganization of factors on the ribosome and structural changes in the ribosome itself.	[Lorsch, Jon R.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Dever, Thomas E.] Eunice Kennedy Shriver NICHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Lorsch, JR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.	jlorsch@jhmi.edu; tdever@nih.gov	Dever, Thomas/GSE-0966-2022	Dever, Thomas/0000-0001-7120-9678; Lorsch, Jon/0000-0002-4521-4999	National Institutes of Health [GM62128]; NICHD, National Institutes of Health; Human Frontier Science Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Human Frontier Science Program(Human Frontier Science Program); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62128 (to J.R.L.) and by the Intramural Research Program of the NICHD, National Institutes of Health (to T. E. D.). This work was also supported by a grant from the Human Frontier Science Program (to J.R.L.). This is the third article in the Thematic Minireview Series on Protein Synthesis. This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Acker MG, 2006, J BIOL CHEM, V281, P8469, DOI 10.1074/jbc.M600210200; Algire MA, 2005, MOL CELL, V20, P251, DOI 10.1016/j.molcel.2005.09.008; Alone PV, 2008, MOL CELL BIOL, V28, P6877, DOI 10.1128/MCB.01147-08; Alone PV, 2006, J BIOL CHEM, V281, P12636, DOI 10.1074/jbc.M511700200; Andersen GR, 2001, COLD SPRING HARB SYM, V66, P425, DOI 10.1101/sqb.2001.66.425; Asano K, 1999, EMBO J, V18, P1673, DOI 10.1093/emboj/18.6.1673; Battiste JL, 2000, MOL CELL, V5, P109, DOI 10.1016/S1097-2765(00)80407-4; Bieniossek C, 2006, J MOL BIOL, V360, P457, DOI 10.1016/j.jmb.2006.05.021; Cheung YN, 2007, GENE DEV, V21, P1217, DOI 10.1101/gad.1528307; Cochella L, 2005, SCIENCE, V308, P1178, DOI 10.1126/science.1111408; Conte MR, 2006, BIOCHEMISTRY-US, V45, P4550, DOI 10.1021/bi052387u; Das S, 2000, MOL CELL BIOL, V20, P3942, DOI 10.1128/MCB.20.11.3942-3950.2000; Das S, 2001, J BIOL CHEM, V276, P6720, DOI 10.1074/jbc.M008863200; Erickson FL, 1996, EMBO J, V15, P6311, DOI 10.1002/j.1460-2075.1996.tb01021.x; Erickson FL, 2001, GENETICS, V158, P123; Fekete CA, 2007, EMBO J, V26, P1602, DOI 10.1038/sj.emboj.7601613; Gutierrez P, 2004, PROTEIN SCI, V13, P659, DOI 10.1110/ps.03506604; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Huang HK, 1997, GENE DEV, V11, P2396, DOI 10.1101/gad.11.18.2396; Ito T, 2004, STRUCTURE, V12, P1693, DOI 10.1016/j.str.2004.07.010; Kapp LD, 2006, RNA, V12, P751, DOI 10.1261/rna.2263906; Kapp LD, 2004, J MOL BIOL, V335, P923, DOI 10.1016/j.jmb.2003.11.025; Kolitz SE, 2010, FEBS LETT, V584, P396, DOI 10.1016/j.febslet.2009.11.047; Kolitz SE, 2009, RNA, V15, P138, DOI 10.1261/rna.1318509; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Maag D, 2006, J MOL BIOL, V356, P724, DOI 10.1016/j.jmb.2005.11.083; Maag D, 2005, MOL CELL, V17, P265, DOI 10.1016/j.molcel.2004.11.051; Marintchev A, 2003, P NATL ACAD SCI USA, V100, P1535, DOI 10.1073/pnas.0437845100; Mitchell SF, 2008, J BIOL CHEM, V283, P27345, DOI 10.1074/jbc.R800031200; Nanda JS, 2009, J MOL BIOL, V394, P268, DOI 10.1016/j.jmb.2009.09.017; Nika J, 2001, J BIOL CHEM, V276, P1051, DOI 10.1074/jbc.M007398200; Olsen DS, 2003, EMBO J, V22, P193, DOI 10.1093/emboj/cdg030; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Paulin FEM, 2001, CURR BIOL, V11, P55, DOI 10.1016/S0960-9822(00)00025-7; Reibarkh M, 2008, J BIOL CHEM, V283, P1094, DOI 10.1074/jbc.M708155200; Roll-Mecak A, 2004, J BIOL CHEM, V279, P10634, DOI 10.1074/jbc.M310418200; Saini AK, 2010, GENE DEV, V24, P97, DOI 10.1101/gad.1871910; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Schmitt E, 2002, EMBO J, V21, P1821, DOI 10.1093/emboj/21.7.1821; Sokabe M, 2006, P NATL ACAD SCI USA, V103, P13016, DOI 10.1073/pnas.0604165103; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stolboushkina E, 2008, J MOL BIOL, V382, P680, DOI 10.1016/j.jmb.2008.07.039; Wei ZY, 2006, J MOL BIOL, V359, P1, DOI 10.1016/j.jmb.2006.03.037; Yamamoto Y, 2005, P NATL ACAD SCI USA, V102, P16164, DOI 10.1073/pnas.0507960102; Yatime L, 2006, STRUCTURE, V14, P119, DOI 10.1016/j.str.2005.09.020; Yatime L, 2004, J BIOL CHEM, V279, P15984, DOI 10.1074/jbc.M311561200; Yatime L, 2007, P NATL ACAD SCI USA, V104, P18445, DOI 10.1073/pnas.0706784104; YOON HJ, 1992, MOL CELL BIOL, V12, P248, DOI 10.1128/MCB.12.1.248; Yu YP, 2009, NUCLEIC ACIDS RES, V37, P5167, DOI 10.1093/nar/gkp519	49	62	64	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21203	21207		10.1074/jbc.R110.119743	http://dx.doi.org/10.1074/jbc.R110.119743			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20444698	Green Published, hybrid			2022-12-27	WOS:000279516100003
J	Wong, VSC; Yeung, A; Schultz, W; Brubaker, PL				Wong, Victor S. C.; Yeung, Andrea; Schultz, William; Brubaker, Patricia L.			R-spondin-1 Is a Novel beta-Cell Growth Factor and Insulin Secretagogue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCAGON-LIKE PEPTIDE-1; PROTEIN-KINASE; BINDING-PROTEIN; WNT; EXPRESSION; GLUCOSE; CATENIN; ACTIVATION; APOPTOSIS; PROLIFERATION	R-spondin-1 (Rspo1) is an intestinal growth factor known to exert its effects through activation of the canonical Wnt (cWnt) signaling pathway and subsequent expression of cWnt target genes. We have detected Rspo1 mRNA in murine islets and the murine MIN6 and beta TC beta-cell lines, and Rspo1 protein in MIN6 beta-cells. Rspo1 activated cWnt signaling in MIN6 beta-cells by increasing nuclear beta-catenin and c-myc, a cWnt target gene. Rspo1 also induced insulin mRNA expression in MIN6 cells. Analysis of MIN6 and mouse beta-cell proliferation by [H-3]thymidine and BrdU incorporation, respectively, revealed that Rspo1 stimulated cell growth. Incubation of MIN6 and mouse beta-cells with cytokines (IL1 beta/TNF alpha/interferon-gamma) significantly increased cellular apoptosis; this increase was abolished by pretreatment with Rspo1. Rspo1 also stimulated insulin secretion in a glucose-independent fashion. We further demonstrated that the glucagon-like peptide-1 receptor agonist, exendin4 (EX4), stimulated Rspo1 mRNA transcript levels in MIN6 cells in a glucose-, time-, dose-, and PI3-kinase-dependent fashion. This effect was not limited to this beta-cell line, as similar time-dependent increases in Rspo1 were also observed in the beta TC beta-cell line and mouse islets in response to EX4 treatment. Together, these studies demonstrate that Rspo1 is a novel beta-cell growth factor and insulin secretagogue that is regulated by EX4. These findings suggest that Rspo1 and the cWnt signaling pathway may serve as a novel target to enhance beta-cell growth and function in patients with type 2 diabetes.	[Wong, Victor S. C.; Yeung, Andrea; Schultz, William; Brubaker, Patricia L.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Brubaker, Patricia L.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Brubaker, PL (corresponding author), Univ Toronto, Dept Physiol, Rm 3366 Med Sci Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	p.brubaker@utoronto.ca	Wong, Victor/I-7722-2019	Wong, Victor/0000-0003-1415-2825	Canadian Diabetes Association [2374]; Banting and Best Diabetes Centre (BBDC), University of Toronto; Ontario Graduate program; Canadian Institutes of Health Research; Canada Research Chairs program; University of Toronto	Canadian Diabetes Association; Banting and Best Diabetes Centre (BBDC), University of Toronto(University of Toronto); Ontario Graduate program; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs program(Canada Research Chairs); University of Toronto(University of Toronto)	This work was supported by an operating grant from the Canadian Diabetes Association (2374) and by an equipment grant from the Banting and Best Diabetes Centre (BBDC), University of Toronto.; Supported by graduate studentships from BBDC, Ontario Graduate program, Canadian Institutes of Health Research and Paul and Sally Wang (University of Toronto).; Supported by BBDC Summer Studentships, University of Toronto.; Supported by the Canada Research Chairs program. To whom correspondence should be addressed: Rm. 3366 Medical Sciences Bldg., University of Toronto, 1 King's College Circle, Toronto, ON M5S 1A8, Canada. Tel./Fax: 416-978-2593; E-mail: p. brubaker@utoronto.ca.	Arnette D, 2003, J BIOL CHEM, V278, P32517, DOI 10.1074/jbc.M301174200; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Bonner-Weir S, 2000, ENDOCRINOLOGY, V141, P1926, DOI 10.1210/en.141.6.1926; Bouwens L, 2005, PHYSIOL REV, V85, P1255, DOI 10.1152/physrev.00025.2004; Briaud I, 2003, DIABETES, V52, P974, DOI 10.2337/diabetes.52.4.974; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chen YJ, 2004, INT J DEV BIOL, V48, P867, DOI 10.1387/ijdb.041882yc; Costes S, 2006, DIABETES, V55, P2220, DOI 10.2337/db05-1618; Ding WG, 1997, DIABETES, V46, P792, DOI 10.2337/diabetes.46.5.792; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Etheridge SL, 2004, STEM CELLS, V22, P849, DOI 10.1634/stemcells.22-5-849; Everly DN, 2004, J VIROL, V78, P11648, DOI 10.1128/JVI.78.21.11648-11655.2004; Friedrichsen BN, 2006, J ENDOCRINOL, V188, P481, DOI 10.1677/joe.1.06160; Fujino T, 2003, P NATL ACAD SCI USA, V100, P229, DOI 10.1073/pnas.0133792100; Gomez E, 2002, J BIOL CHEM, V277, P48146, DOI 10.1074/jbc.M209165200; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gyulkhandanyan AV, 2006, J BIOL CHEM, V281, P9361, DOI 10.1074/jbc.M508542200; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Heller RS, 2002, DEV DYNAM, V225, P260, DOI 10.1002/dvdy.10157; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hussain MA, 2006, MOL CELL BIOL, V26, P7747, DOI 10.1128/MCB.02353-05; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kemp DM, 2001, ENDOCRINOLOGY, V142, P1179, DOI 10.1210/en.142.3.1179; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Krutzfeldt J, 2010, DIABETOLOGIA, V53, P123, DOI 10.1007/s00125-009-1578-2; Lee SH, 2008, EXP DIABETES RES, DOI 10.1155/2008/728763; Lester LB, 1997, P NATL ACAD SCI USA, V94, P14942, DOI 10.1073/pnas.94.26.14942; Li L, 2005, DIABETOLOGIA, V48, P1339, DOI 10.1007/s00125-005-1787-2; Li LX, 2006, ENDOCRINOLOGY, V147, P3318, DOI 10.1210/en.2006-0155; Liu Z, 2009, DIABETOLOGIA, V52, P1589, DOI 10.1007/s00125-009-1384-x; Liu ZY, 2008, J BIOL CHEM, V283, P8723, DOI 10.1074/jbc.M706105200; Loder MK, 2008, BIOCHEM SOC T, V36, P357, DOI 10.1042/BST0360357; Lyu J, 2003, J BIOL CHEM, V278, P13487, DOI 10.1074/jbc.M300591200; MacDonald PE, 2001, MOL ENDOCRINOL, V15, P1423, DOI 10.1210/me.15.8.1423; Martens GA, 2009, VITAM HORM, V80, P507, DOI 10.1016/S0083-6729(08)00617-1; Mawson A, 2005, MOL CELL ENDOCRINOL, V229, P161, DOI 10.1016/j.mce.2004.08.002; Meares GP, 2007, J BIOL CHEM, V282, P16989, DOI 10.1074/jbc.M700610200; Mohamed OA, 2004, BIOL REPROD, V71, P417, DOI 10.1095/biolreprod.103.025692; Morin PJ, 1996, P NATL ACAD SCI USA, V93, P7950, DOI 10.1073/pnas.93.15.7950; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Nam JS, 2007, GENE EXPR PATTERNS, V7, P306, DOI 10.1016/j.modgep.2006.08.006; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Orford K, 1999, J CELL BIOL, V146, P855, DOI 10.1083/jcb.146.4.855; Papadopoulou S, 2005, DIABETES, V54, P2844, DOI 10.2337/diabetes.54.10.2844; Park S, 2006, J BIOL CHEM, V281, P1159, DOI 10.1074/jbc.M508307200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pigeau GM, 2009, DIABETES, V58, P2084, DOI 10.2337/db08-1371; Ranheim EA, 2005, BLOOD, V105, P2487, DOI 10.1182/blood-2004-06-2334; Rhee CS, 2002, ONCOGENE, V21, P6598, DOI 10.1038/sj.onc.1205920; Rulifson IC, 2007, P NATL ACAD SCI USA, V104, P6247, DOI 10.1073/pnas.0701509104; Schinner S, 2008, DIABETOLOGIA, V51, P147, DOI 10.1007/s00125-007-0848-0; Strovel ET, 1999, EXP CELL RES, V253, P637, DOI 10.1006/excr.1999.4700; Stump RJW, 2003, DEV BIOL, V259, P48, DOI 10.1016/S0012-1606(03)00179-9; Torii K, 2008, CELL SIGNAL, V20, P1256, DOI 10.1016/j.cellsig.2008.02.013; Trumper J, 2005, DIABETOLOGIA, V48, P1534, DOI 10.1007/s00125-005-1820-5; Vasavada RC, 2006, INT J BIOCHEM CELL B, V38, P931, DOI 10.1016/j.biocel.2005.08.003; Vuga LJ, 2009, AM J RESP CELL MOL, V41, P583, DOI 10.1165/rcmb.2008-0201OC; Wang Q, 2004, DIABETOLOGIA, V47, P478, DOI 10.1007/s00125-004-1327-5; Wang XL, 2001, ENDOCRINOLOGY, V142, P1820, DOI 10.1210/en.142.5.1820; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Welters HJ, 2008, TRENDS ENDOCRIN MET, V19, P349, DOI 10.1016/j.tem.2008.08.004; Xavier GD, 2009, DIABETES, V58, P894, DOI 10.2337/db08-1187; Yun SI, 2009, APOPTOSIS, V14, P771, DOI 10.1007/s10495-009-0348-4	66	20	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21292	21302		10.1074/jbc.M110.129874	http://dx.doi.org/10.1074/jbc.M110.129874			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20442404	Green Published, hybrid			2022-12-27	WOS:000279516100014
J	Zhou, M; Liu, ZX; Zhao, YH; Ding, Y; Liu, H; Xi, YG; Xiong, W; Li, GY; Lu, JR; Fodstad, O; Riker, AI; Tan, M				Zhou, Ming; Liu, Zixing; Zhao, Yuhua; Ding, Yan; Liu, Hao; Xi, Yaguang; Xiong, Wei; Li, Guiyuan; Lu, Jianrong; Fodstad, Oystein; Riker, Adam I.; Tan, Ming			MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER; LACTATE-DEHYDROGENASE; TAXOL; OVARIAN; PROLIFERATION; DEREGULATION; METASTASIS; SIGNATURES; MIR-125B; MIR-222	Paclitaxel (Taxol) is an effective chemotherapeutic agent for treatment of cancer patients. Despite impressive initial clinical responses, the majority of patients eventually develop some degree of resistance to Taxol-based therapy. The mechanisms underlying cancer cells resistance to Taxol are not fully understood. MicroRNA (miRNA) has emerged to play important roles in tumorigenesis and drug resistance. However, the interaction between the development of Taxol resistance and miRNA has not been previously explored. In this study we utilized a miRNA array to compare the differentially expressed miRNAs in Taxol-resistant and their Taxol-sensitive parental cells. We verified that miR-125b, miR-221, miR-222, and miR-923 were up-regulated in Taxol-resistant cancer cells by real-time PCR. We further investigated the role and mechanisms of miR-125b in Taxol resistance. We found that miR-125b was up-regulated in Taxol-resistant cells, causing a marked inhibition of Taxol-induced cytotoxicity and apoptosis and a subsequent increase in the resistance to Taxol in cancer cells. Moreover, we demonstrated that the pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) is a direct target of miR-125b. Down-regulation of Bak1 suppressed Taxol-induced apoptosis and led to an increased resistance to Taxol. Restoring Bak1 expression by either miR-125b inhibitor or re-expression of Bak1 in miR-125b-overexpressing cells recovered Taxol sensitivity, overcoming miR-125-mediated Taxol resistance. Taken together, our data strongly support a central role for miR-125b in conferring Taxol resistance through the suppression of Bak1 expression. This finding has important implications in the development of targeted therapeutics for overcoming Taxol resistance in a number of different tumor histologies.	[Zhou, Ming; Liu, Zixing; Zhao, Yuhua; Ding, Yan; Liu, Hao; Xi, Yaguang; Fodstad, Oystein; Tan, Ming] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36604 USA; [Tan, Ming] Univ S Alabama, Dept Cell Biol & Neurosci, Mobile, AL 36604 USA; [Zhou, Ming; Xiong, Wei; Li, Guiyuan] Cent S Univ, Canc Res Inst, Changsha 410008, Hunan, Peoples R China; [Fodstad, Oystein] Norwegian Radium Hosp, Inst Canc Res, N-0310 Oslo, Norway; [Lu, Jianrong] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Riker, Adam I.] Ochsner Hlth Syst, Ochsner Canc Inst, New Orleans, LA 70121 USA	University of South Alabama; University of South Alabama; Central South University; University of Oslo; State University System of Florida; University of Florida; Ochsner Health System	Tan, M (corresponding author), 1660 Spring Hill Ave, Mobile, AL 36604 USA.	mtan@usouthal.edu	Tan, Ming/ABD-5847-2021; Zhao, Yuhua/H-3210-2013; Xie, Huangming/B-2260-2012; Lu, Jianrong/F-5240-2013	Tan, Ming/0000-0003-2007-9898; Zhao, Yuhua/0000-0002-4060-631X; Lu, Jianrong/0000-0002-4969-6040; Xi, Yaguang/0000-0003-3681-9352	Cancer Research Foundation; Norwegian Radiumhospitalet Legater [334003]	Cancer Research Foundation; Norwegian Radiumhospitalet Legater	This work was supported by the Vincent F. Kilborn, Jr., Cancer Research Foundation (to M. T.) and The Norwegian Radiumhospitalet Legater (Project 334003, to M. T. and O.F.).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Bousquet M, 2008, J EXP MED, V205, P2499, DOI 10.1084/jem.20080285; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; CHEN LP, 1995, GYNECOL ONCOL, V56, P231; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; FISHER DE, 1994, CELL, V78, P539, DOI 10.1016/0092-8674(94)90518-5; Fujita Y, 2008, BIOCHEM BIOPH RES CO, V377, P114, DOI 10.1016/j.bbrc.2008.09.086; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Gebeshuber CA, 2009, EMBO REP, V10, P400, DOI 10.1038/embor.2009.9; Goncalves A, 2001, P NATL ACAD SCI USA, V98, P11737, DOI 10.1073/pnas.191388598; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Henley D, 2007, CANCER CHEMOTH PHARM, V59, P235, DOI 10.1007/s00280-006-0262-1; Henson BJ, 2009, GENE CHROMOSOME CANC, V48, P569, DOI 10.1002/gcc.20666; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Ichimi T, 2009, INT J CANCER, V125, P345, DOI 10.1002/ijc.24390; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kan T, 2009, GASTROENTEROLOGY, V136, P1689, DOI 10.1053/j.gastro.2009.02.002; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Lu J, 2009, CLIN CANCER RES, V15, P1326, DOI 10.1158/1078-0432.CCR-08-0954; Martello LA, 2003, CANCER RES, V63, P1207; Mohri T, 2009, INT J CANCER, V125, P1328, DOI 10.1002/ijc.24459; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Ofir R, 2002, CELL DEATH DIFFER, V9, P636, DOI 10.1038/sj.cdd.4401012; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; PANDA D, 1994, P NATL ACAD SCI USA, V91, P11358, DOI 10.1073/pnas.91.24.11358; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Pickering MT, 2009, ONCOGENE, V28, P140, DOI 10.1038/onc.2008.372; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Sellappan S, 2004, CANCER RES, V64, P3479, DOI 10.1158/0008-5472.CAN-3299-2; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Sorrentino A, 2008, GYNECOL ONCOL, V111, P478, DOI 10.1016/j.ygyno.2008.08.017; Tan M, 2002, MOL CELL, V9, P993, DOI 10.1016/S1097-2765(02)00510-5; Tan M, 2007, ADV EXP MED BIOL, V608, P119; Veerla S, 2009, INT J CANCER, V124, P2236, DOI 10.1002/ijc.24183; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Welch DR, 1997, CLIN EXP METASTAS, V15, P272, DOI 10.1023/A:1018477516367; Wu WL, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj015; Xia HF, 2009, CELL PHYSIOL BIOCHEM, V23, P347, DOI 10.1159/000218181; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100; Zhao JJ, 2008, J BIOL CHEM, V283, P31079, DOI 10.1074/jbc.M806041200; Zhao YH, 2009, ONCOGENE, V28, P3689, DOI 10.1038/onc.2009.229; Zhou M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-33; Zhou R, 2010, NUCLEIC ACIDS RES, V38, P3222, DOI 10.1093/nar/gkq056; Zhou R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000681	56	326	343	0	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21496	21507		10.1074/jbc.M109.083337	http://dx.doi.org/10.1074/jbc.M109.083337			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20460378	Green Published, hybrid			2022-12-27	WOS:000279516100036
J	Kalastavadi, T; True, HL				Kalastavadi, Tejas; True, Heather L.			Analysis of the [RNQ(+)] Prion Reveals Stability of Amyloid Fibers as the Key Determinant of Yeast Prion Variant Propagation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN GENE; PSI+ PRION; TRANSLATION TERMINATION; SPECIES BARRIERS; PIN+; URE3; CONFORMATIONS; DISEASES; STRAINS	Variation in pathology of human prion disease is believed to be caused, in part, by distinct conformations of aggregated protein resulting in different prion strains. Several prions also exist in yeast and maintain different self-propagating structures, referred to as prion variants. Investigation of the yeast prion [PSI+] has been instrumental in deciphering properties of prion variants and modeling the physical basis of their formation. Here, we describe the generation of specific variants of the [RNQ(+)] prion in yeast transformed with fibers formed in vitro in different conditions. The fibers of the Rnq1p prion-forming domain (PFD) that induce different variants in vivo have distinct biochemical properties. The physical basis of propagation of prion variants has been previously correlated to rates of aggregation and disaggregation. With [RNQ(+)] prion variants, we found that the prion variant does not correlate with the rate of aggregation as anticipated but does correlate with stability. Interestingly, we found that there are differences in the ability of the [RNQ(+)] prion variants to faithfully propagate themselves and to template the aggregation of other proteins. Incorporating the mechanism of variant formation elucidated in this study with that previously proposed for [PSI+] variants has provided a framework to separate general characteristics of prion variant properties from those specific to individual prion proteins.	[Kalastavadi, Tejas; True, Heather L.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63108 USA	Washington University (WUSTL)	True, HL (corresponding author), 660 S Euclid Ave,Box 8228, St Louis, MO 63108 USA.	heather.true@wustl.edu	True, Heather/D-2979-2012		National Institutes of Health [GM072228]; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM072228 (to H. L. T.) and the National Science Foundation.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Bardill JP, 2009, PRION, V3, P151, DOI 10.4161/pri.3.3.9662; Bardill JP, 2009, J MOL BIOL, V388, P583, DOI 10.1016/j.jmb.2009.03.036; Bradley ME, 2003, GENETICS, V165, P1675; Bradley ME, 2002, P NATL ACAD SCI USA, V99, P16392, DOI 10.1073/pnas.152330699; Brown JCS, 2009, GENE DEV, V23, P2320, DOI 10.1101/gad.1839109; Chesebro B, 2003, BRIT MED BULL, V66, P1, DOI 10.1093/bmb/66.1.1; Chien P, 2003, NATURE, V424, P948, DOI 10.1038/nature01894; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Croes EA, 2004, J NEUROL NEUROSUR PS, V75, P1166, DOI 10.1136/jnnp.2003.020198; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 1996, GENETICS, V144, P1375; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Derkatch IL, 2000, EMBO J, V19, P1942, DOI 10.1093/emboj/19.9.1942; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Edskes HK, 2009, GENETICS, V181, P1159, DOI 10.1534/genetics.108.099929; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; King A, 2003, NEUROPATH APPL NEURO, V29, P98, DOI 10.1046/j.1365-2990.2003.00423.x; Kochneva-Pervukhova NV, 2001, YEAST, V18, P489, DOI 10.1002/yea.700; Kovacs GG, 2002, J NEUROL, V249, P1567, DOI 10.1007/s00415-002-0896-9; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Nemecek J, 2009, P NATL ACAD SCI USA, V106, P1892, DOI 10.1073/pnas.0812470106; Ohhashi Y, 2010, NAT CHEM BIOL, V6, P225, DOI 10.1038/NCHEMBIO.306; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Patel BK, 2007, J MOL BIOL, V365, P773, DOI 10.1016/j.jmb.2006.10.069; Patel BK, 2009, NAT CELL BIOL, V11, P344, DOI 10.1038/ncb1843; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Perrett S, 2008, CURR OPIN STRUC BIOL, V18, P52, DOI 10.1016/j.sbi.2007.12.005; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Resende CG, 2003, MOL MICROBIOL, V49, P1005, DOI 10.1046/j.1365-2958.2003.03608.x; Scheibel T, 2001, CURR BIOL, V11, P366, DOI 10.1016/S0960-9822(01)00099-9; Schlumpberger M, 2001, MOL CELL BIOL, V21, P7035, DOI 10.1128/MCB.21.20.7035-7046.2001; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Serio TR, 1999, ANNU REV CELL DEV BI, V15, P661, DOI 10.1146/annurev.cellbio.15.1.661; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2005, CELL, V121, P49, DOI 10.1016/j.cell.2005.03.008; Tanaka M, 2006, METHOD ENZYMOL, V412, P185, DOI 10.1016/S0076-6879(06)12012-1; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; TERAVANESYAN MD, 1993, MOL MICROBIOL, V7, P683, DOI 10.1111/j.1365-2958.1993.tb01159.x; Tessier PM, 2007, NATURE, V447, P556, DOI 10.1038/nature05848; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Tuite MF, 2003, NAT REV MOL CELL BIO, V4, P878, DOI 10.1038/nrm1247; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603; Uptain SM, 2001, EMBO J, V20, P6236, DOI 10.1093/emboj/20.22.6236; Vitrenko YA, 2007, CURR GENET, V51, P309, DOI 10.1007/s00294-007-0127-0; Vitrenko YA, 2007, J BIOL CHEM, V282, P1779, DOI 10.1074/jbc.M609269200; Wadsworth JD, 2003, BRIT MED BULL, V66, P241, DOI 10.1093/bmb/66.1.241; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 1995, YEAST, V11, P1671, DOI 10.1002/yea.320111609; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	57	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20748	20755		10.1074/jbc.M110.115303	http://dx.doi.org/10.1074/jbc.M110.115303			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20442412	hybrid, Green Published			2022-12-27	WOS:000279228600039
J	Duriseti, S; Goetz, DH; Hostetter, DR; LeBeau, AM; Wei, Y; Craik, CS				Duriseti, Sai; Goetz, David H.; Hostetter, Daniel R.; LeBeau, Aaron M.; Wei, Ying; Craik, Charles S.			Antagonistic Anti-urokinase Plasminogen Activator Receptor (uPAR) Antibodies Significantly Inhibit uPAR-mediated Cellular Signaling and Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; IN-VITRO; CELLS; METASTASIS; VITRONECTIN; PROGRESSION; ALPHA-5-BETA-1; IDENTIFICATION; ADHESION; INVASION	Interactions between urokinase plasminogen activator receptor (uPAR) and its various ligands regulate tumor growth, invasion, and metastasis. Antibodies that bind specific uPAR epitopes may disrupt these interactions, thereby inhibiting these processes. Using a highly diverse and naive human fragment of the antigen binding (Fab) phage display library, we identified 12 unique human Fabs that bind uPAR. Two of these antibodies compete against urokinase plasminogen activator (uPA) for uPAR binding, whereas a third competes with beta 1 integrins for uPAR binding. These competitive antibodies inhibit uPAR-dependent cell signaling and invasion in the non-small cell lung cancer cell line, H1299. Additionally, the integrin-blocking antibody abrogates uPAR/beta 1 integrin-mediated H1299 cell adhesion to fibronectin and vitronectin. This antibody and one of the uPAR/uPA antagonist antibodies shows a significant combined effect in inhibiting cell invasion through Matrigel/Collagen I or Collagen I matrices. Our results indicate that these antagonistic antibodies have potential for the detection and treatment of uPAR-expressing tumors.	[Wei, Ying] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Wei, Ying] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Duriseti, Sai] Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94158 USA; [Goetz, David H.; Hostetter, Daniel R.; LeBeau, Aaron M.; Craik, Charles S.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wei, Y (corresponding author), HSE 201,514 Parnassus Ave, San Francisco, CA 94143 USA.	ying.wei@ucsf.edu; craik@cgl.ucsf.edu			National Institutes of Health [5T32GM008284-22, CA128765, GM073210, CA125564]; Leukemia and Lymphoma Society [5552-06]; NATIONAL CANCER INSTITUTE [R01CA125564, R01CA128765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073210, T32GM008284] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5T32GM008284-22 (to S. D.), CA128765 and GM073210 (to C. S. C.), and CA125564 and CA125564 (to Y. W. and Harold A. Chapman). This work was also supported by Leukemia and Lymphoma Society Fellowship 5552-06 (to D. R. H.).	Alfano D, 2005, THROMB HAEMOSTASIS, V93, P205, DOI 10.1160/TH04-09-0592; Ass K, 2008, CANCER TREAT REV, V34, P122, DOI 10.1016/j.ctrv.2007.10.005; BUSSO N, 1994, J CELL BIOL, V126, P259, DOI 10.1083/jcb.126.1.259; Carriero MV, 1999, CANCER RES, V59, P5307; Chaurasia P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004617; D'Alessio S, 2009, FRONT BIOSCI-LANDMRK, V14, P4575, DOI 10.2741/3550; Dano K, 2005, THROMB HAEMOSTASIS, V93, P676, DOI 10.1160/TH05-01-0054; Dass CR, 2008, CANCER BIOL THER, V7, P1262, DOI 10.4161/cbt.7.8.6265; de Haard HJ, 1999, J BIOL CHEM, V274, P18218, DOI 10.1074/jbc.274.26.18218; Gaultier A, 2010, MATRIX BIOL, V29, P22, DOI 10.1016/j.matbio.2009.08.003; GYETKO MR, 1994, J CLIN INVEST, V93, P1380, DOI 10.1172/JCI117114; He Y, 2007, CLIN CANCER RES, V13, P3115, DOI 10.1158/1078-0432.CCR-06-2088; HolstHansen C, 1996, CLIN EXP METASTAS, V14, P297; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Kanse SM, 1996, EXP CELL RES, V224, P344, DOI 10.1006/excr.1996.0144; Kogianni G, 2009, EUR J CANCER, V45, P685, DOI 10.1016/j.ejca.2008.11.023; Lakka SS, 2001, CLIN CANCER RES, V7, P1087; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mazar AP, 2008, CLIN CANCER RES, V14, P5649, DOI 10.1158/1078-0432.CCR-07-4863; Mondino A, 2004, TRENDS IMMUNOL, V25, P450, DOI 10.1016/j.it.2004.06.004; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Okumura Y, 1997, FEBS LETT, V402, P181, DOI 10.1016/S0014-5793(96)01523-2; Ragno P, 2006, CELL MOL LIFE SCI, V63, P1028, DOI 10.1007/s00018-005-5428-1; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; SCHNAPER HW, 1995, J CELL PHYSIOL, V165, P107, DOI 10.1002/jcp.1041650114; Sitrin RG, 2000, J IMMUNOL, V165, P3341, DOI 10.4049/jimmunol.165.6.3341; Solberg H, 2001, J HISTOCHEM CYTOCHEM, V49, P237, DOI 10.1177/002215540104900211; Streuli CH, 2009, J CELL SCI, V122, P171, DOI 10.1242/jcs.018945; Tang CH, 2008, J CELL SCI, V121, P3747, DOI 10.1242/jcs.029769; Tarui T, 2003, J BIOL CHEM, V278, P29863, DOI 10.1074/jbc.M304694200; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Tyndall JDA, 2008, RECENT PAT ANTI-CANC, V3, P1, DOI 10.2174/157489208783478711; van der Pluijm G, 2001, AM J PATHOL, V159, P971, DOI 10.1016/S0002-9440(10)61773-7; WEI Y, 1994, J BIOL CHEM, V269, P32380; Wei Y, 2007, J BIOL CHEM, V282, P3929, DOI 10.1074/jbc.M607989200	35	47	52	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26878	26888		10.1074/jbc.M109.077677	http://dx.doi.org/10.1074/jbc.M109.077677			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20501655	hybrid, Green Published			2022-12-27	WOS:000281172700019
J	Maun, HR; Wen, XH; Lingel, A; de Sauvage, FJ; Lazarus, RA; Scales, SJ; Hymowitz, SG				Maun, Henry R.; Wen, Xiaohui; Lingel, Andreas; de Sauvage, Frederic J.; Lazarus, Robert A.; Scales, Suzie J.; Hymowitz, Sarah G.			Hedgehog Pathway Antagonist 5E1 Binds Hedgehog at the Pseudo-active Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SONIC HEDGEHOG; ANIMAL DEVELOPMENT; CRYSTAL-STRUCTURE; ANTIBODY; PROTEIN; CANCER; CDO; COMPLEX; DIFFERENTIATION; REQUIREMENT	Proper hedgehog (Hh) signaling is crucial for embryogenesis and tissue regeneration. Dysregulation of this pathway is associated with several types of cancer. The monoclonal antibody 5E1 is a Hh pathway inhibitor that has been extensively used to elucidate vertebrate Hh biology due to its ability to block binding of the three mammalian Hh homologs to the receptor, Patched1 (Ptc1). Here, we engineered a murine: human chimeric 5E1 (ch5E1) with similar Hh-binding properties to the original murine antibody. Using biochemical, biophysical, and x-ray crystallographic studies, we show that, like the regulatory receptors Cdon and Hedgehog-interacting protein (Hhip), ch5E1 binding to Sonic hedgehog (Shh) is enhanced by calcium ions. In the presence of calcium and zinc ions, the ch5E1 binding affinity increases 10-20-fold to tighter than 1 nM primarily because of a decrease in the dissociation rate. The co-crystal structure of Shh bound to the Fab fragment of ch5E1 reveals that 5E1 binds at the pseudo-active site groove of Shh with an epitope that largely overlaps with the binding site of its natural receptor antagonist Hhip. Unlike Hhip, the side chains of 5E1 do not directly coordinate the Zn2+ cation in the pseudo-active site, despite the modest zinc-dependent increase in 5E1 affinity for Shh. Furthermore, to our knowledge, the ch5E1 Fab-Shh complex represents the first structure of an inhibitor antibody bound to a metalloprotease fold.	[Hymowitz, Sarah G.] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA; [Wen, Xiaohui; de Sauvage, Frederic J.; Scales, Suzie J.] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Hymowitz, SG (corresponding author), Genentech Inc, Dept Biol Struct, 1 DNA Way, San Francisco, CA 94080 USA.	hymowitz@gene.com	Lingel, Andreas/AAP-5078-2021; de Sauvage, Frederic/ABE-8400-2020; Scales, Suzie J./H-4507-2019	de Sauvage, Frederic/0000-0002-5275-2584; Scales, Suzie J./0000-0003-2544-0283	National Institutes of Health; NIGMS; United States Department of Energy	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Energy(United States Department of Energy (DOE))	We thank Kurt Schroeder for growing the mouse 5E1 hybridoma; Wendy Sandoval for N-terminally sequencing 5E1; Yongmei Chen and Yan Wu for making the ch5E1 mammalian expression construct; George Dutina, Mark Nagel, and Erin Harrod for expressing and purifying ch5E1; Richard Vandlen for isolation of ch5E1 Fab; Hua Tian for the mouse embryo; Steven Russell for atomic absorption spectroscopy, and Christine Yu for mounting and characterizing the crystals. We also gratefully acknowledge our collaborators at Curis, Inc. (Cambridge, MA), for providing the mouse 5E1 hybridoma. ALS beamline 5.0.1 and the Berkeley Center for Structural Biology are supported by the National Institutes of Health, NIGMS, and United States Department of Energy.	Allen BL, 2007, GENE DEV, V21, P1244, DOI 10.1101/gad.1543607; Angot E, 2008, STEM CELLS, V26, P2311, DOI 10.1634/stemcells.2008-0297; Arnaud J, 2008, CLIN CHEM, V54, P1892, DOI 10.1373/clinchem.2008.108142; Bailey JM, 2009, ONCOGENE, V28, P3513, DOI 10.1038/onc.2009.220; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bishop B, 2009, NAT STRUCT MOL BIOL, V16, P698, DOI 10.1038/nsmb.1607; BOROWSKI M, 1986, J BIOL CHEM, V261, P4969; Bosanac I, 2009, NAT STRUCT MOL BIOL, V16, P691, DOI 10.1038/nsmb.1632; Capurro MI, 2008, DEV CELL, V14, P700, DOI 10.1016/j.devcel.2008.03.006; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Day ES, 1999, BIOCHEMISTRY-US, V38, P14868, DOI 10.1021/bi9910068; Devy L, 2009, CANCER RES, V69, P1517, DOI 10.1158/0008-5472.CAN-08-3255; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Farady CJ, 2008, J MOL BIOL, V380, P351, DOI 10.1016/j.jmb.2008.05.009; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Fu M, 2004, J CELL BIOL, V166, P673, DOI 10.1083/jcb.200401077; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Ganesan R, 2009, STRUCTURE, V17, P1614, DOI 10.1016/j.str.2009.09.014; HALL TMT, 1995, NATURE, V378, P212, DOI 10.1038/378212a0; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; HORN IR, 1995, J BIOL CHEM, V270, P11770, DOI 10.1074/jbc.270.20.11770; Huang MD, 2004, J BIOL CHEM, V279, P14338, DOI 10.1074/jbc.M314011200; Huang SH, 2006, CARCINOGENESIS, V27, P1334, DOI 10.1093/carcin/bgi378; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Incardona JP, 2000, P NATL ACAD SCI USA, V97, P12044, DOI 10.1073/pnas.220251997; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kang JS, 1997, J CELL BIOL, V138, P203, DOI 10.1083/jcb.138.1.203; Kang JS, 2002, EMBO J, V21, P114, DOI 10.1093/emboj/21.1.114; KOBAYASHI K, 1991, J BIOCHEM-TOKYO, V109, P551, DOI 10.1093/oxfordjournals.jbchem.a123418; Koyama E, 2003, DEV DYNAM, V226, P149, DOI 10.1002/dvdy.10217; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; MAUN HR, 2010, BIOL CHEM IN PRESS; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McLellan JS, 2008, NATURE, V455, P979, DOI 10.1038/nature07358; McLellan JS, 2006, P NATL ACAD SCI USA, V103, P17208, DOI 10.1073/pnas.0606738103; Outram SV, 2000, IMMUNITY, V13, P187, DOI 10.1016/S1074-7613(00)00019-4; Peng LF, 2009, BIOORG MED CHEM LETT, V19, P6319, DOI 10.1016/j.bmcl.2009.09.089; Pepinsky RB, 2000, J BIOL CHEM, V275, P10995, DOI 10.1074/jbc.275.15.10995; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Podlasek CA, 1999, DEV BIOL, V209, P28, DOI 10.1006/dbio.1999.9229; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; PRICKETT KS, 1989, BIOTECHNIQUES, V7, P580; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Stanton BZ, 2009, NAT CHEM BIOL, V5, P154, DOI 10.1038/nchembio.142; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; Vyas N, 2008, CELL, V133, P1214, DOI 10.1016/j.cell.2008.05.026; Wallace VA, 1999, DEVELOPMENT, V126, P2901; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; WARD SL, 1992, MOL IMMUNOL, V29, P83, DOI 10.1016/0161-5890(92)90160-Y; Wijgerde M, 2002, GENE DEV, V16, P2849, DOI 10.1101/gad.1025702; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu Y, 2007, P NATL ACAD SCI USA, V104, P19784, DOI 10.1073/pnas.0708251104; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Zhang W, 2006, DEV CELL, V10, P657, DOI 10.1016/j.devcel.2006.04.005; Zhou TQ, 2005, P NATL ACAD SCI USA, V102, P14575, DOI 10.1073/pnas.0507267102	61	104	107	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26570	26580		10.1074/jbc.M110.112284	http://dx.doi.org/10.1074/jbc.M110.112284			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20504762	Green Published, hybrid			2022-12-27	WOS:000280921000073
J	Kim, CH; Shin, YP; Noh, MY; Jo, YH; Han, YS; Seong, YS; Lee, IH				Kim, Chong Han; Shin, Yong Pyo; Noh, Mi Young; Jo, Yong Hun; Han, Yeon Soo; Seong, Yeon Sun; Lee, In Hee			An Insect Multiligand Recognition Protein Functions as an Opsonin for the Phagocytosis of Microorganisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; GREAT WAX MOTH; GALLERIA-MELLONELLA; APOLIPOPHORIN-III; INNATE IMMUNITY; CDNA CLONING; PATTERN-RECOGNITION; LIPOTEICHOIC ACID; HOST-DEFENSE; BOMBYX-MORI	We characterize a novel pathogen recognition protein obtained from the lepidopteran Galleria mellonella. This protein recognizes Escherichia coli, Micrococcus luteus, and Candida albicans via specific binding to lipopolysaccharides, lipoteichoic acid, and beta-1,3-glucan, respectively. As a multiligand receptor capable of coping with a broad variety of invading pathogens, it is constitutively produced in the fat body, midgut, and integument but not in the hemocytes and is secreted into the hemolymph. The protein was confirmed to be relevant to cellular immune response and to further function as an opsonin that promotes the uptake of invading microorganisms into hemocytes. Our data reveal that the mechanism by which a multiligand receptor recognizes microorganisms contributes substantially to their phagocytosis by hemocytes. A better understanding of an opsonin with the required repertoire for detecting diverse invaders might provide us with critical insights into the mechanisms underlying insect phagocytosis.	[Kim, Chong Han; Shin, Yong Pyo; Lee, In Hee] Hoseo Univ, Dept Biotechnol, Asan 336795, Chungnam, South Korea; [Noh, Mi Young; Jo, Yong Hun; Han, Yeon Soo] Chonnam Natl Univ, Coll Agr & Life Sci, Dept Agr Biol, Kwangju 500257, South Korea; [Seong, Yeon Sun] Dankook Univ, Coll Med, Dept Biochem, Cheonan 330714, Chungnam, South Korea	Hoseo University; Chonnam National University; Dankook University	Lee, IH (corresponding author), Hoseo Univ, Dept Biotechnol, Asan 336795, Chungnam, South Korea.	leeih@hoseo.edu	SEONG, YEON-SUN/B-2485-2016	SEONG, YEON-SUN/0000-0002-4743-8048	National Research Foundation of Korea [NRF 2009-007/968]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by National Research Foundation of Korea Grant NRF 2009-007/968.	Boman HG, 1998, SCAND J IMMUNOL, V48, P15; Costa SCP, 2005, J INSECT PHYSIOL, V51, P39, DOI 10.1016/j.jinsphys.2004.10.014; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Franc NC, 1996, IMMUNITY, V4, P431, DOI 10.1016/S1074-7613(00)80410-0; Frobius AC, 2000, EUR J BIOCHEM, V267, P2046, DOI 10.1046/j.1432-1327.2000.01207.x; Halwani AE, 2000, J INVERTEBR PATHOL, V76, P233, DOI 10.1006/jipa.2000.4978; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Iimura Y, 1998, ARCH INSECT BIOCHEM, V38, P119, DOI 10.1002/(SICI)1520-6327(1998)38:3&lt;119::AID-ARCH2&gt;3.0.CO;2-N; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kim CH, 2004, MOL CELLS, V17, P262; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Kurucz E, 2007, CURR BIOL, V17, P649, DOI 10.1016/j.cub.2007.02.041; Lagueux M, 2000, P NATL ACAD SCI USA, V97, P11427, DOI 10.1073/pnas.97.21.11427; Lee YS, 2004, INSECT MOL BIOL, V13, P65, DOI 10.1111/j.1365-2583.2004.00462.x; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Ling EJ, 2009, INSECT BIOCHEM MOLEC, V39, P263, DOI 10.1016/j.ibmb.2008.12.006; Moita LF, 2005, IMMUNITY, V23, P65, DOI 10.1016/j.immuni.2005.05.006; Nagai T, 2000, J BIOL CHEM, V275, P29264, DOI 10.1074/jbc.M002556200; Park SY, 2005, DEV COMP IMMUNOL, V29, P43, DOI 10.1016/j.dci.2004.06.001; Schmidt O, 2010, ANNU REV ENTOMOL, V55, P485, DOI 10.1146/annurev.ento.54.110807.090618; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Scott MG, 1999, INFECT IMMUN, V67, P6445; Shrivastava B, 2003, INSECT BIOCHEM MOLEC, V33, P1025, DOI 10.1016/S0965-1748(03)00117-6; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Stuart LM, 2008, NAT REV IMMUNOL, V8, P131, DOI 10.1038/nri2240; Takehana A, 2004, EMBO J, V23, P4690, DOI 10.1038/sj.emboj.7600466; Wang XG, 2006, CELL MICROBIOL, V8, P1581, DOI 10.1111/j.1462-5822.2006.00732.x; Watanabe A, 2006, J IMMUNOL, V177, P4594, DOI 10.4049/jimmunol.177.7.4594; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Whitten MMA, 2004, J IMMUNOL, V172, P2177, DOI 10.4049/jimmunol.172.4.2177; Yoshida H, 1996, J BIOL CHEM, V271, P13854, DOI 10.1074/jbc.271.23.13854; Yu XQ, 2002, EUR J BIOCHEM, V269, P1827, DOI 10.1046/j.1432-1033.2002.02830.x; Yu XQ, 2000, J BIOL CHEM, V275, P37373, DOI 10.1074/jbc.M003021200	34	22	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25243	25250		10.1074/jbc.M110.134940	http://dx.doi.org/10.1074/jbc.M110.134940			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20519517	hybrid, Green Published			2022-12-27	WOS:000280682400017
J	Suzuki-Inoue, K; Inoue, O; Ding, G; Nishimura, S; Hokamura, K; Eto, K; Kashiwagi, H; Tomiyama, Y; Yatomi, Y; Umemura, K; Shin, Y; Hirashima, M; Ozaki, Y				Suzuki-Inoue, Katsue; Inoue, Osamu; Ding, Guo; Nishimura, Satoshi; Hokamura, Kazuya; Eto, Koji; Kashiwagi, Hirokazu; Tomiyama, Yoshiaki; Yatomi, Yutaka; Umemura, Kazuo; Shin, Yonchol; Hirashima, Masanori; Ozaki, Yukio			Essential in Vivo Roles of the C-type Lectin Receptor CLEC-2 EMBRYONIC/NEONATAL LETHALITY OF CLEC-2-DEFICIENT MICE BY BLOOD/LYMPHATIC MISCONNECTIONS AND IMPAIRED THROMBUS FORMATION OF CLEC-2-DEFICIENT PLATELETS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-AGGREGATION; LYMPHATIC VASCULATURE; GLYCOPROTEIN-VI; PODOPLANIN; ACTIVATION; COLLAGEN; BLOOD; MICE; GPVI; SYK	CLEC-2 has been described recently as playing crucial roles in thrombosis/hemostasis, tumor metastasis, and lymphangiogenesis. The snake venom rhodocytin is known as a strong platelet activator, and we have shown that this effect is mediated by CLEC-2 (Suzuki-Inoue, K., Fuller, G. L., Garc a, A., Eble, J. A., Pohlmann, S., Inoue, O., Gartner, T. K., Hughan, S. C., Pearce, A. C., Laing, G. D., Theakston, R. D., Schweighoffer, E., Zitzmann, N., Morita, T., Tybulewicz, V. L., Ozaki, Y., and Watson, S. P. (2006) Blood 107, 542-549). Podoplanin, which is expressed on the surface of tumor cells, is an endogenous ligand for CLEC-2 and facilitates tumor metastasis by inducing platelet aggregation. Mice deficient in podoplanin, which is also expressed on the surface of lymphatic endothelial cells, show abnormal patterns of lymphatic vessel formation. In this study, we report on the generation and phenotype of CLEC-2-deficient mice. These mice are lethal at the embryonic/neonatal stages associated with disorganized and blood-filled lymphatic vessels and severe edema. Moreover, by transplantation of fetal liver cells from Clec-2(-/-) or Clec-2(+/+) embryos, we were able to demonstrate that CLEC-2 is involved in thrombus stabilization in vitro and in vivo, possibly through homophilic interactions without apparent increase in bleeding tendency. We propose that CLEC-2 could be an ideal novel target protein for an anti-platelet drug, which inhibits pathological thrombus formation but not physiological hemostasis.	[Suzuki-Inoue, Katsue; Inoue, Osamu; Ozaki, Yukio] Univ Yamanashi, Clin & Lab Med Dept, Fac Med, Yamanashi 4093898, Japan; [Ding, Guo; Hirashima, Masanori] Kobe Univ, Div Vasc Biol, Dept Physiol & Cell Biol, Sch Med, Kobe, Hyogo 6500017, Japan; [Nishimura, Satoshi] Univ Tokyo, Dept Cardiovasc Med, Tokyo 1138655, Japan; [Nishimura, Satoshi] Univ Tokyo, Dept Lab Med, Grad Sch Med, Tokyo 1138655, Japan; [Nishimura, Satoshi] Univ Tokyo, Dept Translat Syst Biol & Med Initiat, Tokyo 1138655, Japan; [Nishimura, Satoshi] PREST, Japan Sci & Technol Agcy, Bunkyo Ku, Tokyo 1138655, Japan; [Hokamura, Kazuya; Umemura, Kazuo] Hamamatsu Univ Sch Med, Dept Pharmacol, Hamamatsu, Shizuoka 4313192, Japan; [Eto, Koji] Univ Tokyo, Stem Cell Bank, Ctr Stem Cell Biol & Regenerat Med, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Kashiwagi, Hirokazu] Osaka Univ, Dept Haematol & Oncol, Grad Sch Med C9, Suita, Osaka 5650871, Japan; [Yatomi, Yutaka] Osaka Univ Hosp, Dept Blood Transfus, Osaka 5650879, Japan; [Shin, Yonchol] Kogakuin Univ, Dept Appl Chem, Fac Engn, Tokyo 1920015, Japan	University of Yamanashi; Kobe University; University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Hamamatsu University School of Medicine; University of Tokyo; Osaka University; Osaka University; Kogakuin University	Suzuki-Inoue, K (corresponding author), Univ Yamanashi, Clin & Lab Med Dept, Fac Med, 1110 Shimokato, Yamanashi 4093898, Japan.	katsuei@yamanashi.ac.jp; oinoue@yamanashi.ac.jp	Hirashima, Masanori/ABC-9204-2021	Hirashima, Masanori/0000-0002-0190-4381; Yatomi, Yutaka/0000-0003-1719-4297; Tomiyama, Yoshiaki/0000-0001-7645-0989	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the Ministry of Health, Labor, and Welfare of Japan.	Abtahian F, 2003, SCIENCE, V299, P247, DOI 10.1126/science.1079477; BreitenederGeleff S, 1997, AM J PATHOL, V151, P1141; Cambi A, 2003, CURR OPIN CELL BIOL, V15, P539, DOI 10.1016/j.ceb.2003.08.004; Cambien B, 2003, J CLIN INVEST, V112, P1589, DOI 10.1172/JCI200319284; Christou CM, 2008, BIOCHEM J, V411, P133, DOI 10.1042/BJ20071216; Fu JX, 2008, J CLIN INVEST, V118, P3725, DOI 10.1172/JCI36077; Fuller GLJ, 2007, J BIOL CHEM, V282, P12397, DOI 10.1074/jbc.M609558200; Hirashima M, 2008, DEV BIOL, V316, P149, DOI 10.1016/j.ydbio.2008.01.023; Hughes CE, 2010, BLOOD, V115, P2947, DOI 10.1182/blood-2009-08-237834; Ichise H, 2009, DEVELOPMENT, V136, P191, DOI 10.1242/dev.025353; Inoue O, 2006, BLOOD, V107, P1405, DOI 10.1182/blood-2005-06-2406; Inoue O, 2009, FEBS LETT, V583, P81, DOI 10.1016/j.febslet.2008.11.026; Kato Y, 2008, CANCER SCI, V99, P54, DOI 10.1111/j.1349-7006.2007.00634.x; Kerrigan AM, 2009, J IMMUNOL, V182, P4150, DOI 10.4049/jimmunol.0802808; Law DA, 1999, NATURE, V401, P808, DOI 10.1038/44599; Mangin P, 2006, BLOOD, V107, P4346, DOI 10.1182/blood-2005-10-4244; Marshall ASJ, 2004, EUR J IMMUNOL, V34, P18, DOI 10.1002/eji.200324641; May F, 2009, BLOOD, V114, P3464, DOI 10.1182/blood-2009-05-222273; Miura Y, 2002, J BIOL CHEM, V277, P46197, DOI 10.1074/jbc.M204029200; MOROI M, 1989, J CLIN INVEST, V84, P1440, DOI 10.1172/JCI114318; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Nishimura S, 2008, J CLIN INVEST, V118, P710, DOI 10.1172/JCI33328; Schacht V, 2005, AM J PATHOL, V166, P913, DOI 10.1016/S0002-9440(10)62311-5; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Shin Y, 1998, BIOCHEM BIOPH RES CO, V245, P741, DOI 10.1006/bbrc.1998.8516; SUGIYAMA T, 1987, BLOOD, V69, P1712; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Suzuki-Inoue K, 2003, BLOOD, V102, P1367, DOI 10.1182/blood-2003-01-0029; Suzuki-Inoue K, 2001, BLOOD, V98, P3708, DOI 10.1182/blood.V98.13.3708; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200; Takizawa H, 2010, J CLIN INVEST, V120, P179, DOI 10.1172/JCI39503; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Uhrin P, 2010, BLOOD, V115, P3997, DOI 10.1182/blood-2009-04-216069; Watson AA, 2009, BIOCHEMISTRY-US, V48, P10988, DOI 10.1021/bi901427d	34	179	182	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24494	24507		10.1074/jbc.M110.130575	http://dx.doi.org/10.1074/jbc.M110.130575			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20525685	hybrid, Green Published			2022-12-27	WOS:000280542100022
J	Arent, S; Christensen, CE; Pye, VE; Norgaard, A; Henriksen, A				Arent, Susan; Christensen, Caspar E.; Pye, Valerie E.; Norgaard, Allan; Henriksen, Anette			The Multifunctional Protein in Peroxisomal beta-Oxidation STRUCTURE AND SUBSTRATE SPECIFICITY OF THE ARABIDOPSIS THALIANA PROTEIN MFP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENOYL-COA HYDRATASE; FATTY-ACID OXIDATION; ANGSTROM CRYSTAL-STRUCTURE; RAT-LIVER PEROXISOMES; ACYL-COA; COENZYME-A; DELTA(3)-DELTA(2)-ENOYL-COA ISOMERASE; L-3-HYDROXYACYL-COA DEHYDROGENASE; JASMONATE BIOSYNTHESIS; STRUCTURAL BASIS	Plant fatty acids can be completely degraded within the peroxisomes. Fatty acid degradation plays a role in several plant processes including plant hormone synthesis and seed germination. Two multifunctional peroxisomal isozymes, MFP2 and AIM1, both with 2-trans-enoyl-CoA hydratase and L-3-hydroxyacyl-CoA dehydrogenase activities, function in mouse ear cress (Arabidopsis thaliana) peroxisomal beta-oxidation, where fatty acids are degraded by the sequential removal of two carbon units. A deficiency in either of the two isozymes gives rise to a different phenotype; the biochemical and molecular background for these differences is not known. Structure determination of Arabidopsis MFP2 revealed that plant peroxisomal MFPs can be grouped into two families, as defined by a specific pattern of amino acid residues in the flexible loop of the acyl-binding pocket of the 2-trans-enoyl-CoA hydratase domain. This could explain the differences in substrate preferences and specific biological functions of the two isozymes. The in vitro substrate preference profiles illustrate that the Arabidopsis AIM1 hydratase has a preference for short chain acyl-CoAs compared with the Arabidopsis MFP2 hydratase. Remarkably, neither of the two was able to catabolize enoyl-CoA substrates longer than 14 carbon atoms efficiently, suggesting the existence of an uncharacterized long chain enoyl-CoA hydratase in Arabidopsis peroxisomes.	[Arent, Susan; Christensen, Caspar E.; Pye, Valerie E.; Norgaard, Allan; Henriksen, Anette] Carlsberg Lab, Prot Chem Grp, DK-2500 Copenhagen, Denmark		Henriksen, A (corresponding author), Carlsberg Lab, Prot Chem Grp, Gamle Carlsberg Vej 10, DK-2500 Copenhagen, Denmark.	anette@crc.dk	Christensen, Caspar Elo/K-2753-2014	Christensen, Caspar Elo/0000-0002-0214-8477; Pye, Valerie E/0000-0001-9616-2992; Henriksen, Anette/0000-0003-4051-5079	Danish Natural Science Research Council	Danish Natural Science Research Council(Danish Natural Science Research Council)	This work was supported by the Danish Natural Science Research Council, which provided a postdoctoral stipend through DANSYNC (to S. A.) and synchrotron beam time.	ADAMS MJ, 1994, STRUCTURE, V2, P651, DOI 10.1016/S0969-2126(00)00066-6; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afitlhile MM, 2005, PLANT PHYSIOL BIOCH, V43, P603, DOI 10.1016/j.plaphy.2005.03.016; BAHNSON BJ, 1991, BIOCHEMISTRY-US, V30, P5894, DOI 10.1021/bi00238a013; Bahnson BJ, 2002, BIOCHEMISTRY-US, V41, P2621, DOI 10.1021/bi015844p; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barycki JJ, 2000, J BIOL CHEM, V275, P27186; Barycki JJ, 1999, BIOCHEMISTRY-US, V38, P5786, DOI 10.1021/bi9829027; Barycki JJ, 2001, J BIOL CHEM, V276, P36718, DOI 10.1074/jbc.M104839200; Benning MM, 1996, BIOCHEMISTRY-US, V35, P8103, DOI 10.1021/bi960768p; Benning MM, 2000, BIOCHEMISTRY-US, V39, P4630, DOI 10.1021/bi9928896; Castillo MC, 2004, PLANT PHYSIOL, V135, P85, DOI 10.1104/pp.104.039925; CONSTANTINIDES PP, 1985, J BIOL CHEM, V260, P7573; COOPER TG, 1969, J BIOL CHEM, V244, P3514; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DAWSON RMC, 1978, DATA BIOCH RES, P191; Delker C, 2007, PHYTOCHEMISTRY, V68, P1642, DOI 10.1016/j.phytochem.2007.04.024; Eastmond PJ, 2000, BIOCHEM SOC T, V28, P95, DOI 10.1042/bst0280095; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel CK, 1998, J MOL BIOL, V275, P847, DOI 10.1006/jmbi.1997.1491; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fath A, 2000, PLANT MOL BIOL, V44, P255, DOI 10.1023/A:1026584207243; Feng YG, 2002, BIOCHEMISTRY-US, V41, P12883, DOI 10.1021/bi020382g; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Gille C, 2003, BIOINFORMATICS, V19, P2489, DOI 10.1093/bioinformatics/btg354; Goepfert S, 2006, J BIOL CHEM, V281, P35894, DOI 10.1074/jbc.M606383200; Graham IA, 2002, PROG LIPID RES, V41, P156, DOI 10.1016/S0163-7827(01)00022-4; GUHNEMANNSCHAFER K, 1995, PLANTA, V196, P642, DOI 10.1007/BF01106755; Guney E, 2008, NUCLEIC ACIDS RES, V36, pD662, DOI 10.1093/nar/gkm813; He XY, 1997, BIOCHEMISTRY-US, V36, P261, DOI 10.1021/bi961841e; Hooks MA, 1999, PLANT J, V20, P1, DOI 10.1046/j.1365-313X.1999.00559.x; HOOKS MA, 1995, PHYTOCHEMISTRY, V40, P657, DOI 10.1016/0031-9422(95)98169-H; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Ishikawa M, 2004, EMBO J, V23, P2745, DOI 10.1038/sj.emboj.7600298; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kiema TR, 1999, BIOCHEMISTRY-US, V38, P2991, DOI 10.1021/bi981646v; KINDL H, 1987, BIOCH PLANTS, V9, P31; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAZAROW PB, 1978, J BIOL CHEM, V253, P1522; LEMIEUX B, 1990, THEOR APPL GENET, V80, P234, DOI 10.1007/BF00224392; Leonard PM, 2004, J BIOL CHEM, V279, P31312, DOI 10.1074/jbc.M403514200; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Li CY, 2005, PLANT CELL, V17, P971, DOI 10.1105/tpc.104.029108; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOLLER W, 1985, FEBS LETT, V186, P1, DOI 10.1016/0014-5793(85)81326-0; MULLERNEWEN G, 1995, EUR J BIOCHEM, V228, P68, DOI 10.1111/j.1432-1033.1995.tb20230.x; Mursula AM, 2004, FEBS LETT, V557, P81, DOI 10.1016/S0014-5793(03)01450-9; NOYES B E, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1334, DOI 10.1073/pnas.71.4.1334; Ogmen U, 2005, NUCLEIC ACIDS RES, V33, pW331, DOI 10.1093/nar/gki585; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; PALOSAARI PM, 1990, J BIOL CHEM, V265, P2446; Partanen ST, 2004, J MOL BIOL, V342, P1197, DOI 10.1016/j.jmb.2004.07.039; Pedersen L, 2004, ACTA CRYSTALLOGR D, V60, P1125, DOI 10.1107/S0907444904007577; Pinfield-Wells H, 2005, PLANT J, V43, P861, DOI 10.1111/j.1365-313X.2005.02498.x; PREISIGMULLER R, 1994, J BIOL CHEM, V269, P20475; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Richmond TA, 1999, PLANT CELL, V11, P1911, DOI 10.1105/tpc.11.10.1911; Rylott EL, 2006, PLANT J, V45, P930, DOI 10.1111/j.1365-313X.2005.02650.x; Sakurai T, 2005, NUCLEIC ACIDS RES, V33, pD647, DOI 10.1093/nar/gki014; Schilmiller AL, 2007, PLANT PHYSIOL, V143, P812, DOI 10.1104/pp.106.092916; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Taskinen JP, 2006, J MOL BIOL, V355, P734, DOI 10.1016/j.jmb.2005.10.085; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Titorenko VI, 2002, J CELL BIOL, V156, P481, DOI 10.1083/jcb.200111075; Tsuchiya D, 2006, STRUCTURE, V14, P237, DOI 10.1016/j.str.2005.10.011; UCHIDA Y, 1992, J BIOL CHEM, V267, P1034; WILLADSEN P, 1975, EUR J BIOCHEM, V54, P247, DOI 10.1111/j.1432-1033.1975.tb04134.x; YANG SY, 1985, J BIOL CHEM, V260, P2862; YANG SY, 1986, J BIOL CHEM, V261, P5390; Yao KW, 1996, J BIOL CHEM, V271, P17816, DOI 10.1074/jbc.271.30.17816; Ylianttila MS, 2006, J MOL BIOL, V358, P1286, DOI 10.1016/j.jmb.2006.03.001; Zolman BR, 2008, GENETICS, V180, P237, DOI 10.1534/genetics.108.090399	77	33	39	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24066	24077		10.1074/jbc.M110.106005	http://dx.doi.org/10.1074/jbc.M110.106005			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20463021	Green Published, hybrid			2022-12-27	WOS:000280291400057
J	Mattiello, T; Fiore, G; Brown, ER; d'Ischia, M; Palumbo, A				Mattiello, Teresa; Fiore, Gabriella; Brown, Euan R.; d'Ischia, Marco; Palumbo, Anna			Nitric Oxide Mediates the Glutamate-dependent Pathway for Neurotransmission in Sepia officinalis Chromatophore Organs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDOLEAMINE 2,3-DIOXYGENASE; RYANODINE RECEPTOR; SYNTHASE; LOCALIZATION; RELEASE; CALCIUM; DONORS; SQUID; STIMULATION; SKELETAL	Chromatophore organs are complex and unique structures responsible for the variety of body coloration patterns used by cephalopods to communicate and camouflage. They are formed by a pigment-containing cytoelastic sacculus, surrounded by muscle fibers directly innervated from the brain. Muscle contraction and relaxation are responsible for expansion and retraction of the pigment-containing cell. Their functioning depends on glutamate and Phe-Met-Arg-Phe-NH2-related peptides, which induce fast and slow cell expansion, respectively, and 5-hydroxytryptamine, which induces retraction. Apart from these three substances and acetylcholine, which acts presynaptically, no other neuroactive compounds have so far been found to be involved in the neuroregulation of chromatophore physiology, and the detailed signaling mechanisms are still little understood. Herein, we disclose the role of nitric oxide (NO) as mediator in one of the signaling pathways by which glutamate activates body patterning. NO and nitric-oxide synthase have been detected in pigment and muscle fibers of embryo, juvenile, and adult chromatophore organs from Sepia officinalis. NO-mediated Sepia chromatophore expansion operates at slower rate than glutamate and involves cGMP, cyclic ADP-ribose, and ryanodine receptor activation. These results demonstrate for the first time that NO is an important messenger in the long term maintenance of the body coloration patterns in Sepia.	Stn Zool Anton Dohrn, Lab Cellular & Dev Biol, I-80121 Naples, Italy; [Brown, Euan R.] Stn Zool Anton Dohrn, Lab Anim Physiol & Evolut, I-80121 Naples, Italy; [d'Ischia, Marco] Univ Naples Federico II, Dept Organ Chem & Biochem, I-80126 Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli; Stazione Zoologica Anton Dohrn di Napoli; University of Naples Federico II		palumbo@szn.it	d'Ischia, Marco/C-9837-2011; Brown, Euan Robert/I-2389-2019; Brown, Euan R/A-5558-2008	d'Ischia, Marco/0000-0002-7184-0029; Brown, Euan Robert/0000-0002-5995-834X; Brown, Euan R/0000-0002-5995-834X; Palumbo, Anna/0000-0002-5972-5589				Campbell RK, 2007, AM J PHYSIOL-GASTR L, V292, pG1543, DOI 10.1152/ajpgi.00111.2006; Carvajal JA, 2000, J CELL PHYSIOL, V184, P409, DOI 10.1002/1097-4652(200009)184:3<409::AID-JCP16>3.3.CO;2-B; Chao DS, 1996, METHOD ENZYMOL, V268, P488; Davidson SK, 2004, CELL MICROBIOL, V6, P1139, DOI 10.1111/j.1462-5822.2004.00429.x; Di Cosmo A, 2000, J COMP NEUROL, V428, P411, DOI 10.1002/1096-9861(20001218)428:3<411::AID-CNE3>3.0.CO;2-#; Di Cristo C, 2007, EUR J NEUROSCI, V26, P1599, DOI 10.1111/j.1460-9568.2007.05765.x; DUBAS F, 1986, J EXP BIOL, V121, P1; Fiore G, 2004, BIOCHEM J, V378, P785, DOI 10.1042/BJ20031864; FLOREY E, 1969, AM ZOOL, V9, P429; FOX HM, 1960, NATURE ANIMAL COLOUR, P50; Halm MP, 2003, COMP BIOCHEM PHYS C, V134, P139, DOI 10.1016/S1532-0456(02)00223-5; Han Q, 2003, INSECT MOL BIOL, V12, P483, DOI 10.1046/j.1365-2583.2003.00433.x; Hanlon R, 2007, CURR BIOL, V17, pR400, DOI 10.1016/j.cub.2007.03.034; HANLON RT, 1988, PHILOS T ROY SOC B, V320, P437, DOI 10.1098/rstb.1988.0087; Keefer LK, 1996, METHOD ENZYMOL, V268, P281; KOBZIK L, 1994, NATURE, V372, P546, DOI 10.1038/372546a0; Kojima H, 1999, ANGEW CHEM INT EDIT, V38, P3209, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3209::AID-ANIE3209>3.0.CO;2-6; LEMAIRE J, 1970, Bulletin de la Societe Zoologique de France, V95, P773; Li Q, 2009, NITRIC OXIDE-BIOL CH, V21, P69, DOI 10.1016/j.niox.2009.04.001; Lima PA, 2003, EUR J NEUROSCI, V17, P507, DOI 10.1046/j.1460-9568.2003.02477.x; LIMA PA, 1997, J PHYSL, pP2; LIMA PA, 1998, J PHYSL, pP127; Loi PK, 1997, J EXP BIOL, V200, P1483; Loi PK, 1996, J EXP BIOL, V199, P1177; Lopez AS, 2006, IMMUNOL LETT, V106, P163, DOI 10.1016/j.imlet.2006.05.008; Messenger JB, 2001, BIOL REV, V76, P473, DOI 10.1017/S1464793101005772; Packard A., 1977, Symposia of the Zoological Society of London, P191; Palumbo A, 1999, J NEUROCHEM, V73, P1254, DOI 10.1046/j.1471-4159.1999.0731254.x; Palumbo A, 2000, J BIOL CHEM, V275, P16885, DOI 10.1074/jbc.M909509199; Palumbo A, 2007, ADV EXP BIOL, V1, P45, DOI 10.1016/S1872-2423(07)01002-2; Ramamurthi A, 1997, CHEM RES TOXICOL, V10, P408, DOI 10.1021/tx960183w; ROBERTSON JD, 1994, P ROY SOC B-BIOL SCI, V256, P269, DOI 10.1098/rspb.1994.0080; Robertson JD, 1996, P ROY SOC B-BIOL SCI, V263, P1739, DOI 10.1098/rspb.1996.0254; Schipp R., 1999, Invertebrate Neuroscience, V4, P9, DOI 10.1007/s101580050002; Schmidt K, 1997, N-S ARCH PHARMACOL, V355, P457, DOI 10.1007/PL00004969; Stoyanovsky D, 1997, CELL CALCIUM, V21, P19, DOI 10.1016/S0143-4160(97)90093-2; Thomas SR, 2007, J BIOL CHEM, V282, P23778, DOI 10.1074/jbc.M700669200; Tu YJ, 2000, BRAIN RES, V865, P211, DOI 10.1016/S0006-8993(00)02222-8; Welshhans K, 2007, EUR J NEUROSCI, V26, P1537, DOI 10.1111/j.1460-9568.2007.05768.x; Willmott N, 1996, J BIOL CHEM, V271, P3699; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234	41	21	21	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24154	24163		10.1074/jbc.M109.083428	http://dx.doi.org/10.1074/jbc.M109.083428			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20516065	hybrid, Green Published			2022-12-27	WOS:000280291400065
J	Snyder, M; Huang, XY; Zhang, JJ				Snyder, Marylynn; Huang, Xin-Yun; Zhang, J. Jillian			Stat3 Directly Controls the Expression of Tbx5, Nkx2.5, and GATA4 and Is Essential for Cardiomyocyte Differentiation of P19CL6 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTORS; SIGNAL TRANSDUCERS; DNA-BINDING; GENE; HEART; GROWTH; ACTIVATION; ROLES; INHIBITION	The transcription factor Stat3 (signal transducer and activator of transcription 3) mediates many physiological processes, including embryogenesis, stem cell self-renewal, and postnatal survival. In response to gp130 receptor activation, Stat3 becomes phosphorylated by the receptor-associated Janus kinase, forms dimers, and enters the nucleus where it binds to Stat3 target genes and regulates their expression. In this report, we demonstrate that Stat3 binds directly to the promoters and regulates the expression of three genes that are essential for cardiac differentiation: Tbx5, Nkx2.5, and GATA4. We further demonstrate that Tbx5, Nkx2.5, and GATA4 expression is dependent on Stat3 in response to ligand treatment and during ligand-independent differentiation of P19CL6 cells into cardiomyocytes. Finally, we show that Stat3 is necessary for the differentiation of P19CL6 cells into beating cardiomyocytes. All together, these results demonstrate that Stat3 is required for the differentiation of cardiomyocytes through direct transcriptional regulation of Tbx5, Nkx2.5, and GATA4.	[Snyder, Marylynn; Huang, Xin-Yun; Zhang, J. Jillian] Cornell Univ, Dept Physiol & Biophys, Weill Med Coll, New York, NY 10065 USA	Cornell University	Zhang, JJ (corresponding author), Cornell Univ, Dept Physiol & Biophys, Weill Med Coll, 1300 York Ave, New York, NY 10065 USA.	jjz2002@med.cornell.edu			National Institutes of Health [HL091525]; American Heart Association [0455896T]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL091525 (to X.-Y.H.). This work was also supported by American Heart Association Grant 0455896T (to J.J.Z.).	Akira S, 2000, ONCOGENE, V19, P2607, DOI 10.1038/sj.onc.1203478; AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Akira S, 1999, STEM CELLS, V17, P138, DOI 10.1002/stem.170138; Aparicio OM, 2005, CURR PROTOC MOL BIOL; Becker S, 1998, FEBS LETT, V441, P141, DOI 10.1016/S0014-5793(98)01543-9; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Foshay K, 2005, STEM CELLS, V23, P530, DOI 10.1634/stemcells.2004-0293; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Garry DJ, 2006, CELL, V127, P1101, DOI 10.1016/j.cell.2006.11.031; Grepin C, 1997, DEVELOPMENT, V124, P2387; GREPIN C, 1995, MOL CELL BIOL, V15, P4095; HabaraOhkubo A, 1996, CELL STRUCT FUNCT, V21, P101, DOI 10.1247/csf.21.101; Hagihara K, 2005, GENES CELLS, V10, P1051, DOI 10.1111/j.1365-2443.2005.00900.x; Haspel RL, 1996, EMBO J, V15, P6262, DOI 10.1002/j.1460-2075.1996.tb01016.x; Hatcher CJ, 2004, PHYSIOL GENOMICS, V18, P129, DOI 10.1152/physiolgenomics.00060.2004; Hatcher CJ, 2003, TRENDS MOL MED, V9, P512, DOI 10.1016/j.molmed.2003.10.004; Haura EB, 2005, NAT CLIN PRACT ONCOL, V2, P315, DOI 10.1038/ncponc0195; Heinrich PC, 1998, Z ERNAHRUNGSWISS, V37, P43; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Horb ME, 1999, DEVELOPMENT, V126, P1739; Ichiba M, 1998, J BIOL CHEM, V273, P6132, DOI 10.1074/jbc.273.11.6132; Kami K, 2002, J HISTOCHEM CYTOCHEM, V50, P1579, DOI 10.1177/002215540205001202; Kataoka Y, 2003, J BIOL CHEM, V278, P44178, DOI 10.1074/jbc.M304884200; Lerner L, 2003, GENE DEV, V17, P2564, DOI 10.1101/gad.1135003; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Liu N, 2006, CURR OPIN CELL BIOL, V18, P715, DOI 10.1016/j.ceb.2006.10.003; Liu TH, 2005, CURR APPL PHYS, V5, P218, DOI 10.1016/j.cap.2003.11.089; Maitra M, 2009, DEV BIOL, V326, P368, DOI 10.1016/j.ydbio.2008.11.004; Megeney LA, 1996, DEV GENET, V19, P139, DOI 10.1002/(SICI)1520-6408(1996)19:2<139::AID-DVG5>3.0.CO;2-A; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; OLSON EN, 1993, CIRC RES, V72, P1, DOI 10.1161/01.RES.72.1.1; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Pikkarainen S, 2004, CARDIOVASC RES, V63, P196, DOI 10.1016/j.cardiores.2004.03.025; Rajasingh J, 2007, CIRC RES, V101, P910, DOI 10.1161/CIRCRESAHA.107.156786; Ramsauer K, 2007, P NATL ACAD SCI USA, V104, P2849, DOI 10.1073/pnas.0610944104; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; Riazi AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005698; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Sehgal PB, 2008, SEMIN CELL DEV BIOL, V19, P329, DOI 10.1016/j.semcdb.2008.07.003; SEIDEL HM, 1995, P NATL ACAD SCI USA, V92, P3041, DOI 10.1073/pnas.92.7.3041; Shen YH, 2004, MOL CELL BIOL, V24, P407, DOI 10.1128/MCB.24.1.407-419.2004; Snyder M, 2005, P NATL ACAD SCI USA, V102, P14539, DOI 10.1073/pnas.0507479102; Snyder M, 2008, J BIOL CHEM, V283, P3791, DOI 10.1074/jbc.M706976200; Snyder M, 2009, J BIOL CHEM, V284, P13466, DOI 10.1074/jbc.M809471200; Sun W, 2006, FEBS LETT, V580, P5880, DOI 10.1016/j.febslet.2006.09.054; Tanaka M, 1999, DEVELOPMENT, V126, P1269; Xu WF, 2005, J INTERF CYTOK RES, V25, P113, DOI 10.1089/jir.2005.25.113; Yang JB, 2008, CELL RES, V18, P443, DOI 10.1038/cr.2008.41; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yu ZY, 2002, BIOCHEM J, V367, P97, DOI 10.1042/BJ20020588; Zhang XK, 1999, MOL CELL BIOL, V19, P7138	54	45	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23639	23646		10.1074/jbc.M110.101063	http://dx.doi.org/10.1074/jbc.M110.101063			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20522556	Green Published, hybrid			2022-12-27	WOS:000280291400014
J	Ivanov, SV; Goparaju, CMV; Lopez, P; Zavadil, J; Toren-Haritan, G; Rosenwald, S; Hoshen, M; Chajut, A; Cohen, D; Pass, HI				Ivanov, Sergey V.; Goparaju, Chandra M. V.; Lopez, Peter; Zavadil, Jiri; Toren-Haritan, Ginat; Rosenwald, Shai; Hoshen, Moshe; Chajut, Ayelet; Cohen, Dalia; Pass, Harvey I.			Pro-tumorigenic Effects of miR-31 Loss in Mesothelioma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALIGNANT PLEURAL MESOTHELIOMA; METHYLTHIOADENOSINE PHOSPHORYLASE; TUMOR-SUPPRESSOR; HOMOZYGOUS DELETIONS; ARRAY-CGH; RT-PCR; CANCER; MICRORNAS; GENE; QUANTIFICATION	The human genome encodes several hundred microRNA (miRNA) genes that produce small (21-23n) single strand regulatory RNA molecules. Although abnormal expression of miRNAs has been linked to cancer progression, the mechanisms of this dysregulation are poorly understood. Malignant mesothelioma (MM) of pleura is an aggressive and highly lethal cancer resistant to conventional therapies. We and others previously linked loss of the 9p21.3 chromosome in MM with short time to tumor recurrence. In this study, we report that MM cell lines derived from patients with more aggressive disease fail to express miR-31, a microRNA recently linked with suppression of breast cancer metastases. We further demonstrate that this loss is due to homozygous deletion of the miR-31-encoding gene that resides in 9p21.3. Functional assessment of miR-31 activity revealed its ability to inhibit proliferation, migration, invasion, and clonogenicity of MM cells. Re-introduction of miR-31 suppressed the cell cycle and inhibited expression of multiple factors involved in cooperative maintenance of DNA replication and cell cycle progression, including pro-survival phosphatase PPP6C, which was previously associated with chemotherapy and radiation therapy resistance, and maintenance of chromosomal stability. PPP6C, whose mRNA is distinguished with three miR-31-binding sites in its 3'-untranslated region, was consistently down-regulated by miR-31 introduction and upregulated in clinical MM specimens as compared with matched normal tissues. Taken together, our data suggest that tumor-suppressive propensity of miR-31 can be used for development of new therapies against mesothelioma and other cancers that show loss of the 9p21.3 chromosome.	[Ivanov, Sergey V.] Vanderbilt Univ Sch Med, Dept Otolaryngol, Nashville, TN 37232 USA; [Goparaju, Chandra M. V.; Pass, Harvey I.] NYU, Langone Med Ctr, Dept Cardiothorac Surg, New York, NY 10016 USA; [Lopez, Peter; Zavadil, Jiri] NYU, Langone Med Ctr, Dept Pathol, New York, NY 10016 USA; [Zavadil, Jiri; Pass, Harvey I.] NYU, Inst Canc, New York, NY 10016 USA; [Zavadil, Jiri] NYU, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA; [Toren-Haritan, Ginat; Rosenwald, Shai; Hoshen, Moshe; Chajut, Ayelet; Cohen, Dalia] Rosetta Genom Ltd, IL-76706 Rehovot, Israel	Vanderbilt University; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; New York University	Ivanov, SV (corresponding author), 654 Preston Res Bldg,2220 Pierce Ave, Nashville, TN 37232 USA.	sergey.v.ivanov@vanderbilt.edu	Zavadil, Jiri/ABG-1780-2020; Lopez, Peter/AAP-7234-2020	Zavadil, Jiri/0000-0003-0640-5562; Ivanov, Sergey/0000-0001-9770-7237; Lopez, Peter/0000-0002-8587-7148; Pass, Harvey/0000-0003-3222-3471	NCI; Mesothelioma Applied Research Foundation, Santa Barbara, CA	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mesothelioma Applied Research Foundation, Santa Barbara, CA	This work was supported, in whole or in part, by a National Institutes of Health grant from NCI, Early Detection Research Network I (to H. I. P. and Mesothelioma Biomarker Discovery Laboratory). This work was also supported by a grant from the Mesothelioma Applied Research Foundation, Santa Barbara, CA, and by donations from Belluck and Fox, LPC, and the Stephen Banner Lung Cancer Foundation.	Bastians H, 1996, J CELL SCI, V109, P2865; CALDAS C, 1994, NAT GENET, V8, P27, DOI 10.1038/ng0994-27; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2007, J CLIN INVEST, V117, P2059, DOI 10.1172/JCI32577; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Chang LL, 2003, J UROLOGY, V170, P595, DOI 10.1097/01.ju.0000067626.37837.3e; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; CHENG JQ, 1994, CANCER RES, V54, P5547; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Dacic S, 2008, VIRCHOWS ARCH, V453, P627, DOI 10.1007/s00428-008-0689-3; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Garcia-Castellano JM, 2002, CLIN CANCER RES, V8, P782; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Goshima G, 2003, EMBO J, V22, P2752, DOI 10.1093/emboj/cdg266; Grafstrom E, 2005, CLIN CANCER RES, V11, P2991, DOI 10.1158/1078-0432.CCR-04-1731; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ivanov SV, 2009, INT J CANCER, V124, P589, DOI 10.1002/ijc.23949; Ivanova AV, 2009, CLIN CANCER RES, V15, P2602, DOI 10.1158/1078-0432.CCR-08-2755; Ji Lin, 2005, Future Oncol, V1, P79, DOI 10.1517/14796694.1.1.79; Karikari CA, 2005, MOL CANCER THER, V4, P1860, DOI 10.1158/1535-7163.MCT-05-0103; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; Lesueur F, 2008, BRIT J CANCER, V99, P364, DOI 10.1038/sj.bjc.6604470; Li WW, 2004, ONCOL RES, V14, P373, DOI 10.3727/0965040041292332; Lingjaerde OC, 2005, BIOINFORMATICS, V21, P821, DOI 10.1093/bioinformatics/bti113; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Mi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004395; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Moore E, 1999, J PATHOL, V187, P403, DOI 10.1002/(SICI)1096-9896(199903)187:4<403::AID-PATH284>3.0.CO;2-J; Murthy SS, 1999, J CELL PHYSIOL, V180, P150, DOI 10.1002/(SICI)1097-4652(199908)180:2<150::AID-JCP2>3.0.CO;2-H; NOBORI T, 1991, CANCER RES, V51, P3193; NOBORI T, 1993, CANCER RES, V53, P1098; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Pass HI, 2010, CANCER RES, V70, P1916, DOI 10.1158/0008-5472.CAN-09-3993; PASS HI, 1995, ANN THORAC SURG, V59, P835, DOI 10.1016/0003-4975(95)00045-M; Petersen I, 2000, BRAIN PATHOL, V10, P395; Racanelli AC, 2009, CANCER RES, V69, P5467, DOI 10.1158/0008-5472.CAN-08-4979; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Senff NJ, 2009, J INVEST DERMATOL, V129, P1149, DOI 10.1038/jid.2008.357; Sharpless NE, 2005, MUTAT RES-FUND MOL M, V576, P22, DOI 10.1016/j.mrfmmm.2004.08.021; Usvasalo A, 2008, LEUKEMIA RES, V32, P1228, DOI 10.1016/j.leukres.2008.01.014; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Veerla S, 2009, INT J CANCER, V124, P2236, DOI 10.1002/ijc.24183; ZHANG Y, 2009, MED ONCOL IN PRESS	47	102	108	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22807	22815		10.1074/jbc.M110.100354	http://dx.doi.org/10.1074/jbc.M110.100354			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20463022	hybrid, Green Published			2022-12-27	WOS:000279999900013
J	Kultti, A; Karna, R; Rilla, K; Nurminen, P; Koli, E; Makkonen, KM; Si, JT; Tammi, MI; Tammi, RH				Kultti, Anne; Karna, Riikka; Rilla, Kirsi; Nurminen, Pertti; Koli, Elina; Makkonen, Katri M.; Si, Jutong; Tammi, Markku I.; Tammi, Raija H.			Methyl-beta-cyclodextrin Suppresses Hyaluronan Synthesis by Down-regulation of Hyaluronan Synthase 2 through Inhibition of Akt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; LIPID RAFTS; CHOLESTEROL CONTENT; EPIDERMAL-KERATINOCYTES; DERMAL FIBROBLASTS; TGF-BETA; STREPTOCOCCUS-EQUISIMILIS; DIFFERENTIAL REGULATION; ACTIVATES HYALURONAN; GENE-EXPRESSION	Hyaluronan synthases (HAS1-3) are integral plasma membrane proteins that synthesize hyaluronan, a cell surface and extracellular matrix polysaccharide necessary for many biological processes. It has been shown that HAS is partly localized in cholesterol-rich lipid rafts of MCF-7 cells, and cholesterol depletion with methyl-beta-cyclodextrin (M beta CD) suppresses hyaluronan secretion in smooth muscle cells. However, the mechanism by which cholesterol depletion inhibits hyaluronan production has remained unknown. We found that cholesterol depletion from MCF-7 cells by M beta CD inhibits synthesis but does not decrease the molecular mass of hyaluronan, suggesting no major influence on HAS stability in the membrane. The inhibition of hyaluronan synthesis was not due to the availability of HASsubstrates UDP-GlcUA and UDP-GlcNAc. Instead, M beta CD specifically down-regulated the expression of HAS2 but not HAS1 or HAS3. Screening of signaling proteins after M beta CD treatment revealed that phosphorylation of Akt and its downstream target p70S6 kinase, both members of phosphoinositide 3-kinase-Akt pathway, were inhibited. Inhibitors of this pathway suppressed hyaluronan synthesis and HAS2 expression in MCF-7 cells, suggesting that the reduced hyaluronan synthesis by M beta CD is due to down-regulation of HAS2, mediated by the phosphoinositide 3-kinase-Akt-mTOR-p70S6K pathway.	[Kultti, Anne; Karna, Riikka; Rilla, Kirsi; Nurminen, Pertti; Koli, Elina; Makkonen, Katri M.; Tammi, Markku I.; Tammi, Raija H.] Univ Eastern Finland, Inst Biomed, FIN-70211 Kuopio, Finland; [Makkonen, Katri M.] Univ Eastern Finland, Dept Biosci, FIN-70211 Kuopio, Finland; [Si, Jutong] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	University of Eastern Finland; University of Eastern Finland; Fred Hutchinson Cancer Center	Kultti, A (corresponding author), POB 1627, FIN-70211 Kuopio, Finland.	anne.kultti@uef.fi	Tammi, Markku/AAQ-7878-2021	Rilla, Kirsi/0000-0002-7862-5727	Academy of Finland [107173, 108484]; Sigrid Juselius Foundation; Finnish Cancer Foundations; The Mizutani Foundation; Finnish Cultural Foundation; The North Savo Cancer Foundation; Emil Aaltonen Foundation; Kuopio University Foundation; Paavo Koistinen Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Foundations; The Mizutani Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); The North Savo Cancer Foundation; Emil Aaltonen Foundation; Kuopio University Foundation; Paavo Koistinen Foundation	This work was supported by Academy of Finland Grants 107173 and 108484 (to M. I. T.), grants from the Sigrid Juselius Foundation (to M. I. T. and R. H. T.), Finnish Cancer Foundations (to R. H. T.), The Mizutani Foundation (to M. I. T.), Finnish Cultural Foundation (to A. K.), The North Savo Cancer Foundation (to A. K.), Emil Aaltonen Foundation (to A. K.), Kuopio University Foundation (to A. K.), and Paavo Koistinen Foundation (to A. K.).	Barnes K, 2004, BIOCHEM J, V378, P343, DOI 10.1042/BJ20031186; Bourguignon LYW, 2007, J BIOL CHEM, V282, P19426, DOI 10.1074/jbc.M610054200; Chai S, 2005, CIRC RES, V96, P583, DOI 10.1161/01.RES.0000158963.37132.8b; Christian AE, 1997, J LIPID RES, V38, P2264; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; Dattilo JB, 1998, ANN VASC SURG, V12, P168, DOI 10.1007/s100169900136; David-Raoudi M, 2009, ARTHRITIS RHEUM-US, V60, P760, DOI 10.1002/art.24302; dos Santos SM, 2007, BIOCHEM BIOPH RES CO, V354, P216, DOI 10.1016/j.bbrc.2006.12.202; Evanko SP, 1998, AM J PATHOL, V152, P533; GERTLER MM, 1950, CIRCULATION, V2, P205, DOI 10.1161/01.CIR.2.2.205; Glazer HP, 2009, CELL CYCLE, V8, P1738, DOI 10.4161/cc.8.11.8619; Goentzel BJ, 2006, BIOCHEM J, V396, P347, DOI 10.1042/BJ20051782; Graaf MR, 2004, J CLIN ONCOL, V22, P2388, DOI 10.1200/JCO.2004.02.027; Grosse PY, 1998, BRIT J CANCER, V78, P1165, DOI 10.1038/bjc.1998.648; Hooper NM, 1999, MOL MEMBR BIOL, V16, P145, DOI 10.1080/096876899294607; Jacobson A, 2000, BIOCHEM J, V348, P29, DOI 10.1042/0264-6021:3480029; Jans R, 2004, J INVEST DERMATOL, V123, P564, DOI 10.1111/j.0022-202X.2004.23221.x; Jiang BH, 2008, BBA-PROTEINS PROTEOM, V1784, P150, DOI 10.1016/j.bbapap.2007.09.008; Jokela TA, 2008, J BIOL CHEM, V283, P7666, DOI 10.1074/jbc.M706001200; Kabouridis PS, 2000, EUR J IMMUNOL, V30, P954, DOI 10.1002/1521-4141(200003)30:3<954::AID-IMMU954>3.3.CO;2-P; Kakizaki I, 2004, J BIOL CHEM, V279, P33281, DOI 10.1074/jbc.M405918200; Kakizaki I, 2002, EUR J BIOCHEM, V269, P5066, DOI 10.1046/j.1432-1033.2002.03217.x; Kaneko E, 2000, CORONARY ARTERY DIS, V11, P599, DOI 10.1097/00019501-200012000-00005; Karvinen S, 2003, J BIOL CHEM, V278, P49495, DOI 10.1074/jbc.M310445200; Kultti A, 2006, J BIOL CHEM, V281, P15821, DOI 10.1074/jbc.M512840200; Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002; Le Lay S, 2001, J BIOL CHEM, V276, P16904, DOI 10.1074/jbc.M010955200; Li LL, 2007, BIOCHEM J, V404, P327, DOI 10.1042/BJ20061757; Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959; Liao PL, 2009, TOXICOL LETT, V190, P172, DOI 10.1016/j.toxlet.2009.07.012; Liu P, 2004, AM J PHYSIOL-CELL PH, V286, pC317, DOI 10.1152/ajpcell.00073.2003; Mermelstein CS, 2007, DIFFERENTIATION, V75, P184, DOI 10.1111/j.1432-0436.2006.00129.x; Misra S, 2005, J BIOL CHEM, V280, P20310, DOI 10.1074/jbc.M500737200; Monslow J, 2004, J BIOL CHEM, V279, P20576, DOI 10.1074/jbc.M312666200; Monslow J, 2006, J BIOL CHEM, V281, P18043, DOI 10.1074/jbc.M510467200; Motoyama K, 2009, EUR J PHARM SCI, V38, P249, DOI 10.1016/j.ejps.2009.07.010; Oguchi T, 2004, CONNECT TISSUE RES, V45, P197, DOI 10.1080/03008200490523031; Pasonen-Seppanen S, 2003, J INVEST DERMATOL, V120, P1038, DOI 10.1046/j.1523-1747.2003.12249.x; Pasonen-Seppanen SM, 2008, J INVEST DERMATOL, V128, P797, DOI 10.1038/sj.jid.5701098; Pienimaki JP, 2001, J BIOL CHEM, V276, P20428, DOI 10.1074/jbc.M007601200; Platz EA, 2006, JNCI-J NATL CANCER I, V98, P1819, DOI 10.1093/jnci/djj499; Porstmann T, 2005, ONCOGENE, V24, P6465, DOI 10.1038/sj.onc.1208802; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Pummill PE, 2003, J BIOL CHEM, V278, P19808, DOI 10.1074/jbc.M301097200; Qi MS, 2009, J CELL BIOCHEM, V106, P1031, DOI 10.1002/jcb.22081; Saavalainen K, 2007, J BIOL CHEM, V282, P11530, DOI 10.1074/jbc.M607871200; Sakr SW, 2008, J BIOL CHEM, V283, P36195, DOI 10.1074/jbc.M807772200; Schlame M, 2009, BBA-BIOMEMBRANES, V1788, P2080, DOI 10.1016/j.bbamem.2009.04.019; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; STEHBENS WE, 1975, LANCET, V1, P724; Storch CH, 2007, J PHARMACOL EXP THER, V323, P257, DOI 10.1124/jpet.107.122994; Stuhlmeier KM, 2005, J IMMUNOL, V174, P7376, DOI 10.4049/jimmunol.174.11.7376; Stuhlmeier KM, 2004, J BIOL CHEM, V279, P8753, DOI 10.1074/jbc.M303945200; Stuhlmeier KM, 2004, RHEUMATOLOGY, V43, P164, DOI 10.1093/rheumatology/keh014; Swyer GIM, 1942, CANCER RES, V2, P372; Tlapak-Simmons VL, 2004, BIOCHEMISTRY-US, V43, P9234, DOI 10.1021/bi049468v; Tlapak-Simmons VL, 1999, J BIOL CHEM, V274, P4239, DOI 10.1074/jbc.274.7.4239; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; TRISCOTT MX, 1986, J BIOL CHEM, V261, P6004; Tuluc F, 2003, INT IMMUNOPHARMACOL, V3, P1775, DOI 10.1016/j.intimp.2003.08.002; Uchiyama T, 2005, BIOCHEM BIOPH RES CO, V327, P927, DOI 10.1016/j.bbrc.2004.12.092; Wang PY, 2003, EMBO J, V22, P2658, DOI 10.1093/emboj/cdg255; Weigel PH, 2006, J BIOL CHEM, V281, P36542, DOI 10.1074/jbc.M606529200; Yamada Y, 2004, J INVEST DERMATOL, V122, P631, DOI 10.1111/j.0022-202X.2004.22332.x; Zhang W, 2000, BIOCHEM J, V349, P91, DOI 10.1042/0264-6021:3490091; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026; ZILVERSMIT DB, 1975, AM J CARDIOL, V35, P559, DOI 10.1016/0002-9149(75)90840-1	67	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22899	22908		10.1074/jbc.M109.088435	http://dx.doi.org/10.1074/jbc.M109.088435			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20501660	Green Published, hybrid			2022-12-27	WOS:000279999900023
J	Nicolaes, GAF; Bock, PE; Segers, K; Wildhagen, KCAA; Dahlback, B; Rosing, J				Nicolaes, Gerry A. F.; Bock, Paul E.; Segers, Kenneth; Wildhagen, Karin C. A. A.; Dahlback, Bjorn; Rosing, Jan			Inhibition of Thrombin Formation by Active Site Mutated (S360A) Activated Protein C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION-FACTOR VA; PEPTIDE-BOND CLEAVAGES; BLOOD-COAGULATION; FACTOR-XA; FACTOR VIIIA; ANTICOAGULANT ACTIVITY; SUBSTRATE-SPECIFICITY; MEDIATED CLEAVAGES; FACTOR VA(R506Q); BINDING-SITE	Activated protein C (APC) down-regulates thrombin formation through proteolytic inactivation of factor Va (FVa) by cleavage at Arg(506) and Arg(306) and of factor VIIIa (FVIIIa) by cleavage at Arg(336) and Arg(562). To study substrate recognition by APC, active site-mutated APC (APC(S360A)) was used, which lacks proteolytic activity but exhibits anticoagulant activity. Experiments in model systems and in plasma show that APC(S360A), and not its zymogen protein C(S360A), expresses anticoagulant activities by competing with activated coagulation factors X and IX for binding to FVa and FVIIIa, respectively. APC(S360A) bound to FVa with a K-D of 0.11 +/- 0.05 nM and competed with active site-labeled Oregon Green activated coagulation factor X for binding to FVa. The binding of APC(S360A) to FVa was not affected by protein S but was inhibited by prothrombin. APC(S360A) binding to FVa was critically dependent upon the presence of Arg(506) and not Arg(306) and additionally required an active site accessible to substrates. Inhibition of FVIIIa activity by APC(S360A) was > 100-fold less efficient than inhibition of FVa. Our results show that despite exosite interactions near the Arg(506) cleavage site, binding of APC(S360A) to FVa is almost completely dependent on Arg(506) interacting with APC(S360A) to form a nonproductive Michaelis complex. Because docking of APC to FVa and FVIIIa constitutes the first step in the inactivation of the cofactors, we hypothesize that the observed anticoagulant activity may be important for in vivo regulation of thrombin formation.	[Nicolaes, Gerry A. F.; Segers, Kenneth; Wildhagen, Karin C. A. A.; Rosing, Jan] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, NL-6200 MD Maastricht, Netherlands; [Bock, Paul E.] Vanderbilt Univ, Dept Pathol, Sch Med, Nashville, TN 37232 USA; [Dahlback, Bjorn] Lund Univ, Dept Lab Med, Wallenberg Lab, Univ Hosp, SE-20502 Malmo, Sweden	Maastricht University; Vanderbilt University; Lund University; Skane University Hospital	Nicolaes, GAF (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, NL-6200 MD Maastricht, Netherlands.	G.Nicolaes@bioch.unimaas.nl	Nicolaes, Gerry A.F./A-8421-2016	Nicolaes, Gerry A.F./0000-0002-2482-0412; Dahlback, Bjorn/0000-0003-1546-0328	National Institutes of Health [RO1 HL038779]; Netherlands Organization for Scientific Research [916-046-330]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038779] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 HL038779 (to P. E. B.). This work was also supported by VIDI Grant 916-046-330 from the Netherlands Organization for Scientific Research (to G. A. F. N.).	Baglin TP, 2002, P NATL ACAD SCI USA, V99, P11079, DOI 10.1073/pnas.162232399; Baugh RJ, 2000, J BIOL CHEM, V275, P28826, DOI 10.1074/jbc.M005266200; Bianchini EP, 2005, P NATL ACAD SCI USA, V102, P10099, DOI 10.1073/pnas.0504704102; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; Bock PE, 1997, J BIOL CHEM, V272, P19837, DOI 10.1074/jbc.272.32.19837; BOCK PE, 1989, ARCH BIOCHEM BIOPHYS, V273, P375, DOI 10.1016/0003-9861(89)90496-7; Bradford HN, 2010, J BIOL CHEM, V285, P328, DOI 10.1074/jbc.M109.070334; BROEKMANS AW, 1983, NEW ENGL J MED, V309, P340, DOI 10.1056/NEJM198308113090604; Cawthern KM, 1998, BLOOD, V91, P4581, DOI 10.1182/blood.V91.12.4581.412k12_4581_4592; deGroot BL, 1997, PROTEINS, V29, P240, DOI 10.1002/(SICI)1097-0134(199710)29:2<240::AID-PROT11>3.0.CO;2-O; Friedrich U, 2001, J BIOL CHEM, V276, P23105, DOI 10.1074/jbc.M103138200; FRIEDRICH U, 1994, THROMB HAEMOSTASIS, V72, P567; Gailani D, 2001, BLOOD, V97, P3117, DOI 10.1182/blood.V97.10.3117; Gale AJ, 1997, PROTEIN SCI, V6, P132; Gale AJ, 2000, BLOOD, V96, P585; Gale AJ, 2002, J BIOL CHEM, V277, P28836, DOI 10.1074/jbc.M204363200; GRIFFIN JH, 1981, J CLIN INVEST, V68, P1370, DOI 10.1172/JCI110385; Hacisalihoglu A, 2007, J BIOL CHEM, V282, P32974, DOI 10.1074/jbc.M706529200; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; JOSSO F, 1965, THROMB DIATH HAEMOST, VS, P35; Kojima Y, 1998, J BIOL CHEM, V273, P14900, DOI 10.1074/jbc.273.24.14900; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; KRISHNASWAMY S, 1990, J BIOL CHEM, V265, P3708; Lu GM, 2005, J BIOL CHEM, V280, P15471, DOI 10.1074/jbc.M500881200; Manithody C, 2003, BLOOD, V101, P4802, DOI 10.1182/blood-2003-01-0126; MARLAR RA, 1989, J PEDIATR-US, V114, P528, DOI 10.1016/S0022-3476(89)80688-2; Mather T, 1996, EMBO J, V15, P6822, DOI 10.1002/j.1460-2075.1996.tb01073.x; Nicolaes GAF, 2004, EUR J BIOCHEM, V271, P2724, DOI 10.1111/j.1432-1033.2004.04201.x; NICOLAES GAF, 1995, J BIOL CHEM, V270, P21158, DOI 10.1074/jbc.270.36.21158; Nicolaes GAF, 1999, BIOCHEMISTRY-US, V38, P13584, DOI 10.1021/bi991165r; Nicolaes Gerry A F, 2003, Semin Vasc Med, V3, P33, DOI 10.1055/s-2003-38331; Norstrom EA, 2006, J BIOL CHEM, V281, P31486, DOI 10.1074/jbc.M606441200; O'Brien LM, 2000, BLOOD, V95, P1714, DOI 10.1182/blood.V95.5.1714.005k40_1714_1720; Orcutt SJ, 2004, J BIOL CHEM, V279, P54927, DOI 10.1074/jbc.M410866200; Panizzi P, 2006, J BIOL CHEM, V281, P1169, DOI 10.1074/jbc.M507955200; ROSING J, 1995, J BIOL CHEM, V270, P27852, DOI 10.1074/jbc.270.46.27852; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Segers K, 2008, J BIOL CHEM, V283, P22573, DOI 10.1074/jbc.M801724200; Segers K, 2006, PROTEINS, V64, P968, DOI 10.1002/prot.21051; SELIGSOHN U, 1984, NEW ENGL J MED, V310, P559, DOI 10.1056/NEJM198403013100904; SHEN L, 1994, J BIOL CHEM, V269, P18735; Shen L, 1998, J BIOL CHEM, V273, P31086, DOI 10.1074/jbc.273.47.31086; Sun YH, 2003, BLOOD, V101, P2277, DOI 10.1182/blood-2002-06-1691; Tran S, 2008, J BIOL CHEM, V283, P6648, DOI 10.1074/jbc.M708036200; VARADI K, 1995, THROMB HAEMOSTASIS, V73, P730; Villoutreix BO, 2001, J COMPUT AID MOL DES, V15, P13, DOI 10.1023/A:1011158717139; Ye S, 2001, NAT STRUCT BIOL, V8, P979, DOI 10.1038/nsb1101-979; Yegneswaran S, 2007, J BIOL CHEM, V282, P28353, DOI 10.1074/jbc.M704316200; Yegneswaran S, 2009, THROMB HAEMOSTASIS, V101, P55, DOI 10.1160/TH08-07-0491	49	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22888	22898		10.1074/jbc.M110.131029	http://dx.doi.org/10.1074/jbc.M110.131029			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20484050	hybrid, Green Published			2022-12-27	WOS:000279999900022
J	Plafker, KS; Nguyen, L; Barneche, M; Mirza, S; Crawford, D; Plafker, SM				Plafker, Kendra S.; Nguyen, Linda; Barneche, Mark; Mirza, Saima; Crawford, David; Plafker, Scott M.			The Ubiquitin-conjugating Enzyme UbcM2 Can Regulate the Stability and Activity of the Antioxidant Transcription Factor Nrf2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-DEPENDENT TRANSCRIPTION; OXIDATIVE STRESS; RESPONSE ELEMENT; NUCLEAR IMPORT; PROTEASOMAL DEGRADATION; INDUCIBLE EXPRESSION; GENE-EXPRESSION; SENSOR KEAP1; PLASMID DNA; E3 LIGASE	The transcription factor nuclear factor E2-related factor 2 (Nrf2) induces the expression of antioxidant gene products that neutralize reactive oxygen species and restore redox homeostasis. Nrf2 is constitutively degraded by the ubiquitin proteolytic system in unperturbed cells, but this turnover is arrested in response to oxidative stress, thereby leading to Nrf2 accumulation. Yet, a mechanistic understanding of how Nrf2 stabilization and transcriptional activation are coupled remains to be determined. We have discovered that the ubiquitin-conjugating enzyme UbcM2 is a novel regulator of Nrf2. Recombinant Nrf2 and UbcM2 form a complex upon alkylation of a non-catalytic cysteine in UbcM2, Cys-136. Substitution of this cysteine with a phenylalanine (C136F) to mimic cysteine oxidation/alkylation results in constitutive binding of UbcM2 to Nrf2 and an increased half-life of the transcription factor in vivo. We provide evidence that UbcM2 and Nrf2 form a nuclear complex utilizing the DNA binding, Neh1 domain, of Nrf2. Finally, we demonstrate that UbcM2 can enhance the transcriptional activity of endogenous Nrf2 and that Cys-136 and the active-site cysteine, Cys-145, jointly contribute to this regulation. Collectively, these data identify UbcM2 as a novel component of the Nrf2 regulatory circuit and position cysteine 136 as a putative redox sensor in this signaling pathway. This work implicates UbcM2 in the restoration of redox homeostasis following oxidative stress.	[Plafker, Kendra S.; Nguyen, Linda; Barneche, Mark; Mirza, Saima; Crawford, David; Plafker, Scott M.] Univ Oklahoma, Dept Cell Biol, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; [Crawford, David] Univ Oklahoma, Dept Pediat, Hlth Sci Ctr, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Plafker, SM (corresponding author), Univ Oklahoma, Dept Cell Biol, Hlth Sci Ctr, 940 Stanton L Young Blvd,BMSB 538, Oklahoma City, OK 73104 USA.	scott-plafker@ouhsc.edu			National Center for Research Resources, National Institutes of Health [P20RR024215]; American Health Assistance Foundation [M2009095]; Oklahoma Center for the Advancement of Science and Technology [HR08-076]; Karl Kirchgessner Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024215] Funding Source: NIH RePORTER	National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Health Assistance Foundation(BrightFocus Foundation); Oklahoma Center for the Advancement of Science and Technology; Karl Kirchgessner Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant P20RR024215 from the National Center for Research Resources (title: Mentoring Diabetes Research in Oklahoma). Additional funding (to S. M. P.) in support of this work was kindly provided by the American Health Assistance Foundation (Grant M2009095), The Oklahoma Center for the Advancement of Science and Technology (Grant HR08-076), and a Karl Kirchgessner Foundation Vision Research Grant.	ADAM SA, 1991, CELL, V66, P837, DOI 10.1016/0092-8674(91)90431-W; Chan KM, 1999, P NATL ACAD SCI USA, V96, P12731, DOI 10.1073/pnas.96.22.12731; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Guo YG, 2008, BIOCHEM BIOPH RES CO, V374, P570, DOI 10.1016/j.bbrc.2008.07.064; Hong F, 2005, J BIOL CHEM, V280, P31768, DOI 10.1074/jbc.M503346200; Hong F, 2005, CHEM RES TOXICOL, V18, P1917, DOI 10.1021/tx0502138; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; ITOH K, 1995, MOL CELL BIOL, V15, P4184, DOI 10.1128/mcb.15.8.4184; Jeong WS, 2005, J BIOCHEM MOL BIOL, V38, P167; Karapetian RN, 2005, MOL CELL BIOL, V25, P1089, DOI 10.1128/MCB.25.3.1089-1099.2005; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kobayashi M, 2002, GENES CELLS, V7, P807, DOI 10.1046/j.1365-2443.2002.00561.x; Kobayashi S, 2004, J MOL ENDOCRINOL, V32, P69, DOI 10.1677/jme.0.0320069; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Marini MG, 1997, J BIOL CHEM, V272, P16490, DOI 10.1074/jbc.272.26.16490; McMahon M, 2001, CANCER RES, V61, P3299; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; Nguyen T, 2005, J BIOL CHEM, V280, P32485, DOI 10.1074/jbc.M503074200; Nguyen T, 2003, J BIOL CHEM, V278, P4536, DOI 10.1074/jbc.M207293200; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Pan X, 2006, BIOCHEM BIOPH RES CO, V344, P727, DOI 10.1016/j.bbrc.2006.03.194; Plafker KS, 2009, BIOCHEMISTRY-US, V48, P3527, DOI 10.1021/bi801971m; Plafker KS, 2008, INVEST OPHTH VIS SCI, V49, P5611, DOI 10.1167/iovs.08-1698; Plafker SM, 2000, EMBO J, V19, P5502, DOI 10.1093/emboj/19.20.5502; Plafker SM, 2004, J CELL BIOL, V167, P649, DOI 10.1083/jcb.200406001; Poukka H, 1999, J BIOL CHEM, V274, P19441, DOI 10.1074/jbc.274.27.19441; Rachakonda G, 2008, CHEM RES TOXICOL, V21, P705, DOI 10.1021/tx700302s; RADU A, 1995, P NATL ACAD SCI USA, V92, P1769, DOI 10.1073/pnas.92.5.1769; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Sekhar KR, 2002, ONCOGENE, V21, P6829, DOI 10.1038/sj.onc.1205905; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Stewart D, 2003, J BIOL CHEM, V278, P2396, DOI 10.1074/jbc.M209195200; Sun Z, 2007, MOL CELL BIOL, V27, P6334, DOI 10.1128/MCB.00630-07; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Watai Y, 2007, GENES CELLS, V12, P1163, DOI 10.1111/j.1365-2443.2007.01118.x; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Yokota K, 2007, J BIOL CHEM, V282, P1998, DOI 10.1074/jbc.M607741200; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	49	43	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23062	23072		10.1074/jbc.M110.121913	http://dx.doi.org/10.1074/jbc.M110.121913			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20484052	Green Published, hybrid			2022-12-27	WOS:000279999900041
J	Aquilano, K; Vigilanza, P; Baldelli, S; Pagliei, B; Rotilio, G; Ciriolo, MR				Aquilano, Katia; Vigilanza, Paola; Baldelli, Sara; Pagliei, Beatrice; Rotilio, Giuseppe; Ciriolo, Maria Rosa			Peroxisome Proliferator-activated Receptor gamma Co-activator 1 alpha (PGC-1 alpha) and Sirtuin 1 (SIRT1) Reside in Mitochondria POSSIBLE DIRECT FUNCTION IN MITOCHONDRIAL BIOGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION-FACTOR-A; DNA; LOCALIZATION; ASSOCIATION; NUCLEOIDS; ENZYMES; MUSCLE; PGC-1; MTDNA	The transcriptional co-activator PGC-1 alpha and the NAD(+)-dependent deacetylase SIRT1 are considered important inducers of mitochondrial biogenesis because in the nucleus they regulate transcription of nucleus-encoded mitochondrial genes. We demonstrate that PGC-1 alpha and SIRT1 are also present inside mitochondria and are in close proximity to mtDNA. They interact with mitochondrial transcription factor A (TFAM) as assessed by confocal microscopy analysis and by blue native-PAGE. Nucleoid purification allowed us to identify SIRT1 and PGC-1 alpha as proteins associated with native and cross-linked nucleoids, respectively. After mtDNA immunoprecipitation analysis, carried out on mitochondrial extracts, we found that PGC-1 alpha is present on the same D-loop region recognized by TFAM. Finally, by oligonucleotide pulldown assay, we found PGC-1 alpha and SIRT1 associated with the TFAM consensus sequence (human mitochondrial transcription factor-binding site H). The results obtained suggest that in mitochondria PGC-1 alpha and SIRT1 may function as their nuclear counterparts and represent the genuine factors mediating the cross-talk between nuclear and mitochondrial genome. Finally, this work adds new knowledge on the function of SIRT1 and PGC-1 alpha and highlights the direct involvement of such proteins in regulation of mitochondrial biogenesis.	[Aquilano, Katia; Vigilanza, Paola; Baldelli, Sara; Pagliei, Beatrice; Rotilio, Giuseppe; Ciriolo, Maria Rosa] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; [Rotilio, Giuseppe; Ciriolo, Maria Rosa] Ist Ricovero & Cura Carattere Sci, I-00165 Rome, Italy	University of Rome Tor Vergata	Ciriolo, MR (corresponding author), Univ Roma Tor Vergata, Dept Biol, Via Ric Sci 1, I-00133 Rome, Italy.	ciriolo@bio.uniroma2.it	AQUILANO, KATIA/K-8888-2016; Ciriolo, Maria Rosa/K-6572-2016; BALDELLI, SARA/G-4318-2015	AQUILANO, KATIA/0000-0002-5905-9870; BALDELLI, SARA/0000-0001-7003-3172; Ciriolo, Maria Rosa/0000-0002-7863-9029	Ministero della Salute; MIUR; Fondazione Roma Research [2008]	Ministero della Salute(Ministry of Health, Italy); MIUR(Ministry of Education, Universities and Research (MIUR)); Fondazione Roma Research(Fondazione Roma)	This work was supported in part by grants from Ministero della Salute and MIUR and by Fondazione Roma Research Grant 2008 (to P. V.).	Aquilano K, 2006, FASEB J, V20, P1683, DOI 10.1096/fj.05-5225fje; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; BOGENHAGEN DF, 1985, J BIOL CHEM, V260, P6466; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Camacho-Carvajal MM, 2004, MOL CELL PROTEOMICS, V3, P176, DOI 10.1074/mcp.T300010-MCP200; Chang JS, 2010, J BIOL CHEM, V285, P18039, DOI 10.1074/jbc.M109.083121; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chow LS, 2007, J APPL PHYSIOL, V102, P1078, DOI 10.1152/japplphysiol.00791.2006; Dinardo MM, 2003, BIOCHEM BIOPH RES CO, V301, P187, DOI 10.1016/S0006-291X(02)03008-5; Finkel T, 2006, NATURE, V444, P151, DOI 10.1038/444151a; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Kang D, 2007, MITOCHONDRION, V7, P39, DOI 10.1016/j.mito.2006.11.017; Kaufman BA, 2000, P NATL ACAD SCI USA, V97, P7772, DOI 10.1073/pnas.140063197; Kawakami Y, 2005, P NATL ACAD SCI USA, V102, P2414, DOI 10.1073/pnas.0407510102; Kienhofer J, 2009, FASEB J, V23, P2034, DOI 10.1096/fj.08-113571; Knutti D, 2001, TRENDS ENDOCRIN MET, V12, P360, DOI 10.1016/S1043-2760(01)00457-X; Kucej M, 2008, J CELL SCI, V121, P1861, DOI 10.1242/jcs.028605; Lin JD, 2009, MOL ENDOCRINOL, V23, P2, DOI 10.1210/me.2008-0344; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Pellon-Malson M, 2007, BBA-MOL CELL BIOL L, V1771, P830, DOI 10.1016/j.bbalip.2007.04.001; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Sun FC, 2006, BIOCHEM J, V396, P31, DOI 10.1042/BJ20051916; Tanno M, 2010, J BIOL CHEM, V285, P8375, DOI 10.1074/jbc.M109.090266; Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Zhang YB, 2009, J BIOL CHEM, V284, P32813, DOI 10.1074/jbc.M109.037556	34	248	259	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21590	21599		10.1074/jbc.M109.070169	http://dx.doi.org/10.1074/jbc.M109.070169			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20448046	Green Published, hybrid			2022-12-27	WOS:000279516100045
J	Guang, W; Ding, H; Czinn, SJ; Kim, KC; Blanchard, TG; Lillehoj, EP				Guang, Wei; Ding, Hua; Czinn, Steven J.; Kim, K. Chul; Blanchard, Thomas G.; Lillehoj, Erik P.			Muc1 Cell Surface Mucin Attenuates Epithelial Inflammation in Response to a Common Mucosal Pathogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICOBACTER-PYLORI INFECTION; SPLICE VARIANTS; H-DNA; EXPRESSION; GENE; PHOSPHORYLATION; IDENTIFICATION; COLONIZATION; ACTIVATION; INHIBITION	Helicobacter pylori infection of the gastric mucosa causes an active-chronic inflammation that is strongly linked to the development of duodenal and gastric ulcers and stomach cancer. However, greater than 80% of individuals infected with H. pylori are asymptomatic beyond histologic inflammation, and it is unknown what factors influence the incidence and character of bacterial-associated gastritis and related disorders. Because previous studies demonstrated that the Muc1 epithelial glycoprotein inhibited inflammation during acute lung infection by Pseudomonas aeruginosa, we asked whether Muc1 might also counter-regulate gastric inflammation in response to H. pylori infection. Muc1(-/-) mice displayed increased bacterial colonization of the stomach and greater TNF-alpha and keratinocyte chemoattractant transcript levels compared with Muc1(+/+) mice after experimental H. pylori infection. Knockdown of Muc1 expression in AGS human gastric epithelial cells by RNA interference was associated with increased phosphorylation of I kappa B alpha, augmented activation and nuclear translocation of NF-kappa B, and enhanced production of interleulin-8 compared with Muc1-expressing cells. Conversely, Muc1 overexpression was correlated with decreased NF-kappa B activation, reduced interleulin-8 production, and diminished I kappa B kinase beta (IKK beta)/IKK gamma coimmunoprecipitation compared with cells expressing Muc1 endogenously. Cotransfection of AGS cells with Muc1 plus IKK beta, but not a catalytically inactive IKK beta mutant, reversed the Muc1 inhibitory effect. Finally, Muc1 formed a coimmunoprecipitation complex with IKK gamma but not with IKK beta. These results are consistent with the hypothesis that Muc1 binds to IKK gamma, thereby inhibiting formation of the catalytically active IKK complex and blocking the ability of H. pylori to stimulate I kappa B alpha phosphorylation, NF-kappa B activation, and downstream inflammatory responses.	[Lillehoj, Erik P.] Univ Maryland, Dept Pediat, Sch Med, Baltimore, MD 21201 USA; [Kim, K. Chul] Temple Univ Sch Med, Dept Physiol, Philadelphia, PA 19140 USA; [Kim, K. Chul] Temple Univ Sch Med, Lung Ctr, Philadelphia, PA 19140 USA	University System of Maryland; University of Maryland Baltimore; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Lillehoj, EP (corresponding author), Univ Maryland, Dept Pediat, Sch Med, 655 W Baltimore St,BRB 13-029, Baltimore, MD 21201 USA.	elillehoj@peds.umaryland.edu		Lillehoj, Erik/0000-0002-2710-1704; , Erik/0000-0003-0910-6074	United States Public Health Service [AI072291, AI083463, AI055710]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083463, R56AI055710, R01AI055710, R21AI072291] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by United States Public Health Service Grants AI072291 (to E.P.L.), AI083463 (to E.P.L.), and AI055710 (to T.G.B.).	Ahmad R, 2007, NAT CELL BIOL, V9, P1419, DOI 10.1038/ncb1661; Altschuler Y, 2000, MOL BIOL CELL, V11, P819, DOI 10.1091/mbc.11.3.819; Beswick EJ, 2005, INFECT IMMUN, V73, P2736, DOI 10.1128/IAI.73.5.2736-2743.2005; BICKLEY J, 1993, J MED MICROBIOL, V39, P338, DOI 10.1099/00222615-39-5-338; Burgel PR, 2004, THORAX, V59, P992, DOI 10.1136/thx.2003.018879; Byrd JC, 2000, GASTROENTEROLOGY, V118, P1072, DOI 10.1016/S0016-5085(00)70360-X; Carraway KL, 2003, BIOESSAYS, V25, P66, DOI 10.1002/bies.10201; CORREA P, 1988, CANCER RES, V48, P3554; Ding H, 2009, INFECT IMMUN, V77, P5543, DOI 10.1128/IAI.00532-09; Eaton KA, 2001, INFECT IMMUN, V69, P2902, DOI 10.1128/IAI.69.5.2902-2908.2001; Fox JG, 2001, NEW ENGL J MED, V345, P829, DOI 10.1056/NEJM200109133451111; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; Gottwein JM, 2001, J INFECT DIS, V184, P308, DOI 10.1086/322032; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Hinojosa-Kurtzberg AM, 2003, AM J PHYSIOL-GASTR L, V284, pG853, DOI 10.1152/ajpgi.00326.2002; Imbert Y, 2006, EXP EYE RES, V83, P493, DOI 10.1016/j.exer.2006.01.031; Kardon R, 1999, INVEST OPHTH VIS SCI, V40, P1328; KOVARIK A, 1993, J BIOL CHEM, V268, P9917; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Lee IJ, 2003, AM J PHYSIOL-LUNG C, V284, pL160, DOI 10.1152/ajplung.00342.2000; LEVINE SJ, 1995, J INVEST MED, V43, P241; Lillehoj EP, 2003, BIOCHEM BIOPH RES CO, V307, P743, DOI 10.1016/S0006-291X(03)01260-9; Linden S, 2004, BIOCHEM J, V384, P263, DOI 10.1042/BJ20040402; Linden SK, 2008, HELICOBACTER, V13, P81, DOI 10.1111/j.1523-5378.2008.00587.x; Linden SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000617; Lu WJ, 2006, J IMMUNOL, V176, P3890, DOI 10.4049/jimmunol.176.7.3890; MacFarlane AJ, 2007, NUTR REV, V65, pS157, DOI [10.1111/j.1753-4887.2007.tb00355.x, 10.1301/nr.2007.dec.S157-S166]; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; Marshall B, 2002, CLIN MED, V2, P147, DOI 10.7861/clinmedicine.2-2-147; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Mcguckin MA, 2007, GASTROENTEROLOGY, V133, P1210, DOI 10.1053/j.gastro.2007.07.003; McNamara D, 2008, DIGEST LIVER DIS, V40, P504, DOI 10.1016/j.dld.2008.02.031; Nelson KL, 1996, J BIOL CHEM, V271, P18061, DOI 10.1074/jbc.271.30.18061; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Pahwa GS, 1996, J BIOL CHEM, V271, P26543, DOI 10.1074/jbc.271.43.26543; Panchal PC, 2003, CURR OPIN GASTROEN, V19, P4, DOI 10.1097/00001574-200301000-00002; Peleteiro B, 2007, WORLD J GASTROENTERO, V13, P1885, DOI 10.3748/wjg.v13.i12.1885; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Rad R, 2009, GASTROENTEROLOGY, V136, P2247, DOI 10.1053/j.gastro.2009.02.066; Radziejewska I, 2008, HEPATO-GASTROENTEROL, V55, P1887; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; Schmitz JM, 2009, J HISTOCHEM CYTOCHEM, V57, P457, DOI 10.1369/jhc.2009.952473; SPICER AP, 1995, J BIOL CHEM, V270, P30093; Sujanuma M, 2008, INT J CANCER, V123, P117, DOI 10.1002/ijc.23484; Talarico S, 2009, J CLIN MICROBIOL, V47, P1680, DOI 10.1128/JCM.00273-09; Tsuji S, 2003, ALIMENT PHARM THER, V18, P82, DOI 10.1046/j.1365-2036.18.s1.22.x; Vinall LE, 2002, GASTROENTEROLOGY, V123, P41, DOI 10.1053/gast.2002.34157; Wang HH, 2004, BIOCHEM BIOPH RES CO, V321, P448, DOI 10.1016/j.bbrc.2004.06.167; Wang RQ, 2006, J GASTROEN HEPATOL, V21, P425, DOI 10.1111/j.1440-1746.2005.04006.x; Wilson KT, 2007, GASTROENTEROLOGY, V133, P288, DOI 10.1053/j.gastro.2007.05.008; ZRIHANLICHT S, 1995, INT J CANCER, V62, P245, DOI 10.1002/ijc.2910620303	54	66	68	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20547	20557		10.1074/jbc.M110.121319	http://dx.doi.org/10.1074/jbc.M110.121319			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20430889	Green Published, hybrid			2022-12-27	WOS:000279228600017
J	Khosla, C				Khosla, Chaitan			Thematic Minireview Series on Antibacterial Natural Products: New Tricks for Old Dogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PROTEIN-SYNTHESIS		[Khosla, Chaitan] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Khosla, Chaitan] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Khosla, Chaitan] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Khosla, C (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	khosla@stanford.edu		Khosla, Chaitan/0000-0001-6529-495X	NIGMS NIH HHS [R01 GM087934] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087934] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Lorsch JR, 2010, J BIOL CHEM, V285, P21203, DOI 10.1074/jbc.R110.119743; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; Merrick WC, 2010, J BIOL CHEM, V285, P21197, DOI 10.1074/jbc.R110.111476; Merrick WC, 2010, J BIOL CHEM, V285, P21195, DOI 10.1074/jbc.R110.140012	4	1	1	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27499	27499		10.1074/jbc.R110.150417	http://dx.doi.org/10.1074/jbc.R110.150417			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20522550	Green Published, hybrid			2022-12-27	WOS:000281404100002
J	Trajtenberg, F; Grana, M; Ruetalo, N; Botti, H; Buschiazzo, A				Trajtenberg, Felipe; Grana, Martin; Ruetalo, Natalia; Botti, Horacio; Buschiazzo, Alejandro			Structural and Enzymatic Insights into the ATP Binding and Autophosphorylation Mechanism of a Sensor Histidine Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; DOMAIN; CHEA; PHOSPHORYLATION; DEPHOSPHORYLATION; SPECIFICITY; CATALYSIS	DesK is a sensor histidine kinase (HK) that allows Bacillus subtilis to respond to cold shock, triggering the adaptation of membrane fluidity via transcriptional control of a fatty acid desaturase. It belongs to the HK family HPK7, which includes the nitrogen metabolism regulators NarX/Q and the antibiotic sensor LiaS among other important sensor kinases. Structural information on different HK families is still scarce and several questions remain, particularly concerning the molecular features that determine HK specificity during its catalytic autophosphorylation and subsequent response-regulator phosphotransfer reactions. To analyze the ATP-binding features of HPK7 HKs and dissect their mechanism of autophosphorylation at the molecular level, we have studied DesK in complex with ATP using high resolution structural approaches in combination with biochemical studies. We report the first crystal structure of an HK in complex with its natural nucleotidic substrate. The general fold of the ATP-binding domain of DesK is conserved, compared with well studied members of other families. Yet, DesK displays a far more compact structure at the ATP-binding pocket: the ATP lid loop is much shorter with no secondary structural organization and becomes ordered upon ATP loading. Sequence conservation mapping onto the molecular surface, semi-flexible protein-protein docking simulations, and structure-based point mutagenesis allow us to propose a specific domain-domain geometry during autophosphorylation catalysis. Supporting our hypotheses, we have been able to trap an autophosphorylating intermediate state, by protein engineering at the predicted domain-domain interaction surface.	[Trajtenberg, Felipe; Ruetalo, Natalia; Botti, Horacio; Buschiazzo, Alejandro] Inst Pasteur Montevideo, Unit Prot Crystallog, Montevideo 11400, Uruguay; [Grana, Martin] Inst Pasteur Montevideo, Unit Bioinformat, Montevideo 11400, Uruguay; [Buschiazzo, Alejandro] Inst Pasteur, Dept Struct Biol & Chem, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Buschiazzo, A (corresponding author), Inst Pasteur Montevideo, Unit Prot Crystallog, Mataojo 2020, Montevideo 11400, Uruguay.	alebus@pasteur.edu.uy	Buschiazzo, Alejandro/W-1095-2018	Buschiazzo, Alejandro/0000-0002-2509-6526; Trajtenberg, Felipe/0000-0003-0427-5549; Grana, Martin/0000-0003-1182-8236	Agencia Nacional de Investigacion e Innovacion, Uruguay (ANII) [FCE2007_219, FCE2007_377]; Agence Nationale de la Recherche, France [ANR-06-PCVI-0009-01]	Agencia Nacional de Investigacion e Innovacion, Uruguay (ANII); Agence Nationale de la Recherche, France(French National Research Agency (ANR))	This work was supported in part by Grants FCE2007_219 (to A.B.) and FCE2007_377 (to M.G.) from the Agencia Nacional de Investigacion e Innovacion, Uruguay (ANII) and Grant ANR-06-PCVI-0009-01 (to A.B.) from the Agence Nationale de la Recherche, France.	Aguilar PS, 2001, EMBO J, V20, P1681, DOI 10.1093/emboj/20.7.1681; Albanesi D, 2004, J BACTERIOL, V186, P2655, DOI 10.1128/JB.186.9.2655-2663.2004; Albanesi D, 2009, P NATL ACAD SCI USA, V106, P16185, DOI 10.1073/pnas.0906699106; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bilwes AM, 1999, CELL, V96, P131, DOI 10.1016/S0092-8674(00)80966-6; Bilwes AM, 2001, NAT STRUCT BIOL, V8, P353, DOI 10.1038/86243; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cai SJ, 2003, J MOL BIOL, V329, P495, DOI 10.1016/S0022-2836(03)00446-7; Casino P, 2009, CELL, V139, P325, DOI 10.1016/j.cell.2009.08.032; Cybulski LE, 2004, J BIOL CHEM, V279, P39340, DOI 10.1074/jbc.M405150200; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dehner A, 2003, CHEMBIOCHEM, V4, P870, DOI 10.1002/cbic.200300658; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Dutta R, 1999, MOL MICROBIOL, V34, P633, DOI 10.1046/j.1365-2958.1999.01646.x; Espenson J. H, 1995, CHEM KINETICS REACTI, P15; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Hsing WH, 1998, J BACTERIOL, V180, P4538, DOI 10.1128/JB.180.17.4538-4546.1998; HULTQUIST DE, 1966, BIOCHEMISTRY-US, V5, P322, DOI 10.1021/bi00865a041; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kotting C, 2006, P NATL ACAD SCI USA, V103, P13911, DOI 10.1073/pnas.0604128103; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Lindsley JE, 2000, METH MOL B, V95, P57; Lott JS, 2006, J BIOL CHEM, V281, P22131, DOI 10.1074/jbc.M603062200; Machius M, 2001, P NATL ACAD SCI USA, V98, P11218, DOI 10.1073/pnas.201220098; Marina A, 2005, EMBO J, V24, P4247, DOI 10.1038/sj.emboj.7600886; Marina A, 2001, J BIOL CHEM, V276, P41182, DOI 10.1074/jbc.M106080200; Markowitz Victor M., 2007, V395, P35; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; NINFA EG, 1993, J BACTERIOL, V175, P7024, DOI 10.1128/jb.175.21.7024-7032.1993; Noriega CE, 2008, J BACTERIOL, V190, P3869, DOI 10.1128/JB.00092-08; Plowman GD, 1999, P NATL ACAD SCI USA, V96, P13603, DOI 10.1073/pnas.96.24.13603; Scaramozzino F, 2009, J BACTERIOL, V191, P687, DOI 10.1128/JB.01184-08; SCHWEINS T, 1995, NAT STRUCT BIOL, V2, P36, DOI 10.1038/nsb0195-36; Siryaporn A, 2008, MOL MICROBIOL, V70, P494, DOI 10.1111/j.1365-2958.2008.06426.x; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Surette MG, 1996, J BIOL CHEM, V271, P939, DOI 10.1074/jbc.271.2.939; TAWA P, 1994, BIOCHEMISTRY-US, V33, P7917, DOI 10.1021/bi00191a019; TAWA P, 1994, J BACTERIOL, V176, P4210, DOI 10.1128/jb.176.14.4210-4218.1994; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; Wolanin PM, 2002, GENOME BIOL, V3; Zhang J, 2005, J AM CHEM SOC, V127, P11709, DOI 10.1021/ja051199o	43	40	41	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24892	24903		10.1074/jbc.M110.147843	http://dx.doi.org/10.1074/jbc.M110.147843			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20507988	hybrid, Green Published			2022-12-27	WOS:000280542100062
J	Cassano, S; Agnese, S; D'Amato, V; Papale, M; Garbi, C; Castagnola, P; Ruocco, MR; Castellano, I; De Vendittis, E; Santillo, M; Amente, S; Porcellini, A; Avvedimento, EV				Cassano, Silvana; Agnese, Savina; D'Amato, Valentina; Papale, Massimo; Garbi, Corrado; Castagnola, Patrizio; Ruocco, Maria Rosaria; Castellano, Immacolata; De Vendittis, Emmanuele; Santillo, Mariarosaria; Amente, Stefano; Porcellini, Antonio; Avvedimento, Enrico Vittorio			Reactive Oxygen Species, Ki-Ras, and Mitochondrial Superoxide Dismutase Cooperate in Nerve Growth Factor-induced Differentiation of PC12 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDOX REGULATION; NEURONAL DIFFERENTIATION; NEURITE OUTGROWTH; HYDROGEN-PEROXIDE; NADPH OXIDASE; PROTEIN; ACTIVATION; MICROTUBULES; EXPRESSION; RECEPTORS	Nerve growth factor (NGF) induces terminal differentiation in PC12, a pheochromocytoma-derived cell line. NGF binds a specific receptor on the membrane and triggers the ERK1/2 cascade, which stimulates the transcription of neural genes. We report that NGF significantly affects mitochondrial metabolism by reducing mitochondrial-produced reactive oxygen species and stabilizing the electrochemical gradient. This is accomplished by stimulation of mitochondrial manganese superoxide dismutase (MnSOD) both transcriptionally and post-transcriptionally via Ki-Ras and ERK1/2. Activation of MnSOD is essential for completion of neuronal differentiation because 1) expression of MnSOD induces the transcription of a neuronal specific promoter and neurite outgrowth, 2) silencing of endogenous MnSOD by small interfering RNA significantly reduces transcription induced by NGF, and 3) a Ki-Ras mutant in the polylysine stretch at the COOH terminus, unable to stimulate MnSOD, fails to induce complete differentiation. Overexpression of MnSOD restores differentiation in cells expressing this mutant. ERK1/2 is also downstream of MnSOD, as a SOD mimetic drug stimulates ERK1/2 with the same kinetics of NGF and silencing of MnSOD reduces NGF-induced late ERK1/2. Long term activation of ERK1/2 by NGF requires SOD activation, low levels of hydrogen peroxide, and the integrity of the microtubular cytoskeleton. Confocal immunofluorescence shows that NGF stimulates the formation of a complex containing membrane-bound Ki-Ras, microtubules, and mitochondria. We propose that active NGF receptor induces association of mitochondria with plasma membrane. Local activation of ERK1/2 by Ki-Ras stimulates mitochondrial SOD, which reduces reactive oxygen species and produces H(2)O(2). Low and spatially restricted levels of H(2)O(2) induce and maintain long term ERK1/2 activity and ultimately differentiation of PC12 cells.	[Cassano, Silvana; Agnese, Savina; D'Amato, Valentina; Papale, Massimo; Garbi, Corrado; Avvedimento, Enrico Vittorio] Univ Naples Federico 2, CNR, Ist Endocrinol & Oncol Sperimentale, Dipartimento Biol & Patol Mol & Cellulare, I-80131 Naples, Italy; [Santillo, Mariarosaria] Univ Naples Federico 2, Dipartimento Neurosci, Sez Fisiol, I-80131 Naples, Italy; [Ruocco, Maria Rosaria; Castellano, Immacolata; De Vendittis, Emmanuele] Univ Naples Federico 2, Dipartimento Biochim & Biotecnol Med, I-80131 Naples, Italy; [Amente, Stefano] Univ Naples Federico 2, Dipartimento Biol Strutturale & Funz, I-80126 Naples, Italy; [Porcellini, Antonio] Univ Molise, Dipartimento Sci Salute, I-86100 Campobasso, Italy; [Castagnola, Patrizio] Ist Nazl Ric Canc, I-16132 Genoa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; University of Molise; University of Genoa; IRCCS AOU San Martino IST	Avvedimento, EV (corresponding author), Univ Naples Federico 2, CNR, Ist Endocrinol & Oncol Sperimentale, Dipartimento Biol & Patol Mol & Cellulare, Via S Pansini,5, I-80131 Naples, Italy.	avvedim@unina.it	Castagnola, Patrizio/H-2029-2012; Porcellini, Antonio/E-1900-2011; Papale, Massimo/AAQ-2370-2020; Castellano, Immacolata/AAD-5523-2019; Amente, Stefano/AAU-7605-2020; Porcellini, Antonio/AAC-6097-2019	Castagnola, Patrizio/0000-0003-2008-9199; Porcellini, Antonio/0000-0001-6882-9518; Papale, Massimo/0000-0002-8278-5045; Amente, Stefano/0000-0003-0612-6096; CASSANO, SILVANA/0000-0001-9868-7936; Castellano, Immacolata/0000-0002-4274-6738	Associazione Italiana per la Ricerca sul Cancro; Ministero Italiano per l'Universita e la Ricerca Scientifica; Fondo per gli Investimenti della Ricerca di Base; Ministero della Salute	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero Italiano per l'Universita e la Ricerca Scientifica; Fondo per gli Investimenti della Ricerca di Base(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Ministero della Salute(Ministry of Health, Italy)	This work was supported in part by the Associazione Italiana per la Ricerca sul Cancro, Ministero Italiano per l'Universita e la Ricerca Scientifica, Fondo per gli Investimenti della Ricerca di Base, and Project "Colon," Ministero della Salute, FSN 2004.	Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Bedogni B, 2003, J BIOL CHEM, V278, P16510, DOI 10.1074/jbc.M301089200; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Bumeister R, 2004, CURR BIOL, V14, P439, DOI 10.1016/j.cub.2004.02.037; Cassano S, 1999, J BIOL CHEM, V274, P32574, DOI 10.1074/jbc.274.46.32574; Castellano I, 2009, BIOPOLYMERS, V91, P1215, DOI 10.1002/bip.21208; Chada SR, 2004, CURR BIOL, V14, P1272, DOI 10.1016/j.cub.2004.07.027; Chada SR, 2003, J EXP BIOL, V206, P1985, DOI 10.1242/jeb.00263; Chen Q, 1997, J BIOL CHEM, V272, P15247, DOI 10.1074/jbc.272.24.15247; Chen Z, 2000, J BIOL CHEM, V275, P41251, DOI 10.1074/jbc.M006687200; Cuda G, 2002, CIRCULATION, V105, P968, DOI 10.1161/hc0802.104324; DAMON DH, 1990, J CELL BIOL, V110, P1333, DOI 10.1083/jcb.110.4.1333; Ding AH, 1996, J EXP MED, V183, P1899, DOI 10.1084/jem.183.4.1899; FAULKNER KM, 1994, J BIOL CHEM, V269, P23471; Fukano T, 2007, CELL STRUCT FUNCT, V32, P9, DOI 10.1247/csf.06019; Gadjev I, 2008, INT REV CEL MOL BIO, V270, P87, DOI 10.1016/S1937-6448(08)01403-2; Galeotti T, 2005, BIOMED PHARMACOTHER, V59, P197, DOI 10.1016/j.biopha.2005.03.002; Ginsberg MD, 2003, J MOL BIOL, V327, P885, DOI 10.1016/S0022-2836(03)00173-6; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HANCOCK JF, 1991, EMBO J, V10, P4033, DOI 10.1002/j.1460-2075.1991.tb04979.x; HEASLEY LE, 1992, MOL BIOL CELL, V3, P545, DOI 10.1091/mbc.3.5.545; Hu YM, 2005, J BIOL CHEM, V280, P39485, DOI 10.1074/jbc.M503296200; Ibi M, 2006, FREE RADICAL BIO MED, V40, P1785, DOI 10.1016/j.freeradbiomed.2006.01.009; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; JANSSENTIMMEN U, 1989, GENE, V80, P325, DOI 10.1016/0378-1119(89)90296-5; Kemmerling U, 2007, CELL CALCIUM, V41, P491, DOI 10.1016/j.ceca.2006.10.001; Kim JW, 2008, BIOCHEM PHARMACOL, V76, P1577, DOI 10.1016/j.bcp.2008.08.007; KREIS TE, 1987, EMBO J, V6, P2597, DOI 10.1002/j.1460-2075.1987.tb02550.x; Lax I, 2002, MOL CELL, V10, P709, DOI 10.1016/S1097-2765(02)00689-5; Lazarovici P, 1997, J BIOL CHEM, V272, P11026, DOI 10.1074/jbc.272.17.11026; MARCHISIO PC, 1993, EXP CELL RES, V205, P205, DOI 10.1006/excr.1993.1078; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MorishimaKawashima M, 1996, MOL BIOL CELL, V7, P893, DOI 10.1091/mbc.7.6.893; Muller M, 2005, EXP CELL RES, V303, P114, DOI 10.1016/j.yexcr.2004.09.025; PETER P, 2006, BIOCHIMIE, P123; Prior IA, 2001, J CELL SCI, V114, P1603; Ranganathan AC, 2001, J BIOL CHEM, V276, P14264, DOI 10.1074/jbc.M100199200; SAMPATH D, 1994, J NEUROCHEM, V62, P2476; Santillo M, 2001, CURR BIOL, V11, P614, DOI 10.1016/S0960-9822(01)00159-2; SCHEWE T, 1995, GEN PHARMACOL-VASC S, V26, P1153, DOI 10.1016/0306-3623(95)00003-J; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Suzukawa K, 2000, J BIOL CHEM, V275, P13175, DOI 10.1074/jbc.275.18.13175; Svegliati S, 2005, J BIOL CHEM, V280, P36474, DOI 10.1074/jbc.M502851200; Takii Y, 2003, ELECTROCHIM ACTA, V48, P3381, DOI 10.1016/S0013-4686(03)00408-0; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Vilhardt F, 2004, EMBO J, V23, P739, DOI 10.1038/sj.emboj.7600066; Wright JH, 1997, MOL BIOL CELL, V8, P1575, DOI 10.1091/mbc.8.8.1575; Wu CB, 2007, TRAFFIC, V8, P1503, DOI 10.1111/j.1600-0854.2007.00636.x; Zhou ZX, 2000, J HISTOCHEM CYTOCHEM, V48, P585, DOI 10.1177/002215540004800502	50	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24141	24153		10.1074/jbc.M109.098525	http://dx.doi.org/10.1074/jbc.M109.098525			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20495008	Green Published			2022-12-27	WOS:000280291400064
J	Guo, X; Xu, KF; Zhang, JF; Li, HG; Zhang, WY; Wang, HA; Lange, AJ; Chen, YE; Huo, YQ; Wu, CD				Guo, Xin; Xu, Kefeng; Zhang, Jifeng; Li, Honggui; Zhang, Weiyu; Wang, Huan; Lange, Alex J.; Chen, Y. Eugene; Huo, Yuqing; Wu, Chaodong			Involvement of Inducible 6-Phosphofructo-2-kinase in the Anti-diabetic Effect of Peroxisome Proliferator-activated Receptor gamma Activation in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ADIPOSE-TISSUE; INSULIN-RESISTANCE; PPAR-GAMMA; OBESITY; ADIPOCYTES; ROSIGLITAZONE; EXPRESSION; LIVER; FAT; DISRUPTION	PFKFB3 is the gene that codes for the inducible isoform of 6-phosphofructo-2-kinase (iPFK2), a key regulatory enzyme of glycolysis. As one of the targets of peroxisome proliferator-activated receptor gamma (PPAR gamma), PFKFB3/iPFK2 is up-regulated by thiazolidinediones. In the present study, using PFKFB3/iPFK2-disrupted mice, the role of PFKFB3/iPFK2 in the anti-diabetic effect of PPAR gamma activation was determined. In wild-type littermate mice, PPAR gamma activation (i.e. treatment with rosiglitazone) restored euglycemia and reversed high fat diet-induced insulin resistance and glucose intolerance. In contrast, PPAR gamma activation did not reduce high fat diet-induced hyperglycemia and failed to reverse insulin resistance and glucose intolerance in PFKFB3(+/-) mice. The lack of anti-diabetic effect in PFKFB3(+/-) mice was associated with the inability of PPAR gamma activation to suppress adipose tissue lipolysis and proinflammatory cytokine production, stimulate visceral fat accumulation, enhance adipose tissue insulin signaling, and appropriately regulate adipokine expression. Similarly, in cultured 3T3-L1 adipocytes, knockdown of PFKFB3/iPFK2 lessened the effect of PPAR gamma activation on stimulating lipid accumulation. Furthermore, PPAR gamma activation did not suppress inflammatory signaling in PFKFB3/iPFK2-knockdown adipocytes as it did in control adipocytes. Upon inhibition of excessive fatty acid oxidation in PFKFB3/iPFK2-knockdown adipocytes, PPAR gamma activation was able to significantly reverse inflammatory signaling and proinflammatory cytokine expression and restore insulin signaling. Together, these data demonstrate that PFKFB3/iPFK2 is critically involved in the anti-diabetic effect of PPAR gamma activation.	[Guo, Xin; Li, Honggui; Wu, Chaodong] Texas A&M Univ, Intercollegiate Fac Nutr, Dept Nutr & Food Sci, College Stn, TX 77843 USA; [Xu, Kefeng] Morehouse Sch Med, Cardiovasc Res Inst, Atlanta, GA 30310 USA; [Zhang, Jifeng; Chen, Y. Eugene] Univ Michigan, Med Ctr, Ctr Cardiovasc, Dept Internal Med, Ann Arbor, MI 48105 USA; [Zhang, Weiyu; Wang, Huan; Huo, Yuqing] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Lange, Alex J.] Univ Minnesota, Sch Med, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Huo, Yuqing] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China	Texas A&M University System; Texas A&M University College Station; Morehouse School of Medicine; University of Michigan System; University of Michigan; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Peking University	Chen, YE (corresponding author), 1150 W Med Ctr Dr,MSRB 3 7301E, Ann Arbor, MI 48015 USA.	echenum@med.umich.edu; yuqing@umn.edu; cdwu@tamu.edu			National Institutes of Health [HL78679, HL080569, HL68878, HL89544, HL75397]; American Diabetes Association [1-10-BS-76, 1-10-JF-54]; American Heart Association [0835237N, 0840025N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078679, R01HL068878, R01HL080569, R01HL089544, R01HL075397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL78679 and HL080569 (to Y.H.) and HL68878, HL89544, and HL75397 (to Y.E.C.). This work was also supported by American Diabetes Association Grants 1-10-BS-76 (to Y.H.) and 1-10-JF-54 (to C.W.).; Supported by American Heart Association National Career Development Grant 0835237N.; An established investigator of the American Heart Association ( Grant 0840025N).	Atsumi T, 2005, DIABETES, V54, P3349, DOI 10.2337/diabetes.54.12.3349; Berger J, 1996, ENDOCRINOLOGY, V137, P4189, DOI 10.1210/en.137.10.4189; Berger JJ, 1999, J APPL PHYSIOL, V87, P227, DOI 10.1152/jappl.1999.87.1.227; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Chao L, 2000, J CLIN INVEST, V106, P1221, DOI 10.1172/JCI11245; Chesney J, 2005, BIOCHEM BIOPH RES CO, V331, P139, DOI 10.1016/j.bbrc.2005.02.193; Combs TP, 2002, ENDOCRINOLOGY, V143, P998, DOI 10.1210/endo.143.3.8662; Devine JH, 1999, J BIOL CHEM, V274, P13604, DOI 10.1074/jbc.274.19.13604; Diaz-Delfin J, 2007, DIABETES, V56, P1865, DOI 10.2337/db06-1293; Duplus E, 2003, BIOCHIMIE, V85, P1257, DOI 10.1016/j.biochi.2003.10.016; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Forest C, 2003, BIOCHEM SOC T, V31, P1125; Franckhauser S, 2006, DIABETES, V55, P273, DOI 10.2337/diabetes.55.02.06.db05-0482; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Grundy Scott M, 2006, Nat Rev Drug Discov, V5, P295, DOI 10.1038/nrd2005; Guan HP, 2002, NAT MED, V8, P1122, DOI 10.1038/nm780; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Huo YQ, 2010, J BIOL CHEM, V285, P3713, DOI 10.1074/jbc.M109.058446; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kershaw EE, 2007, AM J PHYSIOL-ENDOC M, V293, pE1736, DOI 10.1152/ajpendo.00122.2007; Kintscher U, 2005, AM J PHYSIOL-ENDOC M, V288, pE287, DOI 10.1152/ajpendo.00440.2004; Kolak M, 2007, J CLIN ENDOCR METAB, V92, P720, DOI 10.1210/jc.2006-1465; Krentz AJ, 2000, BMJ-BRIT MED J, V321, P252, DOI 10.1136/bmj.321.7256.252; Lebovitz HE, 2001, J CLIN ENDOCR METAB, V86, P280, DOI 10.1210/jc.86.1.280; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Leroyer SN, 2006, J BIOL CHEM, V281, P13141, DOI 10.1074/jbc.M512943200; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Norris AW, 2003, J CLIN INVEST, V112, P608, DOI 10.1172/JCI200317305; Permana PA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1076, DOI 10.1152/ajpendo.91013.2008; Phillips LS, 2001, DIABETES CARE, V24, P308, DOI 10.2337/diacare.24.2.308; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Ranganathan G, 2006, J LIPID RES, V47, P2444, DOI 10.1194/jlr.M600248-JLR200; STANSBIE D, 1976, BIOCHEM J, V160, P413, DOI 10.1042/bj1600413; Stienstra R, 2008, J BIOL CHEM, V283, P22620, DOI 10.1074/jbc.M710314200; Subauste AR, 2007, AM J PHYSIOL-ENDOC M, V293, pE159, DOI 10.1152/ajpendo.00629.2006; Sugii S, 2009, P NATL ACAD SCI USA, V106, P22504, DOI 10.1073/pnas.0912487106; Tan GD, 2003, NAT MED, V9, P811, DOI 10.1038/nm0703-811; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2004, ENDOCRINOLOGY, V145, P2214, DOI 10.1210/en.2003-1580; Wu CD, 2005, CELL METAB, V2, P131, DOI 10.1016/j.cmet.2005.07.003; Wu CD, 2001, J CLIN INVEST, V107, P91, DOI 10.1172/JCI11103; Wu CD, 2006, AM J PHYSIOL-ENDOC M, V291, pE536, DOI 10.1152/ajpendo.00126.2006; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhang JF, 2004, P NATL ACAD SCI USA, V101, P10703, DOI 10.1073/pnas.0403652101	54	35	35	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23711	23720		10.1074/jbc.M110.123174	http://dx.doi.org/10.1074/jbc.M110.123174			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20498376	Green Published, hybrid			2022-12-27	WOS:000280291400021
J	Ishikura, S; Weissman, AM; Bonifacino, JS				Ishikura, Shuhei; Weissman, Allan M.; Bonifacino, Juan S.			Serine Residues in the Cytosolic Tail of the T-cell Antigen Receptor alpha-Chain Mediate Ubiquitination and Endoplasmic Reticulum-associated Degradation of the Unassembled Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; QUALITY-CONTROL; LIGASE; PROTEASOME; SUBUNIT; HRD1; UBIQUITYLATION; DESTRUCTION; PROMOTES; LYSINE	The T-cell antigen receptor (TCR) alpha-chain (TCR alpha) is a type I integral membrane protein that becomes ubiquitinated and targeted to the endoplasmic reticulum (ER)-associated degradation (ERAD) pathway when it fails to assemble into the heteromeric TCR complex. Remarkably, TCR alpha has a cytosolic tail of only five amino acid residues (i.e. RLWSS), none of which is the conventional ubiquitin acceptor, lysine. Herein we report that substitution of two conserved serine residues in the cytosolic tail of TCR alpha to alanine decreased ubiquitination, whereas placement of additional serine residues enhanced it. Moreover, replacement of the cytosolic serine residues by other ubiquitinatable residues (i.e. cysteine, threonine, or lysine) allowed ubiquitination to take place. Serine-dependent ubiquitination perfectly correlated with targeting of TCR alpha for ERAD. We also found that this ubiquitination was mediated by the ER-localized ubiquitin ligase, HRD1. These findings indicate that serine-dependent, HRD1-mediated ubiquitination targets TCR alpha to the ERAD pathway.	[Ishikura, Shuhei; Bonifacino, Juan S.] Eunice Kennedy Shriver NICHD, Cell Biol & Metab Program, Bethesda, MD 20892 USA; [Weissman, Allan M.] NCI, Lab Prot Dynam & Signaling, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bonifacino, JS (corresponding author), 9000 Rockville Pike, Bethesda, MD 20892 USA.	juan@helix.nih.gov		Bonifacino, Juan S./0000-0002-5673-6370	National Institutes of Health Intramural AIDS Targeted Antiviral Program (IATAP); NICHD and NCI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008909] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD008834] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC009392] Funding Source: NIH RePORTER	National Institutes of Health Intramural AIDS Targeted Antiviral Program (IATAP)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD and NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural AIDS Targeted Antiviral Program (IATAP) and the Intramural Programs of NICHD and NCI.	Alarcon B, 2003, IMMUNOL REV, V191, P38, DOI 10.1034/j.1600-065X.2003.00017.x; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; BONIFACINO JS, 1990, SCIENCE, V247, P79, DOI 10.1126/science.2294595; BONIFACINO JS, 1989, J CELL BIOL, V109, P73, DOI 10.1083/jcb.109.1.73; BONIFACINO JS, 1990, CELL, V63, P503, DOI 10.1016/0092-8674(90)90447-M; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Cadwell K, 2008, J VIROL, V82, P4184, DOI 10.1128/JVI.02264-07; Call ME, 2007, NAT REV IMMUNOL, V7, P841, DOI 10.1038/nri2186; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; Cattaneo M, 2008, J CELL PHYSIOL, V215, P794, DOI 10.1002/jcp.21364; CHEN C, 1988, J CELL BIOL, V107, P2149, DOI 10.1083/jcb.107.6.2149; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; Grou CP, 2009, J BIOL CHEM, V284, P10504, DOI 10.1074/jbc.M808978200; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; HOU D, 1994, J BIOL CHEM, V269, P14244; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; KLAUSNER RD, 1990, ANNU REV CELL BIOL, V6, P403, DOI 10.1146/annurev.cb.06.110190.002155; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Lee SJ, 1998, EXP MOL MED, V30, P159, DOI 10.1038/emm.1998.23; Lenk U, 2002, J CELL SCI, V115, P3007; LIPPINCOTTSCHWARTZ J, 1988, CELL, V54, P209, DOI 10.1016/0092-8674(88)90553-3; MANOLIOS N, 1990, SCIENCE, V249, P274, DOI 10.1126/science.2142801; Mardones GA, 2007, MOL BIOL CELL, V18, P3486, DOI 10.1091/mbc.E07-02-0190; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Omura T, 2006, J NEUROCHEM, V99, P1456, DOI 10.1111/j.1471-4159.2006.04155.x; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Tait SWG, 2007, J CELL BIOL, V179, P1453, DOI 10.1083/jcb.200707063; Tiwari S, 2001, J BIOL CHEM, V276, P16193, DOI 10.1074/jbc.M007640200; Tsai YC, 2007, NAT MED, V13, P1504, DOI 10.1038/nm1686; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Wang XL, 2009, J CELL BIOL, V187, P655, DOI 10.1083/jcb.200908036; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Yang H, 2007, EXP CELL RES, V313, P538, DOI 10.1016/j.yexcr.2006.10.031; Yang M, 1998, J EXP MED, V187, P835, DOI 10.1084/jem.187.6.835; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800; Yu H, 1999, J BIOL CHEM, V274, P36852, DOI 10.1074/jbc.274.52.36852	48	66	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23916	23924		10.1074/jbc.M110.127936	http://dx.doi.org/10.1074/jbc.M110.127936			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20519503	Green Published, hybrid			2022-12-27	WOS:000280291400042
J	Li, XF; Zhang, R; Zhang, HF; He, Y; Ji, WD; Min, W; Boggon, TJ				Li, Xiaofeng; Zhang, Rong; Zhang, Haifeng; He, Yun; Ji, Weidong; Min, Wang; Boggon, Titus J.			Crystal Structure of CCM3, a Cerebral Cavernous Malformation Protein Critical for Vascular Integrity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAXILLIN LD MOTIFS; 2-HIT MECHANISM; MUTATIONS; GENE; KRIT1; PATHOGENESIS; DOMAIN; TOOL	CCM3 mutations are associated with cerebral cavernous malformation (CCM), a disease affecting 0.1-0.5% of the human population. CCM3 (PDCD10, TFAR15) is thought to form a CCM complex with CCM1 and CCM2; however, the molecular basis for these interactions is not known. We have determined the 2.5 angstrom crystal structure of CCM3. This structure shows an all alpha-helical protein containing two domains, an N-terminal dimerization domain with a fold not previously observed, and a C-terminal focal adhesion targeting (FAT)-homology domain. We show that CCM3 binds CCM2 via this FAT-homology domain and that mutation of a highly conserved FAK-like hydrophobic pocket (HP1) abrogates CCM3-CCM2 interaction. This CCM3 FAT-homology domain also interacts with paxillin LD motifs using the same surface, and partial CCM3 co-localization with paxillin in cells is lost on HP1 mutation. Disease-related CCM3 truncations affect the FAT-homology domain suggesting a role for the FAT-homology domain in the etiology of CCM.	[Zhang, Haifeng; He, Yun; Ji, Weidong; Min, Wang] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Yale University; Yale University	Min, W (corresponding author), Yale Univ, Sch Med, Dept Pathol, 10 Amistad St,401B, New Haven, CT 06520 USA.	wang.min@yale.edu; titus.boggon@yale.edu	Li, Xiaofeng/F-3735-2011; ji, weidong/AAX-7397-2020		National Institutes of Health [R01 HL077357, HL085789]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077357, R01HL085789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL077357 and HL085789 (to W. M.) and by startup funds (to T.J.B.).	Akers AL, 2009, HUM MOL GENET, V18, P919, DOI 10.1093/hmg/ddn430; Arold ST, 2002, STRUCTURE, V10, P319, DOI 10.1016/S0969-2126(02)00717-7; Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004; Denier C, 2004, AM J HUM GENET, V74, P326, DOI 10.1086/381718; Gault J, 2005, STROKE, V36, P872, DOI 10.1161/01.STR.0000157586.20479.fd; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Guclu B, 2005, NEUROSURGERY, V57, P1008, DOI 10.1227/01.NEU.0000180811.56157.E1; GUNEL M, 1995, P NATL ACAD SCI USA, V92, P6620, DOI 10.1073/pnas.92.14.6620; Hayashi I, 2002, NAT STRUCT BIOL, V9, P101, DOI 10.1038/nsb755; He Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000722; Hoellerer MK, 2003, STRUCTURE, V11, P1207, DOI 10.1016/j.str.2003.08.010; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Kim BH, 2009, NUCLEIC ACIDS RES, V37, pW532, DOI 10.1093/nar/gkp328; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Labouge P, 2007, LANCET NEUROL, V6, P237, DOI 10.1016/S1474-4422(07)70053-4; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liquori CL, 2003, AM J HUM GENET, V73, P1459, DOI 10.1086/380314; Lulo J, 2009, BIOCHEM BIOPH RES CO, V383, P347, DOI 10.1016/j.bbrc.2009.04.011; Nikolopoulos SN, 2000, J CELL BIOL, V151, P1435, DOI 10.1083/jcb.151.7.1435; Pagenstecher A, 2009, HUM MOL GENET, V18, P911, DOI 10.1093/hmg/ddn420; Revencu N, 2006, J MED GENET, V43, P716, DOI 10.1136/jmg.2006.041079; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; Serebriiskii I, 1997, ONCOGENE, V15, P1043, DOI 10.1038/sj.onc.1201268; Stahl S, 2008, HUM MUTAT, V29, P709, DOI 10.1002/humu.20712; Voss K, 2007, NEUROGENETICS, V8, P249, DOI 10.1007/s10048-007-0098-9; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Whitehead KJ, 2004, DEVELOPMENT, V131, P1437, DOI 10.1242/dev.01036; Zawistowski JS, 2005, HUM MOL GENET, V14, P2521, DOI 10.1093/hmg/ddi256; Zhang J, 2007, NEUROSURGERY, V60, P353, DOI 10.1227/01.NEU.0000249268.11074.83	35	67	73	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24099	24107		10.1074/jbc.M110.128470	http://dx.doi.org/10.1074/jbc.M110.128470			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20489202	Green Published, hybrid			2022-12-27	WOS:000280291400060
J	Minajigi, A; Francklyn, CS				Minajigi, Anand; Francklyn, Christopher S.			Aminoacyl Transfer Rate Dictates Choice of Editing Pathway in Threonyl-tRNA Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PROTEIN-SYNTHESIS; QUALITY-CONTROL; ACTIVE-SITE; ZINC ION; MECHANISM; DISCRIMINATION; ACIDS; MISTRANSLATION; PHENYLALANINE	Aminoacyl-tRNA synthetases hydrolyze aminoacyl adenylates and aminoacyl-tRNAs formed from near-cognate amino acids, thereby increasing translational fidelity. The contributions of pre- and post-transfer editing pathways to the fidelity of Escherichia coli threonyl-tRNA synthetase (ThrRS) were investigated by rapid kinetics. In the pre- steady state, asymmetric activation of cognate threonine and noncognate serine was observed in the active sites of dimeric ThrRS, with similar rates of activation. In the absence of tRNA, seryl-adenylate was hydrolyzed 29-fold faster by the ThrRS catalytic domain than threonyl-adenylate. The rate of seryl transfer to cognate tRNA was only 2-fold slower than threonine. Experiments comparing the rate of ATP consumption to the rate of aminoacyl-tRNA(AA) formation demonstrated that pre- transfer hydrolysis contributes to proofreading only when the rate of transfer is slowed significantly. Thus, the relative contributions of pre- and post-transfer editing in ThrRS are subject to modulation by the rate of aminoacyl transfer.	[Francklyn, Christopher S.] Univ Vermont, Dept Biochem, Coll Med, Burlington, VT 05405 USA; Univ Vermont, Cell & Mol Biol Program, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Francklyn, CS (corresponding author), Univ Vermont, Dept Biochem, Coll Med, Hlth Sci Complex,89 Beaumont Ave, Burlington, VT 05405 USA.	Christopher.Francklyn@uvm.edu			National Institutes of Health, NIGMS [GM54899]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054899] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54899 from NIGMS.	Ambrogelly A, 2005, FEBS LETT, V579, P6017, DOI 10.1016/j.febslet.2005.09.025; Beuning PJ, 2000, P NATL ACAD SCI USA, V97, P8916, DOI 10.1073/pnas.97.16.8916; Boniecki MT, 2008, P NATL ACAD SCI USA, V105, P19223, DOI 10.1073/pnas.0809336105; Bovee ML, 2003, BIOCHEMISTRY-US, V42, P15102, DOI 10.1021/bi0355701; Dock-Bregeon AC, 2000, CELL, V103, P877, DOI 10.1016/S0092-8674(00)00191-4; Dock-Bregeon AC, 2004, MOL CELL, V16, P375, DOI 10.1016/S1097-2765(04)00591-X; Dulic M, 2010, J BIOL CHEM, V285, P23799, DOI 10.1074/jbc.M110.133553; FERSHT A, 1999, STRUCTURE MECH PROTE, P377; FERSHT AR, 1981, PROC R SOC SER B-BIO, V212, P351, DOI 10.1098/rspb.1981.0044; FERSHT AR, 1977, BIOCHEMISTRY-US, V16, P1025, DOI 10.1021/bi00624a034; Francklyn CS, 2008, BIOCHEMISTRY-US, V47, P11695, DOI 10.1021/bi801500z; Gruic-Sovulj I, 2007, FEBS LETT, V581, P5110, DOI 10.1016/j.febslet.2007.09.058; Guth E, 2005, BIOCHEMISTRY-US, V44, P3785, DOI 10.1021/bi047923h; Guth E, 2009, J BIOL CHEM, V284, P20753, DOI 10.1074/jbc.M109.021311; Guth EC, 2007, MOL CELL, V25, P531, DOI 10.1016/j.molcel.2007.01.015; Hati S, 2006, J BIOL CHEM, V281, P27862, DOI 10.1074/jbc.M605856200; Hauenstein SI, 2008, J BIOL CHEM, V283, P21997, DOI 10.1074/jbc.M801838200; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JAKUBOWSKI H, 1981, NUCLEIC ACIDS RES, V9, P3105, DOI 10.1093/nar/9.13.3105; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Lin L, 1996, NATURE, V384, P33, DOI 10.1038/384033b0; LIN SX, 1983, BIOCHEMISTRY-US, V22, P681, DOI 10.1021/bi00272a024; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; Ling J, 2007, RNA, V13, P1881, DOI 10.1261/rna.684107; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; Minajigi A, 2008, P NATL ACAD SCI USA, V105, P17748, DOI 10.1073/pnas.0804247105; Mursinna RS, 2001, BIOCHEMISTRY-US, V40, P5376, DOI 10.1021/bi002915w; Nomanbhoy TK, 1999, MOL CELL, V4, P519, DOI 10.1016/S1097-2765(00)80203-8; Nomanbhoy TK, 2000, P NATL ACAD SCI USA, V97, P5119, DOI 10.1073/pnas.090102197; Pauling L., 1957, FESTSCHRIFT ARTHUR S, P597; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; Sankaranarayanan R, 2000, NAT STRUCT BIOL, V7, P461; SCHMIDT E, 1994, SCIENCE, V264, P265, DOI 10.1126/science.8146659; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Splan KE, 2008, METHODS, V44, P119, DOI 10.1016/j.ymeth.2007.10.009; Splan KE, 2008, J BIOL CHEM, V283, P7128, DOI 10.1074/jbc.M709902200; Tan M, 2010, J BIOL CHEM, V285, P3235, DOI 10.1074/jbc.M109.060616; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; TSUI WC, 1981, NUCLEIC ACIDS RES, V9, P4627, DOI 10.1093/nar/9.18.4627; Uter NT, 2005, J BIOL CHEM, V280, P23966, DOI 10.1074/jbc.M414259200; Waas WF, 2007, BIOCHEMISTRY-US, V46, P12062, DOI 10.1021/bi7007454; YAMANE T, 1977, P NATL ACAD SCI USA, V74, P2246, DOI 10.1073/pnas.74.6.2246; Zaher HS, 2009, NATURE, V457, P161, DOI 10.1038/nature07582	44	45	45	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23810	23817		10.1074/jbc.M110.105320	http://dx.doi.org/10.1074/jbc.M110.105320			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20504770	Green Published, hybrid			2022-12-27	WOS:000280291400031
J	Gable, K; Gupta, SD; Han, GS; Niranjanakumari, S; Harmon, JM; Dunn, TM				Gable, Kenneth; Gupta, Sita D.; Han, Gongshe; Niranjanakumari, Somashekarappa; Harmon, Jeffrey M.; Dunn, Teresa M.			A Disease-causing Mutation in the Active Site of Serine Palmitoyltransferase Causes Catalytic Promiscuity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY SENSORY NEUROPATHY; AFFINITY-PEPTIDE CHROMATOGRAPHY; SPHINGOLIPID BIOSYNTHESIS; BASE SYNTHESIS; SUBUNIT; YEAST; SPTLC1; ACCUMULATION; PURIFICATION; PROTEIN	The autosomal dominant peripheral sensory neuropathy HSAN1 results from mutations in the LCB1 subunit of serine palmitoyltransferase (SPT). Serum from patients and transgenic mice expressing a disease-causing mutation (C133W) contain elevated levels of 1-deoxysphinganine (1-deoxySa), which presumably arise from inappropriate condensation of alanine with palmitoyl-CoA. Mutant heterodimeric SPT is catalytically inactive. However, mutant heterotrimeric SPT has similar to 10-20% of wild-type activity and supports growth of yeast cells lacking endogenous SPT. In addition, long chain base profiling revealed the synthesis of significantly more 1-deoxySa in yeast and mammalian cells expressing the heterotrimeric mutant enzyme than in cells expressing wild-type enzyme. Wild-type and mutant enzymes had similar affinities for serine. Surprisingly, the enzymes also had similar affinities for alanine, indicating that the major affect of the C133W mutation is to enhance activation of alanine for condensation with the acyl-CoA substrate. In vivo synthesis of 1-deoxySa by the mutant enzyme was proportional to the ratio of alanine to serine in the growth media, suggesting that this ratio can be used to modulate the relative synthesis of sphinganine and 1-deoxySa. By expressing SPT as a single-chain fusion protein to ensure stoichiometric expression of all three subunits, we showed that GADD153, a marker for endoplasmic reticulum stress, was significantly elevated in cells expressing mutant heterotrimers. GADD153 was also elevated in cells treated with 1-deoxySa. Taken together, these data indicate that the HSAN1 mutations perturb the active site of SPT resulting in a gain of function that is responsible for the HSAN1 phenotype.	[Dunn, Teresa M.] Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, Bethesda, MD 20184 USA; [Harmon, Jeffrey M.] Uniformed Serv Univ Hlth Sci, Dept Pharmacol, Bethesda, MD 20184 USA	Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA	Dunn, TM (corresponding author), 4301 Jones Bridge Rd, Bethesda, MD 20184 USA.	tdunn@usuhs.mil		Harmon, Jeffrey/0000-0001-7833-931X	National Institutes of Health [NS47717]; USPHS, National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)United States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS47717 (to T.M.D.) from the USPHS, National Institute of Neurological Disorders and Stroke.	Bejaoui K, 2001, NAT GENET, V27, P261, DOI 10.1038/85817; Dawkins JL, 2001, NAT GENET, V27, P309, DOI 10.1038/85879; Dedov VN, 2004, BBA-MOL BASIS DIS, V1688, P168, DOI 10.1016/j.bbadis.2003.12.005; Eichler FS, 2009, J NEUROSCI, V29, P14646, DOI 10.1523/JNEUROSCI.2536-09.2009; Gable K, 2002, J BIOL CHEM, V277, P10194, DOI 10.1074/jbc.M107873200; Gable K, 2000, J BIOL CHEM, V275, P7597, DOI 10.1074/jbc.275.11.7597; Gupta SD, 2009, J LIPID RES, V50, P1630, DOI 10.1194/jlr.M800580-JLR200; Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106; Han GS, 2006, J BIOL CHEM, V281, P39935, DOI 10.1074/jbc.M609365200; Han GS, 2004, J BIOL CHEM, V279, P53707, DOI 10.1074/jbc.M410014200; Hanada K, 2000, J BIOL CHEM, V275, P8409, DOI 10.1074/jbc.275.12.8409; Hanada K, 1998, J BIOL CHEM, V273, P33787, DOI 10.1074/jbc.273.50.33787; Hanada Kentaro, 2003, Methods Mol Biol, V228, P163, DOI 10.1385/1-59259-400-X:163; Hornemann T, 2006, J BIOL CHEM, V281, P37275, DOI 10.1074/jbc.M608066200; Hornemann T, 2009, J BIOL CHEM, V284, P26322, DOI 10.1074/jbc.M109.023192; Hornemann T, 2009, NEUROGENETICS, V10, P135, DOI 10.1007/s10048-008-0168-7; Luheshi LM, 2009, FEBS LETT, V583, P2581, DOI 10.1016/j.febslet.2009.06.030; McCampbell A, 2005, HUM MOL GENET, V14, P3507, DOI 10.1093/hmg/ddi380; Nakamura T, 2009, APOPTOSIS, V14, P455, DOI 10.1007/s10495-008-0301-y; Nicholson GA, 2001, AM J HUM GENET, V69, P655, DOI 10.1086/323252; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Penno A, 2010, J BIOL CHEM, V285, P11178, DOI 10.1074/jbc.M109.092973; Pruett ST, 2008, J LIPID RES, V49, P1621, DOI 10.1194/jlr.R800012-JLR200; Raman MCC, 2009, J BIOL CHEM, V284, P17328, DOI 10.1074/jbc.M109.008680; Tsegaye Y, 2007, J BIOL CHEM, V282, P28195, DOI 10.1074/jbc.M705074200; Yard BA, 2007, J MOL BIOL, V370, P870, DOI 10.1016/j.jmb.2007.04.086; Zitomer NC, 2009, J BIOL CHEM, V284, P4786, DOI 10.1074/jbc.M808798200	27	78	81	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22844	22850		10.1074/jbc.M110.122259	http://dx.doi.org/10.1074/jbc.M110.122259			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20504773	Green Published, hybrid			2022-12-27	WOS:000279999900017
J	Lemon, SM				Lemon, Stanley M.			Induction and Evasion of Innate Antiviral Responses by Hepatitis C Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DOUBLE-STRANDED-RNA; TOLL-LIKE RECEPTOR-3; NF-KAPPA-B; INTERFERON REGULATORY FACTOR-3; PLASMACYTOID DENDRITIC CELLS; NONSTRUCTURAL PROTEIN 5A; RIG-I; VIRAL-INFECTION; ADAPTER PROTEIN; TRANSCRIPTION FACTORS	Persistent hepatitis C virus infection is associated with progressive hepatic fibrosis and liver cancer. Acute infection evokes several distinct innate immune responses, but these are partially or completely countered by the virus. Hepatitis C virus proteins serve dual functions in replication and immune evasion, acting to disrupt cellular signaling pathways leading to interferon synthesis, subvert Jak-STAT signaling to limit expression of interferon-stimulated genes, and block antiviral activities of interferon-stimulated genes. The net effect is a multilayered evasion of innate immunity, which negatively influences the subsequent development of antigen-specific adaptive immunity, thereby contributing to virus persistence and resistance to therapy.	Univ N Carolina, Inflammatory Dis Inst, Lineberger Comprehens Canc Ctr, Div Infect Dis,Dept Med,Ctr Translat Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Lemon, SM (corresponding author), Univ N Carolina, Inflammatory Dis Inst, Lineberger Comprehens Canc Ctr, Div Infect Dis,Dept Med,Ctr Translat Immunol, Chapel Hill, NC 27599 USA.	smlemon@med.unc.edu			NIAID [U19-AI40035-14, R21-AI081058-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI040035, R21AI081058] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grants U19-AI40035-14 and R21-AI081058-1 from NIAID. This is the third article in the Thematic Minireview Series on Hepatitis C Virus. This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Abe T, 2007, J VIROL, V81, P8953, DOI 10.1128/JVI.00649-07; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Baril M, 2009, J VIROL, V83, P1299, DOI 10.1128/JVI.01659-08; Bigger CB, 2001, J VIROL, V75, P7059, DOI 10.1128/JVI.75.15.7059-7066.2001; Blindenbacher A, 2003, GASTROENTEROLOGY, V124, P1465, DOI 10.1016/S0016-5085(03)00290-7; Bode JG, 2003, FASEB J, V17, P488, DOI 10.1096/fj.02-0664fje; Chang JH, 2010, LIVER INT, V30, P311, DOI 10.1111/j.1478-3231.2009.02144.x; Chang S, 2007, J LEUKOCYTE BIOL, V82, P479, DOI 10.1189/jlb.0207128; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Chen ZH, 2007, J VIROL, V81, P964, DOI 10.1128/JVI.02076-06; Cheng G, 2006, P NATL ACAD SCI USA, V103, P8499, DOI 10.1073/pnas.0602957103; Christen V, 2007, HEPATOLOGY, V46, P558, DOI 10.1002/hep.21611; Dansako H, 2009, ARCH VIROL, V154, P801, DOI 10.1007/s00705-009-0375-z; Decalf J, 2007, J EXP MED, V204, P2423, DOI 10.1084/jem.20070814; Duong FHT, 2006, HEPATOLOGY, V43, P796, DOI 10.1002/hep.21116; Duong FHT, 2004, GASTROENTEROLOGY, V126, P263, DOI 10.1053/j.gastro.2003.10.076; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; Ferreon JC, 2005, J BIOL CHEM, V280, P20483, DOI 10.1074/jbc.M500422200; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Funami K, 2007, J IMMUNOL, V179, P6867, DOI 10.4049/jimmunol.179.10.6867; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gale MJ, 1997, VIROLOGY, V230, P217, DOI 10.1006/viro.1997.8493; Garaigorta U, 2009, CELL HOST MICROBE, V6, P513, DOI 10.1016/j.chom.2009.11.004; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Huang Y, 2007, P NATL ACAD SCI USA, V104, P985, DOI 10.1073/pnas.0609954104; Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07; Jouan L, 2010, J HEPATOL, V52, P167, DOI 10.1016/j.jhep.2009.11.011; Kabelitz D, 2007, CURR OPIN IMMUNOL, V19, P1, DOI 10.1016/j.coi.2006.11.018; Kanda T, 2009, J VIROL, V83, P8463, DOI 10.1128/JVI.00751-09; Kanto T, 2007, HEPATOL RES, V37, pS319, DOI 10.1111/j.1872-034X.2007.00236.x; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Kim KA, 2009, J HEPATOL, V50, P705, DOI 10.1016/j.jhep.2008.12.021; KNIPE D, 2007, FIELDS VIROLOGY, P1253; Kriegs M, 2009, J BIOL CHEM, V284, P28343, DOI 10.1074/jbc.M109.038877; Lau DTY, 2008, HEPATOLOGY, V47, P799, DOI 10.1002/hep.22076; Lee J, 2006, P NATL ACAD SCI USA, V103, P1828, DOI 10.1073/pnas.0510801103; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Liang YQ, 2008, GASTROENTEROLOGY, V135, P1710, DOI 10.1053/j.gastro.2008.07.023; Liang YQ, 2009, GASTROENTEROLOGY, V137, P1448, DOI 10.1053/j.gastro.2009.07.050; Lin WY, 2006, J VIROL, V80, P9226, DOI 10.1128/JVI.00459-06; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Morrow MP, 2009, BLOOD, V113, P5868, DOI 10.1182/blood-2008-11-190520; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Nakamura M, 2008, HEPATOL INT, V2, P222, DOI 10.1007/s12072-008-9055-4; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Otsuka M, 2005, HEPATOLOGY, V41, P1004, DOI 10.1002/hep.20666; Panne D, 2004, EMBO J, V23, P4384, DOI 10.1038/sj.emboj.7600453; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Pestka S, 2007, J BIOL CHEM, V282, P20047, DOI 10.1074/jbc.R700004200; Pflugheber J, 2002, P NATL ACAD SCI USA, V99, P4650, DOI 10.1073/pnas.062055699; POECK H, 2010, J NAT IMMUNOL, V11, P63; Randall G, 2006, GASTROENTEROLOGY, V131, P1584, DOI 10.1053/j.gastro.2006.08.043; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Ritchie KJ, 2004, NAT MED, V10, P1374, DOI 10.1038/nm1133; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sarasin-Filipowicz M, 2009, MOL CELL BIOL, V29, P4841, DOI 10.1128/MCB.00224-09; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Seki E, 2008, HEPATOLOGY, V48, P322, DOI 10.1002/hep.22306; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shimakami T, 2009, CURR OPIN PHARMACOL, V9, P537, DOI 10.1016/j.coph.2009.08.008; Shimoike T, 2009, ANTIVIR RES, V83, P228, DOI 10.1016/j.antiviral.2009.05.004; Shin EC, 2007, J INTERF CYTOK RES, V27, P985, DOI 10.1089/jir.2007.0039; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Taguchi T, 2004, J GEN VIROL, V85, P959, DOI 10.1099/vir.0.19513-0; Takahashi K, 2010, P NATL ACAD SCI USA, V107, P7431, DOI 10.1073/pnas.1002301107; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Tasaka M, 2007, J GEN VIROL, V88, P3323, DOI 10.1099/vir.0.83056-0; Taylor DR, 2001, J VIROL, V75, P1265, DOI 10.1128/JVI.75.3.1265-1273.2001; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Uze G, 2007, BIOCHIMIE, V89, P729, DOI 10.1016/j.biochi.2007.01.008; Wang CF, 2003, J VIROL, V77, P3898, DOI 10.1128/JVI.77.7.3898-3912.2003; Wang N, 2009, J VIROL, V83, P9824, DOI 10.1128/JVI.01125-09; Yang Y, 2007, P NATL ACAD SCI USA, V104, P7253, DOI 10.1073/pnas.0611506104; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoshida R, 2008, J BIOL CHEM, V283, P36211, DOI 10.1074/jbc.M806576200; Zhang CH, 2009, J INTEGR PLANT BIOL, V51, P29, DOI 10.1111/j.1744-7909.2008.00765.x	100	79	82	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22739	22745		10.1074/jbc.R109.099556	http://dx.doi.org/10.1074/jbc.R109.099556			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20457596	hybrid, Green Published			2022-12-27	WOS:000279999900004
J	Stefanini, I; Trabocchi, A; Marchi, E; Guarna, A; Cavalieri, D				Stefanini, Irene; Trabocchi, Andrea; Marchi, Emmanuela; Guarna, Antonio; Cavalieri, Duccio			A Systems Biology Approach to Dissection of the Effects of Small Bicyclic Peptidomimetics on a Panel of Saccharomyces cerevisiae Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICAL GENOMICS; BIOACTIVE COMPOUNDS; SMALL MOLECULES; TARTARIC ACID; YEAST; ENANTIOPURE; EXPRESSION; GENETICS; MUTATION; LIBRARY	In recent years, an approach called "chemical genetics" has been adopted in drug research to discover and validate new targets and to identify and optimize leads by high throughput screening. In this work, we tested the ability of a library of small peptidomimetics to induce phenotypic effects with functional implications on a panel of strains of the budding yeast Saccharomyces cerevisiae, both wild type and mutants, for respiratory function and multidrug resistance. Further elucidation of the function of these peptidomimetics was assessed by testing the effects of the compound with the most prominent inhibitory activity, 089, on gene expression using DNA microarrays. Pathway analysis showed the involvement of such a molecule in inducing oxidative damage through alterations in mitochondrial functions. Transcriptional experiments were confirmed by increased levels of ROS and activation of mitochondrial membrane potential. Our results demonstrate the influence of a functional HAP1 gene in the performance of S. cerevisiae as a model system.	[Stefanini, Irene; Marchi, Emmanuela; Cavalieri, Duccio] Univ Florence, Dept Pharmacol Mario Aiazzi Mancini, I-50139 Florence, Italy; [Trabocchi, Andrea; Guarna, Antonio] Univ Florence, Dept Chem Ugo Schiff, I-50139 Florence, Italy	University of Florence; University of Florence	Trabocchi, A (corresponding author), Via Lastruccia 13, I-50019 Florence, Italy.	andrea.trabocchi@unifi.it; duccio.cavalieri@unifi.it	Stefanini, Irene/V-5673-2017; Trabocchi, Andrea/H-7942-2014; CAVALIERI, DUCCIO/T-3097-2017	Stefanini, Irene/0000-0002-5629-9174; Trabocchi, Andrea/0000-0003-1774-9301; CAVALIERI, DUCCIO/0000-0001-6426-5719	Network of Excellence in Nutrigenomics (NuGO) [FOOD-CT-2004-506360]; European Union [LSHB-CT-2004-512074]; Network of Excellence DC-THERA [242220]; Fondazione RomaMinistero dell'Istruzione, dell'Universita e della Ricerca Programmi di ricerca di Rilevante Interesse Nazionale [519MIUR060]; Consorzio Interuniversitario Nazionale "Metodologie e Processi Innovativi di Sintesi"	Network of Excellence in Nutrigenomics (NuGO); European Union(European Commission); Network of Excellence DC-THERA; Fondazione RomaMinistero dell'Istruzione, dell'Universita e della Ricerca Programmi di ricerca di Rilevante Interesse Nazionale; Consorzio Interuniversitario Nazionale "Metodologie e Processi Innovativi di Sintesi"	This work was supported by Network of Excellence in Nutrigenomics (NuGO) Grant FOOD-CT-2004-506360, European Union Grant LSHB-CT-2004-512074, the Network of Excellence DC-THERA (Dendritic Cells for Novel Immunotherapies), SYBARIS Grant Agreement 242220, Fondazione Roma, Consorzio Interuniversitario Nazionale "Metodologie e Processi Innovativi di Sintesi" and Ministero dell'Istruzione, dell'Universita e della Ricerca Programmi di ricerca di Rilevante Interesse Nazionale Grant 519MIUR060.	Beltrame L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004128; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Brenner C, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-240; Burke MD, 2004, ANGEW CHEM INT EDIT, V43, P46, DOI 10.1002/anie.200300626; Cavalieri D, 2007, BIOINFORMATICS, V23, P2631, DOI 10.1093/bioinformatics/btm333; Gaisne M, 1999, CURR GENET, V36, P195, DOI 10.1007/s002940050490; GANTE J, 1994, ANGEW CHEM INT EDIT, V33, P1699, DOI 10.1002/anie.199416991; Giaever G, 2003, TRENDS PHARMACOL SCI, V24, P444, DOI 10.1016/S0165-6147(03)00225-6; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; Guarna A, 2002, TETRAHEDRON, V58, P9865, DOI 10.1016/S0040-4020(02)01297-8; Guarna A, 1999, J ORG CHEM, V64, P7347, DOI 10.1021/jo9904967; Hickman MJ, 2007, MOL CELL BIOL, V27, P7414, DOI 10.1128/MCB.00887-07; Hoon S, 2008, TRENDS PHARMACOL SCI, V29, P499, DOI 10.1016/j.tips.2008.07.006; Huang J, 2004, P NATL ACAD SCI USA, V101, P16594, DOI 10.1073/pnas.0407117101; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Landry CR, 2006, GENE, V366, P343, DOI 10.1016/j.gene.2005.10.042; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Lo MMC, 2004, J AM CHEM SOC, V126, P16077, DOI 10.1021/ja045089d; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; Machetti F, 2007, J COMB CHEM, V9, P454, DOI 10.1021/cc060120o; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Resnick MA, 2000, MUTAT RES-FUND MOL M, V451, P1, DOI 10.1016/S0027-5107(00)00036-1; Romualdi C, 2005, NUCLEIC ACIDS RES, V33, pW644, DOI 10.1093/nar/gki497; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; Spring DR, 2005, CHEM SOC REV, V34, P472, DOI 10.1039/b312875j; Stockwell BR, 2000, TRENDS BIOTECHNOL, V18, P449, DOI 10.1016/S0167-7799(00)01499-2; Tamura KI, 2004, J BIOSCI BIOENG, V98, P159, DOI 10.1016/S1389-1723(04)00260-9; Trabocchi A, 2006, SYNLETT, P331, DOI 10.1055/s-2006-926249; Trabocchi A, 2002, J ORG CHEM, V67, P7483, DOI 10.1021/jo0202132; Verkman AS, 2004, AM J PHYSIOL-CELL PH, V286, pC465, DOI 10.1152/ajpcell.00397.2003; Zheng X. F. Steven, 2002, Current Issues in Molecular Biology, V4, P33; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167	37	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23475	23483		10.1074/jbc.M110.125153	http://dx.doi.org/10.1074/jbc.M110.125153			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20501664	Green Published, hybrid			2022-12-27	WOS:000279999900079
J	Martin-Galiano, AJ; Buey, RM; Cabezas, M; Andreu, JM				Martin-Galiano, Antonio J.; Buey, Ruben M.; Cabezas, Marta; Andreu, Jose M.			Mapping Flexibility and the Assembly Switch of Cell Division Protein FtsZ by Computational and Mutational Approaches	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOBACTERIUM-TUBERCULOSIS FTSZ; ALPHA-BETA-TUBULIN; GTP HYDROLYSIS; STRUCTURAL INSIGHTS; ESSENTIAL DYNAMICS; ESCHERICHIA-COLI; BINDING-PROTEINS; POLYMERIZATION; RESIDUE; DOMAIN	The molecular switch for nucleotide-regulated assembly and disassembly of the main prokaryotic cell division protein FtsZ is unknown despite the numerous crystal structures that are available. We have characterized the functional motions in FtsZ with a computational consensus of essential dynamics, structural comparisons, sequence conservation, and networks of co-evolving residues. Employing this information, we have constructed 17 mutants, which alter the FtsZ functional cycle at different stages, to modify FtsZ flexibility. The mutant phenotypes ranged from benign to total inactivation and included increased GTPase, reduced assembly, and stabilized assembly. Six mutations clustering at the long cleft between the C-terminal beta-sheet and core helix H7 deviated FtsZ assembly into curved filaments with inhibited GTPase, which still polymerize cooperatively. These mutations may perturb the predicted closure of the C-terminal domain onto H7 required for switching between curved and straight association modes and for GTPase activation. By mapping the FtsZ assembly switch, this work also gives insight into FtsZ druggability because the curved mutations delineate the putative binding site of the promising antibacterial FtsZ inhibitor PC190723.	[Martin-Galiano, Antonio J.; Cabezas, Marta; Andreu, Jose M.] CSIC, Ctr Invest Biol, Madrid 28040, Spain; [Buey, Ruben M.] Paul Scherrer Inst, CH-5232 Villigen, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Martin-Galiano, AJ (corresponding author), CSIC, Ctr Invest Biol, Ramiro Maeztu 9, Madrid 28040, Spain.	a.martin@cib.csic.es; j.m.andreu@cib.csic.es	Martinez-Buey, Ruben/K-4296-2014	Martinez-Buey, Ruben/0000-0003-1263-0221; Martin-Galiano, Antonio Javier/0000-0002-6662-329X; Andreu, Jose M/0000-0001-8064-6933	Ministerio de Ciencia e Innovacion [BFU2008-00013]; Comunidad Autonoma de Madrid [S-BIO-0214-2006]; Juan de la Cierva; Federation of European Biochemical Societies; Comunidad de Madrid	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comunidad Autonoma de Madrid(Comunidad de Madrid); Juan de la Cierva(Instituto de Salud Carlos III); Federation of European Biochemical Societies; Comunidad de Madrid(Comunidad de Madrid)	This work was supported by grants from Ministerio de Ciencia e Innovacion BFU2008-00013 and Comunidad Autonoma de Madrid S-BIO-0214-2006 (to J. M. A.). This work was also supported by a Juan de la Cierva contract (to A. J. M.-G.), a Federation of European Biochemical Societies postdoctoral fellowship (to R. M. B.), and a contract from Comunidad de Madrid (to M. C.).	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Addinall SG, 2005, J BACTERIOL, V187, P358, DOI 10.1128/JB.187.1.358-365.2005; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Andreu JM, 2002, J BIOL CHEM, V277, P43262, DOI 10.1074/jbc.M206723200; Andreu JM, 2010, J BIOL CHEM, V285, P14239, DOI 10.1074/jbc.M109.094722; Bennett MJ, 2009, BIOCHEMISTRY-US, V48, P4858, DOI 10.1021/bi900200q; Buey RM, 2007, J MOL BIOL, V365, P411, DOI 10.1016/j.jmb.2006.09.091; Buey RM, 2006, BIOCHEMISTRY-US, V45, P5933, DOI 10.1021/bi060334m; Chen Y, 2007, J BIOL CHEM, V282, P27736, DOI 10.1074/jbc.M703788200; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; DAI K, 1994, J BACTERIOL, V176, P130, DOI 10.1128/JB.176.1.130-136.1994; deGroot BL, 1997, PROTEINS, V29, P240, DOI 10.1002/(SICI)1097-0134(199710)29:2<240::AID-PROT11>3.0.CO;2-O; Diaz JF, 2001, J BIOL CHEM, V276, P17307, DOI 10.1074/jbc.M010920200; DIAZ JF, 1993, BIOCHEMISTRY-US, V32, P10067, DOI 10.1021/bi00089a023; Diaz-Espinoza R, 2007, PROTEIN SCI, V16, P1543, DOI 10.1110/ps.072807607; Dimitrov A, 2008, SCIENCE, V322, P1353, DOI 10.1126/science.1165401; Dorleans A, 2009, P NATL ACAD SCI USA, V106, P13775, DOI 10.1073/pnas.0904223106; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elie-Caille C, 2007, CURR BIOL, V17, P1765, DOI 10.1016/j.cub.2007.08.063; Erickson HP, 2009, P NATL ACAD SCI USA, V106, P9238, DOI 10.1073/pnas.0902258106; Erickson HP, 1998, TRENDS CELL BIOL, V8, P133, DOI 10.1016/S0962-8924(98)01237-9; Feucht A, 2005, MICROBIOL-SGM, V151, P2053, DOI 10.1099/mic.0.27899-0; Flores SC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-167; Gebremichael Y, 2008, BIOPHYS J, V95, P2487, DOI 10.1529/biophysj.108.129072; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Gromiha MM, 2004, PROG BIOPHYS MOL BIO, V86, P235, DOI 10.1016/j.pbiomolbio.2003.09.003; Gupta P, 2008, BIOCHEM BIOPH RES CO, V368, P445, DOI 10.1016/j.bbrc.2008.01.115; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Hatley ME, 2003, P NATL ACAD SCI USA, V100, P14445, DOI 10.1073/pnas.1835919100; Haydon DJ, 2008, SCIENCE, V321, P1673, DOI 10.1126/science.1159961; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Huecas S, 2004, FEBS LETT, V569, P43, DOI 10.1016/j.febslet.2004.05.048; Huecas S, 2003, J BIOL CHEM, V278, P46146, DOI 10.1074/jbc.M307128200; Huecas S, 2008, BIOPHYS J, V94, P1796, DOI 10.1529/biophysj.107.115493; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kapoor S, 2009, EXPERT OPIN THER TAR, V13, P1037, DOI 10.1517/14728220903173257; KODAMA T, 1986, J BIOCHEM-TOKYO, V99, P1465, DOI 10.1093/oxfordjournals.jbchem.a135616; Lan GH, 2008, BIOPHYS J, V95, P4045, DOI 10.1529/biophysj.108.132837; Lappchen T, 2008, CHEM BIOL, V15, P189, DOI 10.1016/j.chembiol.2007.12.013; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lock RL, 2008, NAT REV DRUG DISCOV, V7, P324, DOI 10.1038/nrd2510; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lowe J, 1999, EMBO J, V18, P2364, DOI 10.1093/emboj/18.9.2364; Lu C, 2001, BMC Microbiol, V1, P7, DOI 10.1186/1471-2180-1-7; Lu CL, 2000, J BACTERIOL, V182, P164, DOI 10.1128/JB.182.1.164-170.2000; Miraldi ER, 2008, BIOPHYS J, V95, P2470, DOI 10.1529/biophysj.107.126219; MIXON MB, 1995, SCIENCE, V270, P954, DOI 10.1126/science.270.5238.954; Monahan LG, 2009, MOL MICROBIOL, V74, P1004, DOI 10.1111/j.1365-2958.2009.06914.x; Nogales E, 2006, CURR OPIN STRUC BIOL, V16, P221, DOI 10.1016/j.sbi.2006.03.005; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Oliva MA, 2003, J BIOL CHEM, V278, P33562, DOI 10.1074/jbc.M303798200; Oliva MA, 2007, J MOL BIOL, V373, P1229, DOI 10.1016/j.jmb.2007.08.056; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Redick SD, 2005, J BACTERIOL, V187, P2727, DOI 10.1128/JB.187.8.2727-2736.2005; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Scheffers DJ, 2001, FEBS LETT, V494, P34, DOI 10.1016/S0014-5793(01)02310-9; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VANAALTEN DMF, 1995, PROTEINS, V22, P45, DOI 10.1002/prot.340220107; Vaughan S, 2004, J MOL EVOL, V58, P19, DOI 10.1007/s00239-003-2523-5; Vollmer W, 2006, APPL MICROBIOL BIOT, V73, P37, DOI 10.1007/s00253-006-0586-0; Wang K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-385	66	41	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22554	22565		10.1074/jbc.M110.117127	http://dx.doi.org/10.1074/jbc.M110.117127			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20472561	Green Published, hybrid			2022-12-27	WOS:000279702200067
J	Solomon, E; Li, H; Muggy, SD; Syta, E; Zolkiewska, A				Solomon, Emilia; Li, Hui; Muggy, Sara Duhachek; Syta, Emilia; Zolkiewska, Anna			The Role of SnoN in Transforming Growth Factor beta 1 induced Expression of Metalloprotease- Disintegrin ADAM12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BREAST-CANCER; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ANAPHASE-PROMOTING COMPLEX; TGF-BETA; KNEE OSTEOARTHRITIS; CARDIAC-HYPERTROPHY; COLORECTAL CANCERS; CELL-PROLIFERATION; TUMOR PROGRESSION; CANDIDATE GENES	Increased expression of metalloprotease-disintegrin ADAM12 is a hallmark of several pathological conditions, including cancer, cardiovascular disease, and certain inflammatory diseases of the central nervous system or the muscoskeletal system. We show that transforming growth factor beta 1 (TGF beta 1) is a potent inducer of ADAM12 mRNA and protein in mouse fibroblasts and in mouse and human mammary epithelial cells. Induction of ADAM12 is detected within 2 h of treatment with TGF beta 1, is Smad2/Smad3-dependent, and is a result of derepression of the Adam12 gene. SnoN, a negative regulator of the TGF beta signaling pathway, is a master regulator of ADAM12 expression in response to TGF beta 1 stimulation. Overexpression of SnoN in NIH3T3 cells reduces the magnitude of ADAM12 induction by TGF beta 1 treatment. Down-regulation of SnoN expression by short hairpin RNA enhances TGF beta 1-induced expression of ADAM12. In a panel of TGF beta 1-responsive cancer cell lines with high expression of SnoN, induction of ADAM12 by TGF beta 1 is significantly impaired, suggesting that the endogenous SnoN plays a role in regulating ADAM12 expression in response to TGF beta 1. Identification of SnoN as a repressor of the ADAM12 gene should contribute to advances in the studies on the role of ADAM12 in tumor progression and in the development of other pathologies.	[Solomon, Emilia; Li, Hui; Muggy, Sara Duhachek; Syta, Emilia; Zolkiewska, Anna] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA	Kansas State University	Zolkiewska, A (corresponding author), Kansas State Univ, Dept Biochem, 141 Chalmers Hall, Manhattan, KS 66506 USA.	zolkiea@ksu.edu	LI, HUI/G-1227-2011; Solomon, Emilia/AAH-9319-2021	LI, HUI/0000-0002-4114-8349; Solomon, Emilia/0000-0003-0265-9792	National Institutes of Health [GM065528]; Terry C. Johnson Center for Basic Cancer Research at Kansas State University; NATIONAL CANCER INSTITUTE [R15CA151065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065528] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Terry C. Johnson Center for Basic Cancer Research at Kansas State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM065528 and Innovative Research Award from Terry C. Johnson Center for Basic Cancer Research at Kansas State University. This is Contribution 10-117-J from the Kansas Agricultural Experiment Station.	Atfi A, 2007, J CELL BIOL, V178, P201, DOI 10.1083/jcb.200612046; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; Cao Y, 2002, J BIOL CHEM, V277, P26403, DOI 10.1074/jbc.M110814200; Carl-McGrath S, 2005, INT J ONCOL, V26, P17; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dyczynska E, 2008, INT J CANCER, V122, P2634, DOI 10.1002/ijc.23405; Fedak PWM, 2006, CIRCULATION, V113, P238, DOI 10.1161/CIRCULATIONAHA.105.571414; Frohlich C, 2006, CLIN CANCER RES, V12, P7359, DOI 10.1158/1078-0432.CCR-06-1066; Holt G, 2007, CLIN ORTHOP RELAT R, P240, DOI 10.1097/BLO.0b013e31804b4147; Iba K, 1999, AM J PATHOL, V154, P1489, DOI 10.1016/S0002-9440(10)65403-X; Keating DT, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-114; Kim IY, 1996, CANCER RES, V56, P44; Kodama T, 2004, AM J PATHOL, V165, P1743, DOI 10.1016/S0002-9440(10)63429-3; Kveiborg M, 2005, CANCER RES, V65, P4754, DOI 10.1158/0008-5472.CAN-05-0262; Kveiborg M, 2008, INT J BIOCHEM CELL B, V40, P1685, DOI 10.1016/j.biocel.2008.01.025; Le Pabic H, 2005, J HEPATOL, V43, P1038, DOI 10.1016/j.jhep.2005.05.025; Le Pabic H, 2003, HEPATOLOGY, V37, P1056, DOI 10.1053/jhep.2003.50205; Le Scolan E, 2008, CANCER RES, V68, P3277, DOI 10.1158/0008-5472.CAN-07-6793; Leask A, 2007, CARDIOVASC RES, V74, P207, DOI 10.1016/j.cardiores.2006.07.012; Lendeckel U, 2005, J CANCER RES CLIN, V131, P41, DOI 10.1007/s00432-004-0619-y; Levy L, 2007, MOL CELL BIOL, V27, P6068, DOI 10.1128/MCB.00664-07; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Lynch MA, 2001, GENE EXPRESSION, V9, P157, DOI 10.3727/000000001783992560; Ma GF, 2005, J RHEUMATOL, V32, P1943; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mino N, 2009, J SURG ONCOL, V100, P267, DOI 10.1002/jso.21313; Mitsui Y, 2006, CANCER RES, V66, P9913, DOI 10.1158/0008-5472.CAN-06-0377; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Nagano Y, 2007, J BIOL CHEM, V282, P20492, DOI 10.1074/jbc.M701294200; Peduto L, 2006, ONCOGENE, V25, P5462, DOI 10.1038/sj.onc.1209536; Pot I, 2008, CURR MOL MED, V8, P319, DOI 10.2174/156652408784533797; Pouliot F, 1999, INT J CANCER, V81, P98, DOI 10.1002/(SICI)1097-0215(19990331)81:1<98::AID-IJC17>3.0.CO;2-9; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; Roy R, 2004, J BIOL CHEM, V279, P51323, DOI 10.1074/jbc.M409565200; Sarker KP, 2005, J BIOL CHEM, V280, P13037, DOI 10.1074/jbc.M409367200; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stroschein SL, 2001, GENE DEV, V15, P2822; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Sun Y, 1999, P NATL ACAD SCI USA, V96, P12442, DOI 10.1073/pnas.96.22.12442; Swanborg RH, 2001, IMMUNOL REV, V184, P129, DOI 10.1034/j.1600-065x.2001.1840112.x; Tan RY, 2006, J AM SOC NEPHROL, V17, P2781, DOI 10.1681/ASN.2005101055; Toft-Hansen H, 2004, J IMMUNOL, V173, P5209, DOI 10.4049/jimmunol.173.8.5209; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Valdes AM, 2006, ARTHRITIS RHEUM-US, V54, P533, DOI 10.1002/art.21621; Valdes AM, 2004, ARTHRITIS RHEUM-US, V50, P2497, DOI 10.1002/art.20443; Wan Y, 2001, MOL CELL, V8, P1027, DOI 10.1016/S1097-2765(01)00382-3; Wang X, 2009, HYPERTENSION, V54, P575, DOI 10.1161/HYPERTENSIONAHA.108.127670; Wang X, 2009, CIRCULATION, V119, P2480, DOI 10.1161/CIRCULATIONAHA.108.835488; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Yang JW, 2003, J AM SOC NEPHROL, V14, P3167, DOI 10.1097/01.ASN.0000099373.33259.B2; Zhang F, 2002, FEBS LETT, V527, P58, DOI 10.1016/S0014-5793(02)03163-0; Zhou S, 1998, MOL CELL, V2, P121, DOI 10.1016/S1097-2765(00)80120-3; Zhu QW, 2007, MOL CELL BIOL, V27, P324, DOI 10.1128/MCB.01394-06	57	27	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					21969	21977		10.1074/jbc.M110.133314	http://dx.doi.org/10.1074/jbc.M110.133314			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20457602	hybrid, Green Published			2022-12-27	WOS:000279702200009
J	Wang, Z; Wu, T; Shi, L; Zhang, L; Zheng, W; Qu, JAY; Niu, RF; Qi, RZ				Wang, Zhe; Wu, Tao; Shi, Lin; Zhang, Lin; Zheng, Wei; Qu, Jianan Y.; Niu, Ruifang; Qi, Robert Z.			Conserved Motif of CDK5RAP2 Mediates Its Localization to Centrosomes and the Golgi Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE POLE BODY; GAMMA-TUBULIN COMPLEXES; MICROTUBULE NUCLEATION; CELL-CYCLE; PROTEIN; CALMODULIN; CENTRIOLES; APPARATUS; AKAP450; PERICENTRIN	As the primary microtubule-organizing centers, centrosomes require gamma-tubulin for microtubule nucleation and organization. Located in close vicinity to centrosomes, the Golgi complex is another microtubule-organizing organelle in interphase cells. CDK5RAP2 is a gamma-tubulin complex-binding protein and functions in gamma-tubulin attachment to centrosomes. In this study, we find that CDK5RAP2 localizes to the Golgi complex in an ATP- and centrosome-dependent manner and associates with Golgi membranes independently of microtubules. CDK5RAP2 contains a centrosome-targeting domain with its core region highly homologous to the Motif 2 (CM2) of centrosomin, a functionally related protein in Drosophila. This sequence, referred to as the CM2-like motif, is also conserved in related proteins in chicken and zebrafish. Therefore, CDK5RAP2 may undertake a conserved mechanism for centrosomal localization. Using a mutational approach, we demonstrate that the CM2-like motif plays a crucial role in the centrosomal and Golgi localization of CDK5RAP2. Furthermore, the CM2-like motif is essential for the association of the centrosome-targeting domain to pericentrin and AKAP450. The binding with pericentrin is required for the centrosomal and Golgi localization of CDK5RAP2, whereas the binding with AKAP450 is required for the Golgi localization. Although the CM2-like motif possesses the activity of Ca(2+)-independent calmodulin binding, binding of calmodulin to this sequence is dispensable for centrosomal and Golgi association. Altogether, CDK5RAP2 may represent a novel mechanism for centrosomal and Golgi localization.	[Wang, Zhe; Shi, Lin; Qi, Robert Z.] Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China; [Wang, Zhe; Shi, Lin; Qi, Robert Z.] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Wu, Tao; Zheng, Wei; Qu, Jianan Y.] Hong Kong Univ Sci & Technol, Dept Elect & Comp Engn, Kowloon, Hong Kong, Peoples R China; [Zhang, Lin; Niu, Ruifang] Tianjin Med Univ, Canc Inst & Hosp, Tianjin, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Tianjin Medical University	Qi, RZ (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China.	qirz@ust.hk	WU, Tao/C-9356-2011; Niu, Ruifang/AAJ-8017-2020; WU, Tao/B-9136-2011	Niu, Ruifang/0000-0002-1905-7408; Qi, Robert Zhong/0000-0001-5596-8172; Qu, Jianan/0000-0002-6809-0087	Research Grants Council (General Research Fund and Collaborative Research Fund); University Grants Committee (Area of Excellence and Special Equipment Grant schemes) of Hong Kong	Research Grants Council (General Research Fund and Collaborative Research Fund)(Hong Kong Research Grants Council); University Grants Committee (Area of Excellence and Special Equipment Grant schemes) of Hong Kong	This work was supported by the Research Grants Council (General Research Fund and Collaborative Research Fund) and the University Grants Committee (Area of Excellence and Special Equipment Grant schemes) of Hong Kong.	Bisel B, 2008, J CELL BIOL, V182, P837, DOI 10.1083/jcb.200805045; Bobinnec Y, 1998, J CELL BIOL, V143, P1575, DOI 10.1083/jcb.143.6.1575; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; Chang P, 2000, NAT CELL BIOL, V2, P30, DOI 10.1038/71350; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; del Valle M, 1999, J CELL SCI, V112, P4017; Delaval B, 2010, J CELL BIOL, V188, P181, DOI 10.1083/jcb.200908114; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Flory MR, 2002, CELL GROWTH DIFFER, V13, P47; Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371; Fong KW, 2009, MOL BIOL CELL, V20, P3660, DOI 10.1091/mbc.E09-01-0009; GEISER JR, 1993, MOL CELL BIOL, V13, P7913, DOI 10.1128/MCB.13.12.7913; Gillingham AK, 2000, EMBO REP, V1, P524; Graser S, 2007, J CELL SCI, V120, P4321, DOI 10.1242/jcs.020248; Guarguaglini G, 2005, MOL BIOL CELL, V16, P1095, DOI 10.1091/mbc.E04-10-0939; Hagiwara H, 2006, HISTOCHEM CELL BIOL, V126, P251, DOI 10.1007/s00418-006-0166-5; Haren L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005976; He LS, 2008, J BIOL CHEM, V283, P13252, DOI 10.1074/jbc.M706937200; Hoppeler-Lebel A, 2007, J CELL SCI, V120, P3299, DOI 10.1242/jcs.013102; Keryer G, 2003, MOL BIOL CELL, V14, P2436, DOI 10.1091/mbc.E02-09-0614; Khodjakov A, 1997, CELL MOTIL CYTOSKEL, V38, P311, DOI 10.1002/(SICI)1097-0169(1997)38:4<311::AID-CM1>3.3.CO;2-M; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kodani A, 2009, MOL BIOL CELL, V20, P1192, DOI 10.1091/mbc.E08-08-0834; Larocca MC, 2004, MOL BIOL CELL, V15, P2771, DOI 10.1091/mbc.E03-10-0757; Magdalena J, 2003, J CELL SCI, V116, P743, DOI 10.1242/jcs.00288; Marie M, 2009, MOL BIOL CELL, V20, P4458, DOI 10.1091/mbc.E08-12-1229; Matsumoto Y, 2002, SCIENCE, V295, P499, DOI 10.1126/science.1065693; Miller PM, 2009, NAT CELL BIOL, V11, P1069, DOI 10.1038/ncb1920; Nakagawa Y, 2001, MOL BIOL CELL, V12, P1687, DOI 10.1091/mbc.12.6.1687; Paoletti A, 1996, J CELL SCI, V109, P3089; Rios RM, 2004, CELL, V118, P323; Rivero S, 2009, EMBO J, V28, P1016, DOI 10.1038/emboj.2009.47; Salisbury JL, 2003, CURR BIOL, V13, pR88, DOI 10.1016/S0960-9822(03)00033-2; Sawin KE, 2004, CURR BIOL, V14, P763, DOI 10.1016/j.cub.2004.03.042; Schmidt PH, 1999, J BIOL CHEM, V274, P3055, DOI 10.1074/jbc.274.5.3055; Soung NK, 2006, MOL CELL BIOL, V26, P8316, DOI 10.1128/MCB.00671-06; Spang A, 1996, J CELL SCI, V109, P2229; STIRLING DA, 1994, EMBO J, V13, P4329, DOI 10.1002/j.1460-2075.1994.tb06753.x; Sundberg HA, 1996, J CELL BIOL, V133, P111, DOI 10.1083/jcb.133.1.111; Takahashi M, 1999, J BIOL CHEM, V274, P17267, DOI 10.1074/jbc.274.24.17267; Verde I, 2001, J BIOL CHEM, V276, P11189, DOI 10.1074/jbc.M006546200; Witczak O, 1999, EMBO J, V18, P1858, DOI 10.1093/emboj/18.7.1858; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Zhang J, 2007, MOL BIOL CELL, V18, P4037, DOI 10.1091/mbc.E07-05-0474	48	89	96	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22658	22665		10.1074/jbc.M110.105965	http://dx.doi.org/10.1074/jbc.M110.105965			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20466722	Green Published, hybrid			2022-12-27	WOS:000279702200076
J	Hanau, S; Montin, K; Cervellati, C; Magnani, M; Dallocchio, F				Hanau, Stefania; Montin, Katy; Cervellati, Carlo; Magnani, Morena; Dallocchio, Franco			6-Phosphogluconate Dehydrogenase Mechanism EVIDENCE FOR ALLOSTERIC MODULATION BY SUBSTRATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE DECARBOXYLATION; CANDIDA-UTILIS; ENZYME; BINDING; NADP; COENZYME; SUBUNITS; ANALOG; SITE	The reductive carboxylation of ribulose-5-phosphate (Ru5P) by 6-phosphogluconate dehydrogenase (6PGDH) from Candida utilis was investigated using kinetic isotope effects. The intrinsic isotope effect for proton abstraction from Ru5P was found at 4.9 from deuterium isotope effects on V and V/K and from tritium isotope effects on V/K. The presence of 6-phosphogluconate (6PG) in the assay mixture changes the magnitude of the observed isotope effects. In the absence of 6PG (D)(V/K) and (D)(V) are 1.68 and 2.46, respectively, whereas the presence of 6PG increases (D)(V/K) to 2.84 and decreases (D)(V) to 1.38. A similar increase of (T)(V/K) is observed as 6PG builds up in the reaction mixture. These data indicate that in the absence of 6PG, a slow step, which precedes the chemical process, is rate-limiting for the reaction, whereas in the presence of 6PG, the rate-limiting step follows the isotope-sensitive step. Kinetic analysis of reductive carboxylation shows that 6PG at low concentrations decreases the K-m of Ru5P, whereas at higher concentrations, the usual competitive pattern is observed. These data indicate that full activity of 6PGDH is achieved when one subunit carries out the catalysis and the other subunit carries an unreacted 6PG. Thus, 6PG is like an allosteric activator of 6PGDH.	[Hanau, Stefania; Montin, Katy; Cervellati, Carlo; Magnani, Morena; Dallocchio, Franco] Univ Ferrara, Dipartmento Biochim & Biol Mol, I-44100 Ferrara, Italy	University of Ferrara	Hanau, S (corresponding author), Univ Ferrara, Dipartmento Biochim & Biol Mol, Via Borsari 46, I-44100 Ferrara, Italy.	hns@unife.it	Cervellati, Carlo/K-6453-2015; Hanau, Stefania/AAG-7510-2021; Hanau, Stefania/AAG-7534-2021	Cervellati, Carlo/0000-0003-4777-6300; Hanau, Stefania/0000-0002-2817-9941				ADAMS MJ, 1994, STRUCTURE, V2, P651, DOI 10.1016/S0969-2126(00)00066-6; BERDIS AJ, 1993, BIOCHEMISTRY-US, V32, P2036, DOI 10.1021/bi00059a021; Cleland W W, 1980, Methods Enzymol, V64, P104; COOK PF, 1981, BIOCHEMISTRY-US, V20, P1790, DOI 10.1021/bi00510a013; DALLOCCHIO F, 1981, J BIOL CHEM, V256, P778; DISCHE Z, 1962, METHODS CARBOHYDR CH, V1, P481; HANAU S, 1992, BIOCHIM BIOPHYS ACTA, V1122, P273, DOI 10.1016/0167-4838(92)90404-2; HANAU S, 1992, BIOCHIM BIOPHYS ACTA, V1159, P262, DOI 10.1016/0167-4838(92)90054-H; HANAU S, 1993, BIOCHEM J, V291, P325, DOI 10.1042/bj2910325; Hwang CC, 1998, BIOCHEMISTRY-US, V37, P15698, DOI 10.1021/bi981288w; Hwang CC, 1998, BIOCHEMISTRY-US, V37, P12596, DOI 10.1021/bi980611s; Karsten WE, 1998, BIOCHEMISTRY-US, V37, P15691, DOI 10.1021/bi9812827; Lei Z, 1999, BIOCHEMISTRY-US, V38, P11231, DOI 10.1021/bi990433i; Li L, 2006, J BIOL CHEM, V281, P25568, DOI 10.1074/jbc.M601154200; LIENHARD GE, 1964, BIOCHEMISTRY-US, V3, P190, DOI 10.1021/bi00890a009; Montin K, 2007, FEBS J, V274, P6426, DOI 10.1111/j.1742-4658.2007.06160.x; NOLTMANN EA, 1972, ENZYMES, V6, P272; RENDINA AR, 1984, BIOCHEMISTRY-US, V23, P6257, DOI 10.1021/bi00320a056; RIPPA M, 1972, BIOCHEM BIOPH RES CO, V48, P764, DOI 10.1016/0006-291X(72)90672-9; RIPPA M, 1973, J BIOL CHEM, V248, P4920; Rippa M, 1975, Methods Enzymol, V41, P237; Rippa M, 1998, BBA-PROTEIN STRUCT M, V1429, P83, DOI 10.1016/S0167-4838(98)00222-2; SOMMERCORN J, 1982, J BIOL CHEM, V257, P9424	23	17	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21366	21371		10.1074/jbc.M110.105601	http://dx.doi.org/10.1074/jbc.M110.105601			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20452987	Green Published, hybrid			2022-12-27	WOS:000279516100022
J	Neagoe, I; Stauber, T; Fidzinski, P; Bergsdorf, EY; Jentsch, TJ				Neagoe, Ioana; Stauber, Tobias; Fidzinski, Pawel; Bergsdorf, Eun-Yeong; Jentsch, Thomas J.			The Late Endosomal ClC-6 Mediates Proton/Chloride Countertransport in Heterologous Plasma Membrane Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL STORAGE DISEASE; CHLORIDE CHANNEL FAMILY; DENTS-DISEASE; CELLS; ACIDIFICATION; ANTIPORTER; TRANSPORTERS; PROTEINS; KIDNEY; DETERMINANTS	Members of the CLC protein family of Cl- channels and transporters display the remarkable ability to function as either chloride channels or Cl-/H+ antiporters. Due to the intracellular localization of ClC-6 and ClC-7, it has not yet been possible to study the biophysical properties of these members of the late endosomal/lysosomal CLC branch in heterologous expression. Whereas recent data suggest that ClC-7 functions as an antiporter, transport characteristics of ClC-6 have remained entirely unknown. Here, we report that fusing the green fluorescent protein (GFP) to the N terminus of ClC-6 increased its cell surface expression, allowing us to functionally characterize ClC-6. Compatible with ClC-6 mediating Cl-/H+ exchange, Xenopus oocytes expressing GFP-tagged ClC-6 alkalinized upon depolarization. This alkalinization was dependent on the presence of extracellular anions and could occur against an electrochemical proton gradient. As observed in other CLC exchangers, ClC-6-mediated H+ transport was abolished by mutations in either the "gating" or "proton" glutamate. Overexpression of GFP-tagged ClC-6 in CHO cells elicited small, outwardly rectifying currents with a Cl- > I- conductance sequence. Mutating the gating glutamate of ClC-6 yielded an ohmic anion conductance that was increased by additionally mutating the "anion-coordinating" tyrosine. Additionally changing the chloride-coordinating serine 157 to proline increased the NO3- conductance of this mutant. Taken together, these data demonstrate for the first time that ClC-6 is a Cl-/H+ antiporter.	Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Jentsch, TJ (corresponding author), Max Delbruck Ctr Mol Med, Leibniz Inst Mol Pharmakol, Robert Rossle Str 10, D-13125 Berlin, Germany.	Jentsch@fmp-berlin.de	Stauber, Tobias/E-4005-2010; Berindan-Neagoe, Ioana/AAH-9854-2019; Fidzinski, Pawel/AAM-8884-2020	Stauber, Tobias/0000-0003-0727-6109; Fidzinski, Pawel/0000-0001-6373-4763; Jentsch, Thomas/0000-0002-3509-2553	Deutsche Forschungsgemeinschaft [SFB740]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by a grant from the Deutsche Forschungsgemeinschaft (SFB740).	Accardi A, 2005, J GEN PHYSIOL, V126, P563, DOI 10.1085/jgp.200509417; Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Beitz E, 2006, BIOL CELL, V98, P101, DOI 10.1042/BC20050025; Bergsdorf EY, 2009, J BIOL CHEM, V284, P11184, DOI 10.1074/jbc.M901170200; Brandt S, 1995, FEBS LETT, V377, P15, DOI 10.1016/0014-5793(95)01298-2; Buyse G, 1997, J BIOL CHEM, V272, P3615, DOI 10.1074/jbc.272.6.3615; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Friedrich T, 1999, J BIOL CHEM, V274, P896, DOI 10.1074/jbc.274.2.896; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Gunther W, 2003, PFLUG ARCH EUR J PHY, V445, P456, DOI 10.1007/s00424-002-0950-6; Gunther W, 1998, P NATL ACAD SCI USA, V95, P8075, DOI 10.1073/pnas.95.14.8075; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P1241, DOI 10.1074/jbc.M407030200; Hara-Chikuma M, 2005, BIOCHEM BIOPH RES CO, V329, P941, DOI 10.1016/j.bbrc.2005.02.060; Ignoul S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000474; Jayaram H, 2008, P NATL ACAD SCI USA, V105, P11194, DOI 10.1073/pnas.0804503105; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Jentsch TJ, 2007, J PHYSIOL-LONDON, V578, P633, DOI 10.1113/jphysiol.2006.124719; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; KIEFERLE S, 1994, P NATL ACAD SCI USA, V91, P6943, DOI 10.1073/pnas.91.15.6943; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Li XH, 2002, AM J PHYSIOL-CELL PH, V282, pC1483, DOI 10.1152/ajpcell.00504.2001; Li XH, 2000, J BIOL CHEM, V275, P35994, DOI 10.1074/jbc.M002712200; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; Ludewig U, 1996, NATURE, V383, P340, DOI 10.1038/383340a0; Matsuda JJ, 2008, AM J PHYSIOL-CELL PH, V294, pC251, DOI 10.1152/ajpcell.00338.2007; Mohammad-Panah R, 2003, J BIOL CHEM, V278, P29267, DOI 10.1074/jbc.M304357200; Nguitragool W, 2006, J MOL BIOL, V362, P682, DOI 10.1016/j.jmb.2006.07.006; NOVARINO G, 2010, SCIENCE IN PRESS; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Picollo A, 2009, NAT STRUCT MOL BIOL, V16, P1294, DOI 10.1038/nsmb.1704; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; Poet M, 2006, P NATL ACAD SCI USA, V103, P13854, DOI 10.1073/pnas.0606137103; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Schwake M, 2001, J BIOL CHEM, V276, P12049, DOI 10.1074/jbc.M010642200; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; Suzuki T, 2006, J CELL PHYSIOL, V206, P792, DOI 10.1002/jcp.20516; WEINERT S, 2010, SCIENCE IN PRESS; Zdebik AA, 2008, J BIOL CHEM, V283, P4219, DOI 10.1074/jbc.M708368200; Zifarelli G, 2009, EMBO J, V28, P175, DOI 10.1038/emboj.2008.284	41	62	63	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21689	21697		10.1074/jbc.M110.125971	http://dx.doi.org/10.1074/jbc.M110.125971			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20466723	Green Published, hybrid			2022-12-27	WOS:000279516100056
J	Rather, LJ; Knapp, B; Haehnel, W; Fuchs, G				Rather, Liv J.; Knapp, Bettina; Haehnel, Wolfgang; Fuchs, Georg			Coenzyme A-dependent Aerobic Metabolism of Benzoate via Epoxide Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BURKHOLDERIA-XENOVORANS LB400; COA CATABOLIC PATHWAY; VITAMIN-K 2,3-EPOXIDE; AZOARCUS-EVANSII; CRYSTAL-STRUCTURE; MULTICOMPONENT MONOOXYGENASES; RIBONUCLEOTIDE REDUCTASE; CROTONASE-SUPERFAMILY; ANAEROBIC DEGRADATION; ALKENE MONOOXYGENASE	In the aerobic metabolism of aromatic substrates, oxygenases use molecular oxygen to hydroxylate and finally cleave the aromatic ring. In the case of the common intermediate benzoate, the ring cleavage substrates are either catechol (in bacteria) or 3,4-dihydroxybenzoate (protocatechuate, mainly in fungi). We have shown before that many bacteria, e. g. Azoarcus evansii, the organism studied here, use a completely different mechanism. This elaborate pathway requires formation of benzoyl-CoA, followed by an oxygenase reaction and a nonoxygenolytic ring cleavage. Benzoyl-CoA transformation is catalyzed by the iron-containing benzoyl-CoA oxygenase (BoxB) in conjunction with an FAD and iron-sulfur centers containing reductase (BoxA), which donates electrons from NADPH. Here we show that benzoyl-CoA oxygenase actually does not form the 2,3-dihydrodiol of benzoyl-CoA, as formerly postulated, but the 2,3-epoxide. An enoyl-CoA hydratase (BoxC) uses two molecules of water to first hydrolytically open the ring of 2,3-epoxybenzoyl-CoA, which may proceed via its tautomeric seven-membered oxepin ring form. Then ring C2 is hydrolyzed off as formic acid, yielding 3,4-dehydroadipyl-CoA semialdehyde. The semialdehyde is oxidized by a NADP(+)-dependent aldehyde dehydrogenase (BoxD) to 3,4-dehydroadipyl-CoA. Final products of the pathway are formic acid, acetyl- CoA, and succinyl-CoA. This overlooked pathway occurs in 4-5% of all bacteria whose genomes have been sequenced and represents an elegant strategy to cope with the high resonance energy of aromatic substrates by forming a nonaromatic epoxide.	[Rather, Liv J.; Fuchs, Georg] Univ Freiburg, Fak Biol, Lehrstuhl Mikrobiol, D-79104 Freiburg, Germany; [Knapp, Bettina; Haehnel, Wolfgang] Univ Freiburg, Fak Biol, Lehrstuhl Biochem, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Fuchs, G (corresponding author), Univ Freiburg, Fak Biol, Lehrstuhl Mikrobiol, Schanzlestr 1, D-79104 Freiburg, Germany.	georg.fuchs@biologie.uni-freiburg.de			Deutsche Forschungsgemeinschaft [FU 118/16-3, HA 1084/9-1]; Graduiertenkolleg Biochemie der Enzyme	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduiertenkolleg Biochemie der Enzyme	This work was supported by Deutsche Forschungsgemeinschaft Grants FU 118/16-3 and HA 1084/9-1 and by the Graduiertenkolleg Biochemie der Enzyme.	Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERS HJ, 1995, INT J SYST BACTERIOL, V45, P327, DOI 10.1099/00207713-45-2-327; Bains J, 2009, J BIOL CHEM, V284, P16377, DOI 10.1074/jbc.M900226200; Bennett KL, 2002, J MASS SPECTROM, V37, P179, DOI 10.1002/jms.271; BUCH K, 1995, FEBS LETT, V376, P45, DOI 10.1016/0014-5793(95)01243-9; Choi YS, 2008, P NATL ACAD SCI USA, V105, P6858, DOI 10.1073/pnas.0712073105; COLBY J, 1977, BIOCHEM J, V165, P395, DOI 10.1042/bj1650395; COLIGAN JE, 1995, CURR PROTOC PROTEIN; CORY EJ, 1966, J AM CHEM SOC, V88, P4750; Dalluge JJ, 2002, ANAL BIOANAL CHEM, V374, P835, DOI 10.1007/s00216-002-1554-x; de Visser SF, 2008, CHEM-EUR J, V14, P4533, DOI 10.1002/chem.200701802; Denef VJ, 2006, APPL ENVIRON MICROB, V72, P585, DOI 10.1128/AEM.72.1.585-595.2006; Denef VJ, 2005, J BACTERIOL, V187, P7996, DOI 10.1128/JB.187.23.7996-8005.2005; Dupard-Jullen CL, 2007, ANAL BIOANAL CHEM, V387, P1027, DOI 10.1007/s00216-006-1003-3; Eberhard ED, 2004, J AM CHEM SOC, V126, P7188, DOI 10.1021/ja0482381; Gallagher SC, 1997, EUR J BIOCHEM, V247, P635, DOI 10.1111/j.1432-1033.1997.00635.x; Gescher J, 2006, J BACTERIOL, V188, P2919, DOI 10.1128/JB.188.8.2919-2927.2006; Gescher J, 2005, MOL MICROBIOL, V56, P1586, DOI 10.1111/j.1365-2958.2005.04637.x; Gescher J, 2002, J BACTERIOL, V184, P6301, DOI 10.1128/JB.184.22.6301-6315.2002; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553; Isin EM, 2008, ANAL BIOANAL CHEM, V392, P1019, DOI 10.1007/s00216-008-2244-0; Kawaguchi K, 2006, FEMS MICROBIOL LETT, V257, P208, DOI 10.1111/j.1574-6968.2006.00165.x; LEE JJ, 1984, BIOCHEMISTRY-US, V23, P2246, DOI 10.1021/bi00305a024; Lindqvist Y, 1996, EMBO J, V15, P4081, DOI 10.1002/j.1460-2075.1996.tb00783.x; Mohamed ME, 2001, J BACTERIOL, V183, P1899, DOI 10.1128/JB.183.6.1899-1908.2001; MUKHARJI I, 1985, P NATL ACAD SCI USA, V82, P2713, DOI 10.1073/pnas.82.9.2713; Murray LJ, 2007, ACCOUNTS CHEM RES, V40, P466, DOI 10.1021/ar600040e; Musaev DG, 2002, J AM CHEM SOC, V124, P4135, DOI 10.1021/ja0176393; Nakano C, 2007, BIOSCI BIOTECH BIOCH, V71, P2543, DOI 10.1271/bbb.70331; NORDLUND P, 1990, NATURE, V345, P593, DOI 10.1038/345593a0; ORNSTON LN, 1966, J BIOL CHEM, V241, P3776; Perez-Pantoja D, 2008, FEMS MICROBIOL REV, V32, P736, DOI 10.1111/j.1574-6976.2008.00122.x; Rabus R, 2005, ARCH MICROBIOL, V183, P27, DOI 10.1007/s00203-004-0742-9; RETEY J, 1966, EXPERIENTIA, V22, P72, DOI 10.1007/BF01900153; ROSENZWEIG AC, 1993, NATURE, V366, P537, DOI 10.1038/366537a0; Sazinsky MH, 2006, BIOCHEMISTRY-US, V45, P15392, DOI 10.1021/bi0618969; Sazinsky MH, 2004, J BIOL CHEM, V279, P30600, DOI 10.1074/jbc.M400710200; Schuhle K, 2003, J BACTERIOL, V185, P4920, DOI 10.1128/JB.185.16.4920-4929.2003; Small FJ, 1997, J BIOL CHEM, V272, P24913, DOI 10.1074/jbc.272.40.24913; STANIOR U, 1984, ARCH PHARM, V317, P1042, DOI 10.1002/ardp.19843171211; TSCHECH A, 1987, ARCH MICROBIOL, V148, P213, DOI 10.1007/BF00414814; VOGEL E, 1967, ANGEW CHEM INT EDIT, V6, P385, DOI 10.1002/anie.196703851; Zaar A, 2004, MOL MICROBIOL, V54, P223, DOI 10.1111/j.1365-2958.2004.04263.x; Zaar A, 2001, J BIOL CHEM, V276, P24997, DOI 10.1074/jbc.M100291200; ZEHR BD, 1989, ANAL BIOCHEM, V182, P157, DOI 10.1016/0003-2697(89)90734-3	46	39	47	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20615	20624		10.1074/jbc.M110.124156	http://dx.doi.org/10.1074/jbc.M110.124156			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20452977	hybrid, Green Published			2022-12-27	WOS:000279228600025
J	Guan, Y; Omueti-Ayoade, K; Mutha, SK; Hergenrother, PJ; Tapping, RI				Guan, Yue; Omueti-Ayoade, Katherine; Mutha, Sarita K.; Hergenrother, Paul J.; Tapping, Richard I.			Identification of Novel Synthetic Toll-like Receptor 2 Agonists by High Throughput Screening	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNITY; MICROBIAL LIPOPROTEINS; BACTERIAL LIPOPROTEINS; ADJUVANT; VACCINE; RECOGNITION; LIPOPEPTIDE; RESPONSES; TLR; DISCRIMINATION	Toll-like receptors (TLRs) play a central role in host defense by inducing inflammatory and adaptive immune responses following infection. Drugs that target TLRs are of considerable interest as potential inflammatory regulators, vaccine adjuvants, and novel immunotherapeutics. TLR2, in cooperation with either TLR1 or TLR6, mediates responses to a wide variety of microbial products as well as products of host tissue damage. In an effort to understand the structural basis of TLR2 recognition and uncover novel TLR2 agonists, a synthetic chemical library of 24,000 compounds was screened using an IL-8-driven luciferase reporter in cells expressing these human receptors. The screening yielded several novel TLR2-dependent activators that utilize TLR1, TLR6, or both as co-receptors. These novel small molecule compounds are aromatic in nature and structurally unrelated to any known TLR2 agonists. The three most potent compounds do not exhibit synergistic activity, nor do they act as pseudoantagonists toward natural TLR2 activators. Interestingly, two of the compounds exhibit species specificity and are inactive toward murine peritoneal macrophages. Mutational analysis reveals that although the central extracellular region of TLR1 is required for stimulation, there are subtle differences in the mechanism of stimulation mediated by the synthetic compounds in comparison with natural lipoprotein agonists. The three most potent compounds activate cells in the nanomolar range and stimulate cytokine production from human peripheral blood monocytes. Our results confirm the utility of high throughput screens to uncover novel synthetic TLR2 agonists that may be of therapeutic benefit.	Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Tapping, Richard I.] Univ Illinois, Coll Med, Urbana, IL 61801 USA; [Mutha, Sarita K.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Hergenrother, Paul J.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Tapping, RI (corresponding author), B103 CLSL,MC110,601 S Goodwin Ave, Urbana, IL 61801 USA.	tapping@illinois.edu		, Katherine/0000-0002-8822-6607	National Institutes of Health [AI052344]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052344, R21AI052344] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI052344 (to R.I.T.).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6; Cirino Patrick C, 2003, Methods Mol Biol, V231, P3; FEARON DT, 1997, NATURE, V388, P323; Gallorini S, 2009, P NATL ACAD SCI USA, V106, P17481, DOI 10.1073/pnas.0903313106; Grabiec A, 2004, J BIOL CHEM, V279, P48004, DOI 10.1074/jbc.M405311200; Guan Y, 2010, J IMMUNOL, V184, P5094, DOI 10.4049/jimmunol.0901888; Hauguel TM, 2008, FRONT BIOSCI-LANDMRK, V13, P2806, DOI 10.2741/2887; Ingale S, 2007, NAT CHEM BIOL, V3, P663, DOI 10.1038/nchembio.2007.25; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Lahiri A, 2008, VACCINE, V26, P6777, DOI 10.1016/j.vaccine.2008.09.045; Liang S, 2009, VACCINE, V27, P4302, DOI 10.1016/j.vaccine.2009.05.027; Liang S, 2009, J IMMUNOL, V182, P2978, DOI 10.4049/jimmunol.0803737; Liu XP, 2008, VACCINE, V26, P786, DOI 10.1016/j.vaccine.2007.11.080; Makkouk A, 2009, IMMUNOPHARM IMMUNOT, V31, P331, DOI 10.1080/08923970902802926; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Miyake K, 2007, SEMIN IMMUNOL, V19, P3, DOI 10.1016/j.smim.2006.12.002; Monie TP, 2009, IMMUNOL REV, V227, P161, DOI 10.1111/j.1600-065X.2008.00735.x; Moyle PM, 2008, CURR MED CHEM, V15, P506, DOI 10.2174/092986708783503249; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Omueti KO, 2007, J IMMUNOL, V178, P6387, DOI 10.4049/jimmunol.178.10.6387; Omueti KO, 2005, J BIOL CHEM, V280, P36616, DOI 10.1074/jbc.M504320200; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; PAZZAGLI M, 1992, ANAL BIOCHEM, V204, P315, DOI 10.1016/0003-2697(92)90245-3; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Tapping RI, 2009, SEMIN IMMUNOL, V21, P175, DOI 10.1016/j.smim.2009.05.003; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554; Zhang Z, 2006, CELL MOL LIFE SCI, V63, P2901, DOI 10.1007/s00018-006-6189-1	39	42	45	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23755	23762		10.1074/jbc.M110.116046	http://dx.doi.org/10.1074/jbc.M110.116046			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20504771	Green Published, hybrid			2022-12-27	WOS:000280291400026
J	Suzuki, S; Yokoyama, U; Abe, T; Kiyonari, H; Yamashita, N; Kato, Y; Kurotani, R; Sato, M; Okumura, S; Ishikawa, Y				Suzuki, Sayaka; Yokoyama, Utako; Abe, Takaya; Kiyonari, Hiroshi; Yamashita, Naoya; Kato, Yuko; Kurotani, Reiko; Sato, Motohiko; Okumura, Satoshi; Ishikawa, Yoshihiro			Differential Roles of Epac in Regulating Cell Death in Neuronal and Myocardial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BH3-ONLY PROTEIN BIM; INDUCED APOPTOSIS; 3-NITROPROPIONIC ACID; HYDROGEN-PEROXIDE; GENE-EXPRESSION; HUNTINGTONS-DISEASE; ALZHEIMERS-DISEASE; CARDIAC MYOCYTES; PDE4 INHIBITOR; UP-REGULATION	Cell survival and death play critical roles in tissues composed of post-mitotic cells. Cyclic AMP (cAMP) has been known to exert a distinct effect on cell susceptibility to apoptosis, protecting neuronal cells and deteriorating myocardial cells. These effects are primarily studied using protein kinase A activation. In this study we show the differential roles of Epac, an exchange protein activated by cAMP and a new effector molecule of cAMP signaling, in regulating apoptosis in these cell types. Both stimulation of Epac by 8-p-methoxyphenylthon-2'-O-methyl-cAMP and overexpression of Epac significantly increased DNA fragmentation and TUNEL (terminal deoxynucleotidyltransferase-mediated biotin nick end-labeling)-positive cell counts in mouse cortical neurons but not in cardiac myocytes. In contrast, stimulation of protein kinase A increased apoptosis in cardiac myocytes but not in neuronal cells. In cortical neurons the expression of the Bcl-2 interacting member protein (Bim) was increased by stimulation of Epac at the transcriptional level and was decreased in mice with genetic disruption of Epac1. Epac-induced neuronal apoptosis was attenuated by the silencing of Bim. Furthermore, Epac1 disruption in vivo abolished the 3-nitropropionic acid-induced neuronal apoptosis that occurs in wild-type mice. These results suggest that Epac induces neuron-specific apoptosis through increasing Bim expression. Because the disruption of Epac exerted a protective effect on neuronal apoptosis in vivo, the inhibition of Epac may be a consideration in designing a therapeutic strategy for the treatment of neurodegenerative diseases.	[Yokoyama, Utako] Yokohama City Univ, Grad Sch Med, Cardiovasc Res Inst, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Yamashita, Naoya] Yokohama City Univ, Grad Sch Med, Dept Mol Pharmacol & Neurobiol, Yokohama, Kanagawa 2360004, Japan; [Abe, Takaya; Kiyonari, Hiroshi] RIKEN Ctr Dev Biol, Lab Anim Resources & Genet Engn, Kobe, Hyogo 6500047, Japan; [Ishikawa, Yoshihiro] Univ Med & Dent New Jersey, Cardiovasc Res Inst, Dept Cell Biol, Newark, NJ 07103 USA; [Ishikawa, Yoshihiro] Univ Med & Dent New Jersey, Dept Mol Med, Newark, NJ 07103 USA; [Ishikawa, Yoshihiro] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA	Yokohama City University; Yokohama City University; RIKEN; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Yokoyama, U (corresponding author), Yokohama City Univ, Grad Sch Med, Cardiovasc Res Inst, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	utako@yokohama-cu.ac.jp	Yokoyama, Utako/AAD-1404-2022; Kiyonari, Hiroshi/N-7936-2015	Yokoyama, Utako/0000-0003-1803-0155; 	Ministry of Health, Labor, and Welfare; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Yokohama Foundation for Advanced Medical Science; Kanae Foundation for the Promotion for Medical Science; Miyata Cardiology Research Promotion Funds; Takeda Science Foundation; Sumitomo Foundation; Japan Heart Foundation; Kowa Life Science Foundation; Cosmetology Research Foundation; Uehara Memorial Foundation; Kitsuen Research Foundation; Japan Space Forum	Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yokohama Foundation for Advanced Medical Science; Kanae Foundation for the Promotion for Medical Science; Miyata Cardiology Research Promotion Funds; Takeda Science Foundation(Takeda Science Foundation (TSF)); Sumitomo Foundation; Japan Heart Foundation; Kowa Life Science Foundation; Cosmetology Research Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Kitsuen Research Foundation; Japan Space Forum	This work was supported by a grant-in-aid for Scientific Research (KAKENHI) (to U. Y. and S. S.) and by grants from the Ministry of Health, Labor, and Welfare (to Y. I.), the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to Y. I.), the Yokohama Foundation for Advanced Medical Science (to U. Y.), the Kanae Foundation for the Promotion for Medical Science (to U. Y.), the Miyata Cardiology Research Promotion Funds (to U. Y.), the Takeda Science Foundation (to U. Y.), the Sumitomo Foundation (to U. Y.), the Japan Heart Foundation Research Grant (to U. Y.), the Kowa Life Science Foundation (to U. Y.), the Cosmetology Research Foundation (to Y. I.), the Uehara Memorial Foundation (to U. Y.), the Kitsuen Research Foundation (to Y. I.), and the Japan Space Forum (to Y. I.).	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Biju MP, 2005, AM J PHYSIOL-RENAL, V289, pF1217, DOI 10.1152/ajprenal.00233.2005; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Brouillet E, 2005, J NEUROCHEM, V95, P1521, DOI 10.1111/j.1471-4159.2005.03515.x; Cai BB, 2008, APOPTOSIS, V13, P803, DOI 10.1007/s10495-008-0218-5; Chae IH, 2004, CLIN CHIM ACTA, V341, P83, DOI 10.1016/j.cccn.2003.11.009; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; Communal C, 2005, ARCH MAL COEUR VAISS, V98, P236; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; Dong JW, 2003, CELL RES, V13, P385, DOI 10.1038/sj.cr.7290184; Geng YJ, 1999, CIRC RES, V84, P34; Grandoch M, 2009, J LEUKOCYTE BIOL, V86, P847, DOI 10.1189/jlb.0109048; Guo JF, 2009, CIRC RES, V104, P660, DOI 10.1161/CIRCRESAHA.108.186288; Hirotani S, 2002, CIRCULATION, V105, P509, DOI 10.1161/hc0402.102863; Hoyt KR, 1997, NEUROCHEM RES, V22, P333, DOI 10.1023/A:1022403224901; Huang C, 2009, BRAIN RES, V1257, P75, DOI 10.1016/j.brainres.2008.11.088; ISHIKAWA N, 1992, J BIOL CHEM, V267, P14366; Iwatsubo K, 2004, J BIOL CHEM, V279, P40938, DOI 10.1074/jbc.M314238200; Iwatsubo K, 2007, AM J PHYSIOL-CELL PH, V293, pC1498, DOI 10.1152/ajpcell.00088.2007; Jonakait GM, 2009, BRAIN RES, V1285, P30, DOI 10.1016/j.brainres.2009.06.037; Kaufmann T, 2009, IMMUNITY, V30, P56, DOI 10.1016/j.immuni.2008.10.017; Kobayashi Y, 1997, BRAIN RES, V778, P309, DOI 10.1016/S0006-8993(97)01072-X; Kwak HJ, 2008, CELL SIGNAL, V20, P803, DOI 10.1016/j.cellsig.2007.12.011; Kwon G, 2004, J BIOL CHEM, V279, P8938, DOI 10.1074/jbc.M310330200; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Mandavilli BS, 2005, MOL BRAIN RES, V133, P215, DOI 10.1016/j.molbrainres.2004.10.033; Mattson MP, 2003, TRENDS MOL MED, V9, P196, DOI 10.1016/S1471-4914(03)00046-7; McPhee I, 2005, BIOCHEM SOC T, V33, P1330, DOI 10.1042/BST0331330; Muller T, 2008, PROG NEUROBIOL, V85, P393, DOI 10.1016/j.pneurobio.2008.05.002; Murray AJ, 2008, MOL CELL NEUROSCI, V38, P578, DOI 10.1016/j.mcn.2008.05.006; O'Driscoll C, 2007, J NEUROCHEM, V103, P860, DOI 10.1111/j.1471-4159.2007.04827.x; O'Reilly LA, 2000, AM J PATHOL, V157, P449, DOI 10.1016/S0002-9440(10)64557-9; Okumura S, 2003, CIRC RES, V93, P364, DOI 10.1161/01.RES.0000086986.35568.63; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Pandey M, 2008, J NEUROCHEM, V104, P420, DOI 10.1111/j.1471-4159.2007.04996.x; Parvathenani LK, 2000, NEUROREPORT, V11, P2293, DOI 10.1097/00001756-200007140-00045; Porat S, 1999, ANN NY ACAD SCI, V893, P372, DOI 10.1111/j.1749-6632.1999.tb07858.x; Pugh PC, 2006, MOL CELL NEUROSCI, V31, P586, DOI 10.1016/j.mcn.2005.11.012; Putcha GV, 2001, NEURON, V29, P615, DOI 10.1016/S0896-6273(01)00238-0; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Roscioni SS, 2008, N-S ARCH PHARMACOL, V377, P345, DOI 10.1007/s00210-007-0246-7; Tiwari S, 2004, BLOOD, V103, P2661, DOI 10.1182/blood-2003-06-2154; Ulucan C, 2007, AM J PHYSIOL-HEART C, V293, pH1662, DOI 10.1152/ajpheart.00159.2007; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wang CY, 2007, J PHYSIOL-LONDON, V584, P191, DOI 10.1113/jphysiol.2007.135616; Wang XM, 2005, J BIOL CHEM, V280, P16705, DOI 10.1074/jbc.M501819200; WHITTEMORE ER, 1995, NEUROSCIENCE, V67, P921, DOI 10.1016/0306-4522(95)00108-U; Yamashita N, 2006, J NEUROSCI, V26, P13357, DOI 10.1523/JNEUROSCI.4276-06.2006; Yokoyama U, 2006, AM J PHYSIOL-HEART C, V290, pH1660, DOI 10.1152/ajpheart.00100.2004; Yokoyama U, 2008, AM J PHYSIOL-HEART C, V295, pH1547, DOI 10.1152/ajpheart.01317.2007; Yokoyama U, 2008, P NATL ACAD SCI USA, V105, P6386, DOI 10.1073/pnas.0801490105; Zhang LZ, 2004, J BIOL CHEM, V279, P20858, DOI 10.1074/jbc.M310643200	53	61	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24248	24259		10.1074/jbc.M109.094581	http://dx.doi.org/10.1074/jbc.M109.094581			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20516079	Green Published, hybrid			2022-12-27	WOS:000280291400074
J	Jones, DM; McLauchlan, J				Jones, Daniel M.; McLauchlan, John			Hepatitis C Virus: Assembly and Release of Virus Particles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NONSTRUCTURAL PROTEIN 5A; SIGNAL PEPTIDE PEPTIDASE; CORE PROTEIN; LIPID DROPLET; LOW-DENSITY; RNA REPLICATION; COMPENSATORY MUTATIONS; NONTRANSLATED REGION; TRANS-ENCAPSIDATION; CELL TRANSMISSION	Hepatitis C virus is a blood-borne virus that typically establishes a chronic infection in the liver, which often results in cirrhosis and hepatocellular carcinoma. Progress in understanding the complete virus life cycle has been greatly enhanced by the recent availability of a tissue culture system that produces infectious virus progeny. Thus, it is now possible to gain insight into the roles played by viral components in assembly and egress and the cellular pathways that contribute to virion formation. This minireview describes the key determining viral and host factors that are needed to produce infectious virus.	[Jones, Daniel M.; McLauchlan, John] MRC, Virol Unit, Glasgow G11 5JR, Lanark, Scotland		McLauchlan, J (corresponding author), MRC, Virol Unit, Church St, Glasgow G11 5JR, Lanark, Scotland.	j.mclauchlan@mrcvu.gla.ac.uk			UK Medical Research Council; European Commission [HEALTH-F4-2008-202272]; MRC [MC_U130184143] Funding Source: UKRI; Medical Research Council [MC_U130184143] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the UK Medical Research Council and funds awarded to the LipidomicNet Consortium (HEALTH-F4-2008-202272) by the European Commission. This is the second article in the Thematic Minireview Series on Hepatitis C Virus. This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Adair R, 2009, J GEN VIROL, V90, P833, DOI 10.1099/vir.2008.006049-0; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Appel N, 2006, J BIOL CHEM, V281, P9833, DOI 10.1074/jbc.R500026200; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Benga WJA, 2010, HEPATOLOGY, V51, P43, DOI 10.1002/hep.23278; Blanchard E, 2003, J VIROL, V77, P10131, DOI 10.1128/JVI.77.18.10131-10138.2003; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Boulant S, 2006, J BIOL CHEM, V281, P22236, DOI 10.1074/jbc.M601031200; Brohm C, 2009, J VIROL, V83, P11682, DOI 10.1128/JVI.00691-09; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Corless L, 2010, J GEN VIROL, V91, P362, DOI 10.1099/vir.0.017285-0; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; El-Hage N, 2003, J GEN VIROL, V84, P2761, DOI 10.1099/vir.0.19305-0; Elazar M, 2004, J VIROL, V78, P11393, DOI 10.1128/JVI.78.20.11393-11400.2004; Friebe P, 2002, J VIROL, V76, P5326, DOI 10.1128/JVI.76.11.5326-5338.2002; Friebe P, 2001, J VIROL, V75, P12047, DOI 10.1128/JVI.75.24.12047-12057.2001; Friebe P, 2009, J VIROL, V83, P11989, DOI 10.1128/JVI.01508-09; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Gastaminza P, 2006, J VIROL, V80, P11074, DOI 10.1128/JVI.01150-06; Gibbons GF, 2004, BIOCHEM SOC T, V32, P59, DOI 10.1042/BST0320059; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Griffin SDC, 2004, J GEN VIROL, V85, P451, DOI 10.1099/vir.0.19634-0; Griffin SDC, 2003, FEBS LETT, V535, P34, DOI 10.1016/S0014-5793(02)03851-6; Griffin S, 2008, HEPATOLOGY, V48, P1779, DOI 10.1002/hep.22555; Han QX, 2009, VIRUS RES, V145, P63, DOI 10.1016/j.virusres.2009.06.005; Hope RG, 2002, J BIOL CHEM, V277, P4261, DOI 10.1074/jbc.M108798200; Hourioux C, 2007, CELL MICROBIOL, V9, P1014, DOI 10.1111/j.1462-5822.2006.00848.x; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Hugle T, 2001, VIROLOGY, V284, P70, DOI 10.1006/viro.2001.0873; Hussy P, 1996, VIROLOGY, V224, P93, DOI 10.1006/viro.1996.0510; Icard V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004233; Ishii K, 2008, BIOCHEM BIOPH RES CO, V371, P446, DOI 10.1016/j.bbrc.2008.04.110; Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09; Jirasko V, 2008, J BIOL CHEM, V283, P28546, DOI 10.1074/jbc.M803981200; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; Jones DM, 2009, J VIROL, V83, P2163, DOI 10.1128/JVI.01885-08; Kim YK, 2002, BIOCHEM BIOPH RES CO, V290, P105, DOI 10.1006/bbrc.2001.6167; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Lai CK, 2008, J VIROL, V82, P8838, DOI 10.1128/JVI.00398-08; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Ma YH, 2008, J VIROL, V82, P7624, DOI 10.1128/JVI.00724-08; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Mensenkamp AR, 2001, J HEPATOL, V35, P816, DOI 10.1016/S0168-8278(01)00249-5; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moradpour D, 2004, J VIROL, V78, P7400, DOI 10.1128/JVI.78.14.7400-7409.2004; Murayama A, 2007, J VIROL, V81, P8030, DOI 10.1128/JVI.02088-06; Murray CL, 2007, J VIROL, V81, P10220, DOI 10.1128/JVI.00793-07; Nielsen SU, 2008, J GEN VIROL, V89, P2507, DOI 10.1099/vir.0.2008/000083-0; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Okamoto K, 2008, J VIROL, V82, P8349, DOI 10.1128/JVI.00306-08; Olofsson SO, 2005, J INTERN MED, V258, P395, DOI 10.1111/j.1365-2796.2005.01556.x; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Phan T, 2009, J VIROL, V83, P8379, DOI 10.1128/JVI.00891-09; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Ploss A, 2010, P NATL ACAD SCI USA, V107, P3141, DOI 10.1073/pnas.0915130107; Roingeard P, 2004, BIOL CELL, V96, P103, DOI 10.1016/j.biolcel.2003.11.006; Roingeard P, 2008, HISTOCHEM CELL BIOL, V130, P561, DOI 10.1007/s00418-008-0447-2; Russell RS, 2008, P NATL ACAD SCI USA, V105, P4370, DOI 10.1073/pnas.0800422105; Sakai A, 2003, P NATL ACAD SCI USA, V100, P11646, DOI 10.1073/pnas.1834545100; SANTOLINI E, 1994, J VIROL, V68, P3631, DOI 10.1128/JVI.68.6.3631-3641.1994; Schaller T, 2007, J VIROL, V81, P4591, DOI 10.1128/JVI.02144-06; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Song YT, 2006, J VIROL, V80, P11579, DOI 10.1128/JVI.00675-06; Steinmann E, 2008, J VIROL, V82, P7034, DOI 10.1128/JVI.00118-08; Steinmann E, 2007, PLOS PATHOG, V3, P962, DOI 10.1371/journal.ppat.0030103; StGelais C, 2007, ANTIVIR RES, V76, P48, DOI 10.1016/j.antiviral.2007.05.001; Targett-Adams P, 2008, J VIROL, V82, P2182, DOI 10.1128/JVI.01565-07; Targett-Adams P, 2008, J BIOL CHEM, V283, P16850, DOI 10.1074/jbc.M802273200; Teis D, 2009, CELL, V137, DOI 10.1016/j.cell.2009.03.027; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Tellinghuisen TL, 2008, J VIROL, V82, P1073, DOI 10.1128/JVI.00328-07; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Timpe JM, 2008, HEPATOLOGY, V47, P17, DOI 10.1002/hep.21959; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Witteveldt J, 2009, J GEN VIROL, V90, P48, DOI 10.1099/vir.0.006700-0; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06; Yi MK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000403; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	86	82	86	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22732	22738		10.1074/jbc.R110.133017	http://dx.doi.org/10.1074/jbc.R110.133017			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20457608	Green Published, hybrid			2022-12-27	WOS:000279999900003
J	Nie, J; Xie, P; Liu, L; Xing, GC; Chang, ZJ; Yin, YX; Tian, CY; He, FC; Zhang, LQ				Nie, Jing; Xie, Ping; Liu, Lin; Xing, Guichun; Chang, Zhijie; Yin, Yuxin; Tian, Chunyan; He, Fuchu; Zhang, Lingqiang			Smad Ubiquitylation Regulatory Factor 1/2 (Smurf1/2) Promotes p53 Degradation by Stabilizing the E3 Ligase MDM2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEIN LIGASE; ARF TUMOR-SUPPRESSOR; NEGATIVE REGULATOR; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; PATHWAY; DOMAIN; RESCUE; INHIBITION; DELETION	The tumor suppressor p53 protein is tightly regulated by a ubiquitin-proteasomal degradation mechanism. Several E3 ubiquitin ligases, including MDM2 (mouse double minute 2), have been reported to play an essential role in the regulation of p53 stability. However, it remains unclear how the activity of these E3 ligases is regulated. Here, we show that the HECT-type E3 ligase Smurf1/2 (Smad ubiquitylation regulatory factor 1/2) promotes p53 degradation by enhancing the activity of the E3 ligase MDM2. We provide evidence that the role of Smurf1/2 on the p53 stability is not dependent on the E3 activity of Smurf1/2 but rather is dependent on the activity of MDM2. We find that Smurf1/2 stabilizes MDM2 by enhancing the heterodimerization of MDM2 with MDMX, during which Smurf1/2 interacts with MDM2 and MDMX. We finally provide evidence that Smurf1/2 regulates apoptosis through p53. To our knowledge, this is the first report to demonstrate that Smurf1/2 functions as a factor to stabilize MDM2 protein rather than as a direct E3 ligase in regulation of p53 degradation.	[Nie, Jing; Xie, Ping; Xing, Guichun; Chang, Zhijie; Tian, Chunyan; He, Fuchu; Zhang, Lingqiang] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing 100850, Peoples R China; [Nie, Jing; Xie, Ping; Chang, Zhijie; He, Fuchu] Tsinghua Univ, Sch Life Sci, Beijing 100842, Peoples R China; [Liu, Lin] Gen Hosp Chinese Peoples Liberat Army, Inst Gen Surg, Beijing 100853, Peoples R China; [Yin, Yuxin] Peking Univ, Dept Pathol, Sch Basic Med Sci, Beijing 100191, Peoples R China	Academy of Military Medical Sciences - China; Tsinghua University; Peking University	Tian, CY (corresponding author), Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing 100850, Peoples R China.	tiancy@nic.bmi.ac.cn; hefc@nic.bmi.ac.cn; zhanglq@nic.bmi.ac.cn	Chang, Zhijie/AAH-8109-2019	Tian, Chunyan/0000-0003-1589-293X; Chang, Zhijie/0000-0003-1567-3227	National Basic Research Program [2007CB914601, 2006CB910802, 2009CB918402, 2010CB912202]; National Natural Science Foundation [30830029, 30800177]; National Key Technologies R&D Program for New Drugs [2009ZX09503-002, 2009ZX09301-002]; State Key Laboratory of Proteomics [K200802]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Technologies R&D Program for New Drugs(National Key Technology R&D Program); State Key Laboratory of Proteomics	The work was supported by National Basic Research Program Grants 2007CB914601, 2006CB910802, 2009CB918402, and 2010CB912202, National Natural Science Foundation Project Grants 30830029 and 30800177, National Key Technologies R&D Program for New Drugs Grants 2009ZX09503-002 and 2009ZX09301-002, and State Key Laboratory of Proteomics Grant K200802.	Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Chang YC, 1998, CELL GROWTH DIFFER, V9, P79; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Finch RA, 2002, CANCER RES, V62, P3221; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Jin CY, 2009, CANCER RES, V69, P735, DOI 10.1158/0008-5472.CAN-08-1463; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kawai H, 2007, CANCER RES, V67, P6026, DOI 10.1158/0008-5472.CAN-07-1313; Laine A, 2007, ONCOGENE, V26, P1477, DOI 10.1038/sj.onc.1209924; LANE DP, 1992, NATURE, V358, P16; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li L, 2007, P NATL ACAD SCI USA, V104, P7951, DOI 10.1073/pnas.0701916104; Li Y, 2008, ONCOGENE, V27, P3700, DOI 10.1038/sj.onc.1211032; Linares LK, 2007, NAT CELL BIOL, V9, P331, DOI 10.1038/ncb1545; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Lu KF, 2008, NAT CELL BIOL, V10, P994, DOI 10.1038/ncb1760; LUNA RMD, 1995, NATURE, V378, P203; Marine JC, 2005, BIOCHEM BIOPH RES CO, V331, P750, DOI 10.1016/j.bbrc.2005.03.151; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Okamoto K, 2009, FEBS LETT, V583, P2710, DOI 10.1016/j.febslet.2009.07.021; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Poyurovsky MV, 2007, EMBO J, V26, P90, DOI 10.1038/sj.emboj.7601465; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Suzuki A, 2008, CANCER SCI, V99, P986, DOI 10.1111/j.1349-7006.2008.00779.x; Tian C, 2009, NAT CELL BIOL, V11, P580, DOI 10.1038/ncb1864; Uldrijan S, 2007, EMBO J, V26, P102, DOI 10.1038/sj.emboj.7601469; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Yang W, 2008, CELL CYCLE, V7, P670, DOI 10.4161/cc.7.5.5701; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	49	64	66	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22816	22828		10.1074/jbc.M110.126920	http://dx.doi.org/10.1074/jbc.M110.126920			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20484049	hybrid, Green Published			2022-12-27	WOS:000279999900014
J	Zhang, YQ; Kubiseski, TJ				Zhang, Yuqian; Kubiseski, Terrance J.			Caenorhabditis elegans wsp-1 Regulation of Synaptic Function at the Neuromuscular Junction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROENDOCRINE CELLS; RHO-GTPASES; N-WASP; ACTIN; PROTEIN; CYTOSKELETAL; EXOCYTOSIS; VESICLES	The Rho GTPase members and their effector proteins, such as the Wiskott-Aldrich syndrome protein (WASP), play critical roles in regulating actin dynamics that affect cell motility, endocytosis, cell division, and transport. It is well established that Caenorhabditis elegans wsp-1 plays an essential role in embryonic development. We were interested in the role of the C. elegans protein WSP-1 in the adult nematode. In this report, we show that a deletion mutant of wsp-1 exhibits a strong sensitivity to the neuromuscular inhibitor aldicarb. Transgenic rescue experiments demonstrated that neuronal expression of WSP-1 rescued this phenotype and that it required a functional WSP-1 Cdc42/Rac interactive binding domain. WSP-1-GFP fusion protein was found localized presynaptically, immediately adjacent to the synaptic protein RAB-3. Strong genetic interactions with wsp-1 and other genes involved in different stages of synaptic transmission were observed as the wsp-1(gm324) mutation suppresses the aldicarb resistance seen in unc-13(e51), unc-11(e47), and snt-1 (md290) mutants. These results provide genetic and pharmacological evidence that WSP-1 plays an essential role to stabilize the actin cytoskeleton at the neuronal active zone of the neuromuscular junction to restrain synaptic vesicle release.	[Zhang, Yuqian; Kubiseski, Terrance J.] York Univ, Dept Biol, N York, ON M3J 1P3, Canada; [Kubiseski, Terrance J.] York Univ, Dept Neurosci, N York, ON M3J 1P3, Canada	York University - Canada; York University - Canada	Kubiseski, TJ (corresponding author), York Univ, Dept Biol, 4700 Keele St, N York, ON M3J 1P3, Canada.	tkubises@yorku.ca		Kubiseski, Terrance/0000-0001-9388-8608	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada.	Bernstein BW, 1998, MOL BRAIN RES, V53, P236, DOI 10.1016/S0169-328X(97)00319-7; BRENNER S, 1974, GENETICS, V77, P71; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gasman S, 2004, MOL BIOL CELL, V15, P520, DOI 10.1091/mbc.E03-06-0402; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Gu T, 1998, MOL CELL BIOL, V18, P4556, DOI 10.1128/MCB.18.8.4556; Halpain S, 2003, NAT NEUROSCI, V6, P101, DOI 10.1038/nn0203-101; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Johnstone IL, 1996, EMBO J, V15, P3633, DOI 10.1002/j.1460-2075.1996.tb00732.x; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Locke CJ, 2008, JOVE-J VIS EXP, V18, P837, DOI DOI 10.3791/837; Mahoney TR, 2006, NAT PROTOC, V1, P1772, DOI 10.1038/nprot.2006.281; Malacombe M, 2006, BBA-MOL CELL RES, V1763, P1175, DOI 10.1016/j.bbamcr.2006.09.004; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Ramesh N, 2009, IMMUNOL RES, V44, P99, DOI 10.1007/s12026-008-8086-1; Richmond Janet, 2005, WormBook, P1; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Shakir MA, 2008, GENETICS, V179, P1957, DOI 10.1534/genetics.108.088963; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Soderling SH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.255pe5; Tal T, 2002, DEV BIOL, V243, P260, DOI 10.1006/dbio.2002.0571; van der Linden AM, 2001, GENETICS, V158, P221; Wang XH, 1996, J PHYSIOL-LONDON, V491, P187, DOI 10.1113/jphysiol.1996.sp021206; Withee J, 2004, GENETICS, V167, P1165, DOI 10.1534/genetics.103.025676	28	6	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23038	23044		10.1074/jbc.M109.096164	http://dx.doi.org/10.1074/jbc.M109.096164			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20501656	Green Published, hybrid			2022-12-27	WOS:000279999900038
J	de Oca, PM; Malarde, V; Proust, R; Dautry-Varsat, A; Gesbert, F				Montes de Oca B, Pavel; Malarde, Valerie; Proust, Richard; Dautry-Varsat, Alice; Gesbert, Franck			Ectodomain Shedding of Interleukin-2 Receptor beta and Generation of an Intracellular Functional Fragment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P75 NEUROTROPHIN RECEPTOR; REGULATED INTRAMEMBRANE PROTEOLYSIS; CELL-LINE; IL-2 RECEPTOR; GAMMA-CHAIN; CLEAVAGE; ENDOCYTOSIS; LEUKEMIA; PROTEIN; NOTCH	Interleukin-2 (IL-2) regulates different functions of various lymphoid cell subsets. These are mediated by its binding to the IL-2 receptor (IL-2R) composed of three subunits (IL2-R alpha, -beta, and -gamma(c)). IL-2R beta is responsible for the activation of several signaling pathways. Ectodomain shedding of membrane receptors is thought to be an important mechanism for down-regulation of cell surface receptor abundance but is also emerging as a mechanism that cell membrane-associated molecules require for proper action in vivo. Here, we demonstrate that IL-2R beta is cleaved in cell lines of different origin, including T cells, generating an intracellular 37-kDa fragment (37 beta ic) that comprises the full intracellular C-terminal and transmembrane domains. Ectodomain shedding of IL-2R beta decreases in a mutant deleted of the juxtamembrane region, where cleavage is predicted to occur, and is inhibited by tissue inhibitor of metalloproteases-3. 37 beta ic is tyrosine-phosphorylated and associates with STAT-5, a canonic signal transducer of IL-2R. Finally, lymphoid cell transfection with a truncated form of IL-2R beta mimicking 37 beta ic increases their proliferation. These data indicate that IL-2R beta is subject to ectodomain shedding generating an intracellular fragment biologically functional, because (i) it is phosphorylated, (ii) it associates with STAT5A, and (iii) it increases cell proliferation.	[Gesbert, Franck] Univ Paris 11, INSERM, UMR S1004, F-94807 Villejuif, France; [Montes de Oca B, Pavel; Malarde, Valerie; Dautry-Varsat, Alice; Gesbert, Franck] Inst Pasteur, CNRS, URA2582, F-75015 Paris, France; [Montes de Oca B, Pavel] Inst Nacl Neurol & Neurocirug, Excitatory Amino Acids Lab, Mexico City 14269, DF, Mexico; [Proust, Richard; Gesbert, Franck] Univ Paris 11, Inst Andre Lwoff, UMR S1004, F-94807 Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Saclay	Gesbert, F (corresponding author), Univ Paris 11, INSERM, UMR S1004, 14 Ave Paul Vaillant Couturier, F-94807 Villejuif, France.	franck.gesbert@u-psud.fr			Action Concertee; Iniciative Biologie Cellulaire; Moleculaire et Structurale; Institut Pasteur	Action Concertee; Iniciative Biologie Cellulaire; Moleculaire et Structurale; Institut Pasteur(European Commission)	This work was supported in part by Action Concertee, Iniciative Biologie Cellulaire, Moleculaire et Structurale.; Supported by Joshi (2005-2006) and Cantarini (2006-2007) fellowships for postdoctoral studies from Institut Pasteur. To whom correspondence may be addressed: Excitatory Amino Acids Laboratory, Instituto Nacional de Neurologia y Neurocirugia, D.F., 14269, Mexico. Tel.: 52-55-5606-3822 (ext. 2013 or 5059); Fax: 52-55-5528-8036; E-mail: pavel73@hotmail.com.	Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; Bar-Or A, 2003, BRAIN, V126, P2738, DOI 10.1093/brain/awg285; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Delespine-Carmagnat M, 2000, EUR J IMMUNOL, V30, P59, DOI 10.1002/1521-4141(200001)30:1<59::AID-IMMU59>3.0.CO;2-1; Diaz-Rodriguez E, 1999, EUR J NEUROSCI, V11, P1421, DOI 10.1046/j.1460-9568.1999.00552.x; EVANS GA, 1994, J BIOL CHEM, V269, P23407; FernandezBotran R, 1996, ADV IMMUNOL, V63, P269, DOI 10.1016/S0065-2776(08)60858-5; Fujimura S, 2004, INT J ONCOL, V25, P437; Gaffen SL, 2001, CYTOKINE, V14, P63, DOI 10.1006/cyto.2001.0862; Galichet A, 2008, BIOCHEM BIOPH RES CO, V370, P1, DOI 10.1016/j.bbrc.2008.02.163; Gesbert F, 2004, CURR TOP MICROBIOL, V286, P119; Gesbert F, 1998, J BIOL CHEM, V273, P18273, DOI 10.1074/jbc.273.29.18273; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; HEMAR A, 1995, J CELL BIOL, V129, P55, DOI 10.1083/jcb.129.1.55; Herman C, 1998, J IMMUNOL, V160, P2478; HONDA M, 1990, J IMMUNOL, V145, P4131; HORI T, 1987, BLOOD, V70, P1069; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; KAWAHARA A, 1994, MOL CELL BIOL, V14, P5433, DOI 10.1128/MCB.14.8.5433; Kheradmand F, 2002, BIOESSAYS, V24, P8, DOI 10.1002/bies.10037; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Maasho K, 2004, J IMMUNOL METHODS, V284, P133, DOI 10.1016/j.jim.2003.10.010; Maatta JA, 2006, MOL BIOL CELL, V17, P67, DOI 10.1091/mbc.E05-05-0402; Meissner U, 2001, BLOOD, V97, P183; Michihara A, 2005, BIOL PHARM BULL, V28, P947, DOI 10.1248/bpb.28.947; Mori N, 2002, BLOOD, V99, P1341, DOI 10.1182/blood.V99.4.1341; Nelson BH, 1998, ADV IMMUNOL, V70, P1, DOI 10.1016/S0065-2776(08)60386-7; Parks AL, 2007, TRENDS GENET, V23, P140, DOI 10.1016/j.tig.2007.01.008; Pise-Masison CA, 2002, CANCER RES, V62, P3562; Polavarapu R, 2008, AM J PATHOL, V172, P1355, DOI 10.2353/ajpath.2008.070975; Robertson MJ, 1996, EXP HEMATOL, V24, P406; RUBIN LA, 1985, J IMMUNOL, V135, P3172; Sauvonnet N, 2005, J CELL BIOL, V168, P155, DOI 10.1083/jcb.200406174; Six E, 2003, P NATL ACAD SCI USA, V100, P7638, DOI 10.1073/pnas.1230693100; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Tsakadze NL, 2006, J BIOL CHEM, V281, P3157, DOI 10.1074/jbc.M510797200; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; Urra S, 2007, J BIOL CHEM, V282, P7606, DOI 10.1074/jbc.M610458200; Wang XD, 2002, J BIOL CHEM, V277, P50510, DOI 10.1074/jbc.M208738200; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Wilhelmsen K, 2004, MOL CELL BIOL, V24, P454, DOI 10.1128/MCB.24.1.454-464.2004; Zampieri N, 2005, J BIOL CHEM, V280, P14563, DOI 10.1074/jbc.M412957200	46	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22050	22058		10.1074/jbc.M109.093088	http://dx.doi.org/10.1074/jbc.M109.093088			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20495002	hybrid, Green Published			2022-12-27	WOS:000279702200017
J	Paris, Z; Changmai, P; Rubio, MAT; Zikova, A; Stuart, KD; Alfonzo, JD; Lukes, J				Paris, Zdenek; Changmai, Piya; Rubio, Mary Anne T.; Zikova, Alena; Stuart, Kenneth D.; Alfonzo, Juan D.; Lukes, Julius			The Fe/S Cluster Assembly Protein Isd11 Is Essential for tRNA Thiolation in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE DESULFURASE; THIO-MODIFICATION; MITOCHONDRIAL; COMPLEX; BIOGENESIS; FRATAXIN; LOCALIZATION; ACTS; 2-THIOURIDINE; BIOSYNTHESIS	Fe/S clusters are part of the active site of many enzymes and are essential for cell viability. In eukaryotes the cysteine desulfurase Nfs (IscS) donates the sulfur during Fe/S cluster assembly and was thought sufficient for this reaction. Moreover, Nfs is indispensable for tRNA thiolation, a modification generally required for tRNA function and protein synthesis. Recently, Isd11 was discovered as an integral part of the Nfs activity at an early step of Fe/S cluster assembly. Here we show, using a combination of genetic, molecular, and biochemical approaches, that Isd11, in line with its strong association with Nfs, is localized in the mitochondrion of T. brucei. In addition to its involvement in Fe/S assembly, Isd11 also partakes in both cytoplasmic and mitochondrial tRNA thiolation, whereas Mtu1, another protein proposed to collaborate with Nfs in tRNA thiolation, is required for this process solely within the mitochondrion. Taken together these data place Isd11 at the center of these sulfur transactions and raises the possibility of a connection between Fe/S metabolism and protein synthesis, helping integrate two seemingly unrelated pathways.	[Paris, Zdenek; Changmai, Piya; Zikova, Alena; Lukes, Julius] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, CR-37005 Ceske Budejovice, Budweis, Czech Republic; [Paris, Zdenek; Changmai, Piya; Zikova, Alena; Lukes, Julius] Univ S Bohemia, Fac Sci, Ceske Budejovice 37005, Budweis, Czech Republic; [Rubio, Mary Anne T.; Alfonzo, Juan D.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Rubio, Mary Anne T.; Alfonzo, Juan D.] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA; [Zikova, Alena; Stuart, Kenneth D.] Seattle Biomed Res Inst, Seattle, WA 98109 USA	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Center for Infectious Disease Research	Lukes, J (corresponding author), Branisovska 31, Ceske Budejovice 37005, Czech Republic.	jula@paru.cas.cz	Zikova, Alena/G-7855-2014; Lukes, Julius/H-6760-2012; Changmai, Piya/AAA-8208-2019; Paris, Zdenek/G-7349-2014	Zikova, Alena/0000-0002-8686-0225; Lukes, Julius/0000-0002-0578-6618; Paris, Zdenek/0000-0003-1019-7719; Changmai, Piya/0000-0003-3307-0585	National Institutes of Health [AI065935, GM084065]; National Science Foundation [MCB-0620707]; Czech Science Foundation [204/ 09/1667]; Ministry of Education of the Czech Republic [LC07032, 2B06129, 6007665801]; Praemium Academiae award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Praemium Academiae award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI065935 (to K. D. S.) and GM084065 and National Science Foundation Grant MCB-0620707 (to J. D. A.), Czech Science Foundation Grant 204/ 09/1667, Ministry of Education of the Czech Republic Grants LC07032, 2B06129, and 6007665801, and a Praemium Academiae award (to J. D. L.).	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; AGRIS PF, 1973, BIOCHEMISTRY-US, V12, P4331, DOI 10.1021/bi00746a005; Besteiro S, 2005, TRENDS PARASITOL, V21, P185, DOI 10.1016/j.pt.2005.02.008; Bruske EI, 2009, J BIOL CHEM, V284, P36491, DOI 10.1074/jbc.M109.064527; Crain PF, 2002, RNA, V8, P752, DOI 10.1017/S1355838202022045; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; Goldberg AV, 2008, NATURE, V452, P624, DOI 10.1038/nature06606; Hashimi H, 2008, RNA, V14, P970, DOI 10.1261/rna.888808; Hashimi H, 2009, RNA, V15, P588, DOI 10.1261/rna.1411809; Huang B, 2008, RNA, V14, P2183, DOI 10.1261/rna.1184108; Jensen BC, 2007, MOL BIOCHEM PARASIT, V151, P28, DOI 10.1016/j.molbiopara.2006.10.002; Johansson MJO, 2008, MOL CELL BIOL, V28, P3301, DOI 10.1128/MCB.01542-07; Kamenski P, 2007, MOL CELL, V26, P625, DOI 10.1016/j.molcel.2007.04.019; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Long S, 2008, P NATL ACAD SCI USA, V105, P13468, DOI 10.1073/pnas.0806762105; Marelja Z, 2008, J BIOL CHEM, V283, P25178, DOI 10.1074/jbc.M804064200; Mihara H, 2002, P NATL ACAD SCI USA, V99, P6679, DOI 10.1073/pnas.102176099; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; Nakai Y, 2004, J BIOL CHEM, V279, P12363, DOI 10.1074/jbc.M312448200; Nakai Y, 2007, MOL CELL BIOL, V27, P2841, DOI 10.1128/MCB.01321-06; Noma A, 2009, NUCLEIC ACIDS RES, V37, P1335, DOI 10.1093/nar/gkn1023; Panigrahi AK, 2001, MOL CELL BIOL, V21, P6833, DOI 10.1128/MCB.21.20.6833-6840.2001; Panigrahi AK, 2008, MOL CELL PROTEOMICS, V7, P534, DOI 10.1074/mcp.M700430-MCP200; Poliak P, 2010, FEBS J, V277, P383, DOI 10.1111/j.1742-4658.2009.07489.x; Ramazzotti A, 2004, FEBS LETT, V557, P215, DOI 10.1016/S0014-5793(03)01498-4; Richards TA, 2006, MOL BIOL EVOL, V23, P1341, DOI 10.1093/molbev/msl001; Saas J, 2000, J BIOL CHEM, V275, P2745, DOI 10.1074/jbc.275.4.2745; Schlieker CD, 2008, P NATL ACAD SCI USA, V105, P18255, DOI 10.1073/pnas.0808756105; Shan YX, 2007, HUM MOL GENET, V16, P929, DOI 10.1093/hmg/ddm038; Shi YB, 2009, HUM MOL GENET, V18, P3014, DOI 10.1093/hmg/ddp239; SIMPSON AM, 1989, NUCLEIC ACIDS RES, V17, P5427, DOI 10.1093/nar/17.14.5427; Smid O, 2006, J BIOL CHEM, V281, P28679, DOI 10.1074/jbc.M513781200; Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200; Vondruskova E, 2005, J BIOL CHEM, V280, P2429, DOI 10.1074/jbc.M405933200; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Wohlgamuth-Benedum JM, 2009, J BIOL CHEM, V284, P23947, DOI 10.1074/jbc.M109.029421; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031; Zikova A, 2008, MOL CELL PROTEOMICS, V7, P1286, DOI 10.1074/mcp.M700490-MCP200; Zutz A, 2009, BBA-BIOENERGETICS, V1787, P681, DOI 10.1016/j.bbabio.2009.02.009	43	30	30	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22394	22402		10.1074/jbc.M109.083774	http://dx.doi.org/10.1074/jbc.M109.083774			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20442400	Green Published, hybrid			2022-12-27	WOS:000279702200052
J	Song, GA; Kim, HJ; Woo, KM; Baek, JH; Kim, GS; Choi, JY; Ryoo, HM				Song, Gin-Ah; Kim, Hyun-Jung; Woo, Kyung-Mi; Baek, Jeong-Hwa; Kim, Gwan-Shik; Choi, Jin-Young; Ryoo, Hyun-Mo			Molecular Consequences of the ACVR1(R206H) Mutation of Fibrodysplasia Ossificans Progressiva	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA RECEPTOR; OSTEOBLAST DIFFERENTIATION; I RECEPTOR; OSTEOGENIC DIFFERENTIATION; FK506-BINDING PROTEIN; FKBP12 FUNCTIONS; NATURAL-HISTORY; MICE LACKING; EXPRESSION; ALK2	Fibrodysplasia ossificans progressiva (FOP), a rare genetic and catastrophic disorder characterized by progressive heterotopic ossification, is caused by a point mutation, c.617G>A; p.R206H, in the activin A receptor type 1 (ACVR1) gene, one of the bone morphogenetic protein type I receptors (BMPR-Is). Although altered BMP signaling has been suggested to explain the pathogenesis, the molecular consequences of this mutation are still elusive. Here we studied the impact of ACVR1 R206H mutation on BMP signaling and its downstream signaling cascades in murine myogenic C2C12 cells and HEK 293 cells. We found that ACVR1 was the most abundant of the BMPR-Is expressed in mesenchymal cells but its contribution to osteogenic BMP signal transduction was minor. The R206H mutant caused weak activation of the BMP signaling pathway, unlike the Q207D mutant, a strong and constitutively active form. The R206H mutant showed a decreased binding affinity for FKBP1A/FKBP12, a known safeguard molecule against the leakage of transforming growth factor (TGF)-beta or BMP signaling. The decreased binding affinity of FKBP1A to the mutant R206H ACVR1 resulted in leaky activation of the BMP signal, and moreover, it decreased steady-state R206H ACVR1 protein levels. Interestingly, while WT ACVR1 and FKBP1A were broadly distributed in plasma membrane and cytoplasm without BMP-2 stimulation and then localized in plasma membrane on BMP-2 stimulation, R206H ACVR1 and FKBP1A were mainly distributed in plasma membrane regardless of BMP-2 stimulation. The impaired binding to FKBP1A and an altered subcellular distribution by R206H ACVR1 mutation may result in mild activation of osteogenic BMP-signaling in extraskeletal sites such as muscle, which eventually lead to delayed and progressive ectopic bone formation in FOP patients.	[Song, Gin-Ah; Woo, Kyung-Mi; Baek, Jeong-Hwa; Kim, Gwan-Shik; Choi, Jin-Young; Ryoo, Hyun-Mo] Seoul Natl Univ, Sch Dent, Program BK21, Dept Mol Genet, Seoul 110749, South Korea; [Song, Gin-Ah; Woo, Kyung-Mi; Baek, Jeong-Hwa; Kim, Gwan-Shik; Choi, Jin-Young; Ryoo, Hyun-Mo] Seoul Natl Univ, Dent Res Inst, Seoul 110749, South Korea; [Kim, Hyun-Jung] BioRunx Co Ltd, Bone Res Inst, Seoul 110749, South Korea; [Song, Gin-Ah; Choi, Jin-Young] Seoul Natl Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Seoul 110749, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Ryoo, HM (corresponding author), 28 Yeongeon Dong, Seoul 110749, South Korea.	hmryoo@snu.ac.kr	Baek, Jeong-Hwa/A-8628-2012; Ryoo, Hyun-Mo/D-5839-2012; Woo, Kyung Mi/A-2793-2009	Ryoo, Hyun-Mo/0000-0001-6769-8341; Woo, Kyung Mi/0000-0002-2782-1189	Korean Government [KRF-2008-313-E00562]; Ministry of Health and Welfare [A010252]	Korean Government(Korean Government); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Korea Research Foundation grant funded by the Korean Government (KRF-2008-313-E00562) and by the Korea Health 21 R&D Project, Ministry of Health and Welfare (Project A010252).	Acampora D, 1999, DEVELOPMENT, V126, P3795; Aghdasi B, 2001, P NATL ACAD SCI USA, V98, P2425, DOI 10.1073/pnas.041614198; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Aridor M, 2000, TRAFFIC, V1, P836, DOI 10.1034/j.1600-0854.2000.011104.x; Billings PC, 2008, J BONE MINER RES, V23, P305, DOI 10.1359/JBMR.071030; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; Chen Y, 2005, HUM MOL GENET, V14, P2559, DOI 10.1093/hmg/ddi259; Chen YG, 1997, EMBO J, V16, P3866, DOI 10.1093/emboj/16.13.3866; Chen Z, 2010, FASEB J, V24, P357, DOI 10.1096/fj.09-138446; Cho YD, 2009, J BIOL CHEM, V284, P25230, DOI 10.1074/jbc.M109.008391; COHEN RB, 1993, J BONE JOINT SURG AM, V75A, P215, DOI 10.2106/00004623-199302000-00008; CONNOR JM, 1982, J BONE JOINT SURG BR, V64, P76, DOI 10.1302/0301-620X.64B1.7068725; CONNOR JM, 1993, J MED GENET, V30, P687, DOI 10.1136/jmg.30.8.687; de la Pena LS, 2005, J BONE MINER RES, V20, P1168, DOI 10.1359/JBMR.050305; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Esapa CT, 2005, HUM MOL GENET, V14, P295, DOI 10.1093/hmg/ddi026; FRUMAN DA, 1994, FASEB J, V8, P391, DOI 10.1096/fasebj.8.6.7513288; Fukuda T, 2009, J BIOL CHEM, V284, P7149, DOI 10.1074/jbc.M801681200; Gregersen N, 2000, J INHERIT METAB DIS, V23, P441, DOI 10.1023/A:1005663728291; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Gu ZY, 1999, DEVELOPMENT, V126, P2551; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hartung A, 2006, MOL CELL BIOL, V26, P7791, DOI 10.1128/MCB.00022-06; HEITMAN J, 1992, NEW BIOL, V4, P448; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Howell GJ, 2006, INT REV CYTOL, V252, P1, DOI 10.1016/S0074-7696(06)52005-4; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Kaartinen V, 2004, DEVELOPMENT, V131, P3481, DOI 10.1242/dev.01214; Kaplan FS, 2008, PEDIATRICS, V121, pE1295, DOI 10.1542/peds.2007-1980; Kaplan Frederick S, 2009, Hum Mutat, V30, P379, DOI 10.1002/humu.20868; Kevenaar ME, 2009, HUM REPROD, V24, P241, DOI 10.1093/humrep/den353; Kim YJ, 2004, J BIOL CHEM, V279, P50773, DOI 10.1074/jbc.M404145200; Kishigami S, 2004, DEV BIOL, V276, P185, DOI 10.1016/j.ydbio.2004.08.042; Kitterman JA, 2005, PEDIATRICS, V116, pE654, DOI 10.1542/peds.2005-0469; KOENIG BB, 1994, MOL CELL BIOL, V14, P5961, DOI 10.1128/MCB.14.9.5961; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Lavery K, 2008, J BIOL CHEM, V283, P20948, DOI 10.1074/jbc.M800850200; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200; LIU F, 1995, MOL CELL BIOL, V15, P3479; Lopes SMCD, 2004, GENE DEV, V18, P1838, DOI 10.1101/gad.294004; MacMillan D, 2005, J CELL SCI, V118, P5443, DOI 10.1242/jcs.02657; Newberry EP, 1998, BIOCHEMISTRY-US, V37, P16360, DOI 10.1021/bi981878u; Nohe A, 2005, J CELL SCI, V118, P643, DOI 10.1242/jcs.01402; Olmsted-Davis E, 2007, AM J PATHOL, V170, P620, DOI 10.2353/ajpath.2007.060692; Renlund N, 2007, J ENDOCRINOL, V195, P95, DOI 10.1677/JOE-07-0281; Ryoo HM, 1997, MOL ENDOCRINOL, V11, P1681, DOI 10.1210/me.11.11.1681; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; Schiene-Fischer C, 2001, FEBS LETT, V495, P1, DOI 10.1016/S0014-5793(01)02326-2; Shafritz AB, 1996, NEW ENGL J MED, V335, P555, DOI 10.1056/NEJM199608223350804; Shen Q, 2009, J CLIN INVEST, V119, P3462, DOI 10.1172/JCI37412; Shore EM, 2008, BONE, V43, P427, DOI 10.1016/j.bone.2008.05.013; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; SIEKIERKA JJ, 1989, J IMMUNOL, V143, P1580; Smith KA, 2009, CIRCULATION, V119, P3062, DOI 10.1161/CIRCULATIONAHA.108.843714; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Timerman AP, 1996, J BIOL CHEM, V271, P20385, DOI 10.1074/jbc.271.34.20385; van Dinther M, 2010, J BONE MINER RES, V25, P1208, DOI [10.1002/jbmr.091110, 10.1359/jbmr.091110]; Wang TW, 1996, CELL, V86, P435, DOI 10.1016/S0092-8674(00)80116-6; Whiteman P, 2003, HUM MOL GENET, V12, P727, DOI 10.1093/hmg/ddg081; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Yamaguchi T, 2006, J MOL ENDOCRINOL, V36, P569, DOI 10.1677/jme.1.01966; Yao DY, 2000, J BIOL CHEM, V275, P13149, DOI 10.1074/jbc.275.17.13149; Yoon WJ, 2008, J BIOL CHEM, V283, P32751, DOI 10.1074/jbc.M803183200; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888	67	85	88	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22542	22553		10.1074/jbc.M109.094557	http://dx.doi.org/10.1074/jbc.M109.094557			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20463014	hybrid, Green Published			2022-12-27	WOS:000279702200066
J	Bock, BC; Tagscherer, KE; Fassl, A; Kramer, A; Oehme, I; Zentgraf, HW; Keith, M; Roth, W				Boeck, Barbara C.; Tagscherer, Katrin E.; Fassl, Anne; Kraemer, Anika; Oehme, Ina; Zentgraf, Hans-Walter; Keith, Martina; Roth, Wilfried			The PEA-15 Protein Regulates Autophagy via Activation of JNK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; MALIGNANT GLIOMA-CELLS; GLIOBLASTOMA CELLS; OVARIAN-CANCER; CYTOPLASMIC SEQUESTRATION; INDUCED APOPTOSIS; CHROMOSOME 17Q; RAS ACTIVATION; JUN; PHOSPHORYLATION	PEA-15/PED (phosphoprotein enriched in astrocytes 15 kDa/phosphoprotein enriched in diabetes) is a death effector domain-containing protein which is known to modulate apoptotic cell death. The mechanism by which PEA-15 inhibits caspase activation and increases ERK (extracellular-regulated kinase) activity is well characterized. Here, we demonstrate that PEA-15 is not only pivotal in the activation of the ERK pathway but also modulates JNK (c-Jun N-terminal kinase) signaling. Upon overexpression of PEA-15 in malignant glioma cells, JNK is potently activated. The PEA-15-induced JNK activation depends on the phosphorylation of PEA-15 at both phosphorylation sites (serine 104 and serine 116). The activation of JNK is substantially inhibited by siRNA-mediated down-regulation of endogenous PEA-15. Moreover, we demonstrate that glioma cells overexpressing PEA-15 show increased signs of autophagy in response to classical autophagic stimuli such as ionizing irradiation, serum deprivation, or rapamycin treatment. In contrast, the non-phosphorylatable mutants of PEA-15 are not capable of promoting autophagy. The inhibition of JNK abrogates the PEA-15-mediated increase in autophagy. In conclusion, our data show that PEA-15 promotes autophagy in glioma cells in a JNK-dependent manner. This might render glioma cells more resistant to adverse stimuli such as starvation or ionizing irradiation.	[Boeck, Barbara C.; Tagscherer, Katrin E.; Fassl, Anne; Kraemer, Anika; Keith, Martina; Roth, Wilfried] German Canc Res Ctr, Dept Mol Neurooncol, D-69120 Heidelberg, Germany; [Oehme, Ina] German Canc Res Ctr, Dept Pediat Oncol, D-69120 Heidelberg, Germany; [Zentgraf, Hans-Walter] German Canc Res Ctr, Dept Monoclonal Antibodies & Electron Microscopy, D-69120 Heidelberg, Germany; [Roth, Wilfried] Heidelberg Univ, Inst Pathol, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Roth, W (corresponding author), German Canc Res Ctr, Dept Mol Neurooncol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	W.Roth@dkfz.de	Fassl, Anne/AAA-5249-2022; Oehme, Ina/AAF-3600-2021; Tagscherer, Katrin/AAS-3809-2021	Tagscherer, Katrin/0000-0002-0657-6399	Deutsche Krebshilfe	Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by a grant from the Deutsche Krebshilfe (to W. R.) (German Cancer Aid, Max Eder Program).	Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bartholomeusz C, 2006, ONCOGENE, V25, P79, DOI 10.1038/sj.onc.1209014; Bartholomeusz C, 2008, CANCER RES, V68, P9302, DOI 10.1158/0008-5472.CAN-08-2592; Behrens A, 2000, ONCOGENE, V19, P2657, DOI 10.1038/sj.onc.1203603; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bock BC, 2000, J BIOL CHEM, V275, P14231, DOI 10.1074/jbc.275.19.14231; Burgess GS, 1998, BLOOD, V92, P2450, DOI 10.1182/blood.V92.7.2450.2450_2450_2460; Cheng Y, 2008, BIOCHEM BIOPH RES CO, V376, P483, DOI 10.1016/j.bbrc.2008.09.018; Clark GJ, 1997, J BIOL CHEM, V272, P1677, DOI 10.1074/jbc.272.3.1677; Condorelli G, 2002, J BIOL CHEM, V277, P11013, DOI 10.1074/jbc.M110934200; Cripe LD, 2002, LEUKEMIA, V16, P799, DOI 10.1038/sj.leu.2402457; Cui J, 2006, CANCER RES, V66, P10024, DOI 10.1158/0008-5472.CAN-06-0136; Cui Q, 2007, J PHARMACOL SCI, V105, P317, DOI 10.1254/jphs.FP0070336; Daido S, 2005, CANCER RES, V65, P4368, DOI 10.1158/0008-5472.CAN-04-4202; Dong G, 2001, CANCER RES, V61, P4797; Duerr EM, 1998, ONCOGENE, V16, P2259, DOI 10.1038/sj.onc.1201756; ECCLES DM, 1990, ONCOGENE, V5, P1599; Eckert A, 2008, ONCOGENE, V27, P1155, DOI 10.1038/sj.onc.1210732; Formisano P, 2005, ONCOGENE, V24, P7012, DOI 10.1038/sj.onc.1208871; Formstecher E, 2001, DEV CELL, V1, P239, DOI 10.1016/S1534-5807(01)00035-1; FRANKLIN CC, 1992, P NATL ACAD SCI USA, V89, P7247, DOI 10.1073/pnas.89.15.7247; FUTREAL PA, 1992, CANCER RES, V52, P2624; GAO X, 1995, CANCER RES, V55, P1002; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heo JS, 2004, EMBO J, V23, P2185, DOI 10.1038/sj.emboj.7600212; Ito H, 2005, INT J ONCOL, V26, P1401; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Kanzawa T, 2003, J NEUROSURG, V99, P1047, DOI 10.3171/jns.2003.99.6.1047; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Knobbe CB, 2002, NEURO-ONCOLOGY, V4, P196; Kubes M, 1998, J NEUROCHEM, V71, P1307; LAEMMLI UK, 1970, J MOL BIOL, V47, P69, DOI 10.1016/0022-2836(70)90402-X; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Li JY, 2008, J NEURO-ONCOL, V88, P11, DOI 10.1007/s11060-008-9529-1; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lomonaco SL, 2009, INT J CANCER, V125, P717, DOI 10.1002/ijc.24402; Oleinik NV, 2007, ONCOGENE, V26, P7222, DOI 10.1038/sj.onc.1210526; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Peacock JW, 2009, MOL CELL BIOL, V29, P1222, DOI 10.1128/MCB.01660-08; Potapova O, 2000, J BIOL CHEM, V275, P24767, DOI 10.1074/jbc.M904591199; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ramos JW, 2000, MOL BIOL CELL, V11, P2863, DOI 10.1091/mbc.11.9.2863; Renault F, 2003, BIOCHEM PHARMACOL, V66, P1581, DOI 10.1016/S0006-2952(03)00514-8; Renault-Mihara F, 2006, MOL BIOL CELL, V17, P5141, DOI 10.1091/mbc.E05-11-1072; Renganathan H, 2005, BIOCHEM J, V390, P729, DOI 10.1042/BJ20050378; RUSSELL SEH, 1990, ONCOGENE, V5, P1581; SAITO H, 1993, CANCER RES, V53, P3382; Sato K, 2007, CANCER RES, V67, P9677, DOI 10.1158/0008-5472.CAN-07-1462; Scarlatti F, 2008, CELL DEATH DIFFER, V15, P1318, DOI 10.1038/cdd.2008.51; Sharif A, 2003, ANN NY ACAD SCI, V1010, P43, DOI 10.1196/annals.1299.006; SMEAL T, 1992, MOL CELL BIOL, V12, P3507, DOI 10.1128/MCB.12.8.3507; Thorburn J, 2009, AUTOPHAGY, V5, P247, DOI 10.4161/auto.5.2.7552; Tohma Y, 1998, J NEUROPATH EXP NEUR, V57, P684, DOI 10.1097/00005072-199807000-00005; Trencia A, 2003, MOL CELL BIOL, V23, P4511, DOI 10.1128/MCB.23.13.4511-4521.2003; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yang YM, 2003, CLIN CANCER RES, V9, P391	59	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21644	21654		10.1074/jbc.M109.096628	http://dx.doi.org/10.1074/jbc.M109.096628			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20452983	hybrid, Green Published			2022-12-27	WOS:000279516100051
J	El Gazzar, M; McCall, CE				El Gazzar, Mohamed; McCall, Charles E.			MicroRNAs Distinguish Translational from Transcriptional Silencing during Endotoxin Tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; GENE-SPECIFIC CONTROL; ALPHA MESSENGER-RNA; AU-RICH ELEMENTS; INHIBITION; DOXYCYCLINE; EXPRESSION; PROTEINS; HISTONE; BINDING	We reported that gene-selective formation of facultative heterochromatin silences transcription of acute inflammatory genes during endotoxin (LPS) tolerance, according to function. We discovered that reversal of the epigenetically silenced transcription restored mRNA levels but not protein synthesis. Here, we find that translation repression of tumor necrosis factor-alpha (TNF alpha) occurs independent of transcription silencing during LPS tolerance. The process required to disrupt protein synthesis followed Toll-like receptor 4 (TLR4)-dependent induction of microRNA (miR)-221, miR-579, and miR-125b, which coupled with RNA-binding proteins TTP, AUF1, and TIAR at the 3'-untranslated region to arrest protein synthesis. TTP and AUF1 proteins linked to miR-221, whereas TIAR coupled with miR-579 and miR-125b. Functional inhibition of miR-221 prevented TNF alpha mRNA degradation, and blocking miR-579 and miR-125b precluded translation arrest. The functional specificity of the TNF alpha 3'-untranslated region was demonstrated using luciferase reporter with mutations in the three putative miRNA binding sites. Post-transcriptional silencing was gene-specific, because it did not affect production of the I kappa B alpha anti-inflammatory protein. These results suggest that TLR4-dependent reprogramming of inflammatory genes is regulated at two separate and distinct levels. The first level of control is mediated by epigenetic modifications at the promoters that control transcription. The second and previously unrecognized level of control is mediated by TLR4-dependent differential expression of miRNAs that exert post-transcriptional controls. The concept of distinct regulation of transcription and translation was confirmed in murine sepsis. We conclude that transcription- and translation-repressive events combine to tightly regulate pro-inflammatory genes during LPS tolerance, a common feature of severe systemic inflammation.	[El Gazzar, Mohamed; McCall, Charles E.] Wake Forest Univ, Sch Med, Sect Mol Med, Dept Internal Med, Winston Salem, NC 27157 USA; [McCall, Charles E.] Wake Forest Univ, Sch Med, Translat Sci Inst, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University	El Gazzar, M (corresponding author), Wake Forest Univ, Sch Med, Sect Mol Med, Dept Internal Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	melgazza@wfubmc.edu	Huang, H/E-9490-2010		National Institutes of Health [R01AI065791, R01AI079144]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079144, R01AI065791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI065791 and R01AI079144.	Amin AR, 1996, P NATL ACAD SCI USA, V93, P14014, DOI 10.1073/pnas.93.24.14014; Asirvatham AJ, 2008, MOL IMMUNOL, V45, P1995, DOI 10.1016/j.molimm.2007.10.035; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Chan C, 2005, J IMMUNOL, V175, P461, DOI 10.4049/jimmunol.175.1.461; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chen XP, 2009, J BIOL CHEM, V284, P27857, DOI 10.1074/jbc.M109.000950; Chen XP, 2009, CLIN VACCINE IMMUNOL, V16, P104, DOI 10.1128/CVI.00320-08; Chung DR, 2008, J INFECTION, V56, P44, DOI 10.1016/j.jinf.2007.09.009; Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001; El Gazzar M, 2008, J BIOL CHEM, V283, P32198, DOI 10.1074/jbc.M803446200; El Gazzar M, 2007, J BIOL CHEM, V282, P26857, DOI 10.1074/jbc.M704584200; El Gazzar M, 2010, J BIOL CHEM, V285, P1259, DOI 10.1074/jbc.M109.067330; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Foster SL, 2009, CLIN IMMUNOL, V130, P7, DOI 10.1016/j.clim.2008.08.015; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gueydan C, 1999, J BIOL CHEM, V274, P2322, DOI 10.1074/jbc.274.4.2322; Han J, 1990, Eur Cytokine Netw, V1, P71; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hau HH, 2007, J CELL BIOCHEM, V100, P1477, DOI 10.1002/jcb.21130; Hoyt JC, 2006, J IMMUNOL, V176, P567, DOI 10.4049/jimmunol.176.1.567; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Ketting RF, 2007, CELL, V131, P1226, DOI 10.1016/j.cell.2007.12.004; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; LARUE KEA, 1994, J EXP MED, V180, P2269, DOI 10.1084/jem.180.6.2269; Lindeman JHN, 2009, CIRCULATION, V119, P2209, DOI 10.1161/CIRCULATIONAHA.108.806505; Lu JY, 2006, GENE DEV, V20, P3174, DOI 10.1101/gad.1467606; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mattes J, 2007, AM J RESP CELL MOL, V36, P8, DOI 10.1165/rcmb.2006-0227TR; McCall CE, 2007, AM J RESP CRIT CARE, V175, P763, DOI 10.1164/rccm.200610-1436CP; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Smale ST, 2003, NAT IMMUNOL, V4, P607, DOI 10.1038/ni0703-607; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Stenvang J, 2008, BIOCHEM SOC T, V36, P1197, DOI 10.1042/BST0361197; Stoecklin G, 2003, MOL CELL BIOL, V23, P3506, DOI 10.1128/MCB.23.10.3506-3515.2003; Suarez Y, 2010, J IMMUNOL, V184, P21, DOI 10.4049/jimmunol.0902369; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Wen HT, 2008, BLOOD, V111, P1797, DOI 10.1182/blood-2007-08-106443; Yoza BK, 1998, CLIN DIAGN LAB IMMUN, V5, P281, DOI 10.1128/CDLI.5.3.281-287.1998	57	113	115	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20940	20951		10.1074/jbc.M110.115063	http://dx.doi.org/10.1074/jbc.M110.115063			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20435889	Green Published, hybrid			2022-12-27	WOS:000279228600058
J	DiNatale, BC; Schroeder, JC; Francey, LJ; Kusnadi, A; Perdew, GH				DiNatale, Brett C.; Schroeder, Jennifer C.; Francey, Lauren J.; Kusnadi, Ann; Perdew, Gary H.			Mechanistic Insights into the Events That Lead to Synergistic Induction of Interleukin 6 Transcription upon Activation of the Aryl Hydrocarbon Receptor and Inflammatory Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; GENE-EXPRESSION; AH RECEPTOR; CELL-LINE; BREAST-CARCINOMA; PROSTATE-CANCER; AUTOCRINE LOOP; GROWTH-FACTOR; KINASE-ALPHA; IKK-ALPHA	The aryl hydrocarbon receptor (AHR) is the ligand-activated transcription factor responsible for mediating the toxicological effects of dioxin and xenobiotic metabolism. However, recent evidence has implicated the AHR in additional, nonmetabolic physiological processes, including immune regulation. Certain tumor cells are largely nonresponsive to cytokine-mediated induction of the pro-survival cytokine interleukin (IL) 6. We have demonstrated that multiple nonresponsive tumor lines are able to undergo synergistic induction of IL6 following combinatorial treatment with IL1 beta and the AHR agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin. Such data implicate the AHR in tumor expansion, although the mechanistic basis for the AHR-dependent synergistic induction of IL6 has not been determined. Here, we demonstrate that ligand-activated AHR is involved in priming the IL6 promoter through binding to nonconsensus dioxin response elements located upstream of the IL6 start site. Such binding appears to render the promoter more permissive to IL1 beta-induced binding of NF-kappa B components. The nature of the AHR-dependent increases in IL6 promoter transcriptional potential has been shown to involve a reorganization of repressive complexes as exemplified by the presence of HDAC1 and HDAC3. Dismissal of these HDACs correlates with post-translational modifications of promoter-bound NF-kappa B components in a time-dependent manner. Thus the AHR plays a role in derepressing the IL6 promoter, leading to synergistic IL6 expression in the presence of inflammatory signals. These observations may explain the association between enhanced expression of AHR and tumor aggressiveness. It is likely that AHR-mediated priming is not restricted to the IL6 promoter and may contribute to the expression of a variety of genes, which do not have consensus dioxin response elements.	[Perdew, Gary H.] Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA; Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Perdew, GH (corresponding author), Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA.	ghp2@psu.edu		Francey, Lauren J/0000-0002-9700-2277				Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Armenante F, 1999, NUCLEIC ACIDS RES, V27, P4483, DOI 10.1093/nar/27.22.4483; Asgeirsson KS, 1998, CYTOKINE, V10, P720, DOI 10.1006/cyto.1998.0349; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Badache A, 2001, CANCER RES, V61, P383; Baglole CJ, 2008, J BIOL CHEM, V283, P28944, DOI 10.1074/jbc.M800685200; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Bunger MK, 2008, TOXICOL SCI, V106, P83, DOI 10.1093/toxsci/kfn149; Cavarretta IT, 2007, ONCOGENE, V26, P2822, DOI 10.1038/sj.onc.1210097; Chen BL, 2005, J IMMUNOL, V175, P1310, DOI 10.4049/jimmunol.175.2.1310; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen LF, 2003, J MOL MED, V81, P549, DOI 10.1007/s00109-003-0469-0; Chiaro CR, 2007, MOL PHARMACOL, V72, P1369, DOI 10.1124/mol.107.038968; Conze D, 2001, CANCER RES, V61, P8851; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Denison MS, 1998, TARG ORG T, P3; DINATALE BC, 2010, CYTOTECHNOL IN PRESS; Faggioli L, 1996, EUR J BIOCHEM, V239, P624, DOI 10.1111/j.1432-1033.1996.0624u.x; Frericks M, 2008, TOXICOL APPL PHARM, V232, P268, DOI 10.1016/j.taap.2008.07.009; Furness SGB, 2009, PHARMACOL THERAPEUT, V124, P336, DOI 10.1016/j.pharmthera.2009.09.004; Gillesby BE, 1997, BIOCHEMISTRY-US, V36, P6080, DOI 10.1021/bi962131b; Gloire G, 2007, J BIOL CHEM, V282, P21308, DOI 10.1074/jbc.M610728200; Gouedard C, 2004, MOL CELL BIOL, V24, P5209, DOI 10.1128/MCB.24.12.5209-5222.2004; Hershko DD, 2002, AM J PHYSIOL-REG I, V283, pR1140, DOI 10.1152/ajpregu.00161.2002; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; Hollingshead BD, 2008, CANCER RES, V68, P3609, DOI 10.1158/0008-5472.CAN-07-6168; Ishida M, 2010, CARCINOGENESIS, V31, P287, DOI 10.1093/carcin/bgp222; Kayama H, 2008, J BIOL CHEM, V283, P12468, DOI 10.1074/jbc.M709965200; Kharat I, 1996, J BIOL CHEM, V271, P10533, DOI 10.1074/jbc.271.18.10533; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Kobayashi S, 2008, RHEUMATOLOGY, V47, P1317, DOI 10.1093/rheumatology/ken259; Kuwata H, 2006, IMMUNITY, V24, P41, DOI 10.1016/j.immuni.2005.11.004; Ndlovu MN, 2009, MOL CELL BIOL, V29, P5488, DOI 10.1128/MCB.01657-08; Patel RD, 2009, LAB INVEST, V89, P695, DOI 10.1038/labinvest.2009.24; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Privalsky ML, 2004, ANNU REV PHYSIOL, V66, P315, DOI 10.1146/annurev.physiol.66.032802.155556; Quivy V, 2004, BIOCHEM PHARMACOL, V68, P1221, DOI 10.1016/j.bcp.2004.05.039; Safe S, 1998, TOXICOL LETT, V103, P343; Safe S, 1995, Arch Toxicol Suppl, V17, P99; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Sasser AK, 2007, FASEB J, V21, P3763, DOI 10.1096/fj.07-8832com; Sasser AK, 2007, CANCER LETT, V254, P255, DOI 10.1016/j.canlet.2007.03.012; Schnekenburger M, 2007, BBA-GENE STRUCT EXPR, V1769, P569, DOI 10.1016/j.bbaexp.2007.07.002; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; SWANSON HI, 1995, J BIOL CHEM, V270, P26292, DOI 10.1074/jbc.270.44.26292; Vogel CFA, 2007, BIOCHEM BIOPH RES CO, V363, P722, DOI 10.1016/j.bbrc.2007.09.032; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Xu Y, 2008, MOL CANCER THER, V7, P2367, DOI 10.1158/1535-7163.MCT-08-0238; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamamoto Masahiro, 2008, Journal of Infection and Chemotherapy, V14, P265, DOI 10.1007/s10156-008-0619-y	51	82	87	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24388	24397		10.1074/jbc.M110.118570	http://dx.doi.org/10.1074/jbc.M110.118570			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20511231	Green Published, hybrid			2022-12-27	WOS:000280542100010
J	Markovics, JA; Araya, J; Cambier, S; Jablons, D; Hill, A; Wolters, PJ; Nishimura, SL				Markovics, Jennifer A.; Araya, Jun; Cambier, Stephanie; Jablons, David; Hill, Arthur; Wolters, Paul J.; Nishimura, Stephen L.			Transcription of the Transforming Growth Factor beta Activating Integrin beta 8 Subunit Is Regulated by SP3, AP-1, and the p38 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICE LACKING; C-JUN; GENE; EXPRESSION; PROMOTER; BINDING; PROTEIN; ALPHA; ALPHA-V-BETA-8; FAMILY	Integrin alpha v beta 8 is a critical regulator of transforming growth factor beta activation in vasculogenesis during development, immune regulation, and endothelial/ epithelial-mesenchymal homeostasis. Recent studies have suggested roles for integrin beta 8 in the pathogenesis of chronic obstructive pulmonary disease, brain arteriovenous malformations, and select cancers (Araya, J., Cambier, S., Markovics, J. A., Wolters, P., Jablons, D., Hill, A., Finkbeiner, W., Jones, K., Broaddus, V. C., Sheppard, D., Barzcak, A., Xiao, Y., Erle, D. J., and Nishimura, S. L. (2007) J. Clin. Invest. 117, 3551- 3562; Su, H., Kim, H., Pawlikowska, L., Kitamura, H., Shen, F., Cambier, S., Markovics, J., Lawton, M. T., Sidney, S., Bollen, A. W., Kwok, P. Y., Reichardt, L., Young, W. L., Yang, G. Y., and Nishimura, S. L. (2010) Am. J. Pathol. 176, 1018- 1027; Culhane, A. C., and Quackenbush, J. (2009) Cancer Res. 69, 7480-7485; Cambier, S., Mu, D. Z., O-Connell, D., Boylen, K., Travis, W., Liu, W. H., Broaddus, V. C., and Nishimura, S. L. (2000) Cancer Res. 60, 7084-7093). Here we report the first identification and characterization of the promoter for ITGB8. We show that a SP binding site and a cyclic AMP response element (CRE) in the ITGB8 core promoter are required for its expression and that Sp1, Sp3, and several AP-1 transcription factors form a complex that binds to these sites in a p38-dependent manner. Furthermore, we demonstrate the requirement for Sp3, ATF-2, and p38 for the transcription and protein expression of integrin beta 8. Additionally, reduction of SP3 or inhibition of p38 blocks alpha v beta 8-mediated transforming growth factor beta activation. These results place integrin beta 8 expression and activity under the control of ubiquitous transcription factors in a stress-activated and pro-inflammatory pathway.	[Markovics, Jennifer A.; Araya, Jun; Cambier, Stephanie; Nishimura, Stephen L.] Univ Calif San Francisco, Sch Med, Dept Pathol, Div Pulm, San Francisco, CA 94143 USA; [Jablons, David; Hill, Arthur] Univ Calif San Francisco, Sch Med, Dept Surg, Div Pulm, San Francisco, CA 94143 USA; [Wolters, Paul J.] Univ Calif San Francisco, Sch Med, Dept Med, Div Pulm, San Francisco, CA 94143 USA; [Wolters, Paul J.] Univ Calif San Francisco, Sch Med, Lung Biol Ctr, Div Pulm, San Francisco, CA 94143 USA; [Araya, Jun] Jikei Univ, Sch Med, Div Resp Dis, Dept Internal Med, Tokyo 1058461, Japan	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Jikei University	Nishimura, SL (corresponding author), UCSF SFGH Bldg 3,Rm 211,1001 Potrero Ave, San Francisco, CA 94110 USA.	stephen.nishimura@ucsf.edu			National Institutes of Health [HL090662, HL63993, NS04415]; University of California San Francisco; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063993, R01HL090662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Francisco(University of California System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL090662, HL63993, and NS04415 (to S. L. N.).; Supported by a grant from the Resource Allocation Program at the University of California San Francisco.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Aluwihare P, 2009, J CELL SCI, V122, P227, DOI 10.1242/jcs.035246; Angel P, 2002, BIOCHEM PHARMACOL, V64, P949, DOI 10.1016/S0006-2952(02)01158-9; Angel P, 2001, ONCOGENE, V20, P2413, DOI 10.1038/sj.onc.1204380; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Aouadi M, 2006, BIOCHIMIE, V88, P1091, DOI 10.1016/j.biochi.2006.06.003; Araya J, 2007, J CLIN INVEST, V117, P3551, DOI 10.1172/JCI32526; Araya J, 2006, AM J PATHOL, V169, P405, DOI 10.2353/ajpath.2006.060049; Bader BL, 1998, CELL, V95, P507, DOI 10.1016/S0092-8674(00)81618-9; Bajic VB, 2002, BIOINFORMATICS, V18, P198, DOI 10.1093/bioinformatics/18.1.198; Bhoumik A, 2008, CELL CYCLE, V7, P2341, DOI 10.4161/cc.6388; Block KL, 1996, BLOOD, V88, P2071, DOI 10.1182/blood.V88.6.2071.bloodjournal8862071; Borovecki F, 2005, P NATL ACAD SCI USA, V102, P11023, DOI 10.1073/pnas.0504921102; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; Brudno M, 2007, NUCLEIC ACIDS RES, V35, pW669, DOI 10.1093/nar/gkm279; Cambier S, 2005, AM J PATHOL, V166, P1883, DOI 10.1016/S0002-9440(10)62497-2; Cambier S, 2000, CANCER RES, V60, P7084; Citron BA, 2008, J NEUROSCI RES, V86, P2499, DOI 10.1002/jnr.21695; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; CULHANE AC, 2009, J CANC RES, V69, P7480; Czyz M, 1999, EUR J BIOCHEM, V265, P638, DOI 10.1046/j.1432-1327.1999.00754.x; Danen EHJ, 2003, J PATHOL, V201, P632, DOI 10.1002/path.1472; Eckert RL, 2004, J INVEST DERMATOL, V123, P13, DOI 10.1111/j.0022-202X.2004.22723.x; Finkbeiner WE., 1997, LUNG SCI FDN, P415; FitzGerald PC, 2004, GENOME RES, V14, P1562, DOI 10.1101/gr.1953904; Fujita N, 2004, METHODS, V33, P81, DOI 10.1016/j.ymeth.2003.10.022; Gingras ME, 2009, INVEST OPHTH VIS SCI, V50, P57, DOI 10.1167/iovs.08-2059; Goodwin A, 2009, BIOCHEM SOC T, V37, P849, DOI 10.1042/BST0370849; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hale KK, 1999, J IMMUNOL, V162, P4246; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Heintzman ND, 2007, CELL MOL LIFE SCI, V64, P386, DOI 10.1007/s00018-006-6295-0; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Huang S, 1997, IMMUNITY, V6, P739, DOI 10.1016/S1074-7613(00)80449-5; Huang XZ, 2000, MOL CELL BIOL, V20, P755, DOI 10.1128/MCB.20.3.755-759.2000; Hui LJ, 2007, CELL CYCLE, V6, P2429, DOI 10.4161/cc.6.20.4774; Hynes RO, 2004, MATRIX BIOL, V23, P333, DOI 10.1016/j.matbio.2004.08.001; Jackson Paul F., 2002, Current Topics in Medicinal Chemistry, V2, P1011, DOI 10.2174/1568026023393372; Jarad G, 2002, J BIOL CHEM, V277, P47826, DOI 10.1074/jbc.M204901200; Kardassis D, 1999, J BIOL CHEM, V274, P29572, DOI 10.1074/jbc.274.41.29572; Katabami K, 2006, J CELL BIOCHEM, V97, P530, DOI 10.1002/jcb.20663; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KITABAYASHI I, 1995, EMBO J, V14, P3496, DOI 10.1002/j.1460-2075.1995.tb07356.x; Krishna M, 2008, CELL MOL LIFE SCI, V65, P3525, DOI 10.1007/s00018-008-8170-7; Kruger I, 2007, DEV DYNAM, V236, P2235, DOI 10.1002/dvdy.21222; Lai CF, 2000, J BIOL CHEM, V275, P36400, DOI 10.1074/jbc.M002131200; Lakhe-Reddy S, 2006, J BIOL CHEM, V281, P19688, DOI 10.1074/jbc.M601110200; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; LoGrasso PV, 1997, BIOCHEMISTRY-US, V36, P10422, DOI 10.1021/bi9706778; Lu N, 2010, MATRIX BIOL, V29, P166, DOI 10.1016/j.matbio.2009.11.003; Maekawa T, 1999, J BIOL CHEM, V274, P17813, DOI 10.1074/jbc.274.25.17813; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; McCarty JH, 2002, MOL CELL BIOL, V22, P7667, DOI 10.1128/MCB.22.21.7667-7677.2002; MOYLE M, 1991, J BIOL CHEM, V266, P19650; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Mu ZY, 2008, MECH DEVELOP, V125, P508, DOI 10.1016/j.mod.2008.01.003; Nishimura SL, 2009, AM J PATHOL, V175, P1362, DOI 10.2353/ajpath.2009.090393; Noti JD, 1997, J BIOL CHEM, V272, P24038, DOI 10.1074/jbc.272.38.24038; Noti JD, 2000, J BIOL CHEM, V275, P8959, DOI 10.1074/jbc.275.12.8959; OHLER U, 2000, P PAC S BIOCOMPUT, V5, P380; Proctor JM, 2005, J NEUROSCI, V25, P9940, DOI 10.1523/JNEUROSCI.3467-05.2005; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Reddy SPM, 2002, AM J PHYSIOL-LUNG C, V283, pL1161, DOI 10.1152/ajplung.00140.2002; Reimold AM, 2001, INT IMMUNOL, V13, P241, DOI 10.1093/intimm/13.2.241; Rosmarin AG, 1998, J BIOL CHEM, V273, P13097, DOI 10.1074/jbc.273.21.13097; Shi W, 2007, PHYSIOL GENOMICS, V31, P374, DOI 10.1152/physiolgenomics.00085.2006; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Smale ST, 1997, BBA-GENE STRUCT EXPR, V1351, P73, DOI 10.1016/S0167-4781(96)00206-0; STEPHENS LE, 1995, GENE DEV, V9, P1883, DOI 10.1101/gad.9.15.1883; Su H, 2010, AM J PATHOL, V176, P1018, DOI 10.2353/ajpath.2010.090453; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Takaoka AS, 1998, J BIOL CHEM, V273, P33848, DOI 10.1074/jbc.273.50.33848; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Woo IS, 2002, INT J ONCOL, V20, P527; Yang ZW, 2007, J CELL BIOL, V176, P787, DOI 10.1083/jcb.200611044; Ye JP, 1996, MOL CELL BIOL, V16, P6178; Zhen GH, 2007, AM J RESP CELL MOL, V36, P244, DOI 10.1165/rcmb.2006-0180OC; Zhu JW, 2002, DEVELOPMENT, V129, P2891; Zutter MM, 1999, BLOOD, V93, P1600, DOI 10.1182/blood.V93.5.1600.405k04_1600_1611	81	24	26	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24695	24706		10.1074/jbc.M110.113977	http://dx.doi.org/10.1074/jbc.M110.113977			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20519498	hybrid, Green Published			2022-12-27	WOS:000280542100042
J	Pye, VE; Christensen, CE; Dyer, JH; Arent, S; Henriksen, A				Pye, Valerie E.; Christensen, Caspar E.; Dyer, James H.; Arent, Susan; Henriksen, Anette			Peroxisomal Plant 3-Ketoacyl-CoA Thiolase Structure and Activity Are Regulated by a Sensitive Redox Switch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID BETA-OXIDATION; ACYL-COA OXIDASES; ARABIDOPSIS-THALIANA; CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; MULTIFUNCTIONAL PROTEIN; BRASSICA-NAPUS; CATALASE; H2O2; TRIACYLGLYCEROL	The breakdown of fatty acids, performed by the beta-oxidation cycle, is crucial for plant germination and sustainability. beta-Oxidation involves four enzymatic reactions. The final step, in which a two-carbon unit is cleaved from the fatty acid, is performed by a 3-ketoacyl-CoA thiolase (KAT). The shortened fatty acid may then pass through the cycle again (until reaching acetoacetyl-CoA) or be directed to a different cellular function. Crystal structures of KAT from Arabidopsis thaliana and Helianthus annuus have been solved to 1.5 and 1.8 angstrom resolution, respectively. Their dimeric structures are very similar and exhibit a typical thiolase-like fold; dimer formation and active site conformation appear in an open, active, reduced state. Using an interdisciplinary approach, we confirmed the potential of plant KATs to be regulated by the redox environment in the peroxisome within a physiological range. In addition, co-immunoprecipitation studies suggest an interaction between KAT and the multifunctional protein that is responsible for the preceding two steps in beta-oxidation, which would allow a route for substrate channeling. We suggest a model for this complex based on the bacterial system.	Carlsberg Lab, Prot Chem Grp, DK-2500 Copenhagen, Denmark; [Dyer, James H.] Montclair State Univ, Dept Chem & Biochem, Montclair, NJ 07043 USA	Montclair State University	Pye, VE (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland.	vpye@tcd.ie; anette@crc.dk	Christensen, Caspar Elo/K-2753-2014	Christensen, Caspar Elo/0000-0002-0214-8477; Pye, Valerie E/0000-0001-9616-2992; Henriksen, Anette/0000-0003-4051-5079	Danish Natural Science Research Council	Danish Natural Science Research Council(Danish Natural Science Research Council)	This work was supported by the Danish Natural Science Research Council, which provided a postdoctoral stipend through DANSYNC (to S. A.) and synchrotron beam time.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALTOMARE RE, 1974, BIOTECHNOL BIOENG, V16, P1675, DOI 10.1002/bit.260161209; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Arent S, 2010, J BIOL CHEM, V285, P24066, DOI 10.1074/jbc.M110.106005; Brehelin C, 2004, PHOTOSYNTH RES, V79, P295, DOI 10.1023/B:PRES.0000017165.55488.ca; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carrie C, 2007, PLANT MOL BIOL, V63, P97, DOI 10.1007/s11103-006-9075-1; CHANCE B, 1952, ARCH BIOCHEM BIOPHYS, V41, P404, DOI 10.1016/0003-9861(52)90469-4; Cheeseman JM, 2006, J EXP BOT, V57, P2435, DOI 10.1093/jxb/erl004; Dansen TB, 2001, IUBMB LIFE, V51, P223; DAWSON RM, 1974, DATA BIOCH RES, P191; Delker C, 2007, PHYTOCHEMISTRY, V68, P1642, DOI 10.1016/j.phytochem.2007.04.024; Dutton P L, 1978, Methods Enzymol, V54, P411; Eastmond PJ, 2000, BIOCHEM SOC T, V28, P95, DOI 10.1042/bst0280095; Eaton S, 2000, BIOCHEM SOC T, V28, P177, DOI 10.1042/bst0280177; Eccleston VS, 1998, PLANT CELL, V10, P613, DOI 10.1105/tpc.10.4.613; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Fritz R, 2007, FREE RADICAL BIO MED, V42, P1119, DOI 10.1016/j.freeradbiomed.2007.01.014; Germain V, 2001, PLANT J, V28, P1, DOI 10.1046/j.1365-313X.2001.01095.x; HASHIMOTO F, 1987, BIOCHIM BIOPHYS ACTA, V921, P142; Hayashi M, 1998, PLANT CELL, V10, P183, DOI 10.1105/tpc.10.2.183; Hooks MA, 1996, BIOCHEM J, V320, P607, DOI 10.1042/bj3200607; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Ishikawa M, 1997, BIOCHEM J, V328, P815, DOI 10.1042/bj3280815; Ishikawa M, 2004, EMBO J, V23, P2745, DOI 10.1038/sj.emboj.7600298; KINDL H, 1987, BIOCH PLANTS, V9, P31; KIRKMAN HN, 1987, J BIOL CHEM, V262, P660; KNOOP F, 1905, CHEM PHYSL PATHOL S, V6, P150; Koch M, 2001, AM J BOT, V88, P534, DOI 10.2307/2657117; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lardinois OM, 1996, BBA-PROTEIN STRUCT M, V1298, P180, DOI 10.1016/S0167-4838(96)00130-6; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Laskowski RA, 1997, TRENDS BIOCHEM SCI, V22, P488, DOI 10.1016/S0968-0004(97)01140-7; LAZAROW PB, 1978, J BIOL CHEM, V253, P1522; Mason JT, 2006, BIOCHEMISTRY-US, V45, P13409, DOI 10.1021/bi061136y; Mathieu M, 1997, J MOL BIOL, V273, P714, DOI 10.1006/jmbi.1997.1331; MATHIEU M, 1994, STRUCTURE, V2, P797, DOI 10.1016/S0969-2126(94)00081-6; MILLIS KK, 1993, J ORG CHEM, V58, P4144, DOI 10.1021/jo00067a060; Mueller S, 2002, BIOCHEM J, V363, P483, DOI 10.1042/0264-6021:3630483; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neill S, 2002, CURR OPIN PLANT BIOL, V5, P388, DOI 10.1016/S1369-5266(02)00282-0; Nicholls P., 1963, ENZYMES, V8, P147; Nyathi Y, 2006, BBA-MOL CELL RES, V1763, P1478, DOI 10.1016/j.bbamcr.2006.08.031; Olesen C, 1997, FEBS LETT, V412, P138, DOI 10.1016/S0014-5793(97)00766-7; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Reumann S, 2009, PLANT PHYSIOL, V150, P125, DOI 10.1104/pp.109.137703; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Richmond TA, 1999, PLANT CELL, V11, P1911, DOI 10.1105/tpc.11.10.1911; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schiedl AC, 2004, PROTEIN EXPRES PURIF, V33, P25, DOI 10.1016/j.pep.2003.08.022; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; Schwarzlander M, 2008, J MICROSC-OXFORD, V231, P299, DOI 10.1111/j.1365-2818.2008.02030.x; Setterdahl AT, 2003, BIOCHEMISTRY-US, V42, P14877, DOI 10.1021/bi0302088; Simova-Stoilova L, 2009, PLANT GROWTH REGUL, V58, P107, DOI 10.1007/s10725-008-9356-6; Sinclair AM, 2009, PLANT J, V59, P231, DOI 10.1111/j.1365-313X.2009.03863.x; Sundaramoorthy R, 2006, J MOL BIOL, V359, P347, DOI 10.1016/j.jmb.2006.03.032; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsuchiya D, 2006, STRUCTURE, V14, P237, DOI 10.1016/j.str.2005.10.011; van Roermund CWT, 2003, CELL MOL LIFE SCI, V60, P1838, DOI 10.1007/s00018-003-3076-x; VANVELDHOVEN PP, 1992, J BIOL CHEM, V267, P20065; Willekens H, 1997, EMBO J, V16, P4806, DOI 10.1093/emboj/16.16.4806; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yao KW, 1996, J BIOL CHEM, V271, P17816, DOI 10.1074/jbc.271.30.17816; Zhu HB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-27; Zolman BR, 2008, GENETICS, V180, P237, DOI 10.1534/genetics.108.090399	68	27	27	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					24078	24088		10.1074/jbc.M110.106013	http://dx.doi.org/10.1074/jbc.M110.106013			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20463027	Green Published, hybrid			2022-12-27	WOS:000280291400058
J	Chang, HK; Lee, JR; Liu, TA; Suen, CS; Arreola, J; Shieh, RC				Chang, Hsueh-Kai; Lee, Jay-Ron; Liu, Tai-An; Suen, Ching-Shu; Arreola, Jorge; Shieh, Ru-Chi			The Extracellular K+ Concentration Dependence of Outward Currents through Kir2.1 Channels Is Regulated by Extracellular Na+ and Ca2+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFIER POTASSIUM CHANNELS; GUINEA-PIG; ANOMALOUS RECTIFICATION; VENTRICULAR MYOCYTES; INWARD RECTIFICATION; MYOCARDIAL ISCHEMIA; SODIUM-CHANNELS; PORE REGION; BLOCK; INACTIVATION	It has been known for more than three decades that outward Kir currents (I-K1) increase with increasing extracellular K+ concentration ([K+](o)). Although this increase in I-K1 can have significant impacts under pathophysiological cardiac conditions, where [K+](o) can be as high as 18 mM and thus predispose the heart to re-entrant ventricular arrhythmias, the underlying mechanism has remained unclear. Here, we show that the steep [K+](o) dependence of Kir2.1-mediated outward I-K1 was due to [K+](o)-dependent inhibition of outward I-K1 by extracellular Na+ and Ca2+. This could be accounted for by Na+/Ca2+ inhibition of I-K1 through screening of local negative surface charges. Consistent with this, extracellular Na+ and Ca2+ reduced the outward single-channel current and did not increase open-state noise or decrease the mean open time. In addition, neutralizing negative surface charges with a carboxylate esterifying agent inhibited outward I-K1 in a similar [K+](o)-dependent manner as Na+/Ca2(+). Site-directed mutagenesis studies identified Asp(114) and Glu(153) as the source of surface charges. Reducing K+ activation and surface electrostatic effects in an R148Y mutant mimicked the action of extracellular Na+ and Ca2+, suggesting that in addition to exerting a surface electrostatic effect, Na+ and Ca2+ might inhibit outward I-K1 by inhibiting K+ activation. This study identified interactions of K+ with Na+ and Ca2+ that are important for the [K+](o) dependence of Kir2.1-mediated outward I-K1.	[Arreola, Jorge] Autonomous Univ San Luis Potosi, Inst Phys, San Luis Potosi 78290, Mexico; [Chang, Hsueh-Kai; Lee, Jay-Ron; Liu, Tai-An; Suen, Ching-Shu; Shieh, Ru-Chi] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan	Universidad Autonoma de San Luis Potosi; Academia Sinica - Taiwan	Arreola, J (corresponding author), Autonomous Univ San Luis Potosi, Inst Phys, San Luis Potosi 78290, Mexico.	arreola@dec1.ifisica.uaslp.mx; ruchi@ibms.sinica.edu.tw	ARREOLA, JORGE/HGE-4524-2022; Arreola, Jorge/B-1042-2009	ARREOLA, JORGE/0000-0002-5354-3709; 	Academia Sinica in Taiwan; National Science Council of Taiwan [98-2320-B001-009-MY3]	Academia Sinica in Taiwan(Academia Sinica - Taiwan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Academia Sinica in Taiwan and National Science Council of Taiwan Grant 98-2320-B001-009-MY3.	Alagem N, 2001, J PHYSIOL-LONDON, V534, P381, DOI 10.1111/j.1469-7793.2001.00381.x; BIERMANS G, 1987, PFLUG ARCH EUR J PHY, V410, P604, DOI 10.1007/BF00581320; Carabelli V, 2001, J PHYSIOL-LONDON, V532, P73, DOI 10.1111/j.1469-7793.2001.0073g.x; CHANDLER WK, 1965, J PHYSIOL-LONDON, V180, P821, DOI 10.1113/jphysiol.1965.sp007733; Claydon TW, 2004, BIOPHYS J, V87, P2407, DOI 10.1529/biophysj.103.039073; D'Avanzo N, 2005, J GEN PHYSIOL, V125, P493, DOI 10.1085/jgp.200409175; Dhamoon AS, 2005, HEART RHYTHM, V2, P316, DOI 10.1016/j.hrthm.2004.11.012; DUDLEY SC, 1993, J GEN PHYSIOL, V101, P651, DOI 10.1085/jgp.101.5.651; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; HAGIWARA S, 1979, J PHYSIOL-LONDON, V292, P251, DOI 10.1113/jphysiol.1979.sp012849; HAGIWARA S, 1976, J GEN PHYSIOL, V67, P621, DOI 10.1085/jgp.67.6.621; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARVEY RD, 1988, J GEN PHYSIOL, V91, P593, DOI 10.1085/jgp.91.4.593; Hayashi M, 2007, PFLUG ARCH EUR J PHY, V455, P455, DOI 10.1007/s00424-007-0309-0; Hilgemann Donald W., 1995, P307; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hille B., 2001, IONIC CHANNELS EXCIT, P814; HIRCHE H, 1980, J MOL CELL CARDIOL, V12, P579, DOI 10.1016/0022-2828(80)90016-4; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; ISHIHARA K, 1989, J PHYSIOL-LONDON, V419, P297, DOI 10.1113/jphysiol.1989.sp017874; ISHIHARA K, 1994, J MEMBRANE BIOL, V142, P55; JANSE MJ, 1989, PHYSIOL REV, V69, P1049, DOI 10.1152/physrev.1989.69.4.1049; KLEBER AG, 1984, J MOL CELL CARDIOL, V16, P389, DOI 10.1016/S0022-2828(84)80610-0; Kubo Y, 1996, RECEPTOR CHANNEL, V4, P73; LEECH CA, 1981, J PHYSIOL-LONDON, V319, P295, DOI 10.1113/jphysiol.1981.sp013909; Lopatin AN, 1996, J GEN PHYSIOL, V108, P105, DOI 10.1085/jgp.108.2.105; Lopatin AN, 2001, J MOL CELL CARDIOL, V33, P625, DOI 10.1006/jmcc.2001.1344; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; MACKINNON R, 1989, BIOCHEMISTRY-US, V28, P8092, DOI 10.1021/bi00446a020; MATSUDA H, 1993, J PHYSIOL-LONDON, V460, P311, DOI 10.1113/jphysiol.1993.sp019473; Matsuda H, 2003, J PHYSIOL-LONDON, V548, P361, DOI 10.1113/jphysiol.2003.038844; MATSUDA H, 1984, J PHYSIOL-LONDON, V357, P553, DOI 10.1113/jphysiol.1984.sp015517; Murata Y, 2002, J PHYSIOL-LONDON, V544, P665, DOI 10.1113/jphysiol.2002.030650; OHMORI H, 1978, J PHYSIOL-LONDON, V281, P77, DOI 10.1113/jphysiol.1978.sp012410; PARDO LA, 1992, P NATL ACAD SCI USA, V89, P2466, DOI 10.1073/pnas.89.6.2466; PENNEFATHER P, 1992, BIOPHYS J, V61, P448, DOI 10.1016/S0006-3495(92)81850-7; Shieh RC, 1999, J BIOL CHEM, V274, P17424, DOI 10.1074/jbc.274.25.17424; SIGWORTH FJ, 1980, NATURE, V283, P293, DOI 10.1038/283293a0; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; STANDEN NB, 1979, J PHYSIOL-LONDON, V294, P497, DOI 10.1113/jphysiol.1979.sp012943; STANFIELD PR, 1994, J PHYSIOL-LONDON, V475, P1; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Yang J, 1997, P NATL ACAD SCI USA, V94, P1568, DOI 10.1073/pnas.94.4.1568	44	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23113	23123		10.1074/jbc.M110.121186	http://dx.doi.org/10.1074/jbc.M110.121186			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20495007	Green Published, hybrid			2022-12-27	WOS:000279999900046
J	Krupenko, NI; Dubard, ME; Strickland, KC; Moxley, KM; Oleinik, NV; Krupenko, SA				Krupenko, Natalia I.; Dubard, Marianne E.; Strickland, Kyle C.; Moxley, Kelly M.; Oleinik, Natalia V.; Krupenko, Sergey A.			ALDH1L2 Is the Mitochondrial Homolog of 10-Formyltetrahydrofolate Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONE-CARBON METABOLISM; SERINE HYDROXYMETHYLTRANSFERASES; C-1-TETRAHYDROFOLATE SYNTHASE; TRIFUNCTIONAL ENZYME; HYDROLASE; EXPRESSION; PROTEIN; LIVER; PURIFICATION; SYNTHETASE	Cytosolic 10-formyltetrahydrofolate dehydrogenase (FDH, ALDH1L1) is an abundant enzyme of folate metabolism. It converts 10-formyltetrahydrofolate to tetrahydrofolate and CO2 in an NADP(+)-dependent reaction. We have identified a gene at chromosome locus 12q24.11 of the human genome, the product of which has 74% sequence similarity with cytosolic FDH. This protein has an extra N-terminal sequence of 22 amino acid residues, predicted to be a mitochondrial translocation signal. Transfection of COS-7 or A549 cell lines with a construct in which green fluorescent protein was introduced between the leader sequence and the rest of the putative mitochondrial FDH (mtFDH) has demonstrated mitochondrial localization of the fusion protein, suggesting that the identified gene encodes a mitochondrial enzyme. Purified pig liver mtFDH displayed dehydrogenase/hydrolase activities similar to cytosolic FDH. Real-time PCR performed on an array of human tissues has shown that although cytosolic FDH mRNA is highest in liver, kidney, and pancreas, mtFDH mRNA is most highly expressed in pancreas, heart, and brain. In contrast to the cytosolic enzyme, which is not detectable in cancer cells, the presence of mtFDH was demonstrated in several human cancer cell lines by conventional and real-time PCR and by Western blot. Analysis of genomes of different species indicates that the mitochondrial enzyme is a later evolutionary product when compared with the cytosolic enzyme. We propose that this novel mitochondrial enzyme is a likely source of CO2 production from 10-formyltetrahydrofolate in mitochondria and plays an essential role in the distribution of one-carbon groups between the cytosolic and mitochondrial compartments of the cell.	[Krupenko, Natalia I.; Dubard, Marianne E.; Strickland, Kyle C.; Moxley, Kelly M.; Oleinik, Natalia V.; Krupenko, Sergey A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Krupenko, SA (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave, Charleston, SC 29425 USA.	krupenko@musc.edu	Strickland, Kyle/Q-7135-2019	Strickland, Kyle/0000-0003-1636-5277	National Institutes of Health [DK54388]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK54388 (to S.A.K.).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Anderson DD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005839; Anguera MC, 2006, J BIOL CHEM, V281, P18335, DOI 10.1074/jbc.M510623200; APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; BARLOWE C K, 1988, Biofactors, V1, P171; CHAMPION KM, 1994, P NATL ACAD SCI USA, V91, P11338, DOI 10.1073/pnas.91.24.11338; Christensen KE, 2006, BIOESSAYS, V28, P595, DOI 10.1002/bies.20420; Christensen KE, 2005, J BIOL CHEM, V280, P7597, DOI 10.1074/jbc.M409380200; Chumanevich AA, 2004, J BIOL CHEM, V279, P14355, DOI 10.1074/jbc.M313934200; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; COOK RJ, 1991, J BIOL CHEM, V266, P4965; COOK RJ, 1982, BIOCHEMISTRY-US, V21, P4427, DOI 10.1021/bi00261a036; Donato H, 2007, J BIOL CHEM, V282, P34159, DOI 10.1074/jbc.M707627200; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 2001, BBA-MOL CELL RES, V1541, P114, DOI 10.1016/S0167-4889(01)00145-8; Femandez-Checa JC, 2005, TOXICOL APPL PHARM, V204, P263, DOI 10.1016/j.taap.2004.10.001; Fox JT, 2008, VITAM HORM, V79, P1, DOI 10.1016/S0083-6729(08)00401-9; Fox JT, 2009, J BIOL CHEM, V284, P31085, DOI 10.1074/jbc.M109.035576; GARCIAMARTINEZ LF, 1993, BIOCHEMISTRY-US, V32, P4671, DOI 10.1021/bi00068a027; GARROW TA, 1993, J BIOL CHEM, V268, P11910; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gregory JF, 2002, ANNU REV NUTR, V22, P199, DOI 10.1146/annurev.nutr.22.120701.083554; HUM DW, 1988, J BIOL CHEM, V263, P15946; HUM DW, 1991, PROTEIN ENG, V4, P493, DOI 10.1093/protein/4.4.493; Kisliuk RL, 1999, CANC DRUG DISC DEV, P13; KREBS HA, 1976, BIOCHEM J, V158, P341, DOI 10.1042/bj1580341; Krupenko SA, 2002, CELL GROWTH DIFFER, V13, P227; KRUPENKO SA, 1995, J BIOL CHEM, V270, P519, DOI 10.1074/jbc.270.2.519; Krupenko SA, 2001, J BIOL CHEM, V276, P24030, DOI 10.1074/jbc.M009257200; KRUPENKO SA, 1995, BIOCHEM J, V306, P651, DOI 10.1042/bj3060651; KRUPENKO SA, 1995, PROTEIN EXPRES PURIF, V6, P457, DOI 10.1006/prep.1995.1061; Krupenko SA, 1999, J BIOL CHEM, V274, P35777, DOI 10.1074/jbc.274.50.35777; Krupenko SA, 2009, CHEM-BIOL INTERACT, V178, P84, DOI 10.1016/j.cbi.2008.09.007; Lamers Y, 2009, J NUTR, V139, P666, DOI 10.3945/jn.108.103580; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEMASTERS JJ, 1984, J BIOL CHEM, V259, P3058; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MASUDA T, 1987, J BIOCHEM, V101, P643, DOI 10.1093/jb/101.3.643; Oleinik NV, 2007, ONCOGENE, V26, P7222, DOI 10.1038/sj.onc.1210526; Oleinik NV, 2005, BIOCHEM J, V391, P503, DOI 10.1042/BJ20050533; Patel H, 2002, ARCH BIOCHEM BIOPHYS, V403, P145, DOI 10.1016/S0003-9861(02)00203-5; PAUKERT JL, 1977, BIOCHEM BIOPH RES CO, V77, P147, DOI 10.1016/S0006-291X(77)80176-9; Pike ST, 2010, J BIOL CHEM, V285, P4612, DOI 10.1074/jbc.M109.079855; Reuland SN, 2006, PROTEIN SCI, V15, P1076, DOI 10.1110/ps.052062806; Reuland SN, 2003, J BIOL CHEM, V278, P22894, DOI 10.1074/jbc.M302948200; Spencer AC, 2004, NUCLEIC ACIDS RES, V32, P5464, DOI 10.1093/nar/gkh886; Strickland KC, 2010, J BIOL CHEM, V285, P1627, DOI 10.1074/jbc.M109.080556; TEPHLY TR, 1992, TOXICOL APPL PHARM, V116, P142, DOI 10.1016/0041-008X(92)90155-L; THIGPEN AE, 1990, J BIOL CHEM, V265, P7907; Tsybovsky Y, 2007, BIOCHEMISTRY-US, V46, P2917, DOI 10.1021/bi0619573; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; VILLAR E, 1985, J BIOL CHEM, V260, P2245; Wagner C, 1995, FOLATE HLTH DIS, P23; Walkup AS, 2005, ARCH BIOCHEM BIOPHYS, V442, P196, DOI 10.1016/j.abb.2005.08.007; Woeller CF, 2007, J BIOL CHEM, V282, P17623, DOI 10.1074/jbc.M702526200	56	66	68	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23054	23061		10.1074/jbc.M110.128843	http://dx.doi.org/10.1074/jbc.M110.128843			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20498374	Green Published, hybrid			2022-12-27	WOS:000279999900040
J	Samuel, CE				Samuel, Charles E.			Thematic Minireview Series: Elucidating Hepatitis C Virus-Host Interactions at the Biochemical Level	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material									[Samuel, Charles E.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Samuel, Charles E.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Samuel, CE (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	samuel@lifesci.ucsb.edu			NIAID NIH HHS [R01 AI012520, R01 AI012520-34, R37 AI012520, R01 AI020611-25, AI-12520, R01 AI020611, AI-20611] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020611, R01AI012520, R37AI012520] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Appel N, 2006, J BIOL CHEM, V281, P9833, DOI 10.1074/jbc.R500026200; Jones DM, 2010, J BIOL CHEM, V285, P22732, DOI 10.1074/jbc.R110.133017; Knipe DM, 2007, FIELDS VIROLOGY; Lemon SM, 2010, J BIOL CHEM, V285, P22739, DOI 10.1074/jbc.R109.099556; Raney KD, 2010, J BIOL CHEM, V285, P22725, DOI 10.1074/jbc.R110.125294; Samuel CE, 2006, J BIOL CHEM, V281, P8305, DOI 10.1074/jbc.R500032200; von Hahn T, 2008, J BIOL CHEM, V283, P3689, DOI 10.1074/jbc.R700024200	7	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22723	22724		10.1074/jbc.R110.142240	http://dx.doi.org/10.1074/jbc.R110.142240			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20457611	hybrid, Green Published			2022-12-27	WOS:000279999900001
J	Zhou, Y; Hagood, JS; Lu, BG; Merryman, WD; Murphy-Ullrich, JE				Zhou, Yong; Hagood, James S.; Lu, Baogen; Merryman, W. David; Murphy-Ullrich, Joanne E.			Thy-1-Integrin alpha(v)beta(5) Interactions Inhibit Lung Fibroblast Contraction-induced Latent Transforming Growth Factor-beta 1 Activation and Myofibroblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; SMOOTH MUSCLE ACTIN; IDIOPATHIC PULMONARY-FIBROSIS; LIGHT-CHAIN PHOSPHATASE; INTEGRIN-LINKED KINASE; TGF-BETA; IN-VIVO; EXTRACELLULAR-MATRIX; BINDING-PROTEIN; GRANULATION-TISSUE	Myofibroblasts, key effector cells in tissue fibrosis, are specialized contractile cells. Lung myofibroblast contraction induces integrin alpha(v)beta(5)-dependent latent transforming growth factor (TGF)-beta 1 activation suggests that myofibroblast contractility may be a driving force for the persistent myofibroblast differentiation observed in fibrotic lungs. Understanding the mechanisms that regulate fibroblast contraction and mechanotransduction will add new insights into the pathogenesis of lung fibrosis and may lead to new therapeutic approaches for treating fibrotic lung diseases. We and others previously demonstrated that lung fibroblast expression of Thy-1 prevents lung fibrosis. The mechanisms underlying the anti-fibrotic effect of Thy-1 are not well understood. In this study, we showed that Thy-1 interacts with integrin alpha(v)beta(5), both in a cell-free system and on the cell surface of rat lung fibroblasts. Thy-1-integrin alpha(v)beta(5) interactions are RLD-dependent because mutated Thy-1, in which RLD is replaced by RLE, loses the ability to bind the integrin. Furthermore, Thy-1 expression prevents fibroblast contraction-induced, integrin alpha(v)beta(5)-dependent latent TGF-beta 1 activation and TGF-beta 1-dependent lung myofibroblast differentiation. In contrast, lack of Thy-1 expression or disruption of Thy-1-alpha(v)beta(5) interactions renders lung fibroblasts susceptible to contraction-induced latent TGF-beta 1 activation and myofibroblast differentiation. These data suggest that Thy-1-integrin alpha(v)beta(5) interactions inhibit contraction-induced latent TGF-beta 1 activation, presumably by blocking the binding of extracellular matrix-bound latent TGF-beta 1 with integrin alpha(v)beta(5). Our studies suggest that targeting key mechanotransducers to inhibit mechanotransduction might be an effective approach to inhibit the deleterious effects of myofibroblast contraction on lung fibrogenesis.	[Zhou, Yong; Lu, Baogen] Univ Alabama, Div Pulm Allergy & Crit Care Med, Dept Med, Birmingham, AL 35294 USA; [Murphy-Ullrich, Joanne E.] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Hagood, James S.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Merryman, W. David] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37240 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Diego; Vanderbilt University	Zhou, Y (corresponding author), Univ Alabama, Div Pulm Allergy & Crit Care Med, Dept Med, Tinsley Harrison Tower 437B,1900 Univ Blvd, Birmingham, AL 35294 USA.	yzhou@uab.edu	Merryman, W. David/AAY-4781-2021		National Institutes of Health [HL097215, HL094707, HL082818, HL86706]; American Heart Association [0835432N, 0835496N]; Department of Medicine, University of Alabama at Birmingham; National Center for Research Resources, National Institutes of Health [C06 RR 15490]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015490] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL097215, R01HL082818, K25HL094707, R21HL086706] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Department of Medicine, University of Alabama at Birmingham; National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL097215 (to Y.Z.), HL094707 (to W. D. M.), HL082818 (to J. S. H.), and HL86706 (to J. E. M.-U.). This work was also supported by American Heart Association Scientist Development Grant 0835432N, start-up funding from the Department of Medicine, University of Alabama at Birmingham (to Y. Z.), and American Heart Association Scientist Development Grant 0835496N (to W. D. M.). A part of the present study was conducted in a facility constructed with support from Research Facilities Improvement Program Grant C06 RR 15490 from the National Center for Research Resources, National Institutes of Health.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Ahamed J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006608; Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; Arora PD, 1999, AM J PATHOL, V154, P871, DOI 10.1016/S0002-9440(10)65334-5; Asano Y, 2006, J INVEST DERMATOL, V126, P1761, DOI 10.1038/sj.jid.5700331; Avalos AM, 2002, BIOL RES, V35, P231, DOI 10.4067/S0716-97602002000200015; Barker TH, 2004, J BIOL CHEM, V279, P23510, DOI 10.1074/jbc.M402169200; Barker TH, 2004, EXP CELL RES, V295, P488, DOI 10.1016/j.yexcr.2004.01.026; Bogatcheva NV, 2003, AM J PHYSIOL-LUNG C, V285, pL415, DOI 10.1152/ajplung.00364.2001; Carlson MA, 2002, SURGERY, V131, P332, DOI 10.1067/msy.2002.120673; CHAPONNIER C, 1995, J CELL BIOL, V130, P887, DOI 10.1083/jcb.130.4.887; Chaudhry SS, 2007, J CELL BIOL, V176, P355, DOI 10.1083/jcb.200608167; Dallas SL, 2005, J BIOL CHEM, V280, P18871, DOI 10.1074/jbc.M410762200; Deng JT, 2002, BIOCHEM J, V367, P517, DOI 10.1042/BJ20020522; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; Gauldie J, 2007, BIOCHEM SOC T, V35, P661, DOI 10.1042/BST0350661; GENTRY LE, 1990, BIOCHEMISTRY-US, V29, P6851, DOI 10.1021/bi00481a014; GENTRY LE, 1988, MOL CELL BIOL, V8, P4162, DOI 10.1128/MCB.8.10.4162; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; Goodwin A, 2009, BIOCHEM SOC T, V37, P849, DOI 10.1042/BST0370849; Grinnell F, 1999, EXP CELL RES, V248, P608, DOI 10.1006/excr.1999.4440; Grinnell F, 1998, J INVEST DERMATOL, V110, P771, DOI 10.1046/j.1523-1747.1998.00192.x; Hagood JS, 2005, AM J PATHOL, V167, P365, DOI 10.1016/S0002-9440(10)62982-3; Hagood JS, 2001, CHEST, V120, p64S, DOI 10.1378/chest.120.1_suppl.S64; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736; HEDMAN K, 1979, J CELL BIOL, V81, P83, DOI 10.1083/jcb.81.1.83; Hermosilla T, 2008, BBA-MOL CELL RES, V1783, P1111, DOI 10.1016/j.bbamcr.2008.01.034; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Hinz B, 2002, J CELL BIOL, V157, P657, DOI 10.1083/jcb.200201049; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hinz Boris, 2009, Curr Rheumatol Rep, V11, P120; Hyytiainen M, 2004, CRIT REV CL LAB SCI, V41, P233, DOI 10.1080/10408360490460933; KARLSSON JO, 1994, ANAL BIOCHEM, V219, P144, DOI 10.1006/abio.1994.1243; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Keski-Oja J, 2004, TRENDS CELL BIOL, V14, P657, DOI 10.1016/j.tcb.2004.10.003; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; King TE, 2001, AM J RESP CRIT CARE, V164, P1025, DOI 10.1164/ajrccm.164.6.2001056; Koli K, 2004, J CELL BIOL, V167, P123, DOI 10.1083/jcb.200403067; LAWRENCE DA, 1984, J CELL PHYSIOL, V121, P184, DOI 10.1002/jcp.1041210123; Leyton L, 2001, CURR BIOL, V11, P1028, DOI 10.1016/S0960-9822(01)00262-7; Liao YF, 2002, J BIOL CHEM, V277, P14467, DOI 10.1074/jbc.M201100200; Margadant C, 2010, EMBO REP, V11, P97, DOI 10.1038/embor.2009.276; MCINTOSH JC, 1994, EUR RESPIR J, V7, P2131, DOI 10.1183/09031936.94.07122131; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; Nozaki Y, 2000, AM J RESP CELL MOL, V23, P460, DOI 10.1165/ajrcmb.23.4.3958; Parizi M, 2000, EXP CELL RES, V254, P210, DOI 10.1006/excr.1999.4754; Peterson LJ, 2004, MOL BIOL CELL, V15, P3497, DOI 10.1091/mbc.E03-09-0696; Rege TA, 2006, EXP CELL RES, V312, P3752, DOI 10.1016/j.yexcr.2006.07.029; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Saalbach A, 2005, ONCOGENE, V24, P4710, DOI 10.1038/sj.onc.1208559; Saharinen J, 1996, EMBO J, V15, P245, DOI 10.1002/j.1460-2075.1996.tb00355.x; Sanders YY, 2007, AM J RESP CELL MOL, V36, P226, DOI 10.1165/rcmb.2006-0178OC; Sheppard D, 2005, CANCER METAST REV, V24, P395, DOI 10.1007/s10555-005-5131-6; Taipale J, 1996, J HISTOCHEM CYTOCHEM, V44, P875, DOI 10.1177/44.8.8756760; TAIPALE J, 1994, J CELL BIOL, V124, P171, DOI 10.1083/jcb.124.1.171; TAIPALE J, 1992, J BIOL CHEM, V267, P25378; Tomasek JJ, 2006, WOUND REPAIR REGEN, V14, P313, DOI 10.1111/j.1743-6109.2006.00126.x; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Wetzel A, 2004, J IMMUNOL, V172, P3850, DOI 10.4049/jimmunol.172.6.3850; Wetzel A, 2006, J INVEST DERMATOL, V126, P441, DOI 10.1038/sj.jid.5700072; WILBORN J, 1995, J CLIN INVEST, V95, P1861, DOI 10.1172/JCI117866; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Wilson DP, 2005, BIOCHEM J, V392, P641, DOI 10.1042/BJ20051173; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539; Zhou Y, 2004, AM J PATHOL, V165, P659, DOI 10.1016/S0002-9440(10)63330-5; Zhou Y, 2009, AM J PATHOL, V174, P21, DOI 10.2353/ajpath.2009.080620	70	94	95	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22382	22393		10.1074/jbc.M110.126227	http://dx.doi.org/10.1074/jbc.M110.126227			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20463011	hybrid, Green Published			2022-12-27	WOS:000279702200051
J	D'Angelo, ME; Bird, PI; Peters, C; Reinheckel, T; Trapani, JA; Sutton, VR				D'Angelo, Michael E.; Bird, Phillip I.; Peters, Christoph; Reinheckel, Thomas; Trapani, Joseph A.; Sutton, Vivien R.			Cathepsin H Is an Additional Convertase of Pro-granzyme B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPEPTIDYL-PEPTIDASE-II; TARGET-CELL APOPTOSIS; CYTOTOXIC LYMPHOCYTES; DNA FRAGMENTATION; SERINE PROTEASES; LYTIC GRANULES; ACTIVATION; INHIBITION; PURIFICATION; EXPRESSION	The serine protease granzyme B (GrB) is the most potent proapoptotic cytotoxin of the granule exocytosis pathway of cytotoxic lymphocytes. GrB is synthesized as a zymogen (proGrB) and activated in cytotoxic granules by the lysosomal cysteine protease cathepsin C (CatC) which removes the N-terminal dipeptide Gly-Glu. It has been shown recently that mice lacking CatC nonetheless express significant residual GrB activity, indicating the presence of additional proGrB convertases. Here, we describe an assay to assess activation of proGrB and show that the amino-peptidase cathepsin H (CatH) has proGrB convertase activity in vitro, whereas dipeptidylpeptidase II does not. We generated mice lacking both CatC and CatH expression (CatCH(-/-)) and found that their lymphocytes have reduced convertase activity compared with those from CatC-deficient mice. Despite this, cytotoxic lymphocytes from CatCH(-/-) mice retain cytotoxic activity and some residual GrB activity. We conclude that CatH can act as an additional proGrB convertase and that other protease/s (apart from dipeptidylpeptidase II) must also possess convertase activity. This indicates a great deal of functional redundancy in GrB maturation, which would prevent pathogen-mediated immune suppression by via convertase inhibition.	[D'Angelo, Michael E.; Bird, Phillip I.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Peters, Christoph; Reinheckel, Thomas] Univ Freiburg, Inst Mol Med & Cell Res, D-79104 Freiburg, Germany; [Trapani, Joseph A.; Sutton, Vivien R.] Peter MacCallum Canc Ctr, Canc Cell Death Lab, Melbourne, Vic 8006, Australia	Monash University; University of Freiburg; Peter Maccallum Cancer Center	Bird, PI (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	phillip.bird@med.monash.edu.au; viv.sutton@petermac.org	Reinheckel, Thomas/AAL-9761-2021	Reinheckel, Thomas/0000-0001-9866-9105; Bird, Phillip/0000-0002-6695-606X; Trapani, Joseph/0000-0003-0983-1532; D'Angelo, Michael/0000-0001-9342-0132	Australian postgraduate award; National Health and Medical Research Council of Australia (NHMRC) [490900, 288999, 454569]	Australian postgraduate award(Australian Government); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	Supported by an Australian postgraduate award.; Supported by Program Grant 490900 from the National Health and Medical Research Council of Australia (NHMRC). To whom correspondence may be addressed: Dept. of Biochemistry and Molecular Biology, Monash University, Clayton, 3800 Victoria, Australia. Tel.: 61-3-9902-9365; Fax: 61-3-99029500; E-mail: phillip.bird@med.monash.edu.au.; Recipient of a senior fellowship from the NHMRC (288999).; Supported by Program Grant 454569 from the NHMRC.	Andrade F, 2007, EMBO J, V26, P2148, DOI 10.1038/sj.emboj.7601650; BURKHARDT JK, 1990, J CELL BIOL, V111, P2327, DOI 10.1083/jcb.111.6.2327; Buzza MS, 2008, J BIOL CHEM, V283, P22498, DOI 10.1074/jbc.M709080200; Buzza MS, 2005, J BIOL CHEM, V280, P23549, DOI 10.1074/jbc.M412001200; CAPUTO A, 1993, J BIOL CHEM, V268, P17672; Davis JE, 2003, J IMMUNOL METHODS, V276, P59, DOI 10.1016/S0022-1759(03)00077-2; de Haar Susanne F, 2004, Hum Mutat, V23, P524, DOI 10.1002/humu.9243; GRIFFITHS GM, 1993, J CELL BIOL, V120, P885, DOI 10.1083/jcb.120.4.885; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; Kaiserman D, 2006, J CELL BIOL, V175, P619, DOI 10.1083/jcb.200606073; Leiting B, 2003, BIOCHEM J, V371, P525, DOI 10.1042/BJ20021643; LOBE CG, 1986, SCIENCE, V232, P858, DOI 10.1126/science.3518058; Maes MB, 2005, BIOCHEM J, V386, P315, DOI 10.1042/BJ20041156; Methot N, 2007, J BIOL CHEM, V282, P20836, DOI 10.1074/jbc.M702615200; Pham CTN, 2004, J IMMUNOL, V173, P7277, DOI 10.4049/jimmunol.173.12.7277; Pham CTN, 1999, P NATL ACAD SCI USA, V96, P8627, DOI 10.1073/pnas.96.15.8627; Prakash MD, 2009, IMMUNOL CELL BIOL, V87, P249, DOI 10.1038/icb.2008.98; SALVESEN G, 1990, BIOCHEMISTRY-US, V29, P5304, DOI 10.1021/bi00474a013; SHI LF, 1992, J EXP MED, V175, P553, DOI 10.1084/jem.175.2.553; Simon MM, 1997, J EXP MED, V186, P1781, DOI 10.1084/jem.186.10.1781; SMYTH MJ, 1995, J IMMUNOL, V154, P6299; Sun J, 2001, J BIOL CHEM, V276, P15177, DOI 10.1074/jbc.M006645200; Sun JR, 1999, BIOCHEM BIOPH RES CO, V261, P251, DOI 10.1006/bbrc.1999.0989; Sutton VR, 2007, J CELL BIOL, V176, P425, DOI 10.1083/jcb.200609077; Sutton VR, 1997, J IMMUNOL, V158, P5783; YANNELLI JR, 1986, J IMMUNOL, V136, P377	26	53	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20514	20519		10.1074/jbc.M109.094573	http://dx.doi.org/10.1074/jbc.M109.094573			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20435891	Green Published, hybrid			2022-12-27	WOS:000279228600012
J	Raska, M; Takahashi, K; Czernekova, L; Zachova, K; Hall, S; Moldoveanu, Z; Elliott, MC; Wilson, L; Brown, R; Jancova, D; Barnes, S; Vrbkova, J; Tomana, M; Smith, PD; Mestecky, J; Renfrow, MB; Novak, J				Raska, Milan; Takahashi, Kazuo; Czernekova, Lydie; Zachova, Katerina; Hall, Stacy; Moldoveanu, Zina; Elliott, Matt C.; Wilson, Landon; Brown, Rhubell; Jancova, Dagmar; Barnes, Stephen; Vrbkova, Jana; Tomana, Milan; Smith, Phillip D.; Mestecky, Jiri; Renfrow, Matthew B.; Novak, Jan			Glycosylation Patterns of HIV-1 gp120 Depend on the Type of Expressing Cells and Affect Antibody Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; N-LINKED GLYCOSYLATION; BROADLY NEUTRALIZING ANTIBODIES; RESONANCE MASS-SPECTROMETRY; ENVELOPE GLYCOPROTEIN; V3 LOOP; IMMUNE-RESPONSES; O-GLYCOSYLATION; CARBOHYDRATE EPITOPES; IGA NEPHROPATHY	Human immunodeficiency virus type 1 (HIV-1) entry is mediated by the interaction between a variably glycosylated envelope glycoprotein (gp120) and host-cell receptors. Approximately half of the molecular mass of gp120 is contributed by N-glycans, which serve as potential epitopes and may shield gp120 from immunerecognition. The role of gp120 glycans in the host immune response to HIV-1 has not been comprehensively studied at the molecular level. We developed a new approach to characterize cell-specific gp120 glycosylation, the regulation of glycosylation, and the effect of variable glycosylation on antibody reactivity. A model oligomeric gp120 was expressed in different cell types, including cell lines that represent host-infected cells or cells used to produce gp120 for vaccination purposes. N-Glycosylation of gp120 varied, depending on the cell type used for its expression and the metabolic manipulation during expression. The resultant glycosylation included changes in the ratio of high-mannose to complex N-glycans, terminal decoration, and branching. Differential glycosylation of gp120 affected envelope recognition by polyclonal antibodies from the sera of HIV-1-infected subjects. These results indicate that gp120 glycans contribute to antibody reactivity and should be considered in HIV-1 vaccine design.	[Jancova, Dagmar] Palacky Univ, Dept Immunol, Olomouc 77100, Czech Republic; [Vrbkova, Jana] Palacky Univ, Dept Math Anal & Applicat Math, Olomouc 77100, Czech Republic; [Raska, Milan; Takahashi, Kazuo; Hall, Stacy; Moldoveanu, Zina; Elliott, Matt C.; Brown, Rhubell; Tomana, Milan; Mestecky, Jiri; Novak, Jan] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Wilson, Landon; Barnes, Stephen] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham, AL 35294 USA; [Smith, Phillip D.; Mestecky, Jiri] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Renfrow, Matthew B.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; Vet Affairs Med Ctr, Birmingham, AL 35205 USA; [Mestecky, Jiri] Charles Univ Prague, Fac Med 1, Inst Microbiol & Immunol, Prague 12108, Czech Republic	Palacky University Olomouc; Palacky University Olomouc; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Charles University Prague	Raska, M (corresponding author), Hnevotinska 3, Olomouc 77200, Czech Republic.	raskamil@uab.edu; renfrow@uab.edu; jannovak@uab.edu	ZACHOVÁ, Kateřina/AAG-5599-2019; Raska, Milan/E-9813-2013	Raska, Milan/0000-0002-8572-7246; Renfrow, Matthew B./0000-0002-4193-7305	National Institutes of Health [DK047322, AI028147, AI083027, RR-20136, T35 HL007473, AI078477, DK054495, AI067854, AI071739]; Research Services of the Veterans Administration; Ministry of Education, Youth and Sport, Czech Republic [KONTAKT ME875, MSM 6198959223, MSM 0021620812]; University of Alabama Mucosal HIV and Immunobiology Center [DK064400]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR020136] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL007473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI028147, U19AI028147, U19AI067854, P01AI083027, U01AI028147, U01AI067854, R21AI078477, P01AI071739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047322, R24DK064400, R01DK054495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Services of the Veterans Administration; Ministry of Education, Youth and Sport, Czech Republic(Ministry of Education, Youth & Sports - Czech RepublicCzech Republic Government); University of Alabama Mucosal HIV and Immunobiology Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK047322, AI028147, AI083027, RR-20136, T35 HL007473, AI078477, DK054495, AI067854, and AI071739, the Research Services of the Veterans Administration, Grants KONTAKT ME875, MSM 6198959223, and MSM 0021620812 from the Ministry of Education, Youth and Sport, Czech Republic, and a Pilot Project University of Alabama Mucosal HIV and Immunobiology Center Grant DK064400.	Astronomo RD, 2008, J VIROL, V82, P6359, DOI 10.1128/JVI.00293-08; Balzarini J, 2007, NAT REV MICROBIOL, V5, P583, DOI 10.1038/nrmicro1707; Balzarini O, 2005, LANCET INFECT DIS, V5, P726, DOI 10.1016/S1473-3099(05)70271-1; Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Clevestig P, 2006, J GEN VIROL, V87, P607, DOI 10.1099/vir.0.81510-0; Decker JM, 2005, J EXP MED, V201, P1407, DOI 10.1084/jem.20042510; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Fauci AS, 2008, NATURE, V453, P289, DOI 10.1038/453289a; Gao F, 2003, AIDS RES HUM RETROV, V19, P817, DOI 10.1089/088922203769232610; Go EP, 2008, J PROTEOME RES, V7, P1660, DOI 10.1021/pr7006957; Gomes MM, 2008, BIOCHEMISTRY-US, V47, P11285, DOI 10.1021/bi801185b; Gray ES, 2007, J VIROL, V81, P10769, DOI 10.1128/JVI.01106-07; Grigorian A, 2007, J BIOL CHEM, V282, P20027, DOI 10.1074/jbc.M701890200; Grundner C, 2002, J VIROL, V76, P3511, DOI 10.1128/JVI.76.7.3511-3521.2002; Hanke T, 2007, J GEN VIROL, V88, P1, DOI 10.1099/vir.0.82493-0; HANSEN JES, 1991, J VIROL, V65, P6461, DOI 10.1128/JVI.65.12.6461-6467.1991; Hansen JES, 1996, ARCH VIROL, V141, P291, DOI 10.1007/BF01718400; HANSEN JES, 1990, J VIROL, V64, P2833, DOI 10.1128/JVI.64.6.2833-2840.1990; HANSEN JES, 1992, APMIS, V100, P96; Hinkula J, 2007, EXPERT REV VACCINES, V6, P203, DOI 10.1586/14760584.6.2.203; Ho YS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-14; Huang XL, 1997, BIOCHEMISTRY-US, V36, P10846, DOI 10.1021/bi9703655; Irungu J, 2008, J AM SOC MASS SPECTR, V19, P1209, DOI 10.1016/j.jasms.2008.05.010; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Klein A, 2008, ADV CLIN CHEM, V46, P51, DOI 10.1016/S0065-2423(08)00402-2; Kothe DL, 2007, VIROLOGY, V360, P218, DOI 10.1016/j.virol.2006.10.017; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Letvin NL, 2007, J VIROL, V81, P12368, DOI 10.1128/JVI.00822-07; Li HL, 2008, J IMMUNOL, V180, P4011, DOI 10.4049/jimmunol.180.6.4011; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; LI Y, 1993, J VIROL, V67, P584, DOI 10.1128/JVI.67.1.584-588.1993; Lin G, 2007, CURR HIV RES, V5, P514, DOI 10.2174/157016207782418489; Liu JY, 2007, VACCINE, V25, P2951, DOI 10.1016/j.vaccine.2006.05.081; Lu S, 2008, HUM VACCINES, V4, P449, DOI 10.4161/hv.4.6.6179; Lu S, 2006, SPRINGER SEMIN IMMUN, V28, P255, DOI 10.1007/s00281-006-0028-1; McCaffrey RA, 2004, J VIROL, V78, P3279, DOI 10.1128/JVI.78.7.3279-3295.2004; Meng G, 2002, NAT MED, V8, P150, DOI 10.1038/nm0202-150; MIZUOCHI T, 1990, J BIOL CHEM, V265, P8519; MIZUOCHI T, 1988, BIOCHEM J, V254, P599, DOI 10.1042/bj2540599; Mizuochi T, 1988, Biomed Chromatogr, V2, P260; MONTEFIORI DC, 1988, P NATL ACAD SCI USA, V85, P9248, DOI 10.1073/pnas.85.23.9248; Moore JS, 2005, AIDS, V19, P381, DOI 10.1097/01.aids.0000161767.21405.68; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Pantophlet R, 2009, J VIROL, V83, P1649, DOI 10.1128/JVI.02046-08; Pinter A, 2005, J VIROL, V79, P6909, DOI 10.1128/JVI.79.11.6909-6917.2005; Pollakis G, 2001, J BIOL CHEM, V276, P13433, DOI 10.1074/jbc.M009779200; Polzer S, 2002, VIROLOGY, V304, P70, DOI 10.1006/viro.2002.1760; Poon AFY, 2007, PLOS COMPUT BIOL, V3, P110, DOI 10.1371/journal.pcbi.0030011; Raska M, 2008, VACCINE, V26, P1541, DOI 10.1016/j.vaccine.2008.01.035; Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679; Reitter JN, 1998, J VIROL, V72, P5399, DOI 10.1128/JVI.72.7.5399-5407.1998; REITZ MS, 1994, AIDS RES HUM RETROV, V10, P1143, DOI 10.1089/aid.1994.10.1143; Renfrow MB, 2007, ANAL BIOANAL CHEM, V389, P1397, DOI 10.1007/s00216-007-1500-z; Renfrow MB, 2005, J BIOL CHEM, V280, P19136, DOI 10.1074/jbc.M411368200; Robinson HL, 2007, CLIN PHARMACOL THER, V82, P686, DOI 10.1038/sj.clpt.6100408; Rong R, 2007, J VIROL, V81, P5658, DOI 10.1128/JVI.00257-07; Sailaja G, 2007, VIROLOGY, V362, P331, DOI 10.1016/j.virol.2006.12.014; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scanlan CN, 2003, ADV EXP MED BIOL, V535, P205; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Smith O, 1997, NAT MED, V3, P372, DOI 10.1038/nm0497-372b; Smith PD, 2003, J LEUKOCYTE BIOL, V74, P642, DOI 10.1189/jlb.0503219; Tomana M, 1999, J CLIN INVEST, V104, P73, DOI 10.1172/JCI5535; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Wada Y, 2007, GLYCOBIOLOGY, V17, P411, DOI 10.1093/glycob/cwl086; Wain LV, 2007, MOL BIOL EVOL, V24, P1853, DOI 10.1093/molbev/msm110; WAINBERG MA, 1988, CAN MED ASSOC J, V138, P797; Wang S, 2008, VACCINE, V26, P1098, DOI 10.1016/j.vaccine.2007.12.024; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wolk T, 2006, MED MICROBIOL IMMUN, V195, P165, DOI 10.1007/s00430-006-0016-z; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhu XG, 2000, BIOCHEMISTRY-US, V39, P11194, DOI 10.1021/bi000432m	77	117	143	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20860	20869		10.1074/jbc.M109.085472	http://dx.doi.org/10.1074/jbc.M109.085472			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20439465	Green Published, hybrid			2022-12-27	WOS:000279228600050
J	Kresge, N; Simoni, RD; Hill, RL				Kresge, Nicole; Simoni, Robert D.; Hill, Robert L.			The Discovery of Glyoxysomes: the Work of Harry Beevers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							CASTOR BEAN ENDOSPERM; GLYOXYLATE CYCLE; CARBOHYDRATE; CONVERSION; FAT											BREIDENBACH RW, 1967, BIOCHEM BIOPH RES CO, V27, P462, DOI 10.1016/S0006-291X(67)80007-X; CHRISPEELS MJ, 2005, BIOGRAPHICAL MEMOIR, V86, P1; COOPER TG, 1969, J BIOL CHEM, V244, P3514; KORNBERG HL, 1957, BIOCHIM BIOPHYS ACTA, V26, P531, DOI 10.1016/0006-3002(57)90101-4; KORNBERG HL, 1957, NATURE, V180, P35, DOI 10.1038/180035a0	5	1	1	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20								10.1074/jbc.O110.000228	http://dx.doi.org/10.1074/jbc.O110.000228			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20464792	Green Published, hybrid			2022-12-27	WOS:000277399000004
